[{
  "_id": {
    "$oid": "69048208fb505ee7538f0422"
  },
  "note_id": "11279026-DS-5",
  "subject_id": 11279026,
  "hadm_id": 28311141,
  "note_type": "DS",
  "note_seq": 5,
  "charttime": "2136-08-29 00:00:00",
  "storetime": "2136-08-29 14:46:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: NEUROLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nHeadache\n \nMajor Surgical or Invasive Procedure:\nLumbar Puncture\n\n \nHistory of Present Illness:\n___ is a ___ year-old morbidly obese man with a long\nlist of chronic medical conditions (see below) who presents with\n___ headache. The headache has been constant for nine days. It\nhas not responded to a long list of medications given at two\ndifferent outside hospitals for presumed migraine HA disorder.\nThe headache started rather suddenly nine days ago while he was\nat an OSH for cardiac and GI workup for chest/epigastric pain.\nThis workup (at ___) was negative for PE with negative D-dimer,\nnegative for acute MI with negative troponins -- although\npulmonary hypertension and LVH were evident on echo -- and\npositive for GERD / gastric erosions on EGD, treated \nsuccessfully\nby starting a PPI and metoclopromide. They were unable to\nalleviate his headache despite attempted Tx with BDZ, narcotics,\naspirin, Fioricet, toradol, DHE, Zofran, and Imitrex. He was\ndischarged to home with a prescription for zolmitriptan 1.25mg\nq2h PRN (in addition to the PPI and Reglan), which did not help,\nand he returned to another OSH ED (___) for treatment of the\nHA. They were unable to Dx or treat his HA effectively either. \nAt\nsome point, an MRI was attempted in an outside facility with an\nopen/large-bore MRI, but his body habitus (almost 500 lbs)\nprevented it.\n\nHis headache is throbbing and pounding in quality. The location\nof the headache was initially in his mid-forehead, but soon \nafter\nextended back through primarily the left side of his head (it\ndoes not extend as far as the right temple) and it extends back\nto his neck. He says at times it feels like someone is pouding\nhis spine with a hammer. There is definite photophobia and mild\nphonophobia and, interestingly, blurred vision which during the\nexamination below, the patient described as pulsatile. There has\nbeen some nausea, no vomiting, but this does not seem to bother\nhim as much as the pain, photophobia, and blurred vision. There\nis nothing that seems to make the HA go away, not even\ntemporarily. He is still able to sleep, and it does not seem to\nawaken him from sleep, but it is present whenever he is awake. \nIV\nopiate medication (Dilaudid 1mg) \"takes the edge off\" from ___\nto ___ without actually diminishing the throbbing sensation,\nphotophobia, and pulsatile blurred vision. Besides the visual\nsymptoms listed above, he does not endorse any associated\nNeurologic deficits or changes (see ROS below).\n\nHe said that before this 9-day headache, he can only recall one\nor two headaches over the past ___ years, and neither was\nanything near as severe as this. The only prolonged or severe\nheadache he had was around the age of ___, lasted several days,\ndidn't respond to OTC analgesics, and was a/w severe nausea and\nseveral episodes of vomiting before it stopped. Thus, he does\nhave a history suspicious for migraine headache disorder, even \nif\nit has not recurred in ___ years.\n\nROS:\nOn neuro ROS, the pt denies diplopia, dysarthria, dysphagia,\nlightheadedness, vertigo, tinnitus or hearing difficulty. Denies\ndifficulties producing or comprehending speech recently (says\ngenerically he has experienced episodes of word-finding\ndifficulty in the past, but does not know the contex). Denies\nfocal weakness, numbness, parasthesiae. No bowel or bladder\nincontinence or retention. Denies incoordination.\n\nOn general review of systems, the pt denies recent fever or\nchills.  No night sweats or recent weight loss or gain. Denies\ncough, shortness of breath.  Denies current chest pain or\ntightness, palpitations.  Denies vomiting, diarrhea, \nconstipation\nor abdominal pain. No recent change in bowel or bladder habits. \nNo dysuria. Denies arthralgias or myalgias. Denies rash.\n\n \nPast Medical History:\n1. Morbid obesity (420 lbs prior to recent stay in Rehab --> 490\nlbs now; recent attempt with ?8lbs weight loss; desire for\nbariatric surgery)\n2. HTN\n3. HL\n4. OSA on BiPAP at night\n5. DM2 on Byetta (exenatide) and metformin\n6. Mood/anxiety disorder on BDZ\n7. remote h/o suicide attempt ___\n8. Asthma/COPD on steroid controller and PRN albuterol\n9. chronic LBP on oxy/oxy\n10. reported h/o MRSA+ nasal swab at OSH in ___\n11. reported h/o cellulitis in bilateral LEs and abdominal wall\n12. h/o Left foot surgically-repaired Fx\n13. ?reported h/o heart failure, with OSH echo 2wk ago noting \n60%\nEF, pulmonary hypertension, concentric LVH, and mild valvular\ndisease -- note that pt is on Lasix 80mg qWk for ___\n14. Erectile dysfunction on Cialis\n15. h/o surgical hernia repair\n\n \nSocial History:\n___\nFamily History:\n**Significant for several (four?) maternal uncles who have died\nin their late-___ or ___ of confirmed or presumed cardiac causes\n(d. ___ ; ___ s/p CABG @___ ; ___ ; ___ s/p CABG @___), a\nfew with CAD s/p CABG prior to death. Mother is alive, but\nmorbidly obese as well, with multiple medical complications. Dad\nis alive and relatively more healthy.\n\n \nPhysical Exam:\nVital signs at triage:\n98.8F   80   183/93 (140-160/50-70 at OSH ED)\nRR 16  SaO2 95% 2L NC (90% RA)\n\nGeneral: Awake, cooperative, NAD. Wearing Bipap nasal mask. c/o\nheadache. Morbidly obese body habitus. Several tattoos on all\nextremities.\nHEENT: Poorly ___ hair/beard. Normocephalic and atraumatic. No\nscleral icterus. Mucous membranes are moist. No lesions noted in\noropharynx.\nNeck: Obese and short. Supple, with full range of motion and no\nnuchal rigidity. No carotid bruits appreciated. No\nlymphadenopathy was appreciated.\nPulmonary: Lungs CTA bilaterally. Non-labored breathing, calmly\nwith BiPAP. Gynecomastia.\nCardiac: RRR, distant HS.\nAbdomen: Obese, large pannus with striae. Non-tender and\nnon-distended.\nExtremities: Warm and well-perfused. R>L 2+ pitting ___ to\nmid-shin. ___ radial, ___ DP pulses symmetric.\nSkin: several tattoos of varying level of sophistication.\n\n*****************\nNeurologic examination:\n\nMental Status exam: Grossly normal, cognitively intact.\nAwake and alert spontaneously. Oriented to person, year, month,\ndate, day of week, season, city, location, reason for treatment.\nAble to relate history without difficulty. Attentive, and able \nto\nname ___ back through ___, including # of terms for each\n___. Speech was not dysarthric. Repetition was intact. \nLanguage\nis fluent with intact repetition and comprehension, normal\nprosody, and normal affect. There were no paraphasic errors.\nNaming is intact. There was no evidence of apraxia or neglect or\nideomotor apraxia. Calculation was intact (answers seven \nquarters\nin $1.75, albeit slowly).\n\n-Cranial Nerves:\nI: Olfaction not tested.\nII: PERRL, 3 to 2mm and brisk. Central/foveal visual acuity is \nat\nleast ___ in each eye, uncorrected (as tested at bedside by\niPhone Snellen chart), although the patient noted pulsatile\nvisual blurring that obscured his view somewhat in sync with the\npounding sensations in his head.\n**Visual fields are grossly restricted peripherally in all\nquadrants.\n**Fundoscopic examination was limited by patient eye movements /\nblinking (photophobic HA); I was unable to appreciate either\nvenous pulsations or sharp/normal optic disc margins; in fact,\nthe disc margins may have been a bit blurred bilaterally, but I\ncannot state this with certainty. I did not appreciate any\narterial nicking or hemorrhages or retinal discolorations.\nIII, IV, VI: EOMs full with no nystagmus. No saccadic intrusion\nduring smooth pursuits. Normal saccades.\nV: Facial sensation intact and subjectively symmetric to light\ntouch V1-V2-V3.\nVII: No ptosis, no flattening of either nasolabial fold. Brow\nelevation is symmetric. Eye closure is strong and symmetric.\nNormal, symmetric facial elevation with smile.\nVIII: Hearing is intact to finger-rub bilaterally. Pt. said\nfinger-rub was louder on the Left, but that may have been due to\ninterference from loud BiPAP machine on the right.\nIX, X: Palate elevates symmetrically.\nXI: ___ equal strength in trapezii and SCM bilaterally.\nXII: Tongue protrusion is midline.\n\n-Motor:\nNo pronator drift, and no parietal up-drift bilaterally.\nNo tremor or fasciculations were observed. No asterixis.\nDifficult to appreciate muscle bulk due to thick overlying fat.\nTone seemed normal. No flaccidity, hypertonicity, or spasticity\nnoted.\n\n Delt Bic Tri  WE  FF  FE IO |  IP   Q   ___  ___  ___\nL  5-  5-  5-   5-  ___    4+   5    5    5   5     5\nR  ___    ___  5    4+   5    5    5   5     5\nTwo notes:\n- the \"5-\" denotes full strenght of the LUE, but not quite as\nstrong as \"my strong arm\" on the Right.\n- the \"4+\" IPs I think were more limited by body angle and\nhabitus (heavy pannus atop thighs) rather than actual weakness.\n\n-Sensory:\nNo gross deficits to light touch, pinprick, cold sensation, or\nvibratory sensation in either distal lower extremity. \nEyes-closed\nFinger-to-nose testing revealed no proprioceptive deficit (did\nnot miss nose).\n\n-Reflex examination (left; right):\nBiceps (++;++)\nTriceps  (++;++)\nBrachioradialis (++;++)\nQuadriceps / patellar (+;+)\n___ / achilles (++;++)\nPlantar response was indeterminate bilaterally (strong \nwithdrawal\nresponse; toes may have been up-going, moreso on Right, but it \nis\nnot definite).\n\n-Coordination:\nFinger-nose-finger testing with no dysmetria or intention \ntremor.\nNo dysdiadochokinesia noted on rapid-alternating hand movements\nor toe-tapping.\n\n-Gait:\nDeferred (morbidly obese pt. in ED bed on BiPAP at ___.\n\n \nPertinent Results:\n___ 09:30AM CEREBROSPINAL FLUID (CSF)  PROTEIN-40 \nGLUCOSE-94\n___ 09:30AM CEREBROSPINAL FLUID (CSF)  WBC-3 RBC-8* POLYS-0 \n___ ___ 04:50AM URINE  bnzodzpn-NEG barbitrt-POS opiates-NEG \ncocaine-NEG amphetmn-NEG mthdone-NEG\n___ 02:07AM   K+-4.2\n___ 02:00AM URINE  COLOR-Yellow APPEAR-Clear SP ___\n___ 02:00AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-2* PH-7.0 \nLEUK-NEG\n___ 01:55AM   GLUCOSE-145* UREA N-10 CREAT-0.7 SODIUM-141 \nPOTASSIUM-4.4 CHLORIDE-99 TOTAL CO2-32 ANION GAP-14\n___ 01:55AM   CRP-43.5*\n___ 01:55AM   WBC-15.9* RBC-4.43* HGB-12.1* HCT-37.2* \nMCV-84 MCH-27.4 MCHC-32.7 RDW-15.9*\n___ 01:55AM   NEUTS-73.9* ___ MONOS-4.4 EOS-2.8 \nBASOS-0.5\n___ 01:55AM   PLT COUNT-258\n___ 01:55AM   ___ PTT-22.0 ___\n___ 01:55AM   SED RATE-35*\n \nBrief Hospital Course:\nMr. ___ was admitted to the neurology service on ___ \nwith subacute headache which worsened over the course of 10 days \nto a severe pounding headache.  He had an LP which showed that \nhe did not have a meningitis. Unfortunately, an opening pressure \ncould not be obtained as an LP could not be done in the lateral \ndecubitus position because of technical reasons, and could not \nbe done in the interventional radiology fluoroscopy suite.  He \nhad a CT head with vessel imaging (CTA/CTV) which did not show \nany abnormalities or evidence of  venous sinus thrombosis.  He \nwas treated for presumed status migrainous with Medrol taper.  \nHe also received a Magnesium infusion. He initially improved, \nbut then had more severe headache as well as visual symptoms.  A \nfundoscopic examination was limited as he could not tolerate it, \nhowever there was no optic disk abnormalities seen.  An LP was \nattempted on the floor but was unsuccessful.  For technical \nreasons related to his body weight and size, the LP could not be \ndone in the interventional radiology suite with fluoroscopic \nguidance. Because we could not obtain an opening pressure and \nbecause symptoms did not completely improve and idiopathic \nintracranial hypertension could not be excluded, a decision was \nmade to initiate empiric treatment with Acetazolamide for \nincreased intracranial pressure (pseudotumor cerebri). \nCorresponding to this possibility was some blurring in the \ninferior nasal field of the left eye. His headache did improve \nafter starting this.  He was also given muscle relaxants to \ntreat a muscle spasm component to his pain, which was evident on \npalpation.\n\nHe was continued on all other home medications including his \nstanding oxycontin and prn oxycodone for chronic backpain.  His \nMetformin was held as he received contrast, but was reinitiated \nupon discharge.  Blood sugars were monitored and he was \nmaintained on a sliding insulin scale.  \n\nWe recommend limiting analgesics, avoiding nicotine, and formal \nvisual field testing.  If headaches persist or worsen, chronic \npain medications such as Amitriptyline or Topamax could be \nconsidered.\n\nWe would also recommend that weight loss measures, including \npossible bariatric surgery, be expedited to minimize the risk of \npermanent visual compromise.  A letter was given to Mr. ___ to \nthis effect. \n \nMedications on Admission:\nMedications:\n1. Simvastatin 80mg qhs\n2. Zetia 10mg daily\n3. Lasix 80mg qweekly\n4. Advair 500/50 bid\n5. metformin 1000mg bid\n6. Byetta (exenatide) s.c. 10mcg bid\n7. Aspirin 81mg daily\n8. Albuterol nebs q4h PRN\n9. Albuterol HFA inh ___ puffs q4h PRN\n10. MVI daily\n11. Cialis 10mg PRN\n12. Oxycontin, dose uncertain for LBP\n13. Oxycodone 30mg q6h PRN for LBP\n\n \nDischarge Medications:\n1. simvastatin 40 mg Tablet Sig: Two (2) Tablet PO QHS (once a \nday (at bedtime)).  \n2. Zetia 10 mg Tablet Sig: One (1) Tablet PO once a day.  \n3. Lasix 80 mg Tablet Sig: One (1) Tablet PO once a week.  \n4. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n5. metformin 1,000 mg Tablet Sig: One (1) Tablet PO twice a day. \n \n6. Byetta 10 mcg/0.04 mL Pen Injector Sig: One (1)  Subcutaneous \ntwice a day.  \n7. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \nPO DAILY (Daily).  \n8. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \n___ Puffs Inhalation Q4H (every 4 hours) as needed for SOB.  \n9. albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for \nNebulization Sig: One (1)  Inhalation Q4H (every 4 hours) as \nneeded for SOB.  \n10. multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n11. oxycodone 40 mg Tablet Extended Release 12 hr Sig: Three (3) \nTablet Extended Release 12 hr PO Q12H (every 12 hours) as needed \nfor chronic pain (home medication/dose).  \n12. miconazole nitrate 2 % Cream Sig: One (1) Appl Topical BID \n(2 times a day).\nDisp:*1 tube* Refills:*2*\n13. miconazole nitrate 2 % Powder Sig: One (1) Appl Topical TID \n(3 times a day) as needed for yeast infection.  \n14. cyclobenzaprine 10 mg Tablet Sig: 0.5 Tablet PO TID (3 times \na day) as needed for muscle spasm.\nDisp:*30 Tablet(s)* Refills:*0*\n15. oxycodone 5 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6 \nhours) as needed for low back pain.  \n16. acetazolamide 250 mg Tablet Sig: One (1) Tablet PO Q12H \n(every 12 hours).\nDisp:*60 Tablet(s)* Refills:*1*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nStatus migrainosus\n\n \nDischarge Condition:\nWe feel that there is a field cut in the left nasal visual \nfield.\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou were admitted to ___ neurology service with severe \nheadache for 9 days that did not respond to multiple \nmedications.  You had a lumbar puncture in the emergency room \nand your spinal fluid was negative for meningitis. You had a \nhead CT scan with vessel imaging which did not show any clots.  \nYou were started on high dose oral steroids to treat presumed \n\"status migrainous\" which is a persistent migraine headache.  \nYou were also given a magnesium infusion to help improve your \nheadache. It also seems that you had a muscle spasm component to \nyour pain, which can be relieved with hot packs. \n\nBecause of your visual symptoms, and your risk of \"pseudotumor \ncerebri,\" you were started Acetazolamide for presumed increased \nintracranial pressure.  \n\nYou will require labs prior to your appointment in the Neurology \nClinic.  You will also need to see Ophthalmology for formal \nvisual field testing. This has been arranged for you.  If you \nwould like this to be done in ___, you can call your \nPCP to help you coordinate these tests.  \n\nWeight loss will be a very important component to help improve \nyour symptoms. We have provided you with a letter expressing our \nconcerns about this diagnosis to help have your bariatric \nsurgical evaluation expedited.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048208fb505ee7538f0423"
  },
  "note_id": "11279026-DS-6",
  "subject_id": 11279026,
  "hadm_id": 29379122,
  "note_type": "DS",
  "note_seq": 6,
  "charttime": "2136-12-27 00:00:00",
  "storetime": "2136-12-27 19:06:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nheadache and syncope\n \nMajor Surgical or Invasive Procedure:\nNone.\n \nHistory of Present Illness:\n___ morbid obesity, HTN, HL, OSA, DM2, depression, asthma, \nhistory of HF previously admitted here with severe headache and \ngiven the presumptive diagnosis of pseudotumor cerebri (an \nopening pressure was never able to be obtained, he did have an \nunremarkable CTA/CTV, discharged on acetazolamide), now \ncomplains of severe headache times the last 3 days, gradual \nonset not similar to prior headache as current is global and \nprior was more frontal. In addition he reports 2 episodes of \nsyncope, yesterday and today.  \nHe was evaluated in the ___ ED for headache on ___ \nstarting gradual onset about 3 days ago with waxing/waning \nsymptoms that is global. He denies fever, chills, photophobia. \nOf note, he has not been taking his acetazolamide. OSH labs were \nperformed and in chart for reference - show WBC ~ 15.  \nFor snycope, when he attempted to get off the couch, he \"passed \nout.\" He was unconscious for an unknown amount of time but \nreported left sided chest palpitations and worsening headache. \nHe also reported that one of his cousins saw his face was \ndroopy. He also reports various tingling and numbness that is \nalso ___. He has never \"blacked out\" before. He did not have \nthis with his prior headache or any time in the past. He does \ndescribe feeling slightly lightheaded prior to syncope. He \ndenies any apparent trauma from the syncope, no neck pain. He \nhad no tongue biting or incontinence. He went to ___ \n___, however they were unable to fit into their scanners, \nso he was transferred here.  \n.  \nIn the ED, initial VS: ___ 155/102 20 93%. Physical exam \nlimited secondary to habitus. EKG SR 83, NA/NI, sub-mm STE aVF, \nno STEMI. He was given toradol 30 mg IV, morphine 8 mg IV, \ncompazine 10 mg IV, benadryl 25 mg IV for headache. Labs \nsignificant for WBC 16.5, Hgb 12.8. CT head showed no acute \nintracranial process. Prelim CXR with no acute abnormality. \nNeuro was consulted and said to admit to medicine for sycnope \n___. They will follow for headache.  \nVS prior to transfer were 98.4 83 ___ 18 94% on BiPap  \n.  \nOn the floor, he complianed of moderate headache. He appeared \nfatigue and hungry. He was caught chewing tobacco.  \n.  \nROS: Denies fever, night sweats, vision changes, rhinorrhea, \ncongestion, sore throat, cough, abdominal pain, nausea, \nvomiting, diarrhea, constipation, BRBPR, melena, hematochezia, \ndysuria, hematuria.  \n+ subjective chills, intermittent chest discomfort over past few \ndays\n \nPast Medical History:\n1. Morbid obesity (420 lbs prior to recent stay in Rehab --> 490 \n \nlbs now; recent attempt with ?8lbs weight loss; desire for  \nbariatric surgery)  \n2. HTN  \n3. HL  \n4. OSA on BiPAP at night  \n5. DM2 on Byetta (exenatide) and metformin  \n6. Mood/anxiety disorder on BDZ  \n7. remote h/o suicide attempt ___  \n8. Asthma/COPD on steroid controller and PRN albuterol  \n9. chronic LBP on oxy/oxy  \n10. reported h/o MRSA+ nasal swab at OSH in ___  \n11. reported h/o cellulitis in bilateral LEs and abdominal wall  \n\n12. h/o Left foot surgically-repaired Fx  \n13. ?reported h/o heart failure, with OSH echo 2wk ago noting  \n60%  \nEF, pulmonary hypertension, concentric LVH, and mild valvular  \ndisease -- note that pt is on Lasix 80mg qWk for ___  \n14. Erectile dysfunction on Cialis  \n15. h/o surgical hernia repair\n \nSocial History:\n___\nFamily History:\nMaternal uncles died in their late-___ or ___ of cardiac causes\n(d. ___ ; ___ s/p CABG @33 ; ___ ; ___ s/p CABG @38) \nMother is alive, but morbidly obese with multiple medical \nproblems \nDad is alive, relatively healthy\n\n \nPhysical Exam:\nON ADMISSION:\nVS: T 98.4 BP 150/92 HR 74 RR 22 poX 93 RA Glc 170  \nGENERAL: Obese, NAD  \nHEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear.  \nNECK: Supple  \nHEART: Distant  \nLUNGS: Distant  \nABDOMEN: Obese, pannus limiting exam  \nEXTREMITIES: 1+ pretibial edema  \nLYMPH: No cervical LAD.  \nNEURO: Awake, A&Ox3, CNs II-XII intact, muscle grossly intact\n.\nON DISCHARGE:\nO:VS: Tc:98.1 Tm:98.3 BP:137/79(110-157/49-104) HR:70(64-76) \nRR:20 O2Sat:95BiPAP  \nGENERAL: Obese, NAD  \nHEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear.  \nNECK: Supple  \nHEART: Distant  \nLUNGS: Distant  \nABDOMEN: Obese, pannus limiting exam  \nEXTREMITIES: 1+ pretibial edema  \nLYMPH: No cervical LAD.  \nNEURO: Awake, A&Ox3, CNs II-XII intact, muscle grossly intact\n \nPertinent Results:\nON ADMISSION:\n___ 11:15PM BLOOD WBC-16.5* RBC-4.91 Hgb-12.8* Hct-39.5* \nMCV-80* MCH-26.2* MCHC-32.5 RDW-16.1* Plt ___\n___ 11:15PM BLOOD Neuts-76.1* ___ Monos-2.9 Eos-1.3 \nBaso-0.5\n___ 11:15PM BLOOD Glucose-190* UreaN-12 Creat-1.0 Na-139 \nK-4.3 Cl-99 HCO3-31 AnGap-13\n.\nSIGNIFICANT INTERVAL LABS:\n___ 07:25PM BLOOD CK(CPK)-37*\n___ 07:10AM BLOOD CK(CPK)-32*\n___ 07:25PM BLOOD CK-MB-1 cTropnT-<0.01\n___ 12:35PM BLOOD CK-MB-1 cTropnT-<0.01\n___ 07:10AM BLOOD CK-MB-1 cTropnT-<0.01\n___ 07:10AM BLOOD Calcium-8.7 Phos-3.9 Mg-1.8\n.\nON DISCHARGE:\n___ 06:40AM BLOOD WBC-16.4* RBC-4.82 Hgb-12.9* Hct-39.7* \nMCV-82 MCH-26.8* MCHC-32.5 RDW-16.0* Plt ___\n___ 06:40AM BLOOD Glucose-200* UreaN-16 Creat-1.0 Na-135 \nK-4.0 Cl-100 HCO3-25 AnGap-14\n___ 06:40AM BLOOD Calcium-9.1 Phos-3.1 Mg-2.0\n.\nSTUDIES:\n___ EKG: Sinus rhythm. Rightward axis. Low voltage. No \nprevious tracing available for comparison.  \nRate PR QRS QT/QTc P QRS T \n 83 ___ 39 82 62\n.\n___ CXR: Chronic elevation of the right hemidiaphragm. \nCardiomegaly, with elevated central venous pressure. No \npneumonia or frank pulmonary edema. \n.\n___ EKG: Sinus rhythm. Low voltage. Otherwise, normal \ntracing. Compared to the previous tracing of ___ no \nsignificant change.  \nRate PR QRS QT/QTc P QRS T \n 76 156 92 388/416 46 71 67\n.\n___ CT HEAD NON-CON:  No acute intracranial process. Please \nnote if clinical concern is high for mass, then contrast MR is \nmore sensitive.\n.\n___ EEG:  This is a normal mostly drowsy or asleep EEG. No \nfocal \nabnormalities or epileptiform discharges are present. If \nclinically \nindicated, continuous EEG recording with automated spike and \nseizure \ndetection algorithms may provide additional diagnostic \ninformation.\n \nBrief Hospital Course:\nThis is the brief hospital course for a ___ year-old morbidly \nobese gentleman who presented with headache and syncope in the \nsetting of chronic HTN, DMII, OSA, and a recent \"possible,\" \ndiagnosis of pseudotumor cerebri. The following is a problem \nlist for the patient and the interventions which were done \nduring this admission.\n.\nSyncope:\nNormal EEG ruled out seizure. Cardiac etiologies were ruled out \nwith normal telemetry, troponins, and numerous EKGs. His \ncomplaints of dizziness upon standing were suggestive of \northostatic hypotension as the cause of his syncope. \nOrthostatics normal during hospital stay, most likely dehydrated \nfrom acetazolamide use at home. \n-Encouraged PO intake on discharge\n.\nHeadache: Neurology and ophthomology consults recommended \nfull,complete ___ of pseudotumor cerebri. Due to patient's \nbody habitus, LP for opening pressure and MRI for rule out \nlesion/infection could not be done here. Visual field testing \nshould be performed as an outpatient.  \n-Continue Acetazolamide 500 mg BID as outpatient.\n-Follow-up with PCP in ___ for referral to neurologist \nand ophthomologist for visual field testing and management of \npseudotumor cerebri as well as query into leukocytosis baseline.\n.\nLeukocytosis: No evidence of infection, afebrile entire hospital \nstay, no cough, negative UA. Patient with leukocytosis at \nbaseline.\n.\nChronic Low Back Pain: on narcotics for pain control: home \nOxycotin and Oxycodone\n.\nOSA: BiPAP almost constantly while here, on it at home as well  \n.  \nLower extremity edema: Non-pitting on lower extremities, on home \nlasix  \n. \nHTN: Blood pressure under control, continue Metoprolol at home \nand lasix\n. \nHL: Started Atorvastin 80 mg, continued Zetia\n.  \nObesity: Morbid obesity, given fall precautions, nutrition \nconsult \n. \nAsthma/COPD: Appears stable, continued home advair, albuterol  \n.\nDM2: Continue home Exenatide and Metformin\n.\nAn appointment with the patient's PCP was scheduled for the \nfollowing week. He was told and encouraged to attend to receive \na neurologist and ophthomologist referral. The patient was also \nencouraged to remind his PCP to ___ his leukocytosis in \nfurther detail.\n \nMedications on Admission:\n1. simvastatin 40 mg Tablet Sig: Two (2) Tablet PO QHS (once a  \nday (at bedtime)).  \n2. Zetia 10 mg Tablet Sig: One (1) Tablet PO once a day.  \n3. Lasix 40 mg Tablet Sig: One (1) Tablet PO once a week.  \n4. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig:  \n\nOne (1) Disk with Device Inhalation BID (2 times a day).  \n5. metformin 1,000 mg Tablet Sig: One (1) Tablet PO twice a day. \n \n6. Byetta 10 mcg/0.04 mL Pen Injector Sig: One (1) Subcutaneous  \n\ntwice a day.  \n7. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable  \n\nPO DAILY (Daily).  \n8. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig:  \n___ Puffs Inhalation Q4H (every 4 hours) as needed for SOB.  \n9. albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for  \nNebulization Sig: One (1) Inhalation Q4H (every 4 hours) as  \nneeded for SOB.  \n10. multivitamin Tablet Sig: One (1) Tablet PO DAILY  \n(Daily).  \n11. oxycodone 40 mg Tablet Extended Release 12 hr Sig: Three (3) \n \nTablet Extended Release 12 hr PO Q12H (every 12 hours) as needed \n \nfor chronic pain (home medication/dose).  \n12. miconazole nitrate 2 % Cream Sig: One (1) Appl Topical BID  \n(2 times a day).  \nDisp:*1 tube* Refills:*2*  \n13. miconazole nitrate 2 % Powder Sig: One (1) Appl Topical TID  \n\n(3 times a day) as needed for yeast infection.  \n14. cyclobenzaprine 10 mg Tablet Sig: 0.5 Tablet PO TID (3 times \n \na day) as needed for muscle spasm.  \nDisp:*30 Tablet(s)* Refills:*0*  \n15. oxycodone 5 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6  \nhours) as needed for low back pain.\n \nDischarge Medications:\n1. ezetimibe 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n2. furosemide 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n3. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n4. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \n___ Puffs Inhalation Q6H (every 6 hours) as needed for SOB.  \n5. oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 \nhours) as needed for back pain.\nDisp:*3 Tablet(s)* Refills:*0*\n6. oxycodone 40 mg Tablet Extended Release 12 hr Sig: Three (3) \nTablet Extended Release 12 hr PO Q12H (every 12 hours).  \n7. acetazolamide 250 mg Tablet Sig: Two (2) Tablet PO BID (2 \ntimes a day).\nDisp:*120 Tablet(s)* Refills:*2*\n8. atorvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).\nDisp:*30 Tablet(s)* Refills:*2*\n9. metformin 1,000 mg Tablet Sig: One (1) Tablet PO twice a day. \n \n10. Byetta 10 mcg/0.04 mL Pen Injector Sig: One (1) SC \nSubcutaneous twice a day.  \n11. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \nPO once a day.  \n12. albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for \nNebulization Sig: One (1) neb Inhalation every ___ hours as \nneeded for shortness of breath or wheezing.  \n13. Multiple Vitamins     Tablet Sig: One (1) Tablet PO once a \nday.  \n14. cyclobenzaprine 10 mg Tablet Sig: 0.5 Tablet PO three times \na day as needed for muscle spasms.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary: likely Pseudotumor Cerebri \nSecondary : Dehydration\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nIt was a pleasure taking care of you at ___ \n___. You were admitted for headache and fainting \nspells. Neurology was consulted and determined that you most \nlikely have pseudotumor cerebri but additional tests are needed \nto make a diagnosis. You should follow up with your primary care \nphysician on ___ at 11:40 so that he can refer you \nto a neurologist and set up visual field testing with an eye \ndoctor, ___.  \n\nAdditionally, we tested you for possible causes of your fainting \nspells and determined that most likely you were dehydrated from \ntaking the diuretic acetazolamide for you headache. You had an \nEEG which did not show signs of a seizure. We encourage you to \nincrease your intake of water to stay hydrated while taking this \nmedication. \n\nWe have made the following changes to your medications:\n- Change Acetazolamide to 500 mg twice a day\n- Change Simvastatin to Atorvastatin 40 mg daily\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048208fb505ee7538f0424"
  },
  "note_id": "11279026-DS-7",
  "subject_id": 11279026,
  "hadm_id": 24259248,
  "note_type": "DS",
  "note_seq": 7,
  "charttime": "2140-04-23 00:00:00",
  "storetime": "2140-04-29 21:41:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nAbdominal Pain\n \nMajor Surgical or Invasive Procedure:\nEGD\n\n \nHistory of Present Illness:\nACUTE CARE SURGERY CONSULT HISTORY & PHYSICAL\n\nCC: abdominal pain\n\nHPI: Mr. ___ is a ___ man with morbid obesity and\nmultiple associated comorbidities who was transferred from an \nOSH\ntoday for cholecystitis. \n\nHe was in his USOH until two weeks ago he started having\nepigastric pain radiating to the right side that was a/w nausea\nand vomiting. He went to ___ where he was found to\nhave a WBC of 15k, and elevated alk phos but otherwise normal\nLFTs/lipase. A RUQ US was non-diagnostic given his body habitus\nand a CT was unable to be performed, also ___ to his body\nhabitus. He was thus transferred to ___ \nwhere\nhe underwent CT abdomen/pelvis which showed moderate\nhepatosplenomegaly but no evidence of cholecystitis. he \ncontinued\nto have pain so a HIDA was ordered but could not be performed,\nagain ___ his weight. He was thus discharged on a 7-day course \nof\naugmentin and instructions to follow-up at ___\nfor a HIDA.\n\nIn the interim, his symptoms have progressed over the last 4 \ndays\nto the point where he can only tolerate liquids. He returned to\n___ today where his WBC was found to be 13.7, TB 0.5, APhos 120,\nALT 16, AST 8, lipase 47. He underwent repeat CT (the images and\nofficial reports of which were not sent with him), which\nreportedly revealed findings concerning for cholecystitis. \n\nDenies fevers, chills, diarrhea, changes in bowel habits, chest\npain, SOB, urinary freq/urgency, dysuria\n \nPast Medical History:\nmorbid obesity, IDDM, HTN, HPL, ?CHF, pulmonary HTN, asthma,\nOSA (on bipap at night), COPD, chronic back pain, mood/anxiety\ndisorder, hx of SI/SA, erectile dysfunction\n \nSocial History:\n___\nFamily History:\nMaternal uncles died in their late-___ or ___ of cardiac causes\n(d. ___ ; ___ s/p CABG @___ ; ___ ; ___ s/p CABG @___) \nMother is alive, but morbidly obese with multiple medical \nproblems \nDad is alive, relatively healthy\n\n \nPhysical Exam:\nADMISSION PHYSICAL:\n==============\nVS - 98.7 66 140/76 16 92% 2L  \nGEN - NAD, awake/alert\nHEENT - NCAT, EOMI, no scleral icterus, MMM\n___ - RRR, distant heart sounds ___ body habitus\nPULM - diminished breath sounds at bases, no W/R/R\nABD - morbidly obese, soft, nondistended; severe epigastric and\nRUQ TTP with ___\nEXTREM - warm, non-pitting edema\n\nDISCHARGE PHYSICAL:\n==============\nVitals: T 98.3, BP 138/82, P 82, R 20, O2 97 on CPAP\nGeneral: Alert, oriented, no acute distress\nHEENT: Sclera anicteric, MMM, oropharynx clear\nLungs: Limited by body habitus. Otherwise CTA b/l\nCV: Limited by body habitus. RRR, no appreciable m/r/g, faint \nS1/S2\nAbdomen: obese, soft, tender especially over epigastric/RUQ, \nnon-distended, bowel sounds present, no rebound tenderness or \nguarding\nExt: Warm, well perfused, 1+ ___ edema\n \nPertinent Results:\nADMISSION LABS:\n===========\n___ 07:20PM BLOOD WBC-12.9* RBC-4.59* Hgb-12.8* Hct-39.2* \nMCV-86 MCH-28.0 MCHC-32.7 RDW-15.7* Plt ___\n___ 07:20PM BLOOD Neuts-75.5* Lymphs-17.1* Monos-4.2 \nEos-2.4 Baso-0.7\n___ 07:20PM BLOOD ___ PTT-30.0 ___\n___ 07:20PM BLOOD ALT-11 AST-12 AlkPhos-112 TotBili-0.5\n___ 07:20PM BLOOD Lipase-29\n___ 03:24AM BLOOD cTropnT-<0.01\n___ 07:20PM BLOOD Albumin-3.7\n___ 04:15AM BLOOD Calcium-9.2 Phos-3.6 Mg-1.9\n___ 07:28PM BLOOD Lactate-0.8\n\nDISCHARGE LABS:\n===========\n___ 07:00AM BLOOD WBC-12.2* RBC-4.65 Hgb-12.7* Hct-40.0 \nMCV-86 MCH-27.4 MCHC-31.9 RDW-15.8* Plt ___\n___ 07:00AM BLOOD Glucose-212* UreaN-11 Creat-0.8 Na-138 \nK-4.6 Cl-98 HCO3-32 AnGap-13\n\nMICROBIOLOGY:\n==========\n___ 7:15 pm BLOOD CULTURE\n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___: \n      STAPHYLOCOCCUS EPIDERMIDIS.    FINAL SENSITIVITIES. \n         COAG NEG STAPH does NOT require contact precautions, \nregardless of\n         resistance. \n         Oxacillin RESISTANT Staphylococci MUST be reported as \nalso\n         RESISTANT to other penicillins, cephalosporins, \ncarbacephems,\n         carbapenems, and beta-lactamase inhibitor combinations. \n\n         Rifampin should not be used alone for therapy. \n         This isolate is presumed to be resistant to clindamycin \nbased on\n         the detection of inducible resistance . \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             STAPHYLOCOCCUS EPIDERMIDIS\n                             |   \nCLINDAMYCIN-----------       R\nERYTHROMYCIN----------   =>8 R\nGENTAMICIN------------ <=0.5 S\nLEVOFLOXACIN----------     4 R\nOXACILLIN-------------   =>4 R\nRIFAMPIN-------------- <=0.5 S\nVANCOMYCIN------------     1 S\n\n   Aerobic Bottle Gram Stain (Final ___: \n      Reported to and read back by ___. ___ ON ___ AT 0105. \n\n      GRAM POSITIVE COCCI IN CLUSTERS.\n\n___ 5:35 am BLOOD CULTURE\n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH.\n\nPERTINENT STUDIES:\n=============\n\nHIDA SCAN (___)\nFINDINGS:\nSerial images over the abdomen show homogeneous uptake of tracer \ninto the\nhepatic parenchyma.\nAt 30 minutes, the gallbladder is visualized.\nIMPRESSION:  No evidence of acute cholecystitis.\n\nEKG (___)\nProbable sinus rhythm. Generalized low voltage. Vertical axis. \nSomewhat late\nR wave progression. Compared to the previous tracing of ___ \nthe rate is\nnow slower. Artifact on the previous tracing precludes further \ncomparison.\nClinical correlation is suggested.\n IntervalsAxes\n___\n___\n\nCXR (___)\nIMPRESSION: \nNo relevant change. Low lung volumes. Elevation of the right \nhemidiaphragm.\nMild cardiomegaly. Minimal fluid overload but no overt pulmonary \nedema.  No\npleural effusions.  No pneumonia.\n\nCT ABD/PELVIS W CONTRAST (___)\nIMPRESSION:\n1. No acute intra-abdominal process.\n2. Hepatomegaly with elevation right hemidiaphragm.\n3. Bilateral femoral head avascular necrosis.\n\nEGD (___) and PATHOLOGY\nMildly irregular z-line was noted - this was not biopsied due to \npatient discomfort during the procedure\nErythema and friability were noted throughout the stomach body \nand antrum compatible with gastritis. (biopsy)\nSeveral small erosions were appreciated throughout the stomach \nbody. (biopsy)\nNormal mucosa in the duodenum\nOtherwise normal EGD to third part of the duodenum\n\nStomach Biopsy Pathology: \nFocal features consistent with chemical type injury.\n \nBrief Hospital Course:\nPatient is a ___ with a history of obesity, COPD, OSA on CPAP, \nIDDM, CHF who presented from an OSH with epigastric/RUQ \nabdominal pain for a HIDA scan. HIDA scan and CT abd/pelvis were \nboth negative. Patient then had an EGD which showed gastritis. \nCardiology was consulted to rule out atypical angina. EKG was \nnormal and troponins were negative.\n\n#Abdominal pain - based on EGD, most likely due to gastritis. \nBiopsy results were pending as was H. pylori testing. We would \nalso consider narcotic bowel syndrome given long term opioid \nuse. We increased the patient's pantoprazole to 40 mg PO BID \nwith some improvement in symptoms.\n\n#Cardiac workup - We did not feel this was atypical angina. \nCardiology recommended continuing statin and aspirin as well as \nconsidering metoprolol succinate 25 mg daily provided the \npatient's HR is stable in the 70-80s (he was often in the ___ \nhere).\n\n#Staph epidermidis bacteremia - Patient clinically did not \nappear bacteremic and does not have an indwelling line or valve \nthat would merit treatment. Antibiotics were discontinued prior \nto discharge.\n\n#CHF\n- Continue furosemide 40 mg QAM and QNOON\n\n#IDDM - At home takes insulin 70/30 100U QAM, ___ 90U QPM, and \nmetformin 1000 mg BID. Patient to resume these meds on discharge\n- Held home metformin\n- Given decreased PO, now getting 70/30 50U QAM and QPM and ISS\n\n#OSA\n- Continue home CPAP\n\n#COPD\n- Continue home tiotropium, albuterol, fluticasone-salmeterol \n500/50\n\n#Back pain\n- Continue home oxycodone 30 mg Q4H PRN pain (max 4 per day), \noxycontin 80 mg PO Q12H\n\n==TRANSITIONAL ISSUES==\n[ ] patient may benefit from metoprolol succinate 25 mg PO daily \nif his HR is consistently > 70 given is his risk for \ncardiovascular disease\n[ ] our GI department should contact the patient with the \nresults from his EGD biopsy\n[ ] chronic pain management - patient was given 2 days worth of \nhome pain meds upon discharge, as he reported missing an \nappointment to fill these meds when initially hospitalized and \nthe time frame was consistent with the last reported Rx from PCP \noffice\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 81 mg PO DAILY \n2. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n3. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath or \nwheezing \n4. TraZODone 100 mg PO HS \n5. MetFORMIN (Glucophage) 1000 mg PO BID \n6. Atorvastatin 40 mg PO DAILY \n7. Furosemide 80 mg PO BID \n8. 70/30 100 Units Breakfast\nHumalog ___ 90 Units BedtimeMax Dose Override Reason: Home \nregimen\n\n9. Lorazepam 2 mg PO Q8H:PRN anxiety \n10. OxyCODONE SR (OxyconTIN) 80 mg PO Q12H \n11. OxycoDONE (Immediate Release)  30 mg PO Q4H:PRN pain \n12. carisoprodol 350 mg oral BID:PRN pain \n13. Pantoprazole 40 mg PO Q24H \n14. Aluminum-Magnesium Hydrox.-Simethicone 10 mL PO QID:PRN \nstomach discomfort \n15. Docusate Sodium 100 mg PO HS constipation \n\n \nDischarge Medications:\n1. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath or \nwheezing \n2. Aspirin 81 mg PO DAILY \n3. Atorvastatin 40 mg PO DAILY \n4. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n5. Furosemide 80 mg PO BID \n6. 70/30 100 Units Breakfast\nHumalog ___ 90 Units BedtimeMax Dose Override Reason: Home \nregimen\n\n7. OxycoDONE (Immediate Release)  30 mg PO Q4H:PRN pain \nRX *oxycodone 30 mg 1 tablet(s) by mouth every four (4) hours \nDisp #*8 Tablet Refills:*0\n8. OxyCODONE SR (OxyconTIN) 80 mg PO Q12H \nRX *oxycodone [OxyContin] 80 mg 1 tablet(s) by mouth every \ntwelve (12) hours Disp #*4 Tablet Refills:*0\n9. Pantoprazole 40 mg PO Q12H \nRX *pantoprazole 40 mg 1 tablet(s) by mouth every twelve (12) \nhours Disp #*60 Tablet Refills:*0\n10. Aluminum-Magnesium Hydrox.-Simethicone 10 mL PO QID:PRN \nstomach discomfort \n11. carisoprodol 350 mg oral BID:PRN pain \n12. Docusate Sodium 100 mg PO HS constipation \n13. Lorazepam 2 mg PO Q8H:PRN anxiety \n14. MetFORMIN (Glucophage) 1000 mg PO BID \n15. TraZODone 100 mg PO HS \n16. Carbamide Peroxide 6.5% ___ DROP AD BID Duration: 4 Days \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY: abdominal pain\nSECONDARY: gastritis\nStaphylococcus epidermidis bacteremia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou were admitted to the hospital for abdominal pain. Initially, \nthe concern was that you had an infection of your gallbladder \nhowever a HIDA scan showed that this was not the case. A CT scan \nof your abdomen also did not show any clear cause of you \nabdominal pain. You got an EGD (scope) which found that the \ninside lining of your stomach was inflamed (gastritis). We \nincreased your antacid medicine to help treat this. Biopsies of \nyour stomach were taken and you should call our GI department to \nfollow up on those results if you do not hear from them in the \nnext week, or your PCP can refer you to a GI doctor in ___ \n___.\n\nOur cardiologists also evaluated you to make sure that your pain \nwas not coming from your heart, however you had a normal EKG and \nno laboratory evidence of heart injury. If you have any chest \npain, you should tell your PCP right away and see a \ncardiologist. Your blood tested positive for a bacteria called \nStaphylococcus epidermidis. We think this was just from \ncontamination of the blood we took to culture. We do not think \nyou have any infection and stopped your antibiotics.\n\nYou should call your PCP (see information below) on ___ to \nschedule a follow up appointment.\n\nIt was a pleasure taking care of you,\n\nSincerely,\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048208fb505ee7538f0425"
  },
  "note_id": "11279026-DS-8",
  "subject_id": 11279026,
  "hadm_id": 20816839,
  "note_type": "DS",
  "note_seq": 8,
  "charttime": "2140-10-24 00:00:00",
  "storetime": "2140-10-25 13:00:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nBack Pain\n\n \nMajor Surgical or Invasive Procedure:\n___: Intubation\n \nHistory of Present Illness:\n___ yo M w/ morbid obesity (uses CPAP continuously, \nhypoventilation syndrome), IDDM, chronic LBP, who presents from \nOSH d/t concern for cauda equina. Patient was on a step ladder \nabout 4 feet in the air when he lost his balance and fell down \nyesterday onto grass, fell on his buttock/back. Has had a \nworsening lower back pain since then, started 1 day afterwards. \nIn addition, he has had a few episodes of urinary incontinence, \nand reports that his lower extremities are weaker and associated \nwith decreased sensation in both his legs. Patient denied \nfever/chills, nausea/vomiting, diarrhea, chest pain, dyspnea, \nadditional complaints. Initially seen at OSH but sent to ___ \nfor concern of caude equina.\n\nIn the ED, initial vitals:  81 144/70 12 94% RA\n-Labs notable for WBC 15.8 (which is chronic), mild anemia of \n___.\n-Given concern for caude equina, pt had a code cord called, CT \nwas a poor study (no localized ___ defect) as pt could not lay \nflat and thus it was decided to intubate pt and obtain MRI.\n-MRI showed some disc bulging/narrowing at L3-4 but otherwise \nunremarkable.\n-Spine reviwed MRI and did not see any need for surgical \nintervention.\n-Pt was given Fent/Prop gtt for sedation while intubated, and \nalso lorazepam/dilaudid.\nOn transfer, vitals were: sedated 97.8 61 124/57 18 92% \nIntubation\n \nOn arrival to the MICU, pt is intuabted and sedated.\n\nReview of systems:  \nUnable to obtain\n\n \nPast Medical History:\nMorbid obesity c/b OSA/hypoventilation, on CPAP \nIDDM\nHTN\nHPL\n?CHF, unclear EF\nPulmonary HTN\nAsthma\nCOPD\nChronic back pain\nMood/anxiety disorder\nHx of SI/SA\nErectile dysfunction\nB/l femoral head AVN\n \nSocial History:\n___\nFamily History:\n-Maternal uncles died in their late-___ or ___ of cardiac causes \n(d. ___ ; ___ s/p CABG @___ ; ___ ; ___ s/p CABG @___) \n-Mother is alive, but morbidly obese with multiple medical \nproblems \n-Dad is alive, relatively healthy\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM\nVitals: T 98.3, 72, 145/77, 91% on CMV\nGENERAL: intubated and sedated \nHEENT: ETT in place \nNECK: thick neck \nLUNGS: mechanical breath sounds  \nCV: Regular rate and rhythm, no MRG \nABD: obese, soft, no rebound or guarding \nEXT: Warm, well perfused, 1+ pitting edema bilaterally \nSKIN:  dry scaling skin on feet, erythema under skin folds\n \nDISCHARGE PHYSICAL EXAM:\nVitals: Tm 98.3, 133/63, 88, 21, 92% on CPAP (50% FiO2, EPAP 8 / \nIPAP 10)\nGENERAL: Alert and oriented x3, NAD\nHEENT: Anicteric sclera, conjunctival injection bilaterally, MMM\nNECK: thick neck\nLUNGS: Clear to aucultation anteriorly\nCV: Regular rate and rhythm, no MRG\nABD: obese, soft, no rebound or guarding  \nEXT: Warm, well perfused, 1+ pitting edema bilaterally\nNEURO: No sensation to soft touch in ___, intact \nsensation to pressure in ___, able to move ___ \n___ but limited by pain. UEs motor/sensory intact \nbilaterally. A&Ox3.\n\n \nPertinent Results:\n=== ADMISSION LABS ===\n\n___ 03:50PM BLOOD WBC-15.8* RBC-4.87 Hgb-13.5* Hct-39.1* \nMCV-80* MCH-27.8 MCHC-34.7 RDW-16.4* Plt ___\n___ 03:50PM BLOOD Neuts-81.4* Lymphs-14.3* Monos-3.2 \nEos-0.6 Baso-0.5\n___ 03:50PM BLOOD Glucose-228* UreaN-7 Creat-0.7 Na-134 \nK-4.7 Cl-96 HCO3-27 AnGap-16\n\n=== IMAGING ===\n \nCT Spine (___):\n1. No evidence of fracture or malalignment. \n2. Extremely limited intrathecal detailed of the size of the \npatient, but at least moderate canal narrowing due to a \ndegenerative disc osteophyte complex at the L3-4 level as above \n3. Partial right lower lobe atelectasis probably associated with \nmarked \nelevation of the right hemidiaphgram. \n  \nMRI SPINE (___):\n1. Mild thoracic and lumbar spondylosis as described above. \n2. No evidence of cord or cauda equina compression. \n\nCXR\n1.  ET tube terminating 5 cm above the carina. \n2.  Low lung volumes.  Multifocal airspace opacities in the \nright middle and lower lobe are worrisome for aspiration versus \npneumonia, and correlate with consolidations identified on \nrecent CT examination \n\n=== DISCHARGE LABS ===\n\n___ 05:54AM BLOOD WBC-17.2* RBC-4.95 Hgb-13.5* Hct-40.7 \nMCV-82 MCH-27.3 MCHC-33.2 RDW-16.5* Plt ___\n___ 05:54AM BLOOD Neuts-74.7* ___ Monos-4.4 Eos-2.5 \nBaso-0.4\n___ 07:40AM BLOOD Glucose-156* UreaN-25* Creat-1.0 Na-139 \nK-3.9 Cl-99 HCO3-30 AnGap-14\n___ 07:40AM BLOOD Mg-1.___ year old male with history of morbid obesity, obesity \nhypoventilation syndrome (uses CPAP continuously) and chronic \nlow back pain who was transferred to ___ from an OSH for \nconcern regarding cauda equina syndrome.\n\n# Acute on Chronic Back Pain: The patient developed acute on \nchronic low back pain in setting of a fall. At the OSH he \nreported urinary incontinence and bilateral lower extremity \nweakness concerning for cauda equina syndrome so he was \ntransferred to ___ for further evaluation. On arrival, he \nunderwent CT and MRI of the spine which revealed no evidence of \ncord compression. Patient was seen by the Ortho-Spine service \nwho felt that there was no indication for surgery. He had \nrequired intubation in order to lay flat and still for the MRI - \nintubation and extubation were without complication. After \nextubation pain management was continued. Oxycontin was \nincreased from 80 to 100mg BID and prn oxycodone was continued. \nGabapentin, lidocaine patch, standing tylenol and naproxen were \nalso started for pain control during his admission. Patient was \nevaluated by physical therapy who recommended rehab.\n\n=== TRANSITIONAL ISSUES ===\n\n# Acute on Chronic Back Pain:\n- Started gabapentin, lidocaine patch, standing tylenol and \nnaproxen while inpatient. Oxycontin was increased from 80 to \n100mg BID and prn oxycodone was continued. \n\n# Choronic Leukocytosis: Unclear etiology. Normal differential.\n- Outpatient Heme-Onc follow up\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath or \nwheezing \n2. Aspirin 81 mg PO DAILY \n3. Atorvastatin 40 mg PO DAILY \n4. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n5. Furosemide 80 mg PO BID \n6. OxycoDONE (Immediate Release)  30 mg PO Q4H:PRN pain \n7. OxyCODONE SR (OxyconTIN) 80 mg PO Q12H \n8. Pantoprazole 40 mg PO Q12H \n9. Aluminum-Magnesium Hydrox.-Simethicone 10 mL PO QID:PRN \nstomach discomfort \n10. carisoprodol 350 mg oral BID:PRN pain \n11. Docusate Sodium 100 mg PO HS constipation \n12. Lorazepam 2 mg PO Q8H:PRN anxiety \n13. MetFORMIN (Glucophage) 1000 mg PO BID \n14. TraZODone 100 mg PO HS \n15. Carbamide Peroxide 6.5% ___ DROP AD BID \n16. 70/30 100 Units Breakfast\nHumalog ___ 90 Units BedtimeMax Dose Override Reason: home \nmeds\n\n \nDischarge Medications:\n1. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath or \nwheezing \n2. Aspirin 81 mg PO DAILY \n3. Atorvastatin 40 mg PO DAILY \n4. Docusate Sodium 100 mg PO HS constipation \n5. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n6. Furosemide 80 mg PO BID \n7. 70/30 100 Units Breakfast\nHumalog ___ 90 Units Bedtime\nInsulin SC Sliding Scale using HUM InsulinMax Dose Override \nReason: home meds\n\n8. Pantoprazole 40 mg PO Q12H \n9. TraZODone 100 mg PO HS \n10. Acetaminophen 1000 mg PO Q8H \n11. Gabapentin 300 mg PO TID \n12. Lidocaine 5% Patch 1 PTCH TD QAM \n13. Naproxen 500 mg PO Q12H Duration: 7 Days \n14. Polyethylene Glycol 17 g PO DAILY \n15. Bisacodyl 10 mg PO/PR DAILY:PRN constipation \n16. Senna 8.6 mg PO BID \n17. Tizanidine 4 mg PO TID \n18. Aluminum-Magnesium Hydrox.-Simethicone 10 mL PO QID:PRN \nstomach discomfort \n19. Carbamide Peroxide 6.5% ___ DROP AD BID \n20. carisoprodol 350 mg oral BID:PRN pain \n21. Lorazepam 2 mg PO Q8H:PRN anxiety \n22. MetFORMIN (Glucophage) 1000 mg PO BID \n23. OxycoDONE (Immediate Release)  30 mg PO Q6H:PRN pain \nRX *oxycodone 30 mg 1 tablet(s) by mouth every six (6) hours \nDisp #*15 Tablet Refills:*0\n24. OxyCODONE SR (OxyconTIN) 100 mg PO Q12H \nRX *oxyCODONE  100 mg by mouth every twelve (12) hours Disp #*15 \nTablet Refills:*0\n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary Diagnosis:\n- Acute on Chronic Back Pain\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou were transferred to ___ on ___ with a severe \nexacerbation of your chronic back pain, urinary incontinence and \nweakness of your legs. We performed imaging studies and excluded \nspinal cord conditions that could cause neurological compromise. \nYou were also evaluated by our spine surgeons who felt that \nthere was no need for surgical intervention. You are now ready \nfor discharge to a rehabilitation facility where you will work \non improving your mobility and functional status before \nreturning home.\n\nIt was a pleasure to take care of you during your hospital stay.\n\nSincerely,\nYour ___ Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904821bfb505ee75390d398"
  },
  "note_id": "14841111-DS-13",
  "subject_id": 14841111,
  "hadm_id": 20945071,
  "note_type": "DS",
  "note_seq": 13,
  "charttime": "2149-10-03 00:00:00",
  "storetime": "2149-10-03 09:22:00",
  "text": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: CARDIOTHORACIC\n \nAllergies: \nRed Dye\n \nAttending: ___.\n \nChief Complaint:\nDyspnea on exertion\n \nMajor Surgical or Invasive Procedure:\n___ Aortic Valve Replacement(23mm ___ porcine)\n\n \nHistory of Present Illness:\nMr. ___ is a very nice ___ ___ gentleman with a \nhistory of aortic stenosis, diabetes mellitus, hyperlipidemia, \nhypertension, and pseudodementia. An echocardiogram in ___ \ndemonstrated severe aortic stenosis with an aortic valve area of \n0.8 cm2 with peak and mean gradients of 56 mmHg and 39 mmHg, \nrespectively. A stress echocardiogram in ___ revealed \nfurther progression of his aortic stenosis with peak and mean\ngradients of 85 mmHg and 54 mmHg, respectively. Recently he has \nnoted onset of dyspnea on exertion with walking uphill or \nclimbing stairs. He was referred to Dr. ___ surgical \nconsultation.\n\nHe noted dyspnea on exertion as described above and mild lower \nextremity edema. He denied syncope, dizziness, lightheadedness, \nshortness of breath at rest, chest pain, palpitations, \northopnea, or paroxysmal nocturnal dyspnea.\n \nPast Medical History:\nAortic Stenosis\nDepression\nDiabetes Mellitus Type II\nHyperlipidemia\nHypertension\nObesity\nOsteoarthritis \nPseudodementia\n \nSocial History:\n___\nFamily History:\nFather died at age ___ of Alzheimer's disease.\nMother died in her ___ of a postpartum hemorrhage.\nHe has two brothers, two sisters, and no children. One of his \nsisters has\ndiabetes and another has hypertension and hyperlipidemia. There \nis no family history notable for stroke, early coronary artery \ndisease or sudden cardiac death.\n \nPhysical Exam:\nVital Signs sheet entries for ___: \nBP: 159/54. HR: 81. O2 Sat%: 94. RR: 15. Pain Score: 0.\nHeight: 62\"  Weight: 175 lb\n\nGeneral: Pleasant man, resting in bed comfortably post cath. \nSkin: warm, dry, intact\nHEENT: PERRLA, EOMI, Native teeth in fair repair\nNeck:  Supple, full ROM\nChest: Lungs clear bilaterally\nHeart: Regular rate and rhythm, III/VI SEM heard ___ at LUSB \nAbdomen: Normal BS, soft, non-distended, non-tender \nExtremities: Warm, well-perfused, 1+ edema \nVaricosities: None \nNeuro: Grossly intact \nPulses:\nDP           Right: 2+  Left: 2+\n___           Right: 2+  Left: 2+\nRadial       Right: 2+  Left: 2+\nFemoral:     right -cath site no hematoma\n\nCarotid Bruit: transmitted murmur vs. bruit\n\nDischarge Examination \n\nHEENT: PERRLA, EOMI\nNeck:  Supple, full ROM\nChest: Lungs clear bilaterally\nHeart: Regular rate and rhythm\nAbdomen: Normal BS, soft, non-distended, non-tender \nExtremities: Warm, well-perfused, 1+ ___ edema \nNeuro: Grossly intact \nSternal wound: clean, dry, intact\n \nPertinent Results:\nCardiac Catheterization ___\nRight Dominant \nLMCA: 40% eccentric distal stenosis at the trifurcation.\nLAD: diffusely calcified. Ostial 30% stenosis and mid 30% \nstenosis. ___ Diagonal has 50% stenosis.\nLCX: 40-50% OM1 stenosis.\nRI: proximal ___ stenosis.\nRCA: diffusely calcified. Ostial/proximal 50% stenosis.\n\n___ ECHOCARDIOGRAPHY REPORT\nLeft Ventricle - Septal Wall Thickness:   *1.2 cm   0.6 - 1.1 cm \n  \nLeft Ventricle - Inferolateral Thickness:   *1.2 cm   0.6 - 1.1 \ncm   \nLeft Ventricle - Diastolic Dimension:   5.0 cm   <= 5.6 cm   \nLeft Ventricle - Ejection Fraction:   55%   >= 55%   \nLeft Ventricle - Stroke Volume:   53 ml/beat       \nAorta - Ascending:   3.2 cm   <= 3.4 cm   \nAortic Valve - Peak Velocity:   *4.2 m/sec   <= 2.0 m/sec   \nAortic Valve - Peak Gradient:   *72 mm Hg   < 20 mm Hg   \nAortic Valve - Mean Gradient:   46 mm Hg       \nAortic Valve - LVOT pk vel:   7.50 m/sec       \nAortic Valve - LVOT VTI:   17       \nAortic Valve - LVOT diam:   2.0 cm       \n  \nFindings   \nLEFT ATRIUM: Good (>20 cm/s) ___ ejection velocity. \nRIGHT ATRIUM/INTERATRIAL SEPTUM: No ASD by 2D or color Doppler. \nLEFT VENTRICLE: Mild symmetric LVH. Normal LV cavity size. \nOverall normal LVEF (>55%). \nRIGHT VENTRICLE: Normal RV chamber size and free wall motion. \nAORTA: Normal ascending aorta diameter. Complex (>4mm) atheroma \nin the descending thoracic aorta. No thoracic aortic dissection. \n\nAORTIC VALVE: ?# aortic valve leaflets. Severely \nthickened/deformed aortic valve leaflets. Severe AS (area \n<1.0cm2). Mild (1+) AR. \nMITRAL VALVE: Normal mitral valve leaflets with trivial MR. \n___ VALVE: Normal tricuspid valve leaflets with trivial \nTR. \nPULMONIC VALVE/PULMONARY ARTERY: Normal pulmonic valve leaflet. \nNo PS. Physiologic PR. \nPERICARDIUM: No pericardial effusion. \n  \nPre-bypass \n No atrial septal defect is seen by 2D or color Doppler. There \nis mild symmetric left ventricular hypertrophy. The left \nventricular cavity size is normal. Left ventricular function is \nnormal with no regional wall motion abnormalities. Right \nventricular chamber size and free wall motion are normal. There \nare complex atheroma in the descending thoracic aorta. No \nthoracic aortic dissection is seen. The number of aortic valve \nleaflets cannot be determined due to severe calcification. The \naortic valve leaflets are severely thickened/deformed. There is \nsevere aortic valve stenosis (valve area <1.0cm2). Mild (1+) \naortic regurgitation is seen. The ascending aorta is normal in \nsize. The mitral valve appears structurally normal with trivial \nmitral regurgitation. The tricuspid valve appears normal with \ntrivial tricuspid regurgitation. There is no pericardial \neffusion.\n\n Post-bypass\n The patient is on a phenylephrine infusion and is A-V paced.\n A well-seated bioprosthetic valve is seen in the aortic \nposition. No paravalvular leak is seen. Residual mean gradient \nacross the bioprosthetic aortic valve is within acceptable \nlimits.\n Biventricular function is preserved. No evidence of thoracic \naortic dissection. The remainder of the exam is unchanged.   \n\nCXR ___\nCompared to ___. \nModerate enlargement of cardiac silhouette has increased since \n___.  No pneumothorax or appreciable pleural effusion.  \nModerate left lower lobe atelectasis has increased. \nRight jugular line ends in the low SVC. \n\n \nBrief Hospital Course:\nHe was admitted to ___ on ___ for cardiac \ncatheterization. The study demonstrated moderate three vessel \ncoronary coronary artery disease. He remained stable overnight \nand was taken to the operating room the next day. He underwent \naortic valve replacement. Please see operative note for full \ndetails. He tolerated the procedure well and was transferred to \nthe CVICU on neosynephrine and paced.  He was weaned from \nsedation that evening, awoke and was extubated.  POD 1 his chest \ntubes were removed, started Lasix, Lopressor and lisinopril.  \nLater that evening he was weaned off nicardipine that had been \nstarted for blood pressure control.  However is blood glucose \nincreased and he was restarted on insulin drip and remained in \nthe CVICU.  He has baseline pseudodementia and that evening was \nmild confusion and agitation that he was given additional \nSeroquel above his home dose and was able to rest.  POD 2 his \nglipizide and insulin were further adjusted and he was weaned \noff the insulin drip.  Due to increased heart rate the \nlisinopril was stopped to allow further betablocker.  He \ncontinued to progress and was transferred to the floor and \nramelteon was added for sleep.  POD 3 he was less interactive \nthe ramelteon was discontinued and he was more interactive by \nthe afternoon, Seroquel was reduced back to home dose of 12.5 mg \nBID, epicardial wires removed.  He was seen by physical therapy \nfor strength and mobility, recommendation for home with ___, \nwalker and family assistance.  His niece is very supportive and \nwill be with him to assist at home. On post-operative day five \nhe was discharged to his niece's home.\n\n \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. amLODIPine 5 mg PO DAILY \n2. Aspirin 81 mg PO DAILY \n3. Atorvastatin 40 mg PO QPM \n4. GlipiZIDE XL 10 mg PO BID \n5. Lisinopril 20 mg PO DAILY \n6. QUEtiapine Fumarate 12.5 mg PO BID \n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild  \n2.  Docusate Sodium 100 mg PO BID  \n3.  Furosemide 20 mg PO DAILY Duration: 7 Days \nRX *furosemide 20 mg one tablet(s) by mouth daily Disp #*7 \nTablet Refills:*2 \n4.  Metoprolol Succinate XL 100 mg PO DAILY \nRX *metoprolol succinate 100 mg one tablet(s) by mouth daily \nDisp #*30 Tablet Refills:*2 \n5.  Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First \nLine  \n6.  Potassium Chloride 10 mEq PO DAILY Duration: 7 Days \nRX *potassium chloride 10 mEq one capsule(s) by mouth daily Disp \n#*7 Capsule Refills:*2 \n7.  Ranitidine 150 mg PO DAILY Duration: 1 Month \nRX *ranitidine HCl 150 mg one capsule(s) by mouth daily Disp \n#*30 Capsule Refills:*0 \n8.  Tamsulosin 0.4 mg PO QHS \nRX *tamsulosin 0.4 mg one capsule(s) by mouth daily Disp #*30 \nCapsule Refills:*2 \n9.  GlipiZIDE 10 mg PO QAM  \n10.  GlipiZIDE 5 mg PO QPM \nRX *glipizide 5 mg one tablet(s) by mouth with dinner Disp #*30 \nTablet Refills:*2 \n11.  amLODIPine 5 mg PO DAILY  \n12.  Aspirin 81 mg PO DAILY  \n13.  Atorvastatin 40 mg PO QPM  \n14.  QUEtiapine Fumarate 12.5 mg PO BID  \n15.DME\nwheelchair s/p AVR\nprognosis: good\n___: 6 months\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nAortic stenosis s/p aortic valve replacement \nCoronary artery disease as per cardiac catheterization\nDiabetes Mellitus Type 2\nPseudodementia \n\nSecondary diagnosis \nDepression\nHyperlipidemia\nHypertension\nObesity\nOsteoarthritis \nRight eye cataract surgery\n\n \nDischarge Condition:\nAlert and oriented x3, non focal \nAmbulating with walker \nSternal pain managed with acetaminophen \nSternal Incision - healing well, no erythema or drainage\nEdema 1+\n\n \nDischarge Instructions:\nPlease shower daily -wash incisions gently with mild soap, no \nbaths or swimming, look at your incisions daily\n \nPlease - NO lotion, cream, powder or ointment to incisions\n \nEach morning you should weigh yourself and then in the evening \ntake your temperature, these should be written down on the chart\n \nNo driving for approximately one month and while taking \nnarcotics\n\nClearance to drive will be discussed at follow up appointment \nwith surgeon\n \nNo lifting more than 10 pounds for 10 weeks\n \n**Please call cardiac surgery office with any questions or \nconcerns ___. Answering service will contact on call \nperson during off hours**\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753933669"
  },
  "note_id": "19550378-DS-24",
  "subject_id": 19550378,
  "hadm_id": 27305040,
  "note_type": "DS",
  "note_seq": 24,
  "charttime": "2142-04-17 00:00:00",
  "storetime": "2142-04-17 13:40:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROLOGY\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin\n \nAttending: ___.\n \nChief Complaint:\nWorsening Rt. foot weakness and upper and lower extremity distal \nparastehsias\n \nMajor Surgical or Invasive Procedure:\nAdministration of Plasmapheresis\n \nHistory of Present Illness:\nMs. ___ is a ___ year old right handed female with ongoing \nhistory of idiopathic polyneuropathy since ___ s/p multiple \nplasmapheresis cycles here for worsening Rt. foot weakness with \ngradual and progressive numbness in her hands and feet, in a \nglove and sock distribution. The right foot weakness started ___ \nmonths ago when she noticed difficulty getting out of her \nwheelchair to get to the bathroom. This weakness was not \naccompanied by pain or numbness initially. Numbness later \ndeveloped in her hands and feet. She has no tingling sensation \nwith this numbness and no pain but she finds it difficult to \ngrip objects. She now states she has mild trouble swallowing her \nown saliva but no difficulty breathing. \n.\nHer neurological issues first started in ___ when she noticed \nleg weakness. This weakness developed gradually over ___ year and \nbrought her to ___ where she was admitted and worked up for 3 \nmonths because she got to the point where she was unable to \nambulate. At this time she had no numbness or pain. From this \npoint on she was wheelchair bound and was initially treated wiht \nGabapentin. She later developed pain in her knees that led to \nbilateral knee replacement, left in ___ and rightin ___. In \naddition to leg wekaness she also developed proximal muscle \nweakness, finding it difficult to get out of chair, that \nprogressed to difficulty breathing/swallowing by ___. At this \npoint she was treated with IVIG without success and was then \ntreated with plasmapheresis, ___ was effective. She comments \non a history of  ___ treatments of plasmapheresis, without \ncompletion of the 5 cycles yet. Treatment was stopped early for \nheart spasms and suspected heart attack on two of her \ntreatments.\n.\nShe also has ongoing incontinence that has had unclear workup. \nThis has been ongoing for ___ years and she recently developed \nbowel incontinence six times over the past 6 months. Of note is \nthats she is on heavy bowel regimen at the ___ for an \n\"illeus\" that has been ongoing ofr about ___ years.\n.\nOn review of records she has had extensive workup for this \nneurosensory deficit. It progressed to causing hypophonia, \ndysarthria and trouble breathing before initiation of \nplasmapheresis treatment. She has also had abdominal pain and \ntrouble with constipation.\n\n \nPast Medical History:\n1)Severe idiopathic axonal sensorimotor polyneuropathy: improved \nafter plasmapheresis; coccygeal pain and constipation. Seen in \nGI clinic by Dr ___ thinks the constipation is\nlikely to be a combination of colonic inertia, neuromuscular\ndisease and immobility. Recent colonoscopy ___ - polypectomy \n(insufficient tissue on path). Diverticulosis on old CT abdomen. \n\n2)HTN \n3)Depression \n4)GERD \n5)history of vitamin B12 deficiency \n6)diverticulosis \n7)s/p hysterectomy for leiomyomata, C section\n8)s/p knee replacement \n9)  Morbid obesity\n10) breast lumpectomy left. \n\n \nSocial History:\n___\nFamily History:\nNo history of neurologic disease. A number of family members \nwith lung and breast cancer, diabetes mellitus. The patient's \nmother was diagnosed with colon\ncancer when she was ___ years old.  No other family members with\ncolon cancer, rectal cancer, or other ___ related cancers.\n\n \nPhysical Exam:\nON ADMISSION:\nPhysical Exam:\nVS: T. 98.6 BP 118/76 HR 86 Resp 20 99RA\nGeneral: very pleasant morbidly obese lady\nHEENT: NC AT, hearing intact to finger rub (slight reduction \nleft side), fundus difficult to visualize due to bilateral \ncataracts, oropahrynx clear, upper and lower dentures, no \nJVD/LAD/thyromegaly\nCV: RRR, normal S1 a nd S2, no mrg\nResp: CTAB, no spinal tenderness\nAbd:  soft, NT, ND, present BS no abdominal bruits, no HSM\nExtremeties: warm and moist, 2+ DP and radial pulses, trace \nedema abive ankles bilaterally\nSkin: MMM, no rash, petichiae or echymosis\n.\nNeuro: \nMental Status:\nAlert and attentive doing months of the year backwards without \nproblem. Recalled ___ objects on recall and her speech had \nnormal cadence and rhythm. Responded to questions appropriately, \nfollowing complex commands and giving a clear history of \nillness. \n.\nCranial nerves:\nI-not assessed\nII-visual fields intact to confrontation, PERRL (___)\nIII, IV, VI- EOMI\nV-temporal and masseter strength intact, sensation to light \ntouch intact\nVII-facial muscles intact\nVIII-hearing mildly reduced to left side\nIX, X- symmetric palate elevation \nXI-sternomastoid and trapezius ___\nXII-tongue midline \n.\nMotor:\nBulk-atrophy ___ dorsal web space Lt hand>Rt hand otherwise \nnormal bulk. No dystonia, clonus, pronator drift, or asterixis. \nNo tremor in hands. ?restlessness of both feet. \nStrength-\n    Del ___  ___  WE  FF FE  IP  Q  Ham DF  PF\nRt.  4+  5    4+  ___   ___-  5   5 \nLt.  4+  5    4+  ___   ___-  5   5\n.\nSensory: \nIntact to light touch\nDiffuse impairment to propioception with inability to sit still \nwith eyes closed, chorea like motion of fingers in ormberg \nposition with eyes closed, and inability to sense joint position \nin finger, wrist, elbow bilaterally and toe and ankle \nbilaterally. \nVibratory sense decreased to above knee bilaterally and to wrist \nbilaterally.\nImpaired to sharp PP in feet bilaterally with hyperesthesia \nLt.>Rt.\n.\nDTR: \n    ___  ___  ___  Pat  Ach  Babinski\nRt. 0    0    0     0     0     -\nLt. 0    0    0     0     0     -\n.\nCoordination: Intact to finger to nose\n.\nGait: not assessed\n\n \nPertinent Results:\nHgb A1C 6.4\nIF Ab negative\nVit B12 328\nMethyl Malonic Acid pending\n\nPost-void bladder scan 8cc\n\n \nBrief Hospital Course:\nMs. ___ is a ___ year old female with history of severe \nidiopathic sensorimotor axonal polyneuropathy who comes in with \nworsening sympotms of parasthesias in upper and lower \nextremities bilaterally and worsening Rt. foot weakness. She has \nresponded well to plasmapheresis in the past but has never \ncompleted the full 5 cycle series. She was admitted for elective \nplasmapheresis and close montioring as she has had concerning \nsymptoms related to the treatment in the past. During her first \npheresis she experienced abdominal pain, nausea, vomit x1, and \nlost control of her bowels x1. She also had low blood pressure, \nSBP of 100, during the high flow pheresis (70). She felt better \non slow flow and had no sympotms after pheresis. The night \nbefore her second cycle of pheresis she was nauseous and vomited \nmultiple times with abdominal pain. EKG was unchanged from prior \nones. She tolerated her second pheresis well with minimal \nabdominal pain and felt relief from her N/V afterwards. The \nremaining cycles of pheresis went well.  Her neurologic exam \nshowed improved strength and improved sensation.  She worked \nclosely with physical therapy to get out of bed to chair.\n\nDuring her hospitalization it was noted that she had elevated \nglucose levels.  We obtained a consult from the ___ Diabet___ \n___.  After further review of her labwork, it was concluded \nthat she is indeed diabetic.  She received a nutrition consult \nfor diabetic diet teaching.  Also, she was started on Metformin \n500 mg daily with dinner.  It was also noted that her she has \nlow lipid levels so her simvastatin dose was decreased to 10 mg \ndaily.  \n\nOn the ___, she was started on ciprofloxacin for a urine \nculture postive for gram negative rods >100,000.  Once \nsensitivities came back sensitive the same day, she was switched \nto nitrofurantoin with a plan for a 7 day course.  \n\n \nMedications on Admission:\n1. Lidocaine 12 hours on 12 off- lower back\n2. Acetminophen 100mg PO daily PRN\n3. Lorazepam 0.5mg Q6 PRN\n4. Amlodipine 5mg daily\n5. Metoclopramide 10mg TID\n6. ASA 81mg daily\n7. Bisacodyl 5mg daily PRN\n8. nitroglycerin PRN chest pain\n9. Bupropion 100mg BID\n10. Omeprazole 20mg BID\n11. Docusate Sodium 100mg BId\n12. Furosemide 20mg daily\n13. Polyethylene glycol 17g BID\n14. Glycerin supp PRN\n15. Sertraline 100mg daily\n16. Isosorbide mononitrate ER 60mg daily\n17. Simvastatin 20mg daily\n18. Lactulose 15ml TID\n19. Multivit.\n20. Fiber\n\n \nDischarge Medications:\n1. Amlodipine 2.5 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n2. Bupropion HCl 100 mg Tablet Sig: One (1) Tablet PO BID (2 \ntimes a day).  \n3. Furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n4. Isosorbide Mononitrate 60 mg Tablet Sustained Release 24 hr \nSig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).  \n5. Lactulose 10 gram/15 mL Syrup Sig: Fifteen (15) ML PO TID (3 \ntimes a day).  \n6. Lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: \nOne (1) Adhesive Patch, Medicated Topical DAILY (Daily): on at 8 \nam, off at 8 pm.  \n7. Metoclopramide 10 mg Tablet Sig: One (1) Tablet PO TID (3 \ntimes a day).  \n8. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Tablet, \nSublingual Sublingual PRN (as needed) as needed for chest pain.  \n\n9. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO BID (2 times a day).  \n10. Sertraline 50 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n11. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \nPO DAILY (Daily).  \n12. Bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: One (1) \nTablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for \nconstipation.  \n13. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID \n(2 times a day).  \n14. Glycerin (Adult)     Suppository Sig: One (1) Suppository \nRectal PRN (as needed) as needed for constipation.  \n15. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n16. Polyethylene Glycol 3350 17 gram/dose Powder Sig: Seventeen \n(17) g PO BID (2 times a day).  \n17. Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 \nhours) as needed for anxiety.  \n18. Prochlorperazine Maleate 10 mg Tablet Sig: One (1) Tablet PO \nQ6H (every 6 hours) as needed for nausea.  \n19. Simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).\nDisp:*30 Tablet(s)* Refills:*2*\n20. Nitrofurantoin (Macrocryst25%) 100 mg Capsule Sig: One (1) \nCapsule PO BID (2 times a day) for 7 days.  \n21. Metformin 500 mg Tablet Sig: One (1) Tablet PO once a day: \nat dinner.\nDisp:*30 Tablet(s)* Refills:*2*\n\n \nDischarge Disposition:\nExtended Care\n \nDischarge Diagnosis:\nPrimary\n1. Severe idiopathic axonal sensorimotor polyneuropathy\n\n \nDischarge Condition:\nStable.  Neurological examination is notable for bilateral \npsedoathetosis and decrements in proprioception (able to \nperceive at MCP and ankle - this is improved from admission).\n\n \nDischarge Instructions:\nYou were seen at ___ because you wanted to undergo plasma \nexchange treatment for your nerve problems. You have had this \ntreatment before, and it has worked in the past. Your treatment \nwent well with the plasma exchange, although early on you did \nget abdominal pain during the exchange.\n.\nYou also had your urinary incontinence problem looked at but \nwill need further studies done as an outpatient to have this \nlooked at.\nYour labwork also showed that your sugars were mildly elevated \non multiple blood draws, showing that you may be developing \ndiabetes. You should discuss these findings with your PCP.\n.\nPlease note that the antibiotic nitrofurantoin was started to \ntreat a urinary tract infection.  The medication metformin was \nalso started for diabetes.\n.\nPlease seek medical attention if you develop increasing weakness \n- especially on one side of your body, shaking of the limbs, \nchanges in vision, chest discomfort, shortness of breath, \nlightheadedness, or any other symptom you find concerning.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee75393366a"
  },
  "note_id": "19550378-DS-25",
  "subject_id": 19550378,
  "hadm_id": 26786046,
  "note_type": "DS",
  "note_seq": 25,
  "charttime": "2144-02-29 00:00:00",
  "storetime": "2144-03-09 15:42:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROLOGY\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin\n \nAttending: ___.\n \nChief Complaint:\nprogressive worsening numbness in arms and legs\n\n \nMajor Surgical or Invasive Procedure:\ncatheter placement, 5-days of plasmaphresis\n \nHistory of Present Illness:\nMs. ___ is an obese right-handed ___ ___ year-old \nwoman w/ PMH of severe idiopathic axonal sensorimotor \npolyneuropathy previously responsive to plasmapheresis, HTN, \nDMII, HLD, and depression p/w with worsening numbness and \nweakness secondary to her chronic axonal polyneuropathy.  She \nhas baseline chronic numbness distally that has gradually moved \nproximally from ankles to midshin bilaterally.  Numbness now \nalso extends from her fingers to her forearm, but spares her \nface.  She denies saddle anesthesia but has baseline \nincontinence described as infrequent episodes where she has \nbowel movements at night. In the daytime she feels an urge and \ncan make it to the bathroom. Specifically, she denies numbness \nwhen wiping. She reports some associated weakness in her hands \nover the last few months that has caused her to drop objects \nmore frequently. She has difficulty holding onto smaller objects \nsuch as a fork or toothbrush.  She reports that she has had \nmultiple episodes of increased numbness over the past ___ years \nthat typically present in a similar fashion and have been \nsuccessfully treated with plasma exchange.   She also reports \nintermittent bilateral tension headaches and brief episodes of \nchest discomfort (lasting ___ seconds) that have occurred over \nthe past few months as well. \n .\nThe patient first noticed the onset of neurological symptoms as\nearly as ___.  As a result of difficulty walking and severe \nknee\npain, she underwent bilateral knee replacements over the course\nof the subsequent ___ years (___).  Despite the\noperations, she required the assistance of a cane to ambulate\nsecondary to lower extremity weakness.  After falling while\nperforming transfers, the patient ultimately became wheelchair\nbound by approximately ___.  By ___, the weakness extended \nfrom\nthe lower extremities into the trunk and upper extremities.  \nExacerbations in numbness and weakness have been successfully \ntreated with plasma exchange in the past.  She typically notes \nimprovement ___ months after treatment.  Per prior records, she \nhas received 4 plasma exchange treatments most recently in ___ \nand ___. \nShe was admitted for similar symptoms in ___ with numbness of \nlower extremities, upper extremities, trunk, neck, and face to \nthe level of the lower lip. Dr. ___ for a new \nsession of plasmapheresis and she gradually improved.  Of note, \nshe has had complications with plasmaphresis in the past \nincluding coronary vasospasm, bradycardia, and a central line \ninfection.\n.\nAt her current baseline she can walk 150 feet with a walker.  \nShe eats and can transfer independently. She can wash and dress \nherself and can use the toilet with an assistive device. \n.\nShe was recently seen by Cardiology who determined that she most \nlikely was not suffering from chronic heart failure (of note she \nhas no documented evidence of heart failure or stress-test \ninduced ischemia in our system). They recently discontinued her \nlasix and decreased her imdur. \n\n \nPast Medical History:\n- Severe idiopathic axonal sensorimotor polyneuropathy\n* initial sx in ___ (weakness and sensory loss in legs -->\nabdomen --> arms)\n* responsive to plasmapheresis (last sessions ___\n* prior evaluation (per Dr. ___ dated ___:\n- Sural nerve biopsy: marked loss of large and small myelinated\naxons\n- Vitamin B12 deficiency\n- HTN\n- DM (type II)\n- GERD\n- Depression\n- Diverticulosis\n.\nPAST SURGICAL HISTORY:\n- c-section x 2\n- hysterectomy for leiomyomata\n- left breast lumpectomy\n- bilateral knee replacements\n- portacath (since removed)\n- surgery related to recent abdominal hematoma related to sc\nheparin\n\n \nSocial History:\n___\nFamily History:\nFAMILY HISTORY:\n- negative for neurological conditions\n- positive for DM (mother, brother), malignancy (mother - liver,\ncervical, colon; father - lung), CAD (mother)\n\n \nPhysical Exam:\nPHYSICAL EXAMINATION:\nVitals: T: 97.2 P:  68   BP: 138/80  SaO2: 99%  RA\nGeneral: Awake, cooperative, NAD.\nHEENT: Normocephalic, atraumatic, no scleral icterus noted. \nMucus\nmembranes moist, no lesions noted in oropharynx\nNeck: Supple. No carotid bruits appreciated. \nCardiac: Regular rate, normal S1 and S2.\nPulmonary: Lungs clear to auscultation bilaterally anteriorly.\nAbdomen: Obese. Normoactive bowel sounds.  Soft.  Non-tender,\nnon-distended.\nExtremities: No evidence of cyanosis or edema.  \nSkin: no rashes or concerning lesions noted.\n.\n.\nNEUROLOGIC EXAMINATION:\n.\nMental Status:\n* Degree of Alertness: Alert.  Able to relate history without\ndifficulty.\n* Orientation: Oriented to person, place, day, month, year,\nsituation\n* Attention: Attentive.  Able to name the days of the week\nforwards and backwards without difficulty.\n* Memory:   Pt demonstrated knowledge of recent events.  \n* Language: Language is fluent without evidence of paraphasic\nerrors.  Repetition is intact.  Comprehension appears intact; pt\nable to correctly follow midline and appendicular commands. \nProsody is normal.  Pt able to name high and low frequency\nobjects without difficulty.  \n* Calculation: Pt able to calculate number of quarters in $1.50\n* Neglect: No evidence of sensory (no extinction with double\nsimultaneous stimulation) neglect. No evidence of apraxia.\n.\n.\nCranial Nerves:\n* I: Olfaction not evaluated. \n* II: PERRL 2-->1mm and brisk.  Visual fields full \n* III, IV, VI: EOMI without nystagmus or diplopia\n* V: Facial sensation intact to light touch in the V1, V2, V3\ndistributions.\n* VII: No facial droop, facial musculature symmetric.\n* VIII: Hearing intact to finger-rub bilaterally. \n* IX, X: Palate elevates symmetrically. \n* XI: ___ strength in trapezii and SCM bilaterally.\n* XII: Tongue protrudes in midline.  \n.\n.\nMotor:\n* Bulk: Atrophy in the small muscles of the hands and feet\nbilaterally.\n* Tone: Normal.  No evidence of cogwheel rigidity or paratonia. \n* Drift: No pronator drift bilaterally.\n* Adventitious Movements: No tremor or asterixis noted.  \nPseudoathetosis of fingers with arm raise.\n.\nMotor examination:  \n Her neck flexors and extensors are ___.  \n   D  B  T  WF WE FF  FE  IP  Q  HS   DF  ___  \nL  ___   ___  5     ___   \nR  ___   ___  5     ___   \n.\nReflexes:\nbiceps 2+ bilaterally\nAbsent triceps, brachioradialis, patella, achilles. \nPlantar reflexes:   flexor bilaterally \n.\nSensation:\n* Light Touch: intact bilaterally in upper + lower extremities\n* Pinprick: UE diminished from mid-forearm distally in left \nupper extremities intact in the right upper extremity\n___: diminished from mid-shin distally in left lower extremities, \nintact in right lower extremity foot to knee, diminished on \nplantar surface of foot\n* Vibration: upper extremities intact, ___- right: vibration \nundetected in malleolus or patella, left: detected only at \npatella\n* Proprioception: absent in great toe bilaterally, present at \nankles bilaterally \n.\nCoordination\n* Finger-to-nose: intact with intention tremor bilaterally\n\n \nPertinent Results:\n___ 05:10AM BLOOD WBC-7.1 RBC-4.13* Hgb-12.9 Hct-36.3 \nMCV-88 MCH-31.3 MCHC-35.6* RDW-13.5 Plt ___\n___ 09:35PM BLOOD ___ PTT-23.0 ___\n___ 09:35PM BLOOD Glucose-99 UreaN-11 Creat-0.9 Na-142 \nK-4.1 Cl-103 HCO3-31 AnGap-12\n___ 05:15AM BLOOD Calcium-9.7 Phos-4.8* Mg-1.9\n___ 09:35PM BLOOD VitB12-258\n\nImaging:\n     \n___\nKUB\nFINDINGS: Multiple loops of air-filled small and large bowel are \nseen \nthroughout the abdomen. Small bowel loops are mild-to-moderately \ndistended, whereas large bowel loops are of normal caliber. Air \nis also seen distally within the rectosigmoid region. Absence of \nupright view limits assessment for air-fluid levels or free \nintraperitoneal air. Observed bowel gas pattern may be due to \nileus, but followup obstruction series would be helpful to \nexclude the possibility of an early or partial small bowel \nobstruction \n\nLabs at discharge:\n\n___ 05:10AM BLOOD WBC-8.5 RBC-3.84* Hgb-11.6* Hct-34.6* \nMCV-90 MCH-30.2 MCHC-33.5 RDW-14.2 Plt ___\n___ 05:10AM BLOOD Plt ___\n___ 05:10AM BLOOD Glucose-96 UreaN-8 Creat-1.1 Na-145 K-4.5 \nCl-106 HCO3-33* AnGap-11\n___ 05:10AM BLOOD Calcium-9.1 Phos-4.9* Mg-2.0\n \nBrief Hospital Course:\nMs. ___ is an obese right-handed ___ ___ year-old \nwoman w/ PMH of severe idiopathic axonal sensorimotor \npolyneuropathy previously responsive to plasmapheresis, HTN, \nDMII, HLD, and depression who presented with worsening numbness \nand weakness secondary to her chronic axonal polyneuropathy.  \nMs. ___ was admitted to the General Neurology Service on \n___ and baseline labs, vitamin B12 level, and EKG were \nobtained which were all normal prior to starting a course of \nplasmaphresis (planned 5 sessions, scheduled every other day, as \nwas effective for her in the past).\n\n After her first session she developed transient nausea and had \none episode of emesis for which she recieved IV zofran prn, but \nshe subsequently tolerated the 4 remaining sessions very well.  \nBy her ___ session she reported subjective improvement in lower \nextremity weakness and numbness of the dorsal aspect of her feet \nbilaterally.  \n\nNeurologic exam at discharge showed significantly improved ___ \nstrength throughout except delts and ___ (4+/5).  Also slightly \nimproved sensory exam, with proprioception at ankles and \nvibration intact at the malleolus bilaterally.  She was \ndischarged on ___ and will follow up with Dr. ___ \nDr. ___ in clinic on ___ as an outpatient.\n \nMedications on Admission:\nMEDICATIONS:\nMetoclopramide 10 mg PO TID \nProchlorperazine 10 mg PO Q6H:PRN nausea \nAspirin 81 mg PO DAILY \nOmeprazole 20 mg PO BID\nSimvastatin 20 mg PO DAILY \nLidocaine 5% Patch 1 PTCH TD DAILY on at 8 am, off at 8 pm \nAmlodipine 5 mg PO DAILY bisacodyl\nSertraline 100 mg PO DAILY \nBuPROPion 100 mg PO BID  \nMultivitamins 1 TAB PO DAILY  \nLactulose 15 mL PO TID  \nPolyethylene Glycol 17 g PO BID  \nBisacodyl 5 mg PO DAILY:PRN constipation \nGlycerin Supps 1 SUPP PR PRN constipation  \nNitroglycerin SL 0.3 mg SL PRN chest pain; may use q 5 min x 3  \nDocusate Sodium 100 mg PO BID \nIsosorbide Mononitrate (Extended Release) 60 mg PO DAILY  \nUltram 50 mg PO QD\nMetformin HCl 500mg 1 tab PO BID\nNeurontin 100mg PO BID\nMilk of magnesia prn\nAtivan 0.5 mg 1 tab q 6 hrs prn\nRobitussin prn\nDuonebs q4 hrs prn\nFleet enema prn\n\n \nDischarge Medications:\nMEDICATIONS:\nMetoclopramide 10 mg PO TID \nProchlorperazine 10 mg PO Q6H:PRN nausea \nAspirin 81 mg PO DAILY \nOmeprazole 20 mg PO BID\nSimvastatin 20 mg PO DAILY \nLidocaine 5% Patch 1 PTCH TD DAILY on at 8 am, off at 8 pm \nAmlodipine 5 mg PO DAILY bisacodyl\nSertraline 100 mg PO DAILY \nBuPROPion 100 mg PO BID  \nMultivitamins 1 TAB PO DAILY  \nLactulose 15 mL PO TID  \nPolyethylene Glycol 17 g PO BID  \nBisacodyl 5 mg PO DAILY:PRN constipation \nGlycerin Supps 1 SUPP PR PRN constipation  \nNitroglycerin SL 0.3 mg SL PRN chest pain; may use q 5 min x 3  \nDocusate Sodium 100 mg PO BID \nIsosorbide Mononitrate (Extended Release) 60 mg PO DAILY  \nUltram 50 mg PO QD\nMetformin HCl 500mg 1 tab PO BID\nNeurontin 100mg PO BID\nMilk of magnesia prn\nAtivan 0.5 mg 1 tab q 6 hrs prn\nRobitussin prn\nDuonebs q4 hrs prn\nFleet enema prn\n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nIdiopathic sensorimotor polyneuropathy.\n\n \nDischarge Condition:\nCondition: in no distress\nMental status: alert, fully oriented and coherent\nAmbulatory status: improved strength, ambulates to chair with \nhelp of ___.\nPertinent findings on physical examination upon discharge:\nMotor:\n* Bulk: Atrophy in the small muscles of the hands and feet\nbilaterally.\n* Tone: Normal.  No evidence of cogwheel rigidity or paratonia. \n* Drift: No pronator drift bilaterally.\n* Adventitious Movements: No tremor or asterixis noted.  \nPseudoathetosis of fingers with arm raise.\n.\nMotor examination:  \n Her neck flexors and extensors are ___.  \n   D  B  T  WF WE FF  FE  IP  Q  HS   DF  ___  \nL  ___   ___  5     ___   \nR  ___   ___  5     ___   \n.\nReflexes:\nbiceps 2+ bilaterally\nAbsent triceps, brachioradialis, patella, achilles. \nPlantar reflexes:   flexor bilaterally \n.\nSensation:\n* Light Touch: intact bilaterally in upper + lower extremities\n* Pinprick: UE diminished from mid-forearm distally in left \nupper extremities intact in the right upper extremity\n___: diminished from mid-shin distally in left lower extremities, \nintact in right lower extremity foot to knee, diminished on \nplantar surface of foot\n* Vibration: upper extremities intact, ___- right: vibration \nundetected in malleolus or patella, left: detected only at \npatella\n* Proprioception: absent in great toe bilaterally, present at \nankles bilaterally \n.\nCoordination\n* Finger-to-nose: intact with intention tremor bilaterally\n\n \nDischarge Instructions:\nDear ___,\n\n___ has been a pleasure taking care of you.\nYou were admitted to us for plasmapheresis, in the setting of \nleg weakness, numbness of your arms, a condition we are calling \npolyneuropathy.\nYou were admitted on ___, a central was placed on ___, \nand we started the plasmapheresis on ___. You received a \ntotal of 5 pheresis courses:\n___ and ___.\nYou had vomiting after the first pheresis. You did not have any \nfurther nausea or vomiting. You reported some fatigue, which is \nexpected after the plasmapheresis.\nYou also reported improvement in your strength.\nDuring this admission, you had a problem with constipation, and \nyou responded well to bisacodyl suppositories. This problem can \nbe related to staying in bed and not moving around a lot. We \nencourage you to move as much as possible, as well as drinking \nfluids, eating a fiber rich diet, and if need be, please \nadminister bisacodyl suppository as needed.\nWe will not be making any changes to your home medications.\nWe would like you to follow up with Dr. ___ we have \nmade the appointment for you.\nPlease contact our neurology office with any questions or \nconcerns.\nYou will be discharged back to rehabilitation at ___.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee75393366b"
  },
  "note_id": "19550378-DS-26",
  "subject_id": 19550378,
  "hadm_id": 24419086,
  "note_type": "DS",
  "note_seq": 26,
  "charttime": "2145-04-24 00:00:00",
  "storetime": "2145-04-25 17:21:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROLOGY\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin\n \nAttending: ___.\n \nChief Complaint:\nWorsening numbness\n \nMajor Surgical or Invasive Procedure:\nCentral line placement for plasmapheresis\n\n \nHistory of Present Illness:\nMs. ___ is an obese right-handed ___ ___\nyear-old woman w/ PMH of severe idiopathic axonal sensorimotor\npolyneuropathy previously responsive to plasmapheresis, HTN,\nDMII, HLD, and depression p/w with worsening numbness and\nweakness secondary to her chronic axonal polyneuropathy, \nadmitted\nfor elective plasmapheresis.\n.\nPatient has baseline chronic numbness distally that has \ngradually\nmoved proximally from ankles to midshin bilaterally. At \nbaseline,\nshe is in a wheelchair and lives in assisted living facility in\n___, where she requires assistance for showering and\ndressing but is able to transfer herself and eat independently.\nShe has urinary incontinence and requires For the past two\nmonths, she has had increased numbness in her hands and feet. \nShe\nhas noticed these symptoms in that her feet seem to \"buckle\" \nmore\nat the ankles, and she has less sensation in her feet and \nankles.\nIn her hands, she has been having decreased sensation as well:\nhas been dropping things more and having difficulty with\nactivities like picking knife up off the table to eat and using\nher hands to get her Pullups on. As she has had similar symptoms\nin the past which responded well to plasmapheresis, she is being\nadmitted today for scheduled plasmapheresis at the request of \nher\nprimary neurologist Dr. ___. \n.\nThe patient first noticed the onset of neurological symptoms as  \n\nearly as ___. As a result of difficulty walking and severe knee \n\n\npain, she underwent bilateral knee replacements over the course  \n\nof the subsequent ___ years (___). Despite the  \noperations, she required the assistance of a cane to ambulate  \nsecondary to lower extremity weakness. After falling while  \nperforming transfers, the patient ultimately became wheelchair  \nbound by approximately ___. By ___, the weakness extended from \n\n\nthe lower extremities into the trunk and upper extremities.\nExacerbations in numbness and weakness have been successfully\ntreated with plasma exchange in the past. She typically notes\nimprovement ___ months after treatment. Per prior records, she\nhas received 4 plasma exchange treatments most recently in ___ and ___.  \nShe was admitted for similar symptoms in ___ with numbness in\nher distal hands and feet as well as urge incontinence, which\nimproved gradually with plasmapheresis. \n.\nOf note, patient has had complications with plasmapheresis in \nthe\npast including coronary vasospasm, bradycardia and central line\ninfection. Her most recent plasmapheresis session in ___ was\ncomplicated only by transient nausea and emesis. \n.\nOn neurologic review of symptoms, patient endorses mildly \nblurred\nvision which has been present for the past month. She also\nendorses chronic frontal tension headache for which she does not\ntake medications. Endorses chronic dizziness and vertigo which\nare exacerbated by going from lying to standing and improved by\nlying still. \n.\nOn general review of systems, patient endorses occasional brief\nepisodes of chest pain at rest (of note, was ruled out for\nchronic CHF in ___. Also endorses urinary urgency and burning\nduring urination which she believes may indicate that she has a\nUTI. She also endorses generally poor energy level overall for\nthe past several months. \n \nPast Medical History:\nPAST MEDICAL HISTORY:  \n- Severe idiopathic axonal sensorimotor polyneuropathy  \n* initial sx in ___ (weakness and sensory loss in legs -->  \nabdomen --> arms)  \n* responsive to plasmapheresis (last sessions ___  \n\n* prior evaluation (per Dr. ___ dated ___:  \n- Sural nerve biopsy: marked loss of large and small myelinated  \n\naxons  \n- Vitamin B12 deficiency  \n- HTN  \n- DM (type II)  \n- GERD  \n- Depression  \n- Diverticulosis  \n.  \nPAST SURGICAL HISTORY:  \n- c-section x 2  \n- hysterectomy for leiomyomata  \n- left breast lumpectomy  \n- bilateral knee replacements  \n- portacath (since removed)  \n- surgery related to recent abdominal hematoma related to sc  \nheparin  \n \nSocial History:\n___\nFamily History:\nFAMILY HISTORY:\n- negative for neurological conditions\n- positive for DM (mother, brother), malignancy (mother - liver, \ncervical, colon; father - lung), CAD (mother)\n\n \nPhysical Exam:\nPHYSICAL EXAM: \n-Vitals: 98.1 115/74 69 18 99% RA\n-General: obese older woman lying supine in bed, talking\ncomfortably with examiner.  \n-HEENT: Normocephalic, atraumatic, no scleral icterus noted.\nMucus  \nmembranes moist, no lesions noted in oropharynx  \nNeck: Supple. No carotid bruits appreciated.  \nCardiac: Regular rate, normal S1 and S2.  \nPulmonary: Lungs clear to auscultation bilaterally anteriorly.  \nAbdomen: Obese. Normoactive bowel sounds. Soft. Non-tender,  \nnon-distended.  \nExtremities: No evidence of cyanosis or edema.  \nSkin: no rashes or concerning lesions noted.  \n.  \n-Neurological:  \n\nMental status:  She is awake, alert, and oriented x3.  She is\ncapable of telling a coherent history. For memory, registration\nand recall are ___ at 0 and 5 minutes. Normal prosody. No\ndysarthria or paraphasic errors. \n\nCranial nerves:  Her acuity is normal.  Her pupils are equal and\nreactive to light. Extraocular movements are intact.  Her face \nis\nstrong and there is no dysarthria. She has no ptosis or\nfatigability.  Her hearing is intact. Tongue protrusion is\nstrong.  \n\nMotor examination:  There is decreased bulk in the small muscles\nof the hands and feet. Her neck flexors and extensors are ___.  \n\n   D  B  T  WF WE FE ADM APB IP Q  HS DF\nL  ___   4-  ___- 5  5\nR  ___-  4-  ___- 5  5\n\nReflexes: Absent throughout. Toes are downgoing bilaterally.\n\nSensation: Decreased pinprick and light touch sensation in both\ndistal lower extremities, L>R. Also decreased pinprick and light\ntouch in left upper extremity. No vibratory sense in ankles or\nknees. Poor proprioception, particularly on left hand compared \nto\nright. \n\nGait: not tested\n \nPertinent Results:\nADMISSION LABS:\n\n___ 04:30AM BLOOD WBC-4.7 RBC-4.48 Hgb-13.4 Hct-40.8 MCV-91 \nMCH-29.9 MCHC-32.9 RDW-13.7 Plt ___\n___ 01:20AM BLOOD Neuts-87.2* Lymphs-9.3* Monos-2.7 Eos-0.5 \nBaso-0.3\n___ 04:30AM BLOOD ___ PTT-30.6 ___\n___ 04:30AM BLOOD Glucose-86 UreaN-16 Creat-1.0 Na-143 \nK-4.4 Cl-104 HCO3-31 AnGap-12\n___ 04:30AM BLOOD Calcium-9.4 Phos-5.1* Mg-2.0\n\nPERIPHERAL NEUROPATHY WORKUP: \n- VitB12-1064*\n- %HbA1c-5.4 eAG-108\n- Methylmalonic acid: 192 \n- SPEP: no specific abnormalities\n- UPEP: no protein \n\nMICROBIOLOGY: \n\nURINE CULTURE (___): \n\n   ESCHERICHIA COLI.    10,000-100,000 ORGANISMS/ML.. \n         PRESUMPTIVE IDENTIFICATION. \n         Cefazolin interpretative criteria are based on a dosage \nregimen of\n         2g every 8h. \n         Piperacillin/tazobactam sensitivity testing available \non request. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             ESCHERICHIA COLI\n                             |   \nAMPICILLIN------------  =>32 R\nAMPICILLIN/SULBACTAM--     4 S\nCEFAZOLIN-------------   <=4 S\nCEFEPIME--------------   <=1 S\nCEFTAZIDIME-----------   <=1 S\nCEFTRIAXONE-----------   <=1 S\nCIPROFLOXACIN---------<=0.25 S\nGENTAMICIN------------   <=1 S\nMEROPENEM-------------<=0.25 S\nNITROFURANTOIN--------  <=16 S\nTOBRAMYCIN------------   <=1 S\nTRIMETHOPRIM/SULFA----  =>16 R\n \nBrief Hospital Course:\n___ woman with a severe, idiopathic large-fiber \npolyneuropathy or sensory neuronopathy, admitted for scheduled \nplasmapheresis in setting of continued progression of her \nnumbness and proprioceptive sensory loss. \n\n# NEURO: Patient was admitted to the General Neurology service. \nPlasmapheresis line was placed without complication. She \nunderwent 5 sessions of plasmapheresis. She was monitored on \ntelemetry throughout given her history of coronary vasospasm \nwith plasmapheresis. Her course was complicated by severe \nband-like lower abdominal pain following the first session, \nwhich was worked up extensively and found to be most likely \nrelated to transient vasospasm or fluid shifts after \nplasmapheresis, as well as an overly aggressive bowel regimen. \nPlasmapheresis was held for three days while her abdominal pain \nwas treated. With vigorous hydration prior to plasmapheresis as \nwell as supportive care with lorazepam for nausea, her abdominal \npain was better controlled. She then underwent the next four \nsessions of plasmapheresis. On the evening following removal of \nher pheresis line, she spiked a fever to 102, likely related to \ntransient bacteremia caused by line removal. Her line site \nappeared uninfected and infectious workup (blood cultures x2, \nurine culture, CXR) were normal. She remained afebrile for 24 \nhours following this. \n\nOn admission, patient's neuro exam was notable for atrophy in \nthe small muscles of the hands and feet bilaterally, symmetric \nweakness of the extensors of the upper extremities, diffuse \nareflexia, decreased sensation to light touch and pinprick L>R, \nand severely decreased vibration and proprioception in the feet \nand lower legs bilaterally, and pseudoathetosis of both feet, \nall consistent with known diagnosis of severe sensorimotor \npolyneuropathy.  On discharge her neuro exam had improved \nslightly in that joint position sense at the ankles was mildly \nimproved. Of note, it typically takes ___ weeks for patient to \nexperience benefits from plasmapheresis. \n\n# ID: On admission, patient complained of dysuria and was found \nto have a UTI (E. coli, sensitive to everything but TMP-SMX). \nShe was treated with a 5-day course of Ciprofloxacin and her \nsymptoms improved. \n\n=====================\nTRANSITIONS OF CARE: \n- Studies pending on discharge = blood cultures (___) \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Magnesium Citrate 300 mL PO QMON \n2. Magnesium Citrate 300 mL PO QTHUR \n3. TraMADOL (Ultram) 50 mg PO DAILY \n4. Acetaminophen 650 mg PO DAILY \n5. Aspirin 81 mg PO DAILY \n6. Sertraline 100 mg PO DAILY \n7. Multivitamins 1 TAB PO DAILY \n8. Vitamin D 1000 UNIT PO DAILY \n9. Psyllium 1 PKT PO BID \n10. Gabapentin 100 mg PO BID \n11. BuPROPion 100 mg PO BID \n12. Docusate Sodium 100 mg PO BID \n13. Lactulose 30 mL PO TID \n14. Simvastatin 20 mg PO HS \n15. Lorazepam 0.5 mg PO Q6H:PRN anxiety \n16. Bisacodyl 10 mg PO DAILY:PRN constipation \n17. Cyanocobalamin 1000 mcg IM/SC MONTHLY \n\n \nDischarge Medications:\n1. Acetaminophen 650 mg PO DAILY \n2. Aspirin 81 mg PO DAILY \n3. Bisacodyl 10 mg PO DAILY:PRN constipation \n4. BuPROPion 100 mg PO BID \n5. Cyanocobalamin 1000 mcg IM/SC MONTHLY \n6. Docusate Sodium 100 mg PO BID \n7. Gabapentin 100 mg PO BID \n8. Lactulose 30 mL PO TID \n9. Lorazepam 0.5 mg PO Q6H:PRN anxiety \n10. Magnesium Citrate 300 mL PO QMON \n11. Magnesium Citrate 300 mL PO QTHUR \n12. Multivitamins 1 TAB PO DAILY \n13. Psyllium 1 PKT PO BID \n14. Sertraline 100 mg PO DAILY \n15. Simvastatin 20 mg PO HS \n16. TraMADOL (Ultram) 50 mg PO DAILY \n17. Vitamin D 1000 UNIT PO DAILY \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\n1. Severe axonal sensorimotor polyneuropathy\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nDear Ms. ___, \n\nYou were admitted to the hospital for plasmapheresis to treat \nyour sensorimotor axonal polyneuropathy. You received 5 sessions \nof plasmapheresis. You had several episodes of abdominal pain \nfollowing plasmapheresis which we believe may have been related \nto transient fluid shifts: this was helped with IV fluids. On \nthe day after your last session of plasmapheresis, you had a \nfever. The cause for this was not found but was likely caused by \nremoval of your plasmapheresis catheter causing brief \nintroduction of bacteria to your blood. You are being discharged \nto home with physical therapy, and will follow up with your \nneurologist and primary care doctor within the next couple of \ndays.  \n.\nPlease attend the follow-up appointment listed below with Dr. \n___ to follow up on your hospitalization. \n.\nWe did not make any changes to your home medications. Please \ncontinue to take them as you were prior to hospitalization. \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee75393366c"
  },
  "note_id": "19550378-DS-27",
  "subject_id": 19550378,
  "hadm_id": 26215406,
  "note_type": "DS",
  "note_seq": 27,
  "charttime": "2145-12-15 00:00:00",
  "storetime": "2145-12-15 10:41:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin\n \nAttending: ___.\n \nChief Complaint:\nabdominal pain, diarrhea\n \nMajor Surgical or Invasive Procedure:\nMonitor BP; has previously been on amlodipine and long acting\nnitrates. She was restarted on amlodipine on ___.\n \nHistory of Present Illness:\n___ year-old woman w/ PMH of severe idiopathic axonal \nsensorimotor polyneuropathy previously responsive to \nplasmapheresis, HTN, DMII, HLD, and depression who is admitted \nto the Medicine service with complaints of abdominal pain and \ndiarrhea. \n\nHer symptoms started on ___.  She had diarrhea, lower abd \npain and a headache.  The headache has waxed and waned and is \ndescribed as a dull frontal headache.  She's had some nausea \nwith emesis as well.  These symptoms prompted her to present to \nthe ED on ___.  She had a full work up including CT A/P that \nshowed pandiverticulosis but no evidence for acute abnormalities \naccounting for her discomfort.  Per ED note, her headache \nresolved during that stay.  She was discharged to home.\n\nToday, she re-presented to the ED noting that she continued to \nfeel poorly with nausea and emesis.  She's not had any further \ndiarrhea.  The abdominal pain is described as lower (in the \nsuprapubic region).  There are no exacerbating or relieving \nfactors that she's noted.  She mostly complains of pain in her \nlateral left leg that she says is chronic but worse than normal. \n She denies any trauma or falls.  \n\nIn the ED: vital signs were: 98.8  72  185/85  18  92-98% RA.  \nShe received IV ketorolac, ondansetron, hydromorphone as well as \noxcodone and tramadol.  LFTs were remarkable for: AST 44, ALT \n26, AP 119, TotBil 0.8, CPK of 950.\nPatient denies any chest pain or pressure presently though says \nabout a month ago she had some that lasted 2 days, that she took \none SL nitroglycerin for it and 90 min later the pain resolved.\n\nPresently, she has no nausea, the pain in the abd and leg is \nbetter after \"whatever they gave me in the ED\" and she notes \nonly a mild dull headache.  No new weakness.  No fevers, chills, \nshortness of breath.  No lymphadenopathy, no dysuria.\n\nShe believes she's caught a \"bug\" that has been going around her \nliving facility noting that numerous staff and residents have \nbeen sick.  She however goes on to say she does not know what \nsymptoms these folks have had.\n\nReview of Systems:  \n(+) as per HPI above\n(-) fever, chills, night sweats, headache, vision changes, \nrhinorrhea, congestion, sore throat, cough, shortness of breath, \nchest pain, BRBPR, melena, hematochezia, dysuria, hematuria.\n \nPast Medical History:\nFrom OMR - confirmed with patient\n\nPAST MEDICAL HISTORY:  \n- Severe idiopathic axonal sensorimotor polyneuropathy  \n* initial sx in ___ (weakness and sensory loss in legs -->  \nabdomen --> arms)  \n* responsive to plasmapheresis (last sessions ___  \n\n* prior evaluation (per Dr. ___ dated ___:  \n- Sural nerve biopsy: marked loss of large and small myelinated  \n\naxons  \n- Vitamin B12 deficiency  \n- HTN  \n- DM (type II)  \n- GERD  \n- Depression  \n- Diverticulosis  \n.  \nPAST SURGICAL HISTORY:  \n- c-section x 2  \n- hysterectomy for leiomyomata  \n- left breast lumpectomy  \n- bilateral knee replacements  \n- portacath (since removed)  \n- surgery related to recent abdominal hematoma related to sc  \nheparin  \n \nSocial History:\n___\nFamily History:\nfrom OMR\n- negative for neurological conditions\n- positive for DM (mother, brother), malignancy (mother - liver, \ncervical, colon; father - lung), CAD (mother)\n\n \nPhysical Exam:\nAdmission:\nGENERAL: Pleasant, well appearing obese woman in NAD  \nVS: 98.2  162/98  78  18  100% RA\nHEENT: Normocephalic, atraumatic. No conjunctival pallor. No \nscleral icterus.  + lipoma behind right ear, non-tender\nPERRLA/EOMI. MMM. OP clear. Neck Supple, No LAD.  \nCARDIAC: Regular rate.  HS distant. \nLUNGS: CTAB, good air movement biaterally.  \nABDOMEN: NABS. Soft. + TTP suprapubic pain and also diffusely.  \nNo RT/guarding. \nEXTREMITIES: No edema or calf pain.  FROM of left hip.  No \nreproducible tenderness over left lateral thigh btwn knee and \nhip where patient notes pain. \nSKIN: No rashes/lesions, ecchymoses.  \nNEURO: A&Ox3. Appropriate. CN ___ grossly intact. ___ and \nspeech appropriate. Gait assessment deferred  \nPSYCH: Listens and responds to questions appropriately, pleasant \n\n\nDischarge: \nAfebrile  152/75  P65  R18  95RA\nGEN: comfortable, NAD\nRESP: CTA B\nCV: RRR.\nAbd: obese. +NABS. Soft, nt/nd.\n\n \nPertinent Results:\nECG Study Date of ___  4:47:06 ___ \nSinus rhythm. Biatrial abnormality. Cannot exclude prior \ninferior-posterior myocardial infarction. Compared to the \nprevious tracing of ___ multiple abnormalities as described \nare new. \n \nECG Study Date of ___  8:34:02 AM \nSinus rhythm. Compared to the previous tracing there is no \nsignificant change. \n \n\n___ 09:30AM BLOOD WBC-12.4* RBC-6.09* Hgb-18.4* Hct-52.6* \nMCV-86 MCH-30.2 MCHC-35.0 RDW-13.8 Plt ___\n___ 06:40AM BLOOD WBC-8.9 RBC-5.45* Hgb-16.5* Hct-48.3* \nMCV-89 MCH-30.4 MCHC-34.2 RDW-14.2 Plt ___\n___ 09:30AM BLOOD Glucose-115* UreaN-17 Creat-0.9 Na-130* \nK-4.0 Cl-88* HCO3-28 AnGap-18\n___ 06:40AM BLOOD Glucose-108* UreaN-14 Creat-0.9 Na-136 \nK-3.8 Cl-96 HCO3-30 AnGap-14\n___ 09:30AM BLOOD ALT-26 AST-44* CK(CPK)-950* AlkPhos-119* \nTotBili-0.8\n___ 06:40AM BLOOD ALT-22 AST-32 CK(CPK)-411* AlkPhos-95 \nTotBili-0.8\n___ 09:30AM BLOOD Lipase-32\n___ 10:20AM BLOOD CK-MB-9 cTropnT-0.03*\n___ 06:40AM BLOOD CK-MB-5\n___ 06:40AM BLOOD Calcium-8.8 Phos-2.8 Mg-2.1\n___ 09:30AM BLOOD Albumin-4.6\n___ 01:54PM URINE Color-Straw Appear-Clear Sp ___\n___ 01:54PM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG\n\n___ BLOOD CULTURE Blood Culture, Routine-PENDING \nEMERGENCY WARD \n___ BLOOD CULTURE Blood Culture, Routine-PENDING \nEMERGENCY WARD \n\n \nBrief Hospital Course:\nMs. ___ is a ___ yo F with functional impairment (WC bound) \nsecondary to severe idiopathic neuropathy (treated with yearly \nplasmapheresis) admitted with 4 days of lower abdominal pain, \ndiarrhea ___, none since, no dysuria, no fevers, + dull \nheadache, some nausea and vomiting (last episode of emesis \n___.  She has been afebrile and CT scan was reassuring.  Her \nLFTs were slightly elevated on presentation but normalized after \n24 hours.  Her CPK was elevated on admission but has come down \nwith hydration.  She notes intermittent CP that does not sound \nanginal (not exertional, will last x hours to days, then \nresolves); EKGs here have been without ischemic changes.  \nTroponins and CPK-MBs have been flat.  She has been treated \nsupportively for a viral gastroenteritis.  Her diet was slowly \nadvanced which she tolerated well.  Her nausea and abdominal \npain improved, and was nearly resolved by the time of discharge.\n\nAcute Issues:\n## Probable acute viral syndrome\n## Nausea, vomiting, dehydration, diarrhea\n## Abnormal LFTs\n--Improved with supportive care\n\n## L thigh pain\n## Elevated CPK\nSuspect patient's left thigh pain was likely due to immobility, \nand inadequate pressure relief causing underlying muscle damage, \nas evidenced by CPK elevation on admission to 950.  CPK \ndowntrended prior to discharge.  Her pain was helped by cool \npacks.\n\n## Hypertension - histoy of this, not on antihtn medications at \ntime of admission, but quite hypertensive in the ED and still \nhypertensive on the gen med floor.  Suspect component of pain \ncontributing.  She was started on low-dose amlodipine during the \nadmission, which may be uptitrated as needed.\n\nChronic Issues:\n## Idiopathic neuropathy\n--continued chronic meds. F/u with Dr. ___ as needed\n\n## Depression\n--continue chronic meds (gabapentin, buproprion, tramadol, \nsertraline)\n\n## B12 deficiency\n--qmonthly injection\n\n## CAD with h/o MI after plasphapheresis\n## hypercholesterolemia\n--continue ASA, statin\n\nTransitional Issues:\n--Pt reported difficult mobility, and will be discharged to \nrehab for Physicial Therapy.  Pt is also developing sacral \npressure ulcers, and should focus on frequent re-positioning.\n--Follow up blood pressure control and titrate medications as \nneeded.\n--Please note EKG report in results section. Consider cardiology \nreferral as an outpatient, if appropriate.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Lactulose 15 mL PO TID \n2. Acetaminophen 1000 mg PO DAILY \n3. Gabapentin 100 mg PO BID \n4. BuPROPion 100 mg PO BID \n5. Lorazepam 0.5 mg PO Q6H:PRN as needed \n6. bisacodyl *NF* 5 mg Oral once a day as needed for \nconstipation \n7. Docusate Sodium 100 mg PO BID \n8. Glycerin Supps ___AILY:PRN as needed \n9. magnesium hydroxide *NF* unknown  Oral as needed \n10. Polyethylene Glycol 17 g PO BID \n11. psyllium seed (with dextrose) *NF* 1 (one) Powder  Oral \nDaily \n12. Simvastatin 20 mg PO DAILY \n13. Multivitamins 1 TAB PO DAILY \n14. Nitroglycerin SL 0.4 mg SL ASDIR \n15. TraMADOL (Ultram) 50 mg PO DAILY \n16. Aspirin 81 mg PO DAILY \n17. Sertraline 100 mg PO DAILY \n18. Vitamin D Dose is Unknown  PO DAILY \n19. Cyanocobalamin Dose is Unknown  IM/SC MONTHLY \n\n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO DAILY \n2. Aspirin 81 mg PO DAILY \n3. bisacodyl *NF* 5 mg Oral once a day as needed for \nconstipation \n4. BuPROPion 100 mg PO BID \n5. Docusate Sodium 100 mg PO BID \n6. Gabapentin 100 mg PO BID \n7. Lactulose 15 mL PO TID \n8. Lorazepam 0.5 mg PO Q6H:PRN as needed \n9. Multivitamins 1 TAB PO DAILY \n10. Polyethylene Glycol 17 g PO BID \n11. Sertraline 100 mg PO DAILY \n12. Simvastatin 20 mg PO DAILY \n13. TraMADOL (Ultram) 50 mg PO DAILY \n14. Amlodipine 5 mg PO DAILY \nRX *amlodipine 5 mg 1 tablet(s) by mouth once a day Disp #*30 \nTablet Refills:*0\n15. Cyanocobalamin 0 mcg IM/SC MONTHLY \n16. Glycerin Supps ___AILY:PRN as needed \n17. magnesium hydroxide *NF* 0 mg ORAL AS NEEDED \n18. Nitroglycerin SL 0.4 mg SL ASDIR \n19. psyllium seed (with dextrose) *NF* 1 (one) Powder  Oral \nDaily \n20. Vitamin D 1000 UNIT PO DAILY \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\n## Nausea, vomiting, dehydration, diarrhea\n## Elevated CPK\n## Abnormal LFTs\n## Idiopathic neuropathy\n## Hypertension - histoy of this, not on antihtn medications, \nbut\nquite hypertensive in the ED and periodically hypertensive on \nthe\ngen med floor.  Suspect component of pain contributing.\n## Depression\n## B12 deficiency\n## CAD with h/o MI after plasphapheresis\n## hypercholesterolemia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nYou were admitted to the hospital with some nausea, vomiting, \ndiarrhea and abdominal pain.  You developed these symptoms which \nwere similar to what some of the other folks at ___ \n___ had, so perhaps it was a viral syndrome.  You had a CT \nscan that was reassuring.  You improved with supportive care but \nwere still quite tired after the past week's illness so are \nbeing discharge to ___ rehab for some ongoing care and \nsupport.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee75393366d"
  },
  "note_id": "19550378-DS-28",
  "subject_id": 19550378,
  "hadm_id": 29751524,
  "note_type": "DS",
  "note_seq": 28,
  "charttime": "2146-10-15 00:00:00",
  "storetime": "2146-10-15 20:32:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin / Tegaderm\n \nAttending: ___.\n \nChief Complaint:\nneuropathy\n \nMajor Surgical or Invasive Procedure:\npheresis catheter placement\n\n \nHistory of Present Illness:\n___ admitted from home to undergo plasmapheresis for her severe \nidiopathic axonal senorimotor polyneuropathy.  Last pheresis was \nin ___.  She had recent progressive ataxia related to her \nneuropathy and last saw her neurologist, Dr. ___ in ___, who advised her treatment with pheresis.  Other than some \nincreased ataxia and distal extremity discomfort from her \nneuropathy, she has not had recent health changes and as such \n13pt ROS is negative without recent pulmonary, cardiac, new \nabdominal symptoms beyond chronic constipation, new joint pains \nother than chronic knee pain, rashes, fevers, weight loss, mood \nchanges.\n\nP=\n \nPast Medical History:\nFrom ___ - confirmed with patient\n\nPAST MEDICAL HISTORY:  \n- Severe idiopathic axonal sensorimotor polyneuropathy  \n* initial sx in ___ (weakness and sensory loss in legs -->  \nabdomen --> arms)  \n* responsive to plasmapheresis (last sessions ___, \n___  \n* prior evaluation (per Dr. ___ dated ___:  \n- Sural nerve biopsy: marked loss of large and small myelinated  \n\naxons  \n- Vitamin B12 deficiency  \n\n*Past D/c Summary also lists DM2 but patient not on therapy for \nDM2\n- HTN  \n- DM (type II)  \n- GERD  \n- Depression  \n- Diverticulosis  \n.  \nPAST SURGICAL HISTORY:  \n- c-section x 2  \n- hysterectomy for leiomyomata  \n- left breast lumpectomy  \n- bilateral knee replacements  \n- portacath (since removed)  \n- surgery related to recent abdominal hematoma related to sc  \nheparin  \n \nSocial History:\n___\nFamily History:\nfrom OMR\n- negative for neurological conditions\n- positive for DM (mother, brother), malignancy (mother - liver, \ncervical, colon; father - lung), CAD (mother)\n\n \nPhysical Exam:\n97 142/69 65\npleasant aox3 obese female lying in bed\nclear bs\nregular s1 and s2\nsoft abd\nshe has bilateral spontaneous movement of both her feet\nshe has impaired position sense of her fingers and toes and her \ngrip is weaker on L than right, dimished sensation to light \ntouch to both feet\nno rash\nno pitting edema to either ankle\n\nExam on discharge:\nVS:98.3 BP: 93/47 HR: 52 R: 18 O2: 100% RA\nWell appearing young woman, laying in bed in NAD.\nHEENT: MMM. No cervical lymphadenopathy. No tonsillar erythema \nor\nexudate. Mild scleral icterus.\nLungs: Clear B/L on auscultation\nAbd: Soft, Slightly tender on palpation of epigastrium, RUQ. No\nrebound or guarding\nEXT: No edema, no rashes\n\n \nPertinent Results:\n___ 09:30PM BLOOD WBC-6.7 RBC-4.40 Hgb-13.6 Hct-41.1 MCV-94 \nMCH-31.0 MCHC-33.2 RDW-13.8 Plt ___\n___ 09:30PM BLOOD Glucose-119* UreaN-12 Creat-1.0 Na-140 \nK-3.9 Cl-103 HCO3-30 AnGap-11\n___ 09:30PM BLOOD CK(CPK)-100\n___ 09:30PM BLOOD Calcium-9.6\n \nBrief Hospital Course:\nThis is a ___ woman with a severe, idiopathic \nlarge-fiber polyneuropathy or predominantly sensory neuronopathy \nnow admitted for plasmapheresis treatment due to progressive \nataxia related to her polyneuropathy. \n\n#Polyneuropathy\nThe patient was admitted for plasmapheresis  She had pheresis \ncatheter placed on ___.  She received 5 treatments of \nplasmapheresis.  She remained on telemetry given her past h/o \ncoronary vasospasm around the time of past plasmapheresis.  \nTelemetry was unremarkable and she had no report of chest pain \nor dyspnea during this admission.   She tolerated the procedures \nwell and was discharged home following her ___ treatment. She \nwill follow up with her neurologist, Dr. ___ as an \noutpatient.\n\n#Hypertension\nContinued amlodipine\n\n#Hyperlipidemia\nContinued Statin, ASA\n\n#Depression/Anxiety\nContinued lorazepam/sertraline\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 1000 mg PO DAILY \n2. Aspirin 81 mg PO DAILY \n3. bisacodyl 5 mg Oral once a day as needed for constipation \n4. BuPROPion 100 mg PO BID \n5. Docusate Sodium 100 mg PO BID \n6. Gabapentin 100 mg PO BID \n7. Lactulose 15 mL PO TID \n8. Lorazepam 0.5 mg PO Q6H:PRN as needed \n9. Multivitamins 1 TAB PO DAILY \n10. Polyethylene Glycol 17 g PO BID \n11. Sertraline 100 mg PO DAILY \n12. Simvastatin 20 mg PO DAILY \n13. TraMADOL (Ultram) 50 mg PO DAILY \n14. Amlodipine 5 mg PO DAILY \n15. Cyanocobalamin 0 mcg IM/SC MONTHLY \n16. Glycerin Supps ___AILY:PRN as needed \n17. Nitroglycerin SL 0.4 mg SL ASDIR \n18. psyllium seed (with dextrose) 1 (one) Powder  Oral Daily \n19. Vitamin D 1000 UNIT PO DAILY \n\n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO DAILY \n2. Amlodipine 5 mg PO DAILY \n3. Aspirin 81 mg PO DAILY \n4. bisacodyl 5 mg Oral once a day as needed for constipation \n5. BuPROPion 100 mg PO BID \n6. Docusate Sodium 100 mg PO BID \n7. Gabapentin 100 mg PO BID \n8. Glycerin Supps ___AILY:PRN as needed \n9. Lactulose 15 mL PO TID \n10. Lorazepam 0.5 mg PO Q6H:PRN as needed \n11. Multivitamins 1 TAB PO DAILY \n12. Nitroglycerin SL 0.4 mg SL ASDIR \n13. Polyethylene Glycol 17 g PO BID \n14. Sertraline 100 mg PO DAILY \n15. Simvastatin 20 mg PO DAILY \n16. Vitamin D 1000 UNIT PO DAILY \n17. Cyanocobalamin 0 mcg IM/SC MONTHLY \n18. psyllium seed (with dextrose) 1 (one) Powder  Oral Daily \n19. TraMADOL (Ultram) 50 mg PO DAILY \n20. Miconazole Powder 2% 1 Appl TP BID \n\n \nDischarge Disposition:\nHome\n \nFacility:\n___\n \nDischarge Diagnosis:\nIdiopathic neuropathy refractory to treatment\nHypertension\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n \nDischarge Instructions:\nIt was a pleasure taking care of you during your recent \nadmission to ___. You were admitted for plasmapheresis as \ntreatment for your symptomatic neuropathy. You had 5 treatments \nwhile hospitalized which you tolerated well. You will need to \nfollow up with your neurologist, Dr. ___ in ___ as \nscheduled.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee75393366e"
  },
  "note_id": "19550378-DS-29",
  "subject_id": 19550378,
  "hadm_id": 27496577,
  "note_type": "DS",
  "note_seq": 29,
  "charttime": "2147-03-02 00:00:00",
  "storetime": "2147-03-02 17:34:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin / Tegaderm\n \nAttending: ___.\n \nChief Complaint:\nAbdominal pain\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ multiple comorbidities presents with 8 hrs of mid/epigastric \nabdominal pain, nausea and nonbillous emesis, CT suggestive of \npartial small bowel obstruction. \n\nPatient reports she has been feeling her general state of health \nat her assisted living facility, had a sandwich for dinner and \nwoke up at 12am with severe epigastric pain with extreme nausea \nand clear emesis x6. She has been passing flatus and last BM was \nlast night and in the ED.  Upon presentation to the ED, patient \nhad normal vitals, labs notable for normal WBC, N 79%, chem and\nLFTs. CT scan w/IV contrast showed dilated fluid filled loops of \njejunum without any transition point c/f low grade partial small \nbowel obstruction. An NGT was placed which drained about 200cc \nof clear/saliva-like fluid. Patient received zofran and 1L NS \nbolus. She currently reports persistent ___ epigastric pain and \nright knee pain. She had one episode of 20cc emesis in ED. She \nhas never had an EGD;her last c-scope was ___ notable for \ndiverticulosis. She denies any fevers, chills, weight loss, \nBRBPR, melena or dysuria.\n\n \nPast Medical History:\nFrom ___ - confirmed with patient\n\nPAST MEDICAL HISTORY:  \n- Severe idiopathic axonal sensorimotor polyneuropathy  \n* initial sx in ___ (weakness and sensory loss in legs -->  \nabdomen --> arms)  \n* responsive to plasmapheresis (last sessions ___, \n___  \n* prior evaluation (per Dr. ___ dated ___:  \n- Sural nerve biopsy: marked loss of large and small myelinated  \n\naxons  \n- Vitamin B12 deficiency  \n\n*Past D/c Summary also lists DM2 but patient not on therapy for \nDM2\n- HTN  \n- DM (type II)  \n- GERD  \n- Depression  \n- Diverticulosis  \n.  \nPAST SURGICAL HISTORY:  \n- c-section x 2  \n- hysterectomy for leiomyomata  \n- left breast lumpectomy  \n- bilateral knee replacements  \n- portacath (since removed)  \n- surgery related to recent abdominal hematoma related to sc  \nheparin  \n \nSocial History:\n___\nFamily History:\nfrom OMR\n- negative for neurological conditions\n- positive for DM (mother, brother), malignancy (mother - liver, \ncervical, colon; father - lung), CAD (mother)\n\n \nPhysical Exam:\nPHYSICAL EXAM:\n98.0  73  152/64  20  96%RA\nGEN: A&O, morbidly obese, NGT in place, uncomfortable\nHEENT: No scleral icterus, mucus membranes moist\nCV: RRR, No M/G/R\nPULM: Clear to auscultation b/l, No W/R/R\nABD: Soft, obese, nondistended, tender to deep palpation in\nepigastric, periumbilical region, no rebound or guarding,\nno palpable masses\nExt: No ___ edema, ___ warm and well perfused\n\nDischarge Physical Exam:\nVS: 99.0, 67, 142/62, 18, 99%ra\nGEN: AA&O x 3, NAD, calm, cooperative.\nHEENT: (-)LAD, mucous membranes moist, trachea midline, EOMI, \nPERRL.\nCHEST: Clear to auscultation bilaterally, (-) cyanosis.\nABDOMEN: (+) BS x 4 quadrants, soft, non tender to palpation, \nnon-distended. EXTREMITIES: Warm, well perfused, pulses \npalpable, no edema.\n \nPertinent Results:\n___ 09:20AM BLOOD WBC-6.3 RBC-4.52 Hgb-13.8 Hct-41.2 MCV-91 \nMCH-30.5 MCHC-33.4 RDW-14.0 Plt ___\n___ 05:30AM BLOOD WBC-5.7 RBC-4.80 Hgb-14.7 Hct-43.9 MCV-92 \nMCH-30.6 MCHC-33.4 RDW-14.0 Plt ___\n___ 09:20AM BLOOD Glucose-105* UreaN-12 Creat-0.9 Na-141 \nK-3.8 Cl-102 HCO3-27 AnGap-16\n___ 05:30AM BLOOD Glucose-143* UreaN-14 Creat-1.0 Na-142 \nK-4.0 Cl-101 HCO3-30 AnGap-15\n___ 05:30AM BLOOD ALT-19 AST-21 AlkPhos-96 TotBili-0.4\n\nABD/PELVIC CT:\n1. Dilated loops of jejunum in the left upper quadrant may \nrepresent focal ileus or less likely internal hernia. No \ndefinite transition point is  identified. No free air free \nfluid. 2. Pancolonic diverticulosis without diverticulitis. \n\n \nBrief Hospital Course:\n___ multiple comorbidities presents with 8 hrs of mid/epigastric \nabdominal pain, nausea and nonbillous emesis, CT suggestive of \npartial small bowel obstruction. Her bowel obstruction is low \ngrade on imaging and patient is not obstructed functionally. The \npatient is significantly symptomatic and is admitted to ___ \nservice for serial abdominal exams with bowel rest and \nhydration. The patient was hemodynamically stable. \n\nOn HD#2, the patient has a resolution of bowel obstruction, \nreporting large bowel movement and flatus. Diet was \nprogressively advanced as tolerated to a regular diet with good \ntolerability. The patient voided without problem. During this \nhospitalization, the patient remained at her baseline activity \nof transferring to and from the bed independantly, was adherent \nwith respiratory toilet and incentive spirometry, and actively \nparticipated in the plan of care. The patient received \nsubcutaneous heparin and venodyne boots were used during this \nstay.\n.\nAt the time of discharge, the patient was doing well, afebrile \nwith stable vital signs. The patient was tolerating a regular \ndiet, voiding without assistance, and pain was resolved.  The \npatient was discharged back to her assisted living residence. \nThe patient received discharge teaching and follow-up \ninstructions with understanding verbalized and agreement with \nthe discharge plan.\n\n \nMedications on Admission:\n1. Amlodipine 5 mg PO DAILY \n2. Aspirin 81 mg PO DAILY \n3. BuPROPion 100 mg PO BID \n4. Docusate Sodium 100 mg PO BID \n5. Gabapentin 100 mg PO BID \n6. Ondansetron 4 mg PO ONCE MR1 Duration: 1 Dose \nRX *ondansetron 4 mg 1 tablet(s) by mouth every six (6) hours \nDisp #*20 Tablet Refills:*0\n7. Sertraline 100 mg PO DAILY \n8. Simvastatin 20 mg PO DAILY \n\n \nDischarge Medications:\n1. Amlodipine 5 mg PO DAILY \n2. Aspirin 81 mg PO DAILY \n3. BuPROPion 100 mg PO BID \n4. Docusate Sodium 100 mg PO BID \n5. Gabapentin 100 mg PO BID \n6. Ondansetron 4 mg PO ONCE MR1 Duration: 1 Dose \nRX *ondansetron 4 mg 1 tablet(s) by mouth every six (6) hours \nDisp #*20 Tablet Refills:*0\n7. Sertraline 100 mg PO DAILY \n8. Simvastatin 20 mg PO DAILY \n9. TraMADOL (Ultram) 50 mg PO QID \nRX *tramadol [Ultram] 50 mg 1 tablet(s) by mouth four times a \nday Disp #*30 Tablet Refills:*0\n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPartial small bowel obstruction\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nPlease call your doctor or nurse practitioner or return to the \nEmergency Department for any of the following:\n*You experience new chest pain, pressure, squeezing or \ntightness.\n*New or worsening cough, shortness of breath, or wheeze.\n*If you are vomiting and cannot keep down fluids or your \nmedications.\n*You are getting dehydrated due to continued vomiting, diarrhea, \nor other reasons. Signs of dehydration include dry mouth, rapid \nheartbeat, or feeling dizzy or faint when standing.\n*You see blood or dark/black material when you vomit or have a \nbowel movement.\n*You experience burning when you urinate, have blood in your \nurine, or experience a discharge.\n*Your pain in not improving within ___ hours or is not gone \nwithin 24 hours. Call or return immediately if your pain is \ngetting worse or changes location or moving to your chest or \nback.\n*You have shaking chills, or fever greater than 101.5 degrees \nFahrenheit or 38 degrees Celsius.\n*Any change in your symptoms, or any new symptoms that concern \nyou.\n\nPlease resume all regular home medications, unless specifically \nadvised not to take a particular medication. Also, please take \nany new medications as prescribed.\n\nPlease get plenty of rest, continue to ambulate several times \nper day, and drink adequate amounts of fluids. Avoid lifting \nweights greater than ___ lbs until you follow-up with your \nsurgeon.\n\nAvoid driving or operating heavy machinery while taking pain \nmedications.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee75393366f"
  },
  "note_id": "19550378-DS-30",
  "subject_id": 19550378,
  "hadm_id": 27191438,
  "note_type": "DS",
  "note_seq": 30,
  "charttime": "2147-07-08 00:00:00",
  "storetime": "2147-07-08 13:12:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin / Tegaderm \n/ diazepam\n \nAttending: ___.\n \nChief Complaint:\nNausea, vomiting\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nThis is a ___ w/ h/o DM2, idiopathic axonal sensorimotor \npolyneuropathy, SBO, coronary vasospasm who presents with one \nday of N/V. She began vomiting evening prior to presentation \n(she says too many to count), accompanied by chills, body aches, \nlower abdominal pain, and substernal left chest pain immediately \nafter her vomiting episodes without associated symptoms. She \ntook nitro. The pain resolved within 5 minutes. None since. No \nURI symptoms. Lives in assisted living, several other residents \nwith similar symptoms.\n\nShe does note ongoing issues with constipation, though has had \nseveral loose BMs in the last couple of days.  \n\nIn the ED, initial vitals: 96.7 67 180/72 18 95% RA \nLabs and CT abd/pelvis reassuring. EKG wnl, trops neg x2.\n\nPt received:\n___ 01:50 IV Ondansetron 4 mg \n___ 01:50 IVF 1000 mL NS 1000 mL  \n___ 02:15 IV Metoclopramide 10 mg  \n___ 03:00 PO Aspirin   \n___ 03:00 IH Albuterol 0.083% Neb Soln  \n___ 03:00 IH Ipratropium Bromide Neb   \n___ 03:41 IV Lorazepam 1 mg  \n___ 09:01 IV Diazepam 10 mg  \n___ 12:06 IV Prochlorperazine 10 mg \n___ 12:06 IV DiphenhydrAMINE 25 mg  \n\nBriefly apneic after receiving 10 mg valium but quickly \nrecovered. She was unable to tolerate POs. \n \nVitals prior to transfer: 99.0 72 143/98 22 96% RA  \n\nCurrently, the patient notes mild lower back pain that started \nduring the present episode without other associated symptoms. \n \nPast Medical History:\n- Severe idiopathic axonal sensorimotor polyneuropathy  \n* initial sx in ___ (weakness and sensory loss in legs -->  \nabdomen --> arms)  \n* responsive to plasmapheresis ~yearly, last ___ \n- Vitamin B12 deficiency\n- Partial SBO, managed conservatively, ___   \n- DM2 (not on medication)\n- HTN   \n- GERD  \n- Depression  \n- Diverticulosis\n- Coronary vasospam on amlodipine \n\nPAST SURGICAL HISTORY:  \n- c-section x 2  \n- hysterectomy for leiomyomata  \n- left breast lumpectomy  \n- bilateral knee replacements  \n- portacath (since removed)  \n- surgery related to recent abdominal hematoma related to sc  \nheparin  \n\n \nSocial History:\n___\nFamily History:\nfrom OMR\n- negative for neurological conditions\n- positive for DM (mother, brother), malignancy (mother - liver, \ncervical, colon; father - lung), CAD (mother)\n\n \nPhysical Exam:\nON ADMISSION:\n=============\nVitals- 98.8 150/77 68 18 96% RA \nGeneral- Alert, oriented, no acute distress  \nHEENT- Sclerae anicteric, MMM, oropharynx clear  \nNeck- supple, JVP not elevated\nLungs- CTAB no wheezes, rales, rhonchi  \nCV- RRR, Nl S1, S2, systolic murmur at the ___ \nAbdomen- Obese, soft, mild ttp in the bilateral lower quadrants, \nbowel sounds present, no rebound tenderness or guarding, no \norganomegaly  \nGU- no foley  \nExt- warm, well perfused, no clubbing, cyanosis or edema  \nNeuro- CNs2-12 grossly intact, moving all extremities\n\nON DISCHARGE:\n=============\nVS: 98.2 134/76 70 20 97RA\nGENERAL: Well appearing, alert, oriented, no acute distress.\nHEENT: MMM, oropharynx clear.\nNECK: Supple, JVD not elevated\nCV: RRR, normal S1, S2. Systolic murmur at ___.\nRESP: Clear to auscultation bilaterally.\nABD: +BS, soft, nondistended, nontender to palpation.\nGU: No foley\nEXT: Warm and well perfused. No edema.\nSKIN: No rashes.\n\n \nPertinent Results:\nON ADMISSION:\n======================================\n___ 01:20AM   PLT COUNT-178\n___ 01:20AM   NEUTS-77.7* LYMPHS-12.4* MONOS-6.5 EOS-3.3 \nBASOS-0.1\n___ 01:20AM   WBC-5.8 RBC-4.76 HGB-14.9 HCT-43.2 MCV-91 \nMCH-31.3 MCHC-34.5 RDW-13.9\n___ 01:20AM   ALBUMIN-3.9\n___ 01:20AM   cTropnT-<0.01\n___ 01:20AM   LIPASE-21\n___ 01:20AM   ALT(SGPT)-18 AST(SGOT)-24 ALK PHOS-89 TOT \nBILI-0.5\n___ 01:20AM   estGFR-Using this\n___ 01:23AM   LACTATE-1.6\n___ 02:40AM URINE  MUCOUS-RARE\n___ 02:40AM URINE  RBC-<1 WBC-<1 BACTERIA-NONE YEAST-NONE \nEPI-0\n___ 02:40AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR \nGLUCOSE-NEG KETONE-10 BILIRUBIN-NEG UROBILNGN-NEG PH-7.5 \nLEUK-NEG\n___ 02:40AM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 02:40AM URINE  UHOLD-HOLD\n___ 02:40AM URINE  HOURS-RANDOM\n___ 07:45AM   cTropnT-<0.01\n\nON DISCHARGE:\n============================\n___ 05:26AM BLOOD WBC-4.4 RBC-4.73 Hgb-14.6 Hct-42.2 MCV-89 \nMCH-30.8 MCHC-34.5 RDW-14.1 Plt ___\n___ 05:26AM BLOOD Glucose-113* UreaN-20 Creat-1.0 Na-139 \nK-3.7 Cl-101 HCO3-26 AnGap-16\n___ 05:26AM BLOOD Calcium-9.0 Phos-3.6 Mg-2.1\n\nMICRO:\n========================\nUrine Culture: No growth\n\nBlood Culture: Pending, no growth to date\n\nC. difficile DNA amplification assay (Final ___: \n      Negative for toxigenic C. difficile by the Illumigene DNA\n      amplification assay\n\nSTUDIES:\nCT ABD/PELVIS (___)\n1.  Diverticulosis throughout the colon without signs of \ndiverticulitis. \n2.  No convincing evidence of small bowel obstruction. Tortuous \ncolon with cecum positioned in the midline, and mild prominence \nof distal small bowel, but no focal zone of transition. \n3.  Stable right adrenal nodule dating back to ___. \n4.  Slight thickening of the distal sigmoid colon may be due to \ncollapsed segment. Suggest followup nonemergent endoscopy. \n\nCXR ___:\nNo acute cardiopulmonary process. \n\n \nBrief Hospital Course:\n___ with PMH significant for DM2, idiopathic axonal \nsensorimotor polyneuropathy, SBO, coronary vasospasm who \npresents with one day of nausea, vomiting, and loose stools.\n\n# VIRAL GASTROENTERITIS:\nGiven sick contacts, chills, body aches, the patient's symptoms \nwere felt to be secondary to viral gastroenteritis. She did not \nhave any URI symptoms or myalgias to suspect influenza. CT \nABD/PELVIS showed diverticulosis and slight thickening of the \ndistal sigmoid colon, which may be due to a collapsed segment. \nBlood cultures with no growth to date. C difficile was negative. \nThe patient was treated with IVF and anti-emetics. Her diet was \nadvanced slowly. Her symptoms improved by day 2 of \nhospitalization. \n\n# ACUTE KIDNEY INJURY:\nCr was elevated at 1.8 on day 2 of hospitalization, from \nbaseline of 0.8. FENa was 0.08%, which was consistent with a \npre-renal etiology. She did not have any episodes of \nhypotension. She was not on nephrotoxic medications. She was \ntreated with IVF.\n\n# CHEST PAIN:\nSuspect this may be esophageal irritation in the setting of \nvomiting given temporality. Troponins were negative x 2. EKG was \nalso reassuring. The patient was given omeprazole. She was \ncontinued on medications for CAD/coronary vasospasm. Simvastatin \nwas switched to atorvastatin given drug interaction with \namlodipine.\n\n# DM2: \nHbA1c was 5.4% in ___ without therapy. Her glucose with daily \nchemistries were normal.\n\n# CHRONIC PAIN:\nShe was continued on tramadol and gabapentin.\n\n# SENSIROMOTOR NEUROPATHY: \nShe will have outpatient follow up with plasmapheresis as \nplanned. \n\n# DEPRESSION:\nShe was continued on sertraline. \n\n# HOME MEDICATIONS:\n- Continued eye drops.\n- Held psyllium.  \n\nTRANSITIONAL ISSUES:\n* CT Abd/Pelvis showed slight thickening of the distal sigmoid \ncolon, which may be due to collapsed segment. Radiology \nsuggested followup with nonemergent endoscopy.\n* Simvastatin switched to atorvastatin due to drug interaction \nwith amlodipine.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 1000 mg PO DAILY \n2. Artificial Tears 2 DROP BOTH EYES Q6H:PRN dry eyes \n3. Aspirin 81 mg PO DAILY \n4. Docusate Sodium 100 mg PO BID \n5. Bisacodyl 5 mg PO DAILY:PRN constipation \n6. Lactulose 15 mL PO TID \n7. Lorazepam 0.5 mg PO Q6H:PRN anxiety \n8. Polyethylene Glycol 17 g PO Q12H \n9. Multivitamins 1 TAB PO DAILY \n10. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain \n11. Reguloid (psyllium husk;<br>psyllium seed (sugar)) 0.52 gram \noral BID \n12. Cyanocobalamin 1000 mcg PO DAILY \n13. Vitamin D 1000 UNIT PO DAILY \n14. BuPROPion 100 mg PO BID \n15. Sertraline 100 mg PO DAILY \n16. Amlodipine 2.5 mg PO DAILY \n17. Gabapentin 100 mg PO BID \n18. Ondansetron 4 mg PO Q6H:PRN nausea \n19. Simvastatin 20 mg PO DAILY \n20. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \n\n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO DAILY \n2. Amlodipine 2.5 mg PO DAILY \n3. Artificial Tears 2 DROP BOTH EYES Q6H:PRN dry eyes \n4. Aspirin 81 mg PO DAILY \n5. BuPROPion 100 mg PO BID \n6. Cyanocobalamin 1000 mcg PO DAILY \n7. Docusate Sodium 100 mg PO BID \n8. Gabapentin 100 mg PO BID \n9. Lactulose 15 mL PO TID \n10. Lorazepam 0.5 mg PO Q6H:PRN anxiety \n11. Multivitamins 1 TAB PO DAILY \n12. Polyethylene Glycol 17 g PO Q12H \n13. Sertraline 100 mg PO DAILY \n14. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \n15. Vitamin D 1000 UNIT PO DAILY \n16. Bisacodyl 5 mg PO DAILY:PRN constipation \n17. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain \n18. Ondansetron 4 mg PO Q6H:PRN nausea \n19. Reguloid (psyllium husk;<br>psyllium seed (sugar)) 0.52 gram \noral BID \n20. Atorvastatin 10 mg PO QPM \nRX *atorvastatin 10 mg 1 tablet(s) by mouth daily Disp #*30 \nTablet Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary diagnoses:\nViral gastroenteritis\nAcute kidney injury\nConstipation\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure caring for you at ___. You were admitted \nwith a gastrointestinal infection. You were treated with IV \nfluids and nausea medications. Your kidney function was \ndecreased on admission, but improved with IV fluids. We are glad \nyou are feeling better. \n\nBest wishes,\n\nYour ___ Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753933670"
  },
  "note_id": "19550378-DS-31",
  "subject_id": 19550378,
  "hadm_id": 21917882,
  "note_type": "DS",
  "note_seq": 31,
  "charttime": "2147-07-23 00:00:00",
  "storetime": "2147-07-23 16:25:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin / Tegaderm \n/ diazepam\n \nAttending: ___\n \nChief Complaint:\ncc: nausea/vomiting\n \nMajor Surgical or Invasive Procedure:\nNGT decompression\n\n \nHistory of Present Illness:\n___ y/o female with history of idopathic axional polyneuropathy \ntreated with plasmapheresis, HTN, recurrent pertial SBO with \nrecent admission for abdominal pain, nausea and vomiting, \npresents with recurrent symptoms.\n\nShe reports she never felt totally better after her recent \ndischarge. Then one day prior to presentation developed \nnausea/vomiting abdominal pain and diarrhea. She reports lower \nabdominal pain which radiates to her epigastrum. Pain is ___ in \nsererity. Pain medication helps a little. She has vomited a \nnumber of times. Denies blood in vomitus. Last BM was this \nmorning, thinks she continues to pass gas. She has no fever but \nhas had chills. Also complains of SOB which she associates with \nher pain. She does report some chest pain which she says is not \nlike her cardiac pain and seems to radiate from her epigastrum.  \nShe also endorses a headache.\n\nRemainder of 12 point ROS asked and negative.\n \nPast Medical History:\n- Severe idiopathic axonal sensorimotor polyneuropathy  \n* initial sx in ___ (weakness and sensory loss in legs -->  \nabdomen --> arms)  \n* responsive to plasmapheresis ~yearly, last ___ \n* now wheelchair-bound\n- Vitamin B12 deficiency\n- Partial SBO, managed conservatively, ___   \n- DM2 (not on medication)\n- HTN   \n- GERD  \n- Depression  \n- Diverticulosis\n- Coronary vasospam on amlodipine \n\nPAST SURGICAL HISTORY:  \n- c-section x 2  \n- hysterectomy for leiomyomata  \n- left breast lumpectomy  \n- bilateral knee replacements  \n- portacath (since removed)  \n- surgery related to abdominal hematoma secondary to \nsubcutaneous heparin  \n\n \nSocial History:\n___\nFamily History:\nfrom ___, confirmed with patient\n- negative for neurological conditions\n- positive for DM (mother, brother), malignancy (mother - liver, \ncervical, colon; father - lung), CAD (mother)\n\n \nPhysical Exam:\nVS: 98.3 BP: 151/75 HR: 77 R: 20 O2: 100% 2L\nObese female laying in bed in some distress due to pain and \nnausea\nPain ___\nHEENT: NGT in place, MMM, no oral lesions\nLungs: Clear b/l on anterior auscultation\n___: RRR, S1, S2 present\nABD: Soft, tender on palpation of lower quadrants, left>right, \nepigastrum, no rebound or guarding\nEXT: No edema\nNEURO: AAOx3, difficult to asses stregnth due to patient \ncooperation\nPsych: ___ and cooperative\n \nPertinent Results:\n___ 09:45AM   ___ PTT-29.3 ___\n___ 07:59AM   ___ PTT-UNABLE TO  ___\n___ 07:46AM   COMMENTS-GREEN TGOP\n___ 07:46AM   LACTATE-1.3\n___ 07:39AM   GLUCOSE-149* UREA N-16 CREAT-0.9 SODIUM-140 \nPOTASSIUM-5.1 CHLORIDE-102 TOTAL CO2-24 ANION GAP-19\n___ 07:39AM   estGFR-Using this\n___ 07:39AM   ALT(SGPT)-23 AST(SGOT)-29 ALK PHOS-91 TOT \nBILI-0.5\n___ 07:39AM   LIPASE-36\n___ 07:39AM   ALBUMIN-4.4\n___ 07:39AM   WBC-8.0# RBC-5.15 HGB-15.6 HCT-46.8 MCV-91 \nMCH-30.3 MCHC-33.4 RDW-14.1\n___ 07:39AM   NEUTS-79.7* LYMPHS-14.7* MONOS-3.5 EOS-1.9 \nBASOS-0.2\n___ 07:39AM   PLT COUNT-___\nIMPRESSION: \n1. Distended gas and fluid-filled small bowel loops, with 2 \ntransition points \nthe left upper quadrant, raising concern for closed loop small \nbowel \nobstruction. No evidence of abdominopelvic free fluid or free \nair. \n2. Severe colonic diverticulosis, with no evidence of \ndiverticulitis. \n3. Stable right adrenal nodule. \n\nCT Chest: ___\nIMPRESSION:  \n1.  Orogastric tube terminates in the stomach. \n2.  Low lung volumes. Left costophrenic angle is not clearly \nvisualized, could be secondary to atelectasis, pleural effusion \nor also secondary to patient's positioning and overlying soft \ntissues \n\n \nBrief Hospital Course:\nMs ___ is a ___ w/ h/o DM2 (diet-controlled), idiopathic axonal \nsensorimotor polyneuropathy rx with plasmapheresis, recurrent \npartial SBO, coronary vasospasm, with recent admission for \nnausea/vomiting with negative CT thought to be viral gastritis. \nRe-presented with similar symptoms, CT with evidence of partial \nSBO. Surgery following. Improved quickly with conservativ mgmt. \nNGT clamped and then removed ___. Tolerating po's.  Diet \nadvanced slowly.  Deconditioned and working with ___, who \nrecommended ___ rehab. Pt declined and strongly prefers \nto go home, feels she is very close to her baseline level of \nactivity.  \n\n#partial small bowel obstruction: possibly secondary to \npolyneuropathy. Gen surgery consulted, agreed with conservative \nmgmt including bowel rest, NGT, IVF. Diet gradually advanced, \ntolerated well. Nutrition consulted re low residue diet, pt \nexpressed understanding. F/u with GI Dr. ___ as outpatient\n\n#Coronary vasospasm\nAmlodipine, ASA, statin held on admit\n--Statin resumed ___\n--Resumed ASA, amlodipine ___\n\n# Chronic pain\n- resumed gabapentin ___\n- resumed prn ultram ___\n\n# SENSORIMOTOR NEUROPATHY: \nNeurology Dr. ___ of admission, no acute issues.\n\n# DEPRESSION:\n-- resumed sertraline, bupropion ___\n\n#Chronic constipation\n-- resumed miralax ___, rest of bowel regimen on discharge\n\n# disp: ___ consulted, recs as noted above.  Nursing obrtained \northotics for feet for transfers.\n\n#Code: Full- confirmed with patient\n#NOK: Niece ___- ___\n#communication with PCP ___, NP via email\n\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Acetaminophen 1000 mg PO DAILY \n2. Amlodipine 2.5 mg PO DAILY \n3. Artificial Tears 2 DROP BOTH EYES Q6H:PRN dry eyes \n4. Aspirin 81 mg PO DAILY \n5. BuPROPion 100 mg PO BID \n6. Cyanocobalamin 1000 mcg PO DAILY \n7. Docusate Sodium 100 mg PO BID \n8. Gabapentin 100 mg PO BID \n9. Lactulose 15 mL PO TID \n10. Lorazepam 0.5 mg PO Q6H:PRN anxiety \n11. Multivitamins 1 TAB PO DAILY \n12. Polyethylene Glycol 17 g PO Q12H \n13. Sertraline 100 mg PO DAILY \n14. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \n15. Vitamin D 1000 UNIT PO DAILY \n16. Bisacodyl 5 mg PO DAILY:PRN constipation \n17. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain \n18. Ondansetron 4 mg PO Q6H:PRN nausea \n19. Reguloid (psyllium husk;<br>psyllium seed (sugar)) 0.52 gram \noral BID \n20. Atorvastatin 10 mg PO QPM \n\n \nDischarge Medications:\n1. Amlodipine 2.5 mg PO DAILY \n2. Artificial Tears 2 DROP BOTH EYES Q6H:PRN dry eyes \n3. Aspirin 81 mg PO DAILY \n4. Atorvastatin 10 mg PO QPM \n5. BuPROPion 150 mg PO BID \n6. Gabapentin 100 mg PO BID \n7. Polyethylene Glycol 17 g PO Q12H \n8. Sertraline 75 mg PO DAILY \n9. Acetaminophen 650 mg PO QHS:PRN pain \n10. Cyanocobalamin 1000 mcg IM/SC QMONTH \n11. Docusate Sodium 100 mg PO BID \n12. Multivitamins 1 TAB PO DAILY \n13. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain \n14. Ondansetron 4 mg PO Q6H:PRN nausea \n15. Vitamin D 1000 UNIT PO BID \n16. Lorazepam 0.5 mg PO QDAY PRN anxiety \n17. Bisacodyl 5 mg PO DAILY:PRN constipation \n18. Lactulose 30 mL PO TID \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nrecurrent partial small bowel obstruction, possibly secondary to \npolyneuropathy\n\nSECONDARY:\n# axonal sensorineural polyneuropathy\n# DM type II (diet-controlled)\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nIt was a pleasure taking care of you during your recent \nadmission to ___. You were admitted with nausea, vomiting and \nabdominal pain and found to have a bowel obstruction. You were \nmanaged conservatively with the help of the surgical team and \nyou improved. Please follow a low-fiber diet as discussed with \nthe nutritionist.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753933671"
  },
  "note_id": "19550378-DS-32",
  "subject_id": 19550378,
  "hadm_id": 20840647,
  "note_type": "DS",
  "note_seq": 32,
  "charttime": "2147-08-12 00:00:00",
  "storetime": "2147-08-12 12:47:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin / Tegaderm \n/ diazepam\n \nAttending: ___.\n \nChief Complaint:\naxonal sensorimotor polyneuropathy\n \nMajor Surgical or Invasive Procedure:\nright temporary pheresis line\n \nHistory of Present Illness:\nThis is a lovely ___ y/o female with a history notable for severe \nidiopathic axonal sensorimotor polyneuropathy, coronary \nvasospasm, recent pSBO with discharge 1.5 weeks ago, who is \nadmitted for plasmapheresis for her severe neuropathy.  She has \nhad pheresis several times over the years with good effect, last \none being in ___ (this one did not have much benefit though per \npatient).  At the recommendation of her neurologist, she is \nundergoing plasmapheresis again, with a plan for 5 sessions \nevery other day.  \n\nOf note, she was recently hospitalized from ___ for a \npartial small bowel obstruction, which was possibly related to \nher polyneuropathy.  She improved with conservative treatment \nand was discharged in stable condition.\n\nCurrently, she has no new concerns or complaints.  She underwent \nplacement of a temp pheresis line with no problems; she reports \nthe pain has decreased at the site.  She had her first session \nof pheresis without any problems.  \n\nOn ROS, she notes occasional abdominal pain at night, which \nwakes her up at night but resolves on its own.  Occasional \nnausea, no vomiting.  +loose stools the past few days, but it \nwas formed yesterday.  +flatus.  12-pt ROS otherwise negative in \ndetail except for as noted above. \n\n \nPast Medical History:\n- Severe idiopathic axonal sensorimotor polyneuropathy  \n* initial sx in ___ (weakness and sensory loss in legs -->  \nabdomen --> arms)  \n* responsive to plasmapheresis ~yearly, last ___ \n* now wheelchair-bound\n- Vitamin B12 deficiency\n- Partial SBO, managed conservatively, ___   \n- DM2 (not on medication)\n- HTN   \n- GERD  \n- Depression  \n- Diverticulosis\n- Coronary vasospam on amlodipine \n\nPAST SURGICAL HISTORY:  \n- c-section x 2  \n- hysterectomy for leiomyomata  \n- left breast lumpectomy  \n- bilateral knee replacements  \n- portacath (since removed)  \n- surgery related to abdominal hematoma secondary to \nsubcutaneous heparin  \n\n \nSocial History:\n___\nFamily History:\nfrom ___, confirmed with patient\n- negative for neurological conditions\n- positive for DM (mother, brother), malignancy (mother - liver, \ncervical, colon; father - lung), CAD (mother)\n\n \nPhysical Exam:\nVS: Tc 98.1, BP 128/50, HR 67, RR 18, SaO2 100/RA\nGeneral: Pleasant female, laying in bed comfortably, in NAD, AO \nx 3\nHEENT: Anicteric sclerae, MMM OP clear\nNeck: supple, no LAD, +temp right IJ pheresis line, no bleeding \nc/d/i\nChest: CTA anteriorly\nCV: RRR s1 s2 normal\nAbd: soft, obese, NT/ND, NABS\nExt: no c/c/e, wwp\nNeuro: decrease in pinprick and light touch in both lower \nextremties distally\nSkin: warm, dry, no rashes\n\n \nPertinent Results:\nNo recent lab or imaging results. \n \nBrief Hospital Course:\nASSESSMENT & PLAN:  ___ y/o F with idiopathic severe axonal \nsensorimotor polyneuropathy, recent SBO, admitted for \nplasmapheresis for her neuropathy with course complicated by \nmalpositioning of pharesis catheter now s/p removal and \nreplacement of new line doing well.\n  \n# Idiopathoic severe axonal, sensorimotor polyneuropathy\n# Coronary vasospasm potentially ___ prior plasmapharesis\n# Recent partial SBO, potentially second to polyneuropathy\n   Ms. ___ was admitted for 5 sessions of pheresis (QOD).  She \nhad a pheresis catheter placed which required repositioning due \nto dislodgment.  However, otherwise, Ms. ___ tolerated the \npheresis without any complications.  She was placed on tele \ngiven prior h/o STE after plasmapheresis (? ___ coronary \nvasospasm).  There was no notable no events on tele and \ncontinued to be asymptomatic on floor.  Norvasc was temporarily \nheld ___ low BP while pheresis.  However, given h/o vasospasm, \nthe decision to resume it on d/c. \n\n# Chronic constipation: Ms. ___ has a long history of \nconstipation and even SBO attributed to autonomic dysfunction \n(possibly from polyneuropatyh).  She was given extesnive bowel \nregimen - and has some loose stools as a result.  She felt, she \nwas still constipated and thus elected to continue with the \nregimen.  She had extensive questions about appropriate diet - \nand a nutrition consult was provided to instruct her on a high \nfiber diet.  The norvasc may also potentially contribute to some \nconstipation, however, due to past h/o ST elevation from \nvasospasm, we opted to restart it on discharge\n\n# Hyperglycemia: History of DM, off medications for ___ years. \n ___ have been high in the hospital but they were postprandial.  \nA1c 5.7%.  There was no need for ___ during the hospitalization \nthereafter. \n\n# HTN\n - on ASA.  ___ benefit from ACEI given ? h/o DM2.  On \namlodipine on discharge.\n# Depression and anxiety\n- Continue bupropion/zoloft/lorazepam prn\n# Chronic pain\n- Continue gabapentin, tramadol prn    \n      \n#FEN:   [] IVF   [X] Oral   [] NPO   [] Tube Feeds   [] \nParenteral\n#DVT PROPHYLAXIS: [x] Heparin sc [] Mechanical [] Therapeutic \nINR\n#LINES/DRAINS:   [X] Peripheral   [] PICC   [X] CVL   [] Foley\n - difficult access.  OK to maintain present IV for now\n#PRECAUTIONS: None\n#COMMUNICATION: Niece ___ - ___\n#CONSULTS: none\n#CODE STATUS: [x] Full Code []DNR/DNI\n#DISPOSITION: d/c'd to ___\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.  \nConfirmed with ___. ___ medication list. \n1. Amlodipine 2.5 mg PO DAILY \n2. Atorvastatin 10 mg PO QPM \n3. BuPROPion 150 mg PO BID \n4. Gabapentin 100 mg PO BID \n5. Lactulose 15 mL PO TID \n6. Lorazepam 0.5 mg PO DAILY:PRN anxiety \n7. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain \n8. Ondansetron 4 mg PO Q8H:PRN nausea \n9. Sertraline 75 mg PO DAILY \n10. Acetaminophen 650 mg PO QHS: PRN pain \n11. Aspirin 81 mg PO DAILY \n12. Polyethylene Glycol 17 g PO BID \n13. cyanocobalamin (vitamin B-12) 1,000 mcg/mL injection qMONTH \n14. Docusate Sodium 100 mg PO BID \n15. Multivitamins 1 TAB PO DAILY \n16. Vitamin D 1000 UNIT PO BID \n17. Bisacodyl 5 mg PO DAILY:PRN constipation \n18. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \n\n \nDischarge Medications:\n1. Acetaminophen 650 mg PO QHS: PRN pain \n2. Aspirin 81 mg PO DAILY \n3. Atorvastatin 10 mg PO QPM \n4. Bisacodyl 5 mg PO DAILY:PRN constipation \n5. BuPROPion 150 mg PO BID \n6. Docusate Sodium 100 mg PO BID \n7. Gabapentin 100 mg PO BID \n8. Lactulose 15 mL PO TID \n9. Lorazepam 0.5 mg PO DAILY:PRN anxiety \n10. Multivitamins 1 TAB PO DAILY \n11. Polyethylene Glycol 17 g PO BID \n12. Sertraline 75 mg PO DAILY \n13. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \n14. Vitamin D 1000 UNIT PO BID \n15. Amlodipine 2.5 mg PO DAILY \n16. cyanocobalamin (vitamin B-12) 1,000 mcg/mL injection qMONTH \n17. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain \n18. Ondansetron 4 mg PO Q8H:PRN nausea \n19. Psyllium 1 PKT PO TID:PRN Constipation \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nChronic idiopathic sensorimotor polyneuropathy\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n \nDischarge Instructions:\nIt was a pleasure looking after you, Ms. ___.  As you know, you \nwere admitted for 5 days of pheresis treatment.  Although there \nwere some challenges with the pheresis catheter, you tolerated \nthe procedure well without any signficant complications.\n   Please resume all your home medications.  Norvasc was held \ntemporarily due to low blood pressures, particularly during \npheresis.  This should be resumed since your blood pressure is \nnow low otherwise.   \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753933672"
  },
  "note_id": "19550378-DS-33",
  "subject_id": 19550378,
  "hadm_id": 29011484,
  "note_type": "DS",
  "note_seq": 33,
  "charttime": "2148-11-18 00:00:00",
  "storetime": "2148-11-18 15:34:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin / Tegaderm \n/ diazepam\n \nAttending: ___\n \nChief Complaint:\nMonitoring with pheresis\n\n \nMajor Surgical or Invasive Procedure:\nPheresis catheter placement\n\n \nHistory of Present Illness:\n___ woman with morbid obesity, history of Idiopathic axonal \nsensorimotor polyneuropathy treated with periodic plasmapheresis \ncomplicated previously with vasospasm and ST elevation, who is \nadmitted for course of plasmapheresis.\n\nRegarding her extensive neurologic workup: per OMR: \nShe initially presented to ___ in ___ for evaluation of man \nyears of symptoms, including lower extremity weakness which \nprogressed proximally, decreased sensation, and paresthesias. \nShe was wheelchair bound at the time of evaluation. She had \nextensive workup including sural nerve biopsy which showed \nsevere loss of\nall fiber types and NCS showed severe sensory axonal \npolyneuropathy without myopathy. Labs sent including anti-Ro, \nanti-La, ___, HIV, Lyme, anti-IF were all negative. She \nwas treated with serial 5-day courses of IVIg with improvement. \nUltimately treated w/ plasmapheresis with some effect.\n\nAt this point sessions occur about yearly (her last session was \nin ___. Of note, she has had adverse reactions to pheresis \nin the past including provocation of coronary vasospasm and \ncentral line infection. Therefore she is admitted for monitoring \nduring this course of pheresis. Per review of cardiology notes, \nit\nappears that she had an episode of chest discomfort in ___ with \nSTE on EKG in V3, V4, with follow up PMIBI also in ___ \nunremarkable. She is on atorvastatin for her hyperlipidemia.\n\nPer discussion w/ pt today: her first pheresis was in ___ and \nwas c/b vasospasm, bradycardia, and she subsequently had \nplasmapheresis in ___, and most recently underwent plasma \nexchange in ___. She usually tells her neurology team \nwhen she feels her symptoms have progressed to the point where \nshe needs to have plasmapheresis, and they have been discussing \ndoing it since last ___ but finally in the past ___ months she \nfelt her progressive weakness (arms and legs, left side worse \nthan right). SHe is chronically wheelchair bound as a result of \nthis process but states that at times she gets to the point (as \nnow)\nwhere she can no longer write due to weakness in the arms and \nhands and that prompted her to come in for pheresis this time.  \nShe reports that she gets progressive numbness in the \nextremities also with her progressive demyelinating disease and \nthat this has progressed along with weakness. Fatigue is also a \nsignificant symptom.   Otherwise her medical history is \nsignificant for recurrent partial bowel obstructions which hav \nnever been surgically managed, and she takes aggressive bowel \nmedications to prevent constipation. Her last bowel movement was \nthis morning and she hasn't had issues with this in months.\n\nShe underwent her first session today ___ (has triple lumen IJ \ntemp line w/ tip in lower SVC, approved for use). Given her h/o \nbradycardia during pheresis she was on tele, initial HR was 59, \nshe did not tolerate the initial rate of pheresis (stated she \nfelt \"funny\") and stated she felt she would pass out, but \nultimately tolerated a lower rate. HR was 57, sinus brady, at \nthe time of that infusion. Ultimately she felt better after \nstopping\nthe infusion and pheresis resumed, which she tolerated without \nfurther events.\n\nAt the time of my interview she denies chest pain, dizziness, \nlightheadedness, shortness of breath. She does use nitroglycerin \nfor CP at home but states the last time she required this was \n___ months ago. She notes that she has had a chronic \nnonproductive cough for the past few months, along with \nintermittent mild\nheadaches for the past few months, but these are not present \ncurrently, and she denies fevers, dysuria, diarrhea, \nnausea/vomiting. All other 10 point ROS negative.\n \nPast Medical History:\nSevere idiopathic axonal sensorimotor polyneuropathy with\nsymptoms beginning in the late ___ or early ___. Symptoms began\nwith weakness and sensory loss in the legs proximally. Symptoms\nhave been responsive to plasmapheresis approximately yearly. As\nnoted above, she is wheelchair bound.\nTREATMENT HISTORY:\n___ Weakness and sensory loss in legs, torso and arms\n___ Visit with Dr. ___\n___ Sural nerve biopsy\nPathology: marked loss of large and small myelinated axons \n___ - ___ IVIG\n___ Worse symptoms with dysarthria, hypophonia, and dsypahgia \n___ Plasmapheresis, had coronary vasospasm, bradycardia and \none episode of bilateral shoulder pain\n___ line infection\n___ Plasmapheresis, nausea, vomiting\n___ Plasmapheresis, transient nausea and emesis\n___ Plasmaexchange\n___ Had abdominal pain, procedure postponed\n___ - ___ Plasma exchange x4\n___ Plasma exchange #1\n\nVitamin B12 deficiency\nHistory of partial small-bowel obstruction\nDiabetes, not on any medications at present\nHypertension\nGERD\nDepression\nDiverticulosis\nCoronary vasospasm\nStatus post C-section x 2\nStatus post hysterectomy for leiomyomata\nLeft breast lumpectomy\nStatus post bilateral knee replacements\nHistory of abdominal hematoma due to subcutaneous heparin\n\n \nSocial History:\n___\nFamily History:\nMother, brother with diabetes. Mother with liver, cervix, and\ncolon cancer, as well as CAD; father with lung cancer.\n\n \nPhysical Exam:\nAdmission:\nVITAL SIGNS:  98.2  ___  56  20  100% RA\nGeneral:  NAD, morbidly obese female resting in bed comfortably\nHEENT:  MMM, no OP lesions, no cervical, supraclavicular, or\naxillary adenopathy, no thyromegaly\nCV:  RR, NL S1S2 no S3S4 MRG\nPULM:  CTAB\nGI:  BS+, soft, NTND, no masses or hepatosplenomegaly\nLIMBS:  No edema, clubbing, tremors, or asterixis; no inguinal\nadenopathy. \nSKIN:  No rashes or skin breakdown\nNEURO: Oriented x3. PERRLA, EOMI. Pt has ___ strength in LUE\nand LLE slightly worse than right side, but states this is\nchronically worse. able to lift lower legs off examining table.\n\nDischarge:\nVS: 98.2PO 138 / 58 R Lying 63 16 98 RA \nGen: NAD, sitting in bed comfortably. \nEyes: EOMI, sclerae anicteric\nENT: MMM, OP clear\n___: RRR, no MRG \nResp: normal effort, no accessory muscle use, lungs CTA ___.\nGI: soft, NT, ND, BS+, obese\nSkin: Central line on right anterior chest wall c/d/i\nNeuro: AAOx3. Strength ___ in upper and lower extremities\nPsych: Full range of affect.\n\n \nPertinent Results:\nAdmission:\n___ 08:00AM   GLUCOSE-96 UREA N-14 CREAT-1.0 SODIUM-141 \nPOTASSIUM-4.7 CHLORIDE-102 TOTAL CO2-31 ANION GAP-13\n___ 08:00AM   estGFR-Using this\n___ 08:00AM   ALK PHOS-99\n___ 08:00AM   CALCIUM-9.6 PHOSPHATE-3.8 MAGNESIUM-2.1\n___ 08:00AM   WBC-4.3 RBC-4.49 HGB-13.4 HCT-41.5 MCV-92 \nMCH-29.8 MCHC-32.3 RDW-14.1 RDWSD-48.0*\n___ 08:00AM   PLT COUNT-178\n\nDischarge:\n___ 09:02AM BLOOD WBC-6.0 RBC-4.24 Hgb-13.0 Hct-39.2 MCV-93 \nMCH-30.7 MCHC-33.2 RDW-15.8* RDWSD-53.8* Plt ___\n___ 09:02AM BLOOD Glucose-145* UreaN-15 Creat-0.9 Na-139 \nK-4.1 Cl-106 HCO3-25 AnGap-12\n___ 09:02AM BLOOD Calcium-9.4 Phos-3.5 Mg-1.___ year old female with idiopathic axonal sensorimotor \npolyneuropathy requiring almost yearly plasmapheresis presented \nwith recurrent symptoms of distal numbness and weakness. She was \nadmitted for pheresis given history of coronary vasospasm with \nprior plasma exchange. \n\n# Idiopathic severe axonal sensorimotor polyneuropathy: Patient \nhad been experiencing progressive distal weakness and numbness \nmost notable in her RLE. She has a history of coronary vasospasm \nin setting of prior plasmapheresis. Patient received first \nplasmapheresis on the day of admission. She felt like she was \ngoing to pass out during the pheresis but this did not recur in \nsubsequent sessions. The patient completed a total of 5 sessions \nof plasmaphersis. She was monitored on telemetry without any \nincidents and she experienced no cardiac symptoms. She will \nfollow up with her neurologist on discharge.\n\n# Hyperlipidemia: continued atorvastatin\n\n# Chronic constipation/History of bowel obstructions: Patient \nwas continued on bowel regimen and had regular bowel movements.\n\n# Hyperglycemia: History of DM, off medications for ___ years. \nLast hemoglobinA1c was low therefore FSBS were not checked.\n\n# Depression and anxiety: Continued bupropion/zoloft/lorazepam \nprn\n\n# Chronic pain: Continued gabapentin\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. amLODIPine 2.5 mg PO DAILY \n2. Atorvastatin 10 mg PO QPM \n3. BuPROPion 150 mg PO BID \n4. Gabapentin 100 mg PO BID \n5. Lactulose 15 mL PO Q8H:PRN constipation \n6. LORazepam 0.5 mg PO QHS:PRN insomani \n7. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain \n8. Ondansetron 4 mg PO Q8H:PRN nausea \n9. Sertraline 75 mg PO DAILY \n10. Aspirin 81 mg PO DAILY \n11. Bisacodyl 10 mg PO DAILY:PRN constipation \n12. Docusate Sodium 100 mg PO BID \n13. Polyethylene Glycol 17 g PO BID \n\n \nDischarge Medications:\n1. amLODIPine 2.5 mg PO DAILY \n2. Aspirin 81 mg PO DAILY \n3. Atorvastatin 10 mg PO QPM \n4. Bisacodyl 10 mg PO DAILY:PRN constipation \n5. BuPROPion 150 mg PO BID \n6. Docusate Sodium 100 mg PO BID \n7. Gabapentin 100 mg PO BID \n8. Lactulose 15 mL PO Q8H:PRN constipation \n9. LORazepam 0.5 mg PO QHS:PRN insomani \n10. Ondansetron 4 mg PO Q8H:PRN nausea \n11. Polyethylene Glycol 17 g PO BID \n12. Sertraline 75 mg PO DAILY \n13. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain \n14. Miconazole Powder 2% 1 Appl TP TID:PRN skin irritation \nRX *miconazole nitrate 2 % Apply to affected area three times a \nday prn Disp #*1 Bottle Refills:*0\n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nIdiopathic axonal sensorimotor polyneuropathy \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nMs. ___,\n\nYou were admitted for plasmapheresis to treat your idiopathic \naxonal sensorimotor polyneuropathy. You had no adverse reactions \nto the plasmaphereisis. No changes were made to your home \nmedications. \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753933673"
  },
  "note_id": "19550378-DS-34",
  "subject_id": 19550378,
  "hadm_id": 27631454,
  "note_type": "DS",
  "note_seq": 34,
  "charttime": "2148-11-21 00:00:00",
  "storetime": "2148-11-23 10:50:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin / Tegaderm \n/ diazepam\n \nAttending: ___.\n \nChief Complaint:\nAbdominal pain, nausea, vomiting\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\n___ w/ morbid obesity, polyneuropathy requiring serial \nplasmepheresis, s/p C sectionx2 and hysterectomy, multiple SBO \nmanaged conservatively who presents with abdominal pain, nausea\nand vomiting. Patient was discharged yesterday after receiving \nplasmapheresis for several days due to demyelinating disease. \nShe was doing well at the time of discharge. At around ___\nyesterday she developed acute onset abdominal pain associated \nwith nausea and 7 episodes of non bilious vomiting. This is \nsimilar, yet more severe,than her prior episode of partial small \nbowel obstruction.  She has been passing flatus and has several \nbowel movements. She otherwise denies fever/chills. In ED she \ncontinues to be afebrile, non toxic looking with stable vital \nsings. \n \nPast Medical History:\nSevere idiopathic axonal sensorimotor polyneuropathy with\nsymptoms beginning in the late ___ or early ___. Symptoms began\nwith weakness and sensory loss in the legs proximally. Symptoms\nhave been responsive to plasmapheresis approximately yearly. As\nnoted above, she is wheelchair bound.\nTREATMENT HISTORY:\n___ Weakness and sensory loss in legs, torso and arms\n___ Visit with Dr. ___\n___ Sural nerve biopsy\nPathology: marked loss of large and small myelinated axons \n___ - ___ IVIG\n___ Worse symptoms with dysarthria, hypophonia, and dsypahgia \n___ Plasmapheresis, had coronary vasospasm, bradycardia and \none episode of bilateral shoulder pain\n___ line infection\n___ Plasmapheresis, nausea, vomiting\n___ Plasmapheresis, transient nausea and emesis\n___ Plasmaexchange\n___ Had abdominal pain, procedure postponed\n___ - ___ Plasma exchange x4\n___ Plasma exchange #1\n\nVitamin B12 deficiency\nHistory of partial small-bowel obstruction\nDiabetes, not on any medications at present\nHypertension\nGERD\nDepression\nDiverticulosis\nCoronary vasospasm\nStatus post C-section x 2\nStatus post hysterectomy for leiomyomata\nLeft breast lumpectomy\nStatus post bilateral knee replacements\nHistory of abdominal hematoma due to subcutaneous heparin\n\n \nSocial History:\n___\nFamily History:\nMother, brother with diabetes. Mother with liver, cervix, and\ncolon cancer, as well as CAD; father with lung cancer.\n\n \nPhysical Exam:\nAdmission Physical Exam:\nVitals: T 96.7, HR 82, BP 135/73, RR 16, sat 99%/RA\nGEN: A&Ox3, appears comfortable, non toxic looking\nHEENT: No scleral icterus, mucus membranes moist\nCV: RRR, \nPULM: Clear to auscultation b/l, no labored breathing\nABD: obese, Soft, moderately distended, TTP at R lower abdomen,\nno rebound or guarding, non peritoneal \nExt: No ___ edema, ___ warm and well perfused\n\nDischarge Physical exam:\nVS: 98.8, 64, 120/43, 18, 99 RA\nGen: Awake alert, sitting up in bed. Pleasant and interactive.\nHEENT: No deformity. PERRL, EOMI. Neck supple, trachea midline.\nCV: RRR\nResp: Clear to auscultation bilaterally.\nAbd: Obese, soft, non-tender. Active bowel sounds.\nExtremities: Obese, warms and dry. 2+ ___ pulses.\nNeuro: A&Ox3. Follows commands and moves all extremities equal \nand strong. Speech is clear and fluent. \n \nPertinent Results:\n___ 06:10AM BLOOD WBC-7.6 RBC-4.36 Hgb-13.6 Hct-41.4 MCV-95 \nMCH-31.2 MCHC-32.9 RDW-16.3* RDWSD-57.1* Plt ___\n___ 06:27AM BLOOD WBC-8.8 RBC-4.47 Hgb-14.2 Hct-41.7 MCV-93 \nMCH-31.8 MCHC-34.1 RDW-16.3* RDWSD-54.5* Plt ___\n___ 08:40AM BLOOD WBC-6.5 RBC-4.29 Hgb-13.2 Hct-39.7 MCV-93 \nMCH-30.8 MCHC-33.2 RDW-16.2* RDWSD-54.7* Plt ___\n___ 06:10AM BLOOD ___ PTT-23.9* ___\n___ 02:45AM BLOOD ___ PTT-27.6 ___\n___ 06:10AM BLOOD Glucose-101* UreaN-11 Creat-0.8 Na-143 \nK-4.0 Cl-106 HCO3-27 AnGap-14\n___ 02:45AM BLOOD Glucose-158* UreaN-15 Creat-1.0 Na-138 \nK-8.0* Cl-103 HCO3-25 AnGap-18\n___ 08:40AM BLOOD Glucose-90 UreaN-15 Creat-0.8 Na-139 \nK-4.2 Cl-106 HCO3-23 AnGap-14\n___ 06:10AM BLOOD Calcium-9.4 Phos-3.4 Mg-1.9\n___ 08:40AM BLOOD Calcium-9.2 Phos-3.5 Mg-1.8\n___ 03:02AM BLOOD Lactate-1.3 K-4.4\n\n___ CT Ab/Pelvis\n1. Partial or early small bowel obstruction, with a transition \npoint in the\nleft abdomen.  No evidence of ischemia or perforation.\n2. 2.7 x 2.4 cm right adrenal nodule, stable from ___.\n \nBrief Hospital Course:\nMs. ___ is a ___ yo F admitted to the Acute Care Surgery service \nwith abdominal pain, nausea and vomiting. She has a past medical \nhistory significant for idiopathic axonal sensorimotor \npolyneuropathy requiring plasmapheresis, diverticulitis, \nhysterectomy, and diabetes. She had a CT scan that showed a \nsmall bowel obstruction with transition point in the left upper \nquadrant. She was made NPO, given IV fluids and admitted the \nfloor hemodynamically stable for further management.\n\nOn HD1 she had flatus and a bowel movement. Her diet was \nadvanced sequentially to regular with good tolerability. The \npatient voided without problem. During this hospitalization, the \npatient ambulated early and frequently, was adherent with \nrespiratory toilet and incentive spirometry, and actively \nparticipated in the plan of care. The patient received \nsubcutaneous heparin and venodyne boots were used during this \nstay.\n\nAt the time of discharge, the patient was doing well, afebrile \nwith stable vital signs. The patient was tolerating a regular \ndiet, having bowel movements, ambulating, voiding without \nassistance, and pain was well controlled.  The patient was \ndischarged home without services. The patient received discharge \nteaching and follow-up instructions with understanding \nverbalized and agreement with the discharge plan.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. amLODIPine 2.5 mg PO DAILY \n2. Aspirin 81 mg PO DAILY \n3. Atorvastatin 10 mg PO QPM \n4. Bisacodyl 10 mg PO DAILY:PRN constipation \n5. BuPROPion 150 mg PO BID \n6. Docusate Sodium 100 mg PO BID \n7. Gabapentin 100 mg PO BID \n8. Lactulose 15 mL PO Q8H:PRN constipation \n9. LORazepam 0.5 mg PO QHS:PRN insomani \n10. Ondansetron 4 mg PO Q8H:PRN nausea \n11. Polyethylene Glycol 17 g PO BID \n12. Sertraline 75 mg PO DAILY \n13. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain \n14. Miconazole Powder 2% 1 Appl TP TID:PRN skin irritation \n\n \nDischarge Medications:\n1. amLODIPine 2.5 mg PO DAILY \n2. Aspirin 81 mg PO DAILY \n3. Atorvastatin 10 mg PO QPM \n4. Bisacodyl 10 mg PO DAILY:PRN constipation \n5. BuPROPion 150 mg PO BID \n6. Docusate Sodium 100 mg PO BID \n7. Gabapentin 100 mg PO BID \n8. Lactulose 15 mL PO Q8H:PRN constipation \n9. LORazepam 0.5 mg PO QHS:PRN insomani \n10. Miconazole Powder 2% 1 Appl TP TID:PRN skin irritation \n11. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain \n12. Polyethylene Glycol 17 g PO BID \n13. Sertraline 75 mg PO DAILY \n14. Ondansetron 4 mg PO Q8H:PRN nausea \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPartial small bowel obstruction \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the Acute Care surgery service with \nabdominal pain, nausea, and vomiting. You had a CT scan that \nshowed a small bowel obstruction. You were given IVF and managed \nnon-operatively. You are now tolerating a regular diet and \nhaving bowel function. You are now ready to be discharged home \nto continue your recovery.\n\nPlease note the following discharge instructions:\nPlease call your doctor or nurse practitioner or return to the \nEmergency Department for any of the following:\n*You experience new chest pain, pressure, squeezing or \ntightness.\n*New or worsening cough, shortness of breath, or wheeze.\n*If you are vomiting and cannot keep down fluids or your \nmedications.\n*You are getting dehydrated due to continued vomiting, diarrhea, \nor other reasons. Signs of dehydration include dry mouth, rapid \nheartbeat, or feeling dizzy or faint when standing.\n*You see blood or dark/black material when you vomit or have a \nbowel movement.\n*You experience burning when you urinate, have blood in your \nurine, or experience a discharge.\n*Your pain in not improving within ___ hours or is not gone \nwithin 24 hours. Call or return immediately if your pain is \ngetting worse or changes location or moving to your chest or \nback.\n*You have shaking chills, or fever greater than 101.5 degrees \nFahrenheit or 38 degrees Celsius.\n*Any change in your symptoms, or any new symptoms that concern \nyou.\n\nPlease resume all regular home medications, unless specifically \nadvised not to take a particular medication. Also, please take \nany new medications as prescribed.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753933674"
  },
  "note_id": "19550378-DS-35",
  "subject_id": 19550378,
  "hadm_id": 21825106,
  "note_type": "DS",
  "note_seq": 35,
  "charttime": "2149-02-20 00:00:00",
  "storetime": "2149-02-20 18:40:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin / Tegaderm \n/ diazepam\n \nAttending: ___.\n \nChief Complaint:\nAbdominal Pain, Nausea, Vomiting\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ female with a history of C-section\nx 2, hysterectomy, morbid obesity and a history of recurrent \nSBOs\nmanaged conservatively who presents with abdominal pain, nausea\nand vomiting.\n\nThe patient's most recent admission was to the ACS service on\n___ for a recurrent SBO, which presented in a similar\nfashion to her presenting complaints today. She was made NPO, \nand\nhad return of bowel function within the first hospital day\nwithout requiring NG tube decompression. She was discharged\nthereafter in good condition. \n\nOn evaluation today, she reports having experiencing colicky\nepigastric pain since mid-day yesterday which has worsened\novernight, and associated nausea with 3 bouts of bilious emesis\nsince time of onset. She initially had a large episode of\ndiarrhea, but since that time had not been having bowel \nmovements\nor passing flatus. She does report having had passed flatus\napproximately 1 hour prior to our consultation, however, and\nfeels an improvement in her nausea and pain since that time (now\nreportedly minimal). Otherwise no fevers/chills, no\nlethargy/malaise, no weight loss, no BRBPR.\n\n \nPast Medical History:\nSevere idiopathic axonal sensorimotor polyneuropathy with\nsymptoms beginning in the late ___ or early ___. Symptoms began\nwith weakness and sensory loss in the legs proximally. Symptoms\nhave been responsive to plasmapheresis approximately yearly. As\nnoted above, she is wheelchair bound.\nTREATMENT HISTORY:\n___ Weakness and sensory loss in legs, torso and arms\n___ Visit with Dr. ___\n___ Sural nerve biopsy\nPathology: marked loss of large and small myelinated axons \n___ - ___ IVIG\n___ Worse symptoms with dysarthria, hypophonia, and dsypahgia \n___ Plasmapheresis, had coronary vasospasm, bradycardia and \none episode of bilateral shoulder pain\n___ line infection\n___ Plasmapheresis, nausea, vomiting\n___ Plasmapheresis, transient nausea and emesis\n___ Plasmaexchange\n___ Had abdominal pain, procedure postponed\n___ - ___ Plasma exchange x4\n___ Plasma exchange #1\n\nVitamin B12 deficiency\nHistory of partial small-bowel obstruction\nDiabetes, not on any medications at present\nHypertension\nGERD\nDepression\nDiverticulosis\nCoronary vasospasm\nStatus post C-section x 2\nStatus post hysterectomy for leiomyomata\nLeft breast lumpectomy\nStatus post bilateral knee replacements\nHistory of abdominal hematoma due to subcutaneous heparin\n\n \nSocial History:\n___\nFamily History:\nMother, brother with diabetes. Mother with liver, cervix, and\ncolon cancer, as well as CAD; father with lung cancer.\n\n \nPhysical Exam:\nGEN: NAD, well appearing\nHEENT: NCAT, trachea midline\nCV: RRR, 2+ radial pulses b/l\nRESP: breathing comfortably on room air\nGI: obese, soft, non-TTP, no distension, rebound or guarding, no \nmasses or hernias on palpation\nEXT: well perfused\n \nPertinent Results:\n___ 07:00AM BLOOD WBC-6.5 RBC-4.61 Hgb-13.6 Hct-43.1 MCV-94 \nMCH-29.5 MCHC-31.6* RDW-13.5 RDWSD-46.6* Plt ___\n___ 08:42AM BLOOD Neuts-67.1 ___ Monos-6.2 Eos-2.9 \nBaso-0.3 Im ___ AbsNeut-4.47 AbsLymp-1.52 AbsMono-0.41 \nAbsEos-0.19 AbsBaso-0.02\n___ 07:00AM BLOOD Plt ___\n___ 07:00AM BLOOD Glucose-104* UreaN-11 Creat-0.8 Na-140 \nK-4.2 Cl-102 HCO3-31 AnGap-11\n___ 08:42AM BLOOD ALT-15 AST-28 AlkPhos-119* TotBili-0.5\n___ 07:00AM BLOOD Calcium-9.0 Phos-3.7 Mg-2.2\n___ 01:06PM BLOOD Lactate-1.8\n \nBrief Hospital Course:\nMs. ___ was admitted to the hospital for management of her \nsmall bowel obstruction. She has an extensive history of \nmultiple small bowel obstructions that have all previously \nresolved with medical management. Upon admission to the ___ \nteam, she received a nasogastric tube for bowel decompression \nand was made NPO. Over the course of her stay, she slowly \nexperienced a return of her bowel function and she was passing \ngas appropriately. Her diet was advanced in a stepwise fashion \nuntil she was tolerating a regular diet with no issues. At the \ntime of discharge, she denied abdominal discomfort, nausea, \nvomiting and was passing gas and tolerating a regular diet. She \nwas OOB to chair as she is wheelchair dependent. She was \ndischarged to her long term care facility with no additional \nmedications. She was instructed to follow up with Dr. ___ in \nclinic at her designated appointment time. \n\nCT Scan:\n1. Small bowel obstruction with likely transition point in the \ndistal ileum.  \nNo evidence of bowel ischemia or perforation. \n2. Stable 2.7 x 2.3 cm right adrenal nodule, unchanged since \n___. \n\n \nMedications on Admission:\n1.  AmLODIPine 2.5 mg PO DAILY  \n2.  Aspirin 81 mg PO DAILY  \n3.  Atorvastatin 10 mg PO QPM  \n4.  BuPROPion 150 mg PO BID  \n5.  Gabapentin 100 mg PO BID  \n6.  Omeprazole 20 mg PO DAILY  \n7.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n \nDischarge Medications:\n1.  AmLODIPine 2.5 mg PO DAILY  \n2.  Aspirin 81 mg PO DAILY  \n3.  Atorvastatin 10 mg PO QPM  \n4.  BuPROPion 150 mg PO BID  \n5.  Gabapentin 100 mg PO BID  \n6.  Omeprazole 20 mg PO DAILY  \n7.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nSmall Bowel Obstruction\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Unable to ambulate, wheelchair dependent\n\n \nDischarge Instructions:\nMs. ___,\n\nYou were admitted to the hospital for a small bowel obstruction. \nYou were given bowel rest and intravenous fluids and a \nnasogastric tube was placed in your stomach to decompress your \nbowels. Your obstruction has subsequently resolved after \nconservative management. You have tolerated a regular diet, are \npassing gas and your pain is controlled with pain medications by \nmouth. You may return home to finish your recovery.  \n \nIf you have any of the following symptoms please call the office \nfor advice or go to the emergency room if severe: increasing \nabdominal distension, increasing abdominal pain, nausea, \nvomiting, inability to tolerate food or liquids, prolonged loose \nstool, or extended constipation.  \n \nThank you for allowing us to participate in your care! Our hope \nis that you will have a quick return to your life and usual \nactivities. \n\nGood luck!  \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753933675"
  },
  "note_id": "19550378-DS-36",
  "subject_id": 19550378,
  "hadm_id": 23785024,
  "note_type": "DS",
  "note_seq": 36,
  "charttime": "2149-10-11 00:00:00",
  "storetime": "2149-10-12 19:20:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROLOGY\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin / Tegaderm \n/ diazepam\n \nAttending: ___\n \nChief Complaint:\nAdmission for treatment of autoimmune idiopathic axonal\npolyneuropathy\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\nMs. ___ is a ___ woman with history of progressive sensory\nneuropathy suspected to be autoimmune in nature treated with\nperiodic plasmapheresis who is admitted for course of\nplasmapheresis.\nShe initially presented to ___ in ___ for evaluation of many\nyears of symptoms, including lower extremity weakness which\nprogressed proximally, decreased sensation, and paresthesias. \nShe\nhad extensive workup including sural nerve biopsy which showed\nsevere loss of all fiber types and NCS showed severe sensory\naxonal polyneuropathy without myopathy. Labs sent including\nanti-Ro, anti-La, ___, HIV, Lyme, anti-IF were all\nnegative and a clear etiology of her symptoms were not\nidentified. Weakness has been felt to be reflective of sensory\ndeafferentation. There have been numerous prior therapeutic\nattempts including IVIG, which she did not respond to.  She has\nbeen more recently getting periodic plasmapheresis and this has\nhelped her significantly to the point that she was improving \nsome\nof her mobility as of ___. \n\nIn ___, she began to notice increased hand cramping and\nnumbness, while lower extremity symptoms remained relatively\nstable. Plasmapheresis was delayed until ___ when the patient\nfelt her symptoms were clearly becoming worse. Unfortunately, \nshe\ndid not respond as well to that course of treatment, partly due\nto subsequent medical issues over the ___ including small\nbowel obstruction requiring repeat hospitalization. The patient\nnoted significant decline in her mood and functional capacity\nover the fall and has been struggling to get back to her ___ baseline. She reports some increase in bilateral hand\nnumbness and in dropping objects over the past 5 months. Plan \nwas\nfor another trial of plasmapheresis to assist in her symptom\ncontrol. \n\nOn neuro ROS, the pt endorses headache, near-daily, bifrontal or\nholocephalic, aching. Other than daily scheduled Tylenol, takes\nno medications for this. Denies loss of vision, blurred vision,\ndiplopia, dysarthria, dysphagia, lightheadedness, vertigo,\ntinnitus or hearing difficulty. Denies difficulties producing or\ncomprehending speech.  Denies focal weakness, nor new numbness,\nparasthesiae. No bowel or bladder incontinence or retention.\nDenies new difficulty with gait.\n\nOn general review of systems, the pt endorses approx. 3 months \nof\ndecreased appetite, and possibly some concomitant weight loss.\nDenies recent fever or chills.  No night sweats or recent weight\ngain. Denies cough, shortness of breath.  Denies chest pain or\ntightness, palpitations.  Denies nausea, vomiting, diarrhea,\nconstipation or abdominal pain.  No recent change in bowel or\nbladder habits.  No dysuria.  Denies arthralgias or myalgias.\nDenies rash.\n\n \nPast Medical History:\nSevere idiopathic axonal sensorimotor polyneuropathy with\nsymptoms beginning in the late ___ or early ___. Symptoms began\nwith weakness and sensory loss in the legs proximally. Symptoms\nhave been responsive to plasmapheresis approximately yearly. As\nnoted above, she is wheelchair bound.\nVitamin B12 deficiency\nHistory of repeated partial small-bowel obstruction; requires \nlow\nresidue diet\nDiabetes, not on any medications at present\nHypertension\nGERD\nDepression\nDiverticulosis\nCoronary vasospasm\nStatus post C-section x 2\nStatus post hysterectomy for leiomyomata\nLeft breast lumpectomy\nStatus post bilateral knee replacements\nHistory of abdominal hematoma due to subcutaneous heparin\n\n \nSocial History:\n___\nFamily History:\nNo family history of neurologic disease\nother than a brother who is ___ with recent symptoms of dementia.\nMother and brother had diabetes.  Mother had liver, cervical and\ncolon cancer.  Father had lung cancer.  Mother had coronary\nartery disease as well.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM: \nGeneral: Awake, cooperative, obese woman lying in bed in NAD.\nFreuqently makes small, nonstereotyped movements of b/l hands \nand\nfeet at fingers, wrist, toes and ankles. \nHEENT: NC/AT, no scleral icterus noted, MMM. R IJ CVL in place,\ndressing c/d/I. \nPulmonary: Breathing comfortably, no tachypnea nor increased WOB\nCardiac: skin warm, well-perfused. \nAbdomen: soft, ND\nExtremities: Symmetric, 1+ pitting edema BLE. \n\nNeurologic:\n\n-Mental Status: Alert, oriented x 3. Provides linear and logical\nhistory. Attentive, able to subtract serial 3's from 20. \nLanguage\nis fluent with intact comprehension to cross-body commands. \nThere\nwere no paraphasic errors. \n\n-Cranial Nerves: PERRL 3->2.  EOMI without nystagmus. Facial\nsensation intact to light touch. Face symmetric at rest and with\nactivation. Hearing intact to conversation. Palate elevates\nsymmetrically. ___ strength in trapezii bilaterally. Tongue\nprotrudes in midline.\n\n-Motor: Normal bulk, tone throughout. No pronator drift\nbilaterally. Pseudoathetosis bilaterally with outstretched arms. \n\nNo adventitious movements, such as tremor, noted. No asterixis\nnoted.\n  Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___\nL  5    ___   5  5     5   5    5  5     5          \nR  5    ___   5  5     5   5    5  5     5          \n\n-Sensory: Pinprick impaired to proximal forearm LUE and\nmid-forearm RUE. Pinprick impaired to approx. level of ankle \nBLE.\nProprioception intact to large movements at the DIP on LUE, and\nlarge movements at the wrist RUE, as well as small movements of\nthe ankle on the L and very large movements of the ankle on the\nR.  \n\n-DTRs:\n   Bi Tri ___ Pat Ach Pec jerk   Crossed Abductors\n L  0  0    0    0   0                     \n R  0  0    0    0   0                     \nPlantar response was flexor on the R, equivocal on the L. \n\n-Coordination: No intention tremor. No dysmetria on FNF\nbilaterally.\n\n==========================================\nDISCHARGE PHYSICAL EXAM: \n\nVitals: Tm/c: 98.6/97.4 BP: 106-139/50-73 HR: 64-69 RR: ___ \nSaO2: 95-100% RA \nGeneral: Awake, cooperative, obese woman sitting up in bed \neating breakfast in NAD. \nHEENT: NC/AT, no scleral icterus noted, MMM. C/D/I dressing over \nprior R IJ pheresis line site.  \nPulmonary: Breathing comfortably, no tachypnea nor increased WOB\nCardiac: skin warm, well-perfused. \nAbdomen: soft, no ttp.  \nExtremities: Symmetric, 1+ pitting edema BLE. \n\nNeurologic:\n-Mental Status: Alert, oriented to medical situation. Attentive \nto exam. Speech fluent without paraphasic errors. \n-Cranial Nerves: EOMI without nystagmus. Facial activation \nsymmetric. No dysarthria. \n-Motor: No pronator drift. Continuous pseudochoreiform movements \nof bilateral fingers, wrists, ankles and toes, which increase \nwith eyes closed. No adventitious movements, such as tremor, \nnoted. \n  Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___\nL  5    ___  4+ 4+    5    ___     5          \nR  5    ___  4+ 4+    5    ___     5          \n-Sensory: Pinprick impaired to mid-forearm BUE. Pinprick \nimpaired to approx. level of ankle BLE.\nProprioception intact to large movements at the wrist BUE as \nwell as near-maximal movements at the ankle bilaterally. \n-Coordination: No intention tremor. No dysmetria on FNF\nbilaterally.\n\n \nPertinent Results:\n___ 05:56AM BLOOD WBC-4.5 RBC-4.28 Hgb-13.0 Hct-40.4 MCV-94 \nMCH-30.4 MCHC-32.2 RDW-14.6 RDWSD-50.6* Plt ___\n___ 04:32AM BLOOD ___ PTT-23.2* ___\n___ 05:56AM BLOOD Glucose-90 UreaN-12 Creat-0.9 Na-144 \nK-4.5 Cl-105 HCO3-29 AnGap-15\n___ 05:56AM BLOOD Calcium-9.1 Phos-4.2 Mg-2.0\n___ 05:56AM BLOOD %HbA1c-5.4 eAG-108\n\nIMAGING: \n___ Pheresis Catheter Placement: Catheter tip in the right \natrium.\n\n___ AXR: Dilated loops of small bowel with air-fluid levels \nconcerning for a small bowel obstruction. \n\n___ CXR: NG tube tip isin the stomach.  Central catheter tip is \nin the lower SVC.   There is mild vascular congestion.  There is \nno pneumothorax.  If any there are small bilateral effusions. \n\n___ CT a/p: 1.   Findings compatible with partial small bowel \nobstruction.  No intraperitoneal free air. \n2.  Pancolonic diverticulosis, without evidence of \ndiverticulitis. \n3.  Stable right adrenal lesion measuring up to 2.7 cm. \n\n \nBrief Hospital Course:\nMs. ___ was admitted for scheduled PLEX. Course was complicated \nby partial SBO, managed conservatively with surgical \nconsultation with NG tube to suction. The SBO resolved. She \nfinished the 5 sessions of PLEX without event. \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Ondansetron ODT 4 mg PO Q6H:PRN nausea \n2. Lactulose 30 mL PO TID \n3. Acetaminophen 650 mg PO DAILY \n4. Bacitracin Ointment 1 Appl TP BID \n5. Gabapentin 100 mg PO BID \n6. buPROPion HCl 200 mg oral DAILY \n7. BuPROPion XL (Once Daily) 150 mg PO QPM \n8. zinc ox-aloe ___ E 11.3 % topical ASDIR \n9. zinc oxide 20 % topical BID \n10. LORazepam 0.5 mg PO DAILY:PRN unknown \n11. bisacodyl 5 mg oral DAILY:PRN \n12. Bisacodyl ___ID:PRN constipation \n13. Docusate Sodium 100 mg PO BID \n14. Polyethylene Glycol 17 g PO BID \n15. Fleet Enema (Saline) ___AILY:PRN constipation \n16. amLODIPine 1.25 mg PO DAILY \n17. dextran 70-hypromellose 0.1-0.3 % ophthalmic Q6H:PRN \n18. Multivitamins W/minerals 1 TAB PO DAILY \n19. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN x 3 as needed for chest \npain \n20. melatonin 4 mg oral QHS:PRN \n21. diclofenac sodium 1 % topical Q8H:PRN \n22. nystatin 100,000 unit/gram topical BID \n23. Aspirin 81 mg PO DAILY \n24. Sertraline 75 mg PO DAILY \n25. TraZODone 25 mg PO QHS:PRN insomnia \n26. Cyanocobalamin 1000 mcg IM/SC QMONTH \n27. Vitamin D 1000 UNIT PO BID \n\n \nDischarge Medications:\n1.  Polyethylene Glycol 17 g PO TID  \n2.  Acetaminophen 650 mg PO DAILY  \n3.  amLODIPine 1.25 mg PO DAILY  \n4.  Aspirin 81 mg PO DAILY  \n5.  Bacitracin Ointment 1 Appl TP BID  \n6.  bisacodyl 5 mg oral DAILY:PRN  \n7.  Bisacodyl ___ID:PRN constipation  \n8.  buPROPion HCl 200 mg oral DAILY  \n9.  BuPROPion XL (Once Daily) 150 mg PO QPM  \n10.  Cyanocobalamin 1000 mcg IM/SC QMONTH  \n11.  dextran 70-hypromellose 0.1-0.3 % ophthalmic Q6H:PRN  \n12.  diclofenac sodium 1 top topical Q8H:PRN pain  \n13.  Docusate Sodium 100 mg PO BID  \n14.  Fleet Enema (Saline) ___AILY:PRN constipation  \n15.  Gabapentin 100 mg PO BID  \n16.  Lactulose 30 mL PO TID  \n17.  LORazepam 0.5 mg PO DAILY:PRN unknown  \n18.  melatonin 4 mg oral QHS:PRN  \n19.  Multivitamins W/minerals 1 TAB PO DAILY  \n20.  Nitroglycerin SL 0.4 mg SL Q5MIN:PRN x 3 as needed for \nchest pain  \n21.  nystatin 100,000 unit/gram topical BID  \n22.  Ondansetron ODT 4 mg PO Q6H:PRN nausea  \n23.  Sertraline 75 mg PO DAILY  \n24.  TraZODone 25 mg PO QHS:PRN insomnia  \n25.  Vitamin D 1000 UNIT PO BID  \n26.  zinc ox-aloe ___ E 11.3 % topical ASDIR  \n27.  zinc oxide 20 % topical BID  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nAutoimmune sensory polyneuropathy\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nMs. ___,\nYou were admitted for your scheduled session of plasma exchange. \nWhile you were here, you also developed another partial small \nbowel obtstruction, and needed a tube from your nose into your \nstomach for a few days. That got better and you were feeling and \neating well before you left the hospital. You finished your five \nsessions of plasma exchange without any provblems. \n\nFollow up with Dr. ___ as listed below. You are also on the \nwait list for a closer appointment with her. \n\nSincerely, \nYour ___ Neurology Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753933676"
  },
  "note_id": "19550378-DS-37",
  "subject_id": 19550378,
  "hadm_id": 28726695,
  "note_type": "DS",
  "note_seq": 37,
  "charttime": "2150-10-12 00:00:00",
  "storetime": "2150-10-12 19:07:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROLOGY\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin / Tegaderm \n/ diazepam\n \nAttending: ___\n \nChief Complaint:\nNumbness, tingling\n \nMajor Surgical or Invasive Procedure:\nTemporary pheresis line placement ___\nPlasma exchange x5 (___)\n\n \nHistory of Present Illness:\nMs. ___ is a ___, right-handed woman with a history of \ndiabetes followed by Dr. ___ severe idiopathic large \nfiber polyneuropathy with predominantly sensory features and \nsome autoimmune inflammatory features. \n\nShe initially presented to ___ in ___ for evaluation of many \nyears of symptoms, including lower extremity weakness which \nprogressed proximally, decreased sensation, and paresthesias.  \nShe had extensive workup including sural nerve biopsy which \nshowed severe loss of all fiber types and NCS showed severe \nsensory axonal polyneuropathy without myopathy. Labs sent \nincluding anti-Ro, anti-La, ___, HIV, Lyme, anti-IF \nwere all negative and a clear etiology of her symptoms were not \nidentified. Weakness has been felt to be reflective of sensory \ndeafferentation. There have been numerous prior therapeutic\nattempts including IVIG, which she did not respond to.  She has \nbeen more recently getting periodic plasmapheresis and this has \nhelped her significantly.\n\nHer last plasmapheresis was performed in ___. Course was \ncomplicated by partial SBO, managed conservatively with surgical \n\nconsultation with NG tube to suction. The SBO resolved. She \nfinished the 5 sessions of PLEX without event. Notably, she also \nhas a history of coronary vasospasm that has occurred with PLEX. \nThis was over ___ years ago. \n\nShe was last seen in ___ at which point she complained \nof decreased sensation, particularly in her hands. She was \ndropping everything from her hands, knocking over objects if she \ndoesn't look. In general, her hand dexterity was worse-even when \nshe is watching what she is doing. She is now not walking at \nall. She got a new wheelchair. She has 7 aides that work with \nher at ___, but she finds this very overwhelming. She \nis transferring on her own but doesn't transfer by herself into \nor out of bed. She still needs help with dressing, showering, \nand hair. She is still having headaches. Other than the above, \nshe noted diminished appetite. She is continuing to follow with \nher GI doctor and maintains some dietary restrictions; \nspecifically, a low fiber/low residue diet with a regular bowel \nregimen. Onions and peppers are triggers and she mostly avoids \nvegetables. She does have some shortness of breath over the past \nyear. She has occasional chest pain for which she uses \nnitroglycerin; she estimates taking this 3 times in the last 6 \nmonths. She had an episode of dizziness, more described as a \nblurred vision. There were no other concerning neurologic \nsymptoms at the time. The vision changes lasted about 1 hour. \n\nDue complaints of worsening sensory symptoms, she has agreed to \nadmission for plasmapheresis. Upon arrival to ___, she \nconfirms the history as above. She reports feeling numb \"from my \nfeet to my lip\", and is hopeful that the PLEX will help with her \nnumbness. \n\nNeurologic review of systems as described in the HPI. \n\nOn general review of systems, the pt denies recent fever or \nchills.  No night sweats or recent weight loss or gain. Denies \ncough, shortness of breath.  Denies chest pain or tightness, \npalpitations.  Denies nausea, vomiting, diarrhea, constipation \nor abdominal pain.  No recent change in bowel or bladder habits. \n No dysuria.  Denies arthralgias or myalgias. Denies rash.\n\n \nPast Medical History:\nSevere idiopathic axonal sensorimotor polyneuropathy with \nsymptoms beginning in the late ___ or early ___. Symptoms began \nwith weakness and sensory loss in the legs proximally. Symptoms \nhave been responsive to plasmapheresis approximately yearly. As \nnoted above, she is wheelchair bound.\nVitamin B12 deficiency\nHistory of repeated partial small-bowel obstruction; requires \nlow residue diet\nDiabetes\nHypertension\nGERD\nDepression\nDiverticulosis\nCoronary vasospasm\nStatus post C-section x 2\nStatus post hysterectomy for leiomyomata\nLeft breast lumpectomy\nStatus post bilateral knee replacements\nHistory of abdominal hematoma due to subcutaneous heparin\n \nSocial History:\n___\nFamily History:\nNo family history of neurologic disease other than a brother who \nis ___ with recent symptoms of dementia. Mother and brother had \ndiabetes.  Mother had liver, cervical and colon cancer.  Father \nhad lung cancer.  Mother had coronary artery disease as well.\n \nPhysical Exam:\nON ADMISSION\n============\nVitals: Temp: 98.1 PO BP: 146/77 HR: 66 RR: 18 O2 sat: 100% RA  \nGeneral: Awake, cooperative, NAD, obese.\nHEENT: NC/AT, no scleral icterus noted, MMM, edentulous\nNeck: Supple, no carotid bruits appreciated. No nuchal rigidity\nPulmonary: Lungs CTA bilaterally without R/R/W\nCardiac: RRR, nl. S1S2, no M/R/G noted\nAbdomen: soft, NT/ND, normoactive bowel sounds, no masses or\norganomegaly noted.\nExtremities: No ___ edema.\nSkin: no rashes or lesions noted.\n\nNeurologic:\n-Mental Status: Alert, oriented x 3. Able to relate history\nwithout difficulty. Attentive, able to name ___ backward without\ndifficulty. Language is fluent with intact repetition and\ncomprehension. Normal prosody. There were no paraphasic errors.\nSpeech was not dysarthric. Able to follow both midline and\nappendicular commands. \n-Cranial Nerves:\nII, III, IV, VI:  PERRL 3 to 2mm and brisk. EOMI without\nnystagmus. Normal saccades. VFF to confrontation. \nV: Facial sensation intact to light touch and pin prick.\nVII: No facial droop, facial musculature symmetric.\nVIII: Hearing intact to finger-rub bilaterally.\nIX, X: Palate elevates symmetrically.\nXI: ___ strength in trapezii and SCM bilaterally.\nXII: Tongue protrudes in midline.\n-Motor: Normal bulk, tone throughout. No pronator drift\nbilaterally.\nThere is prominent pseudoathetosis of the feet, and to a lesser\ndegree in the hands. No asterixis noted.\n  Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___\nL  4    ___   ___  4+  4+   5  5     5     5  \nR  5    ___   ___  5-  5    5  5     5     4+   \n-Sensory: There is decreased sensation to pinprick in both hands\nto about the wrists. Joint position sense is absent in bilateral\ntoes, and intact only to large amplitude movements in the \nankles;\nalso absent in the fingers throughout, but intact at the wrists.\nVibration is only felt at the knees bilaterally, intact in the\nfingers. \n-DTRs:\n  Bi Tri ___ Pat Ach\nL  0  0    0    0   0\nR  0  0    0    0   0\nPlantar response was flexor bilaterally.\n-Coordination: No intention tremor, no dysdiadochokinesia noted.\nNo dysmetria on FNF bilaterally.\n-Gait: wheelchair bound at baseline.\n\nON DISCHARGE\n============\nVitals: Temp: 98.6 PO BP: 148/76 L Lying HR: 67 RR: 18 O2 sat:\n95% O2 delivery: Ra \nGeneral: Awake, cooperative, NAD, obese.\nHEENT: NC/AT, edentulous\nPulmonary: Breathing comfortably on room air\nExtremities: No ___ edema.\nSkin: no rashes or lesions noted.\n\nNeurologic:\nMS: awake, alert, and attentive to interview.\nCN: Pupils equal and reactive. Eye movements full with no\nnystagmus. Face symmetric, no dysarthria. \nMotor: Bulk, tone, normal. Pseudoathetosis in both legs, and in\narms with eyes closed.\n  Delt Bic Tri WrE FFl FE IO IP Quad Ham TA \nL  4    ___   ___  4    5   4+  5   \nR  5    ___   ___  4+   ___\nCoord: No dysmetria.\nSensory: There is significant inaccuracy bilaterally when\nperforming finger to nose with eyes closed.\n \nPertinent Results:\n___ 03:09AM BLOOD WBC-6.1 RBC-4.24 Hgb-13.0 Hct-39.5 MCV-93 \nMCH-30.7 MCHC-32.9 RDW-15.2 RDWSD-51.9* Plt ___\n___ 08:45AM BLOOD ___\n___ 06:05AM BLOOD Glucose-107* UreaN-12 Creat-1.0 Na-145 \nK-4.6 Cl-110* HCO3-25 AnGap-10\n___ 01:00PM BLOOD ALT-11 AST-14 LD(LDH)-256* AlkPhos-100 \nTotBili-0.5\n___ 06:05AM BLOOD Calcium-8.7 Phos-4.3 Mg-1.8\n \nBrief Hospital Course:\nMs. ___ is a ___ woman with a longstanding history of a \npredominantly sensory polyneuropathy with previous work-up \nsuggestive of an Autoimmune/inflammatory cause. She has \npreviously not responded with IVIG. She was transitioned to \nplasmapheresis and initially experienced significant improvement \nin her symptoms. At her last neurology appointment she reported \nworsening sensory symptoms, since at least ___. She was \ntherefore admitted to undergo plasmapheresis. She had a \ntemporary pheresis line placed, and subsequently had 5 \ntreatments of plasmapheresis. There were no complications. She \nwas discharged back to her home, with previous services in \nplace. \n\nTransitional issues: \n-follow-up with neurology\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Ondansetron 4 mg PO Q6H:PRN nausea \n2. Lactulose 15 mL PO DAILY \n3. Acetaminophen 650 mg PO Q4H:PRN Pain - Mild \n4. Bacitracin Ointment 1 Appl TP BID \n5. Gabapentin 100 mg PO BID \n6. Zinc Oxide Diaper Cream (dimethicone-ZnOx-vit A-D-aloe) ___ \n% topical DAILY:PRN \n7. LORazepam 0.5 mg PO DAILY:PRN anxiety \n8. Bisacodyl ___ID:PRN constipation \n9. Docusate Sodium 100 mg PO BID \n10. Polyethylene Glycol 17 g PO BID \n11. Sodium Polystyrene Sulfonate 30 gm PR ONCE constipation \n12. dextran 70-hypromellose (PF) 0.1-0.3 % ophthalmic (eye) QID \n13. Atorvastatin 10 mg PO QPM \n14. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain \n15. melatonin 1 mg oral QHS:PRN \n16. nystatin 100,000 unit/gram topical BID \n17. Aspirin 81 mg PO DAILY \n18. TraZODone 25 mg PO QHS:PRN insomnia \n19. Sertraline 75 mg PO DAILY \n20. Multivitamins 1 TAB PO DAILY \n21. BuPROPion (Sustained Release) 200 mg PO QAM \n22. BuPROPion (Sustained Release) 150 mg PO QHS \n23. Cyanocobalamin 1000 mcg IM/SC ONCE \n24. diclofenac sodium 1 % topical TID:PRN \n\n \nDischarge Medications:\n1.  Acetaminophen 650 mg PO Q4H:PRN Pain - Mild  \n2.  Aspirin 81 mg PO DAILY  \n3.  Atorvastatin 10 mg PO QPM  \n4.  Bacitracin Ointment 1 Appl TP BID  \n5.  Bisacodyl ___ID:PRN constipation  \n6.  BuPROPion (Sustained Release) 200 mg PO QAM  \n7.  BuPROPion (Sustained Release) 150 mg PO QHS  \n8.  Cyanocobalamin 1000 mcg PO DAILY  \n9.  dextran 70-hypromellose (PF) 0.1-0.3 % ophthalmic (eye) QID  \n\n10.  diclofenac sodium 1 APPL topical TID:PRN pain  \n11.  Docusate Sodium 100 mg PO BID  \n12.  Gabapentin 100 mg PO BID  \n13.  Lactulose 15 mL PO DAILY  \n14.  LORazepam 0.5 mg PO DAILY:PRN anxiety  \n15.  melatonin 1 mg oral QHS:PRN  \n16.  Multivitamins 1 TAB PO DAILY  \n17.  Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain  \n18.  nystatin 100,000 unit/gram topical BID  \n19.  Ondansetron 4 mg PO Q6H:PRN nausea  \n20.  Polyethylene Glycol 17 g PO BID  \n21.  Sertraline 75 mg PO DAILY  \n22.  Sodium Polystyrene Sulfonate 30 gm PR ONCE constipation  \n23.  TraZODone 25 mg PO QHS:PRN insomnia  \n24.  Zinc Oxide Diaper Cream (dimethicone-ZnOx-vit A-D-aloe) \n___ % topical DAILY:PRN  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nIdiopathic large fiber polyneuropathy\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure caring for you at ___ \n___.\n\nYou were in the hospital to undergo plasma exchange. You had a \nlarge IV line placed, and underwent 5 treatments of plasma \nexchange. There were no complications.\n\nOnce you leave the hospital, you will return home. You should \nfollow up with Dr. ___ as listed below.\n\nBest wishes,\nYour ___ team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753933677"
  },
  "note_id": "19550378-DS-38",
  "subject_id": 19550378,
  "hadm_id": 20326880,
  "note_type": "DS",
  "note_seq": 38,
  "charttime": "2151-02-14 00:00:00",
  "storetime": "2151-02-14 09:30:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin / Tegaderm \n/ diazepam\n \nAttending: ___.\n \nChief Complaint:\nHA, abd pain\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ presented with HA and abd pain. \nHer abd pain began after dinner on ___ dull, ___, without\nradiation.  + nausea/diarrhea.  Developed fever to 101 -> to ED\nfor eval.  In the ED, WBC 17.3 and CT with small amount of\ntransverse colon thickening.  Pt treated with \ncipro/metronidazole\nand admitted for further care.\n\nOn admission to the medical service, she reports marked\nimprovement, with abd pain ___, headache ___ and resolution of\nher nausea.  Her last diarrhea/vomiting were in the ED.\n \nPast Medical History:\nSevere idiopathic axonal sensorimotor polyneuropathy with \nsymptoms beginning in the late ___ or early ___. Symptoms began \nwith weakness and sensory loss in the legs proximally. Symptoms \nhave been responsive to plasmapheresis approximately yearly. As \nnoted above, she is wheelchair bound.\nVitamin B12 deficiency\nHistory of repeated partial small-bowel obstruction; requires \nlow residue diet\nDiabetes\nHypertension\nGERD\nDepression\nDiverticulosis\nCoronary vasospasm\nStatus post C-section x 2\nStatus post hysterectomy for leiomyomata\nLeft breast lumpectomy\nStatus post bilateral knee replacements\nHistory of abdominal hematoma due to subcutaneous heparin\n \nSocial History:\n___\nFamily History:\nNo family history of neurologic disease other than a brother who \nis ___ with recent symptoms of dementia. Mother and brother had \ndiabetes.  Mother had liver, cervical and colon cancer.  Father \nhad lung cancer.  Mother had coronary artery disease as well.\n \nPhysical Exam:\nDischarge exam:\n===============\nVS: T 98.2 PO     BP 115 / 74     HR 57     RR 18   pOx 95% RA   \n      \nGENERAL:  NAD\nHead:  NC/AT\nEyes: anicteric sclera\nEars/Nose/Mouth/Throat:  MMM, no OP lesions appreciated, no \nfrontal or maxillary sinus tenderness to palpation, grossly \nnormal hearing\nNeck:  normal aROM\nResp:  decreased breath sounds in b/l lung bases (shallow depth \nof inspiration), otherwise breath sounds are clear and she has \nnormal WOB at rest and with conversation \nCV:  RR, normal S1S2, +systolic murmur (___) heard best over \nRUSB\nGI:  obese, soft, NT/ND, bowel sounds present\nSkin:  No rashes or lesions noted\nExtremities:  No pitting edema\nNeuro:  awake, alert, conversant with clear speech, moving all \n4s with no difficulty and with normal coordination and no \ntremor/asterixis\nPsych: calm, cooperative, pleasant\n \nPertinent Results:\nADMISSION LABS:\n================\n\n___ 11:35AM BLOOD WBC-17.3* RBC-4.92 Hgb-15.3 Hct-46.3* \nMCV-94 MCH-31.1 MCHC-33.0 RDW-14.6 RDWSD-48.7* Plt ___\n___ 11:35AM BLOOD Neuts-92.0* Lymphs-3.6* Monos-3.6* \nEos-0.1* Baso-0.2 Im ___ AbsNeut-15.91* AbsLymp-0.62* \nAbsMono-0.62 AbsEos-0.02* AbsBaso-0.03\n___ 11:35AM BLOOD ___ PTT-21.5* ___\n___ 07:20AM BLOOD Glucose-70 UreaN-18 Creat-1.0 Na-144 \nK-4.0 Cl-102 HCO3-28 AnGap-14\n___ 07:20AM BLOOD Calcium-9.0 Phos-4.1 Mg-1.9\n___ 01:14PM BLOOD Lactate-1.5\n.\n.\nMICRO:\n========\n-Bld cx ___ growing Group B strep\n___ 11:14 am BLOOD CULTURE\n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___: \n      BETA STREPTOCOCCUS GROUP B.    FINAL SENSITIVITIES. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             BETA STREPTOCOCCUS GROUP B\n                             |   \nCEFTRIAXONE-----------<=0.12 S\nCLINDAMYCIN-----------<=0.25 S\nERYTHROMYCIN----------<=0.12 S\nPENICILLIN G----------  0.12 S\nVANCOMYCIN------------   0.5 S\n\n   Aerobic Bottle Gram Stain (Final ___: \n      Reported to and read back by ___. ___ ON ___ AT \n0130. \n      GRAM POSITIVE COCCI IN PAIRS AND CHAINS. \n\n   Anaerobic Bottle Gram Stain (Final ___: \n      GRAM POSITIVE COCCI IN PAIRS AND CHAINS. \n\n-Repeat cx on ___ and ___ NGTD\n\n-U/A was not suggestive of inflammation or infection;\ncorresponding UCx grew E. coli with resistance to Ampicillin,\nAmp+Sulbactam, Cipro, and TMP/SMX\n.\n.\nIMAGING:\n=========\n___ CXR:\n\"1. Mild pulmonary vascular congestion. \n2. No focal consolidations or pleural abnormality.\"\n\n___ CT abd/pelvis: \n\"1. Diverticulosis without evidence of diverticulitis.  No\nevidence for colitis.\n2. No gastrointestinal obstruction.\"\n.\n.\nDISCHARGE LABS: (last labs prior to discharge)\n===============\n___ 10:55AM BLOOD WBC-6.5 RBC-4.37 Hgb-13.3 Hct-41.1 MCV-94 \nMCH-30.4 MCHC-32.4 RDW-13.6 RDWSD-47.7* Plt ___\n___ 10:55AM BLOOD UreaN-13 Creat-1.0 Na-141 K-4.1 Cl-101 \nHCO3-29 AnGap-11\n \nBrief Hospital Course:\n# Fever, abdominal pain, nausea and diarrhea x1 day\nPt with abdominal pain, nausea, and diarrhea prior to admission. \n She had a leukocytosis but CT abd/pelvis showed no acute \npathology.  She had no evidence for abscess or obstruction.  She \nreceived antibiotics in the ED for possible transverse colitis \n(on the preliminary radiology read), with marked improvement by \nthe time she reached the medical floor. She was treated with \nciprofloxacin/metronidazole through ___. Her abd pain resolved \nfully and she was able to transition to her PO diet without an \nissue. \n\nUnclear etiology. Possibly she had a food-borne illness or SBO \nthat then resolved. No stool studies could be sent because after \narrival on floor she had no BM. \n.\n.\n\n# Group B strep bacteremia w/ sepsis - Her blood culture x 1 \nfrom admission showed Group B strep. Initially was given dose of \nvancomycin on ___, but transitioned to CTX once GBS speciated. \nID was consulted and they felt that given her age/comorbidities \nthat she should be treated with IV antibiotics x 2 weeks. First \ndose of CTX given via midline on ___. A TTE was obtained and \nshowed no evidence of endocarditis. ID team recommended against \n___. There was no clear source for her Group B strep bacteremia, \nand we suspect that her initial GI symptoms may in fact have \nbeen result of sepsis from a primary Group B strep bacteremia, \nrather than the bacteremia having been the result of a GI \nprocess.\n\n[] Complete 14-day total course of Ceftriaxone via midline; last \nday will be ___.\n.\n.\n# Possible HFpEF (new diagnosis)\nShe did have an o2 requirement initially (___) which resolved \nwith time and getting up to chair. CXR showed mild pulmonary \nvascular congestion.  TTE showed elevated PCWP and elevated E/e' \nwithout reduced LVEF, overall suggestive of HFpEF.  She has \nmultiple risk factors for HFpEF.  The mild hypoxia resolved and \naside from generalized non-pitting edema (of unclear chronicity) \nshe did not have signs/symptoms concerning for decompensated CHF \nat the time of discharge.\n\n[]Please check daily weights, consider initiation of loop \ndiuretic if weight increasing or if patient develops other signs \nto suggest worsening CHF (worsening pitting edema in dependent \nareas, orthopnea, dry cough, SOB/DOE, etc.)\n[]She has cardiology follow-up scheduled on ___\n.\n.\n\n# Recurrent headaches - she reported that she has had recurrent \nheadaches for months which she believes are worsening. During \nhospital stay, easily treated with tylenol. We recommended she \ndiscuss with her neurologist. \n.\n.\n\n# Idiopathyic axonal sensorimotor polyneuropathy - Continued \ngabapentin. Outpatient f/u per Neuro.\n.\n.\n.\n.\n.\nTime in care: greater than 30 minutes in discharge-related \nactivities today.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 650 mg PO Q4H:PRN Pain - Mild \n2. Aspirin 81 mg PO DAILY \n3. Atorvastatin 10 mg PO QPM \n4. Bacitracin Ointment 1 Appl TP BID \n5. Bisacodyl ___ID:PRN constipation \n6. Docusate Sodium 100 mg PO BID \n7. Gabapentin 100 mg PO BID \n8. Multivitamins 1 TAB PO DAILY \n9. Ondansetron 4 mg PO Q6H:PRN nausea \n10. Polyethylene Glycol 17 g PO BID \n11. Sertraline 100 mg PO DAILY \n12. TraZODone 25 mg PO QHS:PRN insomnia \n13. LORazepam 0.5 mg PO DAILY:PRN anxiety \n14. melatonin 1 mg oral QHS:PRN \n15. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain \n16. nystatin 100,000 unit/gram topical BID \n17. Zinc Oxide Diaper Cream (dimethicone-ZnOx-vit A-D-aloe) ___ \n% topical DAILY:PRN \n18. Cyanocobalamin 1000 mcg PO DAILY \n\n \nDischarge Medications:\n1.  CefTRIAXone 2 gm IV Q 24H \nRX *ceftriaxone in dextrose,iso-os 2 gram/50 mL 2 gm IV once a \nday Disp #*13 Intravenous Bag Refills:*0 \n2.  Acetaminophen 650 mg PO Q4H:PRN Pain - Mild  \n3.  Aspirin 81 mg PO DAILY  \n4.  Atorvastatin 10 mg PO QPM  \n5.  Bacitracin Ointment 1 Appl TP BID  \n6.  Bisacodyl ___ID:PRN constipation  \n7.  Cyanocobalamin 1000 mcg PO DAILY  \n8.  Docusate Sodium 100 mg PO BID  \n9.  Gabapentin 100 mg PO BID  \n10.  Lactulose 30 mL PO DAILY:PRN constipation  \n11.  LORazepam 0.5 mg PO DAILY:PRN anxiety  \n12.  melatonin 1 mg oral QHS:PRN  \n13.  Multivitamins 1 TAB PO DAILY  \n14.  Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain  \n15.  nystatin 100,000 unit/gram topical BID  \n16.  Ondansetron 4 mg PO Q6H:PRN nausea  \n17.  Polyethylene Glycol 17 g PO BID  \n18.  Sertraline 100 mg PO DAILY  \n19.  TraZODone 25 mg PO QHS:PRN insomnia  \n20.  Zinc Oxide Diaper Cream (dimethicone-ZnOx-vit A-D-aloe) \n___ % topical DAILY:PRN  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\n# Fever/abdominal pain/nausea/diarrhea\n# Group B strep bacteremia w/ sepsis\n# Pulmonary edema w/ mild hypoxia on ___ - possible HFpEF \nexacerbation\n# Constipation (chronic)\n# Headache (chronic)\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\n___, \n\nYou were admitted with belly pain, nausea, vomiting. Luckily \nthese symptoms improved quickly and you were able to begin \neating.\n\nUnfortunately a blood culture grew a bacteria for which we need \nto treat you with antibiotics for 2 weeks. \n\nDuring your hospital stay your headaches which you are having at \nhome continued. We recommend you discuss more with your primary \ncare doctor and neurologist. \n\nBest of luck!\n\nYour ___ team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753933678"
  },
  "note_id": "19550378-DS-39",
  "subject_id": 19550378,
  "hadm_id": 22725439,
  "note_type": "DS",
  "note_seq": 39,
  "charttime": "2151-06-20 00:00:00",
  "storetime": "2151-06-21 11:58:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin / Tegaderm \n/ diazepam\n \nAttending: ___.\n \nChief Complaint:\nNeeds CT colonography due to difficulty with bowel prep\n \nMajor Surgical or Invasive Procedure:\nCT colonography on ___\n \nHistory of Present Illness:\n___ y.o F with diet controlled DM, HTN, GERD, history of repeated \npartial small-bowel obstruction, severe idiopathic axonal \nsensorimotor polyneuropathy admitted as a direct admission for \nbowel prep for CT colography. \n\nUpon arrival to the floor, the patient appeared well. She \nreported approximately 2 days of diarrhea, but denied blood in \nher diarrhea. She otherwise denied fevers, chills, abdominal \npain. She endorsed intermittent chest pain, for which she \nfollows with her cardiologist. The chest pain usually occurs at \nnight while lying in bed and is associated with shortness of \nbreath. The chest pain usually resolves with 2 nitroglycerin. \nShe endorsed stable shortness of breath with exertion, which \noccurs even with transfer. \n\n \nPast Medical History:\nSevere idiopathic axonal sensorimotor polyneuropathy with \nsymptoms beginning in the late ___ or early ___. Symptoms began \nwith weakness and sensory loss in the legs proximally. Symptoms \nhave been responsive to plasmapheresis approximately yearly. As \nnoted above, she is wheelchair bound.\nVitamin B12 deficiency\nHistory of repeated partial small-bowel obstruction; requires \nlow residue diet\nDiabetes\nHypertension\nGERD\nDepression\nDiverticulosis\nCoronary vasospasm\nStatus post C-section x 2\nStatus post hysterectomy for leiomyomata\nLeft breast lumpectomy\nStatus post bilateral knee replacements\nHistory of abdominal hematoma due to subcutaneous heparin\n \nSocial History:\n___\nFamily History:\nNo family history of neurologic disease other than a brother who \nis ___ with recent symptoms of dementia. Mother and brother had \ndiabetes.  Mother had liver, cervical and colon cancer.  Father \nhad lung cancer.  Mother had coronary artery disease as well.\n \nPhysical Exam:\nADMISSION: \nVITALS: 97.7 PO 148 / 82 L Lying 60 16 93 RA \nGENERAL: Alert and in no apparent distress\nEYES: Anicteric, pupils equally round\nENT: Ears and nose without visible erythema, masses, or trauma. \nOropharynx without visible lesion, erythema or exudate\nMucous membranes dry\nCV: Heart regular, + systolic murmur\nRESP: Lungs clear to auscultation anteriorly with good air\nmovement bilaterally\nGI: Abdomen soft, non-distended, non-tender to palpation\nMSK: Neck supple, moves all extremities, strength grossly full\nand symmetric bilaterally in all limbs\nSKIN: No rashes or ulcerations noted\nNEURO: Alert, oriented, face symmetric, gaze conjugate with \nEOMI,\nspeech fluent, moves all limbs\nPSYCH: pleasant, appropriate affect\nEXT: warm, mild edema at the level of the ankles\n\nDISCHARGE: \nTemp: 98.4 PO BP: 139/70 HR: 59 RR: 18 O2 sat:\n95% O2 delivery: Ra \nGENERAL: Alert and in no apparent distress\nEYES: Anicteric, pupils equally round\nENT: Ears and nose without visible erythema, masses, or trauma. \nOropharynx without visible lesion, erythema or exudate\nMucous membranes dry\nCV: Heart regular, + systolic murmur\nRESP: Lungs clear to auscultation anteriorly with good air\nmovement bilaterally\nGI: Abdomen soft, non-distended, non-tender to palpation\nMSK: Neck supple, moves all extremities, strength grossly full\nand symmetric bilaterally in all limbs\nSKIN: No rashes or ulcerations noted\nNEURO: Alert, oriented, face symmetric, gaze conjugate with \nEOMI,\nspeech fluent, moves all limbs\nPSYCH: pleasant, appropriate affect\nEXT: warm, mild edema at the level of the ankles\n \nPertinent Results:\nLABS AT DISCHARGE: \n================\n___ 06:10AM BLOOD WBC-4.9 RBC-4.35 Hgb-12.9 Hct-41.6 MCV-96 \nMCH-29.7 MCHC-31.0* RDW-14.4 RDWSD-50.6* Plt ___\n___ 01:45PM BLOOD UreaN-7 Creat-0.8 Na-147 K-4.1 Cl-99 \nHCO3-33* AnGap-15\n\nIMAGING:\n=======\n___ CT Colonography\nIMPRESSION:\n1. No concerning colonic lesions are identified.  1 cm ileocecal \nvalve lipoma. The exam is limited by thickening of approximately \n10 cm of nondistended colon in the hepatic flexure as well as \npoor distention of the upper rectum and mid sigmoid colon.  \nExtensive pancolonic diverticulosis seen without diverticulitis.\n2. 5.0 cm mass in the right adrenal gland shows bulk fat, \nconsistent with myelolipoma.\n \nBrief Hospital Course:\n___ with diet controlled DM, HTN, GERD, history of repeated \npartial small-bowel obstruction, severe idiopathic axonal \nsensorimotor polyneuropathy, with a FH of colon cancer admitted \nfor inpatient colonoscopy prep with planned CT colography.\n\nPatient has had failed multiple extended bowel preps due to a \nlong and tortuous colon so patient admitted for prep in order to \nundergo Virtual CT colonography. Attempt on ___ with poor prep \nand motion artifact. Repeat on ___ without any concerning \nfindings. (Refer to pertinent results section). Patient to \nfollow with PCP to discuss final results. \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 650 mg PO Q4H:PRN Pain - Mild \n2. Aspirin 81 mg PO DAILY \n3. Atorvastatin 10 mg PO QPM \n4. Bacitracin Ointment 1 Appl TP BID \n5. Cyanocobalamin 1000 mcg PO DAILY \n6. Docusate Sodium 100 mg PO BID \n7. Gabapentin 100 mg PO BID \n8. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain \n9. Sertraline 150 mg PO DAILY \n10. TraZODone 25 mg PO QHS:PRN insomnia \n11. Multivitamins 1 TAB PO DAILY \n12. nystatin 100,000 unit/gram topical BID \n13. Polyethylene Glycol 17 g PO BID \n14. Zinc Oxide Diaper Cream (dimethicone-ZnOx-vit A-D-aloe) ___ \n% topical DAILY:PRN \n15. Lactulose 30 mL PO DAILY:PRN constipation \n16. diclofenac sodium 1 % topical TID \n17. Melatin (melatonin) 1 mg oral QHS:PRN \n\n \nDischarge Medications:\nNO CHANGES TO YOUR MEDICATIONS\n1. Acetaminophen 650 mg PO Q4H:PRN Pain - Mild \n2. Aspirin 81 mg PO DAILY \n3. Atorvastatin 10 mg PO QPM \n4. Bacitracin Ointment 1 Appl TP BID \n5. Cyanocobalamin 1000 mcg PO DAILY \n6. Docusate Sodium 100 mg PO BID \n7. Gabapentin 100 mg PO BID \n8. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN chest pain \n9. Sertraline 150 mg PO DAILY \n10. TraZODone 25 mg PO QHS:PRN insomnia \n11. Multivitamins 1 TAB PO DAILY \n12. nystatin 100,000 unit/gram topical BID \n13. Polyethylene Glycol 17 g PO BID \n14. Zinc Oxide Diaper Cream (dimethicone-ZnOx-vit A-D-aloe) ___ \n% topical DAILY:PRN \n15. Lactulose 30 mL PO DAILY:PRN constipation \n16. diclofenac sodium 1 % topical TID \n17. Melatin (melatonin) 1 mg oral QHS:PRN \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \n___ Diagnosis:\nscheduled admission for CT colonography prep\n\n \nDischarge Condition:\nstable\n \nDischarge Instructions:\nDear Ms. ___, \n\nIt was a privilege to care for you at the ___ \n___. You were admitted for a CT colonoscopy given \ndifficulty with bowel prep and incomplete colonoscopy due to \nyour colon anatomy. Preliminarily the results show nothing \nconcerning, which is good news! You can discuss the full results \nwith your PCP at follow up. \n\nPlease continue all medications as prescribed and follow up with \nall appointments as detailed below. \n\nWe wish you the best! \n\nSincerely,\nYour ___ Team  \n \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753933679"
  },
  "note_id": "19550378-DS-40",
  "subject_id": 19550378,
  "hadm_id": 27016663,
  "note_type": "DS",
  "note_seq": 40,
  "charttime": "2152-06-02 00:00:00",
  "storetime": "2152-06-02 19:12:00",
  "text": " \nName:  ___                      Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPenicillins / Tetracycline / Grapefruit / Amoxicillin / Tegaderm \n/ diazepam\n \nAttending: ___\n \nPertinent Results:\nADMISSION/SIGNIFICANT LABS: \n===========================\n___ 09:38AM BLOOD WBC-5.2 RBC-4.49 Hgb-13.4 Hct-41.7 MCV-93 \nMCH-29.8 MCHC-32.1 RDW-14.4 RDWSD-49.2* Plt ___\n___ 09:38AM BLOOD Glucose-94 UreaN-10 Creat-0.9 Na-141 \nK-4.7 Cl-101 HCO3-25 AnGap-15\n___ 09:38AM BLOOD Albumin-4.1 Calcium-9.5 Phos-3.9 Mg-1.9\n\n___ 06:20AM BLOOD Cortsol-14.3 DHEA-SO-43\n___ 11:39AM BLOOD ALDOSTERONE-PND\n___ 11:39AM BLOOD RENIN - FROZEN-PND\n___ 11:39AM BLOOD ACTH - FROZEN-PND\n___ 06:20AM BLOOD Metanephrines (Plasma)-PND\n\nMICRO: \n======\n___ 11:35 am URINE\n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \nWITH SKIN\n      AND/OR GENITAL CONTAMINATION. \n\nBlood Cx NGTD x2 \n\nIMAGING/OTHER STUDIES: \n======================\nCT a/p  \n1.  No acute findings in the abdomen or pelvis. \n2.  Extensive pancolonic diverticulosis without evidence of \nacute diverticulitis. \n3.  Redemonstration of a 4.4 cm heterogeneous right adrenal mass\nwith foci of  bulk fat, suggesting a myelolipoma, unchanged.\n\nRenal U/S: \n1. Limited examination was terminated early due to patient \ndiscomfort. \n2. Limited sonographic examination of the right kidney\ndemonstrated normal morphology.  Normal waveform, but slightly \nincreased resistive index of the main right renal artery. \n3. The left kidney and urinary bladder were not assessed on the\ncurrent study. \n\nLABS ON DISCHARGE: \n=================\n___ 06:30AM BLOOD WBC-7.3 RBC-4.88 Hgb-14.5 Hct-45.4* \nMCV-93 MCH-29.7 MCHC-31.9* RDW-14.2 RDWSD-48.7* Plt ___\n___ 06:30AM BLOOD Glucose-106* UreaN-11 Creat-0.9 Na-143 \nK-4.4 Cl-98 HCO3-30 AnGap-15\n___ 06:30AM BLOOD Mg-1.___ with hx of obesity, sensory neuropathy (following with \nneurology, receives IVIg infusions), diet controlled DM2, GERD, \nrepeated partial SBOs presenting with headache and nausea with \nassociated LLQ pain x ___ days, found to have hypertensive \ncrisis. \n\n# Hypertensive crisis: \nPresented with headaches and nausea/vomiting with SBP > 200. \nPreviously on BP agents but have been since discontinued with \nexception of Imdur (prescribed for coronary vasospasms). \nRequired multiple IV agents in the ED but subsequently well \nmanaged on the floor with oral agents. Started on HCTZ 12.5 and \namlodipine 5mg with significant improvement in blood pressures \nand resolution of associated symptoms. CT abd/pelvis obtained in \nsetting of \"LLQ\" pain, notable for 4.4 cm heterogeneous right \nadrenal mass with foci of bulk fat, suggesting a myelolipoma, \nunchanged from prior imaging. Due to her markedly elevated BP \nand adrenal findings, secondary work up for HTN was initiated \nwith plasma renin/aldosterone and metanephrines pending at the \ntime of discharge. Due to stability of blood pressure, these \nresults can be followed up as an outpatient.  Additionally on \nthis admission, renal artery ultrasound was obtained but results \nlimited as patient did not tolerate due to pain; the left kidney \nwas not visualized and the right kidney had normal vascular wave \nform, lowering likelihood of RAS. Patient will need ongoing \nmonitoring of blood pressure. If she continues to have \nintermittent episodes of severe hypertension, suspicion for \npheochromocytoma would increase (unless pending plasma \nmetanephrines results are reassuring). \n   \n# Frontal headache: \nCT head without acute process (mass, bleed, etc). Markedly \nimproved with treatment of HTN.\n\n# Lateral hip/thigh pain: \nHistory and exam consistent with meralgia paresthetica and \npatients notes improvement with topical lidocaine patches. \nPrescription provided on discharge. \n\n# Insomnia: \n# Depression: \nContinued home trazodone 50 mg qHS insomnia. Continued home \nsertraline 175 mg PO daily. \n\n# Hx of coronary vasospasm: \nContinued home isosorbide mononitrate ER 60 mg PO daily. \n\n# Chronic constipation: \n# Intermittent partial SBOs: \nRecently seen by surgeon Dr. ___, plan to continue current \nbowel regimen: \ndocusate 100 mg PO BID, home miralax 17 g PO BID, lactulose 15 \nmL qAM.\n\n# Sensory polyneuropathy: \nContinued home gabapentin 100 mg PO BID\n\nTRANSITIONAL ISSUES: \n====================\n[] new BP medications: hydrochlorothiazide 12.5 mg daily, \namlodipine 5mg daily; continue to monitor BP and titrate as \nindicated. \n[] Plasma metanephrines and renin/aldosterone pending on \ndischarge. \n\n> 30 mins spent coordinating discharge\n \n\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfurther investigation.\n1. TraZODone 50 mg PO QHS:PRN insomnia \n2. Sertraline 175 mg PO DAILY \n3. Multivitamins 1 TAB PO DAILY \n4. Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY \n5. Gabapentin 100 mg PO BID \n6. Atorvastatin 10 mg PO QPM \n7. Aspirin 81 mg PO DAILY \n8. Polyethylene Glycol Dose is Unknown  PO Frequency is Unknown \n9. Nystop (nystatin) 100,000 unit/gram topical BID \n10. Docusate Sodium 100 mg PO BID \n11. Lactulose Dose is Unknown  PO Frequency is Unknown \n12. LORazepam 0.5 mg PO DAILY:PRN anxiety \n13. diclofenac sodium 1 % topical TID:PRN pain \n14. Cyanocobalamin 1000 mcg IM/SC ONCE PER MONTH \n15. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain \n\n \nDischarge Medications:\n1.  amLODIPine 5 mg PO DAILY \nRX *amlodipine 5 mg 5 mg by mouth once a day Disp #*30 Tablet \nRefills:*0 \n2.  Hydrochlorothiazide 12.5 mg PO DAILY \nRX *hydrochlorothiazide 12.5 mg 1 tablet(s) by mouth once a day \nDisp #*30 Tablet Refills:*0 \n3.  Lidocaine 5% Patch 2 PTCH TD QAM \nRX *lidocaine 4 % apply two patches to affected area once a day \nDisp #*10 Patch Refills:*0 \n4.  Lactulose 30 mL PO DAILY  \n5.  Polyethylene Glycol 17 g PO DAILY  \n6.  Aspirin 81 mg PO DAILY  \n7.  Atorvastatin 10 mg PO QPM  \n8.  Cyanocobalamin 1000 mcg IM/SC ONCE PER MONTH  \n9.  diclofenac sodium 1 % topical TID:PRN pain  \n10.  Docusate Sodium 100 mg PO BID  \n11.  Gabapentin 100 mg PO BID  \n12.  Isosorbide Mononitrate (Extended Release) 60 mg PO DAILY  \n13.  LORazepam 0.5 mg PO DAILY:PRN anxiety  \n14.  Multivitamins 1 TAB PO DAILY  \n15.  Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain  \n16.  Nystop (nystatin) 100,000 unit/gram topical BID  \n17.  Sertraline 175 mg PO DAILY  \n18.  TraZODone 50 mg PO QHS:PRN insomnia  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\n# hypertensive crisis: \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nDear Ms. ___, \n\nIt was a privilege to care for you at the ___ \n___. You were admitted with headache, nausea, and \nvomiting that occurred secondary to dangerously high blood \npressures. You were started on two blood pressure medications \nand your blood pressure is now at a safe level. \n\nPlease continue all medications as prescribed. Dr. ___ will \ncontinue to check your blood pressure and make adjustments as \nneeded. \n\nWe wish you the best!\n\nSincerely, \nYour ___ Team \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820dfb505ee7538f7649"
  },
  "note_id": "12160754-DS-12",
  "subject_id": 12160754,
  "hadm_id": 26814370,
  "note_type": "DS",
  "note_seq": 12,
  "charttime": "2152-02-11 00:00:00",
  "storetime": "2152-02-11 11:26:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: ORTHOPAEDICS\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \n___ Complaint:\nright knee pain\n \nMajor Surgical or Invasive Procedure:\n___: right patellofemoral replacement\n\n \nHistory of Present Illness:\n___ year old male presenting for elective right patellofemoral \nreplacement\n \nPast Medical History:\nn/a\n \nSocial History:\n___\nFamily History:\nnoncontributory\n \nPhysical Exam:\nWell appearing in no acute distress  \nAfebrile with stable vital signs  \nPain well-controlled  \nRespiratory: CTAB  \nCardiovascular: RRR  \nGastrointestinal: NT/ND  \nGenitourinary: Voiding independently  \nNeurologic: Intact with no focal deficits  \nPsychiatric: Pleasant, A&O x3  \nMusculoskeletal Lower Extremity:  \n* Aquacel dressing with scant serosanguinous drainage  \n* Thigh full but soft  \n* No calf tenderness  \n* ___ strength  \n* SILT, NVI distally  \n* Toes warm\n\n \nPertinent Results:\n___ 07:05AM BLOOD Hgb-10.0* Hct-30.3*\n___ 07:17AM BLOOD Hgb-12.0* Hct-36.4*\n___ 07:05AM BLOOD Creat-1.2\n___ 07:17AM BLOOD Creat-1.2\n___ 06:54PM URINE Color-Yellow Appear-Clear Sp ___\n___ 06:54PM URINE Blood-NEG Nitrite-NEG Protein-TR* \nGlucose-NEG Ketone-TR* Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-SM*\n___ 06:54PM URINE RBC-1 WBC-5 Bacteri-NONE Yeast-NONE Epi-1 \nTransE-1\n___ 06:54PM URINE Mucous-RARE*\n \nBrief Hospital Course:\nThe patient was admitted to the orthopedic surgery service and \nwas taken to the operating room for above described procedure. \nPlease see separately dictated operative report for details. The \nsurgery was uncomplicated and the patient tolerated the \nprocedure well. Patient received perioperative IV antibiotics.\n\nPostoperative course was remarkable for the following:\nPOD #1, patient had complained of burning sensation with void.  \nUrinalysis was obtained which results were negative for urinary \ntract infection. Urine culture results were pending at the time \nof discharge and patient will be contacted if further treatment \nis needed.\nPOD #2, drain was discontinued. Patient cleared ___ without \nfurther issues.\n\nOtherwise, pain was controlled with a combination of IV and oral \npain medications.  The patient received Aspirin 81 mg twice \ndaily for DVT prophylaxis starting on the morning of POD#1.  The \nsurgical dressing will remain on until POD#7 after surgery. The \npatient was seen daily by physical therapy. Labs were checked \nthroughout the hospital course and repleted accordingly. At the \ntime of discharge the patient was tolerating a regular diet and \nfeeling well.  The patient was afebrile with stable vital signs. \n The patient's hematocrit was acceptable and pain was adequately \ncontrolled on an oral regimen. The operative extremity was \nneurovascularly intact and the dressing was intact. \n\nThe patient's weight-bearing status is weight bearing as \ntolerated on the operative extremity. \n\nMr. ___ is discharged to home with services in stable \ncondition.\n \nMedications on Admission:\nNone\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q8H \n2.  Aspirin EC 81 mg PO BID \n3.  Docusate Sodium 100 mg PO BID \n4.  Gabapentin 300 mg PO TID \n5.  OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain \n6.  Pantoprazole 40 mg PO Q24H \n7.  Senna 8.6 mg PO BID \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nright patellofemoral replacement\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\n1. Please return to the emergency department or notify your \nphysician if you experience any of the following: severe pain \nnot relieved by medication, increased swelling, decreased \nsensation, difficulty with movement, fevers greater than 101.5, \nshaking chills, increasing redness or drainage from the incision \nsite, chest pain, shortness of breath or any other concerns.\n \n2. Please follow up with your primary physician regarding this \nadmission and any new medications and refills. \n \n3. Resume your home medications unless otherwise instructed.\n \n4. You have been given medications for pain control. Please do \nnot drive, operate heavy machinery, or drink alcohol while \ntaking these medications. As your pain decreases, take fewer \ntablets and increase the time between doses. This medication can \ncause constipation, so you should drink plenty of water daily \nand take a stool softener (such as Colace) as needed to prevent \nthis side effect.  Call your surgeons office 3 days before you \nare out of medication so that it can be refilled.  These \nmedications cannot be called into your pharmacy and must be \npicked up in the clinic or mailed to your house.  Please allow \nan extra 2 days if you would like your medication mailed to your \nhome.\n \n5. You may not drive a car until cleared to do so by your \nsurgeon.\n \n6. Please call your surgeon's office to schedule or confirm your \nfollow-up appointment in three (3) weeks.\n \n7. SWELLING: Ice the operative joint 20 minutes at a time, \nespecially after activity or physical therapy. Do not place ice \ndirectly on the skin. You may wrap the knee with an ace bandage \nfor added compression. Please DO NOT take any non-steroidal \nanti-inflammatory medications (NSAIDs such as Celebrex, \nibuprofen, Advil, Aleve, Motrin, naproxen etc) until cleared by \nyour physician.\n \n8. ANTICOAGULATION: Please continue your Aspirin 81mg twice \ndaily with food for four (4) weeks to help prevent deep vein \nthrombosis (blood clots).  Continue Pantoprazole daily while on \nAspirin to prevent GI upset (x 4 weeks).  If you were taking \nAspirin prior to your surgery, take it at 325 mg twice daily \nuntil the end of the 4 weeks, then you can go back to your \nnormal dosing.\n \n9. WOUND CARE: Please remove Aquacel dressing on POD#7 after \nsurgery. It is okay to shower after surgery after 5 days but no \ntub baths, swimming, or submerging your incision until after \nyour four (4) week checkup. Please place a dry sterile dressing \non the wound after aqaucel is removed each day if there is \ndrainage, otherwise leave it open to air. Check wound regularly \nfor signs of infection such as redness or thick yellow drainage. \n Staples will be removed by your doctor at follow-up appointment \napproximately 3 weeks after surgery.\n \n10. ___ (once at home): Home ___, dressing changes as \ninstructed, and wound checks.\n \n11. ACTIVITY: Weight bearing as tolerated on the operative \nextremity. Mobilize with assistive devices (___) if \nneeded. ___ brace locked in ___t all \ntimes. No strenuous exercise or heavy lifting until follow up \nappointment.\n\nPhysical Therapy:\n___ brace locked in ___t all times\nWean assistive device as able\nMobilize frequently\n\nTreatments Frequency:\nremove aquacel POD#7 after surgery\napply dry sterile dressing daily if needed after aquacel \ndressing is removed\nwound checks daily after aquacel removed\nstaple removal and replace with steri-strips at follow up visit \nin clinic \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048213fb505ee753900924"
  },
  "note_id": "13281196-DS-14",
  "subject_id": 13281196,
  "hadm_id": 23732844,
  "note_type": "DS",
  "note_seq": 14,
  "charttime": "2122-10-01 00:00:00",
  "storetime": "2122-10-02 11:42:00",
  "text": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: OBSTETRICS/GYNECOLOGY\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___\n \nChief Complaint:\ns/p fall\n \nMajor Surgical or Invasive Procedure:\n1. Open reduction internal fixation of right trimalleolar ankle \nfracture.\n2. Open reduction internal fixation of syndesmotic disruption.\n \nHistory of Present Illness:\n___ G2P1 at 33w0d presents to L&D from the ___ ED s/p fall. \nPatient reports fall took place at 7:30am when she was walking \nfrom her home to her car, everted/abducted her ankle and fell, \nlanding on her ankle. No VB or LoF. +AFM throughout day.\n\nED Course:\nSeen in ED where X-ray revealed \"a trimalleolar fracture with \ndisplaced fracture components and mild residual posterior \nsubluxation of the talus with respect to the tibial plafond.\" \nOrthopedics consult was obtained and plan was determined for \nsurgery. U/S in radiology revealed a reassuring EFW and BPP, and \nNST was reactive in the ED.  She was brought to L&D to have \nprolonged monitoring prior to her surgery.\n \nPast Medical History:\nPRENATAL COURSE\n___: ___\nLabs: B-/Ab-/RI/RPRNR/HBsAg-/HIV-\nU/S:\n1. BPP ___, AFI 19, vtx, fund plac\n2. ___ EFW 2011g, 53%\nTesting: increased risk ERA 1:18 DS, amnio nl\n\nOBSTETRIC HISTORY\n___ SVD, fullterm, 6#6, no complications\n\nGYNECOLOGIC HISTORY\nh/o abnl pap, s/p LEEP, cryo\ndenies h/o STIs\n\nPAST MEDICAL HISTORY\nnone\n\nPAST SURGICAL HISTORY\nnone\n \nSocial History:\n___\nFamily History:\nnon-contributory\n \nPhysical Exam:\n(on admission)\nVS: 126/77, 103\nGENERAL: uncomfortable\nCV: RRR\nLUNGS: CTAB\nABDOMEN: soft, gravid, NT\nEXTREMITIES: RLE splinted and bandaged, toes showing. Patient \ncan feel fingers touching toes distally. LLE full ROM, no pain, \nno edema\nSVE: LCP\nFHT: 120, mod var, +A no decels\nTOCO: sporadic insensate ctxns, 4 in last hour\n \nPertinent Results:\n___ WBC-10.7 RBC-3.94 Hgb-10.8 Hct-32.3 MCV-82 Plt-209\n___ WBC-11.4 RBC-3.37 Hgb-10.0 Hct-28.7 MCV-85 Plt-196\n___ ___ PTT-25.5 ___ ___ ___ PTT-25.8 ___ ___ BLOOD FetlHgb-0\n___ BLOOD Glucose-92 UreaN-7 Creat-0.5 Na-138 K-3.8 Cl-109* \nHCO3-22 AnGap-11\n___ URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG \nKetone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-NEG\n \nBrief Hospital Course:\n___ yo G2P1001 admitted at 33w0d with right ankle fracture s/p \nfall.\n.\nMs ___ was transferred to labor and delivery from the emergency \ndepartment. On arrival, she had only rare contractions and her \ncervix was closed and long. There was no evidence of preterm \nlabor or abrupion. Fetal testing was reassuring. She received a \ncourse of betamethasone for fetal lung maturity (complete on \n___ and the NICU was consulted. She received a dose of Rhogam \ndue to Rh negative status. Kleihauer-___ was negative. She was \ncontinued on a Dilaudid PCA for pain control. She remained on \nlabor and delivery for continuous monitoring until HD#2 (___) \nwhen she underwent an ORIF of right trimalleolar fracture and \nORIF of syndesmotic disruption under spinal anesthesia. Please \nsee operative report for details.\n.\nPostoperatively, she returned to labor and delivery for \nprolonged monitoring. She developed some irregular preterm \ncontractions which resolved and her cervix remained closed. \nFetal testing was reassuring. The orthopedic team followed her \nclosely. She initially was continued on a PCA and also underwent \na nerve block for pain control. She was started on sc lovenox \nfor VTE prophylaxis. She had no complications for the remainder \nof her hospital course. Physical therapy was consulted and \ncleared her for discharge home. She will have close outpatient \nfollowup.\n \nMedications on Admission:\nprenatal vitamins\n \nDischarge Medications:\n1. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day) as needed for Constipation.\nDisp:*60 Capsule(s)* Refills:*3*\n2. Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q6H (every \n6 hours) as needed for Pain.  \n3. Enoxaparin 40 mg/0.4 mL Syringe Sig: One (1) injection \nSubcutaneous Q 24H (Every 24 Hours).\nDisp:*28 injection* Refills:*2*\n4. Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2 \ntimes a day).\nDisp:*60 Tablet(s)* Refills:*2*\n5. Oxycodone-Acetaminophen ___ mg Tablet Sig: ___ Tablets PO \nQ4H (every 4 hours) as needed for pain.\nDisp:*60 Tablet(s)* Refills:*0*\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\ns/p fall\nRight Weber right ankle fracture dislocation trimalleolar with \nsyndesmotic disruption\n \nDischarge Condition:\nMental Status: Clear and coherent\nLevel of Consciousness: Alert and interactive\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane)\n \nDischarge Instructions:\nUse your crutches and walker as instructed by ___.  Keep all of \nyour appointments.  Take your lovenox daily.  Use the codeine as \nneeded for pain.  Do not drive.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048213fb505ee753900925"
  },
  "note_id": "13281196-DS-15",
  "subject_id": 13281196,
  "hadm_id": 23523429,
  "note_type": "DS",
  "note_seq": 15,
  "charttime": "2127-06-19 00:00:00",
  "storetime": "2127-06-20 08:48:00",
  "text": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: OBSTETRICS/GYNECOLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \nChief Complaint:\nright lower quadrant pain\n \nMajor Surgical or Invasive Procedure:\nLaparoscopic ovarian cystectomy\n\n \nHistory of Present Illness:\n___ yo G2P2 presents to ED with RLQ pain.  Started acutely\nyesterday morning and has been intermittent throughout.  Became\nsevere again today.  Some mild nausea, no emesis or fevers.  No\nbowel or bladder complaints.\n \nPast Medical History:\nOb/gyn hx:\n- SVD x2, no comps\n- previously on OCPs, no contraception currently\n- menses q month, LMP 5 weeks prior\n- denies hx STDs, cysts, fibroids\n- remote hx LEEP age ___\n\nPMHx: denies\nPSHx: LEEP, ankle surgery\nMeds: PNV\nAll: NKDA\n\n \nSocial History:\n___\nFamily History:\nnon-contributory\n \nPhysical Exam:\nOn admission:\nO: temp 98.2 HR 93 130/60 RR 18 100% RA\nNAD, appears well overall but uncomfortable with movement\nRRR\nCTAB\nabd soft, nondistended.  diffusely TTP with guarding, min \nrebound\npelvic: no abnl discharge or blood in vault\nBME: min CMT, right adnexa very TTP, unable to appreciate cyst\n\nOn day of discharge:\nafebrile, vital signs stable\nGen: NAD\nPulm: normal work of breathing\nAbd: soft, nondistended, appropriate TTP, no rebound or guarding\n \nPertinent Results:\n___ 09:55PM   WBC-8.5 RBC-3.43* HGB-9.8* HCT-28.1* MCV-82 \nMCH-28.6 MCHC-34.9 RDW-12.3\n___ 09:55PM   PLT COUNT-176\n \nBrief Hospital Course:\nMs. ___ was admitted to the gynecology service for serial \nabdominal exams and pain control and underwent a laparoscopic \nright ovarian cystectomy for a ruptured hemorrhagic cyst with \nhemoperitoneum. Her postoperative course was uncomplicated and \non post-operative day 0 she was tolerating a regular diet, \nvoiding spontaneously, ambulating independently and her pain was \nwell controlled. She was discharged home in good condition with \noutpatient followup. \n \nMedications on Admission:\npnv\n \nDischarge Medications:\n1. Ibuprofen 600 mg PO Q6H:PRN pain \nRX *ibuprofen 600 mg 1 tablet(s) by mouth every six (6) hours \nDisp #*45 Tablet Refills:*1\n2. Docusate Sodium 100 mg PO BID \nRX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp \n#*60 Tablet Refills:*0\n3. HYDROmorphone (Dilaudid) 2 mg PO q 6 hours prn pain Duration: \n1 Dose \nRX *hydromorphone 2 mg ___ tablet(s) by mouth every six (6) \nhours Disp #*30 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nHemorrhagic cyst\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the gynecology service after your \nprocedure. You have recovered well and the team believes you are \nready to be discharged home. Please call Dr. ___ \noffice with any questions or concerns. Please follow the \ninstructions below.\n\nGeneral instructions:\n* Take your medications as prescribed.\n* Do not drive while taking narcotics.\n* Take a stool softener such as colace while taking narcotics to \nprevent constipation.\n* Do not combine narcotic and sedative medications or alcohol.\n* Do not take more than 4000mg acetaminophen (APAP) in 24 hrs.\n* No strenuous activity until your post-op appointment.\n* No heavy lifting of objects >10 lbs for 2 weeks.\n* You may eat a regular diet.\n* You may walk up and down stairs.\n\nIncision care:\n* You may shower and allow soapy water to run over incision; no \nscrubbing of incision. No bath tubs for 6 weeks.\n* If you have steri-strips, leave them on. They will fall off on \ntheir own or be removed during your followup visit.\n\nTo reach medical records to get the records from this \nhospitalization sent to your doctor at home, call ___.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048207fb505ee7538ee302"
  },
  "note_id": "11031053-DS-4",
  "subject_id": 11031053,
  "hadm_id": 27753248,
  "note_type": "DS",
  "note_seq": 4,
  "charttime": "2126-12-30 00:00:00",
  "storetime": "2126-12-31 17:17:00",
  "text": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: NEUROLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nWorsening L weakness\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\nThis is a ___ year old man with a history of untreated\nhypertension and right corona radiata infarct on ___ who\npresents with increased left arm and leg weakness this morning.\n\nOn ___ the patient had mild left arm and leg weakness and\nnumbness on his drive home from work. He went to bed that night\nand the next morning he was having trouble walking and his wife\nnoted a left facial droop. He went to ___ where he was \nfound\nto have 2 small infarcts in the right corona radiata. Vessel\nimaging reportedly showed a right vertebral occlusion so he was\nbriefly placed on heparin gtt, then changed to just full dose\naspirin. He had an echo which showed and 65% without PFO. He was\nsent to rehab yesterday and at that time he reports he was able\nto walk and left arm was able to be elevated with a slight \ndrift.\nWhile at rehab and at ___ his blood pressure had been\ndifficult to control. His wife doesn't think it was ever very\nlow. He also was found to have mildly elevated LFTs so statin\ndose was decreased.\n\nEarly this morning at 3am the patient woke to use the bathroom\nand noted worse leg weakness and a nearly flaccid left arm. He\nwas sent to ___ where head CT showed no bleed. Because of\nknown vertebral occlusion he was placed back on heparin gtt with\na bolus at 13:35.\n \nOn neuro ROS, the pt denies headache, loss of vision, blurred\nvision, diplopia, dysphagia, lightheadedness, vertigo, tinnitus\nor hearing difficulty. Denies difficulties producing or\ncomprehending speech.  Denies focal numbness, parasthesiae. No\nbowel or bladder incontinence or retention. \n \nOn general review of systems, the pt denies recent fever or\nchills.  No night sweats or recent weight loss or gain. Denies\ncough, shortness of breath.  Denies chest pain or tightness,\npalpitations.  Denies nausea, vomiting, diarrhea, constipation \nor\nabdominal pain.  No recent change in bowel or bladder habits.  \nNo\ndysuria.  Denies arthralgias or myalgias. Denies rash.\n\n \nPast Medical History:\nStroke as above \nHTN (not known until stroke)\n\n \nSocial History:\n___\nFamily History:\nFamily Hx: Does not know father. No strokes, seizures on \nmother's\nside.\n\n \nPhysical Exam:\nADMISSION EXAM\nVitals: 98.2 94 159/98 18 98% \nGeneral: Awake, cooperative, NAD. \nHEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in\noropharynx \nNeck: Supple\nPulmonary: Lungs CTA bilaterally \nCardiac: RRR, nl. S1S2\nExtremities: no edema bilaterally. \n \nNeurologic: \n\n-Mental Status: Alert, oriented x 3.  Able to relate history\nwithout difficulty.  Attentive, able to name ___ backward \nwithout\ndifficulty.  Language is fluent with intact repetition and\ncomprehension.  Normal prosody.  There were no paraphasic \nerrors.\nPt. was able to name both high and low frequency objects.  \nSpeech\nwas mildly dysarthric. Able to follow both midline and\nappendicular commands. There was no evidence of neglect.\n  \n-Cranial Nerves: \nII: PERRL 3 to 2mm and brisk.  VFF to confrontation. \nIII, IV, VI: EOMI without nystagmus.  Normal saccades. \nV: Facial sensation intact to light touch. \nVII: left lower facial droop. \nVIII: Hearing intact to finger-rub bilaterally.  \nIX, X: Palate elevates symmetrically.  \nXI: ___ strength in trapezii and SCM bilaterally. \nXII: Tongue protrudes in midline with normal strength\n \n-Motor: Normal bulk, tone throughout. \n  Delt Bic Tri WrE FFl FE IO IP Quad Ham TA Gastroc  \nL  0    ___   ___  4   5    3+ 4+    5        \nR  5    ___   ___  5   5    5  5     5        \n \n-Sensory: No deficits to light touch, pinprick, proprioception\nthroughout. \n \n-DTRs: \n  Bi Tri ___ Pat Ach \nL  2  2    2    2   1 \nR  2  2    2    2   1\nPlantar response was upgoing on the left.\n \n-Coordination: No dysmetria on FNF or HKS on the right, cannot \non\nthe left.\n \n-Gait: deferred\n\n \nPertinent Results:\n___ 08:25PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG \ncocaine-NEG amphetmn-NEG mthdone-NEG\n___ 08:25PM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 04:50PM   GLUCOSE-129* UREA N-20 CREAT-1.0 SODIUM-138 \nPOTASSIUM-4.5 CHLORIDE-104 TOTAL CO2-21* ANION GAP-18\n___ 04:50PM   ALT(SGPT)-84* AST(SGOT)-47* ALK PHOS-62 TOT \nBILI-2.1*\n___ 04:50PM   cTropnT-<0.01\n___ 04:50PM   ALBUMIN-4.3\n___ 04:50PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG \nbnzodzpn-NEG barbitrt-NEG tricyclic-NEG\n___ 04:50PM   WBC-7.8 RBC-5.13 HGB-16.4 HCT-46.8 MCV-91 \nMCH-32.0 MCHC-35.0 RDW-12.8\n___ 04:50PM   NEUTS-68.8 ___ MONOS-9.0 EOS-2.2 \nBASOS-0.7\n___ 04:50PM   PLT COUNT-225\n___ 04:50PM   ___ PTT-150* ___\n\nLiver ultrasound:\nIMPRESSION:  \n1.  Diffusely echogenic liver compatible with hepatic steatosis. \nHowever, more advanced forms of liver disease such as \nsteatohepatitis, cirrhosis, and fibrosis cannot be excluded by \nultrasound. \n  \n2. No focal suspicious liver lesions within the right hepatic \nlobe. The left hepatic lobe is not well visualized on this \nexamination. \n\nMRI brain: IMPRESSION: \n1. New small infarct lateral to the previously identified right \ninternal \ncapsule infarcts.  No acute intracranial hemorrhage. \n2. Old infarct with associated chronic blood products in the \nleft frontal \nlobe.  Chronic small vessel ischemic disease. \n\n \nBrief Hospital Course:\nMr. ___ was admitted to the stroke service, floor with \ntelemetry, for workup of worsened left-sided weakness.\n\nMRI brain showed increased diffusion abnormality in the right \ncorona radiata, in the same area as the previous stroke. This \nwas thought to be stuttering of his orignial stroke, and his \nblood pressure medications were held for permissive \nhypertension. He was observed for several days, and his \nneurologic exam remained stable. He was therefore discharged off \nof his blood pressure medications, these will be added back on \ngradually at rehab. His LDL was low at 38, and so his \natorvastatin was stopped.\n\nHe underwent a liver ultrasound which showed fatty liver. \nHepatitis panel was sent and was negative. Further workup was \ndeferred to outpatient management.\n\nOUTSTANDING ISSUES\n[ ] Held lisinopril and nifedipine for permissive HTN. Please \nadd these back on gradually (one at a time) in two to three days \ntime, with goal blood pressure 120-140.\n[ ] Stroke follow up as previously scheduled on prior admission.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 325 mg PO DAILY \n2. Atorvastatin 10 mg PO QPM \n3. Lisinopril 10 mg PO DAILY \n4. NIFEdipine CR 60 mg PO DAILY \n5. Heparin 5000 UNIT SC TID \n\n \nDischarge Medications:\n1. Aspirin 325 mg PO DAILY \n2. Heparin 5000 UNIT SC TID \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nIschemic stroke in the right corona radiata\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou were admitted to ___ with \nworsening of left arm weakness. We repeated your MRI, and found \nthat you had no new strokes, but that the stroke that you \nalready had was enlarged somewhat. We stopped your blood \npressure medications and let your blood pressure go higher to \nimprove blood flow to that area.\n\nWe did a liver ultrasound that showed fatty liver. Your tests \nfor hepatitis were negative. This should be followed up by your \nprimary care physician. You also have follow up with Dr. ___ \nin the stroke department here.\n\nWe STOPPED your simvastatin, as your cholesterol levels were \nlow.\n\nIt was a pleasure taking care of you during this \nhospitalization.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904823ffb505ee75392c257"
  },
  "note_id": "18647837-DS-16",
  "subject_id": 18647837,
  "hadm_id": 27090518,
  "note_type": "DS",
  "note_seq": 16,
  "charttime": "2150-05-01 00:00:00",
  "storetime": "2150-05-04 12:32:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: UROLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nprostatic regrowth and 1cm bladder stone.\n \nMajor Surgical or Invasive Procedure:\ncystolithalopaxy and transurethral resection of prostate.\n\n \nHistory of Present Illness:\n___ Hx BPH s/p laser TURP, now wit prostatic regrowth and 1cm \nbladder stone.\n \nPast Medical History:\nPMH:\n  Dyspepsia \n  Depressive disorder \n  Hypercholesterolemia \n  COLORECTAL POLYPS \n  History of actinic keratosis \n  History of squamous cell carcinoma of skin \n DM (diabetes mellitus), type 1 \n  ARTHRALGIA - KNEE \n  History of tobacco use \n  Insulin pump in place \n  Thyroid function study abnormality \n  Osteochondritis dissecans of knee \n  Mass of breast, right \n  Gross hematuria \n  Essential hypertension, benign \n  Multiple thyroid nodules \n  Thyroid nodule \n  Type 1 diabetes with renal manifestations, controlled \n  Albuminuria \n  Type 1 diabetes with renal manifestations, controlled \n Type 1 diabetes mellitus with microalbuminuria \n  Insomnia \n\n \nSocial History:\n___\nFamily History:\nFather  AAA [OTHER]; heart disorder \nMother  ___ Onset \n\n \nPhysical Exam:\nWDWN, NAD, AVSS\nAbdomen soft, non-distended \nBilateral lower extremities w/out edema, pitting or pain to deep \npalpation of calves\n \nPertinent Results:\n___ 06:05AM BLOOD WBC-8.3 RBC-3.83* Hgb-12.0* Hct-36.8* \nMCV-96 MCH-31.3 MCHC-32.6 RDW-12.8 RDWSD-45.7 Plt ___\n___ 06:05AM BLOOD Glucose-41* UreaN-15 Creat-0.9 Na-138 \nK-4.0 Cl-100 HCO3-29 AnGap-13\n \nBrief Hospital Course:\nMr. ___ was admitted to Urology service after bipolar \ntransurethral resection of prostate and bladder stone removal. \nNo concerning intraoperative events occurred; please see \ndictated operative note for details. The patient received \n___ antibiotic prophylaxis. The patient's \npostoperative course was uncomplicated. He received intravenous \nantibiotics and continuous bladder irrigation overnight. On POD1 \nthe CBI was discontinued and Foley catheter was removed with an \nactive vodiding trial.  Post void residuals were checked. His \nurine was clear-pink and and without clots. He remained \na-febrile throughout his hospital stay.  At discharge, the \npatient had pain well controlled with oral pain medications, was \ntolerating regular diet, ambulating without assistance, and \nvoiding without difficulty.  He was given pyridium and oral pain \nmedications along with explicit instructions to follow up in \nclinic.\n\n \nMedications on Admission:\nThe patient's OMR Medication list (as of ___: \n   amitriptyline \namitriptyline 50 mg tablet \n1 tablet(s) by mouth every night \n (Prescribed by Other Provider)  \n   atorvastatin \natorvastatin 20 mg tablet \n1 tablet(s) by mouth once a day \n (Prescribed by Other Provider)  \n   insulin aspart [Novolog] \nNovolog 100 unit/mL subcutaneous solution \n insulin pump \n (Prescribed by Other Provider)  \n   lisinopril \nlisinopril 5 mg tablet \n1 tablet(s) by mouth once a day \n (Prescribed by Other Provider)  \n   tamsulosin \ntamsulosin 0.4 mg capsule \n1 capsule(s) by mouth twice a day \n (Prescribed by Other Provider)  \n   aspirin [Adult Low Dose Aspirin] \nAdult Low Dose Aspirin 81 mg tablet,delayed release \n1 tablet(s) by mouth once a day \n (Prescribed by Other Provider)  \n \na  This medication list has been confirmed with the patient  \n\n \nDischarge Medications:\n1.  Docusate Sodium 100 mg PO BID \nRX *docusate sodium [Colace] 100 mg ONE capsule(s) by mouth \ntwice a day Disp #*60 Capsule Refills:*0 \n2.  OxyCODONE (Immediate Release) 2.5 mg PO Q4H:PRN Pain - \nModerate \nRX *oxycodone 5 mg 2.5 tablet(s) by mouth Q4hrs Disp #*10 Tablet \nRefills:*0 \n3.  Phenazopyridine 100 mg PO TID dysuria Duration: 3 Days \nRX *phenazopyridine [Pyridium] 100 mg ONE tablet(s) by mouth \nQ8hrs Disp #*9 Tablet Refills:*0 \n4.  Insulin  Pump SC (Self Administering Medication)Insulin \nAspart (Novolog) (non-formulary)\nTarget glucose: 80-180\n \n5.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  \n6.  Amitriptyline 50 mg PO QHS  \n7.  Aspirin EC 81 mg PO DAILY \nRESUME WHEN URINE CLEAR OR YELLOW FOR THREE DAYS   \n8.  Atorvastatin 20 mg PO QPM  \n9.  Lisinopril 5 mg PO DAILY  \n10.  Tamsulosin 0.4 mg PO BID  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\n  Benign prostatic hypertrophy w/ lower urinary tract symptoms, \nbladder stone\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nThese steps can help you recover after your procedure. \nDO drink plenty of water to flush out the bladder. \nDO avoid straining during a bowel movement. Eat \nfiber-containing foods and avoid foods that can cause \nconstipation. Ask your doctor if you should take a laxative if \nyou do become constipated. \nDon't take blood-thinning medications until your doctor says \nit's OK. \nDon't do any strenuous activity, such as heavy lifting, for \nfour to six weeks or until your doctor says it's OK. \nDon't have sex. You'll likely be able to resume sexual \nactivity in about four to six weeks. \nDon't drive until your doctor says it's OK. ___, you can \ndrive once your catheter is removed and you're no longer taking \nprescription pain medications. \n\nYou may continue to periodically see small amounts of blood in \nyour urine--this is normal and will gradually improve. You may \nhave clear or yellow urine that periodically turns pink/red \nthroughout the healing process. Generally, the discoloration of \nthe urine is OK unless it transitions from ___, \n___ Aid to a very dark, thick or like tomato juice \ncolor\n\nResume your pre-admission/home medications EXCEPT as noted. \nYou should ALWAYS call to inform, review and discuss any \nmedication changes and your post-operative course with your \nprimary care team.  \n\nUnless otherwise advised, blood thinning medications like \nASPIRIN should be held until the urine has been clear/yellow for \nat least three days.  Your medication reconciliation will note \nif you may resume aspirin or prescription blood thinners (like \nCoumadin (warfarin), Xarelto, Lovenox, etc.)\n\nIf needed, you will be prescribed an antibiotic to continue \nafter discharge or save until your Foley catheter is removed \n(called a trial of void or void trial).  \n\nYou may be discharged home with a medication called PYRIDIUM \nthat will help with the \"burning\" pain you may experience when \nvoiding. This medication may turn your urine bright orange.\n\nColace has been prescribed to avoid post surgical constipation \nand constipation related to narcotic pain medication. \nDiscontinue if loose stool or diarrhea develops. Colace is a \nstool softener, NOT a laxative, and it is available \nover-the-counter \n\nAVOID STRAINING for bowel movements as this may stir up \nbleeding.  Avoid  constipating foods for ___ weeks, and drink \nplenty of fluids to keep hydrated\n\nNo vigorous physical activity or sports for 4 weeks or until \notherwise advised\n\nDo not lift anything heavier than a phone book (10 pounds) or \nparticipate in high intensity physical activity (which includes \nintercourse) for a minimum of four weeks or until you are \ncleared by your Urologist in follow-up\n\nAcetaminophen (Tylenol) should be your first-line pain \nmedication. A narcotic pain medication may also be prescribed \nfor breakthrough or moderate pain.  \n\nThe maximum daily Tylenol/Acetaminophen dose is 3 grams from \nALL sources. \n\nDo not drive or drink alcohol while taking narcotics and do \nnot operate dangerous machinery.  \n\nWHEN YOU ARE DISCHARGED WITH A FOLEY CATHETER:\no-Please also reference the nursing handout and instructions on \nroutine care and hygiene\n\no-Your Foley should be secured to the catheter secure on your \nthigh at ALL times until your follow up with the surgeon.\n\no-DO NOT allow anyone outside your urologist/team \nrepresentative remove your Foley for any reason.\n\no-Wear Large Foley bag for majority of time. The leg bag (if \nprovided)  is for short-duration periods and the bag must be \nemptied frequently.\n\no-Do NOT drive if you have a Foley in place (for your \nsafety-but of course you may be a passenger\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904822dfb505ee75391a9cb"
  },
  "note_id": "16501810-DS-8",
  "subject_id": 16501810,
  "hadm_id": 25758161,
  "note_type": "DS",
  "note_seq": 8,
  "charttime": "2165-07-22 00:00:00",
  "storetime": "2165-07-22 12:49:00",
  "text": " \nName:  ___                        Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: OBSTETRICS/GYNECOLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\n___ yo nullip with ___ ___ by LMP and US now at 40 ___\npresenting to rule out labor.  US in triage showed BPP ___ (-2 \nfor\nmovement and tone) though AFI normal at 12.2.  Given GA and \ntesting results, decision was made to keep pt for monitoring and \ninduction/augmentation of labor if no labor.\n\nNotes aFM.  No LOF.  No VB. No UCs.\n\n \nMajor Surgical or Invasive Procedure:\ns/p cesarean\n\n \nHistory of Present Illness:\n___ yo nullip with ___ ___ by LMP and US now at 40 ___\npresenting to rule out labor.  US in triage showed BPP ___ (-2 \nfor\nmovement and tone) though AFI normal at 12.2.  Given GA and \ntesting results, decision was made to proceed with further \nmonitoring and induction/augmentation if no further labor.\n\nNotes aFM.  No LOF.  No VB. No UCs.\n\n \nPast Medical History:\nPNC:\n1. Dating as above\n2. Apositive/AntibodyNeg/HBSAG POS/RI/RPR NR/HIV neg/GBS pos\n3. HBSAG POS:eAG neg, wnl lfts, viral load undetectable.\n4. ERA Low Risk FFS WNL\n\nPOBHX:\nG1P0\n\nPGYNHX: \n1. Reg cycles\n2. No STDS\n3. No abnl paps\n\nPMHX:\n1. Hepatitis B as above\n\nPSHX:\n1. Left Hip Fx with MVA age ___\n\n \nSocial History:\n___\nFamily History:\nnoncontributory\n \nPhysical Exam:\nExam on Admission:\nWell Appearing NAD\nBP 109/61 HR ___\nFHR REactive Negative CST No decels\nToco q ___ mild\nCor RRR\nLungs CTAB\nAbd Gravid NT\nSVE Per RN ___\nExt No cords\n\nExam on Discharge:\nWell Appearing NAD\nAFVSS\nCV RRR\nLungs CTAB\nAbd NT, ff<U\nGU min bleeding on pad\nExt No cords\n\n \nPertinent Results:\n___ 08:00PM BLOOD WBC-7.9 RBC-2.66* Hgb-8.5* Hct-24.9* \nMCV-94 MCH-31.8 MCHC-34.0 RDW-15.4 Plt ___\n___ 10:50AM BLOOD WBC-7.5 RBC-2.24* Hgb-7.0* Hct-21.1* \nMCV-94 MCH-31.2 MCHC-33.1 RDW-15.0 Plt ___\n___ 11:35AM BLOOD Hct-25.3*\n___ 06:09AM BLOOD WBC-8.9 RBC-2.29*# Hgb-7.3*# Hct-22.3*# \nMCV-98 MCH-32.0 MCHC-32.8 RDW-14.8 Plt ___\n___ 01:13PM BLOOD WBC-10.0 RBC-3.41* Hgb-11.0* Hct-32.5* \nMCV-95 MCH-32.1* MCHC-33.7 RDW-14.6 Plt ___\n___ 02:00PM BLOOD WBC-9.1 RBC-4.30 Hgb-13.8 Hct-40.9 MCV-95 \nMCH-32.0 MCHC-33.6 RDW-14.7 Plt ___\n___ 06:09AM BLOOD Neuts-78.6* Lymphs-13.6* Monos-6.8 \nEos-0.8 Baso-0.2\n \nBrief Hospital Course:\nPatient is a ___ G1P1 admitted to obstetrics who delivered by \nprimary low transverse cesarean for arrest of dilation and \nchorioamnionitis. Her intrapartum course was complicated by \nchorio, sepsis and post-partum hemorrhage.\n\nFor her chorioamnionitis and sepsis she was treated with \nAmpicillin, Gentamycin, and Clindamycin until 24 hours afebrile \nand clinically resolved. \n\nRegarding her postpartum hemorrhage, her intraoperative course \nwas complicated by uterine atony and her total EBL was 1400cc. \nShe was treated with 20units of pitocin, cytotec, methergine and \nhemabate intraoperatively with resolution of her atony. Please \nsee operative report for full details. Post-operatively her \nhematocrit nadired at 21.1 on POD#2 and she received 1 unitPRBC \nfor symptomatic blood loss anemia. Her post-transfusion hct was \n24.9 and her symptoms were improved.\n\nThe remainder of her postpartum course was uncomplicated and she \nwas felt to be safe to be discharged to home on ___.\n\n \nMedications on Admission:\nPNV\n \nDischarge Medications:\n1. Docusate Sodium 100 mg PO BID Constipation \nRX *docusate sodium 100 mg 1 capsule(s) by mouth twice daily \nDisp #*60 Capsule Refills:*2\n2. Ferrous Sulfate 325 mg PO BID \nRX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth \ntwice daily Disp #*60 Tablet Refills:*2\n3. Ibuprofen 600 mg PO Q6H:PRN Pain \nRX *ibuprofen 600 mg 1 tablet(s) by mouth every 6 hours Disp \n#*50 Tablet Refills:*2\n4. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO Q4H:PRN Pain \nRX *oxycodone-acetaminophen 5 mg-325 mg 1 tablet(s) by mouth \nevery 4 hours Disp #*30 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\ns/p primary cesarean\nchorioamnionitis s/p antibiotics\ns/p postpartum hemorrhage, blood loss anemia, s/p 1 unit pRBC \ntransfusion\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nsee nursing sheets\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048230fb505ee75391e101"
  },
  "note_id": "16926894-DS-7",
  "subject_id": 16926894,
  "hadm_id": 25181412,
  "note_type": "DS",
  "note_seq": 7,
  "charttime": "2127-09-17 00:00:00",
  "storetime": "2127-09-17 19:42:00",
  "text": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: SURGERY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nAbdominal pain\n \nMajor Surgical or Invasive Procedure:\n___ placement of drain\n\n \nHistory of Present Illness:\n___ is a ___ who is presenting here to the ED\nw/ a ~3 day hx of worsening lower abd discomfort and abd\ndistension. He says it feels like \"gas,\" and has never had these\nsx before. He endorses some chills and n/v, and at least 2 days\nof watery diarrhea. He was in ___ for business but returned today\nand presented here for further evaluation. He denies f/s,\nlightheadedness and/or dizziness, chest pain, SOB, blurry \nvision,\nh/a's, BRBPR, melena, difficulty urinating, arthralgias,\nmyalgias, or skin changes; ROS is o/w -ve except as noted above.\nHere labs show WBC 17.___/P was obtained which showed\nperforated appendicitis, for which we were consulted.\n\n \nPast Medical History:\nHLD\n \nSocial History:\n___\nFamily History:\nno fam hx of colon CA or IBD\n\n \nPhysical Exam:\nADMISSION\nPhys Ex:\nVS - 100.5 93 131/64 18 97% RA \nGen - NAD\nCV - RRR\nPulm - non-labored breathing, no resp distress, satting\nadequately on RA\nAbd - soft, moderately distended, RLQ ttp w/ guarding, no\nrebound, -ve Rovsing's, -ve psoas, -ve obturator\nMSK & extremities/skin - no leg swelling observed b/l\n\nDISCHARGE\nGen - NAD\nCV - RRR\nPulm - non-labored breathing, no resp distress, satting\nadequately on RA\nAbd - soft, nondistended, ___ drain in place, NTTP\n\n \nPertinent Results:\n___ 04:55PM   WBC-17.4* RBC-3.65* HGB-11.7* HCT-34.4* \nMCV-94 MCH-32.1* MCHC-34.0 RDW-14.4 RDWSD-50.9*\n\nCTAP ___:\nAcute appendicitis with necrotic perforated appendix with \nappendicolith and \nextensive surrounding phlegmon with adjacent colonic \ninflammation. \n\n \nBrief Hospital Course:\nThis is a ___ man who presented with abdominal pain found to \nhave perforated appendicitis on CTAP. The patient was medically \nmanaged. Repeat CTAP showed interval development of RLQ \ncollection, for which an ___ drain was placed. The patient has \nfollow up with ACS as an outatient. He is finishing a 14 day \ntotal course of antibiotics.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Simvastatin 20 mg PO QPM \n2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n3. Minocycline 50 mg PO Q24H \n\n \nDischarge Medications:\n1.  Amoxicillin-Clavulanic Acid ___ mg PO Q12H Duration: 9 Days \nRX *amoxicillin-pot clavulanate 875 mg-125 mg 2 tablet(s) by \nmouth twice a day Disp #*16 Tablet Refills:*0 \n2.  OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - \nModerate \n  Reason for PRN duplicate override: Alternating agents for \nsimilar severity\nRX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp \n#*15 Tablet Refills:*0 \n3.  Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY  \n4.  Minocycline 50 mg PO Q24H  \n5.  Simvastatin 20 mg PO QPM  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPerforated Appendicitis \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou were admitted to the Acute Care Surgery on ___ with \nabdominal pain and found to have a perforated appendicitis. You \nwere treated with antibiotics. An ___ drain was placed to help \nmanage a localized abscess (bacterial collection). \n\nYou are now safe for discharge. You should take the prescribed \nantibiotics for 8 more days. \n\nYou should follow up with the Acute Care Service in ___ weeks. \nYou need to empty your drain on a daily basis. A ___ nurse has \nbeen arranged to visit you at home to help with this. \n\nDrain Care:\n\n *Please look at the site every day for signs of infection \n(increased redness or pain, swelling, odor, yellow or bloody \ndischarge, warm to touch, fever).\n\n *Maintain suction of the bulb.\n\n *Note color, consistency, and amount of fluid in the drain. \nCall the doctor, ___, or ___ nurse if the amount \nincreases significantly or changes in character.\n\n *Be sure to empty the drain frequently. Record the output, if \ninstructed to do so.\n\n *You may shower; wash the area gently with warm, soapy water.\n\n *Keep the insertion site clean and dry otherwise.\n\n *Avoid swimming, baths, hot tubs; do not submerge yourself in \nwater.\n\n *Make sure to keep the drain attached securely to your body to \nprevent pulling or dislocation.\n\nPlease call your doctor or nurse practitioner or return to the \nEmergency Department for any of the following:\n\n *You experience new chest pain, pressure, squeezing or \ntightness.\n\n *New or worsening cough, shortness of breath, or wheeze.\n\n *If you are vomiting and cannot keep down fluids or your \nmedications.\n\n *You are getting dehydrated due to continued vomiting, \ndiarrhea, or other reasons. Signs of dehydration include dry \nmouth, rapid heartbeat, or feeling dizzy or faint when standing.\n\n *You see blood or dark/black material when you vomit or have a \nbowel movement.\n\n *You experience burning when you urinate, have blood in your \nurine, or experience a discharge.\n\n *You have shaking chills, or fever greater than 101.5 degrees \nFahrenheit or 38 degrees Celsius.\n\n *Any change in your symptoms, or any new symptoms that concern \nyou.\n\nPlease note the following discharge instructions: \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048230fb505ee75391e102"
  },
  "note_id": "16926894-DS-8",
  "subject_id": 16926894,
  "hadm_id": 28646159,
  "note_type": "DS",
  "note_seq": 8,
  "charttime": "2127-10-01 00:00:00",
  "storetime": "2127-10-06 13:21:00",
  "text": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: SURGERY\n \nAllergies: \nBactrim\n \nAttending: ___.\n \nChief Complaint:\nAbdominal pain, diarrhea \n \nMajor Surgical or Invasive Procedure:\nNone \n \nHistory of Present Illness:\n___ is a ___ w/ recent hospitalization ___ to \n___ for perforated appendicitis managed non-operatively w/ ___ \ndrain placement who is presenting here to the ED w/ worsening \nabd pain and diarrhea. After d/c he was initially doing well, \nhis ___ cx's resulted growing MDR E. coli and Shigella. The E. \ncoli was resistant to augmentin, which he was d/c'd on, and was \nthus\nswitched to bactrim this past ___. Also on ___ he developed \nsome worsening abd pain, and yesterday night started having \nwatery diarrhea. He has had persistent output from his ___ drain, \nfluctuating from ___ ml/day. He is tolerating PO w/o \ndifficulty. He denies any f/c/s, lightheadedness and/or\ndizziness, chest pain, SOB, h/a's, blurry vision, BRBPR, melena, \nn/b difficulty urinating, myalgias, arthralgias, or skin \nchanges; ROS is o/w -ve except as noted before. Here labs showed \nWBC 16.2, Cr 1.4, and lactate 2.2, and a CT A/P showed interval \ndecrease in RLQ abscess cavity (drained by ___ pigtail), but also \ncolts of ascending colon, for which we were consulted.\n\n \nPast Medical History:\nHLD\n \nSocial History:\n___\nFamily History:\nno fam hx of colon CA or IBD\n\n \nPhysical Exam:\nAdmission Physical Exam:\n\nGEN: pleasant, NAD, interactive, non toxic appearing \nEENT: PERRL, EOMI, sclerae anicteric, moist mucous membranes, no\nulcers / lesions / thrush  \nNECK:  supple\nCARD: RRR, normal S1, S2, no murmurs / rubs / gallops  \nPULM: clear to auscultation bilaterally w/o wheezes / rhonchi /\nrales  \nBACK: no focal tenderness, no costovertebral angle tenderness  \nABDM: erythema surrounding RLQ drain, somewhat tender to\npalpation around that site, no peritoneal signs  \nMSK: no joint swelling or erythema  \nEXTR: warm and well perfused, no edema, 2+ DP pulses palpable\nbilaterally  \nLYMPH: no cervical lymphadenopathy  \nSKIN: no rashes, no jaundice  \nNEURO: awake, alert and oriented x3, CN ___ intact, ___ \nstrength\nbil, reflexes 1+ bilaterally, normal sensitivity  \nPSYCH: non-anxious, normal affect \nACCESS:  PIV\n\nDischarge Physical Exam:\nVS: T: 99.2 PO BP: 124/76 L Lying HR: 93 RR: 18 O2: 96% Ra \nGEN: A+Ox3, NAD\nHEENT: normocephalic, atraumatic\nCV: RRR\nPULM: no respiratory distress, breathing comfortably on room air\nABD: soft, non-distended, non-tender to palpation.  RLQ prior ___ \ndrain site with no s/s infection, gauze dressing cdi\nEXT: no edema b/l\n \nPertinent Results:\nIMAGING:\n\n___: CT Abdomen/Pelvis:\n1. Right frontal lateral approach pigtail catheter terminates in \nthe right \nlower quadrant, with substantial interval decrease in size of \npreviously seen abscess, which is now collapsed around the \ncatheter tip.  No new abscess. \n2. Wall thickening of the ascending colon and at the hepatic \nflexure is \ncompatible with colitis of an infectious or inflammatory \netiology. \n\n___: CXR (PA & LAT):\n  \nPatchy basilar opacities suggesting atelectasis.  No definite \nevidence of \npneumonia. \n\nLABS:\n\n___ 08:18PM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 08:18PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR* \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 \nLEUK-NEG\n___ 08:18PM URINE  RBC-4* WBC-1 BACTERIA-NONE YEAST-NONE \nEPI-0\n___ 08:18PM URINE  MUCOUS-RARE*\n___ 03:44PM   ALT(SGPT)-64* AST(SGOT)-31 ALK PHOS-133* TOT \nBILI-0.3\n___ 03:44PM   ALBUMIN-4.4\n___ 03:44PM   ___ PTT-28.4 ___\n___ 03:13PM   LACTATE-2.2*\n___ 03:05PM   GLUCOSE-99 UREA N-23* CREAT-1.4* SODIUM-140 \nPOTASSIUM-5.0 CHLORIDE-100 TOTAL CO2-25 ANION GAP-15\n___ 03:05PM   ALT(SGPT)-68* AST(SGOT)-36 ALK PHOS-140* TOT \nBILI-0.4\n___ 03:05PM   ALBUMIN-4.5 CALCIUM-9.9 PHOSPHATE-4.1 \nMAGNESIUM-2.6\n___ 03:05PM   WBC-16.2* RBC-4.36* HGB-14.1 HCT-43.3 MCV-99* \nMCH-32.3* MCHC-32.6 RDW-14.3 RDWSD-52.3*\n___ 03:05PM   NEUTS-90.3* LYMPHS-4.2* MONOS-4.8* EOS-0.1* \nBASOS-0.2 IM ___ AbsNeut-14.66* AbsLymp-0.68* AbsMono-0.78 \nAbsEos-0.01* AbsBaso-0.03\n___ 03:05PM   PLT COUNT-377\n \nBrief Hospital Course:\nMr. ___ is a ___ y/o M w/ recent hospitalization for \nperforated appendicitis managed non-operatively w/ ___ drain \nplacement who is presented to ___ this admission with \nworsening abdominal pain and diarrhea.  After first hospital \ndischarge, his ___ cultures resulted growing MDR E. coli and \nShigella. The E. coli was\nresistant to augmentin, which he was d/c'd on, and was thus \nswitched to Bactrim. On this admission, labs showed WBC 16.2, Cr \n1.4, and lactate 2.2, and a CT A/P showed interval decrease in \nRLQ abscess cavity.  Stool studies and RPR were sent.  He was \nstarted on Bactrim DS 2 tabs PO BID + metronidazole 500 mg PO \nTID.  ID was consulted and recommended extending the antibiotic \nduration to 4 days beyond drain removal. Stool study later came \nback indicating that shigella was resistant to Bactrim.  Given \nthat there was shigella in the ___ fluid collection which was \nsensitive to Bactrim, the patient remained on Bactrim, \nmetronidazole and was also started on cefpodoxime.  \n\nThe patient's bowel movements became more formed during his \nhospital stay.  His ___ drain was removed on ___ as there was \nno fluid coming from the drain. At the time of discharge, the \npatient was doing well, afebrile and hemodynamically stable.  \nThe patient was tolerating a diet, ambulating, voiding without \nassistance, and pain was well controlled.  The patient received \ndischarge teaching and follow-up instructions with understanding \nverbalized and agreement with the discharge plan.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n2. Amoxicillin-Clavulanic Acid ___ mg PO Q12H \n3. Minocycline 50 mg PO Q24H \n4. Simvastatin 20 mg PO QPM \n5. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - \nModerate \n  Reason for PRN duplicate override: Alternating agents for \nsimilar severity\n\n \nDischarge Medications:\n1.  Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild/Fever  \n2.  Cefpodoxime Proxetil 400 mg PO/NG Q12H \nRX *cefpodoxime 200 mg 2 tablet(s) by mouth every twelve (12) \nhours Disp #*18 Tablet Refills:*0 \n3.  MetroNIDAZOLE 500 mg PO TID \nTake with food  \nRX *metronidazole [Flagyl] 500 mg 1 tablet(s) by mouth three \ntimes a day Disp #*13 Tablet Refills:*0 \n4.  Sulfameth/Trimethoprim DS 2 TAB PO BID \nRX *sulfamethoxazole-trimethoprim 800 mg-160 mg 2 tablet(s) by \nmouth twice a day Disp #*18 Tablet Refills:*0 \n5.  Simvastatin 20 mg PO QPM  \n6. HELD- Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY  This \nmedication was held. Do not restart Emtricitabine-Tenofovir \n(Truvada) until Your creatinine level is 1.2 or less  \n7. HELD- Minocycline 50 mg PO Q24H  This medication was held. Do \nnot restart Minocycline until your course of oral antibiotics \nhas completed \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nColitis of ascending colon\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou were admitted to the hospital with abdominal pain and \ndiarrhea and were found to have inflammation of part of your \ncolon. The fluid from your abscess grew out bacteria including \nEscherichia coli, Shigella sonnei and Bacteroides fragilis.  You \nwere initially kept on the antibiotic, Bactrim (sulfamethoxazole \nand trimethoprim), to treat both the Shigella and E. coli.  You \nwere also started on another antibiotic, called Flagyl \n(metronidazole) to treat the Bacteroides.  A stool sample was \nsent while you were in the hospital which again showed shigella, \nbut the shigella was resistant to Bactrim.  Therefore, you were \nstarted on a new antibiotic, called Cefpodoxime to treat the \nshigella.   Your abdominal drain was ultimately removed and you \nwill continue on oral antibiotics for an additional 4 (four) \ndays.\n\nYou are now ready to be discharged home.  Please note the \nfollowing discharge instructions:\n\nPlease call your doctor or nurse practitioner or return to the \nEmergency Department for any of the following:\n\n*You experience new chest pain, pressure, squeezing or \ntightness.\n*New or worsening cough, shortness of breath, or wheeze.\n*If you are vomiting and cannot keep down fluids or your \nmedications.\n*You are getting dehydrated due to continued vomiting, diarrhea, \nor other reasons. Signs of dehydration include dry mouth, rapid \nheartbeat, or feeling dizzy or faint when standing.\n*You see blood or dark/black material when you vomit or have a \nbowel movement.\n*You experience burning when you urinate, have blood in your \nurine, or experience a discharge.\n*Your pain in not improving within ___ hours or is not gone \nwithin 24 hours. Call or return immediately if your pain is \ngetting worse or changes location or moving to your chest or \nback.\n*You have shaking chills, or fever greater than 101.5 degrees \nFahrenheit or 38 degrees Celsius.\n*Any change in your symptoms, or any new symptoms that concern \nyou.\n\nPlease resume all regular home medications, unless specifically \nadvised not to take a particular medication. Also, please take \nany new medications as prescribed.\n\nPlease get plenty of rest, continue to ambulate several times \nper day, and drink adequate amounts of fluids. Avoid lifting \nweights greater than ___ lbs until you follow-up with your \nsurgeon.\nAvoid driving or operating heavy machinery while taking pain \nmedications.\n\nIncision Care:\n*Please call your doctor or nurse practitioner if you have \nincreased pain, swelling, redness, or drainage from the incision \nsite.\n*Avoid swimming and baths until your follow-up appointment.\n*You may shower, and wash surgical incisions with a mild soap \nand warm water. Gently pat the area dry.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048230fb505ee75391e103"
  },
  "note_id": "16926894-DS-9",
  "subject_id": 16926894,
  "hadm_id": 21506912,
  "note_type": "DS",
  "note_seq": 9,
  "charttime": "2127-10-09 00:00:00",
  "storetime": "2127-10-09 12:34:00",
  "text": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: SURGERY\n \nAllergies: \nBactrim\n \nAttending: ___.\n \nChief Complaint:\nthrombocytopenia \n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ year old man on PrEP with a recent perforated appendicitis \nand\nhad been readmitted for colitis of the ascending colon and \ninsufficient antiobiotic coverage based on updated sensitivity\ndata. He had been discharged on ___nd on\nappropriate antiobitic coverage. On clinic follow-up ___, he\nwas noted to have platelets of 10, repeat 17 (301 at discharge).\nHe did not feel unwell and had stable vitals at that time. He\nonly noted fatigue, mild blurry vision at night, and a rash\nbeginning ___. He also reported mild epistaxis at night. He\ndenied blood in stools or urine, bleeding from gums, or \nbruising.\nHe reported good appetite, normal BMs, no urinary problems, no\nfever/chills, no nausea/vomiting, and otherwise felt improved.\n \nPast Medical History:\nHLD\n \nSocial History:\n___\nFamily History:\nno fam hx of colon CA or IBD\n\n \nPhysical Exam:\nAdmission: \nVitals: ___ Temp: 97.8 PO BP: 120/71 HR: 80 RR: 18 O2\nsat: 98% O2 delivery: Ra \nGEN: A&O, NAD\nHEENT: No scleral icterus, mucus membranes moist\nCV: RRR, No M/G/R\nPULM: Clear to auscultation b/l, No W/R/R\nABD: Soft, nondistended, nontender, no rebound or guarding,\nnormoactive bowel sounds, no palpable masses\nExt: non-blanching purpuric lesions scattered on bilateral lower\nextremities, nontender, no ___ edema, ___ warm and well perfused\n\nDischarge:\n\nVitals: Temp: 97.8 PO BP: 124/71 L Lying HR: 71 RR: 18 O2 sat: \n99% O2 delivery: Ra  \nGEN: A&O, NAD\nHEENT: No scleral icterus, mucus membranes moist\nCV: RRR, No M/G/R\nPULM: Clear to auscultation b/l, No W/R/R\nABD: Soft, nondistended, nontender, no rebound or guarding,\nnormoactive bowel sounds, no palpable masses\nExt: no ___ edema, ___ warm and well perfused\n \nPertinent Results:\n___ 02:50PM BLOOD WBC-7.0 RBC-4.22* Hgb-13.7 Hct-40.9 \nMCV-97 MCH-32.5* MCHC-33.5 RDW-14.0 RDWSD-50.6* Plt Ct-17*\n___ 06:26AM BLOOD WBC-6.0 RBC-3.62* Hgb-11.8* Hct-35.4* \nMCV-98 MCH-32.6* MCHC-33.3 RDW-14.0 RDWSD-50.1* Plt Ct-45*\n___ 07:00AM BLOOD WBC-8.1 RBC-3.55* Hgb-11.7* Hct-34.9* \nMCV-98 MCH-33.0* MCHC-33.5 RDW-13.7 RDWSD-49.6* Plt ___\n___ 06:26AM BLOOD Glucose-95 UreaN-17 Creat-1.2 Na-142 \nK-4.8 Cl-102 HCO3-28 AnGap-12\n___ 07:00AM BLOOD Glucose-95 UreaN-11 Creat-1.0 Na-139 \nK-4.4 Cl-100 HCO3-24 AnGap-15\n___ 02:50PM BLOOD ALT-177* AST-86* AlkPhos-162* TotBili-0.4\n___ 06:26AM BLOOD ALT-142* AST-69* LD(LDH)-261* AlkPhos-117 \nTotBili-0.3\n___ 06:26AM BLOOD Albumin-4.0 Calcium-9.0 Phos-5.4* Mg-2.4\n___ 07:00AM BLOOD Calcium-8.8 Phos-4.2 Mg-2.___ year old man on PrEP with a recent perforated appendicitis \nand\nhad been readmitted for colitis of the ascending colon and \ninsufficient antiobiotic coverage based on updated sensitivity\ndata. He had been discharged on ___nd on\nappropriate antiobitic coverage. On clinic follow-up ___, he\nwas noted to have platelets of 10, repeat 17 (301 at discharge).\nHe did not feel unwell and had stable vitals at that time. He\nonly noted fatigue, mild blurry vision at night, and a rash\nbeginning ___. He also reported mild epistaxis at night.\n\nHe was directly admitted from clinic for monitoring and repeat \nlab work. The Infectious disease team and Hematology were \nconsulted for evaluation of his thrombocytopenia. Infectious \ndisease believed that his anti-biotic regimen may be the \netiology of his thrombocytopenia, but since his previous \ninfection had been resolved they did not feel he would need any \nfurther antibiotics. \n\nHematology also evaluated the patient and believed that the most \nlikely etiology is medication induced thrombocytopenia from his \nantibiotic regimen. They also considered autoimmune \nthrombocytopenia, or pseudo-thrombocytopenia. They recommended \ncontinuing to monitor his platelet count and if it continued to \ntrend in the right direction he would be appropriate for \ndischarge with follow up and a repeat CBC. \n\nOn the morning of discharge the patient continued to show \nimprovement in his platelet number (___). He was tolerating a \nregular diet, was in no pain, was independently ambulatory. He \nwas given appropriate follow up appointments as well as a \nlaboratory requisition for follow up CBC and electrolytes which \nshould be collected ___ days following discharge per hematology \nrecommendations. The patient expressed good understanding of \nthese instructions and was discharged home in good condition. \n \nMedications on Admission:\nFEXOFENADINE - fexofenadine 180 mg tablet. 1 Tablet(s) by mouth  \n\n once a day as needed for allergies  \n SIMVASTATIN - simvastatin 20 mg tablet. 1 Tablet(s) by mouth \nonce  \n a day    \n truvada (for PrEP)  \n\n \nDischarge Medications:\n1.  Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY  \n2.  Simvastatin 20 mg PO QPM  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nThrombocytopenia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou were admitted to the Acute Care Surgery Service on ___ \nwith a rash on your thighs and a low platelet count. Your \nantibiotics were stopped and your repeat platelet counts are \ngradually improving. Hematology service was consulted and felt \nyour low platelets were caused by the antibiotics you were \ntaking. Fortunately the platelet count is quickly increasing now \nthat you have stopped taking antibiotics. You should have your \nblood work checked again in ___ days (early next week is fine). \nYou are medically clear for discharge home. \n\nYou are now doing better, tolerating a regular diet, and your \nblood counts are improving. You are now ready to be discharged \nto home to continue your recovery.\n\nPlease follow up in the Acute Care Surgery Clinic to discuss \nfurther operative planning. \n\nPlease call your doctor or nurse practitioner or return to the \nEmergency Department for any of the following:\n*You experience new chest pain, pressure, squeezing or \ntightness.\n*New or worsening cough, shortness of breath, or wheeze.\n*If you are vomiting and cannot keep down fluids or your \nmedications.\n*You are getting dehydrated due to continued vomiting, diarrhea, \nor other reasons. Signs of dehydration include dry mouth, rapid \nheartbeat, or feeling dizzy or faint when standing.\n*You see blood or dark/black material when you vomit or have a \nbowel movement.\n*You experience burning when you urinate, have blood in your \nurine, or experience a discharge.\n*Your pain in not improving within ___ hours or is not gone \nwithin 24 hours. Call or return immediately if your pain is \ngetting worse or changes location or moving to your chest or \nback.\n*You have shaking chills, or fever greater than 101.5 degrees \nFahrenheit or 38 degrees Celsius.\n*Any change in your symptoms, or any new symptoms that concern \nyou.\n\nPlease resume all regular home medications, unless specifically \nadvised not to take a particular medication. Also, please take \nany new medications as prescribed.\n\nPlease get plenty of rest, continue to ambulate several times \nper day, and drink adequate amounts of fluids.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048237fb505ee75392511f"
  },
  "note_id": "17791179-DS-9",
  "subject_id": 17791179,
  "hadm_id": 26058210,
  "note_type": "DS",
  "note_seq": 9,
  "charttime": "2128-08-11 00:00:00",
  "storetime": "2128-08-12 11:54:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nPositive blood cultures\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\nMs. ___ is a ___ year old woman, with no significant past \nmedical history, who presents today for evaluation after \ndischarge from the ___ with possible septic joint and/or \ncellulitis, now found to have positive blood cultures.  \n \nPatient was sent in from ___ office to ___ on ___ with concern \nfor R hand cellulitis with concern for septic joint. Evaluation \nat that time showed 2 lesions in the right arm, without red \nstreaking. She was treated with vanco x1 and Benadryl (for \nitching) and improved in ___. She was sent home on Keflex, but \nwas called to return in the setting of positive blood cultures \nfor Viridian Streptococci. She presented to the ER on ___ for \nfurther evaluation including endocarditis workup, as she was \nreporting night sweats, but then left AMA due to concerns over \nchildcare for her children.  \n\nShe subsequently got 1 dose of IM ceftriaxone at the ___ office \non ___. She now presents for admission and workup for \nendocarditis. At this time she denies fever, chest pain. \nEndorses new night sweats and chronic shortness of breath with \nambulating for > ___ years. No headache, vision changes, dysuria, \nvaginal discharge. Exam reveals new murmur. Of note, she has a \nhistory of multiple recent dental procedures, most recent being \ncavity filling ___ months prior.\n\nIn the ___, initial vitals were: 98.2 89 113/95 16 100%  \nLabs notable for WBC 7.5, Hgb 10.8, Hct 34.8, Platelet 240. PMN \n48%,L41%  \n\nOn the floor, patient endorses above history, but also adds that \nin the last 3 days she has had no more fevers and her rash over \nher wrist, elbow and lateral arm have improved. She reports that \nshe never had any impairments to AROM or PROM over her joints in \nRUE. She also reports catching a bedbug in her house, and feels \nas though the area of redness that started over her wrist and \nelbow started out as a bug bite. She also reports her mother was \nrecently diagnosed with a heart valve issue two weeks prior.  \n \nPast Medical History:\n1. Herpes Simplex\n2. History of R hand cellulitis ___\n \nSocial History:\n___\nFamily History:\nNon-contributory.  \n \nPhysical Exam:\n=====================================================\nADMISSION PHYSICAL EXAM\n\nVital Signs: 98.8 PO 128 / 70 84 16 100 RA  \nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclerae anicteric, MMM, teeth with poor dentition, old \ncaries, no ulcerations, braces in place  \nCV: Regular rate and rhythm, systolic ___ murmur over left \nsternal border, non radiating, with apex of murmur closer to S1  \n\nLungs: Clear to auscultation bilaterally, no wheezes, rales, \nrhonchi  \nAbdomen: Soft, non-tender, non-distended, bowel sounds present, \nno organomegaly, no rebound or guarding  \nGU: No foley  \nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema, blanching non indurated, erythematous rash on lateral \nright arm, improving (3 cm), minor area of erythema over doral \naspect of proximal right hand. Full AROM and PROM at shoulder, \nelbow and wrist  \nNeuro: CNII-XII intact, ___ strength upper/lower extremities, \ngrossly normal sensation, 2+ reflexes bilaterally, gait \ndeferred.\n=====================================================\n\nDISCHARGE PHYSICAL EXAM\n\nVital Signs: Tm 97.5, HR 89, BP 127/57, RR 16, SaO2 99% RA\nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclerae anicteric, MMM, o/p clear\nCV: RRR, systolic ___ murmur at USB, non radiating, with apex of \nmurmur closer to S1  \nLungs: Clear to auscultation bilaterally\nAbdomen: Soft, non-tender, non-distended, NABS, no organomegaly, \nno rebound or guarding   \nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema, resolved swelling of R forearm, two punctate lesions on \ndorsum of right arm, no rash. Full ROM of wrist, elbow, and \nshoulder. No other skin lesions found. \nNeuro: CNII-XII intact, moving all extremities normally.\n \nPertinent Results:\nADMISSION LABS:\n=====================================================\n___ 06:23PM BLOOD WBC-7.5 RBC-4.21 Hgb-10.8* Hct-34.8 \nMCV-83 MCH-25.7* MCHC-31.0* RDW-15.2 RDWSD-45.1 Plt ___\n___ 06:23PM BLOOD Neuts-48.5 ___ Monos-7.7 Eos-2.4 \nBaso-0.3 Im ___ AbsNeut-3.65 AbsLymp-3.09 AbsMono-0.58 \nAbsEos-0.18 AbsBaso-0.02\n___ 05:30AM BLOOD ___ PTT-27.1 ___\n___ 06:23PM BLOOD Glucose-81 UreaN-12 Creat-0.6 Na-137 \nK-4.2 Cl-105 HCO3-21* AnGap-15\n___ 05:30AM BLOOD ALT-26 AST-21 LD(LDH)-150 AlkPhos-54 \nTotBili-0.3\n___ 05:30AM BLOOD Albumin-3.9 Calcium-8.5 Phos-3.7 Mg-2.1\n___ 06:23PM BLOOD CRP-9.1*\n___ BLOOD Lyme IgG, IgM negative\n___ BLOOD Anaplasma IgG & IgM pending at time of discharge\n\nDISCHARGE LABS:\n=====================================================\n___ 05:40AM BLOOD WBC-7.2 RBC-4.60 Hgb-11.7 Hct-37.7 MCV-82 \nMCH-25.4* MCHC-31.0* RDW-15.3 RDWSD-45.1 Plt ___\n___ 04:55AM BLOOD Glucose-84 UreaN-12 Creat-0.7 Na-139 \nK-4.3 Cl-105 HCO3-23 AnGap-15\n___ 04:55AM BLOOD Calcium-8.9 Phos-3.6 Mg-2.1\n\nMICROBIOLOGY:\n=====================================================\n___ blood cultures: ___ bottles growing Strep viridans\nBlood cultures from ___, and \n___ showed no growth to date (final results pending).\n\nIMAGING: \n=====================================================\nR wrist & elbow XR (___): Slight soft tissue swelling \nproximal right forearm.  Otherwise normal appearance \nradiographically.\n\nR shoulder XR (___): Normal\n\nPanorex (___): Read pending at time of discharge\n\nTTE (___): The left atrium is normal in size. No atrial \nseptal defect is seen by 2D or color Doppler. Left ventricular \nwall thickness, cavity size and regional/global systolic \nfunction are normal (LVEF = 60%). Tissue Doppler imaging \nsuggests a normal left ventricular filling pressure \n(PCWP<12mmHg). Right ventricular chamber size and free wall \nmotion are normal. The diameters of aorta at the sinus, \nascending and arch levels are normal. The aortic valve leaflets \n(3) appear structurally normal with good leaflet excursion and \nno aortic stenosis or aortic regurgitation. The mitral valve \nappears structurally normal with trivial mitral regurgitation. \nThere is no pericardial effusion. \n\n___ EKG: normal sinus rhythm, rate 79\n \nBrief Hospital Course:\nMs ___ is a ___ woman with no significant past medical \nhistory who presented initially for R arm cellulitis ___, \nadmitted for workup for infective endocarditis with ___ blood \ncultures growing S. viridans and new heart murmur.\n\n# Strep viridans bacteremia: The patient initially presented to \nthe ___ with R arm cellulitis on ___, was treated with Keflex \nand discharged, and was then called to return when one blood \nculture bottle from ___ grew Strep viridans. She was noted \nto have a new systolic murmur. She was started on ceftriaxone \nand daily surveillance blood cultures remained negative. She \nremained afebrile. A TTE was normal with no valvular \nabnormalities or evidence of endocarditis. She was seen by the \nInfectious Disease service, who felt that in light of the \npatient's clinical stability and negative subsequent blood \ncultures, the initial positive blood culture may have reflected \ncontamination from the patient's skin rather than a true \nbloodstream infection. Antibiotics were discontinued with a plan \nfor outpatient followup and repeat blood cultures 1 week after \ndischarge.\n\nTRANSITIONAL ISSUES:\n=====================\n-To PCP: ___ send blood cultures in one week per ID.\n-Follow-up pending blood cultures.\n-No ID follow-up needed.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. norgestrel-ethinyl estradiol 0.3-30 mg-mcg oral DAILY \n2. triamcinolone acetonide 0.5 % topical BID \n\n \nDischarge Medications:\n1.  norgestrel-ethinyl estradiol 0.3-30 mg-mcg oral DAILY  \n2.  triamcinolone acetonide 0.5 % topical BID  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS:\n===================\nPositive blood culture\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure caring for you during your hospitalization. \nYou were called back to the hospital because one of your blood \nculture bottles from your Emergency Department visit was growing \na bacteria. We placed you on IV antibiotics for this potential \ninfection, though subsequent blood cultures remained negative. A \nheart ultrasound was normal and showed no infection of your \nheart valves. The Infectious Disease thinks that the positive \nblood culture was not a true infection.\n\nIt is very important that you keep your follow-up appointment \nwith your primary care physician. She will recheck blood \ncultures at that visit.\n\nWe wish you the best!\n\nSincerely,\nYour ___ Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048238fb505ee7539257d3"
  },
  "note_id": "17842382-DS-12",
  "subject_id": 17842382,
  "hadm_id": 28870546,
  "note_type": "DS",
  "note_seq": 12,
  "charttime": "2158-04-16 00:00:00",
  "storetime": "2158-05-13 13:50:00",
  "text": " \nName:  ___              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROSURGERY\n \nAllergies: \nfluorescine IV dye / Shellfish / Estrogens / Penicillins / Sulfa\n \nAttending: ___.\n \nChief Complaint:\nelective admission for clipping of right anterior choroidal \nartery aneurysm. \n \nMajor Surgical or Invasive Procedure:\nCraniotomy for Aneurysm Clipping \n\n \nHistory of Present Illness:\nThis is s ___ year old female who presents electively for \nclipping of right anterior choroidal artery aneurysm. \n \nPast Medical History:\nHTN, CVA, s/p coiling Pcom aneurysm, right anterior chorodal \naneurysm, + smoker, hypothyroid, reflux, CVA ___ with left \nsided weakness and dysarthria with residual numbness lue \n___ digits, ___ diagnostic angiogramspetoplasty/ \ntonsilectomy ___ with emobiliation p com aneurysm.\n \nSocial History:\n___\nFamily History:\nnon contributory\n \nPhysical Exam:\nUpon discharge: \nA&Ox3 \nPERRL \nface symmetric \n___ Strength throughout \nIncision c/d/i \n\n \nBrief Hospital Course:\nThis is a ___ year old female who presented today for elective \ncraniotomy for clipping of right anterior choroidal aneurysm.  \nThe patient intraoperative had a low serum potassium and this \nwas repleated intr operative.  The patient was recovered in the \nPACU.  In the pacu the patient experienced three episodes of \n___ beats of SVT. An EKG was performed and reviewed by the PACU \nresident which was found to be within normal limits.  Cardiac \nenzymes were sent and the first set was :\nCK: 253  MB: 5  Trop-T: <0.01. \n\nElectrolytes were sent and the serum magnesium was found to be \nlow and was repleated.  The patient was sleepy but \nneurologically intact at the time of her post operative exam.  \nThere was full strength noted in all four extremities.  The \npatient was transferred to the intensive care untiland the serum \npotasium was fount to be low again and was repleated. \n\nOn ___,  The patient complained of blurred vision when both \neyes were open.  The patient was neurologically intact on exam.  \nThe patients diet was advanced as tolerated.  The foley catheter \nand the arterial line was discontinued.  The patient was \nmobilized out of bed.  The patient was transferred to the floor \nin stable condition when a bed was ready. Consultations for ___ \nand OT were placed. The patient had a 6 beat run of vtach, labs \nwere obtained and her potassium was repleted.\n\nOn ___, the patient remained neurologically stable. However \nduring activity and with physical therapy and nursing the \npatient's O2 sats would drop to the 80's. She was also noted to \nhave some hallucinations, which could be related to her pain \nmedications. She kept in patient one more day for further \nmonitoring.\n\nOn ___ Patient was neurologically stable. O2 sats improved both \nat rest and with activity. She was tolerating an advanced diet \nand ambulating independently. She was discharged home in good \ncondition.   \n\n \nMedications on Admission:\nasa 81, lipitor, colace, synthroid, lisinopril, lopressor, \nzantac\n\n \nDischarge Medications:\n1. Acetaminophen 325-650 mg PO Q6H:PRN fever or pain \n2. Atorvastatin 80 mg PO QPM \n3. Bisacodyl 10 mg PO/PR DAILY:PRN constipation \n4. Levothyroxine Sodium 112 mcg PO DAILY \n5. Lisinopril 40 mg PO DAILY \n6. Metoprolol Tartrate 50 mg PO DAILY \n7. Metoprolol Tartrate 25 mg PO QHS \n8. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain \nRX *oxycodone 5 mg 1 tablet(s) by mouth Q6-8H PRN pain Disp #*20 \nTablet Refills:*0\n9. MEDrol (Pak) (methylPREDNISolone) 4 mg oral daily \nfollow instructions per pharmacist for taper \nRX *methylprednisolone [Medrol (Pak)] 4 mg ___ tablets(s) by \nmouth daily Disp #*1 Dose Pack Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nanterior choroidal artery aneurysm \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDischarge Instructions\n \nElective Aneurysm Clipping\n \nCall your neurosurgeons office and speak to the Nurse \nPractitioner if you experience:\n\n \n\n-     Any neurological issues, such as change in vision, speech \nor movement\n\n \n\n-     Swelling, drainage, or redness of your incision\n\n \n\n-     Any problems with medications, such as nausea vomiting or \nlethargy\n\n \n\n-     Fever greater than 101.5 degrees Fahrenheit\n\n \n\n-     Headaches not relieved with prescribed medications\n\n \n\nActivity:\n\n \n\n-     Start to resume all activities as you tolerate  but start \nslowly and increase at your own pace.\n\n \n\n-     Do not operate any motorized vehicle for at least 10 days \nafter your surgery  your Nurse Practitioner can give you more \ndetail at the time of your suture removal.  \n\n \n\nIncision Care:\n\n \n\n-     Keep your wound clean and dry.\n\n \n\n-     Do not use shampoo until your sutures are removed. \n\n \n\n-     When you are allowed to shampoo your hair, let the shampoo \nrun off the incision line.  Gently pad the incision with a towel \nto dry.\n\n \n\n-     Do not rub, scrub, scratch, or pick at any scabs on the \nincision line.\n\n \n\n-     You need your sutures removed 7 to 10 days after surgery\n\n \n\n \n\n \n\nPost-Operative Experiences: Physical\n\n \n\n-     Jaw pain on the same side as your surgery; this goes away \nafter about a month\n\n \n\n-     You may experience constipation.  Constipation can be \nprevented by:\n\n \n\no     Drinking plenty of fluids\n\no     Increasing fiber in your diet by eating vegetables, \nprunes, fiber rich breads and cereals, or fiber supplements\n\no     Exercising\n\no     Using over-the-counter bowel stimulants or laxatives as \nneeded, stopping usage if you experience loose bowel movements \nor diarrhea\n\n \n\n-     Fatigue which will slowly resolve over time\n\n \n\n-     Numbness or tingling in the area of the incision; this can \ntake weeks or months to fully resolve\n\n \n\n-     Muffled hearing in the ear near the incision area\n\n \n\n-     Low back pain or shooting pain down the leg which can \nresolve with increased activity\n\n \n\nPost-Operative Experiences: Emotional\n\n \n\n-     You may experience depression.  Symptoms of depression can \ninclude\n\n \n\no     Feeling down or sad\n\no     Irritability, frustration, and confusion\n\no     Distractibility\n\no     Lower Self-Esteem/Relationship Challenges\n\no     Insomnia\n\no     Loneliness\n\n \n\n-     If you experience these symptoms, you can contact your \nPrimary Care Provider who can make a referral to a Psychologist \nor Psychiatrist\n\n \n\n-     You can also seek out a local Brain Aneurysm Support Group \nin your area through the Brain Aneurysm Foundation\n\n \n\no     More information can be found at ___\n\n \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820efb505ee7538f8344"
  },
  "note_id": "12267290-DS-3",
  "subject_id": 12267290,
  "hadm_id": 26615473,
  "note_type": "DS",
  "note_seq": 3,
  "charttime": "2141-11-25 00:00:00",
  "storetime": "2141-11-25 15:25:00",
  "text": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nagitation s/p fall\n \nMajor Surgical or Invasive Procedure:\nMechanical Intubation\n\n \nHistory of Present Illness:\nMr. ___ is a ___ with unknown past medical history who was \nreportedly drinking at the ___ game this evening when he \nfell (\"face-planted\") into the ground in front of the bathroom. \nHe was seen by EMS and was profoundly agitated and \nverbally/physically abusive and thus was handcuffed for \ntransport to the ___ ED for evaluation.  \nIn the ED, initial vitals: 125 141/93 22 97% RA. FSBG 65. \nPatient was noted to again be verbally and physically abusive, \nunable to give a history due to presumed intoxication. He \nreceived 5mg of IM haldol x2 and 1L of NS without significant \nimprovement in behavior or agitation, reportedly swinging at \nstaff in the ED. He was then given 2mg IM ativan at which point \nhe became less agitated but began desatting to the ___ with poor \nrespiratory effort. Given need for further diagnostic testing, \npatient was intubated with etomidate 20 mg and succinylcholine \n40. He was sedated with fentanyl and versed. Labs in the ED \nnotable for serum EtOH of 393 and positive urine cocaine. He had \nan anion gap of 18 with bicarb of 21. Abg after intubation \n___/494 on FiO2 of 100%, rate of 20, TV of 500 and PEEP of \n5. CT head in ED negative for bleed, Cspine negative for \nfracture.  \nOf note, patient's girlfriend reportedly accompanied him to the \nED however was escorted out due to intoxication prior to \ntransfer to the ICU.  \nOn arrival to the MICU, patient intubated, sedated with HR of \n77, BP of 118/72. Vent settings of CMV, tidal volume 500, RR26, \nFiO2 40%, PEEP 5. Patient unable to provide further history.  \nReview of systems: Unable to obtain given sedation/intubation.  \n\n \nPast Medical History:\nunknown\n \nSocial History:\n___\nFamily History:\nunknown\n \nPhysical Exam:\n77 130/66 24 100 on RA\nGENERAL: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNECK: supple, JVP not elevated, no LAD  \nLUNGS: Clear to auscultation bilaterally, no wheezes, rales, \nrhonchi  \nCV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, \ngallops  \nABD: soft, non-tender, non-distended, bowel sounds present, no \nrebound tenderness or guarding, no organomegaly  \nEXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \n\n \nPertinent Results:\n___ 01:24PM   LACTATE-2.1*\n___ 01:02PM   GLUCOSE-74 UREA N-10 CREAT-0.7 SODIUM-143 \nPOTASSIUM-3.7 CHLORIDE-108 TOTAL CO2-20* ANION GAP-19\n___ 01:02PM   CALCIUM-8.6 PHOSPHATE-3.0 MAGNESIUM-1.6\n___ 05:13AM   LACTATE-2.5*\n___ 05:03AM   GLUCOSE-76 UREA N-9 CREAT-0.7 SODIUM-146* \nPOTASSIUM-3.5 CHLORIDE-112* TOTAL CO2-18* ANION GAP-20\n___ 05:03AM   CK(CPK)-255\n___ 05:03AM   CALCIUM-8.2* PHOSPHATE-2.2* MAGNESIUM-1.6\n___ 05:03AM   WBC-8.1 RBC-4.27* HGB-13.5* HCT-40.8 MCV-96 \nMCH-31.7 MCHC-33.2 RDW-13.3\n___ 05:03AM   PLT COUNT-163\n___ 02:45AM   ___ PO2-128* PCO2-31* PH-7.41 TOTAL \nCO2-20* BASE XS--3\n___ 02:45AM   LACTATE-2.2*\n___ 01:21AM URINE  HOURS-RANDOM\n___ 01:21AM URINE  HOURS-RANDOM\n___ 01:21AM URINE  UHOLD-HOLD\n___ 01:21AM URINE  GR HOLD-HOLD\n___ 01:21AM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG \ncocaine-POS amphetmn-NEG mthdone-NEG\n___ 01:21AM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 01:21AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 \nLEUK-NEG\n___ 11:46PM   TYPE-ART RATES-20/ TIDAL VOL-500 PEEP-5 \nO2-100 PO2-494* PCO2-49* PH-7.29* TOTAL CO2-25 BASE XS--3 \nAADO2-185 REQ O2-39 -ASSIST/CON INTUBATED-INTUBATED\n___ 10:35PM   GLUCOSE-73 UREA N-9 CREAT-0.8 SODIUM-143 \nPOTASSIUM-3.9 CHLORIDE-104 TOTAL CO2-21* ANION GAP-22*\n___ 10:35PM   estGFR-Using this\n___ 10:35PM   ALT(SGPT)-18 AST(SGOT)-27 ALK PHOS-39* TOT \nBILI-0.2\n___ 10:35PM   ASA-NEG ___ ACETMNPHN-NEG \nbnzodzpn-NEG barbitrt-NEG tricyclic-NEG\n___ 10:35PM   WBC-9.5 RBC-4.76 HGB-15.3 HCT-44.7 MCV-94 \nMCH-32.1* MCHC-34.2 RDW-13.4\n___ 10:35PM   NEUTS-47.4* LYMPHS-45.1* MONOS-5.1 EOS-1.2 \nBASOS-1.1\n___ 10:35PM   PLT COUNT-208\n___ 10:35PM   PLT COUNT-___ with unknown PMH presented following fall at ___ \nwhile intoxicated now admitted to ICU intubated and sedated due \nto agitation and inability to protect his airway in setting of \nalcohol and cocaine intoxication.  \n\n#Hypoxemic respiratory failure: Patient with inability to \noxygenate appropriately and protect his airway in setting of \nEtOH/cocaine intoxication and sedating meds in ED with sats of \n80% when not agitated. Arrived on the MICU intubated. Patient \nwas exbutated sucessfully. After which Sp02% would desaturated \nto the 85%, this likely ___ to aspiration pnuemonitits from \ninsult described above and given the HPI. He was kept on \nsupplemental oxygen for thearpy and observed for 24 hour period. \nAfter which resolved. He was instructed  should follow up with \nhis PCP regarding the possibility of OSA\n\n#Anion gap acidosis: likely ethanol related, mild lactic \nacidosis as well. Patient was given 1L NS bolus and resolved \nafter fluid bolus.\n\n#Ethanol/cocaine intoxication: alcohol use history, history of \nwithdrawal unknown at this point. He came sedated with fentanyl \nand midazolam which stopped to extubation. He was put on \nthiamine and folate and CIWA once extubated and alochol \nuse/history clarified. Social work was consulted for his alcohol \nuse. He was monitored and wanted to leave AMA but was encouraged \nto stay for another 24 hours. He was sent out with instructions \nto abstain from alcohol, to join alcohol anonymous and to \nconsider a drug-detox day program. He was also instructed to \nreturn to the ED should he have any danger signs of alcohol \nwithdrawal (i.e. chest pain, agititation, seizures, etc). \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. This patient is not taking any preadmission medications\n\n \nDischarge Medications:\nNone\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary: Alcohol intoxication, cocaine use, respiratory failure\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMr. ___, \nIt was a pleasure taking care of you at ___. You were admitted \nbecause your were intoxicated with alcohol and cocaine. You had \nto be intubated because you were having difficulty breathing. \nYou were admitted to the medical intensive care unit. You were \nable to be extubaed quickly and you were able to breath on your \nown without any problems. Your oxygen levels were low at night. \n\nPlease follow up with your primary care provider. You should \nalso consider alcoholics anonymous or speaking with a \ndrug-treatment program to help with your substance abuse. \n\nRegards, \nYour ___ Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904822afb505ee75391852c"
  },
  "note_id": "16212352-DS-8",
  "subject_id": 16212352,
  "hadm_id": 21385310,
  "note_type": "DS",
  "note_seq": 8,
  "charttime": "2144-04-30 00:00:00",
  "storetime": "2144-04-30 17:32:00",
  "text": " \nName:  ___               Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nSulfa (Sulfonamide Antibiotics)\n \nAttending: ___.\n \nChief Complaint:\nChest pain\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ with a sig PMHx of HTN, HLD, T2DM who presents from his PCP\ndue to chest pain x2 weeks and TWI in lateral leads.\n\nThree weeks prior to admission, he states he developed burning\nupper chest pain after meals. The pain lasts ___ minutes and\nresolved with burping, flatulence, ___. The pain is\nonly associated with meals. He also adds that he has had a 10 lb\nweight loss in the 3 weeks, but denies any fevers or chills. He\ndenies any associated dyspnea, palpitations, presyncope or\nsyncope. \n\nHe presented to his PCP ___ ___ due to these symptoms. His PCP \nhad\npreviously checked an h.pylori stool antigen in ___ which\nwas positive, and had subsequently started him on quadruple\ntherapy, of which he only was given ___ medications. \n\nAt his PCP appointment yesterday, and EKG was checked which\nshowed LVH and TWI in lateral leads, so he was sent to ___ after\nreceiving aspirin 324 mg en route. \n \nPast Medical History:\nProstate cancer s/p prostatectomy\nGERD\nH. pylori infection\nScalp lesion\nDM2\nHTN\nHLD\n \nSocial History:\n___\nFamily History:\nBrother with MI\nMother with CVA, deceased\nFather deceased\n \nPhysical ___:\nADMISSION PHYSICAL EXAM:\nVS: T 98.9, HR 72, BP 160/72, RR 18, O2 100% RA\nGENERAL: NAD\nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva,\nMMM\nNECK: supple, no LAD, no JVD\nHEART: RRR, S1/S2, no murmurs, gallops, or rubs\nLUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably\nwithout use of accessory muscles\nABDOMEN: nondistended, nontender in all quadrants, no\nrebound/guarding, no hepatosplenomegaly\nEXTREMITIES: no cyanosis, clubbing, or edema\nPULSES: 2+ radial pulses bilaterally\nNEURO: A&Ox3, moving all 4 extremities with purpose\nSKIN: warm and well perfused, no excoriations or lesions, no\nrashes\n\nDISCHARGE PHYSICAL EXAM:\n24 HR Data (last updated ___ @ 613)\nTemp: 98.4 (Tm 98.4), BP: 112/64 (112-139/62-80), HR: 77\n(69-83), RR: 16 (___), O2 sat: 97% (96-98), O2 delivery: RA,\nWt: 126.7 lb/57.47 kg  \nGENERAL: NAD. Speaks some ___. Responds appropriately.\nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, MMM. Scar on right\nscalp.\nNECK: supple, no LAD, no JVD\nHEART: RRR, S1/S2, no murmurs, gallops, or rubs\nLUNGS: CTAB, normal work of breathing.\nABDOMEN: nondistended, nontender to palpation in all four\nquadrants, normal bowel sounds. No evidence of hepatomegaly.\nEXTREMITIES: no cyanosis, clubbing, or edema\nNEURO: A&Ox3, moving all 4 extremities\nSKIN: warm and well perfused, no excoriations or lesions, no\nrashes\n\n \nPertinent Results:\nADMISSION LABS:\nCBC: WBC 12.4 Hgb 13.4 Hct 41.3 Plt 312\nCoags: ___ 13.3 PTT 25.4 INR 1.2\nTrop < 0.01\nCK-MB 1\nCK 108\nChem 7: Na 132 K 5.7 (hemolyzed) Cl 94 HCO3 26 AG 12 BUN 111 \nCreat 1.0\nAlbumin 3.6\n\nPERTINENT LABS:\nTrop < 0.01 x 2\nK 4.5 (on repeat labs during admission)\n\nDISCHARGE LABS:\n___ 07:15AM BLOOD WBC-5.8 RBC-4.60 Hgb-13.0* Hct-39.7* \nMCV-86 MCH-28.3 MCHC-32.7 RDW-12.9 RDWSD-40.0 Plt ___\n___ 07:15AM BLOOD ___ PTT-26.5 ___\n___ 07:45AM BLOOD Glucose-182* UreaN-13 Creat-1.0 Na-137 \nK-4.3 Cl-97 HCO3-26 AnGap-14\n___ 07:45AM BLOOD Calcium-9.3 Phos-4.2 Mg-2.0\n\nPERTINENT IMAGING/STUDIES:\n\nCXR ___:\nRight perihilar mass with associated right upper lobe partial\ncollapse, highly concerning for neoplasm. Further assessment \nwith\nchest CT with IV contrast is recommended. \n\nCTA Chest ___:\n1. No evidence of pulmonary embolism or acute aortic \nabnormality.\n2. 6.7 x 4.9 x 6.4 cm right upper lobe mass concerning for\nprimary lung malignancy which completely obstructs right upper\nlobe bronchus and results in associated partial collapse of the\nright upper lobe.\n3. Adjacent, nodular ___ opacities in the right upper\nlobe likely represent postobstructive infection.\n4. Mediastinal lymphadenopathy with borderline right hilar node\nand prominent right supraclavicular node.\n5. Numerous sclerotic osseous lesions compatible with known\nprostate metastases.\n\nCT Head ___\n1. No evidence for intracranial metastatic disease.\n2. No acute intracranial hemorrhage or infarction.\n3. Mild background global parenchymal volume loss and evidence \nof chronic\nsmall vessel ischemic disease.\n\n___: MRI Brain w/ w/o Contrast:\n1. No evidence for intracranial metastatic disease. \n2. No acute intracranial hemorrhage or infarction. \n3. Mild background global parenchymal volume loss and evidence \nof\nchronic \nsmall vessel ischemic disease. \n\n___:\n1. Severe fixed defect involving the inferior wall and apical \nportion of the myocardium.  2. Moderate hypokinesis of the\ninferior wall and apex.  Left ventricular cavity size is mildly\nenlarged, LVEF is 37%. \n\n \nBrief Hospital Course:\nMr. ___ is a ___ with a sig PMHx of HTN, HLD, T2DM who \npresents from his PCP with acute chest pain and new TWI in the \nlateral leads, found to have a right lung mass. \n\nACUTE ISSUES:\n==============\n#Lung Mass: Mr. ___ presented with two weeks of bilateral \nburning chest pain and was noted to have CXR/CTA findings \nconsistent with a 6.7 x 4.9 x 6.4cm right upper lobe mass; the \netiology of his chest discomfort is likely related to \ncompression from his lung mass or dyspepsia, as below. The lung \nmass was highly concerning for malignancy so a MRI brain was \nperformed for metastasis evaluation and was negative. Due to the \nobstructive nature of the mass, a post-obstructive infection was \nconsidered; however, antibiotics were held given his hemodynamic \nstability. IP is planning on doing a lung biopsy tentatively on \n___ as outpatient. This needs to be scheduled. \n\n#Chest pain: As noted above, patient presented with burning \nchest pain, worse after eating, and was noted to have TWI in \nlateral leads. His troponins were negative and were consistent \nwith atypical chest pain. He received full-dose aspirin en route \nto hospital, and a p-mibi was recommended as inpatient, which \nrevealed a severe fixed defect involving the inferior wall and \napical portion of the myocardium. It also showed a moderate \nhypokinesis of the inferior wall and apex. Findings consistent \nwith likely old MI. He was continued on his home aspirin and \nstatin. He was discharged on Metoprolol 12.5mg, which should be \nuptitrated as tolerated. His echo showed an ejection fraction of \n50%. \n\n# Dyspepsia\n# H pylori positive: Mr. ___ had a with positive stool H. \npylori test on ___ but finished 14 days of only three \nmedications (PPI, bismuth, flagyl) and not tetracycline. There \nwas apparent confusion regarding pharmacy filling medications, \nso he was unaware that there were four medications. Quadruple \ntherapy was initiated while inpatient (without retesting) given \nhigh likelihood of untreated infection (___), to be completed \n___.\n\n# Weight loss: Patient's weight loss is concerning for \nmalignancy associated cachexia. Reportedly, he had a EGD and \ncolonoscopy in ___ in ___ which was normal. His \nalbumin level was normal.\n\nCHRONIC ISSUES:\n===============\n# Hx of scalp lesion: Patient had a history of concern for basal \ncell carcinoma on scalp and underwent excision of scalp lesion \non ___. The pathology revealed mixed syringocystadenoma \npapilliferum and basaloid neoplasm consistent with \ntrichroblastoma, pigmented, ulcerated, with marked acute and \nchronic inflammation, with scale-crust. He was to follow up with \nsurgery on ___ for complete excision with clear margins. \n\n#DM2: Patient's sugar levels are well-controlled on current \nmeds. His Hgb A1c was 5.9 on ___. His home metformin was \nheld, and he was maintained on insulin sliding scale while \nin-house.\n\n#Hypertension: Patient was maintained on losartan-HCTZ 50-12.5mg \n(home dose) while in-house. \n\n# Tinea on back: Patient has prior documented tinea on back and \nat home was using ketoconazole shampoo and cream. He was \nasymptomatic, so this was held during admission.\n\n# Hx of prostate cancer s/p prostatectomy: Treated in ___. PSA \nwas 0 in ___. Hx of sclerotic metastases. Should continue \nto have PSA monitoring given the bone lesions noted on imaging. \n\nTRANSITIONAL ISSUES:\n=====================\nDischarge weight: 57.47\nDischarge Cr: 1.0\n\n[] Complete quadruple therapy for H. pylori given that prior \ninfection was unlikely inadequately treated (___)\n -- PPI\n -- Bismuth\n -- Flagyl\n -- Tetracycline\n[] Clarify goals with family. Note that patient has capacity and \nhas right to know about diagnoses despite family's good \nintentions for not disclosing information to patient. Social \nsupport as needed.\n[] Hematology/oncology follow-up\n[] Patient found to have CAD based on stress testing but only \nshowed fixed defect. He was discharged on Metoprolol succinate \n12.5mg, which can be titrated up as he tolerates, statin and \naspirin.  \n[] IP was unable to do lung biopsy while in-house. He should get \ncalled by clinic to schedule an appointment (likely ___. \n\nGreater than 30 minutes spent in care coordination and \ncounseling on the day of discharge. \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Simvastatin 40 mg PO QPM \n2. Aspirin 81 mg PO DAILY \n3. MetFORMIN XR (Glucophage XR) 750 mg PO DAILY \n4. Omeprazole 20 mg PO DAILY \n5. losartan-hydrochlorothiazide 50-12.5 mg oral DAILY \n6. Ketoconazole Shampoo 1 Appl TP ASDIR \n7. Ketoconazole 2%  1 Appl TP BID Back \n\n \nDischarge Medications:\n1.  Bismuth Subsalicylate Chewable 524 mg PO TID Duration: 14 \nDays \nRX *bismuth subsalicylate [Bismatrol] 262 mg 2 tablets by mouth \nthree times a day Disp #*96 Tablet Refills:*0 \n2.  Metoprolol Succinate XL 12.5 mg PO DAILY \nRX *metoprolol succinate 25 mg 0.5 (One half) tablet(s) by mouth \ndaily Disp #*30 Tablet Refills:*0 \n3.  MetroNIDAZOLE 250 mg PO/NG QID Duration: 14 Days \nRX *metronidazole 250 mg 1 tablet(s) by mouth four times a day \nDisp #*43 Tablet Refills:*0 \n4.  Tetracycline 500 mg PO QID Duration: 14 Days \nRX *tetracycline 500 mg 1 capsule(s) by mouth four times a day \nDisp #*42 Capsule Refills:*0 \n5.  Omeprazole 20 mg PO BID Duration: 14 Days \nRX *omeprazole 20 mg 1 capsule(s) by mouth twice a day Disp #*21 \nCapsule Refills:*0 \n6.  Aspirin 81 mg PO DAILY  \n7.  Ketoconazole 2%  1 Appl TP BID Back  \n8.  Ketoconazole Shampoo 1 Appl TP ASDIR  \n9.  losartan-hydrochlorothiazide 50-12.5 mg oral DAILY  \n10.  MetFORMIN XR (Glucophage XR) 750 mg PO DAILY  \n11.  Simvastatin 40 mg PO QPM  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS:\nLung mass\nH. pylori infection\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nThank you for coming to ___!\n\nWHY WERE YOU ADMITTED?\n- You were admitted for chest pain\n\nWHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL?\n- You had a chest x-ray and CT scan which showed a lung mass. We \nhave to biopsy it to determine what it is.\n- You had an ultrasound of your heart (echocardiogram) which \nshowed one heart wall area was not working as well as the \nothers.\n- You had a stress ultrasound (also known as a nuclear scan) to \nlook at how your heart responded when it had to work harder and \nthis was reassuring. \n- We restarted your quadruple (4 medication) therapy for your H. \npylori infection since it can be contributing to your \ndiscomfort. \n\nWHAT SHOULD YOU DO WHEN YOU LEAVE THE HOSPITAL?\n- You will need to complete therapy for your H.pylori infection. \nYou should take these medications until ___. \n- We are truly very sorry that we weren't able to complete the \nlung biopsy while you were in the hospital. Someone will call \nyou to schedule the biopsy (likely ___. You will need to \nfast the night before the procedure. If you don't hear from \nsomeone by ___, please call ___. \n\nIt was a pleasure taking care of you! We wish you all the best.\n\nYour ___ Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904821afb505ee75390d0d8"
  },
  "note_id": "14816885-DS-4",
  "subject_id": 14816885,
  "hadm_id": 20217322,
  "note_type": "DS",
  "note_seq": 4,
  "charttime": "2146-04-05 00:00:00",
  "storetime": "2146-04-06 18:07:00",
  "text": " \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nShellfish Derived / Egg / Loratadine\n \nAttending: ___.\n \nChief Complaint:\nLower GI bleed\n \nMajor Surgical or Invasive Procedure:\nEGD\nColonoscopy\n\n \nHistory of Present Illness:\nMs. ___ is a ___ year-old woman presenting with BRBPR since \nthis AM and some intermittent crampy abdominal pain.  \n\nReports >16 episodes of fresh blood, few mixed with stool.  She \ndenies melena.  She also has some lower abdominal cramping prior \nto defecation, which then resolved.  She has tenderness to \npalpation.  No nausea/vomiting.  Pt reports lightheadedness, but \nnot orthostatic.  This is the first episode of rectal bleeding.  \nNo NSAIDs, ASA use.  Did not eat much today.  + chills, no \nfevers.  No weight loss.\n\nOf note, per PCP notes, she had a colonoscopy in ___ with \nextensive diverticulosis.\n\nIn the ED, initial VS were:  97.4 98 102/66 18 99.  Labs were \nnotable for HCT 35.9.  GI was consulted.  Bleeding scan was \nordered.  The patient received 1L NS.  She has 2 PIVs.  Vitals \nprior to transfer to the floor were:  T96, 65, 123/72, 16, 99RA. \n  \n\nReview of Systems:  \n(+) Per HPI:  headache, palpitations, chronic low back pain, \nrash on back of head (pruritic)  \n(-) Denies fever, night sweats, recent weight loss or gain. \nDenies sinus tenderness, rhinorrhea or congestion. Denies chest \npain or tightness. Denies cough, shortness of breath, or \nwheezes. No dysuria, urinary frequency. Denies Denies rashes. \nAll other review of systems negative. \n \nPast Medical History:\nDiverticulosis\nPeptic ulcer disease, h/o H. pylori but was not able to tolerate \nthe treatment\nAllergic rhinitis\nGERD\nSpinal stenosis\nOsteoarthritis of the knee\nOsteopenia\nVitamin D deficiency\nStress urinary incontinence\nObesity\n \nSocial History:\n___\nFamily History:\nHer brothers have ulcers, DM.  Her sisters have DM.\n \nPhysical Exam:\nVitals:  95.9, 125/75, 71, 18, 100RA\nGen: NAD, AOX3 \nHEENT: MMM, sclera anicteric, not injected\nNeck: no LAD\nCardiovascular: RRR normal s1, s2, II/VI systolic murmur at USBs\nRespiratory: Clear to auscultation bilaterally, no wheezes, \nrales or rhonchi  \nAbd: normoactive bowel sounds, soft, mildly tender in lower \nquadrant, non distended\nExtremities: No edema, 2+ ___ pulses\nIntegument: Warm, moist, no rash or ulceration  \nPsychiatric: appropriate, pleasant, not anxious \n \nPertinent Results:\nAdmission labs:\n___ 04:25PM   WBC-6.9 RBC-3.84* HGB-11.9* HCT-35.9* MCV-93 \nMCH-30.9 MCHC-33.1 RDW-14.5\n___ 04:25PM   NEUTS-68.5 ___ MONOS-4.2 EOS-1.8 \nBASOS-0.2\n___ 04:25PM   PLT COUNT-176\n___ 04:25PM   GLUCOSE-116* UREA N-24* CREAT-0.7 SODIUM-139 \nPOTASSIUM-4.0 CHLORIDE-106 TOTAL CO2-25 ANION GAP-12\n___ 04:25PM   ___ PTT-24.7 ___\n\nHCT ___ 44.1\n\nECG: \n1. Small Hiatal hernia\n2. Otherwise normal EGD to third part of the duodenum\n\nColonoscopy:\n1. Numerous diverticuli\n\nBleeding study:\n1. Normal study without evidence of GI bleeding up to 4 hours \nafter injection \n\n \nBrief Hospital Course:\n1. Lower GIB.  Given findings on bleeding study, EGD, and \ncolonoscopy, this was most likely due to diverticulosis.  At the \ntime of discharge, patient had not experienced episode of \nbleeding for >48 hours.\n\n2. Acute blood loss anemia.  HCT nadired at 24 requiring 2 units \nof pRBC.  HCT on day of discharge was 33.6\n \nMedications on Admission:\nOmeprazole 20 mg daily prn\nLoratadine 10 mg daily prn\nMiralax\nSertraline 50 mg daily (not taking per daughter)\n___ 100 mg daily\nFluticasone NS\n\n \nDischarge Medications:\n1. Omeprazole 20 mg Tablet, Delayed Release (E.C.) Sig: One (1) \nTablet, Delayed Release (E.C.) PO once a day.  \n2. Loratadine 10 mg Tablet Sig: One (1) Tablet PO once a day as \nneeded for allergy symptoms.  \n3. Gabapentin 100 mg Capsule Sig: One (1) Capsule PO TID (3 \ntimes a day).  \n4. Fluticasone  Nasal\n5. Miralax  Oral\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\n1. Diverticulosis\n2. Acute blood loss anemia\n \nDischarge Condition:\nHemodynamically stable\n \nDischarge Instructions:\nYou were admitted with bleeding which was likely due to \ndiverticuli in the colon.  The bleeding stopped on it's own \nthough you required 2 units of blood transfusion.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904821afb505ee75390d0d9"
  },
  "note_id": "14816885-DS-5",
  "subject_id": 14816885,
  "hadm_id": 23089370,
  "note_type": "DS",
  "note_seq": 5,
  "charttime": "2153-09-11 00:00:00",
  "storetime": "2153-09-11 20:59:00",
  "text": " \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nShellfish Derived / Egg / Loratadine\n \nAttending: ___.\n \nChief Complaint:\nBright Red Blood per Rectum\n \nMajor Surgical or Invasive Procedure:\nMesenteric Arteriogram ___\n \nHistory of Present Illness:\nMs. ___ is a ___, ___ speaking only woman with \npast\nmedical history of diverticulosis and diverticular bleed ___ \nwho\npresents with 3 episodes of bright red blood per rectum.\n\nShe woke up this morning and felt the urge to defecate where she\nhad bright red blood per rectum. She had one more episode,\nprompting her son to bring her to the emergency room for\nevaluation. While in the emergency room, she had another episode\nof blood per rectum. She had headache that she describes as her\nchronic headaches that is worsening. She is also having some\nlightheadedness but denies any vision changes, confusion, or\ninability to ambulate. She denies any associated chest pain,\ndyspnea, palpitations, abdominal pain, or back pain. She is on \nno\nanticoagulants but does take naproxen twice daily. \n\nShe had a colonoscopy in ___ which showed severe \ndiverticulosis,\nand in ___ she had rectal bleeding requiring 2 units of packed\nred blood cells and admission which was diagnosed as\ndiverticulosis. She has not had a colonoscopy since nor has she\nhad any more bleeding episodes since ___.\n\nIn the ED, initial VS were:  \nT 97.4 HR 91 BP 129/59 RR 16 O2100% RA \nExam notable for: Mild suprapubic tenderness, normal rectal tone\nwith frank blood on exam, no hemorrhoids noted.\nEKG:  NSR\nLabs showed:  \nWBC 6.9 -> 7.6\nHgb 13.3 -> 11.7\nHct 41.2 -> 36.4\nPlt 168 -> 219\nNormal coagulation labs: ___ 10.8 PTT 26.6 INR 1.0\nChem 10 normal\nLactate 1.5\n\nPatient received:  1L NS. Transfused 1unit Prbc.\nImaging showed:  \nCTA abd with large amount of active extravasation of contrast\ninto the sigmoid colon.   Likely blood products within the\nrectum. \nConsults:  \nACS was consulted and recommended management by ___ and will\nfollow.\n___ was consulted and recommended mesenteric arteriogram. She was\ntaken to procedure. Active extravasation was not found and no\nembolization was performed. She remained in the PACU for\nmonitoring post-procedure and was transferred the medicine \nfloor.\n\nOn arrival to the floor, patient reports some lightheadedness\nwhen changing position after her ___ procedure. She has RLQ\ncramping abdominal discomfort which is stable from this morning.\nShe is having small volume maroon BM. Denies chest pain,\nlightheadedness, vision changes at present. Daughter at bedside.\n \nREVIEW OF SYSTEMS: 10 point ROS reviewed and negative except as\nper HPI  \n\n \nPast Medical History:\nSpinal Stenosis  \nOA  \nGERD  \nVitamin D deficiency  \nH pylori  \nPsoriasis  \nNeuropathy  \nConstipation  \nDiverticula  \npreDM  \nhistory of corneal transplant, penetrating keratopathy  \n \nSocial History:\n___\nFamily History:\nHer brothers have ulcers, DM.  Her sisters have DM.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVS:  97.5 PO 131 / 80 R Lying 79 18 100 RA \nGENERAL: NAD, resting in bed on bed rest with knee stabilizer in \nplace. comfortable appearing\nHEENT: anicteric sclera, MMM  \nHEART: RRR, S1/S2, no murmurs appreciated\nLUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \nABDOMEN: soft, nondistended, mild ttp in R and LLQ, no\nrebound/guarding. smear dark maroon stool on pad\nEXTREMITIES: no cyanosis, clubbing, or edema. R groin access \nsite with blood on dressing, not saturated, no bruit, R DP pulse \nintact.    \nNEURO: moving all 4 extremities with purpose  \nSKIN: warm and well perfused \n\n \nPertinent Results:\nAdmission Labs:\n--------------\n___ 11:19AM BLOOD WBC-6.9 RBC-4.40 Hgb-13.3 Hct-41.2# \nMCV-94 MCH-30.2 MCHC-32.3 RDW-15.0 RDWSD-52.1* Plt ___\n___ 11:19AM BLOOD Neuts-58.1 ___ Monos-6.9 Eos-2.9 \nBaso-0.6 Im ___ AbsNeut-3.98 AbsLymp-2.13 AbsMono-0.47 \nAbsEos-0.20 AbsBaso-0.04\n___ 11:19AM BLOOD ___ PTT-26.6 ___\n___ 11:19AM BLOOD Glucose-96 UreaN-17 Creat-0.5 Na-140 \nK-4.6 Cl-103 HCO3-25 AnGap-12\n___ 11:19AM BLOOD Calcium-8.9 Phos-3.1 Mg-2.2\n___ 11:29AM BLOOD Lactate-1.5\n\nNotable Labs:\n-------------\n___ 07:05AM BLOOD calTIBC-242* Ferritn-165* TRF-186* \nIron-54\n___ 07:05AM BLOOD Ret Aut-2.0 Abs Ret-0.07\n\nImaging:\n--------\nMesenteric Arteriogram ___:\nFINDINGS: Narrowing of the proximal ___ however no active \nhemorrhage is identified in the region of concern in the sigmoid \ncolon on the prior CT scan. \nIMPRESSION: ___ and SMA angiograms without evidence of active \nhemorrhage. \n\nCT Abdomen Pelvis ___:\nIMPRESSION: \n1. Large amount of active extravasation of contrast into the \nsigmoid colon, possibly from a diverticular bleed.  Likely blood \nproducts within the rectum. \n2. Diverticuolosis. \n\nColonoscopy ___\nImpression: \nDiverticulosis of the whole colon\nNo evidence of active GI bleeding.\nOtherwise normal colonoscopy to cecum \n\nDischarge Labs:\n----------------\n___ 07:10AM BLOOD WBC-7.3 RBC-3.55* Hgb-10.7* Hct-33.5* \nMCV-94 MCH-30.1 MCHC-31.9* RDW-16.5* RDWSD-55.8* Plt ___\n___ 07:10AM BLOOD Glucose-119* UreaN-3* Creat-0.5 Na-144 \nK-3.8 Cl-106 HCO3-23 AnGap-15\n\n \nBrief Hospital Course:\nSummary:\n------------\nMs. ___ is a ___, ___ speaking only woman with \npast medical history of diverticulosis and lower GI bleed who \npresented with 3 episodes of bright red blood per rectum and \nactive extravasation on CTA that was not found on mesenteric \narteriogram or colonoscopy.\n\nACUTE ISSUES:\n-------------\n\n#Bright red blood per rectum:\n#Diverticular bleed:\nThe most likely source of bleeding was a diverticular bleed. She \npresented with large volume melena, with history of diverticular \nbleed and CTA showing active\nextravasation supporting diverticular bleeding exacerbated by \nnaproxen use. Of note, she also has history of H. Pylori, per \nAtrius records treated in ___ but never had TOC. She was \ntransfused a total of 2 units pRBC with evidence of \ninappropriate response, although she remained hemodynamically \nstable. Attempt at embolization at ___ via mesenteric arteriogram \non ___ but no active bleeding source identified. Stools waxed \nand waned between bloody and brown, and therefore colonoscopy \nwas preformed on ___ to identify bleeding source. Colonoscopy \nrevealed diverticulosis throughout the colon without active \nbleed. She should avoid NSAIDS, and may benefit from surgery as \nthis episode represents a ___ significant bleed. When she was \ndischarged, she was having non-bloody bowel movements and was \nhemodynamically stable with stable hematocrit, and tolerating a \nregular diet.\n\nCHRONIC ISSUES:\n----------------\n#H/O corneal transplant, L eye penetrating keratopathy: We \ncontinued her home prednisolone drops.\n\n#Fungal ear infection: She is not currently on medication. She \nreported that she finished a one-month course.\n\n#Osteoarthritis:\n#Chronic pain:\n#Neuropathy:\nWe continued her home gabapentin\n\n#Plaque psoriasis: She uses betamethasone at home, but is not \ncurrently needing this medication.\n\nTRANSITIONAL ISSUES:\n#Diverticulosis: She should not take NSAIDs. She would likely \nbenefit from GI follow up vs. surgery if bleeding recurs.\n\n#Hpylori History:  Unclear if she has received therapy for \npresumed prior H Pylori Infection.  Please consider therapy if \nindicated and not already completed.\n\n#STOPPED MEDS:\n- Naproxen due to bleeding risk\n\n#HELD MEDS\n- Acyclovir because unclear why taking.\n\n#Discharge HGB: 10.6.\n\n#CODE STATUS: Full (presumed)\n#CONTACT: Son, ___, ___\n \n___ on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP LEFT EYE EVERY \nOTHER DAY \n2. Vitamin D 1000 UNIT PO DAILY \n3. Polyethylene Glycol 17 g PO DAILY \n4. Acyclovir 400 mg PO Q12H \n5. Gabapentin 200 mg PO TID \n6. Naproxen 500 mg PO Q12H \n7. Omeprazole 20 mg PO DAILY \n8. Betamethasone Valerate 0.1% Cream 1 Appl TP Frequency is \nUnknown \n9. Calcipotriene 0.005% Cream 1 Appl TP Frequency is Unknown \n10. Loratadine 10 mg PO DAILY \n\n \nDischarge Medications:\n1.  Betamethasone Valerate 0.1% Cream 1 Appl TP PRN psoriasis  \n2.  Calcipotriene 0.005% Cream 1 Appl TP PRN psoriasis  \n3.  Gabapentin 200 mg PO TID  \n4.  Loratadine 10 mg PO DAILY  \n5.  Omeprazole 20 mg PO DAILY  \n6.  Polyethylene Glycol 17 g PO DAILY  \n7.  PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP LEFT EYE EVERY \nOTHER DAY  \n8.  Vitamin D 1000 UNIT PO DAILY  \n9. HELD- Acyclovir 400 mg PO Q12H  This medication was held. Do \nnot restart Acyclovir until you see your primary care doctor\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary Diagnosis:\n------------------\nLower GI Bleed\nDiverticulosis\nAnemia\n\nSecondary Diagnosis:\n--------------------\nNeuropathy\nHistory of Corneal Transplant\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear  Ms. ___,  \nIt was a pleasure to take care of you at ___.  \n\nWHY WERE YOU HERE?  \nYou were admitted to the hospital because you had blood in your \nstool\n\nWHAT WAS DONE WHILE YOU WERE IN THE HOSPITAL  \n- While you were in the hospital you had imaging of your belly, \nwhich showed bleeding, but when they tried to find where the \nbleeding was coming from, it had stopped. \n- You had a colonoscopy, and there was no bleeding seen. \n\n \nWHAT SHOULD YOU DO WHEN YOU GET HOME?  \n1) Please follow up at your outpatient appointments.  \n2) Please take your medications as prescribed. \n3) Please call your doctor if you develop any bloody stools. \n4) Do not take motrin, ibuprofen, advil, naproxen or alleve as \nthese may increase the chance of bleeding. \n\nWe wish you the best!  \nYour ___ Care Team  \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904823bfb505ee753928e19"
  },
  "note_id": "18251740-DS-17",
  "subject_id": 18251740,
  "hadm_id": 21932342,
  "note_type": "DS",
  "note_seq": 17,
  "charttime": "2140-03-04 00:00:00",
  "storetime": "2140-03-25 18:25:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nLipitor\n \nAttending: ___.\n \nChief Complaint:\npalpitations, CP, SOB  \n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nPt is a ___ with DM (diet controlled), hypothyroid, depression \n(on buproprion)otherwise no major cardiac history presents with \n___ mo h/o palpitations, presents overngiht with worsening \npalpitations and associated with lightheadedness, SOB x1hr prior \nto arrival with L sided chest pain. She has had several previous \nepisodes of palpitations, first lasted half an hour, second a \nlittle longer, neither associated with chest pain (per pt more \nfeeling heart beating very hard). Pt was seen by her PCP ___. \n___ ___ with c/o palpitations and dizziness, and had \noffice EKG with NSR. CBC and TSH were checked and normal and \necho was normal.  \n.  \nEMS was called and she was found to have new AFib with RVR to \n180, and was converted in the field with 15mg IV dilt.  \n. \nIn the ED: 97.6 100 90/55 (this appears to be only a little \nbelow baseline per OMR records and per her) 16 97 RA. She was in \nsinus in the ED. Labs with chem7 HCO3 20, BUN 23, Glucose 251, \notherwise normal. CBC normal. Trop/CK/MB negative. She was given \nASA 325 and 2L NS.  \n.  \nShe denies any new med changes, any infectious localizing \nsources. On the floor, her EKG shows a NSR and is normal. She \ncurrently feels \"pretty good\" and does not look ill.  \n.  \nReview of Systems: As above, also with increased fatigue noted \nwith usual walks and daily activities (hasn't prevented her from \ndoing them but she feels more tired). Also reports chronic \nconstipation and diarrhea which she associated w/taking fish \noil; denies blood in stool or burning on urinatin. She \nacknowledges ___ swelling at end of day that resolves \nw/elevation. Otherwise, no f/c/ns, vision changes, HEENT \nproblems, SOB, DOE, dysphagia, n/v/d/abd pain, PND, orthopnea.  \n.  \n\n \nPast Medical History:\nPast Medical History:  \n1. Impaired glucose tolerance/borderline DMII (diet controlled, \nnot on meds)  \n2. Hypothyroidism  \n3. Osteoporosis - last bone density was in ___, did not  \ntolerate bisphosphonate after very short trial.  \n4. Hyperlipidemia - with statin intolerance  \n5. Cataracts  \n6. Diverticulosis - colonoscopy ___ ago \n7. Depression: recurred in ___, seen by ___  \n8. She denies any AMI's, CVA's, HTN (actually her bp appears to \nrun on the low side) \n \nSocial History:\n___\nFamily History:\nThe patient grew up in a foster home and has no  \nchildren. She didn't know her family so doesn't know much FHx, \nbut states has one aunt with throat ca and another with stroke. \nNo other known cardiac family hx.\n \nPhysical Exam:\nVitals: T:96.0  BP:106/64 (105-106/57-64) P:80  ___  SaO2: \n97% RA gluc=95 wgt 60.9 \nGeneral: Awake, alert, NAD, pleasant, appropriate, cooperative.  \n\nHEENT: NCAT, PERRL, EOMI, no scleral icterus, MMM, no lesions \nnoted in OP, no lymphadenopathy noted  \nNeck: supple, no significant JVD or carotid bruits appreciated  \nPulmonary: Lungs CTA bilaterally, no wheezes, ronchi or rales\nCardiac: RR, nl S1 S2, no tachycardia, no murmurs, rubs or \ngallops appreciated\nAbdomen: soft, NT, ND, normoactive bowel sounds, no masses or \norganomegaly noted  \nExtremities: No edema, 2+ radial and pedal pulses b/l\nSkin: no rashes or lesions noted.  \nNeurologic: Alert, oriented x 3. Able to relate history without \ndifficulty. Cranial nerves II-XII intact. Moving all 4 \nextremeties independently.\n \nPertinent Results:\n___ 07:00AM BLOOD WBC-5.3 RBC-3.74* Hgb-11.7* Hct-36.1 \nMCV-97 MCH-31.4 MCHC-32.5 RDW-13.3 Plt ___\n___ 12:10AM BLOOD WBC-6.9 RBC-4.21 Hgb-13.8 Hct-39.9 MCV-95 \nMCH-32.9* MCHC-34.7 RDW-13.6 Plt ___\n___ 07:00AM BLOOD Neuts-59.4 ___ Monos-4.9 Eos-1.7 \nBaso-0.9\n___ 12:10AM BLOOD Neuts-59.7 ___ Monos-5.2 Eos-1.0 \nBaso-0.6\n___ 07:00AM BLOOD Plt ___\n___ 12:10AM BLOOD Plt ___\n___ 07:00AM BLOOD Ret Aut-PND\n___ 07:00AM BLOOD Glucose-102* UreaN-29* Creat-0.7 Na-141 \nK-4.1 Cl-108 HCO3-24 AnGap-13\n___ 12:10AM BLOOD Glucose-251* UreaN-23* Creat-1.0 Na-140 \nK-3.6 Cl-105 HCO3-20* AnGap-19\n___ 07:00AM BLOOD CK(CPK)-PND\n___ 12:10AM BLOOD CK(CPK)-84\n___ 07:00AM BLOOD CK-MB-PND\n___ 12:10AM BLOOD cTropnT-<0.01\n___ 12:10AM BLOOD CK-MB-2\n___ 07:00AM BLOOD Calcium-7.7* Phos-3.7 Mg-1.9\n___ 07:00AM BLOOD TSH-PND\n.\n___\nFINDINGS: There is minimal posterior dependent atelectasis. \nOtherwise, the \nlungs are clear. No pneumothorax, or pleural effusions are \npresent. The \ncardiac silhouette, hilar, and mediastinal contours appear \nnormal. \nIMPRESSION: No acute cardiopulmonary process. \n.\nEKG ___: Done on floor admission, NSR 67, normal axis, normal \nintervals, normal QRS complexes, normal RWP, normal ST segments \nand T waves.  \n \nBrief Hospital Course:\nPt is a ___ female with history of DM (diet controlled), \nhypothyroid, depression, no major cardiac disease, who was admit \nwith palpitations and found to have atrial fibrillation with \nrapid ventricular response (hr in 180s). On the way to the ED \nthe pt was given 15 mg IV of Dilt in the field and converted to \nsinus rhythm.  \n.  \nWhile in the hospital, pt was started on metoprolol for rate \ncontrol. In addition, given that she had a CHADS score of 2, she \nwas told to begin warfarin on day of discharge and given a \nprescription for warfarin w/outpt follow-up with her PCP and \ncardiologist for additional management. Heparin bridge was not \nfelt to be warrented given her low risk and that beginning \ncoumadin alone was sufficient. The pt was discharged in stable \ncondition w/further workup and managment in the outpt setting.\n\n \nMedications on Admission:\n1. Synthroid 50 mcg once daily  \n2. buproprion 75 mg BID  \n3. Calcium/vitamin D supplement daily  \n4. Spectravite senior tab  \n5. multivitamin once daily  \n6. Fish oil 1 tab bid  \n7. VitD 50,000 unit tab once week but pt states she hasn't \nstarted yet  \n\n \nDischarge Medications:\n1. Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) \nTablet, Chewable PO DAILY (Daily).  \n2. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: One (1) \nTablet PO DAILY (Daily).  \n3. Omega-3 Fatty Acids     Capsule Sig: One (1) Capsule PO BID \n(2 times a day).  \n4. Levothyroxine 25 mcg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n5. Bupropion HCl 75 mg Tablet Sig: One (1) Tablet PO BID (2 \ntimes a day).  \n6. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \nhours) as needed for pain.  \n7. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).\nDisp:*60 Capsule(s)* Refills:*2*\n8. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday) as needed for constipation.\nDisp:*30 Tablet(s)* Refills:*0*\n9. Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr \nSig: One (1) Tablet Sustained Release 24 hr PO once a day.\nDisp:*30 Tablet Sustained Release 24 hr(s)* Refills:*2*\n10. Warfarin 2.5 mg Tablet Sig: One (1) Tablet PO once a day.\nDisp:*30 Tablet(s)* Refills:*2*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAtrial Fibrillation with rapid ventricular response\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou came to the hospital because you were experiencing \npalpitations, shortness of breath, possible chest pain and \nfatigue. While in the hospital you were found to have atrial \nfibrillation which is an irregularly fast rhythm of your heart. \nYou were treated with medications to help your heart to beat at \na normal rate again. Your symptoms resolved and you were \ndischarged home.\n. \nThe following changes were made you your medications:\n- Please START taking Metroprolol Succinate 25mg daily\n- Please START taking Coumadin 2.5mg daily\n- Please continue to take all of your other home medications as \nprescribed.\nPlease be sure to take all medication as prescribed.\n.\nBecause you are starting Coumadin, you will need to have your \nINR checked on WED ___. The INR indicates whether or note \nyour blood is suficiently anticoagulated to prevent clots from \nforming in your heart if the irregular heart rhytm recurs. This \ncolts pose a stroke risk which is why it is important to take \nyour Coumadin and monitor your INR.\n.\nPlease be sure to keep all follow-up appointments with your PCP \nand your cardiologist.\n.\nIt was a please taking care of you and we wish you a speedy \nrecovery.\n. \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904823bfb505ee753928e1a"
  },
  "note_id": "18251740-DS-18",
  "subject_id": 18251740,
  "hadm_id": 29228700,
  "note_type": "DS",
  "note_seq": 18,
  "charttime": "2141-11-11 00:00:00",
  "storetime": "2141-11-12 19:39:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nLipitor / Lovastatin / Fosamax\n \nAttending: ___.\n \nChief Complaint:\nShortness of breath\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ w/ h/o AFib and diet controlled diabetes presenting with 2 \nweek h/o worsening shortness of breath and productive cough.\nPatient was in her usual state of health until 2 weeks ago when \nshe suddenly developed non-productive cough, tightness of chest, \nand malaise. She then developed sputum production but never \nlooked at until today, which was brown/rust colored. She had \nsubjective fever and chills. Alos reports an episode of night \nsweat during this period. She had appetite loss and minimal oral \nintake. She felt increasingly difficult to breath and fatigued. \nShe noticed worsening palpitations. She also reports several day \nhistory of dysuria, malodorous urine, and burning involving her \nbladder area. She had been recently treated for UTI w/ \nnitrofurantoin antibiotic ___ and has remained symptom free \nuntil recently. She also reports constant ___ burning sensation \nin her stomach during this period. Of note, this was similar to \nher prior gastritis symptoms. She denies any ASA or NSAIDS use. \nShe had a small formed BM today. Denies hematochezia or melana. \nShe noticed worsenig pallor lately. Concered about possible \nweight gain recently. She denies orthopnea. She has a long \nhistory of leg swelling, which as not changed lately.  \n\nShe was seen by her PCP on the day of admission and was found to \nhave O2 sat of 89% on RA, HR 101. Per PCP, her exams were \nnotable for dry mucus membranes, left TM injected, coarse breath \nsounds bilaterally with rhonchi on right.  She was sent to the \nED for hypoxia and workup of potential pneumonia. \n.  \nIn the ED, initial VS were: 99.7 92 140/62 20 92% 2L. CXR showed \ninccreased interstitial marking possibly due to fluid overload, \nbut  superimposed infectious process could not excluded. There \nwas a more confluent opacity in the right lung base. Notable \nlabs as follows: Na was 132, BNP 677, Hct 30.1, WBC 11.6, INR \n5.4. She was also noted to have cloudy, foul-smelling urine in \nthe ED. UA showed trace leukesterase, WBC 10, negative nitrites. \nUrine culture and legionella antigen were sent. Patient was \ngiven a dose of ceftriaxone 1gm and azithromycin 500mg IV.  \nVitals on transfer were 98.1po  117/58 85  19  97% 2.5L. She was \nadmitted to the medicine service for the further management and \nevaluation.\n.  \nReview of systems:  \n(+) Per HPI  \n(-) Denies sinus tenderness, rhinorrhea or congestion. \n\n \nPast Medical History:\n1. Diabetes Mellitus Type 2 - diet controlled; HbA1C 6.2\n2. Chronic Atrial Fibrillation - on warfarin\n3. Hypothyroidism  \n4. Osteoporosis - last bone density was in ___, did not \ntolerate bisphosphonate after very short trial.  \n5. Hyperlipidemia - with statin intolerance  \n6. Cataracts  \n7. Diverticulosis \n8. Depression: recurred in ___, seen by ___  \n9. Gastritis\n\n \nSocial History:\n___\nFamily History:\nThe patient grew up in a foster home and has no  \nchildren. She didn't know her family so doesn't know much ___, \nbut states has one aunt with throat ca and another with stroke. \nNo other known cardiac family hx.\n \nPhysical Exam:\nAdmission Physical Exam:  \nPhysical Exam:  \nVitals: 98.8 112/64 91 24 92 on 2L\nGeneral: Alert, interactive, no acute distress. Pale  \nHEENT: Sclera anicteric, MM dry, oropharynx clear  \nNeck: supple, JVP not elevated, no LAD  \nLungs: coarse breath sounds b/l, L > R, diffuse expiratory \nwheezing on RUL, RLL, frequent productive cough\nCV: Tachycardic, regular rhythm, NL S1, S2, no murmurs, rubs, \ngallops  \nAbdomen: soft, non-tender, non-distended, bowel sounds present, \nno guarding, no organomegaly, no CVA tenderness  \nExt: 2+ nonpitting edema, warm, well perfused, 2+ pulses, no \nclubbing, cyanosis or edema  \nNeuro: CN II-XII grossly intact, no gross focal deficits \n\n.\nDischarge Physical Exam\nPhysical Exam:  \nVitals: 97.8 130/60 79 18 93RA\nGeneral: Alert, interactive, no acute distress\nHEENT: Sclera anicteric, MM moist, oropharynx clear, no \ndischarges, erythema, or tenderness involving the external ears \nb/l.   \nNeck: supple, JVP not elevated, no LAD  \nLungs: coarse breath sounds with diffuse crackles bilaterally L \nworse than R, no wheezes\nCV: regular rate, rhythm, NL S1, S2, no murmurs, rubs, gallops  \nAbdomen: large ecchymosis at the heparin inj site, soft, \nnon-tender, non-distended, bowel sounds present, no guarding, no \norganomegaly, no CVA tenderness  \nExt: 1+ nonpitting edema unchanged from the previous day, warm, \nwell perfused, 2+ pulses, no clubbing, cyanosis or edema  \nNeuro: CN II-XII grossly intact, no gross focal deficits, \nhearing inteact \n\n \nPertinent Results:\n___ 03:40PM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 03:40PM URINE  BLOOD-TR NITRITE-NEG PROTEIN-TR \nGLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-TR\n___ 03:40PM URINE  RBC-2 WBC-10* BACTERIA-FEW YEAST-NONE \nEPI-0\n___ 01:00PM   GLUCOSE-137* UREA N-12 CREAT-0.6 SODIUM-132* \nPOTASSIUM-3.3 CHLORIDE-94* TOTAL CO2-27 ANION GAP-14\n___ 01:00PM   cTropnT-<0.01 proBNP-677*\n___ 01:00PM   LACTATE-1.3\n___ 01:00PM   WBC-11.6*# RBC-3.24* HGB-10.4*# HCT-30.1*# \nMCV-93 MCH-32.0 MCHC-34.4 RDW-13.0\n___ 01:00PM   NEUTS-89.4* LYMPHS-7.5* MONOS-2.2 EOS-0.4 \nBASOS-0.4\n___ 01:00PM   PLT COUNT-421#\n___ 01:00PM   ___ PTT-42.8* ___\n___ 07:30AM BLOOD WBC-6.4 RBC-3.40* Hgb-10.8* Hct-32.2* \nMCV-95 MCH-31.8 MCHC-33.5 RDW-13.8 Plt ___\n___ 07:30AM BLOOD ___ PTT-43.6* ___\n___ 07:44AM BLOOD Ret Aut-1.2\n___ 07:30AM BLOOD Glucose-101* UreaN-12 Creat-0.7 Na-141 \nK-4.0 Cl-103 HCO3-30 AnGap-12\n___ 06:45AM BLOOD cTropnT-<0.01\n___ 07:30AM BLOOD Mg-2.0\n___ 07:44AM BLOOD calTIBC-150* VitB12-GREATER TH \n___ Ferritn-638* TRF-115*\n\n \nBrief Hospital Course:\n___ with past medical history notable for AF, diet controlled \nDM, hypothyroidism, and recent UTI treatment p/w 2wk h/o \nworsening SOB, productive cough, subjective fever and chills and \ndysuria, malodorous urine.\n\n#  SHORTNESS OF BREATH\nPatient was diagnosed with pneumonia given the constellation of \nsymptoms involving initially non-productive to productive cough, \nworsening shortness of breath, chest tightness, subjective fever \nor chills, and malaise. CXR shows bilateral interstitial \nthickening and possible RLL involvement. Influenza swaps were \nnegative. Patient was treated with azithromycin and ceftriaxone \nand then switched to levofloxacin. She remained afebrile and \nhemodynamically stable. Her respiratory status improved upon \nantibiotics administration. She gradually came off O2 \nsupplement. Her leukocytosis resolved. Her ambulatory O2 sat was \n95% on RA. She was discharged with the plan to complete the \ntotal 7day course of antibiotics. \n.\n# diarrhea: Patient developed loose stools a couple of days \nprior to discharge.  It was thought this was due to the \nantibiotics as her cdiff was negative. She was given immodium \nand it improved.\n.\n# UTI\nShe presented with dysuria, malodorous urine, and microscopic \nurine exam notable for increased WBC and few bacteria. UCx was \npositive for pan-sensitive E.coli. She was treated with azithro \n+ ceftriaxone initially and switched to levofloxacin as above. \n.\n# ANEMIA\nPer OMR, she had significant Hct drop from 41 to 30 over the 3 \nmonth period since ___. There was no evidence of active \nbleeding. Guaic was neg. Normocytic with inappropriate rectic \nwith nl iron study/folate/B12 was consistent with anemia of \nchronic illness. Her Hct remained stable.\n.\n# ELEVATED INR\nShe presented with INR of 5.4. Coumadin was held initially. It \nwas restarted at 2mg once her INR came close to her target range \nof ___ (Please see the lab section). She was discharged on 2mg \ncoumadin with the instruction to get her INR checked on ___ at \nthe ___ clinic.\n.\n# NEW DIASTOLIC LV DYSFUNCTION\nEchocardiogram revealed new grade II diastolic LV dysfunction. \nThere however was no evidence of pulmonary edema throughout the \n___ hospital course. She was recommended to start taking \nlisinopril 2.5mg daily upon discharge and follow up with PCP.\n.\n#  SWALLOWING DIFFICULTY\nShe developed a sudden difficulty swallowing her pill on \nhospital day #2. Speech and Swallow consult was made. It was \nthought to be functional difficulty. It resolved spontaneously \nwithin hours. \n.\n\n#  Hearing difficulty\nShe developed sudden onset hearing diminishment and crackles on \nhospital day 2. There was no evidence of infection upon exam. It \nwas thought to be related to her current PNA/URI. Patient \nrequested an ENT follow up arrangement upon discharge.\n\n# Chronic Atrial Fibrillation \nPatient remained hemodynamically stable on coumadin throughout \nthe course\n\n# Diabetes Mellitus\nGlucose was well controlled in insulin sliding scale. \n.  \n# Hypothyroidism: \nShe continued on outpatient levothyroxine regimen.\n\n# TRANSITIONAL ISSUE\n- Resolution of PNA symptoms\n- Follow up on anemia\n- INR check, ___\n- Follow up on ear complaints, ENT visit scheduled\n- Started on lisinopril - check electrolytes in ___\n- Follow up on new diastolic LV dysfunction\n \nMedications on Admission:\n- bupropion HCl 75 mg Tablet BID (take ___ tablet before 5pm)\n- levothyroxine [Synthroid] 50 mcg Tablet - Take 2 tablets on \n___ for a total of 100 mcg\n- metoprolol succinate 25 mg Tablet Extended Release 24 hr daily\n- warfarin 2.5 mg Tablet - AS DIRECTED BY ___ CLINIC\n- acetaminophen 325 mg Tablet, ___ Tablet(s) Q6H: PRN\n- calcium citrate-vitamin D3 315 mg-200 unit - 2 Tabs BID with \nfood\n- geriatric multivit w/iron-min [___ Senior] - 1 tablet \ndaily\n- omega-3 fatty acids-vitamin E [Fish Oil] - 1,000 mg Capsule x3 \ncapsules daily \n \nDischarge Medications:\n1. bupropion HCl 75 mg Tablet Sig: One (1) Tablet PO BID (2 \ntimes a day): by mouth.\n2. levothyroxine 50 mcg Tablet Sig: 1 tablet daily ___ through \n___, 2 tablets on ___ Tablet PO once a day: by mouth.\n3. metoprolol succinate 25 mg Tablet Extended Release 24 hr Sig: \nOne (1) Tablet Extended Release 24 hr PO once a day: by mouth.\n4. warfarin 2 mg Tablet Sig: One (1) Tablet PO Once Daily at 4 \n___: by mouth AS DIRECTED BY ___ CLINIC.\n5. acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \nhours) as needed for pain: as needed for pain; by mouth.\n6. Calcium Citrate + D 315-200 mg-unit Tablet Sig: Two (2) \nTablet PO twice a day: 2 tablets twice daily with food.\n7. Spectravite Senior Tablet Sig: One (1) Tablet PO once a day: \nby mouth.\n8. omega-3 fatty acids Capsule Sig: One (1) Capsule PO TID (3 \ntimes a day): by mouth.\n9. levofloxacin 750 mg Tablet Sig: One (1) Tablet PO once a day \nfor 1 days: take on ___. Disp:*1 Tablet(s)* Refills:*0*\n10. Imodium A-D 2 mg Tablet Sig: One (1) Tablet PO as needed for \nloose stool as needed for diarrhea for 10 doses. Disp:*10 \nTablet(s)* Refills:*0*\n11. Guaifenesin AC ___ mg/5 mL Liquid Sig: Five (5) mL PO \ntwice a day as needed for cough: This medication may make you \nsleepy. Do not drive while using this medication. Disp:*1 \nbottle* Refills:*0*\n12. Outpatient Lab Work INR check by ___ clinic \non ___. Outpatient Lab Work electrolytes checked on ___ by Dr. \n___\n14. lisinopril 2.5 mg Tablet Sig: One (1) Tablet PO once a day. \nDisp:*30 Tablet(s)* Refills:*0*\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS\nPneumonia\nUrinary tract infection\nSupratherapeutic INR\n\nSECONDARY DIAGNOSIS\n1. Diabetes Mellitus Type 2 - diet controlled. \n2. Paroxysmal Atrial Fibrillation\n3. Hypothyroidism  \n4. Osteoporosis \n5. Hyperlipidemia - with statin intolerance\n6. Cataracts  \n7. Diverticulosis \n8. Depression  \n9. Venous insufficiency \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the ___ for pneumonia and urinary tract \ninfection on ___. \n\nYour breathing improved quickly with the antibiotics \n(ceftriaxone/azithromycin initially, which was switched to oral \nlevofloxacin). By the time of your discharge, you were able to \nbreath well without oxygen supplement and walk around without \nany difficulty. \n\nThe burning sensation you had with urinating also resolved \nquickly upon treatment with the above antibiotics. Your blood \nculture was pending at the time of discharge. Please follow up \non this with your PCP.\n\nYou unfortunately developed diarrhea. We think this is related \nto the antibiotics given to treat pneumonia and urinary tract \ninfection. You tested negative for C. difficile. We started you \non anti-diarrheal agent prior to discharge. You can take 2mg \nafter each loose stool until you feel better. Diarrhea should \nresolve once you complete your last dose of antibiotics on ___. \nYou should continue to drink plenty of fluids to avoid becoming \ndehydrated.\n\nYou also developed some congestion involving both of your ears \nwith some minor hearing diminishement. There was no evidence of \nactive infection in your ears. We think this is related to your \nongoing pneumonia and prior upper respiratory tract infection. \nWe have scheduled an appointment with the ear nose throat \nspecialist.\n\nYou came in with elevated INR of 5.4. We held coumadin initially \nand decreased the dose to 2mg. It came down to the target range \n___ (3.1 on ___ by the time of your discharge. You should have \nINR rechecked on ___. \n\nWe found that you were anemic. This was a significant change \nfrom your last blood count measured in ___. The tests \nwe ordered were all fine (iron study, folate, B12). You did not \nhave blood in your stool. You should follow up with your PCP on \nthis issue. \n\nThe repeat ultrasound of your heart should a new mild difficulty \nwith your heart relaxation (left ventricular diastolic \ndysfunction), but you did not have any complication related to \nthis during this hospital stay. We started you on a new \nmedication called lisinopril, which is known to be beneficial in \nthis condition. You should follow up with PCP on this issue and \nhave your labs checked within 2 weeks.\n\nWe made the following changes to your medications:\n\n- ADDED levofloxacin (last day ___\n- ADDED lisinopril (given new findings on the heart ultrasound)\n- ADDED imodium for diarrhea\n- ADDED guafenesin for cough suppressant\n- DECREASED coumadin dose to 2mg\n\nYou should finish your antibiotics course by taking your last \ndose on ___.\n\nYou will be followed by the transitions of care team from Dr. \n___. They will call you tomorrow to check in to see \nhow you are doing.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904823afb505ee753927e56"
  },
  "note_id": "18128149-DS-12",
  "subject_id": 18128149,
  "hadm_id": 25193644,
  "note_type": "DS",
  "note_seq": 12,
  "charttime": "2145-12-12 00:00:00",
  "storetime": "2145-12-14 21:41:00",
  "text": " \nName:  ___                     Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\n Right lower extremity Charcot foot\n \nMajor Surgical or Invasive Procedure:\n1.  Abdominal aortogram.\n2.  Right lower extremity angiogram.\n3.  Percutaneous trans-luminal angioplasty and stenting of the\nright popliteal artery, as well as angioplasty of the proximal\nright superficial femoral artery\n4.  Percutaneous trans-luminal angioplasty of the peroneal\nartery using a 2-mm balloon.\n\n \nHistory of Present Illness:\nMs. ___ is a ___ type 1 diabetic, history of diabetic \nneuropathy, history of Charcot of the right foot.  She was \nreferred by the\n___ Foot and Ankle Department.  She\nstates that she has had increasing deformity of her right lower\nextremity.  She has baseline neuropathy and known Charcot of her\nhindfoot.  \n \nPast Medical History:\nInsulin-dependent diabetes ___ years.  Hemoglobin A1c 7.2, \nHypertension, Arthritis\n \nPhysical Exam:\nGen: NAD, AOx3 \nHEENT: PEERLA, no neck masses, no LAD \nPULM: unlabored breathing, normal chest excursion \nCV: RRR, no m/r/g \nAbd: soft, non-distended, non-tender, no masses \nExt: LLE: left groin with dressing in place C/D/I, no hematoma \nor swelling. Right foot with markedly enlarged heel\n\n \nPertinent Results:\n___ 07:50AM BLOOD WBC-4.6 RBC-4.02 Hgb-11.2 Hct-34.0 MCV-85 \nMCH-27.9 MCHC-32.9 RDW-16.3* RDWSD-50.6* Plt ___\n___ 09:11AM BLOOD WBC-10.3* RBC-3.18* Hgb-8.8* Hct-26.9* \nMCV-85 MCH-27.7 MCHC-32.7 RDW-16.2* RDWSD-49.9* Plt ___\n___ 07:50AM BLOOD Plt ___\n___ 07:50AM BLOOD Glucose-117* UreaN-14 Creat-0.7 Na-133* \nK-4.8 Cl-94* HCO3-26 AnGap-13\n___ 09:11AM BLOOD Glucose-168* UreaN-17 Creat-0.8 Na-131* \nK-5.5* Cl-89* HCO3-23 AnGap-19*\n___ 07:50AM BLOOD Calcium-8.9 Phos-4.1 Mg-1.5*\n \nBrief Hospital Course:\nMs ___ is a ___ with charcot disease of the Right foot who was \ntransferred from ___ and admitted to the ___ \n___ on ___. The patient was taken to the \nendovascular suite and underwent diagnostic and therapeutic \nangiogram. For details of the procedure, please see the \nsurgeon's operative note. The patient tolerated the procedure \nwell without complications and was brought to the \npost-anesthesia care unit in stable condition. After a brief \nstay, the patient was transferred to the vascular surgery floor \nwhere she remained through the rest of the hospitalization.\n\nPost-operatively, she did well without any groin swelling. She \nwas able to tolerate a regular diet, get out of bed and ambulate \nwithout assistance, void without issues, and pain was controlled \non oral medications alone. She was deemed ready for discharge, \nand was given the appropriate discharge and follow-up \ninstructions.\n\n \nDischarge Medications:\n1.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild  \n2.  Clopidogrel 75 mg PO DAILY \nRX *clopidogrel 75 mg 1 tablet(s) by mouth once a day Disp #*30 \nTablet Refills:*0 \n3.  Docusate Sodium 100 mg PO BID:PRN constipation \nRX *docusate sodium 100 mg 1 tablet(s) by mouth BID PRN Disp \n#*20 Tablet Refills:*0 \n4.  OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Severe \nRX *oxycodone 5 mg 1 tablet(s) by mouth Q6H PRN Disp #*20 Tablet \nRefills:*0 \n5.  Senna 8.6 mg PO BID:PRN constipation  \n6.  Gabapentin 300 mg PO TID  \n7.  Lisinopril 10 mg PO DAILY  \n8.  Omeprazole 40 mg PO DAILY  \n9.  Propranolol 20 mg PO BID  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nRight lower extremity Charcot foot\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nIt was a pleasure taking care of you at ___ \n___. You were admitted to the hospital after surgery \non your leg. This surgery was done to improve blood flow to your \nleg. You tolerated the procedure well and are now ready to be \ndischarged from the hospital. Please follow the recommendations \nbelow to ensure a speedy and uneventful recovery.\n\nVascular Leg Surgery Discharge Instructions\n\nWhat to except:\nIt is normal feel tired for ___ weeks after your surgery\nIt is normal to have leg swelling. Keep your leg elevated as \nmuch as possible. This will decrease the swelling. \nYour leg will feel tired and sore. This usually passes within a \nfew weeks.\nYour incision will be sore, slightly raised, and pink. Any \ndrainage should decrease or stop with in the first 2 weeks. \nIf you are home, you will likely receive a visit from a \nVisiting Nurse ___. Members of your health care team will \ndiscuss this with you before you go home. \n\nMedications:\nBefore you leave the hospital, you will be given a list of all \nthe medicine you should take at home. If a medication that you \nnormally take is not on the list or a medication that you do not \ntake is on the list please discuss it with the team! \n\nIt is very important that you take Aspirin every day! You \nshould never stop this medication before checking with your \nsurgeon. You also will take Plavix (clopidrogel) everyday for \nthe next ___ days\n\nPain Management:\nIt is normal to feel some discomfort/pain following surgery. \nThis pain is often described as soreness. \nYou may take Tylenol (acetaminophen ) as needed for pain. You \nwill also receive a prescription for stronger pain medicine, if \nthe Tylenol doesnt work, take prescription medicine. \nNarcotic pain medication can be very constipating, please also \ntake a stool softner such as Colace. If constipation becomes a \nproblem, your pharmacist can suggest additional over the counter \nmedications. \nYour pain medicine will work better if you take it before your \npain gets to severe. \nYour pain should get better day by day. If you find the pain is \ngetting worse instead of better, please contact your surgeon. \n\n Activity:\n Please wear appropriate shoes when bearing weight on Right leg \nwith  charcot foot \nWalking is good because it helps your muscles get stronger and \nimproves blood flow. Start with short walks. If you can, go a \nlittle further each time, letting comfort be your guide. \nTry not to go up and downstairs too much in the first weeks. \nUse stairs only once or twice a day until your incision is fully \nhealed and you are back to your usual strength.\nAvoid things that may constrict blood flow or put pressure on \nyour incision, such as tight shoes, socks or knee highs.\nDo not take a tub bath or swim until your staples are removed \nand your wound is healed. \nWhen you sit, keep your leg elevated to reduce swelling.\nIf swelling in your leg is getting worse, lie down with your \nleg up on a pillows. If your swelling continues, please call \nyour surgeon. You may be instructed to use special elastic \nbandages or stockings.\nTry not to sit in the same position for a long while. For \nexample, ___ go on a long car ride. \nYou may go outside. But avoid traveling long distances until \nyou see your surgeon at your next visit. \nYou may resume sexual activity after your incisions are well \nhealed.\n\nYour incision\n\nYour incision may be slightly red around the stitches or \nstaples. This is normal.\nIt is normal to have a small amount of clear or light red fluid \ncoming from your incision.\n\n This will decrease and stop in a few days. If it does not stop, \nor if you have a lot of fluid coming out., please call your \nsurgeon.\nYou may shower 48 hours after your surgery. Do not let the \nshower spray right on the incision, Let the soapy water run over \nthe incision, then rinse. Gently pat the area dry. Do not scrub \nthe incision, Do not apply ointment or lotions to the incision.\nYou do not need to cover the incision if there is no drainage, \nIf there is a small amount of drainage, put a small sterile \ngauze or Bandaid over the incison.\nIt is normal to feel a firm ridge along the incision, This will \ngo away as your wound heals. \nAvoid direct sun exposure to the incision area for 6 months. \nThis will help keep the scar from becoming discolored.\nOver ___ months, your incision will fade and become less \nprominent.\n\nDiet and Bowels\nIt is normal to have a decreased appetite. Your appetite will \nreturn over time. Follow a well-balanced, health healthy diet, \nwithout too much salt and fat. \nPrescription pain medicine might make you constipated. If \nneeded, you may take a stool softener (such as Colace) or gentle \nlaxative (ask your pharmacist for recommendations).\n\n Drinking more fluid may also help.\nIf you go 48 hours without a bowel movement, or having pain \nmoving your bowels, call your primary care physician.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048249fb505ee7539368dd"
  },
  "note_id": "19932739-DS-16",
  "subject_id": 19932739,
  "hadm_id": 27776048,
  "note_type": "DS",
  "note_seq": 16,
  "charttime": "2159-08-28 00:00:00",
  "storetime": "2159-08-28 16:22:00",
  "text": " \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROLOGY\n \nAllergies: \nPenicillins\n \nAttending: ___\n \nChief Complaint:\ndifficulty speaking x 3 days\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ woman with cocaine use and anxiety \nwho presents with right sided weakness and word finding \ndifficulties. She is a poor historian, and husband does not live \nwith her so does not know specifics. Unable to get ahold of \ndaughter, who does live with her. \n\nThree days ago, she felt like her right side was not working \ncorrectly. It was hard for her to make sentences, and she was \nunable to say what she wanted to say. She could not say how long \nthis lasted for, but did say it came and went over the last \nthree days. Today, she went to work at ___ when symptoms \nagain started. She went to the bathroom to see if it would pass, \nbut it would not. She was also shaking and trembling. Brought to \nED, perseverates on shaking and speech difficulties. \n\nSpoke to husband on the phone, who relayed that pt was very \nupset yesterday. Her granddaughter was reportedly choked by the \nschool security officer. She went to the school to talk to them, \nbut she became so angry that she was unable to get her words \nout. Since then, she has been shaky per granddaughter. \n\nOf note, pt is a daily cocaine user but stopped 3 days ago. \n\n \nPast Medical History:\nPMH/PSH: anxiety, psych, mitral valve regurg\n \nSocial History:\n- tobacco: yes\n- EtOH: denies\n- illicits: cocaine, usually daily, last use 3 days ago\n- MJ: denies\n\n- Modified Rankin Scale:\n [X] 0: No symptoms\n [] 1: No significant disability - able to carry out all usual \nactivities despite some symptoms\n [] 2: Slight disability: able to look after own affairs without \nassistance but unable to carry out all previous activities\n [] 3: Moderate disability: requires some help but able to walk \nunassisted\n [] 4: Moderately severe disability: unable to attend to own \nbodily needs without assistance and unable to walk unassisted\n [] 5: Severe disability: requires constant nursing care and \nattention, bedridden, incontinent\n [] 6: Dead\n \nFamily History:\nunknown\n \nPhysical Exam:\nPHYSICAL EXAMINATION\nVitals:  T: 97.8F  HR: 87  BP: 135/62  RR: 26  SaO2: 100% RA\nGeneral: very shaky, tremulous, anxious\nHEENT: NCAT,  no oropharyngeal lesions, neck supple\n___: tachycardic\nPulmonary: tachypneic\nAbdomen: Soft, NT, ND\nExtremities: Warm, no edema\n\nNeurologic Examination:\n- Mental status: Unable to relate history, having trouble \nfinding words and stuttering. Is eventually able to talk in \nhalting but complete sentences using more complicated words. \nUnable to name low frequency objects. Intact verbal \ncomprehension. Mild dysarthria in setting of shaking. No \nevidence of hemineglect. No left-right confusion. Able to follow \nboth midline and appendicular commands.\n\n- Cranial Nerves: PERRL 3->2 brisk. VF full to number counting. \nEOMI, no nystagmus. Decreased sensation to left face in V1-V3 \ndistribution. L NLFF. Hearing intact to finger rub bilaterally.  \nPalate elevation symmetric. SCM/Trapezius strength ___ \nbilaterally. Tongue midline.\n\n- Motor: Normal bulk and tone. Drift in RUE in setting of \nintense shaking. Low amplitude high frequency shaking of all \nextremities and head, RUE>LUE. Give away weakness. \n\n   [___]\n L   5     5    5    5    ___    5    5-*  5    5    5\n R   5     5    5    4+   4+  5-  5    5    5-*  5    5    5  \n  \n - Reflexes: \n    [Bic] [Tri] [___] [Quad] [Gastroc]\n  L  3+    2+     3+      3+       2\n  R  3+    2+     3+      3+       2  \n\n- Sensory: decreased sensation to light touch in RUE and RLE\n\n- Coordination: No dysmetria with finger to nose testing \nbilaterally. Good speed and intact cadence with rapid \nalternating movements.\n\n- Gait: deferred\n \nPertinent Results:\n___ 05:00AM BLOOD WBC-8.9 RBC-4.12 Hgb-11.8 Hct-36.7 MCV-89 \nMCH-28.6 MCHC-32.2 RDW-13.4 RDWSD-44.0 Plt ___\n___ 06:03PM BLOOD Neuts-53.8 ___ Monos-8.2 Eos-6.3 \nBaso-0.7 Im ___ AbsNeut-5.17 AbsLymp-2.97 AbsMono-0.79 \nAbsEos-0.61* AbsBaso-0.07\n___ 05:00AM BLOOD Glucose-88 UreaN-12 Creat-1.0 Na-140 \nK-3.6 Cl-105 HCO3-23 AnGap-16\n___ 05:00AM BLOOD ALT-11 AST-18 LD(LDH)-244 AlkPhos-93 \nTotBili-0.6\n___ 05:00AM BLOOD TotProt-6.6 Albumin-4.0 Globuln-2.6 \nCholest-191\n___ 06:03PM BLOOD %HbA1c-5.8 eAG-120\n___ 05:00AM BLOOD Triglyc-63 HDL-39 CHOL/HD-4.9 \nLDLcalc-139*\n___ 06:03PM BLOOD TSH-2.0\n___ 10:45PM URINE bnzodzp-NEG barbitr-NEG opiates-NEG \ncocaine-POS* amphetm-NEG oxycodn-NEG mthdone-NEG\n\nImaging:\nMRI Brain ___\nLate acute infarcts involving the left basal ganglia and left \ntemporal and \nparietal lobes with a punctate focus also seen in the left \nfrontal lobe are \nconsistent with embolic phenomena in the left MCA distribution.  \nNo \nhemorrhage. \n\nCT angiogram ___\n1. Acute left MCA territory infarcts with the largest focus \ninvolving the left basal ganglia as described above are better \nappreciated on the subsequent MRI. \nNo hemorrhage. \n2. Tapering and moderate short segment narrowing of the mid M1 \nsegment of the left middle cerebral artery with preserved flow \nmore distally.  The circle of ___ is otherwise unremarkable. \n3. Unremarkable neck CTA aside from mild atherosclerotic plaque \nat the right carotid bifurcation.  No internal carotid artery \nstenosis by NASCET criteria. \n4. 4 mm pulmonary nodule along the periphery of the left upper \nlobe. \n  \nRECOMMENDATION(S): \nFor incidentally detected single solid pulmonary nodule smaller \nthan 6 mm, no CT follow-up is recommended in a low-risk patient, \nand an optional CT in 12 months is recommend in a high-risk \npatient. \n\nEchocardiogram ___\nThe left atrium and right atrium are normal in cavity size. With \nmaneuvers, there is early appearance of agitated \nsaline/microbubbles in the left atrium/left ventricle most \nconsistent with a patent foramen ovale. Additionally, late \nsaline contrast is seen in left heart suggesting intrapulmonary \nshunting. Normal left ventricular wall thickness, cavity size, \nand regional/global systolic function (biplane LVEF = 57 %). The \nestimated cardiac index is normal (>=2.5L/min/m2). Doppler \nparameters are indeterminate for left ventricular diastolic \nfunction. Right ventricular chamber size and free wall motion \nare normal. The aortic valve leaflets (3) appear structurally \nnormal with good leaflet excursion and no aortic stenosis or \naortic regurgitation. No masses or vegetations are seen on the \naortic valve. The mitral valve leaflets are structurally normal. \nThere is no mitral valve prolapse. No mass or vegetation is seen \non the mitral valve. Mild (1+) mitral regurgitation is seen. The \nestimated pulmonary artery systolic pressure is normal. No \nvegetation/mass is seen on the pulmonic valve. There is no \npericardial effusion. \n\nIMPRESSION: Patent foramen ovale suggested. No echocardiographic \nevidence of endocarditis. Normal biventricular cavity sizes with \npreserved global and regional biventricular systolic function. \nMild mitral and tricuspid regurgitation.  \n\n___ Dopplers ___ negative for DVT\nMRV Pelvis ___\nLeft adnexal mass measuring 22 x 29 x 21 mm is suggestive of a \ndermoid, but is incompletely evaluated on this MRV study. \nCorrelation with pelvic ultrasound advised. \n\n \nBrief Hospital Course:\nMs. ___ was admitted to the neurology service where she was \nmonitored on telemetry and had normal sinus rhythm. Her deficits \nimproved slowly over the course of the hospitalization. She was \nstarted on aspirin immediately, and once LDL resulted at 135 she \nwas started on atorvastatin 80 mg QPM. MRI confirmed scattered \ninfarcts, the largest of which was in the left frontal lobe. \nEcho was significant for a PFO. ___ dopplers were negative. MRV \nnegative for thrombus but did show an adnexal mass which should \nbe followed up as an outpatient. Blood cultures were sent to \nevaluate for endocarditis and these had no growth at time of \ndischarge. \n\nAHA/ASA Core Measures for Ischemic Stroke and Transient Ischemic \nAttack\n1. Dysphagia screening before any PO intake? (x) Yes, confirmed \ndone - () Not confirmed  () No\n2. DVT Prophylaxis administered? (x) Yes - () No\n3. Antithrombotic therapy administered by end of hospital day 2? \n(x) Yes - () No\n4. LDL documented? (x) Yes (LDL = 135) - () No\n5. Intensive statin therapy administered? (simvastatin 80mg, \nsimvastatin 80mg/ezetemibe 10mg, atorvastatin 40mg or 80 mg, \nrosuvastatin 20mg or 40mg, for LDL > 70) (x) Yes - () No [if LDL \n>70, reason not given:\n[ ]  Statin medication allergy \n[ ]  Other reasons documented by physician/advanced practice \nnurse/physician ___ (physician/APN/PA) or pharmacist\n[ ]  LDL-c less than 70 mg/dL\n ]\n6. Smoking cessation counseling given? (x) Yes - () No [reason \n() non-smoker - () unable to participate]\n7. Stroke education (personal modifiable risk factors, how to \nactivate EMS for stroke, stroke warning signs and symptoms, \nprescribed medications, need for followup) given (verbally or \nwritten)? (x) Yes - () No\n8. Assessment for rehabilitation or rehab services considered? \n(x) Yes - () No\n9. Discharged on statin therapy? (x) Yes - () No [if LDL >70, \nreason not given:\n[ ]  Statin medication allergy \n[ ]  Other reasons documented by physician/advanced practice \nnurse/physician ___ (physician/APN/PA) or pharmacist\n[ ]  LDL-c less than 70 mg/dL\n10. Discharged on antithrombotic therapy? (x) Yes [Type: (x) \nAntiplatelet - () Anticoagulation] - () No\n11. Discharged on oral anticoagulation for patients with atrial \nfibrillation/flutter? () Yes - () No - (x) N/A\n \nMedications on Admission:\nnone\n \nDischarge Medications:\n1.  Aspirin 81 mg PO DAILY \nRX *aspirin 81 mg 1 tablet(s) by mouth daily Disp #*30 Tablet \nRefills:*0 \n2.  Atorvastatin 80 mg PO QPM \nRX *atorvastatin 80 mg 1 tablet(s) by mouth QPM Disp #*30 Tablet \nRefills:*0 \n3.Outpatient Speech/Swallowing Therapy\nEvaluate and treat. Ischemic stroke 434.11\n4.Outpatient Physical Therapy\nEvaluate and treat 434.11 ischemic strokes\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nIschemic stroke in the left MCA due to cocaine use\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\nYou were hospitalized due to symptoms of right sided weakness \nand trouble speaking resulting from an ACUTE ISCHEMIC STROKE, a \ncondition where a blood vessel providing oxygen and nutrients to \nthe brain is blocked by a clot. The brain is the part of your \nbody that controls and directs all the other parts of your body, \nso damage to the brain from being deprived of its blood supply \ncan result in a variety of symptoms.\nStroke can have many different causes, so we assessed you for \nmedical conditions that might raise your risk of having stroke. \nIn order to prevent future strokes, we plan to modify those risk \nfactors. Your risk factors are:\nhigh cholesterol\nnarrowing of the blood vessels in the brain\nPFO (patent foramen ovale- a connection between two chambers in \nthe heart)\nWe are changing your medications as follows:\nAspirin 81 mg daily\nAtorvastatin 80 mg daily\nPlease take your other medications as prescribed.\n\nPlease follow up with Neurology and your primary care physician \nas listed below. You will need to call to schedule this \nappointment once you have active insurance. \n\nIf you experience any of the symptoms below, please seek \nemergency medical attention by calling Emergency Medical \nServices (dialing 911). In particular, since stroke can recur, \nplease pay attention to the sudden onset and persistence of \nthese symptoms:\n- Sudden partial or complete loss of vision\n- Sudden loss of the ability to speak words from your mouth\n- Sudden loss of the ability to understand others speaking to \nyou\n- Sudden weakness of one side of the body\n- Sudden drooping of one side of the face\n- Sudden loss of sensation of one side of the body\n\nSincerely,\nYour ___ Neurology Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048206fb505ee7538ebbaf"
  },
  "note_id": "10718726-DS-14",
  "subject_id": 10718726,
  "hadm_id": 26625494,
  "note_type": "DS",
  "note_seq": 14,
  "charttime": "2177-10-05 00:00:00",
  "storetime": "2177-10-05 17:07:00",
  "text": " \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nSulfa (Sulfonamide Antibiotics)\n \nAttending: ___.\n \nChief Complaint:\nneck pain\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\n___ yo F hx Afib on ASA 325mg who fell from sitting today and \nsustained cervical fractures.  Per patient she was doing \ncolonoscopy prep when she became lightheaded yesterday morning, \nwent into the kitchen, sat at the table and put her head down. \nThe next thing she remembers is waking up on the floor with \nsignificant neck pain.  She got herself up off the floor and \ninto\nbed however the pain worsened and so she went to OSH ED \nwherehead CT was negative, CT Cspine showed C2 and C3 fx, CXR \nshowed 8th rib fx and she was transferred to ___ for further \neval.  She complains of significant neck pain that worsens with \nmovement and right flank pain that worsens with movement.  \nDenies numbness, weakness or tingling.\n\n \nPast Medical History:\nparoxysmal Afib (only on asa)\nHTN\ns/p sigmoidectomy for diverticulitis\n\n \nSocial History:\n___\nFamily History:\nNC\n \nPhysical Exam:\nADMISSION EXAM:\n=========================\nO: HR: 59 BP: 100/37 RR: 17 Sat: 94%\nGen: WD/WN, comfortable, NAD. In Cervical Hard collar\nHEENT: normocephalic, atraumatic\nNeck: C-Collar\nExtrem: Warm and well-perfused.\nNeuro:\nMental status: Awake and alert, cooperative with exam, normal\naffect.\nOrientation: Oriented to person, place, and date.\nMotor:\n      D    B     T    WE   WF    IP    Q  H     AT    ___    G\nR  pain w/movement; ___ in UE    5    5   5    5      5     5  \nL    5     5     5     5   5     5    5   5    5      5     5\n\nSensation: Intact to light touch.\n\nReflexes: B T Br Pa Ac\nRight     ___   2  1 \nLeft      ___   2  1\nNo ___\nNo Clonus\nToes downgoing bilaterally\n\nDISCHARGE EXAM:\n===================\nVS: T= 98.4 BP=81/40-136/56 HR= 85(65-156) RR=18 O2 sat= 92% 2L  \n\nGENERAL:comfortable in NAD. Oriented x3. Mood, affect \nappropriate.  \nHEENT: NCAT. Sclera anicteric. Conjunctiva were pink, no pallor \nor cyanosis of the oral mucosa.  \nNECK: C-collar in place, unable to assess JVP\nCARDIAC: RR, normal S1, S2. No m/r/g. No thrills, lifts. No S3 \nor S4.  \nLUNGS: Poor inspiratory effort ___ to collar/fracture. CTAB, no \ncrackles, wheezes or rhonchi.  \nABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not \nenlarged by palpation. No abdominal bruits.  \nEXTREMITIES: No c/c/e.  \nSKIN: No stasis dermatitis, ulcers, scars, or xanthomas.  \nPULSES:  \nRight: DP 2+  \nLeft: DP 2+\n \nPertinent Results:\nADMISSION LABS:\n========================\n___ 09:40AM   GLUCOSE-115* UREA N-29* CREAT-1.1 SODIUM-140 \nPOTASSIUM-3.6 CHLORIDE-99 TOTAL CO2-28 ANION GAP-17\n___ 09:40AM   CALCIUM-9.7 PHOSPHATE-4.7* MAGNESIUM-2.1\n___ 09:40AM   WBC-11.9* RBC-4.05* HGB-11.2* HCT-34.9* \nMCV-86 MCH-27.6 MCHC-32.0 RDW-14.3\n___ 09:40AM   PLT COUNT-276\n___ 09:40AM   ___ PTT-27.2 ___\n\nIMAGING:\n===================\n___ MRI C-spine\nIMPRESSION: 1. C2 and C3 acute nondisplaced fractures. No \nligamentous injury or epidural hematoma.   \n2. Superior endplate fractures of the T1 and T2 vertebral bodies \nwithout loss of height. Annular tear in the anterior T1-2 disc. \n\n___ MRI/MRA of neck IMPRESSION: \n1. No evidence of vertebral or carotid artery dissection.     \n2. Approximately 50% stenosis of the proximal left internal \ncarotid artery. \n\nMICRO: NONE\n===================\n\nDISCHARGE:\n=====================\n___ 04:45AM BLOOD WBC-9.2 RBC-3.61* Hgb-9.9* Hct-31.0* \nMCV-86 MCH-27.6 MCHC-32.1 RDW-14.2 Plt ___\n___ 04:45AM BLOOD Glucose-102* UreaN-23* Creat-0.9 Na-138 \nK-3.6 Cl-98 HCO3-32 AnGap-12\n___ 04:45AM BLOOD Calcium-8.7 Phos-3.9 Mg-2.0\n___ 04:45AM BLOOD TSH-PND\n \nBrief Hospital Course:\n___ year old female with HTN, AFib (on ASA), HLD, who was \nintially admitted for ACS service for c2/3 fracture who was \ntransferred to cardiology for further management of afib w/ rvr. \n \n\nACTIVE ISSUES:\n=====================\n# C2/C3 fracture: On ___, the patient was admitted from the \nED after a syncopal episode related likely to dehydration in the \nsetting of colonoscopy prep. She had an MRI which showed a C2 \nand C3 fracture, but without evidence of ligamentous damage. A \nhard collar was fitted which was to be worn at all times. She \nwas transferred to the floor for evaluation and treatment.\n\n# Paroxysmal A.fib with RVR: She developed AFib with RVR which \nfailed to resolve with IV metoprolol 5mg x2 doses, IV metoprolol \n10mg x1 dose, and 10mg IV diltiaziam x1 dose, therefore she was \ntransferred to the TSICU for a diltiazem gtt. On hospital day 2 \nshe converted to sinus rhythm so the dilt gtt was stopped, she \nwas restarted on her home dose of metoprolol 50mg BID, and she \nwas transferred to the floor under the neurosurgery service. On \nhospital day 3, she again went into AFib with RVR. She received \n75mg PO metoprolol, 5mg IV metoprolol x3, and 15mg IV diltiazem \nand converted to SR. She was transferred to the cardiology \nservice for further management of her AFib. While on tele, the \npatient remained in sinus rhythm in the ___ and was discharged \nto rehab on her home dose of metoprolol 50mg BID. The patient \nreported that her cardiologist and her discussed anticoagulation \nand recommended that she be on aspirin 325 as opposed to \ncoumadin. With her paroxysmal atrial fibrillation, it should be \nconsidered if she would benefit from an anti-arrhthymic. \n\nCHRONIC ISSUES:\n=====================\n# HTN: Has been well controlled this admission on her home \nmedications. No epsisodes of hypotension during afib with RVR.  \nShe was maintained on home valsartan, and HCTZ.\n \n#HLD: she was maintained home pravastatin.\n\nTRANSITIONAL ISSUES:\n===========================\n# TSH pending at the time of discharge\n# With the patient's paroxysmal a.fib, she may benefit from \nchemical cardioversion\n# Anti-coagulation: would recommend re-considering starting \ncoumadin for anti-coagulation\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 325 mg PO DAILY \n2. Pravastatin 80 mg PO DAILY \n3. Valsartan 80 mg PO DAILY \nHold for SBP<100\n \n4. Metoprolol Tartrate 50 mg PO BID \n5. Hydrochlorothiazide 25 mg PO DAILY \n\n \nDischarge Medications:\n1. Acetaminophen 325 mg PO Q6H:PRN Pain \n2. Aspirin 325 mg PO DAILY \n3. Bisacodyl 10 mg PO/PR DAILY:PRN constipation \n4. Docusate Sodium 100 mg PO BID \n5. Heparin 5000 UNIT SC TID \n6. Hydrochlorothiazide 25 mg PO DAILY \n7. Metoprolol Tartrate 50 mg PO BID \n8. OxycoDONE (Immediate Release)  2.5-5 mg PO Q4H:PRN pain \nRX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours \nDisp #*30 Tablet Refills:*0\n9. Pravastatin 80 mg PO HS \n10. Senna 1 TAB PO BID:PRN constipation \n11. Sodium Chloride 0.9%  Flush 3 mL IV Q8H:PRN line flush \n12. Valsartan 80 mg PO DAILY \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary: C2 and C3 non-displaced fractures, T1 and T2 superior \nendplate fractures, paroxysmal atrial fibrillation \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nGait is steady, but has impaired activity tolerance.\n\n \nDischarge Instructions:\nDear ___,\n\n___ was a pleasure taking care of you here at ___ \n___! You came to the hospital after you \nfell while preparing for your colonoscopy. Our imaging studies \nshowed that you had a fracture of your neck, more specifically \nthe vertebrae labeled, C2-C3 and upper back, the vertebrae \nlabeled T1-T2. \n\nWhile you were in the hospital, you intermittently had a fast \nirregular heart rate called atrial fibrillation. While you were \nhaving the a.fib, you did not have any symptoms of chest pain or \npalpitations. We did not change your medications for fear that \nyour heart rate would be too slow. From talking with you, you \nseemed to have talked with your cardiologists about coumadin to \nthin your blood because atrial fibrillation puts you at \nincreased risk for stroke. We continued you on aspirin 325.\n\nThe following are recommendations from the neurosurgeons who saw \nyou while in the hospital.\nDo not smoke.\nNo pulling up, lifting more than 10 lbs., or excessive bending \nor twisting.\nLimit your use of stairs to ___ times per day.\nYou are required to wear your cervical collar at all times.\nYou may shower briefly without the collar or back brace; \nunless you have been instructed otherwise.\nTake your pain medication as instructed; you may find it best \nif taken in the morning when you wake-up for morning stiffness, \nand before bed for sleeping discomfort.\nDo not take any anti-inflammatory medications such as Motrin, \nAdvil, Aspirin, and Ibuprofen etc. unless directed by your \ndoctor.\nIncrease your intake of fluids and fiber, as pain medicine \n(narcotics) can cause constipation. We recommend taking an over \nthe counter stool softener, such as Docusate (Colace) while \ntaking narcotic pain medication.\nClearance to drive and return to work will be addressed at \nyour post-operative office visit.\n\nCALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE \nFOLLOWING:\n\nPain that is continually increasing or not relieved by pain \nmedicine.\nAny weakness, numbness, tingling in your extremities.\nFever greater than or equal to 10.5 F. \nAny change in your bowel or bladder habits (such as loss of \nbowl or urine control). \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904823cfb505ee75392981b"
  },
  "note_id": "18320665-DS-22",
  "subject_id": 18320665,
  "hadm_id": 24506053,
  "note_type": "DS",
  "note_seq": 22,
  "charttime": "2126-01-11 00:00:00",
  "storetime": "2126-01-11 15:36:00",
  "text": " \nName:  ___               Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nShellfish Derived\n \nAttending: ___\n \nChief Complaint:\nAbnormal labs,acute renal failure\n\n \nMajor Surgical or Invasive Procedure:\nUS guided renal biopsy \n\n \nHistory of Present Illness:\n___ yo female with history of HTN, chronic HBV, osteoporosis\nreferred from primary care doctor for work up of acute renal\nfailure.\n\nShe was referred due rising creatnine, proteinuria, anemia on\nlabs; she feels well. Her labs were at baseline in ___ with\ncr of 0.8 and Hg 12.9; routine labs in ___ showed cr of 1.2,\nand Hg 10.6. At this point, she was told to hydrate and return\nfor repeat testing in 1 month, at which point cr rose to 1.8,\nspot prtn:cr 3, albumin:cr ___.8.  \n\nIn the ED, initial VS were: 97.0 74 144/65 17 98% RA \nExam notable for: unremarkable\nECG: none\nLabs showed: BUN/Cr ___, BMP lytes otherwise wnl, H/H\n10.___.2\nImaging showed: none\nConsults: renal, will see in am\nPatient received: nothing\nTransfer VS were: 98.1 65 144/62 16 98% RA \n\nOn arrival to the floor, patient reports she feels well. She \neats\nregularly and has good hydration. She is generally adherent to\nher antihypertensive, misses 1/week (skipped am ___\n\nDenies shortness of breath, lower extremity edema. No recent \nsore\nthroat or upper respiratory symptoms, hemoptysis, recent rashes\nor skin changes, joint swelling or pain. No melena, \nhematochezia,\nhematuria, last ___ ___ with one polyp. She is urinating well,\ndenies hematuria, frothy urine, back pain, history of kidney\nstones.  \n\nShe does occasionally use motrin, about twice per month. She\nnever has used this heavily. No PPI use. She has chronic\nhepatitis B, never on medication, thought to be vertically\ntransmitted at birth. Her hypertension is longstanding but\nwell-controlled per patient.\n\n \nPast Medical History:\nchronic hepatitis B (she believes vertically transmitted)\nhypertension\nosteoporosis\nasthma\n\n \nSocial History:\n___\nFamily History:\nWent into foster care at an early age, does not know parent's\nhealth. Has five daughters who are healthy and wihtout kidney\nproblems or rheumatologic issues.\n\n \nPhysical Exam:\nADMISSION EXAM:\n================\nVS: 98.4 PO 151 / 70 L Sitting 64 18 99 Room Air \nGENERAL: NAD, pleasant\nHEENT: AT/NC, anicteric sclera, MMM\nCV: RRR, soft systolic ejection murmur best appreciated at ___,\nno gallops, or rubs\nPULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably\nwithout use of accessory muscles\nGI: abdomen soft, nondistended, nontender in all quadrants, no\nrebound/guarding, no hepatosplenomegaly\nEXTREMITIES: no cyanosis, clubbing, or edema\nNEURO: Alert, moving all 4 extremities with purpose, face\nsymmetric, no tremors\nDERM: warm and well perfused, no lesions, no rashes\n\nDISCHARGE EXAM:\n=================\nVS: 98.4 PO 151 / 70 L Sitting 64 18 99 Room Air \nGENERAL: NAD, pleasant\nHEENT: AT/NC, anicteric sclera, MMM\nCV: RRR, soft systolic ejection murmur best appreciated at ___,\nno gallops, or rubs\nPULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably\nwithout use of accessory muscles\nGI: abdomen soft, nondistended, nontender in all quadrants, no\nrebound/guarding, no hepatosplenomegaly\nEXTREMITIES: no cyanosis, clubbing, or edema\nNEURO: Alert, moving all 4 extremities with purpose, face\nsymmetric, no tremors\nDERM: warm and well perfused, no lesions, no rashes\n\n \nPertinent Results:\n___ 07:20AM BLOOD WBC-4.8 RBC-3.61* Hgb-10.9* Hct-33.6* \nMCV-93 MCH-30.2 MCHC-32.4 RDW-15.4 RDWSD-53.0* Plt ___\n___ 07:20AM BLOOD Glucose-91 UreaN-19 Creat-1.4* Na-147 \nK-4.7 Cl-111* HCO3-21* AnGap-15\n___ 08:45PM BLOOD ALT-17 AST-24 AlkPhos-45 TotBili-0.2\n___ 08:00AM BLOOD Calcium-9.2 Phos-4.1 Mg-2.4 Iron-68 \nCholest-239*\n___ 08:00AM BLOOD calTIBC-289 Ferritn-167* TRF-222\n___ 08:00AM BLOOD Triglyc-131 HDL-76 CHOL/HD-3.1 \nLDLcalc-137*\n___ 08:00AM BLOOD FreeKap-37.8* ___ Fr K/L-2.1*\n___ 08:45PM BLOOD C3-119 C4-33\n___ 05:28PM BLOOD HIV Ab-NEG\n___ 05:28PM BLOOD HCV Ab-NEG\n \nBrief Hospital Course:\n___ F with hx of HTN, Chronic HBV, osteoporosis presenting for\nworkup of acute renal failure with proteinuria and albuminuria. \n\n#acute renal failure\n#proteinuria \n#chronic HBV, HBeAB+\nPt with acute rise in Cr. from 0.8 to 1.8 in the past 6 months\nwith a 1.2 to 1.8 rise in the past 4 weeks. Urinalysis\nsignificant for trace blood on UA and elevated Prot/Cr 3.0 and\n___ ___.8. Creatinine 1.3 this morning. Other than her \nrise\nin creatinine she has no other electrolyte disturbances and is\neuvolemic on exam. Because of her proteinuria, nephrotic causes\nof kidney injury are most likely including membranous\nnephropathy, which can be a sequela of Hep B, minimal change\ndisease or FSGS. Other etiologies include nephritic causes which\ninclude RPGN but less likely since pt's creatinine is not \nacutely\nincreasing and has actually improved over the past 24 hours.\nAcute poststreptococcal glomerulonephritis is also less likely\ngiven pt denies any recent infection.  Less likely are \niatrogenic\ncauses given she does not take nephrotoxic medication. Other\npossibilities include a neoplastic process. \n\nher workup was notable for a negative HIV, HCV, UPEP, normal \nC3/C4.  She underwent a renal biopsy on ___, results to be \nfollowed up by nephrology.  Her ___, anti-DSDNA, ANCA, Anti-GBM, \nAnti-streptolysin O, kappa/lambda and SPEP were PENDING on \ndischarge. \n\n#chronic congenital HBV, HBeAB+\nViral load is 2.8, elevated since ___. Normal LFTs. She last \nsaw\nher Hepatologist in ___ who does not think she needed acute\ntreatment. \n\n#normocytic anemia\nReticulocytes appropriately elevated with borderline high RDW.\nNormal iron, TIBC, transferrin. Elevated ferritin likely\nreflective of anemia of chronic disease.  \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Alendronate Sodium 70 mg PO 1X/WEEK (___) \n2. Montelukast 10 mg PO DAILY \n3. amLODIPine 10 mg PO DAILY \n4. ProAir RespiClick (albuterol sulfate) 90 mcg/actuation \ninhalation Q6H:PRN \n5. Fluticasone Propionate 110mcg 2 PUFF IH BID \n\n \nDischarge Medications:\n1. Alendronate Sodium 70 mg PO 1X/WEEK (___) \n2. Montelukast 10 mg PO DAILY \n3. amLODIPine 10 mg PO DAILY \n4. ProAir RespiClick (albuterol sulfate) 90 mcg/actuation \ninhalation Q6H:PRN \n5. Fluticasone Propionate 110mcg 2 PUFF IH BID \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAcute renal failure\nanemia of chronic disease \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\n======================  \nDISCHARGE INSTRUCTIONS  \n======================  \nDear ___ was a privilege caring for you at ___.  \n\nWHY WAS I IN THE HOSPITAL?  \n- Lab tests that measure how well your kidney works were \nabnormal and your doctors were concerned that something was \ndamaging your kidneys.\n- The number of red blood cells in your blood is lower than \nnormal.\n\nWHAT HAPPENED TO ME IN THE HOSPITAL?  \n- In the hospital, multiple laboratory tests were done to figure \nout what could be damaging your kidneys. \n- Tests were also done to find out why your red blood cell count \nwas low.  \n- A sample of your kidney tissue was obtained so that doctors \n___ at it under a microscope.  \n\nWHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?  \n- Continue to take all your medicines and keep your \nappointments.  \n\nWe wish you the best!  \n\nSincerely,  \nYour ___ Team  \n ========================  \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb410"
  },
  "note_id": "12628495-DS-15",
  "subject_id": 12628495,
  "hadm_id": 28169530,
  "note_type": "DS",
  "note_seq": 15,
  "charttime": "2159-06-12 00:00:00",
  "storetime": "2159-06-12 11:31:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: SURGERY\n \nAllergies: \nPatient recorded as having No Known Allergies to Drugs\n \nAttending: ___.\n \nChief Complaint:\nPatient admitted for weight reduction surgery.\n \nMajor Surgical or Invasive Procedure:\nStatus Post Laparoscopic Gastric Band\n\n \nHistory of Present Illness:\nThe patient is a ___ gentleman who\nundergoes evaluation by ___ bariatric\nprogram, deemed good candidate for surgical weight loss. He\ndemonstrated a good understanding of the risks, benefits and\nalternatives to weight loss surgery. \n \nPast Medical History:\n:hypertension, dyslipidemia with  \nelevated triglycerides, GERD and sleep apnea on CPAP (setting \nnot  \nknown).  \n \nSocial History:\n___\nFamily History:\nFamily history is noted for father living age ___ with heart\ndisease, diabetes and obesity; mother deceased age ___ of cancer.\nHe owns a ___ and is married living with wife age ___\nand they have 3 grown children one son a ___ at ___.\n\n \nPhysical Exam:\nHis blood pressure was high at 142/98, pulse 97 and O2 \nsaturation\n97% on room air.  On physical examination ___ was casually\ndressed in no distress.  His skin was warm, dry with no rashes \nor\nlesions. Sclerae were anicteric, conjunctiva clear, pupils were\nequal round and reactive to light, fundi were normal, mucous\nmembranes were slightly dry secondary to fasting, tongue was \npink\nand the oropharynx was without exudate or hyperemia.  Trachea \nwas\nin the midline and the neck was supple with no adenopathy,\nthyromegaly or carotid bruits.  Chest was symmetric and the \nlungs\nwere clear to auscultation bilaterally with good air movement. \nCardiac exam was regular rate and rhythm, normal S1 and S2, no\nmurmurs, rubs or gallops.  The abdomen was obese but soft and\nnon-tender, non-distended with normal bowel sounds and no\nappreciable masses, no hernias and no incision scars.  There was\nno spinal tenderness or flank pain.  Lower extremities were\nwithout edema, venous stasis or clubbing.  There was no evidence\nof swelling of the joints or joint inflammation.  There were no\nfocal neurological deficits and gait was normal.\n\n \nPertinent Results:\n___ 07:05AM BLOOD Glucose-102 UreaN-12 Creat-0.7 Na-141 \nK-4.1 Cl-106 HCO3-26 AnGap-13\n___ 10:30AM BLOOD Glucose-104 UreaN-11 Creat-0.8 Na-141 \nK-3.9 Cl-107 HCO3-25 AnGap-13\n___ 10:30AM BLOOD Calcium-9.4 Phos-4.1 Mg-2.0\n___ 07:05AM BLOOD Mg-2.1\n \nBrief Hospital Course:\nPatient admitted for and underwent a laparoscopic gastric band. \nHe tolerated the procedure very well. Unfortunately he was \nunable to advance his diet secondary to nausea and vomiting. On \n___ he went back to the operating room and underwent  \nRevision of band balloon and Band adjustment. ON ___ upper \ngi study was done and confirmed no leak or obstruction. He was \nrapidly progressed to a stage 3 diet without problems.\n\nWe will discharge him to home today on a stage 3 diet. Diet, \nmedication and discharge instructions were reviewed and \ndiscussed. He will follow up with Dr. ___ in 2 weeks.\n \nMedications on Admission:\nAtenolol 50 mg daily for hypertension;  \nSimvastatin 20 mg daily, Tricor 145 mg daily and Omega-3 Fatty  \nAcids (fish oil) 1200 mg-144 mg daily for hyperlipidemia; \nvitamin  \nB12 500 mcg daily, vitamin D 1000 units daily and multivitamins  \n\nwith minerals daily for nutritional supplementation  \n\n \nDischarge Medications:\n1. Roxicet ___ mg/5 mL Solution Sig: ___ ml PO every four (4) \nhours as needed for pain.\nDisp:*500 ml* Refills:*0*\n2. Colace 50 mg/5 mL Liquid Sig: Ten (10) ml PO twice a day.\nDisp:*500 ml* Refills:*0*\n3. Atenolol 50 mg Tablet Sig: One (1) Tablet PO once a day.  \n4. Simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day.  \n5. Tricor 145 mg Tablet Sig: One (1) Tablet PO once a day.  \n6. medication\nPlease resume your multivitamins. Please crush all your meds.\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary Diagnosis: Obesity\n\n \nDischarge Condition:\nStable\n\n \nDischarge Instructions:\nDischarge Instructions: Please call your surgeon or return to \nthe emergency department if you develop a fever greater than \n101.5, chest pain, shortness of breath, severe abdominal pain, \npain unrelieved by your pain medication, severe nausea or \nvomiting, severe abdominal bloating, inability to eat or drink, \nfoul smelling or colorful drainage from your incisions, redness \nor swelling around your incisions, or any other symptoms which \nare concerning to you.\n\nDiet: Stay on Stage III diet until your follow up appointment. \nDo not self advance\ndiet, do not drink out of a straw or chew gum.\n\nMedication Instructions:\nResume your home medications, CRUSH ALL PILLS.\nYou will be starting some new medications:\n1.  You are being discharged on medications to treat the pain \nfrom your operation. These medications will make you drowsy and \nimpair your ability to drive a motor vehicle or operate \nmachinery safely. You MUST refrain from such activities while \ntaking these medications.\n2. You should begin taking a chewable complete multivitamin with \nminerals. No gummy vitamins.\n3. You should take a stool softener, Colace, twice daily for \nconstipation as needed, or until you resume a normal bowel \npattern.\n4. You must not use NSAIDS (non-steroidal anti-inflammatory \ndrugs) Examples are Ibuprofen, Motrin, Aleve, Nuprin and \nNaproxen. These agents will cause bleeding and ulcers in your \ndigestive system.\n\nActivity:\nNo heavy lifting of items ___ pounds for 6 weeks. You may \nresume moderate\nexercise at your discretion, no abdominal exercises.\n\nWound Care:\nYou may shower, no tub baths or swimming. \nIf there is clear drainage from your incisions, cover with \nclean, dry gauze. \nYour steri-strips will fall off on their own. Please remove any \nremaining strips ___ days after surgery.\nPlease call the doctor if you have increased pain, swelling, \nredness, or drainage from the incision sites. \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048234fb505ee7539212dc"
  },
  "note_id": "17308561-DS-11",
  "subject_id": 17308561,
  "hadm_id": 21870658,
  "note_type": "DS",
  "note_seq": 11,
  "charttime": "2120-01-06 00:00:00",
  "storetime": "2120-01-06 21:57:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nnaproxen\n \nAttending: ___.\n \nChief Complaint:\nAbdominal Pain\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nBriefly, Ms. ___ is a ___ F with PMH COPD (intermittent \nhome O2) on prednisone for exacerbation, ?OSA, tobacco abuse, \n\"micro strokes,\" hypothyroidism, HTN, HLD, who transferred from \nOSH for management of acute renal failure and pelvic hematoma \nafter being treated for DVT (despite lack of evidence for DVT) \nwith coumadin.  She presented to OSH on ___ with acute onset of \nabdominal pain.  She was found to have WBC was 15.5, INR 2.3, Cr \n1.0 (baseline unknown), HCT 33 (unclear baseline).  CT showed \nlarge rectus sheath hematoma tracking along the pelvic sidewall \nmeasuring 14x8x7cm and compressing the left ureter, also showed \npericardial effusion.  Echo showed LVEF 55-60%, small \ncircumferential effusion.  Renal ultrasound showed left \nhydronephrosis.  Her HCT trended down from 33.2 to 24.5 and WBC \nincreased from 15.5 to 26.2 prior to transfer. She was treated \nwith 4UFFP and 2U PRBCs, HCT increased to 29.6 and INR 1.0 on \ntransfer.  In addition, she developed low grade temperatures \n99.5 (Tmax 100.1) and she was started on vancomycin and zosyn \nout of concern for infection.  \n\nOn arrival to ___, VS were 100.4 104/60 86 18 92-98% 1L NC\npatient was notably altered. She reports worsening abdominal \npain. She also reports the urge to urinate despite having a \ncatheter in place. \n\nThis morning, she reports that she was able to get some sleep, \nher abdomen is still tender, but pain is ___ compared to ___ \nwhen she was initially admitted to OSH.\n\nUpon further review of OSH records, patient was found to have \napical ballooning of LV with apical akinesis c/w Takotsubo CM \nwith EF 35-40%.  Repeat echo showed apical hypokinesis with \nEF50%.  The patient was subsequently started on AC enlight of \nthese findings.\n\nROS: per HPI, denies fever, chills, night sweats, headache, \nvision changes, rhinorrhea, congestion, sore throat, cough, \nshortness of breath, chest pain, abdominal pain, nausea, \nvomiting, diarrhea, constipation, BRBPR, melena, hematochezia, \ndysuria, hematuria.  \n \n\n \nPast Medical History:\n- COPD, on 5L NC at home. Continued smoker. Respiratory failure \n@ ___ on CPAP.  \n- Smoker  \n- MVA in ___ s/p back surgery with rod placement  \n- PID, s/p ex lap many years ago  \n- Cholelithiasis  \n- Hypothyroidism  \n- Hypertension  \n- Hyperlipidemia  \n\n \nSocial History:\n___\nFamily History:\nNC\n \nPhysical Exam:\nADMISSION EXAM:\nGENERAL - Well-appearing * yo M/F who appears comfortable, \nappropriate and in NAD  \nHEENT - NC/AT, PERRL, EOMI, sclerae anicteric, MMM, OP clear  \nNECK - supple, no thyromegaly, no JVD, no carotid bruits  \nLUNGS - Lungs are clear to ausculatation bilaterally, moving air \nwell and symmetrically, resp unlabored, no accessory muscle use  \n\nHEART - PMI non-displaced, RRR, S1-S2 clear and of good quality \nwithout murmurs, rubs or gallops  \nABDOMEN - NABS, soft/NT/ND, no masses or HSM, no \nrebound/guarding  \nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs) \n \nNEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength \n___ throughout, sensation grossly intact throughout, DTRs 2+ and \nsymmetric  \n\nDISCHARGE EXAM:\nVS:98.3 136/72 71 18 96%2L\nGENERAL - Well-developed female, sitting up in bed, NAD\nHEENT - NC/AT, PERRL, EOMI, sclerae anicteric, dry, OP clear  \nNECK - supple, no thyromegaly, no JVD, no carotid bruits  \nLUNGS: coarse breath sounds with faint wheezing\nHEART - RRR, normal S1S2 II/VI systolic murmur at apex\nABDOMEN - soft, degree of distention unchanged, minimally TTP \nover lower quadrants, +BS\nEXTREMITIES - WWP, no c/c/e, b/l ___ pulses dopplerable (radials, \nDPs), 2+ ___ non-pitting, edema worse over feet, extending to \nknee, L>R \nNEURO - awake, A&Ox3, CN II-XII grossly intact, sensation and \nstrength grossly intact in b/l UE and ___.  Gait normal.\n\n \nPertinent Results:\nADMISSION LABS:\n___ 09:31PM   WBC-21.7* RBC-2.64* HGB-8.4* HCT-24.4* MCV-93 \nMCH-31.8 MCHC-34.3 RDW-14.4\n___ 09:31PM   NEUTS-89.1* LYMPHS-5.7* MONOS-4.8 EOS-0.1 \nBASOS-0.3\n___ 09:31PM   PLT COUNT-209\n___ 09:31PM   GLUCOSE-107* UREA N-25* CREAT-1.4* SODIUM-139 \nPOTASSIUM-4.4 CHLORIDE-104 TOTAL CO2-26 ANION GAP-13\n___ 09:31PM   CALCIUM-8.2* PHOSPHATE-2.7 MAGNESIUM-2.2\n\nCXR ___:\nIMPRESSION:    \nBoth lower lobes are severely atelectatic, possibly collapse.  \nSmall bilateral pleural effusions may be present.  Upper lungs \nclear.  Heart size mildly enlarged. \n  \nAlthough this is marked as an upright radiograph, there is no \nfluid level in the stomach to confirm that.  There is a \nsuggestion of subdiaphragmatic free air outlining both sides of \nan upper abdominal loop in the midline.  Truly upright or left \ndecubitus view of the upper abdomen is recommended.  Dr. ___ \nwas paged and Dr ___ discussed the findings by telephone \nat the time of dictation. \n  \n___. ___ \n\n___ U/S ___:\nIMPRESSION:  No DVT of the left lower extremity.\n___. ___ \n___. ___ \n\n___ ___:\nThe left atrium is mildly dilated. No atrial septal defect is \nseen by 2D or color Doppler. The estimated right atrial pressure \nis at least 15 mmHg. Left ventricular wall thickness, cavity \nsize and regional/global systolic function are normal (LVEF \n>55%). No masses or thrombi are seen in the left ventricle. \nThere is no ventricular septal defect. Right ventricular chamber \nsize and free wall motion are normal. The diameters of aorta at \nthe sinus, ascending and arch levels are normal. The aortic \nvalve leaflets (3) are mildly thickened but aortic stenosis is \nnot present. Trace aortic regurgitation is seen. The mitral \nvalve leaflets are mildly thickened. There is no mitral valve \nprolapse. Mild (1+) mitral regurgitation is seen. The tricuspid \nvalve leaflets are mildly thickened. There is moderate pulmonary \nartery systolic hypertension. There is a small pericardial \neffusion. There are no echocardiographic signs of tamponade.   \n___, MD\n\nDISCHARGE LABS:\n\n___ 10:18AM BLOOD WBC-11.2* RBC-3.55* Hgb-11.3* Hct-34.4* \nMCV-97 MCH-31.7 MCHC-32.7 RDW-14.8 Plt ___\n___ 10:18AM BLOOD Plt ___\n___ 10:18AM BLOOD Glucose-129* UreaN-12 Creat-0.7 Na-140 \nK-4.8 Cl-104 HCO3-28 AnGap-13\n___ 06:50AM BLOOD Calcium-8.2* Phos-3.1 Mg-2.___SSESSMENT/PLAN:\n___ with extensive PMH including COPD on home O2, tobacco abuse, \n?OSA presenting from OSH with rectal sheath hematoma and ARF.\n\n# Abdominal Pain: Initially thought to be ___ pelvic hematoma. \nExam initially concerning for acute abdomen possibly from \nhematoma/hemoperitoneum.  Lactate was normal. STAT CXR without \nfree air under diaphragm, but was not an upright film.  \nAbdominal pain still there but improved.  HCT stable at 31.9. \nRepeat CT abdomen showed slightly larger hematoma but no active \nextravasation and organizing components suggesting that her body \nis beginning to heal.  ACS is ok with her progress as long as \nHCT remains stable and has signed off. She was initially treated \nwith IV pain meds then switched to PO.  She should continue to \nhave serial abdominal exams at rehab and physician should be \nnotified if any acute changes in abdominal distention.\n\n# Anemia: HCT was stable ___ hours but decreased to 21.6.  She \nmay have continued bleeding from intraabdominal source. Patient \nmay have slow ooze from known hematoma.  She received 2UPRBC and \nHCT is slowly increasing, and was 34.2 on discharge.  \nReticulocyte count was 3.7 indicating appropriate BM response to \nanemia.  HCT should be monitored weekly while in rehab.\n\n# Hematuria: unclear etiology. Urology thought could be ___ to \npelvic hematoma and would presume that would resolve with \nresolution of clot.  However, may also be ___ to traumatic foley \ninsertion, but foley has been out for >48hr and hematuria \ncontinues.  Repeat u/a showed less RBCs which is promising.  CT \nabdomen showed mass effect on bladder, but her kidney function \ncontinues to be stable.  Urine cytology was negative for \nmalignancy.  She should f/u with urology upon discharge for \ncontinued monitoring.\n\n#LLE edema: Concerning for DVT, but ___ was negative.  \nPatient reports that this she has had ___ edema L>R for years, \nwill multiple u/s in the past that was negative.  Currently \nlikely ___ to venous or lymphatic congestion from left sided \npelvic hematoma. Repeat ___ ultrasound was negative for DVT.\n\n#Takotsubo: Upon further review of OSH records, patient was \nfound to have apical ballooning of LV with apical akinesis c/w \nTakotsubo CM with EF 35-40%.  Repeat echo showed apical \nhypokinesis with EF50%.  The patient was subsequently started on \nAC enlight of these findings.  Repeat Echo was normal and given \ncomplications of AC, continued AC was not started.\n\n# ARF: ___ be multifactorial and ___ to hypovolemia versus \nbleeding from elevated INR. Last Cr at OSH 1.8. Normal baseline, \nCr normalized today at 0.7. No need for intervention per Urology \nrecs.  Urine cytology was negative for malignancy.\n\n# Fever, Leukocytosis: Unclear etiology. Infectious v. \ninflammatory. Hematoma could explain both however given \nconcerning exam, would cover broadly for intra-abdominal source. \nWill discontinue abx for now and monitor clinically.  WBC could \nbe ___ steroids, patient has been afebrile today.  If she \nbecomes febrile will need ___ vs. surgical drainage of hematoma \nfor culture. She remained afebrile with initially elevated WBC \nwhich could be attributed to systemic corticosteroids for COPD \nexacerbation.  She continued to be afebrile during her \nhospitalization and was not treated with Abx.\n\n# COPD: recent flare, on steroids for taper.  SOB may be \ncomplicated by increased abdominal pressure.  CXR was \nessentially unchanged from prior.  She was treated with long \nprednisone taper, Albuterol and ipratroprium meds and albuterol \nprn as well.\n\n# Altered Mental Status: Patient with several reasons for \ndelirium including ?infection v. intra-abdominal source. Other \nprcoesses including primary CNS, med effect, toxic metabolic.  \nCT head yesterday showed chronic changes, but no concerns for \nacute changes.  Acute change possibly ___ to acute delirium ___ \nmultiple different hospitals over the last 3 weeks.  She should \nhave OT evaluation at rehab and f/u with Cognitive Neurology. \n\n# Hypertension: hold medications given current clinical status.  \nPatient with lower bp this morning that over last 48hours \nconcerning for developing SIRS.  However, is likely ___ \nhypovolemia in setting of known rectal sheath hematoma.  She may \nhave had continued bleeding after getting 2U at OSH and her own \nBM has yet to compensate for acute blood loss. Encouragingly she \nis not tachycardic, has been afebrile, WBC is normal, and is not \ntachypneic.  She responded appropriately to IVF and BP remained \nstable while hospitalized.  BP meds were NOT restarted while \nhospitalized.  These should be restarted when appropriate as an \noutpatient.\n\n# Hypothyroidism: continue home medications\n\nTRANSITIONAL ISSUES:\n- Patient needs f/u with urology for Hematuria\n- Patient should have OT eval at rehab and Cognitive Neurology \nfollow-up.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Guaifenesin ER 600 mg PO Q12H \n2. Aspirin 81 mg PO DAILY \n3. BusPIRone 50 mg PO BID \n4. Diltiazem Extended-Release 180 mg PO DAILY \nhold for sbp < 100 and hr < 60 \n5. Fluoxetine 20 mg PO DAILY \n6. Gabapentin 800 mg PO TID \n7. Levothyroxine Sodium 50 mcg PO DAILY \n8. Lisinopril 5 mg PO DAILY \nhold for sbp < 100 \n9. Nicotine Patch 21 mg TD DAILY \n10. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n11. Albuterol-Ipratropium ___ PUFF IH Q4H:PRN sob \n12. PredniSONE 40 mg PO DAILY \nTapered dose - DOWN \n13. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain \n14. Acetaminophen 650 mg PO Q6H:PRN pain \n15. Zolpidem Tartrate 5 mg PO HS:PRN pain \n16. Lorazepam 0.5 mg PO Q4H:PRN anxiety \n17. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n18. Tiotropium Bromide 1 CAP IH DAILY \n19. Pravastatin 20 mg PO DAILY \n\n \nDischarge Medications:\n1. Acetaminophen 650 mg PO Q6H:PRN pain \n2. BusPIRone 50 mg PO BID \n3. Fluoxetine 20 mg PO DAILY \n4. Fluticasone-Salmeterol Diskus (250/50)  1 INH IH BID \n5. Gabapentin 800 mg PO TID \n6. Levothyroxine Sodium 50 mcg PO DAILY \n7. Nicotine Patch 21 mg TD DAILY \n8. Pravastatin 20 mg PO DAILY \n9. PredniSONE 10 mg PO DAILY \n1 pill on ___, then ___ pill for three days then stop. \nTapered dose - DOWN \n10. Albuterol 0.083% Neb Soln 1 NEB IH Q6H dyspnea, shortness of \nbreath \n11. Albuterol 0.083% Neb Soln 1 NEB IH Q2H:PRN sob, wheezing \n12. Famotidine 20 mg PO BID \n13. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN pain \nRX *hydromorphone [Dilaudid] 2 mg ___ tablet(s) by mouth Every \n___ Disp #*60 Tablet Refills:*0\n14. Ipratropium Bromide Neb 1 NEB IH Q6H shortness of breath, \ndyspnea \n15. Nicotine Lozenge 2 mg PO Q2H:PRN urge to smoke \n16. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n17. Lorazepam 0.5 mg PO Q4H:PRN anxiety \n18. Tiotropium Bromide 1 CAP IH DAILY \n19. Zolpidem Tartrate 5 mg PO HS:PRN pain \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nRectal Sheath Hematoma (bleeding into abdomen)\nHematuria (Blood in your urine)\n\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMs. ___, you were admitted to ___ \n___ after being transferred from an outside hospital with \ncomplaints of worsening abdominal pain.  You were found to have \nblood in your abdomen that was compressing your kidneys.  This \nis likely a complication of being on blood thinners for your \nheart condition.  Your blood counts were low and you recieved \ntransfusion of blood while in the hospital and your blood counts \nhave continued to be stable.  An ultrasound of your heart showed \nthat your heart is functioning much better and you no longer \nneed to be on blood thinners. \n\nWe also took a picture of your head and you were not having any \nbleeding in the brain making us pretty sure that you did not \nhave a stroke.  However, you will have follow-up with Cognitive \nNeurology to assess the cause and extent of your memory \nimpairment.\n\nWhile in the hospital you had blood in your urine.  This was \nevaluated by the kidney doctors and repeat tests of your urine \nshowed improved kidney function and less blood in the urine.  \nHowever, you should be followed-up as an outpatient by a Kidney \nspecialist.\n\nYou worked with Physical Therapy while in the hospital and your \nCOPD treatment was continued.  You oxygen levels were low while \nyou walked and it was recommended that you be discharged to a \nRehabilitation Hospital where you can continue to get physical \ntherapy while your lungs recover.\n\nPlease see below for your follow-up appointments.\n\nIt was a pleasure caring for you and we wish you a speedy \nrecovery.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048234fb505ee7539212dd"
  },
  "note_id": "17308561-DS-12",
  "subject_id": 17308561,
  "hadm_id": 25884126,
  "note_type": "DS",
  "note_seq": 12,
  "charttime": "2120-02-02 00:00:00",
  "storetime": "2120-02-03 20:28:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nnaproxen\n \nAttending: ___.\n \nChief Complaint:\nPE  \n\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ with COPD on home O2, HTN, recent takotsubo cardiomyopathy \non anticoag, and recent COPD flare transferred from OSH for \nmanagement of newly dx'd PE, COPD exacerbation and concern for \npost-obstructive pna. Pt was recently hospitalized at ___ \n___ for COPD exacerbation and found to have takotsubo CM on \nTTE and started on lovenox and warfarin. She was readmitted to \n___ with spontaneous rectus sheath and pelvic hematoma on \nsystemic anticoagulation and discharged to rehab on ___. She's \nhad multiple episodes of COPD exacerbations requiring BIPAP for \nhypoxemia. Of note, during her ___ hospitalization, he \nhad L>R ___ evidence of DVT. Also has gross hematuria with \nnegative cytology.  \nShe was admitted to ___ ___ with ___ findings \nconcernign for celluitis and started on vancomycin then switched \nto acnef. PICC line placed. Blood cultures NGTD. LENIS negative. \nCT scan of abd showed persistence of pelvic and rectus sheath \nhematoma with lateralizaiton of her bladder ___ hematoma and \npossible ureteral obstruction. Foley cath was discontinued at \npt's request. Levofloxacin started empirically for presumed pna. \nOn ___ pt developed severe hypoeia 70% O2 on NC and was on 100% \nFiO2 NRB to maintain sats>90%. No evidence of wheezing on exam. \nShe was started on IV solumedrol for presumed COPD exacerbation. \nCT chest was positive for b/l PE and partial R lower lobe \ncolpase w retained secretionsn and LLL consoliddation with air \nbronchograms. Empiric abx for pulmonary source started with \nvancomycin and zosyn.  \nRegarding procoagulability, vascular surgery consult \nrecommending pelvic venography via CT/MRI for work up of \npossible pelvic vs high iliac source for clot ___ \nsyndrome). RUE picc u/s and b/l ___ negative for clot.  \nOn arrival to the floor, pt feels well. She has abd pain ___ \nhematoma but it is improving slowly. Her respiratory status is \nat baseline and she is comfortable at 4L NC. Denies cough, \nsputum production, chest pain, SOB, BRBPR, dysuria. Has had \nhematuria intermittently since hospitalization for hematoma and \nrecurrent since foley dc'd 4 days ago.  \n \nREVIEW OF SYSTEMS:  \n(+)  \n(-) fever, chills, night sweats, headache, vision changes, \nrhinorrhea, congestion, sore throat, cough, shortness of breath, \nchest pain, nausea, vomiting, diarrhea, constipation, BRBPR, \nmelena, hematochezia, dysuria.  \n\n \nPast Medical History:\n- COPD, on 5L NC at home. Continued smoker. Respiratory failure \n@ ___ on CPAP.  \n- Smoker  \n- MVA in ___ s/p back surgery with rod placement  \n- PID, s/p ex lap many years ago  \n- Cholelithiasis  \n- Hypothyroidism  \n- Hypertension  \n- Hyperlipidemia  \n\n \nSocial History:\n___\nFamily History:\nmother - colon cancer, age ___\n \nPhysical Exam:\nADMITTING EXAM\nVS - 98.7 135/74 76 18 79/RA 92/4LNC  \nGENERAL - chronically ill appearing woman in NAD, comfortable, \nappropriate  \nHEENT - NC/AT, PERRL, EOMI, sclerae anicteric, MMM, OP clear  \nNECK - supple, no thyromegaly, no JVD, no carotid bruits  \nLUNGS - occasional end expiratory wheeze, no rales/rhonchi, no \nresp distress  \nHEART - PMI non-displaced, RRR, no MRG, nl S1-S2  \nABDOMEN - NABS, soft, large lower abd hematoma tender to \npalpation, firm  \nEXTREMITIES - warm, distal pulses intact, 3+ pitting edema to \nknees, L greater than R  \nNEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength \n___ throughout, sensation grossly intact throughout  \n\nDISCHARGE EXAM\nT 98.0 Tm 99.3  111/59  72  18  97% 2L\nGEN awake, alert, oriented woman in NAD  \nHEENT NCAT MMM EOMI sclera anicteric, OP clear  \nNECK supple, no JVD, no LAD  \nPULM good air entry, scattered wheezes bilaterally\nCV RRR normal S1/S2, systolic murmur heard at apex \nABD tenderness to palpation across lower abdominal quadrant b/l, \nmildly distended, soft in lower right and left quadrants, no \nrebound or guarding, normoactive bowel sounds, no palpable \nmasses, no evidence of hepatosplenomegaly. No ecchymoses on \nlower left and right quadrants,with no skin breakdown or \nulceration. Midline incision scar.  \nEXT LLE has erythema from ankle to knee encircling calf with \noverlying fine skin blisters, warm, slightly tender, there is \nbilateral pitting edema L greater than R. Right and left side \nimproved from yesterday. Active peeling on lower extremities. \nNEURO no focal neurological deficits, motor function grossly \nnormal.  \nSKIN LLE skin changes as noted above\n \n\n \nPertinent Results:\nADMISSION LABS\n\n___ 11:20PM   GLUCOSE-86 UREA N-15 CREAT-0.7 SODIUM-142 \nPOTASSIUM-4.1 CHLORIDE-99 TOTAL CO2-32 ANION GAP-15\n___ 11:20PM   ALT(SGPT)-10 AST(SGOT)-19 ALK PHOS-69 TOT \nBILI-0.3\n___ 11:20PM   ALBUMIN-3.6 CALCIUM-9.0 PHOSPHATE-3.3 \nMAGNESIUM-2.1\n___ 11:20PM   WBC-11.3* RBC-3.57* HGB-11.1* HCT-34.4* \nMCV-97 MCH-31.2 MCHC-32.3 RDW-14.3\n___ 11:20PM   PLT COUNT-371\n\nDISCHARGE LABS\n\n___ 07:00AM BLOOD WBC-7.0 RBC-3.27* Hgb-10.5* Hct-32.2* \nMCV-98 MCH-32.0 MCHC-32.5 RDW-14.7 Plt ___\n___ 07:00AM BLOOD Glucose-100 UreaN-10 Creat-0.7 Na-141 \nK-4.1 Cl-103 HCO3-32 AnGap-10\n___ 07:00AM BLOOD ___ PTT-76.9* ___\n\nPERTINENT RESULTS\n___ 06:24AM BLOOD ___ PTT-136.7* ___\n___ 05:12AM BLOOD ___ PTT-67.2* ___\n___ 05:20AM BLOOD ___ PTT-58.7* ___\n___ 12:21AM BLOOD ___ PTT-83.8* ___\n___ 05:50AM BLOOD ___ PTT-83.0* ___\n\nMICRO\nnone\n\nIMAGING\n\n CHEST (PA & LAT) Study Date of ___ 12:11 AM \n \nFinal Report \nREASON FOR EXAMINATION:  Evaluation of the patient with COPD and \nacute \nhypoxemia and newly diagnosed pulmonary embolism. \n  \nPA and lateral upright chest radiographs were reviewed in \ncomparison to \n___. \n  \nRight PICC line tip is at the level of the mid SVC.  Heart size \nand \nmediastinum are unremarkable.  Bilateral pleural effusions and \nbibasilar areas of atelectasis changed, moderate.  No \npneumothorax is seen.  Mild vascular engorgement is present, but \nno overt pulmonary edema is present.  Right ascending aortic \ndilatation is suspected and should be further potentially \ncorrelated with chest CT to exclude the possibility of ascending \naortic aneurysm versus other pathology. \n \nBrief Hospital Course:\n___ year old female with hx. COPD, HTN, recent anticoagulation \nfor takotsobu's cardiomyopathy complicated by spontaneous rectus \nsheath and retroperitoneal hematoma, presenting from OSH after \nsuffering bilateral PEs in the setting of treatment for LLE \ncellulitis and postobstructive pneumonia.\n\n# Pulmonary Emboli:  Patient acutely decompensated on ___ ___ngio consistent with bilateral PEs.  Source was unclear as \nbilateral LENIs were negative.  Likely represented provoked PE \nin the setting of infection and prolonged hospitalization.  \nPatient was started on a heparin drip with target PTT 60-80.  \nOnce she was therapeutic, coumadin was started.  The heparin \ndrip was discontinued after 24h overlap of being therapeutic on \ncoumadin.  Patient is being discharged on a coumadin schedule of \n2 mg ___ and 4 mg ___.  She will have her \nINR followed by her PCP, ___ draw on ___.\n\n# Pneumonia:  Patient transferred from OSH with CT thorax with \nfindings concerning for postobstructive pneumonia.  She was \nstarted on IV Vanc/zosyn empirically on ___.  IV Vanc and \nZosyn were continued in house for a total of 8 days of therapy.  \nShe remained afebrile, without a white count, and her \nrespiratory status remained stable and she was breathing \ncomfortably on 2 liters NC on day of discharge.  She will \ncontinue to need vancomycin 750 mg Q12H through her PICC for \ncellulitis.\n\n# Rectus sheath and pelvic hematoma: Spontaneously occured \nduring systemic anticoagulation for takotsubo (which has since \nresolved on repeat ECHO).  ACS consulted on prior admission in \n___ and recommended trending hematocrit, has been stable on \nall recent imaging.  Her coagulation parameters were closely \nmonitored and hematocrits remain stable this admission.  Patient \nwas given the warning signs to look out for during the next ___ \nmonths as she is on anticoagulation including sudden worsening \nabdominal pain and new bruising or bleeding, in which case she \nshould call her physician.\n\n# Cellulitis: Prior LENIs negative for DVT.  Likely staph.  Was \ninitially on IV Vanc then switched to Ancef.  Placed back on IV \nvanc on ___ and this was continued this hospitalization.  \nPatient's redness and swelling was much improved.  She will need \nto complete a 14 day course of vancomycin (last day ___ \nthrough her ___ line.  \n\n# COPD:  Patient's breathing was at or near baseline during \nadmission.  At times she felt somewhat short of breath and \nrequested standing nebulizer treatments.  She remains satting \nwell on 2L NC and in no distress at the time of this writing.  \nHer home medications in addition to nebulizers are being \ncontinued.\n\n# Hematuria: patient has had hematuria since prior \nhospitalization thought provoked by traumatic foley in the \nsetting of anticoagulation.  Prior cytology negative.  Urology \nwas consulted and recommended outpatient f/u unless starts \npassing clots.  Her urine remained dark brown throughout \nhospitalization without any evidence of clots.  She continued to \nbe incontient despite detrol.  She has an appointment scheduled \nwith urology for further management of this problem.\nCHRONIC ISSUES\n# HTN: continued home metoprolol  \n# HL: continued home statin  \n# Dilated CBD: Incidentally found on CT imaging for her PE.  \nFurther workup including possible nonemergent MRCP and ERCP as \nper outpatient physicians once acute cardiopulmonary issues \nresolve.  \n\nTRANSITIONAL ISSUES\nPatient is being discharged to rehab to complete her course of \nIV Vanc through her PICC line.  She will need close INR \nmonitoring with next blood draw on ___, with results faxed \nto her PCP.  She will likely need a ___ month course of coumadin \nas this appears to be a provoked PE.  She needs further \nmanagement re: chronic health issues including COPD regimen, \nneed for home oxygen, as well as dilated CBD as above.  \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN sob \n2. Atorvastatin 10 mg PO DAILY \n3. Ascorbic Acid ___ mg PO BID \n4. BusPIRone 15 mg PO BID \n5. Clotrimazole Cream 1 Appl TP BID \n6. Docusate Sodium 100 mg PO BID \n7. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n8. Ferrous Sulfate 325 mg PO DAILY \n9. Furosemide 20 mg IV BID \n10. Fluoxetine 20 mg PO DAILY \n11. Gabapentin 600 mg PO TID \n12. Heparin IV per Weight-Based Dosing Guidelines\n\n13. Levothyroxine Sodium 75 mcg PO DAILY \n14. Metoprolol Tartrate 12.5 mg PO BID \n15. MethylPREDNISolone Sodium Succ 40 mg IV Q 12H \n16. OxycoDONE-Acetaminophen Elixir 5 mL PO Q4H:PRN pain \n17. Potassium Chloride 20 mEq PO DAILY Duration: 24 Hours \nHold for K > \n18. Pantoprazole 40 mg PO Q12H \n19. Piperacillin-Tazobactam 3.375 g IV Q6H \n20. Senna 2 TAB PO HS \n21. Tolterodine 2 mg PO BID \n22. Vancomycin 1000 mg IV Q 12H \n\n \nDischarge Medications:\n1. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN sob \n2. Ascorbic Acid ___ mg PO BID \n3. Atorvastatin 10 mg PO DAILY \n4. BusPIRone 15 mg PO BID \n5. Clotrimazole Cream 1 Appl TP BID \n6. Ferrous Sulfate 325 mg PO DAILY \n7. Fluoxetine 20 mg PO DAILY \n8. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n9. Levothyroxine Sodium 75 mcg PO DAILY \n10. Metoprolol Tartrate 12.5 mg PO BID \n11. Pantoprazole 40 mg PO Q12H \n12. Tolterodine 2 mg PO BID \n13. Vancomycin 750 mg IV Q 12H \n14. Furosemide 40 mg PO DAILY \n15. Ipratropium Bromide Neb 1 NEB IH Q6H \n16. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain \n17. Warfarin 2 mg PO 2X/WEEK (___) \nplease give on ___ and ___ \n18. Warfarin 4 mg PO 5X/WEEK (___) \n19. Nicotine Patch 21 mg TD DAILY \n20. Docusate Sodium 100 mg PO BID \n21. Aluminum-Magnesium Hydrox.-Simethicone ___ mL PO QID:PRN \nepigastric discomfort \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary: Pulmonary emboli\n         Cellulitis\n         HCAP\n\nSecondary: Retroperitoneal hematoma\n           Hematuria\n           COPD\n           \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear ___,\n\n___ was a pleasure to take care of you at ___.  You were \nadmitted because you developed clots in your lungs while being \ntreated for a cellulitis and pneumonia.  You were giving blood \nthinning medications (heparin and then coumadin) as well as \nantibiotics.  You tolerated the therapy well and are being \ndischarged on coumadin.  You will need to complete a course of \nantibiotics through your ___ line.\n\nPlease make the following changes to your medications:\n\nPlease START coumadin 2 mg on ___ and ___ and 4 mg on \n___, and ___.  \n\nPlease START Vancomycin 750 mg twice a day through your PICC \nline.  You will need to take this through ___.\n\nYou will need to have blood work done to check your INR (for \ncoumadin monitoring) on ___.  The results will be faxed to \nyour primary care physician who will help you with any dose \nadjustments that need to be made.  Please keep the follow-up \nappointments below.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048234fb505ee7539212de"
  },
  "note_id": "17308561-DS-13",
  "subject_id": 17308561,
  "hadm_id": 23033552,
  "note_type": "DS",
  "note_seq": 13,
  "charttime": "2126-04-22 00:00:00",
  "storetime": "2126-04-22 18:25:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nnaproxen / Lovenox\n \nAttending: ___.\n \nChief Complaint:\nCC: ___ post ERCP\n \nMajor Surgical or Invasive Procedure:\nERCP\n\n \nHistory of Present Illness:\nHPI(4): \nMs. ___ is a ___ female with hx of COPD/asthma (on \n3L\nhome O2), HTN, HLD, hypothyroidism, depression/anxiety, \nTakotsubo\ncardiomyopathy ___, resolved), recent mechanical fall \nresulting\nin L 10th rib fracture and L3 process fracture found to have CBD\ndilation with choledocholithiasis on imaging presenting for \nERCP,\nnow s/p sphincterotomy/sphincteroplasty and sludge extraction \nand\nadmitted for monitoring.\n\nMs. ___ reports intermittent ___ and periumbilical abdominal\npain with associated N/V over the past 3 months without \njaundice.\nLast episodes of emesis was 2d ago, non-bloody and non-bilious.\nReports intentional weight loss over this period while dieting.\nDenies F/C, diarrhea/constipation, melena/hematochezia.\n\nShe was reaching over to pick up her dog on ___ when she fell \nand\nstruck her L-chest. She was taken to ___ where imaging\nshowed acute L lateral 10th rib fracture and L L3 transverse\nprocess fracture as well as CBD dilation. LFTs were not checked.\nShe left AMA from the ED to take care of her dog. She\nsubsequently underwent ___ U/S on ___ at ___ that\ndemonstrated CBD dilation to 1.3 cm with a 4mm stone in the\ndistal CBD and cholelithiasis without acute cholecystitis. \n\nShe presented ___ for ERCP, which showed a 1.4 cm CBD with\nfilling defects c/w sludge. A biliary sphincterotomy was\nperformed followed by a sphincteroplasty (from 8->9mm given\ninability to safely make sufficiently long sphincterotomy) with\nsludge removal. \n\nOn arrival to the floor, Ms. ___ reports ___ epigastric\nabdominal pain radiating to the back with associated nausea but\nno emesis. Reports that her SOB/DOE are at baseline in the\nsetting of severe COPD. She denies F/C, CP, cough,\ndiarrhea/constipation, melena/hematochezia, dysuria/hematuria,\nheadaches, new rashes. \n \nROS: Pertinent positives and negatives as noted in the HPI.  All\nother systems were reviewed and are negative. \n \nPast Medical History:\n- COPD, on 5L NC at home. Continued smoker. Respiratory failure \n@ ___ on CPAP.  \n- Smoker  \n- MVA in ___ s/p back surgery with rod placement  \n- PID, s/p ex lap many years ago  \n- Cholelithiasis  \n- Hypothyroidism  \n- Hypertension  \n- Hyperlipidemia  \n\n \nSocial History:\n___\nFamily History:\nmother - colon cancer, age ___\n \nPhysical Exam:\nAdmission exam:\n\n24 HR Data (last updated ___ @ ___)\nTemp: 98.3 (Tm 98.3), BP: 122/68, HR: 79, RR: 16, O2 sat: 95%, \nO2\ndelivery: 3L NC, Wt: 136 lb/61.69 kg  \nGENERAL: NAD, sitting comfortably in bed\nEYES: PERRL, anicteric sclerae\nENT: OP clear\nCV: RRR, nl S1, S2, no M/R/G, no JVD\nRESP: CTAB, no crackles, wheezes, or rhonchi\nGI: + BS, soft, ND, mild epigastric TTP without R/G\nGU: No suprapubic fullness or tenderness to palpation\nSKIN: No rashes or ulcerations noted\nMSK: Lower extremities warm without edema\nNEURO: AOx3, CN II-XII intact, ___ strength in all extremities,\nsensation grossly intact throughout, gait testing deferred\nPSYCH: pleasant, appropriate affect\n\nDischarge exam:\n___ 1602 Temp: 97.9 PO BP: 133/78 Sitting HR: 92 RR: 18 O2 \nsat: 91% O2 delivery: RA \n\nGENERAL: NAD, sitting comfortably in bed\nEYES: PERRL, anicteric sclerae\nENT: OP clear\nCV: RRR, nl S1, S2, no M/R/G, no JVD\nRESP: CTAB, no crackles, wheezes, or rhonchi\nGI: + BS, soft, ND, mild tenderness to palpation in b/l upper \nquadrants, no R/G\nGU: No suprapubic fullness or tenderness to palpation\nSKIN: No rashes or ulcerations noted\nMSK: Lower extremities warm without edema\nNEURO: AOx3, CN II-XII intact, ___ strength in all extremities,\nsensation grossly intact throughout, gait testing deferred\nPSYCH: pleasant, appropriate affect\n\n \nPertinent Results:\nAdmission labs:\n\nWBC 13.4, Hgb 12.7, Plt 239\nINR 1.1\nBMP WNL (w/exception of gluc 68)\nLFTs WNL\nLipase 33\nCa/Mg/Phos WNL\n\nBCx (___): pending x 2\n\nERCP/EUS (___):\nEUS: CBD dilated to 1.2 cm with rounded hyperechoic heterogenous\nmaterial 4-5mm in size with no shadowing, c/w stone\nmaterial/sludge. \nERCP: CDB 14mm. L/R hepatic ducts and intrahepatic branches\nmildly dilated. GB not well visualized. Filling defects c/w\nsludge seen. Biliary sphincterotomy performed. Sphincteroplasty\nwith CRE balloon from 8mm to 9mm done given difficult angle and\nfolds making longer sphincterotomy unsafe. Biliary tree swept\nwith sludge removal. Final cholangiogram with no filling defects\nin CBD.\n\n___:\n------------\n___ U/S (___):\n1. The distal common bile duct is dilated measuring 1.3 cm. A 4\nmm stone is noted in the distal common duct. MRCP might be of\nfurther consideration.\n2. Cholelithiasis with no evidence of acute cholecystitis.\n\nCT chest w/cont (___):\nLeft 10th rib fracture. No other acute findings.\n\nCT A/P w/cont (___):\n1. Acute left lateral 10th rib fracture and left L3 transverse\nprocess fracture.\n2. Common bile duct dilatation. MRCP with and without contrast \nis\nrecommended for further evaluation as an outpatient.\n\nTTE (___):\nThe left atrium is mildly dilated. No atrial septal defect is\nseen by 2D or color Doppler. The estimated right atrial pressure\nis at least 15 mmHg. Left ventricular wall thickness, cavity \nsize\nand regional/global systolic function are normal (LVEF >55%). No\nmasses or thrombi are seen in the left ventricle. There is no\nventricular septal defect. Right ventricular chamber size and\nfree wall motion are normal. The diameters of aorta at the \nsinus,\nascending and arch levels are normal. The aortic valve leaflets\n(3) are mildly thickened but aortic stenosis is not present.\nTrace aortic regurgitation is seen. The mitral valve leaflets \nare\nmildly thickened. There is no mitral valve prolapse. Mild (1+)\nmitral regurgitation is seen. The tricuspid valve leaflets are\nmildly thickened. There is moderate pulmonary artery systolic\nhypertension. There is a small pericardial effusion. There are \nno\nechocardiographic signs of tamponade.   \n\nDischarge plans:\n\n___ 07:11AM BLOOD WBC-12.8* RBC-3.97 Hgb-12.0 Hct-37.7 \nMCV-95 MCH-30.2 MCHC-31.8* RDW-13.1 RDWSD-45.8 Plt ___\n___ 07:11AM BLOOD Glucose-117* UreaN-10 Creat-0.7 Na-145 \nK-4.4 Cl-106 HCO3-28 AnGap-11\n___ 07:11AM BLOOD ALT-29 AST-35 AlkPhos-93 TotBili-0.5\n___ 07:11AM BLOOD Calcium-8.5 Phos-3.8 Mg-1.5*\n \nBrief Hospital Course:\nMs. ___ is a ___ female with hx of COPD/asthma (on \n3L\nhome O2), HTN, HLD, hypothyroidism, depression/anxiety, \nTakotsubo\ncardiomyopathy ___, resolved), recent mechanical fall \nresulting\nin L 10th rib fracture and L3 process fracture found to have CBD\ndilation with choledocholithiasis on imaging presenting for \nERCP,\nnow s/p sphincterotomy/sphincteroplasty and sludge extraction,\nadmitted for monitoring.\n\n# Abdominal pain:\n# Nausea:\n# Leukocytosis:\n# Cholelithiasis/choledocholithiasis:\nDescribes 3 months of intermittent abdominal pain with N/V,\nlikely secondary to symptomatic cholelithiasis and\ncholedocholithiasis. ERCP performed ___ showed CBD dilation \nwith\nsludge, suggestive of prior stones, although nl LFTs suggest\nstone may have passed. Sphincterotomy and sphincteroplasty\nperformed. Patient complaining of moderate abdominal pain/nausea\npost-procedurally, but benign exam makes perforation unlikely \nand\nnl lipase 2x exonerates post-ERCP pancreatitis. Mild \nleukocytosis is\nlikely stress response to procedure and it improved modestly on \nHOD2 but not yet resolved; low suspicion for cholangitis or \ncholecystitis in absence of fevers. Blood cultures obtained \nwhich showed no growth to date (though not final) prior to \ndischarge.\nPain was adequately controlled with dilaudid IV followed by \ntramadol and APAP prn for pain which pt has at home as well. \nAbdominal exam improved prior to discharge with minimal ongoing \ntenderness to palpation but ok'd by ERCP for discharge home.\n\n# COPD:\nStable on home 3L NC. Continued home Spiriva, Advair in place of \nhome symbicort (NF), held home Trelegy (NF) and was given \nduonebs q6h PRN\n\n# HTN:\nNormotensive. Home BP meds ___ with plans to \nrestart on the day following discharge. \n\n# HLD:Home atorvastatin\n\n# Hypothyroidism: Home levothyroxine\n\n# Depression/anxiety: Medications reviewed with patients PCP; \nplan to continue home home bupropion 50mg daily, buspirone 15mg \nTID, venlafaxine 75mg ER TID (odd dosing, but confirmed with \npatient and fill history).\n\nTransitional issues:\n[ ] ___ with local general surgery providers for gallbladder \nremoval\n[ ] Repeat CBC in 1 week to ensure resolution of mild \nleukocytosis\n\n> 30 minutes were spent in discharge planning and coordination \nof care on the day of discharge. \n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Venlafaxine XR 75 mg PO TID \n2. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation \ninhalation BID \n3. BuPROPion 100 mg PO DAILY \n4. Spironolactone 25 mg PO BID \n5. BusPIRone 15 mg PO TID \n6. Diltiazem Extended-Release 240 mg PO DAILY \n7. Levothyroxine Sodium 100 mcg PO DAILY \n8. Losartan Potassium 100 mg PO DAILY \n9. Tiotropium Bromide 1 CAP IH DAILY \n10. Trelegy Ellipta (fluticasone-umeclidin-vilanter) 100-62.5-25 \nmcg inhalation daily \n11. Atorvastatin 40 mg PO QPM \n12. TraMADol 50 mg PO Q6H:PRN Pain - Moderate \n\n \nDischarge Medications:\n1.  Ondansetron 4 mg PO Q8H:PRN Nausea/Vomiting - First Line \nRX *ondansetron 4 mg 1 tablet(s) by mouth Every 8 hours Disp #*6 \nTablet Refills:*0 \n2.  Atorvastatin 40 mg PO QPM  \n3.  BuPROPion 100 mg PO DAILY  \n4.  BusPIRone 15 mg PO TID  \n5.  Diltiazem Extended-Release 240 mg PO DAILY  \n6.  Levothyroxine Sodium 100 mcg PO DAILY  \n7.  Losartan Potassium 100 mg PO DAILY  \n8.  Spironolactone 25 mg PO BID  \n9.  Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation \ninhalation BID  \n10.  Tiotropium Bromide 1 CAP IH DAILY  \n11.  TraMADol 50 mg PO Q6H:PRN Pain - Moderate  \n12.  Trelegy Ellipta (fluticasone-umeclidin-vilanter) \n100-62.5-25 mcg inhalation daily  \n13.  Venlafaxine XR 75 mg PO TID  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nCholelithiasis\nCholedocholithiasis s/p ERCP\nGalllstones\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou came to the hospital for further evaluation of gallstones in \nthe liver drainage system. You underwent a specialized procedure \n(ERCP) to open the drainage system and you improved.\n\nYou developed some abdominal pain after the procedure which \nresolved with pain medication and time. \n\nIt is very important that you follow up with your local doctors \nin ___ to arrange for gallbladder removal in the near \nfuture. You can resume your normal medications tomorrow morning \nas you have been.\n\nIf you develop fevers, chills, chest pain, worsening abdominal \npain, nausea, vomiting please call your doctor or return to the \nemergency department. \n\nIt was a pleasure taking care of you! \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048220fb505ee753911a1b"
  },
  "note_id": "15385484-DS-20",
  "subject_id": 15385484,
  "hadm_id": 24999004,
  "note_type": "DS",
  "note_seq": 20,
  "charttime": "2188-05-16 00:00:00",
  "storetime": "2188-05-17 17:25:00",
  "text": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nChest pain radiating to the arms consistent with unstable angina\n \nMajor Surgical or Invasive Procedure:\nCardiac catheterization\n\n \nHistory of Present Illness:\n___ with a h/o HTN who presented to the ED as a transfer from ___ \n___ with chest pain.\n\nThe patient initially presented to urgent care on ___ with one \nepisode of right arm and shoulder pain which self resolved last \nnight. She then developed substernal chest pain and Rt arm/jaw \npain around 1500 this afternoon while reading the paper. Denies \ndiaphoresis, dyspnea, n/v. \n\nShe was then sent to OSH, where she was found to have elevated \ntroponin to 0.03. EKG showed T-wave inversions in V1-V4. Patient \nreceived a full ASA, nitro, and a heparin gtt at OSH, and was \ntransferred to ___ for admission to cardiology for a possible \ncath. The patient denies any f/c, n/v/d, ___ edema. No history \nof acute coronary syndrome.\n \nIn the ED, initial VS were: T97.2 HR 66 BP 140/77 RR 14 SpO2 97% \nRA \n\nExam notable for: \n- N/A \n \nLabs showed: \n- CBC: Plt 147 otherwise WNL\n- Chem10: Grossly WNL\n- Coags: INR 1.4 \n\nImaging showed: \n \nPatient received: \n___ 21:24 IV Heparin  \n \nConsults:\n- Atrius cards rec admission for cath  \n\nOn arrival to the floor, patient endorses history above. Denies \ncurrent CP, dyspnea, diaphoresis, n/v. \n \nREVIEW OF SYSTEMS:  \n10 point ROS reviewed and negative except as per HPI  \n \nPast Medical History:\nHTN\n \nSocial History:\n___\nFamily History:\nNone known\n \nPhysical Exam:\nGENERAL: NAD  \nHEENT: AT/NC, EOMI, sclera anicteric, conjunctiva clear, MMM  \nNECK: supple, no JVD  \nHEART: RRR, S1/S2, II/VI holosystolic murmur prominent at RUSB,\nno radiation to carotids. No R/G \nLUNGS: respirations unlabored, CTAB, no wheezes, rales, rhonchi\nABDOMEN: nondistended, nontender, no rebound no guarding, no HSM \n\nEXTREMITIES: no edema   \nNEURO: AOx3, moving all 4 extremities with purpose  \n \nPertinent Results:\n___ 06:50AM BLOOD Triglyc-97 HDL-90 CHOL/HD-1.9 LDLcalc-62\n___ 06:50AM BLOOD Glucose-75 UreaN-10 Creat-0.7 Na-139 \nK-3.9 Cl-100 HCO3-25 AnGap-14\n___ 06:50AM BLOOD WBC-4.8 RBC-3.89* Hgb-12.4 Hct-36.3 \nMCV-93 MCH-31.9 MCHC-34.2 RDW-12.9 RDWSD-43.9 Plt ___\n \nBrief Hospital Course:\n# Unstable angina\nPatient with history of hypertension and hyperlipidemia \npresenting with resting chest, arm, and jaw pain, found to have \nt-wave inversions on EKG consistent with unstable angina. \nManaged medically until catheterization on day of admission, \nwhich revealed 80-90% left anterior descending artery stenosis, \n90% left circumflex stenosis, and 90% right coronary artery \nstenosis. Drug-eluting stent was placed in the left anterior \ndescending without complications. Procedure was well tolerated \nand symptoms improved. Patient was discharged on aspirin, \nstatin, Plavix, metoprolol. Will have cardiology ___ \n___. \n\n# Hypertension\nDiscontinued atenolol, hydrochlorothiazide. Started on \nmetoprolol at discharge.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Simvastatin 20 mg PO QPM \n2. atenolol-chlorthalidone 50-25 mg oral DAILY \n3. Potassium Chloride 20 mEq PO DAILY \n4. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg \ncalcium- 200 unit oral DAILY \n5. Multivitamins 1 TAB PO DAILY \n\n \nDischarge Medications:\n1.  Aspirin 81 mg PO DAILY  \n2.  Atorvastatin 40 mg PO QPM  \n3.  Clopidogrel 75 mg PO DAILY to prevent stent thrombosis  \n4.  Metoprolol Succinate XL 50 mg PO DAILY  \n5.  Calcium 600 + D(3) (calcium carbonate-vitamin D3) 600 mg \ncalcium- 200 unit oral DAILY  \n6.  Multivitamins 1 TAB PO DAILY  \n7. HELD- Potassium Chloride 20 mEq PO DAILY  This medication was \nheld. Do not restart Potassium Chloride until you see your \nprimary care doctor.\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY:\n- unstable angina / non ST elevation myocardial infarction \n(NSTEMI)\n- coronary artery disease\n\nSECONDARY:\n- hypertension\n- hyperlipidemia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure taking care of you at the ___ \n___!\n\nWHY WAS I IN THE HOSPITAL?\n==========================\n- You experienced pain in your right shoulder/jaw and lower \nchest concerning for a problem with your heart\n\nWHAT HAPPENED IN THE HOSPITAL?\n==============================\n- We performed a study to look at the vessels that carry blood \nto your heart muscle\n\nWHAT SHOULD I DO WHEN I GO HOME?\n================================\n-It is very important to take your aspirin and clopidogrel (also \nknown as Plavix) every day.  \n-These two medications keep the stents in the vessels of the \nheart open and help reduce your risk of having a future heart \nattack.  \n-If you stop these medications or miss ___ dose, you risk causing \na blood clot forming in your heart stents, and you may die from \na massive heart attack.  \n-Please do not stop taking either medication without taking to \nyour heart doctor. \n-___ review your ___ appointments.\n\nThank you for allowing us to be involved in your care, we wish \nyou all the best!  \n\n Your ___ Healthcare Team  \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048220fb505ee753911a1c"
  },
  "note_id": "15385484-DS-21",
  "subject_id": 15385484,
  "hadm_id": 29499915,
  "note_type": "DS",
  "note_seq": 21,
  "charttime": "2189-06-21 00:00:00",
  "storetime": "2189-06-21 14:45:00",
  "text": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \nChief Complaint:\ndifficulty forming words, hand tingling\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ yo woman with cardiac history  on DAPT who\npresents with left hand numbness/tingling and difficulty forming\nwords, found to have small R convexal SAH.\n\nYesterday was watching TV and she saw people walking by on her\nleft, though this was inside her house and there was just a wall\nthere. The people would walk by very quickly. She clarifies that\nit was the same person walking by: a woman who was not tall with\ngrey hair. There was no associated noise/auditory phenomena. \nThis\nlasted <1 minute, and ended when she turned her body more to the\nright so she could no longer see the wall. She was then directly\nfacing the TV in the room. She has never hallucinated before. \n\nToday Ms. ___ woke up at 0730 and was feeling well. She first\nnoticed something was wrong the first time she spoke, which was\nspeaking with daughter in law. Ms. ___ had trouble getting\nwords out, clarified to mean not word-finding, but difficulty\nmaking her mouth form the words. She thinks her speech is now\npretty much back to normal, though possibly still a bit\ndifficulty to get words out. \n\nShe also notes left hand numbness, which she thinks started this\nmorning, though she thinks it could have started late last \nnight.\nShe noticed it when she tried to pick up a piece of paper but \nhad\ndifficulty. There are associated paresthesiae in the hand. \n\nShe endorses R frontal pressure-like headache, at times radiates\nacross forehead. This is a chronic headache followed by \nNeurology\nDr. ___. No change in headache over the past several days. \nShe\nthinks it may have gotten intense in severity yesterday ___, \nwhich\nalso happens occasionally.  \n\n \nPast Medical History:\nBasal cell carcinoma of neck \nSquamous cell carcinoma \nHyperlipidemia \nEssential hypertension \nActinic keratosis \nOsteoarthritis \nOsteopenia \nCAD s/p stenting ___ (Cardiologist Dr. ___\nmoderately increase LA volume index on TTE ___\nunstable angina pectoris \nNeck pain \nModerate aortic stenosis with valve area 0.9 cm2.\nModerate pulm art systolic hypertension\ns/p cataract surgery OS, pt unsure if done OD\n \nSocial History:\n___\nFamily History:\nFather d. of stomach cancer\nMother d. of CHF\nMaternal uncle d. of stomach cancer. \nMGM with stroke, details unknown \n \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM\n=======================\nVitals:  T: 98 HR: ___ BP: 107-156/63-108 RR: ___ SaO2: 98%\nRA\nGeneral: Awake, cooperative, NAD.\nHEENT: no scleral icterus, MMM, no oropharyngeal lesions. \nPulmonary: Breathing comfortably, no tachypnea nor increased WOB\nCardiac: Skin warm, well-perfused. \nAbdomen: soft, ND\nExtremities: Symmetric, no edema. Arthritic deformities both\nhands. \n\nNeurologic Examination:\n- Mental status: Awake, alert, oriented to ___,\n___. Able to relate history with some difficulty (at \ntimes\nis vague about timeline of events). Attentive, able to name ___\nbackward without difficulty. Speech is fluent with normal \ngrammar\nand syntax. No paraphasic errors. Naming intact to low frequency\nwords. Repetition intact. Comprehension intact to complex,\ncross-body commands. Normal prosody.  \n\n-Cranial Nerves: Pupils both slightly irregular. 3->2.5 OD, 3->2\nOS. VFF to confrontation. Subtle decreased abduction OS at\nextreme leftgaze with pt reporting horizontal diplopia, \nunchanged\nfrom baseline. Facial sensation intact to light touch. Face\nsymmetric at rest and with activation. Hearing intact to\nconversation. Palate elevates symmetrically. ___ strength in\ntrapezii bilaterally. Tongue protrudes in midline and moves\nbriskly to each side. No dysarthria. \n\n- Motor:  Normal bulk and tone. L pronation and slight upward\ndrift. No tremor nor asterixis. No pseudoathetosis. \n  Delt Bic Tri WrE FFl FE IO IP Quad Ham TA Gastroc         \nL  5    ___   ___  5-  5    4+ 5                  \nR  5    ___   ___  5-  5    4+ 5                 \nSubtle weakness L worse than right ADM (4 range)\n\n-DTRs:\n   Bi Tri ___ Pat Ach Pec jerk   Crossed Abductors\n L  3  2    3    1   0                        \n R  3  2    3    1   0                           \nPlantar response was flexor bilaterally.\n\n-Sensory: Decreased sensation to LT and PP over part of L hand.\nTo LT it is 75% of normal, and PP is absent in this area. The\narea encompasses the left thumb and the radial aspect of the\ndorsum of the left hand. The second digit has normal sensation.\nProprioception impaired L thumb. Unable to sense maximal\nmovements at the IP joint. At the MCP joint she is able to feel\nmedium but not the smallest movements. \n\n- Coordination: No dysmetria with finger to nose testing\nbilaterally. \n\n- Gait: deferred\n\nDISCHARGE PHYSICAL EXAM\n=======================\nGen: comfortable, no distress, pleasant\nHEENT: neck supple, no oral lesions\nPulm: normal work of breathing\nCard: regular rate rhythm\nAbd: soft, nontender, nondistended\nExtremities: warm, no edema\n\nNeuro:\nAwake and alert, oriented to person, place, date, able to \nrecount\nhistory without difficulty, speech is fluent, no paraphasic\nerrors, follows simple commands.\n\n-Cranial Nerves: Pupils both slightly irregular. 3->2.5 OD, 3->2\nOS. VFF to confrontation. Diplopia left gaze (chronic). Facial\nsensation intact to light touch. Face symmetric at rest and with\nactivation. Hearing intact to conversation. Palate elevates\nsymmetrically. ___ strength in trapezii bilaterally. Tongue\nprotrudes in midline and moves briskly to each side. No\ndysarthria. \n\n- Motor:  Normal bulk and tone. No pronation.\n  Delt Bic Tri WrE FFl FE IO IP Quad Ham TA\nL  5    ___   ___  5   5    5   5                  \nR  5    ___   ___  5   5    5   5\n\n-DTRs:\n   Bi Tri ___ Pat Ach Pec jerk   Crossed Abductors\n L  3  2    3    1   0                        \n R  3  2    3    1   0                           \nPlantars flexor bilaterally\n\nGait: narrow based\n \nPertinent Results:\nADMISSION LABS\n==============\n___ 12:34PM BLOOD WBC-6.0 RBC-3.81* Hgb-12.2 Hct-35.1 \nMCV-92 MCH-32.0 MCHC-34.8 RDW-12.5 RDWSD-42.5 Plt ___\n___ 12:34PM BLOOD Neuts-62.8 ___ Monos-7.5 Eos-0.3* \nBaso-0.2 Im ___ AbsNeut-3.77 AbsLymp-1.74 AbsMono-0.45 \nAbsEos-0.02* AbsBaso-0.01\n___ 12:34PM BLOOD Plt ___\n___ 12:34PM BLOOD ___ PTT-24.3* ___\n___ 11:36PM BLOOD Glucose-87 UreaN-9 Creat-0.5 Na-131* \nK-4.0 Cl-95* HCO3-23 AnGap-13\n___ 12:34PM BLOOD Glucose-106* UreaN-11 Creat-0.6 Na-129* \nK-3.7 Cl-91* HCO3-20* AnGap-18\n___ 12:34PM BLOOD ALT-17 AST-24 AlkPhos-81 TotBili-1.3\n___ 12:34PM BLOOD cTropnT-<0.01\n___ 12:34PM BLOOD Albumin-4.1 Calcium-9.6 Phos-2.3* Mg-1.3*\n___ 11:36PM BLOOD Osmolal-263*\n___ 11:36PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nBnzodzp-NEG Barbitr-NEG Tricycl-NEG\n___ 12:34PM BLOOD ASA-NEG Acetmnp-NEG Tricycl-NEG\n___ 01:38PM BLOOD Lactate-2.1*\n\nDISCHARGE LABS\n==============\n___ 06:05AM BLOOD WBC-4.8 RBC-3.45* Hgb-10.9* Hct-32.3* \nMCV-94 MCH-31.6 MCHC-33.7 RDW-13.0 RDWSD-44.6 Plt ___\n___ 06:05AM BLOOD Plt ___\n___ 06:05AM BLOOD ___ PTT-26.9 ___\n___ 06:05AM BLOOD Glucose-93 UreaN-12 Creat-0.6 Na-134* \nK-4.2 Cl-101 HCO3-23 AnGap-10\n___ 06:05AM BLOOD Calcium-8.5 Phos-3.0 Mg-1.5*\n\nIMAGING\n=======\nCTA HEAD W&W/O C & RECONS Study Date of ___  \nIMPRESSION:\n1. No evidence of high-grade stenosis, occlusion, aneurysm, or \ndissection \ninvolving the great vessels of the head or neck. \n2. Stable appearance of small volume subarachnoid blood located \nin the right frontal region at the approximate location of the \nright middle frontal gyrus, and adjacent small subdural hematoma \nalong the right frontoparietal convexity measuring up to 5 mm. \n3. Mild to moderate atherosclerotic disease, as described above. \n\n4. 9 mm hypodense nodule within the right thyroid lobe.  If this \nfinding is not previously known and no previous imaging has been \nobtained, then would recommend dedicated follow-up thyroid \nultrasound as an outpatient on a nonemergent basis.\n \nBrief Hospital Course:\nMs. ___ is a ___ woman with a past medical history of \nCAD s/p stents ___, on ASA and plavix), HLD, HTN, cataracts \ns/p surgery who presented with one day of difficulty forming \nwords, left hand parasthesias, transient visual hallucination, \nfound to have frontal subarachnoid hemorrhage and small right \nfrontoparietal convexity subdural hematoma, nonsurgical per \nNeurosurgical evaluation. History notable for hitting head on \ndoor one week prior, information which that was not provided to \nus initially despite inquiring about it. MRI with no change in \nhemorrhage. Etiology most suspicious for trauma. However, CAA is \nalso in the differential. Exam notable for chronic left gaze \ndiplopia, intermittently left index finger tingling which \nresolved at discharge. Her visual hallucination, which did not \nreoccur in the hospital, is not clearly understood, low \nsuspicion for seizure but is at risk given potential for \ncortical irritation from hemorrhage. Given its resolution, AED \nand EEG were deferred. After discussion with outpatient \ncardiologist, decision made to stop plavix and restart aspirin \nin one week.\n\nTRANSITIONAL ISSUES\n===================\n[] restart aspirin 81 mg daily 1 week after discharge (___)\n[] STOP Plavix, no longer needed\n\nAHA/ASA Core Measures for Intracerebral Hemorrhage \n1. Dysphagia screening before any PO intake? (x) Yes - () No. If \nno, reason why: \n2. DVT Prophylaxis administered? () Yes - (x) No. If no, why not \n(bleeding risk, hemorrhage, etc.) BLEEDING RISK\n3. Smoking cessation counseling given? () Yes - (x) No [reason \n(x) non-smoker - () unable to participate] \n4. Stroke education (personal modifiable risk factors, how to \nactivate EMS for stroke, stroke warning signs and symptoms, \nprescribed medications, need for followup) given in written \nform?\n(x) Yes - () No \n5. Assessment for rehabilitation and/or rehab services \nconsidered? (x) Yes - () No. If no, why not? (I.e. patient at \nbaseline functional status)\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 81 mg PO DAILY \n2. Clopidogrel 75 mg PO DAILY \n3. Hydrochlorothiazide 12.5 mg PO DAILY \n4. irbesartan 150 mg oral DAILY \n5. Atorvastatin 40 mg PO QPM \n6. Metoprolol Succinate XL 50 mg PO DAILY \n7. Potassium Chloride 10 mEq PO DAILY \n\n \nDischarge Medications:\n1.  Aspirin 81 mg PO DAILY \nDo not start until ___.  Atorvastatin 40 mg PO QPM  \n3.  Hydrochlorothiazide 12.5 mg PO DAILY  \n4.  irbesartan 150 mg oral DAILY  \n5.  Metoprolol Succinate XL 50 mg PO DAILY  \n6.  Potassium Chloride 10 mEq PO DAILY \nHold for K >  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___ \n \nDischarge Diagnosis:\nsubarachnoid hemorrhage\nsubdural hemorrhage\ncerebral amyloid angiopathy\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were hospitalized due to symptoms of difficulty forming \nwords, tingling in your hands, resulting from an ACUTE CEREBRAL \nHEMORRHAGE, which is a small area of bleeding in your brain. The \nbrain is the part of your body that controls and directs all the \nother parts of your body, so damage bleeding in the brain can \nresult in a variety of symptoms.\n\nCerebral hemorrhage can have many different causes. In your case \nit could have resulted from small trauma to your head that you \nsuffered several days ago. In addition, you might have an \nunderlying condition called cerebral amyloid angiopathy which is \ncommon in your age group and predisposes to bleeding. However, \nyour MRI of your brain did not show any obvious evidence of \nthis. \n\nWe are changing your medications as follows:\n 1) please STOP Plavix (clopidigrel)\n 2) please restart your aspirin one week after discharge \n(___)\n\nPlease take your other medications as prescribed.\nPlease follow up with your doctors as listed below.\n\nIf you experience any of the symptoms below, please seek \nemergency medical attention by calling Emergency Medical \nServices (dialing 911). In particular, since stroke can recur, \nplease pay attention to the sudden onset and persistence of \nthese symptoms:\n - Sudden partial or complete loss of vision  \n - Sudden loss of the ability to speak words from your mouth  \n - Sudden loss of the ability to understand others speaking to \nyou  \n - Sudden weakness of one side of the body  \n - Sudden drooping of one side of the face  \n - Sudden loss of sensation of one side of the body  \n\nSincerely,  \nYour ___ Neurology Team  \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048203fb505ee7538e83ce"
  },
  "note_id": "10283230-DS-10",
  "subject_id": 10283230,
  "hadm_id": 25967736,
  "note_type": "DS",
  "note_seq": 10,
  "charttime": "2187-07-18 00:00:00",
  "storetime": "2187-07-18 13:11:00",
  "text": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: NEUROLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nacute onset vertigo; called as Code Stroke\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMr. ___ is a ___ year-old right-handed man with a PMH\nsignificant for CAD s/p L coronary stent, HTN, spinal stenosis,\nHLD and possible NPH who presented to ___ with acute \nonset\nvertigo and was transferred to ___ as a Code Stroke. He was in\nhis usual state of good health today until he developed vertigo\naround 6:45 ___. Actually, according to the patient, he initially\nsaid his symptoms began at 5:45 ___, but his wife arrived later\nand clarified the timing of events and she said the actual onset\nwas around 6:45 ___. He was at his laptop, just finishing a \nsnack,\nwhen his wife called him into the kitchen for dinner. He said \nhis\nsymptoms started when standing to go to the kitchen. He does not\nrecall which way the room was spinning, but believes it may have\nbeen counter-clockwise. He was able to make it to the kitchen,\nbut knew he would not be able to eat and went to the bathroom,\nbut did not vomit at that time. He then went to lie down on the\ncouch and vomited what he estimated to be a quart of liquid. He\nlay there for about half hour with not moving his head and\nthought he was doing better, but when he opened his eyes and\nraised his head, the vertigo returned. At that time, he went to\nthe hospital. He notes that moving his head made the vertigo\nworse, but initially, it was present even at rest. It did not\nmatter which direction he moved his head. At ___, he\nreceived ASA 81 mg x 4 tabs, Ativan and Zofran. He was then\ntransferred to ___ for further care. Currently, he notes that\nhe is feeling much better, but notes the vertiginious sensation\nwhen moving his head in either direction; however, now it \nappears\nas if the room is moving laterally rather than spinning. \n  Of note, he says he a similar case of vertigo about 2 weeks\nago, but that only lasted about ___ minutes and self-resolved;\nhe does say that he vomited a little bit at that time. His wife\nsays that including today's episode, he has now had 3 episodes \nof\nvertigo in the last 3 weeks. No prior history of vertigo. No\nrecent viral illnesses. He did have hot water squirted into both\nof his ears at the end of ___ to clean wax out. No hearing \nloss\nor tinnitus associated with the vertigo. \n  \n \nNeuro ROS: Positive for the acute onset vertigo as noted above.\nAlso positive for pressure-type right frontal and left occipital\nheadaches, going up to about ___ in intensity and occurring\napprox. every other day for the past 3 weeks. His last headache\nwas yesterday. No loss of vision, blurred vision, dipolopia,\ndysarthria, dysphagia, tinnitus, hearing difficulty, producing \nor\ncomprehending speech. No focal focal weakness. He does have\ntingling in his hands and in his feet up to his calfs when \nlaying\nfor a while. His wife also notes that he has a long-standing\nbroad-based gait and drags his left leg when he walks; this has\nbeen attributed to possible NPH in the past. He adds that he\nfeels like he is on the deck of a ship everyday for a long time,\nthough possibly worse over the past 3 weeks. No bowel or bladder\nincontinence. No significant cognitive changes as per his wife,\nthough she notes that he has had increasing difficulty with\nattention. \n \nGeneral ROS: Positive for the nausea and vomiting associated \nwith\nthe vertigo. No fever or chills, cough, shortness of breath,\nchest pain or tightness, palpitations, abdominal pain, dysuria.\nor rash. He has been having myalgias, for which a trial of d/c\nSimvastatin was tried a few weeks ago, but this has not resulted\nin any significant improvement.\n \nPast Medical History:\n-gastroesophageal reflux\n-colon polyps\n-HTN\n-spinal stenosis s/p decompression and fusion L3-5\n-BPH s/p TURP\n-HLD \n-Raynaud's\n-?NPH \n-CAD s/p L coronary stent \n \nSocial History:\n___\nFamily History:\nHis mother and father are deceased during the\n___. Maternal aunt with ___ and HTN and CAD in\nmaternal family. Father's history unknown. No known strokes in\nthe family. \n\n \nPhysical Exam:\nVitals: T: 97.5 P: 90 R: 18  BP: 151/89  SaO2: 99% RA\n\nGeneral: Awake, cooperative, NAD. \nHEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in\noropharynx \nNeck: Supple \nPulmonary: lcta b/l  \nCardiac: RRR, S1S2, no murmurs appreciated\nAbdomen: soft, NT/ND, +BS \nExtremities: feet cold and erythematous, but good pedal pulses\nb/l; no edema \n \nNeurologic: \n\n___ Stroke Scale score was:  0\n1a. Level of Consciousness: 0  \n1b. LOC Question: 0  \n1c. LOC Commands: 0  \n2. Best gaze: 0  \n3. Visual fields: 0  \n4. Facial palsy: 0  \n5a. Motor arm, left: 0  \n5b. Motor arm, right: 0  \n6a. Motor leg, left: 0  \n6b. Motor leg, right: 0  \n7. Limb Ataxia: 0  \n8. Sensory: 0  \n9. Language: 0  \n10. Dysarthria: 0  \n11. Extinction and Neglect: 0  \n\nMental Status: Awake, alert, oriented to person, place and date. \n\nAble to relate history, though made some mistakes with regard to\ntiming.  Attentive, able to name ___ backward without \ndifficulty.\nAble to follow both midline and appendicular commands. Able to\nperform simple calculations. No right-left confusion. Able to\nregister 3 objects but recall ___ at 5 minutes ___ with\nprompting). No evidence of apraxia or neglect  \n\nLanguage: speech is clear, fluent, nondysarthric with intact\nnaming, repetition and comprehension. Normal prosody. There were\nno paraphasic errors. Able to read without difficulty.  \n\nCranial Nerves: \nI: Olfaction not tested.  \nII: PERRL 1 mm to pinpoint b/l.  VFF to confrontation. Unable to\nassess fundi due to small pupils.  \nIII, IV, VI: nystagmus when looking right. No nystagmus when\nlooking left. On vertical gaze, there is again horizontal\nnystagmus noted, but no vertical nystagmus. \nV: Diminished light touch in V1 and V2 on  right (90% of left)\nand diminished pinprick in V1 on right. \nVII: No facial droop, facial musculature symmetric. \nVIII: Hearing intact to finger-rub bilaterally.  \nIX, X: Palate elevates symmetrically.  \nXI: ___ strength in trapezii and SCM bilaterally. \nXII: Tongue protrudes in midline.\n \nMotor: Normal bulk, tone throughout. No pronator drift\nbilaterally. \nNo adventitious movements, such as tremor, noted. No asterixis\nnoted. \n  Delt Bic Tri WrE FFl FE IP Quad Ham TA Gastroc  \nL  5    ___   ___   5    5  5     5    \nR  5    ___   ___   5    5  5     5   \n \nSensory: Diminished light touch RLE (70%) compared to left. No\ndifferences to light touch in UE. There is diminished pinprick \nin\nthe RUE (90%) compared to the left but is intact in the ___ b/l.\nThere is decreased vibratory sense up to the knee on the right,\nbut only mildly diminished on the left. There is mildly\ndiminished proprioceptive loss on the right greater than left. \nNo\nextinction to DSS. \n \nDTRs: 3+ at biceps/triceps/brachioradialis/patellae on left and\n2+ on right. Unable to elicit ankle jerks b/l. Extensor plantar\nresponse b/l. \n \nCoordination: No intention tremor or dysmetria on finger-nose,\nFNF or HKS bilaterally. There was slight overshoot with \nmirroring\non the right compared to the left. No rebound noted. Finger\ntapping into crease is slow, but accurate b/l. \n \nGait: Able to stand, but felt unsteady and was leaning on bed.\nWhen he put his feet together, he began leaning over to the \nright\nand became more unsteady, so he was placed back in bed. Unable \nto\nassess gait further. \n\n___ testing was positive with head turned to the right,\nbut not to the left. When turned to the right, this exacerbated\nthe vertigo and the nystagmus to the right was more pronounced. \n\n \nPertinent Results:\nRadiologic Data: \n___   MR HEAD W/O CONTRAST - prelim: Lateral \nventriculomegaly, out of proportion to sulcal prominence, \nincreased slightly compared to ___. Correlate clinically \nfor normal pressure hydrocephalus. \n   \n___   CHEST (PORTABLE AP): No previous images. Low lung \nvolumes may account for some of the prominence of the transverse \ndiameter of the heart. No vascular congestion or pleural \neffusion. Specifically, no evidence of acute focal pneumonia. \n            \n___   CTA HEAD/NECK/BRAIN: No acute interval change \ncompared to the prior examinations.  Persistent lateral \nventriculomegaly. No flow limiting stenosis or evidence of \ninfarct.   \n\nLabs on admission:\n___ 11:20PM BLOOD WBC-7.8 RBC-4.10* Hgb-13.2* Hct-38.3* \nMCV-94 MCH-32.2* MCHC-34.4 RDW-14.0 Plt ___\n___ 11:20PM BLOOD Neuts-85.1* Lymphs-11.2* Monos-2.8 \nEos-0.6 Baso-0.3\n___ 11:20PM BLOOD ___ PTT-20.7* ___\n___ 11:20PM BLOOD Glucose-132* UreaN-24* Creat-0.9 Na-142 \nK-4.2 Cl-104 HCO3-29 AnGap-13\n___ 11:20PM BLOOD Calcium-8.7 Phos-2.5* Mg-1.9\n___ 11:20PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nBnzodzp-NEG Barbitr-NEG Tricycl-NEG\n.\nLabs on discharge:\n___ 07:15AM BLOOD WBC-5.2 RBC-3.91* Hgb-12.7* Hct-36.8* \nMCV-94 MCH-32.4* MCHC-34.5 RDW-14.1 Plt ___\n___ 07:15AM BLOOD Glucose-103* UreaN-22* Creat-1.0 Na-142 \nK-4.0 Cl-106 HCO3-30 AnGap-10\n___ 07:15AM BLOOD ALT-21 AST-17 AlkPhos-55\n___ 07:15AM BLOOD cTropnT-<0.01\n___ 07:15AM BLOOD Calcium-8.9 Phos-3.2 Mg-2.0 Cholest-197\n___ 07:15AM BLOOD %HbA1c-5.7 eAG-117\n___ 07:15AM BLOOD Triglyc-94 HDL-56 CHOL/HD-3.5 LDLcalc-122\n \nBrief Hospital Course:\nMr. ___ is a ___ year-old right-handed man with a PMH \nsignificant for CAD s/p L coronary stent, HTN, spinal stenosis, \nHLD and possible NPH who presented to ___ with acute \nonset vertigo and was transferred to ___ as a Code Stroke. His\nsymptoms are now significantly improved, though he still notes \nvertigo with head movements. On exam, his NIHSS is 0; he has \nnystagmus when looking to the right, but not the left and no \ndysmetria, though he has slight overshoot with mirroring on the\nright. He also falls to the right when standing with his feet \ntogether. On ___ testing, his symptoms are reproduced \nwhen head is turned to the right and his nystagmus is more \npronounced as well. There is no acute process noted on imaging\nand no flow limiting stenosis noted on CTA. The recent history \nof 2 similar, though shorter and less severe events, and the \npositive ___ maneuver indicate that this is likely a \nperipheral process. However, he does have vascular risk factors,\nthis event was of acute onset, he was admitted to the Neurology \nStroke Service for further work-up for a possible stroke. \n\nNeurology: MRI negative for stroke. However, due to his stroke \nrisk factors, ASA 81mg daily started. HbA1c: 5.7, LDL 122. \nStarted on simvastatin 20mg daily for stroke risk reduction. Pt \nto follow-up with Dr. ___ continued outpatient workup of \nchronic, progressive lower extremity paresthesias and wide-based \ngait. Pt may take meclizine for vertigo upon discharge.\n\nCardiology: Initially allowed BP to autoregulate, held Lisinpril \nat time of admission, will restart at time of discharge. CXR \nwithout focal findings.\n\n___ recommended pt be discharged to rehab. Patient and family \nin agreement.\n \nMedications on Admission:\n-Naproxen 500 mg bid prn \n-Lisinopril 10 mg daily \n-Ranitidine 150 mg prn   \n-coenzyme Q10 daily   \n-Vitamin D\n-Vitamin C \n-Multivitamin daily \n-Celexa 30mg daily\n\n \nDischarge Medications:\n1. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n2. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \nPO DAILY (Daily).  \n3. naproxen 500 mg Tablet Sig: One (1) Tablet PO twice a day as \nneeded for pain.  \n4. lisinopril 10 mg Tablet Sig: One (1) Tablet PO once a day.  \n5. ranitidine HCl 150 mg Capsule Sig: One (1) Capsule PO once a \nday as needed for heartburn.  \n6. Vitamin D  Oral\n7. Vitamin C  Oral\n8. simvastatin 20 mg Tablet Sig: One (1) Tablet PO once a day.\nDisp:*30 Tablet(s)* Refills:*0*\n9. Celexa 10 mg Tablet Sig: Three (3) Tablet PO once a day.  \n10. meclizine 12.5 mg Tablet Sig: One (1) Tablet PO twice a day \nas needed for vertigo.  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___ \n___\n \nDischarge Diagnosis:\nVertigo\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Mr. ___,\n \nYou were admitted for dizziness.  An MRI showed that you did NOT \nhave a stroke.  However, due to your stroke risk factors, you \nwere started on aspirin 81mg daily for stroke protection.  Your \nstroke risk factors were checked.  Your LDL cholesterol was 122. \n You were started on simvastatin 20mg daily to lower your \ncholesterol.  You were checked for blood glucose control with a \nHgB A1c.  The level was 5.7.  You need to continue your blood \npressure control.  You should not smoke. \n \nYou should continue to eat a low fat healthy diet, and follow up \nwith your primary care physician and Dr. ___ as noted below.\n \nIt was a pleasure taking care of you.  \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904822bfb505ee753918a53"
  },
  "note_id": "16253586-DS-8",
  "subject_id": 16253586,
  "hadm_id": 28069781,
  "note_type": "DS",
  "note_seq": 8,
  "charttime": "2153-03-23 00:00:00",
  "storetime": "2153-03-24 21:50:00",
  "text": " \nName:  ___                       Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nBRBPR \n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\n Mrs. ___ is a ___ with history of colon polyps who underwent \nscreening colonoscopy on ___ found to have 2 cecal sessile \nadenoma (Cecal ___ s/p polypectomy/endoclip and Cecal \n___ s/p mucosal resection/endoclip) who presents with 1 \nday of abdominal cramping and BRBPR.  Patient reports having 5+ \nmaroon colored/bloody stools from 2am-6am however her last BM at \n6:30am was normal without any blood. She is not on any blood \nthinner. No nausea, vomiting, hematamesis, melena, \nlightheadedness, syncope.  No shortness of breath or chest pain. \n No fevers, chills or night sweats. \n\nIn the ED, initial vitals: 97 126/75 18 98% ra.  She did have \none BP of 92/70 which returned back to normal after 5 minutes \nwithout intervention. Labs notable for: Hgb/HCT 11.5/33.2 down \nfrom 12.7/38.4 in ___.  Normal chem 10; normal LFTs, normal \nlactate. GI consult was called who felt that patient has late \npolypectomy bleed and recommended initiating GoLytely prep for \ncolonoscopy in ___.  GI recommended admission to ___ \n___ floor however ED felt patient needed ICU level \ncare for monitoring. Patient received 1L NS in the ED prior to \n___ transfer. \n\nOn arrival to the ___, patient appears well without any \ncomplaints.  \n\n \nPast Medical History:\n- Sessile Cecal Adenoma ___ s/p polypectomy and mucosal resection \nas well as endoclip\n- Hx of Hemorrhoids\n- Peripheral Neuropathy\n- Bilateral hallux valgus deformities\n- Bilateral second hammertoe deformities\n \n\n \nSocial History:\n___\nFamily History:\nMother had uterine cancer and prostate cancer. Her father had \naunt with breast cancer.  The patient is divorced, two children \nand two grandchildren son boys ___ and ___ months.\n\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n========================\nGENERAL: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNECK: supple, JVP not elevated, no LAD  \nLUNGS: Clear to auscultation bilaterally, no wheezes, rales, \nrhonchi  \nCV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, \ngallops  \nABD: soft, non-tender, non-distended, bowel sounds present, no \nrebound tenderness or guarding, no organomegaly  \nEXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \nSKIN: No rashes \nNEURO:  alert and oriented x3\n\nDISCHARGE PHYSICAL EXAM:\n========================\nVitals:98.4 BP: 120/82 HR: 80 R: 16 O2: 98% RA\nGENERAL: NAD, well appearing\nHEENT: Sclera anicteric, MMM, oropharynx clear  \nLUNGS: Clear to auscultation bilaterally, no wheezes, rales,\nrhonchi  \nCV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs,\ngallops  \nABD: soft, non-tender, non-distended, bowel sounds present, no\nrebound tenderness or guarding\nEXT: Warm, well perfused, no clubbing, cyanosis or edema  \nSKIN: No rashes  \nNEURO: alert and oriented x3  \npsych: calm, cooperative\n \n\n \nPertinent Results:\nADMISSION LABS:\n===============\n___ 07:45AM BLOOD WBC-5.8 RBC-3.87* Hgb-11.5* Hct-33.2* \nMCV-86 MCH-29.7 MCHC-34.5 RDW-14.5 Plt ___\n___ 07:45AM BLOOD Neuts-64.2 ___ Monos-4.9 Eos-2.4 \nBaso-0.8\n___ 08:52AM BLOOD ___ PTT-26.8 ___\n___ 07:45AM BLOOD Glucose-124* UreaN-25* Creat-0.8 Na-138 \nK-4.4 Cl-104 HCO3-25 AnGap-13\n___ 07:45AM BLOOD ALT-16 AST-26 AlkPhos-65 TotBili-0.6\n___ 07:45AM BLOOD Albumin-4.3\n___ 08:43AM BLOOD Lactate-1.8\n\nDISCHARGE LABS:\n===============\n\n___ 06:55AM BLOOD WBC-4.4 RBC-3.49* Hgb-10.3* Hct-29.4* \nMCV-84 MCH-29.7 MCHC-35.1* RDW-13.8 Plt ___\n___ 06:55AM BLOOD Glucose-99 UreaN-12 Creat-0.8 Na-137 \nK-4.4 Cl-104 HCO3-29 AnGap-___ with history of colon polyps who underwent screening \ncolonoscopy on ___ found to have 2 cecal sessile adenoma \n(Cecal ___ s/p polypectomy/endoclip and Cecal ___ \ns/p mucosal resection/endoclip) who presented with 1 day of \nmaroon colored stools.\n\n# Postpolypectomy bleeding:\nMost likely late post polypectomy especially since patient had \nmucosal resection of one sessile cecal polyp.  Patient had an \nendoclip placed during procedure which likely prevented early \nbleeding. No AVMs, diverticulosis or internal hemorrhoids on \nrecent colonoscopy.  Patient was hemodynamically stable on \nadmission with HCT of 33.6. Last maroon colored stool was the \nmorning of admission without further BMs in 5 hours.  Very low \nsuspicion for upper GI bleed given hemodynamic instability \nwithout any melena. Mainatined active type and cross with 2 PIVs \nin place. No PPI given given very low suspicion for upper GI \nbleed. Hemoglobin trended and remained stable. Advanced from \nclear liquid and then to regular without recurrence of bleed. \nThe patient was discharged home.\n\n# Peripheral Neuropathy: continued gabapentin and PRN tylenol\n\nTransitional issues:\n- recommend repeat CBC at PCP follow up\n \n___ on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Multivitamins 1 TAB PO DAILY \n\n \nDischarge Medications:\n1. Multivitamins 1 TAB PO DAILY \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPost- polypectomy bleeding\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nIt was a pleasure taking care of you during your recent \nadmission to ___. You were admitted with bleeding following \nyour colonoscopy. You were monitored for continued bleeding and \nyour blood counts were stable. You have likely stopped bleeding \non your own.\nPlease follow up with your PCP as scheduled for a repeat CBC \n(blood count).\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048215fb505ee753904841"
  },
  "note_id": "13773889-DS-6",
  "subject_id": 13773889,
  "hadm_id": 29079502,
  "note_type": "DS",
  "note_seq": 6,
  "charttime": "2135-09-09 00:00:00",
  "storetime": "2135-09-09 09:51:00",
  "text": " \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: CARDIOTHORACIC\n \nAllergies: \n___ recorded as having No Known Allergies to Drugs\n \nAttending: ___.\n \nChief Complaint:\nchest pain\n\n \nMajor Surgical or Invasive Procedure:\nCoronary artery bypass grafting x5(Left internal mammary artery \nto left anterior descending artery; reverse saphenous vein graft \nto the diagonal artery, obtuse marginal artery; sequential vein \ngraft to the posterior left ventricle branch artery and the \nposterior descending artery)on ___.\n\n \nHistory of Present Illness:\nThis ___ year old male with a history of hypertension who has \nbeen experiencing chest pain and dyspnea with exertion since \n___.  He reports that he feels chest pain and that his \nbreathing becomes labored when walking up hill\nor up stairs.  His symptoms subside within seconds after he \nrests. He failed a stress ___ and his subsequent cardiac cath \nrevealed multivessel coronary artery disease. Cardiac surgery \nwas consulted for revascularization.\n\n \nPast Medical History:\nHTN\nRight rotator cuff surgery ___ yrs ago\nAppendectomy in his ___\nTonsillectomy \n \nSocial History:\n___\nFamily History:\nFamily History:noncontributory\n\n \nPhysical Exam:\nAdmission Physical Exam\n\nPulse: 80 Resp:17  O2 sat: 100%\nB/P  ___\nHeight: 5 feet 9 inches    Weight:196 pounds\n\nGeneral:\nSkin: Dry [x] intact [x]\nHEENT: PERRLA [x] EOMI [x]\nNeck:  Supple [x] Full ROM [x]\nChest: Lungs clear bilaterally [x]\nHeart: RRR [x]  Irregular []  Murmur\nAbdomen: Soft [x] non-distended [x] non-tender [x]  bowel sounds\n+ [x]\nExtremities: Warm [x], well-perfused [x]  Edema Varicosities:\nNone [x]\nNeuro: Grossly intact[x]\nPulses:\nFemoral      Right:2+   Left:2+\nDP           Right:2+   Left:2+\n___           Right:2+   Left:2+\nRadial       Right:2+   Left:2+\n\nCarotid Bruit        Right:-    Left:-\n \nPertinent Results:\n___ 05:45AM BLOOD WBC-10.7 RBC-3.34* Hgb-10.7* Hct-29.9* \nMCV-89 MCH-31.9 MCHC-35.8* RDW-13.8 Plt ___\n___ 12:08PM BLOOD WBC-5.8 RBC-2.76*# Hgb-9.1*# Hct-24.9*# \nMCV-90 MCH-32.9* MCHC-36.6* RDW-12.9 Plt ___\n___ 03:54AM BLOOD ___ PTT-27.6 ___\n___ 01:31PM BLOOD ___ PTT-35.3* ___\n___ 05:45AM BLOOD Glucose-116* UreaN-22* Creat-1.2 Na-137 \nK-4.2 Cl-100 HCO3-30 AnGap-11\n___ 01:31PM BLOOD UreaN-16 Creat-0.9 Na-139 K-4.1 Cl-111* \nHCO3-24 AnGap-8\n \n\n___ ECHOCARDIOGRAPHY REPORT\n\n___       ___ MRN:   ___       TEE (Complete) \nDone ___ at 10:50:06 AM      FINAL  \nReferring Physician     ___  \n___ - Department of Cardiac S\n___  Status: Inpatient DOB: ___ \nAge (years): ___ M  Hgt (in):  \nBP (mm Hg): /  Wgt (lb):  \nHR (bpm):  BSA (m2):  \nIndication: Intraoperative TEE for CABG  \nICD-9 Codes: 424.2 \n___ Information  \nDate/Time: ___ at 10:50    ___ MD: ___, MD \n___ Type: TEE (Complete) Sonographer: ___, MD \nDoppler: Full Doppler and color Doppler ___ Location: \nAnesthesia West OR cardiac \nContrast: None Tech Quality: Adequate \nTape #: 2010AW2-: Machine: AW5 \nEchocardiographic Measurements  \nResults  Measurements  Normal Range  \nLeft Ventricle - Inferolateral Thickness:  1.1 cm  0.6 - 1.1 cm  \n\nLeft Ventricle - Diastolic Dimension:  3.9 cm  <= 5.6 cm  \nLeft Ventricle - Ejection Fraction:  >= 55%  >= 55%  \nAorta - Sinus Level:  3.5 cm  <= 3.6 cm  \nAorta - Sinotubular Ridge:  2.9 cm  <= 3.0 cm  \nAorta - Ascending:  3.2 cm  <= 3.4 cm  \nAortic Valve - Peak Gradient:  8 mm Hg  < 20 mm Hg  \nAortic Valve - LVOT diam:  2.0 cm     \n \nFindings  \nLEFT ATRIUM: No spontaneous echo contrast or thrombus in the \n___ or the RA/RAA. Good (>20 cm/s) ___ ejection velocity. All \nfour pulmonary veins identified and enter the left atrium. \n\nRIGHT ATRIUM/INTERATRIAL SEPTUM: No ASD by 2D or color Doppler. \n\nLEFT VENTRICLE: Wall thickness and cavity ___ were \nobtained from 2D images. Normal LV wall thickness, cavity size, \nand global systolic function (LVEF>55%). \n\nRIGHT VENTRICLE: Normal RV chamber size and free wall motion. \n\nAORTA: Normal aortic diameter at the sinus level. Focal \ncalcifications in aortic root. Normal ascending aorta diameter. \nSimple atheroma in ascending aorta. Focal calcifications in \nascending aorta. Simple atheroma in aortic arch. Normal \ndescending aorta diameter. Simple atheroma in descending aorta. \n\nAORTIC VALVE: Mildly thickened aortic valve leaflets (3). No AS. \nNo AR. \n\nMITRAL VALVE: Mildly thickened mitral valve leaflets. ___ of the \nmitral chordae (normal variant). No resting LVOT gradient. No \nMS. ___ MR ___ normal limits). \n\nTRICUSPID VALVE: Normal tricuspid valve leaflets. Mild [1+] TR. \n\nPULMONIC VALVE/PULMONARY ARTERY: Pulmonic valve not well seen. \nPhysiologic (normal) PR. \n\nGENERAL COMMENTS: A TEE was performed in the location listed \nabove. I certify I was present in compliance with ___ \nregulations. The ___ was under general anesthesia throughout \nthe procedure. No TEE related complications. The ___ appears \nto be in sinus rhythm. Results were personally reviewed with the \nMD caring for the ___.  \nConclusions  \nPRE BYPASS No spontaneous echo contrast or thrombus is seen in \nthe body of the left atrium/left atrial appendage or the body of \nthe right atrium/right atrial appendage. No atrial septal defect \nis seen by 2D or color Doppler. Left ventricular wall thickness, \ncavity size, and global systolic function are normal (LVEF>55%). \nRight ventricular chamber size and free wall motion are normal. \nThere are simple atheroma in the ascending aorta. There are \nsimple atheroma in the aortic arch. There are simple atheroma in \nthe descending thoracic aorta. The aortic valve leaflets (3) are \nmildly thickened but aortic stenosis is not present. No aortic \nregurgitation is seen. The mitral valve leaflets are mildly \nthickened. Physiologic mitral regurgitation is seen (within \nnormal limits). Dr. ___ was notified in person of the results in \nthe operating room at the time of the study.\n\nPOST BYPASS The ___ is atrially paced. There is normal \nbiventricular systolic function. The chordal ___ is more \nprominent and there may be some slight valvular ___ but a \nsignificant gradient does not exist. The mitral regurgitation is \nnow mild but appears central. The thoracic aorta appears intact \nafter decannulation. No other significant changes from the \npre-bypass study.   \n  I certify that I was present for this procedure in compliance \nwith ___ regulations.\n\nElectronically signed by ___, MD, Interpreting physician \n___ ___ 12:23  \n   \n\n ___ ___. All rights reserved.\n\n \nBrief Hospital Course:\n___ Mr. ___ was taken to the operating room and \nunderwent Coronary artery bypass grafting x5 ( Left internal \nmammary artery to left anterior descending artery;\nreverse saphenous vein graft to the diagonal artery, obtuse \nmarginal artery; sequential vein graft to the posterior left \nventricle branch artery and the posterior descending artery) \nwith Dr. ___. Please see operative report for further details. \nHe tolerated the procedure well and was transferred to the CVICU \nintubated and sedated in critical but stable condition. He awoke \nneurologically intact and was extubated without difficulty. All \nlines and drains were discontinued in a timely fashion. He was \nweaned off pressors and Beta-blocker/Statin/Aspirin and diuresis \nwas initiated. POD#1 he was transferred to the step down unit \nfor further monitoring. Physical therapy was consulted for \nevaluation of strength and mobility. ___ the foley cath was \ndiscontinued and he failed to void. A foley was reinserted, \nFlomax was initiated and ultimately prior to discharge \n___ voided. He continued to progress and was cleared by \n___ discharge to home with ___ on POD# 5. All follow up \nappointments were advised.\n\n \nMedications on Admission:\nATORVASTATIN [LIPITOR] -  - 20 mg Tablet - 1 Tablet(s) by mouth \nonce daily\nLISINOPRIL -  10 mg Tablet - 1Tablet(s) by mouth once daily\nTIMOLOL \n \nDischarge Medications:\n1. atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).\nDisp:*60 Tablet(s)* Refills:*2*\n2. ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2 \ntimes a day).\nDisp:*60 Tablet(s)* Refills:*2*\n3. aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1) \nTablet, Delayed Release (E.C.) PO DAILY (Daily).\nDisp:*60 Tablet, Delayed Release (E.C.)(s)* Refills:*2*\n4. oxycodone-acetaminophen ___ mg Tablet Sig: ___ Tablets PO \nQ4H (every 4 hours) as needed for pain.\nDisp:*50 Tablet(s)* Refills:*0*\n5. potassium chloride 20 mEq Tab Sust.Rel. Particle/Crystal Sig: \nOne (1) Tab Sust.Rel. Particle/Crystal PO Q12H (every 12 hours) \nfor 7 days.\nDisp:*14 Tab Sust.Rel. Particle/Crystal(s)* Refills:*0*\n6. Lasix 20 mg Tablet Sig: One (1) Tablet PO twice a day for 7 \ndays.\nDisp:*14 Tablet(s)* Refills:*0*\n7. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).\nDisp:*60 Capsule(s)* Refills:*2*\n8. metoprolol tartrate 50 mg Tablet Sig: One (1) Tablet PO TID \n(3 times a day).\nDisp:*90 Tablet(s)* Refills:*2*\n9. tamsulosin 0.4 mg Capsule, Sust. Release 24 hr Sig: One (1) \nCapsule, Sust. Release 24 hr PO HS (at bedtime).\nDisp:*60 Capsule, Sust. Release 24 hr(s)* Refills:*2*\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___.\n \nDischarge Diagnosis:\nCoronary artery disease\ns/p CABG x5 on ___\nHypertension\n\n \nDischarge Condition:\nAlert and oriented x3 nonfocal \nAmbulating with steady gait\nIncisional pain managed with \nIncisions: \nSternal - healing well, no erythema or drainage \nLeg Right/Left - healing well, no erythema or drainage. Edema \n \n\n \nDischarge Instructions:\nPlease shower daily including washing incisions gently with mild \nsoap, no baths or swimming until cleared by surgeon. Look at \nyour incisions daily for redness or drainage\nPlease NO lotions, cream, powder, or ointments to incisions \nEach morning you should weigh yourself and then in the evening \ntake your temperature, these should be written down on the chart \n\nNo driving for approximately one month and while taking \nnarcotics, will be discussed at follow up appointment with \nsurgeon when you will be able to drive \nNo lifting more than 10 pounds for 10 weeks\nPlease call with any questions or concerns ___\nFemales: Please wear bra to reduce pulling on incision, avoid \nrubbing on lower edge\n**Please call cardiac surgery office with any questions or \nconcerns ___. Answering service will contact on call \nperson during off hours**\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048210fb505ee7538fca31"
  },
  "note_id": "12793992-DS-4",
  "subject_id": 12793992,
  "hadm_id": 29405120,
  "note_type": "DS",
  "note_seq": 4,
  "charttime": "2118-12-06 00:00:00",
  "storetime": "2118-12-06 11:42:00",
  "text": " \nName:  ___           Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROSURGERY\n \nAllergies: \nlatex\n \nAttending: ___.\n \nChief Complaint:\nFall with headstrike\n \nMajor Surgical or Invasive Procedure:\n___ - Stage I - Neuronavigated left combined \ntranslabirinthe approach to skull base for resection of \npetroclival meningioma and right frontal EVD placement\n___ - Diagnostic cerebral angiogram\n___ - Stage II - Neuronavigated left combined \ntranslabirinthe approach to skull base for resection of \npetroclival meningioma\n___ - PEG placed at the bedside (ACS)\n___ - VPS insertion and Trach (with ACS) \n \nHistory of Present Illness:\nEu Critcal ___, AKA ___, is a ___ F with \nhistory of hypothyroidism and peripheral neuropathy who presents \nas transfer from OSH s/p fall with possible head strike. \nAccording to OSH records, family reported a witnessed fall in \nthe bathroom today ___ with unclear headstrike, no loss of\nconsciousness. Patient was brought to OSH where NCHCT revealed \nsevere asymmetry in the brainstem with surrounding edema \nconcerning for underlying mass lesion. Neurosurgery was \nconsulted for recommendations. \n\nOf note, patient was hypertensive to SBP 170s at OSH and was \ninitiated on nicardipine gtt. \n \nPast Medical History:\nHypothyroidism, peripheral neuropathy, unsteady gait at\nbaseline, otherwise unknown\n\n \nSocial History:\n___\nFamily History:\nUnknown s/t mental status, no family at bedside\n\n \nPhysical Exam:\nON ADMISSION\n===========\n___\nGen: elderly woman, restless \nHEENT: normocephalic, nontraumtic\nNeck: Hard C-collar in place\nExtrem: Warm and well-perfused.\n\n*primarily ___ speaking, able to follow simple\ncommands and answer some questions in ___\nNeuro:\nMental status: Awake and alert, restless, follows simple \ncommands\nOrientation: Oriented to person, ___. Able to report \nabout\nher fall today but generally confused\nLanguage: Speech fluent with good comprehension. No dysarthria \nor\nparaphasic errors.\n\nCranial Nerves:\nI: Not tested\nII: Left pupil 3.5-2mm briskly reactive, right pupil 3-2mm\nbriskly reactive. Visual fields are full to confrontation.\nIII, IV, VI: Extraocular movements intact bilaterally without\nnystagmus.\nV, VII: Left nasal labial fold flattening\nVIII: Hearing intact to voice bilaterally\nIX, X: Palatal elevation symmetrical.\nXI: Sternocleidomastoid and trapezius normal bilaterally.\nXII: Tongue midline without fasciculations.\n\nMotor: Normal bulk and tone bilaterally. No abnormal movements,\ntremors. Strength grossly symmetric throughout, at least ___.\nUnable to assess for pronator drift\n\nSensation: Intact to light touch\n\nToes downgoing bilaterally\n\nCoordination: unable to assess\n\nHandedness: unknown \n=\n=\n=\n=\n=\n=\n=\n=\n=\n================================================================\nON DISCHARGE \n============\nExam:\n___ speaking primarily / partial \"conversational\"\n___\nOpens eyes: [x]spontaneous [ ]to voice [ ]to noxious\nOrientation: [x]Person [x]Place [ ]Time\nFollows commands: [ ]Simple [x]Complex [ ]None\nPupils: Anisocoric, left greater than right, but briskly \nreactive\nbilaterally\nEOMs: [ ]Full [x]Restricted - Limited up gaze, limited left gaze\nFace Symmetric: [ ]Yes [x]No - Dense left facial droop, weak \nclosure of left eye, unable to raise left eyebrow, wrinkle\nforehead\nTongue Midline: [ ]Yes [x]No - Left tongue deviation\nPronator Drift [ ]Yes [x]No     \nSpeech Fluent: [ ]Yes [x]No - slightly dysarthric d/t facial\ndroop \nComprehension intact [x]Yes [ ]No\n\nMotor: Moves bilateral upper extremities antigravity to command\nwith good strength, bilateral delts 4/+/5, Bi/Tri and grip ___.\nBends knees, wiggles toes bilaterally to command. \nSensation: Intact to light touch.\n\nRight VP Shunt Incision: \n- Clean, dry, intact\n- Well healed\n- Good valve recoil\n\n \nPertinent Results:\nPlease refer to OMR for pertinent imaging and lab results. \n \nBrief Hospital Course:\n#Large petroclival meningioma with cerebral edema \nPatient was transferred to ___ from OSH s/p fall with \nheadstrike and ___ findings showing significant asymmetry in \nbrainstem concerning for underlying lesion. MRI was obtained \nwhich demonstrates large petroclival meningioma. Patient was \nadmitted to ___ for close neurologic monitoring and further \nworkup. ENT was consulted for input and audiology evaluation. \nPatient underwent audiology testing on ___ which demonstrated \nthat the patient has profound hearing loss in the left ear and \nmoderate hearing loss in the right ear. Due to concern of \nlocation of the tumor and secondary deficits in swallow, SLP was \nconsulted who downgraded diet. Surgical Options were discussed \nwith the family and it was decided to proceed with surgical \ntumor resection/debulking. In preparation for surgery, CTA head \nand neck was done to evaluate for compression of vertebral \narteries. On ___, the patient underwent a Video Swallow \npre-operatively for a baseline evaluation. Her neuro exam \nremained stable, and she was changed to floor status while \nawaiting surgical plan. On ___ she was noted to have horizontal \ngaze restriction bilaterally with generalized weakness worse on \nher lower extremities. She was started on decadron with insulin \nsliding scale and GI prophylaxis. Patient was brought to the OR \non ___ for Stage 1 of two-part surgical series. On ___, she \nunderwent neuronavigated left craniotomy combined extended \nmiddle fossa approach and translabrinthe approach to skull base \nwith placement of right frontal EVD; this Stage 1 was primarily \ndone for bone work while Stage II was planned for further tumor \nresection. She also underwent diagnostic cerebral angiogram ___ \nto evaluate the cavernous sinus and aterial supply. Both \nprocedures were uncomplicated. See operative note for further \ndetail. Patient remained intubated postoperatively and was \nadmitted to the Neuro ICU for close monitoring. Postoperative \nNCHCT revealed adequate placement of EVD and expected \npostsurgical changes. On ___, the patient went back to the OR \nfor Stage II neuronavigated left craniotomy combined extended \nmiddle fossa approach and translabrinthe approach to skull base \nfor tumor resection. Stage II was an extensively long surgery \nbut otherwise uncomplicated. Please see dedicated operative note \nfor further detail. Patient remained intubated postoperatively \nand returned to the Neuro ICU for further care. An abdominal \ndrain was left in place that was then discontinued on POD#2 \n(___). Postop NCHCT with expected postsurgical changes. She was \nextubated on ___. Following the stage II procedure, she had a \nnotable left facial and left CNVII weakness for which ENT \nevaluated her. She was put on Dexamethasone 10mg Q8hrs x 3 doses \nbefore her Dex was decreased back down to 4mg Q8hrs. Insulin \nsliding scale was increased for elevated blood sugars. Given the \nlocation of the lesion, the left facial weakness was not a \nsurprising post-operative finding and no STAT imaging was \nperformed. Following the resection, her EVD was kept at 10 above \nthe tragus, and raised to 20 on ___ and clamped on ___. \nPatient with AMS and increased ICPs, CTH on ___ revealed \nhydrocephalus and the EVD was opened to 15 above the tragus. \nPatient with increased pain on ___ and low dose oxycodone was \nadded for pain relief. CTH in AM on ___ revealed stable size of \nventricles, residual meningioma, SAH, SDH and IVH with decreased \nsize of extra axial fluid collection. EVD was clamped again on \n___ however, due to ICP sustained in ___ and need for \ntrach/PEG placement, the decision was made to re-open the EVD on \n___ at 15 above the tragus. VPS placement was put on hold \npending trach/PEG placement. PEG was placed at bedside on ___. \nOn ___ patient was noted to have a hematoma at the abdominal \nfat graft site. Patient underwent an ultrasound on ___ evening \nwhich revealed a hematoma and a repeat ultrasound was \nrecommended if hematoma did not clear clinically. Patient \ncontinued to be monitored closely, there were no signs of \ninfection and hematoma remained stable to improved. On ___, a \none-week wean to off of the Decadron was initiated. Patient had \na trach and VP shunt placement on ___. Please see OMR for \noperative reports for more information. VPS was set to 1.0. \nPatient was quickly weaned to trach mask and called out to the \nNIMU. She remained neurologically stable in the NIMU. She was \nmade floor status on ___. She continued to remain neurologically \nstable on the floor. Her staples from her VPS insertion were \nremoved on POD 10. At the time of staple removal, the incision \nwas well-approximated without any active drainage or signs of \ninfection. Patient's neuro exam continued to improve through \nremainder of admission. On day of discharge, she is speaking and \nalert/oriented x 2, she is following commands and moving all \nextremities. \n \n#Afib with RVR\nPatient was given IV metoprolol on ___ for HR of 150. Patient \nwas placed on O2 and a CTA chest to r/o PE which was negative \nhowever did reveal copious amounts of secretions. Patient \nremained on PO metoprolol for rate control while in the \nhospital. She had intermittent runs of SVT, but multiple EKGs \nwere with NSR. She had intermittent PVC's, but electrolytes \ncontinued to be stable. \n\n#Fever/leukocytosis\nPatient became febrile with WBC to 17 on ___. Pan cultures were \nsend. BAL was sent on ___ which was positive for GPCs and \npatient was started on Vancomycin. Pseudomonas found in urine on \n___ overnight, cefepime started however this was switched to \nVancomycin as ID recommended due to likely colonization. On \n___, her Vancomycin was switched to Nafcillin for S. aureus \nfound in her sputum, and completed antibiotic course of \ntreatment on ___.   \n\n#ICU delirium\nOvernight ___ to ___ morning, she was mildly delirious and was \nstarted on Seroquel at bedtime. Her agitation worsened after dex \nso the dose was decreased to 4mg q12h and was slowly tapered \noff. On day of discharge, she had no delirium noted. \n\n#Dysphagia\nSLP evaluated the patient for dysphagia postoperatively. The \npatient was NPO and a NGT was placed. SLP recommended \nconsultation with ACS for PEG placement. ACS evaluated patient \nand agreed to PEG placement, which was done on ___. Tube \nfeedings with glucerna started 24 hours after PEG placement and \ntitrated to goal. On day of discharge, SLP determined that she \ncould have bolus feedings. They recommended obtaining patient's \nweight three times per week. \n\n#?Seizure/syncope\nOn the evening of ___ the patient was on the commode and became \nunresponsive with LUE rhythmic twitching. A STAT NCHCT was \nstable. She was loaded with Keppra and placed on EEG. EEG was \nnormal for over 24 hours and d/c'd. Her Keppra was decreased to \n500mg BID due to side effects. \n\n#Hypoxia, respiratory failure\nOn ___ she was triggered for hypoxia while sitting up with ___. \nHer sats dropped to low 80's. She was placed on NRB with \nimproved sats to mid 90's.  On neurosurgical assessment she was \nnot in distress, and denied CP/SOB. She was made NPO. Medicine \nwas consulted for assistance with management. CXR showed \nbibasilar atelectasis. She was initially started on dual \nantibiotics which were d/c'd as the event was attributed to a \nmucous plug or acute aspiration event without pneumonia. She was \nstarted on duonebs. She resumed her diet and was given 1L IV \nfluids slowly due to NPO overnight and elevated BUN. Medicine \nrecommended stopping duonebs and giving guafenesin and chest ___ \ntherapy. Patient underwent a bronch on ___ which also revealed \ncopious amounts of secretions and BAL sent. She required \nintermittent diuresis with Lasix.  On ___, her sputum was found \nto be growing out S. aureus and her antibiotics were changed \nfrom Vancomycin to Nafcillin for proper coverage. Patient \nremained intubated and there were ongoing discussions for trach \nand PEG placement. ACS was consulted and trach was placed on \n___. On ___, the patient self discontinued her own trach, \nbut it was quickly and easily replaced at the bedside by \nRespiratory. The patient remained stable during this time \nwithout any desats or clinical signs of respiratory distress. On \n___, patient self discontinued her trach. She tolerated on room \nair without any signs of respiratory distress. However, ACS team \nwas consulted and felt that given she had a size 8 trach in \nplace it would be safer to still replace the trach at a smaller \nsize. Trach was replaced with smaller size and with a red cap \non. Patient tolerated well. She was decannulated on ___ which \nshe tolerated well. On day of discharge, she is requiring no \nsupplemental oxygen. \n\n#Left ear blockage\nENT was called on ___ as the patient was noted to have a hard, \nblack, crusty substance in her left ear. ENT believes this to be \ndried blood and OR prep solution and recommended cipro drops BID \nx 10 days. \n\n#Blood pressure\nOn ___, she was borderline hypotensive. She was given 1L of LR, \nand her home amlodipine was held, which improved her systolic \nblood pressures. Her home Amlodipine 10mg daily was resumed on \n___.\n\n#Left Shoulder Injury \nPatient had left arm weakness and c/o left arm pain after \nsustaining fall on that shoulder. ACS tertiary survey was done \nand should xrays were obtained which showed some prominence at \nthe left AC joint. Ortho was consulted who recommended range of \nmotion and activity as tolerated and a sling for comfort. \nPatient will follow up with orthopedics outpatient in ___ weeks. \nNo further inpatient workup indicated. The orthopedics team were \npaged on ___ as the patient had remained inpatient and did not \nfollow-up in their clinic as originally planned and advised the \npatient to follow-up 2 weeks after discharge.\n\n#Right Knee Pain \nPatient with chronic right knee pain and secondary right leg \nweakness. ACS tertiary survey was done and knee Xrays were \nobtained which demonstrated chronic degenerative changes. No \nfurther workup indicated. \n\n#Right Eye Terigium with irritation \nPatient was noted to have swollen right eye with irritation and \nexudates. Optho was consulted and evaluated a Terigium in the \nright eye which was causing excessive eye irritation. Recs were \nappreciated and patient was given artificial tears and gel. \nPatient will follow up with ophthalmology after discharge for \nfurther outpatient workup and management. Patient was \nre-evaluated by ophtho on ___, they dilated the left pupil and \npatient was noted to have epithelial thinning and was given \nerythromycin ointment to the left eye. Ophtho re-evaluated the \npatient on ___ and recommended continuing lubricating drops for \nthe left eye and taping the eye closed at night. She will plan \nto follow-up with outpatient Ophthalmology ___ weeks after \ndischarge. \n\n#Dispo\nShe had a PICC line placed while hospitalized, this was removed \non day of discharge. \n___ and OT were consulted and recommended rehab. Her case was \nescalated to complex case management for lack of insurance. \nPatient was discharged to rehab on ___.  \n \nMedications on Admission:\n- Glucosamine 1500 complex\n- Diclofenac sodium 3% transdermal BID\n- Ibuprofen 600mg TID\n- Norvasc 10mg QD\n- HCTZ 25mg QD\n- Losartan 100mg QD\n- Tylenol ___ Q6hr PRN\n- MVI, levoxyl 125mcg QD\n- Toprol XL 50mg QD\n\n \nDischarge Medications:\n1.  Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild/Fever  \n2.  Albuterol Inhaler ___ PUFF IH Q4H:PRN Wheezing  \n3.  Artificial Tear Ointment 1 Appl LEFT EYE QHS apply then tape \neye shut overnight  \n4.  Artificial Tears GEL 1% 2 DROP LEFT EYE Q2H durin the day \n___  \n5.  Bisacodyl 10 mg PO/PR DAILY:PRN Constipation  \n6.  Ciprofloxacin 0.3% Ophth Soln 2 DROP BOTH EARS TID  \n7.  Famotidine 20 mg PO BID  \n8.  Glycopyrrolate 1 mg PO BID  \n9.  Heparin 5000 UNIT SC BID  \n10.  NPH 7 Units Breakfast\nNPH 7 Units Bedtime\nInsulin SC Sliding Scale using REG Insulin \n11.  LevETIRAcetam Oral Solution 500 mg PO Q12H  \n12.  Levothyroxine Sodium 125 mcg PO DAILY  \n13.  Lidocaine 5% Patch 1 PTCH TD QAM right knww, 12h on 12h off \n \n14.  Metoprolol Tartrate 25 mg PO Q8H  \n15.  Multivitamins W/minerals 1 TAB PO DAILY  \n16.  Polyethylene Glycol 17 g PO DAILY  \n17.  QUEtiapine Fumarate 25 mg PO QHS:PRN insomnia/agitation  \n18.  Senna 8.6 mg PO BID:PRN Constipation  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nLarge petroclival meningioma\nRespiratory failure\nLeft eye exposure keratopathy\n\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nDischarge Instructions\nBrain Tumor\n\nSurgery:\n- You underwent surgery to remove a brain lesion from your \nbrain. \n- You had a VP shunt placed for hydrocephalus. \n- Your shunt is a ___ Strata Valve which is programmable. \nThis will need to be readjusted after all MRIs or exposure to \nlarge magnets.  Your shunt is programmed to 1.0.\n- All of your surgical staples have been removed. \n- You may shower at this time but keep your incision as dry as \npossible until fully healed.\n- It is best to keep your incision open to air but it is ok to \ncover it when outside. \n- Call your surgeon if there are any signs of infection like \nredness, fever, or drainage. \n\nActivity:\n- We recommend that you avoid heavy lifting, running, climbing, \nor other strenuous exercise until your follow-up appointment.\n- You make take leisurely walks and slowly increase your \nactivity at your own pace once you are symptom free at rest. \n___ try to do too much all at once.\n- No driving while taking any narcotic or sedating medication. \n- If you experienced a seizure while admitted, you are NOT \nallowed to drive by law. \n- No contact sports until cleared by your neurosurgeon. You \nshould avoid contact sports for 6 months. \n\nMedications:\n- Please do NOT take any blood thinning medication (Aspirin, \nIbuprofen, Plavix, Coumadin) until cleared by the neurosurgeon. \n- You have been discharged on Keppra (Levetiracetam). This \nmedication helps to prevent seizures. Please continue this \nmedication as indicated on your discharge instruction. It is \nimportant that you take this medication consistently and on \ntime. \n- You may use Acetaminophen (Tylenol) for minor discomfort if \nyou are not otherwise restricted from taking this medication.\n\nWhat You ___ Experience:\n- You may experience headaches and incisional pain. \n- You may also experience some post-operative swelling around \nyour face and eyes. This is normal after surgery and most \nnoticeable on the second and third day of surgery.  You apply \nice or a cool or warm washcloth to your eyes to help with the \nswelling. The swelling will be its worse in the morning after \nlaying flat from sleeping but decrease when up. \n- You may experience soreness with chewing. This is normal from \nthe surgery and will improve with time. Softer foods may be \neasier during this time. \n- Feeling more tired or restlessness is also common.\n- Constipation is common. Be sure to drink plenty of fluids and \neat a high-fiber diet. If you are taking narcotics (prescription \npain medications), try an over-the-counter stool softener.\n\nWhen to Call Your Doctor at ___ for:\n- Severe pain, swelling, redness or drainage from the incision \nsite. \n- Fever greater than 101.5 degrees Fahrenheit\n- Nausea and/or vomiting\n- Extreme sleepiness and not being able to stay awake\n- Severe headaches not relieved by pain relievers\n- Seizures\n- Any new problems with your vision or ability to speak\n- Weakness or changes in sensation in your face, arms, or leg\n\nCall ___ and go to the nearest Emergency Room if you experience \nany of the following:\n- Sudden numbness or weakness in the face, arm, or leg\n- Sudden confusion or trouble speaking or understanding\n- Sudden trouble walking, dizziness, or loss of balance or \ncoordination\n- Sudden severe headaches with no known reason\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904821bfb505ee75390dbe7"
  },
  "note_id": "14903001-DS-18",
  "subject_id": 14903001,
  "hadm_id": 22112196,
  "note_type": "DS",
  "note_seq": 18,
  "charttime": "2122-02-18 00:00:00",
  "storetime": "2122-02-18 17:46:00",
  "text": " \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nAmoxicillin / codeine / iodine\n \nAttending: ___.\n \nChief Complaint:\nAbdominal pain\n \nMajor Surgical or Invasive Procedure:\nSigmoid colectomy  \n___ procedure\n\n \nHistory of Present Illness:\n___ with diverticulitis that has been refractory to medical\nmanagement with multiple courses of PO antibiotics. She \ninitially\npresented to ___ last ___ with acute onset and\nsevere LLQ pain, diverticulitis was diagnosed, she was started \non\na course of Cipro/Flagyl. This was later switched to \nMoxifloxacin\ndue to poor tolerance. She has had ongoing LLQ pain. A\nColonoscopy was attempted last ___, however, the scope was\nunable to pass the descending colon due to an area of narrowing.\nA virtue colonography was done in ___ and found numerous\nscattered sigmoid and narrowing of the distal descending sigmoid\ncolon. She was referred to Dr. ___ to be evaluated\nfor a left colectomy. Approximately 5 days prior to clinic \nvisit,\nshe began to feel \"hard lumps\" superficially in the LLQ and\nincrease in pain. She also reported recent diarrhea without \nblood\nor mucus. \n\n \nPast Medical History:\nsinusitis, hypertension, high cholesterol, asthma, \nhyperglycemia,\nosteoporosis, colonoscopy ___, Cololonoscopy ___ could not\npass scope past sigmoid because of diverticular narrowing and\npoor prep, reflux endoscopy ___ okay atrophic vaginitis\ncervical and lumbar spondylosis\n\n \nSocial History:\n___\nFamily History:\nFamily History: DM- Mother/Father\n\n \nPhysical ___:\nTemp 98.3  HR 84  BP 148/62  RR18  96% RA\nGEN: NAD, AAOx3, pleasant\nCV: RRR\nPULM: CTAB, no respiratory distress\nABD: Soft, nondistended, nontender, ostomy pink and viable with \ngas and small amount of stool. \nEXT: withou edema \n\n \nPertinent Results:\n___ 12:40AM BLOOD WBC-7.8 RBC-3.99* Hgb-10.4* Hct-32.2* \nMCV-81* MCH-26.1* MCHC-32.4 RDW-16.1* Plt ___\n___ 05:30AM BLOOD WBC-13.2* RBC-4.44# Hgb-11.2*# Hct-36.8# \nMCV-83 MCH-25.2* MCHC-30.4* RDW-16.4* Plt ___\n___ 05:05AM BLOOD WBC-10.5 RBC-3.98* Hgb-10.3* Hct-32.3* \nMCV-81* MCH-25.9* MCHC-31.9 RDW-17.0* Plt ___\n\nCT abdomen/pelvis ___\n\nIMPRESSION:  \n  \n1. Sigmoid diverticulitis with perforation and development of a \nphlegmon in the left pericolonic region, with inflammatory soft \ntissue involving the left iliopsoas muscles extending into and \ninvolving the adjacent left anterior abdominal wall musculature. \nA multiloculated abscess is seen involving the left anterior \nabdominal wall musculature with extension into the adjacent \nsubcutaneous tissues at the level of the left iliac crest. \n2. The urinary bladder is deviated to the left hemipelvis and \ndemonstrates uniform, likely inflammatory wall thickening along \nits left lateral aspect extending to the dome. There is no \nevidence of a colovesical fistula. \n3.  Diffusely atrophic pancreatic parenchyma with uniform \ndilatation of the main pancreatic duct, unchanged since ___. Exact etiology for this is not evident on today's \nexam. An additional lobulated hypoattenuating focus in the \nuncinate process likely represents a side branch intraductal \npapillary mucinous neoplasm, stable. \n\n \nBrief Hospital Course:\nBrief Hospital Course:\nThe patient presented Dr. ___ on ___ with very \npainful LLQ and erythema. \n\nGiven the findings, the patient was admitted to ___ and made NPO \nand given IV fluids. She was placed on IV Cipro and Zosyn. CT \nabdomen pelvis revealed a phlegmon in the left pericolonic \nregion and inflammation of the surround muscle and soft tissue. \nDecision was made to take her to the OR the follow day.  She \nunderwent a sigmoid colectomy and ___ procedure on ___. \nShe tolerated the procedure well and was transferred to the \nfloor after an uneventful stay in the PACU.  Her pain was \ninitially managed with PCA. The ostomy was pink and robust, she \nbegan to tolerate sips on POD1. We slowly advanced her to clears \non POD2, her foley was also DC'd and she voided without issue. \nPrevious LLQ erythema significantly resolved. Her bowel funciton \nwas slow to return. We switched her to oral pain regimen on \n___. Her pain was controlled with relatively small amount of \nnarcotics, was OOB and ambulating. She finally passed flatus on \n___, we advanced diet as tolerated to regular. Antibiotics were \ndiscontinued on the same day.  We digitized the stoma and found \na hard stool ball. We instilled mineral oil through the ostomy \nseveral days in a row and provided her with an oral bowel \nregimen.  She had small amount of stool output on ___. She was \ndeemed stable for discharge on ___. \n\nCV: The patient remained stable from a cardiovascular \nstandpoint; vital signs were routinely monitored.\n\nPulmonary: The patient remained stable from a pulmonary \nstandpoint; vital signs were routinely monitored. Good pulmonary \ntoilet, early ambulation and incentive spirometry were \nencouraged throughout hospitalization.\n \nGI/GU/FEN: The patient was initially kept NPO with IV fluids. \nPre op UA was negative. Electrolytes were checked daily and \nrepleted.  \n\nID: The patient's fever curves were closely watched for signs of \ninfection, of which there were none.\n\nHEME: The patient's blood counts were closely watched for signs \nof bleeding, of which there were none.\n\nProphylaxis: The patient received subcutaneous heparin and ___ \ndyne boots were used during this stay and was encouraged to get \nup and ambulate as early as possible.\n\nAt the time of discharge, the patient was doing well, afebrile \nand hemodynamically stable.  The patient was tolerating a diet, \nambulating, voiding without assistance, and pain was well \ncontrolled.  The patient received discharge teaching and \nfollow-up instructions with understanding verbalized and \nagreement with the discharge plan. \n\n \nMedications on Admission:\nErgocalciferol, Advair 100/50, Simvastatin 10', ___ 81, \nAscorbic acid, B-Complex with vitamin C, Probiotic, Fish oil \n \nDischarge Medications:\n1. Acetaminophen 650 mg PO Q8H pain \nTake as needed, no more than 3000 mg in a single day \nRX *acetaminophen 325 mg ___ tablet(s) by mouth Every ___ hours \nDisp #*60 Tablet Refills:*0\n2. Aspirin 81 mg PO DAILY \n3. Docusate Sodium 100 mg PO BID \nRX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth Twice \na day Disp #*60 Capsule Refills:*2\n4. Fluticasone-Salmeterol Diskus (100/50) 1 INH IH BID \n5. Polyethylene Glycol 17 g PO DAILY \nRX *polyethylene glycol 3350 [Miralax] 17 gram/dose 1 cap by \nmouth daily Refills:*1\n6. OxycoDONE (Immediate Release)  2.5-5 mg PO Q4H:PRN pain \nTake as needed for pain. Avoid driving while taking \nRX *oxycodone 5 mg half -1 capsule(s) by mouth every ___ hours \nDisp #*20 Capsule Refills:*0\n7. Senna 8.6 mg PO BID \nRX *sennosides [senna] 8.6 mg 1 capsule by mouth twice daily \nDisp #*60 Capsule Refills:*2\n8. Tiotropium Bromide 1 CAP IH DAILY \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nComplicated Diverticulitis.\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nDear ___, you were admitted to the hospital with a \ncomplicated diverticulitis with abscess. You were taken to the \noperating room and underwent resection of the diseased bowel and \nformation of an end colostomy. You tolerated the procedure well \nand are now being discharged home to continue your recovery with \nthe following instructions.\n \nPlease follow up in the Acute Care Surgery clinic at the \nappointment listed below.\n \nACTIVITY:\n \no  Do not drive until you have stopped taking pain medicine and \nfeel you could respond in an emergency.\no  You may climb stairs. \no  You may go outside, but avoid traveling long distances until \nyou see your surgeon at your next visit.\no  Don't lift more than ___ lbs for 4 weeks. (This is about \nthe weight of a briefcase or a bag of groceries.) \no  You may start some light exercise when you feel comfortable.\no  You will need to stay out of bathtubs or swimming pools for a \ntime while your incision is healing. Ask your doctor when you \ncan resume tub baths or swimming.\n \nHOW YOU MAY FEEL: \no  You may feel weak or \"washed out\" for a couple of weeks. You \nmight want to nap often. Simple tasks may exhaust you.\no  You may have a sore throat because of a tube that was in your \nthroat during surgery.\no  You might have trouble concentrating or difficulty sleeping. \nYou might feel somewhat depressed.\no  You could have a poor appetite for a while. Food may seem \nunappealing.\no  All of these feelings and reactions are normal and should go \naway in a short time.  If they do not, tell your surgeon.\n \nYOUR INCISION:\no Your incisions may be slightly red around the staple line. \nThis is normal. The staples will be removed in clinic.\no You may gently wash away dried material around your incision.\no Avoid direct sun exposure to the incision area.\no Do not use any ointments on the incision unless you were told \notherwise.\no You may see a small amount of clear or light red fluid \nstaining your dressing or clothes. If the staining is severe, \nplease call your surgeon.\no You may shower. As noted above, ask your doctor when you may \nresume tub baths or swimming.\n  \nPAIN MANAGEMENT:\no It is normal to feel some discomfort/pain following abdominal \nsurgery. This pain is often described as \"soreness\". \no Your pain should get better day by day. If you find the pain \nis getting worse instead of better, please contact your surgeon.\no You will receive a prescription for pain medicine to take by \nmouth. It is important to take this medicine as directed. \no Do not take it more frequently than prescribed. Do not take \nmore medicine at one time than prescribed.\no Your pain medicine will work better if you take it before your \npain gets too severe.\no Talk with your surgeon about how long you will need to take \nprescription pain medicine. Please don't take any other pain \nmedicine, including non-prescription pain medicine, unless your \nsurgeon has said its okay.\no If you are experiencing no pain, it is okay to skip a dose of \npain medicine.\no Remember to use your \"cough pillow\" for splinting when you \ncough or when you are doing your deep breathing exercises.\nIf you experience any of the following, please contact your \nsurgeon:\n- sharp pain or any severe pain that lasts several hours\n- pain that is getting worse over time\n- pain accompanied by fever of more than 101\n- a drastic change in nature or quality of your pain\n \nMEDICATIONS:\nTake all the medicines you were on before the operation just as \nyou did before, unless you have been told differently.\nIf you have any questions about what medicine to take or not to \ntake, please call your surgeon.\n\nCurrently your colostomy is allowing the surgery in your large \nintestine or rectum to heal, which does take some time. You will \ncome back to the hospital for reversal of this colostomy at a \ntime decided on by your surgeon. You will follow-up in the \nclinic, and the surgeon will decide when will be the best time \nfor your second surgery. Until this time there is healthy \nintestine that is still functioning as it normally would and it \nwill produce mucus and some may leak or you may feel as though \nyou need to have a bowel movement and you may sit on the toilet \nand empty this mucus, it is normal. \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904821bfb505ee75390dbe8"
  },
  "note_id": "14903001-DS-19",
  "subject_id": 14903001,
  "hadm_id": 22499731,
  "note_type": "DS",
  "note_seq": 19,
  "charttime": "2122-07-27 00:00:00",
  "storetime": "2122-07-28 17:10:00",
  "text": " \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nAmoxicillin / codeine / iodine\n \nAttending: ___.\n \nChief Complaint:\nElective Colostomy Takedown\n \nMajor Surgical or Invasive Procedure:\n___: Colostomy take down, ileostomy formation.\n\n \nHistory of Present Illness:\nPer Operative Report: This woman has had an operation to carry \nthe ___ procedure about 5 months ago.  It was thought that \nshe needed to have her colostomy taken down as she wished to \nhave it done.\n\n \nPast Medical History:\nsinusitis, hypertension, high cholesterol, asthma, \nhyperglycemia,\nosteoporosis, colonoscopy ___, Cololonoscopy ___ could not\npass scope past sigmoid because of diverticular narrowing and\npoor prep, reflux endoscopy ___ okay atrophic vaginitis\ncervical and lumbar spondylosis\n\n \nSocial History:\n___\nFamily History:\nFamily History: DM- Mother/Father\n\n \nPhysical ___:\nClinic visit:  ___:\n\nPhysical exam:\nTemp: 97.0 ; P: 88 ; BP: 176/66 ; RR: 12 ; O2:100%\nGeneral: alert and oriented X3, in no acute distress\nHEENT: oral mucosa moist, no lymphadenopathy\nResp: clear breath sounds bilaterally\nCV: RRR, no murmurs, rubs or gallops\nGI: soft, non-distended, mid-line scar healing well, ostomy in\nplace without surrounding erythema or drainage\nExtremities: skin intact, mobile, absent trauma \n\nPhysical examination upon discharge:  ___:\n\nvital signs:  98.6, 102, bp=133/55, rr=20, 94% room air\n\nGENERAL:  NAD\n\nCV:  ns1, s2, -s3, -s4\nABDOMEN:  soft, mid-line staples clean and dry, ileostomy stoma \npink, left side ostomy side with erythematous border, purulent \ndrainage on dressing, outer border of ostomy dry, normagel \napplied, DSD.\nEXT:  no pedal edema bil, no calf tenderness bil\nNEURO:  alert and oriented x 3, speech clear\n\n \nPertinent Results:\n___ 04:45AM BLOOD WBC-8.1 RBC-4.32 Hgb-12.7 Hct-39.5 MCV-91 \nMCH-29.4 MCHC-32.2 RDW-16.4* RDWSD-54.7* Plt ___\n___ 05:50AM BLOOD WBC-11.0* RBC-4.04 Hgb-11.7 Hct-37.5 \nMCV-93 MCH-29.0 MCHC-31.2* RDW-16.4* RDWSD-56.2* Plt ___\n___ 06:35AM BLOOD WBC-10.4* RBC-3.96 Hgb-11.6 Hct-37.2 \nMCV-94# MCH-29.3# MCHC-31.2* RDW-16.3* RDWSD-56.1* Plt ___\n___ 04:45AM BLOOD Glucose-136* UreaN-12 Creat-0.5 Na-139 \nK-3.3 Cl-96 HCO3-29 AnGap-17\n___ 05:50AM BLOOD Glucose-158* UreaN-6 Creat-0.4 Na-138 \nK-3.2* Cl-97 HCO3-28 AnGap-16\n___ 04:45AM BLOOD Calcium-9.3 Phos-3.6# Mg-3.1*\n \nBrief Hospital Course:\nMs. ___ is a ___ year-old female with a history of a sigmoid \ncolectomy and ___ procedure performed on ___, due to \ndiverticulitis with perforation and\nphlegmon development.  She had been doing well after her \nsurgery.  She returned to the hospital to have a colostomy \ntake-down.\n\nOn ___, she was taken to the operating room where she underwent \ncolostomy take-down, extensive lysis of adhesions, and a loop \nileostomy.  \nThe operative course was stable with a 200cc blood loss. During \nthe procedure, a bridge was placed under the ileostomy.  At the \nclose of the procedure ___ drain was placed in the left \npelvis.  The patient was extubated after the procedure and \nmonitored in the recovery room.  On POD #1, she was started on \nclears and advanced to a regular diet.  Her surgical pain was \ncontrolled with a PCA. She began to have ostomy output on POD \n#3.  She was assisted in caring for her ostomy by the ostomy \nnurse.  She was transitioned to oral analgesia and the PCA was \ndiscontinued. The bridge and ___ drain were removed on POD # \n5.\n\nThe patient was discharged on POD #5 in stable condition.  At \nthe time of discharge, her vital signs were stable and she was \nafebrile.  She was tolerating a regular diet and voiding without \ndifficulty.  Her incisional pain was controlled with oral \nanalgesia. Prior to discharge, the Ostomy nurse reviewed the \ncare of the ileostomy and answered the patient's questions.  \n\nA follow-up appointment was made with Dr. ___ in 1 week.  \n___ services were provided to assist the patient at home in \ncaring for her ileostomy.    \n    \n \nMedications on Admission:\nERGOCALCIFEROL (VITAMIN D2) [VITAMIN D2] - Dosage uncertain -  \n (Prescribed by Other Provider)  \n FLUTICASONE-SALMETEROL [ADVAIR DISKUS] - Advair Diskus 100 \nmcg-50  \n mcg/dose powder for inhalation. twice a day - (Prescribed by  \n Other Provider)  \n SIMVASTATIN - simvastatin 10 mg tablet. 1 tablet(s) by mouth  \n daily - (Prescribed by Other Provider)  \n TIOTROPIUM BROMIDE [SPIRIVA WITH HANDIHALER] - Dosage uncertain \n-  \n (Prescribed by Other Provider)  \n \n Medications - OTC  \n ASCORBIC ACID [ACEROLA C] - Acerola C 500 mg chewable tablet. 1 \n \n tablet(s) by mouth daily - (Prescribed by Other Provider)  \n ASPIRIN - aspirin 81 mg chewable tablet. 1 tablet(s) by mouth  \n daily - (Prescribed by Other Provider)  \n B-COMPLEX WITH VITAMIN C [VITAMIN B COMPLEX WITH C] - Dosage  \n uncertain - (Prescribed by Other Provider)  \n LACTOBACILLUS COMBINATION NO.4 [PROBIOTIC] - Dosage uncertain - \n \n (Prescribed by Other Provider)  \n OMEGA 3-DHA-EPA-FISH OIL [FISH OIL] - Dosage uncertain -  \n (Prescribed by Other Provider)  \n\n \nDischarge Medications:\n1. Fluticasone-Salmeterol Diskus (100/50) 1 INH IH BID \n2. OxycoDONE (Immediate Release)  5 mg PO Q4H:PRN pain \ndo NOT drive or drink alcohol while taking this medication \nRX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours \nDisp #*40 Tablet Refills:*0\n3. Simvastatin 10 mg PO QPM \n4. Tiotropium Bromide 1 CAP IH DAILY \n5. Acetaminophen 650 mg PO Q6H:PRN pain \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nColostomy takedown, loop ileostomy \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou presented to the ___ for an \nelective Colostomy takedown procedure.  You were taken to the \nOperating Room for this procedure on ___.  Because of \ncomplications during surgery, a loop ileostomy was created.  In \nyour follow-up appointment in the Acute Care Surgery clinic, \nplans for an elective procedure for ileostomy takedown will be \ndiscussed. \n\nYou have been visited by the Ostomy nurse and will be discharged \nto home with visiting nurse services.  You have tolerated a \nregular diet, worked with Physical Therapy and your pain is \ncontrolled on oral pain medication.  You are now medically \ncleared to be discharged to home to continue your recovery.\n\nPlease note the following discharge instructions:\n\nPlease call your doctor or nurse practitioner or return to the \nEmergency Department for any of the following:\n*You experience new chest pain, pressure, squeezing or \ntightness.\n*New or worsening cough, shortness of breath, or wheeze.\n*If you are vomiting and cannot keep down fluids or your \nmedications.\n*You are getting dehydrated due to continued vomiting, diarrhea, \nor other reasons. Signs of dehydration include dry mouth, rapid \nheartbeat, or feeling dizzy or faint when standing.\n*You see blood or dark/black material when you vomit or have a \nbowel movement.\n*You experience burning when you urinate, have blood in your \nurine, or experience a discharge.\n*Your pain in not improving within ___ hours or is not gone \nwithin 24 hours. Call or return immediately if your pain is \ngetting worse or changes location or moving to your chest or \nback.\n*You have shaking chills, or fever greater than 101.5 degrees \nFahrenheit or 38 degrees Celsius.\n*Any change in your symptoms, or any new symptoms that concern \nyou.\n\nPlease resume all regular home medications, unless specifically \nadvised not to take a particular medication. Also, please take \nany new medications as prescribed.\n\nPlease get plenty of rest, continue to ambulate several times \nper day, and drink adequate amounts of fluids. Avoid lifting \nweights greater than ___ lbs until you follow-up with your \nsurgeon.\n\nAvoid driving or operating heavy machinery while taking pain \nmedications.\n\nIncision Care:\n*Please call your doctor or nurse practitioner if you have \nincreased pain, swelling, redness, or drainage from the incision \nsite.\n*Avoid swimming and baths until your follow-up appointment.\n*You may shower, and wash surgical incisions with a mild soap \nand warm water. Gently pat the area dry.\n*If you have staples, they will be removed at your follow-up \nappointment.\n*If you have steri-strips, they will fall off on their own. \nPlease remove any remaining strips ___ days after surgery.\n\nMonitoring Ostomy output/ Prevention of Dehydration:\n*Keep well hydrated.\n*Replace fluid loss from ostomy daily.\n*Avoid only drinking plain water. Include Gatorade and/or other \nvitamin drinks to replace fluid.\n*Try to maintain ostomy output between 1000mL to 1500mL per day. \n\n*If Ostomy output >1 liter, take 4mg of Imodium, repeat 2mg with \neach episode of loose stool. Do not exceed 16mg/24 hours.\n \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904821bfb505ee75390dbe9"
  },
  "note_id": "14903001-DS-20",
  "subject_id": 14903001,
  "hadm_id": 28189079,
  "note_type": "DS",
  "note_seq": 20,
  "charttime": "2122-08-04 00:00:00",
  "storetime": "2122-08-08 05:49:00",
  "text": " \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nAmoxicillin / codeine / iodine\n \nAttending: ___.\n \nChief Complaint:\nFluid collection at staple line\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\n___ h/o diverticulitis s/p ___ (___) s/p colostomy \ntakedown with diverting\nileostomy (___) discharged on ___ now p/w N/V, poor po \nintake, dehydration, malaise. Imaging shows sm fluid collection \ndeep to midline inc. \n \nPast Medical History:\nsinusitis, hypertension, high cholesterol, asthma, \nhyperglycemia,\nosteoporosis, colonoscopy ___, Cololonoscopy ___ could not\npass scope past sigmoid because of diverticular narrowing and\npoor prep, reflux endoscopy ___ okay atrophic vaginitis\ncervical and lumbar spondylosis\n\n \nSocial History:\n___\nFamily History:\nFamily History: DM- Mother/Father\n\n \nPhysical ___:\nVS\n98.4 117/54 18 96RA\nGen: AAOx3\nHEENT: NCAT, PERRLA, EOMI, mucosa pink, no LAD\nCV: RRR no mrg\nPulm: CTA ___, no w/r/c\nAbd: s/nt/nd; bsx4; inc: c/d/i; new ostomy bag conforms without \nleakage. ileostomy p/p/p\next: no c/c/e; +2 pulses \n \nPertinent Results:\n___ 03:45PM URINE  HOURS-RANDOM\n___ 03:45PM URINE  HOURS-RANDOM\n___ 03:45PM URINE  UHOLD-HOLD\n___ 03:45PM URINE  GR HOLD-HOLD\n___ 03:45PM URINE  COLOR-Yellow APPEAR-Hazy SP ___\n___ 03:45PM URINE  BLOOD-SM  NITRITE-NEG PROTEIN-30 \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 \nLEUK-LG\n___ 03:45PM URINE  RBC-4* WBC-56* BACTERIA-FEW YEAST-NONE \nEPI-20 TRANS EPI-1\n___ 03:45PM URINE  HYALINE-3*\n___ 03:45PM URINE  MUCOUS-RARE\n___ 12:20PM   LACTATE-1.7 K+-4.4\n___ 12:00PM   GLUCOSE-127* UREA N-49* CREAT-1.6*# \nSODIUM-133 POTASSIUM-6.1* CHLORIDE-90* TOTAL CO2-25 ANION \nGAP-24*\n___ 12:00PM   estGFR-Using this\n___ 12:00PM   CALCIUM-9.8 PHOSPHATE-5.8*# MAGNESIUM-2.1\n___ 12:00PM   WBC-17.1*# RBC-4.20 HGB-12.3 HCT-37.7 MCV-90 \nMCH-29.3 MCHC-32.6 RDW-16.0* RDWSD-52.5*\n___ 12:00PM   NEUTS-78.0* LYMPHS-13.2* MONOS-6.8 EOS-0.8* \nBASOS-0.4 IM ___ AbsNeut-13.33* AbsLymp-2.25 AbsMono-1.17* \nAbsEos-0.14 AbsBaso-0.07\n___ 12:00PM   PLT COUNT-739*#\n \nBrief Hospital Course:\n___ h/o diverticulitis s/p ___ (___) s/p colostomy \ntakedown with diverting\nileostomy (___) discharged on ___ was admitted to ACS \nservice for irritation and pain at ostomy site along with some \ndrainage ___ sm fluid collection deep to midline inc.  pt was \nresuscitated during her hospital stay with IVF. pt was AAOx3 \nthroughout hospitalization. Her pain was well controlled with po \npain medication. Cardiovascular functions were monitored \nroutinely noninvasively and pt was hemodynamically stable. \nPulmonary toilet was encouraged with early oob/amb and IS. pt's \ntolerated a regular diet almost immediately. Her ostomy output \nwas titrated as it's output was too high. She was also given \nteaching on how to titrate her output upon discharge with \nimodium and metamucil wafers. pt's fluid balance was recorded \nand electrolytes were repleted appropriately. Her ostomy output \nwas under control at HD#2. Ostomy nurse was consulted for ostomy \nsite management and wound care. Details of wound care and \nintervention is documented in OMR. pt was afebrile throughout \nhospitalization. ppx was given as HSQ. Upon d/c, pt was doing \nwell, afebrile, and hemodynamically stable wnl. pt received \ndischarge instructions and teaching, along with follow up \ninstructions. pt verbalizes agreement and understanding of \ndischarge plans.\n \nDischarge Medications:\n1. Acetaminophen 650 mg PO TID \n2. Aspirin 81 mg PO DAILY \n3. Ciprofloxacin HCl 250 mg PO Q24H \nRX *ciprofloxacin HCl [Cipro] 250 mg 1 tablet(s) by mouth once a \nday Disp #*10 Tablet Refills:*0\n4. HYDROmorphone (Dilaudid) 2 mg PO Q4H:PRN pain \nRX *hydromorphone [Dilaudid] 2 mg ___ tablet(s) by mouth every \nsix (6) hours Disp #*40 Tablet Refills:*0\n5. Fluticasone-Salmeterol Diskus (100/50) 1 INH IH BID \n6. Omeprazole 20 mg PO DAILY \n7. Simvastatin 10 mg PO QPM \n8. Tiotropium Bromide 1 CAP IH DAILY \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \n___ Diagnosis:\nColostomy takedown, loop ileostomy, dehydration\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou presented to the ___ for an \n\nelective Colostomy takedown procedure.  You were taken to the \nOperating Room for this procedure on ___.  Because of \ncomplications during surgery, a loop ileostomy was created.  In \nyour follow-up appointment in the Acute Care Surgery clinic, \nplans for an elective procedure for ileostomy takedown will be \ndiscussed. \n\nYou have been visited by the Ostomy nurse and will be discharged \n\nto home with visiting nurse services.  You have tolerated a \nregular diet, worked with Physical Therapy and your pain is \ncontrolled on oral pain medication.  You are now medically \ncleared to be discharged to home to continue your recovery.\n\nPlease note the following discharge instructions:\n\nPlease call your doctor or nurse practitioner or return to the \nEmergency Department for any of the following:\n*You experience new chest pain, pressure, squeezing or \ntightness.\n*New or worsening cough, shortness of breath, or wheeze.\n*If you are vomiting and cannot keep down fluids or your \nmedications.\n*You are getting dehydrated due to continued vomiting, diarrhea, \n\nor other reasons. Signs of dehydration include dry mouth, rapid \nheartbeat, or feeling dizzy or faint when standing.\n*You see blood or dark/black material when you vomit or have a \nbowel movement.\n*You experience burning when you urinate, have blood in your \nurine, or experience a discharge.\n*Your pain in not improving within ___ hours or is not gone \nwithin 24 hours. Call or return immediately if your pain is \ngetting worse or changes location or moving to your chest or \nback.\n*You have shaking chills, or fever greater than 101.5 degrees \nFahrenheit or 38 degrees Celsius.\n*Any change in your symptoms, or any new symptoms that concern \nyou.\n\nPlease resume all regular home medications, unless specifically \nadvised not to take a particular medication. Also, please take \nany new medications as prescribed.\n\nPlease get plenty of rest, continue to ambulate several times \nper day, and drink adequate amounts of fluids. Avoid lifting \nweights greater than ___ lbs until you follow-up with your \nsurgeon.\n\nAvoid driving or operating heavy machinery while taking pain \nmedications.\n\nIncision Care:\n*Please call your doctor or nurse practitioner if you have \nincreased pain, swelling, redness, or drainage from the incision \n\nsite.\n*Avoid swimming and baths until your follow-up appointment.\n*You may shower, and wash surgical incisions with a mild soap \nand warm water. Gently pat the area dry.\n*If you have staples, they will be removed at your follow-up \nappointment.\n*If you have steri-strips, they will fall off on their own. \nPlease remove any remaining strips ___ days after surgery.\n\nMonitoring Ostomy output/ Prevention of Dehydration:\n*Keep well hydrated.\n*Replace fluid loss from ostomy daily.\n*Avoid only drinking plain water. Include Gatorade and/or other \nvitamin drinks to replace fluid.\n*Try to maintain ostomy output between 1000mL to 1500mL per day. \n\n*If your ostomy output is too high, you may take take 4mg of \nImodium, repeat 2mg with each episode of loose stool. Do not \nexceed 16mg/24 hours. You may also try Metamucil wafers. \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904821bfb505ee75390dbea"
  },
  "note_id": "14903001-DS-21",
  "subject_id": 14903001,
  "hadm_id": 29896904,
  "note_type": "DS",
  "note_seq": 21,
  "charttime": "2122-09-24 00:00:00",
  "storetime": "2122-09-26 20:07:00",
  "text": " \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nAmoxicillin / codeine / iodine\n \nAttending: ___.\n \nChief Complaint:\ns/p ___ procedure for diverticulitis on ___ and\ncolostomy take-down with loop ileostomy on ___ \n \nMajor Surgical or Invasive Procedure:\n___ ileostomy takedown \n\n \nHistory of Present Illness:\n ___ year-old female s/p ___ procedure for diverticulitis \non ___ and\ncolostomy take-down with loop ileostomy on ___ who presents\ntoday regarding the results of her recent CT and to plan\nileostomy reversal. She reports that she is doing well - her\nostomy output is stable and she has had no recent episodes of\ndehydration. She is tolerating a regular diet without nausea or\nvomiting. Her recent CT scan of the pelvis with rectal contrast\ndemonstrated contrast throughout the colon without evidence of a\nleak. \n\n \nPast Medical History:\nsinusitis, hypertension, high cholesterol, asthma, \nhyperglycemia,\nosteoporosis, colonoscopy ___, Cololonoscopy ___ could not\npass scope past sigmoid because of diverticular narrowing and\npoor prep, reflux endoscopy ___ okay atrophic vaginitis\ncervical and lumbar spondylosis\n\n \nSocial History:\n___\nFamily History:\nFamily History: DM- Mother/Father\n\n \nPhysical ___:\nPHYSICAL EXAMINATION: ___\n\nGENERAL:  Well-appearing\nVITALS: T 97.5 HR 94 BP 138/61 RR 18 O2sat 99% RA, pain 0\nHEART: Regular rate and rhythm\nLUNGS: Breathing comfortably on room air\nABDOMEN: Soft, Nondistended/nontender. Ileostomy with loose\nbrown/green stool. Midline laparotomy incision and prior\ncolostomy site healing well.\nEXTREMITIES: No edema\n\n \nPertinent Results:\n___ 12:50PM BLOOD Hct-37.1\n___ 05:32PM BLOOD Hct-40.4#\n___ 05:50AM BLOOD Glucose-132* UreaN-11 Creat-0.6 Na-141 \nK-3.6 Cl-105 HCO3-29 AnGap-11\n___ 05:50AM BLOOD Calcium-8.4 Phos-2.6* Mg-1.8\n\n___:  cat scan of abdomen and pelvis:\n\nThe colorectal anastomosis is intact without leak.  No abscess.\n \nBrief Hospital Course:\n ___ year-old female s/p ___ procedure for diverticulitis \non ___ and\ncolostomy take-down with loop ileostomy on ___.  Admitted to \nthe hospital for ileostomy take-down.  She was taken to the \noperating room on ___ where she underwent an ileostomy \ntake-down.  The operative course was stable with a 20 cc blood \nloss. Wicks were placed in the abdomen at the time of closure.  \nThe patient was extubated after the procedure and monitored in \nthe recovery room. \n\nThe post-operative course was stable.  The wicks were removed on \nPOD #1. The patient's surgical pain was controlled with a PCA.  \nOn POD # 2, she resumed a regular diet.  She was transitioned \nfrom a PCA to oral analgesia. The patient was discharged home on \nPOD # 2 in stable condition.  She was ambulating and viding \nwithout difficulty.  Her vital signs were stable and she was \nafebrile.  Appointments for follow-up were made with the acute \ncare clinic.  She was encouraged to schedule an appointment with \nher primary care provider.   \n \nMedications on Admission:\n Advair 100-50\", fish oil, omeprazole 20', spiriva 18', ASA  \n 81', simvastatin 10', oxycodone 5 prn, APAP 500 prn pain  \n\n \nDischarge Medications:\n1. Acetaminophen 650 mg PO TID \n2. Docusate Sodium 100 mg PO BID \nRX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice \na day Disp #*30 Capsule Refills:*0\n3. Fluticasone-Salmeterol Diskus (100/50) 1 INH IH BID \n4. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN pain \nthis medication may cause drowsiness, do not drive while on it. \nRX *hydromorphone [Dilaudid] 2 mg ___ tablet(s) by mouth every \nfour (4) hours Disp #*30 Tablet Refills:*0\n5. Omeprazole 20 mg PO DAILY \n6. Senna 8.6 mg PO BID:PRN constipation \n7. Tiotropium Bromide 1 CAP IH DAILY \n8. Simvastatin 10 mg PO QPM \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\ns/p ___ procedure and subsequent colostomy reversal with \nloop ileostomy \n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted to the hospital to have your ileostomy taken \ndown.  You have resumed a regular diet and you are preparing for \ndischarge home with the following instructions:  \n\nDo not drive until you have stopped taking pain medicine and \nfeel you could respond in an emergency.\nYou may climb stairs. \nYou may go outside, but avoid traveling long distances until you \nsee your surgeon at your next visit.\nDon't lift more than ___ lbs for 6 weeks. (This is about the \nweight of a briefcase or a bag of groceries.) This applies to \nlifting children, but they may sit on your lap.)\nYou may start some light exercise when you feel comfortable.\nYou will need to stay out of bathtubs or swimming pools for a \ntime while your incision is healing. Ask your doctor when you \ncan resume tub baths or swimming.\nHeavy exercise may be started after 6 weeks, but use common \nsense and go slowly at first.\nYou may resume sexual activity unless your doctor has told you \notherwise.\n \nHOW YOU MAY FEEL: \n \nYou may feel weak or \"washed out\" for 6 weeks. You might want to \nnap often. Simple tasks may exhaust you.\nYou may have a sore throat because of a tube that was in your \nthroat during surgery.\nYou might have trouble concentrating or difficulty sleeping. You \nmight feel somewhat depressed.\nYou could have a poor appetite for a while. Food may seem \nunappealing.\nAll of these feelings and reactions are normal and should go \naway in a short time.  If they do not, tell your surgeon.\n \nYOUR INCISION:\nYour incision may be slightly red aroudn the stitches or \nstaples. This is normal.\nYou may gently wash away dried material around your incision.\nDo not remove steri-strips for 2 weeks. (These are the thin \npaper strips that might be on your incision.) But if they fall \noff before that that's okay).\nIt is normal to feel a firm ridge along the incision. This will \ngo away.\nAvoid direct sun exposure to the incision area.\nDo not use any ointments on the incision unless you were told \notherwise.\nYou may see a small amount of clear or light red fluid staining \nyour dressing r clothes. If the staining is severe, please call \nyour surgeon.\nYou may shower. As noted above, ask your doctor when you may \nresume tub baths or swimming.\nOve the next ___ months, your incision will fade and become \nless prominent.\n \nYOUR BOWELS:\nConstipation is a common side effect of medicine such as \nPercocet or codeine. If needed, you may take a stool softener \n(such as Colace, one capsule) or gentle laxative (such as milk \nof magnesia, 1 tbs) twice a day. You can get both of these \nmedicines without a prescription.\nIf you go 48 hours without a bowel movement, or have pain moving \nthe bowels, call your surgeon.\nAfter some operations, diarrhea can occur. If you get diarrhea, \ndon't take anti-diarrhea medicines. Drink plenty of fluitds and \nsee if it goes away. If it does not go away, or is severe and \nyou feel ill, please call your surgeon.\n \n \nPAIN MANAGEMENT:\nIt is normal to feel some discomfort/pain following abdominal \nsurgery. This pain is often described as \"soreness\". \nYour pain should get better day by day. If you find the pain is \ngetting worse instead of better, please contact your surgeon.\nYou will receive a prescription from your surgeon for pain \nmedicine to take by mouth. It is important to take this medicine \nas directied. Do not take it more frequently than prescribed. Do \nnot take more medicine at one time than prescribed.\nYour pain medicine will work better if you take it before your \npain gets too severe.\nTalk with your surgeon about how long you will need to take \nprescription pain medicine. Please don't take any other pain \nmedicine, including non-prescription pain medicine, unless your \nsurgeon has said its okay.\nIF you are experiencing no pain, it is okay to skip a dose of \npain medicine.\nRemember to use your \"cough pillow\" for splinting when you cough \nor when you are doing your deep breathing exercises.\nIf you experience any of the folloiwng, please contact your \nsurgeon:\n- sharp pain or any severe pain that lasts several hours\n- pain that is getting worse over time\n- pain accompanied by fever of more than 101\n- a drastic change in nature or quality of your pain\n \nMEDICATIONS:\nTake all the medicines you were on before the operation just as \nyou did before, unless you have been told differently.\nIn some cases you will have a prescription for antibiotics or \nother medication.\nIf you have any questions about what medicine to take or not to \ntake, please call your surgeon.\n \nDANGER SIGNS:\nPlease call your surgeon if you develop:\n- worsening abdominal pain\n- sharp or severe pain that lasts several hours\n- temperature of 101 degrees or higher\n- severe diarrhea\n- vomiting\n- redness around the incision that is spreading\n- increased swelling around the incision\n- excessive bruising around the incision\n- cloudy fluid coming from the wound\n- bright red blood or foul smelling discharge coming from the \nwound\n- an increase in drainage from the wound\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048229fb505ee753917ddc"
  },
  "note_id": "16149168-DS-7",
  "subject_id": 16149168,
  "hadm_id": 21178690,
  "note_type": "DS",
  "note_seq": 7,
  "charttime": "2114-10-26 00:00:00",
  "storetime": "2114-10-26 14:14:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nPenicillins / Tequin / amoxicillin / NSAIDS (Non-Steroidal \nAnti-Inflammatory Drug) / aspirin\n \nAttending: ___.\n \nChief Complaint:\n1. Diabetes mellitus type 2.\n2. Morbid obesity.\n3. Hyperlipidemia.\n4. Asthma.\n\n \nMajor Surgical or Invasive Procedure:\n1. Laparoscopic Roux-en-Y gastric bypass.\n2. Endoscopy.\n\n \nHistory of Present Illness:\n___ woman with longstanding morbid obesity refractory to \nattempts at weight loss by nonoperative means.  Her preoperative \nweight is 315.3 pounds. Given her height, this translates to a \nbody mass index of 54.1 kg/m2.  She has been considering weight \nloss surgery for years. She prefers gastric bypass sighting \nlonger term outcomes.  She does not like the idea of a foreign \nbody aspect of the gastric band.  Her previous unsuccessful \nattempts at weight loss have included Weight Watchers, Slim \nFast, over-the-counter green tea and phentermine as well as \n24-day AdvoCare Challenge.  Using the 24-day AdvoCare Challenge \nand changes in diet, she recently has been able to lose 15 \npounds since ___. She suffers from comorbidities including \ndiabetes mellitus type\n2, hyperlipidemia, asthma, depression and knee pain.  She has \nbeen evaluated by our Multidisciplinary Bariatric Service and \ndeemed a suitable candidate in accordance with National \nInstitutes of Health Consensus Statement. She presents for \nLaparoscopic Roux-en-Y gastric bypass.\n\n \nPast Medical History:\nPast Medical History:\n1. Progesterone autoimmune dermatitis.\n2. Asthma; it has been greater than a year since she has\nrequired steroids.  She quit smoking eight weeks ago and her \nasthma has dramatically improved.\n3.  Depression.\n4.  Migraine headaches, occasional.\n5.  Lactose intolerance.\n6.  Infertility.\n7.  Borderline diabetes mellitus type 2.\n8.  Hyperlipidemia.\n\nPast Surgical History:  Tonsillectomy.\n\n \nSocial History:\n___\nFamily History:\nPaternal grandmother with breast cancer, paternal aunt with \nthyroid cancer, grandmother with GYN cancer, mother with asthma \nand question of COPD. \n\n \nPhysical Exam:\nVitals: VSS\nGEN: A&O, NAD\nHEENT: No scleral icterus, mucus membranes moist\nCV: RRR, No M/G/R\nPULM: Clear to auscultation b/l, No W/R/R\nABD: Soft, nondistended, nontender, incisions c/d/i, no rebound \nor guarding Ext: No ___ edema, ___ warm and well perfused\n\n \nPertinent Results:\n___ 11:51AM   HCT-42.2\n___ 05:02AM BLOOD Hct-37.0\n___ 02:48PM BLOOD Hct-35.9*\n___ 09:15AM BLOOD Hct-34.9*\n\nUpper GI (___):\nNo evidence of leak from the gastrojejunostomy anastomosis\n\nKUB (___):\nGastric outlet obstruction with contrast pooling in gastric \nremnant and esophagus may be risk of aspiration \n\nKUB (___):\nInterval movement of contrast out of the esophagus and into the \nbowel distally. There is still contrast pooling within the \nstomach. \n\nKUB (___):\nLess contrast within the stomach\n\n \nBrief Hospital Course:\nMs ___ presented to ___ holding at ___ on ___ for \nLaparoscopic Roux-en-Y gastric bypass. She tolerated the \nprocedure well without  complications (Please see operative note \nfor further details).  After a brief and uneventful stay in the \nPACU, the patient was transferred to the floor for further \npost-operative management. \n\nNeuro: The patient received morphine PCA with good effect and \nadequate pain control. When tolerating oral intake, the patient \nwas transitioned to oral pain medications.\n\nCV: The patient remained stable from a cardiovascular \nstandpoint; vital signs were routinely monitored. \n\nPulmonary: The patient remained stable from a pulmonary \nstandpoint; vital signs were routinely monitored. Good pulmonary \ntoilet, early ambulation and incentive spirometry were \nencouraged throughout hospitalization.\n\nGI: Post-operatively, the patient was made NPO with IV  fluids. \nAn upper GI study was performed on POD#1 which revealed no leak. \nInitially she was started on a  Bariatric Stage 1 diet but \nbecause the contrast had not passed she was reverted back to \nNPO. On POD#2 a KUB was done which revealed passage of contrast \nthis was confirmed by KUB on POD#3. Diet was again advanced on \nPOD#3, which was well tolerated. Patient's intake and  output \nwere closely monitored, and IV fluid was adjusted when \nnecessary. Electrolytes were routinely followed, and repleted \nwhen necessary. \n\nGU: The patient had a foley catheter placed in the OR, which was \nremoved on POD#1. After the foley was removed, the patient \nvoided without difficulty. \n\nID: The patient's white blood count and fever curves were \nclosely watched for signs of infection, of which there were \nnone.\n\nHematology: The patient's complete blood count was examined \nroutinely. JP appeared sanguinous on POD#2 serial hematocrits \nwere ordered and found to be stable.\n\nSkin: The incision sites were well approximated and intact.\n\nProphylaxis: The patient received subcutaneous heparin. Patient \nwore venodyne boots and was encouraged to get up and ambulate as \nearly as possible following surgery\n\nOn ___, the patient was discharged to home. At discharge, \nshe was tolerating a Satge III bariatric diet, passing flatus, \nstooling, voiding, and ambulating independently. She will \nfollow-up in clinic. This information was communicated to the \npatient directly prior to discharge with verbalized \nunderstanding and agreement.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies \n2. Beclomethasone Dipro. AQ (Nasal) 80 mcg Other BID \n3. Loratadine 10 mg PO DAILY \n4. Vitamin D 1000 UNIT PO 2X/WEEK (MO,TH) \n5. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN asthma \n6. Albuterol Inhaler ___ PUFF IH Q6H:PRN asthma \n\n \nDischarge Medications:\n1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN asthma \n2. Albuterol Inhaler ___ PUFF IH Q6H:PRN asthma \n3. Beclomethasone Dipro. AQ (Nasal) 80 mcg Other BID \n4. Fluticasone Propionate NASAL 2 SPRY NU DAILY:PRN allergies \n5. Loratadine 10 mg PO DAILY \n6. Vitamin D 1000 UNIT PO 2X/WEEK (MO,TH) \n7. Acetaminophen 325-650 mg PO Q6H:PRN pain \nRX *acetaminophen 650 mg/20.3 mL 1 solution(s) by mouth every \nsix (6) hours Refills:*0\n8. OxycoDONE (Immediate Release)  5 mg PO Q4H:PRN pain \n9. Ursodiol 300 mg PO BID \nRX *ursodiol [Actigall] 300 mg 1 capsule(s) by mouth twice a day \nDisp #*60 Capsule Refills:*0\n10. OxycoDONE Liquid 5 mg PO Q4H:PRN pain \nRX *oxycodone 5 mg/5 mL 1 by mouth every four (4) hours \nRefills:*0\n11. Ranitidine (Liquid) 150 mg PO BID \nRX *ranitidine HCl 15 mg/mL 10 ml by mouth twice a day \nRefills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\n1. Diabetes mellitus type 2.\n2. Morbid obesity.\n3. Hyperlipidemia.\n4. Asthma.\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nPlease call your doctor or nurse practitioner if you experience \nthe following:\n*You experience new chest pain, pressure, squeezing or \ntightness.\n*New or worsening cough, shortness of breath, or wheeze.\n*If you are vomiting and cannot keep down fluids or your \nmedications.\n*You are getting dehydrated due to continued vomiting, diarrhea, \nor other reasons. Signs of dehydration include dry mouth, rapid \nheartbeat, or feeling dizzy or faint when standing.\n*You see blood or dark/black material when you vomit or have a \nbowel movement.\n*You experience burning when you urinate, have blood in your \nurine, or experience a discharge.\n*Your pain is not improving within ___ hours or is not gone \nwithin 24 hours. Call or return immediately if your pain is \ngetting worse or changes location or moving to your chest or \nback.\n*You have shaking chills, or fever greater than 101.5 degrees \nFahrenheit or 38 degrees Celsius.\n*Any change in your symptoms, or any new symptoms that concern \nyou.\n\nGeneral Discharge Instructions:\nPlease resume all regular home medications , unless specifically \nadvised not to take a particular medication.  Also, please take \nany new medications as prescribed.\nPlease get plenty of rest, continue to ambulate several times \nper day, and drink adequate amounts of fluids.  Avoid lifting \nweights greater than ___ lbs until you follow-up with your \nsurgeon, who will instruct you further regarding activity \nrestrictions.\nAvoid driving or operating heavy machinery while taking pain \nmedications.\nPlease follow-up with your surgeon and Primary Care Provider \n(PCP) as advised.\n\nIncision Care:\n*Please call your doctor or nurse practitioner if you have \nincreased pain, swelling, redness, or drainage from the incision \nsite.\n*Avoid swimming and baths until your follow-up appointment.\n*You may shower, and wash surgical incisions with a mild soap \nand warm water.  Gently pat the area dry.\n*If you have steri-strips, they will fall off on their own.  \nPlease remove any remaining strips ___ days after surgery.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048229fb505ee753917ddd"
  },
  "note_id": "16149168-DS-8",
  "subject_id": 16149168,
  "hadm_id": 20472885,
  "note_type": "DS",
  "note_seq": 8,
  "charttime": "2116-08-28 00:00:00",
  "storetime": "2116-08-28 17:41:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nPenicillins / Tequin / amoxicillin / NSAIDS (Non-Steroidal \nAnti-Inflammatory Drug) / aspirin\n \nAttending: ___.\n \nChief Complaint:\nAbdominal pain\n \nMajor Surgical or Invasive Procedure:\nNone\n\n___: Abdominal CT scan with IV and PO contrast\n\n \nHistory of Present Illness:\nMs. ___ is a ___ years old woman with history of RYGB on \n___ who presents to clinic complaining of crampy abdominal \npain for the past week that got worse 3 days ago associated with \nnausea and vomiting. She refers eating makes the pain worse and \nresting makes it better. She refers passing gas and having bowel \nmovements and denies fever, chills, dysphagia, chest pain, \nshortness of breath, GERD or any other related symptoms. Rest of \nthe review of systems negative.\n\n \nPast Medical History:\nPast Medical History:\n1. Progesterone autoimmune dermatitis.\n2. Asthma; it has been greater than a year since she has\nrequired steroids.  She quit smoking eight weeks ago and her \nasthma has dramatically improved.\n3.  Depression.\n4.  Migraine headaches, occasional.\n5.  Lactose intolerance.\n6.  Infertility.\n7.  Borderline diabetes mellitus type 2.\n8.  Hyperlipidemia.\n\nPast Surgical History:  Tonsillectomy.\n\n \nSocial History:\n___\nFamily History:\nPaternal grandmother with breast cancer, paternal aunt with \nthyroid cancer, grandmother with GYN cancer, mother with asthma \nand question of COPD. \n\n \nPhysical Exam:\nVS:  \nT: 98.3  HR: 61  BP: 106/60  RR: 18  O2Sat: 95%\n GEN: AA&O x 3, NAD, calm, cooperative. Tolerating regular diet.\n HEENT: (-)LAD, mucous membranes moist, trachea midline, EOMI  \n CHEST: Clear to auscultation bilaterally, (-) cyanosis.  \n CV: Regular rate and rhythm, S1S2 normal, no murmurs.\n ABDOMEN: soft, non-tender, non-distended. No nausea or \nvomiting. Tolerating a regular diet. \n EXTREMITIES: Warm, well perfused, no edema  \n \nPertinent Results:\nLabs:\n\n___ 05:00PM BLOOD WBC-11.5* RBC-4.63 Hgb-14.1 Hct-41.7 \nMCV-90 MCH-30.5 MCHC-33.8 RDW-12.2 RDWSD-39.7 Plt ___\n___ 05:00PM BLOOD Plt ___\n___ 05:00PM BLOOD Glucose-71 UreaN-9 Creat-0.6 Na-140 K-4.0 \nCl-106 HCO3-21* AnGap-17\n___ 05:00PM BLOOD Calcium-9.1 Phos-3.6 Mg-1.9\n\nImaging:\n\n___: Abdominal CT scan\nIMPRESSION:  \nSoft tissue stranding surrounding the jejunum, just distal to \nthe  patient's  gastrojejunal anastomosis.  Findings are \nconcerning for I inflammatory process or ulcer. \nAdjacent enlarged mesenteric lymph nodes, indeterminate, \npossibly reactive. \nIndeterminate focal narrowing of the transverse large bowel, may \nbe transient finding, focal Mass cannot be excluded. \n\n \nBrief Hospital Course:\nThe patient presented to clinic on ___ complaining of \nabdominal pain for the past week that was associated with nausea \nand vomiting on ___. She was evaluated in clinic and because she \nhad increased abdominal pain and could not keep anything down \nafter eating we decided to admit her for pain control, fluid \nresuscitation and imaging.\n  Neuro: The patient was alert and oriented throughout \nhospitalization; pain was initially managed IV dilaudid. Pain \nwas very well controlled. The patient was then transitioned to \noral pain medication once tolerating a stage 3 diet.  \n CV: The patient remained stable from a cardiovascular \nstandpoint; vital signs were routinely monitored.  \n Pulmonary: The patient remained stable from a pulmonary \nstandpoint; vital signs were routinely monitored. Good pulmonary \ntoilet, early ambulation and incentive spirometry were \nencouraged throughout hospitalization.  \n GI/GU/FEN: The patient was initially kept NPO until after her \npain was better controlled and her abdominal CT scan was done. \nShe was the advanced to a stage 3 diet which she tolerated \nwithout any problems. The pt had an abdominal CT scan done \nshowing soft tissue stranding surrounding the jejunum, just \ndistal to the patient's \ngastrojejunal anastomosis.  Findings are concerning for \ninflammatory process \nor ulcer. So we consulted the GI team to schedule an EGD as an \noutpatient for further evaluation.\n ID: The patient's fever curves were closely watched for signs \nof infection, of which there were none.  \n HEME: The patient's blood counts were closely watched for signs \nof bleeding, of which there were none.  \n Prophylaxis: The patient received subcutaneous heparin and ___ \ndyne boots were used during this stay and was encouraged to get \nup and ambulate as early as possible.  \n At the time of discharge, the patient was doing well, afebrile \nand hemodynamically stable. The patient was tolerating a \nbariatric stage 3 diet, ambulating, voiding without assistance, \nand pain was well controlled. The patient received discharge \nteaching and follow-up instructions with understanding \nverbalized and agreement with the discharge plan.  \n\n \nMedications on Admission:\nAlbuterol sulfate HFA 90 mcg/actuation aerosol inhaler \nAlbuterol sulfate 2.5 mg/3 mL (0.083 %) solution for \nnebulization\nQvar 80 mcg/actuation Metered Aerosol oral inhaler\nCitalopram 10 mg tablet\nFluticasone 50 mcg/actuation nasal spray,suspension\n___ 14 mcg/24 hour ___ years) intrauterine device\nTrazodone 50 mg tablet\nUrsodiol 300 mg capsule\nCalcium citrate 250 mg tablet\nCholecalciferol (vitamin D3) 1,000 unit capsule\nVitamin B-12 500 mcg tablet\nFamotidine 10 mg tablet\nClaritin-D 24 Hour 10 mg-240 mg tablet,extended release\nMultivitamin \n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q6H:PRN Pain - Mild \nRX *acetaminophen 500 mg 2 tablet(s) by mouth every six (6) \nhours Disp #*60 Tablet Refills:*0 \n2.  Omeprazole 20 mg PO BID \nRX *omeprazole 20 mg 1 capsule(s) by mouth twice a day Disp #*60 \nCapsule Refills:*0 \n3.  Sucralfate 1 gm PO QID \nRX *sucralfate 1 gram 1 tablet(s) by mouth four times a day Disp \n#*60 Tablet Refills:*0 \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAbdominal pain\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the ward on ___ after presenting to \nclinic complaining of moderate crampy abdominal pain for the \npast week that got worse and associated with nausea and \nvomiting. You are now progressing appropriately, pain is better \ncontrolled and have tolerated you diet. You had an abdominal CT \nscan done that showed soft tissue stranding surrounding the \njejunum, just distal to the anastomosis. These findings are \nconcerning for inflammatory process or ulcer. We will have you \nfollow up with GI so you get an upper endoscopy and determine if \nthere is an ulcer. You are ready to go home and continue your \nrecuperation. \n\nPlease call your surgeon or return to the emergency department \nif you develop a fever greater than 101.5, chest pain, shortness \nof breath, severe abdominal pain, pain unrelieved by your pain \nmedication, severe nausea or vomiting, severe abdominal \nbloating, inability to eat or drink, foul smelling or colorful \ndrainage from your incisions, redness or swelling around your \nincisions, or any other symptoms which are concerning to you.  \n\nDiet: Stay on Stage III diet and advance your diet as tolerated. \nResume your home medications.  \nYou will be starting some new medications:  \n1. Take Tylenol up to 1,000 every 6 hours to relive your pain.\n2. You should begin taking a chewable complete multivitamin with \nminerals. No gummy vitamins.  \n3. You will be taking Omeprazole 20mg twice daily for one  \nmonth. This medicine prevents gastric reflux.  \n4. You must not use NSAIDS (non-steroidal anti-inflammatory \ndrugs) Examples are Ibuprofen, Motrin, Aleve, Nuprin and \nNaproxen. These agents will cause bleeding and ulcers in your \ndigestive system.  \n \nActivity: You may resume moderate exercise at your discretion, \nno abdominal exercises.  \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048229fb505ee753917dde"
  },
  "note_id": "16149168-DS-9",
  "subject_id": 16149168,
  "hadm_id": 22026844,
  "note_type": "DS",
  "note_seq": 9,
  "charttime": "2119-05-13 00:00:00",
  "storetime": "2119-05-13 12:19:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nPenicillins / Tequin / amoxicillin / NSAIDS (Non-Steroidal \nAnti-Inflammatory Drug) / aspirin\n \nAttending: ___.\n \nMajor Surgical or Invasive Procedure:\nNone\n\nattach\n \nPertinent Results:\nLABS: WBC 11.5, hgb 14.8, Cr 0.9\n\nImaging: CT neck: Left parotiditis with reactive lymph nodes. No\ndrainable fluid collection visualized. \nI personally reviewed the CT neck and my interpretation is: Left\nparotid inflammation with swelling of surrounding soft tissue. \nprior records reviewed: history of roux en y, gastric ulcer. \n\nDischarge Labs:\n\n___ 07:10AM BLOOD WBC-6.0 RBC-4.52 Hgb-13.8 Hct-42.4 MCV-94 \nMCH-30.5 MCHC-32.5 RDW-12.5 RDWSD-43.3 Plt ___\n___ 07:10AM BLOOD Plt ___\n___ 07:10AM BLOOD Glucose-74 UreaN-7 Creat-0.9 Na-142 K-4.7 \nCl-105 HCO3-29 AnGap-8*\n___ 07:10AM BLOOD Mg-2.0\n \nBrief Hospital Course:\n#Parotitis\n#facial swelling\n#sepsis- She presented with ___ SIRS criteria (fever, \nleukocytosis) with source of infection from parotitis on CT \nscan. She presented with 3 days of L facial swelling, not \nimproving with outpatient PO doxycycline.  CT showed parotitis \nwith lymphadenopathy with no drainable fluid collections. \nUnclear etiology (viral vs. bacteria). Blood cultures ___ have \nshown NGTD. Had received MMR as a child. Seen by OMFS who \nadvised IV antibiotics with lemon wedeges. She was trialed on \nunasyn with no difficulties (despite reported PCN allergy). She \nwas discharged on augmentin BID  for another 10 days per ___ \nrecs. On discharge her pain and swelling had improved. Her \nleukocytosis and fever resolved. She was discharged with \noxycodone (5mg) #10 tabs to help with pain on discharge. \n\n#s/p roux en y bypass- continued vitamins\n\n#GERD-continued omeprazole\n\n#asthma: continued albuterol\n\n#Anxiety: continued home Lexapro \n\n#restless leg: continued home trazodone \n\nDischarge Physical Exam:\nVitals: temp 98.1; BP 120/77; HR 64; RR 18; O2 95% RA\nGENERAL: Alert and in no apparent distress, facial swelling. \nEYES: Anicteric, pupils equally round\nENT: Left sided facial swelling from mandible extending down to\nneck. tender.  minimal erythema receding from marked boarder. \nno Oropharynx abnormality. \nCV: Heart regular, no murmur, no S3, no S4.  No JVD.\nRESP: Lungs clear to auscultation with good air movement \nbilaterally.  Breathing is non-labored\nGI: Abdomen soft, non-distended, non-tender to palpation.  Bowel \nsounds present.  No HSM\nGU: No suprapubic fullness or tenderness to palpation\nMSK: Neck supple, moves all extremities, strength grossly full\nand symmetric bilaterally in all limbs\nSKIN: No rashes or ulcerations noted\nNEURO: Alert, oriented, face symmetric, gaze conjugate with \nEOMI,\nspeech fluent, moves all limbs, sensation to light touch grossly\nintact throughout\nPSYCH: pleasant, appropriate affect\n\nTransitional Issues:\n[] f/u with OMFS as an outpatient, they will call to schedule an \nappointment\n\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfurther investigation.\n1. Omeprazole 20 mg PO BID \n2. Albuterol Inhaler 2 PUFF IH Q4H:PRN SOB \n3. Cyanocobalamin 500 mcg PO DAILY \n4. Vitamin D 1000 UNIT PO DAILY \n5. Escitalopram Oxalate Dose is Unknown  PO DAILY \n6. TraZODone Dose is Unknown  PO QHS:PRN insomnia \n7. Propranolol Dose is Unknown  PO Q3H:PRN anxiety \n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q6H:PRN Pain - Mild/Fever \nRX *acetaminophen [Pain Relief Extra Strength] 500 mg 2 \ntablet(s) by mouth every eight (8) hours Disp #*30 Tablet \nRefills:*0 \n2.  Amoxicillin-Clavulanic Acid ___ mg PO Q12H \nRX *amoxicillin-pot clavulanate [Augmentin] 875 mg-125 mg 1 \ntablet(s) by mouth twice a day Disp #*20 Tablet Refills:*0 \n3.  Lactobacillus acidophilus 1 mg oral DAILY \nRX *Lactobacillus acidophilus [Probiotic] 10 billion cell 1 \ncapsule(s) by mouth once a day Disp #*10 Capsule Refills:*0 \n4.  OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - \nSevere \nRX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours \nDisp #*10 Tablet Refills:*0 \n5.  Escitalopram Oxalate 5 mg PO DAILY  \n6.  TraZODone 25 mg PO QHS:PRN insomnia, restless leg  \n7.  Albuterol Inhaler 2 PUFF IH Q4H:PRN SOB  \n8.  Cyanocobalamin 500 mcg PO DAILY  \n9.  Omeprazole 20 mg PO BID  \n10.  Vitamin D 1000 UNIT PO DAILY  \n11. HELD- Propranolol Dose is Unknown  PO Q3H:PRN anxiety  This \nmedication was held. Do not restart Propranolol until discharge\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nParotitis\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted to the hospital due to an infection of your \nsalivary glands called parotitis. We treated this with an \nantibiotic and it improved. On discharge from the hospital, you \nshould continue taking augmentin for another 10 days.\n\nPlease follow up with OMFS who will call you to schedule on \n___.\n\nBest of luck in your recovery,\nYour ___ care team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048247fb505ee753934c35"
  },
  "note_id": "19713661-DS-14",
  "subject_id": 19713661,
  "hadm_id": 27063124,
  "note_type": "DS",
  "note_seq": 14,
  "charttime": "2113-11-29 00:00:00",
  "storetime": "2113-11-30 13:49:00",
  "text": " \nName:  ___               Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nTrazodone\n \nAttending: ___.\n \nChief Complaint:\nDirect admission for chemo initiation\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ yo woman with history of alcoholic \ncirrhosis\nand new l adnexal mass c/b pulmonary mets concerning for\nmetastatic ovarian cancer, here as a direct admission for chemo\ninitiation.\n\nMs. ___ ovarian cancer is a recent diagnosis. She\npresented on ___ to the ER with abdominal pain and\nbloating, and found with 9.8cm/10-cm left adnexal mass with\nelevated CA 125 to 1172. CT chest in the following weeks noted\nmultiple bilateral pulmonary mets ranging in size from 2-9mm. CT\nguide biopsy of a concerning right liver lobe subcapsular lesion\nwas negative for malignancy. In recent weeks, Ms. ___ has\nbeen suffering from worsened abdominal pain and bloating.\nOtherwise her ROS is unremarkable. No infectious symptoms, \nhaving\nregular BMs without blood. \n\nOther remarkable medical history includes alcoholic cirrhosis \nper\nfibroscan on ___ with largely normal LFTs, varices noted in\nmiddle esophagus on EGD on ___, and and MELD score of 6. Her\nlast alcohol drink was ___.    \n\n \nPast Medical History:\nPemphigus vulgaris\nGERD\nAlcohol cirrhosis \n \nSocial History:\n___\nFamily History:\nNon-contributory\n \nPhysical Exam:\nADMISSION EXAM:\n\nGENERAL: NAD  \nHEENT: AT/NC, anicteric sclera, MMM  \nNECK: supple, no LAD  \nCV: RRR, S1/S2, no murmurs, gallops, or rubs  \nPULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably\nwithout use of accessory muscles  \nABD: abdomen soft, nondistended, RUQ and lower quadrant\ntenderness to palpation, no rebound/guarding, no\nhepatosplenomegaly  \nEXT: wwp, no cyanosis, clubbing, or edema, 2+ radial pulses\nbilaterally  \nSKIN: Warm and well perfused, no excoriations or lesions, no\nrashes  \nNEURO: Alert, moving all 4 extremities with purpose, face\nsymmetric  \n\n===\nDISCHARGE EXAM:\n\nGENERAL: NAD  \nHEENT: AT/NC, anicteric sclera, MMM  \nNECK: supple, no LAD  \nCV: RRR, S1/S2, no murmurs, gallops, or rubs  \nPULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably\nwithout use of accessory muscles  \nABD: abdomen soft, nondistended, RUQ and lower quadrant\ntenderness to palpation, no rebound/guarding\nEXT: wwp, no cyanosis, clubbing, or edema, 2+ radial pulses\nbilaterally  \nSKIN: Warm and well perfused, no excoriations or lesions, no\nrashes  \nNEURO: Alert, moving all 4 extremities with purpose, face\nsymmetric  \n \nPertinent Results:\nAdmission labs:\n___ 09:44AM BLOOD WBC-5.9 RBC-3.99 Hgb-10.4* Hct-33.0* \nMCV-83 MCH-26.1 MCHC-31.5* RDW-12.0 RDWSD-36.8 Plt ___\n___ 09:44AM BLOOD Glucose-96 UreaN-4* Creat-0.7 Na-136 \nK-4.0 Cl-97 HCO3-28 AnGap-11\n___ 09:44AM BLOOD ALT-17 AST-23 LD(LDH)-277* AlkPhos-164* \nTotBili-0.3\n\nDIscharge labs:\n___ 07:22AM BLOOD WBC-5.3 RBC-4.15 Hgb-10.8* Hct-34.7 \nMCV-84 MCH-26.0 MCHC-31.1* RDW-12.0 RDWSD-36.6 Plt ___\n___ 07:22AM BLOOD Glucose-94 UreaN-6 Creat-0.5 Na-137 K-4.9 \nCl-95* HCO3-31 AnGap-11\n___ 07:22AM BLOOD ALT-14 AST-18 LD(LDH)-266* AlkPhos-154* \nTotBili-0.3\n\nImaging:\nNone\n \nBrief Hospital Course:\nMs. ___ is a ___ yo woman with history of alcoholic \ncirrhosis\nand new l adnexal mass c/b possible pulmonary and liver mets\nconcerning for metastatic ovarian cancer, here as a direct\nadmission for chemo initiation. C1D1 carboplatin on ___.\n\n#Metastatic ovarian cancer\nDiagnosed on ___ in setting of new l adnexal mass. Imaging\nconcerning for bilateral pulmonary and liver mets. Liver\nlesion biopsy was negative for malignancy but was possibly an\ninadequate sample. She received cycle 1 of carboplatin \n(___) with good tolerance.\n\n#Alcohol cirrhosis\nMeld score 6. Varcies noted in mid esophagus on EGD ___. No \nsymptoms of withdrawal here. \n\n#Pain control\nMs. ___ has significant pain from her ovarian cancer. Her \npain was adequately controlled on MS contin 30mg BID and \noxycodone 10mg q4hr as needed. \n\n#Pemphigus vulgaris\nOn prednisone 5mg daily, with GI ppx with omeprazole 40mg daily. \nNo changes were made here. \n\n--\nTransitional issues:\n[] ___ with Dr. ___ for continued chemo management in 3 \nweeks.\n[] titrate opiate regimen per evolving pain burden. discharged \nwith 10 day supply until PCP ___ on ___\n[] consider Bactrim ppx given daily prednisone for pemphigus \nvulgaris.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. PredniSONE 5 mg PO DAILY \n2. FoLIC Acid 1 mg PO DAILY \n3. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - Moderate \n\n4. Omeprazole 40 mg PO DAILY \n5. Morphine SR (MS ___ 15 mg PO Q12H \n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q8H \nRX *acetaminophen [8 Hour Pain Reliever] 650 mg 1 tablet(s) by \nmouth every 6 hours Disp #*30 Tablet Refills:*0 \n2.  Dexamethasone 4 mg PO BID Duration: 2 Days \nRX *dexamethasone 4 mg 1 tablet(s) by mouth twice daily Disp #*3 \nTablet Refills:*0 \n3.  Ondansetron 8 mg PO BID Duration: 2 Days \nRX *ondansetron 8 mg 1 tablet(s) by mouth every 8 hours Disp #*3 \nTablet Refills:*0 \n4.  Morphine SR (MS ___ 30 mg PO Q12H \nRX *morphine [MS ___ 30 mg 1 tablet(s) by mouth twice daily \nDisp #*20 Tablet Refills:*0 \n5.  OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - \nModerate \nRX *oxycodone 10 mg 1 tablet(s) by mouth every 4 hours Disp #*60 \nTablet Refills:*0 \n6.  FoLIC Acid 1 mg PO DAILY  \n7.  Omeprazole 40 mg PO DAILY  \n8.  PredniSONE 5 mg PO DAILY  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nOvarian cancer, possibly metastatic \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\n DISCHARGE INSTRUCTIONS  \n ======================  \n Dear Ms. ___,\n It was a pleasure caring for you at ___ \n___.  \n WHY WAS I IN THE HOSPITAL?  \n -You were admitted to for chemotherapy initation. \n WHAT HAPPENED TO ME IN THE HOSPITAL?  \n -You received your first cycle of chemotherapy.\n -Your pain was managed.\n\n WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?  \n - Continue to take all your medicines and keep your \nappointments.  \n We wish you the best!  \n Sincerely,  \n Your ___ Team \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048206fb505ee7538ed088"
  },
  "note_id": "10889507-DS-4",
  "subject_id": 10889507,
  "hadm_id": 27865822,
  "note_type": "DS",
  "note_seq": 4,
  "charttime": "2125-06-01 00:00:00",
  "storetime": "2125-06-02 09:55:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: OBSTETRICS/GYNECOLOGY\n \nAllergies: \nNSAIDS (Non-Steroidal Anti-Inflammatory Drug) / Reglan\n \nAttending: ___.\n \nChief Complaint:\npreterm contractions\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\n___ G1P0 at ___ presents with preterm ctx. Reports onset of \nctx this afternoon, while shopping at outlets. Went home and \nattempted rest and snack with no improvement in ctx. Some ctx \nare painful and taking her breath away, but not consistently. \nIntensity has been about the same throughout the day, but ctx \nhave become more intense while here in triage. Denies VB, LOF. \nActive FM. Denies fevers, chills, sweats, malaise, N/V, dysuria, \nhematuria, vaginal itching or vulvar irritation. Denies illicit \ndrug use or abdominal trauma. \n \nPast Medical History:\nPNC:\n-___: ___ by ___ US\n-Labs: O+/Ab-/RI/VI/RPRNR/HbsAg-/HIV-/GBS- \n-Screening: NIPT -FFS: wnl, girl\n-GLT: deferred, 1wk FSBG wnl -Vaccines: s/p tdap ___ \n-___ (cMFM): cephalic, ant plac, nl AF, 2219g (47%) \n-___: cephalic, ant placenta, nl AF, BPP ___ \n-Issues:\n#triage eval for PTC 3 weeks ago\n#EIF, with low risk NIPT\n#carrier for Ga___ disease, declined FOB testing\n#hx gastric bypass #elevated AFP\n\nObHx: G1 current\nGynHx: normal periods, no STIs, no abnl paps\nPMH: obesity, hx gastric ulcer (none since stopped NSAIDs), hx \nrecurrent c diff\nPSH: gastric bypass, cholecystectomy \n \nSocial History:\n___\nFamily History:\nnon-contributory\n \nPhysical Exam:\n(on admission)\nVS: 103/77, 79, 98.5\nGen: mildly uncomfortable with ctx, NAD, non-diaphoretic\nResp: nl resp effort\nAbd: soft, gravid, no fundal tenderness SVE @ 0030: \n___ (last ext os 1/int os \nclosed/long/posterior 2+ weeks ago)\nSVE @ 0230: ___\nSSE: deferred\nToco: ___\nFHT: 140/mod var/+accels/-decels\nTAUS: vtx\n \nPertinent Results:\n___ WBC-10.8 RBC-4.14 Hgb-12.1 Hct-35.6 MCV-86 Plt-254\n___ WBC-9.5 RBC-3.99 Hgb-11.7 Hct-35.6 MCV-89 Plt-251\n___ ALT-10 AST-16 LD(LDH)-148 Lipase-25\n___ LD(LDH)-252\n\n___ BLOOD ___ Comment-GREEN TOP\n___ BLOOD Lactate-1.7\n\n___ URINE Blood-NEG Nitrite-NEG Protein-TR Glucose-NEG \nKetone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-LG\n___ URINE RBC-1 WBC-5 Bacteri-FEW Yeast-NONE Epi-2\n\n___ URINE bnzodzp-NEG barbitr-NEG opiates-NEG cocaine-NEG \namphetm-NEG oxycodn-NEG mthdone-NEG\n\nURINE CULTURE (Final ___: \n MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH\n SKIN AND/OR GENITAL CONTAMINATION\n \nBrief Hospital Course:\n___ G1 admitted at 35w6d with preterm contractions. She was \nafebrile and without any evidence of infection or abruption. \nFetal testing was reassuring. She reported persistent painful \ncontractions, however, made very little change over time. She \nunderwent therapeutic rest with morphine and was monitored on \nthe antepartum floor. She continued to required intermittent \ndoses of narcotics due to her painful contractions with minimal \ncervical change. On HD#3, she reported right sided abdominal \npain in between her contractions and was mildly tender on exam. \nShe remained afebrile and tolerating a regular diet throughout \nthe admission. ACS was consulted and recommended an MRI, \nhowever, Ms ___ declined. She was discharged home on ___ \nwith precautions and will have close outpatient follow up. Of \nnote, she had a reassuring ultrasound in the CMFM on ___.\n \nMedications on Admission:\nCa\nVit D3\nB12\nomeprazole\nPNV\n \nDischarge Medications:\nCa\nVit D3\nB12\nomeprazole\nPNV\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\npreterm contractions\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nMs. ___,\n\nYou were admitted to the Antepartum service with painful \ncontractions. You have been monitored closely and underwent \nmultiple cervical exams. We do not think you are in active \nlabor. Given your history of gastric bypass, we consulted \nGeneral Surgery who recommended an MRI. You have declined the \nMRI. We feel that you are safe for discharge home. Please call \nDr. ___ office with any further questions or concerns. \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048206fb505ee7538ed089"
  },
  "note_id": "10889507-DS-5",
  "subject_id": 10889507,
  "hadm_id": 21559444,
  "note_type": "DS",
  "note_seq": 5,
  "charttime": "2127-01-03 00:00:00",
  "storetime": "2127-01-08 14:54:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: OBSTETRICS/GYNECOLOGY\n \nAllergies: \nNSAIDS (Non-Steroidal Anti-Inflammatory Drug) / Reglan\n \nAttending: ___.\n \nChief Complaint:\ndecreased fetal movement\ncontractions\n\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMs. ___ is a lovely ___ G2P1 at ___ presenting with\nDFM and tightening for the past few hours. She states she has\nfelt a little nauseated over the past few days but has not been\nthrowing up. Has had decreased appetite but does feel like she \nis\ndrinking good amount of water. No urinary symptoms. No diarrhea.\nNo VB, LOF, abnormal discharge. Reports tightening is\nuncomfortable and occurring about every 10 minutes.\n\n \nPast Medical History:\nPNC: \n- ___ ___ by LMP c/w ___ trimester U/S\n- Labs Rh pos/Abs neg/Rub I/RPR NR/HBsAg neg/HIV neg/GBS PND\n- Screening - Aneuploidy screening: abnl Panorama - ___ 46XY\n- FFS - wnl\n- GLT - screened with FBS fasting and 1hr PP x 1wk - wnl\n- U/S -  ___: ant placenta, nl AF, 2143g (60%), cephalic\n- Issues\n - She is known ___ carrier, but couple have elected not to\nhave FOB tested\n - h/o gastric bypass - getting growth scans q4wk\n\nOB Hx:\n- G1 SVD - IOL 37wk for persistent DFM, 2970g\n- G2 current\n\nGYN Hx - due for repeat pap postpartum. No known h/o fibroids,\nSTIs.\n\nPMH: \n- h/o recurrent c. diff\n- h/o anemia requiring IV iron\n\nPast Surgical Hx:\n- gastric bypass (cannot have NSAIDs)\n- cholecystectomy\n\n \nPhysical Exam:\nAdmission Physical Exam:\n___ ___: 94\n___ 17:40BP: 108/69 (79)\n___ ___: 93\n___ 17:48Temp.: 98.3F\n___ ___: 94\nGen: NAD\nCV: RRR\nLungs: nl respiratory effort\nAbd: soft, gravid, NT\nSVE: LCP\nSpec: visually closed, no blood in vault or abnormal discharge,\nno pooling\n\nTAUS: vtx, BPP ___\n\nFHT: 150/mod/+accels/-decels\ntoco: q7m\n.\n.\n.\nDischarge Physical Exam \nVS: 98.2, 94/57, 87, 18, O2 95%\nGen: NAD, appears comfortable\nResp: nl respiratory effort\nAbd: soft, gravid, nontender\nExt: nontender w/o edema\n\nDate/Time: ___ at ___\nFHT 130/mod var/+accels/no decels -> reactive\nToco q ___ min\n \nPertinent Results:\n___ 01:10PM BLOOD WBC-14.0* RBC-3.72* Hgb-10.6* Hct-32.9* \nMCV-88 MCH-28.5 MCHC-32.2 RDW-14.0 RDWSD-45.1 Plt ___\n___ 06:38PM BLOOD WBC-12.2* RBC-3.76* Hgb-11.0* Hct-32.3* \nMCV-86 MCH-29.3 MCHC-34.1 RDW-13.6 RDWSD-42.2 Plt ___\n___ 01:10PM BLOOD Neuts-68.2 ___ Monos-5.7 Eos-0.5* \nBaso-0.4 Im ___ AbsNeut-9.57* AbsLymp-3.45 AbsMono-0.80 \nAbsEos-0.07 AbsBaso-0.06\n___ 06:38PM BLOOD Neuts-70.7 ___ Monos-5.2 Eos-0.2* \nBaso-0.2 Im ___ AbsNeut-8.61* AbsLymp-2.82 AbsMono-0.63 \nAbsEos-0.03* AbsBaso-0.03\n___ 01:10PM BLOOD Plt ___\n___ 06:38PM BLOOD Plt ___\n___ 01:10PM BLOOD ALT-10 AST-15\n___ 12:15PM URINE Color-Straw Appear-Clear Sp ___\n___ 06:53PM URINE Color-Straw Appear-Clear Sp ___\n___ 12:15PM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.5 Leuks-TR*\n___ 06:53PM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG\n___ 12:15PM URINE RBC-1 WBC-<1 Bacteri-NONE Yeast-NONE \nEpi-4 TransE-<1\n___ 06:50PM URINE bnzodzp-NEG barbitr-NEG opiates-NEG \ncocaine-NEG amphetm-NEG oxycodn-NEG mthdone-NEG\n___ 06:08PM OTHER BODY FLUID CT-NEG NG-NEG.\n\n \n \n___ 6:53 pm URINE      Source: ___. \n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \nWITH SKIN\n      AND/OR GENITAL CONTAMINATION. \n\n \n \n___ 6:08 pm ANORECTAL/VAGINAL      Source: \nAnorectal/Vaginal. \n\n                            **FINAL REPORT ___\n\n   R/O GROUP B BETA STREP (Final ___: \n      Negative for Group B beta streptococci. \n\n___ 6:08 pm SWAB     Site: VAGINA      Source: Vaginal. \n\n                            **FINAL REPORT ___\n\n   SMEAR FOR BACTERIAL VAGINOSIS (Final ___: \n      GRAM STAIN NEGATIVE FOR BACTERIAL VAGINOSIS. \n\n   YEAST VAGINITIS CULTURE (Final ___:    NEGATIVE FOR \nYEAST. \n\n \n \n___ 1:10 pm BLOOD CULTURE\n\n   Blood Culture, Routine (Pending): \n\n \nBrief Hospital Course:\nOn ___, Ms. ___ was admitted at ___ with decrased \nfetal movement and abdominal tightening. \n\nOn presentation she had a reactive NST and BPP ___ on \nultrasound. For her preterm contractions she had a FFN collected \nwhich was unable to be processed. She was noted to make cervical \nchange from closed to 1cm. She was therefore started on a course \nof betamethasone for fetal lung maturity. Tocolytics were \ndeferred given gestational age. She was monitored on L&D and \nmade slow cervical change to 1.5cm/50% effaced/posterior with no \nfurther changes. She was then monitored on the antepartum \nservice. She continued to have intermittently painful \ncontractions and received IV dilaudid with subsequent relief. \nShe was seen by the NICU given prematurity. \n\nOn HD#3, she reported abdominal tenderness that was \nnonreproducible on exam. Labs were drawn which showed normal \nwhite count with no bandemia, normal LFTs and negative \nurinalysis. She had blood cultures drawn which had no growth to \ndate. \n\nBy hospital day #4 patient was stable with unchanged cervical \nexam and reassuring fetal testing. She was therefore discharged \nhome with close outpatient follow up scheduled. \n \nMedications on Admission:\nPNV, B12, calcium, vitamin D3\n \nDischarge Medications:\nPNV, B12, calcium, vitamin D3\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPre-term contractions \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___, \n\nYou were admitted to the hospital for preterm contractions. You \nwere given betamethasone, a steroid which helps the baby's lungs \namong other benefits. Your contractions and cervical exam \nremained stable and you are now safe to be discharged home.  \n Please call the office for:  \n - Worsening, painful or regular contractions  \n - Vaginal bleeding  \n - Leakage of water or concern that your water broke  \n - Abdominal pain  \n - Nausea/vomiting  \n - Fever, chills  \n - Decreased fetal movement  \n - Other concerns  \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048206fb505ee7538ed08a"
  },
  "note_id": "10889507-DS-6",
  "subject_id": 10889507,
  "hadm_id": 22859510,
  "note_type": "DS",
  "note_seq": 6,
  "charttime": "2127-01-28 00:00:00",
  "storetime": "2127-02-02 13:52:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: OBSTETRICS/GYNECOLOGY\n \nAllergies: \nNSAIDS (Non-Steroidal Anti-Inflammatory Drug) / Reglan\n \nAttending: ___.\n \nChief Complaint:\nnausea, limited po intake\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\n___ G2P1 at ___ who presents as a direct admission for n/v. \nPt reports symptoms started on ___. She's been very nauseous \nand having a hard time drinking fluids. She vomited once 2 \nnights ago, but also with dry heaves. She hasn't been taking \nanything for nausea at home, but got Zofran in triage yesterday. \nShe also reports diarrhea for 2 days. No sick contacts. Denies \nfevers/chills. Woke up at 3am feeling shaky, but not vomiting. \nShe's been having intermittent ctxs, but her cervix was \nunchanged yesterday (2cm). She denies LOF or VB. No painful ctxs \ncurrently. Feeling fetal movement, but its been less since these \nsymptoms started. Pt also c/o a small \"lump\" under her skin \nabove superior aspect of uterus. States it feels like a bruise.\n\nOn arrival to 6S, pt tolerated ___ of a grilled cheese sandwich, \na can of ginger ale, and some water.\n\n \nPast Medical History:\nPNC: \n- ___ ___ by ___ c/w ___ trimester U/S\n- Labs Rh pos/Abs neg/Rub I/RPR NR/HBsAg neg/HIV neg/GBS PND\n- Screening - Aneuploidy screening: abnl Panorama - ___ 46XY\n- FFS - wnl\n- GLT - screened with FBS fasting and 1hr PP x 1wk - wnl\n- U/S -  ___: ant placenta, nl AF, 2143g (60%), cephalic\n- Issues\n - She is known ___ carrier, but couple have elected not to\nhave FOB tested\n - h/o gastric bypass - getting growth scans q4wk\n - h/o admission and beta on ___ and ___ for PTL with change to\n1-2cm/50.\n\nOB Hx:\n- G1 SVD - IOL 37wk for persistent DFM, 2970g\n- G2 current\n\nGYN Hx - due for repeat pap postpartum. No known h/o fibroids,\nSTIs.\n\nPMH: \n- h/o recurrent c. diff\n- h/o anemia requiring IV iron\n\nPast Surgical Hx:\n- gastric bypass (cannot have NSAIDs)\n- cholecystectomy\n \nPhysical Exam:\nOn admission:\nVS: 97.9, 110/73, 81, 18, O2 98%\nGen: NAD\nAbd: soft, gravid, NT. unable to palpate lump under skin \nSVE: deferred ___ on ___\nU/S: vtx, MVP 4.8, BPP ___\n\nOn discharge:\nVitals stable; see flowsheet\nGen: NAD\nAbd: soft, nondistended. Fundus firm ___ FW below umbilicus\nPerineum: scant lochia, no excessive edema/ecchymosis\nExt: no calf tenderness; trace edema\n \nPertinent Results:\n___ BLOOD WBC-9.9 RBC-3.85* Hgb-10.7* Hct-32.9* MCV-86 \nMCH-27.8 MCHC-32.5 RDW-13.6 RDWSD-42.4 Plt ___\n___ BLOOD Glucose-120* UreaN-3* Creat-0.6 Na-137 K-3.9 \nCl-100 HCO3-20* AnGap-17\n\n___ URINE Blood-TR* Nitrite-NEG Protein-30* Glucose-NEG \nKetone-NEG Bilirub-NEG Urobiln-2* pH-6.0 Leuks-LG*\n___ URINE RBC-21* WBC-138* Bacteri-MANY* Yeast-NONE Epi-___ y/o G2P1 admitted at 36w5d with nausea, vomiting, and minimal \npo intake. On admission, she was overall well-appearing and had \nreassuring fetal testing. She was treated with supportive care \nand her nausea improved. In regards to her decreased fetal \nmovement, ultrasound in the ___ was reassuring on HD#2, and she \ncontinued to have reactive NSTs. The decision was made to \nproceed with induction at 37 weeks given her persistent \ndecreased fetal movement. She received 1 Cytotec followed by \nPitocin and had an uncomplicated SVD on ___ and delivered a \nliveborn male weighing 3455 grams with Apgars of 9 and 9. She \nhad an uncomplicated postpartum course and was discharged home \non PPD#2.\n \nMedications on Admission:\nTylenol, PNV\n \nDischarge Medications:\n1.  Acetaminophen ___ mg PO Q6H:PRN Mild Pain  \n2.  Ondansetron ODT 4 mg PO Q8H:PRN nausea  \n3.  OxyCODONE (Immediate Release) 5 mg PO ONCE Duration: 1 Dose \nRX *oxycodone 5 mg 1 tablet(s) by mouth q6hr Disp #*5 Tablet \nRefills:*0 \n4.  Prenatal Vitamins 1 TAB PO DAILY  \n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nvaginal birth\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nPelvic rest\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048206fb505ee7538ed08b"
  },
  "note_id": "10889507-DS-7",
  "subject_id": 10889507,
  "hadm_id": 21794219,
  "note_type": "DS",
  "note_seq": 7,
  "charttime": "2127-04-18 00:00:00",
  "storetime": "2127-04-18 16:48:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nNSAIDS (Non-Steroidal Anti-Inflammatory Drug) / Reglan\n \nAttending: ___.\n \nChief Complaint:\nDiarrhea, right lower quadrant pain\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\n___ with history of RNYGB (___), vaginal delivery of son 2\nmonths prior, and recent bilateral salpingectomy 3 weeks prior \nat\n___ presents with 5 day history of diarrhea (worse than\nher baseline loose stools) and a 12 hour history of RLQ pain. \nShe has also had nausea with wretching.  Reports a low grade \ntemp\nand chills.  Denies dysuria or vaginal discharge.  Denies\ndrainage or pain at recent laparoscopy sites.  Has been seen\npost-operatively by gyn, per patient was told all was normal.  \nOf\nnote, the patient reports an episode similar to her current pain\n___ years ago and she states she was booked for appendectomy but\nher case was suddenly cancelled and she was discharged and her\npain resolved.  She does not know the reason for the change or\nher diagnosis at that hospital visit.\n \nPast Medical History:\nPNC: \n- ___ ___ by LMP c/w ___ trimester U/S\n- Labs Rh pos/Abs neg/Rub I/RPR NR/HBsAg neg/HIV neg/GBS PND\n- Screening - Aneuploidy screening: abnl Panorama - ___ 46XY\n- FFS - wnl\n- GLT - screened with FBS fasting and 1hr PP x 1wk - wnl\n- U/S -  ___: ant placenta, nl AF, 2143g (60%), cephalic\n- Issues\n - She is known Gaucher carrier, but couple have elected not to\nhave FOB tested\n - h/o gastric bypass - getting growth scans q4wk\n - h/o admission and beta on ___ and ___ for PTL with change to\n1-2cm/50.\n\nOB Hx:\n- G1 SVD - IOL 37wk for persistent DFM, 2970g\n- G2 current\n\nGYN Hx - due for repeat pap postpartum. No known h/o fibroids,\nSTIs.\n\nPMH: \n- h/o recurrent c. diff\n- h/o anemia requiring IV iron\n\nPast Surgical Hx:\n- gastric bypass (cannot have NSAIDs)\n- cholecystectomy\n \nSocial History:\n___\nFamily History:\nNonpertitent \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\nVitals: 100.2 108 110/69 22 99% RA \nGEN: A&O, NAD, tearful\nHEENT: No scleral icterus, mucus membranes moist\nCV: mild tachycardia\nPULM: non-labored respirations on room air\nABD: Soft, non-distended but obese, diffusely TTP (worst in \nRLQ),\n+rebound pain, +guarding to RLQ palpation, all 3 recent\nlaparoscopy incisions without erythema or drainage and appear\nwell healed\nExt: No ___ edema, ___ warm and well perfused\n\nDISCHARGE PHYSICAL EXAM\nGEN:AxOx3, tearful \nHEENT: No scleral icterus, mucus membranes are moist, PEERLA, \nEOMI. \nCV: RRR. \nPULM: CTAB. Non-labored breathing. No deformities.\nABD: Soft, nontender, nondistended. No hepatosplenomegaly.\nExt: No ___ edema, no erythema, ___ are warm and well perfused.\n \nPertinent Results:\nADMISSION LABS:\n___ 05:40AM BLOOD Glucose-95 UreaN-3* Creat-0.6 Na-142 \nK-3.8 Cl-102 HCO3-30 AnGap-10\n___ 05:40AM BLOOD WBC-4.9 RBC-3.83* Hgb-9.4* Hct-30.4* \nMCV-79* MCH-24.5* MCHC-30.9* RDW-14.3 RDWSD-41.6 Plt ___\n\nDISCHARGE LABS:\n___ 05:55PM BLOOD WBC-7.0 RBC-4.32 Hgb-10.8* Hct-34.7 \nMCV-80* MCH-25.0* MCHC-31.1* RDW-14.6 RDWSD-42.5 Plt ___\n___ 05:55PM BLOOD Neuts-75.1* Lymphs-16.1* Monos-6.8 \nEos-1.0 Baso-0.7 Im ___ AbsNeut-5.29 AbsLymp-1.13* \nAbsMono-0.48 AbsEos-0.07 AbsBaso-0.05\n___ 05:55PM BLOOD Glucose-87 UreaN-4* Creat-0.7 Na-145 \nK-4.3 Cl-106 HCO3-23 AnGap-16\n___ 09:40AM BLOOD Calcium-9.0 Phos-4.7* Mg-1.9\n\nRADIOOLOGY:\n\nCTA CHEST, ___:\nIMPRESSION: \n1. No evidence of pulmonary embolism. \n2. Consolidations of the left lower lobe may be compatible with \npneumonia. \n3. Small, bilateral pleural effusions with adjacent atelectasis. \n\n4. Status post Roux-en-Y gastric bypass. No evidence of bowel \nobstruction. \n5. The appendix is not definitively seen, but there are no \nsecondary signs of \nacute appendicitis. \n\nCXR, ___:\nIMPRESSION:  \nIn comparison with the study ___, there is increased \nopacification at the \nleft base with blunting the costophrenic angle.  This most \nlikely represents \npleural fluid and atelectatic change.  However, in the \nappropriate clinical \nsetting, superimposed pneumonia could be considered. \nNo vascular congestion or cardiomegaly. \n\nCTAP, ___:\nIMPRESSION: \n1. Mildly prominent loops of small bowel in the left upper and \nright lower \nquadrant without definite transition point to suggest small \nbowel obstruction. \nNo internal hernia, bowel wall thickening, or anastomotic \ncomplications status \npost Roux-en-Y gastric bypass.  These findings may represent a \nnonspecific \ngastroenteritis. \n2. Normal appendix. \n3. Minimal intrahepatic biliary dilatation is likely related to \nprior \ncholecystectomy. \n4. Trace bilateral pleural effusions with adjacent mild \ncompressive \natelectasis.  No focal consolidation. \n\n  \n\n \nBrief Hospital Course:\nMs ___ is a ___ yo F who presented to emergency department on \n___ with abdominal pain and diarrhea approximately 2 weeks \npost operative from bilateral salpingectomy. White blood cell \ncount, differential showed no left shift and normal and CT \nabdomen/pelvis showed no intraabdominal process. Stool sample \nsent and negative for clostridium difficile. She developed a \nworsening cough with shortness of breath on excretion, \nsupplemental oxygen requirement, and wheeze on clinical exam. \nPatient denies history of asthma. Chest X-ray and CTA chest \nconcerning for left lower lobe pneumonia and no pulmonary \nembolism identified. Given clinical picture of community \nacquired pneumonia the medicine team was consulted. Medicine \nsaid that given the absence of leukocytosis and improvement in \nhypoxia with ISS that the diagnosis of pneumonia is not likely. \nThe abdominal pain is likely ___ to a viral gastroenteritis \ngiven the absence of findings on CT scan and gynecological \nevaluation. Her oxycodone was discontinued on ___ and she was \ncontinued on the oral Tylenol. On the day of discharge she was \ntolerating a regular diet, she was ambulatory and her pain was \ncontrolled. She was instructed to follow up as an outpatient \nwith gynecology with any gynecological issues. The patient was \nencouraged to return to the Emergency Department if her pain \ngets worse or she is not able to tolerate PO. The patient was in \nagreement with this plan. \n \nMedications on Admission:\nPrenatal vitamin\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild \nRX *acetaminophen 500 mg 2 tablet(s) by mouth q8hr:PRN Disp #*40 \nTablet Refills:*0 \n2.  GuaiFENesin ___ mL PO Q6H:PRN cough \nRX *guaifenesin 100 mg/5 mL per instructions by mouth q8hr:PRN \nRefills:*0 \n3.  Ondansetron 4 mg PO Q8H:PRN nausea \nRX *ondansetron 4 mg 1 tablet(s) by mouth q8hr:PRN Disp #*10 \nTablet Refills:*0 \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nGastroenteritis, unspecified\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the ___ \nfor abdominal pain on ___. There was concern for \nappendicitis and you were admitted to the General Surgery \nservice with IV antibitioics (zosyn, ceftriaxone, flagyl). A CT \nscan of your abdomen and pelvis at that time did not show any \nabnormalities and the antibiotics were discontinued. Gynecology \nwas consulted given your recent procedure and wished for you to \ncontinue to follow up as an outpatient. You were put on a \nregular diet on ___ which you tolerated well. On ___ you were \nneeding some extra oxygen so we ordered a chest xray which \nshowed that you need to open your lungs more. We gave you \nbreathing treatments which you tolerated well. On ___ your pain \nwas better controlled. On the day of discharge you were \ntolerating a regular diet, you were having bowel movements and \nambulating. You were discharged home in stable condition and \ninstructed to follow up as an outpatient with your gynecologist. \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048235fb505ee753922b67"
  },
  "note_id": "17498747-DS-10",
  "subject_id": 17498747,
  "hadm_id": 28026316,
  "note_type": "DS",
  "note_seq": 10,
  "charttime": "2141-04-14 00:00:00",
  "storetime": "2141-04-15 06:01:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: ORTHOPAEDICS\n \nAllergies: \nbetadine  / Codeine\n \nAttending: ___.\n \nChief Complaint:\n___ s/p resection and proximal tibia replacement\nreconstruction with medial gastrocnemius muscle flap with Dr. \n___\n___ for left proximal tibia chondrosarcoma. She was recently\nadmitted for possible wound infection but her CXR, CT leg, UA,\nlabs and physical exam were not consistent with infection. No \nDVT\nbased on duplex. She was discharged from ___ on ___.\nShe presented again to an ED in ___ two days ago with concern\nfor infection. Per pt report, she received XR and had labs drawn\nwhich did not show infection, but was discharged with\ninstructions to wash the wound with soap and water daily - which\nshe had been doing in the shower. She noted a dark eschar\nstarting a few days ago. She also notes that her wound has a \nfoul\nsmell with some serous vs. purulent drainage. She denies fever,\nchills, nausea, vomiting. Her left foot pain has actually\nimproved and her left leg/ankle swelling has markedly improved.\nOverall she has been feeling well except her left leg pain. \n  \n \nMajor Surgical or Invasive Procedure:\n___ - washout LLE/vac placement \n___ - LLE primary wound closure per plastic surgery \n \nHistory of Present Illness:\n___ s/p resection and proximal tibia replacement\nreconstruction with medial gastrocnemius muscle flap with Dr. \n___\n___ for left proximal tibia chondrosarcoma. She was recently\nadmitted for possible wound infection but her CXR, CT leg, UA,\nlabs and physical exam were not consistent with infection. No \nDVT\nbased on duplex. She was discharged from ___ on ___.\nShe presented again to an ED in ___ two days ago with concern\nfor infection. Per pt report, she received XR and had labs drawn\nwhich did not show infection, but was discharged with\ninstructions to wash the wound with soap and water daily - which\nshe had been doing in the shower. She noted a dark eschar\nstarting a few days ago. She also notes that her wound has a \nfoul\nsmell with some serous vs. purulent drainage. She denies fever,\nchills, nausea, vomiting. Her left foot pain has actually\nimproved and her left leg/ankle swelling has markedly improved.\nOverall she has been feeling well except her left leg pain. \n\n \nPast Medical History:\nDepression, anxiety, reactive airway disease. \ns/p three C-sections, ___, ___ \ns/p breast augmentation  \n \nSocial History:\n___\nFamily History:\nNon contributory \n \nPhysical Exam:\nAdmission Physical Exam: \n\nNAD, A&Ox3\nLeft lower extremity:\nSurgical inicision over anterior tibia shows dark eschar with\nfibrous vs. purulent tissue in the base ~15cm, several smaller\n(1-2cm) areas of eschar in more proximal/distal portions of\nincision. Serous vs. purulent drainage from wound. \nSoft, non-tender thigh with very tender anterior lower leg\n___ fire (very weak ___\n+SILT SPN/DPN/TN/saphenous/sural distributions - improved\nhypersensitivy, possible CPN palsy\n___ pulses, foot warm and well-perfused\n\nDischarge Physical Exam:\nLeft lower extremity: \nSoft, non-tender thigh, tenderness over anterior lower leg \npersists\n___ fire (very weak ___\n+SILT SPN/DPN/TN/saphenous/sural distributions, possible CPN \npalsy\n___ pulses, foot warm and well-perfused\n \nPertinent Results:\n___ 01:50PM BLOOD WBC-8.5 RBC-3.96*# Hgb-11.3*# Hct-35.1*# \nMCV-89 MCH-28.5 MCHC-32.2 RDW-14.2 Plt ___\n___ 06:45PM URINE  COLOR-Yellow APPEAR-Hazy SP ___\n___ 06:45PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 \nLEUK-NEG\n___:45PM URINE  RBC-1 WBC-1 BACTERIA-NONE YEAST-NONE \nEPI-3\n___ 06:45PM URINE  CA OXAL-FEW\n___ 06:45PM URINE  MUCOUS-RARE\n___ 01:50PM   GLUCOSE-84 UREA N-7 CREAT-0.6 SODIUM-140 \nPOTASSIUM-4.1 CHLORIDE-102 TOTAL CO2-27 ANION GAP-15\n___ 01:50PM   estGFR-Using this\n___ 01:50PM   CRP-0.8\n___ 01:50PM   WBC-8.5 RBC-3.96*# HGB-11.3*# HCT-35.1*# \nMCV-89 MCH-28.5 MCHC-32.2 RDW-14.2\n___ 01:50PM   NEUTS-55.0 ___ MONOS-5.8 EOS-3.0 \nBASOS-0.6\n___ 01:50PM   PLT COUNT-427\n___ 01:50PM   ___ PTT-28.2 ___\n___ 01:50PM   SED RATE-23*\n\n___ 07:49AM BLOOD WBC-8.0 RBC-3.37* Hgb-9.8* Hct-30.3* \nMCV-90 MCH-29.0 MCHC-32.2 RDW-13.6 Plt ___\n___ 07:49AM BLOOD Neuts-50.9 ___ Monos-5.7 Eos-4.7* \nBaso-0.7\n___ 07:49AM BLOOD Glucose-96 UreaN-9 Creat-0.5 Na-140 K-3.9 \nCl-109* HCO3-24 AnGap-___ yo female with h/o chrondrosarcoma s/p resection and proximal \ntibia replacement with gastroc flap LLE (___) who presented \nwith black eschar over anterior left tibial wound on ___. \nGiven concern for infection, she was admitted to the orthopedic \nservice in consultation with plastic surgery. Infectious workup \nwas negative with negative cultures and she remained afebrile \nwith normal WBC. On ___, she went to the OR for washout and \ndebridement of eschar with placement of VAC drain over her LLE \nwound. In the OR on ___, the necrotic tissue was limited to \nthe skin and subcutaneous tissue with intact muscle flap and no \nexposure of hardware. \n\nShe was maintained on partial weight-bearing with ___ in \nplace to maximize knee extension as much as tolerated to limit \nfurther development of flexion contracture. On ___, she was \ntaken to the OR again by plastic surgery for further excision of \nnecrotic tissue with successful primary wound closure. Again, it \nwas noted that the muscle flap was viable and the only exposed \nhardware was a portion of the cerclage wire. \n\nDuring the course of her admission, her pain was very difficult \nto control and required consultation by the chronic pain \nservice. When she was admitted for the initial limb salvage \nsurgery in ___, her pain was similarly difficult to \ncontrol and required consultation by the acute pain service and \nchronic pain. The CPS agreed with addition of amitriptyline 25 \nmg PO/NG HS for neuropathic component of pain with continuance \nof gabapentin 800 mg Q8H. Oxycontin was increased to 20mg Q8H \nfor acute on chronic pain and dilaudid was increased to ___ mg \nQ3H prn. It was thought that anxiety might be contributing to \nbreakthrough pain and as such valium 5mg TID was recommended for \nbreakthrough pain. Finally, tylenol 1gm PO Q6H and toradol 30mg \nQ6 were started in an effort to manage her pain.\n \nMedications on Admission:\nctive Medication list as of ___:\n \nMedications - Prescription\nDIAZEPAM - diazepam 10 mg tablet. 1 tablet(s) by mouth every\ntwelve (12) hours as needed for spasm / anxiety Do not take if\nsleepy or somnolent -  (Not Taking as Prescribed)\nENOXAPARIN - enoxaparin 40 mg/0.4 mL Sub-Q Syringe. 40 mg SQ q\nday -  (Not Taking as Prescribed)\nGABAPENTIN - gabapentin 800 mg tablet. one tablet(s) by mouth\nthree times daily -  (Prescribed by Other Provider)\nHYDROMORPHONE - hydromorphone 4 mg tablet. ___ tablet(s) by \nmouth\nq3-6h as needed for pain Should take ___ total q ___ prn pain\nHYDROMORPHONE - hydromorphone 2 mg tablet. ___ tablet(s) by \nmouth\nEvery 3 hrs as needed for Pain\nHYDROMORPHONE [DILAUDID] - Dilaudid 4 mg tablet. ___ tablet(s) \nby\nmouth q3-6h as needed for for pain\nLORAZEPAM - lorazepam 2 mg tablet. 0.5 (One half) tablet(s) by\nmouth Every 6 hours as needed for Anxiety/pain/spasms - \n(Prescribed by Other Provider)\nNORETHINDRONE (CONTRACEPTIVE) [ERRIN] - Errin 0.35 mg tablet. 1\ntablet(s) by mouth at bedtime -  (Prescribed by Other Provider;\nDose adjustment - no new Rx)\nOXYCODONE - oxycodone 10 mg tablet. ___ tablet(s) by mouth\nq4-6h as needed for for pain ok to substitute 5mg tabs if\nnecessary- dose stays the same, ___ po q ___ prn pain -  \n(Not\nTaking as Prescribed)\nOXYCODONE [OXYCONTIN] - OxyContin 20 mg tablet,extended release.\n1 tablet extended release 12 hr(s) by mouth twice a day Take \nonly\none pill q 12 hours\nTRAMADOL - tramadol 50 mg tablet. 2 tablet(s) by mouth three\ntimes daily as needed for pain -  (Prescribed by Other Provider)\n(Not Taking as Prescribed)\nZOLPIDEM - zolpidem 5 mg tablet. ___ to 1 tablet(s) by mouth at\nbedtime as needed for insomnia -  (Prescribed by Other Provider)\n(Not Taking as Prescribed)\n\nPer pt she is taking oxycontin 20mg BID, dilaudid 4mg Q3H for\npain \n\n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO Q6H \n2. Amitriptyline 25 mg PO HS \nRX *amitriptyline 25 mg 1 tablet(s) by mouth at bedtime Disp \n#*30 Tablet Refills:*0\n3. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation \n4. Diazepam 5 mg PO Q 8H pain, spasm \nRX *diazepam 5 mg 1 tablet by mouth every eight (8) hours Disp \n#*90 Tablet Refills:*0\n5. Docusate Sodium 100 mg PO BID \n6. Gabapentin 800 mg PO Q8H \nRX *gabapentin 800 mg 1 tablet(s) by mouth every eight (8) hours \nDisp #*90 Capsule Refills:*0\n7. Senna 1 TAB PO BID \n8. Zolpidem Tartrate 2.5-5 mg PO QHS:PRN Insomnia \nRX *zolpidem [Ambien] 5 mg ___ tablet(s) by mouth at bedtime \nDisp #*60 Tablet Refills:*0\n9. Aspirin 81 mg PO DAILY \n10. OxyCODONE SR (OxyconTIN) 20 mg PO Q8H \n11. HYDROmorphone (Dilaudid) ___ mg PO Q3H:PRN Pain \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nLeft leg wound dehiscence \n \nDischarge Condition:\nalert and oriented, pain controlled on PO meds, voiding \nspontaneously, ambulating independently \n \nDischarge Instructions:\nYou were admitted for concern for infection. You wound was \nwashed out and then closed by Plastic Surgery. Keep knee in \nbrace with your knee out straight (in extension) as much as \npossible. Change dressing every other day per Plastic Surgery. \nUse a dry gauze and tape for dressing your wound. Keep dressing \nover wound dry - please change if it becomes wet. \n\nElevate your leg when you are resting. \n\nTake one baby aspirin per day to help prevent blood clots. \n\nYou can paritally weight bear on your left leg. \nPhysical Therapy:\npartial weight bearing LLE\nkeep ___ locked in extension as much as tolerable \nTreatments Frequency:\nKeep LLE elevated when resting\nChange dressing every other day or if it becomes wet or \nsaturated. \nCan use dry gauze and tape for dressing. \nReapply ACE for the next week. \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048235fb505ee753922b68"
  },
  "note_id": "17498747-DS-11",
  "subject_id": 17498747,
  "hadm_id": 24623338,
  "note_type": "DS",
  "note_seq": 11,
  "charttime": "2141-07-10 00:00:00",
  "storetime": "2141-07-15 07:55:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: ORTHOPAEDICS\n \nAllergies: \nbetadine  / Codeine / Ativan\n \nAttending: ___.\n \nChief Complaint:\nLeft knee pain and swelling\n \nMajor Surgical or Invasive Procedure:\nLeft knee aspirate - No growth to date with almost no fluid in \nknee.\n \nHistory of Present Illness:\n(From ED admission note): ___ with PMH significant for recurrent \nchondrosarcoma of the L distal femur and proximal knee s/p \nproximal tibia reconstruction and hinged L TKA in ___ \nrequiring plastic surgery closure (gastroc flap) presents with 2 \nweek history of worsening L knee pain.  Patient states that she \nfirst noticed the symptoms approximately 2 weeks ago and thought \nher swelling and pain was attributable to strain from ___.  \nHowever, over the following days she noticed progressive \nworsening of her pain and decreasing ability to actively or \npassively flex her knee.  She also has had at least 2 episodes \nof fever, nausea and malaise over the same time period which she \nthought was attributable to a cold.  She has been able to bear \nweight on the L lower extremity, but feels as though it has been \nincreasingly difficult to do so over the past 72 hours.\nin \n \nPast Medical History:\nDepression, anxiety, reactive airway disease. \ns/p three C-sections, ___, ___ \ns/p breast augmentation  \n \nSocial History:\n___\nFamily History:\nNon contributory \n \nPertinent Results:\n___ 11:30PM BLOOD WBC-8.2 RBC-4.09* Hgb-10.8* Hct-34.8* \nMCV-85 MCH-26.3* MCHC-30.9* RDW-14.9 Plt ___\n___ 11:30PM BLOOD Neuts-46.4* Lymphs-44.2* Monos-5.4 \nEos-2.6 Baso-1.4\n___ 11:30PM BLOOD CRP-8.6*\n___ 11:30PM BLOOD ESR-40*\n\n___ 2:15 pm JOINT FLUID     Site: KNEE      LEFT KNEE. \n      Note: Culture results may be compromised by the limited \nvolume (less\n      than 1ml) of specimen received. \n\n   GRAM STAIN (Final ___: \n      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. \n      NO MICROORGANISMS SEEN. \n\n   FLUID CULTURE (Preliminary): \n\n \nBrief Hospital Course:\nPatient was admitted from the ED on ___ for the above issues. \nShe intially refused aspiration of her left knee due to anxiety. \nShe agreed to ultrasound guided aspiration of her knee in \nradiology under conscious sedation on ___. Very little fluid \ncould be seen on ultrasound but a small sample was sent for Gram \nstain and culture. The results of the culture on ___ were \nnegative for any growth. The patient's clinical appearance and \nleft knee continued to improve and she was deemed stable for \ndischarge home on ___.\n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO Q8H \n2. HYDROmorphone (Dilaudid) ___ mg PO Q3H:PRN Pain \nRX *hydromorphone [Dilaudid] 2 mg ___ tablet(s) by mouth every \nthree (3) hours Disp #*70 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nLeft knee mechanical irritation/inflammation\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n \nDischarge Instructions:\nYou may weight bear as tolerated on your left leg. You should \nattempt to keep the leg elevated as much as possible while \nsitting or lying down. You may ice the leg as needed to help \nwith pain and swelling.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048235fb505ee753922b69"
  },
  "note_id": "17498747-DS-12",
  "subject_id": 17498747,
  "hadm_id": 25765251,
  "note_type": "DS",
  "note_seq": 12,
  "charttime": "2142-12-03 00:00:00",
  "storetime": "2142-12-02 17:28:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: ORTHOPAEDICS\n \nAllergies: \nbetadine  / Codeine / Ativan / gabapentin / Butrans\n \nAttending: ___.\n \nChief Complaint:\nchronic draining wound\n \nMajor Surgical or Invasive Procedure:\nirrigation and debridement of left knee prosthesis x 2, lateral \ngastrocnemius flap\n\n \nHistory of Present Illness:\nchondrosarcoma in her proximal tibia.  She\nrecently had a sinus tract develop, and unfortunately this\nwas a result of a deep infection of her tumor prosthesis.\nThe cultures are growing out Pseudomonas and so we\nrecommended another irrigation debridement.  At this point,\nwe did consider removal of all of the implants and placement\nof a spacer, but the patient is really loathe to have to go\nthrough that, and I think it is reasonable to try retention\nof implants and the IV antibiotics at this point.  We talked\nabout risks, benefits, and alternatives of the surgical\nprocedure and she wishes to proceed.\n\n \nPast Medical History:\nDepression, anxiety, reactive airway disease. \ns/p three C-sections, ___, ___ \ns/p breast augmentation  \ns/p proximal tibia reconstruction\n \nSocial History:\n___\nFamily History:\nNon contributory \n \nPhysical Exam:\nGen: NAD AAO\nLLE: SILT SPN/DPN/TN\n___ pulses\nMOtor + ___\nthigh soft, calf soft\ndressing c/d/i\nknee immobilzer in place\n \nPertinent Results:\n___ 10:58AM BLOOD WBC-8.8 RBC-2.90* Hgb-8.1* Hct-25.0* \nMCV-86 MCH-27.8 MCHC-32.2 RDW-15.1 Plt ___\n___ 10:58AM BLOOD Neuts-68.2 ___ Monos-5.3 Eos-4.0 \nBaso-0.4\n___ 10:58AM BLOOD Plt ___\n___ 11:00AM BLOOD UreaN-6 Creat-0.5 Na-144 K-4.5 Cl-110*\n___ 10:58AM BLOOD CRP-18.9*\n___ 11:00AM BLOOD CRP-14.0*\n___ 08:50AM BLOOD CRP-46.6*\n___ 05:00PM BLOOD CRP-116.3*\n___ 05:00PM BLOOD SED RATE-Test \n\n     ___ 2:20 pm TISSUE     Site: LEG      LEFT LEG DEEP \nTISSUE. \n\n                            **FINAL REPORT ___\n\n   GRAM STAIN (Final ___: \n      3+  ___ per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      NO MICROORGANISMS SEEN. \n\n   TISSUE (Final ___: \n      Reported to and read back by ___ ___ 3:40PM \n___. \n      DORIPENEM AND COLISTIN PER ___ ___ ___. \n      PSEUDOMONAS AERUGINOSA.    RARE GROWTH. \n         SENSITIVE TO DORIPENEM MIC =0.5MCG/ML Sensitivity \ntesting\n         performed by Etest. \n         SENSITIVE TO COLISTIN sensitivity testing performed by \n___\n         ___. \n         CEFTOLOZANE/TAZOBACTAM =0.5/4 MCG/ML SUSCEPTIBLE, \nPERFORMED BY\n         CUBIST PHARMACEUTICALS REFERENCE LAB. \n      PSEUDOMONAS AERUGINOSA.    RARE GROWTH.  SECOND STRAIN. \n         SENSITIVE TO DORIPENEM.MIC=0.75 MCG/ML Sensitivity \ntesting\n         performed by Etest. \n         SENSITIVE TO COLISTIN sensitivity testing performed by \n___\n         ___. \n         CEFTOLOZANE/TAZOBACTAM =0.5/4 MCG/ML SUSCEPTABLE, \nPERFORMED BY\n         ___ REFERENCE LAB. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             PSEUDOMONAS AERUGINOSA\n                             |          PSEUDOMONAS AERUGINOSA\n                             |          |   \nCEFEPIME--------------   <=1 S      <=1 S\nCEFTAZIDIME-----------   <=1 S        2 S\nCIPROFLOXACIN---------<=0.25 S   <=0.25 S\nGENTAMICIN------------   <=1 S      <=1 S\nMEROPENEM-------------<=0.25 S   <=0.25 S\nPIPERACILLIN/TAZO-----     8 S        8 S\nTOBRAMYCIN------------   <=1 S      <=1 S\n\n   ANAEROBIC CULTURE (Final ___:    NO ANAEROBES ISOLATED.\n\n___ 12:58 pm SWAB      LEFT LEG WOUND. \n\n                            **FINAL REPORT ___\n\n   GRAM STAIN (Final ___: \n      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      NO MICROORGANISMS SEEN. \n\n   WOUND CULTURE (Final ___: \n      PSEUDOMONAS AERUGINOSA. \n         SPARSE GROWTH OF TWO COLONIAL MORPHOLOGIES. \n         SENSITIVITIES PERFORMED ON CULTURE # ___ ___. \n      KLEBSIELLA OXYTOCA.    1 COLONY ON 1 PLATE. \n         CANNOT RULE OUT CONTAMINATION. \n         CEFTOLOZANE/TAZOBACTAM ___ SUSCEPTIBLE, PERFORMED \nBY CUBIST\n         PHARMACEUTICALS REFERENCE LAB. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             KLEBSIELLA OXYTOCA\n                             |   \nAMPICILLIN/SULBACTAM--     4 S\nCEFAZOLIN-------------    16 R\nCEFEPIME--------------   <=1 S\nCEFTAZIDIME-----------     4 S\nCEFTRIAXONE-----------   <=1 S\nCIPROFLOXACIN---------<=0.25 S\nGENTAMICIN------------   <=1 S\nMEROPENEM-------------<=0.25 S\nPIPERACILLIN/TAZO-----   <=4 S\nTOBRAMYCIN------------   <=1 S\nTRIMETHOPRIM/SULFA----     2 S\n\n   ANAEROBIC CULTURE (Final ___:    NO ANAEROBES ISOLATED. \n\n\n \n \n \n\n \nBrief Hospital Course:\n___ yo F who was admitted ___ following an I+D of the left \nknee with sinus tract excision. She was admitted for IV \nantibioitics and pain control. Acute pain services was consulted \nand managed her pain with a sciatic nerve catheter. Infectious \ndisease was consulted and recommended ___ weeks of IV therapy \nwith 2g cefepime q8h. She went back to the operating room on \n___ for a repeat procedure. Plastics was consulted and was \navailable intraoperatively to examine the wound. In between \nsurgeries a wound vac was placed secondary to being unable to \ncover the skin in the area of the sinus tract which was \npreviously present. Plastic surgery performed a lateral \ngastrocnemius flap on ___. Her hospital course was \nsignificant for difficulties with pain control for which IV \nmedications were required. She remained stable and was medically \nclear for discharge. hopsitalization was prolonged secondary to \ndifficulties with insurance and setting up home services for her \nIV therapy. She had a plan in place on ___ and was \ndischarged home.\n \nMedications on Admission:\nMorphine ER 20mg BID\nErrin\n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO Q8H \n2. Ascorbic Acid ___ mg PO DAILY \n3. CefePIME 2 g IV Q8H \nRX *cefepime [Maxipime] 2 gram 2 g IV every eight (8) hours Disp \n#*48 Vial Refills:*3\n4. Diazepam ___ mg PO Q6H:PRN spasm, pain \nRX *diazepam 5 mg 1 tablet by mouth every six (6) hours Disp \n#*70 Tablet Refills:*0\n5. Enoxaparin Sodium 40 mg SC QAM \nStart: Today - ___, First Dose: Next Routine Administration \nTime \nRX *enoxaparin 40 mg/0.4 mL 1 syringe sc daily Disp #*14 Syringe \nRefills:*0\n6. Errin (norethindrone (contraceptive)) 0.35 mg oral Qhs \n7. HYDROmorphone (Dilaudid) ___ mg PO Q3H:PRN Pain \nRX *hydromorphone 4 mg ___ tablet(s) by mouth q3h Disp #*100 \nTablet Refills:*0\n8. Sodium Chloride 0.9%  Flush ___ mL IV DAILY and PRN, line \nflush \nRX *sodium chloride 0.9 % [Normal Saline Flush] 0.9 % ___ ml \nIV daily Disp #*30 Syringe Refills:*2\n9. Pregabalin 100 mg PO BID \nRX *pregabalin [Lyrica] 100 mg 1 capsule(s) by mouth twice a day \nDisp #*28 Capsule Refills:*0\n10. OxyCODONE SR (OxyconTIN) 20 mg PO Q12H \nRX *oxyCODONE  1 tablet by mouth twice a day Disp #*28 Tablet \nRefills:*0\n11. Docusate Sodium 100 mg PO BID \nRX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day \nDisp #*60 Capsule Refills:*0\n\n \nDischarge Disposition:\nHome with Service\n \nDischarge Diagnosis:\nchronic infection, left knee prosthesis\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nActivity: weight bearing as tolerated LLE. it may be more \ncomfortable to use curtches or a walker until you can use your \ncane. Use your knee immobilizer when up moving around. okay to \ntake immobilizer off while in bed.\n\nDressing: change daily as needed for drainage. okay to leave \nopen to air.\n\nShower: okay to shower, let water run over the incision, do not \nscrub the incision. pat incision dry and reapply dry dressing.\n\nDiet: regular diet\nPhysical Therapy:\nWeight bearing as tolerated. no range of motion of knee. knee \nimmobilzier while ambulating. \nTreatments Frequency:\nchange dressing daily or as needed for drainage\ncefepime 2g q8h\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048235fb505ee753922b6a"
  },
  "note_id": "17498747-DS-7",
  "subject_id": 17498747,
  "hadm_id": 25530390,
  "note_type": "DS",
  "note_seq": 7,
  "charttime": "2140-09-14 00:00:00",
  "storetime": "2140-09-13 16:59:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: ORTHOPAEDICS\n \nAllergies: \nbetadine \n \nAttending: ___.\n \nChief Complaint:\nLeft Knee Pain\n \nMajor Surgical or Invasive Procedure:\nCurretage and Cement of Left Proximal Tibia Chondrosarcoma\n\n \nHistory of Present Illness:\nPatient had left knee pain for many years told she had a cyst.  \nFollowd up with Dr. ___ had ___ performed of left \nproximal ibia lesion found to be a chondrosarcoma.  Patient then \nscheduled for surgery.\n \nPast Medical History:\nSmoker.\n \nSocial History:\n___\nFamily History:\nNC\n \nPhysical Exam:\nGen: NAD, AOx3\nResp: breathing unlabored\nCV: RRR\nLLE: incision clean and dry and intact, able to ankle df, ankle \npf, ___ intact, silt to s/s/sp/dp/t nerves.\n \nPertinent Results:\n___ 06:35AM BLOOD WBC-15.2* RBC-3.82* Hgb-11.7* Hct-36.9 \nMCV-97 MCH-30.6 MCHC-31.7 RDW-14.2 Plt ___\n___ 06:35AM BLOOD Glucose-96 UreaN-8 Creat-0.6 Na-139 K-4.3 \nCl-104 HCO3-27 AnGap-12\n \nBrief Hospital Course:\nPatient admitted post operatively from a curretage and \ncementation of left proximal tibia chondrosarcoma.  She recevied \na block from the pain team but on POD #1 when it wore off had \nextreme pain and had a rescue block performed.  Subsequently on \nPOD#2 after pain team recommendations were instituted, patient \nmuch more comfortable when second block wore off. Throughout her \nsta her vitals were stable and she was afebrile.  She \nsubseuqently was cleared for home by ___ without any need for \nservices.  \n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO Q6H Pain \n2. Aspirin 81 mg PO DAILY Duration: 2 Weeks \n3. BuPROPion (Sustained Release) 150 mg PO BID Smoking \n4. Morphine SR (MS ___ 15 mg PO Q12H \nRX *morphine [MS ___ 15 mg 1 tablet(s) by mouth every twelve \n(12) hours Disp #*30 Tablet Refills:*0\n5. OxycoDONE (Immediate Release)  ___ mg PO Q3H:PRN Pain \nRX *oxycodone 5 mg ___ tablet(s) by mouth every four (___) hours \nDisp #*120 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nChondrosarcoma of Left Tibia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nActivity: Partial Weight Bearing on Left Lower Extremity\n\nDressing/Wound Care: Change dressing daily for first 7 days, \nthen can levae open to air if there is no drainge. For first 7 \ndays please cover with water tight dressing if you are to \nshower.\n\nMedications: Take as directed.  Wean yourself off of the \noxycodone and ms-contin.  The MS ___ should be taken for \napproximatel 10 days, the oxycodone ___ may need longer and ___ \nit for breakthrough pain.  Continue taking the ASA 81 mg daily \nfor two weeks.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048235fb505ee753922b6b"
  },
  "note_id": "17498747-DS-8",
  "subject_id": 17498747,
  "hadm_id": 24429027,
  "note_type": "DS",
  "note_seq": 8,
  "charttime": "2141-03-06 00:00:00",
  "storetime": "2141-03-17 10:08:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: ORTHOPAEDICS\n \nAllergies: \nbetadine  / Codeine\n \nAttending: ___.\n \nChief Complaint:\nLeft tibial chondrosarcoma recurrance\n \nMajor Surgical or Invasive Procedure:\nLeft proximal tibial resection with hinged total knee \nreplacement and soleus flap for chondrosarcoma recurrance\n\n \nHistory of Present Illness:\n___ yo with h/o chondrosarcoma recurrence admitted for hinged TKA \nreplacement\n \nPast Medical History:\nSmoker.\n \nPhysical Exam:\nGen: NAD\nCardiac: RRR by palpation\nPulmonary: no increased WOB\nExt: incision c/d/i, no drainage nor errythema, foot WWP, \n___ pulses. SITLT DP/SP/T. Motor intact ___\n \nBrief Hospital Course:\nPatient was admitted after uncomplicated hinged L TKA for \nchondrosarcoma recurrance. Pain service was involved for post-op \npain management which involved an epidural cath, ketamine gtt \nand eventual weaning to PO pain medications by POD3-4. Post \noperative temperatures ranged to ___ for the first several days \nafter surgery - extensive work-up including chest XR, DVT \nstudies, blood cx, Urine cx and wound aspiration revealed no \nsource of infections and by POD7 the fevers dissipated after \nperioperative ancef was discontinued. Infectious disease was \nconsulted and felt most likely eitology of fevers was drug \nreaction or herpetic ulcer. By POD7 patient was working with ___, \npain was controlled on oral pain medications, patient remained \nafebrile, patient was voiding spontaneously and deemed safe for \ndischarge to home with close family care and plan for follow up \nas scheduled.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Zolpidem Tartrate 5 mg PO HS Insomnia \n2. Gabapentin 500 mg PO TID \n3. TraMADOL (Ultram) 100 mg PO TID Pain \n4. Acetaminophen 1000 mg PO Q6H:PRN Pain \n\n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO Q6H Pain \n2. Gabapentin 800 mg PO TID \n3. Enoxaparin Sodium 40 mg SC Q 24H \n4. Nicotine Patch 14 mg TD DAILY \n5. Zolpidem Tartrate 5 mg PO HS Insomnia \n6. OxyCODONE SR (OxyconTIN) ___ mg PO Q8H Duration: 63 Doses \n30mg 3x/day x3days, 30mg 2x/day x3days, 20mg 2x/day x3days, 10mg \n2x/day x3days, then stop \nRX *oxycodone [OxyContin] 10 mg ___ tablets by mouth As \ninstructed Disp #*63 Tablet Refills:*0\n7. HYDROmorphone (Dilaudid) ___ mg PO Q3H:PRN Pain \nRX *hydromorphone 2 mg ___ tablet(s) by mouth Every 3 hrs Disp \n#*120 Tablet Refills:*0\n8. Lorazepam ___ mg PO Q6H:PRN anxiety, muscle spasm \nRX *lorazepam 2 mg 0.5 (One half) tablet by mouth Every 6 hours \nDisp #*60 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nLeft proximal tibial resection with hinged total knee \nreplacement and soleus flap for chondrosarcoma recurrance\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nActivity: remain partial weight bearing (50% of your weight) on \nyour left lower extremity with your leg fully extended in your \nknee immobilizer at all times when out of bed or sleeping. When \nawake and in bed it is okay to open your knee immobilizer to \nallow your leg to get some fresh air.\n\nWound care/Bathing: You may shower but keep the incision covered \nwith a clean/dry dressing until 7 days after surgery (___), \nat which time you may shower and let the soapy water run over \nthe top of your incsion. Pat your wound completely dry after you \nshower and then cover only if needed with a dry/sterile \ndressing. DO NOT take a bath, hottub or go in the pool (ie: do \nnot submerge your wound) until otherwise instructed.\n\nDriving: Do not drive while you are taking pain medications or \nif you are in pain. This can slow your reaction time and make \nyou distracted. Do not do any tasks that require attention or \nprecise balance, drive, operate machinery or drink alcohol while \ntaking these medications. \n\nMedications: Take your pain medications as perscribed. Narcotic \npain medications can cause constipation, so be sure to drink a \nlot of water and take an over-the-counter stool softner as \nneeded. You may also take Tylenol around the clock to decrease \nyour need for other pain medications, but be sure not to take \nmore than 4 grams of Tylenol each day as it is bad for your \nliver. You do not have to take all of the pain medicine and it \nis ok/expected to decrease the dose and frequency as your pain \nimproves. Try to be off of the pain medicine by the time you \nreturn for your postoperative visit.\n\nFollow up: Follow up as scheduled with Dr ___ Therapy:\nLeft lower extremity: Partial weight bearing LLE with knee in \nextension in knee immobilizer at all times while out of bed or \nasleep. ___ open front of KI while awake in bed for skin care.\n\nTreatments Frequency:\nSite: Left lower extremity incision \nType: Surgical\nDressing: Gauze - dry\nComment: Change on AM of POD 2 by ___, then daily by RN; please \noverwrap any dressing bleedthrough with ABDs and ACE. ___ leave \nopen to air after POD5, keep covered in shower until POD7 after \nwhich may shower without dressing \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048235fb505ee753922b6c"
  },
  "note_id": "17498747-DS-9",
  "subject_id": 17498747,
  "hadm_id": 22967665,
  "note_type": "DS",
  "note_seq": 9,
  "charttime": "2141-03-21 00:00:00",
  "storetime": "2141-03-21 12:08:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: ORTHOPAEDICS\n \nAllergies: \nbetadine  / Codeine\n \nAttending: ___.\n \nChief Complaint:\nSwelling\n \nMajor Surgical or Invasive Procedure:\nNone\n \nBrief Hospital Course:\nPatient came with concern for infection. CXR, CT leg, UA, labs, \nand physical exam not consistent with infection. No DVT based on \nduplex. No ankle septic arthritis based on exam. \n\nSwelling likely from dependent positioning and excessive \nactivity. \n\nPain meds refilled, education provided, patient D/c'd to home.\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nLeg swelling\n\n \nDischarge Condition:\nStable\n\n \nDischarge Instructions:\nLeave wound open to air. Elevate as much as possible. Ok to \nshower, no tub soaks. PWB. Keep knee as straight as possible in \nbrace; no bending. Continue Lovenox as prescribed.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820efb505ee7538f8772"
  },
  "note_id": "12298968-DS-20",
  "subject_id": 12298968,
  "hadm_id": 20768674,
  "note_type": "DS",
  "note_seq": 20,
  "charttime": "2180-02-23 00:00:00",
  "storetime": "2180-02-23 13:05:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: OBSTETRICS/GYNECOLOGY\n \nAllergies: \nCompazine / Amoxicillin\n \nAttending: ___\n \nChief Complaint:\nrecurrent ovarian cancer\n \nMajor Surgical or Invasive Procedure:\nexploratory laparotomy, tumor resection, cystoscopy, umbilical \nhernia repair\n\n \nHistory of Present Illness:\nMs ___ is a ___ year old  who was diagnosed with grade 1 \nStage IIIC serous adenocarinoma of the ovary in ___.  In ___, she underwent exploratory laparotomy with drainage of \nascites, bilateral salpingo-oophorectomy, total abdominal \nhysterectomy, bilateral pelvic lymph node sampling, infracolic \nomentectomy, tumor debulking, and rigid proctosigmoidoscopy.  \n \nPost-operatively she received six cycles of Taxol, carboplatin, \nand Bevacizumab and then completed maintenance Bevacizumab on \nprotocol.  In ___, she restarted Avastin off protocol.  \n\nOn ___ CA125 increased to 94 and a CT torso on ___ showed \na 4.3 cm right pelvic mass consistent with recurrent disease. At \nthat time discussed possible treatment options including \ncytoreduction of mass, however patient preferred to postpone \nuntil the fall.  Patient feels well and reports no symptoms.  \nPatient denies any vaginal bleeding, urinary frequency, urgency, \nconstipation or diarrhea.  Patient also denies weight loss and \nfatigue. She presents at this time for cytoreduction.  \n \nPast Medical History:\nPMH: Ovarian cancer, hypertension\n\nPSH: Hysterectomy and debulking surgery \n\nOB/GYN HISTORY:  She is gravida 1, para 1 woman.  She reports \nher last menstrual cycle was ___ years ago.  She denies any \nhistory of postmenopausal bleeding.  Her last Pap smear was in \n___.  She denies any history of abnormal Pap smears.  She \ndenies any history of pelvic infections.\n \nSocial History:\n___\nFamily History:\nNon-contributory\n \nPhysical Exam:\nOn day of discharge:\nVS:T 98.6 BP 151/62 HR 69 RR 18 SpO2 98% RA\nGeneral: NAD, comfortable\nCV: RRR, no m/r/g\nLungs: CTAB\nAbdomen: soft, non-tender, non-distended, +BS\nIncision: incision intact with staples, bruising extending 1 cm \nabove superior aspect, 2 cm laterally on both sides, and over \nthe mons, no active extravasation, becoming more soft, no \nerythema or discharge\nExt: no edema, no tenderness\n \nPertinent Results:\n___ 07:50PM BLOOD WBC-11.1* RBC-4.02* Hgb-12.6 Hct-36.2 \nMCV-90 MCH-31.3 MCHC-34.7 RDW-13.6 Plt ___\n___ 02:40AM BLOOD WBC-7.0 RBC-3.75* Hgb-11.9* Hct-33.6* \nMCV-90 MCH-31.8 MCHC-35.5* RDW-12.6 Plt ___\n___ 07:50AM BLOOD WBC-6.8 RBC-3.61* Hgb-11.3* Hct-32.3* \nMCV-90 MCH-31.4 MCHC-35.1* RDW-12.6 Plt ___\n___ 08:00AM BLOOD WBC-6.4 RBC-3.68* Hgb-11.7* Hct-33.0* \nMCV-90 MCH-31.7 MCHC-35.4* RDW-12.6 Plt ___\n\n___ 07:50PM BLOOD ___ PTT-32.1 ___\n___ 02:40AM BLOOD ___ PTT-32.1 ___\n___ 02:40AM BLOOD ___ 02:40AM BLOOD Glucose-97 UreaN-17 Creat-0.9 Na-136 \nK-3.7 Cl-102 HCO3-27 AnGap-11\n___ 07:50AM BLOOD Glucose-80 UreaN-12 Creat-0.7 Na-136 \nK-3.6 Cl-99 HCO3-29 AnGap-12\n___ 08:00AM BLOOD Glucose-112* UreaN-9 Creat-0.8 Na-136 \nK-3.9 Cl-97 HCO3-34* AnGap-9\n\n___ 02:40AM BLOOD Calcium-8.3* Phos-4.5# Mg-1.8\n___ 07:50AM BLOOD Calcium-8.7 Phos-2.3*# Mg-1.8\n___ 08:00AM BLOOD Calcium-9.0 Phos-2.7 Mg-2.2\n\nFinal pathology:\n1.  Pelvic mass, excision (A-G):\n1.  Low grade serous neoplasm, see note.\n2.  Mesothelial cyst.\nNote: Although the current sample does not show infiltrative \ninvasion, the appearance is consistent with recurrence of the \npatient's known ovarian low-grade serous carcinoma ___ \n___.\n\n2.  Hernia sac (H):\n1.  Fibroadipose and vascular tissue consistent with hernia sac.\n2.  Psammoma bodies are noted, but no malignancy identified.\n\n \nBrief Hospital Course:\nOn ___, Ms. ___ was admitted to the gynecology \noncology service after undergoing exploratory laparotomy, tumor \nresection, cystoscopy, and umbilical hernia repair. Please see \nthe operative report for full details.  \n\nImmediately post-op, her pain was controlled with IV dilaudid, \ntoradol, and acetaminophen. On the afternoon of post-operative \nday 0, her incision dressing was noted to be saturated with \nblood and incision was oozing. Pressure dressing was applied and \ntoradol and heparin were held. CBC and coags were obtained and \nwere within normal limits. Overnight on post-operative day 0, \npatient was noted to have low urine output. She received a fluid \nbolus and urine output increased appropriately. There was no \nevidence for bleeding and CBC and coags were stable. On \npost-operative day 1, pressure dressing was changed with minimal \nstaining on dressing. Heparin was restarted for DVT prophylaxis. \n\n\nOn post-operative day 1, her urine output was adequate and she \nwas ambulatory so her foley was removed and she voided \nspontaneously. On post-operative day 2, her diet was advanced \nwithout difficulty to regular and she was transitioned to PO \npercocet and ibupofen. \n\nBy post-operative day 3, she was tolerating a regular diet, \nvoiding spontaneously, ambulating independently, and pain was \ncontrolled with oral medications. She was then discharged home \nin stable condition with outpatient follow-up scheduled with Dr. \n___.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. anastrozole *NF* 1 mg Oral daily \n2. Hydrochlorothiazide 25 mg PO DAILY \n3. Lisinopril 40 mg PO DAILY \n4. Docusate Sodium 100 mg PO BID \n\n \nDischarge Medications:\n1. anastrozole *NF* 1 mg Oral daily \n2. Hydrochlorothiazide 25 mg PO DAILY \n3. Lisinopril 40 mg PO DAILY \n4. Docusate Sodium 100 mg PO BID \nRX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day \nDisp #*60 Capsule Refills:*2\n5. Ibuprofen 600 mg PO Q6H:PRN pain \nRX *ibuprofen 600 mg 1 tablet(s) by mouth every six (6) hours \nDisp #*60 Tablet Refills:*2\n6. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO Q4H:PRN pain \nRX *oxycodone-acetaminophen 5 mg-325 mg ___ tablet(s) by mouth \nevery four (4) hours Disp #*60 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nrecurrent ovarian cancer\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n  \nYou were admitted to the gynecologic oncology service after \nundergoing the procedures listed below. You have recovered well \nafter your operation, and the team feels that you are safe to be \ndischarged home. Please follow these instructions:  \n\n* Take your medications as prescribed.  \n* Do not drive while taking narcotics.  \n* Do not combine narcotic and sedative medications or alcohol  \n* Do not take more than 4000mg acetaminophen (APAP) in 24 hrs  \n* No strenuous activity until your post-op appointment  \n* Nothing in the vagina (no tampons, no douching, no sex) for 12 \nweeks.  \n* No heavy lifting of objects >10 lbs for 6 weeks.  \n* You may eat a regular diet  \n\nIncision care:  \n* You may shower and allow soapy water to run over incision; no \nscrubbing of incision. No bath tubs for 6 weeks.    \n* If you have staples, they will be removed at your follow-up \nvisit.  \n \nTo reach medical records to get the records from this \nhospitalization sent to your doctor at home, call ___.  \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820efb505ee7538f8773"
  },
  "note_id": "12298968-DS-21",
  "subject_id": 12298968,
  "hadm_id": 23012754,
  "note_type": "DS",
  "note_seq": 21,
  "charttime": "2186-07-30 00:00:00",
  "storetime": "2186-07-31 21:45:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: OBSTETRICS/GYNECOLOGY\n \nAllergies: \nCompazine / Amoxicillin\n \nAttending: ___\n \nChief Complaint:\nrecurrent ovarian cancer\n \nMajor Surgical or Invasive Procedure:\nExploratory laparotomy, radical resection of recurrent ovarian \ncancer, resection of pelvic tumor, rectosigmoid resection with \nreanastomosis, rigid proctoscopy,\n\n \nHistory of Present Illness:\nMs. ___ is a lovely ___ with a history of recurrent\nlow-grade serous ovarian cancer, presenting for f/u appointment.\nShe was originally diagnosed in ___ and had a secondary\ncytoreductive surgery in ___. She then developed \nanother\nrecurrence, but was maintained and stable on anastrozole.\nHowever, most recently she was noted to have progression of\ndisease with CA-125 increased to 171 (___) and 104\n(___), from prior 52 (___). Her PET scan on ___\ndemonstrated a complex predominantly cystic mass in the pelvis\nalong the sigmoid colon with eccentric FDG-avid solid component\nand another focal FDG avid soft tissue along the colon in the \nLLQ\nof the abdomen highly suspicious for metastasis. It also\ndemonstrated a hypotenuse nodule in the left lobe of the thyroid\ngland.\n \nPast Medical History:\nPMH: Ovarian cancer, hypertension\n\nPSH: Hysterectomy and debulking surgery \n\nOB/GYN HISTORY:  She is gravida 1, para 1 woman.  She reports \nher last menstrual cycle was ___ years ago.  She denies any \nhistory of postmenopausal bleeding.  Her last Pap smear was in \n___.  She denies any history of abnormal Pap smears.  She \ndenies any history of pelvic infections.\n \nSocial History:\n___\nFamily History:\nNon-contributory\n \nPhysical Exam:\nPre-operative exam:\nGENERAL:  The patient appears her stated age, in no apparent\ndistress.\nHEENT:  Normocephalic, atraumatic.  Eyes:  Sclerae are \nanicteric.\nNECK:  Supple, there are no masses.\nLYMPHATICS:  Lymph node survey, negative cervical,\nsupraclavicular, axillary, and inguinal adenopathy.\nCHEST:  Lungs clear.\nHEART:  Regular rate and rhythm.\nBACK:  No spinal or CVA tenderness.\nABDOMEN:  Soft, nontender, nondistended.  No palpable masses, no\nhepato or splenomegaly.  No fluid wave.\nEXTREMITIES:  There is no clubbing, cyanosis, or edema.  There \nis\nno calf tenderness to palpation.\nPELVIC: deferred today given consultative nature of this visit\n\nDay of discharge exam:\nGen: resting comfortably, NAD\nCardiac: RRR, no m/r/g\nPulmonary: CTAB, no w/r/r\nAbdomen: soft, NTND, no r/g, +bs\nIncision: c/d/i\nExtremities: WWP, calves nontender, pboots on\n \nPertinent Results:\nComplete Blood Count:\n\n___ 06:30AM BLOOD WBC-8.6 RBC-4.74 Hgb-14.4 Hct-43.1 MCV-91 \nMCH-30.4 MCHC-33.4 RDW-12.7 RDWSD-42.5 Plt ___\n___ 10:50PM BLOOD WBC-13.5* RBC-3.91 Hgb-12.0 Hct-36.3 \nMCV-93 MCH-30.7 MCHC-33.1 RDW-13.0 RDWSD-43.9 Plt ___\n___ 02:00AM BLOOD WBC-14.9* RBC-3.88* Hgb-11.9 Hct-36.2 \nMCV-93 MCH-30.7 MCHC-32.9 RDW-13.0 RDWSD-44.6 Plt ___\n___ 08:30AM BLOOD WBC-13.8* RBC-3.62* Hgb-11.0* Hct-33.9* \nMCV-94 MCH-30.4 MCHC-32.4 RDW-13.0 RDWSD-44.6 Plt ___\n___ 07:00AM BLOOD WBC-9.9 RBC-3.80* Hgb-11.7 Hct-35.2 \nMCV-93 MCH-30.8 MCHC-33.2 RDW-13.2 RDWSD-44.8 Plt ___\n\nChemistries:\n\n___ 06:30AM BLOOD UreaN-14 Creat-0.9 Na-141 K-5.8* Cl-105 \nHCO3-24 AnGap-12\n___ 06:30AM BLOOD Calcium-9.8 Phos-3.6 Mg-2.0\n___ 10:50PM BLOOD Glucose-141* UreaN-16 Creat-1.0 Na-139 \nK-4.2 Cl-101 HCO3-27 AnGap-11\n___ 10:50PM BLOOD Calcium-8.7 Phos-5.4* Mg-1.8\n___ 02:00AM BLOOD Glucose-125* UreaN-18 Creat-1.0 Na-135 \nK-4.1 Cl-99 HCO3-23 AnGap-13\n___ 02:00AM BLOOD Calcium-8.5 Phos-5.0* Mg-1.8\n___ 08:30AM BLOOD Glucose-68* UreaN-20 Creat-0.9 Na-138 \nK-4.2 Cl-101 HCO3-24 AnGap-13\n___ 08:30AM BLOOD Calcium-8.5 Phos-3.1 Mg-1.7\n___ 07:00AM BLOOD Glucose-93 UreaN-12 Creat-0.8 Na-144 \nK-3.6 Cl-105 HCO3-28 AnGap-11\n___ 07:00AM BLOOD Calcium-8.8 Phos-2.5* Mg-1.8\n \nBrief Hospital Course:\nMs. ___ was admitted to the gynecologic oncology service \nafter undergoing Exploratory laparotomy, radical resection of \nrecurrent ovarian cancer, resection of pelvic tumor, \nrectosigmoid resection with reanastomosis, rigid proctoscopy,\ncystoscopy. Please see the operative report for full details.  \n\nHer post-operative course is detailed as follows. Immediately \npostoperatively, her pain was controlled with Epidural. Her diet \nwas advanced without difficulty and she was transitioned to \noxycodone, acetaminophen and ibuprofen. On post-operative day \n#1, She developed oliguria likely secondary to hypovolemia. She \nhad a normal and stable hematocrit and Creatinine. Her urine \noutput improved after receiving a total of 2L fluid. \n\nOn post-operative day 2, her urine output was adequate and her \nFoley removed.\n\nBy post-operative day 3, she was tolerating a regular diet, \nvoiding spontaneously, ambulating independently, and pain was \ncontrolled with oral medications. She was then discharged home \nin stable condition with outpatient follow-up scheduled.\n\n \nMedications on Admission:\nAtorvastatin 20 mg PO QPM\nLisinopril 40 mg PO BID\nNIFEdipine (Extended Release) 30 mg PO DAILY\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q8H \ndo not exceed 4000mg in 24 hours \nRX *acetaminophen 500 mg ___ tablet(s) by mouth every six (6) \nhours Disp #*60 Tablet Refills:*1 \n2.  Docusate Sodium 100 mg PO BID \ndo not take if having loose stool  \nRX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp \n#*60 Tablet Refills:*1 \n3.  Enoxaparin Sodium 40 mg SC DAILY \ntake as directed \nRX *enoxaparin 40 mg/0.4 mL 40 mg subcutaneous once a day Disp \n#*25 Syringe Refills:*0 \n4.  Ibuprofen 600 mg PO Q6H:PRN Pain - Mild \ntake with food \nRX *ibuprofen 600 mg 1 tablet(s) by mouth every six (6) hours \nDisp #*60 Tablet Refills:*1 \n5.  OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - \nModerate \ndo not drink or drive while taking \nRX *oxycodone 5 mg ___ tablet(s) by mouth every ___ hours Disp \n#*25 Tablet Refills:*0 \n6.  Atorvastatin 20 mg PO QPM  \n7.  Lisinopril 40 mg PO BID  \n8.  NIFEdipine (Extended Release) 30 mg PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nrecurrent ovarian cancer\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the gynecologic oncology service after \nundergoing the procedures listed below. You have recovered well \nafter your operation, and the team feels that you are safe to be \ndischarged home. Please follow these instructions: \n\n* Your staples will be removed within 2 weeks from your surgery. \nThis appointment should already been scheduled for you. Please \ncall if you do not have an appointment scheduled. \n* Take your medications as prescribed.  We recommend you take \nnon-narcotics (i.e. Tylenol, ibuprofen) regularly for the first \nfew days post-operatively, and use the narcotic as needed. As \nyou start to feel better and need less medication, you should \ndecrease/stop the narcotic first.\n* Take a stool softener to prevent constipation. You were \nprescribed Colace. If you continue to feel constipated and have \nnot had a bowel movement within 48hrs of leaving the hospital \nyou can take a gentle laxative such as milk of magnesium.  \n* Do not drive while taking narcotics.  \n* Do not combine narcotic and sedative medications or alcohol.  \n* Do not take more than 4000mg acetaminophen (tylenol) in 24 \nhrs.  \n* No strenuous activity until your post-op appointment.  \n* Nothing in the vagina (no tampons, no douching, no sex) for 12 \nweeks.  \n* No heavy lifting of objects >10 lbs for 6 weeks.  \n* You may eat a regular diet.\n* It is safe to walk up stairs.  \n\nIncision care:  \n* You may shower and allow soapy water to run over incision; no \nscrubbing of incision. No bath tubs for 6 weeks.  \n* If you have staples, they will be removed at your follow-up \nvisit.\n\nConstipation:\n* Drink ___ liters of water every day.\n* Incorporate 20 to 35 grams of fiber into your daily diet to \nmaintain normal bowel function. Examples of high fiber foods \ninclude:\nWhole grain breads, Bran cereal, Prune juice, Fresh fruits and \nvegetables, Dried fruits such as dried apricots and prunes, \nLegumes, Nuts/seeds. \n* Take Colace stool softener ___ times daily.\n* Use Dulcolax suppository daily as needed.\n* Take Miralax laxative powder daily as needed. \n* Stop constipation medications if you are having loose stools \nor diarrhea.  \n\nTo reach medical records to get the records from this \nhospitalization sent to your doctor at home, call ___.  \n\n\nCall your doctor at ___ for:  \n* fever > 100.4  \n* severe abdominal pain  \n* difficulty urinating  \n* vaginal bleeding requiring >1 pad/hr  \n* abnormal vaginal discharge  \n* redness or drainage from incision  \n* nausea/vomiting where you are unable to keep down fluids/food \nor your medication  \n* chest pain or difficulty breathing \n* onset of any concerning symptoms \n\nLovenox injections:\n* Patients having surgery for cancer have risk of developing \nblood clots after surgery. This risk is highest in the first \nfour weeks after surgery. You will be discharged with a daily \nLovenox (blood thinning) medication. This is a preventive dose \nof medication to decrease your risk of a forming a blood clot. A \nvisiting nurse ___ assist you in administering these \ninjections. \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048247fb505ee75393454c"
  },
  "note_id": "19661870-DS-10",
  "subject_id": 19661870,
  "hadm_id": 22135027,
  "note_type": "DS",
  "note_seq": 10,
  "charttime": "2182-02-07 00:00:00",
  "storetime": "2182-02-13 08:37:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: ORTHOPAEDICS\n \nAllergies: \nIodine; Iodine Containing / Cardizem / Morphine / Vancomycin / \nPenicillins / Propofol\n \nAttending: ___\n \nChief Complaint:\nRight hip pain\n \nMajor Surgical or Invasive Procedure:\nRight THA\n\n \nHistory of Present Illness:\n___ year old male with a history of chronic hip pain.  To date He \nhas failed\nconservative management including phycial therapy and \ninjections. He has\nradiographic signs of advanced arthritis including sclerosis and \njoint space\nnarrowing.   Since this is severly affecting his ADLs,  we have \ndecided that\njoint replacement would be the best option to restore function.  \n \n\n \nPast Medical History:\nDM-II on lantus (intermittently takes ___\nCAD s/p MI ___\nHTN\nLow back pain\nglaucoma\nimpotence\ncurrent smoking\nperipheral neuropathy\ntrivial  MR\n___\n\n \nSocial History:\n___\nFamily History:\nFather-CAD\nMother-DM\n \nPhysical Exam:\nWell apprearing male in no acute distress. Afebrile with stable \nvital signs\nand controlled pain.\no Respiratory: CTAB\no Cardiovascular: RRR\no Gastrointestinal: NABS\no Genitourinary: voiding w/o foley\no Lymph: no LAD\no Musculoskeletal-Extremities: RLE SILT sp/dp/saph/sural. no \ncalf tenderness,\n___ strength in the rightlower extremity.\no Neurologic: in tact with no focal deficits\no Integument: no rashes, incision clean, dry and in tact without \nerythema or\ndrainage\no Psychiatric: pleasant w/o psychosis\n \nPertinent Results:\n___ 08:35AM BLOOD WBC-15.5* RBC-3.87* Hgb-9.9* Hct-31.7* \nMCV-82 MCH-25.6* MCHC-31.3 RDW-17.2* Plt ___\n___ 07:55AM BLOOD WBC-15.9* RBC-3.89* Hgb-10.5* Hct-31.6* \nMCV-81* MCH-27.1 MCHC-33.4 RDW-17.3* Plt ___\n___ 08:10AM BLOOD WBC-16.1* RBC-3.98* Hgb-10.4* Hct-31.7* \nMCV-80* MCH-26.1* MCHC-32.8 RDW-17.2* Plt ___\n___ 08:35AM BLOOD Plt ___\n___ 07:55AM BLOOD Plt ___\n___ 08:10AM BLOOD Plt ___\n___ 11:01AM BLOOD Plt ___\n___ 08:10AM BLOOD Calcium-8.4 Phos-3.7 Mg-1.9\n___ 07:40PM BLOOD Calcium-8.9 Phos-4.2 Mg-1.9\n___ 11:01AM BLOOD Calcium-8.3* Phos-3.3 Mg-1.9\n\n \nBrief Hospital Course:\nThe patient was admitted on ___ and, later that day, was \ntaken to the\noperating room by ___ right total hip arthroplasty \nwithout complication.  Please see\noperative report for details. Postoperatively the patient did \nwell.  The patient\nwas initially treated with a PCA followed by PO pain medications \non POD#1.  The\npatient received IV antibiotics for 24 hours postoperatively, as \nwell as lovenox\nfor DVT prophylaxis starting on the morning of POD#1.   The \ndrain was removed\nwithout incident on POD#1. The Foley catheter was removed \nwithout incident. The\nsurgical dressing was removed on POD#2 and the surgical incision \nwas found to be\nclean, dry, and intact without erythema or purulent drainage. \n\nWhile in the hospital, the patient was seen daily by physical \ntherapy. Labs were\nchecked throughout the hospital course and repleted accordingly. \nAt the time of\ndischarge the patient was tolerating a regular diet and feeling \nwell.  The\npatient was afebrile with stable vital signs.\nThe patient's hematocrit was stable, and the patient's pain was \nadequately\ncontrolled on a PO regimen. The operative extremity was \nneurovascularly intact\nand the wound was benign. The patient was discharged to home \nwith services or\nrehabilitation in a stable condition.  The patient's \nweight-bearing status was\nweight bearing as tolerated with posterior precautions.\n\n \nMedications on Admission:\nFurosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \nOxycodone 5 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours) \nas needed for pain. Disp:*70 Tablet(s)* Refills:*0* \nMetoprolol Succinate Oral as directed\nLisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \nLatanoprost 0.005 % Drops Sig: One (1) Drop Ophthalmic HS (at \nbedtime).  \nSimvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n \nDischarge Medications:\n1. Lovenox 40 mg/0.4 mL Syringe Sig: One (1) vial Subcutaneous \nonce a day for 21 days: take 1 40mg vial daily.\nDisp:*21 vials* Refills:*0*\n2. Furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n3. Oxycodone 5 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 \nhours) as needed for pain.\nDisp:*70 Tablet(s)* Refills:*0*\n4. Metoprolol Succinate  Oral as directed\n5. Lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n6. Latanoprost 0.005 % Drops Sig: One (1) Drop Ophthalmic HS (at \nbedtime).  \n7. Simvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \n___ Diagnosis:\nRight hip OA\n\n \nDischarge Condition:\ngood\n\n \nDischarge Instructions:\n1. Please return to the emergency department or notify MD if you \nexperience severe pain not relieved by medication, increased \nswelling, decreased sensation, difficulty with movement, fevers \n>101.5, shaking chills, redness or drainage from the incision \nsite, chest pain, shortness of breath or any other concerns.\n2. Please follow up with your PCP regarding this admission and \nany new medications and refills. \n3. Resume your home medications unless otherwise instructed. \n4. You have been given medications for pain control. Please do \nnot operate heavy machinery or drink alcohol when taking these \nmedications. As your pain improves, please decrease the amount \nof pain medication. This medication can cause constipation, so \nyou should drink plenty of water daily and take a stool softener \n(e.g., colace) as needed to prevent this side effect.\n5. You may not drive a car until cleared to do so by your \nsurgeon or your primary physician.\n6. Please keep your wounds clean. You may get the wound wet or \ntake a shower starting 5 days after surgery, but no baths or \nswimming for at least 4 weeks. No dressing is needed if wound \ncontinues to be non-draining. Any stitches or staples that need \nto be removed will be taken out by Dr. ___ at 2 weeks after \nyour surgery.\n7. Please call your surgeon's office to schedule or confirm your \nfollow-up appointment at 4 weeks.\n8. Please DO NOT take any NSAIDs (i.e. celebrex, ibuprofen, \nadvil, motrin, etc). \n9. ANTICOAGULATION: Please continue your lovenox for 3 weeks to \nprevent deep vein thrombosis (blood clots).  After completing \nthe lovenox, please take Aspirin 325mg twice daily for an \nadditional three weeks. \n10. WOUND CARE: Please keep your incision clean and dry. It is \nokay to shower after POD#5 but do not take a tub-bath or \nsubmerge your incision until 4 weeks after surgery. Please place \na dry sterile dressing on the wound each day if there is \ndrainage, otherwise leave it open to air. Check wound regularly \nfor signs of infection such as redness or thick yellow drainage. \nStaples will be removed by Dr. ___ 2 weeks. If you are going \nto rehab, the rehab facility can remove the staples at 2 weeks.\n11. ___ (once at home): Home ___, dressing changes as \ninstructed, wound checks.\n12. ACTIVITY: Weight bearing as tolerated on the operative leg. \nNo strenuous exercise or heavy lifting until follow up \nappointment.  \nPhysical Therapy:\nAs tolerated\nTreatments Frequency:\nPlease keep your wounds clean. You may get the wound wet or take \na shower starting 5 days after surgery, but no baths or swimming \nfor at least 4 weeks. No dressing is needed if wound continues \nto be non-draining. Any stitches or staples that need to be \nremoved will be taken out by Dr. ___ at 2 weeks after your \nsurgery.\n\nWOUND CARE: Please keep your incision clean and dry. It is okay \nto shower after POD#5 but do not take a tub-bath or submerge \nyour incision until 4 weeks after surgery. Please place a dry \nsterile dressing on the wound each day if there is drainage, \notherwise leave it open to air. Check wound regularly for signs \nof infection such as redness or thick yellow drainage. Staples \nwill be removed by Dr. ___ 2 weeks. If you are going to \nrehab, the rehab facility can remove the staples at 2 weeks.\n___ (once at home): Home ___, dressing changes as instructed, \nwound checks.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048247fb505ee75393454d"
  },
  "note_id": "19661870-DS-11",
  "subject_id": 19661870,
  "hadm_id": 27070874,
  "note_type": "DS",
  "note_seq": 11,
  "charttime": "2184-10-12 00:00:00",
  "storetime": "2184-10-13 09:40:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nIodine-Iodine Containing / Cardizem / Morphine / Vancomycin / \nPenicillins / Propofol Analogues / glucose gel\n \nAttending: ___.\n \nChief Complaint:\nShortness of breath\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nMr. ___ is a ___ gentleman with CAD s/p AMI, HTN, DM2, \nCKD (baseline Cr 1.4), and tobacco use who presented to the ED \ndue to dyspnea.  \n.\nAt his baseline, he is not very active due to osteoarthritis and \nlower back pain. Uses a walker to ambulate and can walk 50 feet \nat once before stopping due to pain, but never gets exertional \nchest pain or shortness of breath. He smokes cigarettes and OMR \nnotes a history of COPD but he is unaware of this, and he is not \non any COPD meds. He has chronic ___ edema that is felt to be \nrelated to his vein grafts as well as kidney disease; he had a \nnormal ___ in ___ after his CABG. His edema is controlled with \nLasix and very occasional Metolazone. At an outpatient \nappontment with his PCP ___ ___ he was advised that he could use \nmore Metolazone, but he says that he has been using about the \nsame amount (Lasix 40mg daily and a Metolazone dose every week). \n \n.\nHe was at his baseline until ___ days ago when he started to \nfeel shortness of breath with exertion, feeling dyspneic when \nwalking around roms at home. The dyspnea worsened to the point \nof being present at rest. He denies any chest pain with these \nepisodes (he did have chest pain in the setting of his prior \nMI). Does get slightly lightheaded and sweaty with the shortness \nof breath. His leg swelling is at the same or better compared to \nbaseline. He has had a cough productive of frothy white sputum. \nNo fevers or chills. The shortness of breath seems to be worse \nwhen lying flat but he has no PND and no increase in the number \nof pillows he needed to breathe. No recent prolonged immobility \nor long travel. Due to the fact that his dyspnea worsened and \nwas present at rest he decided to go to the ED.  \n.\nIn the ED, he triggered on arrival for hypoxia to 88%RA. Initial \nVS were: 147/79, 83, 24, 88%RA but when rechecked was 92%RA and \nincreased to 95% on 2L NC. On exam, he was noted to have \nwheezing bilaterally. EKG was sinus rhythm with 1st degree AV \nblock (similar to prior) but with new TWI in II as well as \nV4-V6. Labs were notable for WBC 19 (80.7%N, no bands), Hct 38. \nBUN 53, Cr 2.2 (baseline is 1.4-1.6), Na 132. Lactate 1.9. Due \nto concern for CHF, BNP was checked and was 107. Troponin was \n0.03 so CK/MB were added on and were CK 397, MB 11. CXR showed \nno acute process. He continued to sound wheezy on exam so was \ntreated for COPD with Methylprednisolone 125mg IV, Azithromycin \n500mg PO, and Albuterol/Ipratropium nebs x2. For back pain he \nreceived Oxycodone 5mg-Acetaminophen 325mg. He was admitted to \nMedicine for presumed COPD. VS prior to transfer were: BP \n113/52, HR 88, RR 20, POx 93% 4L NC.  \n.\nOn arrival to the floor, he is comfortable and asks when he can \nbe discharged because his 70th birthday is in 2 days. Breathing \nfine. The nebs helped somewhat. No chest pain. He does not think \nthat he is urinating any less than usual, and his urine does not \nseem particularly dark these days. He is eating and drinking \nfine.  \n .\nREVIEW OF SYSTEMS:  \nPertinent for mild constipation for which he takes some OTC \nsenna and Dulcolax. If his blood sugar gets low he gets \nlightheaded, wobbly on his feet, and develops blurry vision. He \nhas chronic lower back pain, knee and ankle pain. Baseline level \nof ankle edema currently. Right leg is always more swollen than \nthe left.  \nDenies fever, chills, night sweats, headache, vision changes, \nrhinorrhea, sore throat, abdominal pain, nausea, vomiting, \ndiarrhea, BRBPR, melena, hematochezia, dysuria, hematuria. No \nurinary dribbling or feeling of incomplete bladder emptying.\n \nPast Medical History:\nCAD  \n--s/p MI ___ with PCI to LAD ___  \n--s/p CABGx4 ___ (Lima-LAD, SVG-D1, SVG-OM, SVG-PDA), after \npre-op cath before arthroplasty revealed 3VD  \nDM2 on insulin  \nHTN  \nHLD  \nObesity  \ntrivial MR ___ on ___ ___ that was otherwise normal with \nEF>55%)  \nchronic peripheral edema  \nproteinuria and CKD (baseline Cr 1.4)  \ndepression  \nglaucoma  \ntobacco use  \nperipheral neuropathy  \nlow back pain  \ns/p lumbar spinal fusion ___  \ns/p lumbar laminectomy ___  \ns/p lipoma excision from right forearm ___  \ns/p removal of bone spurs from knees bilaterally  \ns/p right hip arthroplasty ___\n \nSocial History:\n___\nFamily History:\nFather-CAD\nMother-DM\n \nPhysical Exam:\nphysical exam on admission\nVITALS: 98.8, 125/64, 83, 20, 94%2L NC  \nroom air: fluctuates between 87-95%  \n2L NC: fluctuates between 90-95%  \n___ glucose: 326  \nGENERAL: comfortable, NAD lying with HOB at 30 degrees  \nHEENT: PERRL, EOMI  \nNECK: no carotid bruits, no JVD  \nLUNGS: diffuse inspiratory and expiratory wheezes with prolonged \ni:e ratio; no rales or rhonchi  \nHEART: regular, normal S1 S2, no MRG  \nABDOMEN: Soft, NT, NABS, no organomegaly  \nEXTREMITIES: RLE>LLE (baseline per patient); 1+ edema to the \nshins bilaterally; 2+ DP pulses bilaterally  \nSKIN: brawny stasis change bilaterally; no erythema  \nNEUROLOGIC: A+OX3  \n\nphysical exam on discharge\nVITALS: 98.0 - ___/60 - 96% 2L I/O: ___//370 +BR\nGENERAL: comfortable, NAD, sitting in chair w. NC on at 2L \n(keeps removing)\nHEENT: EOMI, neck supple, NC\nNECK: no carotid bruits, no JVD  \nLUNGS: no rales or rhonchi, no wheezing at bilateral lung bases\nHEART: regular, normal S1 S2, no MRG\nABDOMEN: Soft, NT, NABS, no organomegaly  \nEXTREMITIES: RLE>LLE (baseline per patient); 1+ edema to the \nshins bilaterally; 2+ DP pulses bilaterally,  \nSKIN: shiny/brawny stasis change bilaterally; no erythema\nNEUROLOGIC: A+OX3, sensation intact BUEs, sensation decrease R>L \n___\n \n___ Results:\n___ 02:00AM BLOOD WBC-19.0*# RBC-3.89* Hgb-10.3* Hct-38.0* \nMCV-81* MCH-26.5* MCHC-32.7 RDW-28.8* Plt ___\n___ 06:45AM BLOOD WBC-20.1* RBC-4.35* Hgb-12.0* Hct-35.6* \nMCV-82 MCH-27.6 MCHC-33.7 RDW-25.4* Plt ___\n___ 02:00AM BLOOD Neuts-80.7* Lymphs-12.8* Monos-4.3 \nEos-1.7 Baso-0.5\n___ 02:00AM BLOOD Glucose-289* UreaN-53* Creat-2.2* Na-132* \nK-3.8 Cl-91* HCO3-25 AnGap-20\n___ 06:45AM BLOOD Glucose-258* UreaN-62* Creat-1.8* Na-133 \nK-4.1 Cl-93* HCO3-27 AnGap-17\n___ 02:00AM BLOOD CK-MB-11* MB Indx-2.8 proBNP-107\n___ 02:00AM BLOOD cTropnT-0.03*\n___ 10:45AM BLOOD CK-MB-15* MB Indx-3.5 cTropnT-0.02*\n___ 07:05PM BLOOD CK-MB-20* MB Indx-3.7 cTropnT-0.01\n___ 06:45AM BLOOD CK-MB-20* MB Indx-3.4 cTropnT-0.02*\n___ 06:45AM BLOOD Phos-3.3 Mg-2.4\n___ 02:22AM BLOOD Lactate-1.9\n\nCXR ___\nFINDINGS:  Single frontal view of the chest demonstrates intact \nmedian \nsternotomy wires.  New irregular opacification at both lung \nbases could be pneumonia due to virus or mycoplasma infection or \naspiration. Vertically oriented lucency projecting to the left \nof the lower trachea could be air in a thick walled esophagus; \nconsider esophagitis or other infiltrative abnormality \nthickening the esophageal wall.  The heart is normal size and \nthere is no vascular congestion or appreciable pleural effusion \nto point to cardiac decompensation.  There is no pneumothorax, \nvascular congestion, or pleural effusion. \n  \nIMPRESSION:  Probably pneumonia, due to aspiration or atypical \npathogen. \nPossible esophageal abnormality should be evaluated at least \nclinically, if not with a contrast swallow.   \natyp pna or aspiration  \n\nEKG ___\nNormal sinus rhythm. Voltage for left ventricular hypertrophy. \nNon-specific ST-T wave changes. Compared to the previous tracing \nof ___ no significant change. \n \nBrief Hospital Course:\nMr. ___ is a ___ gentleman with CAD s/p AMI, HTN, DM2, \nCKD (baseline Cr 1.4), and tobacco use who presented to the ED \ndue to dyspnea.  He was found to have pneumonia and acute kidney \ninjury. His cardiac markers (enzymes, serial EKGs) were also \nfollowed to rule out an MI, and they were stable as well. On \ndischarge, he was instructed to hold his lisinopril, glyburide, \nand metolazone until PCP ___ due to ___. He was discharged \non levofloxacin on day 2 of his hospital course.\n.\n#. Dyspnea, hypoxia:  Mr. ___ presented with leukocytosis, \nshortness of breath, cough, hypoxia, and was found to have \nradiological evidence of basilar pneumoani. He was originally \ntreated for a COPD flare, in light of tobacco use and wheezing \non exam, but has no history of this, and pneumonia  was a more \nlikely cause of his symptoms. Urine legionella was negative. BNP \nwas less than 200, and he had a normal ___ in ___. Originally \ntreated with two days of a steroid burst course \n(methylprednosolone IV was transitioned to prednisone 60mg, \nwhich was stopped by ___. For treatment of pneumonia, he \nwas given one day of azithromycin, and was then started on \nlevofloxacin, which will end ___. He was also treated with \nipratropium nebulizer as well as albuterol inhaler, and given \nsupplemental O2 as tolerated to maintain oxygen saturation >90%. \nOn ambulation his SvO2 was >90.\n. \n#. ___ on CKD: Creatinine was 2.2 on admission, 1.8 on discharge \n(baseline Cr 1.4-1.6). Injury was likely prerenal in the setting \ndecreased intake and recent URI. Also recently uptitrated \ndiuretics for his lower extremity edema and volume depletion \ncould be secondary to this. Lisinopril, metolazone, furosemide \nwere held in the hospital. \n.\n#. CAD s/p MI: Mr. ___ had mild cardiac enzyme elevation, \nnonspecific EKG changes.  He does have a legitimate cardiac \nhistory but it is reassuring that he has no chest pain (pain was \npresent with his previous MI). Cardiac enzymes were negative, \ntelemetry was unrevealing, and EKGs showed nonspecific stable \nchanges. He was continued on ASA 325mg daily, as well as his \npravastatin and metoprolol.\n.\n#. ___ edema: chronic.  This has been attributed to prior vein \ngrafts as well as his CKD. Nothing to suggest CHF at this time, \nespecially with normal pump function on ___ ___ and BNP <200. \nLasix and Metolazone were held in the setting of ___.\n.\n#. HTN: Metoprolol was continued, lisinopril, metolazone, and \nlasix were held for ___. His hypertension was reasonably \nwell-controlled in the hospital.\n.\n#. DM2: HbA1c was 9.5 in ___.  Blood glucose was difficult to \ncontrol secondary to the steroids that were originally given for \nCOPD exacerbation. He was continued on his home dose of Humalin \n70/30 and covered with a Humalog insulin sliding scale. His \nglyburide was held during his hospital course. \n.\n#. HLD: stable.  Pravastatin continued in house.\n.\n#. Depression: stable. Citalopram continued in house.\n.\n#. Lower back pain: stable.  Controlled with Tylenol PRN and \nOxycodone PRN.\n.\n#. Glaucoma: stable.  Xalatan continued in-house.\n.\n#. Esophageal findings on CXR: The patient denies all symptoms \nrelating to esophagus. Further work up deferred to PCP.\n.\n# TRANSITIONAL ISSUES:\n- Metolazone, lisinopril, furosemide, and glyburide were held \nin-house. Pending renal function improvement, these may be \nre-started at ___ appointment per PCP's preference.\n- Please ensure adequate control of glucose as an outpatient \n(may be difficult due to initial steroid regimen). \n- Please ensure compliance with levofloxacin regimen (course \nends ___, and resolution of dyspnea. \n- Mr. ___ could benefit from smoking cessation, and seemed \nwilling to discuss this\n- He could benefit from referral for outpatient PFTs for \ninvestigation of COPD given his initial symptoms\n- Consider further evaluation of esophagus if symptoms develop\n \nMedications on Admission:\nPreadmission medications listed are correct and complete.  \nInformation was obtained from Patient.\n1. Aspirin 325 mg PO DAILY \n2. 70/30 70 Units Breakfast\n70/30 40 Units Bedtime\n3. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS \n4. Citalopram 5 mg PO DAILY \n5. GlyBURIDE 10 mg PO BID \n6. Lisinopril 40 mg PO BID \n7. Metolazone 5 mg PO ONCE OR TWICE WEEKLY \n8. Metoprolol Succinate XL 400 mg PO DAILY \n9. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO EVERY ___ \nHOURS AS NEEDED for pain \n10. Pravastatin 80 mg PO DAILY \n11. Furosemide 40 mg PO DAILY \n12. Vitamin D 800 UNIT PO DAILY \n\n \nDischarge Medications:\n1. Aspirin 325 mg PO DAILY \n2. Citalopram 5 mg PO DAILY \n3. 70/30 70 Units Breakfast\n70/30 40 Units Bedtime\n4. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS \n5. Metoprolol Succinate XL 400 mg PO DAILY \n6. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO EVERY ___ \nHOURS AS NEEDED for pain \ndo not drive or operate machinery while on this medication \n7. Pravastatin 80 mg PO DAILY \n8. Vitamin D 800 UNIT PO DAILY \n9. Furosemide 40 mg PO DAILY \nrestart tomorrow \n10. Levofloxacin 750 mg PO Q24H \n___nds ___ \nRX *Levaquin 750 mg 1 tablet(s) by mouth daily Disp #*8 Tablet \nRefills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY:\npneumonia\nacute kidney injury\n\nSECONDARY:\ndiabetes mellitus\ncoronary artery disease\ntobacco use\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nYou were admitted because of shortness of breath and you were \nfound to have a pneumonia.  You were started on antibiotics.  \nNow your symptoms are much improved and you do not require any \nsupplemental oxygen, so you are safe to be discharged home to \nfinish a course of Levofloxacin (an antibiotic).\n\nPlease keep your PCP ___ (listed below) to follow up \nyour symptoms.  You might benefit from referral for pulmonary \nfunction testing.  In addition, you shuld quit smoking as this \nis a risk factor for emphysema and lung cancer.\n\nNote that while you were here, you were initially started on \nsteroids for presumed emphysema/bronchitis (COPD) but these were \nstopped because you did not need them.  But as a result of \nreceiving a few days of steroids, your blood sugar might be more \nelevated than usual.  Please check your fingersticks every \nmorning and before your largest meal of the day, and if you have \nvalues >300 please call your PCP.\n\nFinally, because of a mild decrease in your kidney function, we \nheld your blood pressure pill, diabetes pill, and diuretic \npills.  Until you see your PCP, please hold (do not take) your \nLisinopril, Glyburide, and Metolazone.  You can restart your \nLasix tomorrow.\n\nWe made the following changes to your medications:\n-START Levoflocaxin (___nds ___\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048247fb505ee75393454e"
  },
  "note_id": "19661870-DS-12",
  "subject_id": 19661870,
  "hadm_id": 22386235,
  "note_type": "DS",
  "note_seq": 12,
  "charttime": "2187-03-19 00:00:00",
  "storetime": "2187-03-19 17:57:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nIodine-Iodine Containing / Cardizem / Morphine / Vancomycin / \nPenicillins / Propofol Analogues / glucose gel / gabapentin / \nNortriptyline / nystatin\n \nAttending: ___.\n \nChief Complaint:\nCervical Cord Compression\n \nMajor Surgical or Invasive Procedure:\n___: anterior cervical spine decompression\n\n \nHistory of Present Illness:\n___ year old Male presents with progressive weakness and back \npain after sustaining a fall 2 weeks and then 2 days prior to \nadmission. The patient notes that his weakness and pain have \nprogressed over the last several weeks although his family tells \nme symptoms started in ___, and that he fell due to the \nweakness 2 days prior to admission. He denies cauda-equina \nsymptoms. In the fall 2 days prior to admission he did have a \nfrontal head strike, where he struck the night stand. He did not \nhave LOC or post-concussive symptoms. He reports severe pain in \nboth shoulders/clavicles and is unable to raise his arms past 90 \ndegrees. He has had chronic weakness of the right foot with foot \ndrop, which is worse.\n\nIn the ED they were concerned for cervical cord compression as \nthey elicited myelopathy signs on exam, so an urgent C/T Spine \nMRI was performed and orthospine was consulted. The MRI was \npositive for cord compression, and so will require decompression \nand fusion of the C-Spine. The patient will require medical \noptimization prior to going to surgery.\n\nIn the ED initial vitals were: 97.8, 149/57, 71, 97%.\n \nPast Medical History:\nCAD  \n--s/p MI ___ with PCI to LAD ___  \n--s/p CABGx4 ___ (Lima-LAD, SVG-D1, SVG-OM, SVG-PDA), after \npre-op cath before arthroplasty revealed 3VD  \nType 2 DM on insulin  \nHypertension\nHyperlipidemia\nObesity  \ntrivial MR ___ on ___ ___ that was otherwise normal with \nEF>55%)  \nchronic peripheral edema  \nproteinuria and CKD (baseline Cr 1.4)  \ndepression  \nglaucoma  \ntobacco use  \nperipheral neuropathy  \nlow back pain  \ns/p lumbar spinal fusion ___  \ns/p lumbar laminectomy ___  \ns/p lipoma excision from right forearm ___  \ns/p removal of bone spurs from knees bilaterally  \ns/p right hip arthroplasty ___\n \nSocial History:\n___\nFamily History:\nFather-CAD\nMother-Type 2 DM\n \nPhysical Exam:\nADMISSION:\nVitals - T: 97.6 BP: 118/68 HR: 64 02 sat: 100%RA  \nGENERAL: Mildly uncomfortable but well appearing man sitting up \nin bed in NAD  \nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, \nMMM, NECK: JVP to ear  \nCARDIAC: RRR, soft heart sounds, no murmurs, gallops, or rubs  \nLUNG: End expiratory rhonchi with no wheeze or crackles, reduced \nbreath sounds throughout  \nABDOMEN: nondistended, +BS, nontender in all quadrants, no \nrebound/guarding  \nEXTREMITIES: ___ with bilateral purplish hue, warm to touch, 2+ \nedema bilaterally to knees  \nPULSES: Reduced pedal pulses bilaterally, 2+ popliteal pulse \nbilaterally  \nBACK: Minimal tenderness to palpation over lumbar spine  \nNEURO: CN II-XII intact, moving extremities equally against \ngravity  \nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes \n\nDISCHARGE:\nPHYSICAL EXAM:  \nVitals - 97.3, 70, 115/79, 98% on RA\nGENERAL: alert and awake\nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, \nMMM, NECK: surgical dressings c/d/i\nCARDIAC: RRR, soft heart sounds, no murmurs, gallops, or rubs  \nLUNG: decreased breath sounds at L>R baseline  \nABDOMEN: obese, NT, no rebound or guarding  \nSKIN: warm and well perfused, no excoriations or lesions, \nerythema bilaterally of feet  \nExt: trace pitting edema bilaterally to ankles, TEDS in place\n\n \nPertinent Results:\nADMISSION LABS:\n\n___ 10:42PM BLOOD WBC-11.1* RBC-3.82* Hgb-11.1* Hct-32.0* \nMCV-84 MCH-29.0 MCHC-34.6 RDW-15.3 Plt Ct-UNABLE TO \n___ 10:42PM BLOOD Neuts-68 Bands-0 Lymphs-17* Monos-9 Eos-3 \nBaso-1 Atyps-2* ___ Myelos-0\n___ 10:42PM BLOOD ___ PTT-31.8 ___\n___ 10:42PM BLOOD Glucose-245* UreaN-111* Creat-2.5* Na-137 \nK-4.1 Cl-93* HCO3-28 AnGap-20\n___ 10:42PM BLOOD CK(CPK)-1144*\n___ 10:42PM BLOOD Calcium-9.8 Phos-5.3* Mg-2.4\n___ 10:42PM BLOOD CRP-7.2*\n\nDISCHARGE LABS:\n\n___ 10:19AM BLOOD WBC-17.7* RBC-3.66* Hgb-10.3* Hct-31.8* \nMCV-87 MCH-28.3 MCHC-32.5 RDW-15.2 Plt Ct-UNABLE TO \n___ 06:10AM BLOOD Glucose-173* UreaN-90* Creat-1.9* Na-142 \nK-4.6 Cl-100 HCO3-26 AnGap-21*\n___ 06:10AM BLOOD Calcium-9.3 Phos-4.4 Mg-2.5\n\nIMAGING:\nMR ___ CONTRAST Study Date of ___ 2:32 AM \nWet Read by ___ on SAT ___ 4:17 AM \nSevere multilevel cervical spondylosis with multilevel disc \nbulges resulting in flattening of the spinal cord from C3 \nthrough C7. Increased T2 signal in the left aspect of the spinal \ncord at the level of C2-3 either represents myelomalacia or cord \nedema however the lack of spinal cord enlargement at this level \nfavors myelomalacia. No prevertebral soft tissue edema. Moderate \nanterolisthesis of C7 on T1. \nScout views of the lumbar spine are included, however the \npatient aborted the examination prior to diagnostic quality \nimages being obtained. There is evidence of prior lumbar spine \nsurgery.\n \nBrief Hospital Course:\n___ y M with complicated medical hx including CAD s/o CABG, DM, \nCOPD, CKD, CHF, ?autoimmune sz who presented with progressive \nback pain, generalized weakness and associated recent fall, \nfound to have cord compression and admitted to medicine for \noptimization prior to surgery.  \n\nACTIVE MEDICAL ISSUES:\n#Cord compression with cervical myelopathy: \nPt presented with pain, increased weakness, and imaging findings \nwith cervical spinal stenosis/cord compression. No bowel/bladder \nchanges and mild tenderness to palpation. Pt went to OR on ___nterior approach. His pain was managed with \noxycodone and APAP.  Pt was evaluated by ___ who recommended home \nwith ___. Per ortho spine, plan for posterior approach surgery \nwhich will be done as an outpatient. Pt offered MRI L spine \nprior to discharge in preparation for surgery however he \npreferred to have as outpatient. Pt will also need outpatient \nfollow up with cardiologist, vascular and PCP for surgical risk \nstratification\n\n#Acute on chronic diastolic CHF: Patient with evidence of volume \noverload and mild respiratory symptoms on admission. He was \ndiuresed prior to surgery. No ___ available since ___, when \nLVEF >55%. Pt's respiratory status improved prior to OR although \nreceived 1.8L intra-op. He was able to be weaned back to room \nair and restarted on home diuretics prior to discharge. He was \ncontinued on home ACE-in and beta blocker.\n\nCHRONIC MEDICAL ISSUES:\n#CAD:  Pt continued on home BB, ___, statin  \n\n# Type 2 Diabetes Uncontrolled with Complications:  Pt continued \non home glargine and HISS  \n\n#CKD Stage 3: Baseline Cr appears to be in low 2s. BUN/Cr on \nadmission slightly worse than prior but likely minimal change in \nGFR with Cr increased from 2.3->2.5. His Cr downtrended to 1.9 \non discharge.\n\n#?Autoimmune dz: Unclear dx, chronically elevated CK and CRP \nwith no significant change from ___.  \n\n#Glacuoma: Pt continued on home Latanoprost\n\nTRANSITIONAL ISSUES:\n[] MRI L spine with and without contrast as outpatient prior to \nsecond stage of surgery\n[] PCP risk stratification as well as follow up with vascular \nsurgery for further risk stratification\n[] Pt needs to wear c collar when ambulating or driving in car\n[] Leukocytosis noted on discharge, likely in setting of recent \nsurgery. Will need follow up cbc in ___ weeks as outpatient to \nensure resolution\n[] Pt's home 80 mg lasix restarted at discharge. He will also \nrestart metolozone 5mg 2x per week.\n[] Weight on discharge: 237 lb\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Lisinopril 40 mg PO DAILY \n2. Triamcinolone Acetonide 0.1% Cream 1 Appl TP BID \n3. Zolpidem Tartrate ___ mg PO QHS insomnia \n4. Metoprolol Succinate XL 400 mg PO DAILY \n5. Pravastatin 80 mg PO QPM \n6. Furosemide 80 mg PO DAILY \n7. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO Q4-6H:PRN pain \n\n8. alpha lipoic acid ___ mg oral daily \n9. Nystatin-Triamcinolone Cream 1 Appl TP BID \n10. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n11. Aspirin 325 mg PO DAILY \n12. Citalopram 20 mg PO DAILY \n13. Metolazone 5 mg PO 2X/WEEK (___) edema, wt gain \n14. Calcitriol 0.25 mcg PO 3X/WEEK (___) \n15. Glargine 84 Units Bedtime\nInsulin SC Sliding Scale using HUM InsulinMax Dose Override \nReason: Home dose\n\n \nDischarge Medications:\n1. Aspirin 325 mg PO DAILY \n2. Calcitriol 0.25 mcg PO 3X/WEEK (___) \n3. Citalopram 20 mg PO DAILY \n4. Furosemide 80 mg PO DAILY \n5. Glargine 84 Units Bedtime\nInsulin SC Sliding Scale using HUM InsulinMax Dose Override \nReason: Home dose\n\n6. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n7. Lisinopril 40 mg PO DAILY \n8. Nystatin-Triamcinolone Cream 1 Appl TP BID \n9. Pravastatin 80 mg PO QPM \n10. Triamcinolone Acetonide 0.1% Cream 1 Appl TP BID \n11. alpha lipoic acid ___ mg oral daily \n12. Metolazone 5 mg PO 2X/WEEK (___) edema, wt gain \n13. Metoprolol Succinate XL 400 mg PO DAILY \n14. Oxycodone-Acetaminophen (5mg-325mg) ___ TAB PO Q4-6H:PRN \npain \n15. Zolpidem Tartrate ___ mg PO QHS insomnia \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \n___ Diagnosis:\nPRIMARY:\nCervical spine cord compression\nAcute on chronic systolic heart failure exacerbation\n\nSECONDARY:\nCAD\nCKD\nDM\n\n \nDischarge Condition:\n \nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nDear Mr. ___,\nIt was a pleasure taking care of you during your stay at ___ \n___. You were admitted to the hospital with neck and back \npain. You were found to have a compression of your spinal cord. \nYou had surgery to help fix this. You will need the second part \nof the surgery in ___ weeks with the spine surgeons. Before you \nhave this surgery, it is very important that you come back to \n___ for an outpatient Lumbar MRI as we have discussed. Please \ncall Dr. ___ office to schedule this as well as schedule \nyour surgery. It is also very important that you wear your \ncervical collar when walking or driving in the car. This is very \nimportant. You will have a visiting nurse to help with wound \ncare.\n\nYou were also found to be in heart failure when you came into \nthe hospital. You received IV lasix (waterpill) to help get \nfluid off. Your breathing improved and you were put back on your \noral lasix dose. Please be sure to weigh yourself daily and call \nyou cardiologist if you weight changes by >3 lb. It is very \nimportant that you follow up with your cardiologist as an \noutpatient.\n\nSincerely,\nYour ___ team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048247fb505ee75393454f"
  },
  "note_id": "19661870-DS-13",
  "subject_id": 19661870,
  "hadm_id": 28494331,
  "note_type": "DS",
  "note_seq": 13,
  "charttime": "2187-03-24 00:00:00",
  "storetime": "2187-03-27 11:16:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \n___ Containing / Cardizem / Morphine / Vancomycin / \nPenicillins / Propofol Analogues / glucose gel / gabapentin / \nNortriptyline / nystatin\n \nAttending: ___\n \nChief Complaint:\nLoss of consciousness\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ y M with complicated medical hx including CAD s/o CABG, DM, \nCOPD, CKD, CHF, who presented with recently underwent cord \ndecompression ___, presenting with witnessed syncopal episode \nfrom home.  Patient is accompanied by his wife who provides some \nof the history as well. Patient was reportedly sitting at home \nin his wheelchair when he told his wife that he was feeling \nunwelling. He saw bright lights, which he typically sees when he \nis hypoglycemic. He asked his wife to check his blood sugars \nwhich were found to be in the ___. Patient subsequently slumped \nover in chair, no headstrike. His wife kept calling his name and \nrubbing his chest to which he would briefly wake up. She \nsubsequently called EMS who found patient to have \nSBP70s/dopplerable (BP typically runs ___ and sugar in \nthe ___ for which he was given ___ amp D50 with improvement in \nsugars to 100s. Lantus had been administered 30 minutes prior to \nevent. Per report, patient was confused and reporting he \ncouldn't see because of bright lights. He states he always has \ndifficulty seeing and notes bright lights when he is \nhypoglycemic. He also noted associated nausea at the time. He \nreceived 2 of Narcan PTA for pinpoint pupils. Last dose of \n___ was early morning of day of \npresentation. Patient and wife deny taking extra doses of \nnarcotics. He was arousable on arrival to ED. \n\nPatient was seen by PCP on day of admission for routine visit \nwith no noted abnormalities. Of note, patient was recently \nadmitted (___) for upper extremity weakness and pain with \nfindings of cervical myelopathy for which he underwent anterior \ndiskectomy ___ with fusion on ___. During this \nhospitalization, he was also found to have decompensated dCHF. \nNo imaging including ___ was done at that time. Last ___ ___ \nshowed EF>55%. He was 237lbs on discharge. Only medication \nchange during this visit was changing lantus to evening (though \nkeeping same dose) and decreasing sliding scale. Patient is \nscheduled for second part of surgery (posterior approach on \n___. His wife has noticed that patient has had decreased po \nintake since the surgery and has been increasingly vegetative \nover hte last week. No major changes in medication other than \nlantus being administered in evening instead of morning as was \ndone prior to surgery. No history of seizures or nonpurposeful \nmovement per wife. No bowel/bladder incontinence. Patient has \nbeen compliant with all medications. \n\nPatient always sleeps in a chair upright. He has been dependent \non a walker since the week prior to his surgery though he used a \nwalker previously. Wife has noted increasing lower extrmeity \nswelling and decreased appetite. \n\nIn the ED initial vitals were: 10 97.5 81 101/45 18 94% 4LNC   \n- Labs were significant for urine/serum tox negative, u/a \nnegative, lactate 2.0, trop 0.08, Creat 2.0 (baseline ___, \nBNP 336, with leukocytosis 16.3.    \n- Pertinent imaging includes negative CT head, CXR with patchy \nopacities in the lung bases, likely atelectasis., CT C ___ \nwith marked prevertebral soft tissue swelling. \n- Patient was given aspirin.\n\nVitals prior to transfer were: HR70 100/60 RR24 99 RA%\nOn the floor, patient notes fatigue but otherwise denies any \npain. He notes very mild shortness of breath. He states he feels \nmuch better than prior to arrival. Wife states he does not \nappear to be at baseline since he appears increasingly tired. \nPaitent intermittently nods off during interview but is awake \nand conversant by the end of our iterview. Patient bradycardic \nto ___ overnight.\n\nReview of Systems:  \n(+) per HPI. Intermittent chills since surgery.\n(-) fever, chest pain, abdominal pain, nausea, vomiting, \ndiarrhea, constipation, dysuria, hematuria.  \n \nPast Medical History:\nCAD  \n- s/p MI ___ with PCI to LAD ___  \n- s/p CABGx4 ___ (___), after \n___ cath before arthroplasty revealed 3VD\nType 2 DM on insulin  \nHypertension\nHyperlipidemia\nObesity  \nTrivial MR ___ on ___ ___ that was otherwise normal with \nEF>55%)  \nChronic peripheral edema  \nProteinuria and CKD (baseline Cr 1.4)  \nDepression  \nGlaucoma  \nTobacco use  \nPeripheral neuropathy  \nLow back pain  \ns/p lumbar spinal fusion ___  \ns/p lumbar laminectomy ___  \ns/p lipoma excision from right forearm ___  \ns/p removal of bone spurs from knees bilaterally  \ns/p right hip arthroplasty ___\n \nSocial History:\n___\nFamily History:\nFather: CAD\nMother: Type 2 DM\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVitals - T98.1 146/61 74 20 98%RA 241BS, 227lbs (Weight 237 on \ndischarge ___  \nGENERAL: NAD, oriented x 3, intermittently drowsing off during \ninterview though more awake by end  \nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, \ndry mucous membranes\nNECK: nontender supple neck, no LAD, unable to assess JVD given \ncervical collar in place but no notable purulence from site of \nprior surgery, steri strips in place  \nCARDIAC: RRR, no murmurs, gallops, or rubs  \nLUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \nABDOMEN: nondistended, +BS, nontender in all quadrants, no \nrebound/guarding  \nEXTREMITIES: mild erythema of b/l ___ (noted to be chronic) with \n1+ pitting edema up to knees; moving all 4 extremities with \npurpose  \nNEURO: CN ___ intact, unable to dorsiflex/plantar flex R foot\nSKIN: warm and well perfused, b/l ___ erythema with 1+ pitting \nedema extending up to knees; poor skin turgor of inner thigh\n\nDISCHARGE PHYSICAL EXAM:\nGENERAL: NAD, oriented x3\nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, \ndry mucous membranes\nNECK: no JVD, no purulence or erythema at prior site of surgery \nwith Steri strips in place  \nCARDIAC: RRR, no murmurs, gallops, or rubs  \nLUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \nABDOMEN: nondistended, +BS, nontender in all quadrants, no \nrebound/guarding  \nEXTREMITIES: mild erythema of b/l ___ (noted to be chronic) with \n1+ pitting edema up to knees; moving all 4 extremities with \npurpose  \nSKIN: warm and well perfused, b/l ___ erythema with 1+ pitting \nedema extending up to knees\n \nPertinent Results:\nADMISSION LABS\n==============\n___ 06:50PM   ___ \n___\n___ 06:50PM   ___ \n___\n___ 06:50PM   ___ \n___ \n___\n___ 06:50PM   PLT ___ TO  PLT ___ TO \n___ 06:50PM   ___ \n___\n___ 06:50PM   ___\n___ 06:50PM   ___\n___ 06:50PM   ___ UREA ___ \n___ TOTAL ___ ANION ___\n___ 06:57PM   ___\n___ 08:10PM URINE  ___ SP ___\n___ 08:10PM URINE  ___ \n___ \n___\n___ 08:10PM URINE  ___ \n___\n___ 08:10PM URINE  ___\n___ 08:10PM URINE  ___ \n___\n\nPERTINENT LABS\n==============\n___ 06:50PM BLOOD ___\n___ 01:29AM BLOOD ___ MB ___\n___ 10:30AM BLOOD ___ MB ___\n\nDISCHARGE LABS\n==============\n___ 01:29AM BLOOD ___ \n___ Plt ___ TO \n___ 01:29AM BLOOD ___ \n___\n___ 01:29AM BLOOD ___ ___\n___ 01:29AM BLOOD ___ \n___\n___ 10:30AM BLOOD CK(CPK)-420*\n___ 01:29AM BLOOD ___\n\nMICROBIOLOGY\n============\n___ 6:50 pm BLOOD CULTURE\n   Blood Culture, Routine (Pending): \n\n___ 7:00 pm BLOOD CULTURE\n   Blood Culture, Routine (Preliminary): \n      STAPHYLOCOCCUS, COAGULASE NEGATIVE. \n         Isolated from only one set in the previous five days. \n         SENSITIVITIES PERFORMED ON REQUEST.\n   Aerobic Bottle Gram Stain (Final ___: \n      GRAM POSITIVE COCCI IN CLUSTERS. \n      Reported to and read back by ___ ___ 17:17. \n\n   Anaerobic Bottle Gram Stain (Final ___: \n      GRAM POSITIVE COCCI IN CLUSTERS. \n\n___ 8:10 pm URINE\n   URINE CULTURE (Final ___: \n      ENTEROBACTER CLOACAE COMPLEX.    ___ \nORGANISMS/ML.. \n         This organism may develop resistance to third \ngeneration\n         cephalosporins during prolonged therapy. Therefore, \nisolates that\n         are initially susceptible may become resistant within \nthree to\n         four days after initiation of therapy.  For serious \ninfections,\n         repeat culture and sensitivity testing may therefore be \nwarranted\n         if third generation cephalosporins were used. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             ENTEROBACTER CLOACAE COMPLEX\n                             |   \nCEFEPIME--------------   <=1 S\nCEFTAZIDIME-----------   <=1 S\nCEFTRIAXONE-----------   <=1 S\nCIPROFLOXACIN---------<=0.25 S\nGENTAMICIN------------   <=1 S\nMEROPENEM-------------<=0.25 S\nNITROFURANTOIN--------    32 S\nPIPERACILLIN/TAZO-----   <=4 S\nTOBRAMYCIN------------   <=1 S\nTRIMETHOPRIM/SULFA----   <=1 S\n\nRADIOLOGY\n=========\n___ ___ W/O CONTRAST\nFINDINGS: \nThe patient is status post anterior cervical fusion accomplished \nby anterior plate with 4 pairs of vertebral body screws and \nintervertebral disc spacers spanning C3 to C6. No hardware \ncomplications or acute fracture is noted. Degenerative changes \nincluding posterior osteophytosis causes severe central canal \nnarrowing from C4 to C7 as well as multilevel bilateral moderate \nto severe neural foraminal narrowing, most pronounced at ___.  \nMild anterolisthesis at ___ is similar to ___ \n(602b:44).  Marked prevertebral soft tissue swelling is noted \nlikely secondary to postsurgical changes, and no loculated fluid \ncollection is seen. The visualized lung apices are clear. \nIMPRESSION:  \n1. Degenerative changes including posterior osteophytosis from \n___ cause severe central canal narrowing. Evaluation for \nintrathecal mass or infection is not well assessed on CT and can \nbe further evaluated with MRI.\n2.  Marked prevertebral soft tissue swelling is likely secondary \nto postsurgical changes, and no loculated fluid collection is \nseen. An MRI with contrast can be obtained if there is continued \nclinical concern for infection. \n\n___ (SINGLE VIEW)\nFINDINGS:\nThe patient is status post median sternotomy and CABG. Heart \nsize is normal. Mediastinal and hilar contours are unremarkable. \nNo pulmonary edema is demonstrated. Patchy opacities in the lung \nbases likely reflect areas of atelectasis. No focal \nconsolidation, pleural effusion or pneumothorax is identified. \nCervical spinal fusion hardware is partially imaged. \nIMPRESSION: \nPatchy opacities in the lung bases, likely atelectasis.\n\n___ HEAD W/O CONTRAST\nFINDINGS: \nNo evidence of hemorrhage, edema, mass effect, or acute large \nterritorial infarction.Mild prominence of the ventricles and \nsulci are consistent with ___ cortical volume loss.Faint \nperiventricular and subcortical white matter hypodensity is most \nlikely sequelae of chronic small vessel ischemic disease.\nThe basal cisterns are patent and there is preservation of \n___ matter differentiation.\nNo fracture identified. Mild mucosal thickening of the left \nsphenoid sinus. The visualized paranasal sinuses, mastoid air \ncells, and middle ear cavities are otherwise clear. The globes \nare unremarkable.\nIMPRESSION: \nChronic changes as described above. No intracranial hemorrhage. \nOf note MR is more sensitive in the detection of subtle \nabnormalities and infection.\n\nOTHER STUDIES\n=============\n___\nSinus rhythm. ___ interval prolongation. T wave flattening in \nleads I and aVL. Compared to the previous tracing of ___ \nthere is probably no significant change.\n\n \nBrief Hospital Course:\nSUMMARY: ___ with a complicated medical history including CAD \ns/p CABG, DM, COPD, CKD, CHF, and ?autoimmune disease recently \nunderwent cord decompression surgery on ___ and presented \nfrom home after a witnessed syncopal event, likely due to \nhypoglycemia from poor nutrition and fluid intake. The patient \nrequested to be discharged before a full work up could be \npursued.\n\nACTIVE ISSUES\n\n# Syncope\nThe etiology of the syncope was not certain, but the cause is \nlikely due to hypoglycemia. The patient recently had surgery and \nhas not been eating as well as he normally does (~25% of his \nnormal nutrition). However, he still takes the same amount of \ninsulin as he previously did, and he took 84 units of insulin \nglargine about 30 minutes prior to the episode. While glargine \nis not typically a peaking insulin, the large amount in \ncombination with 2 units of insulin lispro likely pushed him \ninto a range that is low for him. Previously, he has had similar \nhypoglycemic episodes with finger stick in the ___. No other \nobvious causes were identified. He did not have medication \nchanges. His chest ___ was unrevealing and UA was normal. \nThere were no symptoms or findings to suggest stroke or seizure. \nHis EKG was at baseline, and he had no biomarker increase. A ___ \nwas ordered for the patient. The patient was very adamant about \nbeing discharged on the day of admission, and he refused to \nstay. Given, his preferences, he was discharged with \ninstructions to reduce his insulin by 50% and follow up with PCP \nand ___ provider to adjust insulin to his dietary intake.\n\n# Bacteremia\nShortly before leaving, the microbiology lab reported a positive \nblood culture with gram positive cocci in clusters. Given his \nlack of symptoms and quick improvement and the patient's wishes \nto still be discharged, it was thought that the cultures were \nlikely contaminant and coagulase negative Staph. He was sent \nhome with instructions to return if blood cultures grow S. \naureus or if he develops a fever or feels unwell at all. He \nacknowledged understanding this plan.\n\nATTENDING ADDENDUM -- Cultures returned ___ coag negative staph \n-- no further workup needed (attributing this to contaminant).  \nThe resident team indicated they would notify the patient of \nthis result.\n\nCHRONIC ISSUES\n\n# Cervical Myelopathy\nThe patient is  s/p ___ ACDF with Dr. ___ Orthopedic \n___. There were no concerning symptoms at this admission. \nFurther treatment and work up will be continued as outpatient.\n\n# Unresolved Leukocytosis\nPatient has had a long standing leukocytosis of unclear \netiology. It was presumed to be secondary to surgery or \ninfection on prior admissions. At this point, with no fevers or \nlocalizing symptoms, probability of infection was thought to be \nlow.\n\n# Diabetes\nHome insulin regimen was held with a modified sliding scale used \nwhile inpatient. Please see above for syncope. He was discharged \nwith instructions to take half (42U insulin glargine QPM) of his \nregular regimen (84U insulin glargine QPM).\n\nTRANSITIONAL ISSUES\n- Lantus decreased to 42U daily, will need FSG trended at next \noutpt PCP appt\n- ___ must schedule outpt PCP appt in next 7 days\n- Pt should stop lisinopril dosing until his BP is ___ at \n___'s office as he didnt need it during hospitalization and may \nhave contributed to syncope\n- Pt would likely benefit from outpt ___ to ___ whether or \nnot he has CHF \n- Pt will need to be evaluated by primary care doctor prior to \nplanned surgical procedure next week to ensure that he is \nmedically stable. Results should be communicated to Dr. ___\n\n# Code: DNR/DNI\n# Emergency Contact: ___ (wife, ___\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Metoprolol Succinate XL 400 mg PO DAILY \n2. Lisinopril 40 mg PO DAILY \n3. Pravastatin 80 mg PO QPM \n4. Citalopram 20 mg PO DAILY \n5. Furosemide 40 mg PO DAILY \n6. Metolazone 5 mg PO 2X/WEEK (___) \n7. Aspirin 325 mg PO DAILY \n8. ___ 1 TAB PO ___ PRN \npain \n9. Glargine 84 Units Dinner\nInsulin SC Sliding Scale using HUM InsulinMax Dose Override \nReason: home dose\n\n10. Calcitriol 0.25 mcg PO 3X/WEEK (___) \n11. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n12. Zolpidem Tartrate ___ mg PO QHS:PRN Insomnia \n13. Triamcinolone Acetonide 0.1% Cream 1 Appl TP BID \n14. ___ Cream 1 Appl TP BID \n15. alpha lipoic acid ___ mg oral Daily \n\n \nDischarge Medications:\n1. Aspirin 325 mg PO DAILY \n2. Citalopram 20 mg PO DAILY \n3. Glargine 42 Units Dinner\nInsulin SC Sliding Scale using HUM Insulin\n4. Pravastatin 80 mg PO QPM \n5. Nystatin Oral Suspension 5 mL PO QID \nRX *nystatin 100,000 unit/mL 4 mL by mouth four times a day \nRefills:*0\n6. alpha lipoic acid ___ mg oral Daily \n7. Calcitriol 0.25 mcg PO 3X/WEEK (___) \n8. Furosemide 40 mg PO DAILY \n9. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n10. Metolazone 5 mg PO 2X/WEEK (___) \n11. Metoprolol Succinate XL 400 mg PO DAILY \n12. ___ Cream 1 Appl TP BID \n13. ___ 1 TAB PO ___ PRN \npain \n14. Triamcinolone Acetonide 0.1% Cream 1 Appl TP BID \n15. Zolpidem Tartrate ___ mg PO QHS:PRN Insomnia \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nSyncope\nHypoglycemia\n\n \nDischarge Condition:\nDischarge Condition: Stable, improved\nMental Status: AOx3\nAmbulatory Status: BAseline\n\n \nDischarge Instructions:\nIt was a pleasure taking care of you while you were hospitalized \nat ___. As you know, you were admitted after passing out \nat home. Our workup was unrevealing as to what caused you to \npass out, but it seems that your low sugars may have been the \ncause. Since you are eating less after your surgery, your \ninsulin needs are much lower. Accordingly, you will need to \ndecrease your lantus dosing as we had discussed. It would have \nbeen preferable to test you on this new regimen during your \nhospitalization, but we understand that it is your wish to be \ndischarged home now that you are feeling better. We hope that \nyou continue to feel well. \n\nBelow are a summary of your medication changes:\n-Please decrease Lantus to 42 units\n-Please hold further lisinopril dosing until you are seen by \nyour primary care doctor \n \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048247fb505ee753934550"
  },
  "note_id": "19661870-DS-14",
  "subject_id": 19661870,
  "hadm_id": 22624662,
  "note_type": "DS",
  "note_seq": 14,
  "charttime": "2187-04-13 00:00:00",
  "storetime": "2187-04-15 09:33:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nIodine-Iodine Containing / Cardizem / Morphine / Vancomycin / \nPenicillins / Propofol Analogues / glucose gel / gabapentin / \nNortriptyline / nystatin / adhesive / cardiac electrodes\n \nAttending: ___\n \nChief Complaint:\nadmission for elective cervical laminectomy and fusion of  \nc3-t1  \n\n \nMajor Surgical or Invasive Procedure:\n- Total laminectomy C3-4, 5, 6, and 7; Laminotomy T1-2; Fusion \nC3-T1; Instrumentation C3-T1; Autograft (___)\n\n \nHistory of Present Illness:\n___ with a complicated medical history including CAD s/p CABG, \nDM, COPD, CKD, ?CHF, and spinal stenosis s/p recent cord \ndecompression surgery on ___, who presents for posterior \ncervical fusion surgery ___. \n\nOf note, patient was recently discharged on ___ after \nadmission with syncope, attributed to hypoglycemia. On that \nadmission, also found to have borderline low blood pressures, \nand lisinopril was stopped. He was seen by his PCP ___ \ndischarge for evaluation prior to planned surgery today.  \n\nPt presented today for elective cervical laminectomy and fusion \nof  c3-t1 today with ___. Given medical comorbidities, \nhe is being admitted to medicine for post-operative monitoring. \nEstimated blood loss from procedure was 100cc.  \n\n \nPast Medical History:\nCAD  \n- s/p MI ___ with PCI to LAD ___  \n- s/p CABGx4 ___ (Lima-LAD, SVG-D1, SVG-OM, SVG-PDA), after  \npre-op cath before arthroplasty revealed 3VD  \nType 2 DM on insulin  \nHypertension  \nHyperlipidemia  \nObesity  \nTrivial MR ___ on ___ ___ that was otherwise normal with  \nEF>55%)  \nChronic peripheral edema  \nProteinuria and CKD (baseline Cr 1.4)  \nDepression  \nGlaucoma  \nTobacco use  \nPeripheral neuropathy  \nRight carpal tunnel syndrome s/p Right carpal tunnel release \n(___)\n\ns/p lipoma excision from right forearm ___  \ns/p removal of bone spurs from knees bilaterally  \ns/p right hip arthroplasty ___  \n\nLow back pain  \n- s/p lumbar spinal fusion ___  \n- s/p lumbar laminectomy ___  \n\nCervical spondylosis/stenosis\n- s/p Anterior cervical diskectomy at C3-4, C4-5, C5-6; \nOsteotomy c4-5, c5-6; Fusion C3 to C6; Anterior instrumentation \nC3 to C6; Autograft and allograft (___)\n \nSocial History:\n___\nFamily History:\nFather: CAD  \nMother: Type 2 DM  \n\n \nPhysical Exam:\nEXAM ON ADMISSION TO MEDICINE FLOOR:\n=====================\nVitals: 98.2 (98.2)  110/90 (110-135/40-68)  91 (65-104)  18  \n96% (96-100% RA)\nGeneral: Alert and oriented x 3  \nHEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, pinpoint \npupils, bandage overlying cervical incision c/d/i with drain in \nplace   \nCV: distant heart sounds, Regular rate and rhythm, normal S1 + \nS2, no murmurs, rubs, gallops  \nLungs: Clear to auscultation bilaterally, no wheezes, rales, \nrhonchi  \nAbdomen: Soft, non-tender, non-distended, bowel sounds present, \nno organomegaly, no rebound or guarding  \nExt: Warm, well perfused, in stockings\nNeuro: CNII-XII intact, full strength in upper/lower extremities \nbilaterally, grossly normal sensation bilaterally, gait deferred \n(seated in chair).\n\nEXAM ON DISCHARGE:\n=====================\nPHYSICAL EXAM:  \nVitals: 98.0 (98.7)  133/52 (133-143/52-76)  72 (72-83)  18  98% \n(98-100% RA)\nGeneral: Alert and oriented   \nHEENT: Sclera anicteric, Wound site at neck with overlying \nbandage (blood seen underneath bandage, but none surrounding \nbandage on outside)  \nCV: distant heart sounds, Regular rate and rhythm, normal S1 + \nS2, no murmurs, rubs, gallops  \nLungs: Clear to auscultation bilaterally, no wheezes, rales, \nrhonchi  \nAbdomen: Soft, non-tender, non-distended, bowel sounds present, \nno organomegaly, no rebound or guarding  \nExt: Warm, well perfused, 2+ pitting edema bilaterally\nNeuro: full strength in upper/lower extremities bilaterally, \ngrossly normal sensation bilaterally \n \nPertinent Results:\nLABS ON ADMISSION:\n====================\n___ 09:15AM BLOOD WBC-18.8* RBC-3.44* Hgb-9.7* Hct-29.6* \nMCV-86 MCH-28.1 MCHC-32.8 RDW-15.0 Plt Ct-UNABLE TO \n___ 07:30PM BLOOD Glucose-160* UreaN-82* Creat-1.8* Na-135 \nK-3.5 Cl-98 HCO3-23 AnGap-18\n___ 07:30PM BLOOD Calcium-9.1 Phos-6.0* Mg-2.0\n___ 01:00PM BLOOD Glucose-164* Lactate-0.9 Na-135 K-2.7* \nCl-106\n___ 02:41PM BLOOD Glucose-175* Lactate-1.2 Na-132* K-3.1* \nCl-100\n\nPERTINENT LABS THROUGHOUT STAY:\n================================\n___ 03:33PM URINE Color-Yellow Appear-Hazy Sp ___\n___ 03:33PM URINE Blood-LG Nitrite-NEG Protein-TR \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-LG\n___ 03:33PM URINE RBC->182* WBC-48* Bacteri-FEW Yeast-NONE \nEpi-0\n___ 03:33PM URINE CastHy-10*\n___ 03:33PM URINE Mucous-FEW\n___ 10:48AM URINE Color-Yellow Appear-Hazy Sp ___\n___ 10:48AM URINE Blood-LG Nitrite-NEG Protein-TR \nGlucose-70 Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-LG\n___ 10:48AM URINE RBC->182* WBC-28* Bacteri-NONE Yeast-NONE \nEpi-1\n___ 10:48AM URINE CastHy-1*\n___ 10:48AM URINE Mucous-RARE\n___ 10:48AM URINE Hours-RANDOM UreaN-478 Creat-44 Na-56 \nK-28 Cl-56\n___ 10:48AM URINE Osmolal-387\n\nLABS ON DISCHARGE:\n====================\n___ 06:50AM BLOOD WBC-15.6* RBC-3.19* Hgb-9.1* Hct-27.7* \nMCV-87 MCH-28.6 MCHC-32.8 RDW-15.6* Plt Ct-UNABLE TO \n___ 06:50AM BLOOD Glucose-259* UreaN-79* Creat-1.8* Na-132* \nK-3.7 Cl-92* HCO3-28 AnGap-16\n___ 06:50AM BLOOD Calcium-9.3 Phos-4.0 Mg-2.2\n\nMICROBIOLOGY:\n====================\n___ 3:33 pm URINE      Source: Catheter. \n   URINE CULTURE (Final ___:    NO GROWTH. \n\nSTUDIES:\n====================\nCERVICAL SINGLE VIEW IN OR  Study Date of ___ 12:___, anterior plate and screws and fusion devices are seen \nat multiple levels. Surgical instrumentation is seen \nposteriorly. Onset of clamps overlies the spinous process of the \nC3 vertebral body. Another set of instruments overlies the \nposterior elements inferiorly near the cervio-thoracic junction. \n Detail is obscured by overlying anatomy. Support wires and \ntubing are noted.  \nOn view 2, posterior screws are present at multiple levels. \nAdditional instrumentation is seen posteriorly.   \nOn view 3, multiple posterior pedicle screws and instruments are \nnoted.  \n\nCHEST (PORTABLE AP) Study Date of ___ 4:41 ___ \nIMPRESSION:  \nPulmonary vasculature was engorged on ___.  The \nengorgement has improved, but there is mild interstitial edema \nin the lower lungs.  Heart size is normal.  Pleural effusion is \nminimal if any.  Patient has had median sternotomy, presumably \nfor cardiac surgery. \n\n \nBrief Hospital Course:\nBRIEF HOSPITAL COURSE:\n===========================\n___ with Diabetes, hypertension, CAD, recently discharged on \n___ after admission with syncope, attributed to hypoglycemia \nwho presented for elective cervical fusion for cervical spinal \nstenosis and spondylosis now s/p cervical laminectomy and fusion \nof C3-T1, admitted to the medicine service for post-operative \nmonitoring in the setting of his chronic medical co-morbidities. \nPost-operative course was uncomplicated and as per physical \ntherapy recommendations was discharged to rehab for continued \n___. He was provided w/ appropriate outpatient orthopedic f/u \nappts. \n\nACUTE ISSUES:\n====================\n# S/P Cervical Laminectrony and fusion (___): \nPost-op, patient given 3 doses of IV clindamycin. Ortho \nrecommended soft C-collar to be worn at all times when out of \nbed. SQH and ASA were restarted on ___, and patient was \ntransitioned off IV Dilaudid PCA to standing tylenol + PRN \noxycodone. However, needed methylnaltrexone to stool. Patient \nseen by Physical Therapy, who recommended rehab based on \nimpaired ability to ambulate or transfer self.\n___ recs for nursing include: encourage frequent position changes \nand ambulation with S for hospital setting, and Assist of 2 for \nout of bed to chair with RW 3x/day.\nAt rehab, patient is to have daily dressing changes overlying \ncervical spine incision. Pt will have staples removed at Ortho \nf/u appt. \n\n# Leukocytosis (downtrending): WBC 18.8 initially post-op \n(nothing collected on admission) -> 17.8 -> 15.6; last WBC prior \nto admission was 16.3 (___). WBC initially elevated ___ \nlikely due to stress from surgery. Not on exogenous steroids. \nUrine culture from ___ negative. Prior records show most WBC \ncounts between ___ circumstances unclear. \n\n# Microscopic hematuria: seen ___ AM (>182 RBCs). UA from \n___ showed no RBCs and no blood (so no known hematuria at \nbaseline). Possibly due to Foley placement. Repeat urine from \n___ showed no gross hemauria, but UA still showed >182 RBCs. \nPlease repeat UA as outpatient in 7d to determine whether \nmicroscopic hematuria has resolved.\n\n# Hyponatremia: Na 134 -> 131 -> 132. Possibly due to SIADH from \npain. Continue to trend as outpatient to ensure trending up. \n\n# Diabetes\nPt was recently discharge ~1 month ago after pre-syncope/AMS \npresumed to be due to hypoglycemic episode. Since PO intake at \nthe time was low, home dose lantus and sliding scale was \ndecreased. On this admission, pt's PO intake increased \npost-operatively, as did his insulin requirements. Accordingly, \nHISS was uptitrated. He will need continued blood glucose \nmonitoring and likely uptitrating of his HISS.\n  \n#Anemia: Hct baseline ~34, Hct post-op 27.9 and has remained in \n___ range post-op. Likely ___ blood loss from OR. Please \ncontinue to trend Hct as outpatient.   \n\n#Hypertension: patient was continued on furosemide, metolazone, \nand metoprolol. Metop succinate 400 mg qd was broken up into \nmetop tartrate 100 mg q6h while in-house, but patient will \nresume metop succinate upon discharge. Of note, before this \nhospitalization, patient's PCP had recently stopped lisinopril \nbefore admission bc of recent hypotension; this was not \ncontinued.  \n \n# CAD: s/p CABG in ___ with LIMA to the LAD, vein graft to D1, \nOM, PDA. Patient was continued on pravastatin, and ASA 325 was \nrestarted ___ per Ortho recs.   \n\n# CKD: CKD stage IV c/b renal osteodystrophy with a baseline \ncreatinine of 2.1 to 2.3. Cr now 1.8-2.0 during hospitalization \nwhile being continued on metolazone and furosemide.  \n\n# Hyperlipidemia: pravastatin continued. \n\n# Depression: patient continued on citalopram.  \n \n\nTRANSITIONAL ISSUES:\n======================\n- Dressing overlying cervical wound needs to be changed on daily \nbasis. Staples need to be removed at orthopedic f/u appt\n- Please check sodium level on ___ to ensure hyponatremia has \nresolved\n- Please check H/H on ___ to ensure is uptrending \npost-operatively (baseline Hct = 34)\n- Please continue monitoring blood glucose, and consider \nuptitrating lantus and HISS as needed as PO intake normalizes\n- Please repeat UA as outpatient in 7d to ensure microscopic \nhematuria has resolved.\n\n# Code: DNR/DNI  \n# Emergency Contact: ___ (wife, ___  \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 325 mg PO DAILY \n2. Citalopram 20 mg PO DAILY \n3. Pravastatin 80 mg PO QPM \n4. Nystatin Oral Suspension 5 mL PO QID \n5. alpha lipoic acid ___ mg oral Daily \n6. Calcitriol 0.25 mcg PO 3X/WEEK (___) \n7. Furosemide 40 mg PO DAILY \n8. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n9. Metolazone 5 mg PO 2X/WEEK (___) \n10. Metoprolol Succinate XL 400 mg PO DAILY \n11. Nystatin-Triamcinolone Cream 1 Appl TP BID \n12. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q4-6HOURS PRN \npain \n13. Triamcinolone Acetonide 0.1% Cream 1 Appl TP BID \n14. Zolpidem Tartrate ___ mg PO QHS:PRN Insomnia \n15. Lantus (insulin glargine) 42 units subcutaneous qpm \n16. HumaLOG KwikPen (insulin lispro) sliding scale  subcutaneous \nas directed \n17. Ferrous Sulfate 325 mg PO DAILY \n18. Docusate Sodium 200 mg PO DAILY \n19. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n\n \nDischarge Medications:\n1. Aspirin 325 mg PO DAILY \n2. Calcitriol 0.25 mcg PO 3X/WEEK (___) \n3. Citalopram 20 mg PO DAILY \n4. Docusate Sodium 200 mg PO DAILY \n5. Furosemide 40 mg PO DAILY \n6. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS \n7. Metolazone 5 mg PO 2X/WEEK (___) \n8. Pravastatin 80 mg PO QPM \n9. Triamcinolone Acetonide 0.1% Cream 1 Appl TP BID \n10. alpha lipoic acid ___ mg oral Daily \n11. Ferrous Sulfate 325 mg PO DAILY \n12. Metoprolol Succinate XL 400 mg PO DAILY \n13. Senna 8.6 mg PO BID:PRN constipation \n14. Bisacodyl 10 mg PO/PR DAILY:PRN constipation \n15. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n16. Zolpidem Tartrate ___ mg PO QHS:PRN Insomnia \n17. Acetaminophen 650 mg PO Q6H \n18. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN pain \n19. Glargine 42 Units Dinner\nInsulin SC Sliding Scale using HUM InsulinMax Dose Override \nReason: home dose\n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary:\n- Cervical spondylosis and stenosis\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou were seen admitted to ___ for an elective neck surgery \nwith Dr. ___. The procedure went well, and afterwards, you \nwere transferred to the Medicine service for further observation \nand management. You were transitioned from IV to oral pain \nmedications, and the drain from your neck was removed. You were \nseen by our physical therapists, who felt that given your \nimpaired strength and activity tolerance, you would be ___ \nserved being discharged to a rehab facility. \n\nIt was our pleasure taking care of you, and we wish you all the \n___!\n\nSincerely,\n\nYour ___ Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048247fb505ee753934551"
  },
  "note_id": "19661870-DS-8",
  "subject_id": 19661870,
  "hadm_id": 25303740,
  "note_type": "DS",
  "note_seq": 8,
  "charttime": "2181-03-05 00:00:00",
  "storetime": "2181-03-05 10:06:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nIodine; Iodine Containing / Cardizem / Morphine / Vancomycin\n \nAttending: ___\n \nChief Complaint:\nHypotension\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\nThis is a ___ year-old male with a history of diabetes, \nhypertension and hyperlipidemia who presents with 1 day of \nfever, dyspnea and confusion.  The patient reports being in his \nusual state of health until this AM when he began to feel weak. \nHe was concerned that he was becoming hypoglycemic and thus \ndrank some orange juice and checked his glucose (it was 180).  \nHe rested and when his wife returned, he was found to be weak, \nlethargic with fever and chills.  Thus she called ___.  On \narrival EMS noted the patient to be hypoxic to 89% and pale.  Of \nnote the patient has been treated with dicloxacillin for the \nlast 10 days for a LLE injury that became infected.  He \ndeveloped a rash prior to starting the antibiotics that was \nlocated on his back, chest and arms.  The patient nor wife can \nrecall any change that could cause the rash but do note that the \npatient does frequently have rashes that occur for no clear \nreason.\n\nThe patient was brought to the ER.  Initial vitlas were t 101 BP \n132/78 HR 130 RR 28 02 92% 4L.  Per report cyanotic on arrival \nof EMS, 02 sat 89%.  In the ED the patient was given \nlevofloxacin and then found to have BP of ___.  IV fluids were \ngiven and the patient responded with BP.  Additionally, the \npatient was given Vancomycin.  The patient and wife report that \nhe immediately broke out in hives and became \"red\". The patient \nwas then given solumedrol, benadryl and pepcid with improvement \nin the rash.  He was placed on a NRB prior to transport   \n\nOn arrival to the floor the patient is asymptomatic.  He is more \nalert and currently does not feel shortness of breath.  He feels \nthat in the last hour he has felt significantly improved. \n  \nROS: + nausea prior to admission, vomiting in ER with vancomycin \nreaction. + constiption.  Has had upper chest/back erythematous \nrash. Intermittent ___ edema r>L. The patient denies any weight \nchange,  abdominal pain, diarrhea,  melena, hematochezia, chest \npain,  orthopnea, PND,  cough, urinary frequency, urgency, \ndysuria, , gait unsteadiness, focal weakness, vision changes, \nheadache. \n\n \nPast Medical History:\nDM-II on lantus (intermittently takes ___\nCAD s/p MI ___\nHTN\nLow back pain\nglaucoma\nimpotence\ncurrent smoking\nperipheral neuropathy\ntrivial  MR\n___\n\n \nSocial History:\n___\nFamily History:\nFather-CAD\nMother-DM\n \nPhysical Exam:\nGEN: Well-appearing, well-nourished, no acute distress  \nHEENT: EOMI, PERRL, sclera anicteric, no epistaxis or \nrhinorrhea, MMM, OP Clear  \nNECK: No JVD, carotid pulses brisk, no bruits, no cervical \nlymphadenopathy, trachea midline  \nCOR: RRR, no M/G/R, normal S1 S2, radial pulses +2  \nPULM: Lungs CTAB, no W/R/R  \nABD: Soft, NT, ND, +BS, no HSM, no masses  \nEXT: No C/C/E, no palpable cords  \nNEURO: alert, oriented to person, place, and time. CN II  XII \ngrossly intact. Moves all 4 extremities. Strength ___ in upper \nand lower extremities. Patellar DTR +1. Plantar reflex \ndowngoing. No gait disturbance. No cerebellar dysfunction.  \nSKIN: No jaundice, cyanosis, or gross dermatitis. No ecchymoses. \n\n \nPertinent Results:\nChemistries: \n___ 05:42PM   GLUCOSE-184* UREA N-30* CREAT-1.6* SODIUM-137 \nPOTASSIUM-3.8 CHLORIDE-98 TOTAL CO2-24 ANION GAP-19\n___ 05:42PM   CALCIUM-9.7 PHOSPHATE-2.0* MAGNESIUM-1.8\n___ 05:50PM   LACTATE-3.8*\n\nHematology: \n___ 05:42PM   WBC-15.9* RBC-4.79 HGB-13.7* HCT-39.0* \nMCV-82# MCH-28.6 MCHC-35.2*# RDW-15.0\n___ 05:42PM   NEUTS-87.7* LYMPHS-10.9* MONOS-0.5* EOS-0.6 \nBASOS-0.2\n___ 05:42PM   ___ PTT-23.9 ___\n\nCardiac Enzymes: \n___ 05:42PM BLOOD CK-MB-5\n___ 05:42PM BLOOD cTropnT-0.05*\n___ 05:42PM BLOOD CK(CPK)-252*\n___ 12:15AM BLOOD CK-MB-16* MB Indx-4.2 cTropnT-0.09*\n___ 12:15AM BLOOD CK(CPK)-378*\n___ 02:37PM BLOOD CK-MB-19* MB Indx-2.6 cTropnT-0.15*\n___ 06:01AM BLOOD CK(CPK)-500*\n___ 09:11PM BLOOD CK-MB-15* MB Indx-2.5 cTropnT-0.16*\n___ 09:11PM BLOOD CK(CPK)-603*\n___ 04:00AM BLOOD CK-MB-13* MB Indx-2.5 cTropnT-0.17*\n___ 04:00AM BLOOD CK(CPK)-514*\n\nImaging: \nCT Chest w/o contrast ___: \n1. Innumerable centrilobular nodules measuring up to 5 mm \nthroughout both \nupper lungs. This is most likely infectious in etiology, and \ncould represent \nbronchopneumonia. There is no area of confluent consolidation. \nNeeds F/U \nafter therapy. \n2. Mild emphysematous changes bilaterally. \n3. Mild atherosclerotic calcification. \n4. Bulky appearance to the left adrenal gland, could represent \nadrenal \nadenoma. Adrenal protocol washout CT recommended. \n\nBilateral lower extremity ultrasounds ___: \nNo evidence of DVT of either leg.\n\nCXR ___: no acute cardiopulmonary process\n\nEKG: ECG:  Sinus tachycardia at 128, ST depressions in I, II, \nIII, aVF, V5,V6.  TWI in V4-V6 all new when compared to previous \n___ (which was also tachycardic)\n\nMicrobiology: \n___: blood culture x 2 no growth to date\n___: urine culture no growth to date\n___: legionella antigen negative\n\n \nBrief Hospital Course:\nThis is a ___ year old man with DM, HTN, CAD, Hyperlipidemia who \npresented with confusion, lethargy, fever, and chills concerning \nfor infectious etiology. He was admitted to the ICU for \ntransient hypotension that resolved spontaneously. Blood and \nurine cultures and legionella urine antigen were all negative.  \nChest X-Ray was unremarkable. Chest CT was concerning for \npossible bronchopneumonia although appearance is atypical. It \ndid show innumerable centrilobular nodules measuring up to 5 mm \nthroughout both upper lungs. This is most likely infectious in \netiology.  \nOn presentation he had a new oxygen requirement but this was \nquickly weaned to room air without shortness of breath. He \nbecame afebrile with stable BP through out his stay. He was \nplaced on levofloxacin for five day course for fears of \ncommunity acquired pneumonia by the ICU team ( atypical and \nunlikely presentation. His blood and urine cultures are negative \nto date. His confusion/lethargy resolved prior to arrival to the \nemergency room.  He was noted to have elevated cardiac enzymes. \nHe has history of 95% LAD lesion treated with angioplasty in \n___.  EKG on admission with ST depressions but in the setting \nof tachycardia.  EKG changes resolved upon arrival to ICU.  CKs \nhave peaked and are tending down.  Troponin currently 0.25. \nThere was low suspicion that this represents acute plaque \nrupture given lack of symptoms but could represent demand \nischemia. He was treated with aspirin, atenolol, simvastatin.\nI have explained all of the above to the patient and his wife on \n2 separate occasions (yesterday and today). I advised him to \nremain in hospital to obtain TTE or TEE, chemical myocardial \nstress test, and CT of the abdomen ( adrenal enlargement on the \nCT of the chest). I explained that he probably had a \" minor \nheart attack\" that needs further testing and cardiology \nconsultation. He had unexplained fever, hypotension, confusion, \npulmonary nodules, and cardiac enzymes leak. He may need TEE to \nR/O cardiac source of infection. In addition, he needs stress \n___. In regards to the abnormal chest CT (multiple pulmonary \nnodules on chest CT).  No recent images for comparison. This \nneeds to be repeated after treatment with levofloxacin for \npresumed pneumonia ( can not R/O cardiac emboli, or old fungal \ninfection). He is a smoker with risk of lung malignancy. He also \nneed CT abdomen for the adrenal enlargement seen on CT chest. He \nneeds outpatient cardiac and pulmonary consultations.\nAgain, I expressed the need for longer hospital stay and further \ntesting. He decided to leave with his wife and get all above \ntests in the out patient setting. He understood the risk from \nleaving the hospital prematurely.\n\n \nMedications on Admission:\nASPIRIN - 325 MG TABLET (ENTERIC COATED) - UT DICT\nATENOLOL - 25 mg Tablet - 1 Tablet(s) by mouth once a day bp\nDIAZEPAM - 10 mg Tablet - 1 Tablet(s) by mouth at bedtime as \nneeded for insomnia\nDICLOXACILLIN - 500 mg Capsule - 1 Capsule(s) by mouth four \ntimes a day\nGLYBURIDE - 5 mg Tablet - 3 Tablet(s) by mouth once a day dm\nHYDROCHLOROTHIAZIDE - 25 mg Tablet - 1 by mouth once a day bp\nINSULIN GLARGINE [LANTUS] - 100 unit/mL Solution - 60 units once \na day dm\nLATANOPROST [XALATAN] - 0.005 % Drops - 1 gtt ___ at bedtime\nLIDOCAINE [LIDODERM] - 5 % (700 mg/patch) Adhesive Patch,\nMedicated - apply once a day as needed for for 12 hours per day \nfor low back pain\nLISINOPRIL - 40 mg Tablet - 1 Tablet(s) by mouth once a day bp\nMETFORMIN - 1,000 mg Tablet - 1 Tablet(s) by mouth twice a day \ndm\nROXICET - ___ Tablet - TAKE 2 BY MOUTH EVERY 4 HOURS AS \nNEEDED FOR FOR LBP\nSIMVASTATIN - 20 mg Tablet - 1 Tablet(s) by mouth once a day for \ncholesterol\nTRIAMCINOLONE ACETONIDE - 0.1 % Cream - apply twice a day \naffected area\n\n \nDischarge Medications:\n1. Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n2. Atenolol 25 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n3. Diazepam 5 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) \nas needed.  \n4. Simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n5. Camphor-Menthol 0.5-0.5 % Lotion Sig: One (1) Appl Topical \nQID (4 times a day) as needed.  \n6. Latanoprost 0.005 % Drops Sig: One (1) Drop Ophthalmic HS (at \nbedtime).  \n7. Insulin Glargine 100 unit/mL Cartridge Sig: One (1) 60 \nSubcutaneous at bedtime.  \n8. Levofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q24H (every \n24 hours) for 3 days.\nDisp:*3 Tablet(s)* Refills:*0*\n9. Lisinopril 40 mg Tablet Sig: One (1) Tablet PO once a day.  \n10. Hydrochlorothiazide 25 mg Tablet Sig: One (1) Tablet PO once \na day.  \n11. Glyburide 5 mg Tablet Sig: Three (3) Tablet PO once a day.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nFever.\n\n \nDischarge Condition:\nExcellent\n\n \nDischarge Instructions:\nyou came because of fever, shortness of breath, confusion, and \nalmost passing out. your tests suggested infection (we did not \nfind the source yet) and stress on the heart \"minor heart \nattack\". you felt well and decided to leave even though I \nadvised you to stay for more tests here in the hospital. You \nneed to have chemical stress test, Echocardiogram, CT of the \nabdomen (adrenal protocol), and CT of the chest in 3 months. I \nexplained to you the need for these tests. you decided to have \nthem done in the out patient setting. Please return to the \nhospital if you develop fever, shortness of breath, chest pain, \nor any concerning symptoms. Do not take metformin for now as you \nmay need contrast study ( CT with contrast). Ask your doctor \nwhen to resume it. follow up the results of the blood cultures \nwith your doctor as well.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048247fb505ee753934552"
  },
  "note_id": "19661870-DS-9",
  "subject_id": 19661870,
  "hadm_id": 28196463,
  "note_type": "DS",
  "note_seq": 9,
  "charttime": "2181-09-24 00:00:00",
  "storetime": "2181-09-24 10:03:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: CARDIOTHORACIC\n \nAllergies: \nIodine; Iodine Containing / Cardizem / Morphine / Vancomycin\n \nAttending: ___.\n \nChief Complaint:\npositive stress test- asymptomatic\n \nMajor Surgical or Invasive Procedure:\ncoronary artery bypass x 4 (LIMA-LAD, SVG-Dx2, SVG-OM, SVG-LPDA) \n___\n\n \nHistory of Present Illness:\n___ yo M with history of MI s/p PCI to\nLAD in ___ who was recently noted to have an abnormal stress\ntest during workup for right total hip replacement. Cardiac \ncatheterization reveals coronary artery disease.  The patient is \nreferred for surgical revascularization.\n\n \nPast Medical History:\nDM-II on lantus (intermittently takes ___\nCAD s/p MI ___\nHTN\nLow back pain\nglaucoma\nimpotence\ncurrent smoking\nperipheral neuropathy\ntrivial  MR\n___\n\n \nSocial History:\n___\nFamily History:\nFather-CAD\nMother-DM\n \nPhysical Exam:\nPhysical Exam\n\nPulse:73      Resp:16       O2 sat: 97%RA\nB/P  Right:173/77         Left:161/93 \n___     Weight:252 lbs\n\nGeneral:\nSkin: Dry [x] intact [x]\nHEENT: PERRLA [x] EOMI [x]\nNeck:  Supple [x] Full ROM [x]\nChest: Lungs clear bilaterally [x]\nHeart: RRR [x]  Irregular []  Murmur\nAbdomen: Soft [x] non-distended [x] non-tender [x]  bowel sounds\n+ [x]\nExtremities: Warm [x], well-perfused [x]  Edema -none\nVaricosities: None [x]\nNeuro: Grossly intact\nPulses:\nFemoral      Right: cath site  Left:+2\nDP           Right:  +2 Left:+2\n___           Right:+2   Left:+2\nRadial       Right:+2   Left:+2\n\nCarotid Bruit  -none      Right:  +2  Left:+2\n\n \nPertinent Results:\n___ 06:00AM BLOOD WBC-20.7* RBC-3.19* Hgb-8.0* Hct-24.1* \nMCV-76* MCH-25.1* MCHC-33.3 RDW-19.7* Plt ___\n___ 07:59AM BLOOD Glucose-228* UreaN-25* Creat-1.2 Na-138 \nK-3.7 Cl-102 HCO3-28 AnGap-12\n\n___ 04:30AM BLOOD WBC-15.7* RBC-3.34* Hgb-8.4* Hct-25.7* \nMCV-77* MCH-25.1* MCHC-32.6 RDW-19.8* Plt ___\n___ 04:30AM BLOOD Glucose-52* UreaN-25* Creat-1.2 Na-140 \nK-3.5 Cl-102 HCO3-30 AnGap-12\n\nPre Bypass: The left atrium is mildly dilated. No mass/thrombus \nis seen in the left atrium or left atrial appendage. No atrial \nseptal defect is seen by 2D or color Doppler. There is mild \nsymmetric left ventricular hypertrophy. The left ventricular \ncavity size is normal. Overall left ventricular systolic \nfunction is normal (LVEF>55%). Right ventricular chamber size \nand free wall motion are normal. There are simple atheroma in \nthe aortic arch. There are simple atheroma in the descending \nthoracic aorta. The aortic valve leaflets (3) are mildly \nthickened. There is a minimally increased gradient consistent \nwith minimal aortic valve stenosis. ___ calculates to 1.9 cm2 by \ncontinuity, but appears widely patent and has a plainemtery area \nof 2.4 cm2, limiting factor is likely LVOT diameter, which only \nmeasures 2.0-2.1 cm. Trace aortic regurgitation is seen. The \nmitral valve leaflets are mildly thickened. Mild (1+) mitral \nregurgitation is seen. There is no pericardial effusion.\n\nPost Bypass: Patient is on Phenylepherine and in sinus rhythm. \nBiventricular function is preserved, LVEF >55%, MR is 1+. Aoritc \ncontours intact. Remaining exam is unchanged. All findings \ndiscussedd with surgeons at the tiem of the exam.  \n \nBrief Hospital Course:\nThe patient was admitted and brought to the operating room on \n___ where he underwent coronary artery bypassx4 as detailed \nin the operativen note.  Intraoperatively, the patient developed \na reaction (rash and hypotension) to (likely) propofol.  He was \ntreated with pressors, steroids and benadryl and recovered \nappropriately.  Overall the patient tolerated the procedure well \nand post-operatively was transferred to the CVICU in critical \nbut stable condition for observation and recovery.  POD 1 found \nthe patient extubated, alert and oriented and breathing \ncomfortably.  He was neurologically intact and hemodynamically \nstable, on no inotropic or vasopressor support.  He does have a \nhistory of diabetes mellitus, and ___ was consulted for \nassistance with blood glucose management.  We appreciate their \nrecommendations.  The patient was transferred to telemetry on \nPOD 1.  Chest tubes and pacing wires were discontinued without \ncomplication.  On POD 4 the patient developed some serous \nsternal drainage without erythema.  He remained afebrile and WBC \nwere decreasing from steroid load.  Keflex and cipro were \nstarted and drainage significantly decreased by POD 5. He will \nbe maintained on antibiotics for a 10 day course with \ninstructions to call for fever, erythema, or increased drainage. \n  He was cleared by ___ and discharged to home with ___ services \nand appropriate follow up instructions on POD 4. \n \nMedications on Admission:\nMetformin 1000mg bid\nroxicet PRN for back pain\nTiramcinolone acetonide cream PRN (eczema)\nAtenolol 25mg daily\nLisinopril 40mg daily\nGlyburide 5mg 3 tablets in the am\nSimvastatin 20mg daily\nHCTZ 25mg daily\nLantus 20 Units at hs\nXalatan eye gtt 1 gtt ___\nAspirin 325mg-on hold pre surgery\n\n \nDischarge Medications:\n1. Simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n2. Aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1) \nTablet, Delayed Release (E.C.) PO DAILY (Daily).  \n3. Oxycodone-Acetaminophen ___ mg Tablet Sig: ___ Tablets PO \nQ4H (every 4 hours) as needed for pain.\nDisp:*60 Tablet(s)* Refills:*0*\n4. Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily) for 1 months.\nDisp:*30 Tablet(s)* Refills:*0*\n5. Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every \n4 hours) as needed for pain.  \n6. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).  \n7. Furosemide 40 mg Tablet Sig: One (1) Tablet PO twice a day \nfor 2 weeks.\nDisp:*28 Tablet(s)* Refills:*0*\n8. Potassium Chloride 20 mEq Tab Sust.Rel. Particle/Crystal Sig: \nOne (1) Tab Sust.Rel. Particle/Crystal PO Q12H (every 12 hours) \nfor 2 weeks.\nDisp:*28 Tab Sust.Rel. Particle/Crystal(s)* Refills:*0*\n9. Cephalexin 500 mg Capsule Sig: One (1) Capsule PO Q6H (every \n6 hours) as needed for sternal drainage for 9 days.\nDisp:*36 Capsule(s)* Refills:*0*\n10. Lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).\nDisp:*30 Tablet(s)* Refills:*0*\n11. Ciprofloxacin 250 mg Tablet Sig: Two (2) Tablet PO Q12H \n(every 12 hours) for 9 days.\nDisp:*36 Tablet(s)* Refills:*0*\n12. Metoprolol Tartrate 50 mg Tablet Sig: Three (3) Tablet PO \nTID (3 times a day).\nDisp:*270 Tablet(s)* Refills:*2*\n13. Glyburide 5 mg Tablet Sig: Two (2) Tablet PO BID (2 times a \nday).\nDisp:*120 Tablet(s)* Refills:*2*\n14. Insulin Lispro 100 unit/mL Solution Sig: One (1)  \nSubcutaneous four times a day: SLIDING SCALE.\nDisp:*QS * Refills:*2*\n15. Insulin Glargine 100 unit/mL Solution Sig: Sixty (60) units \nSubcutaneous breakfast.\nDisp:*qs * Refills:*2*\n16. Insulin Glargine 100 unit/mL Solution Sig: Twenty (20) units \nSubcutaneous at bedtime.\nDisp:*qs * Refills:*2*\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \n___ Diagnosis:\ncoronary artery disease, s/p coronary artery bypass this \nadmission\n\n \nDischarge Condition:\ngood\n\n \nDischarge Instructions:\nPlease shower daily including washing incisions, no baths or \nswimming \nMonitor wounds for infection - redness, drainage, or increased \npain \nReport any fever greater than 101 \nReport any weight gain of greater than 2 pounds in 24 hours or 5 \npounds in a week \nNo creams, lotions, powders, or ointments to incisions \nNo driving for approximately one month, and while taking \nnarcotics \nNo lifting more than 10 pounds for 10 weeks \nPlease call with any questions or concerns ___\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904821ffb505ee75391161d"
  },
  "note_id": "15356190-DS-2",
  "subject_id": 15356190,
  "hadm_id": 21683415,
  "note_type": "DS",
  "note_seq": 2,
  "charttime": "2134-09-08 00:00:00",
  "storetime": "2134-09-08 08:32:00",
  "text": " \nName:  ___.              Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: ORTHOPAEDICS\n \nAllergies: \npotassium / Vytorin / warfarin / Advil / aspirin\n \nAttending: ___.\n \nChief Complaint:\nright hip pain\n \nMajor Surgical or Invasive Procedure:\nright THA\n\n \nHistory of Present Illness:\n___ y/o F with severe right hip OA, here for definitive treatment \nin the form of a right THA with Dr. ___.\n \nPast Medical History:\ncarotid stenosis, HTN, ischemic heart dz s/p stenting, 4.2cm \nAAA, OSA, history of PE, spinal stenosis, reflux, colon CA, CKD \nstage 3, \n\n \nSocial History:\n___\nFamily History:\nn/c\n \nPhysical Exam:\nWell appearing in no acute distress  \nAfebrile with stable vital signs  \nPain well-controlled  \nRespiratory: CTAB  \nCardiovascular: RRR  \nGastrointestinal: NT/ND  \nGenitourinary: Voiding independently  \nNeurologic: Intact with no focal deficits  \nPsychiatric: Pleasant, A&O x3  \nMusculoskeletal Lower Extremity:  \n* Incision healing well with Aquacel dressing with scant \nserosanguinous drainage  \n* Thigh full but soft  \n* No calf tenderness  \n* ___ strength  \n* SILT, NVI distally  \n* Toes warm\n\n \nPertinent Results:\n___ 05:50AM BLOOD WBC-15.2* RBC-2.89* Hgb-8.7* Hct-26.9* \nMCV-93 MCH-30.1 MCHC-32.3 RDW-13.9 RDWSD-47.2* Plt ___\n___ 05:30AM BLOOD WBC-11.2* RBC-3.37* Hgb-10.1* Hct-31.2* \nMCV-93 MCH-30.0 MCHC-32.4 RDW-13.5 RDWSD-45.9 Plt ___\n___ 05:30AM BLOOD Glucose-173* UreaN-24* Creat-1.2* Na-140 \nK-4.8 Cl-99 HCO3-23 AnGap-18\n___ 05:30AM BLOOD Calcium-9.2 Phos-3.3 Mg-1.8\n \nBrief Hospital Course:\nThe patient was admitted to the orthopedic surgery service and \nwas taken to the operating room for above described procedure. \nPlease see separately dictated operative report for details. The \nsurgery was uncomplicated and the patient tolerated the \nprocedure well. Patient received perioperative IV antibiotics.\n\nPostoperative course was remarkable for the following:\nPOD#1: Patient with pain well controlled. No overnight issues. \nWorked well with ___. Labs were WNL. Patient reported mild issues \nswallowing. Speech/swallow consult obtained, and reported that \nit is likely GI/GERD related. Will continue to monitor.\nPOD#2: Patient cleared ___ and was discharged to rehab in stable \ncondition.  \n\nOtherwise, pain was controlled with a combination of IV and oral \npain medications.  The patient received Aspirin 81 mg twice \ndaily for DVT prophylaxis starting on the morning of POD#1.  The \nAquacel dressing remained clean and intact without erythema or \nabnormal drainage/saturation. The patient was seen daily by \nphysical therapy. Labs were checked throughout the hospital \ncourse and repleted accordingly. At the time of discharge, the \npatient was tolerating a regular diet and feeling well.  The \npatient was afebrile with stable vital signs.  The patient's \nhematocrit was acceptable and pain was adequately controlled on \nan oral regimen. The operative extremity was neurovascularly \nintact.\n  \nThe patient's weight-bearing status is weight bearing as \ntolerated on the operative extremity. Please use walker or 2 \ncrutches for as long as you need. They physical therapist will \nhelp guide you until you are safe to wean from assistive \ndevices.\n  \nMrs. ___ is discharged to rehab in stable condition.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Atenolol 25 mg PO QHS \n2. Furosemide 20 mg PO DAILY \n3. OxyCODONE--Acetaminophen (5mg-325mg) 1 TAB PO DAILY:PRN Pain \n- Moderate \n4. Omeprazole 20 mg PO DAILY \n5. Aspirin EC 81 mg PO DAILY \n6. Vitamin D 1000 UNIT PO DAILY \n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q8H \nRX *acetaminophen 500 mg 2 tablet(s) by mouth every ___ hours Disp \n#*100 Tablet Refills:*0 \n2.  Apixaban 2.5 mg PO BID \nRX *apixaban [Eliquis] 2.5 mg 1 tablet(s) by mouth twice daily \nDisp #*60 Tablet Refills:*0 \n3.  Docusate Sodium 100 mg PO BID \nRX *docusate sodium 100 mg 1 tablet(s) by mouth twice daily Disp \n#*60 Tablet Refills:*0 \n4.  OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain \nRX *oxycodone 5 mg 1 tablet(s) by mouth every ___ Disp #*10 \nTablet Refills:*0 \n5.  Senna 8.6 mg PO BID \nRX *sennosides 8.6 mg 1 tablet by mouth twice daily Disp #*60 \nTablet Refills:*0 \n6.  Aspirin EC 81 mg PO DAILY  \n7.  Atenolol 25 mg PO QHS  \n8.  Furosemide 20 mg PO DAILY  \n9.  Omeprazole 20 mg PO DAILY  \n10.  Vitamin D 1000 UNIT PO DAILY  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___      \n \nDischarge Diagnosis:\nright hip OA\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\n1. Please return to the emergency department or notify your \nphysician if you experience any of the following: severe pain \nnot relieved by medication, increased swelling, decreased \nsensation, difficulty with movement, fevers greater than 101.5, \nshaking chills, increasing redness or drainage from the incision \nsite, chest pain, shortness of breath or any other concerns.\n  \n2. Please follow up with your primary physician regarding this \nadmission and any new medications and refills. \n  \n3. Resume your home medications unless otherwise instructed.\n  \n4. You have been given medications for pain control. Please do \nnot drive, operate heavy machinery, or drink alcohol while \ntaking these medications. As your pain decreases, take fewer \ntablets and increase the time between doses. This medication can \ncause constipation, so you should drink plenty of water daily \nand take a stool softener (such as Colace) as needed to prevent \nthis side effect.  Call your surgeons office 3 days before you \nare out of medication so that it can be refilled.  These \nmedications cannot be called into your pharmacy and must be \npicked up in the clinic or mailed to your house.  Please allow \nan extra 2 days if you would like your medication mailed to your \nhome.\n  \n5. You may not drive a car until cleared to do so by your \nsurgeon.\n  \n6. Please call your surgeon's office to schedule or confirm your \nfollow-up appointment.\n  \n7. SWELLING: Ice the operative joint 20 minutes at a time, \nespecially after activity or physical therapy. Do not place ice \ndirectly on the skin. \n  \n8. ANTICOAGULATION: Please continue your Eliquis 2.5mg twice \ndaily for four (4) weeks to help prevent deep vein thrombosis \n(blood clots).  \n  \n9. WOUND CARE: Please keep your incision clean and dry. It is \nokay to shower after surgery while wearing your aquacel \ndressing, but no tub baths, swimming, or submerging your \nincision until after your first checkup and cleared by your \nsurgeon. After the aquacel dressing is removed 7 days after your \nsurgery, you may leave the wound open to air. Check the wound \nregularly for signs of infection such as redness or thick yellow \ndrainage and promptly notify your surgeon of any such findings \nimmediately.\n  \n10. ___ (once at home): Home ___, Aquacel removal POD#7, and \nwound checks. If there are suture tags on either end of the \nincision left, please cut the tags flush with the skin on both \nsides on POD#7, when the Aquacel is removed.\n  \n11. ACTIVITY: Weight bearing as tolerated with two crutches or \nwalker for as long as you need. The physical therapist will help \nguide you until you are safe to wean from assistive devices. \nPosterior hip precautions. No strenuous exercise or heavy \nlifting until follow up appointment.  Mobilize frequently. \nPhysical Therapy:\nWBAT RLE\nPosterior hip precautions \nMobilize frequently\nWean assistive devices as able\nTreatments Frequency:\nremove aquacel POD#7 after surgery\napply dry sterile dressing daily if needed after aquacel \ndressing is removed\nwound checks daily after aquacel removed\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fa6de"
  },
  "note_id": "12530259-DS-16",
  "subject_id": 12530259,
  "hadm_id": 27737414,
  "note_type": "DS",
  "note_seq": 16,
  "charttime": "2185-08-28 00:00:00",
  "storetime": "2185-08-28 09:18:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: UROLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nprostate cancer\n \nMajor Surgical or Invasive Procedure:\nRobot-assisted laparoscopic radical prostatectomy.\n\n \nHistory of Present Illness:\n___ w T1c prostate cancer (PSA 7.4) ___ score 7 involving \n___ cores right (apex) (8% and 10% involved). TRUS-measured \nprostate size was 46cc.  He admits significant LUTS with an \nAUASI = 22 despite\nuroxatral and is not sexually active.\n\n \nPast Medical History:\nPMH: HTN, obesity, DM (A1c 8.3), smoking, COPD, OSA, GERD, \nPeptic Ulcers, ?dementia?\n\n \nSocial History:\n___\nFamily History:\nnc\n \nPhysical Exam:\nPhysical Exam on Date of Discharge:\n\nWdWn male, NAD, AVSS\nInteractive, cooperative\nAbdomen soft, appropriately tender along incisions\nIncisions c/d/i w/out evidence hematoma, infection\nExtremities w/out edema or pitting and no report of calf pain\nFoley catheter in place, secured to medial thigh; urine \nyellow/pink and clear\n\n \nPertinent Results:\n___ 06:20AM BLOOD Glucose-97 UreaN-17 Creat-1.2 Na-138 \nK-4.8 Cl-104 HCO3-26 AnGap-___RIEF HOSPITAL COURSE\n\nMr. ___ was admitted to the Urology Service after undergoing \nrobotic assisted laparoscopic prostatectomy. No concerning \nintra-operative events occurred; please see dictated operative \nnote for full details.  The patient received ___ \nantibiotic prophylaxis.  At the end of the procedure the patient \nwas extubated and transported to the PACU for further recovery \nbefore being transferred to the floor.  He was transferred from \nthe PACU in stable condition. On POD0, pain was well controlled \non PCA, hydrated with intravenous fluids for urine output \n>30cc/hour, provided with pneumoboots and incentive spirometry \nfor prophylaxis, and he ambulated once. On POD1, the patient was \nrestarted on home medications, basic metabolic panel and \ncomplete blood count were checked, pain control was transitioned \nfrom PCA to oral analgesics, diet was advanced to a clears/toast \nand crackers diet for breakfast and lunch.  Diet was advanced to \nregular after lunch and with further ambulation, the JP drain \nwas removed.  Foley catheter care and leg bag teaching was \nprovided by nursing. The remainder of the hospital course was \nunremarkable. The patient was discharged in stable condition, \neating well, ambulating independently, and with pain control on \noral analgesics. On exam, incision was clean, dry, and intact, \nwith no evidence of hematoma collection or infection. The \npatient was given explicit instructions to ___ in one week \nfor post-operative evaluation and trial of voiding.\n \nMedications on Admission:\nASA 325'\nActos 15'\nMetformin 1000\"\nLantus 8 QPM\nAmlodipine 10'\ncarvedilol 12.5'\nDiovan 320'\nHCTZ 25'\nZocor 10'\nSpironolactone 50'\nPrilosec 40\"\nAricept 10'\nNamenda 10\"\nZoloft 100'\n\n \nDischarge Medications:\n1. bacitracin zinc 500 unit/g Ointment Sig: One (1) Appl Topical \nTID (3 times a day).  \n2. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day.\nDisp:*60 Capsule(s)* Refills:*2*\n3. hydrocodone-acetaminophen ___ mg Tablet Sig: One (1) Tablet \nPO Q4H (every 4 hours) as needed for breakthrough pain only \n(score>4).\nDisp:*40 Tablet(s)* Refills:*0*\n4. acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \nhours) as needed for pain, fever>100.  \n5. nicotine 14 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr \nTransdermal DAILY (Daily).  \n6. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday).  \n7. carvedilol 12.5 mg Tablet Sig: One (1) Tablet PO twice a day. \n \n8. Namenda 10 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday).  \n9. Aricept 10 mg Tablet Sig: One (1) Tablet PO at bedtime.  \n10. simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n11. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2) \nCapsule, Delayed Release(E.C.) PO BID (2 times a day).  \n12. Diovan HCT ___ mg Tablet Sig: One (1) Tablet PO once a \nday.  \n13. sertraline 50 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n14. metformin 1,000 mg Tablet Sig: One (1) Tablet PO BID (2 \ntimes a day).  \n15. pioglitazone 15 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n16. spironolactone 50 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n17. URAXATRAL\nYOU NO LONGER NEED THIS MEDICATION AS YOUR PROSTATE HAS BEEN \nREMOVED.\n18. Lantus 100 unit/mL Solution Sig: Eight (8) UNITS \nSubcutaneous at bedtime: RESUME pre-admission monitoring and \ndosing.  \n19. SLIDING SCALE INSULIN\nRESUME PRE-ADMISSION GLUCOSE MONITORING AND INSULIN \nDOSING/TITRATION.\n20. Keflex ___ mg Capsule Sig: One (1) Capsule PO three times a \nday for 5 days.\nDisp:*15 Capsule(s)* Refills:*0*\n21. Cipro 500 mg Tablet Sig: One (1) Tablet PO twice a day for 3 \ndays: Start taking on day PRIOR to scheduled Foley removal.\nDisp:*6 Tablet(s)* Refills:*0*\n22. ibuprofen 600 mg Tablet Sig: One (1) Tablet PO three times a \nday as needed for pain.\nDisp:*40 Tablet(s)* Refills:*0*\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPREOPERATIVE DIAGNOSIS:  Prostate cancer.\n\n \nDischarge Condition:\nMental Status: Confused - always (dementia)\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance of cane at \nbaseline\n\n \nDischarge Instructions:\n-please discuss resuming your ASPIRIN with Dr. ___ at your \n___ appointment\n\n-Please also reference the additional handout provided by Dr. \n___  with instructions and information about your surgery and \npost-operative plan of care.\n\n-Resume your pre-admission/home medications except as noted. \nAlways call to inform, review and discuss any medication changes \nand your post-operative course with your primary care doctor\n\n-___ you have been prescribed IBUPROFEN, please note that you may \ntake this in addition to the prescribed NARCOTIC pain \nmedications and/or tylenol.    FIRST, alternate Tylenol \n(acetaminophen) and Ibuprofen for pain control.  \n\n-REPLACE the Tylenol with the prescribed narcotic if the \nnarcotic is combined with Tylenol (examples include brand names \n___, Tylenol #3 w/ codeine and their generic \nequivalents).  ALWAYS discuss your medications (especially when \nusing narcotics or new medications) use with the pharmacist when \nyou first retrieve your prescription if you have any questions.  \n  Use the narcotic pain medication for break-through pain that \nis >4 on the pain scale.\n\n-The MAXIMUM dose of Tylenol (ACETAMINOPHEN) is 4 grams (from \nALL sources) PER DAY and remember that the prescribed narcotic \npain medication may also contain Tylenol (acetaminophen) so this \nneeds to be considered when monitoring your daily dose and \nmaximum.\n\n-If you are taking Ibuprofen (Brand names include ___ \nthis should always be taken with food.  If you develop stomach \npain or note black stool, stop the Ibuprofen.  Ibuprofen works \nbest when taken around the clock.\n\n-Please do NOT drive, operate dangerous machinery, or consume \nalcohol while taking narcotic pain medications.\n\n-As stated, you may resume your pre-admission medications except \nas noted but you no longer need to take medications that shrink \nyour prostate (Hytrin, Avodart, etc.) unless advised to continue \nthem by the urologist\n\n-Please AVOID aspirin or aspirin containing products unless \notherwise advised.\n\n-For your safety and the safety of others; PLEASE DO NOT drive, \noperate dangerous machinery, or consume alcohol while taking \nnarcotic pain medications. Do NOT drive while Foley catheter/Leg \nbag are in place.\n\n-Colace has been prescribed to avoid post surgical constipation \nand constipation related to narcotic pain medication. \nDiscontinue if loose stool or diarrhea develops. Colace is a \nstool softener--it is NOT a laxative.\n\n-You may shower 2 days after surgery, but do not tub bathe, \nswim, soak, or scrub incision for 2 weeks\n\n-If you had a drain removed from your abdomen, bandage strips \ncalled steristrips have been applied to close the wound. Allow \nthese bandage strips to fall off on their own over time but \nplease REMOVE the gauze dressing in 2 days. You may get the \nsteristrips wet.\n\n-No heavy lifting for 4 weeks (no more than 10 pounds)\n\n-Your Foley should be secured to the catheter secure on your \nthigh at ALL times until your follow up with the surgeon.\n\n-Follow up in 1 week for wound check and Foley removal. DO NOT \nhave anyone else other than your Surgeon remove your Foley for \nany reason.\n\n-Wear Large Foley bag for majority of time, leg bag is only for \nshort-term when leaving house.\n\n-Start prescribed antibiotic (Ciprofloxacin) 1 day prior to \nscheduled Foley catheter removal and for two subsequent days\n\n-resume your regular home diet and remember to drink plenty of \nfluids to keep hydrated and to prevent constipation\n\n-___ medical attention for fevers (temp>101.5), worsening pain, \ndrainage or excessive bleeding from incision, chest pain or \nshortness of breath.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fa6df"
  },
  "note_id": "12530259-DS-17",
  "subject_id": 12530259,
  "hadm_id": 29073563,
  "note_type": "DS",
  "note_seq": 17,
  "charttime": "2185-09-02 00:00:00",
  "storetime": "2185-09-06 11:01:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: UROLOGY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\ns/p traumatic foley removal after prostatectomy\n \nMajor Surgical or Invasive Procedure:\nNONE\n\n \nHistory of Present Illness:\nMr. ___ presented to ___ clinic the morning of admission.  \nHe has some baseline cognitive impairment and reportedly awoke \nmildly confused and unfortunately, he pulled his Foley catheter \nout with the balloon\nstill inflated.  This was postoperative day #5 from his radical \nprostatectomy.  \n\n \nPast Medical History:\nPMH: HTN, obesity, DM (A1c 8.3), smoking, COPD, OSA, GERD, \nPeptic Ulcers, ?dementia?\n\n \nSocial History:\n___\nFamily History:\n___\n \nPhysical Exam:\nPhysical Exam on Date of Discharge:\nWdWn male, NAD, AVSS\nconfused at times but pleasant and alert, interactive, \ncooperative\nAbdomen soft, minimaly tender along incisions which are c/d/i \nw/out evidence hematoma, infection\nExtremities w/out edema or pitting and no report of calf pain\n\n \nPertinent Results:\n___ 09:22AM BLOOD WBC-5.0 RBC-3.90* Hgb-10.1* Hct-29.9* \nMCV-77* MCH-26.0* MCHC-33.8 RDW-16.4* Plt ___\n___ 03:40PM BLOOD WBC-4.5 RBC-3.72* Hgb-9.5* Hct-28.9* \nMCV-78* MCH-25.4* MCHC-32.7 RDW-17.1* Plt ___\n___ 09:22AM BLOOD Glucose-182* UreaN-17 Creat-1.4* Na-134 \nK-4.2 Cl-100 HCO3-28 AnGap-10\n___ 03:40PM BLOOD Glucose-153* UreaN-18 Creat-1.4* Na-138 \nK-4.2 Cl-101 HCO3-28 AnGap-13\n___:22AM BLOOD Calcium-9.3 Mg-2.0\n \nBrief Hospital Course:\nMr. ___ presented to ___ clinic the morning of admission.  \nHe has some baseline cognitive impairment and reportedly awoke \nmildly confused and unfortunately, he pulled his Foley catheter \nout with the balloon\nstill inflated.  This was postoperative day #5 from his radical \nprostatectomy.  \n\nUpon presentation, he was clearly incontinent as marked by his \npants, which were stained with urine leakage. He did not \ncomplain of any pain or discomfort.  He \ndescribed the desire to void and so was taken to the restroom \nwhile in clinic. There, he voided a small amount and we scanned \nhis bladder, which showed 0 residual, suggesting that he was in \nfact emptying his bladder well.  \n\nHe was admitted to the urology service for observation and a \nshort course of antibiotics given the traumatic nature of the \nFoley catheter removal.  We will also\ncheck his creatinine and obtain a pelvic ultrasound to rule out \na collection related to anastomotic leak. His hospital course \nwas essentially unremarkable and he was discharged on hospital \nday two.  He was able to void well independently but did have \nsome incontinence with walking about and overnight but otherwise \nwas doing well. His bladder was scanned several times and the \npost void residuals were minimal each time (less than 50cc) \nregardless of volume voided. \n \nMedications on Admission:\nDischarge Medications:\n1. bacitracin zinc 500 unit/g Ointment Sig: One (1) Appl Topical \n\nTID (3 times a day).  \n2. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day.\nDisp:*60 Capsule(s)* Refills:*2*\n3. hydrocodone-acetaminophen ___ mg Tablet Sig: One (1) Tablet \n\nPO Q4H (every 4 hours) as needed for breakthrough pain only \n(score>4).\nDisp:*40 Tablet(s)* Refills:*0*\n4. acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \nhours) as needed for pain, fever>100.  \n5. nicotine 14 mg/24 hr Patch 24 hr Sig: One (1) Patch 24 hr \nTransdermal DAILY (Daily).  \n6. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday).  \n7. carvedilol 12.5 mg Tablet Sig: One (1) Tablet PO twice a day. \n\n \n8. Namenda 10 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday).  \n9. Aricept 10 mg Tablet Sig: One (1) Tablet PO at bedtime.  \n10. simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n11. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2) \n\nCapsule, Delayed Release(E.C.) PO BID (2 times a day).  \n12. Diovan HCT ___ mg Tablet Sig: One (1) Tablet PO once a \nday.  \n13. sertraline 50 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n14. metformin 1,000 mg Tablet Sig: One (1) Tablet PO BID (2 \ntimes a day).  \n15. pioglitazone 15 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n16. spironolactone 50 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n17. URAXATRAL\nYOU NO LONGER NEED THIS MEDICATION AS YOUR PROSTATE HAS BEEN \nREMOVED.\n18. Lantus 100 unit/mL Solution Sig: Eight (8) UNITS \nSubcutaneous at bedtime: RESUME pre-admission monitoring and \ndosing.  \n19. SLIDING SCALE INSULIN\nRESUME PRE-ADMISSION GLUCOSE MONITORING AND INSULIN \nDOSING/TITRATION.\n20. Keflex ___ mg Capsule Sig: One (1) Capsule PO three times a \nday for 5 days.\nDisp:*15 Capsule(s)* Refills:*0*\n21. Cipro 500 mg Tablet Sig: One (1) Tablet PO twice a day for 3 \n\ndays: Start taking on day PRIOR to scheduled Foley removal.\nDisp:*6 Tablet(s)* Refills:*0*\n22. ibuprofen 600 mg Tablet Sig: One (1) Tablet PO three times a \n\nday as needed for pain.\nDisp:*40 Tablet(s)* Refills:*0*\n\n \nDischarge Medications:\n1. acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO Q6H (every \n6 hours) as needed for pain, fever.  \n2. pioglitazone 15 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n3. metformin 500 mg Tablet Sig: Two (2) Tablet PO BID (2 times a \nday).  \n4. amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  \n\n5. carvedilol 6.25 mg Tablet Sig: Two (2) Tablet PO BID (2 times \na day).  \n6. valsartan 160 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). \n \n7. hydrochlorothiazide 12.5 mg Capsule Sig: Two (2) Capsule PO \nDAILY (Daily).  \n8. spironolactone 25 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n9. simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n10. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2) \nCapsule, Delayed Release(E.C.) PO BID (2 times a day).  \n11. donepezil 5 mg Tablet Sig: Two (2) Tablet PO HS (at \nbedtime).  \n12. Namenda 10 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday).  \n13. sertraline 50 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n14. insulin glargine 100 unit/mL Solution Sig: Zero (0)  \nSubcutaneous HS (at bedtime): RESUME PRE ADMISSION INSULIN \nREGIMEN AND MONITORING.  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\ns/p prostatectomy with traumatic foley removal\n\n \nDischarge Condition:\nMental Status: Confused - always (dementia)\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance of cane at \nbaseline\n\n \nDischarge Instructions:\n-please discuss resuming your ASPIRIN with Dr. ___ at your \n___ appointment\n\n-Please also reference the additional handout provided by Dr. \n___  with instructions and information about your surgery and \npost-operative plan of care.\n\n-Resume your pre-admission/home medications except as noted. \nAlways call to inform, review and discuss any medication changes \n\nand your post-operative course with your primary care doctor\n\n-___ you have been prescribed IBUPROFEN, please note that you may \n\ntake this in addition to the prescribed NARCOTIC pain \nmedications and/or tylenol.    FIRST, alternate Tylenol \n(acetaminophen) and Ibuprofen for pain control.  \n\n-REPLACE the Tylenol with the prescribed narcotic if the \nnarcotic is combined with Tylenol (examples include brand names \n___, Tylenol #3 w/ codeine and their generic \nequivalents).  ALWAYS discuss your medications (especially when \nusing narcotics or new medications) use with the pharmacist when \n\nyou first retrieve your prescription if you have any questions.  \n\n  Use the narcotic pain medication for break-through pain that \nis >4 on the pain scale.\n\n-The MAXIMUM dose of Tylenol (ACETAMINOPHEN) is 4 grams (from \nALL sources) PER DAY and remember that the prescribed narcotic \npain medication may also contain Tylenol (acetaminophen) so this \n\nneeds to be considered when monitoring your daily dose and \nmaximum.\n\n-If you are taking Ibuprofen (Brand names include ___ \n\nthis should always be taken with food.  If you develop stomach \npain or note black stool, stop the Ibuprofen.  Ibuprofen works \nbest when taken around the clock.\n\n-Please do NOT drive, operate dangerous machinery, or consume \nalcohol while taking narcotic pain medications.\n\n-As stated, you may resume your pre-admission medications except \n\nas noted but you no longer need to take medications that shrink \nyour prostate (Hytrin, Avodart, etc.) unless advised to continue \n\nthem by the urologist\n\n-Please AVOID aspirin or aspirin containing products unless \notherwise advised.\n\n-For your safety and the safety of others; PLEASE DO NOT drive, \noperate dangerous machinery, or consume alcohol while taking \nnarcotic pain medications. Do NOT drive while Foley catheter/Leg \n\nbag are in place.\n\n-Colace has been prescribed to avoid post surgical constipation \nand constipation related to narcotic pain medication. \nDiscontinue if loose stool or diarrhea develops. Colace is a \nstool softener--it is NOT a laxative.\n\n-You may shower 2 days after surgery, but do not tub bathe, \nswim, soak, or scrub incision for 2 weeks\n\n-No heavy lifting for 4 weeks (no more than 10 pounds)\n\n-resume your regular home diet and remember to drink plenty of \nfluids to keep hydrated and to prevent constipation\n\n-___ medical attention for fevers (temp>101.5), worsening pain, \n\ndrainage or excessive bleeding from incision, chest pain or \nshortness of breath.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fa6e0"
  },
  "note_id": "12530259-DS-18",
  "subject_id": 12530259,
  "hadm_id": 20391336,
  "note_type": "DS",
  "note_seq": 18,
  "charttime": "2186-04-21 00:00:00",
  "storetime": "2186-04-24 12:41:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nAltered Mental Status\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nPatient is a ___ yo man with ah history of dementia, iron def \nanemia, HL, DM  who is admitted for evaluation of his increased \nconfusion.  By report he has been having worsening confusion for \nthe past 6 months, but earlier today the patient took the keys \nto his car and was found by police driving around ___.  He \napparently thought he was late for work.  He was brought into \nthe emergency department where a CXR demonstrated a LUL \nconsolidation concerning for pneumonia.  By his report, \nconfirmed with his wife, he has had a dry cough for the past \nseveral months with a constant level of sputum production that \nhas not worsened in the last several days or weeks.  He denies \nany fevers, chills, SOB, chest pressure or pleuritic pain.  He \nis an active smoker smoking a bag of pipe tobacco a week and has \nbeen smoking a least a PPD since the age of ___.  Additional note \nis made of weightloss of ___ lbs in the last several months \nfor which he has undergone a significant GI work up with \ncolonoscopy and endoscopy which showed small angioectasias in \nthe stomach and doudenum s/p electrocautery.  \n  \nIn the ED, initial vs were 98.5, 165/77, 65, 20, 98%.  A CXR \nshowed a LUL pneumonia and NCHCT with no acute process.  He was \ngiven levofloxacin and admitted for further evaluation.\n.\nOn arrival to the floor, patient reports no cough or dyspnea and \nis resting comfortably on room air.  \n.  \nROS\nDenies fever, chills, night sweats, headache, vision changes, \nrhinorrhea, congestion, sore throat, shortness of breath, chest \npain, abdominal pain, nausea, vomiting, diarrhea, constipation, \nBRBPR, melena, hematochezia, dysuria, hematuria. \nAll other 10-system review negative in detail.  \n\n \nPast Medical History:\n- Iron-deficiency anemia\n- angioectasias in the distal small bowel\n- Hyperlipidemia\n- Hypertension\n- Diabetes\n- Dementia\n- COPD\n- OSA\n- GERD \n- Peptic Ulcers\n\n \nSocial History:\n___\nFamily History:\nnc\n \nPhysical Exam:\nADMISSION EXAM:\nVS 98.9, 172/84, 74, 18 98RA\nGEN Alert, oriented to person and hospital, no acute distress  \nHEENT NCAT MMM EOMI sclera anicteric, OP clear  \nNECK supple, no JVD, no LAD  \nPULM Good aeration, no wheezes or crackles, ronchi at the mid \nback bilaterally\nCV RRR normal S1/S2, no mrg\nABD soft NT ND normoactive bowel sounds, no r/g \nEXT WWP 2+ pulses palpable bilaterally, no c/c/e\nNEURO CNs2-12 intact, motor function grossly normal  \nSKIN no ulcers or lesions\n\nDISCHARGE EXAM:\nVS 97.9, 152/84, 66, 18 97RA\nGEN Alert, oriented to person and hospital, no acute distress  \nHEENT NCAT MMM EOMI sclera anicteric, OP clear  \nNECK supple, no JVD, no LAD  \nPULM Good aeration, no wheezes or crackles, ronchi at the mid \nback bilaterally\nCV RRR normal S1/S2, no mrg\nABD soft NT ND normoactive bowel sounds, no r/g \nEXT WWP 2+ pulses palpable bilaterally, no c/c/e\nNEURO CNs2-12 intact, motor function grossly normal  \nSKIN no ulcers or lesions\n\n \nPertinent Results:\nLABS:\n___ 10:15AM BLOOD WBC-5.9# RBC-3.49* Hgb-8.6* Hct-28.6* \nMCV-82 MCH-24.7* MCHC-30.2* RDW-17.1* Plt ___\n___ 10:15AM BLOOD Neuts-77.4* Lymphs-15.7* Monos-5.7 \nEos-0.8 Baso-0.4\n___ 10:15AM BLOOD Glucose-108* UreaN-16 Creat-1.1 Na-141 \nK-3.6 Cl-105 HCO3-25 AnGap-15\n___ 06:45AM BLOOD Calcium-9.1 Phos-3.4 Mg-2.0\n\nNCHCT: \nFINDINGS: There is no evidence of hemorrhage, edema, mass \neffect, or acute large vascular territory infarction. The \nventricles and sulci are prominent suggesting age-related volume \nloss. Periventricular confluent white matter hypodensities are \nconsistent with chronic small vessel ischemic disease. The basal \ncisterns are patent. No fracture is identified. The visualized \nparanasal sinuses, mastoid air cells, and middle ear cavities \nare clear. \nIMPRESSION: \n1. No acute intracranial process. \n2. Age-related volume loss and small vessel ischemic disease. \n\nCXR:  \nFINDINGS: In the left perihilar region, there is a hazy \nopacification \nconsistent with pneumonia. There is no pulmonary edema, pleural \neffusion, or pneumothorax. The cardiomediastinal silhouette is \nnormal. There is elevation of the left hemidiaphragm, which is \nstable from the prior exam.  \nIMPRESSION: Left perihilar pneumonia. Recommend followup \nradiographs after treatment to ensure resolution. \n\nCHEST CT W/ CONTRAST:\nFINDINGS: There is a 4-cm area of consolidation in the superior \nsegment of the left lower lobe suggestive pneumonia. No \nunderlying masses identified.  Formation of air bronchograms and \nencasement of the left lower lobe pulmonary artery, without \nfilling defects. Surrounding ground-glass opacities extend to \nthe pleural surfaces.  \n  \nSpiculated nodules in the upper lobes, measuring 1.3 x 0.7 cm on \nthe left \n(4:39) and 0.7 x 0.3 cm on the right (4:42). 2-mm smoothly \nmarginated solid nodule in the right upper lobe (4:49), 2-3 mm \nperifissural nodules in the right middle lobe (4:119-120), \nrounded ground-glass opacity in the superior segment of the \nright lower lobe (4:109), and 5-mm ground-glass nodule in the \nleft upper lobe (4:37).  \n \nThere is moderate, apical-predominant centrilobular/paraseptal \nemphysema and pleural parenchymal scarring. Diffuse mild \nperibronchial wall thickening, particularly in the middle and \nlower lobes. No obstructing endobronchial masses.  \n  \nIn the left lung apex, focal pleural irregularity and \ncalcification suggesting chronic disease. No pleural effusions. \n  \nProminent 9-mm subcarinal and 6-mm precarinal lymph nodes are \nlikely reactive but can be reevaluated with follow-up CT.  \n  \nHeart is normal in size, without pericardial effusion. Calcific \natherosclerosis throughout the thoracic aorta and coronary \narteries. The \ncentral pulmonary arteries are unremarkable. \n  \nExamination is not tailored for subdiaphragmatic evaluation, but \nreveals a 1.7-cm exophytic cyst in hepatic segment III. \n  \nMultilevel degenerative changes in the thoracic spine. \n  \nIMPRESSION: Findings consistent with left lower lobe pneumonia \nand pulmonary nodular opacities measuring up to 13 mm of \nuncertain etiology but malignancy is not excluded. Suggest \nradiographic follow-up within four weeks and chest CT in 3 \nmonths to re-assess abnormalitites. \n\n \nBrief Hospital Course:\nASSESSMENT/PLAN: ___ yo w/ dementia, iron def anemia, DM, HTN and \ntobacconism presenting with worsening confusion and found to \nhave a LUL infiltrate on CXR.  \n.  \nPNEUMONIA/LUNG NODULES: the patient was found to have a LUL \nconsolidation on CXR as part of his work up for confusion. The \nconcerning features of this finding include that the patient has \nnot had any worsening of his chronic cough, has not noticed any \nincrease in sputum production, has an extensive tobacco use \nhistory and has had unexplained weightloss over the past ___ \nmonths. Additionally the patient was noted to have a nodule in \nthis area on a CXR from ___ though on repeat imaging with \noblique views this lesion was not observed. These are concerning \nfor possible malignancy especially given the upper lobe \npresentation and a CT CHEST With CONTRAST was performed and \ndemonstrated several spiculated nodules concerning for \nmalignancy though repeat CT in 3 months was recommended for \nmonitoring.  Patient was treated for a CAP with levofloxacin 750 \nmg for 5 days.\n.\nCONFUSION: Patient appears to be at his mental status baseline \nby his wife's report, but his behavior this morning of driving \nis very concerning. His daughter had returned his driver's \nliscence to the DMV after the incident and the patient was \ncontinued on aricept 10 mg daily and sertraline 100 mg QHS and \nmemantine 10 mg BID.  \n.  \nDIABETES: Last A1c 7.1% on ___, currently on BID metformin \nand ___ hold metformin given pending contrast study and \nplace on Humalog SS while in house.  Patient discharged on home \nmedications.\n.  \nHTN: stable, will continue outpatinet amlodipine, carvedilol and \nlosartan  \n.  \nHL: LDL 84 with HDL of 56 and total cholesterol of 153, will \ncontinue home atrovastatin 20 mg daily.  \n.  \nCOPD: No evidence of aucte flare, not hypoxic, on levaquin for \n?PNA will continue home spiriva.  \n.  \nIRON DEFICENCY ANEMIA: Patient with a low ferritin, low iron and \nnormal TIBC with a past microcytosis all consistant with iron \ndeficency likely from chronic GI losses. WIll continue ferrous \nsulfate with colace while inpatient.  \n.\nTRANSITIONAL ISSUES:\n-patient is a DNR/DNI confirmed on this admission\n-patient will need repeat CT chest in 3 months to evaluate lung \nnodules\n-blood cultures pending at time of discharge\n \nMedications on Admission:\n-amlodipine 5 mg daily  \n-atorvastatin 20 mg daily  \n-carvedilol 12.5mg BID  \n-Donepezil 10 mg daily  \n-___ 8 units daily  \n-losartan 50 mg daily  \n-memantine 10 mg daily  \n-metformin 1000 mg BID  \n-omeprazole 40 mg daily  \n-sertraline 100 mg QHS  \n-tiotropium 18 mcg daily  \n-aspirin 325 mg daily  \n-colace 100 mg BID  \n-ferrous sulfate 325 mg daily  \n\n \nDischarge Medications:\n1. amlodipine 5 mg Tablet Sig: Two (2) Tablet PO once a day.\nDisp:*60 Tablet(s)* Refills:*2*\n2. atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n3. carvedilol 12.5 mg Tablet Sig: One (1) Tablet PO BID (2 times \na day).  \n4. donepezil 10 mg Tablet Sig: One (1) Tablet PO HS (at \nbedtime).  \n5. losartan 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n6. memantine 10 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday).  \n7. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n8. sertraline 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n9. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) Cap Inhalation DAILY (Daily).  \n10. aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n11. ferrous sulfate 300  mg (60 mg iron) Tablet Sig: One (1) \nTablet PO DAILY (Daily).  \n12. levofloxacin 750 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily) for 3 days.\nDisp:*3 Tablet(s)* Refills:*0*\n13. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID \n(2 times a day).  \n14. ___ 100 unit/mL Solution Sig: Eight (8) units \nSubcutaneous once a day.  \n15. metformin 1,000 mg Tablet Sig: One (1) Tablet PO twice a \nday.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY:\n-Community Acquired Pneumonia\n-Spiculated lung nodules\n\nSECONDARY:\n- Iron-deficiency anemia\n- angioectasias in the distal small bowel\n- Hyperlipidemia\n- Hypertension\n- Diabetes\n- Dementia\n- COPD\n- OSA\n- GERD \n\n \nDischarge Condition:\nMental Status: Confused - always.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nIt was a pleasure taking care of you while you were in the \nhospital.  You were admitted for evaluation of your confusion \nand found to have a pneumonia.  You were given antibiotics which \nwill treat this infection and should improve your confusion over \nthe next several days.  It is VERY IMPORTANT that you no longer \ndrive a car as this could be EXTREMLY DANGEROUS given your \nconfusion.  \n\nA CAT scan of your lungs showed several small nodules in your \nlugns that could be concerning given your long history of \nsmoking.  Your primary care doctor Dr. ___ was made aware of \nthese findings and you have an appointment in the next several \ndays to follow up with him.\n\nThe following changes were made to your medications:\n-START Levofloxacin 750 mg daily for 3 additional days\n-CONTINUE all other home medications\n-INCREASE amlodipine to 10 mg daily\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fa6e1"
  },
  "note_id": "12530259-DS-19",
  "subject_id": 12530259,
  "hadm_id": 22216049,
  "note_type": "DS",
  "note_seq": 19,
  "charttime": "2186-06-03 00:00:00",
  "storetime": "2186-06-11 08:13:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nhemoptysis \n \nMajor Surgical or Invasive Procedure:\nbronchoscopy with biopsy \n\n \nHistory of Present Illness:\n___ year old male with hx DM, HTN, COPD and current heavy tobacco \nuse who presents with hemoptysis. His son and wife reported \nseeing blood mixed in with mucus on a tissue in the trash can \nyesterday. ___ reports he has been occasionally spitting up \nblood, total of less than a teaspoon. He cannot describe the \nduration of the hemoptysis. Wife reports that he has been having \nDOE with walking short distances and has a productive cough. \nSymptoms associated with ___ pound weight loss over the past \nfew months. However, over the past few weeks he endorses weight \ngain and lower extremity swelling.  \n.\nOf note, he was admitted recently on ___, and treated for a \nlikely post-obstructive PNA with levaquin. At that time, his \nwife had noted a dry cough for the past several months with a \nconstant level of sputum production that had not worsened in the \nlast several days or weeks. Chest CT revealed an LLL infiltrate \nand multiple pulmonary nodules. The ___ was made DNR/DNI \nduring that admission, and the decision was made per the wife to \nnot undergo aggressive workup of the nodules at that time. \nFollow up x-ray was recommended within one month of the CT, with \na repeat CT in 3 months.  \n.\nIn the ED, initial Vitals were 96.0 62 141/61 20 100% on RA. \nExam revealed bilateral rhonchi. EKG: NSR, borderline LAD, TWI \nin V4-V6, unchanged from prior. Labs with HCT close to baseline, \nCr elevated to 1.3. Given 1L IVF. CTA chest with slightly \nenlarged pulmonary nodules and a mass abutting a bronchus, but \nno evidence of pulmonary embolism. He did not produce enough \nsputum for culture, but did have mildly rust colored sputum. \nVital signs prior to transfer: 176/68, 99% RA, 63 NSR, 22 RR, \ntemp 98.3.  \n.\nCurrently, he reports feeling well. He endorses chronic dry \ncough. He denies hemoptysis since admission. Fevers prior to \nprevious admission, but no recent fevers.  \n \nPast Medical History:\n- Iron-deficiency anemia\n- angioectasias in the distal small bowel\n- Hyperlipidemia\n- Hypertension\n- Diabetes\n- Dementia\n- COPD\n- OSA\n- GERD \n- Peptic Ulcers\n\n \nSocial History:\n___\nFamily History:\nDaughter with skin cancer.\n \nPhysical Exam:\nAdmission Physical Exam: \nVS - 98.7 170/70 54 18 98% on RA ___ 208 205.7lbs  \nGENERAL - well-appearing male in NAD, comfortable, appropriate  \nHEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear  \nNECK - supple, no thyromegaly, no JVD, no LAD  \nLUNGS - diffuse rhonchi, L>R, wheezes over LLL  \nHEART - PMI non-displaced, RRR, no MRG, nl S1-S2  \nABDOMEN - +BS, soft/NT/ND, no masses or HSM, no rebound/guarding \n \nEXT - WWP, 1+ RLE edema, no LLE edema, 2+ peripheral pulses \n(radials, DPs)  \nNEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength \n___ throughout, steady not wide based gait  \n. \nDischarge Physical Exam: \nVS - 98.1 179/100 64 18 100%RA  \nGENERAL - well-appearing male in NAD, comfortable, appropriate  \nHEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear  \nNECK - supple, no thyromegaly, no JVD, no LAD  \nLUNGS - scattered rhonchi on left side; no wheezes or rales; \negophany over left lower lobe  \nHEART - PMI non-displaced, RRR, no MRG, nl S1-S2  \nABDOMEN - +BS, soft/NT/ND, no masses or HSM, no rebound/guarding \n \nEXT - WWP, 1+ RLE pitting edema, no LLE edema, 2+ peripheral \npulses (radials, DPs)  \nNEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength \n___ throughout, steady ambulation with cane \n \nPertinent Results:\nADMISSION LABS:  \n___ 03:20PM BLOOD WBC-3.8* RBC-3.35* Hgb-8.2* Hct-27.2* \nMCV-81* MCH-24.5* MCHC-30.1* RDW-16.8* Plt ___\n___ 03:20PM BLOOD Neuts-65.2 ___ Monos-5.8 Eos-2.0 \nBaso-0.9\n___ 03:20PM BLOOD ___ PTT-32.5 ___\n___ 03:20PM BLOOD Glucose-183* UreaN-25* Creat-1.3* Na-140 \nK-3.9 Cl-106 HCO3-26 AnGap-12\n___ 03:20PM BLOOD PSA-<0.1\n___ 03:31PM BLOOD Lactate-1.9\n. \nDISCHARGE LABS:  \n___ 06:00AM BLOOD WBC-4.1 RBC-3.73* Hgb-9.1* Hct-30.4* \nMCV-81* MCH-24.4* MCHC-30.0* RDW-16.4* Plt ___\n___ 06:00AM BLOOD ___ PTT-34.3 ___\n___ 06:00AM BLOOD Glucose-162* UreaN-23* Creat-1.2 Na-143 \nK-4.0 Cl-105 HCO3-28 AnGap-14\n___ 06:00AM BLOOD Calcium-9.4 Phos-3.6 Mg-2.0\n. \nURINE STUDIES: \n___ 03:45PM URINE Color-Yellow Appear-Clear Sp ___\n___ 03:45PM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG\n___ 01:39AM URINE Hours-RANDOM UreaN-602 Creat-74 Na-134 \nK-28 Cl-127\n. \nMICRO: \n___ 6:48 pm SPUTUM EXPECTORATED - contaminated \n.\nIMAGING:\nCTA CHEST ___:  \n1.  No evidence of pulmonary embolism or acute aortic syndrome. \n2.  Left perihilar mass, concerning for primary malignancy. \nInterval clearance of post-obstructive pneumonia.  \n3.  Multiple pulmonary nodules are similar in size compared with \nprior exam. Attention on follow up is recommended. \n. \n___ RIGHT LEG ___: \nNo evidence of deep vein thrombosis in the right leg.\n. \nBRONCHOSCOPY: Two fluoroscopic spot films were obtained \nintraoperatively during bronchoscopy biopsy without radiologist \npresent.  Images demonstrate biopsy of left suprahilar left \nupper lobe mass.  225.4 seconds of fluoroscopic time was used. \nFor full details, please see the operative report. \n.\nCXR ___: No pneumothorax status post biopsy of known left \nhilar mass.\n. \nPATH: \nLEFT LOWER LOBE MASS PATHOLOGY ___: PENDING \nBrushings, left lower lobe ___: PENDING \n \nBrief Hospital Course:\n___ year old man with extensive tobacco history admitted with \nhemoptysis, found to have large mass abutting bronchus.  \n. \n# Hemoptysis/Chest Mass: Given large mass abutting bronchus, \npresence of multiple spiculated nodules on CT, lymphadenopathy, \nweight loss, and recent admission for post obstructive pneumonia \nin the setting of a heavy smoking history, hemoptysis likely due \nto malignancy abutting bronchus.  He underwent CTA that did not \nshow any evidence of pulmonary embolism.  The ___ underwent \ntransbronchial biopsy with interventional pulmonology for \ndiagnosis of mass.  He did not experience any hemoptysis while \ninpatient, and hematocrit remained stable.  The ___ will \nfollow up with interventional pulmonology as an outpatient \nregarding biopsy results.  He will follow up with his PCP ___ \n___.    \n.  \n# ___ edema:  On admission, ___ with unilateral right lower \nextremity edema.  Right ___ negative for DVT.  No palpable \npelvic lymphadenopathy as source of edema.  Exam remained stable \nthroughout admission.  \n.\n# Acute kidney injury: ___ admitted with Cr 1.3 from \nbaseline 1.1. Likely prerenal from sporadic PO intake or blood \nloss.  Improved with IV fluids.  \n.\n# Dementia: Reportedly Alzheimer's per his children. Per his \nwife, he has difficulty processing new information and his \nmemory is worsening. NPH considered on admission, given history \nof incontinence, but no wide-based gate. Recent head CT without \nventriculomegaly more than expected for age.  The ___ \nremained alert and pleasant throughout admission, with \nsituational confusion (thought he was at work) and difficulty \nwith memory.  He was maintained on ___ precautions.  Tethers \nwere limited.  He was continued on donepezil, memantine, and \nsertraline.  \n. \n# Hypertension: ___ moderately hypertensive on admission.  \nHe was continued on home carvedilol, losartan, and amlodipine.  \nAmlodipine dose was increased from 5mg to 10mg, but was titrated \nback down to 5mg daily prior to discharge.  The ___ should \nfollow up with his PCP regarding blood pressure control.\n. \n# COPD: Chronic. The ___ was continued on tiotropium, \nalbuterol nebs prn.\n.   \n# Hyperlipidemia: Chronic. The ___ was continued on \natorvastatin.\n.   \n# Iron deficiency anemia: Chronic.  The ___ was continued on \nferrous sulfate.  \n.   \n# DM II. Chronic, insulin dependent.  Metformin was held \nthroughout admission.  The ___ was continued on lantus with \nan insulin sliding scale.  Metformin was resumed at discharge.   \n  \n. \n# GERD: Chronic. The ___ was continued on omeprazole.  \n.  \n# CODE: DNI/DNR; Reversed to full code for bronchoscopy \n# CONTACT: wife, daughter ___ ___ h ___ \n==========================================\nTRANSITIONAL ISSUES:  \n# bronchoscopy biopsy of pulmonary mass PENDING at the time of \ndischarge.  ___ to follow up with interventional pulmonary \nand his PCP \n# ___ should follow up with PCP for blood pressure check \n \nMedications on Admission:\n1. Amlodipine 5 mg PO DAILY \nHOld for sBP<100. \n2. Atorvastatin 20 mg PO DAILY \n3. Carvedilol 12.5 mg PO BID \nHold for sBP<100 or HR<70. \n4. Donepezil 10 mg PO HS \n5. Glargine 8 Units Breakfast\n6. Losartan Potassium 50 mg PO DAILY \nHOld for sBP<100.\n \n7. MEMAntine *NF* 10 mg Oral daily \n8. Omeprazole 40 mg PO DAILY \n9. Sertraline 100 mg PO HS \n10. Tiotropium Bromide 1 CAP IH DAILY \n11. Aspirin 325 mg PO DAILY \n12. Docusate Sodium 100 mg PO BID \n13. Ferrous Sulfate 325 mg PO DAILY \n\n \nDischarge Medications:\n1. Amlodipine 5 mg PO DAILY \nHOld for sBP<100. \n2. Atorvastatin 20 mg PO DAILY \n3. Carvedilol 12.5 mg PO BID \nHold for sBP<100 or HR<70. \n4. Donepezil 10 mg PO HS \n5. Glargine 8 Units Breakfast\n6. MetFORMIN (Glucophage) 1000 mg PO BID \n7. Losartan Potassium 50 mg PO DAILY \nHOld for sBP<100.\n \n8. MEMAntine *NF* 10 mg Oral daily \n9. Omeprazole 40 mg PO DAILY \n10. Sertraline 100 mg PO HS \n11. Tiotropium Bromide 1 CAP IH DAILY \n12. Aspirin 325 mg PO DAILY \n13. Docusate Sodium 100 mg PO BID \n14. Ferrous Sulfate 325 mg PO DAILY \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nhemoptysis \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (cane).\n\n \nDischarge Instructions:\nMr. ___, \n.\nYou were admitted to the hospital after coughing up blood.  You \nwere found to have a large mass on your lung that was the likely \nsource of bleed.  This mass is concerning, so you underwent a \nprocedure to sample the mass.  You were discharged to home.  You \nshould follow up with the lung doctors and your primary care \nphysician as an outpatient for the results of your test.  \n.\nMEDICATIONS CHANGED THIS ADMISSION:  none \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fa6e2"
  },
  "note_id": "12530259-DS-20",
  "subject_id": 12530259,
  "hadm_id": 25364714,
  "note_type": "DS",
  "note_seq": 20,
  "charttime": "2186-08-02 00:00:00",
  "storetime": "2186-08-02 12:42:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: CARDIOTHORACIC\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nLung cancer\n \nMajor Surgical or Invasive Procedure:\n___\n1. Left thoracotomy.\n2. Left lower lobectomy.\n3. Arterioplasty of lower lobe pulmonary artery.\n4. Mediastinal lymphadenectomy.\n\n___\nBronchoscopy\n\n___\nBronchoscopy\n\n \nHistory of Present Illness:\nThe patient is a ___ gentlman who was admitted to the hospital \non ___ of this year for dyspnea, cough, and some low \nvolume hemoptysis.  He underwent an endoscopy by Dr. ___ on \n___.  No endobronchial disease was noted, but a radial \nEBUS was performed from the superior segment of the left lower \nlobe.  Bronchial washings were positive for adenocarcinoma and \nthe transbronchial biopsy showed atypical cells suspicious for \nlarge cell carcinoma. He has undergone imaging that includes \nboth CT of the head on\n___ that shows no metastatic disease.  CTA of the chest \nshows a left perihilar mass that is 4.0 x 1.9 cm.  This mass is \ncentered in the left lower lobe, but does partially encase the \nleft lower lobe superior segment PA.  There are also two nodules \nin the left upper lobe and a 0.9-cm nodule at the right apex.  \nPET scan performed on ___ shows the hilar mass to be FDG \navid\nwith an SUV of 17.  The left upper lobe nodule is non-FDG avid \nas are other pulmonary nodules.  There was no metastatic disease \non this study. He subsequently underwent a mediastinoscopy with \nlymph node biopsy performed by Dr. ___ at ___ on ___, \nwhich was negative for malignancy. He now presents for surgical \nresection of his lung mass.\n\n \nPast Medical History:\n- Iron-deficiency anemia\n- angioectasias in the distal small bowel\n- Hyperlipidemia\n- Hypertension\n- Diabetes\n- Dementia\n- COPD\n- OSA\n- GERD \n- Peptic Ulcers\n\n \nSocial History:\n___\nFamily History:\nDaughter with skin cancer.\n \nPhysical Exam:\nVS T 98.7, HR 86, BP 150/81, RR 20, O2-sat 95% RA\nGeneral: Appears well, NAD\nHEENT: MMM, no scleral icterus, trachea and tongue midline, no \npalpable lymphadenopathy\nCardiac: RRR, no M/R/G\nPulmonary: CTAB, no rales/rhonchi/wheezes\nAbdomen: Soft, NT/ND, positive bowel sounds, no palpable masses\nExtremities: no edema\n \nPertinent Results:\n___ 02:10PM   WBC-6.3 RBC-3.22* HGB-8.1* HCT-26.2* MCV-81* \nMCH-25.1* MCHC-30.8* RDW-16.5*\n___ 02:10PM   GLUCOSE-187* UREA N-23* CREAT-1.3* SODIUM-142 \nPOTASSIUM-4.7 CHLORIDE-109* TOTAL CO2-25 ANION GAP-13\n\n___ 3:04 pm BRONCHIAL WASHINGS      BRONCHIAL WASH. \n\n                            **FINAL REPORT ___\n\n   GRAM STAIN (Final ___: \n      4+   (>10 per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      3+  ___ per 1000X FIELD):   GRAM NEGATIVE ROD(S). \n      2+   ___ per 1000X FIELD):   MULTIPLE ORGANISMS \nCONSISTENT WITH     \n                                    OROPHARYNGEAL FLORA. \n\n   RESPIRATORY CULTURE (Final ___: \n      10,000-100,000 ORGANISMS/ML. Commensal Respiratory Flora. \n      PSEUDOMONAS AERUGINOSA.    >100,000 ORGANISMS/ML.. \n         Piperacillin/Tazobactam sensitivity testing performed \nby ___\n         ___. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             PSEUDOMONAS AERUGINOSA\n                             |   \nCEFEPIME--------------     4 S\nCEFTAZIDIME-----------   <=1 S\nCIPROFLOXACIN---------<=0.25 S\nGENTAMICIN------------     4 S\nMEROPENEM-------------<=0.25 S\nPIPERACILLIN/TAZO-----       S\nTOBRAMYCIN------------   <=1 S\n\n___\nCXR :In comparison with study of earlier in this date, there is \nlittle \ninterval change.  Substantial opacification of the left \nhemithorax persists with the right lung being essentially clear. \n No appreciable pneumothorax.  Gas within soft tissues is seen \nin the supraclavicular level on the left \n\n___\nCXR :\nThere continues to be elevation of the left hemidiaphragm with \nleft \neffusion and an alveolar infiltrate in the left mid lung.  \nHowever, overall the aeration on the left is much improved.  The \nright lung is clear. \n  \n\n \nBrief Hospital Course:\nThe patient was admitted to the Thoracic Surgery Service for \nevaluation and treatment.  On ___, the patient underwent left \nthoracotomy, left lower lobectomy,\narterioplasty of lower lobe pulmonary artery, mediastinal \nlymphadenectomy, which went well without complication.  After a \nbrief, uneventful stay in the PACU, the patient arrived on the \nfloor NPO, on IV fluids, with a foley catheter, and an epidural \nfor pain control.  The patient was hemodynamically stable.\n\nNeuro: The patient received the epidural with good effect and \nadequate pain control.  When tolerating oral intake, the patient \nwas transitioned to oral pain medications. He was resumed on his \ndementia medications and his narcotics were limited so as not to \npromote more confusion.\n\nCV: The patient remained stable from a cardiovascular \nstandpoint; vital signs were routinely monitored.\n\nPulmonary: The patient had an episode of desaturation into the \n80's when chest physical therapy was being performed. He was \ntransferred to the ICU where bronchoscopy was performed and \nsecretions were evacuated. The secretions were sent for gram \nstain and culture, which grew pan-sensitive pseudomonas. \nOtherwise, the patient remained stable from a pulmonary \nstandpoint; vital signs were routinely monitored. Good pulmonary \ntoilet, early ambulation and incentive spirometry were \nencouraged throughout hospitalization.\n\nGI/GU/FEN: Post-operatively, the patient was made NPO with IV \nfluids. Diet was advanced when appropriate, which was well \ntolerated.  Patient's intake and output were closely monitored, \nand IV fluid was adjusted when necessary.  Electrolytes were \nroutinely followed, and repleted when necessary.\n\nID: The patient's white blood count and fever curves were \nclosely watched for signs of infection. Secretions from \nbronchoscopy were sent for gram stain and culture. The patient \nreceived vancomycin and cefepime for empiric coverage for \npossible pneumonia. This regimen was scaled back to \nciprofloxacin once the culture sensitivities returned. He will \nremain on Cipro thru ___.\n\nEndocrine: Patient was maintained on sliding scale insulin to \ngood effect. His blood sugars were monitored routinely. \n\nHematology: The patient's complete blood count was examined \nroutinely; no transfusions were required.\n\nProphylaxis: The patient received subcutaneous heparin and \nvenodyne boots were used during this stay; was encouraged to get \nup and ambulate as early as possible.\n\nAt the time of discharge, the patient was doing well, afebrile \nwith stable vital signs.  The patient was tolerating a regular \ndiet, ambulating, voiding without assistance, and pain was well \ncontrolled.  The patient received discharge teaching and \nfollow-up instructions with understanding verbalized and \nagreement with the discharge plan.\n\n \nMedications on Admission:\nPreadmission medications listed are correct and complete.  \nInformation was obtained from webOMR.\n1. Losartan Potassium 50 mg PO DAILY \n2. Hydrocortisone Cream 2.5% 1 Appl TP TWICE DAILY \n3. Tiotropium Bromide 1 CAP IH DAILY \n4. Carvedilol 12.5 mg PO BID \n5. MetFORMIN (Glucophage) 500 mg PO BID \n6. Docusate Sodium 100 mg PO BID \n7. MEMAntine *NF* 10 mg Oral twice a day \n8. Amlodipine 5 mg PO DAILY \n9. Atorvastatin 20 mg PO DAILY \n10. Glargine 8 Units Bedtime\n11. Ferrous Sulfate 325 mg PO DAILY \n12. Donepezil 10 mg PO HS \n13. Omeprazole 20 mg PO DAILY \n14. Sertraline 100 mg PO DAILY \n\n \nDischarge Medications:\n1. Amlodipine 5 mg PO DAILY \n2. Atorvastatin 20 mg PO DAILY \n3. Carvedilol 12.5 mg PO BID \n4. Docusate Sodium 100 mg PO BID \n5. Donepezil 10 mg PO HS \n6. Glargine 8 Units Bedtime\n7. MEMAntine *NF* 10 mg Oral twice a day \n8. Omeprazole 40 mg PO DAILY \n9. Sertraline 100 mg PO DAILY \n10. Tiotropium Bromide 1 CAP IH DAILY \n11. Acetaminophen 650 mg PO Q6H \n12. Ciprofloxacin HCl 750 mg PO Q12H \nthru ___ \nRX *Cipro 750 mg 1 tablet(s) by mouth twice a day Disp #*8 \nTablet Refills:*0\n13. OxycoDONE (Immediate Release)  5 mg PO Q4H:PRN pain \nRX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours \nDisp #*20 Tablet Refills:*0\n14. Senna 1 TAB PO BID:PRN constipation \nRX *senna 8.6 mg 1 tablet by mouth twice a day Disp #*20 Tablet \nRefills:*0\n15. TraMADOL (Ultram) 25 mg PO QID \nRX *tramadol 50 mg 0.5 (One half) tablet(s) by mouth four times \na day Disp #*30 Tablet Refills:*0\n16. Ferrous Sulfate 325 mg PO DAILY \n17. Hydrocortisone Cream 2.5% 1 Appl TP TWICE DAILY \n18. Losartan Potassium 50 mg PO DAILY \n19. MetFORMIN (Glucophage) 500 mg PO BID \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nLeft lower lobe lung cancer\nPseudomonas pneumonia\n\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\n* You were admitted to the hospital for lung surgery and you've \nrecovered well. You are now ready for discharge.\n* Continue to use your incentive spirometer 10 times an hour \nwhile awake.\n* Check your incisions daily and report any increased redness or \ndrainage.   Cover the area with a gauze pad if it is draining.\n* Your chest tube dressing may be removed in 48 hours.  If it \nstarts to drain, cover it with a clean dry dressing and change \nit  as needed to keep site clean and dry.\n* You will continue to need pain medication once you are home \nbut you can wean it over a few weeks as the discomfort resolves. \n Make sure that you have regular bowel movements while on \nnarcotic pain medications as they are constipating which can \ncause more problems.  Use a stool softener or gentle laxative to \nstay regular.\n* No driving while taking narcotic pain medication.\n* Take Tylenol  ___ mg every 6 hours in between your narcotic.  \n* Continue to stay well hydrated and eat well to heal your \nincisions\n* Shower daily. Wash incision with mild soap & water, rinse, pat \ndry\n* No tub bathing, swimming or hot tubs until incision healed\n* No lotions or creams to incision site\n* Walk ___ times a day and gradually increase your activity as \nyou can tolerate.\n\nCall Dr. ___ ___ if you experience:\n-Fevers > 101 or chills\n-Increased shortness of breath, chest pain or any other symptoms \nthat concern you.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fa6e3"
  },
  "note_id": "12530259-DS-21",
  "subject_id": 12530259,
  "hadm_id": 28442592,
  "note_type": "DS",
  "note_seq": 21,
  "charttime": "2186-12-09 00:00:00",
  "storetime": "2186-12-10 18:12:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nFalls/Dyspnea on Exertion\n \nMajor Surgical or Invasive Procedure:\nNone.\n\n \nHistory of Present Illness:\n Patient is a very pleasant ___ yo male history of Stage II lung \ncancer status post LLL resection as well as ongoing dementia \npresenting from home after a fall.  Patient is unclear of the \nevents and not aware that he is in the hospital; documented \ndementia at baseline.  Spoke with pt's wife on the phone.  Found \nhusband on the floor lying down.  When patient got up to sit in \nhis chair, that's when he fell.  Patient does not recall \nmechanical fall.  Patient's wife attempted to get him up, and \nwas able to prop patient in a chair with help of the \nmainteneance man.  Patient's daughter ___ was notified of the \nfall, and called the paramedics to take patient to the hospital. \nDr. ___ working on getting patient home oxygen, but \nnot on oxygen at home.\n\nSpeaking with pt's wife, ___ mental status is marginal.  \nHas not been bathing or shaving, with difficulty sleeping.  Has \nbeen confused, but still remembers his wife and children, but \ndoes not recognize his grandchildren or great grandchildren.  \nPatient has been asking for his sisters, who have all passed \naway.\nPatient has not been aggressive or threatening in any way.\n\nIn the ED at ___, blood glucose was reportedly at 314 by EMS.  \n\nVS were: 98.6 72 160/90 16 98% RA. CT head negative.  Labs \nshowed CKD and chronic normocytic anemia, but otherwise no \nabnormalities were noted.  The patient had a CXR that showed \natypical looking pneumonia, but given history concern for \nworsening lung cancer.  Was provided with a dose of levofloxacin \nand transferred to the floor for further workup.\n\nCurrently, the patient is in no acute distress.  Confused but \npleasant.  Dyspnic, on 87% RA, with increase to 99% on 2L O2.\n\nREVIEW OF SYSTEMS:  Per patient, has SOB, but denies fever, \nchills, night sweats, headache, vision changes, rhinorrhea, \ncongestion, sore throat, cough, chest pain, abdominal pain, \nnausea, vomiting, diarrhea, constipation, dysuria.  \n \nPast Medical History:\n- Lung Cancer Stage IIa adenocarcinoma s/p resection in ___  \n- Prostate Cancer  \n- Iron-deficiency anemia  \n- angioectasias in the distal small bowel  \n- Hyperlipidemia  \n- Hypertension  \n- Diabetes  \n- Dementia  \n- COPD  \n- OSA  \n- GERD  \n- Peptic Ulcers  \n- Bilateral DJD  \n- Shoulder pain\n \nSocial History:\n___\nFamily History:\nDaughter with skin cancer.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVS - Temp 98.3 F, 188/84 BP , 85 HR , 32R , 87O2-sat % RA/  RR \n20 99% on 2L  \nGENERAL - NAD, comfortable, appropriate mild respiratory \ndistress  \nHEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear  \nNECK - supple, shoddy LAD in anterior chain biliterally.  \nPosterior lymph node chain with no obvious lymphadenopathy.  No \nthyromegaly, no JVD, no carotid bruits  \nLUNGS - No accessory MM use currently.  CTA bilat, however \ndecrease breath sounds L worse than right.  No wheezes \nappreciated.  Surgical lobectomy scar present on left back/flank \nregion.  No rashes on back. \nHEART - PMI non-displaced, RRR, ___ panystolic apical murmur, nl \nS1-S2  \nABDOMEN - NABS, soft/NT/ND, no masses or HSM, no \nrebound/guarding  \nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs) \n \nSKIN - no rashes or lesions appreciated on arms/legs  \nNEURO - awake conversant and pleasant.  Disoriented to place and \ntime, cannot recall year and thinks he is \"working on the job\".  \nKnows his own name. ___ focally intact with PERRLA 3 to 2 \nmm with light.  Muscle strength ___ throughout, sensation \ngrossly intact throughout, DTRs 2+ and symmetric on patellar and \nbicipital regions, cerebellar exam intact without past pointing. \n Waddling gait, does not move upper extremities with gait.  \nNegative Romberg with no pronantor drift.\n \nDISCHARGE PHYSICAL EXAM:  \nVSS.  No change in rest of exam.\n\n \nPertinent Results:\nADMISSION LABS\n\n___ 04:47AM   ___ TEMP-37 COMMENTS-GREEN TOP \n___ 04:47AM   LACTATE-1.3\n___ 03:40AM URINE  COLOR-Yellow APPEAR-Clear SP ___\n___ 03:40AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 \nLEUK-NEG\n___ 03:40AM URINE  RBC-1 WBC-1 BACTERIA-NONE YEAST-NONE \nEPI-1\n___ 03:40AM URINE  HYALINE-5*\n___ 03:40AM URINE  MUCOUS-RARE\n___ 10:45PM   GLUCOSE-243* UREA N-19 CREAT-1.4* SODIUM-137 \nPOTASSIUM-4.1 CHLORIDE-100 TOTAL CO2-24 ANION GAP-17\n___ 10:45PM   estGFR-Using this\n___ 10:45PM   WBC-10.3# RBC-3.53* HGB-7.9* HCT-25.8* \nMCV-73* MCH-22.4* MCHC-30.6* RDW-20.1*\n___ 10:45PM   NEUTS-83.9* LYMPHS-10.0* MONOS-5.4 EOS-0.6 \nBASOS-0.1\n___ 10:45PM   PLT COUNT-269\n\nDISCHARGE LABS\n\n___ 05:10AM BLOOD WBC-7.8 RBC-3.62* Hgb-7.9* Hct-26.7* \nMCV-74* MCH-21.8* MCHC-29.6* RDW-19.7* Plt ___\n___ 05:10AM BLOOD ___ PTT-33.1 ___\n___ 05:10AM BLOOD Glucose-181* UreaN-12 Creat-1.0 Na-137 \nK-4.0 Cl-99 HCO3-27 AnGap-15\n___ 05:10AM BLOOD Calcium-9.1 Phos-3.0 Mg-1.5*\n\nURINE TESTS\n___ 03:40AM URINE Blood-NEG Nitrite-NEG Protein-TR \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG\n___ 03:40AM URINE Color-Yellow Appear-Clear Sp ___\n___ 03:40AM URINE CastHy-5*\n\nURINE/BLOOD CULTURE: NO GROWTH\n\nIMAGING & REPORTS\n___\n\nECG\nSinus rhythm. Left axis deviation. Lateral ST-T wave \nabnormalities. Since\nthe previous tracing of ___ probably no significant change.\n  IntervalsAxes\n___\n___\n\nCT HEAD\nFINDINGS:  This study is limited due to motion.  Within these \nlimitations,\nthere is no evidence of hemorrhage, edema, mass effect or acute \nlarge vascular\nterritory infarction.  Ventricles and sulci are prominent, \nconsistent with\nage-related atrophy.  There is confluent periventricular white \nmatter\nhypodensity, consistent with chronic small vessel ischemic \ndisease.  The\nvisualized paranasal sinuses and mastoid air cells are clear.  \nThere is no\nfracture.\n \nIMPRESSION:\n1.  Limited study, but no acute intracranial process.\n2.  Age-related chronic small vessel ischemic disease.\n \n\nCXR\nFINDINGS:  The patient has had a prior left lower lobectomy.  \nSince the prior\nexam, nodular pleural thickening encasing the left lung has \nincreased at the\nexpense of aeration of the left lung with stable elevation of \nthe left\nhemidiaphragm. Central adenopathy in the left hilus and adjacent \nmediastinum\nhas also progressed. The right lung is clear.  Cardiomediastinal \nsilhouette is\nunchanged.\n \nIMPRESSION:  Progression of left pleural and nodal metastases.\n \n\nCT CHEST WITH CONTRAST\nFINDINGS:  As compared to the previous examination, the patient \nis after left\nupper lobectomy.  The previously collapsed left postoperative \nlung is now\nbetter ventilated.\n \nHowever, the left pleura is both focally and diffusely thickened \nand shows\nmultiple up to 2.5 cm large nodules.  These are most obvious in \nthe anterior\nand apical lung regions (3, 20) as well as in the inferior and \nposterior\nmedial lung regions (3, 30).  The left lung parenchyma also \nshows evidence of\nintraparenchymal nodules and one questionable endobronchial \nnodule at the\nlevel of the stump (4, 121).\n \nThe entire left hemithorax shows volume loss.  Small areas of \natelectasis are\nseen at the left lung bases.  In the right lung, there are \nmultiple soft\ntissue density nodules with maximum sizes of 5-6 mm.  All these \nnodules are\nlikely to reflect metastatic disease.  The nodules show a \nperipheral and lower\nlobe predominance.\n \nThere is no right pleural effusion.  Moderate pulmonary \nemphysema.\n \nUnchanged coronary calcifications, several lymph nodes, for \nexample in the\nprecarinal and the subcarinal area, are borderline in diameter.  \nModerate\naortic calcifications.\n \nNewly appeared is a 2.5 cm hypodense lesion at the level of the \nright adrenal\ngland, representing an adrenal metastasis.\n \nIMPRESSION:\n1.  Massive pleural metastatic disease in the left hemithorax, \nmultiple left\nintraparenchymal metastasis and one endobronchial metastasis.\n2.  Multiple right lung metastasis.\n3.  Newly appeared right adrenal metastasis.\n4.  Borderline mediastinal lymph nodes.\n5.  No evidence of osteolytic lesions.\n \n \nBrief Hospital Course:\nACTIVE ISSUES\n\nDEMENTIA and FALLS:  Patient's mental status has been \ndeteriorating, leading to recurrent falls at home.  Per his wife \n___, Mr. ___ has often forgot where he is, the year/month, \nand his grandchildren.  He sleeps most of the day, and has been \nhaving falls at home.  On presentation to the hospital, patient \nsuffered a fall prior.  He was evaluated by physical therapy who \nrecommended home with physical therapy.\n\nSTAGE IV LUNG CANCER:  History of lower lobe resection for stage \nII cancer.  On presentation to the hospital, he had a chest xray \nthat was concerning for pleural involvement of malignancy.  \nFollow up CT chest with contrast confirmed diffuse metastatic \ndisease.  A family meeting was held with the patient's HCP \n___, oncology, and medicine.  At the conclusion of the \nmeeting, the decision was made to not pursue any palliative \ntreatment, and to allow the patient to go home with ___ services \nand eventual bridge to hospice care.\n\nCOPD and DYSPNEA:  Initially, ambulating with 83% sats on room \nair.  After several breathing treatments, saturations improved \nto 90% on RA with ambulation.  Patient's PCP currently working \non having home oxygen available for the patient.  Discharged \nhome with home COPD regimen.\n\nINACTIVE ISSUES (CONTINUED HOME REGIMEN)\nDiabetes II\nDepression\nCAD\nHTN\nAnemia\n\nCODE STATUS: DNR DNI\nCONTACT: Wife ___ number: ___  \nCell phone: ___  \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Amlodipine 5 mg PO DAILY \nhold for SBP<100 \n2. Atorvastatin 20 mg PO DAILY \n3. Carvedilol 12.5 mg PO BID \nHold for SBP<100/ HR<60 \n4. Fluticasone Propionate NASAL 1 SPRY NU BID \n5. Donepezil 10 mg PO HS \n6. Hydrocortisone Cream 2.5% 1 Appl TP BID \nApply to scalp lesions BID \n7. Losartan Potassium 50 mg PO DAILY \nhold for SBP<100 \n8. Memantine 10 mg PO BID \n9. MetFORMIN (Glucophage) 1000 mg PO BID \n10. Omeprazole 40 mg PO DAILY \n11. Sertraline 100 mg PO DAILY \n12. Tiotropium Bromide 1 CAP IH DAILY \n13. Tolterodine 1 mg PO BID \n14. Aspirin 325 mg PO DAILY \n15. Docusate Sodium 100 mg PO BID \n16. Ferrous Sulfate 325 mg PO DAILY \n17. Glargine 8 Units Breakfast\n\n \nDischarge Medications:\n1. Amlodipine 5 mg PO DAILY \nhold for SBP<100 \n2. Aspirin 325 mg PO DAILY \n3. Atorvastatin 20 mg PO DAILY \n4. Carvedilol 12.5 mg PO BID \nHold for SBP<100/ HR<60 \n5. Docusate Sodium 100 mg PO BID \n6. Donepezil 10 mg PO HS \n7. Ferrous Sulfate 325 mg PO DAILY \n8. Fluticasone Propionate NASAL 1 SPRY NU BID \n9. Losartan Potassium 50 mg PO DAILY \nhold for SBP<100 \n10. Memantine 10 mg PO BID \n11. Sertraline 100 mg PO DAILY \n12. MetFORMIN (Glucophage) 1000 mg PO BID \n13. Omeprazole 40 mg PO DAILY \n14. Tiotropium Bromide 1 CAP IH DAILY \n15. Glargine 8 Units Breakfast\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary: Metastatic Lung Cancer\nSecondary: Dementia\n\n \nDischarge Condition:\nMental Status: Confused - always.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nMr. ___-\n\nIt has been a pleasure taking care of you at ___ \n___.  You came to the hospital because you \nhad a fall and were also having difficulty breathing.  You were \nobserved for two days, given oxygen, and your breathing \nimproved.  You had a CT scan of your chest that new massess in \nyour left lung, right lung and kidney that are indicative of \nmetastatic disease.  You and your family met with the medical \nteam, and the decision was to have visiting nurses at home to \nhelp with physical therapy.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fa6e4"
  },
  "note_id": "12530259-DS-22",
  "subject_id": 12530259,
  "hadm_id": 26409789,
  "note_type": "DS",
  "note_seq": 22,
  "charttime": "2187-02-01 00:00:00",
  "storetime": "2187-02-01 19:06:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \nChief Complaint:\nFailure to thrive \n \nMajor Surgical or Invasive Procedure:\n___ line placement\n\n \nHistory of Present Illness:\n___ with Alzheimers disease, prostate cancer and metatastic lung \nCA on ___ O2, currently on ___ hospice being cared for by his  \n\nwife, now with progressive weakness and poor appetite over the \npast 2 weeks.  \nHe had abdominal pain 2 weeks ago and workup included an EGD \nwhich revealed an antral mass thought to be a lipoma, a gastric \npolyp and duodenitis. Per his wife, he has had a gradual decline \nin functioning with inability to walk, bowel and bladder \nincontinence, lack of appetite, no intake of solid food during \nthis interval. He has a liquid diet consisting of \nvegetable/fruit juice. During this time, he has had sleep \ndisturbance with increasing insomnia and recently started having \nvisual hallucinations. He also complains of RLE pain in his \nthigh and back of knee which wakes him up at night, its \nnon-radiating, aggravated by movement and alleviated Asper cream \nand by hanging his extremity over the side of the bed. He was \nable to walk and perform his activities of daily living with \nsome assistance at baseline. 1 week ago, his wife noticed that \nhis urine was dark brown. He has not complained of pain during \nurination.  \nHe has lost 30lbs in the last ___ months but more in the past 2 \nweeks due to decreased PO intake. His wife denies any sore \nthroat, shortness of breath, chest pain, abdominal pain, nausea, \ndiarrhea, constipation, BRBPR, melena, hematochezia or dysuria.  \n\nHis wife is increasingly unable to care for him at ___ and is \nconcerned that his RLE pain may be due to metastases to bone. \nHis PCP requests admission for evaluation of failure to thrive.  \n\n \nROS: per HPI, denies fever, chills, night sweats, headache, \nrhinorrhea, congestion.  \n\n \nPast Medical History:\n- Lung Cancer Stage IIa adenocarcinoma s/p resection in ___  \n- Prostate Cancer s/p prostatectomy, robot assisted  \n- Iron-deficiency anemia  \n- angioectasias in the distal small bowel  \n- Hyperlipidemia  \n- Hypertension  \n- Diabetes mellitus type II\n- Dementia  \n- COPD  \n- OSA  \n- GERD  \n- Peptic Ulcers  \n- Bilateral DJD  \n\n \nSocial History:\n___\nFamily History:\nDiabetes in his 2 sisters (deceased) and his daughter. Cancer in \n___ (deceased). ___ in all relatives per wife\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVS - Temp 97.6F, BP 118/54 , HR 72, R 18, O2-sat 100% RA  \nGENERAL - NAD, comfortable, appropriate  \nHEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear \n(dentures out)  \nNECK - supple, no thyromegaly, no JVD  \nHEART - RRR, nl S1-S2, ___ systolic murmur at LSB, no radiation. \n \nLUNGS - CTAB, no r/rh/wh, resp unlabored  \nABDOMEN - NABS, soft/NT/ND, no masses, no rebound/guarding  \nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs, \nPTs)  \nSKIN - no rashes, healed scars on bilateral knees from past \nfalls  \nNEURO - awake, A&O to name not place or time, CNs II-XII grossly \nintact, muscle strength ___ throughout, sensation grossly \nintact throughout, DTRs 2+ and symmetric, FTN testing intact but \nvery slow movement of RUE, gait not tested.  \n\nDISCHARGE PHYSICAL EXAM:\nVS - T ___ F, BP 131/58, HR 96 (range ___ - 100s over past 24 \nhrs) RR 18, O2-sat 97% RA\nGENERAL - NAD, in bed comfortable, pleasant, cooperative\nHEENT - EOMI, moist mucous membranes \nNECK - supple \nHEART - RRR, nl S1-S2, III/VI systolic murmur RUSB  \nLUNGS - decreased breath sounds L lung fields, good air movement \nin R lung, no accessory muscle use\nABDOMEN - hyperactive bowel sounds, soft/NT/ND, no masses or \nHSM, no rebound/guarding  \nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs) \n \nSKIN - no rashes or lesions  \nNEURO - awake, A&Ox1\n\n \nPertinent Results:\nADMISSION LABS:\n___ 09:40PM BLOOD WBC-16.1*# RBC-3.81* Hgb-9.2* Hct-29.5* \nMCV-77* MCH-24.2* MCHC-31.3 RDW-20.1* Plt ___\n___ 09:40PM BLOOD Neuts-85.4* Lymphs-8.1* Monos-4.8 Eos-1.5 \nBaso-0.2\n___ 09:40PM BLOOD ___ PTT-33.6 ___\n___ 03:46AM BLOOD Ret Aut-0.8*\n___ 09:40PM BLOOD Glucose-110* UreaN-43* Creat-2.3*# \nNa-129* K-8.7* Cl-100 HCO3-20* AnGap-18\n___ 09:40PM BLOOD ALT-13 AST-13 CK(CPK)-41* AlkPhos-152* \nTotBili-0.3\n___ 09:40PM BLOOD Albumin-3.9 Calcium-9.5 Phos-5.0*# Mg-1.9\n___ 01:45AM BLOOD ___ pO2-26* pCO2-38 pH-7.21* \ncalTCO2-16* Base XS--13\n___ 01:45AM BLOOD Glucose-40* Lactate-1.0 Na-127* K-4.7 \nCl-113*\n___ 09:40PM BLOOD TSH-3.5\n___ 09:40PM BLOOD VitB___-___\n\nDischarge labs:\n___ 09:00AM BLOOD WBC-14.9* RBC-2.95* Hgb-7.1* Hct-23.3* \nMCV-79* MCH-24.1* MCHC-30.5* RDW-20.6* Plt ___\n___ 03:46AM BLOOD Neuts-84.6* Lymphs-8.4* Monos-5.6 Eos-1.2 \nBaso-0.2\n___ 09:00AM BLOOD Glucose-124* UreaN-14 Creat-1.4* Na-136 \nK-4.3 Cl-105 HCO3-20* AnGap-15\n___ 09:00AM BLOOD Calcium-8.5 Phos-2.5* Mg-1.9\n\n___ EKG:\nus rhythm with borderline P-R interval prolongation. Left atrial \n\nabnormality. Probable left ventricular hypertrophy. Left axis \ndeviation \nconsistent with left anterior fascicular block. Intraventricular \nconduction delay. Possible prior underlying anterior septal \nmyocardial infarction. Peaked T waves strongly suggestive of \nhyperkalemia. Delayed lateral precordial transition. Compared to \nthe previous tracing of ___ axis is more leftward. R wave \nprogression is slower and T wave peaking is new. Clinical \ncorrelation is suggested.  \n\n___ CXR:\nIMPRESSION:  Collapse of the remaining left lung with further \nelevation of a probably paralyzed left hemidiaphragm.  Further \nevaluation with CT would provide a better evaluation of the \nairways and for the etiology of lung collapse. \n\n \nBrief Hospital Course:\nMr. ___ is a ___ year old male enrolled in ___ hospice care \nwith history of lung adenocarcinoma and prostate cancer, \nAlzheimer's dementia, presenting with subacute decline in \nfunctional status over the past 2 weeks, found to have acute \nkidney injury and hyperkalemia with EKG changes, transferred to \nthe MICU for possible HD and monitoring. Patient's hyperkalemia \nwas treated and he was transferred back to the medicine floor.  \nOn ___, he developed fever and was found to have possible \npneumonia, so he was treated for HAP.  Patient has continued to \nimprove throughout hospitalization.\n\nACTIVE ISSUES: \n\n# Hyperkalemia: Presented with ___ and increased oral potassium \nintake in form of orange juice at ___. He had also continued \n___ losartan despite being very dehydrated.  Found to have EKG \nchanges with peaked T waves and PR prolongation. Treated with \ndextrose/insulin, calcium gluconate, kayexelate and 2L of IVF. \nRenal consulted and helped to manage the hyperkalemia. His \npotassium continued to improve and patient was treated with IVF \nand lasix.  Potassium was 4.3 on day of discahrge. \n\n# Pneumonia: Patinet with likely post-opstructive pneumonia.  \nTreated with vanc/zosyn for 8 day course for hospital acquired \npneumonia.  Fevers improved and patient continued to do well.  \nPICC line was placed and patient will continue antibiotics at \ndiscahrge. \n\n# Diarrhea: Patient developed diarrhea on ___.  It was sent \nfor c. diff, which was negative.  Patient remained afebrile with \nbenign abdominal exam. HCT remained stable at his baseline.  It \nis most likely anti-biotic associated diarrhea. \n\n# Acute kidney injury: Presented with ___, creatinine of 2.3 on \nadmission. Felt to be pre-renal in etiology, with additional \ninsult ___ administration. Fractonal excretion of urea and \nsodium point toward pre-renal. Received IVF repletion, losartan \nwas held, patient received IVF resuscitation and creatinine \ngradual improved. Creatinine 1.4 on discharge.  Patient should \nnot be on ___ again. \n\n# Hyponatremia: Likey hypovolemic hyponatremia. Improved rapidly \nwith fluid resuscitation.\n\n# Lung CA/Prostate CA/Goals of Care: Patient coming in from ___ \nhospice, is DNR/DNI. Spoke to wife who would like patient to be \ntreated for reversible conditions.  Patient's code status is \nDNR/DNI, but family expressed wish to continue medical care for \nreversible causes.  \n\nCHRONIC/INACTIVE ISSUES:\n# Anemia: Known iron deficiency anemia and likely anemia of \nchronic disease. Hct at baseline. Patient continued on PPI.  \nAspirin dose was decreased from 325 mg to 81 mg daily following \ndiscussion with PCP.  \n\n# Hypertension: Amlodipine and losartan held during admission.  \nWith poor PO intake, patient does not likely need this \naggressive regimen.  Can monitor blood pressure and consider \nrestarting amlodipine 5 mg daily. \n\n#Alzheimer's: Continue memantine and donepizil.\n\n#Hyperlipidemia: Continued atorvastatin.\n\n#DM: Continued insulin.  Reduced dose as patient has reduced PO \nintake.\n\n#GERD: continued omeprazole.\n\n#COPD: continued tiotropium and fluticasone.\n\nTRANSITIONAL ISSUES:\n-Continue antibiotics for pneumonia. Course complete on ___ \n(8 day course)\n-Check Chemistry on ___ to eval for hyperkalemia\n-Currently holding antihypertensive medications.  Patient had \nnot needed during hospitalization. If patient is hypertensive, \ncan consider amlodipine 5 mg daily.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Amlodipine 5 mg PO DAILY \nhold for SBP<100 \n2. Aspirin 325 mg PO DAILY \n3. Atorvastatin 20 mg PO DAILY \n4. Carvedilol 12.5 mg PO BID \nHold for SBP<100/ HR<60 \n5. Docusate Sodium 100 mg PO BID \n6. Donepezil 10 mg PO HS \n7. Ferrous Sulfate 325 mg PO DAILY \n8. Fluticasone Propionate NASAL 1 SPRY NU BID \n9. Losartan Potassium 50 mg PO DAILY \nhold for SBP<100 \n10. Memantine 10 mg PO BID \n11. Sertraline 100 mg PO DAILY \n12. MetFORMIN (Glucophage) 1000 mg PO BID \n13. Omeprazole 40 mg PO DAILY \n14. Tiotropium Bromide 1 CAP IH DAILY \n15. Glargine 8 Units Breakfast\n\n \nDischarge Medications:\n1. Atorvastatin 20 mg PO DAILY \n2. Docusate Sodium 100 mg PO BID \n3. Donepezil 10 mg PO HS \n4. Ferrous Sulfate 325 mg PO DAILY \n5. Fluticasone Propionate NASAL 1 SPRY NU BID \n6. Memantine 10 mg PO BID \n7. Sertraline 100 mg PO DAILY \n8. Tiotropium Bromide 1 CAP IH DAILY \n9. Piperacillin-Tazobactam 4.5 g IV Q8H \n10. Vancomycin 750 mg IV Q 12H \n11. Omeprazole 40 mg PO DAILY \n12. Glargine 4 Units Bedtime\nInsulin SC Sliding Scale using REG Insulin\n13. Aspirin 81 mg PO DAILY \n14. MetFORMIN (Glucophage) 1000 mg PO BID \n15. Heparin Flush (10 units/ml) 2 mL IV PRN line flush \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY: post-obstructive pneumonia, Acute renal failure, \nfailure to thrive, metastatic lung cancer, metastatic prostate \ncancer\n\n \nDischarge Condition:\nMental Status: Confused - always.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nIt was a pleasure to participate in your care Mr. ___.  You \nwere admitted to the hospital because you were not doing well at \n___.  We found that your potassium was high.  You went to the \nICU for the high potassium.  You also had fevers and a high \nwhite blood cell count and we found that you have pneumonia.  \nYou will be treated with an 8 day course of IV antibiotics.\n\nPlease make the following changes to your medications\n1. STOP losartan\n2. START vancomycin - you will take these medication until \n___\n3. START zosyn - you will take these medications until ___\n4. Decrease aspirin to 81 mg daily\n5. STOP amlodipine\n6. REDUCE glargine insulin and insulin sliding scale (please see \nattached sliding scale)\n\nYou will go to a rehab facility following discharge. \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048213fb505ee753900624"
  },
  "note_id": "13261199-DS-15",
  "subject_id": 13261199,
  "hadm_id": 25810772,
  "note_type": "DS",
  "note_seq": 15,
  "charttime": "2124-10-16 00:00:00",
  "storetime": "2124-10-17 11:08:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\n___ months of intermittent RUQ pain especially after\nlarge/fatty meals\n \nMajor Surgical or Invasive Procedure:\n___ ERCP\n___ laparoscopic cholecystectomy\n\n \nHistory of Present Illness:\n___ with known GB stones/sludge and latent TB previously on\nINH, with ___ months of intermittent RUQ pain especially after\nlarge/fatty meals returns with ~12h of worsening RUQ pain and\nsubjective fever.  She was seen previously in ___ after\nhaving elevated LFT and and a RUQ u/s showed sludge/small \nstones.\nShe was seen in surgical consultation but elected at the time \nfor\nobservation.  She now wishes to undergo treatment as she cannot\ntolerate the pain and she is worried that the gallbladder may\ninterfere with her isoniazid treatment. \n \nPast Medical History:\nlatent TB previously on Isoniazid, held for elevated LFT, B\nthalessemia trait\n\n \nSocial History:\n___\nFamily History:\nnon-contributory\n\n \nPhysical Exam:\nOn Admission Physical Exam:\nVitals: 97.4 80 ___ 95RA\nGEN: A&O, NAD, intermittent pain\nHEENT: No scleral icterus, mucus membranes moist\nCV: RRR, No M/G/R\nPULM: Clear to auscultation b/l, No W/R/R\nABD: Soft, nondistended, mild/moderate TTP in RUQ over GB, GB\nnon-palpable, no rebound or guarding, normoactive bowel sounds,\nno palpable masses\nExt: No ___ edema, ___ warm and well perfused\n \nPertinent Results:\n___ 08:00AM BLOOD WBC-7.4 RBC-4.59 Hgb-13.9 Hct-41.6 MCV-91 \nMCH-30.4 MCHC-33.5 RDW-12.6 Plt ___\n___ 08:00AM BLOOD WBC-7.8 RBC-4.17* Hgb-12.1 Hct-38.4 \nMCV-92 MCH-29.1 MCHC-31.6 RDW-12.8 Plt ___\n___ 07:40AM BLOOD WBC-8.0 RBC-4.57 Hgb-13.8 Hct-42.2 MCV-92 \nMCH-30.1 MCHC-32.7 RDW-12.7 Plt ___\n___ 06:57AM BLOOD WBC-12.3* RBC-5.00# Hgb-14.7 Hct-45.4# \nMCV-91 MCH-29.4# MCHC-32.4 RDW-12.7 Plt ___\n___ 06:57AM BLOOD Neuts-79.6* Lymphs-13.9* Monos-5.7 \nEos-0.4 Baso-0.5\n___ 08:02AM BLOOD ___\n___ 06:57AM BLOOD ___ PTT-31.7 ___\n___ 08:02AM BLOOD Glucose-82 UreaN-4* Creat-0.5 Na-141 \nK-3.7 Cl-104 HCO3-28 AnGap-13\n___ 08:00AM BLOOD Glucose-103* UreaN-4* Creat-0.6 Na-142 \nK-3.6 Cl-104 HCO3-31 AnGap-11\n___ 08:00AM BLOOD Glucose-85 UreaN-7 Creat-0.5 Na-142 K-3.9 \nCl-104 HCO3-28 AnGap-14\n___ 07:40AM BLOOD Glucose-69* UreaN-12 Creat-0.6 Na-141 \nK-3.7 Cl-105 HCO3-24 AnGap-16\n___ 06:57AM BLOOD Glucose-101* UreaN-15 Creat-0.6 Na-141 \nK-4.0 Cl-100 HCO3-24 AnGap-21*\n___ 08:02AM BLOOD ALT-181* AST-120* AlkPhos-203* \nTotBili-0.8\n___ 08:00AM BLOOD ALT-175* AST-76* AlkPhos-174* TotBili-0.6 \nDirBili-0.3 IndBili-0.3\n___ 08:00AM BLOOD ALT-223* AST-123* AlkPhos-175* \nTotBili-0.7 DirBili-0.3 IndBili-0.4\n___ 07:40AM BLOOD ALT-358* AST-314* AlkPhos-206* \nTotBili-1.6*\n___ 06:57AM BLOOD ALT-99* AST-155* LD(LDH)-356* \nAlkPhos-121* TotBili-0.5\n___ 08:02AM BLOOD Lipase-63*\n___ 08:00AM BLOOD Lipase-53\n___ 06:57AM BLOOD Lipase-42\n___ 08:02AM BLOOD Calcium-9.5 Phos-4.0 Mg-1.9\n___ 07:40AM BLOOD Calcium-9.5 Phos-4.1 Mg-2.0\n\nIMAGING:\n\n___ Liver/gallbladder U/S\nCholelithiasis and sludge without evidence of cholecystitis\n\n___ ___\n1.  Cholelithiasis without evidence of cholecystitis or \nintraductal calculi. \n2.  Mild fatty deposition within the liver. \n  \n___ ERCP\nNormal major papilla. Cannulation of the biliary duct was \nsuccessful and deep with a sphincterotome. Normal CBD without \nany filling defects.\nFilling defects in the cystic duct suggestive of stones.  Hence \nsphincterotomy was performed in the 12 o'clock position using a \nsphincterotome. Balloon sweep did not yield any stones or sludge \nfrom the CBD.  Otherwise normal ercp to third part of the \nduodenum.\n\n \nBrief Hospital Course:\nMrs. ___ was admitted on ___ under the Acute Care \nSurgery service for management of her symptomatic cholelithiasis \nand acute cholecystitis. On admission, her WBC was 12.3.  She \nhad a slight transaminitis, elevated alkaline phosphatase of 121 \nand normal total bilirubin.  She was kept NPO, given IV fluids \nand parenteral narcotic and non-narcotic analgesics.  Because \nthe patient is still breast feeding, she was instructed to \ncontinue to use a breast pump but discard the milk. \n\nMrs. ___ underwent a ___ on the day of admission to assess \nfor common bile duct stones.  That exam was negative for stones \nor duct obstruction.  Because the patient was noted to have \nsludge in her CBC on U/S, she underwent an ERCP on ___.  \nAgain, a normal CBD was visualized with normal filling.  There \nwas, however, a filling defect in the cystic duct.  A \nsphincterotomy was performed at that time.  The patient \ntolerated the procedure well.  She was transferred to the \ninpatient ward for further management. \n\nMrs. ___ was taken to the operating room on ___ and \nunderwent a laparoscopic cholecystectomy. Please see operative \nreport for details of this procedure. She tolerated the \nprocedure well and was extubated upon completion. She was \nsubsequently taken to the PACU for recovery. She was transferred \nto the surgical floor hemodynamically stable. Her vital signs \nwere routinely monitored and she remained afebrile and \nhemodynamically stable. She was initially given IV fluids \npostoperatively, which were discontinued when she was tolerating \nPO's. Her diet was advanced on the afternoon of ___ to \nregular, which she tolerated without abdominal pain, nausea, or \nvomiting. She was voiding adequate amounts of urine without \ndifficulty. She was encouraged to mobilize out of bed and \nambulate as tolerated, which she was able to do independently. \nHer pain level was routinely assessed and well controlled at \ndischarge with an oral regimen as needed.\n\nOn ___, she was discharged home with scheduled follow up \nin ___ clinic in ___ weeks.  She was afebrile, hemodynamically \nstable and in no acute distress.  Mrs. ___ will be following \nup with her obstetrician/pediatrician to discuss when she can \nbegin breast feeding again.\n \nMedications on Admission:\nMVI\n\n \nDischarge Medications:\n1. Acetaminophen 650 mg PO Q6H:PRN mild pain \n2. Docusate Sodium 100 mg PO BID \n3. OxycoDONE (Immediate Release)  ___ mg PO Q4H:PRN mod/severe \npain \nRX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours \nDisp #*25 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nSymptomatic cholelithiasis and cholecystitis.\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted to the hospital with acute cholecystitis. You \nwere taken to the operating room and had your gallbladder \nremoved laparoscopically. You tolerated the procedure well and \nare now being discharged home to continue your recovery with the \nfollowing instructions.\n \nPlease follow up in the Acute Care Surgery clinic at the \nappointment listed below.\n \nACTIVITY:\n \no Do not drive until you have stopped taking pain medicine and \nfeel you could respond in an emergency.\no You may climb stairs. \no  You may go outside, but avoid traveling long distances until \nyou see your surgeon at your next visit.\no  Don't lift more than ___ lbs for 4 weeks. (This is about \nthe weight of a briefcase or a bag of groceries.) This applies \nto lifting children, but they may sit on your lap.\no You may start some light exercise when you feel comfortable.\no You will need to stay out of bathtubs or swimming pools for a \ntime while your incision is healing. Ask your doctor when you \ncan resume tub baths or swimming.\n \nHOW YOU MAY FEEL: \no  You may feel weak or \"washed out\" for a couple of weeks. You \nmight want to nap often. Simple tasks may exhaust you.\no  You may have a sore throat because of a tube that was in your \nthroat during surgery.\no  You might have trouble concentrating or difficulty sleeping. \nYou might feel somewhat depressed.\no  You could have a poor appetite for a while. Food may seem \nunappealing.\no  All of these feelings and reactions are normal and should go \naway in a short time.  If they do not, tell your surgeon.\n \nYOUR INCISION:\no Tomorrow you may shower and remove the gauzes over your \nincisions. Under these dressing you have small plastic bandages \ncalled steri-strips. Do not remove steri-strips for 2 weeks. \n(These are the thin paper strips that might be on your \nincision.) But if they fall off before that that's okay).\no Your incisions may be slightly red around the stitches. This \nis normal.\no You may gently wash away dried material around your incision.\no Avoid direct sun exposure to the incision area.\no Do not use any ointments on the incision unless you were told \notherwise.\no You may see a small amount of clear or light red fluid \nstaining your dressing or clothes. If the staining is severe, \nplease call your surgeon.\no You may shower. As noted above, ask your doctor when you may \nresume tub baths or swimming.\n \nYOUR BOWELS:\no Constipation is a common side effect of narcotic pain \nmedications. If needed, you may take a stool softener (such as \nColace, one capsule) or gentle laxative (such as milk of \nmagnesia, 1 tbs) twice a day. You can get both of these \nmedicines without a prescription.\no If you go 48 hours without a bowel movement, or have pain \nmoving the bowels, call your surgeon. \n \nPAIN MANAGEMENT:\no It is normal to feel some discomfort/pain following abdominal \nsurgery. This pain is often described as \"soreness\". \no Your pain should get better day by day. If you find the pain \nis getting worse instead of better, please contact your surgeon.\no You will receive a prescription for pain medicine to take by \nmouth. It is important to take this medicine as directed. o Do \nnot take it more frequently than prescribed. Do not take more \nmedicine at one time than prescribed.\no Your pain medicine will work better if you take it before your \npain gets too severe.\no Talk with your surgeon about how long you will need to take \nprescription pain medicine. Please don't take any other pain \nmedicine, including non-prescription pain medicine, unless your \nsurgeon has said its okay.\no If you are experiencing no pain, it is okay to skip a dose of \npain medicine.\no Remember to use your \"cough pillow\" for splinting when you \ncough or when you are doing your deep breathing exercises.\n\nIf you experience any of the following, please contact your \nsurgeon:\n- sharp pain or any severe pain that lasts several hours\n- pain that is getting worse over time\n- pain accompanied by fever of more than 101\n- a drastic change in nature or quality of your pain\n \nMEDICATIONS:\nTake all the medicines you were on before the operation just as \nyou did before, unless you have been told differently.\nIf you have any questions about what medicine to take or not to \ntake, please call your surgeon.\n \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee753931017"
  },
  "note_id": "19250934-DS-22",
  "subject_id": 19250934,
  "hadm_id": 28792868,
  "note_type": "DS",
  "note_seq": 22,
  "charttime": "2191-12-07 00:00:00",
  "storetime": "2191-12-16 01:07:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCompazine / Motrin / Celexa / Amitriptyline Hcl / Neurontin\n \nAttending: ___.\n \nChief Complaint:\nAbdominal Pain \n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nThis is a ___ year old female with a history of recurrent PEs on \nanticoagulation and recent hysterectomy (___) who presents \nwith abdominal pain. Her pain is located predominantly in her \nleft lower abdomen along the area of her hysterectomy scar. The \npain started yesterday and is non-radiating and exacerbated by \nmovemement and touch. No n/v/d. No constipation or change in \nbowel habits. Her post-op course was complicated by poor wound \nhealing,cellulitis requiring ___ for wound packing and dressing \nchanges. She has also been having intermittent chest pain. Pain \nis described as brief episodes of ___, restro-sternal \nnon-radiating, sharp in character exacerbated by deep breathing. \nNo diaphoresis, no nausea or vomiting.No fevers or chills. She \nstates the pain is similar to her pain with the PEs. She also \njust got over a bad \"cold\" and was told that she needed to get \nsomething to open her airways up. The patient's primary concern \nis the lower abdominal pain. She states that this morning after \nher shower she had fairly sudden onset of lower abd pain along \nher hysterectomy scar.  \n.  \nED COURSE: Initial vital signs were 99.5 117/77 18 98%RA. An EKG \nwas read as sinus at 96. TWI III, avF, ___hanges consistent with prior. CTA was negative for PE. She was \ngiven a dose of ancef for cellulitis.  \n\n \nPast Medical History:\npulmonary embolisms ___ post-op, second unprovoked. neg \nhypercoag eval by heme)  \nfibroids s/p supracervical hysterectomy, repair of bowel serosa \ninjury, cystoscopy (___)  \nosteoarthritis s/p knee replacement  \nobesity  \nsleep apnea  \nanxiety  \n\n \nSocial History:\n___\nFamily History:\nNC  \n\n \nPhysical Exam:\nT: 98.3 BP: 128/70 P: 92 RR: 18 O2 sats: 98%RA wt 107kg  \nGen: NAD, ___ woman resting comfortably  \nHEENT:NCAT, PERRL, EOMI  \nNeck: no masses  \nCV: RRR no MRG, nl S1, S2  \nResp: Clear to ascultation  \nAbd: NABS, soft in upper abd, +erythema, tenderness to pannus \nand surgical scar line in the lower abdomen. No open area to \nscar line. No drainage.  \nExt: no CCE, 2+/4 symmetric pedal pulses  \nNeuro: A,Ox3 coherent response to interview  \nCN: II-XII grossly intact  \nSensation: light touch intact to face/hands/feet  \nStrength: moving all 4 ext symmetrically  \n \n.  \n\n \nPertinent Results:\nEKG: per report sinus at 96. TWI III, avF, ___ \nno changes compared to ___  \nCXR: Lungs are clear bilaterally. There may be a small amount of \natelectasis at the left lung base. Cardiomediastinal silhouette \nis unremarkable. There is no pneumothorax. Visualized osseous \nstructures are intact.  \n.  \nCTA chest: No evidence of pulmonary embolism. no significant \nparenchymal disease.  \n.\n\n___ 06:45PM   GLUCOSE-103 UREA N-9 CREAT-0.8 SODIUM-139 \nPOTASSIUM-4.9 CHLORIDE-104 TOTAL CO2-24 ANION GAP-16\n___ 06:45PM   WBC-6.8# RBC-4.13* HGB-11.2* HCT-34.6* MCV-84 \nMCH-27.2 MCHC-32.5 RDW-14.9\n\n___ 08:03PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-1 PH-5.0 LEUK-NEG\n___ 06:24AM   ___ PTT-40.0* ___\n \nBrief Hospital Course:\nAbdominal pain:  Pain and erythema along hysterectomy scar, \nthought to be secondary to a mild cellulitis.  In the ED she was \nstarted on bactrim and augmentin.  Given her pain out of \nproportion to the extent of infection evident on exam, a CT was \ndone to evaluate for potential abscess.  CT was unremarkable.  \nOB/Gyn was consulted given her history of poor wound healing \nfollowing hysterectomy in ___.  Her pain was felt not to be \nrelated to her surgery/GYN pathology.  She was treated with \ncefazolin overnight and was discharged home with keflex.  She \nremained afebrile and without a WBC throughout her hospital \ncourse.  \n.  \nChest pain: Given her previous history of PE, she had a CTA \nwhich was negative for PE.  Her chest pain is thought to be more \nlikely secondary to bronchospasm from a recent URI.  She was \ncontinued on her home inhalers. \n.  \nHistory of PE: Continued on coumadin.  INR was therapeutic \nthroughout hospital course.  \n\n \nMedications on Admission:\ncoumadin 5mg daily  \nseroquel 600 mg qhs  \nklonopin 0.5 mg bid  \npercocet 1 tab q6  \ntylenol ___ tab q4-6prn  \nalbuterol INH  \nambien 10 mg qhs:prn \n\n \nDischarge Medications:\n1. Clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO BID (2 times \na day).  \n2. Quetiapine 200 mg Tablet Sig: Three (3) Tablet PO HS (at \nbedtime).  \n3. Albuterol 90 mcg/Actuation Aerosol Sig: One (1)  Inhalation \nfour times a day as needed for shortness of breath or wheezing.  \n\n4. Zolpidem 5 mg Tablet Sig: Two (2) Tablet PO HS (at bedtime) \nas needed.  \n5. Warfarin 5 mg Tablet Sig: One (1) Tablet PO once a day.  \n6. Cephalexin 500 mg Capsule Sig: One (1) Capsule PO Q6H (every \n6 hours) for 9 days.\nDisp:*28 Capsule(s)* Refills:*0*\n7. Oxycodone-Acetaminophen ___ mg Tablet Sig: One (1) Tablet \nPO q6 hr prn as needed for 5 days.\nDisp:*10 Tablet(s)* Refills:*0*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nabdominal wall cellulitis\n.\nsecondary diagnoses:\nhistory of pulmonary emboli on coumadin\nfibroids s/p supracervical hysterectomy ___\nobesity\n\n \nDischarge Condition:\nstable, ambulating, eating\n\n \nDischarge Instructions:\nYou were admitted with chest and abdominal pain.  You had a CT \nscan of your chest which did not show any blood clots (pulmonary \nemboli). You were diagnosed with a cellulitis of your abdomen \nand started on a antibiotic called keflex.  You should continue \nthis antibiotic for a total of 9 days.  No other medication \nchanges were made to your medication regimen.  \n.\nPlease call your primary care physician or call ___ if you \nexperience fevers, chills, chest pain, shortness of breath, \nworsening abdominal pain, vomiting, worsening rash or other \nconcerningsymptoms.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee753931018"
  },
  "note_id": "19250934-DS-23",
  "subject_id": 19250934,
  "hadm_id": 28815398,
  "note_type": "DS",
  "note_seq": 23,
  "charttime": "2192-05-09 00:00:00",
  "storetime": "2192-05-09 14:06:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCompazine / Motrin / Celexa / Amitriptyline Hcl / Neurontin\n \nAttending: ___.\n \nChief Complaint:\nCellulitis\n \nMajor Surgical or Invasive Procedure:\nNone.\n\n \nHistory of Present Illness:\nHPI: Ms. ___ ___ yo woman with h/o of PE and s/p \nhysterectomy (___) with site infection and recently history of \nabdominal cellulitis (___) presenting with erythema, pain, and \nswelling around lower abdomen.  The pain is dull and diffuse \nacross her whole abdomen and painful when she moves and with \npalpation.  Nothing relieved the pain including Tylenol so she \npresented on ___ to her NP at her clinic who did not treat at \nthat time but instead discussed the option of imaging  for \ninternal pathology but was concerned for adhesions. When the \nabdomen increasingly painful yesterday (___) the patient \nreturned to the clinic which who sent her to the ED for \nevaluation of infection as her abdomen was now very red in \naddition to painful. She denies any trauma, known skin breaks, \nfevers, chills, nausea, vomiting, or changes to bowel habits. \nShe does have fatigue of the past few months and some sweating \nwithin the past few days.\n\nThe patient's hysterectomy had a complicated post-operative \ncourse in ___ of last year due to poor wound healing \nrequiring incision and drainage for a site infection that \nresolved with regular wound dressing. Notably, an abdominal CT \nin late ___ at time of last cellulitis, which the patient \ndescribes as similar symptoms as she currently presents with, \nwas unremarkable. At that time, the cellulitis was not thought \nto be related to her prior surgery per gyn consultation and she \nresponded to oral antibiotics (keflex) within ___ days.  \nNotably, she has presented several times within the past month \nfor vomiting with some diarrhea without any known food \nconnection. She had an abdominal radiograph ordered for \nabdominal pain on ___ that was unremarkable.\n.\n\n \nPast Medical History:\n1. pulmonary embolism - ___ after left knee replacement, second \nafter stopping coumadin, currently anti-coagulated on couamdin. \nneg \nhypercoag eval by heme)  \n2. cellulitis - treated earlier this year for abdominal \ncellulitis\n3. fibroids s/p supracervical hysterectomy, repair of bowel \nserosa \ninjury, cystoscopy (___)  \n4. fibromyalgia - diagnosed earlier this year by PCP ___ \"leg \nand back pains\"\n5. osteoarthritis s/p bilateral knee replacement\n6. left leg nerve entrapment \n7. ectopic pregnancy  \n8. depression - has seen 5 therapists within the past few years \n9. anxiety  \n10. obesity  \n11. sleep apnea \n12. HSV - need to confirm with patient\n13. migraines\n14. GERD\n15. chronic lower back pain\n16. 2 prior myomectomies\n \nSocial History:\n___\nFamily History:\nnoncontributary (Father's health unknown except potential h/o \nstomach cancer; Mother living at ___ with arthritis and \nosteoporosis; Aunt recently passed at ___ ___nd heart \ndisease. Children healthy; only child.)\n \nPhysical Exam:\nTemp 97.8\nBP 108/78\nPulse 83\nResp 18\nO2 sat 99% ra\nGen - Alert, no acute distress \nHEENT - anicteric, mucous membranes moist \nNeck - no JVD, no cervical lymphadenopathy \nChest - Clear to auscultation bilaterally \nCV - Normal S1/S2, RRR, no murmurs appreciated\nAbd - erythema on R lower abd, marked in pen, tender to light \npalpation but no change in tenderness on deep palp. Abd o/w \nbenign.\nExtr - No edema. 2+ DP pulses bilaterally \nNeuro - Alert and oriented x 3\n.\n\n \nPertinent Results:\n___ 06:02PM   LACTATE-1.6\n___ 05:55PM   GLUCOSE-120* UREA N-4* CREAT-0.9 SODIUM-139 \nPOTASSIUM-3.4 CHLORIDE-103 TOTAL CO2-25 ANION GAP-14\n___ 05:55PM   estGFR-Using this\n___ 05:55PM   WBC-6.3 RBC-4.40 HGB-11.9* HCT-36.8 MCV-84 \nMCH-27.1 MCHC-32.5 RDW-14.6\n___ 05:55PM   NEUTS-71.1* ___ MONOS-4.2 EOS-0.1 \nBASOS-0.1\n___ 05:55PM   PLT COUNT-254\n___ 05:55PM   ___ PTT-42.9* ___\n___ 06:10AM BLOOD WBC-3.7* RBC-4.04* Hgb-10.9* Hct-34.1* \nMCV-84 MCH-27.0 MCHC-32.0 RDW-14.9 Plt ___\n___ 06:15AM BLOOD WBC-4.8 RBC-4.16* Hgb-11.1* Hct-34.9* \nMCV-84 MCH-26.8* MCHC-31.9 RDW-14.8 Plt ___\n___ 05:55PM BLOOD WBC-6.3 RBC-4.40 Hgb-11.9* Hct-36.8 \nMCV-84 MCH-27.1 MCHC-32.5 RDW-14.6 Plt ___\n___ 05:55PM BLOOD Neuts-71.1* ___ Monos-4.2 Eos-0.1 \nBaso-0.1\n___ 06:10AM BLOOD ___\n___ 06:15AM BLOOD ___ PTT-44.7* ___\n___ 06:10AM BLOOD Plt ___\n___ 05:55PM BLOOD ___ PTT-42.9* ___\n___ 06:10AM BLOOD Glucose-111* UreaN-6 Creat-0.7 Na-139 \nK-3.9 Cl-105 HCO3-26 AnGap-12\n___ 05:55PM BLOOD Glucose-120* UreaN-4* Creat-0.9 Na-139 \nK-3.4 Cl-103 HCO3-25 AnGap-___/P: ___ yo F p/w cellulits.\n.\nIt is unclear why patient has developed two superficial skin \ninfections over her abd within 6 months without apparent traums, \nthough her body habitus does put her at risk for poor wound \nhealing if there had been a minor occult skin break.  The \npatient's presentation in the ED was remarkable for vitals of \n98.9 T, 104 HR, 120/75 BP, 20 RR, 100 % O2 saturation. A outline \nwas made of the erythema in the ED and the patient was \nprescribed percocet x 2 tabs, morphine 2 mg, and started on \nUnasyn 3 g iv x1. Her INR was supratherapeutic (~4) so her \ncoumadin was held.\n.\nAfter admission to medicine, she was switched to an IV \ncephalosporin and her pain was managed with morphine and \noxycodone-acetaminophen. The extent of erythema and pain \nimproved overnight and she was switched to an oral antibiotics \non ___. She remained afebrile throughout her stay without \nany concerning systemic symptoms. The border of her erythema was \nmarked and monitered and continues to decrease. Her coumadin was \nheld while here for supratheurapeutic levels. She will be \nrestarted as an outpatient on a lowered dose (5.0mg) as it was \nrecently increased (7.5mg). She was also continued on her home \ndose of anxiety and depression medications. She had a few \nelevated blood pressure measurements this morning that were \ndiscussed with the patient to be followed as an out-patient.\n.\n\n \nMedications on Admission:\nHome medications:\nKlonopin (Clonzepam) 0.5 mg bid\nSeroquel (Quetiapine Fumarate) 600 mg qhs\nAmbien (Zolpidem Tartate) 12.5 mg qhs\nCoumadin (Warfarin )1.5 tablets of 5 mg qd \nAcyclovir 5 % Ointment \nAcetaminophen-Codeine [Tylenol-Codeine #4] 60 mg-300 mg PO q4-6h \nprn \nAlbuterol 90 mcg HFA Aerosol Inhaler \n2 (Two) puff inhaled every six (6) hours as needed for cough \n \nDischarge Medications:\n1. Clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO BID (2 times \na day).  \n2. Quetiapine 200 mg Tablet Sig: Three (3) Tablet PO QHS (once a \nday (at bedtime)).  \n3. Zolpidem 12.5 mg Tablet, Multiphasic Release Sig: One (1) \nTablet, Multiphasic Release PO once a day.  \n4. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \nhours) as needed for pain.  \n5. Cephalexin 500 mg Capsule Sig: One (1) Capsule PO Q6H (every \n6 hours) for 9 days: Started on ___ for a ___. Warfarin 5 mg Tablet Sig: One (1) Tablet PO once a day.  \n\n1. Clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO BID (2 times \na day).  \n2. Quetiapine 200 mg Tablet Sig: Three (3) Tablet PO QHS (once a \nday (at bedtime)).  \n3. Zolpidem 12.5 mg Tablet, Multiphasic Release Sig: One (1) \nTablet, Multiphasic Release PO once a day.  \n4. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \nhours) as needed for pain.  \n5. Cephalexin 500 mg Capsule Sig: One (1) Capsule PO Q6H (every \n6 hours) for 9 days: Started on ___ for a ___isp:*40 Capsule(s)* Refills:*0*\n6. Warfarin 5 mg Tablet Sig: One (1) Tablet PO once a day.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary:\n1. Cellulitis\n2. Elevated blood pressure\n\nSecondary:\n1. Anxiety\n2. Depression\n\n \nDischarge Condition:\nStable. Afebrile. \n\n \nDischarge Instructions:\nYou presented to the hospital with pain, redness, and swelling \non your abdomen consistent with a skin infection. You were \ntreated with antibiotics and your symptoms improved and the \nextent of infection decreased. You had 1 epidsode of elevated \nblood pressure on day of discharge that remitted when checked 1 \nhour later and we discussed with you following up blood pressure \ncontrol as an out-patient. We are holding your blood thinning \nmedication (Coumadin) today but request restarting it tomorrow \non a lowered dose (5mg). \n\nPlease return to the hospital if you have any fevers, chills, \nchest pain, shortness of breath, worsening abdominal pain, \nvomiting, worsening rash or other concerning symptoms.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee753931019"
  },
  "note_id": "19250934-DS-24",
  "subject_id": 19250934,
  "hadm_id": 29539495,
  "note_type": "DS",
  "note_seq": 24,
  "charttime": "2194-06-03 00:00:00",
  "storetime": "2194-06-04 15:42:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCompazine / Motrin / Celexa / Amitriptyline Hcl / Neurontin\n \nAttending: ___.\n \nChief Complaint:\nNausea and Vomiting\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ yo F with h/o PE on coumadin presenting from \nclinic with 6 days of N/V, unable to take POs. States ate \nPopeye's on ___. Then n/v since ___ morning without \nfever or diarrhea. No one else was sick at home. She has been \nunable to keep medications down. She had not eaten anything for \none week and has been unable to tolerate any fluids. On \nadmission she had some lightheadedness.  \n.  \nIn ED, vitals were 99.2 68 97/58 14 99  \nLabs were notable for a creatinine of 12.8. Abdominal US \nnegative for hydro, gallstones and cholecystitis. INR was \nsubtherapeutic at 1.4 and patient was given 120mg enoxaparin. \nAlso given percocet, seroquel and ambien (home meds), warfarin \nand 2L NS. Unable to get repeat labs due to difficult \nvenipuncture.  \n.  \nThis morning, the patient was initially very drowsy. Her \ndrowsiness improved over a few hours and she was able to give a \nhistory. She denies dysuria, abdominal pain. She is no longer \nlightheaded, does not feel nauseous, has not vomited.  \n\n \nPast Medical History:\n1. pulmonary embolism - ___ after left knee replacement, second \nafter stopping coumadin, currently anti-coagulated on couamdin. \nneg \nhypercoag eval by heme)  \n2. cellulitis - treated earlier this year for abdominal \ncellulitis\n3. fibroids s/p supracervical hysterectomy, repair of bowel \nserosa \ninjury, cystoscopy (___)  \n4. fibromyalgia - diagnosed earlier this year by PCP ___ \"leg \nand back pains\"\n5. osteoarthritis s/p bilateral knee replacement\n6. left leg nerve entrapment \n7. ectopic pregnancy  \n8. depression - has seen 5 therapists within the past few years \n9. anxiety  \n10. obesity  \n11. sleep apnea \n12. HSV - need to confirm with patient\n13. migraines\n14. GERD\n15. chronic lower back pain\n16. 2 prior myomectomies\n \nSocial History:\n___\nFamily History:\nnoncontributary (Father's health unknown except potential h/o \nstomach cancer; Mother living at ___ with arthritis and \nosteoporosis; Aunt recently passed at ___ ___nd heart \ndisease. Children healthy; only child.)\n \nPhysical Exam:\nPhysical Exam on Admission ___:\n\nVS - Temp 98.4 F, BP 116/55 , HR 72, R 20, O2-sat 100% RA  \nGENERAL - sleeping but arousable, sedated appearing, NAD  \nHEENT - NC/AT, EOMI but sluggish, dry MM, OP clear  \nNECK - supple, no thyromegaly, no JVD  \nLUNGS - CTA bilat, no r/rh/wh  \nHEART - Hyperdynamic PMI, non-displaced, RRR, no MRG  \nABDOMEN - hypoactive BS, mildly tender suprapubically with \nfullness on exam, no rebound/guarding  \nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs) \n \nSKIN - no rashes or lesions  \nLYMPH - no cervical, axillary, or inguinal LAD  \n\n \nPertinent Results:\n___ 06:30PM BLOOD WBC-6.4# RBC-4.90 Hgb-13.3 Hct-40.0 \nMCV-82 MCH-27.2 MCHC-33.3 RDW-14.2 Plt ___\n___ 07:20PM BLOOD WBC-6.0 RBC-4.08* Hgb-11.4* Hct-33.6* \nMCV-82 MCH-27.9 MCHC-33.8 RDW-14.2 Plt ___\n___ 11:04AM BLOOD WBC-5.2 RBC-4.02* Hgb-11.0* Hct-33.6* \nMCV-84 MCH-27.4 MCHC-32.8 RDW-14.3 Plt ___\n___ 06:30PM BLOOD Neuts-55.6 ___ Monos-9.4 Eos-0.5 \nBaso-0.6\n___ 06:30PM BLOOD ___ PTT-29.2 ___\n___ 11:04AM BLOOD ___ PTT-31.8 ___\n___ 03:22AM BLOOD ESR-45*\n___ 07:20PM BLOOD LMWH-0.42\n___ 06:30PM BLOOD Glucose-116* UreaN-59* Creat-12.8*# \nNa-134 K-4.4 Cl-85* HCO3-24 AnGap-29*\n___ 03:22AM BLOOD Glucose-148* UreaN-55* Creat-9.3*# Na-137 \nK-2.9* Cl-93* HCO3-29 AnGap-18\n___ 07:20PM BLOOD Glucose-152* UreaN-42* Creat-3.9*# Na-140 \nK-3.5 Cl-99 HCO3-30 AnGap-15\n___ 11:04AM BLOOD Glucose-111* UreaN-28* Creat-1.6*# Na-142 \nK-3.9 Cl-103 HCO3-32 AnGap-11\n___ 03:22AM BLOOD CK(CPK)-2877*\n___ 07:20PM BLOOD ALT-19 AST-42* LD(LDH)-278* ___ \nAlkPhos-65 TotBili-0.3\n___ 11:04AM BLOOD ALT-23 AST-38 LD(LDH)-259* CK(CPK)-1286* \nAlkPhos-63 TotBili-0.4\n___ 11:04AM BLOOD Calcium-9.4 Phos-2.0* Mg-1.7\n___ 03:22AM BLOOD CRP-13.4*\n___ 06:35PM BLOOD freeCa-0.94*\n\n_____________________\n\nLIVER U/S ___\nIMPRESSION: \n  \n1. No cholelithiasis or sonographic evidence of acute \ncholecystitis. No \nbiliary ductal dilation. \n  \n2. No renal masses, hydronephrosis or nephrolithiasis. Increased \n\nechogenicity of the renal parenchyma bilaterally suggests \nunderlying medical renal disease. \n\nAbdominal DOPPER ___\nIMPRESSION: Patent renal veins bilaterally, without evidence of \nrenal vein \nthrombosis. \n\n \nBrief Hospital Course:\nMs. ___ is a ___ year old woman with 6 days of N/V and poor PO \nintake who presented with a creatinine 12.8.  \n.  \n#. ARF: Patient initially described only 6 days of nausea and \nvomiting but in further discussion, she revealed that this has \nactually been going on for a month. She has not had any workup \nfor her nausea and vomiting. Her elevated Creatinine was likely \npre-renal, due to profound dyhydration. This is supported by the \nfact that her creatinine improved with IV fluids (from 12 on \nadmission to 1.9 on discharge.) She had not been urinating in \nthe ED but urinated well after several liters of IV fluid. Her \nurinalysis showed casts consistent with ATN, which was thought \nto be consistent with a long-term pre-renal ___ picture per \nrenal consult. CK was elevated and decreased overnight- this was \nalso thought to be consistent with dehydration. There was some \nconcern for renal vein thrombosis given patient's history of PE \nand that she presented with a subtherapeutic INR, but Doppler \nwas negative. Patient denies dysuria but given U/A showing neg \nleuks and nitrites with moderate bacteria, we discharged her on \na three day course of Cipro (she has had UTIs sensitive to this \nin the past.) On a telephone call after discharge, we advised \nthe patient to only take 5 mg Coumadin daily until she sees Dr. \n___ week (decreased from her normal schedule of 7.5 mg \non some days) due to the fact that she was taking Cipro.\n.  \n#. N/V: Patient did not have nausea or vomiting while in the \nhospital. This was thought to be due to viral gastroenteritis in \nthe short term. However, if she truly has had this problem for a \nmonth, she could have another underlying problem. She was told \nto follow this up with her PCP. The patient was able to tolerate \nfood and fluids in the hospital. She was told to contact her PCP \nor return to the ED if unable to tolerate POs. Of note the \npatient was afebrile, without diarrhea, with lipase 77.  \n.  \n#. h/o PE, subtherapeutic INR: Patient had been followed by heme \nand per history needs indefinite anticoagulation. She received a \ntherapeutic dose of lovenox in ED (120mg) while her Cr was 12.8 \nso we held anticoagulation in the hospital. A Factor XA test was \nperformed and was normal and so we decided to restart \nanti-coagulation on discharge. The patient did not need to be \nbridged because she didn't have an active clot (hx of clots over \na year ago per the patient) and so she was restarted on \ncoumadin. On a telephone call after discharge, we advised the \npatient to only take 5 mg Coumadin daily until she sees Dr. \n___ week (decreased from her normal schedule of 7.5 mg \non some days) due to the fact that she was taking Cipro.\n.   \n#. HTN: Patient was not hypertensive here. We held her \nlisinopril during hospitalization and on discharge with \ninstructions to follow this up with her PCP, given her acute \nkidney injury.  \n.  \n#. Psych: We held the patient's psych medication in the hospital \nbecause she ewas sedated from receiving them in the ED. We \nrestarted these on discharge.\n\n \nMedications on Admission:\nSeroquel 600 QHS  \nClonazepam 0.5mg daily  \nAlbuterol inhaler  \nLisinopril 20 mg daily  \nAmbien 12.5 CR daily  \nPercoset 2 tablets q4-6 prn  \nWarfarin 7.5mg MWF and 5 TuThSa  \nFlovent inhaler  \n\n \nDischarge Medications:\n1. Albuterol Sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \n___ Puffs Inhalation Q4H (every 4 hours) as needed for wheezing. \n \n2. Fluticasone 110 mcg/Actuation Aerosol Sig: Two (2) Puff \nInhalation BID (2 times a day).  \n3. Seroquel 400 mg Tablet Sig: 1.5 Tablets PO at bedtime.  \n4. Clonazepam 0.5 mg Tablet Sig: One (1) Tablet PO once a day.  \n5. Ambien CR 12.5 mg Tablet, Multiphasic Release Sig: One (1) \nTablet, Multiphasic Release PO once a day.  \n6. Percocet  Oral\n7. Warfarin 7.5 mg Tablet Sig: One (1) Tablet PO ___, \n___.  \n8. Warfarin 5 mg Tablet Sig: One (1) Tablet PO ___, \n___.  \n9. Outpatient Lab Work\nPlease draw: K, Cr, ___, INR on ___.\n\nPlease fax results to ___, MD at ___.\nAny problem with faxing: phone is ___.\n10. Cipro 250 mg Tablet Sig: One (1) Tablet PO twice a day for 3 \ndays.\nDisp:*6 Tablet(s)* Refills:*0*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary Diagnosis:\nAcute Kidney Injury, likely due to dehydration\n.\nSecondary Diagnoses:\nGastroenteritis, likely viral\nHistory of PE, anti-coagulated\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted to the hospital because you had nausea and \nvomiting. We were worried about your kidneys because our blood \ntests showed that they were not working well when you arrived. \nThis is likely because you were very dehydrated. We gave you a \nlot of IV fluids and your kidney blood tests improved. Because \nyour kidney is not completely back to normal, we think you \nshould stop taking Lisinopril for now. Your primary care doctor \ncan decide when to restart this. We were worried that you might \nhave a UTI so we are going to give you an antibiotic for this \nfor three days.\n.\nIt is very important that you take a lot of fluids at home; if \nyou are unable to hold these down, you should contact your PCP \nand come back to the ED immediately. You should tell your PCP \nabout your ongoing vomiting and she can decide how to work this \nup.\n.\nIn summary\nWe STOPPED your Lisinopril- you should talk to your PCP about \nwhen to restart this.\nWe ADDED Ciprofloxacin- you should take this for three days.\n.\nYou need to go get blood drawn on ___. These tests will be \nfaxed to your primary care doctor.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee75393101a"
  },
  "note_id": "19250934-DS-25",
  "subject_id": 19250934,
  "hadm_id": 23290765,
  "note_type": "DS",
  "note_seq": 25,
  "charttime": "2194-08-13 00:00:00",
  "storetime": "2194-08-13 10:38:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: ORTHOPAEDICS\n \nAllergies: \nCompazine / Motrin / Celexa / Amitriptyline Hcl / Neurontin\n \nAttending: ___\n \n___ Complaint:\nRight knee pain\n \nMajor Surgical or Invasive Procedure:\nRight total knee replacement\n\n \nHistory of Present Illness:\nMs. ___ is a ___ year old women who has left knee pain.  \nShe had a patellafemoral replacement at ___ and continues to \nhave pain.  She has not had any relief with oral medications.  \n \nPast Medical History:\n1. pulmonary embolism - ___ after left knee replacement, second \nafter stopping coumadin, currently anti-coagulated on couamdin. \nneg hypercoag eval by heme)  \n2. cellulitis - treated earlier this year for abdominal \ncellulitis\n3. fibroids s/p supracervical hysterectomy, repair of bowel \nserosa injury, cystoscopy (___)  \n4. fibromyalgia - diagnosed earlier this year by PCP ___ \"leg \nand back pains\"\n5. osteoarthritis s/p bilateral knee replacement\n6. left leg nerve entrapment \n7. ectopic pregnancy  \n8. depression - has seen 5 therapists within the past few years \n9. anxiety  \n10. obesity  \n11. sleep apnea \n12. HSV - need to confirm with patient\n13. migraines\n14. GERD\n15. chronic lower back pain\n16. 2 prior myomectomies\n \nSocial History:\n___\nFamily History:\nnoncontributary (Father's health unknown except potential h/o \nstomach cancer; Mother living at ___ with arthritis and \nosteoporosis; Aunt recently passed at ___ ___nd heart \ndisease. Children healthy; only child.)\n \nPhysical Exam:\nGen: AOx3. NAD\nNeck: Supple\nHeart: Tachy, No M/R/G\nLungs: CTA-B\nAbd: Soft, NTND\nExt: Right knee dressing, clean and dry.  Skin no wamrth, \n     positive ___, FHL, NVI, Negative homens's test\n \nPertinent Results:\n___ 06:35AM BLOOD WBC-5.9 RBC-2.55* Hgb-7.1* Hct-22.4* \nMCV-88 MCH-27.6 MCHC-31.4 RDW-15.4 Plt ___\n___ 06:55AM BLOOD WBC-7.1 RBC-2.78* Hgb-7.7* Hct-23.7* \nMCV-85 MCH-27.8 MCHC-32.6 RDW-14.8 Plt ___\n___ 06:26AM BLOOD WBC-9.4 RBC-2.97* Hgb-8.3* Hct-25.4* \nMCV-85 MCH-27.9 MCHC-32.7 RDW-15.1 Plt ___\n___ 06:32AM BLOOD WBC-8.3 RBC-3.19*# Hgb-8.7*# Hct-27.2* \nMCV-85 MCH-27.4 MCHC-32.1 RDW-15.3 Plt ___\n___ 06:32AM BLOOD Neuts-70.8* Bands-0 ___ Monos-7.3 \nEos-0.9 Baso-0.3\n___ 06:32AM BLOOD Hypochr-2+ Anisocy-1+ Poiklo-1+ \nMacrocy-1+ Microcy-1+ Polychr-NORMAL Ovalocy-1+\n___ 06:35AM BLOOD Plt ___\n___ 06:35AM BLOOD ___ PTT-52.3* ___\n___ 06:55AM BLOOD Plt ___\n___ 06:55AM BLOOD ___ PTT-47.4* ___\n___ 06:26AM BLOOD Plt ___\n___ 06:26AM BLOOD ___ PTT-36.0* ___\n___ 06:32AM BLOOD Plt ___\n___ 06:32AM BLOOD ___ PTT-31.3 ___\n___ 06:32AM BLOOD Calcium-8.5 Phos-2.1* Mg-1.6\n \nBrief Hospital Course:\nThe patient was admitted to the orthopaedic surgery service and \nwas taken to the operating room for above described procedure.  \nPlease see separately dictated operative report for details. The \nsurgery was uncomplicated and the patient tolerated the \nprocedure well. Patient received perioperative IV antibiotics.\n\nOtherwise, pain was initially controlled with a PCA followed by \na transition to oral pain medications on POD#1.  The patient \nreceived lovenox for DVT prophylaxis starting on the morning of \nPOD#1.  The foley was removed on POD#2 and the patient was \nvoiding independently thereafter. The surgical dressing was \nchanged on POD#2 and the surgical incision was found to be clean \nand intact without erythema or abnormal drainage. The patient \nwas seen daily by physical therapy. Labs were checked throughout \nthe hospital course and repleted accordingly. At the time of \ndischarge the patient was tolerating a regular diet and feeling \nwell.  The patient was afebrile with stable vital signs.  The \npatient's hematocrit was acceptable and pain was adequately \ncontrolled on an oral regimen. The operative extremity was \nneurovascularly intact and the wound was benign. \n\nThe patient's weight-bearing status is weight bearing as \ntolerated on the operative extremity. \n \nMs. ___ is discharged to home with services in stable \ncondition with prescriptions for oxycodone for pain.\n\n \nMedications on Admission:\nlisinopril, lorazepam, seroquel, warfarin, colace, \nambien,lovenox, albuterol\n \nDischarge Medications:\n1. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).\nDisp:*60 Capsule(s)* Refills:*2*\n2. Acetaminophen 325 mg Tablet Sig: ___ Tablets PO Q6H (every 6 \nhours).  \n3. Oxycodone 5 mg Tablet Sig: ___ Tablets PO every ___ hours as \nneeded: No driving while taking this medication.\nDisp:*100 Tablet(s)* Refills:*0*\n4. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday) as needed for Constipation.\nDisp:*60 Tablet(s)* Refills:*0*\n5. Calcium Carbonate 200 mg (500 mg) Tablet, Chewable Sig: One \n(1) Tablet, Chewable PO TID (3 times a day).  \n6. Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: One (1) \nTablet PO DAILY (Daily).  \n7. Multivitamin     Tablet Sig: One (1) Cap PO DAILY (Daily).  \n8. Quetiapine 200 mg Tablet Sig: Three (3) Tablet PO HS (at \nbedtime).  \n9. Warfarin 2.5 mg Tablet Sig: Three (3) Tablet PO DAYS \n(___): target INR ___.  \n10. Warfarin 5 mg Tablet Sig: One (1) Tablet PO DAYS \n(___): Target INR ___.  \n11. Lisinopril 30 mg Tablet Sig: One (1) Tablet PO once a day.  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nRight knee osteoarthritis\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\n1. Please return to the emergency department or notify your \nphysician if you experience any of the following: severe pain \nnot relieved by medication, increased swelling, decreased \nsensation, difficulty with movement, fevers greater than 101.5, \nshaking chills, increasing redness or drainage from the incision \nsite, chest pain, shortness of breath or any other concerns.\n\n2. Please follow up with your primary physician regarding this \nadmission and any new medications and refills.  \n\n3. Resume your home medications unless otherwise instructed.\n\n4. You have been given medications for pain control. Please do \nnot drive, operate heavy machinery, or drink alcohol while \ntaking these medications. As your pain decreases, take fewer \ntablets and increase the time between doses. This medication can \ncause constipation, so you should drink plenty of water daily \nand take a stool softener (such as colace) as needed to prevent \nthis side effect.  Call your surgeons office 3 days before you \nare out of medication so that it can be refilled.  These \nmedications cannot be called into your pharmacy and must be \npicked up in the clinic or mailed to your house.  Please allow \nan extra 2 days if you would like your medication mailed to your \nhome.\n\n5. You may not drive a car until cleared to do so by your \nsurgeon or your primary physician.\n\n6. Please keep your wounds clean. You may shower starting five \ndays after surgery, but no tub baths or swimming for at least \nfour weeks. No dressing is needed if wound continues to be \nnon-draining. Any stitches or staples that need to be removed \nwill be taken out by the visiting nurse or rehab facility two \nweeks after your surgery.\n\n7. Please call your surgeon's office to schedule or confirm your \n\nfollow-up appointment in four weeks.\n\n8. Please DO NOT take any non-steroidal anti-inflammatory \nmedications (NSAIDs such as celebrex, ibuprofen, advil, aleve, \nmotrin, etc).\n\n9. ANTICOAGULATION: Please continue your lovenox for three weeks \n\nto help prevent deep vein thrombosis (blood clots).  After \ncompleting the lovenox, please take Aspirin 325mg  TWICE  daily \nfor an additional three weeks.\n\n10. WOUND CARE: Please keep your incision clean and dry. It is \nokay to shower five days after surgery but no tub baths, \nswimming, or submerging your incision until after your four week \ncheckup. Please place a dry sterile dressing on the wound each \nday if there is drainage, otherwise leave it open to air. Check \nwound regularly for signs of infection such as redness or thick \nyellow drainage. \nStaples will be removed at your follow up appointment in 3 \nweeks.\n\n11. ___ (once at home): Home ___, dressing changes as \ninstructed, wound checks.\n\n12. ACTIVITY: Weight bearing as tolerated on the operative \nextremity. CPM as tolerated. No strenuous exercise or heavy \nlifting until follow up appointment.\n\nPhysical Therapy:\nActivity:  Activity as tolerated\n Right lower extremity:  Full weight bearing\n Left lower extremity:  Full weight bearing\nEncourage turn, cough and deep breathe q2h when awake\n\nTreatments Frequency:\nPlease keep your incision clean and dry. It is okay to shower \nfive days after surgery but no tub baths, swimming, or \nsubmerging your incision until after your four week checkup.  \nPlease place a dry sterile dressing on the wound each day if \nthere is drainage, otherwise leave it open to air. Check wound \nregularly for signs of infection such as redness or thick yellow \ndrainage.  Staples will be removed by physician assistant on \nfollow up visit in 3 weeks.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee75393101b"
  },
  "note_id": "19250934-DS-26",
  "subject_id": 19250934,
  "hadm_id": 29186357,
  "note_type": "DS",
  "note_seq": 26,
  "charttime": "2194-08-19 00:00:00",
  "storetime": "2194-08-19 11:56:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: ORTHOPAEDICS\n \nAllergies: \nCompazine / Motrin / Celexa / Amitriptyline Hcl / Neurontin\n \nAttending: ___\n \n___ Complaint:\nIncrease in bleeding due to elevated INR\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\nMs ___ was admitted due to an elevated INR after having \na right TKR on ___.  She was for INR monitoring and a \ntarget INR of ___.  \n \nPast Medical History:\n1. pulmonary embolism - ___ after left knee replacement, second \nafter stopping coumadin, currently anti-coagulated on couamdin. \nneg hypercoag eval by heme)  \n2. cellulitis - treated earlier this year for abdominal \ncellulitis\n3. fibroids s/p supracervical hysterectomy, repair of bowel \nserosa injury, cystoscopy (___)  \n4. fibromyalgia - diagnosed earlier this year by PCP ___ \"leg \nand back pains\"\n5. osteoarthritis s/p bilateral knee replacement\n6. left leg nerve entrapment \n7. ectopic pregnancy  \n8. depression - has seen 5 therapists within the past few years \n9. anxiety  \n10. obesity  \n11. sleep apnea \n12. HSV - need to confirm with patient\n13. migraines\n14. GERD\n15. chronic lower back pain\n16. 2 prior myomectomies\n \nSocial History:\n___\nFamily History:\nn/c\n \nPhysical Exam:\nGEN: AOx3, NAD\nNECK: Supple\nHEART: RRR, no M/R/G\nLUNGS: CTA-B\nABDOMEN: Soft, NTND, NABS\nEXTREMITY; Right knee with small amounts oozing from incision. \nDressings changed daily prn.\n           Negative ___ test, ___ and FHL, \n           positive capillary refill, NVI\n \nPertinent Results:\n___ 06:47AM BLOOD WBC-6.8 RBC-2.77* Hgb-7.6* Hct-24.5* \nMCV-88 MCH-27.3 MCHC-30.9* RDW-16.3* Plt ___\n___ 06:25AM BLOOD WBC-7.4 RBC-2.63* Hgb-7.3* Hct-23.2* \nMCV-88 MCH-27.6 MCHC-31.3 RDW-16.2* Plt ___\n___ 10:00PM BLOOD WBC-9.9# RBC-2.87* Hgb-7.9* Hct-24.8* \nMCV-86 MCH-27.5 MCHC-31.8 RDW-16.1* Plt ___\n___ 10:00PM BLOOD Neuts-61.5 ___ Monos-6.1 Eos-0.5 \nBaso-0.6\n___ 06:47AM BLOOD Plt ___\n___ 06:47AM BLOOD ___\n___ 06:25AM BLOOD Plt ___\n___ 06:25AM BLOOD ___ PTT-46.1* ___\n___ 10:00PM BLOOD Plt ___\n___ 10:00PM BLOOD ___ PTT-43.8* ___\n___ 06:25AM BLOOD Glucose-111* UreaN-7 Creat-0.8 Na-136 \nK-4.2 Cl-100 HCO3-26 AnGap-14\n___ 10:00PM BLOOD Glucose-104* UreaN-6 Creat-0.7 Na-136 \nK-4.1 Cl-98 HCO3-27 AnGap-15\n___ 06:35AM BLOOD ___\n \nBrief Hospital Course:\nMs ___ was admitted from the emergency room with severe \nbleeding from surgical site along with an elevated INR.  She was \nadmitted to monitor her INR with a goal of ___.  She is \ndischarge home on coumadin 5mg and will follow up with her PCP \n___ at ___ (Phone ___ \nor Fax ___ and continue ___ and regular INR checks \nevery ___. She will begin to take keflex ___ four \ntimes per day for 10 days. \n \nMedications on Admission:\ntylenol, colace, MVI, quetiapine, senna, coumadin, oxycodone, \nlisinopril\n \nDischarge Medications:\n1. lisinopril 10 mg Tablet Sig: Three (3) Tablet PO DAILY \n(Daily).  \n2. lorazepam 1 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) \nas needed for anxiety.  \n3. quetiapine 300 mg Tablet Sustained Release 24 hr Sig: Two (2) \nTablet Sustained Release 24 hr PO QHS (once a day (at bedtime)). \n \n4. warfarin 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily): \nTarget INR ___.  Followed by PCP ___ ___.\nDisp:*30 Tablet(s)* Refills:*2*\n5. cephalexin 500 mg Capsule Sig: One (1) Capsule PO four times \na day for 10 days.\nDisp:*40 Capsule(s)* Refills:*0*\n6. Percocet ___ mg Tablet Sig: ___ Tablets PO every ___ \nhours: do not take with additional tylenol.  do not exceed more \nthan 12 tabs in 24 hours.\nDisp:*100 Tablet(s)* Refills:*0*\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nElevated INR\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\n1. Please return to the emergency department or notify your \nphysician if you experience any of the following: severe pain \nnot relieved by medication, increased swelling, decreased \nsensation, difficulty with movement, fevers greater than 101.5, \nshaking chills, increasing redness or drainage from the incision \nsite, chest pain, shortness of breath or any other concerns.\n\n2. Please follow up with your primary physician regarding this \nadmission and any new medications and refills.  \n\n3. Resume your home medications unless otherwise instructed.\n\n4. You have been given medications for pain control. Please do \nnot drive, operate heavy machinery, or drink alcohol while \ntaking these medications. As your pain decreases, take fewer \ntablets and increase the time between doses. This medication can \ncause constipation, so you should drink plenty of water daily \nand take a stool softener (such as colace) as needed to prevent \nthis side effect.  Call your surgeons office 3 days before you \nare out of medication so that it can be refilled.  These \nmedications cannot be called into your pharmacy and must be \npicked up in the clinic or mailed to your house.  Please allow \nan extra 2 days if you would like your medication mailed to your \nhome.\n\n5. You may not drive a car until cleared to do so by your \nsurgeon or your primary physician.\n\n6. Please keep your wounds clean. You may shower starting five \ndays after surgery, but no tub baths or swimming for at least \nfour weeks. No dressing is needed if wound continues to be \nnon-draining. Any stitches or staples that need to be removed \nwill be taken out by ___ on ___ at 1:40PM. \n\n7. Please call your surgeon's office to schedule or confirm your \nfollow-up appointment with ___ (___).\n\n8. Please DO NOT take any non-steroidal anti-inflammatory \nmedications (NSAIDs such as celebrex, ibuprofen, advil, aleve, \nmotrin, etc).\n\n9. ANTICOAGULATION: Please continue your coumadin to help \nprevent deep vein thrombosis (blood clots).  Get INR checked \n___ by ___ and results should be faxed to Dr. ___ \n___ at ___ or called ___ and dose \ncoumadin appropriately.    \n\n10. WOUND CARE: Please keep your incision clean and dry. It is \nokay to shower five days after surgery but no tub baths, \nswimming, or submerging your incision until after your four week \ncheckup. Please place a dry sterile dressing on the wound each \nday if there is drainage, otherwise leave it open to air. Check \nwound regularly for signs of infection such as redness or thick \nyellow drainage. Staples will be removed by ___ at your \nappointment on ___.  \n\n11. ACTIVITY: Weight bearing as tolerated on the operative \nextremity. CPM as tolerated. No strenuous exercise or heavy \nlifting until follow up appointment.\n\n12. Take Keflex ___ four times per day for 10 days.\n\nPhysical Therapy:\nMobilize\nWBAT\nROM unrestricted\nCPM as tolerated\nTreatments Frequency:\nDry sterile dressings daily as needed for drainage.\nWound checks daily.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee75393101c"
  },
  "note_id": "19250934-DS-27",
  "subject_id": 19250934,
  "hadm_id": 20231125,
  "note_type": "DS",
  "note_seq": 27,
  "charttime": "2195-09-26 00:00:00",
  "storetime": "2195-09-26 17:40:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCompazine / Motrin / Celexa / Amitriptyline Hcl / Neurontin\n \nAttending: ___.\n \nChief Complaint:\nPain and swelling in right axilla\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ with a h/o PE on coumadin, s/p hysterectomy with retention \nof ovaries and persistent pelvic fluid collection, fibromyalgia, \ndepression/anxiety who presents with swelling/pain in R axilla \nand abdominal pain. The patient reports that approximately 2 \ndays prior to admission, she was shaving her underarm, when she \nnoticed a painful nodule within her axilla. She reports \nincreasing tenderness in the region over the subsequent days. \nShe denies experiencing this in the past. She denies any \nfevers/chills, surrounding erythema, drainage, or bleeding.  \n\nIn addition, patient also presenting with LLQ and RLQ pain x 4 \ndays that resembles pain she associates with past ovarian cysts. \nShe describes the pain as intermittently sharp, ___ intensity. \nOn the morning of admission, she experienced a small amount of \nblood on the toilet paper following a bowel movement. She states \nthis is consistent with her history of hemorrhoids and anal \nfissures. She denies nausea, vomiting, or diarrhea. No back \npain, dysuria or increased frequency. She is not currently \nsexually active and has no vaginal discharge.  \n  \nIn the ED, initial VS: 98.2 103 131/75 18 100% RA. On exam, \npatient had two harge hemmorhoids, guiac negative. Labs were \nsignificant for INR 12.3, WBC 3.3. CT A/P showed a Richter \nhernia containing short segment loop of ileum in RLQ, with \nsuggestion of focal partial obstruction, but no significant \nupstream dilation (CT unchanged from prior per radiologist), \nnormal appx. Patient was given Clindamycin 150 mg PO X 1 and \nvitamin K 10 mg X 1. She was also given Percocet ___ mg X 2 \nand oxycodone 10 mg X 1. Surgery was consulted who felt no need \nto excise at this time. VS at the time of transfer: 97.8 PO 76 \n152/100 18 98%RA. Fo access, patient has 18G L AC. Patient was \nadmitted to medicine for elevation of INR.  \n  \nCurrently, the patient has no ocute concerns. She states that \nshe last took coumadin ___ (10 mg). Her \nmost recent INR check was 1.6 on ___. She was instructed to \ntake an extra dose of coumadin 10 mg and resume her usual \nregimen.  No recent medication changes (last addition was \nWellbutrin at the end of ___, diet consistent, except for one \nday of decreased appetite 4 days ago.\n \nPast Medical History:\n1. pulmonary embolism - ___ after left knee replacement, second \nafter stopping coumadin, currently anti-coagulated on couamdin. \nneg hypercoag eval by heme)  \n2. cellulitis - treated earlier this year for abdominal \ncellulitis\n3. fibroids s/p supracervical hysterectomy, repair of bowel \nserosa injury, cystoscopy (___)  \n4. fibromyalgia - diagnosed earlier this year by PCP ___ \"leg \nand back pains\"\n5. osteoarthritis s/p bilateral knee replacement\n6. left leg nerve entrapment \n7. ectopic pregnancy  \n8. depression \n9. anxiety  \n10. obesity  \n11. sleep apnea \n12. migraines\n13. GERD\n14. chronic lower back pain\n \nSocial History:\n___\nFamily History:\nFather's health unknown except potential h/o stomach cancer; \nUncle has unknown cancer.\nMother living at ___ with arthritis and osteoporosis\nAunt recently passed at ___ ___nd heart disease.\nGrandmother with breast cancer\nNo siblings\nChildren healthy\n \nPhysical Exam:\nVS - Temp 98.0 F, BP 150/104, HR 80, R 18, O2-sat 100% RA  \nGENERAL - NAD, comfortable  \nHEENT - sclerae anicteric, MMM, OP clear  \nNECK - supple, no JVD, no lymphadenopathy  \nLUNGS - CTA bilat, no r/rh/wh, good air movement  \nBREAST - Bilateral breasts equal, no external lesions, no \ndrainage from nipples, no palpable mass, right nipple slightly \nretracted (no recent change per patient)\nAxilla- Right axilla with 1x3cm nodule, tender, nonerythematous, \nno fluctuance, left axilla with pinpoint tenderness surrounding \nhair follicle\nHEART - RRR, no MRG, nl S1-S2  \nABDOMEN - obese, +BS, soft, mild tenderness in RLQ, no masses or \nHSM, no rebound/guarding  \nLYMPH - No axillary, inguinal lymphadenopathy\nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs) \n \nNEURO - awake, A&Ox3, CNs II-XII intact, motor strength ___ in \nall extremities\n \nPertinent Results:\n___ 06:30AM BLOOD WBC-4.0 RBC-4.03* Hgb-11.1* Hct-34.4* \nMCV-85 MCH-27.4 MCHC-32.2 RDW-13.9 Plt ___\n___ 06:36PM BLOOD WBC-3.3* RBC-4.10* Hgb-11.3* Hct-34.9* \nMCV-85 MCH-27.7 MCHC-32.4 RDW-13.4 Plt ___\n___ 06:36PM BLOOD Neuts-25* Bands-0 Lymphs-64* Monos-8 \nEos-1 Baso-0 Atyps-2* ___ Myelos-0\n___ 06:30AM BLOOD Plt ___\n___ 06:30AM BLOOD ___ PTT-55.1* ___\n___ 07:02PM BLOOD ___ PTT-52.0* ___\n___ 06:36PM BLOOD Plt ___\n___ 06:30AM BLOOD Glucose-101* UreaN-8 Creat-0.8 Na-143 \nK-4.0 Cl-106 HCO3-32 AnGap-9\n___ 06:30AM BLOOD ALT-17 AST-20 AlkPhos-89 TotBili-0.1\n___ 06:30AM BLOOD Calcium-9.3 Phos-4.3# Mg-1.9\n\n___ CT abdomen/pelvis:\nThere is mild atelectasis at the lung bases. Heart is normal in \nsize, without pericardial effusion. There is a moderate sliding \nhiatal hernia.\n \nABDOMEN: The liver enhances homogeneously. Gallbladder is \ncollapsed. The pancreas is unremarkable. There is no intra- or \nextra-hepatic biliary ductal dilation. The spleen is normal in \nsize.\n \nAdrenals are normal. The kidneys enhance and excrete contrast \npromptly and symmetrically, without masses or hydronephrosis.\n \nThe stomach is normal. Again seen is an incisional Richter \nhernia of the distal ileum (2:65), with projection of the \nantimesenteric portion into the surgical defect. There is no \nsignificant wall thickening or inflammatory stranding, and the \nappearance is stable over multiple examinations.\n \nPELVIS: Surgical scar is present in the anterior pelvic wall, \nwith fascial thickening and fat stranding. Uterus is surgically \nabsent, with intact vaginal cuff and mild fascial thickening \nalong the pelvic sidewalls. Adnexa are within normal limits. \nThere is no free fluid or air.\n \nThe appendix is normal. Transverse and sigmoid colon are \nmarkedly redundant. The bladder and distal ureters are \nunremarkable.\n \nMesenteric and retroperitoneal lymph nodes are not \npathologically enlarged.\n \nThere is minimal retrolisthesis at L4-L5, with small diffuse \ndisc bulge that abuts the thecal sac outline. Please note that \nCT cannot visualize intrathecal detail. Moderate facet \nhypertrophy is also present at this level.\n \nIMPRESSION:\n1. No acute abdominal process.\n2. Post-hysterectomy changes.\n3. Unchanged incisional Richter hernia in the right lower \nquadrant.\n \nBrief Hospital Course:\n___ yo F with a h/o PE on coumadin with poor compliance, \nfibromyalgia, depression/anxiety who presents with 2 days of \nswelling and pain at R axilla, noted to have an INR 12.3 in the \nED.  \n\n# Supratherapeutic INR / PE on coumadin: INR ___ s/p 10 mg PO \nvitamin K in ED. Per patient, recent uptitration of coumadin \ndosing due to subtherapeutic INR. Patient endorses streaks of \nblood in the stool and on toilet paper.  Rectal exam in the ED \nrevealed large hemorrhoids and guaiac negative stool.  Hct \nstable.  No evidence of clinically significant bleeding at this \ntime. No indication for acute reversal of her coagulopathy with \nFFP. INR on ___ is 13.4, but unlikely reflecting Vitamin K \neffect.  Will have INR drawn with ___ on ___ and \nmonitor closely as outpatient.  Discharged on no Coumadin.\n\n# R Axillary pain/swelling: Differential for exam finding \nincludes inflamed cyst vs. folliculitis. Low suspicion for \nabscess given lack of fluctuance, fever/chills, leukocytosis. \nSurgery evaluated patient in ED, and did not find abscess \nrequiring I&D.  Received one dose of Clindamycin in the ED, but \ndid not continue on the floor due to potential interaction with \nCoumadin and because of diagnosis of folliculitis is best \ntreated with warm compresses. \n\n# Abdominal pain: Unclear etiology but similar to prior pain \nfrom ovarian cyst. Exam benign. CT abdomen shows no acute \nintra-abdominal pathology.  Hernia is stable from prior per \nradiologist. Pain consistent with prior pain from ovarian cyst \nwith endometrial cells with suspected endometriosis. Continued \non home dose percocet for pain control. Patient has followup \nwith Ob/Gyn, Dr. ___, in 2 weeks.\n\n# HTN: stable.  Continued home lisinopril 30 mg daily.\n  \n# Depression/Anxiety: No evidence of overt psychosis. No SI, \nAH/VH.  Continued home dose Wellbutrin, Seroquel, Ambien, and \nLorazepam.\n\n# Transitional issues:\nWill follow up on ___ with ___ for INR check and \nadjust coumadin dose accordingly.\n \nMedications on Admission:\nBUPROPION HCL - 100 mg Tablet - one Tablet twice a day  \nLEUPROLIDE - 11.25 mg Syringe Kit - for im injection q 3 months  \n\nLISINOPRIL - 30 mg Tablet - 1 Tablet(s) by mouth once a day  \nLORAZEPAM - 1 mg Tablet - one Tablet(s) by mouth each day  \nONDANSETRON HCL - 8 mg Tablet - 1 Tablet(s) by mouth q8h prn \nnausea  \nOXYCODONE-ACETAMINOPHEN - 5 mg-325 mg Tablet - ___ Tablet(s) prn \n \nQUETIAPINE [SEROQUEL] - 200 mg Tablet - 2 Tablet(s) by mouth QHS \n \nTIZANIDINE [ZANAFLEX] - 4 mg Capsule - 2 Capsule(s) by mouth hs  \n\nWARFARIN - 5 mg M-Th, 10 mg ___  \nZOLPIDEM [AMBIEN CR] - 12.5 mg Tablet - 1 Tablet(s) by mouth \ndaily  \nDOCUSATE SODIUM [COLACE] - 100 mg Capsule - 2 capsule daily  \n \nDischarge Medications:\n1. bupropion HCl 100 mg Tablet Sig: One (1) Tablet PO BID (2 \ntimes a day).  \n2. leuprolide (3 month) 11.25 mg Syringe Kit Sig: One (1)  \nIntramuscular q3months.  \n3. lisinopril 20 mg Tablet Sig: 1.5 Tablets PO DAILY (Daily).  \n4. lorazepam 1 mg Tablet Sig: One (1) Tablet PO once a day.  \n5. Zofran 8 mg Tablet Sig: One (1) Tablet PO every eight (8) \nhours as needed for nausea.  \n6. oxycodone-acetaminophen ___ mg Tablet Sig: ___ Tablets PO \nQ6H (every 6 hours) as needed for pain.  \n7. quetiapine 200 mg Tablet Sig: Two (2) Tablet PO QHS (once a \nday (at bedtime)).  \n8. tizanidine 4 mg Capsule Sig: Two (2) Capsule PO at bedtime.  \n9. zolpidem 5 mg Tablet Sig: 2.5 Tablets PO HS (at bedtime).  \n10. Colace 100 mg Capsule Sig: ___ Capsules PO once a day as \nneeded for constipation.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY:\nSupratherapeutic INR\nFolliculitis\nOvarian Cyst\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMs. ___,\n\nIt was a pleasure taking care of you during your \nhospitalization.  You were admitted because your INR (Coumadin) \nlevel was very high.  You had some bleeding in your stool, \nlikely from hemorrhoids.  Your red blood count was stable.  We \ntreated the high INR level with Vitamin K and stopped your \nCoumadin.\n\nYou also have a small infection of the hair follicles in your \narmpit.  This should resolve with warm compresses to the area.\n\nPlease follow up with your Ob/Gyn doctor for further treatment \nof your ovarian cyst.\n\nWe made the following changes to your medications:\nSTOPPED Coumadin\n(You will have your blood drawn on ___ at 1PM with ___ \n___, who will instruct you with Coumadin dosing)\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee75393101d"
  },
  "note_id": "19250934-DS-28",
  "subject_id": 19250934,
  "hadm_id": 24301860,
  "note_type": "DS",
  "note_seq": 28,
  "charttime": "2196-03-25 00:00:00",
  "storetime": "2196-03-25 15:13:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nCompazine / Motrin / Celexa / Amitriptyline Hcl / Neurontin\n \nAttending: ___.\n \nChief Complaint:\nabdominal pain\n \nMajor Surgical or Invasive Procedure:\nLysis of adhesions\n\n \nHistory of Present Illness:\n___ woman with a long history of\nabdominal pain and question of hernia.\nShe again describes as pain as right pelvic as well as lower\nmidline pain that has been present for at least four months.  \nShe\ntells me she has also has associated nausea without emesis.   \nShe tells me the pain is severe at times and is growing weary of\nworrying about it and always conflicted about going to the\nemergency room. \n\n \nPast Medical History:\n1. pulmonary embolism - ___ after left knee replacement, second \nafter stopping coumadin, currently anti-coagulated on couamdin. \nneg hypercoag eval by heme)  \n2. cellulitis - treated earlier this year for abdominal \ncellulitis\n3. fibroids s/p supracervical hysterectomy, repair of bowel \nserosa injury, cystoscopy (___)  \n4. fibromyalgia - diagnosed earlier this year by PCP ___ \"leg \nand back pains\"\n5. osteoarthritis s/p bilateral knee replacement\n6. left leg nerve entrapment \n7. ectopic pregnancy  \n8. depression \n9. anxiety  \n10. obesity  \n11. sleep apnea \n12. migraines\n13. GERD\n14. chronic lower back pain\n \nSocial History:\n___\nFamily History:\nFather's health unknown except potential h/o stomach cancer; \nUncle has unknown cancer.\nMother living at ___ with arthritis and osteoporosis\nAunt recently passed at ___ ___nd heart disease.\nGrandmother with breast cancer\nNo siblings\nChildren healthy\n \nPhysical Exam:\nPhysical Examination:\nGeneral:  She is alert, in no acute distress.\nHEENT:  Pupils are equal.  Sclerae are anicteric.  Oropharynx is\nclear.\nNeck:  Supple, no lymphadenopathy, no bruits.  Trachea is\nmidline.\nLungs:  Clear to auscultation bilaterally.\nHeart:  Regular, no murmurs.\nAbdomen:  Obese, soft and nondistended.  She is tender \nthroughout\nher entire abdomen, particularly in the epigastrium, bilateral\nupper quadrants and in her bilateral lower quadrants.  She has a\ntransverse scar, ___, which is beneath her abdominal\npannus.  There is no infection or breakdown.  There are no\nhernias to palpation.  Extremities are without edema.\nNeurologically, she is nonfocal.\n\n \nPertinent Results:\n___ 09:30AM BLOOD WBC-6.5 RBC-3.71* Hgb-9.6* Hct-32.6* \nMCV-88 MCH-25.9* MCHC-29.4* RDW-14.8 Plt ___\n___ 10:30AM BLOOD WBC-7.0# RBC-4.10* Hgb-11.1* Hct-35.7* \nMCV-87 MCH-27.0 MCHC-31.0 RDW-14.7 Plt ___\n___ 07:20AM BLOOD ___ PTT-78.1* ___\n___ 10:00PM BLOOD ___ PTT-62.7* ___\n___ 02:40PM BLOOD PTT-69.4*\n___ 07:50AM BLOOD PTT-73.8*\n___ 09:30AM BLOOD Glucose-125* UreaN-5* Creat-0.8 Na-139 \nK-3.8 Cl-103 HCO3-29 AnGap-11\n___ 10:30AM BLOOD Glucose-122* UreaN-6 Creat-0.7 Na-139 \nK-3.6 Cl-103 HCO3-28 AnGap-12\n___ 09:30AM BLOOD Calcium-8.3* Phos-3.4 Mg-2.1\n___ 10:30AM BLOOD Calcium-8.7 Phos-2.5*# Mg-1.6\n \nBrief Hospital Course:\nThe patient was admitted after undergoing lysis of adhesions. \nThe patient tolerated the procedure well. She passed gas and was \nable to tolerate a regular diet, that was advanced slowly. The \npatient was able to ambulate, and her pain was well controlled. \nThe patient was kept on a heparin drip to prevent clotting, as \nshe has known history of clots. She was started on coumadin \nprior to discharge. She will continue with lovenox injections \nuntil her INR is therapeutic.\n \nMedications on Admission:\nALBUTEROL SULFATE - 90 mcg HFA Aerosol Inhaler - 2 (Two) puff(s)\ninhaled every ___ hours as needed for cough, difficulty \nbreathing\nBUPROPION HCL - 100 mg Tablet - one Tablet(s) by mouth twice a\nday\nLEUPROLIDE (3 MONTH) [LUPRON DEPOT (3 MONTH)] - 11.25 mg Syringe\nKit - for im injection q 3 months\nLISINOPRIL - 40 mg Tablet - 1 Tablet(s) by mouth once a day\nLORAZEPAM - 1 mg Tablet - one Tablet(s) by mouth each day\nONDANSETRON HCL [ZOFRAN] -  (Prescribed by Other Provider) -\nDosage uncertain\nOXYCODONE-ACETAMINOPHEN - 5 mg-325 mg Tablet - ___ Tablet(s) by\nmouth Q ___ hours\nPANTOPRAZOLE [PROTONIX] -  (Not Taking as Prescribed) - 40 mg\nTablet, Delayed Release (E.C.) - 1 Tablet(s) by mouth twice a \nday\nQUETIAPINE [SEROQUEL] - 200 mg Tablet - 2 Tablet(s) by mouth at\nnight\nTIZANIDINE - 4 mg Tablet - ___ Tablet(s) by mouth at hs\nWARFARIN - 5 mg Tablet - ___ Tablet(s) by mouth mon, wed, fri\nand then 1 tab tues, thurs, sat, sun\nZOLPIDEM [AMBIEN CR] - 12.5 mg Tablet,Ext Release Multiphase - 1\n(One) Tablet(s) by mouth once a day\n \n\n \nDischarge Medications:\n1. albuterol sulfate  Inhalation\n2. bupropion HCl 100 mg Tablet Sig: One (1) Tablet PO BID (2 \ntimes a day).  \n3. lisinopril 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). \n \n4. lorazepam 1 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) \nas needed for sleep.  \n5. oxycodone-acetaminophen ___ mg Tablet Sig: ___ Tablets PO \nevery ___ hours as needed for pain: do not operate heavy \nmachinery while taking this medication.\nDisp:*25 Tablet(s)* Refills:*0*\n6. Protonix  Oral\n7. Seroquel 400 mg Tablet Sig: One (1) Tablet PO at bedtime.  \n8. tizanidine  Oral\n9. warfarin 5 mg Tablet Sig: One (1) Tablet PO once a day.\nDisp:*30 Tablet(s)* Refills:*0*\n10. Lovenox ___ mg/mL Syringe Sig: One (1)  Subcutaneous once a \nday: until INR is ___.\nDisp:*7 * Refills:*2*\n11. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday).  \n12. Ambien  Oral\n13. Colace  Oral\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nAbdominal Adhesions\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nDISCHARGE INSTRUCTIONS:\nYou were admitted to the ___ surgery service for lysis of \nadhesions. \nGeneral Discharge Instructions:\nPlease resume all regular home medications, unless specifically\nadvised not to take a particular medication.  Please take any \nnew\nmedications as prescribed.\nPlease take the prescribed analgesic medications as needed.  You \nmay\nnot drive or operate heavy machinery while taking narcotic \nanalgesic\nmedications.  You may also take acetaminophen (Tylenol) as \ndirected,\nbut do not exceed 4000 mg in one day.\nPlease get plenty of rest, continue to walk several times per \nday, and\ndrink adequate amounts of fluids.  Avoid strenuous physical \nactivity\nand refrain from heavy lifting greater than 10 lbs., until you\nfollow-up with your surgeon, who will instruct you further \nregarding\nactivity restrictions.  Please also follow-up with your primary \ncare\nphysician.\nIncision Care:\n*Please call your surgeon or go to the emergency department if \nyou\nhave increased pain, swelling, redness, or drainage from the \nincision\nsite.\n*Avoid swimming and baths until cleared by your surgeon.\n*You may shower and wash incisions with a mild soap and warm \nwater.\nGently pat the area dry.\n*If you have staples, they will be removed at your follow-up \nappointment.\n*If you have steri-strips, they will fall off on their own.  \nPlease\nremove any remaining strips ___ days after surgery.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee75393101e"
  },
  "note_id": "19250934-DS-29",
  "subject_id": 19250934,
  "hadm_id": 20411539,
  "note_type": "DS",
  "note_seq": 29,
  "charttime": "2197-03-08 00:00:00",
  "storetime": "2197-03-08 19:01:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCompazine / Motrin / Celexa / Amitriptyline Hcl / Neurontin\n \nAttending: ___.\n \nChief Complaint:\nN/V/Abd pain/Diarrhea/chest pain/sob  \n\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ female with a history of pulmonary emboli on \nCoumadin and chronic pain syndrome presents today after 1 week \nof N/V/D and inability to keep down some of her medications, \nincluding warfarin.  \nShe reports that her GI symptoms started last ___. No sick \ncontact or recent travel. No unusual food, antibiotics, or \nsupplements. She reports vomiting and having diarrhea at least 3 \ntimes a day, loose, non-bloody. She has not been able to keep \nher warfarin down. She thought she was going to get better soon, \nbut then developed some chest discomfort and shortness of breath \nthe night before admission, although these symptoms have \nresolved spontaneously. Because of the chest discomfort and SOB, \nshe came to the ED.  \n \nIn the ED, initial VS were: 97.8 81 148/89 16 99% RA. In the ED, \npatient had GYN ultrasound done, which showed 2.1 x 1.7 x 2.2 cm \nright ovary without a mass or cyst but could not r/o torsion. \nGiven the abdominal/pelvic pain with the chest pain/SOB and \nbeing subtherapeutic, patient underwent CTA, which ruled out PE \nand other acute process in the abdomen/pelvic area. There was \nconcern that patient could not manage giving herself Lovenox, \nthey decided to admit her for heparin gtt bridging to warfarin. \nShe received morphine for pain in the ED as well. VS on \ntransfer: 89 158/99 15 100%  \nCurrently, she denies chest pain, shortness of breath. Abd pain \nis much better. She denies any urinary symptoms such as dysuria \nand frequency or urgency.  \n\n \nPast Medical History:\n1. pulmonary embolism - ___ after left knee replacement, second \nafter stopping coumadin, currently anti-coagulated on couamdin. \nneg hypercoag eval by heme)  \n2. cellulitis - treated earlier this year for abdominal \ncellulitis\n3. fibroids s/p supracervical hysterectomy, repair of bowel \nserosa injury, cystoscopy (___)  \n4. fibromyalgia - diagnosed earlier this year by PCP ___ \"leg \nand back pains\"\n5. osteoarthritis s/p bilateral knee replacement\n6. left leg nerve entrapment \n7. ectopic pregnancy  \n8. depression \n9. anxiety  \n10. obesity  \n11. sleep apnea \n12. migraines\n13. GERD\n14. chronic lower back pain\n \nSocial History:\n___\nFamily History:\nFather's health unknown except potential h/o stomach cancer; \nUncle has unknown cancer.\nMother living at ___ with arthritis and osteoporosis\nAunt recently passed at ___ ___nd heart disease.\nGrandmother with breast cancer\nNo siblings\nChildren healthy\n \nPhysical Exam:\nAdmission Exam:\nVS: 98.1, 165/95, 87, 18, 100% RA  \nGENERAL: well appearing obese F  \nHEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, no conjunctival \ninjection, MMM  \nNECK: supple, no LAD, no JVD  \nLUNGS: CTA bilat, no r/rh/wh, good air movement, resp unlabored, \nno accessory muscle use  \nHEART: RRR, no MRG, nl S1-S2  \nABDOMEN: normal bowel sounds, soft, minimally tender to the \nlower pelvic area, non-distended, no rebound or guarding, no \nmasses  \nEXTREMITIES: no edema, 2+ pulses radial and dp  \nNEURO: awake, A&Ox3,  \n.\nDischarge Exam:\n97.7 108/71 82 18 97%RA\nGen: NAD. Obese body habitus\nHEENT: EOMI. MMM. NCAT. PERRL\nCV: RRR. NS1&S2. NMRG\nResp: Decreased breath sounds diffusely. No rales/rhonchi/wheeze\nGI: Diffuse mild TTP. No rebound or guarding. BS+4. S/ND. No \norganomegaly\nExt: No c/c/e\n \nPertinent Results:\nAdmission Labs:\n___ 06:40PM BLOOD WBC-5.2 RBC-4.39 Hgb-11.8* Hct-37.4 \nMCV-85 MCH-26.9* MCHC-31.6 RDW-14.2 Plt ___\n___ 06:40PM BLOOD Glucose-87 UreaN-9 Creat-1.0 Na-141 K-4.4 \nCl-104 HCO3-26 AnGap-15\n.\nDischarge Labs:\n___ 07:50AM BLOOD Calcium-8.9 Phos-4.1 Mg-2.0\n___ 07:50AM BLOOD WBC-5.8 RBC-4.09* Hgb-10.9* Hct-34.6* \nMCV-85 MCH-26.6* MCHC-31.4 RDW-14.0 Plt ___\n___ 07:50AM BLOOD ___ PTT-150* ___\n___ 07:50AM BLOOD Glucose-105* UreaN-8 Creat-0.8 Na-141 \nK-3.5 Cl-104 HCO3-29 AnGap-12\n.\nPertinent Labs:\n___ 06:40PM BLOOD CK-MB-2 cTropnT-<0.01\n___ 07:50AM BLOOD CK-MB-1 cTropnT-<0.01\n___ 09:30AM BLOOD CK-MB-1 cTropnT-<0.01\n.\nUrine Studies:\n___ 06:40PM URINE Blood-NEG Nitrite-NEG Protein-TR \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG\n___ 06:40PM URINE RBC-1 WBC-1 Bacteri-FEW Yeast-NONE Epi-6\n___ URINE URINE CULTURE-PENDING \n.\n___ CTA Chest/Abd/Pelvis:\n1.  No evidence of pulmonary embolus.     \n2.  No findings in the abdomen or pelvis to explain the \npatient's symptoms. \n3.  Suspected adherence of small bowel to the anterior pelvic \nwall at an \nincision site and possible adhesions. \n.\n___ TVU:\n1.  Normal-sized right ovary without an ovarian cyst or mass.  \nArterial and \nvenous waveforms were difficult to visualize, which is likely \ntechnical.  \nOvarian torsion or intermittent torsion cannot be completely \nexcluded on the \nbasis of this exam, although is thought to be less likely. \n2.  Nonvisualization of the left ovary. \n3.  Status post hysterectomy with a normal cervical remnant. \n.\n___ TTE:\nThe left atrium is elongated. No atrial septal defect is seen by \n2D or color Doppler. The estimated right atrial pressure is at \nleast 15 mmHg. Left ventricular wall thickness, cavity size and \nregional/global systolic function are normal (LVEF >65%). The \nestimated cardiac index is normal (>=2.5L/min/m2). Tissue \nDoppler imaging suggests a normal left ventricular filling \npressure (PCWP<12mmHg). Right ventricular chamber size and free \nwall motion are normal. The aortic valve leaflets (3) appear \nstructurally normal with good leaflet excursion and no aortic \nstenosis or aortic regurgitation. The mitral valve appears \nstructurally normal with trivial mitral regurgitation. The \nestimated pulmonary artery systolic pressure is normal. There is \nno pericardial effusion. \nIMPRESSION: Normal biventricular cavity sizes with preserved \nglobal and regional biventricular systolic function. The aortic \narch is mildly dilated.\nCompared with the prior study (images reviewed) of ___, \nthe findings are similar.  \n \nBrief Hospital Course:\n___ with PMH significant for DVT and PE x2 presented with recent \nepisode of chest pain and SOB, sub-therapeutic on coumadin due \nto h/o persistent N/V/D and inability to tolerate meds. \n. \n#Chest pain/SOB: The evening prior to admission, patient \nreported \"stabbing\" b/l pain that was pleuritic in nature, and \ncame on at rest, but eventually resolved on it's own. She was \nconcerned for recurrent PE, so she came to the ED the following \nday. CTA ruled out any embolus. EKG on admission unchanged from \nbaseline with lead II TWI. On the medical floor she had \nrecurrent \"sharp\" chest pain, and new EKG changes, with TWI in \nV2-V6. CE taken at time of pain were negative, as were CE the \nnight before. Evaluated by cardiology who did not believe pain \nto be cardiac in nature, as she has documented EKGs in the past \nwith a similiar pattern. TTE failed to reveal any wall motion \nabnormalities. Patient remained chest pain free for duration of \nhospitalization and was discharged home that evening. Most \nlikely cause of pain thought to be GERD. Will follow-up with \noutpatient physician to discuss ___ stress test.\n.\n#H/o PE:  Patient not taking coumadin prior to arrival due to \nN/V/D (see below), and as a result INR was sub-therapeutic at \n1.1. As she wsa high-risk for recurrent PE given multiple prior \nPEs, she was bridged with sub-cutaneous lovenox. Patient has \nscheduled follow-up at ___ for INR draw on \n___.\n.\n#N/V/D: Patient described 3 day h/o watery diarrhea, and \nnon-bilious, non-bloody emesis. This resolved 48 hours prior to \nthis presentation. She tolerated full meals while in-house. \nLikely due to viral gastroenteritis vs. partial SBO that had \nsince resolved based on CTA findings of bowel adhesion to \nanterior pelvic wall.\n.\n#Chronic pain: Chronic abdominal pain related to ?ovarian cyst. \nTVU revealed R. ovary w/?torsion. No severe pain on physical \nexam that would be consistent with torsion.  Continued on \noxycodone until seen by ob-gyn next week.\n.\n#HTN: Continued lisinopril\n.\n#Depression/anxiety: Continued wellbutrin, lorazepam, and \nseroquel\n.\nTransitional Issues;\n#Will need INR checked on ___ and lovenox d/c'ed when \ncoumadin therapeutic\n \nMedications on Admission:\n1. Albuterol Inhaler 2 PUFF IH Q4-6H PRN SOB \n2. BuPROPion 100 mg PO BID \n3. Calcium Carbonate 600 mg PO DAILY \n4. Lisinopril 40 mg PO DAILY \n5. Lorazepam 0.5 mg PO DAILY PRN anxiety or insomnia \n6. Ondansetron 8 mg PO Q8H:PRN nausea \n7. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO EVERY ___ HR PRN \npain \nRX *oxycodone-acetaminophen 5 mg-325 mg 1 tablet(s) by mouth \nevery six (6) hours Disp #*10 Tablet Refills:*0\n8. Pantoprazole 40 mg PO Q24H \n9. Quetiapine Fumarate 400 mg PO QHS \n10. Tizanidine ___ mg PO TID:PRN spasm \n11. Vitamin D ___ UNIT PO DAILY \n12. Warfarin 7.5 mg PO 3X/WEEK (___) \n13. Warfarin 5 mg PO 4X/WEEK (___) \n14. Enoxaparin Sodium 140 mg SC Q12H \nRX *enoxaparin 150 mg/mL 140 mg SC q12 hours Disp #*28 Syringe \nRefills:*0\n15. Ambien CR *NF* (zolpidem) 12.5 mg Oral qHS  \n16. Clindamycin 1 Appl TP DAILY to scalp \n17. Cyclobenzaprine 10 mg PO TID:PRN spasm \n18. Docusate Sodium 200 mg PO DAILY:PRN constipation \n19. Leuprolide Acetate 11.25 mg IM EVERY 3 MONTHS \n20. lidocaine-menthol *NF* ___ % Topical daily prn pain \n21. Sumatriptan Succinate 50 mg PO ONCE PRN headache \n\n \nDischarge Medications:\n1. Albuterol Inhaler 2 PUFF IH Q4-6H PRN SOB \n2. BuPROPion 100 mg PO BID \n3. Calcium Carbonate 600 mg PO DAILY \n4. Lisinopril 40 mg PO DAILY \n5. Lorazepam 0.5 mg PO DAILY PRN anxiety or insomnia \n6. Ondansetron 8 mg PO Q8H:PRN nausea \n7. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO EVERY ___ HR PRN \npain \nRX *oxycodone-acetaminophen 5 mg-325 mg 1 tablet(s) by mouth \nevery six (6) hours Disp #*10 Tablet Refills:*0\n8. Pantoprazole 40 mg PO Q24H \n9. Quetiapine Fumarate 400 mg PO QHS \n10. Tizanidine ___ mg PO TID:PRN spasm \n11. Vitamin D ___ UNIT PO DAILY \n12. Warfarin 7.5 mg PO 3X/WEEK (___) \n13. Warfarin 5 mg PO 4X/WEEK (___) \n14. Enoxaparin Sodium 140 mg SC Q12H \nRX *enoxaparin 150 mg/mL 140 mg SC q12 hours Disp #*28 Syringe \nRefills:*0\n15. Ambien CR *NF* (zolpidem) 12.5 mg Oral qHS  \n16. Clindamycin 1 Appl TP DAILY to scalp \n17. Cyclobenzaprine 10 mg PO TID:PRN spasm \n18. Docusate Sodium 200 mg PO DAILY:PRN constipation \n19. Leuprolide Acetate 11.25 mg IM EVERY 3 MONTHS \n20. lidocaine-menthol *NF* ___ % Topical daily prn pain \n21. Sumatriptan Succinate 50 mg PO ONCE PRN headache \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary diagnosis:\nAtypical chest pain\nSub-therapeutic INR\n\nSecondary diagnosis:\nhistory of pulmonary embolus\nchronic pain\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nIt was a pleasure caring for ___ at ___. ___ were admitted \nbecause ___ had chest pain, and there was some concern that ___ \nmight have another blood clot in your lung (pulmonary embolus). \nWe took a CAT scan of your chest and stomach and found no blood \nclot. ___ had more chest pain in the morning, and we took an \nelectrocradiogram, blood work, and an echocardiogram, and it \ndoes not look like ___ had any problem with your heart. ___ \nshould have an outpatient stress test within the next ___ months \nto evaluate for blockages in your heart's arteries. \n\nBecause ___ were not able to take your coumadin earlier this \nweek, your INR is very low. We started ___ on heparin and then \nlovenox before ___ were discharged. It is important to take both \nlovenox and coumadin until your INR is high again. Please \nfollow-up in ___. Clinic to have your INR checked. \n\nYour nausea, vomiting, and diarrhea had resolved before ___ were \nadmitted to ___. These symptoms are most likely to a viral \nillness or to partial bowel obstruction from adhesions. It is \nvery important to call your primary care physician if these \nsymptoms recur, because it could be a sign of obstruction.\n\nMedications to START:\nSTART lovenox ___ daily until your INR is >2\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee75393101f"
  },
  "note_id": "19250934-DS-30",
  "subject_id": 19250934,
  "hadm_id": 22074329,
  "note_type": "DS",
  "note_seq": 30,
  "charttime": "2197-05-22 00:00:00",
  "storetime": "2197-05-25 16:34:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCompazine / Motrin / Celexa / Amitriptyline Hcl / Neurontin\n \nAttending: ___.\n \nChief Complaint:\nBRBPR\n \nMajor Surgical or Invasive Procedure:\nEsophagogastroduodenoscopy (EGD) - a scope was used to look at \nthe upper part of your throat and intenstines including stomach \nthat was normal\n\nColonscopy - a scope was used to look at the lower part of your \nintensines such as your colon that was normal except for \nhemorrhoids\n\n \nHistory of Present Illness:\n___ with fibromyalgia and chronic pain, depression, anxiety, h/o \nPE on warfarn who presents with BRBPR. The patient reports she \nhas been noting BRBPR on the toilet paper and coating her stools \nfor the past 1 week. She also notes blood when passing flatus. \nShe denies any lightheadedness, dizziness. She has RUQ abdominal \npain consisitent with her chronic pelvic pain.  \nOn further description of the BRBPR, she describes having \nnoticed several \"jelly-like\" blood clumps in her stool recently. \nShe is sure they are not made out of stool. She denied fevers, \nchills, black stools, nausea, vomiting, hematemesis, coughing, \nlightheadedness, dizzyness, pain on defecation, changes in \nconsistency of bowel movement, vaginal discharge, hematuria, \npain on urination pelvic pain, alcohol or NSAID use. Patient \nreports bilateral edema that in the past week that has affected \nher mobility to some effect. She also complains of flank pain, \nwhich does not get better or worse with bowel movement.  \nOf note the patient has had 2 past PEs. The first occured ___ \nyears ago in the setting of a knee surgery. She coumadin was \ndiscontinued and she subsequently had another PE. The patient \nnotes her INRs have been difficult to manage. She has been as \nhigh as 17 in the past. She was also recently admitted for a \nheparin bridge in the setting of a subtherapeutic INR in ___. \nShe was discharged on a lovenox bridge but has been off of this \nmedications for several weeks.  \n\n \n \nPast Medical History:\n1. pulmonary embolism - ___ after left knee replacement, second \nafter stopping coumadin, currently anti-coagulated on couamdin. \nneg hypercoag eval by heme)  \n2. cellulitis - treated earlier this year for abdominal \ncellulitis\n3. fibroids s/p supracervical hysterectomy, repair of bowel \nserosa injury, cystoscopy (___)  \n4. fibromyalgia - diagnosed earlier this year by PCP ___ \"leg \nand back pains\"\n5. osteoarthritis s/p bilateral knee replacement\n6. left leg nerve entrapment \n7. ectopic pregnancy  \n8. depression \n9. anxiety  \n10. obesity  \n11. sleep apnea \n12. migraines\n13. GERD\n14. chronic lower back pain\n \nSocial History:\n___\nFamily History:\nFather's health unknown except potential h/o stomach cancer; \nUncle has unknown cancer.\nMother living at ___ with arthritis and osteoporosis\nAunt recently passed at ___ ___nd heart disease.\nGrandmother with breast cancer\nNo siblings\nChildren healthy\n \nPhysical Exam:\nAdmissions Exam\n\nVitals: 98 ___ 100% RA  \nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNeck: supple, JVP not elevated, no LAD  \nLungs: Clear to auscultation bilaterally, no wheezes, rales, \nronchi  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nBack: No CVA tenderness  \nAbdomen: soft, mild TTP in RUQ and LUQ no rebound tenderness or \nguarding, no organomegaly  \nExt: Warm, well perfused, 2+ pulses, trace non pitting edema in \nboth ankles.  \n\nDischarge Exam\n\nVitals: 98.5 139/95 69 18 99%RA\nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric \nLungs: Clear to auscultation bilaterally, no wheezes, rales, \nronchi  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops\nAbdomen: soft, mild TTP in mid-epigastric and L lateral side \nwith no rebound tenderness or guarding, no organomegaly\nExt: Warm, well perfused, 2+ pulses, trace non pitting edema in \nboth ankles.  \n \nPertinent Results:\n___ 05:20PM BLOOD WBC-4.4 RBC-4.53 Hgb-12.3 Hct-38.8 MCV-86 \nMCH-27.2 MCHC-31.8 RDW-14.4 Plt ___\n___ 05:20PM BLOOD ___ PTT-58.9* ___\n___ 11:42PM BLOOD\n___ 05:20PM BLOOD Glucose-85 UreaN-7 Creat-0.8 Na-141 \nK-5.2* Cl-108 HCO3-22 AnGap-16\n___ 05:20PM BLOOD ALT-17 AST-32 LD(LDH)-657* AlkPhos-92 \nTotBili-0.2\n___ 06:10AM BLOOD Calcium-9.1 Phos-3.6 Mg-1.8\n___ 05:25PM BLOOD Lactate-1.6 K-3.9\n___ 05:55AM BLOOD WBC-5.7 RBC-4.33 Hgb-12.0 Hct-36.2 MCV-84 \nMCH-27.7 MCHC-33.2 RDW-14.6 Plt ___\n___ 05:20PM BLOOD Neuts-48.0* Lymphs-44.4* Monos-5.6 \nEos-0.9 Baso-1.1\n___ 05:55AM BLOOD Glucose-89 UreaN-4* Creat-0.7 Na-143 \nK-3.5 Cl-106 HCO3-25 AnGap-16\n\n___\nIMPRESSION: No deep vein thrombosis within the right or left \nlower extremity.\n\n___:\nImpression: Normal mucosa was noted until the hepatic flexure. \nThe cecum could not be reached due to the presence of a very \nlong colon and recurrent looping. \nNo discrete lesion was noted. \nThere was stool in the lumen of the colon. No blood was noted.  \nRecommendations: Return to floor under ongoing care. \nFollow-up with Dr. ___ as needed \n___ colonoscopy with adecuate preparation under MAC\nAdditional notes: The procedure was performed by Dr. ___ \nthe GI fellow. The patient's reconciled home medication list is \nappended to this report. No specimen were taken. \n\nEGD (___):\nImpression: Normal mucosa in the esophagus \nSmall hiatal hernia \nNormal mucosa in the stomach \nNormal mucosa in the duodenum\nRecommendations: No discrete lesion was noted in the EGD. No \nblood was noted. Proceed with colonocospy.\nAdditional notes: The procedure was performed by Dr. ___ \nthe ERCP fellow. The patient's reconciled home medication list \nis appended to this report. EBL = zero. Final diagnosis as \nabove. No specimens as above. \n\n \nBrief Hospital Course:\n# BRBPR:\nPatient came with reports of BRBPR in setting of suprtherapeutic \nINR likely hemorrhoidal.   EGD and colonscopy performed that \nidentified no other source for bleeding per GI. While in the ED, \nthe patient was given FFP and Vit K with reversal of INR seen \nwhile waiting for colonscopy/EGD. Her Hct was stable throughout \nadmission with no evidence of any blood in her stools and \notherwise asymptomatic besides occasional abdominal pain (see \nbelow). Pt recommended continue follow-up with GI for future \ncolonscopy with long prep likely needed in the future. Follow-up \nwith PCP setup following discharge.\n.\n# Abdominal pain: \nPatient reports chronic pain due to fibromylagia with pain \nduring admission consistent with her normal pain. No evidence of \nobstruction or acute abdomen noted during admission. Infectious \nwork-up including UA was negative with no vaginal discharge or \nleukocytosis. Pain not associated with periods. LFTs normal Last \nEGD ___ showed non-erosive gastritis. CTA of pelvis ___ showed \nno abdominal pathology but did show adhesions. However, while \nprepping for colonoscopy, patient did state improvement in her \nabdominal pain so could be a component of chronic constipation.\n.\n*** Chronic Diagnoses ***\n.\n# PEs - Patient has a history of 2 PEs (one provoked). INR has \nbeen difficult to manage. Patient recieved FFP and Vitamin K as \nabove with reversal noted. For bridging therapy, heparin drip \nwas initially started prior to colonoscopy/EGD procedure. After \nprocedure, patient was started on Lovenox bridge while being \nrestarted on home Coumadin dosing. Pt instructed to continue \nLovenox shots and follow-up with ___ clinic as arranged for \nINR check shortly after discharge. \n.\n# ___ edema\nUnclear etiology, which has been ongoing for several weeks. DDx \nincludes venous stasis, CHF and DVT. ___ was negative. No \nevents over the tele. Patient reports schedule for outpatient \nholter for palpitations and stress test. Pt sent directly to \ncardiology for Holter montior and further work-up as previously \nestablished by cardiology on outpt basis.\n.\n# Fibromyalgia and chronic pain: \nStable, see above abdominal pain. Continued home oxycodone, \ntizanidine, flexeril without complaint.\n \n# Depression/anxiety: \nStable on home seroquel, bupropion, lorazepam\n.\n# HTN: \nStable on home lisinopril \n.\n*** Transitional Issues ***\n.\n- GI recommended repeat colonscopy in the future for further \nevaluation because of length of her colon and need for more \nadequate prep despite receiving 3L or more of Moviprep prior to \nprocedure\n.\n- Patient was counseled numerous times and stated that she could \nhave her mother or another relative assist who were already \ntrained to assist her in getting her Lovenox shots. Verbalized \nunderstanding of risk of not having the shots while achieving \ntherapeutic INR. \n.\n- Pt set to follow-up with ___ clinic for dose adjustments \nand INR check. Pt has issues with compliance while on warfarin, \nmay benefit from meds like dabigatran where monitoring less but \nmust weigh risks/benefits.\n.\n- * Patient had appointment to pick-up Holter for history of \npalpitations on day of discharge so patient sent to cardiology \nto pick it up.\n \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol Inhaler 2 PUFF IH Q4-6H PRN SOB \n2. BuPROPion 100 mg PO BID \n3. Calcium Carbonate 600 mg PO DAILY \n4. Lisinopril 40 mg PO DAILY \n5. Lorazepam 0.5 mg PO DAILY PRN anxiety or insomnia \n6. Ondansetron 8 mg PO Q8H:PRN nausea \n7. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO EVERY ___ HR PRN \npain \n8. Pantoprazole 40 mg PO Q24H \n9. Quetiapine Fumarate 400 mg PO QHS \n10. Tizanidine ___ mg PO TID:PRN spasm \n11. Vitamin D ___ UNIT PO DAILY \n12. Warfarin 7.5 mg PO 3X/WEEK (___) \n13. Warfarin 5 mg PO 4X/WEEK (___) \n14. Ambien CR *NF* (zolpidem) 12.5 mg Oral qHS  \n15. Cyclobenzaprine 10 mg PO TID:PRN spasm \n16. Docusate Sodium 200 mg PO DAILY:PRN constipation \n17. Leuprolide Acetate 11.25 mg IM EVERY 3 MONTHS \n18. lidocaine-menthol *NF* ___ % Topical daily prn pain \n19. Sumatriptan Succinate 50 mg PO ONCE PRN headache \n\n \nDischarge Medications:\n1. BuPROPion 100 mg PO BID \n2. Calcium Carbonate 600 mg PO DAILY \n3. Docusate Sodium 200 mg PO DAILY:PRN constipation \n4. Lisinopril 40 mg PO DAILY \n5. Lorazepam 0.5 mg PO DAILY PRN anxiety or insomnia \n6. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO EVERY ___ HR PRN \npain \nRX *oxycodone-acetaminophen 5 mg-325 mg 1 tablet(s) by mouth \nEvery 6 hours Disp #*30 Tablet Refills:*0\n7. Pantoprazole 40 mg PO Q24H \n8. QUEtiapine Fumarate 400 mg PO QHS \n9. Tizanidine ___ mg PO TID:PRN spasm \n10. Vitamin D ___ UNIT PO DAILY \n11. Cyclobenzaprine 10 mg PO TID:PRN spasm \n12. Albuterol Inhaler 2 PUFF IH Q4-6H PRN SOB \n13. Ambien CR *NF* (zolpidem) 12.5 mg Oral qHS  \n14. Leuprolide Acetate 11.25 mg IM EVERY 3 MONTHS \n15. lidocaine-menthol *NF* ___ % Topical daily prn pain \n16. Ondansetron 8 mg PO Q8H:PRN nausea \n17. Sumatriptan Succinate 50 mg PO ONCE PRN headache \n18. Enoxaparin Sodium 120 mg SC Q12H \nRX *enoxaparin 120 mg/0.8 mL 1 Injection Sub-Q Every 12 hours. \nDisp #*14 Syringe Refills:*0\n19. Warfarin 7.5 mg PO 3X/WEEK (___) \n20. Warfarin 5 mg PO 4X/WEEK (___) \n21. Ondansetron 4 mg PO Q 8H Nausea \nRX *ondansetron HCl 4 mg 1 tablet(s) by mouth Every 8 hours Disp \n#*30 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nHemorrhoids\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nHello Ms ___,\n.\nYou came in with blood in your stool that may have been due to \nover-thinning of your blood that led to a bleed from your \nhemorrhoids. As a result, the Gastroenterology (GI or stomach) \ndoctors decided we should perform a EGD (scope of the upper part \nof your intestines like stomach) and colonscopy (scope of the \nlower part of your intestines. The GI doctors ___ \nsignificant abnormalities that would have caused your bleed. \nMost likely the blood seen in your stool was due to your \nhemorrhoids bleeding because your blood may have been \nover-thinned and corrected while you were in the hospital.\n.\nBecause of your risk for clot in your lung that you were taking \ncoumadin (Warfarin) for we changed your anticoagulation (blood \nthinning) medication to heparin (the blood thinner through your \nIV). We will send you home on Lovenox, a blood thinner injection \nyou must take as we restart your coumadin, to prevent clots. You \nwill continue to take your coumadin and must follow-up at the \n___ clinic to continue to manage your blood thinning \nmedications and ensure your blood is properly monitored.\n.\nIf you experience any further bleeding or other concerning \nsymptoms such as significantly worse abdominal pain or fever, \nchills, chest pain or shortness of breath please contact your \nprimary care physician or come to the Emergency Room.\n.\nPlease follow-up with your primary care physician after leaving \nthe hospital within ___ weeks. An appointment (see below) has \nbeen made for you at ___ with Dr. ___. \nPlease call them if you need to re-schedule in advance.\n.\nThe following changes in your medications were made:\n.\n- Take 1 injection of enoxaparin (Lovenox) twice a day to thin \nyour blood. The coumadin (warfarin) clinic will instruct you \nwhen you may stop.\n.\nPlease continue your normal home regiment for your Coumadin \n(Warfarin) and will need your INR checked ___ so you \nmust see the ___ nurses to help manage \nyour coumadin.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee753931020"
  },
  "note_id": "19250934-DS-31",
  "subject_id": 19250934,
  "hadm_id": 27932203,
  "note_type": "DS",
  "note_seq": 31,
  "charttime": "2201-05-13 00:00:00",
  "storetime": "2201-05-13 16:53:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: ORTHOPAEDICS\n \nAllergies: \nCompazine / Motrin / Celexa / Amitriptyline Hcl / Neurontin\n \nAttending: ___\n \n___ Complaint:\nLeft knee pain\n \nMajor Surgical or Invasive Procedure:\n___: Left revision TKA\n\n \nHistory of Present Illness:\nHer orthopedic history is significant for a total knee \nreplacement on the left ___, and a right total \nknee replacement in ___. On ___ when \nshe twisted her left knee while chasing her grandson. The \nfollowing day that she felt significant discomfort and \npain--recent films showed loosening of left total knee \narthroplasty.  Admitted for left total knee revision.\n \nPast Medical History:\n1. pulmonary embolism - ___ after left knee replacement, second \nafter stopping coumadin, currently anti-coagulated on couamdin. \nneg hypercoag eval by heme)  \n2. cellulitis - treated earlier this year for abdominal \ncellulitis\n3. fibroids s/p supracervical hysterectomy, repair of bowel \nserosa injury, cystoscopy (___)  \n4. fibromyalgia - diagnosed earlier this year by PCP ___ \"leg \nand back pains\"\n5. osteoarthritis s/p bilateral knee replacement\n6. left leg nerve entrapment \n7. ectopic pregnancy  \n8. depression \n9. anxiety  \n10. obesity  \n11. sleep apnea \n12. migraines\n13. GERD\n14. chronic lower back pain\n \nSocial History:\n___\nFamily History:\nFather's health unknown except potential h/o stomach cancer.\nUncle has unknown cancer.\nMother living at ___ with arthritis and osteoporosis.\nAunt recently passed at ___ ___nd heart disease.\nGrandmother with breast cancer.\nNo siblings.\nChildren healthy.\n \nPhysical Exam:\nWell appearing in no acute distress  \nAfebrile with stable vital signs  \nPain well-controlled  \nRespiratory: CTAB  \nCardiovascular: RRR  \nGastrointestinal: NT/ND  \nGenitourinary: Voiding independently  \nNeurologic: Intact with no focal deficits  \nPsychiatric: Pleasant, A&O x3  \nMusculoskeletal Lower Extremity:  \n* Incision healing well with staples  \n* Scant serosanguinous drainage  \n* Thigh full but soft  \n* No calf tenderness  \n* ___ strength  \n* SILT, NVI distally  \n* Toes warm\n \nPertinent Results:\n___ 06:27AM BLOOD WBC-11.2* RBC-3.54* Hgb-9.7* Hct-29.6* \nMCV-84 MCH-27.4 MCHC-32.8 RDW-14.3 RDWSD-43.6 Plt ___\n___ 09:00PM BLOOD WBC-10.5* RBC-3.44*# Hgb-9.6*# Hct-29.4*# \nMCV-86 MCH-27.9 MCHC-32.7 RDW-14.6 RDWSD-45.0 Plt ___\n___ 08:30AM BLOOD WBC-9.2 RBC-2.72* Hgb-7.2* Hct-22.8* \nMCV-84 MCH-26.5 MCHC-31.6* RDW-14.8 RDWSD-45.1 Plt ___\n___ 07:30AM BLOOD WBC-9.2 RBC-3.30*# Hgb-8.7*# Hct-27.2*# \nMCV-82 MCH-26.4 MCHC-32.0 RDW-14.6 RDWSD-43.8 Plt ___\n___ 11:03AM BLOOD WBC-8.2 RBC-2.32* Hgb-6.1* Hct-20.3* \nMCV-88 MCH-26.3 MCHC-30.0* RDW-14.6 RDWSD-46.7* Plt ___\n___ 07:37AM BLOOD WBC-9.7# RBC-2.86*# Hgb-7.5*# Hct-24.0*# \nMCV-84 MCH-26.2 MCHC-31.3* RDW-14.5 RDWSD-44.2 Plt ___\n___ 06:27AM BLOOD Plt ___\n___ 09:00PM BLOOD Plt ___\n___ 08:30AM BLOOD Plt ___\n___ 07:30AM BLOOD Plt ___\n___ 11:03AM BLOOD Plt ___\n___ 07:37AM BLOOD Glucose-137* UreaN-9 Creat-1.0 Na-140 \nK-4.1 Cl-106 HCO3-24 AnGap-14\n___ 07:37AM BLOOD Calcium-8.1* Phos-3.0 Mg-1.8\n \nBrief Hospital Course:\nThe patient was admitted to the orthopedic surgery service and \nwas taken to the operating room for above described procedure. \nPlease see separately dictated operative report for details. The \nsurgery was uncomplicated and the patient tolerated the \nprocedure well. Patient received perioperative IV antibiotics.\n\nPostoperative course was remarkable for the following:\n- On POD#1, she was triggered for hypotension with a BP of \n___ and low urine output. Her anti-hypertensive medications \nwere held.  She was also administered a 1L bolus of IVF.  She \ncontinued to be hypotensive. Her CBC was re-check and her \nhematocrit drifted down from 34 pre op to 20.3. She was given 2U \nPBRC and responded appropriately.\n- On POD#1, she was persistently tachycardia and complained of \nworsening LLE pain, Lower extremity non-invasive studies were \nunremarkable.  Her heart rate normalized with improved pain \ncontrol\n- On POD#2, the patient triggered again for a BP of ___ \nsystolic.  She was given a bolus of 1L NS and placed hold \nparameters on anti-hypertensives.  Overnight, her blood pressure \ndropped and she was given another 500 mL bolus and Albumin.  \n- Her drain was putting out a significant amount of \nserosanguinous drainage until POD#3 at which point it was \nremoved.  She was given 2 units of blood when her hematocrit was \n22.8.  On POD#4, her hematocrit had stabilized to 29.6.\n- On POD#4, a urinalysis was collected for an increasing white \ncount. This was pending at time of discharge.\n\nOtherwise, pain was controlled with a combination of IV and oral \npain medications.  The patient received Eliquis for DVT \nprophylaxis starting on the morning of POD#1.  The surgical \ndressing was changed and the Silverlon dressing was removed on \nPOD#2. The surgical incision was found to be clean and intact \nwithout erythema or abnormal drainage. The patient was seen \ndaily by physical therapy. Labs were checked throughout the \nhospital course and repleted accordingly. At the time of \ndischarge the patient was tolerating a regular diet and feeling \nwell.  The patient was afebrile with stable vital signs.  The \npatient's hematocrit was acceptable and pain was adequately \ncontrolled on an oral regimen. The operative extremity was \nneurovascularly intact and the wound was benign. \n\nThe patient's weight-bearing status is weight bearing as \ntolerated on the operative extremity. \n \nMs. ___ is discharged to rehab in stable condition.\n \nMedications on Admission:\n1. amLODIPine 10 mg PO DAILY \n2. Atenolol 100 mg PO DAILY \n3. Chlorthalidone 50 mg PO DAILY \n4. Lisinopril 40 mg PO DAILY \n5. QUEtiapine Fumarate 200 mg PO QHS \n6. Zolpidem Tartrate 5 mg PO QHS \n7. LORazepam 1 mg PO DAILY PRN anxiety \n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q8H \n2.  Docusate Sodium 100 mg PO DAILY \n3.  OxyCODONE (Immediate Release) ___ mg PO Q3H:PRN Pain \n4.  Senna 8.6 mg PO DAILY \n5.  leuprolide (3 month) 11.25 mg injection Q3MONTHS  \n6.  amLODIPine 10 mg PO DAILY  \n7.  Apixaban 5 mg PO BID  \n8.  Atenolol 100 mg PO DAILY  \n9.  Chlorthalidone 50 mg PO DAILY  \n10.  Cyclobenzaprine 10 mg PO BID  \n11.  Lisinopril 40 mg PO DAILY  \n12.  LORazepam 1 mg PO DAILY PRN anxiety  \n13.  QUEtiapine Fumarate 200 mg PO QHS  \n14.  Tizanidine 8 mg PO QHS  \n15.  Zolpidem Tartrate 5 mg PO QHS  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \n___ Diagnosis:\nLeft knee aseptic loosening\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\n1. Please return to the emergency department or notify your \nphysician if you experience any of the following: severe pain \nnot relieved by medication, increased swelling, decreased \nsensation, difficulty with movement, fevers greater than 101.5, \nshaking chills, increasing redness or drainage from the incision \nsite, chest pain, shortness of breath or any other concerns.\n \n2. Please follow up with your primary physician regarding this \nadmission and any new medications and refills. \n \n3. Resume your home medications unless otherwise instructed.\n \n4. You have been given medications for pain control. Please do \nnot drive, operate heavy machinery, or drink alcohol while \ntaking these medications. As your pain decreases, take fewer \ntablets and increase the time between doses. This medication can \ncause constipation, so you should drink plenty of water daily \nand take a stool softener (such as Colace) as needed to prevent \nthis side effect.  Call your surgeons office 3 days before you \nare out of medication so that it can be refilled.  These \nmedications cannot be called into your pharmacy and must be \npicked up in the clinic or mailed to your house.  Please allow \nan extra 2 days if you would like your medication mailed to your \nhome.\n \n5. You may not drive a car until cleared to do so by your \nsurgeon.\n \n6. Please call your surgeon's office to schedule or confirm your \nfollow-up appointment in three (3) weeks.\n \n7. SWELLING: Ice the operative joint 20 minutes at a time, \nespecially after activity or physical therapy. Do not place ice \ndirectly on the skin. You may wrap the knee with an ace bandage \nfor added compression. Please DO NOT take any non-steroidal \nanti-inflammatory medications (NSAIDs such as Celebrex, \nibuprofen, Advil, Aleve, Motrin, naproxen etc) until cleared by \nyour physician.\n \n8. ANTICOAGULATION: Your home dose of Eliquis was restarted on \npost-operative day #1, please continue to take it as instructed \nby your PCP.\n \n9. WOUND CARE: Please keep your incision clean and dry. It is \nokay to shower five days after surgery but no tub baths, \nswimming, or submerging your incision until after your four (4) \nweek checkup. Please place a dry sterile dressing on the wound \neach day if there is drainage, otherwise leave it open to air. \nCheck wound regularly for signs of infection such as redness or \nthick yellow drainage. Staples will be removed by your doctor at \nfollow-up appointment approximately 3 weeks after surgery.\n \n10. ___ (once at home): Home ___, dressing changes as \ninstructed, and wound checks.\n \n11. ACTIVITY: Weight bearing as tolerated on the operative \nextremity. Mobilize with assistive devices (___) if \nneeded.  Range of motion at the knee as tolerated. No strenuous \nexercise or heavy lifting until follow up appointment.\n\nPhysical Therapy:\nWBAT LLE\nNo range of motion restrictions\nWean assistive device as able\nMobilize frequently\nTreatments Frequency:\ndaily dressing changes as needed for drainage\nwound checks daily\nice\nstaple removal and replace with steri-strips (at follow up \nvisit)\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee753931021"
  },
  "note_id": "19250934-DS-32",
  "subject_id": 19250934,
  "hadm_id": 25009293,
  "note_type": "DS",
  "note_seq": 32,
  "charttime": "2201-06-03 00:00:00",
  "storetime": "2201-06-05 14:04:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: ORTHOPAEDICS\n \nAllergies: \nCompazine / Motrin / Celexa / Amitriptyline Hcl / Neurontin\n \nAttending: ___\n \n___ Complaint:\nleft knee hematoma\n \nMajor Surgical or Invasive Procedure:\nLeft knee irrigation and debridement and hematoma evacuation\n\n \nHistory of Present Illness:\n___ y/o female s/p left total knee revision ___ presents for \nsuperficial wound dehiscence with acute renal failure now s/p \nleft knee I&D and hematoma evaluation\n \nPast Medical History:\n1. pulmonary embolism - ___ after left knee replacement, second \nafter stopping coumadin, currently anti-coagulated on couamdin. \nneg hypercoag eval by heme)  \n2. cellulitis - treated earlier this year for abdominal \ncellulitis\n3. fibroids s/p supracervical hysterectomy, repair of bowel \nserosa injury, cystoscopy (___)  \n4. fibromyalgia - diagnosed earlier this year by PCP ___ \"leg \nand back pains\"\n5. osteoarthritis s/p bilateral knee replacement\n6. left leg nerve entrapment \n7. ectopic pregnancy  \n8. depression \n9. anxiety  \n10. obesity  \n11. sleep apnea \n12. migraines\n13. GERD\n14. chronic lower back pain\n \nSocial History:\n___\nFamily History:\nFather's health unknown except potential h/o stomach cancer.\nUncle has unknown cancer.\nMother living at ___ with arthritis and osteoporosis.\nAunt recently passed at ___ ___nd heart disease.\nGrandmother with breast cancer.\nNo siblings.\nChildren healthy.\n \nPhysical Exam:\nWell appearing in no acute distress  \nAfebrile with stable vital signs  \nPain well-controlled  \nRespiratory: CTAB  \nCardiovascular: RRR  \nGastrointestinal: NT/ND  \nGenitourinary: Voiding independently  \nNeurologic: Intact with no focal deficits  \nPsychiatric: Pleasant, A&O x3  \nMusculoskeletal Lower Extremity:  \n* Aquacel dressing clean, dry and intact \n* Scant serosanguinous drainage  \n* Thigh full but soft  \n* No calf tenderness  \n* ___ strength  \n* SILT, NVI distally  \n* Toes warm\n\n \nPertinent Results:\n___ 12:30PM BLOOD WBC-9.5 RBC-3.06* Hgb-8.6* Hct-26.1* \nMCV-85 MCH-28.1 MCHC-33.0 RDW-14.7 RDWSD-45.4 Plt ___\n___ 09:00AM BLOOD WBC-9.2 RBC-2.56* Hgb-7.0* Hct-22.0* \nMCV-86 MCH-27.3 MCHC-31.8* RDW-15.1 RDWSD-47.2* Plt ___\n___ 07:30AM BLOOD WBC-11.0* RBC-2.83* Hgb-7.7* Hct-25.0* \nMCV-88 MCH-27.2 MCHC-30.8* RDW-15.0 RDWSD-48.8* Plt ___\n___ 08:20AM BLOOD WBC-9.7# RBC-2.78* Hgb-7.6* Hct-24.3* \nMCV-87 MCH-27.3 MCHC-31.3* RDW-15.1 RDWSD-48.5* Plt ___\n___ 08:25AM BLOOD WBC-4.6 RBC-3.17* Hgb-8.7* Hct-27.3* \nMCV-86 MCH-27.4 MCHC-31.9* RDW-15.0 RDWSD-48.1* Plt ___\n___ 03:00PM BLOOD WBC-5.5 RBC-3.33* Hgb-9.0* Hct-28.2* \nMCV-85 MCH-27.0 MCHC-31.9* RDW-15.0 RDWSD-46.3 Plt ___\n___ 08:00AM BLOOD WBC-5.2 RBC-3.33* Hgb-9.1* Hct-28.4* \nMCV-85 MCH-27.3 MCHC-32.0 RDW-14.9 RDWSD-46.3 Plt ___\n___ 08:15AM BLOOD WBC-5.0 RBC-3.50* Hgb-9.3* Hct-29.8* \nMCV-85 MCH-26.6 MCHC-31.2* RDW-14.9 RDWSD-46.6* Plt ___\n___ 07:47PM BLOOD WBC-7.8 RBC-3.68* Hgb-10.0* Hct-30.9* \nMCV-84 MCH-27.2 MCHC-32.4 RDW-14.8 RDWSD-45.4 Plt ___\n___ 04:43PM BLOOD WBC-8.1 RBC-3.80* Hgb-10.4* Hct-31.7* \nMCV-83 MCH-27.4 MCHC-32.8 RDW-14.9 RDWSD-45.6 Plt ___\n___ 12:30PM BLOOD Neuts-69.5 Lymphs-18.5* Monos-7.3 Eos-3.9 \nBaso-0.3 NRBC-0.2* Im ___ AbsNeut-6.56* AbsLymp-1.75 \nAbsMono-0.69 AbsEos-0.37 AbsBaso-0.03\n___ 09:00AM BLOOD Neuts-67.3 ___ Monos-9.0 Eos-3.9 \nBaso-0.3 Im ___ AbsNeut-6.18* AbsLymp-1.75 AbsMono-0.83* \nAbsEos-0.36 AbsBaso-0.03\n___ 07:47PM BLOOD Neuts-64.8 ___ Monos-9.1 Eos-1.9 \nBaso-0.8 Im ___ AbsNeut-5.02# AbsLymp-1.78 AbsMono-0.71 \nAbsEos-0.15 AbsBaso-0.06\n___ 12:30PM BLOOD Plt ___\n___ 09:00AM BLOOD Plt ___\n___ 07:30AM BLOOD Plt ___\n___ 08:20AM BLOOD Plt ___\n___ 08:25AM BLOOD Plt ___\n___ 08:25AM BLOOD ___ PTT-34.4 ___\n___ 10:00PM BLOOD PTT-75.6*\n___ 03:00PM BLOOD Plt ___\n___ 03:00PM BLOOD ___ PTT-97.7* ___\n___ 08:00AM BLOOD Plt ___\n___ 08:00AM BLOOD ___ PTT-114.7* ___\n___ 01:00AM BLOOD ___ PTT-95.7* ___\n___ 06:50PM BLOOD ___ PTT-81.4* ___\n___ 08:15AM BLOOD Plt ___\n___ 08:15AM BLOOD ___ PTT-29.3 ___\n___ 07:47PM BLOOD Plt ___\n___ 04:43PM BLOOD Plt ___\n___ 12:30PM BLOOD Glucose-106* UreaN-5* Creat-0.6 Na-141 \nK-4.2 Cl-106 HCO3-24 AnGap-11\n___ 09:00AM BLOOD Glucose-98 UreaN-6 Creat-0.7 Na-143 K-4.3 \nCl-108 HCO3-23 AnGap-12\n___ 07:30AM BLOOD Creat-0.8\n___ 08:20AM BLOOD Glucose-107* UreaN-10 Creat-0.9 Na-145 \nK-4.9 Cl-109* HCO3-23 AnGap-13\n___ 08:25AM BLOOD Glucose-93 UreaN-23* Creat-1.0 Na-147* \nK-5.0 Cl-112* HCO3-23 AnGap-12\n___ 03:00PM BLOOD Glucose-110* UreaN-42* Creat-1.5* Na-142 \nK-5.0 Cl-108 HCO3-20* AnGap-14\n___ 08:00AM BLOOD Glucose-111* UreaN-57* Creat-2.1*# Na-145 \nK-4.9 Cl-108 HCO3-21* AnGap-16\n___ 06:50PM BLOOD Glucose-114* UreaN-77* Creat-4.4*# Na-144 \nK-4.8 Cl-106 HCO3-21* AnGap-17*\n___ 08:15AM BLOOD Glucose-104* UreaN-107* Creat-9.1*# \nNa-142 K-4.8 Cl-101 HCO3-20* AnGap-21*\n___ 07:47PM BLOOD Glucose-137* UreaN-119* Creat-14.8* \nNa-136 K-4.8 Cl-90* HCO3-22 AnGap-24*\n___ 04:43PM BLOOD Glucose-118* UreaN-117* Creat-15.0*# \nNa-136 K-5.2* Cl-89* HCO3-22 AnGap-25*\n___ 12:30PM BLOOD ALT-7 AST-10 AlkPhos-96 TotBili-0.3\n___ 09:00AM BLOOD ALT-8 AST-13 AlkPhos-84\n___ 08:15AM BLOOD ALT-8 AST-6 LD(LDH)-349* AlkPhos-96 \nTotBili-0.3\n___ 12:30PM BLOOD Calcium-8.1* Phos-2.5* Mg-1.5*\n___ 09:00AM BLOOD Calcium-8.2* Phos-2.5* Mg-1.3*\n___ 08:20AM BLOOD Calcium-8.3* Phos-2.0* Mg-1.5*\n___ 08:25AM BLOOD Calcium-8.6 Phos-2.2* Mg-1.5*\n___ 03:00PM BLOOD Calcium-8.9 Phos-2.3* Mg-2.2\n___ 08:00AM BLOOD Calcium-9.2 Phos-3.2 Mg-1.7\n___ 06:50PM BLOOD Calcium-8.9 Phos-4.6* Mg-2.0\n___ 08:15AM BLOOD Albumin-3.7 Calcium-9.3 Phos-7.7* Mg-2.4\n___ 07:47PM BLOOD Calcium-9.9 Phos-10.8* Mg-2.8*\n___ 04:43PM BLOOD Calcium-10.2 Phos-11.2* Mg-2.8*\n___ 12:30PM BLOOD CRP-159.3*\n___ 09:00AM BLOOD CRP-168.5*\n___ 07:47PM BLOOD CRP-46.9*\n___ 04:12PM BLOOD Vanco-16.9\n___ 09:00AM BLOOD Vanco-11.8\n___ 07:15PM URINE Color-Yellow Appear-Hazy* Sp ___\n___ 07:15PM URINE Blood-SM* Nitrite-NEG Protein-100* \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.5 Leuks-TR*\n___ 07:15PM URINE RBC-2 WBC-4 Bacteri-NONE Yeast-NONE \nEpi-<1\n___ 07:15PM URINE CastHy-14*\n___ 07:15PM URINE AmorphX-RARE*\n___ 07:15PM URINE Mucous-RARE*\n___ 08:50PM URINE Eos-NEGATIVE  \n___ 08:50PM URINE Hours-RANDOM UreaN-435 Creat-275 Na-33 \nCl-<20 TotProt-162 Phos-59.5 Prot/Cr-0.6*\n___ 08:50PM URINE Osmolal-373\n___ 12:16PM JOINT FLUID TNC-932* ___ Polys-84* \n___ Monos-6 Other-2*\n \nBrief Hospital Course:\nThe patient was admitted to the orthopedic surgery service and \nwas taken to the operating room for above described procedure. \nPlease see separately dictated operative report for details. The \nsurgery was uncomplicated and the patient tolerated the \nprocedure well. Patient received perioperative IV antibiotics.\n\nOn HD #1, her creatinine was 15.0 on admission. A repeat \ncreatinine was obtained which revealed a creatinine of 14.8. \nNephrology was consulted and recommended getting a renal \nultrasound which revealed no hydronephrosis or stones.  They \nalso recommended obtaining urine lytes, a urinalysis, starting \nIV fluids, and inserting a foley catheter to monitor input and \noutput.  Medications that were renally excreted were \ndiscontinued and the Ancef was renally dosed.  Patient's knee \nwas aspirated by interventional radiology, which demonstrated \n932 WBC, ___ RBC, 84 poly's. The cultures, gram stain and \ncrystals were negative. Her WBC was 8.1 and the differential was \nnegative. \n\nOn HD #2, her creatinine was downtrending 9.1 and 4.4 when \nrepeated later in the day. She was started on IV heparin given \nkidney function instead of a Lovenox bridge. Nephrology \nrecommended continuing IV fluids and monitoring I&Os. Her BMP \nwas checked every 12 hours. \n\nOn HD #3, her creatinine continued to downtrend to 2.1, and then \nto 1.5 when repeated later in the day. \n\nOn HD#4, ___, she underwent irrigation and debridement of \nher left knee and hematoma evacuation.  Tissue was sent for \nculture.  Eliquis was restarted on POD#1.  Her medications were \nall dosed back to baseline POD#1 since her creatinine had \nnormalized. \n\nOn HD#5/POD#1, her magnesium was 1.5 and phosphorous was 2.0, \nwhich both were repleted. She was taken off the PCA and started \non oral pain medications.  Infectious disease was consulted when \nher OR cultures came back positive and recommended to switch \nAncef to Cefipime.\n\nOn HD#6/POD#2, labs continued to be monitored.  Infectious \ndisease recommended additional labs to be ordered and cultures \nto be followed.  They recommended continuing the Vancomycin and \nCefepime.\n\nOn HD#7/POD#3, patient was transfused 2 units of red blood cells \nfor hematocrit of 22. Vancomycin was increased from 1,500mg q12h \nto q8h due to sub-therapeutic trough levels of 11.8. Patient had \na PICC line placed with consent.\n\nOn HD#8/POD#4, patient was seen by ID with final recommendations \nregarding discharge home with IV antibiotics. She received her \nfirst dose of Ertapenem 1g while inpatient and tolerated well. \nShe had a vanco trough drawn prior to discharge, which was \ntherapeutic at 16.9. She will be discharged on IV Ertapenem and \nVancomycin.\n\nAt the time of discharge the patient was tolerating a regular \ndiet and feeling well.  The patient was afebrile with stable \nvital signs.  The patient's hematocrit was acceptable and pain \nwas adequately controlled on an oral regimen. The operative \nextremity was neurovascularly intact and the dressing was \nintact. \n\nThe patient's weight-bearing status is weight bearing as \ntolerated on the operative extremity.   \n\nMs. ___ is discharged to home with services in stable \ncondition.\n\n \nMedications on Admission:\n1. amLODIPine 10 mg PO DAILY \n2. Atenolol 100 mg PO DAILY \n3. Chlorthalidone 50 mg PO DAILY \n4. Cyclobenzaprine 10 mg PO BID:PRN muscle spasms \n5. Enoxaparin Sodium 80 mg SC Q12H \nStart: ___, First Dose: Next Routine Administration Time \n6. Leuprolide Acetate 11.25 mg IM EVERY 3 MONTHS \n7. Lisinopril 40 mg PO DAILY \n8. LORazepam 1 mg PO DAILY:PRN anxiety \n9. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - \nModerate \n10. QUEtiapine Fumarate 400 mg PO QHS \n11. Tizanidine 8 mg PO QHS \n12. Zolpidem Tartrate 5 mg PO QHS \n\n \nDischarge Medications:\n1.  Ertapenem Sodium 1 g IV 1X Duration: 1 Dose \n2.  Vancomycin 1500 mg IV Q 12H Duration: 6 Weeks \n3.  Acetaminophen 1000 mg PO Q8H  \n4.  amLODIPine 10 mg PO DAILY  \n5.  Apixaban 5 mg PO BID  \n6.  Atenolol 100 mg PO DAILY  \n7.  Chlorthalidone 50 mg PO DAILY  \n8.  Cyclobenzaprine 10 mg PO BID:PRN muscle spasms  \n9.  Leuprolide Acetate 11.25 mg IM EVERY 3 MONTHS  \n10.  Lisinopril 40 mg PO DAILY  \n11.  LORazepam 1 mg PO DAILY:PRN anxiety  \n12.  OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - \nModerate  \n13.  QUEtiapine Fumarate 400 mg PO QHS  \n14.  Tizanidine 8 mg PO QHS  \n15.  Zolpidem Tartrate 5 mg PO QHS  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \n___ Diagnosis:\nleft knee hematoma \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\n1. Please return to the emergency department or notify your \nphysician if you experience any of the following: severe pain \nnot relieved by medication, increased swelling, decreased \nsensation, difficulty with movement, fevers greater than 101.5, \nshaking chills, increasing redness or drainage from the incision \nsite, chest pain, shortness of breath or any other concerns.\n \n2. Please follow up with your primary physician regarding this \nadmission and any new medications and refills. \n \n3. Resume your home medications unless otherwise instructed.\n \n4. You have been given medications for pain control. Please do \nnot drive, operate heavy machinery, or drink alcohol while \ntaking these medications. As your pain decreases, take fewer \ntablets and increase the time between doses. This medication can \ncause constipation, so you should drink plenty of water daily \nand take a stool softener (such as Colace) as needed to prevent \nthis side effect.  Call your surgeons office 3 days before you \nare out of medication so that it can be refilled.  These \nmedications cannot be called into your pharmacy and must be \npicked up in the clinic or mailed to your house.  Please allow \nan extra 2 days if you would like your medication mailed to your \nhome.\n \n5. You may not drive a car until cleared to do so by your \nsurgeon.\n \n6. Please call your surgeon's office to schedule or confirm your \nfollow-up appointment in three (3) weeks.\n \n7. SWELLING: Ice the operative joint 20 minutes at a time, \nespecially after activity or physical therapy. Do not place ice \ndirectly on the skin. You may wrap the knee with an ace bandage \nfor added compression. Please DO NOT take any non-steroidal \nanti-inflammatory medications (NSAIDs such as Celebrex, \nibuprofen, Advil, Aleve, Motrin, naproxen etc) until cleared by \nyour physician.\n \n8. ANTICOAGULATION: Please continue your Eliquis 5 mg daily to \nhelp prevent deep vein thrombosis (blood clots).  \n\n9. WOUND CARE: Please remove Aquacel dressing on POD#7 after \nsurgery (___). It is okay to shower after surgery after 5 \ndays but no tub baths, swimming, or submerging your incision \nuntil after your four (4) week checkup. Please place a dry \nsterile dressing on the wound after aqaucel is removed each day \nif there is drainage, otherwise leave it open to air. Check \nwound regularly for signs of infection such as redness or thick \nyellow drainage.  Staples will be removed by your doctor at \nfollow-up appointment approximately 3 weeks after surgery.\n \n10. ___ (once at home): Home ___, dressing changes as \ninstructed, and wound checks.\n \n11. ACTIVITY: Weight bearing as tolerated on the operative \nextremity. Mobilize with assistive devices (___) if \nneeded.  Range of motion at the knee as tolerated. No strenuous \nexercise or heavy lifting until follow up appointment.\n\n12. PICC CARE: Per protocol\n\n13. WEEKLY LABS: draw on ___ and send result to ID RNs \nat: ___ R.N.s at ___. \n - CBC/DIFF\n - CHEM 7\n - LFTS\n - ESR/CRP\n - Vanco trough\n\n**All questions regarding outpatient parenteral antibiotics \nshould be directed to the ___ R.N.s at \n___ or to the on-call ID fellow when the clinic is \nclosed.**\nPhysical Therapy:\nWBAT LLE\nNo range of motion restrictions, in knee immobilizer while in \nbed\nAssistive device when ambulating\nMobilize frequently\nTreatments Frequency:\nremove aquacel POD#7 (___) after surgery\napply dry sterile dressing daily if needed after aquacel \ndressing is removed\nwound checks daily after aquacel removed\nice\nstaple removal and replace with steri-strips (at follow up \nvisit)\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee753931022"
  },
  "note_id": "19250934-DS-33",
  "subject_id": 19250934,
  "hadm_id": 27944971,
  "note_type": "DS",
  "note_seq": 33,
  "charttime": "2201-06-22 00:00:00",
  "storetime": "2201-06-22 13:34:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCompazine / Motrin / Celexa / Amitriptyline Hcl / Neurontin\n \nAttending: ___.\n \nChief Complaint:\nfever\n \nMajor Surgical or Invasive Procedure:\n-arthrocentesis/aspiration left knee ___\n \nHistory of Present Illness:\nMs. ___ is a ___ female with the PMH osteoarthritis,  \ns/p bilateral TKAs (___) c/b DVT in requiring LT knee \nrevision ___ after running injury, POD ___ s/p L knee washout \non vanc/ertapenem, who is admitted for ___ and\nfevers.  Pts recent health issues began in ___ when she \ntwisted her knee while running, was subsequently found to have \nloosening of her L total knee replacement, underwent revision \nhowever course was complicated by L knee hematoma with bleeding \nfrom incision, subsequently required revision and debridement \n___, discharged on ___ to complete a 6 week course of IV abx \nfor polymicrobial joint infection (tissues growing grp B strep; \nenterococcus (vanc/amp susceptible); SCN; diptheoids; kleb \npneumo ___ serratia (pan- ___ and mixed bacterial \nflora).   Pt was seen in ___ clinic today for where she was noted \nto be weak and ill-appearing, temp was 103.0, therefore she was \nsent to the ED.  \n\nOn talking with the patient today, she complaints of pain in the \nL knee but is unable to tell me a clear time frame for the \nworsening of the pain, states in general it has persisted since \nher last admission. Also endorses a shooting pain in her hip as \nwell as numbness.  States that she has felt a little confused\nrecently and endorses difficulty breathing over the last week as \nwell as non-productive cough.  She had diarrhea a couple days \nago, none recently, vomiting x 1 on tues.  No new rashes.  She \nhas been taking abx every day and has not had any new \nmedications recently.  Endorses poor appetite recently, can't \nremember last meal.  Denies drainage from line or surgical \nincision.\n\nROS: Pertinent positives and negatives as noted in the HPI.  All \nother systems were reviewed and are negative. \n \nPast Medical History:\n-Osteoarthritis s/p LT TKR ___ s/p RT TKR ___\n-pulmonary embolism - ___ after left knee replacement, second \nafter stopping coumadin, currently on eliquis\n-abd wall cellulitis ___\n-fibroids s/p supracervical hysterectomy, repair of bowel serosa\ninjury, cystoscopy (___)  \n-fibromyalgia, depression, anxiety  \n-left leg nerve entrapment \n-ectopic pregnancy  \n-obesity, OSA, migraines, GERD, chronic lower back pain\n \nSocial History:\n___\nFamily History:\n-Father's health unknown except potential h/o stomach cancer.\n-Uncle has unknown cancer.\n-Mother living at ___ with arthritis, DM, and osteoporosis.\n-Aunt recently passed at ___ ___nd heart disease.\n-Grandmother with breast cancer.\n-No siblings.\n-Children healthy.\n \nPhysical Exam:\nADMISSION EXAM\nVITALS: reviewed in OMR\nGENERAL: Alert and in no apparent distress, morbidly obese\nEYES: Anicteric, pupils equally round\nCV: Heart regular, no murmur, no S3, no S4.  No JVD.\nRESP: Lungs clear to auscultation with diminished air movement\nthroughout.  Breathing is non-labored\nGI: Abdomen soft, non-distended, mild diffuse ttp.  Bowel sounds\npresent.  No HSM\nGU: No GU catheter in place\nMSK: moves all extremities, diminished ROM in L knee.  Sutures \nin\nplace without drainage, swelling in LLE but not hot\nSKIN: No rashes or ulcerations noted\nNEURO: Alert, oriented x3, face symmetric, gaze conjugate with\nEOMI, speech fluent, moves all limbs, sensation to light touch\ngrossly intact throughout\nPSYCH: pleasant, slightly flat affect\n\nDISCHARGE EXAM\n\n \nPertinent Results:\nADMISSION LABS\n___ 11:21AM BLOOD WBC-2.3*# RBC-2.85* Hgb-7.6* Hct-23.6* \nMCV-83 MCH-26.7 MCHC-32.2 RDW-15.6* RDWSD-47.3* Plt ___\n___ 11:21AM BLOOD Neuts-66.0 ___ Monos-11.2 \nEos-0.0* Baso-0.4 NRBC-0.9* Im ___ AbsNeut-1.54*# \nAbsLymp-0.50* AbsMono-0.26 AbsEos-0.00* AbsBaso-0.01\n\n___ 12:19PM BLOOD ___ PTT-42.8* ___\n\n___ 11:21AM BLOOD Glucose-129* UreaN-17 Creat-2.8*# Na-133 \nK-3.3 Cl-94* HCO3-21* AnGap-18*\n___ 11:21AM BLOOD ALT-35 AST-143* AlkPhos-81 TotBili-0.4\n___ 11:21AM BLOOD Albumin-3.0* Calcium-7.9* Phos-2.3* \nMg-1.5*\n___ 04:46AM BLOOD Vanco-46.9*\n\nDISCHARGE LABS\n***\n\nIMAGING/STUDIES \n-Renal US: No hydronephrosis.  The right kidney appears slightly \nmore echogenic,\ncorrelate clinically for medical renal disease.\n\n___ 04:51AM BLOOD WBC-2.5* RBC-2.77* Hgb-7.5* Hct-23.0* \nMCV-83 MCH-27.1 MCHC-32.6 RDW-18.0* RDWSD-54.7* Plt ___\n___ 04:51AM BLOOD Plt ___\n___ 04:51AM BLOOD Glucose-97 UreaN-15 Creat-1.8* Na-147* \nK-3.5 Cl-109* HCO3-24 AnGap-14\n___ 05:10AM BLOOD CK(CPK)-64\n___ 05:26AM BLOOD ALT-20 AST-57* CK(CPK)-201 AlkPhos-65 \nTotBili-0.4\n___ 04:51AM BLOOD Calcium-7.7* Phos-3.4 Mg-1.6\n___ 12:12PM BLOOD calTIBC-153* VitB12-434 Folate-16 \n___ TRF-118*\n___ 11:21AM BLOOD CRP-161.7*\n \nBrief Hospital Course:\n___ h/o osteoarthritis s/p bilateral TKAs ___ and ___ \n(complicated by DVT/PE) w/ left knee revision ___ \n(complicated by hematoma and polymicrobial joint infection on \nvanc/ertapenem  for 6 weeks s/p revision/debridement ___ who \nis admitted for ___ and fevers.\n\n1. ___\n-Urine electrolytes consistent with pre-renal etiology likely \ndue to poor PO intake w/ fever; however, she received 3L IV \nfluids without improvement in creatinine.  In setting of \nsupra-therapuetic vanco trough of 46 there was initial concern \nthis is actually ATN.  Vancomycin was stopped and Switched to IV \nDapto. Renal US without hydronephrosis. Seen by nephrology. Also \nagreed w/ switch. Did not feel ___ was related to AIN either. \nLisinopril held and to be stopped at discharge as well. \nNeohrology also recommended DC of PPI which was done. Cre \nsteadily improved, down to 1.8 at discharge\n\n2. Fever and leukopenia h/o left knee polymicrobial joint \ninfection\n-Patient spiking fever while on vancomycin/ertapenem concerning \nfor resistant organisms or inadequate coverage.  ID was \nconsulted who replaced vancomycin with daptomycin given ___, \nreplaced ertapenem with meropenem, and added levofloxacin \npending arthrocentsis culture, which did not show any growth. \nUltimately discharged on IV Ertapenem and Daptomycin which pt \nwill finish until ___\n\n3. Acute on chronic normocytic anemia\n-Unclear etiology with no reports of bleeding.  ___ be related \nto knee surgery (?hematoma) vs anemia of chronic disease.  She \nnotes multiple blood transfusions over the past few months and \nis worried this contributed to her current infections; because \nof this she declined further transfusions.  Anemia work up \nshowed normal iron level but started on PO iron here.\n\n4. h/o DVT/PE w/ supratherapeutic INR\n-h/o clots during previous surgeries and when coming off \nCoumadin.  She was counted on prophylactic SC heparin until \ncleared by surgery and then transitioned back to home coumadin. \nWill be discharged on 4 mg as INR supratherapeutic at 3.5 today. \nShe should hold warfarin tonight and then have INR checked daily \nuntil therapeautic \n\n5. Acute encephalopathy\n-Likely multifactorial in setting of infection, fever, \nhospitalization, medications.  Zolpidem, cyclobenzaprine, \noxycodone, and lorazepam are all potentially contributing to \nsedation/confusion and tried to minimize polypharmacy.\n- Resolved, at baseline mentation at discharge \n\n6. Hypomagnesemia\n-Repete and monitor.  Chlorthalidone stopped.\n\n7. HTN\n-Chlorthalidone stopped in setting of ___.\n\n>30 minutes spent on discharge planning.  \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol Inhaler 2 PUFF IH Q6H wheezing \n2. amLODIPine 10 mg PO DAILY \n3. Apixaban 5 mg PO BID \n4. Atenolol 100 mg PO DAILY \n5. Chlorthalidone 50 mg PO DAILY \n6. Cyclobenzaprine 10 mg PO BID:PRN spasm \n7. Enoxaparin Sodium 80 mg SC BID \nStart: Today - ___, First Dose: Next Routine Administration \nTime \n8. Ertapenem Sodium 1 g IV Frequency is Unknown \n9. Leuprolide Acetate 11.25 mg IM Q3MONTHS \n10. Lisinopril 40 mg PO DAILY \n11. LORazepam 1 mg PO QHS anxiety \n12. QUEtiapine Fumarate 400 mg PO QHS \n13. Tizanidine 8 mg PO QHS \n14. Vancomycin 1500 mg IV Q 12H \n15. Zolpidem Tartrate 5 mg PO QHS:PRN insomnia \n\n \nDischarge Medications:\n1.  Daptomycin 530 mg IV Q24H \nRX *daptomycin [Cubicin] 500 mg 530 mg IV once a day Disp #*19 \nVial Refills:*0 \n2.  Ertapenem Sodium 1 g IV 1X Duration: 1 Dose \n1 gram daily until ___ \nRX *ertapenem [Invanz] 1 gram 1 gram IV daily Disp #*19 Vial \nRefills:*0 \n3.  Ferrous Sulfate 325 mg PO BID \nRX *ferrous sulfate [Feosol] 325 mg (65 mg iron) 1 tablet(s) by \nmouth twice daily Disp #*60 Tablet Refills:*0 \n4.  Vitamin D 400 UNIT PO DAILY \nRX *ergocalciferol (vitamin D2) 400 unit 1 tablet(s) by mouth \ndaily Disp #*30 Tablet Refills:*0 \n5.  Warfarin 4 mg PO DAILY16 \nHold warfarin today (___). Will need to check INR daily to \nadjust dosing further \nRX *warfarin [Coumadin] 4 mg 1 tablet(s) by mouth daily Disp \n#*30 Tablet Refills:*0 \n6.  Albuterol Inhaler 2 PUFF IH Q6H wheezing  \n7.  Atenolol 100 mg PO DAILY  \n8.  Cyclobenzaprine 10 mg PO BID:PRN spasm  \n9.  Leuprolide Acetate 11.25 mg IM Q3MONTHS  \n10.  LORazepam 1 mg PO QHS anxiety  \n11.  QUEtiapine Fumarate 400 mg PO QHS  \n12.  Zolpidem Tartrate 5 mg PO QHS:PRN insomnia  \n13.Outpatient Lab Work\nCBC w/ Diff 3 days re: leukopenia and anemia D72.819 ,D64.9\nBMP 3 days re: ___ N17.9\nLFT's 3 days re: Elevated LFT's R94.5\nINR daily until INR therapeutic range (___) re: warfarin \nanticoagulation  Z79.01\nWeekly CPK re: Daptomycin use\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\n___\nPolymicrobial left septic knee\nAnemia \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMs. ___,\n\nYou were admitted with fever found to have kidney damage, which \nwas likely from your vancomycin.  Infectious disease was \ninvolved and adjusted your antibiotics.  Your orthopedic \nsurgeons were also involved and you had a joint aspiration of \nyour left knee done on ___. You were discharged on IV \nDaptomycin and Ertapenem \n\nIt was a pleasure taking care of you.  Please be sure that your \nantibiotics are given on regular intervals.  \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee753931023"
  },
  "note_id": "19250934-DS-34",
  "subject_id": 19250934,
  "hadm_id": 22359829,
  "note_type": "DS",
  "note_seq": 34,
  "charttime": "2201-07-04 00:00:00",
  "storetime": "2201-07-04 11:14:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCompazine / Motrin / Celexa / Amitriptyline Hcl / Neurontin / \ndaptomycin / ertapenem\n \nAttending: ___.\n \nChief Complaint:\nneutropenia\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\nCC: called in by ___ clinic for leukopenia and elevated CK\n\nHPI(4): Ms. ___ is a ___ female with h/o left TKR in ___ with\nrecent revision of left knee in ___ of this year complicated by\npolymicrobial prosthetic joint infection currently on prlonged\ncourse of IV dapto / ___, PE on Coumadin recently changed from\neliquis, and anxiety who presented to the ED per ___ clinic recs\nafter she was found to have neutropenia and elevated CK on \nsafety\nlabs today.\n\nIn brief, she underwent total LT knee revision on ___ the\nexplanted LT knee sonication culture on ___ was no growth; post\nop course complicated by LT knee hematoma. no accompanying\nfevers; readmitted on ___. She underwent revision of LT knee\nwith debridement on ___ pt placed on IV vanco/cefepime; deep \nLT\nknee tissue tissue cultures isolated grp B strep; enterococcus\n(vanc/amp susceptible); SCN; diptheroids; kleb pneumo \n___\nserratia (pan- ___ and mixed bacterial flora. She was\ndischarged on ___ to home with plans to complete a 6 week \ncourse\nof IV antibiotics for polymicrobial LT knee PJI. \n\nThe pt was readmitted on ___ with fever to 103.2; LT knee wound\ndrainage.  Labs demonstrated leukopenia with WBC 2.3; new ___\nwith creat of 2.8; vanco level of 46. The IV antibiotic regimen\nwas revised to meropenem 1 gram IV q12h; IV vanco was held.\nShe underwent repeat arthocenesis on ___ ; cell count of joint\nfluid demonstrated 896 WBCs (94% polys). The joint fluid culture\nwas no growth. She was switched to IV daptomycin on ___. Her\nrenal function improved with creatinine of 2.8 on ___.9; WBC was\n2.5. She was discharged on ___ with IV daptomycin 530 mg IV q24h\nand ertapenem 1 gram IV q24h. She was also started on Coumadin \nat\ndischarge. \n\nOutpatient safety labs from ___ (see OMR) showed absolute\nneutropenia with WBC 1.4 (2.8% polys; 88% lypmhs); HCT 26; plt\n3556. Serum creat has decreased 1.3; CPK now increased at 3780. \n\nPatient was also seen in ___ clinic today and dressing was\nchanged. Per ortho note: Low suspicion for knee infection as no\nactive drainage or erythema. Not acute orthopedic intervention\nnecessary. No orthopedic admission necessary. Would agree with a\nmedicine admit to work up lab abnormalities. \n\nROS: Pertinent positives and negatives as noted in the HPI.  All\nother systems were reviewed and are negative. \n+ for fatigue, left knee pain, decreased appetite, constipation\nand more recently low volume loose stool\n- for shortness of breath, fevers, chills, nausea, abdominal\npain, chest pain, palpitations\n\n \nPast Medical History:\n-Osteoarthritis s/p LT TKR ___ s/p RT TKR ___\n-prosthetic joint infection after revision of L knee ___\n-pulmonary embolism - ___ after left knee replacement, second \nafter stopping coumadin, currently on eliquis\n-abd wall cellulitis ___\n-fibroids s/p supracervical hysterectomy, repair of bowel serosa\ninjury, cystoscopy (___)  \n-fibromyalgia, depression, anxiety  \n-left leg nerve entrapment \n-ectopic pregnancy  \n-obesity, OSA, migraines, GERD, chronic lower back pain\n \nSocial History:\n___\nFamily History:\n-Father's health unknown except potential h/o stomach cancer.\n-Uncle has unknown cancer.\n-Mother living at ___ with arthritis, DM, and osteoporosis.\n-Aunt recently passed at ___ ___nd heart disease.\n-Grandmother with breast cancer.\n-No siblings.\n-Children healthy.\n \nPhysical Exam:\nDISCHARGE EXAM:\nVITALS: Afebrile and vital signs stable (see eFlowsheet)\nGENERAL: Alert and in no apparent distress\nEYES: Anicteric, pupils equally round\nENT: Ears and nose without visible erythema, masses, or trauma. \nOropharynx without visible lesion, erythema or exudate\nCV: Heart regular, no murmur\nRESP: Lungs clear to auscultation with good air movement\nbilaterally.  Breathing is non-labored\nGI: Abdomen soft, non-distended, non-tender to palpation.  Bowel\nsounds present. \nGU: No suprapubic fullness or tenderness to palpation\nMSK: Neck supple, moves all extremities. Left knee with slow\nhealing clean based appearing wounds from recent TKA revisions\nPSYCH: pleasant, appropriate affect\nNEUROLOGIC:\nMENTATION: alert and cooperative. Oriented to person and place\nand time.\n \nPertinent Results:\nCOMPLETE BLOOD COUNT WBC RBC Hgb Hct MCV MCH MCHC RDW RDWSD Plt \nCt \n___ 05:40    25.1* 3.17* 8.4* 26.3* 83 26.5 31.9* 17.2* \n52.6* 192 \nSource: Line-PICC \n___ 00:08    21.1* 3.12* 8.2* 25.6* 82 26.3 32.0 17.2* \n51.4* 176 \nSource: Line-Midline \n___ 04:48    15.4* 3.29* 8.5* 27.2* 83 25.8* 31.3* 17.2* \n52.5* 213 \nSource: Line-SL ___ \n___ 07:40    4.8 3.25* 8.6* 27.2* 84 26.5 31.6* 17.1* \n52.0* 240 \n___ 04:54    1.9* 2.82* 7.6* 23.9* 85 27.0 31.8* 16.8* \n52.5* 209 \nSource: Line-___ \n___ 05:44    1.5* 2.47* 6.5* 20.7* 84 26.3 31.4* 16.6* \n51.0* 2361 \nSource: Line-PICC \n___ 05:11    1.3* 2.53* 6.8* 21.3* 84 26.9 31.9* 16.6* \n51.6* 254 \nSource: Line-___ \n___ 22:30    1.5* 3.16* 8.6* 27.2* 86 27.2 31.6* 16.8* \n52.7* 309 \n___ 11:52    1.4*2 3.10* 8.2* 26.6* 86 26.5 30.8* 17.0* \n53.4* 356 \nDIFFERENTIAL Neuts Bands Lymphs Monos Eos Baso Atyps Metas \nMyelos Promyel Blasts NRBC ___ Other AbsNeut AbsLymp \nAbsMono AbsEos AbsBaso \n___ 05:40    58 9* 17* 5 0 0 0 4* 3* 2* 2* 2*       \n16.82* 4.27* 1.26* 0.00* 0.00* \nSource: Line-___ \n___ 04:48    ___ 10 0 0 0 7* 2* 4* 4*2 4*     03 \n8.47* 2.77 1.54* 0.00* 0.00* \nSource: Line-SL ___ \n___ 07:40    17*4 7* 46 17* 1 0 1* 3* 3*   4*2 2* 1*   03 \n1.15* 2.26 0.82* 0.05 0.00* \n___ 04:54    7.5*   74.3* 16.6* 0.0* 0.5               \n1.1*5   0.14* 1.39 0.31 0.00* 0.01 \nSource: Line-___ \n___ 05:44    1* 0 94* 5 0 0 0 0 0             0.02* 1.41 \n0.08* 0.00* 0.00* \nSource: Line-___ \n___ 05:11    1* 0 93* 2* 0 1 3* 0 0             0.01* \n1.25 0.03* 0.00* 0.01 \nSource: Line-PICC \n___ 22:30    4.1*   85.1* 10.1 0.0* 0.7                   \n0.06* 1.26 0.15* 0.00* 0.01 \n___ 11:52    2.8*   88.0* 8.5 0.0* 0.7                   \n0.04* 1.25 0.12* 0.00* 0.01 Review \n \nRENAL & GLUCOSE Glucose UreaN Creat Na K Cl HCO3 AnGap \n___ 05:40      7 1.3* 146* 3.5 ___ \nSource: Line-PICC \n___ 00:08    ___ 143 3.6 ___ \n\nENZYMES & BILIRUBIN ALT AST LD(LDH) CK(CPK) AlkPhos Amylase \nTotBili DirBili \n___ 05:40          1821         \nSource: Line-PICC \n___ 04:54          4052*1         \nSource: Line-PICC \n___ 05:44          5123*1         \nSource: Line-PICC \n___ 05:11    31 113*   6545*1 106*   0.4   \nSource: Line-PICC \n___ 22:30    35 132*     140*   0.4   \n___ 11:52    24 76*   3780*1         Review \n \n\n___ Imaging CT HEAD W/O CONTRAST \nIMPRESSION:  \n  \nNo acute intracranial abnormalities. \n\n \nBrief Hospital Course:\nMs. ___ is a ___ female with h/o left TKR\nin ___ with recent revision of left knee in ___ of this year\ncomplicated by polymicrobial prosthetic joint infection \ncurrently\non prlonged course of IV dapto / ___, PE on Coumadin recently\nchanged from eliquis, and anxiety who presented to the ED per ___\nclinic recs after she was found to have neutropenia and elevated\nCK on routine follow up labwork.\n\n#Neutropenia (now resolved)\n#Leukocytosis now due to neupogen\n-neutropenia was attributed to ertapenem. ANC was as low as 40 \non admission. She was given neupogen for 3 days, with response. \nShe had fevers and flu like symptoms attributed to neupogen. Her \nWBC was 25.1 on discharge day.\n-Repeat CBC 1 week from discharge.\n\n#Likely had daptomycin associated myositis\n-CK was 6540 at its peak, and then downtrended and is normal on \n___ at 182.\n-No weakness on exam. Generalized myalgias/malaise persisted but \nalso was due to neupogen.\n\n#polymicrobial prosthetic joint infection (recent discharge\n___ and was started on daptomycin/meropenem).\n-Zosyn was initiated on ___ and she was immediately taken off \ndaptomycin/ertapenem on admission.\nThe plan prior to admission was to stop abx on ___. The dose of \nzosyn is 4.5 g q8h.\n\n#Anemia:\n-There were no signs of active bleeding or hypotension. \nPatient had decreased hgb<7. No evidence of hemolysis. Thought \nto be from marrow suppression related to ertapenem. She required \ntransfusion of 1 uPRBC on ___.\n\n#history of recurrent DVT/PEs \n-continue on Coumadin (recent switch from eliquis)\n-Dose changed to 2 mg once daily on discharge. Her INR was 3.8 \nbut downtrended to 2.9 on day of discharge. \n\nFinally, of note, on ___ evening, she was found to be drowsy \nand \"slurred speech\"; this recovered on its own and she had CTH \nshowing no intracranial bleed. She had insomnia the nights prior \nand the patient reported feeling not herself for that brief time \nperiod, at that time, due to being roused awake at night. \n\nMs. ___ is clinically stable for discharge today. The total \ntime spent today on discharge planning, counseling and \ncoordination of care today was 40 minutes.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Ertapenem Sodium 1 g IV 1X \n2. Daptomycin 530 mg IV Q24H \n3. Atenolol 100 mg PO DAILY \n4. QUEtiapine Fumarate 400 mg PO QHS \n5. Zolpidem Tartrate 5 mg PO QHS:PRN insomnia \n6. Albuterol Inhaler 2 PUFF IH Q6H wheezing \n7. LORazepam 1 mg PO QHS anxiety \n8. Leuprolide Acetate 11.25 mg ___ Q3MONTHS \n9. Warfarin 4 mg PO DAILY16 \n10. Ferrous Sulfate 325 mg PO BID \n11. Vitamin D 400 UNIT PO DAILY \n12. Cyclobenzaprine 10 mg PO BID:PRN spasm \n13. OxyCODONE--Acetaminophen (5mg-325mg) 1 TAB PO TID:PRN \nBREAKTHROUGH PAIN \n\n \nDischarge Medications:\n1.  Piperacillin-Tazobactam 4.5 g IV Q8H \nRX *piperacillin-tazobactam 4.5 gram 4.5 gram IV every eight (8) \nhours Disp #*18 Vial Refills:*0 \n2.  Sodium Chloride 0.9%  Flush ___ mL IV DAILY and PRN, line \nflush \nRX *sodium chloride 0.9 % 0.9 % ___ cc IV daily Refills:*0 \n3.  Warfarin 2 mg PO DAILY16  \n4.  Albuterol Inhaler 2 PUFF IH Q6H wheezing  \n5.  Atenolol 100 mg PO DAILY  \n6.  Cyclobenzaprine 10 mg PO BID:PRN spasm  \n7.  Ferrous Sulfate 325 mg PO BID  \n8.  Leuprolide Acetate 11.25 mg ___ Q3MONTHS  \n9.  LORazepam 1 mg PO QHS anxiety  \n10.  OxyCODONE--Acetaminophen (5mg-325mg) 1 TAB PO TID:PRN \nBREAKTHROUGH PAIN  \n11.  QUEtiapine Fumarate 400 mg PO QHS  \n12.  Vitamin D 400 UNIT PO DAILY  \n13.  Zolpidem Tartrate 5 mg PO QHS:PRN insomnia  \n14.Outpatient Lab Work\nDraw CBC on ___ with results forwarded to Dr. ___ \n(fax ___ ). D70.2\n15.Outpatient Lab Work\nDraw INR on ___ with results faxed to Dr. ___ \n(fax ___ ). I26.99\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \n___ Diagnosis:\ndrug induced neutropenia\ndaptomycin induced myositis\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nInstructions: Dear Ms. ___, \n\nIt was a pleasure to be a part of your care team at ___ \n___.\n\n====================================\nWhy did you come to the hospital? \n====================================\n\n-You had lab check that showed abnormally low white cell count. \n\n====================================\nWhat happened at the hospital? \n====================================\n\n-You had low white cell count due to your new antibiotic called \nertapenem. This drug was stopped. \n-You also had very high levels of CK, which is found from muscle \ndamage. This likely was due to your new antibiotic called \ndaptomycin. This drug was stopped.\n-You were changed to an antibiotic called Zosyn to continue \ntreatment of your joint infection.\n-You were given a drug called Neupogen to increase your white \ncell count, which was successful. \n\n==================================================\nWhat needs to happen when you leave the hospital? \n==================================================\n\n-Please follow with home services for IV Zosyn for your joint \ninfection. Last day to take is on ___.\n-Take your medications every day and have your CBC laboratory \nlevel checked as directed by your doctors, on ___.\n-Have your INR level drawn on ___. Coumadin dose may require \nadjusting as instructed by your PCP ___.\n-Please attend all of your doctor appointments. \n\nActivity: WBAT LLE, ___ brace at all times, may remove for\nphysical therapy or at night, do not bend knee past 70 degrees\n\nDressing: Apply Betadine twice daily to incision with dry\nsterile dressing changes\n\nIt was a pleasure taking care of you during your stay! \n\nSincerely, \n\nYour ___ team  \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee753931024"
  },
  "note_id": "19250934-DS-35",
  "subject_id": 19250934,
  "hadm_id": 29385524,
  "note_type": "DS",
  "note_seq": 35,
  "charttime": "2203-04-17 00:00:00",
  "storetime": "2203-04-18 07:01:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCompazine / Motrin / Celexa / Amitriptyline Hcl / Neurontin / \ndaptomycin / ertapenem\n \nAttending: ___.\n \nChief Complaint:\nshortness of breath, chest pain\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\n___ F w/ history of recurrent PE (on apixaban), osteoarthritis,\ndepression, anxiety, PTSD, hypertension who comes in for a one\nweek history of chest pain and dyspnea. \n\nShe started having chest pain a week ago, a sharp pain in the\nupper middle chest. Would also feel like a tightening pain. It\nwas constant, not worse exertion. No radiation aside to both\nshoulders. Only experienced a little bit of shortness of breath.\nPain did hurt a bit more with deep breathing. She states both\nfeet are newly swollen.  No recent travel or surgery. No cancer.\nShe takes eliquis for about a month. She states she has only\nmissed a dose or two. She switched from warfarin due to ease of\ncompliance. She takes lupron shots every 3 months but does not\ntake any estrogen. \n\nIn the ED, \n\n- Initial vitals were: 96.4 87 ___ 100% RA \n \n- Exam was notable for: Normal physical exam. No leg tenderness.\nNo extremity swelling. Breathing comfortably. Breath sounds \nclear\nand equal. No murmur.  \n \n- Labs were notable for:  \nCBC wnl\nCoags with ___ 13.9 PTT 37.8 and INR 1.3 \nD-Dimer 883, prompting CTA chest \nBMP wnl with Cr 0.8 and BUN 7\nTroponin T <0.01 and proBNP 57\nb-HCG negative \n\n- Studies were notable for:  \nCTA chest: 1. Multiple acute segmental and subsegmental \npulmonary\nemboli within the bilateral lungs. No pulmonary infarction or\nevidence of right heart strain. 2. No aortic abnormality. 3. \nMild\ndiffuse bronchial airway inflammation. 4. 4 mm right middle lobe\nnodule, stable since ___.\n\n- No consults \n \n- Patient was given:  \n___ 00:11 PO Aspirin 324 mg \n___ 00:47 PO/NG CARVedilol 25 mg \n___ 00:47 PO/NG LamoTRIgine 150 mg  \n___ 00:47 PO/NG QUEtiapine Fumarate 150 mg \n___ 00:47 PO/NG Apixaban 5 mg \n___ 03:10 IV Heparin 6400 UNIT \n___ 03:10 IV Heparin 1450 units/hr \n \nOn arrival to the floor, she states that her pain and breathing\nare both better. She feels like her legs are a bit more swollen\nin her feet bilaterally. She confirms that she has been taking\nher apixban faithfully and maybe has missed one or two doses in\npast month. \n \nPast Medical History:\n-Osteoarthritis s/p LT TKR ___ s/p RT TKR ___\n-prosthetic joint infection after revision of L knee ___\n-pulmonary embolism - ___ after left knee replacement, second \nafter stopping coumadin, currently on eliquis\n-abd wall cellulitis ___\n-fibroids s/p supracervical hysterectomy, repair of bowel serosa\ninjury, cystoscopy (___)  \n-fibromyalgia, depression, anxiety  \n-left leg nerve entrapment \n-ectopic pregnancy  \n-obesity\n-OSA\n-migraines\n-GERD\n-chronic lower back pain\n-hypertension\n \nSocial History:\n___\nFamily History:\n-Father's health unknown except potential h/o stomach cancer.\n-Uncle has unknown cancer.\n-Mother with arthritis, DM, and osteoporosis.\n-Aunt recently passed at ___ ___nd heart disease.\n-Grandmother with breast cancer.\n-No siblings.\n-Children healthy\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \n========================  \nVITALS: reviewed in ___ \nGENERAL: Alert and interactive. In no acute distress.  \nHEENT: PERRL, EOMI. Sclera anicteric and without injection. MMM. \n\nNECK: supple \nCARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No\nmurmurs/rubs/gallops.  \nLUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or\nrales. No increased work of breathing.  \nABDOMEN: Normal bowels sounds, non distended, non-tender to deep\npalpation in all four quadrants. \nEXTREMITIES: No clubbing, cyanosis, or edema.\nSKIN: Warm. Cap No rashes.  \nNEUROLOGIC: AOx3. Moving all 4 limbs spontaneously. ___ strength\nthroughout. Normal sensation.  \n\nDISCHARGE PHYSICAL EXAM:  \n========================  \n24 HR Data (last updated ___ @ 347)\n    Temp: 98.5 (Tm 98.5), BP: 131/80 (115-161/77-105), HR: 70\n(62-77), RR: 18 (___), O2 sat: 99% (95-99), O2 delivery: Ra   \n\nGENERAL: NAD \nCV: RRR, S1/S2, no murmurs, gallops, or rubs \nPULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably\nwithout use of accessory muscles \nEXTREMITIES: trace pitting edema bilaterally. R ankle and foot\nwithout swelling or erythema, mild tenderness with ankle flexion\nand extension, ___ strength. Negative ___ sign bilaterally.\nNo palpable cords.\nNEURO: Photosensitive, CN grossly intact, sinus tenderness.\n \nPertinent Results:\nADMISSION LABS\n================\n___ 09:40PM BLOOD WBC-5.0 RBC-4.35 Hgb-11.6 Hct-37.7 MCV-87 \nMCH-26.7 MCHC-30.8* RDW-14.7 RDWSD-46.8* Plt ___\n___ 09:40PM BLOOD Neuts-51.5 ___ Monos-6.4 Eos-1.4 \nBaso-0.4 Im ___ AbsNeut-2.58 AbsLymp-2.00 AbsMono-0.32 \nAbsEos-0.07 AbsBaso-0.02\n___ 09:40PM BLOOD ___ PTT-37.8* ___\n___ 09:40PM BLOOD Glucose-92 UreaN-7 Creat-0.8 Na-142 K-4.1 \nCl-106 HCO3-25 AnGap-11\n___ 09:40PM BLOOD proBNP-57\n___ 09:40PM BLOOD cTropnT-<0.01\n___ 03:54AM BLOOD cTropnT-<0.01\n\nDISCHARGE LABS\n================\n___ 07:53AM BLOOD WBC-4.8 RBC-5.05 Hgb-13.4 Hct-43.2 MCV-86 \nMCH-26.5 MCHC-31.0* RDW-14.8 RDWSD-45.8 Plt ___\n___ 07:53AM BLOOD ___ PTT-43.9* ___\n___ 07:53AM BLOOD Glucose-98 UreaN-7 Creat-1.2* Na-144 \nK-4.7 Cl-106 HCO3-21* AnGap-17\n___ 07:53AM BLOOD Calcium-9.9 Phos-3.7 Mg-2.0\n\nIMAGING\n==============\n___ CXR\nIMPRESSION\nNo acute cardiopulmonary process.\n\n___ CTA CHEST\n1. Multiple acute segmental and subsegmental pulmonary\nemboli within the bilateral lungs. No pulmonary infarction or\nevidence of right heart strain. 2. No aortic abnormality. 3. \nMild\ndiffuse bronchial airway inflammation. 4. 4 mm right middle lobe\nnodule, stable since ___.\n\n___ CT Head w/out Contrast\nFINDINGS:  \nThere is no evidence of infarction, hemorrhage, edema, or mass. \nThe ventricles and sulci are normal in size and configuration. \nNo osseous abnormalities seen. The paranasal sinuses, mastoid \nair cells, and middle ear cavities are clear. The orbits are \nunremarkable. \nIMPRESSION:  \nNo acute intracranial abnormality. \n\n \nBrief Hospital Course:\nPATIENT SUMMARY\n================\n___ F w/ history of recurrent PE (on apixaban), osteoarthritis, \ndepression, anxiety, PTSD, hypertension who presented with one \nweek of chest pain and dyspnea, found to have acute PE.\n\nTRANSITIONAL ISSUES\n===================\n[ ] Patient experiencing migraines with dizziness and was \ndischarged with a walker and outpatient ___ rehab.\n[ ] Patient reported being on Carvedilol 25mg BID but has no \nfill history for this medication. Please clarify and prescribe \nif indicated.\n[ ] Patient developed migraine headache during this \nhospitalization and was given additional doses of sumatriptan at \ndischarge.\n[ ] NEXT INR TO BE DRAWN ON ___ - Discussed with patient and \nclinic at ___.\n\nACUTE ISSUES\n=============\n#Pulmonary emboli\nPatient presented w/ 1 wk hx of dyspnea, chest pain, and \npleuritic chest pain. CTA chest on ___ confirmed multiple \nacute segmental and subsegmental pulmonary emboli within the \nbilateral lungs. No pulmonary infarction or evidence of right \nheart strain. Patient has a history of 1 provoked and 1 \nunprovoked PE, followed by Dr. ___, prior \nhypercoagulation workup unremarkable. She was previously treated \non warfarin, until about 1 month ago when she was transitioned \nto apixaban. She reports that she only missed 1 or 2 doses of \napixaban this past month, although per PACT review of refill \nhistory she likely has missed 10 days of apixaban since \ninitiating this medication. Decision was made to restart \nwarfarin, initially bridged with heparin gtt then lovenox BID \nguided by factor Xa levels. Warfarin restarted on ___, INR \ntrended daily and was in range at the time of discharge, though \ntrending up at 2.7 on 7.5mg warfarin daily. She was instructed \nto have INR checked on ___ and dose of warfarin adjusted \naccordingly.\n\n#Migraines\nPatient having ___ headaches not relieved by Tylenol or \noxycodone even when BP is well controlled. Reports history of \nmigraines but has not had one in about ___ years. Given \nvasoconstrictive properties of triptans was advised by pharmacy \nto avoid these and try abortive therapy with metoclopramide and \nBenadryl. However, blood pressure improved and she was given two \ndoses of triptan prior to discharge with improvement in \nsymptoms. Patient experiencing migraines with dizziness and was \ndischarged with a walker and outpatient ___ rehab.\n\n#Hypertension\nPt reports taking carvedilol as home med, however none filled \nthis year per PACT review. Initially started carvedilol this \nadmission as presumed home med, discontinued given bradycardia.\n\n#R ankle and foot pain\nPt reports mild R ankle and foot pain and weakness that is not \nnew, does not recall trauma. Suspect MSK pain, exam reassuring. \nHad R foot XR and MRI in ___ and ___ for workup of \npainful soft tissue mass on R dorsal midfoot, studies \nunremarkable. No asymmetric leg swelling or pain although given \nPEs she is at high risk for DVT, already on anticoagulation as \nabove.\n\nCHRONIC/STABLE ISSUES: \n====================== \n#Asthma:\ncontinued home fluticasone - per PACT review, uses this only \nwhen her breathing is bad, not daily\n\n#Osteoarthritis: of left knee s/p replacement surgery and\nRevision surgery. On oxycodone-acetaminophen at home. Gave \nacetaminophen 1000mg TID standing and oxycodone 5mg TID:PRN. \ncontinued tizanidine 8mg qhs \n\n#PTSD\n#Anxiety and mood disorder: is followed by psychiatry here. Was \nrecently seen: recommended continuing quetiapine 150mg qhs,\nlamotrigine 150BID, hydroxyzine 50mg BID PR anxiety, and \nclonidine for ___ flashes and nightmares. These medications were \ncontinued.\n\n#Hot flashes:\ncontinued home clonidine\n\nThis patient was prescribed, or continued on, an opioid pain \nmedication at the time of discharge (please see the attached \nmedication list for details). As part of our safe opioid \nprescribing process, all patients are provided with an opioid \nrisks and treatment resource education sheet and encouraged to \ndiscuss this therapy with their outpatient providers to \ndetermine if opioid pain medication is still indicated.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol Inhaler 2 PUFF IH Q6H:PRN sob \n2. Apixaban 5 mg PO BID \n3. CARVedilol 25 mg PO BID \n4. CloNIDine 0.1 mg PO QHS \n5. fluticasone propionate 220 mcg/actuation inhalation BID \n6. HydrOXYzine 50 mg PO BID:PRN anxiety \n7. LamoTRIgine 150 mg PO BID \n8. Leuprolide Acetate 11.25 mg IM Q3MONTHS \n9. oxyCODONE-acetaminophen ___ mg oral TID:PRN \n10. QUEtiapine Fumarate 150 mg PO QHS \n11. Tizanidine 8 mg PO QHS \n12. Citalopram 10 mg PO DAILY \n13. CloNIDine 0.05 mg PO QAM \n\n \nDischarge Medications:\n1.  Sumatriptan Succinate 50 mg PO DAILY:PRN migraine headache \nDuration: 1 Dose \nRX *sumatriptan succinate 50 mg 1 tablet(s) by mouth once a day \nDisp #*5 Tablet Refills:*0 \n2.  Warfarin 4 mg PO DAILY16 \nAdjust dose on recommendation of ___ clinic \nRX *warfarin 4 mg 1 tablet(s) by mouth once a day Disp #*30 \nTablet Refills:*0 \n3.  Albuterol Inhaler 2 PUFF IH Q6H:PRN sob  \n4.  Citalopram 10 mg PO DAILY  \n5.  CloNIDine 0.1 mg PO QHS  \n6.  CloNIDine 0.05 mg PO QAM  \n7.  fluticasone propionate 220 mcg/actuation inhalation BID  \n8.  HydrOXYzine 50 mg PO BID:PRN anxiety  \n9.  LamoTRIgine 150 mg PO BID  \n10.  Leuprolide Acetate 11.25 mg IM Q3MONTHS  \n11.  oxyCODONE-acetaminophen ___ mg oral TID:PRN pain  \n12.  QUEtiapine Fumarate 150 mg PO QHS  \n13.  Tizanidine 8 mg PO QHS  \n14. HELD- CARVedilol 25 mg PO BID  This medication was held. Do \nnot restart CARVedilol until you talk to your primary care \ndoctor\n15.Outpatient Physical Therapy\nRolling walker\nDiagnosis: Vestibular dizziness\nPrognosis: Good\nLength of Need: 13 months\n16.Outpatient Physical Therapy\nICD 9 Code: ___.* : Vertiginous syndromes and other disorders of \nvestibular system\n\n___\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\n#Recurrent PE (bilateral, multiple segmental/subsegmental)\n#Depression\n#Anxiety\n#PTSD\n#Hypertension\n#Obesity\n#R ankle pain\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n \nIt was a privilege caring for you at ___. \n\nWHY WAS I IN THE HOSPITAL? \n- You were admitted to the hospital because you were having \nchest pain and shortness of breath.\n\nWHAT HAPPENED TO ME IN THE HOSPITAL? \n- A CT scan showed that you have multiple blood clots in your \nlung (pulmonary emboli). These likely occurred because apixaban \nwas not effective enough at thinning your blood, or may have \nbeen at too low a level because of missing some doses.\n- You were started on blood thinning medications called heparin \nthen lovenox to treat your pulmonary emboli. \n- Warfarin, a medication you took in the past, was restarted. \n- Lab tests to measure your coagulation levels were monitored \nclosely. When the levels were safe to treat your pulmonary \nemboli and prevent future clots, you were ready for discharge \nhome.\n- You had headaches that were consistent with migraine \nheadaches. You were given a medication to help treat the \nheadaches.\n\nWHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? \n- Continue to take all your medicines and keep your \nappointments. \n\nWe wish you the best! \n\nSincerely, \nYour ___ Team \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048243fb505ee753930584"
  },
  "note_id": "19161326-DS-2",
  "subject_id": 19161326,
  "hadm_id": 21648220,
  "note_type": "DS",
  "note_seq": 2,
  "charttime": "2155-11-15 00:00:00",
  "storetime": "2155-11-15 19:34:00",
  "text": " \nName:  ___               Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nthioridazine\n \nAttending: ___.\n \nChief Complaint:\nFall with L hip pain\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nHPI: Mr. ___ is a ___ man with history of cirrhosis,\nopioid use disorder on methadone, neuropathy, bilateral hip\nfractures s/p repair presenting after a fall with hip pain.\n\nThe patient reports that he was at the ___ today \nfor\na dermatology appointment to address the skin changes on his\nlegs. He states that his legs have become discolored over the\npast year. He states that this is because of swelling in his\nlegs, and sometimes he gets blisters on his legs that burst. He\nsaw the dermatologist, who prescribed topical mupirocin and\ntriamcinolone cream. He was waiting for The Ride home from the\nappointment, when he lost his balance while walking using his\ncane. He denies any antecedent symptoms such as dizziness,\nlightheadedness, chest pain, palpitations. He did not hit his\nhead or lose consciousness. He felt on his left side and felt\nimmediate pain. An ambulance was called, and he was brought to\n___. \n\nRegarding his medical history, he tells me that he has had two\nprior falls resulting in right and left hip fractures that he \nhad\noperatively repaired. He has a history of heroin use, quit ___ \nyear\nago, currently on methadone 60 mg daily that he gets through the\n___. He reports that he has history of hepatitis C and was \ntreated\nand told he was cured. He believes he has cirrhosis and\nsplenomegaly. He denies any history of ascites or GI bleeding. \nHe\nhas severe neuropathy of both legs, which is why he ambulates\nwith a cane and he states it has contributed to his fall. The\netiology of this neuropathy is unknown; he firmly denies history\nof diabetes. \n\nPrior to his fall, he was feeling in his usual state of health.\nHe denies cough, shortness of breath, abdominal pain, nausea,\nvomiting, diarrhea, dysuria, fevers, chills.\n\nIn the ED, initial vitals: 98.5 -> Tmax 102.6 86 151/94 19 94% \nRA\n-> 94% on 2L NC\nExam notable for: MSK: minimally TTP in left hip, no pain w/\npassive ROM, no spinal tenderness\nLabs notable for: WBC 5.6, Hb 10.7, plt 110, BUN/Cr 32/1.4; UA\nbland, FluPCR negative\nImaging: CT left leg with comminuted left anterior acetabular\nfracture with intra-articular extension. Nondisplaced proximal\nleft superior ramus fracture, contiguous with acetabular\nfracture. Probable left inferior ramus nondisplaced fracture.\nLeft femoral head impaction fracture.\nConsults: Ortho\nPatient given: ceftriaxone 1 gm, azithromycin 500 mg\n\nOn arrival to the floor, he reports that he feels well. No\nshortness of breath or cough. No subjective fevers or chills. No\npain in his left hip as long as he is not moving.\n\nROS: Pertinent positives and negatives as noted in the HPI.  All\nother systems were reviewed and are negative. \n \nPast Medical History:\n- Cirrhosis\n- Hepatitis C s/p treatment\n- Depression\n- Opioid use disorder on methadone\n- ?CKD\n- Hypothyroidism\n- Neuropathy\n- Bilateral hip fractures s/p repair\n \nSocial History:\n___\nFamily History:\n- Mother: ___ cancer\n- Father: Healthy\n \nPhysical ___:\nADMISSION:\n=========\nVITALS: 98.3 115/71 76 20 96 2L NC \nGENERAL: Alert and in no apparent distress\nEYES: Anicteric, pupils equally round\nENT: Ears and nose without visible erythema, masses, or trauma. \nOropharynx without visible lesion, erythema or exudate\nCV: Heart regular, no murmur\nRESP: Lungs clear to auscultation but diminished breath sounds.\nNo wheezes, rales, or rhonchi. Breathing is non-labored.\nGI: Abdomen soft, non-distended, non-tender to palpation. Bowel\nsounds present. \nGU: No suprapubic fullness or tenderness to palpation\nMSK: Neck supple, moves all extremities, strength grossly full\nand symmetric bilaterally in all limbs; left strength exam\nlimited due to pain in left hip\nSKIN: Bilateral venous stasis changes without evidence of\ninfection\nNEURO: Alert, oriented, face symmetric, gaze conjugate with \nEOMI,\nspeech fluent, moves all limbs, sensation to light touch grossly\nintact throughout\nPSYCH: Very pleasant, appropriate affect\n\nDISCHARGE:\n==========\nVITALS:  98.5 BP:114 / 63 HR:56 R:18 98 RA \nGENERAL: Alert and in no apparent distress\nEYES: Anicteric, pupils equally round\nENT: Ears and nose without visible erythema, masses, or trauma. \nOropharynx without visible lesion, erythema or exudate\nCV: Heart regular, no murmur\nRESP: Lungs clear to auscultation. No wheezes, rales, or \nrhonchi. Breathing is non-labored.\nGI: Abdomen soft, non-distended, non-tender to palpation. Bowel\nsounds present. \nGU: No suprapubic fullness or tenderness to palpation\nMSK: Neck supple, moves all extremities, pain on rotation of \nleft hip. No pain on palpation. \nSKIN: Bilateral venous stasis changes,\nNEURO: Alert, oriented, face symmetric, gaze conjugate with \nEOMI,\nspeech fluent, moves all limbs, sensation to light touch grossly\nintact throughout/ No asterixis\nPSYCH: Very pleasant, appropriate affect\n \nPertinent Results:\nADMISSION:\n=========\n___ 06:30PM BLOOD WBC-5.6 RBC-3.69* Hgb-10.7* Hct-33.1* \nMCV-90 MCH-29.0 MCHC-32.3 RDW-15.9* RDWSD-50.9* Plt ___\n___ 06:30PM BLOOD Neuts-76.9* Lymphs-11.8* Monos-10.0 \nEos-0.2* Baso-0.2 Im ___ AbsNeut-4.30 AbsLymp-0.66* \nAbsMono-0.56 AbsEos-0.01* AbsBaso-0.01\n___ 05:13AM BLOOD ___ PTT-32.2 ___\n___ 07:08AM BLOOD ___ 07:08AM BLOOD Ret Aut-5.0* Abs Ret-0.17*\n___ 06:30PM BLOOD Glucose-166* UreaN-32* Creat-1.4* Na-138 \nK-5.3 Cl-98 HCO3-27 AnGap-13\n___ 06:30PM BLOOD ALT-22 AST-51* AlkPhos-107 TotBili-1.0\n___ 07:08AM BLOOD ALT-16 AST-24 LD(LDH)-260* AlkPhos-95 \nTotBili-0.6\n___ 06:30PM BLOOD Albumin-3.8 Calcium-8.7 Phos-2.8 Mg-1.7\n___ 07:08AM BLOOD calTIBC-244* ___ Ferritn-270 \nTRF-188*\n___ 05:13AM BLOOD %HbA1c-5.3 eAG-105\n\nDISCHARGE:\n==========\n___ 10:10AM BLOOD WBC-4.4 RBC-3.72* Hgb-10.6* Hct-34.1* \nMCV-92 MCH-28.5 MCHC-31.1* RDW-15.9* RDWSD-52.5* Plt Ct-96*\n___ 10:10AM BLOOD Glucose-192* UreaN-19 Creat-1.1 Na-141 \nK-4.9 Cl-99 HCO3-31 AnGap-11\n\nUA: negative\nFlu A/B: negative\n\nBCx (___): pending x2\nUCX (___): pending\n\nIMAGING:\n========\nEKG (___):\nBaseline artifact, ST at 100 bpm, borderline LAD, PR 132, QRS \n87,\nQTC 442\n\nCXR (___): \nLung volumes are low. No large consolidation, effusion or\npneumothorax seen. Cardiomediastinal silhouette appears normal. \nNo definite bony abnormality. \n\nRight hip plain films (___):  \nSevere osteoarthritis at the left hip with flattening of the \nleft\nfemoral head with probable underlying fracture. \n\nCT left lower extremity (___):\n1.  Nondisplaced comminuted fracture of the anterior column of\nthe left acetabulum with intra-articular extension to the medial\nwall, and junction with the superior pubic ramus. \n2.  There is also a nondisplaced left inferior ramus fracture. \n3.  There is a minimally impacted periprosthetic subchondral\ninsufficiency fracture of the superior anterior femoral head. \n\nPelvis plain films with Judet views (___): \nMinimally impacted left femoral head subchondral insufficiency\nfracture. Comminuted left anterior column of the acetabulum and\npubic rami fractures are better appreciated and reported on day\nCT. No dislocation. \n\nFemur plain films (___): \nNo fracture or dislocation involving the distal visualized \nfemur.\n\n \nBrief Hospital Course:\n___ man with history of decompensated cirrhosis, HCV s/p \ntreatment, opioid use disorder on methadone, neuropathy, ? CKD, \nbilateral hip fractures s/p repair presenting with L hip pain \nafter a fall, found to have a L hip fracture, fever, and \nhypoxia.\n\n# Mechanical fall:\n# L femoral head collapse c/w AVN:\n# L non-displaced acetabulum fracture:\n# L non-displaced left inferior ramus fracture:\nPatient presented after mechanical fall in setting of neuropathy \nand baseline instability, found to have non-displaced acetabulum \nfracture, non-displaced L inferior ramus fracture, and \n___ L femoral head collapse c/w AVN. Seen by \northopedics and recommended for non-operative management and \ntouch-down weight-bearing to L leg. Pain was controlled with \ntylenol, home methadone, and oxycodone PRN. He will need to f/u \nwith ortho in 2 weeks (appointment requested) and may need \neventual L hip arthroplasty for AVN. Home Ca/vit D continued, \nand patient reports plans as outpatient for IV bisphosphonate. \nHe will be discharged to rehab.\n\n# Hypoxia: \nPatient hypoxic in ED to 88% on RA, weaned to RA on the floor \nwith persistent hypoxia to ___ with ambulation. Etiology \nunclear. CXR underinflated but no pulmonary edema or focal \nconsolidation, and clinically patient does not have pneumonia or \nheart failure. No history of smoking or COPD, and no wheezing on \nexam. PE was a consideration, but Wells score was 0; deferred \nsending D-dimer given likely to be elevated in setting of acute \nfracture. Fat embolus a consideration give fracture, anemia, \nthrombocytopenia (although suspect these are chronic); however, \nno long-bone fracture, no evidence of petechiae, no mental \nstatus changes, and patient appeared clinically well. Overall, \nsuspicion is highest for atelectasis and incentive spirometry \nuse was encouraged. S/p ceftriaxone/azithro in ED for question \nof pneumonia, d/c'd on admission. Hypoxia resolved without \nintervention. \n\n# Fever: \nPatient documented as febrile to 102.6 in ED, however, this \nrapidly resolved without Tylenol. Patient has no localizing \nsigns or symptoms of infection. He had no cough, sputum, or \nshortness of breath, nor CXR findings suggestive of pneumonia. \nAlthough his legs demonstrate chronic changes, he had no \nevidence of superinfection. UA bland; BCx/UCx negative Patient \nhas history of cirrhosis but no evidence of abdominal pain or \nascites on exam to suggest SBP. Fever may have been spurious or \nsecondary to inflammatory response due to fracture. No recurrent \nfevers since admission.\n\n# Neuropathy: \nPatient with history of neuropathy of unclear etiology (denies \ndiabetes, and A1c WNL). Continued home lyrica.\n\n# Venous stasis: \nPatient with chronic venous stasis changes on bilateral lower \nextremities without evidence of infection. Seen by dermatology \nas outpatient on day of admission and prescribed topical \nantibiotics and steroids, which were continued on discharge.\n\n# History of hepatitis C s/p treatment:\n# Cirrhosis: \nPatient reports history of hepatitis C s/p treatment with SVR. \nAlso reports cirrhosis, splenomegaly, and varices without \nascites. No evidence of hepatic encephalopathy, ascites, or \nvariceal bleeding. MELD Na 14 on ___. Home propranolol and \nlactulose were continued.\n\n# Pancytopenia:\nSuspect chronic in setting of cirrhosis and splenomegaly, but \nbaseline unclear. Denies ETOH abuse. Low suspicion for infection \n(no neutropenia), active bleeding, DIC, or hemolysis/MAHA. \nAttempted to request records from PCP's office at ___ \nwithout success (PCP is NP ___.  Pancytopenia \nremained stable.\n\n# ?CKD: \nChronic renal insufficiency per patient, but baseline Cr \nunclear. Cr 1.4 on admission and remained stable. Cr 1.1 on \ndischarge.\n\n# History of opioid use disorder: \nPrior heroin use in remission. Continued on home methadone 60mg \ndaily (confirmed with Veteran's home).\n\n# Depression:\nContinued home escitalopram.\n\n# Hypothyroidism:\nContinued home levothyroxine\n\n# Multiple b/l testicular/scrotal calcifications:\nIncidental finding on CT. ___ represent scrotoliths. Would \nbenefit from outpatient f/u.\n\n** TRANITIONAL **\n[ ] ensure ortho f/u in 2 weeks- Patient can follow up here at \n___ or at ___\n[ ] outpatient f/u for likely scrotoliths\n[ ] outpatient f/u for likely chronic pancytopenia\n\n# Contacts/HCP/Surrogate and Communication: ___ ___ home\nnurse manager, ___\n# Code Status/Advance Care Planning: Full (confirmed)\n\n>30 minutes spent on complex discharge\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. calcium carbonate-vitamin D2 250 (625)-125 mg-unit oral BID \n2. Escitalopram Oxalate 10 mg PO DAILY \n3. Ferrous Sulfate 325 mg PO DAILY \n4. FoLIC Acid 1 mg PO DAILY \n5. ipratropium bromide 0.03 % nasal BID:PRN \n6. Lactulose 30 mL PO BID \n7. Levothyroxine Sodium 75 mcg PO DAILY \n8. Methadone 60 mg PO DAILY \n9. Multivitamins 1 TAB PO DAILY \n10. Pregabalin 100 mg PO BID \n11. Propranolol 40 mg PO QHS \n12. Ranitidine 150 mg PO DAILY \n13. Triamcinolone Acetonide 0.1% Ointment 1 Appl TP BID rash \n14. Mupirocin Ointment 2% 1 Appl TP BID \n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild/Fever  \n2.  Docusate Sodium 100 mg PO BID  \n3.  Heparin 5000 UNIT SC BID \nCan discontinue if mobility improves.  \n4.  Polyethylene Glycol 17 g PO DAILY  \n5.  Ramelteon 8 mg PO QHS:PRN Insomnia \nShould be given 30 minutes before bedtime  \n6.  Senna 8.6 mg PO QHS  \n7.  Lactulose 30 mL PO TID  \n8.  calcium carbonate-vitamin D2 250 (625)-125 mg-unit oral BID  \n\n9.  Escitalopram Oxalate 10 mg PO DAILY  \n10.  Ferrous Sulfate 325 mg PO DAILY  \n11.  FoLIC Acid 1 mg PO DAILY  \n12.  ipratropium bromide 0.03 % nasal BID:PRN  \n13.  Levothyroxine Sodium 75 mcg PO DAILY  \n14.  Methadone 60 mg PO DAILY \nConsider prescribing naloxone at discharge  \n15.  Multivitamins 1 TAB PO DAILY  \n16.  Mupirocin Ointment 2% 1 Appl TP BID  \n17.  Pregabalin 100 mg PO BID  \n18.  Propranolol 40 mg PO QHS  \n19.  Ranitidine 150 mg PO DAILY  \n20.  Triamcinolone Acetonide 0.1% Ointment 1 Appl TP BID rash  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary:\nL hip fracture\n\nSecondary:\nCirrhosis\nOpiate use disorder\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nYou were admitted to the hospital after a fall resulting in a \nleft-sided hip fracture.  You were evaluated by the orthopedic \nsurgery team, who feel that you do not need surgery at this \ntime.  You will need to follow-up with orthopedics in about 2 \nweeks as an outpatient.  Their office is working to make an \nappointment for you, but if you have not heard from them by \nearly next week please contact their office at the number below.\n\nOn arrival to the hospital your oxygen levels were noted to be \nlow and you had a mild fever.  You were monitored for evidence \nof infection, but none was found.\n\nIt will be important to follow-up with your primary care and \nliver doctors after ___ from the rehab.\n\nWith best wishes,\n___ Medicine\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820bfb505ee7538f4883"
  },
  "note_id": "11814229-DS-17",
  "subject_id": 11814229,
  "hadm_id": 29463263,
  "note_type": "DS",
  "note_seq": 17,
  "charttime": "2124-05-23 00:00:00",
  "storetime": "2124-05-23 16:56:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: CARDIOTHORACIC\n \nAllergies: \nZocor / Crestor / Lipitor\n \nAttending: ___.\n \nChief Complaint:\nRUL lung nodule\n \nMajor Surgical or Invasive Procedure:\n___ VATS Right Upper Lobe Wedge Resection \n\n \nHistory of Present Illness:\n___ is an ___ with a RUL nodule found incidentally \non CT during a work up for abdominal pain. She endorse ___ pound \nweight loss over several moths which she felt was due to changes \nin her diet, given abdominal pain and reflux.  Otherwise she had \nan occasional dry cough (but no hemoptysis), and reflux.  She \ndenied CP, SOB, dysuria/hematuria, fevers, chills.  She saw Dr. \n___ in the office on ___ and again on ___.  \nIn the intervening time, she had an FDG-PET scan which showed \nthat the nodule was FDG avid.  The lesion was felt to be \nconcerning and thus the patient was taken to the operating room \non ___ for a VATS wedge resection for diagnostic and \ntherapeutic purposes.\n \nPast Medical History:\nH. Pylori gastritis\nGastritis with metaplasia\nGERD\nHypothyroidism\nHyperlipidemia\nFibroid uterus with ovarian cyst\nMonoclonal gammopathy\nLeft scalp paresthesias\nDistal dysesthesia\nBilateral numbness of feet related to lumbosacral radiculopathy\nBack and neck pain (chronic)\n \nSocial History:\n___\nFamily History:\nPositive for hepatitis C, hemophilia\n\n \nPhysical Exam:\nPhysical Examination on Admission:\nGen: NAD\nHEENT: OP clear\nPulmonary: clear\nCV: rrr\nABD: s/nt/nd\nSkin: warm/dry/no rashes\nNeuro: grossly intact\n\nPhysical Examination on Discharge\nVS: afebrile, VSS\nGen: alert, NAD\nLungs: CTAB, decreased breath sounds at the bases bilaterally; \nchest tube site wound moist with minimal serosanguineous \nstaining, but dressing intact\nCardiac: RRR, S1/S2 normal, no M/R/G\nAbd: soft, nontender, nondistended\nExtremities: no edema, cords, tenderness bilateral legs;\n- RUE: two small excoriations of the skin of the right wrist, \nappearing almost as de-roofed blisters, minimally pink, not \nerythematous or with discharge\n \nPertinent Results:\n___ 09:58AM BLOOD WBC-11.3*# RBC-3.60* Hgb-10.8* Hct-33.4* \nMCV-93 MCH-30.0 MCHC-32.3 RDW-13.6 Plt ___\n___ 09:58AM BLOOD Glucose-176* UreaN-21* Creat-0.9 Na-140 \nK-3.5 Cl-104 HCO3-25 AnGap-15\n___ 09:58AM BLOOD Calcium-8.6 Phos-3.8 Mg-1.9\n\nIntra-operative gram stain ___: 1+ PMNs but no \nmicroorganisms.  Cultures revealed no growth.  ___ prep of the \nlesion was negative for fungus.  Acid fast and fungal cultures \nwere pending at the time of discharge.\n \nBrief Hospital Course:\nThe patient was taken to the operating room on ___ for a \nVATS right upper lobe wedge resection.  The surgeon was Dr. \n___.  Please see the operative note for \ndetails.  A non-tunneled chest tube in the right chest was left \nin plae.  The patient tolerated the procedure well, was taken to \nthe PACU where an air leak was noted in the pleurovac but there \nwere otherwise no events.  Her vital signs remained stable.  She \nwas taken to the floor for monitoring.\n\nShe was started on a diet of clears, which she tolerated well.  \nHer pain was controlled with Percocet.  Chest tube was kept to \nwater seal.  The air leak decreased throughout POD#1.  Her diet \nwas advanced to regular, which she tolerated well.\n\nBy POD#2 her pain requirement had decreased and she was very \ncomfortable.  There was no air leak, and so the chest tube was \npulled and an occlusive dressing put on the former site.  \nPost-pull chest X-ray demonstrated a small hydropneumothorax not \nsignificantly increased in size from the day before.  The \npatient was doing clinically well after removal of the chest \ntube.  On ___, she was ambulating independently, \ntolerating a regular diet, with pain well-controlled, and she \nwas found by physical therapy to be ready to discharge to home.  \nShe was sent home with services including ___ for dressing \ninspection and removal, and home health aide for care needs.\n \nMedications on Admission:\nAspirin 81', Omeprazole 20', Amlodipine 7.5 mg ily, Pravastatin \n10', Levothyroxine 25mcg', Calcitrate, Garlic, MVI, Gas-X\n \nDischarge Medications:\n1. oxycodone-acetaminophen ___ mg Tablet Sig: ___ Tablets PO \nevery ___ hours as needed for pain.\nDisp:*25 Tablet(s)* Refills:*0*\n2. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) \nCapsule, Delayed Release(E.C.) PO DAILY (Daily).  \n3. pravastatin 20 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime).  \n\n4. levothyroxine 25 mcg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n5. amlodipine 2.5 mg Tablet Sig: Three (3) Tablet PO DAILY \n(Daily).  \n6. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day): Take this stool softener if taking Percocet.  \n7. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday) as needed for constipation.  \n8. Aspirin Low Dose 81 mg Tablet, Delayed Release (E.C.) Sig: \nOne (1) Tablet, Delayed Release (E.C.) PO once a day.  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nRight Upper Lobe Lung Nodule\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nCall Dr. ___ ___ if you experience:\n-Fevers > 101 or chills\n-Increased shortness of breath, cough (it is normal to cough up \nblood tinge sputum for a few days) or chest pain\n-Incision develops drainage\n\nInicision Care: \n-You may remove the dressings over your chest tube site after 72 \nhours and cover site with a bandaid until healed.  DO NOT remove \nthe dressing before this time.\n-Should chest tube site begin to drain, reinforce the site as \nneeded.  Again, DO NOT remove the dressing, as the hole in the \nchest wall is still healing, and removing the dressing may allow \nair to enter the chest wall and deflate the lung.\n\nPain\n-Acetaminophen 650 every 6 hours as needed for pain\n-You will be given a prescription for Percocet.  Take ___ \ntablets every ___ hours as needed for pain.  DO NOT TAKE TYLENOL \nWHILE TAKING PERCOCET, as it contains Tylenol.\n-No driving while taking narcotics\n-Take stool softners with narcotics\n\nActivity\n-Wait 48 hours to shower until chest tube dressing is removed. \nAfter this has been removed, you may wash your incisions gently \nwith mild soap & water, rinse, pat dry\n-No tub bathing, swimming or hot tubs until incision healed\n-No lotions or creams to incision site\n-No lifting greater than 10 pounds until seen\n-Walk ___ times a day for ___ minutes increase to a Goal of 30 \nminutes daily\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820bfb505ee7538f4884"
  },
  "note_id": "11814229-DS-18",
  "subject_id": 11814229,
  "hadm_id": 24313076,
  "note_type": "DS",
  "note_seq": 18,
  "charttime": "2130-09-25 00:00:00",
  "storetime": "2130-09-27 16:18:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROLOGY\n \nAllergies: \nZocor / Crestor / Lipitor\n \nAttending: ___.\n \nChief Complaint:\nUnresponsiveness\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ year old woman with past medical history of hypertension and\ndepression (recently started on a trial of sertraline 7 days \nago)\nwho initially presented to ___ after her daughter found\nher unresponsive in bed with right gaze preference and was\nsubsequently transferred to ___ out of concern for R MCA\nsyndrome w possibility of intravascular intervention. History\nnotable for a fit elderly woman with independent mobility who\nrecently started to take sertraline for mood 7 days ago. Three\ndays ago, she complained of some chest pain and shortness of\nbreath and presented to ___ where workup was negative\n(EKG, CXR) and she was sent home. No reported focal weaknesses \nat\nthat time. Since then, she has been more tired but without\nshortness of breath. Yesterday, her daughter reports that she\nsuddenly started drinking more water and they thought this was a\ngood thing because she was so tired. Overnight, the patient fell\nasleep as usual, with her daughter by her side. At around \n4:30AM,\nher daughter noticed that she was not stirring to wake up, like\nshe normally does. The daughter then woke the patient up and saw\nthat her eyes were deviated to the right and she was not\nresponding. No shaking or mouth foaming at that time. EMS was\ncalled and code stroke was activated as above. As LKW was >4\nhours, she was not candidate for tPA and so she was brought to\n___ for neurointerventional evaluation. \n\n \nPast Medical History:\nhypertension on amlodipine 5\nhypothyroidism on levothyroxine 50ucg\nDM2 on metformin\nhyperlipidemia on pravastatin 20\nmood disturbance on sertraline 50mg qhs (started last ___\n\n \nSocial History:\n___\nFamily History:\nNo history of seizures or strokes\n\n \nPhysical Exam:\nADMISSION EXAMINATION\n=====================\nVitals: afebrile< HR ___, BP 120-140s/60s, RR16-18, 100RA \nglucose\n132\nGeneral: Awake, eyes open, agitated, moving all extremities\nHEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in\noropharynx\nNeck: Supple, no carotid bruits appreciated. No nuchal rigidity\nPulmonary: Normal work of breathing\nCardiac: RRR, warm, well-perfused\nAbdomen: soft, non-distended\nExtremities: No ___ edema.\nSkin: no rashes or lesions noted.\n \nNeurologic:\n-Mental Status: Says her name in response to her daughter's\nrequest in ___. Does not regard examiner. Does not follow\ncommands with the exception of just once saying her name. \nPulling\nat lines and moving in CT scanner.\n-Cranial Nerves:\nII, III, IV, VI:  Eye closure tight, cannot assess pupils in\ndetail but appear symmetric and reactive. EOMI without \nnystagmus.\nRight visual field cut to finger threat. \nLip closure is tight and symmetric.\n\n-Motor: Decreased bulk, normal tone throughout. \nNo adventitious movements, such as tremor, noted. No asterixis\nnoted. All extremities are at least anti-gravity and with at\nleast ___ resistance to opposing movements and symmetric. \n-Sensory: Withdraws from noxious in all extremities briskly.\n\n-DTRs: ___ response was flexor bilaterally.\n\n-Coordination: deferred\n\n-Gait: deferred\n\nDISCHARGE EXAMINATION\n=====================\nO/E: VSS. In bed w/ her daughter at the bed side feeding her\nbreakfast. Awake, but lethargic. Slowed & minimal speech. ___ \n--\nintact. Oriented. Moves all extremities well.\n \nPertinent Results:\n___ 02:46AM BLOOD WBC-5.2 RBC-3.33* Hgb-10.3* Hct-29.7* \nMCV-89 MCH-30.9 MCHC-34.7 RDW-14.6 RDWSD-46.9* Plt ___\n___ 06:33AM BLOOD ___ PTT-26.5 ___\n___ 07:00AM BLOOD Glucose-108* UreaN-19 Creat-0.7 Na-142 \nK-4.7 Cl-100 HCO3-20* AnGap-22*\n___ 02:46AM BLOOD Calcium-8.5 Phos-3.4 Mg-2.0\n___ 12:41AM BLOOD %HbA1c-5.7 eAG-117\n___ 12:41AM BLOOD Triglyc-60 HDL-103 CHOL/HD-1.5 LDLcalc-39\n___ 12:41AM BLOOD TSH-1.8  \n___ 03:45PM BLOOD CRP-10.0* ESR-14\n\n___ 05:50AM URINE Color-Yellow Appear-Clear Sp ___\n___ 05:50AM URINE Blood-SM* Nitrite-NEG Protein-TR* \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-MOD*\n___ 05:50AM URINE Hours-RANDOM Creat-183 Na-23 Cl-72\n___ 05:50AM URINE Osmolal-541\n___ 01:14AM URINE Hours-RANDOM Creat-22 Na-<20 Cl-<20\n___ 01:14AM URINE Osmolal-122\n\n___ 8:00 am URINE      CATHETER. \n                            **FINAL REPORT ___\n   URINE CULTURE (Final ___:    NO GROWTH. \n\n___ 6:___RAIN PERFUSION; CTA NECK W&W/OC & RECONS; \nCTA HEAD W&W/O C & RECONS \n1. No convincing evidence for acute intracranial hemorrhage. \n2. increased mean transit time in the region of right middle \ncerebral artery with areas of low blood volume in the frontal \nand parietal lobes indicate ischemia with likely infarct core.  \nHowever, it is difficult to assess the exact size of the \npenumbra.  MRI can help for further assessment to determine the \nsize of the infarct core. \n3. Multifocal atherosclerotic disease, as detailed above, with \nmild \nasymmetrically decreased arborization of the distal right M3/M4 \nbranches.  No convincing large vessel occlusion. \n4. Additional findings, as above. \n\n___ 2:28 ___ MR HEAD W/O CONTRAST \n1. Study is mildly degraded by motion. \n2. No evidence of acute infarct. \n3. Within limits of study, no definite evidence of intracranial \nmass. \n4. Global volume loss and probable microangiopathic changes. \n5. Minimal paranasal sinus disease and nonspecific bilateral \nmastoid fluid as described. \n\n___ 5:___HEST W/CONTRAST \nNo evidence of intrathoracic malignancy or infection. \n  \nMild cardiomegaly.  Moderate atherosclerotic coronary \ncalcification, \nhemodynamic significance indeterminate. \n  \nMild to moderate small airway obstruction. \n\nEEG Study Date of ___ \nThis is an abnormal continuous ICU EEG monitoring study because \nof diffuse background slowing indicative of a mild \nencephalopathy which is \nnonspecific as to etiology. Medication effects, toxic/metabolic \ndisturbances and/or infection are among the most common causes. \nFocal slowing over the right hemisphere is indicative of \ncerebral dysfunction in this region and consistent with the \nknown right MCA stroke. There are no pushbutton activations, \nepileptiform discharges or electrographic seizures. \n\nPortable TTE (Complete) Done ___ at 12:12:03 ___\n1) Normal biventricular regional/global systolic function.\n2) Likely normal LV diastolic function considering age with \nnormal LA size. \n3) Mild aortic regurgitation.\n \nBrief Hospital Course:\n___ woman with history notable for HTN, hypothyroidism, \nDMII, HLD, and depression transferred from ___ after \npresenting with unresponsiveness and right gaze preference \ninitially concerning for acute stroke. Mental status improved \nfollowing admission, with CT and MR brain imaging revealing no \nevidence of underlying acute ischemia or hemorrhage. CT \nperfusion imaging notable for relative decrease in right-sided \nperfusion, which, along with right gaze preference and \nresolution of symptoms, suggest left-sided seizure. EEG \nmonitoring did not demonstrate further concerning epileptiform \ndischarges or seizures during the admission.\n\nInitial laboratory evaluation notable for hypoglycemia, likely \nprecipitating the initial seizure event. Laboratory testing \nconsistent with SIADH, with CT chest not demonstrating evidence \nof underlying malignancy. Review of medications notable for \nrecent initiation of sertraline; per Nephrology evaluation, \nSSRIs have been associated with SIADH. Sertraline discontinued, \nand sodium corrected initially with hypertonic saline and \nsubsequently with free water restriction. Sodium levels \nnormalized and mental status improved prior to discharge.\n\nOf incidental note, TTE obtained for evaluation of new dyspnea \nand exercise intolerance prior to admission demonstrated normal \nsystolic and likely normal age-adjusted diastolic function.\n\nTRANSITIONAL ISSUES\n1. Ambulatory sodium check following discharge to ensure \nresolution of hyponatremia.\n2. Avoidance of further trials of SSRIs.\n3. If continued somnolence after discharge, please contact Dr. \n___ for recommendations regarding potential weaning \nof levetiracetam.\n \nMedications on Admission:\n1. amLODIPine 5 mg PO DAILY \n2. Levothyroxine Sodium 50 mcg PO DAILY \n3. MetFORMIN (Glucophage) 500 mg PO DAILY \n4. Pravastatin 20 mg PO QPM \n5. Sertraline 25 mg PO QHS \n6. Baclofen 10 mg PO BID:PRN Muscle Spasms \n\n \nDischarge Medications:\n1.  LevETIRAcetam 500 mg PO Q12H  \n2.  Omeprazole 20 mg PO DAILY  \n3.  amLODIPine 5 mg PO DAILY  \n4.  Baclofen 10 mg PO BID:PRN Muscle Spasms  \n5.  Levothyroxine Sodium 50 mcg PO DAILY  \n6.  MetFORMIN (Glucophage) 500 mg PO DAILY  \n7.  Pravastatin 20 mg PO QPM  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\n1. Provoked seizure\n2. Syndrome of inappropriate antidiuretic hormone secretion, \nlikely secondary to medication effect from sertraline\n\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were transferred to ___ from \n___ after being found unresponsive. Although there was \ninitial concern that you may have had a stroke, no stroke was \nidentified with CT and MR images of your brain, and your \nsymptoms improved over the course of your stay. Instead, you \nwere found to have very low sodium levels at the time of your \ntransfer, which may have been caused by one of your recent \nmedications (sertraline); these low sodium levels likely led to \na seizure that caused your symptoms.\n\nDuring your stay, you were also seen by the Nephrology service, \nwho also felt that your low sodium was likely related to your \nmedications; you were treated with concentrated saline solution \nand restriction of your free water intake, after which your \nsodium levels improved. You did not have further seizures during \nyour stay.\n\nYou should avoid taking sertraline as a result of your reaction \nto this medication. You may resume taking your other usual \nmedications.\n\nPlease follow up with your primary care provider ___ ___ \nweeks of discharge. Your visiting nurse ___ check your sodium \nlevels at home and send this information to your primary care \nprovider, who will review it with you. Please also follow up \nwith Neurology at the appointment listed below.\n\nIt was a pleasure taking care of you at ___.\n\nSincerely,\nNeurology at ___\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048204fb505ee7538e9ba9"
  },
  "note_id": "10476329-DS-11",
  "subject_id": 10476329,
  "hadm_id": 23482160,
  "note_type": "DS",
  "note_seq": 11,
  "charttime": "2177-07-08 00:00:00",
  "storetime": "2177-07-08 18:47:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___\n \nChief Complaint:\nrectal pain\n \nMajor Surgical or Invasive Procedure:\nDrainage of perirectal abscess, placement ___  \n\n \nHistory of Present Illness:\n___ with history of hemorrhoids since she was a ___ who is \npregnant as of 3 weeks ago (IVF). She presents to the ED with \n___ days of persistent anal discomfort, especially when passing \nstool and sensation of foreign body in the rectum. The patient \nperformed a digital rectal exam and felt a hard, tender mass \nthat she thought was associated with one of her hemorrhoids. She \nhad diarrhea today. No BRBPR, no abdominal pain, no fevers or \nchills.\n\nRegarding her bowel habits, her stool is usually soft but she \ndoes spend sometime sitting on the toilet before she passes \nstool. This has been a habit all her life. She report occasional \nblood in the toilet paper attributed to her hemorrhoids, \nalthough this has not happened recently. \n\nROS: negative for all other systems except as above\n \nPast Medical History:\n1.  Migraines\n2.  Benign breast tumor\n3.  Infertility\n \nSocial History:\n___\nFamily History:\nFamily History: her mother has a history of hemorrhoids. No \nhistory of colorectal cancer or IBD in first or second degree \nrelatives. Aunt had breast cancer. \n\n \nPhysical Exam:\nGen: [x] NAD, [x] AAOx3\nCV: [x] RRR, [] murmur\nResp: [x] breaths unlabored, [x] CTAB, [] wheezing, [] rales\nAbdomen: [x] soft, [] distended, [] tender, [] rebound/guarding\nWound: [x] incisions clean, dry, intact, SS output\nExt: [c] warm, [] tender, [] edema\n\n \nPertinent Results:\n___ 06:32AM BLOOD WBC-16.8* RBC-3.34* Hgb-10.6* Hct-32.1* \nMCV-96 MCH-31.7 MCHC-33.0 RDW-11.9 RDWSD-41.4 Plt ___\n___ 11:40AM BLOOD WBC-19.4* RBC-4.04 Hgb-12.6 Hct-38.3 \nMCV-95 MCH-31.2 MCHC-32.9 RDW-12.1 RDWSD-41.7 Plt ___\n___ 11:40AM BLOOD Neuts-87.0* Lymphs-5.9* Monos-6.3 \nEos-0.1* Baso-0.3 Im ___ AbsNeut-16.86* AbsLymp-1.15* \nAbsMono-1.23* AbsEos-0.01* AbsBaso-0.06\n___ 06:32AM BLOOD Glucose-71 UreaN-9 Creat-0.4 Na-137 K-3.5 \nCl-101 HCO3-20* AnGap-16\n___ 06:32AM BLOOD Calcium-8.5 Phos-3.3 Mg-1.7\n___ 06:32AM BLOOD HCG-1189\n\nMRI\n1. Supralevator abscess in the right ischioanal fossa, measuring \n4.3 x 2.6 x 4.5 cm. This abscesses is contiguous with at least \none transsphincteric fistula at the 6 o'clock position, and \npotentially a second fistula at the 7 o'clock position. There is \nextensive regional edema, reactive lymphadenopathy, and reactive \nanorectum wall thickening. \n  \n2. A fetal pole is not identified, likely due to early \ngestational age of 3 weeks. The endometrial cavity is distended \nwith fluid. \n  \n3. Both ovaries demonstrate evidence of hyperstimulation, on a \nbackground of IVF. \n  \n4. There is moderate free pelvic fluid, which may related to the \nabscess or the ovarian hyperstimulation. \n\n \nBrief Hospital Course:\nMs. ___ 3 weeks pregnant presenting with supralevator \nabscess s/p drainage of abscess and ___ placement on ___. \nShe tolerated the procedure well without complications (Please \nsee operative note for further details). After a brief and \nuneventful stay in the PACU, the patient was transferred to the \nfloor for further post-operative management. \nNeuro: Patient with rectal pain and received Tylenol and \noxycodone for breakthrough pain, hypotensive(bp 53/36),with \nstanding resolved with IV fluid bolus; thereafter normotensive. \nPulm: The patient remained stable from a pulmonary standpoint; \noxygen saturation was routinely monitored. She had good \npulmonary toileting, as early ambulation and incentive \nspirometry were encouraged throughout hospitalization.  \nGI: The patient was initially kept NPO after the procedure. The \npatient was advanced to and tolerated a regular diet. Patient's \nintake and output were closely monitored.  \nGU: The patient voided spontaneously. Urine output was monitored \nas indicated.  \nID: The patient was closely monitored for signs and symptoms of \ninfection and fever, of which there was none.  \nHeme: The patient received subcutaneous heparin and ___ dyne \nboots during this stay. She was encouraged to get up and \nambulate as early as possible. \n\nOn POD#0, the patient was discharged to home. At discharge, she \nwas tolerating a regular diet, passing flatus, voiding, and \nambulating independently. She will follow-up in the clinic in 2 \nweeks. This information was communicated to the patient directly \nprior to discharge. \n \n Post-Surgical Complications During Inpatient Admission:  \n [ ] Post-Operative Ileus resolving w/o NGT  \n [ ] Post-Operative Ileus requiring management with NGT  \n [ ] UTI  \n [ ] Wound Infection  \n [ ] Anastomotic Leak  \n [ ] Staple Line Bleed  \n [ ] Congestive Heart failure  \n [ ] ARF  \n [ ] Acute Urinary retention, failure to void after Foley D/C'd  \n\n [ ] Acute Urinary Retention requiring discharge with Foley \nCatheter  \n [ ] DVT  \n [ ] Pneumonia  \n [ ] Abscess  \n [x] None  \n Social Issues Causing a Delay in Discharge:  \n [ ] Delay in organization of ___ services  \n [ ] Difficulty finding appropriate rehab hospital disposition.  \n\n [ ] Lack of insurance coverage for ___ services  \n [ ] Lack of insurance coverage for prescribed medications.  \n [ ] Family not agreeable to discharge plan.  \n [ ] Patient knowledge deficit related to ileostomy delaying \ndispo  \n [x] No social factors contributing in delay of discharge.  \n \n \nMedications on Admission:\nestradiol 2 mg oral DAILY  \nPrenatal vitamins\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q8H  \n2.  OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - \nModerate \nRX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours \nDisp #*4 Tablet Refills:*0 \n3.  estradiol 2 mg oral DAILY  \n4. Prenatal vitamins\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nSupralevator abscess with fistula \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMs. ___,\nYou were admitted with rectal pain and on MRI found to have a \nperirectal abscess and was taken to operating room for drainage \nof rectal abscess and ___ placement.\n\nGeneral: You will have some residual drowsiness from your \nsedative/anesthetic. You will need to have someone drive you \nhome. Do not drive or operate machinery for 24 hours and/or if \nyou are taking narcotic pain medication the days following \nsurgery.  \nDiet: drink plenty of fluids and eat foods high in fiber. Avoid \nfoods you know will constipate you or give you GI distress \n(plain white bread, pasta). Resume your normal diet when you are \nmoving your bowels normally.  \nActivity: For the first 48 hours avoid strenuous activity./heavy \nlifting. Resume your normal activity when you feel comfortable. \nYou may drive when you have been off narcotic pain medication \nfor 24 hours.  \nPain control: It is normal to have pain for a few weeks \nfollowing surgery. You will go home on a combination of over the \ncounter pain medication and limited amount of narcotic pain \nmedication per OB. You may take 2 Extra Strength Tylenol \n(1000mg) every 8 hours as needed for pain.\nBowel Regimen: Avoid extremes in bowel movements (diarrhea or \nconstipation). You should take a fiber supplement (Metamucil, \nKonsyl, Benefiber, Citrucel): one tablespoon with a glass of \nwater once a day. Be sure to drink fluids all day long. If you \ndo not have a bowel movement in 48 hours after surgery take 30 \nccs Milk of Magnesia (one capful) every 6 hours until bowel \nmovement. If you do not have a bowel movement after 4 doses of \nMilk of Magnesia please call our office. \nRectal Care: It is normal to see blood and mucus on pad or with \nbowel movements. It is normal for your wounds to open up. Warm/ \nhot water is soothing, helps relieve pain, reduces swelling, \nincreases blood flow and promotes healing. It is important to \nkeep the rectal area clean especially after bowel movements. Tub \nbaths (warm water soaks) for ___ minutes ___ times a day \nshould be done especially after every bowel movement. You may \nneed to wear a panty liner or pad on your clothing for spotting. \nIt is normal to have some bleeding with bowel movements for a \nfew weeks following surgery.  \nBowel and Urinary Management: It is normal to have pain with \nbowel movements. This will diminish as healing occurs. \nConstipation or diarrhea make the pain much worse and must be \navoided. Straining should be avoided. Do not sit on the toilet \nfor more than 5 minutes at a time.  \nRectal pain may make it difficult to urinate. If you cannot \nurinate after 6 hours, contact the office. If, after a few days, \nyou lose the ability to urinate this may indicate significant \ninfection. Contact the office immediately or go the closest \nEmergency Room should this occur.  \n Reasons to call the office after your surgery:  \n *Bleeding is excessive (bleeding that will not stop with direct \npressure applied or if you are soaking through the dressing and \nclothing)  \n *If you pass a large amount of blood (one cup or more) or feel \nfaint from bleeding  \n *If you are unable to urinate for 6 hours  \n *If you run a fever greater than 101 degrees  \n *If you have nausea and vomiting that persists making it \ndifficult for you to keep fluids down  \n *Firm painful lump with green/yellow., smelly drainage \n Best Wishes, \nYour ___ Care Team \n \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048216fb505ee753905ffe"
  },
  "note_id": "13956321-DS-19",
  "subject_id": 13956321,
  "hadm_id": 26310063,
  "note_type": "DS",
  "note_seq": 19,
  "charttime": "2179-05-09 00:00:00",
  "storetime": "2179-05-09 14:43:00",
  "text": " \nName:  ___                Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nSyncope  \n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\n___ with PMH hyperlipidemia presenting with syncope x 2. Patient \nwas in USOH today when he felt nauseated, \"woozy\" and \ndiaphoretic while sitting in movie theater. His wife tried to \nwake him up but he was unresponsive and snoring for approx 1 \nminute. He awoke then felt fine. Approximately 10 minutes later, \nhe had second episode lasting approx 30 seconds preceded by \nnausea and accompanied by \"jerking\" per wife. He again awoke \nfeeling fine but his friends helped him to the lobby and 911 was \ncalled. Of note, he had relatively large ___ dinner with \nfriends and ___ glasses of wine which is not unusual alcohol \nintake for him prior to this. When EMS arrived, he was laying on \na bench with BP 70/palp. At this time, he states he was feeling \nfine. He denies CP, palpitations, SOB, bowel or bladder \nincontnence, N/V/D and decreased PO intake. Had prior h/o \nsyncope x 1 ___ years ago when donating blood but no other \nepisodes. Denies h/o CP or SOB with exertion and is quite active \nand exercises daily.  \n.  \nIn the ED, initial VS: 96.6 64 122/84 16 100% NRB. He received \n1L NS. ECG was unremarkable with NSR and intervals HR 68. CXR \nunremarkable and cardiac enzymes negative x 1. VS prior to \ntransfer: 68 125/81 16 100%RA.  \n.  \nROS: Denies fever, chills, night sweats, weight loss, headache, \nvision changes, rhinorrhea, congestion, sore throat, cough, \nshortness of breath, chest pain, abdominal pain, nausea, \nvomiting, diarrhea, constipation, BRBPR, melena, hematochezia, \ndysuria, hematuria, lower extremity edema. Last BM this \nafternoon was normal.  \n\n \nPast Medical History:\nHyperlipidemia  \nSyncope ___ years ago in setting of not eating prior to blood \ndonation  \n\n \nSocial History:\n___\nFamily History:\nNo FH sudden cardiac death.  \n\n \nPhysical Exam:\nAdmission:\nVS: 98.7 140/78 70 20 100%RA  \nGENERAL - well-appearing fit man in NAD, comfortable, \nappropriate  \nHEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear  \nNECK - supple, no thyromegaly, no JVD, no carotid bruits  \nLUNGS - CTA bilat, no r/rh/wh, good air movement, resp unlabored \n \nHEART - RRR, no MRG, nl S1-S2  \nABDOMEN - soft/NT/ND, no masses or HSM, no rebound/guarding  \nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses  \nSKIN - no rashes or lesions  \nLYMPH - no cervical LAD  \nNEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength \n___ throughout, sensation grossly intact throughout  \n\n \nPertinent Results:\n___ 11:30PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-30 \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 \nLEUK-NEG\n___ 11:30PM URINE  RBC-1 WBC-1 BACTERIA-FEW YEAST-NONE \nEPI-0\n___ 09:05PM   GLUCOSE-104* UREA N-18 CREAT-0.9 SODIUM-140 \nPOTASSIUM-3.7 CHLORIDE-102 TOTAL CO2-28 ANION GAP-14\n___ 09:05PM   cTropnT-<0.01\n___ 09:05PM   CALCIUM-9.8 PHOSPHATE-4.6* MAGNESIUM-2.5\n___ 09:05PM   NEUTS-51.6 ___ MONOS-4.6 EOS-2.8 \nBASOS-1.2\n___ 09:05PM   WBC-7.3 RBC-4.68 HGB-14.4 HCT-38.4* MCV-82 \nMCH-30.7 MCHC-37.4* RDW-12.6\n___ 09:05PM   PLT COUNT-354\n\nEKG: NSR HR 68 Normal axis and intervals. JPE. No acute ST or T \nwave changes. QTc 410.  \n\n \nBrief Hospital Course:\n___ with hyperlipidemia presenting with syncope x 2, likely \nvasovagal or related to post-prandial hypotension.\n.  \n#. Syncope: History most c/w vasovagal vs postprandial \nhypotension.  No events on tele and no changes concerning for \nischemia on EKG, cardiac enzymes negative x 2 and no CP, N/V/D \nso less likely due to cardiac etiology.  Also beause of \nprodrome, less likely to be arrhythmogenic.  Per hx from pt's \nwife, had myoclonic jerks, however this can happen in syncope \nand does not suggest a seizure, also did not have post-ictal \nsymptoms or loss of bladder or bowel control.  Considering \nprodrome, most likely vasovagal, vs hypotension post-prandial \nwith EMS recording BP as 70/P after large meal.  Patient was \nstable overnight, felt well in AM, orthostatics negative after \nreceiving fluid o/n.  Was dischargd with PCP ___\n.  \n#. Hyperlipidema: Continued statin, ASA  \n.   \n# PPX: heparin SQ\n# CODE: Confirmed full during admission  \n \nMedications on Admission:\nSimvastatin 20mg PO daily  \nAspirin 81mg PO daily  \nMultivitamin  \nCalcium  \nVitamin C  \nNo OTC supplements or herbal medications \n \nDischarge Medications:\n1. simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n2. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \nPO DAILY (Daily).  \n3. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n4. calcium carbonate 200 mg (500 mg) Tablet, Chewable Sig: One \n(1) Tablet, Chewable PO QID (4 times a day) as needed for gi \nupset.  \n5. Vitamin C 100 mg Tablet Sig: One (1) Tablet PO once a day.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nsyncope\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were seen in the hospital for losing consciousness last \nnight, which was most likely due to vasovagal syncope (temporary \nlow blood flow to the brain, causing you to feel unwell prior to \nlosing consciousness) or hypotension (low blood pressure, which \ncan happen after eating).  Your heart monitor overnight, EKG, \nand bloodwork were normal.  Please discuss this with your \nprimary care doctor, as you may benefit from further workup.\n\nChanges to your medications:\nNo changes were made to your medications\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048212fb505ee7538feee4"
  },
  "note_id": "13079196-DS-16",
  "subject_id": 13079196,
  "hadm_id": 22438183,
  "note_type": "DS",
  "note_seq": 16,
  "charttime": "2150-08-07 00:00:00",
  "storetime": "2150-08-07 11:31:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nMorphine / Oxycodone/Acetaminophen\n \nAttending: ___.\n \nChief Complaint:\n___ F s/p fall vs. assault with facial trauma\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nPt reported waking up at 4:30am morning of admission with R \nfacial/jaw pain and noticed facial swelling. She does not recall \nanything from the night before and denies any knowledge of \nassault or significant etoh intake. CT at ___ \nfound R intraparenchymal hemorrhage, R inferior orbital rim \nfracture, nasal bone fracture. She was transferred from to the \n___ ED and admitted to the trauma service. ETOH on arrival to \n___ was 103.  \n \nPast Medical History:\nMRSA bacteremia\ndepression\nanxiety\nperforated diverticulitis\nL hip surgeries x 4 inc. total hip replacement\nR hip surgery - femur fracture, total hip replacement\n___ procedure\ntakedown colostomy\nappendectomy\ncholecystectomy\n\n \nSocial History:\n___\nFamily History:\nnon-contributory\n \nPhysical Exam:\nOn admission\n\nGen: WD/WN, comfortable, NAD\nVS: 91.9 115 127/88 18 99%RA\nGCS: 15\nHEENT: R periorbital ecchymosis and ___ swelling, 1cmfluid \nswelling over R maxilla. 0.75 cm, 'z' shaped laceration over R \nmaxillary prominence. EOMI. Pupils: ___ bilaterally  \nNeck: Supple.\nLungs: CTA bilaterally.\nCardiac: RRR. S1/S2.\nAbd: Soft, NT, BS+\nExtrem: Warm and well-perfused.\nNeuro:\nMental status: Awake and alert, cooperative with exam, normal \naffect.  \nOrientation: Oriented to person, place, and date.\nRecall: ___ objects at 5 minutes.\nLanguage: Speech fluent with good comprehension and repetition.\nNaming intact. No dysarthria or paraphasic errors.\nCranial Nerves:\nI: Not tested\nII: Pupils equally round and reactive to light, to\nmm bilaterally. Visual fields are full to confrontation.\nIII, IV, VI: Extraocular movements intact bilaterally without\nnystagmus.\nV, VII: Facial strength and sensation intact and symmetric.\nVIII: Hearing intact to voice.\nIX, X: Palatal elevation symmetrical.\nXI: Sternocleidomastoid and trapezius normal bilaterally.\nXII: Tongue midline without fasciculations.\nMotor: Normal bulk and tone bilaterally. No abnormal movements,\ntremors. Strength full power ___ throughout. No pronator drift\nSensation: Intact to light touch, propioception, pinprick and\nvibration bilaterally.\nToes downgoing bilaterally\nCoordination: normal on finger-nose-finger, rapid alternating\nmovements, heel to shin\n \nPertinent Results:\n___ 06:00PM   NEUTS-75.0* ___ MONOS-4.1 EOS-0.9 \nBASOS-0.2\n___ 06:00PM   WBC-9.5 RBC-3.41* HGB-11.4* HCT-34.4* \nMCV-101* MCH-33.4* MCHC-33.1 RDW-15.3\n___ 06:00PM   PLT COUNT-300\n___ 06:00PM   ASA-NEG ___ ACETMNPHN-NEG \nbnzodzpn-NEG barbitrt-NEG tricyclic-NEG\n___ 06:00PM   CALCIUM-8.7 PHOSPHATE-3.3 MAGNESIUM-1.9\n___ 06:00PM   estGFR-Using this\n___ 06:00PM   GLUCOSE-71 UREA N-12 CREAT-0.8 SODIUM-141 \nPOTASSIUM-4.2 CHLORIDE-103 TOTAL CO2-17* ANION GAP-25*\n___ 06:18PM   K+-4.1\n___ 07:30PM URINE  ___ BACTERIA-OCC YEAST-NONE \nEPI-0\n___ 07:30PM URINE  BLOOD-SM NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 \nLEUK-NEG\n___ 07:30PM URINE  COLOR-Yellow APPEAR-Clear SP ___\n___ 07:30PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-POS \ncocaine-NEG amphetmn-NEG mthdone-NEG\n___ 07:30PM URINE  HOURS-RANDOM\n\n___ CT C-SPINE W/O CONTRAST Preliminary reports are not \navailable for viewing.\n___ CT HEAD W/O CONTRAST Preliminary reports are not \navailable for viewing. \n___ CHEST (SINGLE VIEW) There is minimal atelectasis present \nat the lung bases. The cardiomediastinal silhouette is \nunremarkable. There are no rib fractures. There is no \npneumothorax. \n___ PELVIS (AP ONLY) Unread\n___ ABDOMEN (SUPINE ONLY)\nFINDINGS: There is no evidence of gross acute fracture or \ndislocation. Please note, single supine view of the abdomen is \nnot optimized for bony evaluation. Extensive degenerative \nchanges of the lumbar spine are identified. Mild levoscoliosis \nis noted. SI joints are unremarkable. Patient is status post \nbilateral hip replacements. The hardware is intact. Contrast is \nidentified within the bladder, presumably due to prior \nradiological study. Bowel gas pattern is unremarkable. \n\n \nBrief Hospital Course:\nPt was admitted with diagnoses from CT at OSH showing multiple \npunctate hyperdensities in R frontal and R temporal regions c/w \nhemorrhagic contusion, R inferior orbital wall fracuture, nasal \nbone fx, hematoma face. R facial laceration was repaired in the \nED by plastics.  Facial fractures were judged to be \nnonoperative.  Neurosurgery initiated ___nd \nrecommended follow-up with repeat CT.  Ophthalmology consult \nrecommended follow-up eye exam for decreased visual acuity; no \nentrapment was noted.  Pt was admitted to ___ with NGT, PIVs, \nand Foley and placed on CIWA scale. Social work consult was \nobtained regarding ETOH use and safety in the home; patient was \ndeemed to feel safe and able to return home.\n \nDischarge Medications:\n1. Phenytoin Sodium Extended 100 mg Capsule Sig: One (1) Capsule \nPO three times a day for 10 days.\nDisp:*30 Capsule(s)* Refills:*0*\n2. Tylenol Extra Strength 500 mg Tablet Sig: Two (2) Tablet PO \nevery six (6) hours as needed for headache.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\ns/p ?Assault vs. Fall\nRight intraparenchymal hemorrhage \nRight orbital inferior rim fracture \nNasal bone fracture \nRight facial laceration\n \nDischarge Condition:\nHemodynamically stable tolerating a regular diet, pain \ncontrolled\n\n \nDischarge Instructions:\nAVOID blowing your nose because of the nasal fractures.\n\nContinue with the Dilantin (anti-seizure medication) for a total \nof 10 days.\n\nApply ice to right side of face ___ because of the \nswelling.\n\nReturn to the Emergency room for increased headaches, fevers, \nchanges in your vision, increased dizziness, shortness of \nbreath, chest pain, abdominal pain, nausea, vomiting, diarrhea \nand/or any other symtpoms that are concerning to you.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904821dfb505ee753910008"
  },
  "note_id": "15186300-DS-10",
  "subject_id": 15186300,
  "hadm_id": 26863203,
  "note_type": "DS",
  "note_seq": 10,
  "charttime": "2183-07-24 00:00:00",
  "storetime": "2183-07-24 17:30:00",
  "text": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: SURGERY\n \nAllergies: \ntramadol / tramadol / colchicine\n \nAttending: ___\n \nChief Complaint:\nLeg pain\n \nMajor Surgical or Invasive Procedure:\nRight lower leg wound debridement and hematoma washout ___\n\nRight lower leg wound debridement, hematoma washout, and wound \nVAC placement ___\n\n \nHistory of Present Illness:\n___ w/ h/o afib / aflutter on coumadin, CKD, p/w R calf hematoma\ns/p fall two weeks ago. Patient tripped over a backpack and fell\nbackwards on ___. He subsequently developed a hematoma of the R\ncalf. He was being seen by his PCP at ___ and had a\nvisiting nurse for daily evaluations and wound care. Due to\nincreased erythema and concern for cellulitis, ceftriaxone was\nstarted on ___ and he has been receiving daily dosing since\nthen. He was sent to the ED per ___ for further\nwound care. He denies fevers/chills. No sensory deficits in the\nlower extremities. Increased pain over R calf. He has not taken\ncoumadin for a week, INR today is 1.3. WBC 7.7, Hct 29.1. \n\n \nPast Medical History:\nPMH: CKD, afib/aflutter, HTN, BPH\nPSH: b/l knee replacements, L hip replacement, R femur fixation\n \nSocial History:\n___\nFamily History:\nnoncontributory\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n========================\nVS: 97.9, 78, 100/66, 18, 98%RA\nPE:\nAAOx3, NAD\nR calf posterior hematoma, large, skin breakdown, minor drainage\nof old hematoma, R lower leg erythema is circumferential, R foot\nedema, b/l DP palpable\n\nDISCHARGE PHYSICAL EXAM:\n========================\nVS: T 98.7  HR 68  BP 129/75  RR 20  Sat 94% RA\nGen: NAD, A&Ox3 comfortable\nHEENT: No conjuctival pallor, non-icteric sclera\nCV: Irregular rhythm, no MRG\nLung: CTAB\nAbd: Soft, NT, ND\nExt: ~7cm x10cm open wound on right posterior leg with wound vac \nin place, wound is clean and dry, no erythema or exudate\n\n \nPertinent Results:\nADMISSION LABS:\n===============\n___ 01:42PM BLOOD WBC-7.7 RBC-3.06* Hgb-9.1* Hct-29.1* \nMCV-95 MCH-29.7 MCHC-31.3* RDW-14.4 RDWSD-50.1* Plt ___\n___ 01:42PM BLOOD Neuts-68.3 Lymphs-15.5* Monos-11.0 \nEos-3.1 Baso-0.9 Im ___ AbsNeut-5.26 AbsLymp-1.19* \nAbsMono-0.85* AbsEos-0.24 AbsBaso-0.07\n___ 01:42PM BLOOD ___ PTT-29.0 ___\n___ 01:42PM BLOOD Glucose-90 UreaN-14 Creat-0.6 Na-138 \nK-4.9 Cl-100 HCO3-25 AnGap-13\n___ 01:42PM BLOOD Calcium-8.9 Phos-4.0 Mg-2.2\n___ 02:59PM BLOOD Lactate-2.2*\n___ 03:17PM URINE Color-Yellow Appear-Clear Sp ___\n___ 03:17PM URINE Blood-NEG Nitrite-NEG Protein-30* \nGlucose-NEG Ketone-TR* Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG\n___ 03:17PM URINE RBC-2 WBC-1 Bacteri-NONE Yeast-NONE Epi-1\n___ 03:17PM URINE CastHy-3*\n___ 03:17PM URINE Mucous-FEW*\n\nINTERIM LABS:\n=============\n___ 02:59PM BLOOD ___\n\nDISCHARGE LABS:\n===============\n___ 05:10AM BLOOD WBC-9.0 RBC-3.45* Hgb-10.2* Hct-32.2* \nMCV-93 MCH-29.6 MCHC-31.7* RDW-14.1 RDWSD-48.7* Plt ___\n___ 05:10AM BLOOD ___ PTT-29.1 ___\n___ 05:10AM BLOOD Glucose-95 UreaN-19 Creat-0.6 Na-142 \nK-4.0 Cl-102 HCO3-28 AnGap-12\n___ 05:10AM BLOOD Calcium-8.6 Phos-2.2* Mg-2.1\n\nMICROBIOLOGY:\n============= \n___ 1:42 pm BLOOD CULTURE\n                            **FINAL REPORT ___\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n \n___ 1:40 pm BLOOD CULTURE\n                            **FINAL REPORT ___\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n\n___ 3:17 pm URINE\n                            **FINAL REPORT ___\n   URINE CULTURE (Final ___:    NO GROWTH. \n\nIMAGING/STUDIES:\n================\nPATH - Soft Tissue Debridement ___:\n-Skin and subcutis with organizing hematoma, fat necrosis, and \ngranulation tissue.\n \nBrief Hospital Course:\nMr. ___ is a ___ year old male with a history of CKD, atrial \nfibrillation on Coumadin who presented with a right calf \nhematoma after a mechanical fall two weeks ago. He underwent a \nwound debridement and hematoma washout ___. The patient has \na very large right medial calf wound hematoma without obvious \ninfection.  The overlying skin was completely necrotic.  The \ncavity that the evacuated clot had filled was 11 x 7 x 2 cm.  \nThe underlying muscle was viable.  The clot was evacuated, \nnecrotic tissue excised, the wound washed out and a VAC placed. \nAfter getting out of the procedure, he has had soft BPs in the \nPACU. He has received 500 cc of albumin and 2 U pRBCS. He has \nalso received approximately 2 L of crystalloid. His BPs have \nbeen persistently in the ___ so the decision was made to \nadmit the patient to the ___ service for overnight monitoring. \nHis BP's improved to the 100's and he was transferred to the \nfloor. The patient was brought back to OR on ___ because it \nwas thought that there may be additional material to be \ndebrided. During the procedure there was found some necrotic \ntissue that was rather superficial, but overlying the patient's \nfascia. The fascia was opened because of concerned that the \nmuscle may not be viable; found some edema fluid within the \nfascia and the muscle itself was viable. The 11 x 7 cm area was \ndebrided and also ___ elevator was used to remove some of the \ntissue stuck to the fascia. Some skin was debrided as well along \nwith the subcutaneous tissue and that was all sent for \npathologic examination without any significant findings. A VAC \noverlying the area was placed. The patient tolerated the \nprocedure and recovered well. \n\nWhen tolerating a diet, the patient was converted to oral pain \nmedication with continued good effect. His Coumadin was \nrestarted on ___ without evidence of bleeding. Diet was \nprogressively advanced as tolerated to a regular diet with good \ntolerability. The patient voided without problem. During this \nhospitalization, the patient ambulated early and frequently. At \nthe time of discharge, the patient was doing well, afebrile with \nstable vital signs.  The patient was tolerating a regular diet, \nambulating, voiding without assistance, and pain was well \ncontrolled.  The patient was discharged home without services. \nThe patient received discharge teaching and follow-up \ninstructions with understanding verbalized and agreement with \nthe discharge plan.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Tamsulosin 0.4 mg PO QHS \n2. Verapamil 40 mg PO Q24H \n3. Warfarin 5 mg PO DAILY16 \n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q8H  \n2.  Docusate Sodium 100 mg PO BID  \n3.  OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN Pain - \nModerate \n  Reason for PRN duplicate override: pain control\nRX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp \n#*4 Tablet Refills:*0 \n4.  Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First \nLine  \n5.  Senna 17.2 mg PO HS  \n6.  Tamsulosin 0.4 mg PO QHS  \n7.  Verapamil 40 mg PO Q24H  \n8.  Warfarin 5 mg PO DAILY16  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY:\n========\nHematoma\n\nSECONDARY:\n==========\nAfib\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Mr. ___, \n\nYou were admitted to ___ due to \nright leg pain that was found to be due to a large blood clot \nafter a fall two weeks ago. The blood clot was removed and the \nwound washed out thoroughly. A wound vacuum device was applied \nto encourage healing. You tolerated the procedure and are \nhealing well. You are now ready to be discharged to rehab.\n\nPlease call your doctor or nurse practitioner or return to the \nEmergency Department for any of the following:\n*You experience new chest pain, pressure, squeezing or \ntightness.\n*New or worsening cough, shortness of breath, or wheeze.\n*If you are vomiting and cannot keep down fluids or your \nmedications.\n*You are getting dehydrated due to continued vomiting, diarrhea, \nor other reasons. Signs of dehydration include dry mouth, rapid \nheartbeat, or feeling dizzy or faint when standing.\n*You see blood or dark/black material when you vomit or have a \nbowel movement.\n*You experience burning when you urinate, have blood in your \nurine, or experience a discharge.\n*Your pain in not improving within ___ hours or is not gone \nwithin 24 hours. Call or return immediately if your pain is \ngetting worse or changes location or moving to your chest or \nback.\n*You have shaking chills, or fever greater than 101.5 degrees \nFahrenheit or 38 degrees Celsius.\n*Any change in your symptoms, or any new symptoms that concern \nyou.\n\nPlease resume all regular home medications, unless specifically \nadvised not to take a particular medication. Also, please take \nany new medications as prescribed.\n\nPlease get plenty of rest, continue to ambulate several times \nper day, and drink adequate amounts of fluids. Avoid lifting \nweights greater than ___ lbs until you follow-up with your \nsurgeon.\nAvoid driving or operating heavy machinery while taking pain \nmedications.\n\nIncision Care:\n*Please call your doctor or nurse practitioner if you have \nincreased pain, swelling, redness, or drainage from the incision \nsite.\n*Avoid swimming and baths until your follow-up appointment.\n*You may shower, and wash surgical incisions with warm water. \nGently pat the area dry.\n*If you have staples, they will be removed at your follow-up \nappointment.\n\nThank you for allow us to be a part of your care. \n\nSincerely,\n\nYour ___ Surgery Team\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904821dfb505ee753910009"
  },
  "note_id": "15186300-DS-11",
  "subject_id": 15186300,
  "hadm_id": 26530052,
  "note_type": "DS",
  "note_seq": 11,
  "charttime": "2183-10-14 00:00:00",
  "storetime": "2183-10-14 15:53:00",
  "text": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: PLASTIC\n \nAllergies: \ntramadol / tramadol / colchicine\n \nAttending: ___\n \nChief Complaint:\nright lower extremity leg wound\n \nMajor Surgical or Invasive Procedure:\nsplit thickness skin graft to RLE defect.\n \nHistory of Present Illness:\n___ year old male who has been followed for a calf wound \nfollowing fall c/b calf hematoma a few months ago.  The patient \nhas, most recently, managed the wound with a wound VAC.  He is \nhere today for a skin graft to the area.\n\n \nPast Medical History:\nRIGHT IT FRACTURE                                               \nBENIGN PROSTATIC HYPERTROPHY                                    \nATRIAL FIBRILLATION                                             \nAFLUTTER                                                        \nCHRONIC KIDNEY DISEASE                                          \nHYPERTENSION  \n.\nPSH:  DEBRIDEMENT AND WASHOUT OF RIGHT LEG HEMATOMA, VAC    \n___\nPLACEMENT                                                       \n___  \nRIGHT LOWER LEG WOUND DEBRIDEMENT AND WASHOUT         ___\n___                                                         \nIM NAILING RIGHT IT HIP FRACTURE                      ___\n___                                                       \nKNEE SURGERY                                                    \nb/l knee replacements         \n\n \nSocial History:\n___\nFamily History:\nnoncontributory\n \nPhysical Exam:\nPhysical exam per Post operative check ___:\nVitals:\n97.7     104 / 67         61         18         96 RA \nGen: AAOx3 NAD comfortable\nCV: NRRR\nResp: Breathing comfortably RA\nAbd: Soft, benign\nRLE: wrapped with ACE, vac holding suction with scant output;\nneurovascularly in tact\n\n \nPertinent Results:\nADMISSION LABS:\n___ 06:00AM BLOOD WBC-4.3 RBC-3.71* Hgb-10.5* Hct-33.6* \nMCV-91 MCH-28.3 MCHC-31.3* RDW-15.9* RDWSD-52.3* Plt ___\n___ 06:00AM BLOOD ___ PTT-30.7 ___\n___ 06:00AM BLOOD Glucose-140* UreaN-12 Creat-0.6 Na-140 \nK-5.0 Cl-102 HCO3-23 AnGap-15\n___ 06:00AM BLOOD Calcium-8.9 Phos-3.6 Mg-1.8\n.\n___ 09:34AM BLOOD ___\n___ 10:08AM BLOOD ___\n___ 07:22AM BLOOD ___ PTT-37.4* ___\n___ 10:30AM BLOOD ___\n \nBrief Hospital Course:\nThe patient was admitted to the Plastic surgery service on \n___ s/p split thickness skin graft to RLE wound defect.  He \ntolerated the procedure well, was recovered in PACU and then \ntransferred to floor.  A wound vac dressing was maintained over \nskin graft site for 7 days and RLE was immobilized in a soft \nsplint to keep foot dorsiflexed and prevent calf muscle \nmovement.  Patient was TDWB to RLE for transfers and walking but \nexperienced difficulty in maintaining this as evaluated by \nPhysical Therapy so rehab was recommended after hospitalization. \n Nutrition followed patient and recommended supplemental shakes \nand multivitamin to aide with healing.  Pain was treated with \nPRN oxycodone which provided good pain relief for the patient.  \nHome warfarin was restarted on POD#2.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Tamsulosin 0.4 mg PO QHS for BPH \n2. Verapamil SR 180 mg PO Q24H \n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild  \n2.  Docusate Sodium 100 mg PO BID  \n3.  Multivitamins W/minerals 1 TAB PO DAILY  \n4.  OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Severe \nRX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours \nDisp #*15 Tablet Refills:*0 \n5.  Polyethylene Glycol 17 g PO DAILY:PRN Constipation - Second \nLine  \n6.  Senna 8.6 mg PO BID:PRN Constipation - First Line  \n7.  Warfarin 6 mg PO DAILY16  \n8.  Tamsulosin 0.4 mg PO QHS for BPH  \n9.  Verapamil SR 180 mg PO Q24H  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nRight leg wound defect\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\n-You should continue taking your current medication. \n-Elevate your right leg as much as possible\n-You may shower but you must cover your your skin graft site \nwith plastic wrap so it does not get wet.\n- If your right leg graft site or donor site begins to worsen \nafter discharge with an acute change in swelling or pain, please \ncall Dr. ___, to report this.  \n - Your right thigh skin graft DONOR site should be dressed \nevery 3 days with an adaptic covered with a tegaderm dressing.\n - Your right skin graft/repair site will be dressed with a \nxeroform dressing to graft area, fluffed gauzes covered with \nkerlix and then ace wrap daily.  \n.\nActivity:\n- Do not bear full weight on your right leg.  You are to be \n'touch down weight bear' only.\n.\nMedications:\n 1. Resume your regular medications unless instructed otherwise \nand take any new meds as ordered .\n 2. You may take your prescribed pain medication for moderate to \nsevere pain. You may switch to Tylenol or Extra Strength Tylenol \nfor mild pain as directed on the packaging. Please note that \nPercocet and Vicodin have Tylenol as an active ingredient so do \nnot take these meds with additional Tylenol.\n 3. Take prescription pain medications for pain not relieved by \ntylenol.\n 4. Take Colace, 100 mg by mouth 2 times per day, while taking \nthe prescription pain medication. You may use a different \nover-the-counter stool softener if you wish.\n 5. Do not drive or operate heavy machinery while taking any \nnarcotic pain medication. You may have constipation when taking \nnarcotic pain medications (oxycodone, percocet, vicodin, \nhydrocodone, dilaudid, etc.); you should continue drinking \nfluids, you may take stool softeners, and should eat foods that \nare high in fiber.\n6. Please avoid medications such as aspirin, motrin, advil, \nibuprofen, etc (NSAIDS) temporarily during your healing.  You \nmay ask your surgeon when you may restart these medications at \nyour follow up visit.\n.\n Call the office IMMEDIATELY if you have any of the following:\n 1. Signs of infection: fever with chills, increased redness, \nswelling, warmth or tenderness at the surgical site, or unusual \ndrainage from the incision(s).\n 2. A large amount of bleeding from the incision(s) or drain(s).\n 3. Fever greater than 101.5 oF\n 4. Severe pain NOT relieved by your medication.\n .\n Return to the ER if: \n * If you are vomiting and cannot keep in fluids or your \nmedications. \n * If you have shaking chills, fever greater than 101.5 (F) \ndegrees or 38 (C) degrees, increased redness,swelling or \ndischarge from incision, chest pain, shortness of breath, or \nanything else that is troubling you.\n * Any serious change in your symptoms, or any new symptoms that \nconcern you.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904821dfb505ee75391000a"
  },
  "note_id": "15186300-DS-9",
  "subject_id": 15186300,
  "hadm_id": 26875779,
  "note_type": "DS",
  "note_seq": 9,
  "charttime": "2182-02-20 00:00:00",
  "storetime": "2182-02-20 10:53:00",
  "text": " \nName:  ___                  Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: ORTHOPAEDICS\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nRight intertrochanteric femur fracture.\n \nMajor Surgical or Invasive Procedure:\nOpen reduction internal fixation right intertrochanteric hip \nfracture\n \nHistory of Present Illness:\n___ with a-fib on Coumadin, L THA and B TKA (Dr. ___, all within ___ years) who presented to the ___ ED s/p\nmechanical fall from standing with R hip pain. Patient was with\nhis grandchildren at his son's home when he tripped on a \ndoorstep\nand fell backwards landing directly onto his R hip. Had \nimmediate\nR hip pain and inability to bear weight. Denies HS or LOC.\nWitnessed fall by his son. ___ weakness, numbness, or\ntingling. Denies pain elsewhere. Denies other complaints.\n \nPast Medical History:\nA-fib on Coumadin\nBPH\n \nSocial History:\n___\nFamily History:\nnoncontributory\n \nPhysical Exam:\nGen: elderly male in no acute distress\nNeuro: alert and interactive\nCV: palpable DP pulse bilaterally\nPulm: no respiration distress on room air\nRLE: incision Clean, dry intact, mild ___ \necchymosis, fires ___, SILT: ___, \npalpable DP\n \nPertinent Results:\n___ 07:54AM BLOOD WBC-5.4 RBC-3.36* Hgb-10.4* Hct-31.7* \nMCV-94 MCH-31.0 MCHC-32.8 RDW-14.0 RDWSD-48.2* Plt ___\n___ 07:54AM BLOOD ___\n___ 04:50PM BLOOD ___\n___ 10:21AM BLOOD ___\n \nBrief Hospital Course:\nThe patient presented to the emergency department and was \nevaluated by the orthopedic surgery team. The patient was found \nto have right intertrochanteric hip fracture and was admitted to \nthe orthopedic surgery service. The patient was taken to the \noperating room on ___ for open reduction internal fixation \nright intertrochanteric hip fracture with TFN, which the patient \ntolerated well. For full details of the procedure please see the \nseparately dictated operative report. The patient was taken from \nthe OR to the PACU in stable condition and after satisfactory \nrecovery from anesthesia was transferred to the floor. The \npatient was initially given IV fluids and IV pain medications, \nand progressed to a regular diet and oral medications by POD#1. \nThe patient was given ___ antibiotics and \nanticoagulation per routine. The patient's home medications were \ncontinued throughout this hospitalization. The patient worked \nwith ___ who determined that discharge to rehab was appropriate. \nThe ___ hospital course was otherwise unremarkable.\n\nAt the time of discharge the patient's pain was well controlled \nwith oral medications, incisions were clean/dry/intact, and the \npatient was voiding/moving bowels spontaneously. The patient is \nweight-bearing as tolerated in the right lower extremity, and \nwill be discharged on warfarin for DVT prophylaxis. The patient \nwill follow up with Dr. ___ routine. A thorough \ndiscussion was had with the patient regarding the diagnosis and \nexpected post-discharge course including reasons to call the \noffice or return to the hospital, and all questions were \nanswered. The patient was also given written instructions \nconcerning precautionary instructions and the appropriate \nfollow-up care. The patient expressed readiness for discharge.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Warfarin 4 mg PO DAILY16 \n2. Verapamil SR 180 mg PO Q24H \n3. Tamsulosin 0.4 mg PO DAILY \n\n \nDischarge Medications:\n1.  Acetaminophen 650 mg PO Q6H  \n2.  Bisacodyl 10 mg PO/PR DAILY:PRN constipation \nRX *bisacodyl [Ducodyl] 5 mg 2 tablet(s) by mouth daily as \nneeded for constipation Disp #*15 Tablet Refills:*0 \n3.  Calcium Carbonate 500 mg PO TID  \n4.  Docusate Sodium 100 mg PO BID \nRX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth every \n12 hours as needed for constipation Disp #*15 Capsule Refills:*0 \n\n5.  OxyCODONE (Immediate Release) 2.5 mg PO Q4H:PRN Pain \nRX *oxycodone 5 mg 0.5 (One half) tablet(s) by mouth every 4 \nhours as needed for pain Disp #*40 Tablet Refills:*0 \n6.  Senna 8.6 mg PO BID \nRX *sennosides [senna] 8.6 mg 1 tablet by mouth every 12 hours \nas needed for constipation Disp #*15 Tablet Refills:*0 \n7.  TraZODone 25 mg PO HS:PRN insomnia  \n8.  Vitamin D 800 UNIT PO DAILY  \n9.  Warfarin 6 mg PO DAILY16  \n10.  Tamsulosin 0.4 mg PO DAILY  \n11.  Verapamil SR 180 mg PO Q24H  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nRight intertrochanteric femur fracture\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\n- You were in the hospital for orthopedic surgery. It is normal \nto feel tired or \"washed out\" after surgery, and this feeling \nshould improve over the first few days to week. \n- Resume your regular activities as tolerated, but please follow \nyour weight bearing precautions strictly at all times.\n\nACTIVITY AND WEIGHT BEARING:\n- WBAT\n\nMEDICATIONS:\n- Please take all medications as prescribed by your physicians \nat discharge.\n- Continue all home medications unless specifically instructed \nto stop by your surgeon.\n- Do not drink alcohol, drive a motor vehicle, or operate \nmachinery while taking narcotic pain relievers.\n- Narcotic pain relievers can cause constipation, so you should \ndrink eight 8oz glasses of water daily and take a stool softener \n(colace) to prevent this side effect.\n\nANTICOAGULATION:\n- Please take Coumadin per your usual home dosing. Please bridge \nwith Lovenox and discontinue lovenox 24 hours after INR is 2.0 \n\nWOUND CARE:\n- You may shower. No baths or swimming for at least 4 weeks.\n- Any stitches or staples that need to be removed will be taken \nout at your 2-week follow up appointment.\n- Please remain in your dressing and do not change unless it is \nvisibly soaked or falling off.\n\nDANGER SIGNS:\nPlease call your PCP or surgeon's office and/or return to the \nemergency department if you experience any of the following:\n- Increasing pain that is not controlled with pain medications\n- Increasing redness, swelling, drainage, or other concerning \nchanges in your incision\n- Persistent or increasing numbness, tingling, or loss of \nsensation\n- Fever > 101.4\n- Shaking chills\n- Chest pain\n- Shortness of breath\n- Nausea or vomiting with an inability to keep food, liquid, \nmedications down\n- Any other medical concerns\n\nFOLLOW UP:\nPlease follow up with your Orthopaedic Surgeon, Dr. ___. \nYou will have follow up with ___, NP in the \nOrthopaedic Trauma Clinic 14 days post-operation for evaluation. \nCall ___ to schedule appointment upon discharge.\n\nPlease follow up with your primary care doctor regarding this \nadmission within ___ weeks and for and any new \nmedications/refills.\n\nPhysical Therapy:\nWBAT right lower extremity, activity as tolerated right lower \nextremity.\nTreatments Frequency:\nPlease change dressings as needed with gauze and paper tape. \nDC staples at 2 weeks. \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb683"
  },
  "note_id": "12648465-DS-13",
  "subject_id": 12648465,
  "hadm_id": 23432890,
  "note_type": "DS",
  "note_seq": 13,
  "charttime": "2204-06-03 00:00:00",
  "storetime": "2204-06-04 09:20:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine\n \nAttending: ___.\n \nChief Complaint:\nAbdominal pain\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ history of gastric bypass complicated by bowel obstructions \nand hernias presenting with severe abdominal pain x5 days. She \nalso endorses nausea and vomiting which began 2 days ago. \nReports low grade fevers to 100. No chills, diarrhea, BRBPR, \nmelena, dysuria, or hematuria. Patient states the pain is \nlocated in the epigastrium and right lower quadrant and is \ncrampy and severe. It is similar to the pain she has had with \nher bowel obstructions in the past. Her last bowel movement was \n3 days ago. She is passing lots of flatus. She ___ eaten much \nof anything in 2 days. She has been losing weight recently.\n\nOf note, for the past 3 months the patient has noticed decreased \nurine output. She urinates ___ times per day. She has not had \nthis worked up by a doctor.\n\nIn the ED, initial vs were 98.2 78 140/87 16 98%. Heme-negative. \nReceived 2mg IV diaudid. Transfer VS 98 53 97/62 14 100%.  \nOn arrival to the floor, patient reports severe ___ epigastric \nand right sided pain. She feels like she would be able to eat if \nthe pain were controlled.  \n\n \nPast Medical History:\nhypertension, asthma, peptic ulcer disease, DJD, and non-insulin \ndependent diabetes mellitus, gastric bypass, cholecystectomy\n\n \nSocial History:\n___\nFamily History:\nPaternal aunt and maternal uncle with colon cancer. Maternal \naunt with breast cancer. HTN and diabetes runs in the family.\n\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVS  98.3, 109/66, 56, 18, 100% RA\nGEN Alert, oriented, in pain  \nHEENT NCAT MMM EOMI sclera anicteric, OP clear  \nNECK supple, no JVD, no LAD  \nPULM Poor inspiratory effort, CTAB no wheezes, rales, ronchi  \nCV RRR normal S1/S2, no mrg  \nABD soft, tender in epigastrium and right side of abdomen, ND \nhyperactive bowel sounds, no r/g, ___ sign negative  \nEXT WWP 2+ pulses palpable bilaterally, no c/c/e  \nNEURO CNs2-12 intact, motor function grossly normal  \nSKIN no ulcers or lesions  \n\nDischarge Exam:\nVS  98.1, 111/76, 72, 18, 100% RA\nGEN Alert, oriented, NAD  \nHEENT NCAT MMM EOMI sclera anicteric, OP clear    \nPULM CTAB no wheezes, rales, ronchi  \nCV RRR normal S1/S2, no mrg  \nABD soft, tender in epigastrium, ND hyperactive bowel sounds, no \nr/g  \nEXT WWP 2+ pulses palpable bilaterally, no c/c/e  \nNEURO CNs2-12 intact, motor function grossly normal  \nSKIN no ulcers or lesions  \n \nPertinent Results:\nAdmission:\n___ 07:45AM BLOOD WBC-5.1 RBC-3.80* Hgb-12.8# Hct-39.5# \nMCV-104*# MCH-33.7*# MCHC-32.5 RDW-16.1* Plt ___\n___ 07:45AM BLOOD Neuts-77.4* ___ Monos-2.2 Eos-0.5 \nBaso-0.5\n___ 07:45AM BLOOD Glucose-82 UreaN-11 Creat-0.7 Na-137 \nK-5.1 Cl-104 HCO3-28 AnGap-10\n___ 07:45AM BLOOD ALT-21 AST-40 AlkPhos-78 TotBili-0.3\n___ 07:45AM BLOOD Albumin-2.9* Calcium-8.4 Phos-3.6 Mg-1.9\n___ 07:57AM BLOOD Lactate-1.7\n\nDischarge:\n___ 06:45AM BLOOD WBC-5.7 RBC-2.89* Hgb-9.5* Hct-30.0* \nMCV-104* MCH-32.8* MCHC-31.6 RDW-16.3* Plt ___\n___ 06:45AM BLOOD Glucose-71 UreaN-14 Creat-0.6 Na-139 \nK-4.6 Cl-104 HCO3-30 AnGap-10\n___ 06:50AM BLOOD ALT-11 AST-15 AlkPhos-62 TotBili-0.2\n___ 06:45AM BLOOD Calcium-7.9* Phos-3.4 Mg-1.6\n___ 06:50AM BLOOD VitB12-326\n\nImaging:\n___ CT Abdomen Pelvis:\n1.  New pancreatic duct dilation.  New extra-hepatic and left \nintra-hepatic biliary ductal dilation.  Though no obstructing \nmass is seen, further imaging with MRCP is recommended. \n2.  No acute intra-abdominal or intra-pelvic process.  No \nevidence of small bowel obstruction. \n3.  Mild cecal mucosal thickening may represent colitis. \n\n___ MRCP:\nDilation of the main pancreatic duct and biliary tree to the \nampulla without underlying mass identified.  Suspect that a \nduodenal wall or ampullary abnormality (which may include \nstricture, spasm, or mass) accounts for this appearance.  As the \npatient appears to have had a gastric bypass reversal, she may \nbe anatomically amenable to EGD/ERCP evaluation as clinically \nwarranted. \n\n \nBrief Hospital Course:\nBrief Course:\n___ history of gastric bypass complicated by hernias presenting \nwith abdominal pain x3 days. Patient was found to have \npancreatic and common bile duct dilitation on MRCP which appears \nto be consistent with prior imaging obtained from outside \nhospital records since ___ year ago. No mass was identified on \nimaging. ERCP was consulted who recommended that the patient \nfollow up with them as an outpatient for further evaluation with \npossible ERCP. Patient's pain was controlled with dilaudid.\n\nActive Issues:\n#Acute of Chronic Abdominal pain: Unclear etiology. Localized to \nepigastrium and right side. Ddx includes appendicitis, colitis, \ngastritis, PUD, diverticulitis, constipation. No fever, white \ncount, guaiac negative. MRCP showed pancreatic and CBD \ndilitation which seems to have been present for at least a year \nbased on outside records. Ddx includes choledocolithiasis, \nbiliary sludge, sphincter of oddi spasm, pancreatic tumor, \nalthough no evidence of obstructing mass or stone on imaging. No \nelevation in liver function tests. ERCP was consulted and felt \nthat an endoscopic ultrasound would not be feasible given the \npatient's anatomy after her gastric bypass surgery. They \nrecommended that she follow up with them as an outpatient for \npossible ERCP for further workup. We tried to get in touch with \nthe patient's former gastroenterologist at ___ but were \nunsucessful. Patient's pain was controlled with IV dilaudid \ninitially, then she was transitioned to PO dilaudid was she was \ntolerating food. Patient wishes to transfer all of her care from \n___ to ___.\n\n#Anemia: Patient's H/H below baseline, but stable. Likely due to \nchronic malnutrition and dilution after receving fluids. But \nwith history of PUD, GI bleed was kept in the differential. \nHowever, patient continued to have no signs of bleeding and her \nH/H remained stable.\n\n#Anxiety/Depression: There may be a psychiatric component to the \npatient's pain. We continued her home celexa, doxepin, seroquel, \nclonazepam.\n\nInactive Issues: \n#PUD: Continued PPI, carafate\n\n#History of DM: Non-insulin dependent. Resolved after bypass \nsurgery.\n\n#HTN: Diet controlled\n\nTransitional Issues:\n1. Code status: FULL\n2. Contact: Patient's sister ___ (___) ___. Mom ___ \n___  \n3. ___ changes:\n-START Dilaudid as needed for pain\n-START Zofran as needed for nausea\n-START docusate and senna for constipation\n4. Pending Studies: None\n5. Follow up: PCP, ERCP\n\n \nMedications on Admission:\nPreadmission medications listed are correct and complete.  \nInformation was obtained from Patient.\n1. Omeprazole 20 mg PO BID \n2. Clonazepam 2 mg PO TID \n3. TraMADOL (Ultram) 100 mg PO Q6H \n4. FoLIC Acid 1 mg PO DAILY \n5. Vitamin D 400 UNIT PO DAILY \n6. Ascorbic Acid ___ mg PO BID \n7. Sucralfate 1 gm PO QID \n8. Citalopram 40 mg PO DAILY \n9. Quetiapine Fumarate 400 mg PO QHS \n10. Doxepin HCl 75 mg PO HS \n\n \nDischarge Medications:\n1. Citalopram 40 mg PO DAILY \n2. Clonazepam 2 mg PO TID \n3. Doxepin HCl 75 mg PO HS \nRX *doxepin 75 mg 1 capsule(s) by mouth daily Disp #*30 Capsule \nRefills:*0\n4. Quetiapine Fumarate 400 mg PO QHS \nRX *quetiapine 400 mg 1 tablet(s) by mouth daily Disp #*30 \nTablet Refills:*0\n5. Sucralfate 1 gm PO QID \n6. Ascorbic Acid ___ mg PO BID \n7. FoLIC Acid 1 mg PO DAILY \n8. Vitamin D 400 UNIT PO DAILY \n9. Ondansetron 4 mg PO Q8H:PRN nausea \nRX *ondansetron HCl 4 mg 1 tablet(s) by mouth every eight (8) \nhours Disp #*30 Tablet Refills:*0\n10. Docusate Sodium 100 mg PO BID \nRX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day \nDisp #*20 Capsule Refills:*0\n11. Senna 1 TAB PO BID:PRN constipation \nRX *sennosides [senna] 8.6 mg 1 by mouth twice a day Disp #*20 \nTablet Refills:*0\n12. HYDROmorphone (Dilaudid) 4 mg PO Q6H:PRN pain \nhold for sedation, rr<12 \nRX *hydromorphone [Dilaudid] 4 mg 1 tablet(s) by mouth every six \n(6) hours Disp #*30 Tablet Refills:*0\n13. Omeprazole 20 mg PO BID \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary:\nAcute on Chronic abdominal pain\n\nSecondary:\nDepression\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure taking care of you at ___. You were admitted \nbecause of severe abdominal pain, nausea, and vomiting. We \ncontrolled your pain with IV pain medication and transitioned \nyou to oral medicines once you were able to eat. We took an MRI \nof your abdomen which showed dilation of your pancreatic and \nbile ducts. Based on your outside records, it seems as if these \nfindings were present for at least ___ year, but never fully \nevaluated. You will follow up with the gastroenterology \nspecialists for further workup.\n\nPlease make the following changes to your medications:\nSTART Dilaudid as needed for pain\nSTART Zofran as needed for nausea\nSTART docusate and senna for constipation\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb684"
  },
  "note_id": "12648465-DS-14",
  "subject_id": 12648465,
  "hadm_id": 22744960,
  "note_type": "DS",
  "note_seq": 14,
  "charttime": "2204-06-25 00:00:00",
  "storetime": "2204-06-28 20:31:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine\n \nAttending: ___.\n \nChief Complaint:\n Abdominal Pain\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nThis is a ___ with history of multiple abdominal surgeries, \nPUD, DM who presents with abdominal pain. Patient reports that \nsince her last discharge she has had a throbbing pain in her \nabdomen which she states she \"knows is from her stomach.\" States \nthat pain was tolerable while on dilaudid at home. She notes \nthat her pain began getting uncomfortable while she ran out of \ndilaudid. Of note, per PCP note, patient ran out earlier than \nexpected. She reports taking tylenol and tramadol for pain and \nwhile pain was initially tolerable, it became increasingly more \nintense. \n\nOn the ___ prior to admission, patient states pain became \nmore intense. She denies any inciting event. Denies fevers, \nnasuea, vomiting, diarrhea, or changes in bowel habits. Recently \ntravelled to ___ and ___ ___ weeks ago. No sick \ncontacts. No exotic food exposures. Pain continued and became \n\"uncontrollable\" so she presented to the ED for evaluation.\n\nShe describes the pain has constant left mid abdominal pain with \nintermittent episodes of sharp stabbing pain that is non \nradiating. Reports having \"hunger pains\" that are different than \nthis. Her \"hunger pains\" are relieved by food but does not \neffect the other abdominal pain. Last BM was yesterday and was \nnormal.\n\nIn the ED, initial vitals: 10 98.4 100 120/96 18 100%ra. \nEvaluation was significant for Hct of 43.0 but otherwise \nunremarkable labs. Patient received dilaudid 1mg IV x 3. GI was \nconsulted given history of abnormal MRCP who recommended \npossible advanced endoscopy if clinically indicated. Patient was \nthen admitted for further management of pain control. VS prior \nto transfer: 71 127/92 13 100%RA.\n\nCurrently, patient writhing in pain in bed, stating that she \n\"wants to figure out what is going.\" She is easily distracted by \nher pain however. \n  \nROS: per HPI, denies fever, chills, night sweats, headache, \nvision changes, rhinorrhea, congestion, sore throat, cough, \nshortness of breath, chest pain, constipation, BRBPR, melena, \nhematochezia, dysuria, hematuria.  \n \nPast Medical History:\n-hypertension \n-asthma \n-peptic ulcer disease \n-DJD \n-non-insulin dependent diabetes mellitus \n-gastric bypass \n-cholecystectomy\n\nPSurgHx:\n-___- gastric bypass.\n-7 surgeries on the abdomen. \"stomach leak\" hernia, 2 SBOs,\nreverse of the gastric bypass, the most recent surgery was in\n___\n.\n \nSocial History:\n___\nFamily History:\n-Mother: insulin dependent DM, DJD, htn- ___\n-Father: healthy - ___\n-Uncle/Cousin/ Aunt: colon ca, breast ca\n-MGM: seizures-___ deceased\n-MGF: heart ___ deceased\n-PGM: ?edema - elderly deceased\n-PGF: deceased in war\n-Siblings: healthy\n-Children: dtr has DM, she is ___, she was dx at age ___ with T1DM\nbut she is obese.\n \nPhysical Exam:\nAdmission Labs:\nVS: 97.6 152/92 79 18 100 RA\nGENERAL - uncomfortable, teary eyed  \nHEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear  \nNECK - supple, no thyromegaly, no JVD\nHEART - PMI non-displaced, RRR, nl S1-S2, no MRG\nLUNGS - CTAB, no r/rh/wh, good air movement, resp unlabored, no \naccessory muscle use  \nABDOMEN - soft, multiple abdominal scars present, +BS, no HSM, \nTTP in mid abdomen.  \nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs) \n \nSKIN - no rashes or lesions\nNEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength \n___ throughout, sensation grossly intact throughout, DTRs 2+ and \nsymmetric, cerebellar exam intact, steady gait  \n\nDischarge Labs:\nVS: 98.1 100/65 72 16 100%RA \nGENERAL - teary eyed  \nABDOMEN - soft, multiple abdominal scars present, +BS, no HSM \nmild tenderness\n \nPertinent Results:\nAdmission Labs:\n___ 09:20AM BLOOD WBC-4.2 RBC-4.08*# Hgb-13.2# Hct-43.0# \nMCV-105* MCH-32.3* MCHC-30.7* RDW-15.9* Plt ___\n___ 09:20AM BLOOD Neuts-70.3* ___ Monos-4.7 Eos-0.5 \nBaso-0.7\n___ 09:20AM BLOOD Glucose-89 UreaN-9 Creat-0.8 Na-135 K-3.7 \nCl-100 HCO3-24 AnGap-15\n___ 09:20AM BLOOD ALT-12 AST-12 AlkPhos-84 TotBili-0.3\n___ 09:20AM BLOOD Albumin-3.3*\n\nDischarge Labs\n___ 06:25AM BLOOD WBC-4.3 RBC-3.17* Hgb-10.3* Hct-32.4* \nMCV-102* MCH-32.4* MCHC-31.7 RDW-15.7* Plt ___\n___ 12:57PM BLOOD Lactate-1.3\n\nOther Notable Labs\n___ 09:20AM BLOOD ASA-NEG Acetmnp-5* Bnzodzp-NEG \nBarbitr-NEG Tricycl-NEG\n___ 08:34PM URINE bnzodzp-POS barbitr-NEG opiates-POS \ncocaine-NEG amphetm-NEG mthdone-POS\n\nMicro:\n\n___:20 am SEROLOGY/BLOOD      CHEM S# ___. \n\n                            **FINAL REPORT ___\n\n   HELICOBACTER PYLORI ANTIBODY TEST (Final ___: \n      EQUIVOCAL BY EIA. \n           (Reference Range-Negative). \n\n___ KUB:\n Nonobstructive bowel gas pattern.\n.\n \nBrief Hospital Course:\nHOSPITALIZATION COURSE:\n___ with history of multiple abdominal surgeries, PUD, DM who \npresented with abdominal pain of unclear etiology.\n  \nACTIVE ISSUES:\n- Abdominal Pain: Patient presented with similar abdominal pain \nas she had in prior admissions. During this admission, she was \nable to tolerate PO intake without any difficulty. Her bowel \nmovements did not show any blood and there was no reported \nemesis. Labs did not show any frank abnormalities to point to an \netiology. \nGiven history of PUD, h.pylori was sent and was equivocal. \nDecision was made not to treat. Attempts were made to obtain \nprior ___ records however they were not sent. During last \nadmission, patient had CT/MRCP which showed dilatation main \npancreatic duct and biliary tree to the ampulla without \nunderlying mass identified. She was to have an ERCP as an \noutpatient however failed to schedule an appointment. ERCP was \ncontacted however they deferred procedure to outpatient. Upon \nreceiving narcotics, patient would frequently be found \nsomnolent. Additionally, urine tox screen was positive for \nmethadone. Upon discussion with patient, she denied use. \nAttempts to try alternative therapy was met with resistance. \nLastly, patient's daughter was very concerned that patient was \ndisplaying drug seeking behavior. Daughter provided multiple \nletters from prior providers (at ___ who terminated patient \nbecause such behavior (see scanned record for copies of \nletters). Given this evidence, it was decided to pursue \nalternative measures for pain control. Narcotics were \ndiscontinued. A joint meeting with outpatient provider (Dr. \n___ was held with patient during time it was made clear \nthat no further narcotics were to going to be prescribed. USE OF \nNARCOTICS SHOULD BE USED WITH EXTREME CAUTION GIVEN THIS \nBEHAVIOR. Patient was discharged with dicyclomine, tramadol and \nsimethicone. She was also asked to make an appointment with a \npsychiatrist as it was felt that depression was playing a large \nrole with her chronic pain. \n\n# Anxiety/Psychiatric Issues: Patient provided a list of \nmedications. However upon discussion with daughter, it was made \nevident that patient also had history of abuse with \nbenzodiazepines. Pharmacy was contacted and provided collateral \ninformation on some medications but not all. After discussion \nwith PCP (Dr. ___, decision was made to discharge patient \nwith doxepin and seroquel. Clonazepam prescription was given as \na taper as PCP was not going to refill medication. \n\nTRANSITIONAL ISSUES:\n[ ] Would avoid narcotics for pain control\n[ ] Patient needs close psychiatry follow up.\n[ ] Patient needs follow up with ERCP to investigate pancreatic \nduct dilatation\n[ ] Patient needs further work-up for anemia.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Citalopram 40 mg PO DAILY \n2. Clonazepam 2 mg PO TID \nhold for sedation or rr < 10 \n3. Doxepin HCl 75 mg PO HS \n4. Quetiapine Fumarate 300 mg PO QAM \n5. Quetiapine Fumarate 400 mg PO HS \n6. Sucralfate 1 gm PO QID \n7. Ascorbic Acid ___ mg PO BID \n8. FoLIC Acid 1 mg PO DAILY \n9. Vitamin D 400 UNIT PO DAILY \n10. Ondansetron 4 mg PO Q8H:PRN nausea \n11. Docusate Sodium 100 mg PO BID \n12. Senna 1 TAB PO BID \n13. Omeprazole 20 mg PO BID \n14. TraMADOL (Ultram) 75 mg PO Frequency is Unknown \n\n \nDischarge Medications:\n1. Ascorbic Acid ___ mg PO BID \n2. Docusate Sodium 100 mg PO BID \n3. Doxepin HCl 75 mg PO HS \n4. Clonazepam 2 mg PO TID \nhold for sedation or rr < 10 \nRX *clonazepam 2 mg 1 tablet(s) by mouth tapered Disp #*7 Tablet \nRefills:*0\n5. FoLIC Acid 1 mg PO DAILY \n6. Omeprazole 20 mg PO BID \n7. Ondansetron 4 mg PO Q8H:PRN nausea \n8. TraMADOL (Ultram) 75 mg PO Q4H:PRN pain \nRX *tramadol 50 mg 1.5 tablet(s) by mouth every four (4) hours \nDisp #*30 Tablet Refills:*0\n9. Vitamin D 400 UNIT PO DAILY \n10. Sucralfate 1 gm PO QID \n11. Senna 1 TAB PO BID \n12. Quetiapine Fumarate 200 mg PO HS \nRX *quetiapine 200 mg 1 tablet(s) by mouth hs Disp #*7 Tablet \nRefills:*0\n13. Quetiapine Fumarate 100 mg PO QAM \nRX *quetiapine 100 mg 1 tablet(s) by mouth qam Disp #*1 Tablet \nRefills:*0\n14. DiCYCLOmine 20 mg PO QID \nRX *dicyclomine 20 mg 1 tablet by mouth four times a day Disp \n#*40 Tablet Refills:*0\n15. Gabapentin 100 mg PO Q8H \nRX *gabapentin 100 mg 1 capsule(s) by mouth three times a day \nDisp #*21 Capsule Refills:*0\n16. Simethicone 40-80 mg PO QID:PRN gas pain \nRX *simethicone 80 mg 1 tablet by mouth four times a day Disp \n#*20 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAbdominal Pain\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were seen in the hospital because you were having abdominal \npain. Your work-up did not show any acute process going on. We \nare concerned that you have a functional bowel issue that does \nnot requires of the use of narcotics. As such we are giving you \nmedications that will help with intestinal spasms. We had a \ndiscussion with your primary care physician who agrees with \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb685"
  },
  "note_id": "12648465-DS-15",
  "subject_id": 12648465,
  "hadm_id": 27774553,
  "note_type": "DS",
  "note_seq": 15,
  "charttime": "2205-02-18 00:00:00",
  "storetime": "2205-02-18 19:24:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug)\n \nAttending: ___.\n \nChief Complaint:\nabdominal pain \n \nMajor Surgical or Invasive Procedure:\nPICC line placement ___\nPICC line removal ___\nDobhoff placement ___\n\n \nHistory of Present Illness:\n___ with history of opioid abuse, morbid obesity s/p gastric \nbypass ___, multiple SBOs, and recent admission to ___ \nfor esophagitis, who presents with worsening abdominal pain and \ninability to tolerate po's.  \nShe notes that her abdominal pain began ___ year ago and \nprogressively worsened. Today, she describes burning ___ \nepigastric pain that radiates upward and is worse with po \nintake. This pain has been present intermittently and in the \npast 5 days intensely worsened. She has eaten one meal in the \npast 7 days. She reports lightheadedness, especially on \nstanding, which has led to a few falls (no head strikes). She \ndenies nausea, vomiting, fever, chills. No blood in her stool, \nbut she has not had a BM for 4 days. Urine is dark yellow. Also \nhas 7lb weight loss in 6 months.  \n. \nIn the ED, initial vital signs were 97.3 72 140/84 16 100%. \nInitial labs with WBC 8.6, PMN 83.5, HCT 34.7, ALT:51 AP: 115 \nTbili: 1.3 Alb: 2.0 AST: 23 Lip: 5. CHEM 7 unremarkable. She had \nCXR and EKG which were unremarkable. She was started on IVF.  \nOn arrival to the floor, initial vitals were 98.5 106/67 93 18 \n98%RA.  \n \nReview of Systems:  \n(+)  \n(-) fever, chills, night sweats, headache, vision changes, \nrhinorrhea, congestion, sore throat, cough, shortness of breath, \nnausea, vomiting, diarrhea, constipation, BRBPR, melena, \nhematochezia, dysuria, hematuria.  \n\n \nPast Medical History:\n-Morbid obesity (max 448lbs) s/p gastric bypass & CCY at \n___  and complete reversal\n-History of HTN, DM, asthma (prior to gastric bypass)  \n-Opiate addiction: prior intranasal herion, oral dilaudid abuse, \nnow on suboxone  \n-Depression/Anxiety  \n-Esophagitis: EGD ___ showed mild active esophagitis.  \n-DJD  \n-2 SBOs  \n-Menopause completed  \n\nPast Surgical History:  \n-___- gastric bypass & CCY  and subsequent complete \nreversal\n-7 surgeries on the abdomen. \"stomach leak\" hernia, 2 SBOs, \nattempted reverse of the gastric bypass, the most recent in ___ \n \n\n \nSocial History:\n___\nFamily History:\n-Mother: insulin dependent DM, DJD, htn- ___\n-Father: healthy - ___\n-Uncle/Cousin/ Aunt: colon ca, breast ca\n-MGM: seizures-___ deceased\n-MGF: heart ___ deceased\n-PGM: ?edema - elderly deceased\n-PGF: deceased in war\n-Siblings: healthy\n-Children: dtr has DM, she is ___, she was dx at age ___ with T1DM \nbut she is obese.\n \nPhysical Exam:\nAdmission Physical Exam:  \nVitals- 98.5 106/67 93 18 98%RA.  \nGeneral: Cachectic female, alert, oriented x3, NAD  \nHEENT: EOMI, PERRL, oropharynx pink and moist  \nNeck: EJ in place on left. No LAD  \nCV: RRR, no m/r/g  \nLungs: CTAB  \nAbdomen: Scaphoid, redundant skin folds, soft, + epigastric \ntenderness, no rebound or guarding  \nGU: no foley  \nExt: 2+ edema of lower extremities to knees. Warm, well perfused \n \n\nDischarge Physical Exam: \nVitals: 98.5 97.5 ___ 86-118 ___ 100RA\ni/o: 2700/700\nweight: 59.9kg\nGen: cachectic female, alert, oriented x3, NAD, dobhoff tube in \nplace and bridaled\nHEENT: Large 4cm hematoma at posterior occiput.  Tenderness to \nmid posterior neck, EOMI, PERRL, MMM, dry lips\nNeck:  No LAD\nCV:  RRR, no m/r/g\nLungs: CTAB\nAbdomen: Scaphoid, redundant skin folds, soft, + epigastric and \nperiumbilical tenderness, no rebound or guarding\nGU: no foley\nExt: 1+ edema of lower extremities to sacrum.  Warm, well \nperfused\nNeuro: CN ___ and strength grossly intact.\n\n \nPertinent Results:\nAdmission labs:\n___ 03:02PM BLOOD WBC-8.6 RBC-3.31* Hgb-11.2* Hct-34.7* \nMCV-105* MCH-33.7* MCHC-32.1 RDW-16.3* Plt ___\n___ 03:02PM BLOOD Neuts-83.5* Lymphs-12.5* Monos-3.1 \nEos-0.1 Baso-0.9\n___ 07:30AM BLOOD ___ PTT-32.8 ___\n___ 03:02PM BLOOD Glucose-91 UreaN-15 Creat-0.8 Na-139 \nK-4.1 Cl-104 HCO3-28 AnGap-11\n___ 03:02PM BLOOD ALT-51* AST-23 AlkPhos-115* TotBili-1.3\n___ 03:02PM BLOOD Lipase-5\n___ 07:30AM BLOOD Calcium-6.9* Phos-2.5* Mg-1.6\n\nPertinent labs and discharge labs:\n___ 06:12AM BLOOD WBC-4.9 RBC-2.54* Hgb-8.8* Hct-27.3* \nMCV-108* MCH-34.7* MCHC-32.2 RDW-17.4* Plt ___\n___ 06:12AM BLOOD Glucose-82 UreaN-9 Creat-0.4 Na-139 K-4.4 \nCl-112* HCO3-25 AnGap-6*\n___ 06:12AM BLOOD Calcium-7.0* Phos-2.6* ___ \n05:20AM BLOOD calTIBC-57* VitB12-500 ___ Ferritn-89 \nTRF-44*\n___ 05:20AM BLOOD PTH-78*\n___ 12:07PM BLOOD HIV Ab-Negative\n___ 03:02PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nBnzodzp-NEG Barbitr-NEG Tricycl-NEG\n\nPertinent imaging:\nEGD ___- \nEsophagus- Mucosa: Diffuse yellowish plaques most likely \ncompatible with candidiasis were seen in the whole esophagus. \nCold forceps biopsies were performed for histology at the lower \nthird of the esophagus and middle third of the esophagus.  \nExcavated Lesions A few small longitudinal ulcerations were \nfound in the gastroesophageal junction and the cardia.  \nStomach:  \n Lumen: Evidence of a previous gastric bypass with \ngastro-jejunal anastomosis was seen. The gastro-jejuno \nanastomosis was normal and widely patent. No discrete ulcer was \nnoted at this level.  \n Other A small well-organized openning compatible with a gastric \nfistula was noted in the proximal portion of the remanent of the \ngastric pouch, most likely in communication with the excluded \nstomach because large amount of bile was noted in the gastric \npouch.   \nJejunum: Normal mucosa at the efferent limb until 70 cm from \nincisors. \n    Impression: Previous gastric bypass with gastro-jejunal \nanastomosis of the stomach Esophageal candidiasis (biopsy) \nA few small longitudinal ulcerations were found in the \ngastroesophageal junction and the cardia.  small well-organized \nopenning compatible with a gastric fistula was noted in the \nproximal portion of the remanent of the gastric pouch, most \nlikely in communication with the excluded stomach because large \namount of bile was noted in the gastric pouch. \nOtherwise normal EGD to jejunum (efferent limb)\n\nCT head/spine: ___\n1.  There is no acute fracture or alignment abnormality. \n2.  Heterogeneous attenuation of the thyroid gland.  Correlate \nwith prior \nthyroid imaging if available.  If not, further assessment could \nbe performed by thyroid ultrasound on a non-emergent basis. \nFinal attending Comment: a left pleural effusion is also noted. \n\nCXR ___:  \n___ tube has been advanced and is now curled in the \nstomach.  Right-sided PICC line ends in lower SVC.  Small \noverlaying left pleural effusion is unchanged since yesterday, \nmay be slightly worse than ___ and new since ___.  There is no pneumothorax.  The lungs are otherwise clear. \n Mediastinal and cardiac contours are normal.\n\n \nBrief Hospital Course:\n___ with history of opioid abuse, morbid obesity s/p gastric \nbypass  ___, multiple SBOs, and recent admission to ___ \nfor esophagitis, who presents with worsening abdominal pain and \ninability to tolerate po's and was found to have candidal \nesophagitis.  Dobhoff placed for tube feeding.  Course \ncomplicated by mechanical fall.\n\nACUTE ISSUES:\n=============\n\n# Abdominal Pain / Odynophagia / ___: Despite \nchronic abdominal pain, current presentation was primarily for \nodynophagia. Patient had an EGD three months prior which showed \nsevere esophagitis (neg hpylori). She had repeat EGD performed \non ___ which showed severe candidal esophagitis. Biopsies were \ntaken and patient was started on empiric fluconazole with plan \nfor 3 week course (ending ___. Symptoms controlled \nwith zofran prn, carafate slurries QID, omeprazole BID and \ncholestyramine.  Her malnutrition is likely the risk factor for \n___ esophagitis.  HIV Ab was NEGATIVE.   \n\n# Malnutrition: Patient was severely malnourished on \npresentation due to inability to tolerate po's. We had long \ndiscussions with the bariatric team at ___ as well as the \npatient's prior bariatric surgeon (Dr. ___.  Given \nacute cause for decreased po intake (candidal esophagitis), we \nopted to place ___ and start tube feeds. Patient will \ncontinue treatment for esophagitis and if able to improve po \nintake, may have dobhoff removed in the future. If not, will \nneed to consider converting to gastric or jejunal tube.  If G- \nor J-tube needed, in theory, she can have a feeding tube placed \nby endoscopy, as per d/w her prior bariatric surgeon and the \ninpt Bariatric Surgery consult team at ___, her prior gastric \nbypass has been COMPLETELY REVERSED.  Bariatric Surgery \nrecommends that if GI were to defer placement due to history of \ngastric bypass, pt should be referred back to her prior \nBariatric Surgeon at ___ for placement of feeding tube.  \nHowever, after d/w her prior bariatric surgeon, who is now at \n___ / ___, the pt has been terminated from his \npractice and he no longer follows her.  As such, she would need \nto f/u with ___ Bariatric Surgery for any issues related to her \nprior gastric bypass.    \n\n# S/P mechanical fall: She fell the night of ___ after getting \nup to the bathroom unassisted.  No loss of consciousness or \nneurologic deficits.  CT imaging of head and neck were negative \nfor spinal compromise.  Pain control with tylenol and toradol.  \nShe continued suboxone.  No opiods were given.  \n\n# Small left pleural effusion: incidental finding on CT c-spine. \n CXR done which showed very small effusion.  Etiology most \nlikely related to hypoalbuminemia. There was no hypoxia, fever, \nor dyspnea.  There was no chest pain.  \n\nCHRONIC ISSUES:\n===============\n\n# Opioid dependence: history of dilaudid and  heroin use.  Now \non suboxone. Continue on home Buprenorphine-Naloxone (8mg-2mg) 1 \nTAB SL TID \n\n# Lower extremity edema: due to poor po intake and \nhypoalbuminemia.  \n  \n# Macrocytic Anemia: stable throughout admission.\n\n# Elevated ___: improved with po vitamin K to 1.0 at time of \ndischarge. \n\n# DJD: stable, continued vitamin D\n\n# Depression/anxiety: stable, she continued home quetiapine, \ndoxepin.  Current clonazepam dosing is 1mg po BID.\n \nTRANSITIONAL ISSUES:\n- Contact person: ___ (Mother) ___\n- Full Code\n- Tube feeds to be titrated to goal\n- complete course of fluconazole for ___ esophagitis\n- non-emergent thyroid ultrasound to f/u incidental thyroid \nabnormalities on CT C-spine \n- consider repeat CXR or chest imaging to eval for resolution of \nleft pleural effusion if she develops any respiratory or \nconcerning symptoms\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Docusate Sodium 100 mg PO BID:PRN constipation \n2. Doxepin HCl 75 mg PO HS \n3. Clonazepam 2 mg PO TID \nhold for sedation or rr < 10 \n4. Omeprazole 20 mg PO BID \n5. Ondansetron 4 mg PO Q8H:PRN nausea \n6. Vitamin D ___ UNIT PO DAILY \n7. Quetiapine Fumarate 400 mg PO HS \n8. Quetiapine Fumarate 200 mg PO QAM \n9. Buprenorphine-Naloxone (8mg-2mg) 1 TAB SL TID \n\n \nDischarge Medications:\n1. Buprenorphine-Naloxone (8mg-2mg) 1 TAB SL TID \n2. Docusate Sodium 100 mg PO BID:PRN constipation \n3. Doxepin HCl 75 mg PO HS \n4. Omeprazole 20 mg PO BID \n5. Ondansetron 4 mg PO Q8H:PRN nausea \n6. QUEtiapine Fumarate 400 mg PO HS \n7. QUEtiapine Fumarate 200 mg PO QAM \n8. Vitamin D ___ UNIT PO DAILY \n9. Acetaminophen 650 mg PO Q8H:PRN pain \n10. Cholestyramine 4 gm PO BID \n11. Fluconazole 200 mg PO Q24H Duration: 3 Weeks \nending ___ \n12. Polyethylene Glycol 17 g PO TID \n13. Sucralfate 1 gm PO QID \n14. ClonazePAM 1 mg PO BID  \n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nSevere candidal esophagitis\nMalnutrition\nMechanical fall with head strike\nSmall left pleural effusion\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___, \n\nIt was a pleasure taking care of you while you were admitted to \n___.  You were admitted with severe abdominal pain and \ninability to tolerate oral intake.  We have started you on 2 \nmedications: cholestyramine and sucralfate which have improved \nyour symptoms.\n\nAn endoscopy was performed which showed severe inflammation of \nyour esophagus due to ___ (a fungus).  You were started on \nfluconazole, a medications to treat this.  You will need to \ncontinue on fluconazole through ___. \n\nA nasojejunal tube was placed so that you can start tube feeds \nwhile your esophagus heals. If you are able to gain weight and \nstart eating by mouth, this may be removed in the future.  If \nnot, you will need to meet with your bariatric surgeons at \n___ regarding a g-tube placement.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb686"
  },
  "note_id": "12648465-DS-16",
  "subject_id": 12648465,
  "hadm_id": 27567509,
  "note_type": "DS",
  "note_seq": 16,
  "charttime": "2205-02-24 00:00:00",
  "storetime": "2205-02-24 11:28:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug)\n \nAttending: ___.\n \nChief Complaint:\nleg pain\n \nMajor Surgical or Invasive Procedure:\nPICC placement and removal\n \nHistory of Present Illness:\nThe patient is a ___ year old female with a history of \nmalnutrition, esophagitis who is a patient at ___ presents \nwith left leg pain and swelling. She was found DVT on exam. She \nwas sent to ED for further management. Pt denies chest pain, \ndyspnea. No history of DVT/PE. No family history of clotting \ndisorders, confirmed w/ patients mother and sister. \n\nIn the ED, initial vitals were: 97.9 86 102/70 16 100%RA. ED \nnoted that recent EGD showed esophageal candidiasis with a few \nsmall longitudinal ulcerations were found in the \ngastroesophageal junction and the cardia so concern about \nstarting anticoagulation. Vascular surgery was consulted for \nconsideration of IVC filter, recommendation was for systemic \nanticoagulation. A PICC line was placed due to difficulty \nobtaining access. \n\n \nPast Medical History:\n-Morbid obesity (max 448lbs) s/p gastric bypass & CCY at \n___  and complete reversal\n-History of HTN, DM, asthma (prior to gastric bypass)  \n-Opiate addiction: prior intranasal herion, oral dilaudid abuse, \nnow on suboxone  \n-Depression/Anxiety  \n-Esophagitis: EGD ___ showed mild active esophagitis.  \n-DJD  \n-2 SBOs  \n-Menopause completed  \n\nPast Surgical History:  \n-___- gastric bypass & CCY  and subsequent complete \nreversal\n-7 surgeries on the abdomen. \"stomach leak\" hernia, 2 SBOs, \nattempted reverse of the gastric bypass, the most recent in ___ \n \n\n \nSocial History:\n___\nFamily History:\n-Mother: insulin dependent DM, DJD, htn- ___\n-Father: healthy - ___\n-Uncle/Cousin/ Aunt: colon ca, breast ca\n-MGM: seizures-___ deceased\n-MGF: heart ___ deceased\n-PGM: ?edema - elderly deceased\n-PGF: deceased in war\n-Siblings: healthy\n-Children: dtr has DM, she is ___, she was dx at age ___ with T1DM \nbut she is obese.\n \nPhysical Exam:\nVitals: T:97.9  BP:119/89 P:90  R:18   O2:100RA  \nGeneral:  awake, NAD, chronically ill appearing\nHEENT:  moist mucus membranes, dophoff in place\nNeck:  no cervical LAD appreciated\nCV:  S1, S2 regular rhythm, normal rate\nLungs: CTA bilaterally, unlabored respirations\nAbdomen: soft, mild TTP epigastric, no rebound, no guarding\nGU: no foley\nExt: bilateral 1+ lower extremity edema, pulses intact, some \nswelling in left upper extremity, picc line RUE c/d/i \nNeuro: alert, oriented to self, hospital, year, speech fluent, \ntongue midline, move extremities antigravity\n\n \nPertinent Results:\n___ 04:27AM BLOOD WBC-5.0 RBC-2.39* Hgb-8.4* Hct-25.7* \nMCV-108* MCH-35.2* MCHC-32.7 RDW-17.7* Plt ___\n___ 04:27AM BLOOD Plt ___\n___ 04:27AM BLOOD Glucose-93 UreaN-10 Creat-0.4 Na-141 \nK-4.8 Cl-113* HCO3-28 AnGap-5*\n___ 04:27AM BLOOD Calcium-6.9* Phos-2.4* Mg-1.9\n\nTTE ___\nThe left atrium is normal in size. Overall left ventricular \nsystolic function is low normal (LVEF 50-55%) with suggested \nrelative hypokinesis of the basal to mid anteroseptal wall. The \nestimated cardiac index is normal (>=2.5L/min/m2). Tissue \nDoppler imaging suggests a normal left ventricular filling \npressure (PCWP<12mmHg). Right ventricular chamber size and free \nwall motion are normal. The aortic valve leaflets are mildly \nthickened (?#). There is no aortic valve stenosis. No aortic \nregurgitation is seen. The mitral valve appears structurally \nnormal with trivial mitral regurgitation. There is no mitral \nvalve prolapse. ricuspid valve prolapse is present. There may be \nmild tricuspid valve prolapse. The estimated pulmonary artery \nsystolic pressure is normal. There is a trivial/physiologic \npericardial effusion. \nIMPRESSION: Suboptimal image quality. Low-normal global left \nventricular systolic function with relative hypokinesis of the \nbasal to mid anteroseptum (atypical regional dysfunction for \nCAD).  \n\nLower extremity dopplers ___\nIMPRESSION:\nDVT of bilateral popliteal as well as posterior tibial veins.  \nThese findings were communicated at 9:15 a.m. on ___ \nby the technologist to Dr. ___ phone immediately at the \ntime of discovery. \n  \n___\nPICC Placement xray\n \nPreliminary ReportIMPRESSION: Technically successful placement \nof a double-lumen PowerPICC via \nPreliminary Reportthe right brachial vein, the tip is in the \ndistal SVC and the catheter is \nPreliminary Reportready for use. \n\n___\nIMPRESSION: \nPartially occlusive thrombus in the mid left brachial vein.   \n  \nCT Torso ___\nIMPRESSION: \n1.  No evidence of an intra-abdominal or pelvic mass.  \n2.  Consolidative opacity within the right lower lobe, possibly \ninfectious or inflammatory in nature, although given this \npatient's history of lower extremity DVT, infarction secondary \nto a pulmonary embolus cannot be excluded.  linical correlation \nis recommended.   \n3.  New small non hemorrhagic left pleural effusion, small \nvolume ascites, and anasarca.   \n4.  Moderate intrahepatic biliary duct dilatation and mild \ndilatation of the common duct, without evidence of an \nintraductal stone or ___ mass, not significantly \nchanged.   \n5.  Scattered subcentimeter hepatic hypodensities, too small to \ncharacterize, but not significantly changed.  \n  \n  \nDISCHARGE LABS\n\n___ 03:13AM BLOOD WBC-5.7 RBC-2.54* Hgb-9.0* Hct-27.5* \nMCV-108* MCH-35.3* MCHC-32.7 RDW-17.7* Plt ___\n___ 03:13AM BLOOD ___ PTT-61.1* ___\n___ 03:13AM BLOOD Glucose-104* UreaN-11 Creat-0.4 Na-138 \nK-4.4 Cl-106 HCO3-27 AnGap-9\n___ 03:13AM BLOOD Calcium-7.1* Phos-2.8 Mg-1.6\n\n___ 06:00AM BLOOD WBC-6.7 RBC-2.54* Hgb-9.3* Hct-27.2* \nMCV-107* MCH-36.5* MCHC-34.1 RDW-18.2* Plt ___\n___ 06:00AM BLOOD ___ PTT-42.9* ___\n___ 06:00AM BLOOD Plt ___\n___ 06:00AM BLOOD Glucose-101* UreaN-13 Creat-0.4 Na-139 \nK-4.5 Cl-106 HCO3-28 AnGap-10\n___ 06:00AM BLOOD ALT-29 AST-23 AlkPhos-115* TotBili-0.2\n \nBrief Hospital Course:\nThe patient is a ___ year old female with a history of \nmalnutrition requiring tube feeding as well as ___ \nesophagitis on fluconazole with leg pain and swelling found to \nhave bilateral DVT.  \n.\n#BILATERAL DVT: Patient with risk factors of immobility, recent \nhospitalization, chronic illness leading to bilateral DVT. PICC \nline placed in ED and started on systemic anticoagulation with \nheparin. Started coumadin 3mg on ___. No evidence of \nbleeding. Continue heparin gtt until INR>2. Please monitor INR \ndaily. Note that fluconazole can inhibit coumadin metabolism and \nraise the INR.\n.\n___ ESOPHAGITIS: History of odynophagia, EGD with biopsy \nconcerning for fungal esophagitis. HIV testing negative. Started \non fluconazole, PPI BID, carafate. Continue fluconzole through \n___. \n.\n#MALNUTRITION: Malnourished in setting of ___ esophagitis. \nDuring previous admission dobhoff placed and tube feeds started. \nPlan to continue treatment for esophagitis and if able to \nimprove po intake, may have dobhoff removed in the future. If \nnot, will need to consider converting to gastric or jejunal \ntube. \n\n#LEFT ARM SWELLING: Ultrasound revealed a partially occlusive \nthrombus in the mid left brachial vein.\n\n#THYROID NODULE: Noted on CT c-spine during previous admission. \nWill need non-emergent thyroid u/s for further evaluation.\n.\nCHRONIC ISSUES: \n# Opioid dependence: continue home dose of suboxone 1 TAB SL \nTID. Patient's daughter and mother concerned for ongoing \nsubstance abuse via hoarding pills and possibly heroin. She will \nrequire directly-observed medication administration. \n# Macrocytic Anemia: stable \n# Depression/anxiety: Continue quetiapine, doxepin, clonazepam. \nThe doses of the seroquel and clonazepam were reduced due to \nexcessive somnolence while hospitalized.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Buprenorphine-Naloxone (8mg-2mg) 1 TAB SL TID \n2. Docusate Sodium 100 mg PO BID:PRN constipation \n3. Doxepin HCl 75 mg PO HS \n4. Omeprazole 20 mg PO BID \n5. QUEtiapine Fumarate 400 mg PO QHS \n6. QUEtiapine Fumarate 200 mg PO QAM \n7. Vitamin D ___ UNIT PO DAILY \n8. Cholestyramine 4 gm PO BID \n9. Fluconazole 200 mg PO Q24H \n10. Polyethylene Glycol 17 g PO DAILY \n11. Sucralfate 1 gm PO QID \n12. ClonazePAM 1 mg PO BID \n\n \nDischarge Medications:\n1. Buprenorphine-Naloxone (8mg-2mg) 1 TAB SL TID \n2. ClonazePAM 0.5 mg PO BID \n3. Docusate Sodium 100 mg PO BID:PRN constipation \n4. Doxepin HCl 75 mg PO HS \n5. Omeprazole 20 mg PO BID \n6. Polyethylene Glycol 17 g PO DAILY \n7. QUEtiapine Fumarate 100 mg PO QAM \n8. QUEtiapine Fumarate 200 mg PO QHS \n9. Vitamin D ___ UNIT PO DAILY \n10. Heparin IV per Weight-Based Dosing Guidelines\n\n11. Warfarin 3 mg PO DAILY16 \n12. Cholestyramine 4 gm PO BID \nPatient may refuse \n13. Fluconazole 200 mg PO Q24H \n14. Sucralfate 1 gm PO QID \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nDeep vein thrombosis, bilateral lower extremities\nMalnutrition\nSubstance abuse\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nYou were admitted with leg swelling. You were diagnosed with \nblood clots (Deep vein thromboses) in your legs. You were \nstarted on blood thinners for this.\n\nYou were quite sleepy at various times during this \nhospitalization. We are decreasing the dose of Clonazepam and \nSeroquel that you are taking.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb687"
  },
  "note_id": "12648465-DS-17",
  "subject_id": 12648465,
  "hadm_id": 28738299,
  "note_type": "DS",
  "note_seq": 17,
  "charttime": "2205-08-13 00:00:00",
  "storetime": "2205-08-18 21:31:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug)\n \nAttending: ___.\n \nChief Complaint:\nFever and chills\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nThis is a ___ year old woman with a complicated past medical \nhistory including a distant gastric bypass surgery with multiple \nsubsequent abdominal surgeries and complications who presents  \nwith worsening fevers.\nRecent admission in ___ w/ stay in rehab until 9 days ago. \nSince then endorses low grade fevers. Abdominal surgeries \ninclude gastric bypass c/b leak requiring resection, SBO, \ncholecystectomy, intra-abdominal abscess, attempted placement of \nG-tube c/b colonic perforation. Has chronic abdominal pain and \nnausea without vomiting as well as esophageal pain. Now also \nendorses extension of her abdominal pain into her chest and \nback. Denies dyspnea, dysuria, changes in bowel habits, \ndiarrhea, blood in stool.\nShe has had low grade fevers for the past month or so. She had \nbeen told she had acute sinus infection at her rehab about ___ \nweeks ago was given a 10 day course of amoxicillin which she \nfinished about 2 weeks ago. Discharged from rehab ___ and \nliving at home (for first time since ___ for the past 7 days. \nShe has had a dry cough over the last 2 days or so. No shortness \nof breath. Yesterday evening had fever to 102.5 with shaking \nchills for which she just took tylenol. No myalgias. She did \nreceive the flu shot this year. This morning she called her PCP \nat ___ who was requested that she go to the ED as she was \nworried about the possibility of an abdominal abscess. She was \nsubsequently brought in by ambulance from ___.\nOn arrival to the ED initial VS were t99.9 hr77 bp106/68 rr18 O2 \n98%/ra. In the ED she complained of mild DOE and chest pain. A \nCT abdomen and pelvis with IV+PO contrast showed a RLL \ninfiltrate and some mild left intra-hepatic dilitation. Labs \nwere notable for a slightly elevated lactate at 2.3, a WBC of \n10.1 from baseline ~5 with a mild left shift, normal creatinine \nand a potassium of 3.1. She was started on ceftriaxone and \nvancomycin. She also received 40meq of K for a K of 3.1 and some \nIVF.\nOn the floor she is complaining of ___ pain mostly in her \nepigastrum, chest, back and abdomen. She states that her \nabdominal and epigastric pain is essentially at her baseline and \nthat she feels it has just now spread somewhat to her chest and \nback. Seems worse with deep inspiration.\nOf note she reports that she thinks she may have aspirated when \nshe swallowed something a few nights ago and choked. She does \nnot believe she has any documented problems with swallowing but \ndoes have a history of esophagitis. She is on a regular diet at \nhome.\n\nReview of Systems:\n(+) as per HPI\n(-) headache, vision changes, rhinorrhea, congestion, sore \nthroat, cough, shortness of breath, vomiting, diarrhea, \nconstipation, BRBPR, melena, hematochezia, dysuria, hematuria, \nrash, numbness, tingling.\n \nPast Medical History:\n-Morbid obesity (max 448lbs) s/p gastric bypass & CCY at \n___  and complete reversal\n-History of HTN, DM, asthma (prior to gastric bypass)  \n-Opiate addiction: prior intranasal herion, oral dilaudid abuse, \nnow on suboxone  \n-Depression/Anxiety  \n-Esophagitis: EGD ___ showed mild active esophagitis.  \n-DJD  \n-2 SBOs  \n-Menopause completed  \n\nPast Surgical History:  \n-___- gastric bypass & CCY  and subsequent complete \nreversal\n-7 surgeries on the abdomen. \"stomach leak\" hernia, 2 SBOs, \nattempted reverse of the gastric bypass, the most recent in ___ \n \n\n \nSocial History:\n___\nFamily History:\n(Per OMR)\n-Mother: insulin dependent DM, DJD, htn- ___\n-Father: healthy - ___\n-Uncle/Cousin/Aunt: colon ca, breast ca\n-MGM: seizures-___ deceased\n-MGF: heart ___ deceased\n-PGM: ?edema - elderly deceased\n-PGF: deceased in war\n-Siblings: healthy\n-Children: dtr has DM\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n-----------\nVitals: 98.0 BP 99/58 HR 67 RR 18 O2 sat 99/ra\nGeneral: somewhat chronically ill-appearing woman in NAD\nHEENT: PERRLA, EOMI, MMM\nNeck: no JVD\nLungs: diminished breath sounds throughout, faint crackles at \nright base, no wheeze\nCV: regular, distant heart sounds, no murmur appreciated\nAbdomen: mid-epigastric and RUQ tenderness without rebound or \nguarding, + bs, surgical scars\nExt: trace edema\nNeuro: CN2-12 intact, strength and sensation intact throughout\n\nDISCHARGE PHYSICAL EXAM:\n------------\nVitals: 97.9 96/59 68 16 100/RA \nGeneral: NAD, Aox3. Asleep. When awakened, demands pain \nmedication.\nHEENT: PERRLA, EOMI, MMM\nNeck: no JVD\nLungs: CTAB.\nCV: regular, distant heart sounds, no murmur appreciated\nAbdomen: mid-epigastric and RUQ tenderness without rebound or \nguarding, + bs, surgical scars\nExt: trace edema\nNeuro: CN2-12 intact, strength and sensation intact throughout\n \nPertinent Results:\nADMISSION LABS:\n-----------\n\n___ 04:37PM BLOOD WBC-10.1# RBC-3.57* Hgb-10.9* Hct-35.3* \nMCV-99* MCH-30.4 MCHC-30.7* RDW-14.1 Plt ___\n___ 04:37PM BLOOD Neuts-81.0* Lymphs-15.0* Monos-3.0 \nEos-0.6 Baso-0.4\n___ 04:37PM BLOOD ___ PTT-33.4 ___\n___ 04:37PM BLOOD Glucose-97 UreaN-14 Creat-0.8 Na-138 \nK-3.1* Cl-96 HCO3-32 AnGap-13\n___ 04:37PM BLOOD ALT-12 AST-21 AlkPhos-85 TotBili-0.1\n___ 04:37PM BLOOD Albumin-3.5\n\nDISCHARGE LABS:\n----------\n\n___ 07:46AM BLOOD WBC-6.0 RBC-3.07* Hgb-9.2* Hct-30.5* \nMCV-99* MCH-30.1 MCHC-30.3* RDW-14.3 Plt ___\n___ 07:46AM BLOOD Neuts-70.7* ___ Monos-3.6 Eos-1.9 \nBaso-0.5\n___ 07:46AM BLOOD Glucose-77 UreaN-12 Creat-0.7 Na-141 \nK-3.8 Cl-104 HCO3-30 AnGap-11\n\nIMAGING:\n----------\nCTAP ___\nFINDINGS:\n \n___ opacities are seen at the right lower lobe, partly \nimaged,\nindicative of a small airways infectious or inflammatory \nprocess.  The\nvisualized heart and pericardium are unremarkable.  \n \nA small hypodensity in the right lobe of the liver is stable \ncompared to prior\nand may represent a simple cyst.  There is mild intrahepatic \nbiliary ductal\ndilatation of the the left lobe of the liver, which may have \nbeen present on\nprior studies.  The patient is status post cholecystectomy, and \nthe common\nbile duct appears slightly more dilated compared to the prior \nstudy.  The\nportal vein is patent.  The spleen is homogeneous and normal in \nsize.  No\nperipancreatic stranding or fluid collection is seen.  No \ndiscerete pancreatic\nparenchymal lesion is seen. The main pancreatic duct is slightly \ndilated\ncompared to the most recent prior study. The adrenal glands are \nunremarkable. \nThe kidneys present symmetric nephrograms and excretion of \ncontrast without\nsolid or cystic lesions. \n \nThe patient is status post gastric bypass surgery.  The small \nbowel maintains\na normal caliber without evidence of obstruction.  There is \nmoderate fecal\nloading.  The appendix is normal.  The intra-abdominal \nvasculature is \nunremarkable. There is no abdominal free air or free fluid.  \nThere are no\nabdominal wall hernias.  There is no mesenteric or \nretroperitoneal\nlymphadenopathy.  Soft tissue densities along the lower anterior \nabdominal\nwall are the sequela of subcutaneous injections.\n \nThe bladder and terminal ureters are unremarkable.  The uterus \nand ovaries are\nunremarkable.  There is no pelvic sidewall or inguinal \nlymphadenopathy.  There\nis no pelvic free fluid.\n \nNo suspicious lesion is seen in the visualized osseous \nstructures.\n \nIMPRESSION:\n \n1.  Right lower lobe small airways infectious or inflammatory \nprocess,\nincompletely evaluated on this abdominal CT. \n \n2.  Increased prominence of the CBD and main pancreatic duct, \nwith mild left\nintrahepatic biliary ductal dilation, which may have been \npresent on prior\nstudies. MRCP is recommended for further evaluation.   \n \nBrief Hospital Course:\n___  with an extensive history of abdominal surgeries presenting \nwith fevers, chills, and pleuritic chest pain found to have RLL \npneumonia.\n\nACTIVE ISSUES:\n----------------\n# PNA: RLL PNA on CTAP, captured incidentally, with ___ days of \ndry cough and worsening fevers. Relative ___ with mild \nleft shift. Breathing comfortably on room air with good O2 sats. \nTransitioned to doxycycline and clindamycin for CAP with \nanaerobic coverage for presumable aspiration risk, for total ___hose not to change discharge levofloxacin to \ndoxycycline given synergistic QTc prolongation interaction \nbetween methadone and levofloxacin. \n\n# PLEURITIC CHEST PAIN: Due to pulmonary parenchymal and pleural \nirritation in the setting of PNA. Evidenced by a respiro-phasic \nquality. \n\n# CHRONIC ABDOMINAL PAIN IN THE SETTING OF OPIOD DEPENDENCE: \nContinued her home methadone regimen. \n\n# Left Intrahepatic Biliary Dilitation: Mild, new from prior. \nNormal LFTs. RUQ pain and tenderness is consistent with her \nbaseline even per patient's own report. Radiology recommends \nfollowup with a nonurgent MRCP. \n\nCHRONIC ISSUES:\n------------------\n\n# Copper Deficiency: Recently seen by neurology for evaluation \nof long-standing weakness which was felt to be due to copper \ndeficiency. They recommended replacement therapy with copper \ngluconate 8mg x 1 week, 6 mg x 1 week, 4 mg x 1 week, and 2 mg \nthereafter.\n- copper gluconate 2mg daily\n\n# HISTORY OF DVT: On treatment dose lovenox for recent DVT which \nwe will continue.\n\n# Malnutrition: long history of malnutrition in setting of \nextensive bowel surgeries. On multiple repletions which we will \ncontinue.\n\nTRANSITIONAL ISSUES:\n-----------------\n\n# Anxiety: She is on clonazepam 1mg TID which was decreased to \n0.5mg TID during her last hospitalization as she was felt to be \ntoo somnolent some of the time. \n\n# PNA: will complete 7 day course of doxycycline  and \nclindamycin on ___. Warned to watch for signs of C diff \ninfection \n\n# Biliary duct dilation: can consider non-urgent MRCP as \noutpatient\n\n# Chronic pain: pain medications were not adjusted \n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Sucralfate 1 gm PO QID \n2. Omeprazole 20 mg PO BID \n3. Furosemide 40 mg PO BID \n4. Methadone 10 mg PO Q6H \n5. MethaDOSE (methadone) 4ml  oral q4h:prn pain \n6. BuPROPion (Sustained Release) 150 mg PO QAM \n7. Doxepin HCl 75 mg PO HS \n8. QUEtiapine Fumarate 100 mg PO QAM \n9. QUEtiapine Fumarate 300 mg PO QHS \n10. Mirtazapine 22.5 mg PO HS \n11. ClonazePAM 1 mg PO TID \n12. Enoxaparin Sodium 50 mg SC Q12H \nStart: ___, First Dose: Next Routine Administration Time \n13. Magnesium Oxide Dose is Unknown  PO DAILY \n14. Calcitriol Dose is Unknown  PO DAILY \n15. copper gluconate 2 mg oral daily \n16. Vitamin D 1000 UNIT PO DAILY \n17. Cyanocobalamin Dose is Unknown  PO DAILY \n18. Magnesium Citrate Dose is Unknown  PO ONCE \n\n \nDischarge Medications:\n1. BuPROPion (Sustained Release) 150 mg PO QAM \n2. ClonazePAM 1 mg PO TID \n3. copper gluconate 2 mg oral daily \n4. Cyanocobalamin 0 mcg PO DAILY \n5. Doxepin HCl 75 mg PO HS \n6. Enoxaparin Sodium 50 mg SC Q12H \nStart: ___, First Dose: Next Routine Administration Time \n7. Furosemide 40 mg PO BID \n8. Methadone 10 mg PO Q6H \n9. Mirtazapine 22.5 mg PO HS \n10. Omeprazole 20 mg PO BID \n11. QUEtiapine Fumarate 100 mg PO QAM \n12. QUEtiapine Fumarate 300 mg PO QHS \n13. Sucralfate 1 gm PO QID \n14. Vitamin D 1000 UNIT PO DAILY \n15. Clindamycin 300 mg PO Q6H \nStop date: ___ \nRX *clindamycin HCl 300 mg 1 capsule(s) by mouth every 6 hours \nDisp #*28 Capsule Refills:*0\n16. Doxycycline 100mg\n17. Calcitriol 0 mcg PO DAILY \n18. Magnesium Citrate 0 mL PO ONCE Duration: 1 Dose \n19. Magnesium Oxide 0 mg PO DAILY \n20. MethaDOSE (methadone) 4 ml ORAL Q4H:PRN pain \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSES:\nCommunity acquired pneumonia\nPleuritic chest pain\nIntrahepatic duct biliary dilation\n \nSECONDARY DIAGNOSES:\nChronic abdominal pain \nAnxiety\nCopper deficiency\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms ___, \n \nIt was a pleasure taking care of ___ at ___. \n___ were admitted to the hospital because of fever, chills, and \nabdominal pain.  A CT scan of your abdomen did not show a source \nof pain but ___ were found to have a pneumonia, which can \nirritate and cause pain in the lower lung/abdomen region.  We \nhave started ___ on two antibiotics which ___ will continue for \none week. These antibiotics are very strong and can sometimes \nlead to stomach problems, so please let ___ primary doctor know \nright away if ___ are having abdominal cramping or diarrhea.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb688"
  },
  "note_id": "12648465-DS-18",
  "subject_id": 12648465,
  "hadm_id": 27062506,
  "note_type": "DS",
  "note_seq": 18,
  "charttime": "2205-09-16 00:00:00",
  "storetime": "2205-09-19 21:53:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine\n \nAttending: ___.\n \nChief Complaint:\nodynophagia\n \nMajor Surgical or Invasive Procedure:\nEGD\n\n \nHistory of Present Illness:\nThe patient is a ___ year old female with multiple medical \nproblems including distant gastric bypass with multiple \ncomplications and subsequent surgeries, chronic abdominal pain, \nsubstance abuse, and pulmonary embolism currently on lovenox who \npresents with 3 days of odynophagia and burning chest pain. She \nhas chronic epigastric abdominal discomfort and nausea related \nto multiple surgeries. She was in her normal state of health \nuntil three days ago when she developed substernal burning chest \ndiscommfort and odynophagia. She states that these symkptoms are \nidentical to a prior episode of ___ esophagitis in ___. She describes the pain as sharp and burning with \nswallowing - worse with solids than liquids. She can swallow \npills. There is no radiation, no change with position, no \nshortness of breath. She also endorses low grade fever to 100.2 \nat home several days ago, as well as multiple episodes of \ndiarrhea on ___ and ___ which have since resolved. No \nmelana, BRBPR. She reports her weight has been stable at 138 \npounds. \n \nThe patient was admitted in ___ for odynophagia. She had \nan EGD on ___ that demonstrating esophageal candidiasis \nand longitudinal ulcerations at the gastroesophageal junction \nand the cardia. She was treated with a 3 week course of \nfluconazole. She was also given carafate QID, PPI, BID, and \ncholestyramine. An HIV test and H. pylori was negative. A \ndobhoff tube was placed during this admission and tube feeds \nwere started for malnutrition.  She was in rehab from ___ until \n___. Per Dr. ___ G tube was attempted in ___ at \n___ but she developed a hematoma so it was removed. \n\nIn the ED, initial vs were: T98.6 87 134/78 16 96%RA.\nOn exam patient was uncomfortable, complaining of ___ \nmid-sternal CP which she describes as \"esophagus\" pain. Exam is \nnotable for dry mucus membranes, no appreciable oral lesions or \nevidence for candidiasis. \n[ ] CBC with diff, lytes: no leukocytosis \n[x] troponin: negative\n[x] IVF bolus, 1L NS\n[x] EKG: consistent with prior\n[ ] CXR\n[x] Nausea: IV zofran\n[x] pain control: IV dilaudid PRN, pt is on chronic methadone\n[x] GI: touched base with her GI Dr. ___ recs as he has \nnot seen her as a pt before --> GI consult, per GI admit to \nmedicine and they will see her as an inpatient \n \nReview of sytems:  \n(+) Per HPI  \n(-) Ten point review of systems is otherwise negative.  \n \nPast Medical History:\n-Morbid obesity (max 448lbs) s/p gastric bypass & CCY at \n___  and complete reversal\n-History of HTN, DM, asthma (prior to gastric bypass)  \n-Opiate addiction: prior intranasal herion, oral dilaudid abuse, \nnow on suboxone  \n-Depression/Anxiety  \n-Esophagitis: EGD ___ showed mild active esophagitis.  \n-DJD  \n-2 SBOs  \n-Menopause completed  \n\nPast Surgical History:  \n-___- gastric bypass & CCY  and subsequent complete \nreversal\n-7 surgeries on the abdomen. \"stomach leak\" hernia, 2 SBOs, \nattempted reverse of the gastric bypass, the most recent in ___ \n \n\n \nSocial History:\n___\nFamily History:\n-Mother with diabetes\n \nPhysical Exam:\nGeneral: appears older than stated age, comfortable \nHEENT:  anicteric sclera, oropharynx clear\nLungs:  CTA bilaterally, unlabored\nCV:  S1, S2 regular rhythm, normal rate\nAbdomen:  healed surgical scars, soft, non-tender, non-distended\nExt:  warm, distal pulses intact\nSkin:  no obvious rash\nNeuro:  alert, speech fluent, tongue midline\n \n \nPertinent Results:\n___ 10:00AM BLOOD WBC-4.2 RBC-4.10*# Hgb-12.2# Hct-39.2# \nMCV-96 MCH-29.8 MCHC-31.2 RDW-14.0 Plt ___\n___ 06:35AM BLOOD Plt ___\n___ 10:00AM BLOOD Plt ___\n___ 10:00AM BLOOD Glucose-97 UreaN-9 Creat-0.8 Na-141 K-3.5 \nCl-97 HCO3-32 AnGap-16\n___ 06:35AM BLOOD Glucose-81 UreaN-8 Creat-0.7 Na-142 K-3.5 \nCl-105 HCO3-32 AnGap-9\n___ 07:30AM BLOOD Glucose-72 UreaN-8 Creat-0.8 Na-139 K-3.5 \nCl-101 HCO3-32 AnGap-10\n___ 10:00AM BLOOD ALT-10 AST-19 LD(LDH)-219 AlkPhos-112* \nTotBili-0.2\n___ 10:00AM BLOOD Lipase-10\n___ 10:00AM BLOOD cTropnT-<0.01\n___ 06:35AM BLOOD CK-MB-1 cTropnT-<0.01\n___ 07:30AM BLOOD Calcium-8.7 Phos-3.8 Mg-1.8\n___ 07:30AM BLOOD HIV Ab-NEGATIVE\n___ 06:35AM BLOOD COPPER (SERUM)-117\n.\nCXR: \nFINDINGS:  AP upright and lateral views of the chest were \nprovided.  Lungs\nappear clear bilaterally without focal consolidation, effusion \nor\npneumothorax.  There is no free air below the right \nhemidiaphragm.  The\ncardiomediastinal silhouette is normal.  The bony structures are \nintact.\nIMPRESSION:  No acute findings.\n.\nSMALL BOWEL FOLLOW THROUGH\nFINDINGS:\n \nUpon review of prior CT abdomen/pelvis, it was determined that \nthe patient is\nstatus post gastric bypass with complete reversal of the bypass. \n The stomach\nappears slightly deformed with thickened and edematous gastric \nfolds, likely\nsecondary to surgical changes.  Thin barium passes appropriately \nthrough the\ndistal antrum into the duodenum, and then into the jejunum.  \nThere is no\ncontrast filling of the Roux limb, which presumably was closed \nor excised. \nThere is no extravasation of contrast to suggest fistula or \nleak.  Small-bowel\nfollow-through was limited due to patient fatigue and inability \nto tolerate\nswallowing much barium.  Considerable portions of the distal \nsmall bowel are\nonly minimally opacified and contrast opacification was not \npursued to the\nterminal ileum.  There is dilation of small bowel loops at the \nJJ anastomosis.\nMild reflux of contrast past the GE junction into the distal ___ \nof the\nesophagus is noted.  \n \nIMPRESSION:\n1.  Status post gastric bypass, with complete reversal.  \nContrast passes from\nthe stomach into the duodenum and then jejunum as intended, \nwithout\nextravasation of contrast to suggest fistula or leak.  \n2.  Thickened and edematous gastric folds, likely secondary to \nprior\nsurgeries. \n3.  Mild reflux at the GE junction into the distal ___ of the \nesophagus. \n.\n.\nEGD: \nFindings:\nEsophagus:\nMucosa:Erosive esophagitis with ulcerations and contact \nbleeding was seen extending up to 28cm. Cold forceps biopsies \nwere performed for histology at the esophagus; biopsies were \nalso sent for viral culture. \nStomach:\nOtherAn end-end gastrojejunal anastomosis was seen, with a \nsmall remnant gastric pouch. There was also a suture with \ngranulomatous tissue around it in the proximal gastric pouch. \nBile was seen in the remnant gastric pouch as well. \nJejunum:Normal jejunum.\nImpression:Esophagitis (biopsy)\nAn end-end gastrojejunal anastomosis was seen, with a small \nremnant gastric pouch. There was also a suture with \ngranulomatous tissue around it in the proximal gastric pouch. \nBile was seen in the remnant gastric pouch as well.\nOtherwise normal EGD to jejunum\nRecommendations:F/u biopsies\nFurther management per inpatient team\n.\nGI BIOPSY: \nPATHOLOGIC DIAGNOSIS:\nEsophageal mucosal biopsy:\n - Squamous mucosa, with rare eosinophils, spongiosis and \nincreased\nbasal zone regeneration, consistent with mildly active \nesophagitis.\n.\nGI BIOPSY: \nime Taken Not Noted     Log-In Date/Time: ___ 2:07 pm\n      VIRAL CULTURE: R/O CYTOMEGALOVIRUS     Site: ESOPHAGUS\n      TEST VERIFIED BY ___ ___. \n\n   VIRAL CULTURE: R/O CYTOMEGALOVIRUS (Preliminary): \n      No Cytomegalovirus (CMV) isolated. \n\n   CYTOMEGALOVIRUS EARLY ANTIGEN TEST (SHELL VIAL METHOD) (Final \n___: \n      Negative for Cytomegalovirus early antigen by \nimmunofluorescence. \n      Refer to culture results for further information. \n\n   VIRAL CULTURE: R/O HERPES SIMPLEX VIRUS (Preliminary): \n      No Herpes simplex (HSV) virus isolated. \n\n \nBrief Hospital Course:\nASSESSMENT AND PLAN: \n___ year old female with multiple medical problems including \ndistant gastric bypass with multiple complications and \nsubsequent surgeries, chronic abdominal pain on methadone, and \npulmonary embolism now on lovenox who presents with 3 days of \nodynophagia and burning chest pain.\n.\n#ODYNOPHAGIA / ESOPHAGITIS: Her presentation was most consistent \nwith esophagitis due to GERD.  She underwent EGD that confirmed \nesophagitis (grossly and on biopsy).  VIral culture was \nnegative.  She has a history of ___ esophagitis (___) but \nbiopsy did not demonstrate fungus.  HIV test was negative. She \nwas started on PPI BID and sucrulfate (slurry) 1gram QID.  She \nwas given viscous lidocaine to take prior to meals and was able \nto tolerate a regular diet.  EGD noted bile in the stomach so \nshe was started on cholestyramine.  Small bowel follow through \ndid not demonstrate  fistula between remnant and gastric pouch \ncausing non acid bile reflux.  She will continue PPI BID, \nsucrulfate, and cholestyramine until she follows up with GI in \n___ weeks (scheduled). She was given a prescription for GI \ncocktail with lidocaine that she can take for one week.  She was \ngiven a small number of PO dilaudid for pain control.   \n\nCHRONIC:  \n\n#History of Copper deficiency: Followed by neurology and felt \nthat long standing weakness may be ___ copper deficiency so she \nwas started on supplemental copper.  A copper level was checked \nand was within normal limits.  She was continued on copper \ngluconate 2mg daily\n  \n#Hx of DVT: She was continued on lovenox 1mg BID for history of \nvenous thromboembolism. \n \n#Chronic Pain: She was continued on her home of methadone \n\n#Depression/anxiety: She was continued on home Doxepin, \nclonazepam, Quetapin, and Mirtazapin \n  \n# CODE: DNR per patient \n\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. BuPROPion (Sustained Release) 150 mg PO QAM \n2. ClonazePAM 1 mg PO TID \n3. copper gluconate 2 mg oral daily \n4. Doxepin HCl 75 mg PO HS \n5. Enoxaparin Sodium 60 mg SC Q12H \nStart: ___, First Dose: Next Routine Administration Time \n6. Furosemide 40 mg PO BID \n7. Methadone 10 mg PO Q6H \n8. Mirtazapine 22.5 mg PO HS \n9. Omeprazole 20 mg PO BID \n10. QUEtiapine Fumarate 100 mg PO QAM \n11. QUEtiapine Fumarate 300 mg PO QHS \n12. Sucralfate 1 gm PO QID \n13. Vitamin D 1000 UNIT PO DAILY \n14. Cyanocobalamin Dose is Unknown  PO DAILY \n15. Magnesium Oxide Dose is Unknown  PO Frequency is Unknown \n\n \nDischarge Medications:\n1. BuPROPion (Sustained Release) 150 mg PO QAM \n2. ClonazePAM 1 mg PO TID \n3. copper gluconate 2 mg oral daily \n4. Doxepin HCl 75 mg PO HS \n5. Methadone 10 mg PO Q6H \n6. Mirtazapine 22.5 mg PO HS \n7. QUEtiapine Fumarate 100 mg PO QAM \n8. QUEtiapine Fumarate 300 mg PO QHS \n9. Sucralfate 1 gm PO QID \n10. Cholestyramine 4 gm PO TID \nRX *cholestyramine (with sugar) 4 gram 1 packet by mouth three \ntimes a day Disp #*90 Not Specified Refills:*0\n11. Lidocaine Viscous 2% 15 mL PO TID \nRX ___ [FIRST-Mouthwash BLM] 400 \nmg-400 mg-40 mg-25 mg-200 mg/30 mL ___ teaspoons three times a \nday Disp #*450 Milliliter Refills:*0\n12. Omeprazole 40 mg PO BID \nRX *omeprazole 40 mg 1 capsule,delayed ___ by \nmouth twice a day Disp #*60 Capsule Refills:*0\n13. Furosemide 40 mg PO DAILY \n14. Vitamin D 1000 UNIT PO DAILY \n15. Maalox/Diphenhydramine/Lidocaine ___ mL PO QID:PRN \nodynophagia  \n16. HYDROmorphone (Dilaudid) ___ mg PO Q6H:PRN pain \nRX *hydromorphone [Dilaudid] 2 mg ___ tablet(s) by mouth Q6 Disp \n#*35 Tablet Refills:*0\n17. Enoxaparin Sodium 60 mg SC Q12H \nStart: ___, First Dose: Next Routine Administration Time \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nEsophagitis \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nIt was a pleasure to participate in your care. You were admitted \nwith pain when swallowing. You had an upper endoscopy that \nshowed inflammation in your esophagus (esophagitis). A biopsy \nwas taken - it did NOT show an infection. You were treated with \nmedicine to reduce stomach acid (omeprazole, sucrulfate).  There \nmay still be some discomfort with swallowing. For the next week, \nyou should take the GI-cocktail (lidocaine) prior to meals to \nreduce the pain. You were given a prescription for pain \nmedication (dilaudid) as well. This medication can cause \nconstipation - if you do not have a bowel movement every day \nthen you should take a stool softner such as colase or senna. \nYou were scheduled to follow up with the GI doctors in two \n___. \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb689"
  },
  "note_id": "12648465-DS-19",
  "subject_id": 12648465,
  "hadm_id": 26390568,
  "note_type": "DS",
  "note_seq": 19,
  "charttime": "2205-09-30 00:00:00",
  "storetime": "2205-09-30 16:52:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine\n \nAttending: ___.\n \nChief Complaint:\nepigastric pain\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nThe patient is a ___ year old female with multiple medical \nproblems including distant gastric bypass with multiple \ncomplications and subsequent surgeries, chronic abdominal pain, \nsubstance abuse, and pulmonary embolism currently on lovenox who \npresents with persistent odynophagia, abdominal pain and nausea \nand vomiting. She reports that since she was discharged on \n___ she has had persistent pain with eating and swallowing, \nepigastric abdominal pain and nausea and vomiting. She has \nchronic epigastric abdominal discomfort and nausea related to \nmultiple surgeries. She describes the pain as sharp and burning \nwith swallowing - worse with solids than liquids. She can \nswallow pills. There is no radiation, no change with position, \nno shortness of breath.  \nThe patient was admitted last week for odynophagia. Her \npresentation was most consistent with esophagitis due to GERD. \nShe underwent EGD that confirmed esophagitis (grossly and on \nbiopsy). Viral culture was negative. She has a history of \n___ esophagitis (___) but  \nbiopsy did not demonstrate fungus. HIV test was negative. She \nwas started on PPI BID and sucrulfate (slurry) 1gram QID. She \nwas given viscous lidocaine to take prior to meals and was able \nto tolerate a regular diet. EGD noted bile in the stomach so she \nwas started on cholestyramine. Small bowel follow through did \nnot demonstrate fistula between remnant and gastric pouch \ncausing non acid bile reflux. She was discharged on PPI BID, \nsucrulfate, and cholestyramine. She was given a prescription for \nGI cocktail with lidocaine that she can take for one week. She \nwas given a small number of PO dilaudid tabs for pain control. \nShe was in rehab from ___ until ___. Per Dr. ___ G \ntube was attempted in ___ at ___ but she \ndeveloped a hematoma so it was removed.  \n \nShe reports that since discharge she has been uncomfortable. She \nthinks she was discharged \"too soon.\"  \nIn the ED, triage and all subsequent vital signs were normal, \nand she was afebrile. She was given IV dilaudid.\n\nReview of sytems:  \n(+) Per HPI  \n(-) Ten point review of systems is otherwise negative.  \n\n \nPast Medical History:\n-Morbid obesity (max 448lbs) s/p gastric bypass & CCY at \n___  and complete reversal\n-History of HTN, DM, asthma (prior to gastric bypass)  \n-Opiate addiction: prior intranasal herion, oral dilaudid abuse, \nnow on suboxone  \n-Depression/Anxiety  \n-Esophagitis: EGD ___ showed mild active esophagitis.  \n-DJD  \n-2 SBOs  \n-Menopause completed  \n\nPast Surgical History:  \n-___- gastric bypass & CCY  and subsequent complete \nreversal\n-7 surgeries on the abdomen. \"stomach leak\" hernia, 2 SBOs, \nattempted reverse of the gastric bypass, the most recent in ___ \n \n\n \nSocial History:\n___\nFamily History:\n-Mother with diabetes\n \nPhysical Exam:\nVSS\nGeneral: appears older than stated age, comfortable  \nHEENT: OP with white plaques on tongue, no lesions on soft \npalate\nHEENT: anicteric sclera, oropharynx clear  \nLungs: CTA bilaterally, unlabored  \nCV: S1, S2 regular rhythm, normal rate  \nAbdomen: healed surgical scars, soft, mild epigastric ttp, \nnon-distended  \nExt: warm, distal pulses intact  \nSkin: no obvious rash  \nNeuro: alert, speech fluent, tongue midline  \n\n \nPertinent Results:\n___ 08:37AM BLOOD WBC-3.2* RBC-3.70* Hgb-11.2* Hct-35.1* \nMCV-95 MCH-30.4 MCHC-32.1 RDW-14.2 Plt ___\n___ 07:25AM BLOOD WBC-3.2* RBC-3.61* Hgb-10.9* Hct-35.0* \nMCV-97 MCH-30.0 MCHC-31.0 RDW-14.2 Plt ___\n___ 08:37AM BLOOD Neuts-59.9 ___ Monos-3.8 Eos-2.5 \nBaso-0.8\n___ 07:25AM BLOOD Plt ___\n___ 07:25AM BLOOD ___ PTT-33.2 ___\n___ 07:25AM BLOOD Glucose-88 UreaN-6 Creat-0.7 Na-136 K-3.9 \nCl-102 HCO3-27 AnGap-11\n___ 08:37AM BLOOD ALT-10 AST-13 AlkPhos-80 TotBili-0.2\n\n___ 3:06 pm THROAT FOR STREP\n      PERFORM SENSITIVITES FOR ___ SPECIES, CONCERN FOR \nAZOLE\n      RESISTENCE. \n\n   GRAM STAIN- R/O THRUSH (Final ___: \n      NEGATIVE FOR YEAST. \n      NO ___ ORGANISMS SEEN. \n\n   FUNGAL CULTURE (Preliminary): \n\n___ Lower extremity ultrasound with doppler, bilateral: \nIMPRESSION:  \n1.  No evidence of acute DVT in the bilateral lower extremities. \n  \n2.  Small amount of chronic thrombus versus post-DVT wall \nthickening in the \nbilateral popliteal veins. \n3.  Of note, the right peroneal and posterior tibialis veins \nwere not \ndefinitively visualized. \n\n___ MRCP\nIMPRESSION: \n1.  Mild-to-moderate dilation of the extrahepatic bile duct and \ncentral \nintrahepatic bile ducts and mild dilation of the main pancreatic \nduct; \nfindings may be related to sphincter of Oddi dysfunction versus \nless likely \npapillary stenosis.  Overall appearance is similar to the prior \nMRCP study \nfrom ___. \n2.  Fat interdigitation of the pancreas, no findings to suggest \nacute \npancreatitis. \n3.  Prior reversal of gastric bypass surgery with removal of the \nintervening \njejunal limb. Distorted remaining stomach. Widely patent \njejunal-jejunal \nanastomosis. \n\n \nBrief Hospital Course:\n___ year old female with multiple medical problems including \ndistant gastric bypass with multiple complications and \nsubsequent surgeries, subsequent reversal of bypass (removal of \nintervening jejunal limb), chronic abdominal pain, substance \nabuse, and pulmonary embolism currently on Lovenox who presents \nwith odynophagia and burning chest pain.  \n \n# ODYNOPHAGIA and ABDOMINAL PAIN with ESOPHAGITIS: Her \npresentation is similar to prior episodes of admissions for \nesophagitis. Biliary dilation on MRCP is stable, but raised \nconcern for sphincter of Oddi dysfunction versus papillary \nstenosis. Gastroenterology was consulted and requested that \nlevels of micronutrients be checked and that calorie counts be \nperformed to clarify oral intake. There was ongoing concern that \npatient takes her medications not as directed and precipitates \nmethadone or opiate withdrawal, which was supported by patient's \nnegative methadone on her tox screen on admission. She was only \nrecently started on Dilaudid, and this was tapered down during \nthe admission.\n- MRCP reviewed and felt to be chronic.  Her pain was felt to be \ndue to reflux esophagitis and possible dysmotility of some sort. \n She was placed on an aggressive GI cocktail.  Her Methadone was \ndecreased to 10mg TID.  Her Dilaudid was weaned off after \ndiscussions with her and her PCP (opiates not started by current \nPCP, ultimate goal to wean off, dependence issues).  She was \ninitiated on Gabapentin in place of this.\n- Outpatient EUS was recommended and scheduled by GI\n\n# Vitamin B12/Copper deficiency: Followed by neurology and felt \nthat long standing weakness may be due to copper deficiency so \nstarted on supplemental copper.  B12 deficiency also discovered. \n Given 1 week of IM B12, converted to PO B12 on discharge\n\n# Moderate malnutrition: Followed by nutrition.  Was able to \nmaintain counts with meals and carnation TID with meals with \nprotein and milk added.  GI recommended small frequent low fiber \nmeals.\n \n#Hx of DVT: On treatment dose Lovenox for recent DVT. Hematology \nwas consulted about duration of anticoagulation and they \nrecommended continuing Lovenox while patient was still with \nreduced mobility.\n\n#Depression/anxiety: Continued home Doxepin, clonazepam, \nQUEtiapine and Mirtazapine. Of note, pt reports that she has \nbeen taking 1mg Klonopin tid for ___ years,\" but on discussion \nwith her PCP at ___ it was confirmed that she takes 0.5mg \ntid, however this is managed by her psychiatrist, so was \nincreased back to 1mg TID.   \n \n# DNR DNI: Per discussion with patient.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. BuPROPion (Sustained Release) 150 mg PO QAM \n2. ClonazePAM 1 mg PO TID \n3. copper gluconate 2 mg oral daily \n4. Doxepin HCl 75 mg PO HS \n5. Methadone 10 mg PO Q6H \n6. Mirtazapine 22.5 mg PO HS \n7. QUEtiapine Fumarate 100 mg PO QAM \n8. QUEtiapine Fumarate 300 mg PO QHS \n9. Sucralfate 1 gm PO QID \n10. Cholestyramine 4 gm PO TID \n11. Lidocaine Viscous 2% 15 mL PO TID \n12. Omeprazole 40 mg PO BID \n13. Furosemide 40 mg PO DAILY \n14. Vitamin D 1000 UNIT PO DAILY \n15. Maalox/Diphenhydramine/Lidocaine ___ mL PO QID:PRN \nodynophagia  \n16. HYDROmorphone (Dilaudid) ___ mg PO Q6H:PRN pain \n17. Enoxaparin Sodium 60 mg SC Q12H \n\n \nDischarge Medications:\n1. BuPROPion (Sustained Release) 150 mg PO QAM \n2. Cholestyramine 2 gm PO BID \n3. ClonazePAM 1 mg PO TID \n4. copper gluconate 2 mg oral daily \n5. Doxepin HCl 75 mg PO HS \n6. Enoxaparin Sodium 60 mg SC Q12H \nStart: ___, First Dose: Next Routine Administration Time \n7. Furosemide 40 mg PO DAILY \n8. Lidocaine Viscous 2% 15 mL PO TID \nRX *lidocaine HCl 20 mg/mL 15 mL three times a day Disp #*450 \nMilliliter Refills:*0\n9. Maalox/Diphenhydramine/Lidocaine ___ mL PO QID:PRN \nodynophagia  \nRX *alum-mag hydroxide-simeth 200 mg-200 mg-20 mg/5 mL ___ mL \nby mouth three times a day Disp #*450 Milliliter Refills:*0\n10. Methadone 10 mg PO TID \nRX *methadone 10 mg 1 tablet by mouth three times a day Disp #*9 \nTablet Refills:*0\n11. Mirtazapine 22.5 mg PO HS \n12. QUEtiapine Fumarate 100 mg PO QAM \n13. QUEtiapine Fumarate 300 mg PO QHS \n14. Sucralfate 1 gm PO QID \n15. Vitamin D 1000 UNIT PO DAILY \n16. Omeprazole 40 mg PO BID \n17. Multivitamins W/minerals 1 TAB PO DAILY \nRX *multivitamin,tx-minerals   1 tablet(s) by mouth once a day \nDisp #*30 Tablet Refills:*0\n18. Thiamine 100 mg PO DAILY \nRX *thiamine HCl 100 mg 1 tablet(s) by mouth once a day Disp \n#*30 Tablet Refills:*0\n19. Ondansetron 4 mg PO Q8H:PRN nausea \nRX *ondansetron 4 mg 1 tablet,disintegrating(s) by mouth every \neight (8) hours Disp #*30 Tablet Refills:*0\n20. Gabapentin 600 mg PO Q8H \nRX *gabapentin 300 mg 2 capsule(s) by mouth three times a day \nDisp #*180 Capsule Refills:*0\n21. Cyanocobalamin 1000 mcg PO DAILY \nRX *cyanocobalamin (vitamin B-12) 1,000 mcg 1 tablet(s) by mouth \nonce a day Disp #*90 Tablet Refills:*0\n22. Nutritional supplement\nPlease take Carnation instant breafast three times daily with \nfood.  Please add 1 scoop whey protein to liquid.\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nChronic Abdominal pain\nHistory of deep vein thrombosis\nEsophagitis\nMalnutrition\nVitamin B12 Deficiency\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nIt was a pleasure to participate in your care. You were admitted \nwith pain when swallowing. A recent upper endoscopy showed \ninflammation in your esophagus (esophagitis). You were treated \nwith \nmedicine to reduce stomach acid (omeprazole, sucrulfate).  There \nmay still be some discomfort with swallowing. For the next week \nat least, you should take the GI-cocktail prescribed prior to \nmeals to reduce the pain.  Additonally, you will need to follow \nup with gastroenterology for a endoscopic ultrasound.  You will \nbe given enough Methadone to reach your PCP ___.  Please \ndiscuss with her regarding continuation of this medication.\n\nPlease continue your Carnation supplements with meals, and add 1 \nscoop of whey protein and mild for full nutrition.\n\nYou were also seen by the hematology consult service to clarify \nwhether you should continue your lovenox. They felt that you \nshould continue this.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb68a"
  },
  "note_id": "12648465-DS-20",
  "subject_id": 12648465,
  "hadm_id": 28086981,
  "note_type": "DS",
  "note_seq": 20,
  "charttime": "2205-12-04 00:00:00",
  "storetime": "2205-12-05 20:07:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine\n \nAttending: ___.\n \nChief Complaint:\nnausea, vomiting, abdominal pain\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\n___ with hx of distant gastric bypass with multiple \ncomplications, chronic abdominal pain, substance abuse on \nmethadone, and pulmonary embolism currently on lovenox who was \nrecently admitted with persistent odynophagia, abdominal pain \nand nausea, found to have recurrent esophagitis, now presents \nwith 5 days of n/v/abdominal pain. Her last BM was 4 days ago. \nShe reports sharp mid abdominal pain. States that this feels \nlike her prior SBOs, though on the floor she states this is \ndifferent from previous episodes in that that pain is more \nlocalized. Pain is worse on the L. There is some concern that \nshe may have taken extra doxapin and seroquel. EKG with normal \nintervals.  \nIn the ED intial vitals were: ___ pain 98.9 84 143/83 18 100%. \nNGT placed with 20cc yellow output. CT abd/pelvis done that \nshowed no obstruction, reviewed with Bariatric surgery. Received \n4mg dilaudid IV total, zofran, reglan. Vitals prior to transfer \nwere: 98.1 81 132/86 16 97% RA.  \nOn the floor, she continues to complain of pain but laying in \nbed comfortably. NGT in place, asking for more pain medication \nand NGT to suction.  \n\n \nPast Medical History:\n-Morbid obesity (max 448lbs) s/p gastric bypass & CCY at \n___  and complete reversal\n-History of HTN, DM, asthma (prior to gastric bypass)  \n-Opiate addiction: prior intranasal herion, oral dilaudid abuse, \nnow on suboxone  \n-Depression/Anxiety  \n-Esophagitis: EGD ___ showed mild active esophagitis.  \n-DJD  \n-2 SBOs  \n-Menopause completed  \n\nPast Surgical History:  \n-___- gastric bypass & CCY  and subsequent complete \nreversal\n-7 surgeries on the abdomen. \"stomach leak\" hernia, 2 SBOs, \nattempted reverse of the gastric bypass, the most recent in ___ \n \n\n \nSocial History:\n___\nFamily History:\n-Mother with diabetes\n \nPhysical Exam:\nADMISSION PHYSICAL:\nVitals - T: 98.8 BP: 144/90 HR: 76 RR: 14 02 sat: 100%RA  \nGENERAL: mildly uncomfortable appearing, appears stated age  \nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, \npatent nares, MMM, nontender supple neck, no LAD, no JVD, NGT in \nplace draining yellow/green fluid  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \nABDOMEN: nondistended, +BS, tender to palpation in all quadrants \nL>R, voluntary guarding, unable to assess for rebound or \nhepatosplenomegaly due to patient discomfort  \nEXTREMITIES: moving all extremities well, no cyanosis, clubbing \nor edema  \nPULSES: 2+ ___ pulses bilaterally  \nNEURO: CN II-XII intact  \nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes \n.\nDISCHARGE PHYSICAL:\nVitals- T 98.6   ___   18  100% RA\nGeneral- alert, sitting in bed, eating breakfast, NAD \nHEENT- Sclera anicteric, MMM. \nNeck- supple\nLungs- Clear to auscultation bilaterally, no wheezes, rales, \nronchi\nCV- Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops\nAbdomen- Soft. Non-tender, non-distended. Nl BS, no rebound or \nguarding\nGU- no foley\nExt- wwp with no edema\nNeuro- answers all questions appropriately\n \nPertinent Results:\nADMISSION LABS:\n___ 01:55PM BLOOD WBC-4.3 RBC-3.95* Hgb-11.9* Hct-37.6 \nMCV-95 MCH-30.1 MCHC-31.7 RDW-15.6* Plt ___\n___ 01:55PM BLOOD Neuts-76.0* ___ Monos-2.4 Eos-0.7 \nBaso-0.5\n___ 01:55PM BLOOD Glucose-91 UreaN-14 Creat-0.7 Na-141 \nK-4.5 Cl-105 HCO3-25 AnGap-16\n___ 01:55PM BLOOD ALT-12 AST-21 AlkPhos-113* TotBili-0.4\n___ 01:55PM BLOOD Albumin-3.9 Calcium-9.3 Phos-3.7 Mg-1.9\n___ 03:03PM BLOOD Lactate-2.3*\n___ 12:04PM BLOOD Lactate-1.5\n___ 12:04PM BLOOD ___ pO2-78* pCO2-47* pH-7.38 \ncalTCO2-29 Base XS-1 Comment-GREEN TOP\n.\nMICRO:\nBLOOD CX ___ x 3: NEGATIVE\n.\n___ 7:30 pm URINE\n**FINAL REPORT ___\nURINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \nWITH SKIN\n      AND/OR GENITAL CONTAMINATION. \n.\nDISCHARGE LABS:\n___ 03:30PM BLOOD WBC-4.6 RBC-3.91* Hgb-11.8* Hct-38.9 \nMCV-100* MCH-30.3 MCHC-30.4* RDW-15.8* Plt ___\n___ 03:30PM BLOOD ___ PTT-38.4* ___\n___ 03:30PM BLOOD Glucose-154* UreaN-16 Creat-0.8 Na-142 \nK-3.8 Cl-108 HCO3-26 AnGap-12\n___ 03:30PM BLOOD Calcium-9.0 Phos-3.8 Mg-1.9\n.\nIMAGING:  \n___ CXR: FINDINGS: Single portable view of the chest. The \nlungs are clear of focal consolidation or effusion. The \ncardiomediastinal silhouette is within normal limits. \nNasogastric tube seen passing into the gastric body with side \nport past the GE junction. No free intraperitoneal air \nidentified. IMPRESSION: NG tube in appropriate position  \n.\n___ Abd film: IMPRESSION: Large amount of stool within the \ncolon. No evidence of small bowel obstruction or free \nintraperitoneal air. Status post reversal of gastric bypass with \nenteric tube tip likely within the duodenum.  \n.\n___ CT abd/pelvis: \nFINDINGS:  The bases of the lungs demonstrate ___ \nopacities \nbilaterally which indicates small airways infection or \naspiration.  \nTiny hypodensity in the right lobe of the liver is overall \nstable compared to the prior exam and may represent a simple \nhepatic cyst (2;26).  Otherwise, the liver demonstrates no \nconcerning focal lesions.  There is again mild intrahepatic \nbiliary ductal dilatation similar to the prior exam.  The \npatient is status post cholecystectomy with stable mild \ndilatation of the CBD measuring 0.8 cm.  The portal vein appears \nto be patent.  The spleen is homogenous and normal in size.  The \npancreas is normal without evidence of focal lesions or \nperipancreatic stranding.  There is no pancreatic duct \ndilatation.  The adrenal glands bilaterally are normal.  Kidneys \nare normal without evidence of focal solid or cystic lesions.  \nThere appears to be symmetric excretion of contrast.  There is \nno retroperitoneal or mesenteric lymphadenopathy.  No \nintra-abdominal free air or free fluid is identified.   \nThe patient is status post gastric bypass surgery with reversal, \nwith probable removal of the intervening jejunal limb. There is \nappropriate passage of contrast to the distal small bowel and \ncolon.  There is an eneteric tube which appears to terminate \nwithin the duodenum.  The jejunojejunal anastomosis appears to \nbe overall patent and stable in configuration compared to \nmultiple prior studies.  There is no retroperitoneal or \nmesenteric lymphadenopathy. \nCT PELVIS:  The urinary bladder is normal.  The uterus appears \nto be \nunremarkable.  There is no significant pelvic free fluid.  There \nis no pelvic wall or inguinal lymphadenopathy. Soft tissue \ndensities along the lower anterior abdominal wall are sequelae \nof subcutaneous injections. \nOSSEOUS STRUCTURES:  No lytic or blastic lesions concerning for \nmalignancy are identified.   \nIMPRESSION:  \n1.  No evidence of bowel obstruction with oral contrast passing \ninto the \nascending colon. \n2.  Stable mild dilatation of the CBD compared to the prior MRCP \nfrom ___ and again may be related to sphincter of \nOddi dysfunction. \n3.  ___ opacities at the bases of the lungs bilaterally \nis likely \nsecondary to small airways infection or aspiration. \n.\nCT HEAD ___:\nThere is no evidence of hemorrhage, edema, mass, mass effect, or \nlarge\nterritorial infarction. The ventricles and sulci are normal in \nsize and\nconfiguration. The basal cisterns appear patent and there is \npreservation of gray-white matter differentiation. \nNo fracture is identified.  The visualized paranasal sinuses, \nmastoid air\ncells, and middle ear cavities are clear.  \nIMPRESSION:   No intracranial hemorrhage or mass effect.  \nNOTE ADDED IN ATTENDING REVIEW: Incidentally noted is a \n\"partially empty\"\nsella turcica (602b:41), not significantly changed, a common \nvariant.\n \n\n \nBrief Hospital Course:\n___ year old female with multiple medical problems including \ndistant gastric bypass with multiple complications and \nsubsequent surgeries, subsequent reversal of bypass (removal of \nintervening jejunal limb), chronic abdominal pain on methadone, \nh/o substance abuse, and pulmonary embolism currently on \ncoumadin who presents with abdominal pain, nausea and vomiting \nwith course c/b two episodes of lethargy, slurred speech and \npinpoint pupils.\n.\n# Abdominal pain, nausea, vomiting: Presentation initially \nconcerning for partial SBO although abdominal xray and CT did \nnot support this diagnosis. A U/A was negative. She was made \nNPO, including meds; an NGT was placed overnight (___), \ndrained bilious material and was subsequently removed ___ per \npt request. Pt evaluated by bariatric surgery who did not see \nany indication for surgery. Had EGD and EUS ___ (prior to \nadmission) that showed mild esophagitis, small remnant stomach \nwith  gastrojejunal anastamosis, erythema in the stomach, \ndilated pancreatic duct, normal pancreas/pancreatic vasculature. \n Also had MRCP in ___ with recommended repeat MRCP in ___ \nmos. Most likely etiology of abdominal pain/nausea/vomiting is \nconstipation, which may have been precipitated by methadone \nabuse in outpatient setting. Of note, PCP conveyed concern about \npossible methadone abuse.  Ddx includes referred pain from known \nesophagitis vs marginal ulcer at gastrojejunal anastamosis vs \nmalingering. Given reassuring exam, labs and imaging, we managed \nmedically with pantoprazole BID, standing tylenol and home \nmethadone 7.5mg PO TID for pain, and an aggressive bowel regimen \n(senna, colace, miralax, bisacodyl, enema). She was given zofran \nand compazine for nausea with good relief. She was intially made \nNPO, transitioned to clears on ___, and to regular diet on \n___. EKG ___ showed QTc 448 (methadone, zofran can prolong \nQT). EKG ___ with QTc 426. She was weaned to methadone 5mg \nTID and discharged on this dose.  \n.\n# lethargy, pinpoint pupils, slurred speech: First episode \noccurred on ___ of ___. When due for ___ medications, she was \nfound to be AOx1, not compliant with neuro exam, mumbling, with \neyes closed, reported she was unable to move or sit up. \nAwoke/sat up immediately after use of narcan was discussed w/ \nnursing at bedside, reported she did not want narcan and had not \ntaken any extra meds. Neuro exam was then normal. Room search \ninitiated w/no meds found.  Her AM gabapentin, seroquel and \nclonazepam were held. The following AM, she was lethargic, \nslurring her words, unable to fully open eyes, pinpoint pupils.  \nTold her we were going to give narcan.  By the time we returned \nto the room 10 minutes later, she was awake, angry about mention \nof narcan, pupils 2mm and reactive.  Concerning for neurologic \nabnormality vs seizure vs pseudoseizure vs taking medications we \nare not administering. CT head was negative for acute \nabnormalities.  Compazine was discontinued as this was the only \nnew medication we had started.  Methadone was decreased from \nhome dose of 7.5 mg TID to 5mg TID. She was monitored on \ntelemetry for > 24 hrs with no other episodes.\n. \n# Moderate malnutrition with Vitamin B12/Copper deficiency: \nPreviously followed by nutrition. Albumin 3.8 on ___.  \nRestarted home copper gluconate, Vitamin D, Thiamine, \nCyanocobalamin, Multivitamins W/minerals once she was tolerating \nPO. Nutrition was consulted and recommended continuation of \nregular diet with addition of multivitamin and carnation drink \nTID. \n. \n# Hx of DVT with PE in ___ in setting of recent \nhospitalization and immobilization: Pt reports taking coumadin \n4mg ___ and 5mg all other days, although her INR was 1.0 on \nadmission. Followed by Dr. ___ home health aide that \nchecks her INR). Continued home coumadin with lovenox bridge \nwith INR 1.0 at time of discharge. It is possible that her GI \nabsorption is too poor to achieve a therapeutic INR.\n.\n# Depression/anxiety: Restarted home buproprion, clonazepam, \ndoxepin, mirtazapine, seroquel once tolerating PO.\n.\n## Transitional issues:\n- pt with h/o DVT and PE in ___ in setting of recent \nhospitalization and immobilization, reportedly on coumadin but \nwith INR of 1.0 on admission. It is possible that her GI \nabsorption is too poor to achieve a therapeutic INR. She is \ndischarged on a lovenox bridge and her home coumadin dose. An \nINR should be checked on ___, with anti-coagulation to be \nmanaged by Dr. ___.\n- Concern for QT prolongation given methadone and zofran use. \nHer QTc was 426 on ___ and should be rechecked at her next PCP \n___.\n- Patient was continued on home methadone 7.5mg TID for pain \nwhile inpatient. On ___ of ___ she was found to be AOx1, not \ncompliant with neuro exam, mumbling, with eyes closed, reported \nshe was unable to move or sit up. Awoke/sat up immediately after \nuse of narcan was discussed w/ nursing at bedside, reported she \ndid not want narcan and had not taken any extra meds. Neuro exam \nwas then normal. Room search initiated w/ no meds found. Similar \noccurrence on AM of ___ with pinpoint pupils, slurring of \nwords, inability to cooperate with neuro exam. Again resolved \nwithin minutes after discussion of narcan. CT head unremarkable. \nHeld home gabapentin, seroquel, clonazepam on ___ AM and \ndecreased methadone to 5mg TID. Discontinued compazine on ___ \nas this was the only new medication started during admission. \nResumed all home medications ___ of ___. Defer outpatient \nmethadone dosing to Dr. ___.\n- Code: DNR/DNI (confirmed) \n- Emergency Contact: ___ (daughter and HCP): \n___\n- ___ cessation.\n\n \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. BuPROPion (Sustained Release) 150 mg PO QAM \n2. Cholestyramine 2 gm PO BID \n3. ClonazePAM 1 mg PO TID \n4. copper gluconate 2 mg oral daily \n5. Doxepin HCl 75 mg PO HS \n6. Furosemide 40 mg PO DAILY \n7. Lidocaine Viscous 2% 15 mL PO TID:PRN reflux/odynophagia \n8. Maalox/Diphenhydramine/Lidocaine ___ mL PO QID:PRN \nodynophagia  \n9. Methadone 7.5 mg PO TID \n10. Mirtazapine 22.5 mg PO HS \n11. QUEtiapine Fumarate 100 mg PO QAM \n12. QUEtiapine Fumarate 300 mg PO QHS \n13. Vitamin D 1000 UNIT PO DAILY \n14. Omeprazole 40 mg PO BID \n15. Multivitamins W/minerals 1 TAB PO DAILY \n16. Thiamine 100 mg PO DAILY \n17. Ondansetron 4 mg PO Q8H:PRN nausea \n18. Gabapentin 600 mg PO Q8H \n19. Cyanocobalamin 1000 mcg PO DAILY \n20. Warfarin 5 mg PO 5X/WEEK (___) \n21. Warfarin 4 mg PO 2X/WEEK (MO,FR) \n\n \nDischarge Medications:\n1. Outpatient Lab Work\nINR; Dx: history of pulmonary embolism V12.55\nPlease fax results to: ___ \n___ \nPhone: ___ \nFax: ___ \n\n2. BuPROPion (Sustained Release) 150 mg PO QAM \n3. Cholestyramine 2 gm PO BID \n4. ClonazePAM 1 mg PO TID \n5. Cyanocobalamin 1000 mcg PO DAILY \n6. Doxepin HCl 75 mg PO HS \n7. Gabapentin 600 mg PO Q8H \n8. Lidocaine Viscous 2% 15 mL PO TID:PRN reflux/odynophagia \n9. Maalox/Diphenhydramine/Lidocaine ___ mL PO QID:PRN \nodynophagia  \n10. Mirtazapine 22.5 mg PO HS \n11. Multivitamins W/minerals 1 TAB PO DAILY \n12. QUEtiapine Fumarate 100 mg PO QAM \n13. QUEtiapine Fumarate 300 mg PO QHS \n14. Warfarin 5 mg PO 5X/WEEK (___) \n15. Warfarin 4 mg PO 2X/WEEK (MO,FR) \n16. Acetaminophen 1000 mg PO Q8H:PRN pain \nRX *acetaminophen 500 mg 2 tablet(s) by mouth every 8 hours Disp \n#*90 Tablet Refills:*0\n17. Docusate Sodium 100 mg PO BID \nRX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice \na day Disp #*60 Capsule Refills:*0\n18. Enoxaparin Sodium 70 mg SC Q12H \nStart: ___, First Dose: Next Routine Administration Time \nRX *enoxaparin 80 mg/0.8 mL 0.7 ml SC every 12 hours Disp #*30 \nSyringe Refills:*0\n19. Polyethylene Glycol 17 g PO DAILY constipation \nRX *polyethylene glycol 3350 [Miralax] 17 gram 1 packet by mouth \ndaily Disp #*30 Packet Refills:*0\n20. Senna 8.6 mg PO BID \nRX *sennosides [senna] 8.6 mg 1 capsule by mouth twice a day \nDisp #*60 Capsule Refills:*0\n21. copper gluconate 2 mg oral daily \n22. Omeprazole 40 mg PO BID \n23. Ondansetron 4 mg PO Q8H:PRN nausea \n24. Thiamine 100 mg PO DAILY \n25. Vitamin D 1000 UNIT PO DAILY \n26. Furosemide 40 mg PO DAILY \n27. Bisacodyl ___AILY:PRN constipation \nRX *bisacodyl 10 mg 1 suppository(s) rectally at night Disp #*10 \nSuppository Refills:*0\n28. Fleet Enema ___AILY:PRN constipation \nRX *sodium phosphates [Enema] 19 gram-7 gram/118 mL 1 enema(s) \nrectally daily Disp #*10 Each Refills:*0\n29. Bisacodyl 10 mg PO BID:PRN constipation \nRX *bisacodyl [Laxative] 5 mg 2 tablet(s) by mouth twice a day \nDisp #*60 Tablet Refills:*0\n30. Nicotine Patch 21 mg TD DAILY \nRX *nicotine 21 mg/24 hour Apply one patch to arm daily Disp #*7 \nEach Refills:*0\n31. Methadone 5 mg PO TID \nRX *methadone 5 mg 1 tablet by mouth every 8 hours Disp #*15 \nTablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary: abdominal pain, nausea, vomiting, constipation\nSecondary: esophagitis, depression, anxiety, malnutrition with \nvitamin B12 and copper deficiencies, history of DVT with PE on \ncoumadin\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear ___,\n\n___ was a pleasure taking care of you at ___.  You were \nadmitted for nausea, vomiting and abdominal pain.  This was \ninitially concerning for a possible small bowel obstruction, but \nan abdominal xray and abdominal cat scan did not show any \nevidence of obstruction.  Bariatric surgery evaluated you and \nrecommended medical management. The most likely cause of your \nnausea, vomiting and abdominal pain is severe constipation.  \nYour symptoms improved with anti-nausea medications and an \naggressive bowel regimen.  As we discussed, methadone and other \nopiate medications (such as dilaudid, morphine, oxycodone) \nfrequently cause constipation.  We encourage you to work with \nDr. ___ to decrease the amount of methadone you take at \nhome. We have prescibed several medications to help with your \nconstipation.  We recommend that you use senna, colace and \nmiralax daily.  The bisacodyl (by mouth and/or per rectum) and \nthe fleet enema should be used only if you become constipated. \nYou were noted to be very confused and slurring on ___ night \nand ___ morning. We held your medications briefly and \ndecreased your methadone given our concern that your medications \nwere interacting. You did not have further episodes of \nconfusion.\nYour INR (a measure of your coumadin activity) was also very low \nwhen you arrived, suggesting that there was no protective effect \nof coumadin in your body.  We started you on lovenox to help \nprevent blood clots while the coumadin level builds back up.  \nYou should continue to take both lovenox and coumadin at home \nand have your INR checked on ___.  Once your INR is \nat a protective level, you can stop taking the lovenox.  This \nwill be coordinated by your PCP, ___. \nPlease follow up at the appointment listed below.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb68b"
  },
  "note_id": "12648465-DS-21",
  "subject_id": 12648465,
  "hadm_id": 21417295,
  "note_type": "DS",
  "note_seq": 21,
  "charttime": "2205-12-17 00:00:00",
  "storetime": "2205-12-18 12:53:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine\n \nAttending: ___.\n \nChief Complaint:\nabdominal pain, vomiting \n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\nMs. ___ is a ___ year old lady with history of distant \ngastric bypass with multiple complications, chronic abdominal \npain, substance abuse on methadone, and pulmonary embolism \ncurrently on lovenox/warfarin who was recently admitted with \npersistent odynophagia, abdominal pain and nausea, found to have \nrecurrent esophagitis, and a more recent admission for abdominal \npain nausea and vomiting thought to be due to constipation \nsecondary to methadone overuse as outpatient, who comes in with \nabdominal pain and vomiting, similar to her presentation 2 weeks \nago.  \nDuring her last admission ___, her symptoms were initially \nconcerning for partial SBO although abdominal xray and CT did  \nnot support this diagnosis at that time. NG tube was placed but \ncame out overnight. Most likely etiology for her prior \npresentation was constipation, which may have been precipitated \nby methadone abuse in outpatient setting. Her symptoms at that \ntime wre managed medically with pantoprazole BID, standing \ntylenol and home methadone 7.5mg PO TID for pain, and an \naggressive bowel regimen (senna, colace, miralax, bisacodyl, \nenema). Her PCP had emailed on admission regarding concerns \nabout using methadone excessively at home, running out, then \nwithdrawing, and was in the process fo tapering methadone down \nas an outpatient. There have been concerns about opiate use in \nthe past as an outpatient. She was given zofran and compazine \nfor nausea with good relief. She transitioned from NPO to \nregular diet at that time within 48 hr of admission. EKG ___ \nshowed QTc 448, EKG ___ with QTc 426. She was weaned to \nmethadone 5mg TID and discharged on this dose. Of note she had \nseveral episodes of altered mental status w/ pinpoint pupils \nthat resolved spontaneously w/o narcan. The only new med was \ncompazine, this was stopped, her mental status was stable for 24 \nhours, and she was discharged home.  \nInitial vitals in the ED were: 98 100 ___ 99%.  \nLabs were notable for normal chem 7, lactate, coagulation \nprofile, no leukocytosis. CT abd-pelvis with oral contrast \nshowed no obstruction but significant constipation. She was seen \nby Bariatric surgery who recommended admission to Medicine if pt \nunable to tolerate PO's and treatment with 40 BID PPI, carafate, \nand banana bag. In the ED she was not able to tolerate PO. \nPatient was informed that narcotic pain medications will be \navoided as this will worsen her constipation which is likely the \nreason for her symptoms.  \nIn the ED she was given NS 3L, Dilaudid, Zofran, Acetaminophen, \nProtonix, Thiamine, FOlic Acid.  \nVitals prior to transfer were: 98.6 93 148/90 20 100% RA.  \nOn the floor, she reports that since discharge she has only had \none small BM 4 days ago. She feels that she never got better. \nReports emesis of bilious material ___ and continued \nepigastric burning worse when lying flat. Diffuse abdominal pain \nL>R. Reports compliance with miralax, enemas, suppositories, \ndulcolax and colace without any improvement. She feels burning \nchest pain and odynophagia when she swallows, but when her \nstomach is empty feels abdominal pain. No hematemesis. No \nmelena. Potentially saw red in her stool on ___ but is not \nsure about this. Reports severe abdominal pain and nausea, and \nthat zofran helps. Reports she has been taking 4g-5g tylenol \ndaily since discharge.  \n\n \nPast Medical History:\n-Morbid obesity (max 448lbs) s/p gastric bypass & CCY ___ at  \n___ and complete reversal  \n-History of HTN, DM, asthma (prior to gastric bypass)  \n-Opiate addiction: prior intranasal herion, oral dilaudid abuse, \nnow on methadone  \n-Depression/Anxiety  \n-Esophagitis: EGD ___ showed mild active esophagitis.\n-DVT/PE ___  \n-DJD  \n-2 SBOs  \n-Menopause completed  \n\nPast Surgical History:  \n-___- gastric bypass & CCY and subsequent complete  \nreversal  \n-7 surgeries on the abdomen. \"stomach leak\" hernia, 2 SBOs,  \nattempted reverse of the gastric bypass, the most recent in ___\n \nSocial History:\n___\nFamily History:\nMother with diabetes\n \nPhysical Exam:\nAdmission Physical:\n====================\nAfebrile, normotensive\nGENERAL: thin lady lying in bed, appears uncomfortable, no \nrespiratory distress, appears stated age  \nHEENT: EOMI, PERRL, anicteric sclera, MMM, nontender supple \nneck, no LAD, no JVD  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \nABDOMEN: nondistended, +BS, tender to palpation in all quadrants \nL>R, worst LUQ, no rebound  \nEXTREMITIES: moving all extremities well, no cyanosis, clubbing \nor edema  \nPULSES: 2+ ___ pulses bilaterally  \nNEURO: CN II-XII intact  \nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes\n\nDischarge Physical:\n====================\nVitals -  98.5  112/60  95  18  100% RA\nGENERAL: thin lady lying in bed, appears stated age, NAD  \nHEENT: MMM\nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \nABDOMEN: nondistended, +BS, tender to palpation in epigastric \nregion\nEXTREMITIES: moving all extremities well, no cyanosis, clubbing \nor edema  \nNEURO: alert, speech appropriate  \nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes\n \nPertinent Results:\nAdmission Labs: \n=================\n___ 06:40PM BLOOD WBC-4.9 RBC-3.57* Hgb-11.0* Hct-34.5* \nMCV-97 MCH-30.9 MCHC-32.0 RDW-15.7* Plt ___\n___ 06:40PM BLOOD Neuts-50.0 Lymphs-42.8* Monos-3.9 Eos-2.4 \nBaso-0.8\n___ 07:24PM BLOOD ___ PTT-34.4 ___\n___ 06:40PM BLOOD Glucose-87 UreaN-10 Creat-0.7 Na-141 \nK-3.8 Cl-106 HCO3-28 AnGap-11\n___ 06:40PM BLOOD ALT-9 AST-10 AlkPhos-86 TotBili-0.2\n___ 06:40PM BLOOD cTropnT-<0.01\n___ 06:43PM BLOOD Lactate-1.0\n\nUrinalysis:\n============\n___ 01:45AM URINE Color-Straw Appear-Clear Sp ___\n___ 01:45AM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-2* pH-6.5 Leuks-NEG\n\nDischarge Labs:\n=================\n___ 09:34AM BLOOD WBC-4.5 RBC-3.77* Hgb-11.4* Hct-37.1 \nMCV-98 MCH-30.1 MCHC-30.6* RDW-16.0* Plt ___\n___ 08:00AM BLOOD ___\n___ 08:00AM BLOOD Glucose-109* UreaN-11 Creat-0.9 Na-143 \nK-3.8 Cl-105 HCO3-24 AnGap-18\n___ 08:00AM BLOOD Calcium-9.1 Phos-4.3 Mg-2.0\n\nImaging:\n===========\nEKG ___: Normal sinus rhythm. ECG within normal limits. No \ndiagnostic changefrom previous tracing of ___.\n___\n___\n\nCT Abdomen/Pelvis w/ contrast ___: \n1.  No evidence of bowel obstruction with oral contrast passing \nto the level of the colon.\n \n2.  Stable mild dilatation of the CBD compared to the prior CT \nfrom ___, and again may be related to sphincter of \nOddi dysfunction.\n \n3.  Stable ___ opacities at the bases of the lungs \nbilaterally, likely secondary to small airways infection or \naspiration.\n\n \nBrief Hospital Course:\n___ with history of gastric bypass s/p reversal, esophagitis, \nchronic pain, PE presenting with odynophagia, nausea and \nabdominal pain.\n\n# Odynophagia: Differential included recurrent esophagitis vs \nesophageal or anastamotic ulcer vs infection. Without fevers and \nWBC stable from prior with known history of esophagitis and \nreport of lack of adherence to PPI at home, esophagitis was \nthought to be most likely etiology of ___ pain. Her \nesophagitis may also have been worsened by worsened reflux \nrelated to her constipation as below. Given stable hematocrit \nand no evidence of bleeding on exam, EGD was deferred on this \nadmission. Patient was treated with IV PPI BID then transitioned \nto omeprazole BID. Her pain was controlled with home methadone, \nsucralfate and maalox/diphenhydramine/lidocaine mouth wash with \ngood effect and patient was able to tolerate POs prior to \ndischarge. Patient should continue BID PPI until follow-up with \nGI as an outpatient next month. \n\n#Abdominal Pain/nausea/vomiting: Patient with significant pain \nto palpation particularly at LLQ with evidence of significant \nstool burden on CT abdomen on admission and no bowel movement \nfor 6 days prior to admission. No evidence of infection based on \nCT abdomen, WBC count and temperature (afebrile). Likely that \n___ constipation worsened by methadone and zofran which \ncan be constipating. Constipation treated with multiple mineral \noil and tap water enemas as well as miralax, colace and senna \nwith improvement in constipation and abdominal pain. Nausea \nimproved with relief of constipation and IV zofran. Patient was \ntransitioned back to higher dose of PO zofran prior to discharge \nwhich she tolerated well. Patient discharged on aggressive bowel \nregimen. Methadone (likely cause of constipation) to be tapered \nper PCP as below.\n\n# Chronic Pain: Per Dr. ___ PCP), patient is \ncurrently tapering methadone and was scheduled to taper to 5mg \ndaily on day of admission. In the setting of symptoms consistent \nwith esophagitis, further taper of methadone deferred and \npatient was continued on previous dosing of methadone 5mg BID \nwith plan for follow-up at ___ office on ___ for discussion \nregarding further methadone taper. \n\n# Pinpoint pupils and mild impaired responsiveness: Patient with \ndifficulty waking from sleep AM of ___ for ___ minutes. She was \nnoted to be difficult to wake fully with pinpoint pupils, \nanswering questions but unable to move more than a few inches in \nbed. Spontaneously improved with pupils dilated to baseline. \nUnclear etiology. No known seizure history, no post-ictal state. \nNeurology was curbsided and did not reel that description was \nconsistent with any classic seizure presentation. Patient with \nsimilar issue on last admission and is not sure if this happens \nsometimes at home as well. Other considerations for etiology \ninclude sleep disorder vs medication effect given multiple \ncentral acting medications. Patient scheduled for outpatient \nneurology follow-up. Would also consider outpatient sleep study \nif this persists. \n\n# Hx of DVT with PE in ___: PE and DVTs in setting of \nhospitalization and immobilization. Patient with subtherapeutic \n(normal) INR on admission with concern that patient has either \nnot been taking her coumadin or has been unable to absorb \nrelated to prior abdominal surgeries. Patient was continued on \nenoxaparin 70 BID and coumadin 7mg daily on this admission. INR \nof 1.0 on discharge. \n\n  \n# Depression/anxiety: Patient continued on home buproprion, \nclonazepam, doxepin, mirtazapine and seroquel once able to \ntolerate PO medications (HD2).\n \n--\nTransitional Issues:\n- Code: DNR/DNI (confirmed)\n- Emergency Contact: ___ (daughter and HCP): \n___\n- Please repeat MRCP in ___ or ___ for follow-up of possible \nsphincter of Oddi dysfunction\n- Consider social work for placement into day program. At this \ntime, ___ daughter comfortable with patient coming home \nbut concerned about her day time activities and hopeful for \nrespite during the day to help her mom improve\n-Patient with recurrent episode of lethargy on waking, pinpoint \npupils that spontaneously resolved. Per discussion with neuro, \nsymptoms not consistent with seizures but would consider further \nneuro work-up as outpatient and possible sleep study given \nepisodes occur when waking up\n-Continue taper of methadone to 5mg daily and off \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. BuPROPion (Sustained Release) 150 mg PO QAM \n2. Cholestyramine 2 gm PO BID \n3. ClonazePAM 1 mg PO TID \n4. Cyanocobalamin 1000 mcg PO DAILY \n5. Doxepin HCl 75 mg PO HS \n6. Gabapentin 600 mg PO Q8H \n7. Lidocaine Viscous 2% 15 mL PO TID:PRN reflux/odynophagia \n8. Maalox/Diphenhydramine/Lidocaine ___ mL PO QID:PRN \nodynophagia  \n9. Mirtazapine 22.5 mg PO HS \n10. Multivitamins W/minerals 1 TAB PO DAILY \n11. QUEtiapine Fumarate 100 mg PO QAM \n12. QUEtiapine Fumarate 300 mg PO QHS \n13. Warfarin 7 mg PO DAILY16 \n14. Acetaminophen 1000 mg PO Q8H:PRN pain \n15. Docusate Sodium 100 mg PO BID \n16. Enoxaparin Sodium 70 mg SC Q12H \n17. Polyethylene Glycol 17 g PO DAILY constipation \n18. Senna 8.6 mg PO BID \n19. copper gluconate 2 mg oral daily \n20. Omeprazole 40 mg PO BID \n21. Ondansetron 4 mg PO Q8H:PRN nausea \n22. Thiamine 100 mg PO DAILY \n23. Vitamin D 1000 UNIT PO DAILY \n24. Furosemide 40 mg PO DAILY \n25. Bisacodyl ___AILY:PRN constipation \n26. Fleet Enema ___AILY:PRN constipation \n27. Bisacodyl 10 mg PO BID:PRN constipation \n28. Nicotine Patch 21 mg TD DAILY \n29. Methadone 5 mg PO TID \n\n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO Q8H:PRN pain \n2. Bisacodyl ___AILY:PRN constipation \n3. BuPROPion (Sustained Release) 150 mg PO QAM \n4. Cholestyramine 2 gm PO BID \n5. ClonazePAM 1 mg PO TID \n6. Cyanocobalamin 1000 mcg PO DAILY \n7. Docusate Sodium 100 mg PO BID \n8. Doxepin HCl 75 mg PO HS \n9. Enoxaparin Sodium 70 mg SC Q12H \nStart: ___, First Dose: Next Routine Administration Time \nRX *enoxaparin 80 mg/0.8 mL 0.7 mL SC twice a day Disp #*30 \nSyringe Refills:*0\n10. Furosemide 40 mg PO DAILY \n11. Gabapentin 600 mg PO Q8H \n12. Maalox/Diphenhydramine/Lidocaine ___ mL PO QID:PRN \nodynophagia  \n13. Methadone 5 mg PO BID \nRX *methadone 5 mg 1 tablet by mouth twice a day Disp #*8 Tablet \nRefills:*0\n14. Mirtazapine 22.5 mg PO HS \nRX *mirtazapine 45 mg 0.5 (One half) tablet(s) by mouth at \nbedtime Disp #*30 Tablet Refills:*0\n15. Nicotine Patch 21 mg TD DAILY \n16. Omeprazole 40 mg PO BID \nRX *omeprazole 40 mg 1 capsule(s) by mouth twice a day Disp #*30 \nCapsule Refills:*0\n17. Ondansetron 8 mg PO Q8H:PRN nausea \nRX *ondansetron 8 mg 1 tablet(s) by mouth every eight (8) hours \nDisp #*15 Tablet Refills:*0\n18. Polyethylene Glycol 17 g PO BID \nRX *polyethylene glycol 3350 17 gram 17g powder(s) by mouth \ntwice a day Disp #*30 Packet Refills:*0\n19. QUEtiapine Fumarate 100 mg PO QAM \n20. QUEtiapine Fumarate 300 mg PO QHS \n21. Senna 8.6 mg PO BID \nRX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp \n#*30 Tablet Refills:*0\n22. Thiamine 100 mg PO DAILY \n23. Vitamin D 1000 UNIT PO DAILY \n24. Warfarin 7 mg PO DAILY16 \n25. Sucralfate 1 gm PO QID \nRX *sucralfate 1 gram/10 mL 10mL suspension(s) by mouth four \ntimes a day Refills:*0\n26. Bisacodyl 10 mg PO BID:PRN constipation \n27. copper gluconate 2 mg oral daily \n28. Fleet Enema ___AILY:PRN constipation \n29. Multivitamins W/minerals 1 TAB PO DAILY \n30. Lidocaine Viscous 2% 15 mL PO TID:PRN reflux/odynophagia \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary Diagnosis:\n1. Constipation\n2. Esophagitis\n\nSecondary Diagnosis:\n1. Chronic Pain\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the hospital with nausea, abdominal pain \nand pain with swallowing. You had a CT scan done of your abdomen \nwhich showed significant constipation. You were given enemas and \noral medications with relief of your constipation and \nimprovement in your nausea. It is VERY important that you \ncontinue to take your medications for constipation to prevent \nrecurrent abdominal pain.\n\nIn terms of your pain with swallowing, this was thought to be \nsecondary to recurrent esophagitis. You were treated with \nomeprazole (an acid suppression medication), sucralafate and \nmaalox/lidocaine mouth wash with improvement in your pain. Your \nnausea was treated with zofran and you were tolerating food and \nfluids prior to discharge.\n\nFinally, you were continued on methadone during this admission. \nYou are being discharged on your previous methadone dose of 5mg \ntwice per day. It is very important that you take this \nmedication as prescribed. When you follow-up at the ___ \nCenter, you will talk about continuing your methadone taper. \n\nYour INR was low in the hospital and you will go home with \nlovenox injections until your INR is high enough to protect you \nfrom blood clots. You will need to get your next INR drawn \n___ and follow up with your ___ clinic.\n\nIt was a pleasure taking care of you!\nYour ___ Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb68c"
  },
  "note_id": "12648465-DS-22",
  "subject_id": 12648465,
  "hadm_id": 27952350,
  "note_type": "DS",
  "note_seq": 22,
  "charttime": "2205-12-23 00:00:00",
  "storetime": "2205-12-23 17:39:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine\n \nAttending: ___.\n \nChief Complaint:\nabdominal pain\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\n___ w/substance abuse on methadone who presents with recurrent \nabdominal pain, n/v. Pt ___ and ___ with abd pain, n/v. On \nboth admissions pt with normal labs and only finding on CT was \nlarge stool burden. Pt treated for constipation and esophagitis \nand pain improved. She reports not having any BMs since \ndischarge. Has not eaten anything in past 2 days due to nausea \nand vomiting with some dark red-tinged emesis.\nOf note there has been concern for pt abusing her methadone, \nrunning out early, is in the process of tapering dose with PCP.\nIn ED bariatric surgery consulted. Rec CT scan which did not \nshow obstruction, but did find large stool burden. Pt given \nzofran and dilaudid. Emesis was witnessed yellow, no blood seen.\n\nOn arrival to the floor pt reports abdominal pain. Upset because \nshe does not think sx are due to constipation. Also upset that \nshe will not be given dilaudid for pain. States she has been \ncompliant with all medications since discharge. Denies chest \npain.\n\nROS: +as above, otherwise reviewed and negative\n\n \nPast Medical History:\n-Morbid obesity (max 448lbs) s/p gastric bypass & CCY ___ at  \n___ and complete reversal  \n-History of HTN, DM, asthma (prior to gastric bypass)  \n-Opiate addiction: prior intranasal herion, oral dilaudid abuse, \nnow on methadone  \n-Depression/Anxiety  \n-Esophagitis: EGD ___ showed mild active esophagitis.\n-DVT/PE ___  \n-DJD  \n-2 SBOs  \n-Menopause completed  \n\nPast Surgical History:  \n-___- gastric bypass & CCY and subsequent complete  \nreversal  \n-7 surgeries on the abdomen. \"stomach leak\" hernia, 2 SBOs,  \nattempted reverse of the gastric bypass, the most recent in ___\n \nSocial History:\n___\nFamily History:\nMother with diabetes\n \nPhysical Exam:\nVitals: T:98.2 BP:100/68 P:84 R:16 O2:99%ra  \nPAIN: 8\nGeneral: nad\nLungs: clear\nCV: rrr no m/r/g\nAbdomen: hypoactive bowel sounds present, soft, mild diffuse \ntenderness\nExt: no e/c/c\nSkin: no rash\nNeuro: alert, follows commands\n\n \nPertinent Results:\n___ 03:00PM   GLUCOSE-90 UREA N-9 CREAT-0.6 SODIUM-140 \nPOTASSIUM-4.5 CHLORIDE-103 TOTAL CO2-26 ANION GAP-16\n___ 03:00PM   LIPASE-10\n___ 03:00PM   CALCIUM-9.2 PHOSPHATE-4.0 MAGNESIUM-2.1\n___ 03:00PM   WBC-4.4 RBC-3.79* HGB-11.6* HCT-37.2 MCV-98 \nMCH-30.7 MCHC-31.3 RDW-15.7*\n___ 03:00PM   NEUTS-66.5 ___ MONOS-3.3 EOS-0.7 \nBASOS-0.9\n___ 03:00PM   PLT COUNT-286\n___ 03:00PM   ___ PTT-29.3 ___\n\nCT Abd/Pel: \n1.  No evidence of bowel obstruction.  Moderate colonic fecal \nload with no evidence of colitis.   \n2.  Stable central intrahepatic biliary dilatation.   \n\n \nBrief Hospital Course:\n___ yo F with history of gastric bypass s/p reversal and chronic \npain, on methadone who presents with recurrent abdominal pain \ndue to constipation. \n\nConstipation: Patient was treated with an aggressive bowel \nregimen which produced a bowel movement on admission. The \npatient was advised that she was safe for discharge, but she \nrequested a gastroenterology consultation for her constipation. \nGastroenterology also felt that an outpatient colonoscopy would \nbe indicated. They also recommended an EUS to locate the ampulla \nand confirm that ampullary stenosis was not playing a role in \nher chronically dilated biliary tree, and they recommended \noutpatient B12 injections.\n\nDVT/PE: The patient was continued on enoxaparin bridge while her \nINR was \nsubtherapeutic. Coumadin was increased. Of note, the patient did \nreport taking lovenox 80mcg bid instead of the prescribed 70mcg \nbid. ___ RN did encourage her to take the prescribed dose. \n\nEsophagitis: Likely source of scant hematemesis, no blood seen \nsince arrival to ED and hematcrit was stable. Pt reported that \nshe needed prior authorization for bid omeprazole dosing, so she \nhadn't been taking omeprazole. I called her pharmacy and they \nreported that they had filled omeprazole for daily dosing. I \nencouraged the patient to continue taking her omeprazole daily \nwhile awaiting prior auth for bid dosing. Of note, the patient \noften refused her Sucralfate while in the hospital.\n\nChronic pain: Patient is in the midst of a methadone taper per \nher PCP. She was tapered to methadone 5mg daily during this \nhospitalization. \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 1000 mg PO Q8H:PRN pain \n2. Bisacodyl ___AILY:PRN constipation \n3. BuPROPion (Sustained Release) 150 mg PO QAM \n4. Cholestyramine 2 gm PO BID \n5. ClonazePAM 1 mg PO TID \n6. Cyanocobalamin 1000 mcg PO DAILY \n7. Docusate Sodium 100 mg PO BID \n8. Doxepin HCl 75 mg PO HS \n9. Enoxaparin Sodium 70 mg SC Q12H \n10. Furosemide 40 mg PO DAILY \n11. Gabapentin 600 mg PO Q8H \n12. Maalox/Diphenhydramine/Lidocaine ___ mL PO QID:PRN \nodynophagia  \n13. Methadone 5 mg PO BID \n14. Mirtazapine 22.5 mg PO HS \n15. Nicotine Patch 21 mg TD DAILY \n16. Omeprazole 40 mg PO BID \n17. Ondansetron 8 mg PO Q8H:PRN nausea \n18. Polyethylene Glycol 17 g PO BID \n19. QUEtiapine Fumarate 100 mg PO QAM \n20. QUEtiapine Fumarate 300 mg PO QHS \n21. Senna 8.6 mg PO BID \n22. Thiamine 100 mg PO DAILY \n23. Vitamin D 1000 UNIT PO DAILY \n24. Warfarin 7 mg PO DAILY16 \n25. Sucralfate 1 gm PO QID \n26. Bisacodyl 10 mg PO BID:PRN constipation \n27. copper gluconate 2 mg oral daily \n28. Fleet Enema ___AILY:PRN constipation \n29. Multivitamins W/minerals 1 TAB PO DAILY \n30. Lidocaine Viscous 2% 15 mL PO TID:PRN reflux/odynophagia \n\n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO Q8H:PRN pain \n2. Bisacodyl 10 mg PO BID:PRN constipation \n3. BuPROPion (Sustained Release) 150 mg PO QAM \n4. Cholestyramine 2 gm PO BID \n5. ClonazePAM 1 mg PO TID \n6. Cyanocobalamin 1000 mcg PO DAILY \n7. Docusate Sodium 100 mg PO BID \n8. Doxepin HCl 75 mg PO HS \n9. Enoxaparin Sodium 70 mg SC Q12H \nStart: ___, First Dose: Next Routine Administration Time \n10. Fleet Enema ___AILY:PRN constipation \n11. Furosemide 40 mg PO DAILY \n12. Gabapentin 600 mg PO Q8H \n13. Lidocaine Viscous 2% 15 mL PO TID:PRN reflux/odynophagia \n14. Maalox/Diphenhydramine/Lidocaine ___ mL PO QID:PRN \nodynophagia  \n15. Nicotine Patch 21 mg TD DAILY \n16. Mirtazapine 22.5 mg PO HS \n17. Omeprazole 40 mg PO BID \n18. Polyethylene Glycol 17 g PO BID \n19. QUEtiapine Fumarate 100 mg PO QAM \n20. QUEtiapine Fumarate 300 mg PO QHS \n21. Senna 8.6 mg PO BID \n22. Sucralfate 1 gm PO QID \n23. copper gluconate 2 mg oral daily \n24. Multivitamins W/minerals 1 TAB PO DAILY \n25. Ondansetron 8 mg PO Q8H:PRN nausea \n26. Thiamine 100 mg PO DAILY \n27. Vitamin D 1000 UNIT PO DAILY \n28. Bisacodyl 10 mg PO HS \n29. Warfarin 10 mg PO DAILY16 \nRX *warfarin 5 mg 2 tablet(s) by mouth daily Disp #*30 Tablet \nRefills:*0\n30. Methadone 5 mg PO DAILY \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nConstipation\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nYou were admitted to the hospital with nausea, abdominal pain \nand pain with swallowing. You had a CT scan done of your abdomen \n\nwhich showed significant constipation. You were given enemas and \n\noral medications with relief of your constipation and \nimprovement in your nausea. It is VERY important that you \ncontinue to take your medications for constipation to prevent \nrecurrent abdominal pain.\n\nThe gastroenterology team saw you in consultation. They \nrecommend that you take a daily bowel regimen in anticipation of \ngetting a colonscopy soon. They will schedule you for an \noutpatient colonoscopy.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb68d"
  },
  "note_id": "12648465-DS-23",
  "subject_id": 12648465,
  "hadm_id": 21975775,
  "note_type": "DS",
  "note_seq": 23,
  "charttime": "2206-01-18 00:00:00",
  "storetime": "2206-01-18 20:55:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine\n \nAttending: ___\n \nChief Complaint:\nnausea/vomiting/abdominal pain\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nThe patient is a ___ year old female with h/o morbid obesity s/p\ngastric bypass ___ years ago with complications now s/p reversal,\ns/p CCY, ashtma, tobacco use, DM, and narcotic abuse who p/w 9\ndays of n/v and inability to tolerate po intake. While in the ED\nher dtr ___ called to report that her mother abuses pain meds\nand benzos. She was most recently hospitalized at ___ from\n___ with abdominal pain, nausea and vomiting. She was \nfound\nto have moderate fecal loading on CT scan thus started on an\naggressive bowel regimen. She was seen by GI and they \nrecommended\nthat she have an o/p colonoscopy and also direct visualization \nof\nthe ampulla given her biliary ductal dilatation.\nShe then saw Dr. ___ in clinic on ___ with plans for an \no/p\ncolonoscopy and EGD to look at ampulla but pt did not keep this\nappointment because she felt so sick. \n.\nSince her last admission she reports that her constipation has\nimproved because she takes miralax daily, suppositories twice a\nweek and enemas twice per week. She was also able to eat well\nuntil the day before Mother's Day- she usually eat 6 small meals\nper day. After dinner she developed recurrent nausea -> bilious\nemesis without blood with the last day of emesis on ___. \nShe\nhas lost 18 lbs since her admission in ___. \nNo fevers or chills. She does not report diarrhea but her stool\nis loose from her bowel regimen. \n.\nShe has chronic L mid quadrant abdominal pain ___ which\ncontinues and is no better in spite of the improvement in her\nconstipation.\n.\nOver the past two days she developed new supra-pubic pain just\nprior to defecating which improves with defecation.\n.\nShe lives with her son in law's mother who was recently \ndiagnosed\nwith measles.\n.\nShe does not have fever or chills. She does not report chest\npain, shortness of breath, coughing, new rashes, \n.\nShe reports that her reflux is slowly getting better but she is\nunable to eat high fiber foods like salad and she is still\nsleeping with 6 pillows. \n\n+ sneezing which she attributes to allergies\n+ bruising when she takes lovenox. \n\nIn ER: (Triage Vitals:4 97.6 92 92/45 18 98% RA  ) \nMeds Given: Ondansetron 2mg/mL-2mL /Acetaminophen 325mg Tablet x\n2, Ondansetron 2mg/mL-2mL, Acetaminophen (Liquid) 650mg UD Cup \n.\nFluids given: \nRadiology Studies: Adominal CT scan \nconsults called: none\n.\nPAIN SCALE: ___\n \nPast Medical History:\n-Morbid obesity (max 448lbs) s/p gastric bypass & CCY ___ at  \n___ and complete reversal  \n-History of HTN, DM, asthma (prior to gastric bypass)  \n-Opiate addiction: prior intranasal herion, oral dilaudid abuse, \nnow on methadone  \n-Depression/Anxiety  \n-Esophagitis: EGD ___ showed mild active esophagitis.\n-DVT/PE ___  \n-DJD  \n-2 SBOs  \n-Menopause completed  \n\nPast Surgical History:  \n-___- gastric bypass & CCY and subsequent complete  \nreversal  \n-7 surgeries on the abdomen. \"stomach leak\" hernia, 2 SBOs,  \nattempted reverse of the gastric bypass, the most recent in ___\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN.\n \nPhysical Exam:\nPHYSICAL EXAM:  \nVITAL SIGNS: \nPAIN SCORE ___ L sided mid abdomen\n.\n1. VS:  T = 97.8 P = 71 BP = 92/66 RR = 18 O2Sat on  _100% on RA \n\nGENERAL: Thin chronically ill appearing female laying in bed.  \nMentation: alert, speaks in full sentences\n2. Eyes: [] WNL \nPERRL, EOMI without nystagmus, Conjunctiva:\nclear/injection/exudates/icteric Ears/Nose/Mouth/Throat: MMM, no\nlesions noted in OP  \n3. ENT [] WNL\n[] Moist  [] Endentulous  [] Ulcers  [] Erythema  [] JVD ____ cm\n[X] Dry  [] Poor dentition  [] Thrush  [] Swelling  [] Exudate\n4. Cardiovascular [] WNL\n[X] Regular  [] Tachy  [X] S1 [X] S2 [-] Systolic Murmur     /6,\nLocation:\n[] Irregular  []Brady []S3  [] S4  [] Diastolic Murmur    /6,\nLocation:\n[X] Edema RLE  None \n[X] Edema LLE None \n[] Vascular access  [X] Peripheral [] Central site:\n5. Respiratory [X ]WNL\n[] CTA bilaterally  [ ] Rales  [ ] Diminshed\n[] Comfortable     [ ] Rhonchi   [ ] Dullness\n[ ] Percussion WNL  [ ] Wheeze   [] Egophony\n6. Gastrointestinal [ ] WNL\nnabs, soft, redundant skin present, \nWell healed remote midline surgical scar\nL mid quadrant tenderness with moderate palptaion. \n[] Soft/firm  [- Rebound [] No hepatomegaly  [] Non-tender []\nTender [] No splenomegaly\n[] Non distended  [] distended  [] bowel sounds Yes/No  [] \nguiac:\npositive/negative\n7. Musculoskeletal-Extremities [] WNL\n[ ] Tone WNL  [XUpper extremity strength ___ and symmetrical  [\n]Other:\n\n[ ] Bulk WNL    [X] Lower extremity strength ___ and symmetrica \n[\n] Other:\n\n[] Normal gait  []No cyanosis  [ ] No clubbing  [] No joint\nswelling\n\n8. Neurological [] WNL\n\n[X ] Alert and Oriented x 3 [ ] Romberg: Positive/Negative  [ ]\nCN II-XII intact  [+ ] Normal attention  [ ] FNF/HTS WNL []\nSensation WNL  [ ] Delirious/confused  [ ] Asterixis\nPresent/Absent  [ ] Position sense WNL\n\n[ ] Demented  [ ] No pronator drift  [] Fluent speech\nShe has a delayed response to questions but speech is logical. \n9. Integument  [X] WNL\n[] Warm  [] Dry  [] Cyanotic [] Rash:\nnone/diffuse/face/trunk/back/limbs  \n[ ] Cool [] Moist  [] Mottled  [] Ulcer:\nNone/decubitus/sacral/heel: Right/Left\n10. Psychiatric [X] WNL\n\n[X] Appropriate [] Flat affect [] Anxious [] Manic [] \nIntoxicated\n[] Pleasant [] Depressed [] Agitated [] Psychotic \n\n[] Combative\n\n11. Hematologic/Lymphatic  [ ]WNL\n\n[] No cervical ___ [] No axillary ___  [] No supraclavicular ___\n[] No inguinal ___ [] Thyroid WNL [] Other:\n. \n\n \nPertinent Results:\n139  ___   AGap=14 \n----------------\n3.3  26  1.1  \nComments: Glucose: If Fasting, 70-100 Normal, >125 Provisional\nDiabetes \n\nestGFR: 53/64 (click for details)  \nCa: 9.6 Mg: 1.7 P: 5.0\nALT: 13 AP: 82 Tbili: 0.2 Alb: 4.1 \nAST: 27 LDH:  Dbili:  TProt:  \n___:  Lip: 281     \n\n___: 11.6  PTT: 32.3  INR: 1.1  \n\n 97 \n6.9 ___  12.0  227 \n  \n /38.8\\  \n N:71.0 L:24.5 M:3.3 E:0.8 Bas:0.4 \n\nCT abd/pelvis with contrast\nIMPRESSION:\n \n1.  No acute abdominal or pelvic pathology, with no evidence of \nobstruction or\nperforation.\n \n2.  Stable central intrahepatic biliary dilatation.\n \n\nOLD STUDIES\n___\n EGD: Mild esophagitis in the lower third of the\nesophagus, biopsies performed. Previous gastric bypass of the\nstomach, with a small (1-2 cm) remnant stomach and a\ngastrojejunal anastamosis. Erythema of the mucosa in the remnant\nstomach, biopsies performed. \n\nEUS: Dilated pancreas duct to 3.2 mm in the pancreas body,\notherwise normal. Normal pancreas parenchyma and ___\nvasculature. The common bile duct and pancreas head and uncinate\nprocess could not be imaged due to altered gastric anatomy.\nOtherwise normal EGD and upper EUS to jejunum.\n\nMRCP: ___\nIntrahepatic bile duct dilatation and extrahepatic bile duct\ndilatation which \nis mild to moderate and overall similar when compared to the\nprior examination \nfrom ___ with areas of focal narrowing similar to\nprevious. Main \npancreatic duct is also dilated to 4 mm, similar to previous. No\nobstructing \nstones are seen. Status post cholecystectomy. Previous gastric\nbypass \nsurgery with reversal. Remainder findings similar to previous.  \n\n \nBrief Hospital Course:\n___ yo woman with history of gastric bypass s/p reversal and \nchronic abdominal pain, constipation, esophagitis, who presents \nwith worsened abdominal pain (including epigastrum), nausea, \nvomiting\n.\n#Abdominal pain\n#Acute pancreatitis vs. sphincter of Oddi dysfunction vs. other\n#Known esophagitis\n#hx gastric bypass with reversal surgery\n#known stable intra- and extra-hepatic biliary dilation, known \nPD dilation\n\nExact cause of pain is not clear, but she was initially treated \nfor possible acute pancreatitis based on elevated lipase >3x \nupper limit of normal (bowel rest, IVF, supportive care).  \nInterestingly, her lipase normalized rapidly by the next day and \nshe also reported feeling hungry, improved n/v.  She was seen by \nour GI consultants as well who also considered whether she might \nhave an element of sphincter of Oddi dysfunction or ampullary \nstenosis.  They recommended slowly advancing diet as tolerated, \nno plans for endoscopic studies in-house (especially during \nacute exacerbation), and close f/u with GI Dr. ___ \nconsideration of repeat EGD/EUS (ampulla and CBD not visualized \nlast time due to changed anatomy) with possible colonoscopy (hx \nFe deficiency anemia).\n\nShe is now tolerating a regular diet.  We have recommended low \nfat diet with frequent small meals.  \n\n#DVT/PE - continued on lovenox (sub therapeutic INR) and \ncoumadin.  She missed dose of coumadin on ___, held in case any \nstudies planned.\n.\nEsophagitis:  continued PPI\n.\nChronic pain: now off narcotics, tapered off methadone as outpt. \n Continue neurontin.  GI also recommended consideration of \ntricyclic such as amitriptyline for control of chronic pain.  We \navoided opioids during this admission due to her well-reported \npast history of narcotic abuse.  She did receive several doses \nof tramadol in-house which she felt helped her pain, but after \ndiscussion with her PCP, we decided no further tramadol as an \noutpt due to the potential for drug-drug interactions with her \npsychotropic meds.\n\n.\nAnxiety and depression \nContinue bupropion/clonazepam/remeron\n.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 650 mg PO Q4-6H: PRN pain \n2. Bisacodyl 10 mg PO BID:PRN constipation \n3. BuPROPion (Sustained Release) 150 mg PO QAM \n4. ClonazePAM 1 mg PO TID \n5. Cyanocobalamin 1000 mcg PO DAILY \n6. Docusate Sodium 100 mg PO BID \n7. Doxepin HCl 75 mg PO HS \n8. Enoxaparin Sodium 70 mg SC Q12H \n9. Fleet Enema ___AILY:PRN constipation \n10. Furosemide 40 mg PO DAILY \n11. Gabapentin 600 mg PO Q8H \n12. Maalox/Diphenhydramine/Lidocaine ___ mL PO QID:PRN \nodynophagia  \n13. Mirtazapine 22.5 mg PO HS \n14. Omeprazole 40 mg PO BID \n15. Polyethylene Glycol 17 g PO BID \n16. QUEtiapine Fumarate 100 mg PO QAM \n17. QUEtiapine Fumarate 300 mg PO QHS \n18. Senna 8.6 mg PO BID \n19. Sucralfate 1 gm PO QID \n20. Multivitamins W/minerals 1 TAB PO DAILY \n21. Ondansetron 8 mg PO Q8H:PRN nausea \n22. Thiamine 100 mg PO DAILY \n23. Vitamin D 1000 UNIT PO DAILY \n24. Warfarin 13 mg PO DAILY16 \n\n \nDischarge Medications:\n1. Acetaminophen 650 mg PO Q4-6H: PRN pain \n2. Bisacodyl 10 mg PO BID:PRN constipation \n3. BuPROPion (Sustained Release) 150 mg PO QAM \n4. ClonazePAM 1 mg PO TID \n5. Cyanocobalamin 1000 mcg PO DAILY \n6. Docusate Sodium 100 mg PO BID \n7. Doxepin HCl 75 mg PO HS \n8. Enoxaparin Sodium 70 mg SC Q12H \nStart: Today - ___, First Dose: Next Routine Administration \nTime \n9. Fleet Enema ___AILY:PRN constipation \n10. Maalox/Diphenhydramine/Lidocaine ___ mL PO QID:PRN \nodynophagia  \n11. Mirtazapine 22.5 mg PO HS \n12. Multivitamins W/minerals 1 TAB PO DAILY \n13. Polyethylene Glycol 17 g PO BID \n14. QUEtiapine Fumarate 100 mg PO QAM \n15. QUEtiapine Fumarate 300 mg PO QHS \n16. Senna 8.6 mg PO BID \n17. Sucralfate 1 gm PO QID \n18. Thiamine 100 mg PO DAILY \n19. Vitamin D 1000 UNIT PO DAILY \n20. Warfarin 13 mg PO DAILY \n21. Furosemide 40 mg PO DAILY \n22. Gabapentin 600 mg PO Q8H \nRX *gabapentin 600 mg 1 tablet(s) by mouth three times a day \nDisp #*90 Tablet Refills:*0\n23. Omeprazole 40 mg PO BID \n24. Ondansetron 8 mg PO Q8H:PRN nausea \nRX *ondansetron 8 mg 1 tablet(s) by mouth every eight (8) hours \nDisp #*15 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAcute on chronic abdominal pain\nAcute pancreatitis vs. sphincter of Oddi dysfunction\n\nSecondary:\nhx of gastric bypass surgery with reversal\nhx deep vein thrombosis/pulmonary embolism\n\n \nDischarge Condition:\ncondition: stable\nmental status: oriented x 3\nambulatory: independent\n\n \nDischarge Instructions:\nYou were admitted with an exacerbation of your abdominal pain.  \nAlthough we do not know the exact cause of this episode, it may \nbe due to some mild pancreatitis (now resolved on your labs), or \nsome spasms of the outlet area of your biliary tract (sphincter \nof Oddi).  Our GI physicians evaluated you during your stay as \nwell.  They recommend that you followup with Dr. ___ \nanticipate that he may wish to discuss an endoscopy (EGD) with \nultrasound (EUS), and possibly a colonoscopy as well in the \nfuture.\n\nPlease keep your followup appointment with your PCP as well.  \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb68e"
  },
  "note_id": "12648465-DS-24",
  "subject_id": 12648465,
  "hadm_id": 28307575,
  "note_type": "DS",
  "note_seq": 24,
  "charttime": "2206-02-06 00:00:00",
  "storetime": "2206-02-06 22:39:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine\n \nAttending: ___.\n \nChief Complaint:\nfever, chest pain \n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ year old female hx. morbid obesity, HTN, DM, asthma, opioid \nabuse previously on methadone, depression/anxiety, DVT/PE \npresenting with c/o fever and chest pain.  \n\nPatient reports 3d ago the onset of pleuritic chest pain, \ndyspnea, and fevers/chills. Says she was first woken from sleep \nwith pleuritic chest pain, then had progressive dyspnea with \nexertion. Says the chest pain is central/substernal, currently \n___, constant, worse with breathing or lying flat. Radiates to \nright shoulder. Denies worsening with exertion, denies \nnausea/vomiting. Had fever to 101 at home today so called the \nED. Denies sick contacts. Has had a dry cough, no sputum. Denies \n___ edema, weight gain, or orthopnea.  \nPatient was recently admitted ___ with c/o abdominal \npain/vomiting, was initially treated for pancreatitis which \nimproved rapidly and she was thought to have possible Sphincter \nof Oddi dysfunction v ampullary stenosis. Plan was for close f/u \nfor outpatient EGD/EUS with possible colonoscopy.  \n\nPatient called EMS were she was found to be febrile to 102.\n  \nIn the ED initial vitals were: 99.8 95 94/65 18 98% RA. Tm was \n102.4.  \n- Labs were significant for CBC with H/H ___, chem-7 \nunremarkable, trop t and d dimer negative, lactate 2.4. CXR \nshowed concern for right sided multifocal PNA.  \n- Patient was given levofloxacin PO as well as tramadol and \ntylenol.  \n\nOn the floor patient currently c/o ___ chest pain, which has \nbeen going on for the past 3d, nonexertional. Not particularly \nrelieved by the tramadol in the ED. Otherwise feels well.\n \nPast Medical History:\n-Morbid obesity (max 448lbs) s/p gastric bypass & CCY ___ at  \n___ and complete reversal  \n-History of HTN, DM, asthma (prior to gastric bypass)  \n-Opiate addiction: prior intranasal herion, oral dilaudid abuse, \n \nnow on methadone  \n-Depression/Anxiety  \n-Esophagitis: EGD ___ showed mild active esophagitis.  \n-DVT/PE ___  \n-DJD  \n-2 SBOs  \n-Menopause completed  \nPast Surgical History:  \n-___- gastric bypass & CCY and subsequent complete  \nreversal  \n-7 surgeries on the abdomen. \"stomach leak\" hernia, 2 SBOs,  \nattempted reverse of the gastric bypass, the most recent in ___ \n\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n========================\nVitals - 98.8 101/70 hr 81 18 98% RA  \nGENERAL: awake, alert, NAD  \nHEENT: EOMI, PERRLA, OMM no lesions, no JVD  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: mild crackles RLB otherwise clear  \nABDOMEN: nondistended, +BS, mild ttp in epigastrum, no  \nrebound/guarding, no hepatosplenomegaly  \nEXTREMITIES: moving all extremities well, no cyanosis, clubbing \nor  \nedema  \nNEURO: CN II-XII intact, strength ___ in UE and ___ b/l  \nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes\n\nDISCHARGE PHYSICAL EXAM:\n=========================\nVS: 98.8 100-110s/70s 70-80s 18 100/RA  \nGENERAL: Awake, alert in NAD\nHEENT: EOMI, PERRLA, MMM  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: Mild crackles RLB but otherwise clear with aeration heard \nthroughout though poor respiratory effort\nABDOMEN: ND/NT, +BS, no rebound/guarding, no hepatosplenomegaly\nEXTREMITIES: No c/c/e\nNEURO: CN II-XII intact, moving all extremities freely\nSKIN: Warm and well perfused, no excoriations or lesions, no \nrashes\n \nPertinent Results:\nLABS:\n=====\n\n___ 09:45AM BLOOD WBC-7.7 RBC-3.72* Hgb-11.2* Hct-36.4 \nMCV-98 MCH-30.1 MCHC-30.7* RDW-16.1* Plt ___\n___ 01:00PM BLOOD WBC-9.1# RBC-3.54* Hgb-10.6* Hct-34.2* \nMCV-97 MCH-30.0 MCHC-31.0 RDW-15.8* Plt ___\n___ 09:45AM BLOOD ___ PTT-40.8* ___\n___ 01:00PM BLOOD ___ PTT-34.8 ___\n___ 09:45AM BLOOD Glucose-99 UreaN-9 Creat-0.8 Na-141 K-3.7 \nCl-104 HCO3-26 AnGap-15\n___ 01:00PM BLOOD Glucose-85 UreaN-14 Creat-0.8 Na-135 \nK-4.5 Cl-103 HCO3-24 AnGap-13\n___ 01:00PM BLOOD ALT-39 AST-26 LD(LDH)-285* AlkPhos-120* \nTotBili-0.4\n___ 01:00PM BLOOD Lipase-8\n___:00PM BLOOD cTropnT-<0.01\n___ 09:45AM BLOOD Calcium-8.9 Phos-3.4 Mg-1.8\n___ 01:00PM BLOOD Albumin-3.5\n___ 01:00PM BLOOD D-Dimer-287\n___ 01:00PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nBnzodzp-NEG Barbitr-NEG Tricycl-NEG\n___ 09:45AM BLOOD HCV Ab-PND\n___ 01:08PM BLOOD Lactate-2.4*\n\nIMAGING:\n========\nCXR (___):\nFINDINGS:  The cardiomediastinal contours are normal.  There is \nno pleural\neffusion or pneumothorax.  The lungs are well-expanded.  Right \nperihilar and right base opacities are new and concerning for \nmultifocal infectious process. The left lung is essentially \nclear.  The upper abdomen is unremarkable.\n \nIMPRESSION:  Multifocal opacities in the right lung concerning \nfor infection.\n \nBrief Hospital Course:\n___ y/o F w/ PMH of morbid obesity s/p gastric bypass, HTN, DM, \nasthma, opioid abuse previously on methadone, \ndepression/anxiety, and DVT/PE presents with c/o fever and chest \npain found to have radiographic evidence of R sided pneumonia. \n\nACTIVE ISSUES:\n==============\n# R sided pneumonia\nPresentation of cough with fevers and R sided chest pain c/w R \nsided PNA noted on CXR. No e/o ACS with normal EKG and negative \ntropsx1. Additionally D-dimer negative so no e/o PE. CURB 65 \nscore of 1. For PNA, pt was started on PO levofloxacin with no \nfurther episodes of fever noted overnight or into the following. \nWBC on presentation and the following morning was unremarkable \nwith negative lactate. Able to ambulate with saturations in the \n97-100%/RA at time of discharge. Planned for 7 day course of PO \nlevofloxacin for community acquired pneumonia (day ___ to \n___. Given numerous psych medications, QTc was checked and \nwell within normal limits. Arranged close f/u with PCP at time \nof discharge w/ recommended repeat CXR in ___ weeks to ensure \nresolution.\n\nCHRONIC ISSUES:\n===============\n# DVT in ___\nPt with prior documentation of DVT in ___. Had been placed on \nboth enoxaparin and coumadin for therapy. However, despite high \ndoses of coumadin, pt has remained sub-therapeutic on \nmedication. Unclear reason for difficulties in achieving goal \nINR of ___. Previously consulted heme-onc as an inpatient to \nhelp guide therapy duration with recommendation to continue if \npt continued to smoke or remain immobile given extent of clot \nnoted prior. Discussed issue with PCP who can consider possible \nheme-onc reassessment in the future as needed.\n\n# Chronic Pain\nHistory of opioid abuse, previously on methadone. Previously had \nbeen given tramadol for pain control during past admissions not \ncontinued by PCP. Pt with chronic pain complaints here with \nreports of mild R sided chest pain. Refused tylenol for control \nand reports unknown allergy to NSAIDs. Limited prescription of \ntramadol provided for next few days upon discharge.\n\nTRANSITIONAL ISSUES:\n====================\n- F/u BCx pending (anticipate negative)\n- Recommend repeat CXR in ___ weeks to ensure PNA resolution\n- Re-check INR on ___ given fluoroquinolone use\n- Complete abx with levofloxacin for 7 day course (___)\n- Consider anti-coagulation regiment given on both enoxaparin \nand coumadin for DVT/PE in ___, duration and whether coumadin \nneeded if on enoxaparin too\n- F/u HCV added on per outpt providers request\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Acetaminophen 650 mg PO Q6H:PRN pain \n2. Bisacodyl 10 mg PO BID:PRN constipation \n3. BuPROPion (Sustained Release) 150 mg PO QAM \n4. ClonazePAM 1 mg PO TID \n5. Cyanocobalamin 1000 mcg PO DAILY \n6. Docusate Sodium 100 mg PO BID \n7. Doxepin HCl 75 mg PO HS \n8. Enoxaparin Sodium 70 mg SC Q12H \nStart: ___, First Dose: Next Routine Administration Time \n9. Fleet Enema ___AILY:PRN constipation \n10. Maalox/Diphenhydramine/Lidocaine ___ mL PO QID:PRN \nodynophagia \n11. Mirtazapine 22.5 mg PO HS \n12. Multivitamins 1 TAB PO DAILY \n13. Polyethylene Glycol 17 g PO BID \n14. QUEtiapine Fumarate 100 mg PO QAM \n15. QUEtiapine Fumarate 300 mg PO QHS \n16. Senna 8.6 mg PO BID \n17. Sucralfate 1 gm PO QID \n18. Thiamine 100 mg PO DAILY \n19. Vitamin D 1000 UNIT PO DAILY \n20. Warfarin 13 mg PO DAILY16 \n21. Furosemide 40 mg PO DAILY \n22. Gabapentin 600 mg PO TID \n23. Omeprazole 40 mg PO BID \n24. Ondansetron 8 mg PO Q8H:PRN nausea \n\n \nDischarge Medications:\n1. Levofloxacin 750 mg PO DAILY \nLast dose on ___ \nRX *levofloxacin 750 mg 1 tablet(s) by mouth Daily Disp #*5 \nTablet Refills:*0\n2. Acetaminophen 650 mg PO Q6H:PRN pain \n3. Bisacodyl 10 mg PO BID:PRN constipation \n4. BuPROPion (Sustained Release) 150 mg PO QAM \n5. ClonazePAM 1 mg PO TID \n6. Cyanocobalamin 1000 mcg PO DAILY \n7. Docusate Sodium 100 mg PO BID \n8. Doxepin HCl 75 mg PO HS \n9. Enoxaparin Sodium 70 mg SC Q12H \nStart: Today - ___, First Dose: Next Routine Administration \nTime \n10. Fleet Enema ___AILY:PRN constipation \n11. Furosemide 40 mg PO DAILY \n12. Gabapentin 600 mg PO TID \n13. Maalox/Diphenhydramine/Lidocaine ___ mL PO QID:PRN \nodynophagia \n14. Mirtazapine 22.5 mg PO HS \n15. Multivitamins 1 TAB PO DAILY \n16. Omeprazole 40 mg PO BID \n17. Ondansetron 8 mg PO Q8H:PRN nausea \n18. Polyethylene Glycol 17 g PO BID \n19. QUEtiapine Fumarate 100 mg PO QAM \n20. QUEtiapine Fumarate 300 mg PO QHS \n21. Senna 8.6 mg PO BID \n22. Sucralfate 1 gm PO QID \n23. Thiamine 100 mg PO DAILY \n24. Vitamin D 1000 UNIT PO DAILY \n25. Warfarin 13 mg PO DAILY16 \n26. TraMADOL (Ultram) 50 mg PO BID:PRN Pain \nRX *tramadol 50 mg 1 tablet(s) by mouth Twice a day Disp #*10 \nTablet Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPneumonia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the hospital for pneumonia as seen on the \nX-rays of your lung. Your fevers improved while you were here. \nYou will need to continue to take the oral antibiotics \nprescribed for a total of 7 days (last dose on ___. \n\nYou will need to follow-up with your primary care doctor to \nensure that you are improving. You will also need your INR \nchecked earlier as the medication can interact with the warfarin \nthat you are taking.\n\nTake care.\n\n- Your ___ Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb68f"
  },
  "note_id": "12648465-DS-25",
  "subject_id": 12648465,
  "hadm_id": 25685722,
  "note_type": "DS",
  "note_seq": 25,
  "charttime": "2206-05-05 00:00:00",
  "storetime": "2206-05-05 19:14:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine\n \nAttending: ___.\n \nChief Complaint:\nabdominal pain/odynophagia\n \nMajor Surgical or Invasive Procedure:\nEGD with biopsy\n\n \nHistory of Present Illness:\nPt is a ___ y.o female with h.o obesity s/p gastric bypass, CCY \nand reversal of gastric bypass, HTN, DM, asthma, opiate \ndependence/addiction, depression/anxiety, DVT/PE, who presents \nwith epigastric abdominal pain. \nPt reports several months of progressively worsening odynophagia \nand epigastric abdominal pain after eating. Pt feels it is \ndifficult to eat and has been losing weight. 12lbs over last few \nmonths. Pt reports nausea and occasional vomiting. Last vomiting \n___, no hematemesis, no diarrhea, constipation, melena or \nbrbpr. Yesterday, pt ate 1 hard boiled egg, ___ cup popcorn, and \n6oz chicken noodle soup. She reports she has been trying to stay \nhydrated. Pt reports feeling increased weakness and difficulty \nwith mobility due to her nutritional status. Pt reports last BM, \nsmall this am and yesterday normal BM, +flatus. Pt with prior \nh.o candidial esophagitis. Current presentation may be similar \nper pt. Current pain is ___ and \"throbbing\". She otherwise \ndenies travel, sick contacts, new foods. Pt reporting T max \n100.9 at home.\nOther 10PT ROS reviewed and otherwise negative negative \nincluding headache, dizziness, CP, sob, palpitations, cough, \nURI, dysuria, hematuria, joint pain, rash, paresthesias.\n\nIN the ED, pt was given zofran and famotidine. \n \nPast Medical History:\n-Morbid obesity (max 448lbs) s/p gastric bypass & CCY ___ at  \n___ and complete reversal which was unsuccessful (___)\n-multiple prior abdominal surgeries including last surgery \nJ-tube attempt ___ which failed and lead to perforated colon. \n-History of HTN, DM, asthma (prior to gastric bypass)  \n-Opiate addiction: prior intranasal herion, oral dilaudid abuse, \n \nnow on methadone  \n-Depression/Anxiety  \n-Esophagitis: EGD ___ showed mild active esophagitis.  \n-DVT/PE ___  \n-DJD  \n-2 SBOs  \n-Menopause completed  \nPast Surgical History:  \n-___- gastric bypass & CCY and subsequent attempted \ncomplete  \nreversal  \n-7 surgeries on the abdomen. \"stomach leak\" hernia, 2 SBOs,  \nattempted reverse of the gastric bypass, the most recent in ___ \n\n.\nChronic pain\nopiate addiction\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. \n \nPhysical Exam:\nGEN:thin woman, well appearing, NAD\nvitals: \nT 97.8 BP 105/64 HR 70 RR 16 sat 100% on RA\nHEENT: ncat eomi anicteric MMM\nneck: supple\nchest: b/l ae no w/c/r\nheart: s1s2 rr no m/r/g\nabd: +bs, +several well-healed surgical scars, +epigastric \ntenderness to deep palp, no guarding or rebound\next: no c/c/e 2+pulses\nneuro: face symmetric, speech fluent\npsych: calm, cooperative\nskin: no apparent rash\n\nDischarge exam:\nafebrile, normal VS, occasionally has SBP ~90 when resting\nHEENT: ncat eomi anicteric MMM\nneck: supple\nlungs: clear to auscultation\nheart: normal S1, S2, no murmurs\nabd: +bs, +several well-healed surgical scars, non-tender\next: no c/c/e 2+pulses\nneuro: face symmetric, speech fluent\npsych: appropriate\n \nPertinent Results:\nON ADMISSION:\n\n___ 01:00PM   GLUCOSE-82 UREA N-9 CREAT-0.7 SODIUM-135 \nPOTASSIUM-4.3 CHLORIDE-102 TOTAL CO2-27 ANION GAP-10\n___ 01:00PM   estGFR-Using this\n___ 01:00PM   ALT(SGPT)-14 AST(SGOT)-22 ALK PHOS-66 TOT \nBILI-0.4\n___ 01:00PM   LIPASE-10\n___ 01:00PM   ALBUMIN-3.6\n___ 01:00PM   WBC-3.6* RBC-3.77* HGB-11.4* HCT-37.1 MCV-98 \nMCH-30.2 MCHC-30.7* RDW-18.8*\n___ 01:00PM   NEUTS-58.2 ___ MONOS-2.8 EOS-1.9 \nBASOS-0.3\n___ 01:00PM   PLT COUNT-272\n___ 12:00PM URINE  HOURS-RANDOM\n___ 12:00PM URINE  UHOLD-HOLD\n___ 12:00PM URINE  COLOR-Yellow APPEAR-Clear SP ___\n___ 12:00PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-4* PH-6.5 \nLEUK-NEG\n\nCTA ABD/PELVIS\n1.  No evidence of mesenteric ischemia. Widely patent arterial \nvasculature.\n2.  Status post multiple bowel surgeries without any evidence of \nbowel\nobstruction at this time.\n3.  Stable dilatation of the left biliary system as well as the \ncentral\npancreatic duct. Prior MRCP from ___ should be referred \nto for better\nevaluation the biliary tree and pancreatic duct.\n4.  Sigmoid diverticulosis without any evidence of active \ndiverticulitis.\n\nEGD:\nErythema, congestion and friability in the whole esophagus \ncompatible with esophagitis (biopsy)\nGranularity, friability and erythema in the stomach body \ncompatible with gastritis (biopsy)\nNormal mucosa in the jejunum\nOtherwise normal EGD to proximal small bowel \n\nBX: \nGastroesophageal mucosal biopsies, two:\n1. Esophagus:\nSquamous mucosa with acute neutrophilic esophagitis and rare \nyeast forms consistent with ___\nspecies (confirmed with GMS stain).\n2. Stomach:\nOxyntic mucosa with chronic inactive gastritis.\n\nUGI series\nSINGLE CONTRAST UPPER GI:  With the patient in the standing \nposition in right\nposterior oblique, AP, and left posterior oblique positions, \nwater-soluble\ncontrast and subsequently thin barium was administered. Contrast \nwas\nidentified passing through the esophagus without evidence of \nholdup. Contrast\npassed through the stomach and distally past the anastomotic \nsite without\nevidence of leak. No evidence of holdup is seen.  Proximal small \nbowel appears\ndilated.\n \nIMPRESSION:  \nPatient is status post gastric bypass. No evidence of leak \nidentified. \nDilated proximal small bowel loops are seen.  A short follow up \nKUB is\nrecommended to evaluate further.\n \nKUB\nSingle dilated small bowel loop is the jejunojejunostomy \nanastomosis site,\nalso seen on recent CT study.  THis may be physiological. No \ndefinitive\nevidence of obstruction.\n\ncolonoscopy:\nInternal hemorrhoids\nPolyp in the transverse colon (polypectomy)\nPolyp in the descending colon (polypectomy)\nPolyp in the descending colon 2 (polypectomy)\nDiverticulosis of the sigmoid and ascending colon\nNormal mucosa in the terminal ileum\nAbnormal submucosal appearing mucosa with central umbillication \nof unclear etiology in the transverse colon. (biopsy)\nOtherwise normal colonoscopy to cecum and terminal ileum\n\nDISCHARGE LABS:\n\npolyp- adenoma\n\nWBC  RBC Hgb  Hct MCV MCH  MCHC RDW Plt Ct\n4.2 3.35 10.0 32.5 97 30.0 30.9 19.5 232\n\nUreaN Creat Na  K   Cl HCO3\n8     0.6   140 4.6 106 28\n\nALT AST AlkPhos TotBili\n10  18     69   0.1\n\nCalcium Phos Mg\n8.4     3.8  1.7\n\nHELICOBACTER ANTIGEN DETECTION, STOOL \n  Test                          Result              Reference \nRange/Units\nRESULT:                       NOT DETECTED        \n \n\n \n \n \n \n \n\n \nBrief Hospital Course:\n___ w/PMH of gastric bypass, multiple prior abdominal surgeries, \ns/p complete reversal of her gastric bypass, CCY, esophageal \ncandidiasis, opiate abuse, HTN, and DVT/PE p/w epigastric \nabdominal pain and nausea.\n\n# Epigastric abdominal pain/nausea: Pt with recent h/o \nesophageal candidiasis s/p treatment. Now with post prandial \nepigastric pain and odynophagia. EGD notable for esophagitis and \ngastritis; biopsies taken and showed persistent ___. She was \ncontinued on her home PPI and sucralfate with the addition of \ncholestyramine and started on PO fluconazole. She did not \ntolerate cholestyramine. Given ongoing pain, while in house she \nwas evaluated by the bariatric surgery team who did not think \nthat surgical intervention would improve bile reflux. She was \nalso seen by the pain management team who recommended outpatient \nnerve block given concern for nerve entrapment at surgical site \nand continued use of tramadol PRN. She will need outpatient \nfollow-up with ___ further evaluation and treatment. \nFluconazole will finish on ___.\n\n# Leukopenia- Noted on previous admissions as well. Resolved \nwithout intervention. \n\n# Malnutrition: due to odynophagia. PO intake improved \nsignificantly following treatment for esophagitis.\n\nCHRONIC ISSUES\n\n# DVT/PE- Difficulty obtaining a therapeutic INR as an \noutpatient over the past year. Patient was continued on \ntherapeutic lovenox alone during her hospitalization and \ncoumadin was held at discharge given concerns for patient's \nmedication compliance and insight into how to adjust warfarin \ndosages. She has follow-up with ___ further \nconsideration of the risks and benefits of continued \nanticoagulation. \n\n# anxiety/depression: continued home meds (reconciled with \noutpatient psych provider) and weaned clonazepam 0.5/wk per \ntheir recs.  Quetiapine was halved while inpt due to interaction \nwith fluconazole but should be restarted at home dose when \nfluconazole course is completed.\n\n# Medication Reconciliation: Patient has recently filled \nprescriptions at three different pharmacies and reported \ndifferent doses and frequencies for several medications than \nthose noted in OMR. Medications discussed with patient's PCP, \n___, and outpatient nurse. Gabapentin was stopped, \nSeroquel was continued at 100mg qAM and 300mg qPM (but decreased \nwhen fluconazole was started due to interaction), and Klonipin \nwas continued at 0.5mg qAM and 2mg qPM (tapered to 1.5 mg after \n1 week per outpt psychiatrist). She was instructed to choose one \npharmacy to fill all of her prescriptions at to limit confusion \nin the future. She will need close outpatient follow-up with her \nPCP and psychiatrist for further titration of her psychiatric \nmedications.\n\n# hx narcotics abuse: pt was continued on home ___.  Pain \nmanagement was discussed with ___ provider who \npreferred not to dc the patient on ultram, however given ongoing \npain and pain consult recommendations, this was continued. \n\nOUTSTANDING ISSUE:\n-pt to completed 14 day course of fluconazole for esophageal \ncandidiasis\n-ultram should be tapered to complete discontinuation in ___ \ndays\n-pt should follow up in pain management clinic\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n2. Acetaminophen 1000 mg PO Q8H:PRN pain \n3. Buprenorphine-Naloxone (8mg-2mg) 1 TAB SL BID \n4. Cyanocobalamin 1000 mcg PO DAILY \n5. Docusate Sodium 100 mg PO DAILY \n6. Enoxaparin Sodium 70 mg SC Q12H \n7. Omeprazole 20 mg PO BID \n8. Ondansetron 4 mg PO Q8H:PRN nausea \n9. Pantoprazole 40 mg PO Q24H \n10. Sucralfate 1 gm PO QID \n11. ClonazePAM 0.5 mg PO QAM \n12. Doxepin HCl 100 mg PO HS \n13. QUEtiapine Fumarate 100 mg PO QAM \n14. QUEtiapine Fumarate 300 mg PO HS \n15. Multivitamins 1 TAB PO DAILY \n16. Warfarin 22 mg PO DAILY16 \n17. ClonazePAM 2 mg PO NOON \n18. Furosemide 40 mg PO BID \n19. BuPROPion (Sustained Release) 200 mg PO QAM \n\n \nDischarge Medications:\n1. Acetaminophen 325-650 mg PO Q8H:PRN pain \n2. Buprenorphine-Naloxone (8mg-2mg) 1 TAB SL BID \n3. Cyanocobalamin 1000 mcg PO DAILY \n4. Docusate Sodium 100 mg PO DAILY \n5. Doxepin HCl 100 mg PO HS \n6. Enoxaparin Sodium 70 mg SC Q12H \n7. Multivitamins 1 TAB PO DAILY \n8. Omeprazole 40 mg PO BID \n9. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n10. Sucralfate 1 gm PO QID \n11. Cholestyramine 4 gm PO BID \nRX *cholestyramine (with sugar) 4 gram 4 grams by mouth twice a \nday Refills:*0\n12. Ondansetron 4 mg PO Q8H:PRN nausea \n13. Fluconazole 400 mg PO Q24H \nRX *fluconazole 200 mg 2 tablet(s) by mouth daily Disp #*8 \nTablet Refills:*0\n14. BuPROPion (Sustained Release) 200 mg PO QAM \n15. ClonazePAM 1.5 mg PO QHS \n16. ClonazePAM 0.5 mg PO QAM \n17. QUEtiapine Fumarate 50 mg PO QAM \n18. QUEtiapine Fumarate 150 mg PO HS \n19. TraMADOL (Ultram) 50 mg PO BID:PRN pain \nonly take if needed \n20. Bisacodyl 10 mg PO DAILY \n21. Senna 8.6 mg PO BID \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary: Esophagitis, esophageal candidiasis, Gastritis\n\nSecondary: abd pain, history of narcotics abuse on ___, hx \nDVT/PE\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nYou were admitted to the hospital with abdominal pain and weight \nloss. You underwent an EGD notable for esophagitis and \ngastritis. Biopsies were taken and showed yeast infection.  You \nwere continued on your home medications with the addition of \ncholestyramine and ultram for pain control. You will need to \nfollow-up with ___ as an outpatient for ongoing evaluation \nand treatment.\n\nPer your PCP's request, a colonoscopy was performed while you \nwere in the hospital given difficulty with completing the prep \nas an outpatient. This went well, there were a few small polyps, \nand you will likely be due for another colonoscopy in ___ years.\n\nYou were noted to have a small infection in the labial that was \ntreated with ___ baths.\n\nPlease see below for your follow up appointments and \nmedications.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb690"
  },
  "note_id": "12648465-DS-26",
  "subject_id": 12648465,
  "hadm_id": 24820248,
  "note_type": "DS",
  "note_seq": 26,
  "charttime": "2206-12-09 00:00:00",
  "storetime": "2206-12-09 17:15:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine\n \nAttending: ___.\n \nChief Complaint:\npost EGD monitoring\n\n \nMajor Surgical or Invasive Procedure:\nEGD\n\n \nHistory of Present Illness:\n___ complicated PMHx of morbid obesity (448 pounds at max) s/p \nmultiple GI surgeries including J-tube c/b colonic perf, CCY and \nRNYGB with failed subsequent reversal and h/o recurrent \nesophageal candidiasis who presents for post-EGD monitoring. \n\nShe underwent EGD on ___ for recurrent symptoms of burning \nmouth discomfort and dysphagia similar to her prior episodes of \nesophageal candidiasis.  She was seen in GI clinic on ___ ___. At the time, she presented with dysphagia and \nburning in her chest and abdomen. Her prior episodes of \nesophageal candidiasis have been treated with fluconazole \nalthough each episode was not necessarily confirmed by \nendoscopically. She was most treated empirically with \nfluconazole in ___ after which she experienced some symptom \nrelief but only temporarily so. Because of her continued \nsymptoms which have significantly affected her quality of life, \nshe was scheduled for repeat EGD for re-evaluation today. Plan, \nper Dr. ___, was to treat with fluconazole vs \neconazole and optimize her antacid regimen pending EGD findings. \n \n\nHer EGD was notable for severe esophagitis of the mid to distal \nesophagus. The procedure was complicated by a superficial tear \non withdrawal of the scope with active bleeding that was \ninjected with epi and an endoclip was applied for hemostasis.\n\nOn arrival to the floor, pt reports some throbbing discomfort in \nher chest, ___. She reports this is since the EGD. She reports \nsince ___ and milder throbbing in her chest that \nworsened over the last few wks which led to the EGD today. She \nreports she is otherwise feeling ok other than her chronic \nabdominal pain. She had nausea post-EGD that is now resolved.\n\n \nPast Medical History:\n1. Morbid obesity status post gastric bypass and cholecystectomy \n \nin ___ with subsequent reversal surgery at the ___ -  \nmultiple prior abdominal surgeries including a J-tube in ___  \nwith apparent complication of a perforated colon.  \n2. DVT and PE in ___.  \n3. DJD.  \n4. History of SBO.  \n5. Chronic pain.  \n6. History of opiate addiction in the past \n\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. \n \nPhysical Exam:\nAdmission PE:\nVitals: 98.5, 105/65, 71, 20, 100% RA\nGeneral: middle-aged female, sitting up in bed, in NAD\nNeck: supple\nCV: RRR, no murmurs\nLungs: CTAB, breathing comfortably\nAbdomen: soft, nontender with light palpation, scars\nExt: WWP. no ___ edema\n.\nDischarge PE:\nVitals: afebrile, high ___, 60-80s, 97% RA\nGeneral: middle-aged female, sitting up in bed, in NAD\nNeck: supple\nCV: RRR, no murmurs\nLungs: CTAB, breathing comfortably\nAbdomen: soft, nontender with light palpation, scars\nExt: WWP. no ___ edema\n\n \nPertinent Results:\nAdmission Labs:\n___ 02:15PM BLOOD WBC-5.2 RBC-3.44* Hgb-11.3*# Hct-35.3*# \nMCV-102* MCH-32.9*# MCHC-32.1 RDW-13.3 Plt ___\n___ 02:15PM BLOOD ___ PTT-40.3* ___\n.\nOther Labs:\n___ 09:26PM BLOOD WBC-4.9 RBC-3.06* Hgb-10.4* Hct-30.9* \nMCV-101* MCH-34.0* MCHC-33.7 RDW-13.7 Plt ___\n___ 06:25AM BLOOD WBC-4.6 RBC-3.30* Hgb-11.0* Hct-33.4* \nMCV-101* MCH-33.4* MCHC-33.0 RDW-13.5 Plt ___\n___ 06:25AM BLOOD ___\n.\n- EGD: Severe esophagitis, ___ C, noted in the mid to \ndistal esophagus.   \nEvidence of a previous gastric surgical intervention was seen. \nThe gastrojejunal anastamosis was carefully examined and \nappeared normal.   \nOn withdrawal of the gastroscope, a superfical tear was noted at \nthe GE junction that was actively bleeding in the context of the \npatient's elevated INR and severe esophagitis. 1ml of \nepinephrine was injected and an endoclip was applied for \nhemostasis. \nOtherwise normal EGD to third part of the duodenum\n\n \nBrief Hospital Course:\n___ complicated PMHx of morbid obesity (448 pounds at max) s/p \nmultiple GI surgeries including J-tube c/b colonic perf, CCY and \nRNYGB with failed subsequent reversal and h/o recurrent \nesophageal candidiasis who presents for post-EGD monitoring \nafter a superficial tear was noted on scope withdrawal with \nactive bleeding.\n.\n# Superficial tear s/p EGD: Active bleeding was noted with \nhemostasis after an epi injection and clipping. H/H monitored \nand was stable overnight. Pt hemodynamically stable and with no \nBMs and so GI felt comfortable with discharge. Pt initially on \nliquid diet and advanced to regular. Warfarin held but will be \nrestarted in ___ on ___. \nPt was tolerating some POs. She was complaining of increased \npain and burning in her chest but this was felt to be related in \nlarge part to her severe esophagitis and GI did not feel this \nwas a sign of a more serious complication from the EGD. We \nexpect that pt may continue to complain of some increased pain \nand this will subside to baseline level of pain over next couple \nof days. She may have small amount of guiac positive stool given \nbleeding during EGD but she should not have recurrent amounts.\n.\n# Severe esophagitis: Pt put on IV PPI BID and will be \ndischarged on omeprazole to 40mg po BID. Pt should continue \nsucralfate as well. GI recommended possible course of reglan but \nthis was deferred because of risk of tardive dyskinesia in \ncombination with seroquel. Pt given PRN viscous lidocaine.\n.\n# Chronic abd pain: cont methadone, oxycodone, tramadol; EKG \nchecked and QTc 419\n.\n# H/o VTE: warfarin initially held and restarted on discharge\n.\n# Mood disorder: cont seroquel, clonazepam, BuPROPion, Doxepin \n.\n>> Transitional issues:\n# CODE STATUS: Full\n# CONTACT: mother, ___ ___\n# Increased dose of PPI + sucralfate\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 650 mg PO Q4H:PRN pain \n2. Cyanocobalamin 1000 mcg PO DAILY \n3. Docusate Sodium 100 mg PO QHS \n4. Doxepin HCl 100 mg PO HS \n5. Multivitamins 1 TAB PO DAILY \n6. Omeprazole 20 mg PO BID \n7. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n8. Sucralfate 1 gm PO QID \n9. Ondansetron 4 mg PO Q6H:PRN nausea \n10. BuPROPion (Sustained Release) 150 mg PO BID \n11. ClonazePAM 1.5 mg PO QHS \n12. ClonazePAM 0.5 mg PO DAILY at 3pm \n13. QUEtiapine Fumarate 100 mg PO QAM \n14. QUEtiapine Fumarate 300 mg PO HS \n15. TraMADOL (Ultram) 50 mg PO Q4H:PRN pain \n16. Senna 8.6 mg PO QHS \n17. FoLIC Acid 1 mg PO DAILY \n18. Lidocaine 5% Patch 1 PTCH TD QAM \n19. Furosemide 20 mg PO DAILY \n20. cranberry 2 tabs oral BID \n21. Methadone 20 mg PO Q8H \n22. Ascorbic Acid ___ mg PO TID \n23. Ferrous Sulfate 325 mg PO TID \n24. Vitamin D 50,000 UNIT PO MONTHLY \n25. OxycoDONE (Immediate Release)  10 mg PO Q6H:PRN pain \n26. Calcium Carbonate 1000 mg PO QID:PRN GI distress \n27. Guaifenesin ___ mL PO Q6H:PRN cough \n28. Warfarin Dose is Unknown  PO DAILY16 \n\n \nDischarge Medications:\n1. Acetaminophen 650 mg PO Q4H:PRN pain \n2. Ascorbic Acid ___ mg PO TID \n3. BuPROPion (Sustained Release) 150 mg PO BID \n4. Calcium Carbonate 1000 mg PO QID:PRN GI distress \n5. Cyanocobalamin 1000 mcg PO DAILY \n6. Docusate Sodium 100 mg PO QHS \n7. Doxepin HCl 100 mg PO HS \n8. Ferrous Sulfate 325 mg PO TID \n9. FoLIC Acid 1 mg PO DAILY \n10. Lidocaine 5% Patch 1 PTCH TD QAM \n11. Methadone 20 mg PO Q8H \n12. Multivitamins 1 TAB PO DAILY \n13. OxycoDONE (Immediate Release)  10 mg PO Q6H:PRN pain \n14. QUEtiapine Fumarate 100 mg PO QAM \n15. QUEtiapine Fumarate 300 mg PO HS \n16. Senna 8.6 mg PO QHS \n17. Sucralfate 1 gm PO QID \n18. TraMADOL (Ultram) 50 mg PO Q4H:PRN pain \n19. ClonazePAM 1.5 mg PO QHS \n20. ClonazePAM 0.5 mg PO DAILY at 3pm \n21. cranberry 2 tabs oral BID \n22. Furosemide 20 mg PO DAILY \n23. Guaifenesin ___ mL PO Q6H:PRN cough \n24. Omeprazole 40 mg PO BID \n25. Ondansetron 4 mg PO Q8H:PRN nausea \n26. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n27. Vitamin D 50,000 UNIT PO MONTHLY \n28. Lidocaine Viscous 2% 15 mL PO TID:PRN esophagitis pain \n29. Warfarin 10 mg PO DAILY16 \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___ \n \nDischarge Diagnosis:\nPrimary diagnosis: severe esophagitis, Superficial tear s/p EGD\n\nSecondary diagnosis: Morbid obesity status post gastric bypass, \nh/o DVT/PE, chronic pain\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure taking in the hospital. You were admitted for \nmonitoring after your EGD resulted in a small tear in your \nesophagus that was bleeding. This bleeding was stopped during \nthe procedure and your blood counts were monitored and were \nstable. \n\nPlease follow-up at the appointments listed below. Please see \nthe attached list for updates to your home medications.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb691"
  },
  "note_id": "12648465-DS-27",
  "subject_id": 12648465,
  "hadm_id": 28413652,
  "note_type": "DS",
  "note_seq": 27,
  "charttime": "2207-02-19 00:00:00",
  "storetime": "2207-02-19 14:03:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine\n \nAttending: ___.\n \nChief Complaint:\nmelena, abdominal pain\n \nMajor Surgical or Invasive Procedure:\n___ EGD\n___ barium swallow\n\n \nHistory of Present Illness:\nMrs. ___ is a ___ with PMH significant for morbid obesity \ns/p gastric bypass, multiple GI surgeries including J-tube c/b \nperforated colon, CCY, history of recurrent esophageal \ncandidiasis, DVT/PE and recent stroke on coumadin who presents \nfrom rehab with melena. The patient reports 1 week of melena \nonce per day. She was noted to have a decreased H/H (8.7/27.8) \nand transferred to the ED. Coumadin was discontinued 2 days ago \nin light of melena. The patient reports having episodes of \nhypotension (SBP ___ while at rehab. She also complains of \nworsening abdominal pain in the epigastrum. She denies fevers, \nchills, nausea, vomiting, hematemesis, chest pain, and shortness \nof breath.  \n\nOf note, the patient was admitted in ___, where she underwent \nEGD on ___ for recurrent symptoms of dysphagia, which was \nnotable for severe esophagitis of the mid and distal esophagus. \nThe procedure was complicated by a superificial tear on \nwithdrawal of the scope, for which an endoclip was applied for \nhemodstasis.\n\nSince her last discharge, she was seen at ___ with \nacute left facial droop and increased weakness of L limbs. Head \nCT, MRI of head and neck, bilateral carotid ultrasound, echo per \nreport unremarkable. EF 60% without thrombus. \n \nIn the ED, initial vitals: 97.0 70 108/60 18 98% RA. Labs were \nnotable for Hb 9.3 -> 7.6 -> 8.2 -> 11.0 (s/p 1 uRBC, baseline \n___, INR 1.2, BUN 16, Cr 0.8, and lactate 2.0. UA showed \nlarge leuk, positive nitrites, 15 WBC, and few bacteria. CT \nAbd/pelvis showed no acute findings. The patient was given \npantoprazole 40mg IV, zofran 4mg IV, and dilaudid IV, and CTX x \n1. She received 2 units in the ED, with appropriate rise in her \nHct. GI was consulted who recommended EGD in the morning.  \nVitals prior to transfer were: 97.7 67 105/60 16 97% RA.  \n\nUpon arrival to the floor, the patient states that she began \nexperiencing dark tarry stools approximately one week ago, \napproximately once per day. She states that since yesterday, she \nbegan experiencing centrally located abdominal pain, as well as \nburning in the epigastric region, similiar to her esophagitis \npain in the past. She endorses nausea. She states she has \nchronic UTI symptoms which they are unable to treat and endorses \ndysuria and frequency. \n\nUpon review of the ___ rehabilitation records, her Hb was \nstable over the last few days 8.9 (from 11.2 in ___ -> 8.6 \n-> 9.1 -> 8.7 -> sent to ___.\n\n \nPast Medical History:\n- Morbid obesity status post gastric bypass and cholecystectomy \nin ___ with subsequent reversal surgery at the ___ - \nmultiple prior abdominal surgeries including a J-tube in ___ \nwith apparent complication of a perforated colon.  \n- History of recurrent esophageal candidiasis s/p treatment  \n- History of hypertension, DM, and asthma prior to gastric \nbypass.  \n- DVT and PE in ___ on warfarin.  \n- CVA with residual Lt sided weakness and slurred speech  \n- History of SBO  \n- Chronic pain  \n- History of opiate addiction: prior intranasal heroin, oral \ndilaudid abuse, on methaone.  \n- Degenerative disc disease  \n- Depression/anxiety  \n\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\nVitals: 98.0 128/76 53 100% on RA\nAdmission weight: 93.2 kg\nGENERAL: Alert, oriented, no acute distress, tearful  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNECK: supple, JVP difficult to assess, no LAD  \nLUNGS: Clear to auscultation anteriorly, no wheezes, rales, \nrhonchi  \nCV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, \ngallops  \nABD: soft, obese, mild periumbilical tenderness and epigastric \ntenderness, no rebound or gaurding\nEXT: Warm, well perfused, 2+ pulses, trace pedal edema\nNEURO:  alert and oriented, mild left sided facial droop, ___ \nstrength in right upper and lower extremity, ___ strength in \nleft upper and lower extremity\n\nDISCHARGE PHYSICAL EXAM:\nVitals: Tm 99.0, 99/59, 67, 18, 97%RA\nGENERAL: Alert, oriented, uncomfortable with basin in lap \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNECK: supple, JVP difficult to assess \nLUNGS: Clear to auscultation anteriorly, no wheezes, rales, \nrhonchi  \nCV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, \ngallops  \nABD: soft, obese, + diffuse tenderness, bowel sounds present, no \nguarding\nEXT: Warm, well perfused, 2+ pulses, trace pedal edema\nNEURO:  alert and oriented, mild left sided facial droop\n\n \nPertinent Results:\nADMISSION LABS:\n\n___ 11:11PM   HGB-8.2* calcHCT-25\n___ 11:00PM   WBC-3.2* RBC-2.44* HGB-8.2* HCT-25.8* \nMCV-106* MCH-33.8* MCHC-31.9 RDW-14.9\n___ 11:00PM   PLT COUNT-222\n___ 10:15PM   WBC-3.0* RBC-2.17* HGB-7.6* HCT-23.5* \nMCV-109* MCH-35.0* MCHC-32.3 RDW-14.9\n___ 10:15PM   PLT COUNT-179\n___:09PM   LACTATE-2.0 K+-5.2*\n___ 05:45PM   GLUCOSE-72 UREA N-16 CREAT-0.8 SODIUM-135 \nPOTASSIUM-7.7* CHLORIDE-104 TOTAL CO2-26 ANION GAP-13\n___ 05:45PM   ALT(SGPT)-31 AST(SGOT)-136* ALK PHOS-50 TOT \nBILI-0.3\n___ 05:45PM   LIPASE-18\n___ 05:45PM   ALBUMIN-2.8* CALCIUM-7.9* PHOSPHATE-4.5 \nMAGNESIUM-1.8\n___ 05:45PM   ___ PTT-32.8 ___\n___ 05:15PM   GLUCOSE-71 UREA N-16 CREAT-0.8 SODIUM-140 \nPOTASSIUM-5.6* CHLORIDE-106 TOTAL CO2-24 ANION GAP-16\n___ 05:15PM   estGFR-Using this\n___ 05:15PM   WBC-4.2 RBC-2.76* HGB-9.3* HCT-29.3* MCV-106* \nMCH-33.6* MCHC-31.7 RDW-14.8\n___ 05:15PM   NEUTS-43.7* LYMPHS-49.3* MONOS-4.9 EOS-1.8 \nBASOS-0.4\n___ 05:15PM   PLT COUNT-239\n\nDISCHARGE LABS:\n\n___ 01:41AM BLOOD WBC-4.4 RBC-3.31* Hgb-10.8* Hct-34.6 \nMCV-105* MCH-32.6* MCHC-31.2* RDW-15.6* RDWSD-59.9* Plt ___\n___ 01:41AM BLOOD ___ PTT-49.7* ___\n___ 05:43AM BLOOD ___ PTT-50.0* ___\n___ 06:13AM BLOOD ___ PTT-71.9* ___\n___ 06:14AM BLOOD ___ PTT-62.1* ___\n\nCT ABD/PELVIS:  ___\n1. No acute findings within the abdomen or pelvis on CT exam.  \n2. Postsurgical changes from multiple prior bowel surgeries, \nincluding gastric bypass reversal surgery. No evidence of \nobstruction. However, it is difficult to delineate the GI tract \nanatomy. There is no convincing evidence of wall thickening in \nthe gastric remnant. Given history of epigastric pain, \ncorrelation with endoscopy results and surgical report is \nrecommended.  \n3. Unchanged intra and extrahepatic biliary ductal dilatation \nand main pancreatic duct dilatation in the setting of prior \ncholecystectomy.\n\nEGD ___\nGrade C esophagitis in the mid and distal esophagus compatible \nwith severe esophagitis\nEvidence of prior gastric surgical intervention was seen. There \nwas a staple. The anastamosis was carefully examined and \nappeared normal. Two outpouchings were seen, one with retained \nfood contents and small amount of blood. Could not rule out \nfistula.\nNormal mucosa in the duodenum\nOtherwise normal EGD to proximal jejunum\n\nCXR ___\nFINDINGS: \nLinear platelike atelectasis in the left lower lung with similar \nto exam\nearlier on the same date.  Opacity just medial to this is \noverall unchangedand does not have the typical appearance of \npneumonia on the lateral view -maybe some atelectasis. The right \nlung is clear.  No pneumothorax. Small leftpleural effusion.  \nThe heart is normal in size. The mediastinum is not widened. The \nhila are within normal limits.\nIMPRESSION: \nSmall left pleural effusion. No convincing radiographic evidence \nfor\npneumonia.\n\n \nBrief Hospital Course:\n___ with PMH significant for morbid obesity s/p gastric \nbypass, multiple GI surgeries including J-tube c/b perforated \ncolon, CCY, history of recurrent esophageal candidiasis, DVT/PE, \nand CVA on coumadin who presented with melena and anemia. \n\n# Upper GI Bleed: Patient presented with melena, anemia, and \nhypotension at her rehab center with SBP in the ___. In the \n___ ED, she received 2 units of PRBCs with appropriate rise in \nher Hb. EGD on ___ showed Grade C esophagitis in the mid and \ndistal esophagus compatible with severe esophagitis, as well as \ntwo outpouchings. She underwent barium swallow that was negative \nfor fistula. She was continued on pantoprazole 40mg BID. \nHemoglobin on day of discharge was 10.8.\n\n# Urinary Tract Infection: Patient with a positive UA, with \nsymptoms of dysuria, frequency, and worsening abdominal pain. \nPer ___ records, she has a history of MDR and VRE. She was \nstarted on ceftriaxone on ___, however, urine cultures \nsubsequently grew MDR e.coli. She completed a 5 day course of \nzosyn.\n\n# Leukocytosis: Patient with an increased leukocytosis from 4.8 \nto 12.1 while on ceftriaxone for UTI (see above), which could \nrepresent a stress response given recent EGD and upper GI bleed. \nCXR without pneumonia, blood cultures no growth to date. She was \ntreated for UTI as above, with resolution of her leukocytosis. \n\n# Anticoagulation for history of DVT/PE in ___. Coumadin held \nat rehab given concern for GI bleed. Admission INR of 1.2. Prior \nhematology notes recommended ongoing anticoagulation while the \npatient is immobile, particularly during hospitalizations given \nthe extent of her prior VTE.  As she was admitted with UGIB, her \ncoumadin continued to be held. As her H/H were subsequently \nstable, the risks and benefits of resuming coumadin. Her \ncoumadin was restarted with Lovenox SC as bridging therapy. On \nthe day of discharge her INR was 2.1 so her Lovenox was stopped. \nHer INR should be checked daily until her INR stabilizes.\n\n# Acute on Chronic abdominal pain: Patient has a history of \nchronic abdominal pain, and a history of prior narcotic abuse. \nCT A/P was obtained given worsening abdominal pain that was \nnegative for acute process. She was continued on her home \nmethadone, oxycodone, senna, and sulcrafate. \n\nCHRONIC ISSUES: \n\n# History of CVA: Patient has residual left sided weakness. \nLikely not on aspirin given NSAIDS allergy. No record of atrial \nfibrillation of known cause. She reports recrudescence of \nsymptoms which occured in the setting of holding warfarin for an \noutpatient spinal surgery. We attempted unsuccessfully to obtain \nOSH records. Given her severe esophagitis, the risks and \nbenefits of anticoagulation were discussed with the patient and \nthe family, and decision was made to restart anticoagulation \nwith warfarin. \n \n# Anxiety/depression:  Continued home medications: seroquel, \nclonazepam, BuPROPion, Doxepin.\n\n===== TRANSITIONAL ISSUES =====\n\nTRANSITIONAL ISSUES:\n- Given severe esophagitis, patient should be continued on high \ndose PPI BID.\n- Risks/benefits of anticoagulation were discussed with the \nfamily, and the patient was resumed on coumadin; given severe \nesophagitis and risk of re-bleed, recommend re-checking \nhemoglobin/hematocrit on ___. Hgb 10.8 on the day of \ndischarge.\n- Please check INR daily until stabilized on regimen.\n- Full Code\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Ascorbic Acid ___ mg PO TID \n2. BuPROPion (Sustained Release) 150 mg PO BID \n3. Calcium Carbonate 1000 mg PO QID:PRN GI distress \n4. Cyanocobalamin 1000 mcg PO DAILY \n5. Docusate Sodium 100 mg PO QHS \n6. Doxepin HCl 100 mg PO HS \n7. Ferrous Sulfate 325 mg PO TID \n8. FoLIC Acid 1 mg PO DAILY \n9. Lidocaine 5% Patch 1 PTCH TD QAM \n10. Methadone 20 mg PO Q8H \n11. Multivitamins 1 TAB PO DAILY \n12. OxycoDONE (Immediate Release)  10 mg PO Q4H:PRN pain \n13. QUEtiapine Fumarate 100 mg PO QAM \n14. QUEtiapine Fumarate 300 mg PO HS \n15. Senna 8.6 mg PO QHS \n16. Sucralfate 1 gm PO QID \n17. ClonazePAM 1.5 mg PO QHS \n18. ClonazePAM 0.5 mg PO DAILY at 8 am \n19. cranberry 2 tabs oral BID \n20. Furosemide 20 mg PO DAILY \n21. Guaifenesin ___ mL PO Q6H:PRN cough \n22. Ondansetron 4 mg PO Q8H:PRN nausea \n23. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n24. Vitamin D 50,000 UNIT PO MONTHLY \n25. Lidocaine Viscous 2% 15 mL PO TID:PRN esophagitis pain \n26. Warfarin 12 mg PO DAILY16 \n27. Pantoprazole 40 mg PO Q12H \n28. ClonazePAM 1 mg PO DAILY \n\n \nDischarge Medications:\n1. BuPROPion (Sustained Release) 150 mg PO BID \n2. Calcium Carbonate 1000 mg PO QID:PRN GI distress \n3. ClonazePAM 1.5 mg PO QHS \nRX *clonazepam 0.5 mg 3 tablet(s) by mouth at bedtime Disp #*30 \nTablet Refills:*0\n4. ClonazePAM 0.5 mg PO DAILY at 8 am \nRX *clonazepam 0.5 mg 1 tablet(s) by mouth daily Disp #*15 \nTablet Refills:*0\n5. ClonazePAM 1 mg PO DAILY \nRX *clonazepam 1 mg 1 tablet(s) by mouth daily Disp #*15 Tablet \nRefills:*0\n6. Cyanocobalamin 1000 mcg PO DAILY \n7. Docusate Sodium 100 mg PO QHS \n8. Doxepin HCl 100 mg PO HS \n9. Lidocaine Viscous 2% 15 mL PO TID:PRN esophagitis pain \n10. Guaifenesin ___ mL PO Q6H:PRN cough \n11. Methadone 20 mg PO Q8H \nRX *methadone 10 mg 2 tablets by mouth every eight (8) hours \nDisp #*21 Tablet Refills:*0\n12. Multivitamins 1 TAB PO DAILY \n13. OxycoDONE (Immediate Release)  10 mg PO Q6H:PRN pain \nRX *oxycodone 10 mg 1 tablet(s) by mouth every six (6) hours \nDisp #*30 Tablet Refills:*0\n14. QUEtiapine Fumarate 300 mg PO HS \nRX *quetiapine 300 mg 1 tablet(s) by mouth at bedtime Disp #*30 \nTablet Refills:*0\n15. Sucralfate 1 gm PO QID \n16. Senna 8.6 mg PO QHS \n17. QUEtiapine Fumarate 100 mg PO QAM \nRX *quetiapine 100 mg 1 tablet(s) by mouth qam Disp #*30 Tablet \nRefills:*0\n18. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n19. Pantoprazole 40 mg PO Q12H \n20. Ondansetron 4 mg PO Q8H:PRN nausea \nPlease give before meals \n21. FoLIC Acid 1 mg PO DAILY \n22. cranberry 2 tabs oral BID \n23. Ascorbic Acid ___ mg PO TID \n24. Vitamin D 50,000 UNIT PO MONTHLY \n25. Ferrous Sulfate 325 mg PO TID \n26. Furosemide 20 mg PO DAILY \n27. Lidocaine 5% Patch 1 PTCH TD QAM \nRX *lidocaine 5 % (700 mg/patch)  Apply to affected areas Disp \n#*10 Patch Refills:*0\n28. Simethicone 120 mg PO TID abdominal pain \n29. Warfarin 15 mg PO DAILY16 \nAdjust per INR \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary:\nUpper gastrointestinal bleed\nChronic esophagitis\nUrinary Tract Infection\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure taking care of ___ while ___ were admitted to \n___.\n\n___ first came to the hospital because ___ were experiencing \nsome dark stools and were loosing blood. We looked down your \nesophagus which showed evidence of inflammation. We performed an \nadditional study which did not show evidence of a fistula or \ntrack formulation. We treated ___ with IV antibiotics for a \nurinary tract infection \n\nPlease seek medical attention if ___ develop fevers, chills, \nlightheadedness, palpitations, dark and tarry stools, or bloody \nbowel movements.\n\nWe wish ___ all the best of health,\n\nYour ___ healthcare team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb692"
  },
  "note_id": "12648465-DS-28",
  "subject_id": 12648465,
  "hadm_id": 26806763,
  "note_type": "DS",
  "note_seq": 28,
  "charttime": "2207-03-01 00:00:00",
  "storetime": "2207-03-01 14:54:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine\n \nAttending: ___.\n \nChief Complaint:\nhematemisis; abdominal pain\n \nMajor Surgical or Invasive Procedure:\nEGD\n\n \nHistory of Present Illness:\nMrs. ___ is a ___ with PMH significant for morbid obesity \ns/p gastric bypass, multiple GI surgeries including J-tube c/b \nperforated colon, CCY, history of recurrent esophageal \ncandidiasis, DVT/PE and recent stroke previously on warfarin, \nwho was recently admitted for workup of melena in the context of \nanemic HGB 8.7. EGD ___ showed severe esophagitis but otherwise \nunremarkable surgical anatomy. She was given 2 units PRBC and \nstarted pantoprazole. \n\nShe was discharged one week ago, and in that time she reports \ncontinued black stools. This morning at 11AM she had abdominal \npain and vomited coffee grinds. She had a second episode and was \nbrought to the ED. She reports three days of black stools.\n\nIn the ED, initial vitals were:  97.4 66 131/81 12 95% ra, with \npressures settling out in the 90's systolic occasionally the \n80's.\n- Labs were significant for HGB 10.3 compared to discharg HGB \n10.8.  \n- Imaging revealed CXR neg for free air, CT head negative.  \n\nUpon arrival to the floor, she reports diffuse lower abdominal \npain. \n\nREVIEW OF SYSTEMS:  \n(+) Per HPI  \n(-) Denies fever, chills, lightheadedness, chest pain/pressure, \nheadache, dysuria. \n\nTransitional Issues*\n- Anticoagulation: patient needs repeat INR within 2 days after \ndischarge. Can discontinue lovenox when therapeutic (INR ___ \nfor at least 24 hours.\n- Chronic abdominal pain: Patient will require close followup to \nassess best analgesic regimen while minimizing side effects \n(e.g. constipation). \n- Consider need for outpatient colonscopy as clinically \nindicated. \n \nPast Medical History:\n- Morbid obesity status post gastric bypass and cholecystectomy \nin ___ with subsequent reversal surgery at the ___ - \nmultiple prior abdominal surgeries including a J-tube in ___ \nwith apparent complication of a perforated colon.  \n- History of recurrent esophageal candidiasis s/p treatment  \n- History of hypertension, DM, and asthma prior to gastric \nbypass.  \n- DVT and PE in ___ on warfarin.  \n- CVA with residual Lt sided weakness and slurred speech  \n- History of SBO  \n- Chronic pain  \n- History of opiate addiction: prior intranasal heroin, oral \ndilaudid abuse, on methaone.  \n- Degenerative disc disease  \n- Depression/anxiety  \n\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. \n \nPhysical Exam:\nVitals:  Tc 98.5  BP 92/55 (92/55-111/84)  HR 95 (62-95) RR 18 \n99% on RA\nTele: no alarms, HR stable in the ___\nGeneral:  elderly woman sitting in bed in pain, tearful \nHEENT:  anicteric sclera, no conjunctival pallor, OP clear with \nMMM.\nNeck: Supple, R IJ in place, bleeding \nLungs:  clear to auscultation bilaterally, no wheezes, rhonchi \nor crackles\nCV: RRR, no m/r/g\nAbdomen:  normoactive bowel sounds; soft-well healed midline \nscar with some subcutaneous nodules, tender to palpation in the \nmid-epigastrum, nondistended\nExt: warm, well-perfused; no edema\nNeuro: moving all four limbs spontaneously, A&O x3 \n  \n\n \nPertinent Results:\n___ 05:06AM BLOOD WBC-3.9* RBC-3.05* Hgb-9.9* Hct-31.0* \nMCV-102* MCH-32.5* MCHC-31.9* RDW-14.5 RDWSD-54.4* Plt ___\n___ 05:06AM BLOOD ___\n___ 05:06AM BLOOD Glucose-73 UreaN-10 Creat-0.7 Na-144 \nK-4.3 Cl-103 HCO3-30 AnGap-15\n\nCT Scan Abdomen: ___\nIMPRESSION.\n1. Status post reversal of Roux-en-Y gastric bypass.  Oral \ncontrast extends to \nthe mid duodenum without evidence of leak or fistula.  Unchanged \ndistention of \nthe reconstructed small bowel with fecalized material is likely \nchronic and \npost surgical in nature.  No evidence of obstruction. \n2. Unchanged mild diffuse intra- and extrahepatic biliary ductal \ndilation.  \nUnchanged mild prominence of the main pancreatic duct in the \nhead and body of \nthe pancreas. \n3. Status post cholecystectomy. \n  \n\n \nBrief Hospital Course:\n___ y/o F with hx of PE, strokes now on Coumadin, multiple GI \nsurgeries, presents after episode of coffee ground emesis. She \nhad a repeat EGD with improving esophagitis that required no \nintervention. KUB notable for significant constipation. The \npatient had a stable hematocrit throughout the hospitalization \nand no further episodes of hematemesis. She was slowly \nuptitrated back to home dose of coumadin while being bridged \nwith lovenox. On the day of discharge, her INR was 1.6.\n\nDue to ongoing abdominal pain, patient had a CT scan of the \nabdomen to assess for potential fistula or other etiologies of \npain given her multiple past bowel surgeries, which showed \nchronic bile duct dilation but no evidence of fistula, \nobstruction, or other pathologies. \n\n*Transitional Issues*\n***ANTICOAGULATION: Patient will receive LOVENOX twice daily. \nShe will require INR check within 2 days of discharge. Please \ntitrate Coumadin to INR goal of ___. Please discontinue LOVENOX \nwhen INR at goal for >24 hours.\n***PLEASE ASSIST WITH MEDICATIONS\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. BuPROPion (Sustained Release) 150 mg PO BID \n2. Calcium Carbonate 1000 mg PO QID:PRN GI distress \n3. ClonazePAM 1.5 mg PO QHS \n4. ClonazePAM 0.5 mg PO DAILY at 8 am \n5. ClonazePAM 1 mg PO DAILY \n6. Cyanocobalamin 1000 mcg PO DAILY \n7. Docusate Sodium 100 mg PO QHS \n8. Doxepin HCl 100 mg PO HS \n9. Lidocaine Viscous 2% 15 mL PO TID:PRN esophagitis pain \n10. Guaifenesin ___ mL PO Q6H:PRN cough \n11. Methadone 20 mg PO Q8H \n12. Multivitamins 1 TAB PO DAILY \n13. OxycoDONE (Immediate Release)  10 mg PO Q4H:PRN pain \n14. QUEtiapine Fumarate 300 mg PO HS \n15. Sucralfate 1 gm PO QID \n16. Senna 8.6 mg PO QHS \n17. QUEtiapine Fumarate 100 mg PO QAM \n18. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n19. Pantoprazole 40 mg PO Q12H \n20. Ondansetron 4 mg PO Q8H:PRN nausea \n21. FoLIC Acid 1 mg PO DAILY \n22. cranberry 2 tabs oral BID \n23. Ascorbic Acid ___ mg PO TID \n24. Vitamin D 50,000 UNIT PO MONTHLY \n25. Ferrous Sulfate 325 mg PO TID \n26. Furosemide 20 mg PO DAILY \n27. Lidocaine 5% Patch 1 PTCH TD QAM \n28. Simethicone 120 mg PO TID abdominal pain \n29. Warfarin 15 mg PO DAILY16 \n\n \nDischarge Medications:\n1. Ascorbic Acid ___ mg PO TID \n2. BuPROPion (Sustained Release) 150 mg PO BID \n3. Calcium Carbonate 1000 mg PO QID:PRN GI distress \n4. ClonazePAM 1.5 mg PO QHS \n5. ClonazePAM 0.5 mg PO DAILY at 8 am \n6. Cyanocobalamin 1000 mcg PO DAILY \n7. Docusate Sodium 100 mg PO QHS \n8. FoLIC Acid 1 mg PO DAILY \n9. Guaifenesin ___ mL PO Q6H:PRN cough \n10. Lidocaine 5% Patch 1 PTCH TD QAM \n11. Lidocaine Viscous 2% 15 mL PO TID:PRN esophagitis pain \n12. Methadone 20 mg PO Q8H \n13. Multivitamins 1 TAB PO DAILY \n14. OxycoDONE (Immediate Release)  10 mg PO Q4H:PRN pain \n15. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n16. QUEtiapine Fumarate 300 mg PO HS \n17. QUEtiapine Fumarate 100 mg PO QAM \n18. Simethicone 120 mg PO TID abdominal pain \n19. Sucralfate 1 gm PO QID \n20. Enoxaparin Sodium 90 mg SC Q12H \nStart: Today - ___, First Dose: Next Routine Administration \nTime \nPlease take until you achieve an INR of ___ on coumadin. \nRX *enoxaparin 80 mg/0.8 mL 80 mg SC twice a day Disp #*1 \nSyringe Refills:*0\n21. cranberry 2 tabs oral BID \n22. Ferrous Sulfate 325 mg PO TID \n23. Furosemide 20 mg PO DAILY \n24. Ondansetron 4 mg PO Q8H:PRN nausea \n25. Pantoprazole 40 mg PO Q12H \n26. Senna 8.6 mg PO QHS \n27. Vitamin D 50,000 UNIT PO MONTHLY \n28. Warfarin 15 mg PO DAILY16 \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nprimary diagnosis: hematemesis, esophagitis.\n\nsecondary diagnosis: constipation, chronic post-surgical \nabdominal pain. \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure taking care of you while you were admitted to \n___.You first came to the hospital because you \nwere experiencing some vomiting with blood. Our \ngastroenterologist took another look down your throat with a \ncamera and saw irritation of your esophagus that has improved \ncompared to the last study. However, we still believe that this \nis the source of your bleeding. We temporarily stopped your \ncoumadin to reduce the risk of further bleeding. We monitored \nyour blood work to make sure you weren't continuing to lose \nblood and the values remained stable. We then restarted your \nanticouagulation on coumadin slowly and gave you another \nmedication, lovenox, to keep your blood the coumadin works. \nYou will need to take the lovenox until your INR is stable \nbetween ___. You can have your blood measured as an outpatient. \n\nAlso during this hospitalization, you had worsening of your \nabdominal pain. This pain is most likely related to the irration \nof your esophagus provoked while vomiting. The Gastroenterology \ndoctors also performed ___ abdominal Xray which showed that you \nwere severely constipated. This can result from taking opioid \npain relievers. The GI doctors also repeated a CAT scan of your \nstomach. There was no evidence of a fistula or any other \nconcerning findings on this image. \n\nPlease ensure that you get your INR measured soon so that your \ncoumadin can be dosed properly.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb693"
  },
  "note_id": "12648465-DS-29",
  "subject_id": 12648465,
  "hadm_id": 24108407,
  "note_type": "DS",
  "note_seq": 29,
  "charttime": "2207-05-17 00:00:00",
  "storetime": "2207-05-17 15:32:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: SURGERY\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil\n \nAttending: ___\n \nChief Complaint:\nAbdominal pain \n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ y/o female with a PMH of chronic abdominal \npain, morbid obesity s/p gastric bypass, CCY and reversal of \ngastric bypass, HTN, DM, asthma, opiate dependence/addiction, \ndepression/anxiety, DVT/PE, who presented with epigastric/ruq \nabdominal pain for 5 days.  \n \nPast Medical History:\n- Morbid obesity status post gastric bypass and cholecystectomy \nin ___ with subsequent reversal surgery at the ___ - \nmultiple prior abdominal surgeries including a J-tube in ___ \nwith apparent complication of a perforated colon.  \n- History of recurrent esophageal candidiasis s/p treatment  \n- History of hypertension, DM, and asthma prior to gastric \nbypass.  \n- DVT and PE in ___ on warfarin.  \n- CVA with residual Lt sided weakness and slurred speech  \n- History of SBO  \n- Chronic pain  \n- History of opiate addiction: prior intranasal heroin, oral \ndilaudid abuse, on methaone.  \n- Degenerative disc disease  \n- Depression/anxiety  \n\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. \n \nPhysical Exam:\nAdmission Physical Exam:\n\nVitals:  Tc   BP   HR  RR  on RA\nTele: no alarms, HR stable in the \nGeneral:  elderly woman  \nHEENT:  anicteric sclera, no conjunctival pallor, OP clear with \nMMM.\nNeck: Supple,\nLungs:  clear to auscultation bilaterally, no wheezes, rhonchi \nor crackles\nCV: RRR, no m/r/g\nAbdomen:  normoactive bowel sounds; soft, non-tender, \nnondistended\nExt: warm, well-perfused; no edema\nNeuro: moving all four limbs spontaneously, A&O x3 \n\nDischarge Physical Exam: \n\nVitals: Temp: 98.0, BP: 96/60, Pulse: 72, RR: 16, O2: 98% RA\nGeneral: A+Ox3, NAD\nCV: RRR, no m/r/g\nPulm: CTA b/l\nAbdomen: soft, non-distended, non-tender\nExtremeties: warm, well-perfused, no edema \n \nPertinent Results:\nLabs: \n___ 08:52AM BLOOD WBC-7.1# RBC-2.83* Hgb-9.0* Hct-29.0* \nMCV-103* MCH-31.8 MCHC-31.0* RDW-15.9* RDWSD-60.0* Plt ___\n\n___ 04:08AM BLOOD WBC-4.6 RBC-2.83* Hgb-9.1* Hct-29.0* \nMCV-103* MCH-32.2* MCHC-31.4* RDW-15.5 RDWSD-58.6* Plt ___\n___ 05:44AM BLOOD WBC-3.8* RBC-3.37* Hgb-10.6* Hct-33.4* \nMCV-99* MCH-31.5 MCHC-31.7* RDW-14.8 RDWSD-53.2* Plt ___\n___ 06:31AM BLOOD WBC-3.7* RBC-3.02* Hgb-9.6* Hct-30.3* \nMCV-100* MCH-31.8 MCHC-31.7* RDW-14.6 RDWSD-52.7* Plt ___\n___ 06:04AM BLOOD WBC-2.9* RBC-3.38* Hgb-10.6* Hct-33.7* \nMCV-100* MCH-31.4 MCHC-31.5* RDW-14.4 RDWSD-51.8* Plt ___\n___ 05:46AM BLOOD WBC-3.1* RBC-3.38* Hgb-10.5* Hct-33.8* \nMCV-100* MCH-31.1 MCHC-31.1* RDW-14.1 RDWSD-51.1* Plt ___\n\nImaging:\n\n___: CT Abd/Pelvis:\n1. New collection of air within the midline anterior abdomen \nmeasuring up to 2.5 cm, anterior and superior to the mid \ntransverse colon, concerning for a contained perforation or \nfistula.  No fluid or oral contrast is definitively seen within \nthis collection of gas, and there is progressive adjacent soft \ntissue stranding about this area. \n  \n2. Status post gastric bypass reversal.  No evidence of small \nbowel \nobstruction or oral contrast extravasation. \n  \n3. Unchanged mild to moderate intra and extrahepatic biliary \nductal \ndilatation. \n\n___: Esophagus:\n\nLimited study due to residual oral contrast in the large bowel \nin the region of the anastomosis.  Within these limitations no \nevidence of obstruction or leak. \n\n___: CT Abd/Pelvis:\n\n1. Interval decrease in the size of the known anterior midline \nupper abdominal collection, currently 16 x 7 mm (previously 25 x \n13 mm); a small focus of adjacent air appears internal to the \ncollection versus intraluminal, within the adjacent transverse \ncolon.  No evidence of free intraperitoneal elsewhere. \n2. Diffuse intra- and extrahepatic biliary and pancreatic ductal \ndilation \nstatus post cholecystectomy.  No evidence of obstructing mass or \nstone.  While this appears long-standing, dating back to at \nleast ___, given subtle, mildly increased prominence \nover multiple prior studies, non-urgent MRCP versus ERCP should \nbe considered. \n3. Stable postsurgical changes throughout the upper abdomen \nstatus post \nRoux-en-Y gastric bypass reversal.  No evidence of obstruction. \n4. New trace left layering simple pleural effusion. \n5. Other incidental findings as above. \n\n \nBrief Hospital Course:\nMs. ___ is a ___ year-old female with a history of gastric \nbypass and cholecystectomy with subsequent reversal surgery and \nmultiple prior abdominal surgeries including a J-tube in ___ \nwith apparent complication of a perforated colon.  She presented \nto ___ on ___ with complaints of abdominal pain and had a \nCT abdomen/pelvis on HD1 which raised concern for intestinal \nperforation.  She was admitted to the Acute Care Surgery team \nand transferred to the Surgical ICU for serial abdominal exams \nand close observation.  \n  \nOn HD2, the patient had a PICC placed for IV access. On HD3, the \npatient underwent a swallow study and a nasogastric tube was \nplaced into the stomach by a surgery resident Dr. ___ \nfluoroscopic guidance. Given the patient's history of a past \nDVT, heparin gtt was started and serial PTTs were drawn until \nthe patient reached stable therapeutic levels.\n\nAfter remaining stable in the surgical ICU, the patient was then \ntransferred to the step-down surgical floor. \n\nOn HD9, the patient's nasogastric tube was discontinued and she \nwas started on a clear liquid diet.  The patient tolerated a \nclear liquid diet and her home medicines were started.\n\nOn HD10, the patient was evaluated by the Chronic Pain service \nand her pain medicine regimen was adjusted.  \n\nOn HD12 the patient's heparin drip was discontinued and Coumadin \nwas initiated. \n\nNeuro: The patient was alert and oriented throughout \nhospitalization.\n\nCV: The patient remained stable from a cardiovascular \nstandpoint; vital signs were routinely monitored.\n\nPulmonary: The patient remained stable from a pulmonary \nstandpoint; vital signs were routinely monitored. Good pulmonary \ntoilet, early ambulation and incentive spirometry were \nencouraged throughout hospitalization. \n\nGI/GU/FEN: The patient was advanced to a regular diet, which was \nwell tolerated. Patient's intake and output were closely \nmonitored\n\nID: The patient's fever curves were closely watched for signs of \ninfection.  She had blood cultures drawn on HD1 which grew \nStaphylococcus, coagulase negative.  Nasal swab from HD1 was \npositive for MRSA. H.pylori test from HD2 was shown to be \nequivocal.  \n\nHEME: The patient's blood counts were closely watched for signs \nof bleeding, of which there were none.\n\nProphylaxis: ___ dyne boots were used during this stay and was \nencouraged to get up and ambulate as early as possible.\n\nAt the time of discharge, the patient was doing well, afebrile \nand hemodynamically stable.  The patient was tolerating a diet, \nambulating, voiding without assistance, and pain was well \ncontrolled. The patient was noted to have an area of rash and \nskin breakdown between her gluteal folds and miconazole powder \nwas ordered.  The patient was discharged with mepilex dressings \nand was instructed to alternate positioning to her side to \nrelieve pressure.  The patient's left upper extremity PICC was \nremoved on ___.  \n\nThe patient received discharge teaching and follow-up \ninstructions with understanding verbalized and agreement with \nthe discharge plan. \n\n \nMedications on Admission:\nBuPROPion (Sustained Release) 150 mg PO BID  \n Calcium Carbonate 1000 mg PO QID:PRN GI distress  \n ClonazePAM 1.5 mg PO QHS  \n ClonazePAM 0.5 mg PO DAILY at 8 am  \n ClonazePAM 1 mg PO DAILY  \n Cyanocobalamin 1000 mcg PO DAILY  \n Docusate Sodium 100 mg PO QHS  \n Doxepin HCl 100 mg PO HS  \nLidocaine Viscous 2% 15 mL PO TID:PRN esophagitis pain  \n Guaifenesin ___ mL PO Q6H:PRN cough  \n Methadone 20 mg PO Q8H  \n Multivitamins 1 TAB PO DAILY  \n OxycoDONE (Immediate Release) 10 mg PO Q6H:PRN pain  \n QUEtiapine Fumarate 300 mg PO HS  \n Sucralfate 1 gm PO QID  \n Senna 8.6 mg PO QHS  \n QUEtiapine Fumarate 100 mg PO QAM  \n Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n Pantoprazole 40 mg PO Q12H  \n Ondansetron 4 mg PO Q8H:PRN nausea  \n FoLIC Acid 1 mg PO DAILY  \n cranberry 2 tabs oral BID  \n Ascorbic Acid ___ mg PO TID  \nVitamin D 50,000 UNIT PO MONTHLY  \nFerrous Sulfate 325 mg PO TID  \n Furosemide 20 mg PO DAILY  \n Lidocaine 5% Patch 1 PTCH TD QAM  \n Simethicone 120 mg PO TID abdominal pain  \n Warfarin 15 mg PO DAILY16  \n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO Q8H:PRN pain \ndo NOT exceed 3gm in 24 hours \n2. FoLIC Acid 1 mg PO DAILY \n3. Gabapentin 300 mg PO TID Chronic pain \n4. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN pain \ndo NOT drive or drink alcohol while taking this medication \n5. Methadone 20 mg PO TID \n6. Pantoprazole 40 mg PO Q12H \n7. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n8. QUEtiapine extended-release 300 mg PO QHS \n9. QUEtiapine extended-release 100 mg PO QAM \n10. Senna 8.6 mg PO BID \n11. ___  MD to order daily dose PO DAILY16 \n12. Thiamine 100 mg PO DAILY \n13. Ascorbic Acid ___ mg PO DAILY \n14. BuPROPion (Sustained Release) 150 mg PO BID \n15. ClonazePAM 0.5 mg PO QAM \n16. ClonazePAM 1 mg PO DAILY \n17. ClonazePAM 1.5 mg PO QHS \n18. Docusate Sodium 100 mg PO BID \nplease hold for loose stool \n19. Ferrous Sulfate 325 mg PO DAILY \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nIntestinal perforation\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou presented to the ___ on \n___ with complaints of abdominal pain. You were found to \nhave an intestinal perforation. You were admitted to the Acute \nCare Surgery team for further medical treatment. \n\nOver the course of your hospitalization, you have continued to \nimprove.  You are now tolerating a regular diet and your pain is \ncontrolled with oral pain medication.  You are now ready to be \ndischarged to rehab to continue your recovery.  \n\nPlease note the following discharge instructions: \n\nPlease call your doctor or nurse practitioner or return to the \nEmergency Department for any of the following:\n*You experience new chest pain, pressure, squeezing or \ntightness.\n*New or worsening cough, shortness of breath, or wheeze.\n*If you are vomiting and cannot keep down fluids or your \nmedications.\n*You are getting dehydrated due to continued vomiting, diarrhea, \nor other reasons. Signs of dehydration include dry mouth, rapid \nheartbeat, or feeling dizzy or faint when standing.\n*You see blood or dark/black material when you vomit or have a \nbowel movement.\n*You experience burning when you urinate, have blood in your \nurine, or experience a discharge.\n*You have shaking chills, or fever greater than 101.5 degrees \nFahrenheit or 38 degrees Celsius.\n*Any change in your symptoms, or any new symptoms that concern \nyou.\nPlease resume all regular home medications , unless specifically \nadvised not to take a particular medication. Also, please take \nany new medications as prescribed.\nPlease get plenty of rest, continue to ambulate several times \nper day, and drink adequate amounts of fluids. Avoid lifting \nweights greater than ___ lbs until you follow-up with your \nsurgeon.\nAvoid driving or operating heavy machinery while taking pain \nmedications.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb694"
  },
  "note_id": "12648465-DS-30",
  "subject_id": 12648465,
  "hadm_id": 21234028,
  "note_type": "DS",
  "note_seq": 30,
  "charttime": "2207-05-28 00:00:00",
  "storetime": "2207-05-28 21:24:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil\n \nAttending: ___.\n \nChief Complaint:\nfever to 100.8 F, lethargy\n \nMajor Surgical or Invasive Procedure:\nNone \n\n \nHistory of Present Illness:\n___ with complicated abdominal surgery history including recent \ninpatient admission for intestinal perforation, CVA with \nresidual mild L sided weakness, DVT and PE on warfarin who \npresents with concern for altered mental status, general body \nache and temperature as hish as 100.8 per nursing home report. \n\nShe was recently discharged from ___ on ___. She has had abd \npain for ___ weeks that is tolerable on methadone and dilaudid. \nIn recent days she developed \"total body ache\" that she cannot \nlocalize well assoc with worsening abd pain. She reports sharp, \nachy pain on the right side of her abdomen. Per rehab \ndocumentation, she was noted to be more lethargic than her \nbaseline with low grade temperature elevations to 100.8F. Pt \ndenies diarrhea or constipation, is passing gas. She denies SOB \nor cough. Endorses poor PO intake for the past 2 days.\n\nIn the ED her vitals were 98.2 F, BP ___, HR ___, 99% RA. \nLabs showed chronic anemia, WBC 10.4, INR 2.8, lactate 1.6, \nAST/ALT 42/31 and WNL Chem7. Imaging showed improved abdomen, \nconcern for atelectasis vs PNA. She was given 2 mg IV dilaudid, \nZofran, 2 L IVF, levaquin 500 mg and cipro 400 mg. \n\n \n \nPast Medical History:\n- Pneumonia\n- Morbid obesity status post gastric bypass and cholecystectomy \nin ___ with subsequent reversal surgery at the ___ - \nmultiple prior abdominal surgeries including a J-tube in ___ \nwith apparent complication of a perforated colon.  \n- History of recurrent esophageal candidiasis s/p treatment  \n- History of hypertension, DM, and asthma prior to gastric \nbypass.  \n- DVT and PE in ___ on warfarin.  \n- CVA with residual Lt sided weakness and slurred speech  \n- History of SBO  \n- Chronic pain  \n- History of opiate addiction: prior intranasal heroin, oral \ndilaudid abuse, on methaone.  \n- Degenerative disc disease  \n- Depression/anxiety  \n\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. \n \nPhysical Exam:\nON ADMISSION: \n\nVitals: T: 98.1 F, BP: 100s/80s P: 80s R: 18 O2: 100% ra   \nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM  \nNeck: supple, JVP not elevated, no LAD  \nLungs: Clear to auscultation bilaterally, no wheezes, rales, \nrhonchi  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nAbdomen: soft, TTP in RUQ, mildly distended but not tympanitic, \nno rebound tenderness.\nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema \n\nON DISCHARGE: \n\nVitals: T: 98.1 F, BP: 100s/60s P: 70s R: 18 O2: 100% ra   \nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM  \nNeck: supple, JVP not elevated, no LAD  \nLungs: Soft crackles in lung bases b/l   \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nAbdomen: soft, + BS, mildly distended but not tympanitic, no \nrebound tenderness.\nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \n \nPertinent Results:\n==ON ADMISSION==\n\n___ 03:40PM BLOOD WBC-10.4* RBC-2.71* Hgb-8.5* Hct-26.8* \nMCV-99* MCH-31.4 MCHC-31.7* RDW-14.7 RDWSD-53.4* Plt ___\n___ 03:40PM BLOOD Neuts-78.4* Lymphs-14.5* Monos-5.2 \nEos-1.2 Baso-0.3 Im ___ AbsNeut-8.13*# AbsLymp-1.50 \nAbsMono-0.54 AbsEos-0.12 AbsBaso-0.03\n___ 03:40PM BLOOD ___ PTT-42.4* ___\n___ 03:40PM BLOOD Plt ___\n___ 03:05PM BLOOD Glucose-75 UreaN-12 Creat-0.7 Na-139 \nK-4.2 Cl-101 HCO3-27 AnGap-15\n___ 03:05PM BLOOD ALT-31 AST-42* AlkPhos-104 TotBili-0.3\n___ 03:05PM BLOOD Lipase-9\n___ 03:05PM BLOOD Albumin-3.2* Calcium-8.6 Phos-3.6 Mg-1.7\n___ 03:14PM BLOOD Lactate-1.6\n\n==INTERIM LABS==\n\n___ 06:40AM BLOOD WBC-3.9* RBC-2.87* Hgb-9.1* Hct-32.8* \nMCV-114*# MCH-31.7 MCHC-27.7* RDW-15.4 RDWSD-64.0* Plt ___\n___ 07:00AM BLOOD WBC-7.4 RBC-2.59* Hgb-8.1* Hct-26.5* \nMCV-102* MCH-31.3 MCHC-30.6* RDW-14.9 RDWSD-55.8* Plt ___\n___ 06:33AM BLOOD ___ PTT-39.5* ___\n___ 07:00AM BLOOD ___ PTT-40.2* ___\n___ 06:33AM BLOOD Ret Aut-2.4* Abs Ret-0.07\n___ 07:00AM BLOOD ALT-23 AST-27 AlkPhos-90 TotBili-0.3\n\n==MICRO==\n\nBLOOD AND URINE CULTURES STILL PENDING AT TIME OF DISCHARGE \n\n==DISCHARGE LABS==\n\n___ 06:33AM BLOOD WBC-4.6 RBC-2.87* Hgb-9.0* Hct-31.0* \nMCV-108* MCH-31.4 MCHC-29.0* RDW-15.0 RDWSD-59.7* Plt ___\n___ 06:33AM BLOOD Plt ___\n___ 06:33AM BLOOD ___ PTT-39.5* ___\n___ 06:33AM BLOOD Glucose-80 UreaN-12 Creat-0.6 Na-140 \nK-4.1 Cl-104 HCO3-26 AnGap-14\n___ 06:33AM BLOOD Calcium-8.7 Phos-3.9 Mg-1.6\n\n==OTHER RESULTS==\n\nCXR ___ :\n\nCardiomediastinal silhouette is within normal limits.  There is \na hazy opacity at the left base which may represent atelectasis \nor developing infiltrate. Followup to resolution is recommended. \nThere are no pneumothoraces. \n \nCXR ___: \n\nNo acute cardiopulmonary process.\n\nCT ABDOMEN PELVIS ___: \n\n1. Scattered opacity at the left lung base could represent \naspiration or early pneumonia in the proper clinical setting.  \nThis finding could also be related to splinting due to abdominal \npain. \n2. Mild heterogeneity of the liver and periportal edema may be \nrelated to the aggressive IV hydration.  Prominence of the intra \nand extrahepatic biliary ducts as detailed on prior for which \nMRCP or ERCP can be considered. \n3. Interval resolution of previously seen pneumoperitoneum \nwithout evidence of perforation on the present study. \n\n \nBrief Hospital Course:\n___ with complicated abdominal surgical history who presents \nwith lethargy, low grade temperatures and concern by the ED for \nHCAP.  \n\n# Low grade temperature, lethargy: The pt did not present with a \nfever or leukocytosis, so after she had one dose of Cipro and \nLevaquin in the ED, she was monitored for signs and symptoms of \npneumonia. On hospital day 2, she began to complain of increased \nSOB and non-productive cough. CXR showed opacification at the \nLLL and she was started on a 5 day course of Levaquin to be \ncompleted on ___ in the outpatient setting. Blood and urine \ncultures are still pending. She had no other signs of infection; \nUA was negative, she had dilated biliary ducts that in the \nsetting of normal LFTs were unconcerning for cholangitis given \nher presentation. \n\n# abd pain: the pt also presented with chronic abdominal pain \nthat was at the level that it normally was at her nursing home. \nCT AP showed no cause for concern for acute pathology. Her \nabdominal pain was believed to be due to strictures and \nmanipulation of the abdomen from multiple abdominal surgeries. \nThe pt had a history of opiate abuse, and presented from rehab \non 20 mg methadone TID and dilaudid ___ mg PO q4h for pain. \nDuring her hospitalization she was noted to be more drowsy with \na respiratory rate of 12 overnight so her dilaudid was decreased \nto ___ mg PO q4h as needed for pain. She was also treated with \nTylenol q8h. \n\nCHRONIC ISSUES \n\n# History of DVT/PE: the pt reported that she is on life-long \nanticoagulation for DVT/PE. She reported that about 1 week prior \nto admission, she had noticed swelling in her right leg at the \nnursing home. She also reported mild \"throbbing\" pain in the \nRLE. There was no swelling or warmth on exam, and the patient \ncontinued to be therapeutic on her warfarin. \n \n# Chronic pain, anxiety: the pt was continued on her home \ngabapentin, clonazepam.\n\n***Transitional issues***: \n- Pneumonia: pt was started on Levaquin ___, end date is \n___. CXR on ___ showed opacification at the LLL, this should \nbe followed up to resolution with a repeat CXR greater than 6 \nweeks in the future. \n- dilated biliary ducts: seen on CT AP. While this could be \nchronic, MRCP or ERCP should be considered in the future\n-During this hospitalization, there were times when the patient \nappeared very somnolent after her home medications were \nadministered. There is concern that she may be overmedicated \nwith opioids and other sedating meds. Please consider tapering \ndilaudid, methadone, clonopin and Seroquel.\n\nFULL CODE \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 1000 mg PO Q8H:PRN pain \n2. FoLIC Acid 1 mg PO DAILY \n3. Gabapentin 300 mg PO TID Chronic pain \n4. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN pain \n5. Methadone 20 mg PO TID \n6. Pantoprazole 40 mg PO Q12H \n7. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n8. QUEtiapine extended-release 300 mg PO QHS \n9. QUEtiapine extended-release 100 mg PO QAM \n10. Senna 8.6 mg PO BID \n11. ___  MD to order daily dose PO DAILY16 \n12. Thiamine 100 mg PO DAILY \n13. Ascorbic Acid ___ mg PO DAILY \n14. BuPROPion (Sustained Release) 150 mg PO BID \n15. ClonazePAM 0.5 mg PO QAM \n16. ClonazePAM 1 mg PO DAILY \n17. ClonazePAM 1.5 mg PO QHS \n18. Docusate Sodium 100 mg PO BID \n19. Ferrous Sulfate 325 mg PO DAILY \n20. Miconazole Powder 2% 1 Appl TP TID:PRN groin rash \n21. Vitamin D 50,000 UNIT PO MONTHLY \n\n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO Q8H:PRN pain \n2. Ascorbic Acid ___ mg PO DAILY \n3. BuPROPion (Sustained Release) 150 mg PO BID \n4. ClonazePAM 0.5 mg PO QAM \n5. ClonazePAM 1 mg PO DAILY \n6. ClonazePAM 1.5 mg PO QHS \n7. Docusate Sodium 100 mg PO BID \n8. FoLIC Acid 1 mg PO DAILY \n9. Gabapentin 300 mg PO TID Chronic pain \n10. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN pain \nRX *hydromorphone [Dilaudid] 2 mg ___ mg by mouth every four \nhours as needed Disp #*360 Tablet Refills:*0\n11. Methadone 20 mg PO TID \nRX *methadone 10 mg 2 tablets by mouth three times daily Disp \n#*180 Tablet Refills:*0\n12. Pantoprazole 40 mg PO Q12H \n13. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n14. QUEtiapine extended-release 300 mg PO QHS \n15. QUEtiapine extended-release 100 mg PO QAM \n16. Senna 8.6 mg PO BID \n17. Thiamine 100 mg PO DAILY \n18. Warfarin 7 mg PO DAILY16 \n19. Levofloxacin 750 mg PO DAILY Duration: 5 Days \n20. Ferrous Sulfate 325 mg PO DAILY \n21. Miconazole Powder 2% 1 Appl TP TID:PRN groin rash \n22. Vitamin D 50,000 UNIT PO MONTHLY \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary diagnosis: \nPneumonia \n\nSecondary diagnosis: \nChronic abdominal pain \nCVA with residual mild L sided weakness\nDVT and PE on warfarin \n\n \nDischarge Condition:\nActivity Status: Wheelchair bound \nLevel of Consciousness: Alert and interactive.\nMental Status: Clear and coherent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to ___ because of concern for an infection. \nYou had a fever to 100.8 F at your rehab facility. You were \ntreated with one dose of antibiotics in the emergency department \nand stayed in the hospital for monitoring. You were treated with \nyour home medications and started on Levaquin, an antibiotic for \nyour pneumonia. \n\nIt was a pleasure taking care of you and we wish you the best! \n\nSincerely,\nYour ___ team \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb695"
  },
  "note_id": "12648465-DS-31",
  "subject_id": 12648465,
  "hadm_id": 22158442,
  "note_type": "DS",
  "note_seq": 31,
  "charttime": "2207-09-13 00:00:00",
  "storetime": "2207-09-13 11:09:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: ORTHOPAEDICS\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut\n \nAttending: ___.\n \nChief Complaint:\nright knee pain\n \nMajor Surgical or Invasive Procedure:\n___: Arthroscopy, medial meniscectomy, right knee\n\n \nHistory of Present Illness:\n___ yo F with right knee meniscal tear and pain, has failed \nconservative measures and now elects to undergo definitive \nsurgical management\n \nPast Medical History:\nPMH: POP, h/o extensive provoked DVT/PE->on coumadin, asthma, \nCVA ___, myelopathy, DM2 (diet controlled), DM2, h/o obesity \ns/p gastric bypass, s/p CCY->c/b multiple surgeries (7) for \n\"stomach leak\", PUD, severe gastritis/esophagitis w/odynophagia, \nGERD, h/o SBO, recurrent esophageal candidiasis, UTI, macrocytic \nanemia, h/o MRSA\n \nSocial History:\n___\nFamily History:\nNC\n \nPhysical Exam:\nWell appearing in no acute distress  \nAfebrile with stable vital signs  \nPain well-controlled  \nRespiratory: CTAB  \nCardiovascular: RRR  \nGastrointestinal: NT/ND  \nGenitourinary: Voiding independently  \nNeurologic: Intact with no focal deficits  \nPsychiatric: Pleasant, A&O x3  \nMusculoskeletal Lower Extremity:  \n* Arthroscopic portal incision healing well \n* Thigh full but soft  \n* No calf tenderness  \n* ___ strength  \n* SILT, NVI distally  \n* Toes warm\n \nPertinent Results:\n___ 06:59AM BLOOD WBC-7.5 RBC-3.25* Hgb-10.1* Hct-32.3* \nMCV-99* MCH-31.1 MCHC-31.3* RDW-14.6 RDWSD-53.5* Plt ___\n___ 06:33AM BLOOD WBC-6.5# RBC-3.58* Hgb-10.9* Hct-35.4 \nMCV-99* MCH-30.4 MCHC-30.8* RDW-14.0 RDWSD-51.0* Plt ___\n___ 06:59AM BLOOD Plt ___\n___ 06:59AM BLOOD ___\n___ 06:33AM BLOOD Plt ___\n___ 06:33AM BLOOD ___\n \nBrief Hospital Course:\nThe patient was admitted to the orthopedic surgery service and \nwas taken to the operating room for above described procedure. \nPlease see separately dictated operative report for details. The \nsurgery was uncomplicated and the patient tolerated the \nprocedure well. Patient received perioperative IV antibiotics.\n\nPostoperative course was remarkable for the following:\n\n#Chronic pain consult - recs: Dilaudid PCA, with home dosing of \nMethadone, Gabapentin, and Tylenol. The patient was transitioned \nto oral dilaudid at time of discharge, along with pre-operative \nhome dosed oral analgesics.\n  \nThe patient received Coumadin for DVT prophylaxis. Her home \ncurrent dosing of Coumadin was 12mg daily, INR was found to be \nelevated at 3.5, so this was adjusted to 8mg on POD#1. On POD#2, \nher INR 3.7 and her Coumadin dosing was further titrated to 5mg \nprior to discharge back to her long term living rehab. \n\nAt the time of discharge the patient was voiding independently. \nThe surgical dressing was changed on POD#1 and the arthroscopic \nportal incision were found to be clean and intact without \nerythema or abnormal drainage. The patient was seen by physical \ntherapy. At the time of discharge the patient was tolerating a \ndiabetic diet and feeling well.  The patient was afebrile with \nstable vital signs.  The patient's hematocrit was acceptable and \npain was adequately controlled on an oral regimen. The operative \nextremity was neurovascularly intact and the wound was benign. \n\nThe patient's weight-bearing status is weight bearing as \ntolerated on the operative extremity.\n \nMs ___ is discharged to ___ rehab in stable condition.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. ClonazePAM 0.5 mg PO QAM \n2. QUEtiapine Fumarate 100 mg PO QAM \n3. Vitamin B-1 (thiamine HCl (vitamin B1)) 100 mg oral DAILY \n4. Ascorbic Acid ___ mg PO DAILY \n5. Ferrous Sulfate 325 mg PO DAILY \n6. FoLIC Acid 1 mg PO DAILY \n7. Pantoprazole 40 mg PO Q12H \n8. Senna 8.6 mg PO BID \n9. BuPROPion (Sustained Release) 150 mg PO BID \n10. Docusate Sodium 100 mg PO BID \n11. Methadone 20 mg PO TID \n12. Gabapentin 400 mg PO TID \n13. QUEtiapine Fumarate 275 mg PO QHS \n14. Doxepin HCl 100 mg PO HS \n15. Vitamin D ___ UNIT PO QMONTHLY \n16. Sucralfate 1 gm PO QID \n17. Sucralfate 1 gm PO QHS \n18. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n19. Acetaminophen 1000 mg PO Q8H \n20. Ondansetron 4 mg PO Q8H:PRN nausea \n21. Calcium Carbonate 500 mg PO Q4H:PRN gi upset \n22. HYDROmorphone (Dilaudid) 4 mg PO Q4H:PRN pain \n23. Bisacodyl ___AILY:PRN constipation \n24. Furosemide 60 mg PO DAILY \n25. ClonazePAM 1 mg PO AT 2PM \n26. ClonazePAM 1.5 mg PO QHS \n27. Warfarin 12 mg PO DAILY16 \n\n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO Q8H \n2. Bisacodyl ___AILY:PRN constipation \n3. BuPROPion (Sustained Release) 150 mg PO BID \n4. Docusate Sodium 100 mg PO BID \n5. Furosemide 60 mg PO DAILY \n6. Gabapentin 400 mg PO TID \n7. Methadone 20 mg PO TID \n8. Pantoprazole 40 mg PO Q12H \n9. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n10. QUEtiapine Fumarate 100 mg PO QAM \n11. QUEtiapine Fumarate 275 mg PO QHS \n12. Senna 8.6 mg PO BID \n13. Sucralfate 1 gm PO QID \n14. Sucralfate 1 gm PO QHS \n15. Warfarin 12 mg PO DAILY16 \n16. Ascorbic Acid ___ mg PO DAILY \n17. Calcium Carbonate 500 mg PO Q4H:PRN gi upset \n18. ClonazePAM 0.5 mg PO QAM \n19. ClonazePAM 1 mg PO AT 2PM \n20. ClonazePAM 1.5 mg PO QHS \n21. Doxepin HCl 100 mg PO HS \n22. Ferrous Sulfate 325 mg PO DAILY \n23. FoLIC Acid 1 mg PO DAILY \n24. HYDROmorphone (Dilaudid) 4 mg PO Q4H:PRN pain \n25. Ondansetron 4 mg PO Q8H:PRN nausea \n26. Vitamin B-1 (thiamine HCl (vitamin B1)) 100 mg oral DAILY \n27. Vitamin D ___ UNIT PO QMONTHLY \n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nRight knee medial meniscal tear\nLeft knee osteoarthritis\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\n1. Please return to the emergency department or notify your \nphysician if you experience any of the following: severe pain \nnot relieved by medication, increased swelling, decreased \nsensation, difficulty with movement, fevers greater than 101.5, \nshaking chills, increasing redness or drainage from the incision \nsite, chest pain, shortness of breath or any other concerns.\n \n2. Please follow up with your primary physician regarding this \nadmission and any new medications and refills. \n \n3. Resume your home medications unless otherwise instructed.\n \n4. You have been given medications for pain control. Please do \nnot drive, operate heavy machinery, or drink alcohol while \ntaking these medications. As your pain decreases, take fewer \ntablets and increase the time between doses. This medication can \ncause constipation, so you should drink plenty of water daily \nand take a stool softener (such as Colace) as needed to prevent \nthis side effect.  Call your surgeons office 3 days before you \nare out of medication so that it can be refilled.  These \nmedications cannot be called into your pharmacy and must be \npicked up in the clinic or mailed to your house.  Please allow \nan extra 2 days if you would like your medication mailed to your \nhome.\n \n5. You may not drive a car until cleared to do so by your \nsurgeon.\n \n6. Please call your surgeon's office to schedule or confirm your \nfollow-up appointment.\n \n7. SWELLING: Ice the operative joint 20 minutes at a time, \nespecially after activity or physical therapy. Do not place ice \ndirectly on the skin. You may wrap the knee with an ace bandage \nfor added compression. Please DO NOT take any non-steroidal \nanti-inflammatory medications (NSAIDs such as Celebrex, \nibuprofen, Advil, Aleve, Motrin, naproxen etc).\n \n8. ANTICOAGULATION: Please continue your Couamdin as directed by \nthe rehab. Goal INR 2.0-3.0. If you were taking aspirin prior to \nyour surgery, it is OK to continue at your previous dose while \ntaking this medication.  \n \n9. WOUND CARE: Please keep your incision clean and dry. It is \nokay to shower five days after surgery but no tub baths, \nswimming, or submerging your incision until after your four (4) \nweek checkup. Please place a dry sterile dressing on the wound \neach day if there is drainage, otherwise leave it open to air. \nCheck wound regularly for signs of infection such as redness or \nthick yellow drainage. \n \n10. ACTIVITY: Weight bearing as tolerated on the operative \nextremity. Mobilize.  ROM as tolerated. No strenuous exercise or \nheavy lifting until follow up appointment.\n\nPhysical Therapy:\nROMAT bilateral knees\nWBAT\nMobilize frequently\n\nTreatments Frequency:\nDSD daily PRN drainage, okay to leave open to air if no drainage \non dressing\nWound checks\nIce and elevate\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb696"
  },
  "note_id": "12648465-DS-32",
  "subject_id": 12648465,
  "hadm_id": 28743321,
  "note_type": "DS",
  "note_seq": 32,
  "charttime": "2207-10-07 00:00:00",
  "storetime": "2207-10-08 15:09:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut\n \nAttending: ___\n \nChief Complaint:\nRight lower lobe pneumonia\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\nMs. ___ is a ___ with a h/o DVT/PE on warfarin, 2xCVA w/ \nresidual L sided weakness and R facial droop, s/p gastric bypass \nc/b GIBs SBO ?attempted reversal, s/p chole, w/ chronic \nabdominal pain on narcotics, s/p R knee menisectomy (___) \npresenting from OSH from rehab with temp to 102.6, fatigue, \ncough, SOB, found to have a RLL pneumonia.\n\nPt reports 1wk of fatigue, SOB, productive cough, and pleuritic \nchest pain on the right side anteriorly and posteriorly. \n+fever/chills/rigors/diaphoresis. +Nausea. No \nemesis/diarrhea/constipation. No dysuria/urinary frequency.\n\nPatient reports R knee may be more swollen this week than last \nbut hasn't noticed a difference in pain, warmth or redness.\n \nPast Medical History:\nR knee menisectomy ___\nDVT/PE\nDMII \nasthma\nCVA ___ with residual left facial droop\nmyelopathy\nobesity s/p gastric bypass\nsevere gastritis/esophagitis w/odynophagia\nrecurrent esophageal candidiasis,\nmultiple abdominal surgeries for \"stomach leak\"\ns/p CCY\nSBO\nPUD\nGERD\nmacrocytic anemia\nh/o MRSA\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN\nBrother with CHF\n \nPhysical Exam:\nVITALS: Tm 99.3, Tc 98.8, BP 105/65 (80s-110s/50s-60s), HR 72 \n(70s-90s), RR ___\nGENERAL: Alert, oriented, no acute distress  \nHEENT: Sclerae anicteric, MMM, oropharynx clear. Pupils equal, \nround, reactive, 2.5->2. R facial droop.  \nNECK: Supple\nRESP: Patient speaking in full sentences. Poor inspiratory \neffort, but patient moving air bilaterally. Rales in R lung base\nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nABD: Multiple surgical scars visible with crusting along midline \nscar. +BS, soft, nondistended, tenderness to palpation is \nreportedly at baseline.   \nEXT: warm, well perfused, 2+ DP in R foot, 1+ DP in L foot. No \ncyanosis. RLE non edematous. LLE 1+ nonpitting pedal edema.\nNEURO: Alert, oriented. Patient speaking very slowly but no \ndysarthria. CN grossly intact EXCEPT R facial droop. Sensation \ngrossly intact bilaterally. Motor: ___ ___+/5 LUE, ___ in \nboth lower extremities though more difficult to assess. \n\nDischarge:\nVitals: T 98.2 BP 105/82, HR 76, RR 16, O2 100%RA \nGENERAL: Alert, oriented, no acute distress  \nHEENT: Sclerae anicteric, MMM, oropharynx clear. R facial droop. \n \nNECK: Supple\nRESP: Patient speaking in full sentences. Poor inspiratory \neffort, but patient moving air well in L lung, decreased air \nmovement on R side, rales not appreciated\nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nABD:soft, nondistended. No appreciable bulge at site of \npatient's \"hernia-like\" pain with or without valsalva \nEXT: warm, well perfused, 2+ DP in R foot, 1+ DP in L foot. No \ncyanosis. RLE non edematous. LLE 1+ nonpitting pedal edema.\n\n \nPertinent Results:\nCT A/P (OSH ___:  \n IMPRESSION:  \n No acute/subacute intraperitoneal or retroperitoneal process.  \n S/p CCY with stable mild uniform central intrahepatic and \nextrahepatic biliary ductal dilatation. Atrophic pancreas with \nno pancreatic mass.  \n Moderately large stool volume require clinical correlation with \nrespect to possible constipation.  \n Multifocal right middle and right lower lobe peribronchiolar \nnodular ainar infiltrates; pneumonitis. Post therapeutic \nimpaging is required to document complete clearance-resolution.  \n\n CXR (OSH ___:  \n IMPRESSION:  \nRight lower lobe infiltrate compatible with pneumonia in the \nappropriate clinical setting.  \n\n___ 06:10AM BLOOD WBC-4.7 RBC-2.89* Hgb-9.1* Hct-33.1* \nMCV-115*# MCH-31.5 MCHC-27.5* RDW-15.3 RDWSD-64.8* Plt ___\n___ 06:59AM BLOOD WBC-7.7 RBC-2.85* Hgb-8.9* Hct-29.4* \nMCV-103* MCH-31.2 MCHC-30.3* RDW-15.4 RDWSD-58.1* Plt ___\n___ 12:42PM BLOOD WBC-10.5* RBC-3.24* Hgb-9.9* Hct-32.9* \nMCV-102* MCH-30.6 MCHC-30.1* RDW-15.2 RDWSD-56.9* Plt ___\n___ 12:42PM BLOOD Neuts-85.4* Lymphs-10.3* Monos-2.7* \nEos-0.5* Baso-0.2 Im ___ AbsNeut-8.96* AbsLymp-1.08* \nAbsMono-0.28 AbsEos-0.05 AbsBaso-0.02\n___ 05:37PM BLOOD ___\n___ 06:10AM BLOOD Plt ___\n___ 06:59AM BLOOD Plt ___\n___ 06:59AM BLOOD ___ PTT-36.0 ___\n___ 11:44PM BLOOD ___ PTT-31.5 ___\n___ 06:10AM BLOOD Glucose-81 UreaN-9 Creat-0.6 Na-138 K-4.0 \nCl-110* HCO3-23 AnGap-9\n___ 06:59AM BLOOD Glucose-71 UreaN-11 Creat-0.7 Na-139 \nK-3.9 Cl-106 HCO3-23 AnGap-14\n___ 06:59AM BLOOD ALT-31 AST-36 LD(LDH)-202 AlkPhos-79 \nTotBili-0.3\n___ 06:10AM BLOOD Calcium-7.8* Phos-2.0* Mg-1.8\n___ 06:59AM BLOOD Albumin-2.8* Calcium-7.8* Phos-3.0 Mg-1.7\n___ 12:49PM BLOOD Lactate-1.7\n___ 05:00PM URINE Color-Yellow Appear-Clear Sp ___\n___ 05:00PM URINE Blood-NEG Nitrite-NEG Protein-TR \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-2* pH-7.5 Leuks-NEG\n___ 05:00PM URINE RBC-<1 WBC-0 Bacteri-NONE Yeast-NONE \nEpi-1\n___ 03:05PM OTHER BODY FLUID FluAPCR-NEGATIVE \nFluBPCR-NEGATIVE\n \nBrief Hospital Course:\n#HCAP: Patient's symptoms of fever, cough, pleuritic CP w/ CXR \nevidence of RLL infiltrate suggestive of PNA. Patient had recent \nsurgery and came from rehab, therefore HCAP. Patient met sepsis \ncriteria on admission ___. Given 2L NS and started empirically \non vanc/zosyn; blood/urine/sputum cultures drawn. On ___ no \nlonger met criteria as afebrile, normal HR, and WBC 7.7. Had \nSBPs in the high ___ in evening of ___ so received an \nadditional liter of NS. Lasix was held in the setting of \nhypotension. She was initially switched to vanc/cefepime on ___ \nand then further changed to levofloxacin/doxycyline. She was \nobserved on this regimen for one day and then discharged on ___ \ngiven continued clinical improvement.\n\n#History of DVT/PE/Stroke: Patient on warfarin at home though \nINR 1.1 on admission. She was started on a bridge w/ lovenox on \n___ while continuing home dose of warfarin, 12mg. INR 1.1 on \n___. No events during this hospitalization.\n\n#QTc: Patient's initial QTc 599, repeat 429, both on day of \nadmission ___. Elevated QTc likely due to antibiotics. Patient \nwas monitored on telemetry.\n\nChronic issues:\n#Chronic abdominal pain: Pt has pain following multiple \nabdominal surgeries. Received an abd/pelvis CT at the outside \nhospital that was reportedly negative for acute process. We \ncontinued her home pain regimen with good pain control.\n\n#Depression: Patient's home medications were continued with no \nemotional or behavioral issues during hospitalization.\n\nTRANSITIONAL ISSUES:\n- Discharged on PO doxycycline and PO levofloxacin for total 8 \ndays course ___ last day ___ \n- INR: The patient should continue lovenox until INR is in \ntherapeutic range ___.\n- R Knee: Patient should continue physical therapy and \nrehabilitation following R knee menisectomy on ___\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 1000 mg PO Q8H \n2. Bisacodyl ___AILY:PRN constipation \n3. BuPROPion (Sustained Release) 150 mg PO BID \n4. Docusate Sodium 100 mg PO BID \n5. Furosemide 60 mg PO DAILY \n6. Gabapentin 400 mg PO TID \n7. Methadone 20 mg PO TID \n8. Pantoprazole 40 mg PO Q12H \n9. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n10. QUEtiapine Fumarate 100 mg PO QAM \n11. QUEtiapine Fumarate 275 mg PO QHS \n12. Senna 8.6 mg PO BID \n13. Sucralfate 1 gm PO QID \n14. Warfarin 12 mg PO DAILY16 \n15. Ascorbic Acid ___ mg PO DAILY \n16. Calcium Carbonate 500 mg PO Q4H:PRN gi upset \n17. ClonazePAM 0.5 mg PO QAM \n18. ClonazePAM 1 mg PO AT 2PM \n19. ClonazePAM 1.5 mg PO QHS \n20. Doxepin HCl 100 mg PO HS \n21. Ferrous Sulfate 325 mg PO DAILY \n22. FoLIC Acid 1 mg PO DAILY \n23. HYDROmorphone (Dilaudid) 6 mg PO Q4H:PRN pain \n24. Ondansetron 4 mg PO Q8H:PRN nausea \n25. Vitamin B-1 (thiamine HCl (vitamin B1)) 100 mg oral DAILY \n26. Vitamin D ___ UNIT PO QMONTHLY \n\n \nDischarge Medications:\n1. Acetaminophen 1000 mg PO Q8H \n2. Ascorbic Acid ___ mg PO DAILY \n3. Bisacodyl ___AILY:PRN constipation \n4. BuPROPion (Sustained Release) 150 mg PO BID \n5. Calcium Carbonate 500 mg PO Q4H:PRN gi upset \n6. ClonazePAM 0.5 mg PO QAM \n7. ClonazePAM 1 mg PO AT 2PM \n8. ClonazePAM 1.5 mg PO QHS \n9. Docusate Sodium 100 mg PO BID \n10. Doxepin HCl 100 mg PO HS \n11. Ferrous Sulfate 325 mg PO DAILY \n12. FoLIC Acid 1 mg PO DAILY \n13. Gabapentin 400 mg PO TID \n14. HYDROmorphone (Dilaudid) 6 mg PO Q4H:PRN pain \n15. Methadone 20 mg PO TID \n16. Ondansetron 4 mg PO Q8H:PRN nausea \n17. Pantoprazole 40 mg PO Q12H \n18. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n19. QUEtiapine Fumarate 100 mg PO QAM \n20. QUEtiapine Fumarate 275 mg PO QHS \n21. Senna 8.6 mg PO BID \n22. Sucralfate 1 gm PO QID \n23. Vitamin B-1 (thiamine HCl (vitamin B1)) 100 mg oral DAILY \n24. Warfarin 12 mg PO DAILY16 \n25. Enoxaparin Sodium 100 mg SC Q12H \nStart: ___, First Dose: Next Routine Administration Time \n26. Furosemide 60 mg PO DAILY \n27. Vitamin D ___ UNIT PO QMONTHLY \n28. Doxycycline Hyclate 100 mg PO Q12H Duration: 6 Days \nTo end ___. Levofloxacin 750 mg PO DAILY \nlast dose to be given on ___, then please discontinue. \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nSepsis\nHealth Care Associated Pneumonia\n\nSecondary\nPrior stroke \npulmonary embolism\nChronic Abdominal pain on narcotics\n\n \nDischarge Condition:\nMental Status: Alert and oriented to self, place and time\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nYou were admitted to ___ with \npneumonia. You were treated with antibiotics while you were \nhere. You were also given fluids and your home medications. \nWhile you were here, your warfarin blood test showed that the \nlevel was too low so you were put on an additional blood \nthinning medication called lovenox. This medicine is only \nimportant until the warfarin level rises to the appropriate \nlevel and can then be discontinued. \n\nWhile you were here, you had improvement in your cough. Your \nblood tests also indicated that the antibiotics were effectively \nfighting your infection. \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb697"
  },
  "note_id": "12648465-DS-33",
  "subject_id": 12648465,
  "hadm_id": 25887905,
  "note_type": "DS",
  "note_seq": 33,
  "charttime": "2208-07-21 00:00:00",
  "storetime": "2208-07-21 14:59:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: ORTHOPAEDICS\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut\n \nAttending: ___.\n \nChief Complaint:\nright knee osteoarthritis/pain\n \nMajor Surgical or Invasive Procedure:\n___: right total knee arthroplasty\n\n \nHistory of Present Illness:\nPatient is ___ year old female with history of right knee \nosteoarthritis admitted for right complex TKA.\n \nPast Medical History:\nR knee menisectomy ___\nDVT/PE\nDMII \nasthma\nCVA ___ with residual left facial droop\nmyelopathy\nobesity s/p gastric bypass\nsevere gastritis/esophagitis w/odynophagia\nrecurrent esophageal candidiasis,\nmultiple abdominal surgeries for \"stomach leak\"\ns/p CCY\nSBO\nPUD\nGERD\nmacrocytic anemia\nh/o MRSA\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN\nBrother with CHF\n \nPhysical Exam:\nWell appearing in no acute distress  \n Afebrile with stable vital signs  \n Pain well-controlled  \n Respiratory: CTAB  \n Cardiovascular: RRR  \n Gastrointestinal: NT/ND  \n Genitourinary: Voiding independently  \n Neurologic: Intact with no focal deficits  \n Psychiatric: Pleasant, A&O x3  \n Musculoskeletal Lower Extremity:  \n * Incision healing well with staples  \n * Scant serosanguinous drainage  \n * Thigh full but soft  \n * No calf tenderness  \n * ___ strength  \n * SILT, NVI distally  \n * Toes warm  \n \nPertinent Results:\n___ 06:10AM BLOOD WBC-6.5 RBC-2.90* Hgb-8.9* Hct-29.2* \nMCV-101* MCH-30.7 MCHC-30.5* RDW-15.9* RDWSD-59.7* Plt ___\n___ 06:40AM BLOOD WBC-9.0 RBC-2.89* Hgb-8.9* Hct-28.3* \nMCV-98 MCH-30.8 MCHC-31.4* RDW-16.7* RDWSD-60.1* Plt ___\n___ 07:20AM BLOOD WBC-10.7*# RBC-3.19* Hgb-9.9* Hct-31.0* \nMCV-97 MCH-31.0 MCHC-31.9* RDW-17.0* RDWSD-61.1* Plt ___\n___ 11:00AM BLOOD WBC-7.0 RBC-2.86* Hgb-9.0* Hct-28.5* \nMCV-100* MCH-31.5 MCHC-31.6* RDW-13.8 RDWSD-50.7* Plt ___\n___ 07:40PM BLOOD WBC-6.7# RBC-3.23* Hgb-10.1* Hct-33.1* \nMCV-103* MCH-31.3 MCHC-30.5* RDW-13.9 RDWSD-52.1* Plt ___\n___ 09:15AM BLOOD WBC-3.2* RBC-3.56* Hgb-11.2 Hct-36.4 \nMCV-102* MCH-31.5 MCHC-30.8* RDW-13.8 RDWSD-52.8* Plt ___\n___ 05:05PM BLOOD WBC-3.7* RBC-3.41* Hgb-10.7* Hct-35.1 \nMCV-103* MCH-31.4 MCHC-30.5* RDW-14.0 RDWSD-52.8* Plt ___\n___ 09:15AM BLOOD Neuts-46.2 ___ Monos-5.3 Eos-2.8 \nBaso-0.9 Im ___ AbsNeut-1.47*# AbsLymp-1.42 AbsMono-0.17* \nAbsEos-0.09 AbsBaso-0.03\n___ 06:10AM BLOOD Plt ___\n___ 06:10AM BLOOD ___\n___ 06:40AM BLOOD Plt ___\n___ 06:40AM BLOOD ___\n___ 07:20AM BLOOD Plt ___\n___ 07:20AM BLOOD ___\n___ 11:00AM BLOOD Plt ___\n___ 11:00AM BLOOD ___\n___ 07:40PM BLOOD Plt ___\n___ 09:15AM BLOOD Plt ___\n___ 09:15AM BLOOD PTT-69.8*\n___ 12:15AM BLOOD PTT-150*\n___ 05:05PM BLOOD Plt ___\n___ 05:05PM BLOOD PTT-34.8\n___ 06:10AM BLOOD Glucose-80 UreaN-15 Creat-0.8 Na-140 \nK-4.6 Cl-104 HCO3-26 AnGap-15\n___ 06:40AM BLOOD Glucose-78 UreaN-15 Creat-0.6 Na-139 \nK-4.3 Cl-105 HCO3-25 AnGap-13\n___ 07:20AM BLOOD Glucose-72 UreaN-13 Creat-0.7 Na-142 \nK-4.0 Cl-105 HCO3-26 AnGap-15\n___ 11:00AM BLOOD Glucose-149* UreaN-10 Creat-0.8 Na-138 \nK-3.6 Cl-102 HCO3-26 AnGap-14\n___ 05:05PM BLOOD Glucose-90 UreaN-13 Creat-0.9 Na-143 \nK-3.8 Cl-104 HCO3-30 AnGap-13\n___ 06:10AM BLOOD Calcium-8.8 Phos-4.1 Mg-2.0\n___ 05:05PM BLOOD Calcium-9.1 Phos-3.9 Mg-1.6\n \nBrief Hospital Course:\nThe patient was admitted to the orthopedic surgery service \npre-operatively to be started on a heparin drip.  She was taken \nto the operating room for above described procedure. Please see \nseparately dictated operative report for details. The surgery \nwas uncomplicated and the patient tolerated the procedure well. \nPatient received perioperative IV antibiotics.\n\nPostoperative course was remarkable for the following:\nOn POD#1, the patient received 2 units of blood for a hematocrit \nof 28.5.  On POD#2, her hematocrit was 31. \n\nOtherwise, pain was controlled with a PCA post-operatively.  The \nChronic Pain service assisted with co-management of the patient. \n The PCA was discontinued on POD#2 and they assisted with making \nrecommendations for oral pain management.  The patient received \nCoumadin and Lovenox for DVT prophylaxis.  The Coumadin was \nresumed on POD#0 and the Lovenox was started on POD#2.  The \nCoumadin was dosed based on her INR levels.  Lovenox was to be \ncontinued until INR > 2.  The foley was removed and the patient \nwas voiding independently thereafter. The surgical dressing was \nchanged on POD#2 and the surgical incision was found to be clean \nand intact without erythema or abnormal drainage. The patient \nwas seen daily by physical therapy. Labs were checked throughout \nthe hospital course and repleted accordingly. At the time of \ndischarge the patient was tolerating a regular diet and feeling \nwell.  The patient was afebrile with stable vital signs.  The \npatient's hematocrit was acceptable and pain was adequately \ncontrolled on an oral regimen. The operative extremity was \nneurovascularly intact and the wound was benign. \n\nThe patient's weight-bearing status is weight bearing as \ntolerated on the operative extremity.\n\nMs. ___ is discharged to rehab in stable condition.\n \nMedications on Admission:\n1. BuPROPion (Sustained Release) 150 mg PO BID \n2. ClonazePAM 1 mg PO BID \n3. Doxepin HCl 100 mg PO HS \n4. Vitamin D Dose is Unknown  PO DAILY \n5. FoLIC Acid 1 mg PO DAILY \n6. Furosemide 20 mg PO DAILY \n7. Gabapentin 400 mg PO TID \n8. Ipratropium-Albuterol Neb 1 NEB NEB Q6H wheezing \n9. Methadone 20 mg PO TID \n10. Pantoprazole 40 mg PO Q12H \n11. Ondansetron 4 mg PO Q8H:PRN nausea \n12. QUEtiapine Fumarate 75 mg PO QHS \n13. Ranitidine 150 mg PO DAILY \n14. Sucralfate 1 gm PO QID \n15. Ursodiol 500 mg PO BID \n16. Warfarin 10 mg PO AS INSTRUCTED \n17. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild \n18. Ascorbic Acid ___ mg PO DAILY \n19. Bisacodyl 10 mg PR QHS:PRN constipation \n20. Cyanocobalamin 100 mcg PO DAILY \n21. Calcium Carbonate 500 mg PO QID:PRN heartburn \n22. Ferrous Sulfate 325 mg PO DAILY \n23. Docusate Sodium 100 mg PO BID \n24. Milk of Magnesia 30 mL PO Q6H:PRN constipation \n25. Miconazole Powder 2% 1 Appl TP TID:PRN rash \n26. Polyethylene Glycol 17 g PO DAILY \n27. Fleet Enema ___AILY:PRN constipation \n28. Thiamine 100 mg PO DAILY \n \nDischarge Medications:\n1.  Diazepam 2.5-5 mg PO BID:PRN anxiety or muscle spasm  \n2.  Enoxaparin Sodium 30 mg SC Q12H \nStart: Today - ___, First Dose: Next Routine Administration \nTime \ndiscontinue when INR > 2.0 and take Coumadin only  \n3.  HYDROmorphone (Dilaudid) ___ mg PO Q3H:PRN Pain - Moderate  \n\n4.  Acetaminophen 1000 mg PO Q8H  \n5.  Gabapentin 600 mg PO TID  \n6.  Vitamin D 1000 UNIT PO DAILY  \n7.  Ascorbic Acid ___ mg PO DAILY  \n8.  Bisacodyl 10 mg PR QHS:PRN constipation  \n9.  BuPROPion (Sustained Release) 150 mg PO BID  \n10.  Calcium Carbonate 500 mg PO QID:PRN heartburn  \n11.  ClonazePAM 1 mg PO BID  \n12.  Cyanocobalamin 100 mcg PO DAILY  \n13.  Docusate Sodium 100 mg PO BID  \n14.  Doxepin HCl 100 mg PO HS  \n15.  Ferrous Sulfate 325 mg PO DAILY  \n16.  Fleet Enema ___AILY:PRN constipation  \n17.  FoLIC Acid 1 mg PO DAILY  \n18.  Furosemide 20 mg PO DAILY  \n19.  Ipratropium-Albuterol Neb 1 NEB NEB Q6H wheezing  \n20.  Methadone 20 mg PO TID  \n21.  Miconazole Powder 2% 1 Appl TP TID:PRN rash  \n22.  Milk of Magnesia 30 mL PO Q6H:PRN constipation  \n23.  Ondansetron 4 mg PO Q8H:PRN nausea  \n24.  Pantoprazole 40 mg PO Q12H  \n25.  Polyethylene Glycol 17 g PO DAILY  \n26.  QUEtiapine Fumarate 75 mg PO QHS  \n27.  Ranitidine 150 mg PO DAILY  \n28.  Sucralfate 1 gm PO QID  \n29.  Thiamine 100 mg PO DAILY  \n30.  Ursodiol 500 mg PO BID  \n31.  Warfarin 10 mg PO AS INSTRUCTED  \n\n32.Lovenox bridge to Coumadin\nLovenox bridge to Coumadin\nPlease continue Lovenox 30mg BID until INR > 2.0, then \ndiscontinue Lovenox and take Coumadin only. \nINR checks daily\nGoal INR 2.0-3.0\nCoumadin dosing based on INR goal level \n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nright knee osteoarthritis/pain\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\n1. Please return to the emergency department or notify your \nphysician if you experience any of the following: severe pain \nnot relieved by medication, increased swelling, decreased \nsensation, difficulty with movement, fevers greater than 101.5, \nshaking chills, increasing redness or drainage from the incision \nsite, chest pain, shortness of breath or any other concerns.\n\n2. Please follow up with your primary physician regarding this \nadmission and any new medications and refills. \n\n3. Resume your home medications unless otherwise instructed.\n\n4. You have been given medications for pain control. Please do \nnot drive, operate heavy machinery, or drink alcohol while \ntaking these medications. As your pain decreases, take fewer \ntablets and increase the time between doses. This medication can \ncause constipation, so you should drink plenty of water daily \nand take a stool softener (such as Colace) as needed to prevent \nthis side effect.  Call your surgeons office 3 days before you \nare out of medication so that it can be refilled.  These \nmedications cannot be called into your pharmacy and must be \npicked up in the clinic or mailed to your house.  Please allow \nan extra 2 days if you would like your medication mailed to your \nhome.\n\n5. You may not drive a car until cleared to do so by your \nsurgeon.\n\n6. Please call your surgeon's office to schedule or confirm your \nfollow-up appointment.\n\n7. SWELLING: Ice the operative joint 20 minutes at a time, \nespecially after activity or physical therapy. Do not place ice \ndirectly on the skin. You may wrap the knee with an ace bandage \nfor added compression. Please DO NOT take any non-steroidal \nanti-inflammatory medications (NSAIDs such as Celebrex, \nibuprofen, Advil, Aleve, Motrin, naproxen etc).\n\n8. ANTICOAGULATION: Please continue your Coumadin which is being \ndosed based on your INR levels.  You should continue Lovenox 30 \nmg twice daily until your INR > 2.  Once your INR > 2, you can \ndiscontinue the Lovenox and continue Warfarin.  Your INR goal is \n___.  \n\n9. WOUND CARE: Please keep your incision clean and dry. It is \nokay to shower five days after surgery but no tub baths, \nswimming, or submerging your incision until after your four (4) \nweek checkup. Please place a dry sterile dressing on the wound \neach day if there is drainage, otherwise leave it open to air. \nCheck wound regularly for signs of infection such as redness or \nthick yellow drainage. Staples will be removed at your follow-up \nappointment in three weeks.\n\n10. ___ (once at home): Home ___, dressing changes as \ninstructed, wound checks.\n\n11. ACTIVITY: Weight bearing as tolerated on the operative \nextremity. Mobilize.  ROM as tolerated. No strenuous exercise or \nheavy lifting until follow up appointment.\n\nPhysical Therapy:\nWBAT RLE\nNo range of motion restrictions\nMobilize frequently\n\nTreatments Frequency:\ndaily dressing changes as needed for drainage\nwound checks daily\nice\nstaple removal and replace with steri-strips (at follow up visit \nin 3 weeks)\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb698"
  },
  "note_id": "12648465-DS-34",
  "subject_id": 12648465,
  "hadm_id": 24121489,
  "note_type": "DS",
  "note_seq": 34,
  "charttime": "2209-02-04 00:00:00",
  "storetime": "2209-02-04 14:58:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut\n \nAttending: ___\n \nChief Complaint:\nBack and abdominal pain\n\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ yo woman with PMH chronic pain, multiple\nabdominal surgeries including gastric bypass, and \nnephrolithiasis\npresenting with exacerbation of flank/abdominal pain in the\nsetting of known ureteral stone. \n___ with a history of DVT/PE, chronic pain, multiple abdominal\nsurgeries including gastric bypass, presenting for continued \nback\nand abdominal pain.\n\nPatient reports 4 weeks of worsened back and abdominal pain, \nwith\nthe last week being \"just miserable\". She notes that she does \nnot\nhave dysuria but does have worsened back pain with urination. \nShe\ndenies f/c or n/v/d, but does have intermittent hematuria as \nwell\nas urinary urgency and hesitancy. She also feels that her back\npain is worse with movement, limiting her ability to do her \nusual\n___. She finds that nothing is really making it better. The pain\nhas impacted her appetite, leading to reduced PO intake and\nsignificant weight loss. \n\nThe patient has been diagnosed with kidney stones, with ___ CTU\nshowing non-obstructing renal pelvis stone. She has had urology\nfollow-up with cystoscopy on ___, showing no concerning \nlesions,\nand was tx with Flomax and fluids. Most recently saw PCP ___ \n___,\nwho felt that left renal pelvic stone did not appear to be\npassing in spite of medical treatment with tamsulosin, hydration\nand pain control, at which point dilaudid Rx was increased and\nPCP contacted urology.  Urology recommended repeat CTU, which\npatient has not yet scheduled. Back/flank pain and hematuria \nhave\ncontinued for past 2 weeks, also with urinary frequency.\nDecreased PO intake and sleep; some nausea without vomiting. No\nfevers/chills, dysuria, diarrhea, BRBPR. \n\nIn ED, initial vitals 97.6 91 134/81 18 100% RA \nLabs notable for grossly positive UA, WBC 3.1 with normal diff, \nK\n5.5-5.8 (hemolyzed) with resolution to 3.8. Received 20mg\nmethadone x2, CTX 1mg, Flomax 0.4mg, 1g APAP, 2mg IV dilaudid \nVitals on transfer 98.0 80 145/75 18 99% RA \n \nOn arrival to floor, patient reports ___ pain. \n\nROS: Positive as per HPI, all systems reviewed and otherwise\nnegative\n\n \nPast Medical History:\nR knee menisectomy ___\nDVT/PE\nDMII- resolved with weight loss after gastric bypass\nasthma-resolved with weight loss after gastric bypass \nCVA ___ with residual left facial droop\nmyelopathy\nobesity s/p gastric bypass\nsevere gastritis/esophagitis w/odynophagia\nrecurrent esophageal candidiasis,\nmultiple abdominal surgeries for \"stomach leak\"\ns/p CCY\nSBO\nHernia\nPUD\nGERD\nmacrocytic anemia\nh/o MRSA\nosteoarthritis\nnarcotic abuse\narthroplasty \nHTN\nHepatitis C- cleared \nnephrolithiasis \nthyromegaly\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN\nBrother with CHF\n\n \nPhysical Exam:\nADMISSION EXAM:\nVS:  98.3 145/88 60 18 97%RA \nGeneral: Well appearing woman sitting up in bed in NAD\nEyes: PERLL, EOMI, sclera anicteric\nENT: MMM, oropharynx clear without exudate or lesions \nRespiratory: CTAB without crackles, wheeze, rhonchi. \nCardiovascular: RRR, normal S1 and S2, no murmurs, rubs or\ngallops\nGastrointestinal: Soft, nontender, nondistended, +BS, no masses\nor HSM; no CVA tenderness \nExtremities: Warm and well perfused, no peripheral edema \nSkin: warm, no rashes/no jaundice/no skin ulcerations noted\nNeurological: Alert and oriented x3, motor and sensory exam\ngrossly intact \n\nDISCHARGE EXAM:\nVS:  98.3PO 103 / 67 63 18 99 Ra \nGeneral: Well appearing woman sitting up in bed in NAD\nEyes: PERLL, EOMI, sclera anicteric\nENT: MMM, oropharynx clear without exudate or lesions \nRespiratory: CTAB without crackles, wheeze, rhonchi. \nCardiovascular: RRR, normal S1 and S2, no murmurs, rubs or\ngallops\nGastrointestinal: Soft, nontender, nondistended, +BS, no masses\nor HSM\nBack: TTP in L flank\nExtremities: Warm and well perfused, no peripheral edema \nSkin: warm, no rashes/no jaundice/no skin ulcerations noted\nNeurological: Alert and oriented x3, motor and sensory exam\ngrossly intact \n\n \nPertinent Results:\nADMISSION LABS:\n___ 01:20PM URINE  MUCOUS-FEW\n___ 01:20PM URINE  AMORPH-RARE\n___ 01:20PM URINE  RBC-6* WBC-116* BACTERIA-FEW YEAST-NONE \nEPI-<1\n___ 01:20PM URINE  BLOOD-TR NITRITE-NEG PROTEIN-30 \nGLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-4* PH-6.0 LEUK-LG\n___ 01:20PM URINE  COLOR-Yellow APPEAR-Hazy SP ___\n___ 02:30PM   NEUTS-65.1 ___ MONOS-6.4 EOS-0.0* \nBASOS-0.3 IM ___ AbsNeut-2.03# AbsLymp-0.87* AbsMono-0.20 \nAbsEos-0.00* AbsBaso-0.01\n___ 02:30PM   WBC-3.1*# RBC-3.86* HGB-11.5 HCT-36.6 MCV-95 \nMCH-29.8 MCHC-31.4* RDW-14.8 RDWSD-51.1*\n___ 02:30PM   GLUCOSE-84 UREA N-9 CREAT-0.9 SODIUM-138 \nPOTASSIUM-5.5* CHLORIDE-102 TOTAL CO2-22 ANION GAP-20\n___ 02:33PM   LACTATE-1.2 K+-5.8*\n___ 04:11PM   K+-3.8\n\nMicro:\n___ Ucx, Bcx x2 pnd\n\nIMAGING: \n___ CT A/P w/o con\n1. 5 mm calculus in the left renal pelvis is unchanged as\ncompared to CT\nabdomen and pelvis ___. No evidence of hydronephrosis or\nhydroureter.\n2. No acute abnormality in the abdomen or pelvis.\n3. Status post Roux-en-Y gastric bypass and mild dilatation of\nthe\njejunojejunostomy anastomosis is unchanged dating back to CT\nabdomen pelvis\n___.\n\nECG: NSR rate 59, possible old lateral infarct, otherwise normal\nECG; unchanged from prior ___. Qtc 445. \n\nDISCHARGE LABS:\n___ 06:15AM BLOOD WBC-3.5* RBC-3.54* Hgb-10.3* Hct-33.2* \nMCV-94 MCH-29.1 MCHC-31.0* RDW-14.7 RDWSD-50.4* Plt ___\n___ 02:30PM BLOOD Neuts-65.1 ___ Monos-6.4 Eos-0.0* \nBaso-0.3 Im ___ AbsNeut-2.03# AbsLymp-0.87* AbsMono-0.20 \nAbsEos-0.00* AbsBaso-0.01\n___ 06:15AM BLOOD Calcium-8.8 Phos-4.8* Mg-1.___ yo woman with PMH chronic pain, multiple abdominal surgeries\nincluding gastric bypass, and nephrolithiasis presenting with\nexacerbation of flank/abdominal pain in the setting of known\nureteral stone. \n\n#UTI/abdominal pain/back pain/nephrolithiasis/chronic\npain/narcotic abuse: \n  Patient has a history and multiple abdominal surgeries and \nchronic pain, but pain has been exacerbated over the last 4 \nweeks in the setting of previously diagnosed nonobstructive \nureteral stone. Conservative management with pain management and \nFlomax has not been effective in passing the stone and she is \nstill c/o L flank pain.  Per Urology, may consider lithotripsy \nin the near future if pt still symptomatic after UTI treatment.  \n\n   Her Urine culture returned with 2 types of pan-sensitive \ne.coli.  She was treated with CTX with resolution of lower \nabdominal pain and dysuria.  She will complete 7 day course of \nabx with Bactrim on discharge. (Pt also given script for 1 dose \nof flucazole as she states she always gets yeast infections on \nabx and was c/o some recurrent urgency.)\n  Of note, patient has a hx of narcotic abuse, is on a narcotic \ncontract as an outpatient, and has multiple safety alerts in POE \nfor misuse of narcotic medications including possible \nin-hospital overdose, so care was taken to limit increases in \nopioid medications. She was started on home dilaudid on \nadmission but dose was inadvertently increased to ___ prn as \nit was thought that PCP had increased dilaudid dose to up to 4mg \nprn (but on review of OMR, it appears that he had only filled \nchronic 2mg script 1 week early).  Discussed with Dr. ___ \n___ is for patient to fill her monthly script on discharge \n(180# 2mg tabs prescribed to start on ___ and to call clinic if \nshe runs out early b/c she has been taking 4mg prn instead of \n2mg.  She was also continued on home tizanidine and gabapentin. \n\n#History of gastric bypass:  Continued ursodiol, cholestyramine, \nZofran.  Continued home vitamin D, vitamin B12, vitamin C, MVI\n\n#History of DVT/PE/Stroke:  Continued home rivaroxaban\n\n#Depression/anxiety:  Continued bupropion, doxepin, clonazepam, \nquetiapine\n\n#GERD: Continued ranitidine, pantoprazole\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Ascorbic Acid ___ mg PO DAILY \n2. BuPROPion (Sustained Release) 150 mg PO BID \n3. ClonazePAM 1 mg PO QAM \n4. Cyanocobalamin 100 mcg PO DAILY \n5. Doxepin HCl 100 mg PO HS \n6. Methadone 20 mg PO TID \n7. Pantoprazole 40 mg PO Q12H \n8. QUEtiapine Fumarate 75 mg PO QHS \n9. Ranitidine 150 mg PO DAILY \n10. Thiamine 100 mg PO DAILY \n11. Ursodiol 500 mg PO BID \n12. Milk of Magnesia 30 mL PO DAILY:PRN constipation \n13. Ondansetron 4 mg PO Q8H:PRN nausea \n14. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n15. Vitamin D 1000 UNIT PO DAILY \n16. Acetaminophen 1000 mg PO Q8H \n17. Docusate Sodium 100 mg PO BID \n18. Gabapentin 200 mg PO TID \n19. HYDROmorphone (Dilaudid) 2 mg PO Q4H:PRN Pain - Severe \n  Reason for PRN duplicate override: adjusting dose\n20. ClonazePAM 0.5 mg PO QPM \n21. Cholestyramine 4 gm PO DAILY \n22. FoLIC Acid 1 mg PO DAILY \n23. Rivaroxaban 20 mg PO DAILY \n24. Tamsulosin 0.4 mg PO DAILY \n25. Tizanidine 2 mg PO Q8H:PRN knee spasm \n26. Multivitamins W/minerals 1 TAB PO DAILY \n27. Senna 8.6 mg PO BID \n\n \nDischarge Medications:\n1.  Fluconazole 150 mg PO ONCE Duration: 1 Dose \nRX *fluconazole [Diflucan] 150 mg 1 tablet(s) by mouth once Disp \n#*1 Tablet Refills:*0 \n2.  Sulfameth/Trimethoprim DS 1 TAB PO BID Duration: 3 Days \nRX *sulfamethoxazole-trimethoprim [Bactrim DS] 800 mg-160 mg 1 \ntablet(s) by mouth twice per day Disp #*6 Tablet Refills:*0 \n3.  HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Severe  \n4.  Acetaminophen 1000 mg PO Q8H  \n5.  Ascorbic Acid ___ mg PO DAILY  \n6.  BuPROPion (Sustained Release) 150 mg PO BID  \n7.  Cholestyramine 4 gm PO DAILY  \n8.  ClonazePAM 1 mg PO QAM  \n9.  ClonazePAM 0.5 mg PO QPM  \n10.  Cyanocobalamin 100 mcg PO DAILY  \n11.  Docusate Sodium 100 mg PO BID  \n12.  Doxepin HCl 100 mg PO HS  \n13.  FoLIC Acid 1 mg PO DAILY  \n14.  Gabapentin 200 mg PO TID  \n15.  Methadone 20 mg PO TID  \n16.  Milk of Magnesia 30 mL PO DAILY:PRN constipation  \n17.  Multivitamins W/minerals 1 TAB PO DAILY  \n18.  Ondansetron 4 mg PO Q8H:PRN nausea  \n19.  Pantoprazole 40 mg PO Q12H  \n20.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n21.  QUEtiapine Fumarate 75 mg PO QHS  \n22.  Ranitidine 150 mg PO DAILY  \n23.  Rivaroxaban 20 mg PO DAILY  \n24.  Senna 8.6 mg PO BID  \n25.  Tamsulosin 0.4 mg PO DAILY  \n26.  Thiamine 100 mg PO DAILY  \n27.  Tizanidine 2 mg PO Q8H:PRN knee spasm  \n28.  Ursodiol 500 mg PO BID  \n29.  Vitamin D 1000 UNIT PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\n1.  UTI\n2.  Kidney stone\n3.  Chronic abdominal pain\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted for flank pain and frequent urination.  You \nalso have a known kidney stone and you were seen by the urology \nservice.  We found that you had a UTI, and have put you on \nantibiotoics.  You will followup with urology regarding \ntreatment of the stone.  \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb699"
  },
  "note_id": "12648465-DS-35",
  "subject_id": 12648465,
  "hadm_id": 22517237,
  "note_type": "DS",
  "note_seq": 35,
  "charttime": "2209-02-26 00:00:00",
  "storetime": "2209-02-26 11:43:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut\n \nAttending: ___.\n \nChief Complaint:\nDysuria, flank pain\n \nMajor Surgical or Invasive Procedure:\nureteral stent removal ___\n\n \nHistory of Present Illness:\nCC: ___\n\nHPI:\nThis is a ___ with a history of DVT/PE on rivaroxaban, narcotics\ncontract for chronic pain, multiple abdominal surgeries \nincluding\ngastric bypass, nephrolithiasis hospitalized ___ for pan\nsensitive e coli UTI, POD 4 for left retrograde pyelogram, left\nureteroscopy laser lithotripsy, left ureteral stent placement\nwith post op pain, presenting with dysuria and fever.\n\nThe history is obtained from ___ and the ED, the patient is too\nsomnolent to contribute meaningfully. The patient has a\nleft-sided ureteral stone with above admission for pan sensitive\nE coli UTI 3 weeks ago, now POD 4 for lithotripsy and stent\nplacement on ___ (full op note unavailable in ___) who \ndeveloped\nincreasing left sided flank pain, dysuria and fevers. Patient\nstates she had been having left-sided flank pain that\nprecipitated diagnosis of renal stone and has had much worsening\nof her left-sided pain after the stent was placed. 2 days ago \nshe\ndeveloped nausea/vomiting and has not been able to tolerate p.o.\nshe is also developed fever 101.2 starting today. She contacted\nher urology team yesterday who called her in a prescription for\nMacrobid which she has been taking without relief.\n\nHer urine culture at the time of the procedure is growing ESBL e\ncoli.\n\nIn the ED:\nT 101.2  98  102/52  18 98% RA \nUA >180 WBC\nWBC 6.2 \nCr 1.0\nLactate wnl \nRenal ultrasound without evidence of abscess.\nShe was given 1L NS, zosyn, does not appear to have received\nnarcotics, and admitted.\n\nROS: Per hpi, otherwise rest of 10pt review negative\n \nPast Medical History:\nPMH:\nR knee menisectomy ___\nDVT/PE\nDMII- resolved with weight loss after gastric bypass\nAsthma-resolved with weight loss after gastric bypass \nCVA ___ with residual left facial droop\nMyelopathy NOS\nObesity s/p gastric bypass\nSevere gastritis/esophagitis w/odynophagia\nRecurrent esophageal candidiasis,\nMultiple abdominal surgeries for \"stomach leak\"\ns/p CCY\nh/o SBO\nHernia\nPUD\nGERD\nmacrocytic anemia\nh/o MRSA\nosteoarthritis\nnarcotic abuse\narthroplasty \nHTN\nHepatitis C- cleared \nnephrolithiasis \nthyromegaly\n\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN\nBrother with CHF\n\n \nPhysical Exam:\nPHYSICAL EXAM:\n98.1 BP 91/59 67 12 96%RA \nGEN: Sleeping in bed, rouses to voice briefly, doesn't answer\nmore than yes-no questions\nHEENT: Pinpoint pupils, moist membranes\nHEART: RRR, no murmurs\nLUNGS: CTA bilaterally, soft respirations\nABD: Soft, nontender, nondistended\nGU: No folkey\nEXT: Warm,no edema, 2+ dp pulses\n\n \nPertinent Results:\nMICRO:\n\n   URINE CULTURE (Final ___: \n      ESCHERICHIA COLI.    ~300 CFU/mL.  PRESUMPTIVE\nIDENTIFICATION. \n\n                              SENSITIVITIES: MIC expressed in\nMCG/ML\n                     \n_________________________________________________________\n                             ESCHERICHIA COLI\n                             |   \nAMPICILLIN------------  =>32 R\nAMPICILLIN/SULBACTAM--  =>32 R\nCEFAZOLIN-------------  =>64 R\nCEFEPIME--------------       R\nCEFTAZIDIME-----------    16 R\nCEFTRIAXONE-----------  =>64 R\nCIPROFLOXACIN---------   =>4 R\nGENTAMICIN------------   <=1 S\nMEROPENEM-------------<=0.25 S\nNITROFURANTOIN--------  <=16 S\nPIPERACILLIN/TAZO-----   <=4 S\nTOBRAMYCIN------------   <=1 S\nTRIMETHOPRIM/SULFA----  =>16 R\n\nIMAGING:\nRenal ultrasound ___ PRELIM READ\nIMPRESSION: \n1. No hydronephrosis or evidence of perinephric fluid \ncollection.\n\n2. Hypoechoic material in the dependent portion of the bladder\nmay represent debris or blood clot in the setting of recent\ninstrumentation. \n\n \nBrief Hospital Course:\n___ with chronic DVT/PE on rivaroxaban, narcotics contract for \nchronic pain, multiple abdominal surgeries including gastric \nbypass, nephrolithiasis hospitalized ___ for pan sensitive e \ncoli UTI, POD 4 for left retrograde pyelogram, left ureteroscopy \nlaser lithotripsy, left ureteral stent placement with post op \npain, presenting with sepsis and urinary tract pain.\n\nACUTE ISSUES\n# Sepsis from urinary source - ESBL (+)\n# Nephrolithiasis s/p recent lithotripsy and ureteral stent\n# Acute pain (dysuria)\n# Opiate use disorder\n\nCHRONIC ISSUES\n# Chronic VTE\n# s/p gastric bypass\n# Chronic depression\n# Chronic anxiety\n\nShe was placed on Zosyn IV wihtout further fever.  She was seen \nby urology who deferred stent removal until ___.  Patient \ncomplained of pain, and received a 1 or 2 doses of extra \nnarcotics with resultant somnoence without hypoxemia.  Concern \nfor non-malicious painseeking with risk for sedation voiced by \nHMED team to PCP ___.  HMED spoke with pt's HCP who has similar \nconcerns at times with patien'ts home mis-managment of meds.  \nHCP states while feeding pt's cat this week, she found staches \nof meds \"all over the house\" and is concerned about patient's \nability to self-manage her sedatives/pain meds in a safe manner \nwithout risking over-sedation.  Concern shared with PCP.  We \nagree to begin slo benzodiazepine taper initially and she was \nmoved to CLonazepam 0.5m BID (from 1mg QM, 0.5mg ___. Narcotics \nare unchanged. She will need home eval with ___ (sister/HCP \nwould like to be present when this is arranged).  PACT team saw \npatient and said she would qualify for packaged meds, and PCP \nteam could consider locked box for her restricted substance \nscripts in the home (with ___.  PCP team informed.\n\nTizanidine was stopped.  Patient had L ureteral stent removed AM \n___ without complications.  She complained of L flank pain \nthereafter. Post procedure void did not reveal frank hematuria \nor clots.  Urology was notified and said further imaging was not \nindicated.  Patient was given Oxybutin 5mg TIDprn and her pain \nsettled down such that she went to sleep.  She is being \ndischarged to rehab, where expected length of stay is less than \n30 days.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 1000 mg PO Q8H \n2. Ascorbic Acid ___ mg PO DAILY \n3. BuPROPion (Sustained Release) 150 mg PO BID \n4. Cholestyramine 4 gm PO DAILY \n5. ClonazePAM 1 mg PO QAM \n6. ClonazePAM 0.5 mg PO QPM \n7. Cyanocobalamin 100 mcg PO DAILY \n8. Docusate Sodium 100 mg PO BID \n9. Doxepin HCl 100 mg PO HS \n10. FoLIC Acid 1 mg PO DAILY \n11. Gabapentin 200 mg PO TID \n12. Methadone 20 mg PO TID \n13. Multivitamins W/minerals 1 TAB PO DAILY \n14. Ondansetron 4 mg PO Q8H:PRN nausea \n15. Pantoprazole 40 mg PO Q12H \n16. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n17. QUEtiapine Fumarate 75 mg PO QHS \n18. Ranitidine 150 mg PO DAILY \n19. Rivaroxaban 20 mg PO DAILY \n20. Senna 8.6 mg PO BID \n21. Tamsulosin 0.4 mg PO DAILY \n22. Thiamine 100 mg PO DAILY \n23. Tizanidine 2 mg PO Q8H:PRN knee spasm \n24. Ursodiol 500 mg PO BID \n25. Vitamin D 1000 UNIT PO DAILY \n26. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Severe \n27. Milk of Magnesia 30 mL PO DAILY:PRN constipation \n\n \nDischarge Medications:\n1.  Oxybutynin 5 mg PO TID:PRN bladder spasm  \n2.  Piperacillin-Tazobactam 4.5 g IV Q8H \nRX *piperacillin-tazobactam 4.5 gram 4.5 gm IV q8hr Disp #*23 \nVial Refills:*0 \n3.  Sodium Chloride 0.9%  Flush ___ mL IV DAILY and PRN, line \nflush  \n4.  Acetaminophen 1000 mg PO Q8H  \n5.  Ascorbic Acid ___ mg PO DAILY  \n6.  BuPROPion (Sustained Release) 150 mg PO BID  \n7.  Cholestyramine 4 gm PO DAILY  \n8.  ClonazePAM 1 mg PO QAM  \n9.  ClonazePAM 0.5 mg PO QPM  \n10.  Cyanocobalamin 100 mcg PO DAILY  \n11.  Docusate Sodium 100 mg PO BID  \n12.  Doxepin HCl 100 mg PO HS  \n13.  FoLIC Acid 1 mg PO DAILY  \n14.  Gabapentin 200 mg PO TID  \n15.  HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Severe  \n16.  Methadone 20 mg PO TID  \n17.  Milk of Magnesia 30 mL PO DAILY:PRN constipation  \n18.  Multivitamins W/minerals 1 TAB PO DAILY  \n19.  Pantoprazole 40 mg PO Q12H  \n20.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n21.  QUEtiapine Fumarate 75 mg PO QHS  \n22.  Ranitidine 150 mg PO DAILY  \n23.  Rivaroxaban 20 mg PO DAILY  \n24.  Senna 8.6 mg PO BID  \n25.  Tamsulosin 0.4 mg PO DAILY  \n26.  Thiamine 100 mg PO DAILY  \n27.  Ursodiol 500 mg PO BID  \n28.  Vitamin D 1000 UNIT PO DAILY  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nSepsis from urinary source (pyelopephritis)\nChronic nephrolithiasis\nChronic pain syndrome\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted after recent ureter stenting procedure with \nfever and pain.  You were started on IV antibiotics, and due to \nprior resistance pattern will need to complete a course by IV.  \nA PICC line was placed and home antibiotics are arranged. You \nwere restarted on your home pain regimen.  You underwent stent \nremoval by urology.  Concerns were shared regarding your \nsensitivity to over-sedation with your current medical regimen \nand your home managment of your medications.  You are discharged \nto rehab.  We are initiating a slow benzodiazepine (clonazepam) \ntaper in an effort to prevent over sedation with your chronic \nnarcotic regiment. This will continue to be addressed by your \nPCP team, and suggestion was made for home medication evaluation \nto augment safety parameters and minimize drug interactions or \nadverse event.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb69a"
  },
  "note_id": "12648465-DS-36",
  "subject_id": 12648465,
  "hadm_id": 25150998,
  "note_type": "DS",
  "note_seq": 36,
  "charttime": "2209-04-11 00:00:00",
  "storetime": "2209-04-11 12:03:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut\n \nAttending: ___.\n \nChief Complaint:\nnausea, abdominal pain \n \nMajor Surgical or Invasive Procedure:\nEGD ___\n \nHistory of Present Illness:\n___ with an extensive past medical history including\nnephrolithiasis (5mm, nonobstructing stone in L renal pelvis,\natypical urine cytology with subsequent cystoscopy unremarkable,\ncourse complicated by hospitalization for MDE Ecoli urosepsis),\nDVT/PE on xeralto, CVA, severe GERD/esophagitis, chronic\nabdominal pain in setting of gastric bypass c/b SBOs/multiple\nsurgeries/adhesions, chronic lower back pain, chronic opiate use\nwith history of abuse, depression and anxiety who is presenting\nwith coffee ground emesis, persistent nausea and vomiting, and\nadmitted after failed PO challenge.\n\nThe patient reports several days of anorexia and weakness. She\nreports that on the day of admission, he had several episodes of\ncoffe-ground appearing material several times. She endorses\nabdominal pain around her umbilicus. She reported feeling weak\nand presyncopal, without syncopal event or loss of \nconsciousness.\nEvery day she eats, she either feels nausea and vomits, with\nimmediate relief. She reported her vomiting to be productive of\ntypical food products as well as small amounts of coffee-ground\nemesis. She denied bright red blood in emesis or hematochezia.\nShe endorsed one episode of T99.9 oral 2 days ago. Her last \nbowel\nmovement was yesterday.\n\nIn the ED, initial VS were 98.3 80 138/90 16 100% RA.\nCBC with WBC 3.6, H/H of 11.7/37.9, Plt 290. INR 1.1 BMP notable\nfor HCO3 19, BUN/Cr of ___. Troponin negative x 1. Lactate\n1.7. UA negative with trace ketones.\nPhysical exam was notable for diffusely tender abdomen,\nparticularly in the LLQ. Rectal exam significant for brown stool\nin the vault, which was guaic negative. \nCT abdomen/pelvis notable for mild thickening of the distal\ncolonic wall, which may be due to underdistention or mild\ncolitis, likely infectious or inflammatory. \nShe received IV dilaudid 0.5 mg x 3 doses, IV Zofran x 2 doses,\nand IV lorazepam 1 mg x 1. \nIn the ED, she failed an oral PO challenge with continued\nvomiting, so was subsequently admitted to medicine due to failed\nPO challenge.\n\nUpon arrival to the floor, patient stated that she has been\nexperiencing nausea and abdominal pain.  Denies CP, SOB, HA,\ndiarrhea, constipation.\n \nROS: Pertinent positives and negatives as noted in the HPI.  All\nother systems were reviewed and are negative. \n\n \nPast Medical History:\nPMH:\nR knee menisectomy ___\nDVT/PE\nDMII- resolved with weight loss after gastric bypass\nAsthma-resolved with weight loss after gastric bypass \nCVA ___ with residual left facial droop\nMyelopathy NOS\nObesity s/p gastric bypass\nSevere gastritis/esophagitis w/odynophagia\nRecurrent esophageal candidiasis,\nMultiple abdominal surgeries for \"stomach leak\"\ns/p CCY\nh/o SBO\nHernia\nPUD\nGERD\nmacrocytic anemia\nh/o MRSA\nosteoarthritis\nnarcotic abuse\narthroplasty \nHTN\nHepatitis C- cleared \nnephrolithiasis \nthyromegaly\n\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN\nBrother with CHF\n\n \nPhysical Exam:\nVITALS: Afebrile and vital signs stable \nGENERAL: Alert and in no apparent distress\nEYES: Anicteric, pupils equally round\nENT: Ears and nose without visible erythema, masses, or trauma. \nOropharynx without visible lesion, erythema or exudate\nCV: Heart regular,  No JVD.\nRESP: good air movement bilaterally\nGI: Abdomen soft, non-tender\nMSK: Neck supple, moves all extremities, strength grossly full\nand symmetric bilaterally in all limbs\nSKIN: No rashes or ulcerations noted\nNEURO: Alert, oriented, face symmetric, gaze conjugate with \nEOMI,\nspeech fluent, moves all limbs, has left moderate hemiplegia \nwith\n___ weaker than RLE/RUE\n\n \nPertinent Results:\n___ 07:45AM BLOOD Hgb-11.0* Hct-35.3\n___ 06:28AM BLOOD WBC-3.1* RBC-3.75* Hgb-11.2 Hct-36.4 \nMCV-97 MCH-29.9 MCHC-30.8* RDW-16.9* RDWSD-60.6* Plt ___\n___ 06:20AM BLOOD WBC-3.0* RBC-3.61* Hgb-11.0* Hct-34.0 \nMCV-94 MCH-30.5 MCHC-32.4 RDW-16.8* RDWSD-58.8* Plt ___\n___ 10:41PM BLOOD WBC-3.6* RBC-3.92 Hgb-11.7 Hct-37.9 \nMCV-97 MCH-29.8 MCHC-30.9* RDW-17.2* RDWSD-61.0* Plt ___\n___ 06:28AM BLOOD Plt ___\n___ 07:45AM BLOOD Glucose-73 UreaN-17 Creat-0.9 Na-142 \nK-4.5 Cl-102 HCO3-26 AnGap-14\n___ 06:28AM BLOOD Glucose-71 UreaN-8 Creat-1.0 Na-144 K-4.6 \nCl-106 HCO3-25 AnGap-13\n___ 06:20AM BLOOD Glucose-80 UreaN-11 Creat-0.9 Na-141 \nK-4.3 Cl-103 HCO3-25 AnGap-13\n___ 07:10PM BLOOD Glucose-75 UreaN-14 Creat-1.0 Na-144 \nK-4.4 Cl-101 HCO3-19* AnGap-24*\n___ 06:20AM BLOOD ALT-11 AST-19 AlkPhos-119* TotBili-0.5\n___ 07:10PM BLOOD ALT-14 AST-30 AlkPhos-138* TotBili-0.3\n___ 06:20AM BLOOD Calcium-8.8 Phos-4.2 Mg-1.9\n___ 07:10PM BLOOD Albumin-3.4* Calcium-9.2 Phos-4.2 Mg-1.8\n___ 07:45AM BLOOD 25VitD-34\n___ 07:33PM BLOOD Lactate-1.7 K-3.___ year old lady with history of CVA in ___ with residual left\nsided facial droop, prior DVT/PE on rivaroxaban, obesity s/p\ngastric bypass complicated by recurrent SBO ___ adhesions, \nsevere\nesophagitis/gastritis (most recent EGD ___ and GERD,\nnephrolithiasis s/p recent lithotripsy ___ and left ureteral\nstent (removed ___ who presented for abdominal pain and\nadmitted on ___.\n\nPROBLEMS:\n#acute on chronic abdominal pain\n#nausea\n-symptoms likely due to gastritis/esophagitis. Mesenteric \nischemia was ruled -out based on history, exam, and normal \nlactate.  She had no evidence of UTI.  \nShe received a CT AP which showed no SBO, but question of distal \ncolitis; however, she was asymptomatic from this incidental \nfinding, suggesting a resolved\nrecent infection. During her hospital stay, with worsening \nsymptoms, the hospitalist consulted GI who performed EGD on ___. \n This showed esophagitis/gastritis likely\nexplaining her abdominal pain. She is on chronic methadone, \nwhich was continued.  The hospitalist also increased her \nDilaudid from 2 to 4 mg and added Carafate in addition to \nPromethazine. I advised her that the narcotics can contribute to \ngastroparesis and ideally, she should be eweaned off of them \ncompletely.  However, I said I would honor the previous \n___'s decision to do a short -term increase.  I gave 20 \n4mg tabs that should last until her next outpatient apt 4 days \nafter admission. She did not fill her Rx for Dilaudid given on \n___.  I said to give this Rx to her PCP so they could re-write \nit as they saw fit.  \n\n#Weight loss over 55lb since ___ with albumin of 3.4 due to\nmoderate protein/calorie malnutrition, likely due to significant\nGI hx.  She was encouraged to eat small volume, frequent, \nhigh-calorie meals.  \n\n# Coffee ground emesis\n-Patient had reported coffee ground emesis. Of\nnote, no further coffee grounds were observed since in the\nhospital/ED. ___ was negative and patient denied melena, \nmaking\nupper GI bleed very unlikely. Though her witnessed coffee ground \nemesis\ncould have represented ___ tear in setting of\nsignificant vomiting. H/H completely stable with trending.\n\n# history of CVA, DVT/PE- Continued rivaroxaban 20 mg daily\n- neuro exam is baseline for her. Subtle L facial droop.\n\n# History of gastric bypass\nShe was continued on home  Ursodiol 500 mg PO BID, \nCholestyramine 4 gm PO DAILY  \nWe held her home vitamin D, vitamin B12, vitamin C, MVI to \nminimize\npill burden.  However, the ultimate decision about pill burden \ncan be left for a discussion with her and her PCP.  \n\n#Depression/anxiety:  She was continued on her home medications. \n \n\n#GERD: Continued Ranitidine 150 mg PO DAILY and Pantoprazole 40 \nmg PO Q12H \n\nI spent greater than 30 min on discharge planning and \ncoordination of care.  \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 1000 mg PO Q8H \n2. Ascorbic Acid ___ mg PO DAILY \n3. BuPROPion (Sustained Release) 150 mg PO BID \n4. Doxepin HCl 100 mg PO HS \n5. FoLIC Acid 1 mg PO DAILY \n6. Gabapentin 200 mg PO TID \n7. HYDROmorphone (Dilaudid) 2 mg PO Q4H:PRN Pain - Severe \n8. Methadone 20 mg PO TID \n9. Multivitamins W/minerals 1 TAB PO DAILY \n10. Pantoprazole 40 mg PO Q12H \n11. QUEtiapine Fumarate 75 mg PO QHS \n12. Rivaroxaban 20 mg PO DAILY \n13. Senna 8.6 mg PO BID \n14. Thiamine 100 mg PO DAILY \n15. Ursodiol 500 mg PO DAILY \n16. Vitamin D 1000 UNIT PO DAILY \n17. Ranitidine 150 mg PO DAILY \n18. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n19. Cyanocobalamin 100 mcg PO DAILY \n20. Docusate Sodium 100 mg PO BID \n21. ClonazePAM 0.5 mg PO BID anxiety \n22. Ferrous Sulfate 325 mg PO DAILY \n\n \nDischarge Medications:\n1.  Promethazine 12.5 mg PO Q6H:PRN nausea \nRX *promethazine 12.5 mg 1 (One) tab by mouth three times a day \nDisp #*30 Tablet Refills:*0 \n2.  Sucralfate 1 gm PO QID \nRX *sucralfate 1 gram/10 mL 10 ml by mouth four times a day Disp \n#*1 Bottle Refills:*0 \n3.  HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Severe \nRX *hydromorphone 4 mg ___ tablet(s) by mouth four times a day \nDisp #*20 Tablet Refills:*0 \n4.  Acetaminophen 1000 mg PO Q8H  \n5.  Ascorbic Acid ___ mg PO DAILY  \n6.  BuPROPion (Sustained Release) 150 mg PO BID  \n7.  ClonazePAM 0.5 mg PO BID anxiety  \n8.  Cyanocobalamin 100 mcg PO DAILY  \n9.  Docusate Sodium 100 mg PO BID  \n10.  Doxepin HCl 100 mg PO HS  \n11.  Ferrous Sulfate 325 mg PO DAILY  \n12.  FoLIC Acid 1 mg PO DAILY  \n13.  Gabapentin 200 mg PO TID  \n14.  Methadone 20 mg PO TID  \n15.  Multivitamins W/minerals 1 TAB PO DAILY  \n16.  Pantoprazole 40 mg PO Q12H  \n17.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n18.  QUEtiapine Fumarate 75 mg PO QHS  \n19.  Ranitidine 150 mg PO DAILY  \n20.  Rivaroxaban 20 mg PO DAILY  \n21.  Senna 8.6 mg PO BID  \n22.  Thiamine 100 mg PO DAILY  \n23.  Ursodiol 500 mg PO DAILY  \n24.  Vitamin D 1000 UNIT PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nEsophagitis\nGastritis\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n \nDischarge Instructions:\nInstructions: Dear Ms. ___, \n\nIt was a pleasure to be a part of your care team at ___ \n___.\n\n====================================\nWhy did you come to the hospital? \n====================================\n\n-You had abdominal pain and vomiting.\n\n====================================\nWhat happened at the hospital? \n====================================\n\n-You underwent endoscopy procedure which revealed esophagitis \nand gastritis. This may be due to excess acid production in the \nstomach. You were given new medications to protect the stomach \nlining and improve your pain.\n\n==================================================\nWhat needs to happen when you leave the hospital? \n==================================================\n\n-Take your medications every day as directed by your doctors \n-___ attend all of your doctor appointments, this is \nespecially important to help with your gastritis and \nesophagitis.\n\nIt was a pleasure taking care of you during your stay! \n\nSincerely, \n\nYour ___ team  \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb69b"
  },
  "note_id": "12648465-DS-37",
  "subject_id": 12648465,
  "hadm_id": 28237346,
  "note_type": "DS",
  "note_seq": 37,
  "charttime": "2209-04-15 00:00:00",
  "storetime": "2209-04-15 16:31:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut\n \nAttending: ___.\n \nChief Complaint:\naltered mental status\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\n___ with nephrolithiasis (5mm, nonobstructing stone in L renal\npelvis, prior hospitalization for MDE Ecoli urosepsis),\nDVT/PE on xeralto, CVA with residual L sided weakness, severe\nGERD/esophagitis, chronic abdominal pain in setting of gastric\nbypass c/b SBOs/multiple surgeries/adhesions, chronic lower back\npain, chronic opiate use with history of abuse, depression and\nanxiety who is admitted due to concern for altered mental state\nat home. \n\nPt was recently admitted to ___ due to symptoms of gastritis\nand esophagitis and discharged on ___. During her\nhospitalization, she had an increase in her hydromorphone dose\nfrom 2 mg to ___ mg q4 prn and promethazine added for nausea. Pt\ndischarged home with home ___. Yesterday, her sister, daughter,\nand mother visited her and noted that she was forgetful mid\nsentences and was speaking slowly and possibly having trouble\ngetting words out. ___ recommended evaluation in the ED given \nher\nhistory of CVA and concern for possible TIA. Pt also had a fall\nafter standing up too quickly but did not lose consciousness but\nstrike her head.\n\nIn the ED, pt with stable vitals. Exam notable for impaired\nattention, L facial droop and L sided weakness. Urinalysis was\nunremarkable. CT head without contrast was similarly\nunremarkable. Pt admitted for further care and workup of her\nmental status change. \n  \nROS: As above. Denies headache, lightheadedness, dizziness, sore\nthroat, sinus congestion, chest pain, heart palpitations,\nshortness of breath, cough, nausea, vomiting, diarrhea,\nconstipation, urinary symptoms, muscle or joint pains, focal\nnumbness or tingling, skin rash. The remainder of the ROS was\nnegative.\n\n \nPast Medical History:\nR knee menisectomy ___\nDVT/PE\nDMII- resolved with weight loss after gastric bypass\nAsthma-resolved with weight loss after gastric bypass \nCVA ___ with residual left facial droop\nMyelopathy NOS\nObesity s/p gastric bypass\nSevere gastritis/esophagitis w/odynophagia\nRecurrent esophageal candidiasis,\nMultiple abdominal surgeries for \"stomach leak\"\ns/p CCY\nh/o SBO\nHernia\nPUD\nGERD\nmacrocytic anemia\nh/o MRSA\nosteoarthritis\nnarcotic abuse\narthroplasty \nHTN\nHepatitis C- cleared \nnephrolithiasis \nthyromegaly\n \n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN\nBrother with CHF\n\n \nPhysical Exam:\nGEN - NAD, sitting in bed\nHEENT -  mild L facial droop, no scleral icterus\nNECK - supple, no LAD\nCV - rrr, no r/m/g\nRESP - clear b/l\nABD - soft, nt/nd, +bs\nEXT - R knee with surgical scar, no edema\nSKIN - no rashes\nNEURO - alert and oriented x 3, speaks in a fluent though slow\nand sometimes halting manner, able to carry conversation with\nminimal loss of attention, ___ strength in LUE and LLE, ___\nstrength on right, L facial droop, no evidence of neglect\nPSYCH - calm, cooperative\n \nPertinent Results:\n___ 07:05AM   GLUCOSE-82 UREA N-16 CREAT-0.9 SODIUM-143 \nPOTASSIUM-4.3 CHLORIDE-104 TOTAL CO2-28 ANION GAP-11\n___ 07:05AM   ALT(SGPT)-12 AST(SGOT)-17 ALK PHOS-119* TOT \nBILI-0.3\n___ 07:05AM   MAGNESIUM-2.0\n___ 07:05AM   WBC-3.7* RBC-3.20* HGB-9.7* HCT-30.6* MCV-96 \nMCH-30.3 MCHC-31.7* RDW-16.3* RDWSD-58.4*\n___ 07:05AM   PLT COUNT-225\n___ 07:05AM   ___ PTT-32.5 ___\n___ 01:36AM URINE  bnzodzpn-POS* barbitrt-NEG opiates-POS* \ncocaine-NEG amphetmn-POS* oxycodn-POS* mthdone-POS*\n___ 01:36AM URINE  COLOR-Yellow APPEAR-Hazy* SP ___\n___ 01:36AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR* \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-2* PH-6.0 \nLEUK-MOD*\n___ 01:36AM URINE  RBC-1 WBC-4 BACTERIA-FEW* YEAST-NONE \nEPI-4\n___ 11:30PM   GLUCOSE-106* UREA N-21* CREAT-1.0 SODIUM-141 \nPOTASSIUM-3.9 CHLORIDE-104 TOTAL CO2-24 ANION GAP-13\n___ 11:30PM   ALT(SGPT)-11 AST(SGOT)-17 ALK PHOS-118* TOT \nBILI-0.2\n___ 11:30PM   cTropnT-<0.01\n___ 11:30PM   ALBUMIN-2.6* CALCIUM-8.3* PHOSPHATE-4.1 \nMAGNESIUM-1.5*\n___ 11:30PM   ASA-NEG ETHANOL-NEG ACETMNPHN-15 bnzodzpn-NEG \nbarbitrt-NEG tricyclic-NEG\n___ 11:30PM   WBC-5.0 RBC-3.05* HGB-9.5* HCT-29.0* MCV-95 \nMCH-31.1 MCHC-32.8 RDW-16.4* RDWSD-57.3*\n___:30PM   NEUTS-56.2 ___ MONOS-7.2 EOS-1.2 \nBASOS-0.6 IM ___ AbsNeut-2.79 AbsLymp-1.71 AbsMono-0.36 \nAbsEos-0.06 AbsBaso-0.03\n___ 11:30PM   PLT COUNT-220\n___ 11:30PM   ___ PTT-36.0 ___\n___ 09:12PM   LACTATE-1.5\n___ 09:00PM   WBC-5.2# RBC-3.44* HGB-10.1* HCT-33.4* MCV-97 \nMCH-29.4 MCHC-30.2* RDW-16.4* RDWSD-58.7*\n___ 09:00PM   NEUTS-61.3 ___ MONOS-8.0 EOS-1.2 \nBASOS-0.4 IM ___ AbsNeut-3.16# AbsLymp-1.49 AbsMono-0.41 \nAbsEos-0.06 AbsBaso-0.02\n___ 09:00PM   PLT COUNT-225\n___ 08:45AM BLOOD WBC-3.1* RBC-3.43* Hgb-10.5* Hct-32.9* \nMCV-96 MCH-30.6 MCHC-31.9* RDW-16.9* RDWSD-59.5* Plt ___\n___ 08:45AM BLOOD Lupus-POS*\n___ 08:45AM BLOOD Calcium-8.5 Phos-3.7 Mg-1.7\n\nMRI brain ___ FINDINGS:  \n  \nThere are three punctate areas of decreased diffusion (series \n502; image 11) \nin the right cerebellar hemisphere, one of which has corollary \nhigh signal on \nFLAIR imaging (series 7; image 9).  These findings suggest acute \nto subacute \ninfarction of the right cerebellum.  No additional areas of \ninfarction are \nidentified.  There is no evidence of hemorrhage, edema, masses, \nmass effect, \nor midline shift.  The ventricles and sulci are normal in \ncaliber and \nconfiguration.  There is no abnormal enhancement after contrast \nadministration. \n  \nIMPRESSION:  \n  \nThree punctate areas decreased diffusion in the right cerebellar \nhemisphere, \none of which has correlating FLAIR abnormality, suggest acute to \nsubacute \nright cerebellar infarction.  No evidence of hemorrhage or other \ninfarction. \n\n \nBrief Hospital Course:\n___ year old F with prior CVA with L sided weakness and facial\ndroop, history of gastric bypass, gastritis, DVT/PE on\nanticoagulation, and chronic pain and anxiety on multiple pain\nmedications who is now admitted due to concern for altered \nmental\nstate at home. Mental status improved after holding back on\nsedating meds, but MRI showed new right-sided cerebellar stroke. \n\n\n# Altered mental state.  The patient was discharged from her \nprevious hospital stay with clear mental status and no acute \nneuro abnormalities.  However, on arrival to her home, she was \nnoted to have slurred speech per her family and brought to the \nER.  She was admitted to medicine where her sedating medications \nwere tapered, back to Dilaudid 2mg every 4 hours and \nPromethazine to 6.25 (previously getting 25 last hospital stay). \n Her mental status was back to normal with this change.  There \nwas no evidence of metabolic abnormalities or infection that \ncould have been the culprit for her encephalopathy.  I spoke \nwith her PCP, ___, who understood the concerns for \nsedating medications, and acknowledged that he shares the goal \nof tapering them further.  We found a bottle of Dilaudid that \nshe had from discharge that was empty in the bed.  She could not \nfully explain why the bottle did not have the pills in it that \nwere supposed to last 5 days were gone in 2.  We have concerns, \nas does her sister ___, that the patient is not taking her \nmedications at home appropriately, forgets doses, and may take \ntoo many, as she is forgetful.  We suggested that she have \nfurther assistance at home or elsewhere, but she wanted to \nreturn to her home.  We will add services such as ___ in addition \nto nursing services that already exist.  \n\n#Acute/Subacute stroke in the right cerebellum.  The patient had \nan MRI on her second hospital day which showed the above \nfindings.  She was seen by the neurology team who recommended \nthat she have a CTA head and neck as well as an echo with bubble \nstudy.  The strokes were likely embolic in etiology given their \nlocation, and with Lupus anticoagulant positive (one time), this \nraised suspicion that she may have an underlying thrombophilia \ngiven her recent strokes in the past.  The patient has been on \nXarelto for months, and claims to be compliant with this. We \nwere unable to determine if she was non-compliant given above \nissues, or if she were compliant, which would represent a \nfailure of Xarelto.  If she were to fail Xarelto, she could \nconsider Coumadin with INR goal > 2.5.  However, with Hx of 2 GI \nbleeds, this poses risks.  After extensive counseling with the \npatient about the risks and benefits of remaining on Xarelto for \nthe interim, she elected to do this, realizing that there is a \nrisk of further thrombosis.  She will see a stroke specialist as \nan outpatient as well as a hematologist. She was unable to \ncomplete CTA secondary to IV infiltration, and inability to \nplace another one. She declined a midline and said she would be \nbetter hydrated as an outpatient and try again.  Echo was done \nthe evening prior to discharge, where the results are pending at \nthe time of discharge. Her neurologist will use the results to \nhelp determine next steps in treatment. \n\nTotal cholesterol 118 HDL 64 LDL 67 ___ 381; no acute statin \ntherapy was recommended by Neurology, but her stroke MD can \ndecide whether adding one would be beneficial.  She reports an \nallergy to ASA \"upset stomach.\"  Her SBPs has been \nwell-controlled with values averaging 100-130. \n\n# Chronic abdominal and back pain - Her hydrophorphone at prior \ndose of 2mg q4prn, and she continued on methadone at ___s Gabapentin.  \n\n# Anxiety/Depression - continued home meds below, but one \nevening, Clonopin was held secondary to sedation.  \n- clonazepam 0.5 bid\n- buproprion 150 bid\n- quetiapine 75 qhs\n- doxepin 100 qhs\n\n# Gastritis/esophagitis\n- continue Carafate\n- continue pantoprazole \n- continue ranitidine\n\n# CODE STATUS: full\n\n#Dispo - I had a conversation with the patient's sister ___ \n(pt gave consent) who expressed concerns about the patient being \nable to live at home by herself successfully.  She notes that \nthe frequent bounce-backs are a product of her having \ndifficulties in the home and thinks that she would be better in \na closely supervised setting, such as the assisted living-like \nenvironment she was in for ___ years.  I explained that I also \nexpressed these concerns to the patient, but she was adamant \nthat she remain in her home.  She was able to articulate the \nrisks, benefits, and alternatives of doing so.  She was \nagreeable to have more home services. I encouraged her sister to \nshare her concerns with the patient's living environment with \nthe patient herself, as this is ultimately her choice as to \nwhere she lives given her capacity to make her own decisions.  \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. BuPROPion (Sustained Release) 150 mg PO BID \n2. ClonazePAM 0.5 mg PO BID anxiety \n3. Docusate Sodium 100 mg PO BID \n4. Doxepin HCl 100 mg PO HS \n5. Gabapentin 200 mg PO TID \n6. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Severe \n7. Methadone 20 mg PO TID \n8. Pantoprazole 40 mg PO Q12H \n9. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n10. QUEtiapine Fumarate 75 mg PO QHS \n11. Ranitidine 150 mg PO DAILY \n12. Rivaroxaban 20 mg PO DAILY \n13. Senna 8.6 mg PO BID \n14. Ursodiol 500 mg PO DAILY \n15. Promethazine 12.5 mg PO Q6H:PRN nausea \n16. Sucralfate 1 gm PO QID \n17. Ascorbic Acid ___ mg PO DAILY \n18. Cyanocobalamin 100 mcg PO DAILY \n19. Ferrous Sulfate 325 mg PO DAILY \n20. FoLIC Acid 1 mg PO DAILY \n21. Multivitamins W/minerals 1 TAB PO DAILY \n22. Thiamine 100 mg PO DAILY \n23. Vitamin D 1000 UNIT PO DAILY \n24. Acetaminophen 1000 mg PO Q8H \n\n \nDischarge Medications:\n1.  HYDROmorphone (Dilaudid) 2 mg PO TID:PRN BREAKTHROUGH PAIN  \n2.  Promethazine 6.25 mg PO TID:PRN nausea  \n3.  Acetaminophen 1000 mg PO Q8H  \n4.  Ascorbic Acid ___ mg PO DAILY  \n5.  BuPROPion (Sustained Release) 150 mg PO BID  \n6.  ClonazePAM 0.5 mg PO BID anxiety  \n7.  Cyanocobalamin 100 mcg PO DAILY  \n8.  Docusate Sodium 100 mg PO BID  \n9.  Doxepin HCl 100 mg PO HS  \n10.  Ferrous Sulfate 325 mg PO DAILY  \n11.  FoLIC Acid 1 mg PO DAILY  \n12.  Gabapentin 200 mg PO TID  \n13.  Methadone 20 mg PO TID  \n14.  Multivitamins W/minerals 1 TAB PO DAILY  \n15.  Pantoprazole 40 mg PO Q12H  \n16.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n17.  QUEtiapine Fumarate 75 mg PO QHS  \n18.  Ranitidine 150 mg PO DAILY  \n19.  Rivaroxaban 20 mg PO DAILY  \n20.  Senna 8.6 mg PO BID  \n21.  Sucralfate 1 gm PO QID  \n22.  Thiamine 100 mg PO DAILY  \n23.  Ursodiol 500 mg PO DAILY  \n24.  Vitamin D 1000 UNIT PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nLethargy from drug interactions \nCerebellar stroke \n \nDischarge Condition:\nLevel of Consciousness: Lethargic but arousable.\nMental Status: Clear and coherent.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nYou were admitted for lethargy and confusion as noted by your \nfamily.  We made sure that there were no drug interactions or \ncompound effects that can cause sedation, and you received your \nMRI which showed a stroke, so you were seen by the Neurology \nconsulting team.  \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb69c"
  },
  "note_id": "12648465-DS-38",
  "subject_id": 12648465,
  "hadm_id": 22009525,
  "note_type": "DS",
  "note_seq": 38,
  "charttime": "2209-05-06 00:00:00",
  "storetime": "2209-05-09 16:57:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut\n \nAttending: ___.\n \nChief Complaint:\nNausea, vomiting, lethargy\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ h/o mult CVA ___ on xarelto), \nDVT/PE while on Coumadin, now on rivaroxaban, mult CVA CVA with \nresidual weakness, chronic pain, and recent right knee \nmeniscectomy (___), Roux-en-Y gastric bypass, chronic \nabdominal pain, polysubstance abuse, prior CVAs who presents \nw/nausea, vomiting and lethargic.\n\nStates that AM of ___ woke up with bad headache and nausea which \npersisted all day. Then went to dinner with daughter at ___. \nWhile at dinner headache worsened significantly which brought on \nworsening nausea. Subsequently vomited bilious non bloody \nvomitus Patient was with her daughter at the time. Then went \noutside and continued to vomit. \n\nPatient denies any fevers or chest pain. Patient denies any \nblack or bloody stools or dysuria. No dyspnea or cough. Patient \nstates that she has a severe headache. \n\nPatient denies any ingestions including alcohol or illicits. \nPatient found to be hypoglycemic to ___nd \nreceived amps of dextrose here twice.\n\nOf note, patient notes >60lbs of unintentional weight loss since \n___ of this year. She has been evaluated by urology at ___ \nfor cells concerning for TCC, but repeat w/'atypia.' Per patient \nbiopsy results are pending, but she is unclear about specifics. \nAdditionally, mentions she is seeing ___ heme onc again (last \nin ___ Dr. ___ for full hypercoagulability work up \n(negative).\n\nED Course Significant for:\nExam:\nSomnolent, left lower quadrant tenderness, GCS 14, ___ stroke\nscale 0\n\nImaging showing: \nCT head which was reassuring. CT of the abdomen pelvis without \nany acute process (no colitis, no stranding).\n\nIn the ED, initial VS were:\n98.0 133/98 17 100% RA 66 (in field FSBG 55)\n\nLabs showed:\nChem 7 unremarkable\nHb 10.7\n\nLFTs, Lipase, hCG: called lab, they were never drawn \n\nLactate:2.2\n\nUTox: Urine Benzos Pos \n      Urine Mthdne Pos \n      Urine Barbs, Opiates, Cocaine, Amphet, Oxycodone Negative\n \nSerum: positive for TCA\n\nReceived:\n___ 16:25 IV Dextrose 50% 25 gm   \n___ 17:04 IV Ondansetron 4 mg \n___ 17:59 PO/NG HYDROmorphone (Dilaudid) 2 mg\n___  \n___ 20:08 IVF  NS 1000 mL \n___ 20:58 PO Acetaminophen 1000 mg  \n___ 20:58 IV Ondansetron 4 mg \n___ 21:44 IV Dextrose 50% 25 gm \n___ 23:25 IV HYDROmorphone (Dilaudid) .5 mg  \n___ 00:37 PO/NG Doxepin HCl 100 mg \n___ 00:37 PO/NG Gabapentin 200 mg \n___ 00:37 PO/NG QUEtiapine Fumarate 75 mg  \n\nPatient continued to have significant abdominal pain and \ninability to tolerate p.o. secondary to nausea. Patient remains \nsomewhat somnolent although has had improved mental status and \ncoherent after administration of dextrose.\n\nOn arrival to the floor, patient reports improving nausea and \nhas some appetite. Still feels very ill. \n\nREVIEW OF SYSTEMS:  \n(+)PER HPI\n \nPast Medical History:\n- Morbid obesity status post gastric bypass and cholecystectomy  \n\n in ___ with subsequent reversal surgery at the ___ -  \n multiple prior abdominal surgeries including a J-tube in ___  \n with apparent complication of a perforated colon.  \n-Positive PPD  \n -Hepatitis C, chronic \n-Sleep apnea \n- History of recurrent esophageal candidiasis s/p treatment  \n- History of hypertension, DM, and asthma prior to gastric  \n bypass.  \n- DVT and PE in ___ on rivaroxaban \n- CVA with residual Lt sided weakness and slurred speech  \n- History of SBO  \n- Chronic pain  \n- History of opiate addiction: prior intranasal heroin, oral  \ndilaudid abuse, on methaone.  \n- Degenerative disc disease  \n- Depression/anxiety  \n- s/p ___: Arthroscopy, medial meniscectomy, right knee  \n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. Brother with CHF. \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n=========================\nVS:  98.0 PO 93 / 63 84 18 100 RA \nGENERAL: NAD  \nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, \ndry MM\nNECK: supple, no LAD, no JVD  \nHEART: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \nABDOMEN: nondistended, nontender in all quadrants, no \nrebound/guarding, no hepatosplenomegaly  \nEXTREMITIES: no cyanosis, clubbing, or edema\nPULSES: 2+ DP pulses bilaterally  \nNEURO: A&Ox3. CN exam significant for left facial droop and \nasymmetric smile (stable since CVA). Possible visual field \ndefect in superior aspect of visual field in the L eye (unclear \nchronicity).  Otherwise all CN in tact. Strength: ___ weakness \n___ and LL extremity w/flexion (weaker w/extension) Sensation \nintact\nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes\n\nDISCHARGE PHYSICAL EXAM:\n========================\nVitals: 98.1F BP 103/69 HR 73 RR 16 96% on Ra \nGeneral: NAD. Lying comfortably in bed. \nHEENT: Sclera anicteric, MMM. \nNeck: Supple. No tenderness to palpation. \nCV: Regular rate and rhythm, normal S1 + S2. No murmurs, rubs or \ngallops. \nPulm: Normal respiratory effort. CTAB without wheezez, rales, or \nrhonchi. \nAbdomen: Soft, non-distended, non-tender. Normoactive BS. No \nmasses. \nExt: Warm, well perfused, 2+ pulses, no cyanosis or edema.\nSkin: No rashes. Warm. \nNeuro: Alert and interactive. Decreased sensation over left \nface. Left sided facial droop present. Possible visual field \ndefect in superior aspect of visual field in the L eye (unclear \nchronicity). Other CN intact. ___ strength in LUE and LLE. ___ \n___+/5 in RLE. Decreased sensation over left-side. \n(reports this is her baseline\nneurological exam).\nMood: Normal mood and affect. \n\n \nPertinent Results:\nADMISSION LABS:\n================\n___ 04:15PM BLOOD WBC-5.8# RBC-3.55* Hgb-10.7* Hct-34.3 \nMCV-97 MCH-30.1 MCHC-31.2* RDW-16.7* RDWSD-59.8* Plt ___\n___ 04:15PM BLOOD Neuts-65.3 ___ Monos-6.3 Eos-0.3* \nBaso-0.5 Im ___ AbsNeut-3.80 AbsLymp-1.59 AbsMono-0.37 \nAbsEos-0.02* AbsBaso-0.03\n___ 04:15PM BLOOD Glucose-70 UreaN-13 Creat-1.1 Na-144 \nK-4.0 Cl-105 HCO3-28 AnGap-11\n___ 04:15PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nBnzodzp-NEG Barbitr-NEG Tricycl-POS*\n___ 04:36PM BLOOD Lactate-2.2*\n\nPERTINENT LABS:\n================\n___ 10:10AM BLOOD ALT-19 AST-22 AlkPhos-144* TotBili-0.3 \nDirBili-<0.2 IndBili-0.3\n___ 10:10AM BLOOD Lipase-7\n___ 10:10AM BLOOD calTIBC-199* Ferritn-39 TRF-153*\n___ 04:15PM BLOOD Cortsol-25.0*\n___ 07:55AM BLOOD Cortsol-22.7*\n___ 08:10AM BLOOD CRP-1.2\n___ 10:10AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nBnzodzp-NEG Barbitr-NEG Tricycl-POS*\n___ 04:36PM BLOOD Lactate-2.2*\n\nDISCHARGE LABS:\n===============\n___ 07:45AM BLOOD WBC-3.5* RBC-3.37* Hgb-10.5* Hct-33.2* \nMCV-99* MCH-31.2 MCHC-31.6* RDW-16.9* RDWSD-61.4* Plt ___\n___ 07:45AM BLOOD Glucose-80 UreaN-17 Creat-0.9 Na-140 \nK-4.8 Cl-103 HCO3-25 AnGap-12\n\nPERTINENT IMAGING:\n===================\n___ CXR: \nNo acute cardiopulmonary process.\n\n___ CT Head w/o Contrast:\n1. No acute intracranial process. \n2. No acute fracture. \n\n___ CT Abd/Pelvis:\n1. No acute process in the abdomen or pelvis.  Specifically, no \ncolitis. \n2. Status post Roux-en-Y gastric bypass with unchanged mild \ndilatation at the jejunal jejunostomy.  No small bowel \nobstruction. \n3. Status post cholecystectomy with associated stable mild intra \nand extrahepatic biliary ductal dilatation. \n\n___ MRA Head w/ & w/o Contrast:\n1. Mildly motion limited exam. \n2. No evidence for carotid stenosis. \n3. The non dominant left vertebral artery arises directly from \nthe aortic \narch, a normal variant.  The distal left V4 segment demonstrates \n\nasymmetrically decreased contrast enhancement distal to ___ \n___, \ncompatible with non dominant status. \n\n___ MRI Head w/ & w/o Contrast:\n1. Questionable punctate acute infarction in the left pons, seen \non diffusion tracer images only, versus artifact. \n2. Expected evolution of three small right cerebellar hemisphere \ninfarcts \nsince ___. \n\n___ TTE w/ Bubble Study:\nThe left atrium is normal in size. No atrial septal defect or \npatent foramen ovale is seen by 2D, color Doppler or saline \ncontrast with maneuvers. Left ventricular wall thickness, cavity \nsize and regional/global systolic function are normal (LVEF \n>55%). No masses or thrombi are seen in the left ventricle. \nThere is no ventricular septal defect. Right ventricular chamber \nsize and free wall motion are normal. The diameters of aorta at \nthe sinus, ascending and arch levels are normal. The aortic \nvalve leaflets (3) are mildly thickened but aortic stenosis is \nnot present. No masses or vegetations are seen on the aortic \nvalve. No aortic regurgitation is seen. The mitral valve appears \nstructurally normal with trivial mitral regurgitation. No mass \nor vegetation is seen on the mitral valve. The estimated \npulmonary artery systolic pressure is normal. There is no \npericardial effusion.   \n \nBrief Hospital Course:\nMs. ___ is a ___ y/o female with history of multiple CVA \n___ on xarelto) with residual weakness, DVT/PE while on \nCoumadin, now on xarelto, Roux-en-Y gastric bypass, chronic \nabdominal pain, polysubstance use disorder who presented w/ \nnausea, vomiting and headache.\n\nACUTE MEDICAL ISSUES ADDRESSED:\n=============================\n\n#Headache\n#Nausea/Vomiting\n   Patient p/w new progressive headache x 3 weeks, nausea and \nvomiting x 1 day with worsening abdominal pain. CT \nabdomen/pelvis, LFTs and lipase were unremarkable and the n/v \nwas suspected to either be a benign viral gastroenteritis, or to \nbe related to headache. A new severe headache in a ___ year old \npatient was felt to be concerning for secondary headache.\n   The headache was right-sided, radiating from the occiput to \nbehind the R eye. Neuro exam unchanged from baseline other than \na left-sided visual field defect, which is of unclear chonicity; \notherwise no symptomatic evidence of new stroke. Follow-up \nMRI/MRA was only notable for a questionable punctate infarction \nin the left pons, though imaging artifact was also possible. CRP \nwnl, effectively ruling out temporal arteritis. \n   Pseudotumor cerebri was considered, although fundoscopic exam \nwas without papilledema and bedside ultrasound of optic nerve \nalso did not suggest increased sheath diameter. LP was planned, \nbut aborted at the last minute upon realization that the patient \nhad already received lovenox that day. She subsequently improved \nwith symptomatic treatment; thus, LP was deferred. The etiology \nremained unclear at discharge and she will follow up in headache \nclinic.\n\n#Abdominal pain\n#Chronic pain\n#Hx of opiate use disorder\nPt w/ acute on chronic abdominal pain x 1 day, initial exam \nnotable for epigastric and LUQ TTP. Lipase, LFTs unremarkable. \nCT abd/pelvis without acute etiology. Believed to be chronic \nbaseline pain that worsened in the setting of nausea/vomiting. \nShe was continued on methadone, dilaudid, gabapentin, and \nTylenol with minimal additional dilaudid doses required. Weaned \nback to home regimen by discharge.\n\n#Lethargy\nAppeared lethargic on admission but otherwise oriented. She \nreported this was her baseline. There were no clear metabolic \nderangements nor evidence of infectious etiology. Lethargy \nimproved some during hospitalization and was overall thought to \nbe related to polypharmacy in the setting of methadone, \ndilaudid, gabapentin, and clonazepam. \n\n#Recurrent CVA on Anticoagulation\nHas a history of CVA while on xarelto. On that prior admission, \nneurology had wanted CTA head/neck and TTE w/ bubble, but these \nhad not been completed so were belatedly completed on this \nadmission. MRA Neck/Head done during this hospitalization was \noverall unremarkable, other than a questionable punctate \ninfarction in the left pons, though this had no obvious clinical \ncorrelate and imaging artifact was also possible. TTE with \nbubble study was done, and it did not show any PFO or ASD. \nRivaroxaban was briefly switched to lovenox due to nausea and \npoor po intake; however she was switched back to xarelto prior \nto discharge. Of note, her prior positive lupus anticoagulant \nwas felt to be a likely false positive, so a repeat was drawn \nwhile the patient was off anticoagulation as requested by \nHeme/onc, pending at discharge.\n\nCHRONIC ISSUES ADDRESSED:\n=========================\n#Unintentional Weight Loss\n#Abnormal Urine Cytology\nPresented following 60 lbs unintentional weight loss (though \nseems that pt gained 60 lbs then lost 60 lbs within last year). \nShe reports good appetite and po intake prior to her recent \nnausea and vomiting. No fever or night sweats. Of note, she \npreviously had an abnormal urine cytology suspicious for high \ngrade urothelial carcinoma but follow-up cytology was normal. \nHer last colonoscopy in ___ showed polyps. She was unsure when \nher last mammography occurred. Recommend urology follow-up and \ncancer screening as an outpatient. \n\nMEDICATION CHANGES:\n===================\n- None\n\nTRANSITIONAL ISSUES:\n===================\n[ ] Recent weight loss - needs malignancy screening (last \nmammography unknown, last pap unknown, still has not completed \ncystoscopy for prior hematuria and abnormal urine cytology)\n[ ] Will follow up with primary care provider\n[ ] Will follow up with neurology to continue post-stroke care \nand consider further workup for headaches, if indicated. \n[ ] Question of visual field defect on bedside exam; Will \nfollow-up ophthalmology\n[ ] Consider repeat MRI brain in ___ weeks to reevaluate \nquestionable new punctate pontine lesion.\n[ ] If headaches return, consider lumbar puncture to \nconclusively rule out pseudotumor cerebri.\n[ ] Continue to work on decreasing her multiple sedating \nmedications if possible\n\n#CODE: Full (presumed) \n#CONTACT: HCP: mom ___ ___\n \n___ on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Lactulose 10 mL PO BID:PRN constipation \n2. Acetaminophen 1000 mg PO Q8H \n3. Ascorbic Acid ___ mg PO DAILY \n4. BuPROPion (Sustained Release) 150 mg PO BID \n5. ClonazePAM 0.5 mg PO DAILY anxiety \n6. Cyanocobalamin 1000 mcg PO DAILY \n7. Docusate Sodium 100 mg PO BID \n8. Doxepin HCl 100 mg PO HS \n9. Ferrous Sulfate 325 mg PO DAILY \n10. FoLIC Acid 1 mg PO DAILY \n11. Gabapentin 200 mg PO TID \n12. HYDROmorphone (Dilaudid) 2 mg PO Q8H:PRN BREAKTHROUGH PAIN \n13. Methadone 20 mg PO TID \n14. Multivitamins W/minerals 1 TAB PO DAILY \n15. Pantoprazole 40 mg PO Q12H \n16. Promethazine 12.5 mg PO TID:PRN nausea \n17. QUEtiapine Fumarate 75 mg PO QHS \n18. Rivaroxaban 20 mg PO DAILY \n19. Senna 8.6 mg PO BID \n20. Sucralfate 1 gm PO QID \n21. Thiamine 100 mg PO DAILY \n22. Vitamin D 1000 UNIT PO DAILY \n23. Ranitidine 150 mg PO DAILY \n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q8H  \n2.  Ascorbic Acid ___ mg PO DAILY  \n3.  BuPROPion (Sustained Release) 150 mg PO BID  \n4.  ClonazePAM 0.5 mg PO DAILY anxiety  \n5.  Cyanocobalamin 1000 mcg PO DAILY  \n6.  Docusate Sodium 100 mg PO BID  \n7.  Doxepin HCl 100 mg PO HS  \n8.  Ferrous Sulfate 325 mg PO DAILY  \n9.  FoLIC Acid 1 mg PO DAILY  \n10.  Gabapentin 200 mg PO TID  \n11.  HYDROmorphone (Dilaudid) 2 mg PO Q8H:PRN BREAKTHROUGH PAIN  \n\n12.  Lactulose 10 mL PO BID:PRN constipation  \n13.  Methadone 20 mg PO TID  \n14.  Multivitamins W/minerals 1 TAB PO DAILY  \n15.  Pantoprazole 40 mg PO Q12H  \n16.  Promethazine 12.5 mg PO TID:PRN nausea  \n17.  QUEtiapine Fumarate 75 mg PO QHS  \n18.  Ranitidine 150 mg PO DAILY  \n19.  Rivaroxaban 20 mg PO DAILY  \n20.  Senna 8.6 mg PO BID  \n21.  Sucralfate 1 gm PO QID  \n22.  Thiamine 100 mg PO DAILY  \n23.  Vitamin D 1000 UNIT PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\n# Primary diagnosis: headache, nausea, vomiting\n# Secondary diagnosis: Chronic pain, history of thromboembolic \nevents\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n  \nIt was a pleasure to care for you at the ___ \n___.  \n\nWhy did you come to the hospital?  \n- You were admitted because of your severe headache, nausea, and \nvomiting\n  \nWhat did you receive in the hospital?  \n- You received medication to manage your pain and nausea \n- Your head and abdomen were imaged and there was no obvious \ncause for our pain\n- The MRI of your head showed one small lesion, but the \nradiologists could not determine if it represented a new infarct \nor an artifact of the imaging. You should follow-up with \nneurology on ___ who will determine if you need repeat MRI\n- Your blood sugars were monitored and when they were found to \nbe low, you received dextrose through your IV \n- Your heart was monitored on telemetry to ensure that you did \nnot have any arrhythmias\n\nWhat should you do once you leave the hospital?  \n- Please continue taking your medication as prescribed\n- Please follow up with your primary care physician (___)\n- Please follow up with your urologist regarding the abnormal \nurine test you previously had (___)\n- Please follow up with neurology (___)\n- If your headache returns, please be aware you can schedule an \nappointment with the Neurology urgent care clinic by calling \n___.\n\nWe wish you the best!  \n\nSincerely,\n Your ___ Care Team  \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb69d"
  },
  "note_id": "12648465-DS-39",
  "subject_id": 12648465,
  "hadm_id": 20892088,
  "note_type": "DS",
  "note_seq": 39,
  "charttime": "2209-05-28 00:00:00",
  "storetime": "2209-05-30 18:00:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut\n \nAttending: ___.\n \nChief Complaint:\nChest Pain\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ year-old lady with h/o multiple CVA with \nresidual weakness ___ on xarelto), DVT/PE while on \nCoumadin, chronic pain, right knee meniscectomy (___), \nRoux-en-Y gastric bypass, chronic abdominal pain, polysubstance \nabuse, on rivaroxaban who now presents with chest pain that is \nexcacerbated with deep inspiration.  \n\nPatient reports that pain started 4 days ago (___) before \nworsening yesterday and today to ___. The pain is described as \na constant pressure localized to the midsternal region, \nexacerbated by motion and breathing, and alleviated only \npartially by remaining still. She also described the pain as the \npressure of \"someone sitting on my chest\" with prior h/o \nlocalization to the back.  \n In the ED, the patient reported chest pain that radiated to her \nleft arm, concerning for ACS. The patient denied recent trauma, \nshortness of breath, diaphoresis, n/v, fever, chills, headaches, \nURI symptoms, or abdominal pain.  \n \n \nPast Medical History:\n- s/p cholecystectomy and gastric bypass (___), with f/u \ncomplicated by multiple ex lap, gastrectomy, reversal surgery, \nfailed J-tube c/b colonic perforation  \n- multiple SBO during f/u from above  \n- hernia repair  \n- abdominal pain  \n- asthma  \n- peptic ulcer disease  \n- osteoarthritis  \n- narcotic abuse  \n- depression  \n- anxiety  \n- tobacco abuse  \n- muscle weakness / myelopathy  \n- cardiac evaluation  \n- gastroesophageal reflux  \n- lower back pain  \n- lower extremity edema  \n- DVT c/b PE  \n- vulvar folliculitis  \n- arthorplasty - right total knee  \n- stroke - left sided  \n- hepatitis C - positive ab test, negative HCV viral load in 2x \ntests  \n- nephrolithiasis  \n- thyromegaly - TSH wnl, low free T4  \n- h/o HTN and DMII, resolved after gastric bypass per patient  \n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. Brother with CHF.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM\nVITALS: 98.5 PO ___ 17 97 ra  \nGeneral: AOx3, no acute distress  \nHEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRL, no \npinpoint pupils, slight ptosis of left eyelid  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nLungs: Clear to auscultation bilaterally, no wheezes, rales, \nrhonchi  \nAbdomen: Soft, non-tender, non-distended, bowel sounds present, \nno organomegaly, no rebound or guarding, incisions consistent \nwith previous surgery  \nGU: No foley  \nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema, spine non tender to palpation  \nSkin: Warm, dry, no rashes or notable lesions.  \nNeuro: CNII-XII intact with reduced sensation on left side of \nface and slight droop of left eye ___ strength upper/lower \nextremities, grossly normal sensation, 2+ reflexes bilaterally. \n\nDISCHARGE PHYSICAL EXAM\nVITALS: 90.5 Fahrenheit, 80, 124/85, 18, 90% on room air.\nGeneral: AOx3, no acute distress  \nHEENT: Sclerae anicteric, MMM, oropharynx clear, EOMI, PERRL\nCV: Regular rate and rhythm, normal S1 + S2, ___ RUSB SEM, rubs,\ngallops  \nLungs: Clear to auscultation bilaterally, no wheezes, rales,\nrhonchi.  Lidocaine patch on chest.\nAbdomen: Soft, non-tender, non-distended, bowel sounds present,\nno organomegaly, no rebound or guarding, incisions consistent\nwith previous surgery  \nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or\nedema, spine non tender to palpation\nSkin: Warm, dry, no rashes or notable lesions.   \nNeuro: CNII-XII, grossly normal sensation, 2+ reflexes\nbilaterally. \n \nPertinent Results:\nADMISSION LABS\n___ 03:10PM BLOOD WBC-4.3 RBC-3.37* Hgb-10.5* Hct-33.0* \nMCV-98 MCH-31.2 MCHC-31.8* RDW-17.5* RDWSD-63.2* Plt ___\n___ 03:10PM BLOOD Neuts-58.6 ___ Monos-6.3 Eos-0.5* \nBaso-0.7 Im ___ AbsNeut-2.50 AbsLymp-1.44 AbsMono-0.27 \nAbsEos-0.02* AbsBaso-0.03\n___ 03:10PM BLOOD Glucose-72 UreaN-16 Creat-0.9 Na-144 \nK-4.5 Cl-105 HCO3-27 AnGap-12\n___ 03:10PM BLOOD proBNP-195\n___ 03:10PM BLOOD cTropnT-<0.01\n\nPERTINENT RESULTS\n___ EKG\nNo signs of acute ischemia\n\n___ CXR\nNoacutecardiopulmonaryabnormality.\n\n___ CTA CHEST\nHEART AND VASCULATURE: Pulmonary vasculature is well opacified \nto the\nsubsegmental level without filling defect to indicate a \npulmonary embolus. The thoracic aorta is normal in caliber \nwithout evidence of dissection or\nintramural hematoma.  Left vertebral artery arises directly from \nthe aortic\narch, a normal variant.  The heart, pericardium, and great \nvessels are within normal limits. No pericardial effusion is \nseen.\n \nAXILLA, HILA, AND MEDIASTINUM: No axillary, mediastinal, or \nhilar\nlymphadenopathy is present.  No mediastinal mass.\n \nPLEURAL SPACES: No pleural effusion or pneumothorax.\n \nLUNGS/AIRWAYS: Lungs are clear without masses or areas of \nparenchymal\nopacification.  There is mild bibasilar atelectasis.  The \nairways are patent\nto the level of the segmental bronchi bilaterally.\n \nBASE OF NECK: Visualized portions of the base of the neck show \nno abnormality.\n \nABDOMEN:  Included portion of the upper abdomen is notable for \nsurgical clips of the visualized proximal stomach, consistent \nwith known history of gastric bypass.  Low attenuation of the \nliver is compatible with stated ptosis.\n \nBONES: No suspicious osseous abnormality is seen.? There is no \nacute fracture.\n \nIMPRESSION: \nNo evidence of pulmonary embolism or aortic abnormality.\n\n___ Transthoracic echocardiogram\nThe left atrium and right atrium are normal in cavity size. Left \nventricular wall thickness, cavity size and regional/global \nsystolic function are normal (LVEF >55%). The estimated cardiac \nindex is normal (>=2.5L/min/m2). Right ventricular chamber size \nand free wall motion are normal. The diameters of aorta at the \nsinus, ascending and arch levels are normal. The aortic valve \nleaflets (3) appear structurally normal with good leaflet \nexcursion and no aortic stenosis or aortic regurgitation. The \nmitral valve appears structurally normal with trivial mitral \nregurgitation. There is no mitral valve prolapse. There is mild \npulmonary artery systolic hypertension. There is no pericardial \neffusion. \n\nCompared with the prior study (images reviewed) of ___, the \nestimated pulmonary pressure is slightly greater; mild pulmonary \nhypertension is suggested. \n\n___ CARDIAC STRESS TEST\nINTERPRETATION: This ___ year old woman with h/o CVA and PE was\nreferred to the lab for evaluation of chest pain. The patient \nwas\nadmininstered 0.4 mg of Regadenoson IV bolus over 20 seconds. \nThe\npatient presented with ___ left sided chest discomfort, worse \nwith\ninspiration. No reported change in discomfort throughout the \nstudy.\nThere were no significant ST segment changes throughout the \nstudy. The\nrhythm was sinus with no ectopy throughout the study. \nAppropriate\nhemodynamic response to the infusion. Post-MIBI, 125 mg of\nAminophylline IV was administered.\n\nIMPRESSION: Non-anginal type symptoms in the absence of ischemic \nEKG\nchanges. Nuclear report sent separately.\n\n___ CARDIAC PERSANTINE PERFUSION TEST\nThe image quality is adequate but limited due to soft tissue and \nbreast\nattenuation. Left ventricular cavity size is normal.   \nRest and stress perfusion images reveal uniform tracer uptake \nthroughout the left ventricular myocardium.  \nGated images reveal normal wall motion. \nThe calculated left ventricular ejection fraction is 65% with an \nEDV of 70 ml. \n \nIMPRESSION:\n1. Normal myocardial perfusion.\n2. Normal left ventricular cavity size and systolic function.  \n\n \nBrief Hospital Course:\nMs. ___ is a ___ year-old lady with h/o multiple CVA with\nresidual weakness ___ while on xarelto), DVT/PE on\nrivaroxaban, chronic pain, Roux-en-Y gastric bypass, chronic\nabdominal pain, polysubstance use disorder who presented with\ninspiratory chest pain concerning for atypical chest pain versus\nischemia.\n\nACUTE ISSUES\n\n#CHEST PAIN\nPatient presented with several day history of chest pain that \nwas worsened on exertion. Noted to be increasing pain with \ninspiration. Could not localize on herself, was not positional \nin nature, and without radiation to arm or neck. She was worked \nup for infectious etiologies which was negative, CTA which ruled \nout PE, EKG which demonstrated no signs of ischemia on \npresentation, transthoracic echocardiogram which demonstrated no \nsigns of pericardial fluid concerning for pericarditis, and \nPersantine stress echo which demonstrated no signs of ischemic \nchange with stress and normal myocardial perfusion. Of note, her \ntransthoracic echocardiogram demonstrated worsening pulmonary \nartery pressure determined to be mild pulmonary hypertension. \nShe was determined to be atypical chest pain, likely \ncostochondritis, with lidocaine patch to area on chest. NSAIDs \nwere not an option due to her underlying allergy. Patient's \nsymptoms improved after lidocaine patch therapy and continued to \nsubside at discharge.\n\nCHRONIC ISSUES\n\n#CHRONIC PAIN\nHer chronic abdominal pain was managed with her home methadone, \ngabapentin, and Dilaudid.\n\n#SEVERE MALNUTRITION\nPatient has severe malnutrition in context of chronic illness \nrelated to poor PO intake as evidenced by 12.9% weight loss x5 \nmonths and <75% energy intake compared to estimated energy needs \nfor > 1 month.  Her barriers to nutritional intake include \ndecreased stomach capacity and decreased appetite.  She was seen \nby nutrition and PO intake was encouraged.  She will need \nfurther evaluation and encouragement for nutritional \nsupplementation as an outpatient.\n\nTRANSITIONAL ISSUES\n- Lidocaine patch daily to L. chest where inspiratory pain is \nlocalized.\n- Follow up with Dr. ___ evaluation of chest pain, \nfollow up for mild pulmonary hypertension on TTE.\n- Carnation instant breakfast BID\n- Continue home medications as prescribed. \n# Code status: Full\n# Health care proxy/emergency contact: ___ (mother), \n___ \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Lactulose 15 mL PO BID:PRN constipation \n2. Acetaminophen 500 mg PO Q8H:PRN Pain - Mild \n3. Gabapentin 200 mg PO TID \n4. BuPROPion 150 mg PO BID \n5. QUEtiapine Fumarate 75 mg PO QHS \n6. ClonazePAM 0.5 mg PO DAILY \n7. Docusate Sodium 100 mg PO BID \n8. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n9. Senna 8.6 mg PO BID \n10. Rivaroxaban 20 mg PO DAILY \n11. Ranitidine 150 mg PO DAILY \n12. Ferrous Sulfate 325 mg PO DAILY \n13. Multivitamins 1 TAB PO DAILY \n14. HYDROmorphone (Dilaudid) 2 mg PO BID \n15. Methadone 20 mg PO TID \n16. Promethazine 6.25 mg PO BID \n17. Sucralfate 1 gm PO QID \n18. Pantoprazole 40 mg PO Q12H \n19. DULoxetine 20 mg PO DAILY \n20. Doxepin HCl 100 mg PO HS \n21. Cyanocobalamin 100 mcg PO DAILY \n22. FoLIC Acid 1 mg PO DAILY \n23. Thiamine 100 mg PO DAILY \n24. Ascorbic Acid ___ mg PO DAILY \n25. Vitamin D 1000 UNIT PO DAILY \n\n \nDischarge Medications:\n1.  Lidocaine 5% Patch 1 PTCH TD QAM \nTo painful area on chest \nRX *lidocaine 5 % Apply to painful area of chest QAM Disp #*15 \nPatch Refills:*0 \n2.  Acetaminophen 500 mg PO Q8H:PRN Pain - Mild  \n3.  Ascorbic Acid ___ mg PO DAILY  \n4.  BuPROPion 150 mg PO BID  \n5.  ClonazePAM 0.5 mg PO DAILY  \n6.  Cyanocobalamin 100 mcg PO DAILY  \n7.  Docusate Sodium 100 mg PO BID  \n8.  Doxepin HCl 100 mg PO HS  \n9.  DULoxetine 20 mg PO DAILY  \n10.  Ferrous Sulfate 325 mg PO DAILY  \n11.  FoLIC Acid 1 mg PO DAILY  \n12.  Gabapentin 200 mg PO TID  \n13.  HYDROmorphone (Dilaudid) 2 mg PO BID  \n14.  Lactulose 15 mL PO BID:PRN constipation  \n15.  Methadone 20 mg PO TID  \n16.  Multivitamins 1 TAB PO DAILY  \n17.  Pantoprazole 40 mg PO Q12H  \n18.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n19.  Promethazine 6.25 mg PO BID  \n20.  QUEtiapine Fumarate 75 mg PO QHS  \n21.  Ranitidine 150 mg PO DAILY  \n22.  Rivaroxaban 20 mg PO DAILY  \n23.  Senna 8.6 mg PO BID  \n24.  Sucralfate 1 gm PO QID  \n25.  Thiamine 100 mg PO DAILY  \n26.  Vitamin D 1000 UNIT PO DAILY  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS\nAtypical chest pain consistent with costochondritis\n\nSECONDARY DIAGNOSIS\nPulmonary hypertension\nHypoglycemia\nChronic pain\nSubstance use disorder in remission\nHistory of stroke\nHistory of DVT/PE\nDepression\nAnxiety\nSevere malnutrition\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nWHAT BROUGHT YOU INTO THE HOSPITAL?\n- You were admitted for chest pain on exertion. \n\nWHAT WAS DONE FOR YOU IN THE HOSPITAL?\n- Your heart was evaluated for signs of a heart attack, which \nwas negative.\n- You were found to not have any blood clots in your lungs.\n- Your pain was controlled.\n\nWHAT SHOULD YOU DO AFTER LEAVING THE HOSPITAL?\n- You should continue putting on the lidocaine patches to \ncontrol your chest pain.\n- You should follow up with your PCP ___ on ___ \nat 2:30 ___ to follow up your chest pain.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb69e"
  },
  "note_id": "12648465-DS-40",
  "subject_id": 12648465,
  "hadm_id": 24138785,
  "note_type": "DS",
  "note_seq": 40,
  "charttime": "2209-07-22 00:00:00",
  "storetime": "2209-07-22 14:37:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut\n \nAttending: ___.\n \nChief Complaint:\nShortness of breath, leg swelling\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\nMs. ___ is a ___ -year old morbidly obese, woman with DVT/PE, \nDM2, CVA with man admissions this year to the hospital who \npresents with weight gain, leg swelling, shortness\nof breath and hypoxia.\n\nMs. ___ reports feeling short of breath for the last week to \nten days. It has progressed steadily and became most noticeable \nthis past weekend while singing at church. She was not able to \nkeep up with the chorus like she normally can and had to sit \ndown to catch her breath after a short time. On ___ \nshe woke up and became short of breath while standing at the \nkitchen counter making coffee. After resting, she immediately \nbecame short of breath again after washing dishes. She has also \nnoticed that even at rest when talking a lot she is unable to \ncatch her breath. \n\nIn the last 10 days she has also noticed increased swelling in \nher legs and even in her arms. She has had swelling before but \nnever this severe. The swelling is bilateral but her lower\nextremities are not painful. She previously took Lasix and is \nunsure why she stopped. During the last week she has had chest \npain, which has progressed steadily. It is non-exertional and\nnon-positional. It feels \"like someone is sitting on her chest.\" \nShe has not tried anything for this pain and it is different \nfrom her indigestion and chest pain she has had in the past. Her\ndaughter who lives with her became concerned and encouraged her \nto call her doctor who after seeing her in clinic encouraged her \nto go to the ___ for further evaluation. \n\nThe patient report that she has not been eating much \nrecentlybecause she doesn't feel well. She had a ___ year stay at \na rehab facility returning home in ___. From ___ \nuntil\n___, she estimates that she lost over 60 lbs due to \npoor po intake at home. She hospitalized for chest pain at the \nend of ___ and was negative for cardiac work-up, thought \nto have costochondritis. \n\nIn the CDAC yesterday her vitals were stable and she was \ndiuresed with po toresemide due to poor IV access. She \ndesaturated to 70% with ambulation in the ED but had normal \nsaturations at rest. \n\nOn the floor, she says her chest pain is persistent and \nshortness of breath and swelling are improved. She endorses \nfeeling weak and fatigued, has felt nauseous and vomited once on \n___. She denies dysuria or increased urinary frequency but \nhas not had abowel movement in 4 days. She denies fever, chills, \nnight sweats. She denies, palpitations, racing heart, \nlightheadedness or dizziness, new numbness or tingling, focal \nweakness or vision\nchanges.  \n\nREVIEW OF SYSTEMS: A 10-point review of systems was performed \nand all of the other\nreview of systems were negative.  \n \nPast Medical History:\n1. CARDIAC RISK FACTORS  \n- h/o HTN and DMII, resolved after gastric bypass per patient\n2. CARDIAC HISTORY  \n- CABG: None  \n- PERCUTANEOUS CORONARY INTERVENTIONS: None  \n- PACING/ICD: None  \n3. OTHER PAST MEDICAL HISTORY  \n- s/p cholecystectomy and gastric bypass (___), with f/u \ncomplicated by multiple ex lap, gastrectomy, reversal surgery, \nfailed J-tube c/b colonic perforation  \n- multiple SBO during f/u from above  \n- hernia repair  \n- abdominal pain  \n- asthma  \n- peptic ulcer disease  \n- osteoarthritis  \n- narcotic abuse  \n- depression  \n- anxiety  \n- tobacco abuse  \n- muscle weakness / myelopathy  \n- cardiac evaluation  \n- gastroesophageal reflux  \n- lower back pain  \n- lower extremity edema  \n- DVT c/b PE  \n- vulvar folliculitis  \n- arthorplasty - right total knee  \n- stroke - left sided  \n- hepatitis C - positive ab test, negative HCV viral load in 2x \ntests  \n- nephrolithiasis  \n- thyromegaly - TSH wnl, low free T4  \n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. Brother with CHF\n \nPhysical Exam:\n=====================\nADMISSION EXAM\n=====================\nVITALS:  98.1PO 132/80 99 18 100 RA \nGENERAL: Obese female resting in bed eating. NAD. Mood, affect \nappropriate.\nHEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva pink, no \npallor or cyanosis of the oral mucosa. No xanthelasma. Moist \nmucosal membranes.\nNECK: Supple without appreciable LAD or JVD \nCARDIAC: Tachycardic, RR, normal S1, S2. No \nmurmurs/rubs/gallops. No thrills, lifts.  \nLUNGS: Clear to auscultation bilaterally. Resp were unlabored, \nno accessory muscle use. No crackles, wheezes or rhonchi.  \nABDOMEN: Soft, NTND. No HSM or tenderness. multiple scars from \nsurgery. Extra skin from weight loss.   \nEXTREMITIES: 2+ edema in the lower extremities. 1+ edema up to \nthe hip.   \nSKIN: Echymoses on the medial aspect of the foot. Venous stasis \nchanges of shins bilaterally. No ulcers, scars, or xanthomas.  \nPULSES: Distal pulses palpable and symmetric \n\n=====================\nDISCHARGE EXAM\n=====================\n \nPertinent Results:\n======================\nADMISSION LABS\n======================\n___ 09:00PM BLOOD WBC-6.4# RBC-3.09* Hgb-10.0* Hct-31.0* \nMCV-100* MCH-32.4* MCHC-32.3 RDW-17.0* RDWSD-60.8* Plt ___\n___ 09:00PM BLOOD Glucose-94 UreaN-18 Creat-1.0 Na-138 \nK-4.4 Cl-103 HCO3-22 AnGap-13\n___ 09:00PM BLOOD ALT-50* AST-24 AlkPhos-99 TotBili-0.4\n___ 09:00PM BLOOD ALT-50* AST-24 AlkPhos-99 TotBili-0.4\n___ 09:00PM BLOOD Albumin-1.7* Calcium-7.3* Phos-3.5 \nMg-1.5*\n\n======================\nPERTINENT RESULTS\n======================\nLABS\n======================\n___ 09:00PM BLOOD proBNP-193\n___ 09:00PM BLOOD ___ 07:15AM BLOOD 25VitD-21*\n\n======================\nIMAGING/STUDIES\n======================\nRUQUS (___): \n1. Echogenic liver consistent with steatosis. Other forms of \nliver disease and more advanced liver disease including \nsteatohepatitis or significant hepatic fibrosis/cirrhosis cannot \nbe excluded on this study.\n2. Stable mildly dilated common hepatic duct measuring up to 0.9 \ncm, of undetermined significance.\n3. No ascites.\n===\nBilateral lower extremity ultrasound (___):\nNo evidence of deep venous thrombosis in the right or left lower \nextremity veins.\n===\nCXR (___): No radiographic evidence of acute cardiopulmonary \ndisease.\n===\nTTE (___):\nThe left atrium is elongated. Left ventricular wall thickness, \ncavity size, and global systolic function are normal (LVEF>55%). \nThe estimated cardiac index is normal (>=2.5L/min/m2). Tissue \nDoppler imaging suggests a normal left ventricular filling \npressure (PCWP<12mmHg). Doppler parameters are most consistent \nwith normal left ventricular diastolic function. Right \nventricular chamber size and free wall motion are normal. There \nis abnormal septal motion/position. The diameters of aorta at \nthe sinus, ascending and arch levels are normal. The aortic \nvalve leaflets (3) appear structurally normal with good leaflet \nexcursion and no aortic stenosis or aortic regurgitation. The \nmitral valve leaflets are mildly thickened. There is no mitral \nvalve prolapse. No mitral regurgitation is seen. The estimated \npulmonary artery systolic pressure is normal. There is no \npericardial effusion. \n\nCompared with the prior study (images reviewed) of ___, \nestimatedf pulmonary artery pressures are lower. Doppler and \ncolor Doppler data is consistent with normal diastolic function \nand normal PCWP. \n===\nAbdominal xray (___):\nFINDINGS: \nThere is a nonspecific bowel gas pattern.  Copious amount of \nstool is seen within the ascending and transverse colon.  \nSutures are seen in the left mid abdomen.  Phleboliths are noted \nwithin the pelvis.  Degenerative changes and mild scoliosis are \nseen in the lumbar spine.  There are mild degenerative changes \nof the hips.\n \nIMPRESSION: \nNonspecific bowel gas pattern.  Copious amount of stool is seen \nwithin the ascending and transverse colon.\n\n======================\nDISCHARGE LABS\n======================\n\n___ 05:26AM BLOOD WBC-4.8 RBC-2.23* Hgb-7.3* Hct-23.7* \nMCV-106* MCH-32.7* MCHC-30.8* RDW-17.1* RDWSD-65.1* Plt ___\n___ 04:41AM BLOOD WBC-3.7* RBC-2.22* Hgb-7.3* Hct-23.5* \nMCV-106* MCH-32.9* MCHC-31.1* RDW-17.0* RDWSD-64.6* Plt ___\n___ 04:41AM BLOOD ___ PTT-28.4 ___\n___ 04:41AM BLOOD Glucose-68* UreaN-12 Creat-0.6 Na-142 \nK-4.1 Cl-106 HCO3-30 AnGap-6*\n___ 05:26AM BLOOD ALT-36 AST-27 AlkPhos-95 TotBili-0.4\n___ 04:29AM BLOOD CK-MB-4 cTropnT-<0.01\n___ 04:41AM BLOOD Calcium-7.0* Phos-3.2 Mg-1.7\n___ 09:00PM BLOOD NIACIN-Test      \n___ 09:00PM BLOOD VITAMIN B1-WHOLE BLOOD-Test      \n \nBrief Hospital Course:\n___ y/o woman with morbid obesity s/p RYGB (___ II anatomy \nnow), CVA, DVT/PE (xarelto), and chronic pain (methadone) \npresenting with shortness of breath and lower extremity edema, \ninitially presented to the CDAC. TTE with normal systolic \nfunction, valvular function, and pulmonary pressures, CXR clear, \nBNP normal. Patient noted to have severe protein-calorie \nmalnutrition, likely etiology of her lower extremity edema.  She \nwas initially admitted to the cardiology service where she was \ngiven diuresis, which lead to orthostasis, so Midodrine was \nadded.  They initiated tube feeds via NGT and then transferred \nher to the hospitalist service on the ___. \n\n=================\nACTIVE ISSUES\n=================\n# Severe protein-calorie malnutrition c/b peripheral edema: \nPatient noted to have severe malnutrition in setting of prior \ngastric bypass. GI recommended that the patient take small, \nfrequent meals. The cardiology team, along with Nutrition \ndecided to place an NGT tube, and the patient was initiated on \ntube feeds. In discussion with this team, there was no planned \nend-point in this therapy.  I discussed with her primary \noutpatient GI MD. ___ stated that her weight fluxuates, and that \nthe TFs are unnecessary.  In addition, she experienced nausea, \nbloating, and some abdominal pain with these.  The NG tube was \nremoved, and her symptoms improved.  She was able to eat \nsufficient meals and was pleased with her progress.  She will \nfollow-up with Gastroenterology as well as nutrition as an \noutpatient. All of her home medications were kept the same as \nthey were on admission.  \n\n___ edema - the patient had SaO2 of ___ in clinic; however, when \nshe was admitted to the floor, ambulatory SaO2 was 94-95% on RA \nper the report of the medical resident.  The Cardiology team \ntreated her empirically for diastolic heart failure with \nTorsemide, which caused diuresis but also orthostasis.  \nTorsemide was stopped, and we instituted TEDS as well as \nlymphedema wraps.  Wee discussed that mechanical (wraps), and \nnot medical therapy would be best ___ for symptoms of this \nnature.  I also explained that dizziness or orthostasis should \nbe dealt with by having slower movements with position changes.  \nMidodrine was added but caused nausea symptoms, so this was not \nadvised to continue and also to reduce polypharmacy.  \n\n# AVNRT: Patient had single episode of AVNRT that \nself-terminated and has not recurred. Question whether her \npresenting symptom of shortness of breath was perhaps an \narrhythmia, but no further events occurred on telemetry, and she \nexperienced this symptom without any arrhythmia on the monitor.  \nThere is no need for further monitoring at this time.  \n\n# DVT/PE: Patient previously on warfarin but switched to \nrivaroxaban, possibly at a prior rehab stay this year. Patient \ndid have a stroke while on rivaroxaban. Given her gastric bypass \nand limited ability to eat a 500-calorie meal, rivaroxaban may \nbe poorly absorbed and therefore less effective; however, her \nhome compliance with meds is also in question which may have led \nto failure. She was able to take enough food to have AC to be \neffective.  There is no need to consider switching back to \nwarfarin for anticoagulation at this time.  \n\n#Stage II sacral ulcer - she should have off-loading for sitting \nand lying; ___ will continue dressing changes.   \n\n=================\nCHRONIC ISSUES\n=================\n# Chronic Pain\n# Substance Abuse: Patient has ___ of chronic abdominal pain \nsecondary to multiple\nsurgeries as well as ___ substance abuse. She is on a complex \npain regimen, which has been continued while inpatient.  Because \nshe missed her outpatient appointment for refill of Methadone, I \ngave her her 9 pills to last ___, and ___ - \n___.  She states that she has enough at home for ___ and \n___ and can get additional refills with her PCP in the next \nfew days to resume on ___.  She was pleased with this plan.  \n\n\n# Depression/Anxiety: Continued home bupropion, duloxetine, \ndoxepin, queitiapine\n\n# GERD: Continued home ranitidine, PPI, and sucralfate\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. BuPROPion (Sustained Release) 150 mg PO BID \n2. Doxepin HCl 100 mg PO HS \n3. DULoxetine 40 mg oral Daily \n4. FoLIC Acid 1 mg PO DAILY \n5. Gabapentin 200 mg PO TID \n6. Lactulose 15 mL PO BID:PRN constipation \n7. Methadone 20 mg PO TID \n8. Pantoprazole 40 mg PO Q12H \n9. Promethazine 6.25 mg PO BID:PRN nausea \n10. QUEtiapine Fumarate 75 mg PO QHS \n11. Ranitidine 150 mg PO DAILY \n12. Rivaroxaban 20 mg PO DAILY \n13. Sucralfate 1 gm PO QID:PRN GI upset \n14. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild \n15. Ascorbic Acid ___ mg PO DAILY \n16. Vitamin D 1000 UNIT PO DAILY \n17. Cyanocobalamin 100 mcg PO DAILY \n18. Docusate Sodium 100 mg PO BID:PRN constipation \n19. Ferrous Sulfate 325 mg PO DAILY \n20. Multivitamins 1 TAB PO DAILY \n21. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n22. Senna 8.6 mg PO BID:PRN constipation \n23. Thiamine 100 mg PO DAILY \n\n \nDischarge Medications:\n1.  Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry \neyes  \n2.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild  \n3.  Ascorbic Acid ___ mg PO DAILY  \n4.  BuPROPion (Sustained Release) 150 mg PO BID  \n5.  Cyanocobalamin 100 mcg PO DAILY  \n6.  Docusate Sodium 100 mg PO BID:PRN constipation  \n7.  Doxepin HCl 100 mg PO HS  \n8.  DULoxetine 40 mg oral DAILY  \n9.  Ferrous Sulfate 325 mg PO DAILY  \n10.  FoLIC Acid 1 mg PO DAILY  \n11.  Gabapentin 200 mg PO TID  \n12.  Lactulose 15 mL PO BID:PRN constipation  \n13.  Methadone 20 mg PO TID \nRX *methadone 10 mg 2 tab by mouth three times a day Disp #*18 \nTablet Refills:*0 \n14.  Multivitamins 1 TAB PO DAILY  \n15.  Pantoprazole 40 mg PO Q12H  \n16.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n17.  Promethazine 6.25 mg PO BID:PRN nausea  \n18.  QUEtiapine Fumarate 75 mg PO QHS  \n19.  Ranitidine 150 mg PO DAILY  \n20.  Rivaroxaban 20 mg PO DAILY  \n21.  Senna 8.6 mg PO BID:PRN constipation  \n22.  Sucralfate 1 gm PO QID:PRN GI upset  \n23.  Thiamine 100 mg PO DAILY  \n24.  Vitamin D 1000 UNIT PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY:\n- Protein-calorie malnutrition\n- Peripheral edema\n\nSECONDARY:\n- Atrioventricular nodal reentry tachycardia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nDear Ms. ___, \n\nIt was a pleasure taking care of you at the ___ \n___!  You were initially admitted to the \nhospital out of concern for fluid overload and heart failure. \nYou were seen by the cardiologists, but your echocardiogram did \nnot show any significant heart failure.  The diuretics (fluid \npills) made you dizzy, so this was stopped, and wraps to your \nlegs were determined to be the best treatment for the fluid \naccumulation.  In addition, because of weight loss, NG tube with \ntube feedings were tried, but this caused pain and nausea.  You \nwere able to eat on your own without this, and your GI team \nthought that having small, frequent meals would be the best \nstrategy.  \n\nThank you for allowing us to be involved in your care, we wish \nyou all the best!  \n\nYour ___ Healthcare Team  \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb69f"
  },
  "note_id": "12648465-DS-41",
  "subject_id": 12648465,
  "hadm_id": 20492239,
  "note_type": "DS",
  "note_seq": 41,
  "charttime": "2209-07-28 00:00:00",
  "storetime": "2209-07-28 21:37:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut\n \nAttending: ___.\n \nChief Complaint:\ngeneralized body pain, chest heaviness\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\n___ h/o morbid obesity s/p RYGB (Billroth II anatomy now), CVA, \nDVT/PE (xarelto), and chronic pain (methadone), with multiple \nsimilar admissions this past year (last discharge ___ \npresenting from home with generalized body pains as well as \nchest heaviness, and significant lower extremity edema. \n\nShe was discharged from the ___ Service on \n___ for similar lower extremity edema thought to be related to \nsevere protein-calorie malnutrition. Initially she had been \ntreated with tube feeds, but her diet improved during the \nadmission, she experienced bloating and symptoms to the tube\nfeeds, and her outpatient GI did not feel she needed tube feeds \nso they were discontinued. The patient was to have extensive \noutpatient follow up with both GI and nutrition. \n\nHer initial prior admission was to the ___ where she was \ntreated empirically for diastolic HF. She received torsemide, \nbut was unable to tolerate the medication ___ orthostasis. \nMidodrine was attempted, but she developed nausea with the \nmedication. \n\nIn the ED the patient denied cough, dysuria, diarrhea or \nabdominal pain.\n\nIn the ED,\n- Initial vitals: T95.5, HR 98, BP 107/56, RR 18, 100% 2 L NC\n- Exam notable for: Significant bilateral lower extremity edema\n- Labs showed: UA: Leuk (large), WBC 33, Nitr (neg), Epi 1\nCBC: WBC 4.2, Hb 7.1, platelets 244\nOther: trop < 0.01, BMP normal, Alb 1.2, proBNP 456 \n- Imaging showed:  \n* CXR: No acute intrathoracic process. Specifically, no signs of \npneumonia.  Right IJ central venous line terminates in the low \nSVC. No acute cardiopulmonary abnormality.\n\nOn arrival to the floor, pt reports she feels worse than she did \non discharge last week. She said that she has increasing lower \nextremity edema that is rising into her abdomen making her feel \noverall heavy and bloated. \n\nFor her chest heaviness ___ days) she denies difficulty in \nbreathing, she denies cough, denies radiation of the pain to her \narms/jaw. She denies diaphoresis with the pain. \n\nShe says her abdominal pain is worse than previous with the \nheaviness feeling mostly in her entire lower abdomen, not \nconcentrated over her bladder region. She denies fevers, chills, \nincreased nausea/vomiting, frequency or burning with urination. \n\nShe notes she has chronic headaches for which she takes \ngabapentin. Her nausea/vomiting from her GERD/gastroparesis is \nat baseline. Her stools have been regular. She notes chronic \nleft sided weakness/changes in sensation.\n \nPast Medical History:\n1. CARDIAC RISK FACTORS  \n- h/o HTN and DMII, resolved after gastric bypass per patient\n2. CARDIAC HISTORY  \n- CABG: None  \n- PERCUTANEOUS CORONARY INTERVENTIONS: None  \n- PACING/ICD: None  \n3. OTHER PAST MEDICAL HISTORY  \n- s/p cholecystectomy and gastric bypass (___), with f/u \ncomplicated by multiple ex lap, gastrectomy, reversal surgery, \nfailed J-tube c/b colonic perforation  \n- multiple SBO during f/u from above  \n- hernia repair  \n- chronic abdominal pain, peptic ulcer disease   \n- asthma, stroke (left sided), osteoarthritis, GERD, DVT/PE    \n- narcotic abuse, tobacco abuse   \n- depression, anxiety   \n- muscle weakness / myelopathy, chronic low back pain    \n- vulvar folliculitis  \n- arthorplasty - right total knee    \n- hepatitis C - positive ab test, negative HCV viral load in 2x \ntests  \n- nephrolithiasis  \n- thyromegaly - TSH wnl, low free T4  \n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. Brother with CHF\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM\n=====================\n-Vitals:  98.3 PO BP 97/68 HR 98 RR 18 100 Ra \n-General: Alert, oriented, no acute distress  \n-HEENT: Sclerae anicteric, MMM, PERLA, equal eye movements. \noropharynx clear  \n-Neck: supple, JVP not elevated, no LAD  \n-Lungs: CTAB, no wheezes, rales, or rhonchi  \n-CV: RRR, S1/S2, no m/r/g \n-GI: surgical scars present, soft, mildly tender diffusely to \npalpation, worse in the lower abdomen, BS+, no rebound \ntenderness or guarding, no organomegaly  \n-MSK: warm, well perfused, 2+ pulses, no clubbing, cyanosis. \nSignificant pitting and non-pitting edema up to the waste.  \n-Neuro: PERRLA and equal eye movements w/o nystagmus. uvula \nmidline. Smile with droop on left side compared to right. Normal \nfacial strength/neck strenghth.  RT side face with more \npronounced sensation compared to left. Left lower extremities \nwith decreased sensation. Left upper extremity with ___ \nstrength,\nleft lower extremity including foot flexion decreased as \ncompared\nto right. Occasional word finding difficulties\n-Skin:  No rash or lesion\n\nDISCHARGE PHYSICAL EXAM\n======================\nVitals: T 98.4 BP 100-139/67-83 HR 95-102 SaO2 100% RA \n-General: Alert, oriented, no acute distress  \n-HEENT: Sclerae anicteric, MMM, EOMI.\n-Neck: supple \n-Lungs: CTAB, no wheezes, rales, or rhonchi  \n-CV: RRR, S1/S2, no m/r/g \n-GI: surgical scars present, soft, mild-mod tender diffusely to \npalpation, BS+, no rebound tenderness or guarding, no \norganomegaly  \n-MSK: warm, well perfused. trace to 2+ pitting edema ___ and \nabdomen up through the thighs. ___ with skin wrinkling.   \n-Neuro: alert, oriented, no obvious facial asymmetry, moving all \nextremities. previously documented: PERRLA and equal eye \nmovements w/o nystagmus. uvula midline. Smile with droop on left \nside compared to right. Normal facial strength/neck strenghth. \n-Skin:  No rash or lesion\n-Access: CVL in RIJ (placed in ED prior to admission due to \ndifficult access)\n \nPertinent Results:\nADMISSION LABS\n===============\n___ 12:40AM BLOOD WBC-4.2 RBC-2.20* Hgb-7.1* Hct-23.5* \nMCV-107* MCH-32.3* MCHC-30.2* RDW-16.9* RDWSD-64.1* Plt ___\n___ 12:40AM BLOOD Neuts-56.2 ___ Monos-7.4 Eos-0.0* \nBaso-0.2 Im ___ AbsNeut-2.35 AbsLymp-1.51 AbsMono-0.31 \nAbsEos-0.00* AbsBaso-0.01\n___ 12:40AM BLOOD Glucose-76 UreaN-13 Creat-0.6 Na-140 \nK-4.0 Cl-103 HCO3-29 AnGap-8*\n___ 12:40AM BLOOD CK-MB-2 proBNP-456*\n___ 12:40AM BLOOD cTropnT-<0.01\n___ 10:51AM BLOOD CK-MB-2 cTropnT-<0.01\n___ 10:51AM BLOOD Calcium-7.0* Phos-3.5 Mg-1.7\n___ 12:40AM BLOOD Albumin-1.2*\n___ 01:19AM BLOOD ___ pO2-41* pCO2-49* pH-7.40 \ncalTCO2-31* Base XS-3\n___ 12:45AM URINE Color-Yellow Appear-Clear Sp ___\n___ 12:45AM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-LG*\n___ 12:45AM URINE RBC-<1 WBC-33* Bacteri-FEW* Yeast-NONE \nEpi-1\n\nMICROBIOLOGY\n============\n-___ 12:45 am URINE: PSEUDOMONAS AERUGINOSA.    >100,000 \nCFU/mL. \nSENSITIVITIES: MIC expressed in MCG/ML\nCEFEPIME--------------   <=1 S\nCEFTAZIDIME-----------     2 S\nCIPROFLOXACIN---------<=0.25 S\nGENTAMICIN------------     2 S\nMEROPENEM-------------     1 S\nPIPERACILLIN/TAZO-----     8 S\nTOBRAMYCIN------------   <=1 S\n\n-___ 12:40 am BLOOD CULTURE: Pending \n-___ 11:01 pm BLOOD CULTURE: Pending \n\nIMAGING\n=======\nCXR (___): No acute intrathoracic process.  Specifically, \nno signs of pneumonia.\n \nDISCHARGE/INTERVAL LABS\n=====================\n___ 05:16AM BLOOD WBC-4.5 RBC-2.54* Hgb-8.3* Hct-26.3* \nMCV-104* MCH-32.7* MCHC-31.6* RDW-19.0* RDWSD-69.3* Plt ___\n___ 05:16AM BLOOD ___\n___ 05:16AM BLOOD Glucose-68* UreaN-13 Creat-0.7 Na-141 \nK-3.9 Cl-106 HCO3-28 AnGap-7*\n___ 10:51AM BLOOD CK(CPK)-33\n___:16AM BLOOD Calcium-6.6* Phos-3.4 Mg-1.9\n___ 05:54AM BLOOD WBC-4.3 RBC-2.72* Hgb-8.9* Hct-28.2* \nMCV-104* MCH-32.7* MCHC-31.6* RDW-19.2* RDWSD-69.8* Plt ___\n___ 05:16AM BLOOD WBC-4.5 RBC-2.54* Hgb-8.3* Hct-26.3* \nMCV-104* MCH-32.7* MCHC-31.6* RDW-19.0* RDWSD-69.3* Plt ___\n___ 05:16AM BLOOD ___\n___ 05:54AM BLOOD Glucose-68* UreaN-12 Creat-0.6 Na-143 \nK-4.1 Cl-108 HCO3-27 AnGap-8*\n___ 05:54AM BLOOD Albumin-1.1* Calcium-7.0* Phos-3.5 Mg-1.___ y/o woman with morbid obesity s/p RYGB (Billroth II anatomy \nnow), CVA, DVT/PE (xarelto), and chronic pain (on methadone) \npresenting with total body weakness and lower extremity edema \nfound to have urinary tract infection.\n\n=================\nACTIVE ISSUES\n=================\n# Severe protein-calorie malnutrition c/b peripheral edema: \nPatient with recent similar complaints discharged from ___ on \n___. LENIS at that time were negative for clot. Patient \nwithout evidence of diastolic HF on recent ECHO. Patient \ncontinues to have severe malnutrition which is likely the source \nof her lower extremity edema. Current albumin is quiet low at \n1.2 which is even further decreased from her last stay.  The \npatient had recent feeding tube initiation while on the \nCardiology service, but feeds were not tolerated as she had \nabdominal pain, nausea, bloating. Prior hospitalist also reports \nspeaking with her outpatient GI who did not feel tube feeds were \nnecessary. The patient noted increased po intake towards the end \nof her last hospitalization and thus tube feeds were \ndiscontinued. GI recommended gastroparesis diet with small \nfrequent meals and outpatient follow up after her last \ndischarge. During this hospitalization, patient was encouraged \nto consume regular meals which she tolerated well. However, this \nwill be an ongoing issue moving forwards that needs regular \nsurveillance. Continued thiamine, ferrous sulfate, folic acid, \ncyancobalamin, ascorbic acid, multivitamin, vitamin D.  \n\n# Anemia. Patient with anemia with Hb 7.1 on admission. Anemia \nof chronic disease on prior admissions. No bleeding per patient \nhx in urine, stool, or vaginal. Likely worsened because of \nsevere malnutrition. Hb dropped to 6.9 during this admission and \nshe received one unit of PRBC with response to Hb 8.3. On \ndischarge, the Hb was 8.9.\n\n# Pyuria, Urinary tract infection. Patient with positive urine \nanalysis, but no urinary symptoms including dysuria, urinary \nfrequency or urgency. Deferred antibiotics initially given \nabsence of dysuria. However, the patient had intermittent \nepisodes of confusion that could have been attributed to UTI. \nCulture grew pseudomonas, pan-sensitive. She was given 3 days of \nciprofloxacin ___ after AM dose).\n\n# Chronic Pain\n# Substance Abuse\nPatient has h/o chronic abdominal pain  secondary to multiple \nsurgeries as well as h/o substance abuse per prior discharge \nsummary. She is on a complex  pain regimen. Discuss limiting \nnarcotics as they will exacerbate her gastroparesis and limit \nher po intake. Uptitrated gabapentin and uptitrated duloxetine \n___, which can both provide enhanced pain control without \nadditional narcotics.\n\n#Chest heaviness:\nAt her baseline. Unlikely ACS with two rounds of troponins \nnegative. Patient without evidence of edema/opacity on her CXR \nto suggest heart failure or PNA. Likely related to overall \nsensation of generalized swelling. \n\n# DVT/PE: \nPatient previously on warfarin but switched to rivaroxaban, \npossibly at a prior rehab stay this year. Warfarin has difficult \nabsorption in patients with gastric bypass and it is difficult \nto remain in a therapeutic range. Patient did have a stroke \nwhile on rivaroxaban which may be in the setting of her gastric \nbypass (it cannot be absorbed). Of note Apixiban does have \nadequate absorption in gastric bypass patients, and she has been \ntransitioned to this medication. \n\n=================\nCHRONIC ISSUES\n=================\n# Depression/Anxiety. Continued home bupropion, duloxetine, \ndoxepin, queitiapine\n\n# GERD/gastroparesis: Continued home ranitidine, promethazine, \nPPI, and sucralfate\n\nTRANSITIONAL ISSUES\n=================\n#NEW MEDICATIONS\n- Apixaban 5 mg PO/NG BID \n- Multivitamins W/minerals 1 TAB PO DAILY \n- Ciprofloxacin HCl 250 mg PO/NG Q12H Duration 3 days to \ncomplete ___ after AM dose\n\n#CHANGED MEDICATIONS\n- Gabapentin 300 mg PO/NG TID \n\n#STOPPED MEDICATIONS\n- Multivitamins 1 TAB PO DAILY\n- Rivaroxaban 20 mg PO DAILY \n\n[ ] Pseudomonas simple cystitis treatment to complete ___ \nafter Am dose (for 3 day course)\n[ ] Has severe protein calorie malnutrition. Continue to monitor \npo intake\n[ ] Has anemia of chronic disease, continue to monitor\n[ ] Previously on Xarelto, however given history of gastric \nbypass, switched to Apixaban due to concern for adequate \nabsorption with Xarelto\n[ ] Has chronic abdominal pain for which home \nduloxetine/gabapentin were uptitrated, rather than adding on \nadditional narcotic agents\n[ ] Anemia requiring transfusion. Likely chronic inflammation. \nWould recheck CBC in one week after discharge.\n\n#CODE: full\n#COMMUNICATION:  ___ ___ alternate would be\ndaughter ___ ___. Sister ___ \n-___\n___ \n\n>30 minutes spent on discharge planning \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild \n2. Ascorbic Acid ___ mg PO DAILY \n3. BuPROPion (Sustained Release) 150 mg PO BID \n4. Cyanocobalamin 100 mcg PO DAILY \n5. Docusate Sodium 100 mg PO BID:PRN constipation \n6. Doxepin HCl 100 mg PO HS \n7. DULoxetine 40 mg oral DAILY \n8. Ferrous Sulfate 325 mg PO DAILY \n9. FoLIC Acid 1 mg PO DAILY \n10. Gabapentin 200 mg PO TID \n11. Methadone 20 mg PO TID \n12. Pantoprazole 40 mg PO Q12H \n13. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n14. Promethazine 6.25 mg PO BID:PRN nausea \n15. QUEtiapine Fumarate 75 mg PO QHS \n16. Ranitidine 150 mg PO DAILY \n17. Rivaroxaban 20 mg PO DAILY \n18. Senna 8.6 mg PO BID:PRN constipation \n19. Sucralfate 1 gm PO QID:PRN GI upset \n20. Thiamine 100 mg PO DAILY \n21. Vitamin D 1000 UNIT PO DAILY \n22. Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry \neyes \n23. Multivitamins 1 TAB PO DAILY \n24. Lactulose 15 mL PO BID:PRN constipation \n\n \nDischarge Medications:\n1.  Apixaban 5 mg PO BID  \n2.  Ciprofloxacin HCl 250 mg PO Q12H Duration: 4 Doses  \n3.  Multivitamins W/minerals 1 TAB PO DAILY  \n4.  Gabapentin 300 mg PO TID  RX *gabapentin 300 mg 1 capsule(s) \nby mouth three times a day Disp #*90 Capsule Refills:*0 \n5.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild  \n6.  Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry \neyes  \n7.  Ascorbic Acid ___ mg PO DAILY  \n8.  BuPROPion (Sustained Release) 150 mg PO BID  \n9.  Cyanocobalamin 100 mcg PO DAILY  \n10.  Docusate Sodium 100 mg PO BID:PRN constipation  \n11.  Doxepin HCl 100 mg PO HS  \n12.  DULoxetine 40 mg oral DAILY  \n13.  Ferrous Sulfate 325 mg PO DAILY  \n14.  FoLIC Acid 1 mg PO DAILY  \n15.  Lactulose 15 mL PO BID:PRN constipation  \n16.  Methadone 20 mg PO TID  RX *methadone 10 mg 2 Tablets by \nmouth three times a day Disp #*84 Tablet Refills:*0 \n17.  Pantoprazole 40 mg PO Q12H  \n18.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n19.  Promethazine 6.25 mg PO BID:PRN nausea  \n20.  QUEtiapine Fumarate 75 mg PO QHS  \n21.  Ranitidine 150 mg PO DAILY  \n22.  Senna 8.6 mg PO BID:PRN constipation  \n23.  Sucralfate 1 gm PO QID:PRN GI upset  \n24.  Thiamine 100 mg PO DAILY  \n25.  Vitamin D 1000 UNIT PO DAILY \n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSES\n================\nSEVERE PROTEIN CALORIE MALNUTRITION\nANEMIA OF CHRONIC DISEASE\nCHRONIC ABDOMINAL PAIN\n\nSECONDARY DIAGNOSES\n===================\nGASTROPARESIS\nGERD\nHX OF DVT/PE\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear ___\n\n___ was a pleasure taking care of you at ___. Please see below \nfor information on your time in the hospital.\n\nWHY WAS I IN THE HOSPITAL?\nYou felt that you were unable to care for yourself at home \nYou felt generalized weakness and swelling\n\nWHAT HAPPENED IN THE HOSPITAL?\nEncouraged regular po intake \nIncreased home Gabapentin doses given chronic abdominal pain\n\nWHAT SHOULD I DO WHEN I GO HOME?\nPlease take your medications as prescribed and follow up at your \noutpatient appointments. \n\nWe wish you the best in your health.\n-Your Care Team at ___\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb6a0"
  },
  "note_id": "12648465-DS-42",
  "subject_id": 12648465,
  "hadm_id": 22702738,
  "note_type": "DS",
  "note_seq": 42,
  "charttime": "2209-09-03 00:00:00",
  "storetime": "2209-09-03 22:14:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut\n \nAttending: ___.\n \nChief Complaint:\nDyspnea\n \nMajor Surgical or Invasive Procedure:\nIntubation\nCentral venous catheter placement\nPICC line placement \nTracheostomy (___)\nEmbolization of bleeding arteries via R femoral artery approach \n(___)\n\n \nHistory of Present Illness:\nMrs. ___ is a ___ h/o morbid obesity s/p RYGB\n(Billroth II anatomy now), CVA,  DVT/PE (apixiban), and chronic\npain (methadone), with multiple recent admissions for lower\nextremity edema, weakness, and chest pressure.\n\nMost recently, she was admitted from ___ with 8 chest\nheaviness and significant lower extremity edema which was\nattributed to hypoalbuminemia.  She was diagnosed with a UTI and\ntreated with ciprofloxacin and then discharged to rehab.  She \nhas\nremained in rehab over the past 10 days with similar symptoms. \n\nIn the past 2 days at rehab, she has noted that her breathing \nhas\nbecome worse.  She describes worsened chest heaviness with deep\ninspiration and a chronic chest heaviness that is similar in\nquality to her chronic symptoms, although slightly worse.  She\nnotes the chest pressure has been continuous in quality and has\nnot dissipated any point.  She denies any orthopnea or PND\nalthough she has not been laying flat at rehab.  She feels that\nher lower extremity edema is stable from his prior ALT though \nher\nmother who is present notes that it might be slightly worse.  \nShe\nthinks that her abdominal pain is worse than baseline although\nher mother endorses that it is likely similar to her chronic\nsymptoms.  Denies any neck back jaw or arm pain.  Denies any\nnumbness or tingling.  She has not had any nausea or vomiting\nwhich marked her prior admissions for edema and abdominal pain. \nDenies any coughs, specifically any productive cough.  Denies \nany\nheadaches, or fevers but says she has had intermittent chills\nover the past 2 weeks.  She has ongoing twitching sensations\nwhich her mother endorses are stable for several months since \nher\nprior strokes.  Denies any urinary urgency, dysuria, frequency \nor\nhematuria.  Completed her antibiotic course as scheduled at\nrehab.   Her mother notes that she has a petechial appearing \nrash\non her arms and legs which was reportedly present on her last\nadmission on her buttocks but has since spread.  Reports normal\nbowel movements.  She has been trying to eat and drink but has\nhad difficulty getting food down.  Denies feeling lightheaded or\ndizzy but has not had significant orthostatic changes.  Has been\nworking with ___ at rehab.\n \nPast Medical History:\n1. CARDIAC RISK FACTORS  \n- h/o HTN and DMII, resolved after gastric bypass per patient\n2. CARDIAC HISTORY  \n- CABG: None  \n- PERCUTANEOUS CORONARY INTERVENTIONS: None  \n- PACING/ICD: None  \n3. OTHER PAST MEDICAL HISTORY  \n- s/p cholecystectomy and gastric bypass (___), with f/u \ncomplicated by multiple ex lap, gastrectomy, reversal surgery, \nfailed J-tube c/b colonic perforation  \n- multiple SBO during f/u from above  \n- hernia repair  \n- chronic abdominal pain, peptic ulcer disease   \n- asthma, stroke (left sided), osteoarthritis, GERD, DVT/PE    \n- narcotic abuse, tobacco abuse   \n- depression, anxiety   \n- muscle weakness / myelopathy, chronic low back pain    \n- vulvar folliculitis  \n- arthorplasty - right total knee    \n- hepatitis C - positive ab test, negative HCV viral load in 2x \ntests  \n- nephrolithiasis  \n- thyromegaly - TSH wnl, low free T4  \n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. Brother with CHF\n \nPhysical Exam:\nADMISSION EXAM\n===============\nVS: 98.3 PO 90 / 49 101 18 99 (3L O2)\nGeneral: Awake and alert but sleepy and chronically \nill-appearing\nmiddle-aged woman. NAD\nEyes: Anicteric, noninjected\nENT: Sclerae anicteric, MMM, EOMI.\nNeck: supple, no LAD\nLungs: decreased BS at bases. Faint rales in left mid lung, no\nwheezing or rhoncni. Normal WOB\nCV: RRR nl S1/S2, no m/r/g. JVD ~10 \nGI: surgical scars present, soft, mild-mod tender diffusely to \npalpation, BS+, no rebound tenderness or guarding, no \norganomegaly  \nMSK: warm, well perfused. trace to 2+ pitting edema ___ and \nabdomen up through the thighs and sacrum. \nNeuro: alert, oriented x4.  Eyes conjugate facial movements\nsymmetrical.  CN II through XII intact.  5 5 strength in\nbilateral upper extremities.  If the strength is ___, limited \nby\npain and weakness.  Sensation grossly preserved bilateral face\n___, UE.  No dysmetria.  Patient has occasional myoclonic jerking\nof bilateral upper and lower extremities which mother reports is\nchronic.\nSKIN: Petechial rash along right arm and forearm and left arm\nnonblanching.  Multiple skin tears most notably on sacrum and\nright ankle.\n\nDISCHARGE EXAM\n===============\nVS: 99.2, 123, 117/64, 80, 27, 100%/TM\nGENERAL: Intubated, eyes open, anxious appearing, following \nsimple commands  \nENT: Sclerae anicteric, MMM, EOMI.\nNeck: unable to appreciate elevated JVP\nLungs: decreased BS at bases. ___ scattered wheezes anteriorly. \nIntubated.\nCV: RRR nl S1/S2, no m/r/g.\nGI: surgical scars present, soft, mildly tender diffusely to \npalpation, BS+, no rebound tenderness or guarding, no \norganomegaly  \nMSK: warm, well perfused. Gross anasarca diffusely with serous \ndrainage at tears in skin, R>L ___ edema\nNeuro: Eyes conjugate, face symmetric, following simple commands\nSKIN: Petechial rash along right arm and forearm and left arm \nnonblanching.  Multiple skin tears most notably on sacrum and\nright ankle.\n\n \nPertinent Results:\nADMISSION LABS\n==============\n___ 01:06PM BLOOD WBC-8.0# RBC-3.04* Hgb-10.2* Hct-31.3* \nMCV-103* MCH-33.6* MCHC-32.6 RDW-17.5* RDWSD-65.2* Plt ___\n___ 01:06PM BLOOD Neuts-81.1* Lymphs-14.8* Monos-3.1* \nEos-0.0* Baso-0.1 Im ___ AbsNeut-6.50*# AbsLymp-1.19* \nAbsMono-0.25 AbsEos-0.00* AbsBaso-0.01\n___ 09:45PM BLOOD ___ PTT-28.1 ___\n___ 12:50PM BLOOD Glucose-59* UreaN-13 Creat-0.7 Na-138 \nK-4.1 Cl-102 HCO3-24 AnGap-12\n___ 12:50PM BLOOD ALT-92* AST-79* AlkPhos-193* TotBili-0.7\n___ 12:50PM BLOOD proBNP-489*\n___ 05:30AM BLOOD CK-MB-2 cTropnT-<0.01\n___ 12:50PM BLOOD Albumin-1.1* Calcium-7.3* Phos-3.4 Mg-1.6\n___ 05:30AM BLOOD VitB12-___* Folate-16\n___ 05:30AM BLOOD CRP-169.7*\n___ 09:49PM BLOOD ___ pO2-147* pCO2-39 pH-7.41 \ncalTCO2-26 Base XS-0\n___ 01:00PM BLOOD Lactate-1.7\n\nSTUDIES/IMAGING\n===============\n___ CTA Chest\n1. No evidence of pulmonary embolism or aortic dissection. \n2. Large bilateral simple appearing pleural effusions. \n3. Extensive ground-glass opacities throughout the bilateral \nlungs, likely \nsecondary to pulmonary edema however an underlying multifocal \npneumonia cannot be excluded. \n4. Compared to the prior examination, there is extensive edema \nwithin the \nsubcutaneous tissues.  Clinical correlation for volume overload \nis \nrecommended. \n5. Hepatic steatosis. \n6. Sub-centimeter thyroid nodule for which no follow-up is \nrecommended based on ACR criteria listed below. \n\n___ CXR\nThere are multiple pulmonary opacities.  This most likely \nrepresents pulmonary edema however multifocal pneumonia cannot \nbe excluded.  Allowing for differences in technique, this \nappears similar to the CT scan of the chest from ___.   there are bilateral pleural effusions, similar to the \nprevious CT scan.  The heart is not enlarged.  The aorta is \natherosclerotic and tortuous.\n\n___ CT Head\nNo acute intracranial process.\n\n___ TTE\nThe left atrial volume index is normal. Normal left ventricular \nwall thickness, cavity size, and regional/global systolic \nfunction (biplane LVEF = 62 %). The estimated cardiac index is \nnormal (>=2.5L/min/m2). Tissue Doppler imaging suggests a normal \nleft ventricular filling pressure (PCWP<12mmHg). Right \nventricular chamber size and free wall motion are normal. \n[Intrinsic right ventricular systolic function is likely \ndepressed given the severity of tricuspid regurgitation.] There \nis abnormal diastolic septal motion/position consistent with \nright ventricular volume overload. The aortic valve leaflets (3) \nappear structurally normal with good leaflet excursion and no \naortic stenosis or aortic regurgitation. The mitral valve \nappears structurally normal with trivial mitral regurgitation. \nThere is no mitral valve prolapse. Moderate to severe [3+] \ntricuspid regurgitation is seen. There is moderate pulmonary \nartery systolic hypertension. [In the setting of at least \nmoderate to severe tricuspid regurgitation, the estimated \npulmonary artery systolic pressure may be underestimated due to \na very high right atrial pressure.] There is no pericardial \neffusion. A very prominent left pleural effusion is present. \nIMPRESSION: Moderate pulmonary artery systolic hypertension. \nModerate to severe tricuspid regurgitation. Normal biventricular \ncavity sizes with preserved regional and global biventricular \nsystolic function. Compared with the prior study (images \nreviewed) of ___, the severity of tricuspid regurgitation \nand the estimated PA systolic pressure are now much higher. Is \nthere a history to suggest an acute pulmonary process (pulmonary \nembolism, pneumonia, bronchospasm, etc.). \n\n___HEST/ABD/PELVIS W/O \n1. Large acute to subacute left retroperitoneal hematoma, \nintramuscular \nhematomas involving the bilateral psoas and left iliacus muscles \nalso noted.  \nActive bleeding difficult to exclude.  Please correlate \nclinically. \n2. Scattered bilateral pulmonary ground-glass opacities, may \nrepresent \npulmonary edema, with underlying emphysema.  Small to moderate \nleft pleural effusion appears simple. \n3. Support tubes and lines appear in appropriate position. \n4. Other findings as described above. \n\n___ Imaging CTA ABD & PELVIS \nLarge left retroperitoneal hematoma, bilateral intramuscular \npsoas and left iliacus hematomas.  Tiny foci of active bleeding \nwithin the left \nretroperitoneal hematoma and left psoas hematoma, detailed \nabove. \n\n___ Imaging LIVER OR GALLBLADDER US \n1. Echogenic liver consistent with steatosis. Other forms of \nliver disease \nincluding steatohepatitis, hepatic fibrosis, or cirrhosis cannot \nbe excluded on the basis of this examination. \n2. No evidence of acute pancreatitis in the imaged portions of \nthe pancreas. \n3. Again seen the 18.6 x 6.3 cm left retroperitoneum hematoma. \n\n___ EEG:\nThis is an abnormal continuous video-EEG monitoring study due to \n\nthe presence of a slow, disorganized theta frequency background \nwith bursts of generalized slowing and bursts of left temporal \nfocal slowing. These findings indicate left temporal subcortical \ndysfunction and a mild diffuse encephalopathy. There were no \nelectrographic seizures. Compared to the previous day's \nrecording, there are no significant changes. \n\n___ CXR:\nThis is an abnormal continuous video-EEG monitoring study due to \n\nthe presence of a slow, disorganized theta frequency background \nwith bursts of generalized slowing and bursts of left temporal \nfocal slowing. These findings indicate left temporal subcortical \ndysfunction and a mild diffuse encephalopathy. There were no \nelectrographic seizures. Compared to the previous day's \nrecording, there are no significant changes. \n \nMICRO: \n======\nBlood culture (___): negative\nUrine culture (___): negative\nUrine culture (___): yeast\n\nMRSA screen (___): negative\nCSF (___): negative\nCSF Entervirus (___): negative\n\nSputum (___):\n PSEUDOMONAS AERUGINOSA\n                             |          ESCHERICHIA COLI\n                             |          |   \nAMPICILLIN------------             =>32 R\nAMPICILLIN/SULBACTAM--             =>32 R\nCEFAZOLIN-------------             =>64 R\nCEFEPIME--------------     2 S      <=1 S\nCEFTAZIDIME-----------     4 S      <=1 S\nCEFTRIAXONE-----------                8 R\nCIPROFLOXACIN---------<=0.25 S      =>4 R\nGENTAMICIN------------     2 S      <=1 S\nMEROPENEM-------------     1 S   <=0.25 S\nPIPERACILLIN/TAZO-----     8 S      <=4 S\nTOBRAMYCIN------------   <=1 S      <=1 S\nTRIMETHOPRIM/SULFA----             =>16 R\n \n\nDISCHARGE LABS\n==============\n___ 03:09AM BLOOD WBC-11.3* RBC-2.72* Hgb-8.2* Hct-27.3* \nMCV-100* MCH-30.1 MCHC-30.0* RDW-20.6* RDWSD-74.4* Plt ___\n___ 03:09AM BLOOD Plt ___\n___ 03:09AM BLOOD ___ PTT-27.0 ___\n___ 03:09AM BLOOD Glucose-117* UreaN-19 Creat-0.3* Na-146 \nK-3.7 Cl-105 HCO3-28 AnGap-13\n___ 03:09AM BLOOD Calcium-9.0 Phos-3.7 Mg-2.1\n \nBrief Hospital Course:\nInformation for Outpatient Providers: ___ is a \n___ h/o morbid obesity s/p RYGB, CVA, DVT/PE on apixaban, and \nchronic pain on methadone who presented for dyspnea, anasarca, \nweakness, and chest pressure, transferred to ICU for AMS and \nrespiratory failure, found to have non-convulsive status \nepilepticus & anemia w/ newly diagnosed retroperitoneal bleed, \ncourse c/b VAP.\n\nACUTE ISSUES:\n=============\n\n# Toxic metabolic encephalopathy:\n# Non-convulsive status epilepticus: On arrival to hospital, \npatient was oriented and interactive with subsequent decline in \nher mental status over the next 2 days. She was having myoclonic \njerks suggestive of TME, found on EEG to be in non-convulsive \nstatus. Neurology was consulted and titrated anti-epileptic \nmedications in combination until the patient was no longer \nseizing. She was then maintained on lacosamide 200 mg BID & \nlevetiracetam 1500 mg BID.\n\n# Acute hypoxemic respiratory failure: Patient developed \nrespiratory failure, etiology is likely multifactorial iso AMS \nw/ status epilepticus, pulmonary edema. She was later diagnosed \nwith ventilator associated pneumonia. Sputum culture ___ grew \nE.coli and Psuedomonas, for which she was started on broad \nspectrum antibiotics and narrowed to ceftazidime prior to \ndischarge for two week course started ___ (end date ___, which \nwill treat possible UTI as well. Patient underwent tracheostomy \n___ in the setting of extended intubation and was maintained \non a tracheostomy mask. She continued to have copious secretions \nand was unable to tolerate a passy muir valve. \n\n# History of DVT/PE on apixaban:\nThe patient has a remote history of DVT/PE and was admitted on \napixaban. She was maintained on a heparin drip during her acute \nillness but suffered a RP bleed (see below) during which her \nheparin drip was discontinued to allow for ___ intervention. Her \nheparin drip was eventually re-started once she was stable & \nthen she was transitioned back to apixaban. Hemoglobin stable \nupon discharge, 8.2 upon day of discharge. \n\n# Retroperitoneal bleed: She had down-trending H/H & was noted \non CTA ___ to have a large left retroperitoneal hematoma, \nbilateral intramuscular psoas and left iliacus hematomas. ___ was \nconsulted and she underwent successful embolization and remained \nhemodynamically stable post-procedure, with stable hemoglobin. \nShe required multiple blood transfusions during admission. \nApixiban was restarted upon discharge given stable hemoglobin. \n\nCHRONIC ISSUES:\n===============\n\n# Severe protein-calorie malnutrition w/ anasarca: She was noted \nto be severely malnourished which is likely due to inadequate GI \nabsorption ___ poor GI anatomy after her RYGB. She was followed \nby Nutrition & supplemented for multiple deficiencies which she \nwill continue upon discharge. A Dobhoff was placed for tube \nfeeding and tube feeds were initiated. \n\n# Chronic Pain: Chronic abdominal pain secondary to multiple \nsurgeries. Home medications include gabapentin 300 mg PO TID, \nmethadone 20 mg PO TID were initially held in the setting of \naltered mental status. These may be restarted after discharge \nupon discretion of PCP. Patient was not in significant pain. She \nreceived PRN PO dilaudid as needed. Discharged with PRN liquid \noxycodone. \n\n# Depression: Patient was on bupropion 150 mg BID, duloxetine 40 \nmg QD prior to admission, held in the setting of altered mental \nstatus. She was discharged off these medications, they may be \nrestarted after discharge upon discretion of neurology/PCP. \nBupropion should not be restarted. \n\nTRANSITIONAL ISSUES:\n====================\n[ ] Continue ceftazidime (___)\n[ ] F/u with neurology to monitor seizures as outpatient\n[ ] Provide passy-muir valve once secretions decrease\n[ ] F/u with nutrition to monitor tube feeds \n[ ] Consider restarting home pain medications (such as \ngabapentin) and home psychiatric medications (duloxetine) at \ndiscretion of outpatient neurologist/PCP\n\nNEW MEDICATIONS\n___ 2 g IV BID \nLacosamide 200 mg BID \nKeppra 1500 mg BID\nLansoprazole 30 mg PO BID\nMidodrine 10 mg PO TID \nMultivitamin w/ mineral liquid \nNiacin 100 mg PO QID \nZinc sulfate 220 mg PO QD \n\nCHANGED MEDICATIONS\nSeroquel 75 mg QHS changed to 25 mg QHS\n\nHELD MEDICATIONS\nGabapentin 300 mg PO TID\nMethadone 20 mg PO TID\nDoxepin 100 mg PO QHS\nPantoprazole 40 mg PO BID\nBupropion SR 150 mg BID\nDuloxetine 40 mg PO QD \n\nCODE STATUS: Full\nContact: ___ (daughter) ___ \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild \n2. Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry \neyes \n3. Ascorbic Acid ___ mg PO DAILY \n4. BuPROPion (Sustained Release) 150 mg PO BID \n5. Cyanocobalamin 100 mcg PO DAILY \n6. Docusate Sodium 100 mg PO BID:PRN constipation \n7. Doxepin HCl 100 mg PO HS \n8. DULoxetine 40 mg oral DAILY \n9. Ferrous Sulfate 325 mg PO DAILY \n10. FoLIC Acid 1 mg PO DAILY \n11. Gabapentin 300 mg PO TID \n12. Lactulose 15 mL PO BID:PRN constipation \n13. Methadone 20 mg PO TID \n14. Pantoprazole 40 mg PO Q12H \n15. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n16. QUEtiapine Fumarate 75 mg PO QHS \n17. Ranitidine 150 mg PO DAILY \n18. Senna 8.6 mg PO BID:PRN constipation \n19. Sucralfate 1 gm PO QID:PRN GI upset \n20. Thiamine 100 mg PO DAILY \n21. Vitamin D 1000 UNIT PO DAILY \n22. Promethazine 6.25 mg PO BID:PRN nausea \n23. Multivitamins W/minerals 1 TAB PO DAILY \n24. Apixaban 5 mg PO BID \n\n \nDischarge Medications:\n1.  CefTAZidime 2 g IV Q12H \nRX *ceftazidime-dextrose (iso-osm) [Fortaz in dextrose 5 %] 2 \ngram/50 mL 2 g IV twice a day Disp #*26 Intravenous Bag \nRefills:*0 \n2.  LACOSamide 200 mg PO BID \nRX *lacosamide [Vimpat] 200 mg 1 tablet(s) by mouth twice a day \nDisp #*60 Tablet Refills:*0 \n3.  Lansoprazole Oral Disintegrating Tab 30 mg PO BID \nRX *lansoprazole 30 mg 1 capsule(s) by mouth twice a day Disp \n#*60 Capsule Refills:*0 \n4.  LevETIRAcetam 1500 mg PO Q12H \nRX *levetiracetam 500 mg 3 tablet(s) by mouth twice a day Disp \n#*180 Tablet Refills:*0 \n5.  Midodrine 10 mg PO TID \nRX *midodrine 10 mg 1 tablet(s) by mouth three times a day Disp \n#*90 Tablet Refills:*0 \n6.  Multivitamins W/minerals Liquid 15 mL PO DAILY \nRX *multivit-mins-ferrous gluconat [multivitamin with minerals] \n9 mg iron/15 mL 15 cc by mouth once a day Refills:*0 \n7.  Niacin 100 mg PO QID \nRX *niacin 100 mg 1 tablet(s) by mouth QID:PRN Disp #*60 Tablet \nRefills:*0 \n8.  OxycoDONE Liquid 5 mg PO Q8H:PRN Pain - Moderate \nRX *oxycodone 5 mg/5 mL 5 mg by mouth Q8H:PRN Refills:*0 \n9.  Zinc Sulfate 220 mg PO DAILY \nRX *zinc sulfate 220 mg (50 mg zinc) 1 capsule(s) by mouth once \na day Disp #*30 Capsule Refills:*0 \n10.  QUEtiapine Fumarate 25 mg PO QHS \nRX *quetiapine 25 mg 1 tablet(s) by mouth at bedtime Disp #*30 \nTablet Refills:*0 \n11.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild  \n12.  Apixaban 5 mg PO BID  \n13.  Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry \neyes  \n14.  Ascorbic Acid ___ mg PO DAILY  \n15.  Cyanocobalamin 100 mcg PO DAILY  \n16.  Docusate Sodium 100 mg PO BID:PRN constipation  \n17.  Ferrous Sulfate 325 mg PO DAILY  \n18.  FoLIC Acid 1 mg PO DAILY  \n19.  Lactulose 15 mL PO BID:PRN constipation  \n20.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n21.  Promethazine 6.25 mg PO BID:PRN nausea  \n22.  Ranitidine 150 mg PO DAILY  \n23.  Senna 8.6 mg PO BID:PRN constipation  \n24.  Sucralfate 1 gm PO QID:PRN GI upset  \n25.  Thiamine 100 mg PO DAILY  \n26.  Vitamin D 1000 UNIT PO DAILY  \n27. HELD- BuPROPion (Sustained Release) 150 mg PO BID  This \nmedication was held. Do not restart BuPROPion (Sustained \nRelease) until discuss with PCP\n28. HELD- Doxepin HCl 100 mg PO HS  This medication was held. Do \nnot restart Doxepin HCl until discuss with PCP\n29. HELD- DULoxetine 40 mg oral DAILY  This medication was held. \nDo not restart DULoxetine until discuss with PCP\n30. HELD- Gabapentin 300 mg PO TID  This medication was held. Do \nnot restart Gabapentin until discuss with PCP\n31. HELD- Methadone 20 mg PO TID  This medication was held. Do \nnot restart Methadone until discuss with PCP\n\n \n___:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nrespiratory failure\nnon-convulsive status epilepticus \nmalnutrition\nretroperitoneal bleed\nacute blood loss anemia\n\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Lethargic but arousable.\nActivity Status: Bedbound.\n\n \nDischarge Instructions:\nDear Ms. ___ & family,\n\nThank you for allowing for us to care for you at ___ \n___.\n\nWHY YOU WERE ADMITTED:\n-You were admitted for shortness of breath. \n\nWHAT HAPPENED WHEN YOU WERE HERE:\n-We treated you for \"respiratory failure\" -- this is when your \nlungs do not work as good as they should.  At first you were on \na breathing machine and then we put a tracheostomy tube in your \nwind pipe to help you breathe.\n-You had seizures which we treated for a long time until you \nwere no longer seizing.  We are not sure why you were seizing \nbut it was probably due to you being very sick and not having \ngood nutrition.\n-We tried to get fluid off of your body with a water pill called \nLasix. \n\nWHAT YOU SHOULD DO WHEN YOU LEAVE:\n-Continue to take all of the medications as we documented in \nthis discharge summary. \n-Continue to work at your rehabilitation facility to gain \nstrength. \n-Follow-up at all of your appointments \n\nIt was a pleasure caring for you. We wish you the best in your \ncontinued recovery. \n\nSincerely,\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb6a1"
  },
  "note_id": "12648465-DS-43",
  "subject_id": 12648465,
  "hadm_id": 26988390,
  "note_type": "DS",
  "note_seq": 43,
  "charttime": "2209-09-08 00:00:00",
  "storetime": "2209-09-08 21:38:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut\n \nAttending: ___.\n \nChief Complaint:\ns/p fall\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n   \n\n  \n___ ___ ___  \n    Note History     \n\n \n\nNote contains an addendum. See bottom.  \n\nNote Date: ___  Time: 2106\nNote Type: Initial note\nNote Title: Medicine Admission Note\nSigned by ___, MD on ___ at 9:07 pm  Affiliation: \n___\nCosigned by ___, MD on ___ at 2:47 pm\n \n============================================================\nMEDICINE ADMISSION NOTE  \nDate of admission:  ___\n============================================================\n\nPRIMARY CARE PHYSICIAN: ___\n  \nCHIEF COMPLAINT: fall \n \nHISTORY OF PRESENT ILLNESS:  This is a ___ female \nhistory\nof CVA, prior PE on apixaban who presents from her rehab after \nan\nunwitnessed fall. She was recently discharged from ___ after\nbeing admitted from ___. During this admission she\npresented with respiratory failure and ultimately required\ntracheostomy placement ___. She also began treatment for VAP \non\n___ with ceftazidime (Day 14: ___. She was on a heparin gtt\nduring admission for treated of history of DVT/PE but developed\nan RP bleed and underwent successful embolization. She was\ndischarged with Hb of 8.2. She was having myoclonic jerks\nsuggestive of TME, found on EEG to be in non-convulsive status.\nNeurology was consulted and titrated anti-epileptic medications\nin combination until the patient was no longer seizing. She was\nthen maintained on lacosamide 200 mg BID & \nlevetiracetam 1500 mg BID. She also had a Dobhoff placed for\ninitiation of tube feeds during this admission.  \n\nPer report from the rehab facility as patient is a poor \nhistorian\nand nonverbal at baseline patient was seemed apparently somewhat\nagitated and seemed uncomfortable throughout the course of the\nday. She was given Dilaudid overnight and sometime in the early\nmorning she had an unwitnessed fall from her bed to the floor \nand\nwas found face down on floor. Per report her baseline mental\nstatus is that she is able to nod yes or no.\n\nIn the ED she had a trauma workup that was unremarkable. Her\nimaging showed improving retroperitoneal hematomas. \n\nIn the ED, initial vitals: 100.8F, HR 112, BP 125/80, RR 18, 99%\non RA\n\n- Exam notable for:  trach in place with c-collar, dobhoff in\nplace, no obvious external signs of trauma, rhonchus breath\nsounds bilaterally, sacral pressure ulcer\n\n- Labs notable for:  WBC 16.8, Hb 8.1, UA with >182 WBC, Mod\nbacteria, negative nitrites, 7 epis, normal lactate, Na 149 \n\n- Imaging notable for: negative trauma imaging, improvement in\nretroperitoneal hematomas, LUL pneumonia \n\n- Pt given: vanc and zosyn \n\n- Vitals prior to transfer: 98.2F, HR 113, BP115/58, RR21, 100%\nTC \n \nOn the floor,  patient unable to provide significant additional\nhistory. She can nod her head yes/no to questions. Denies chest\npain, shortness or breath, dizziness, head pain. Does indicate\nshe is in pain but cannot specify where.  \n\nREVIEW OF SYSTEMS:  \nComplete ROS obtained and is otherwise negative.\n\n \nPast Medical History:\n- h/o HTN and DMII, resolved after gastric bypass per patient   \n- s/p cholecystectomy and gastric bypass (___), with f/u \ncomplicated by multiple ex lap, gastrectomy, reversal surgery, \nfailed J-tube c/b colonic perforation  \n- multiple SBO during f/u from above  \n- hernia repair  \n- chronic abdominal pain, peptic ulcer disease   \n- asthma, stroke (left sided), osteoarthritis, GERD, DVT/PE    \n- narcotic abuse, tobacco abuse   \n- depression, anxiety   \n- muscle weakness / myelopathy, chronic low back pain    \n- vulvar folliculitis  \n- arthorplasty - right total knee    \n- hepatitis C - positive ab test, negative HCV viral load in 2x \ntests  \n- nephrolithiasis  \n- thyromegaly - TSH wnl, low free T4  \n\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. Brother with CHF\n \nPhysical Exam:\nAdmission Exam:\n=================\nVITALS:  100.2F 116/74 ___ on 35%TM  \nGENERAL: Patient non-verbal, able to follow commands and nod \nhead\nyes/no to questions, NAD  \nHEENT: Normocephalic, atraumatic. Pupils equal, round, and\nreactive bilaterally, extraocular muscles intact. Sclera\nanicteric and without injection. Moist mucous membranes.\nNECK: Trach in place, thick yellow secretions present \nCARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No\nmurmurs/rubs/gallops. No JVD.  \nLUNGS: Clear to auscultation bilaterally w/appropriate breath\nsounds appreciated in all fields. Upper airway sounds \ntransmitted\nacross lung fields bilaterally. \nABDOMEN: Surgical scars present, soft, mildly tender diffusely \nto\npalpation, bowel sounds present, no rebound tenderness or\nguarding, no organomegaly    \nEXTREMITIES: No edema. \nNEUROLOGIC: Able to lift both UE off the bed. Wiggles toes\nbilaterally. \n\nDischarge Exam:\n=================\n___ 1520 Temp: 98.5 BP: 127/85 L Lying HR: 104 RR: 20 O2\nsat: 100% O2 delivery: 35%  Tm  \nGENERAL: NAD \nHEENT: NC/AT, PEERL, EOMI intact, anicteric \nNECK: supple, trach, copious white/yellow secretions\nCARDIAC: RRR, S1/S2, no m/r/g\nLUNGS: unlabored, transmitted upper airway sounds\nGI: surgical scars, soft, normoactive, non-distended, mild\ndiffuse tenderness, no rebound or guarding  \nEXT: WWP, minor swelling on dorsum of right hand\nNEUROLOGIC: awake, alert, attentive, nob-verbal but interactive,\nfollowing simple commands, moving all extremities \n \nPertinent Results:\nAdmission Labs:\n================\n\n___ 10:23AM BLOOD WBC-16.8* RBC-2.66* Hgb-8.1* Hct-27.0* \nMCV-102* MCH-30.5 MCHC-30.0* RDW-20.2* RDWSD-73.8* Plt ___\n___ 10:23AM BLOOD Neuts-89.4* Lymphs-6.1* Monos-2.8* \nEos-0.7* Baso-0.2 Im ___ AbsNeut-14.99*# AbsLymp-1.03* \nAbsMono-0.47 AbsEos-0.12 AbsBaso-0.03\n___ 10:23AM BLOOD Glucose-106* UreaN-17 Creat-0.3* Na-149* \nK-3.3 Cl-108 HCO3-29 AnGap-12\n___ 06:12AM BLOOD ALT-62* AST-49* LD(LDH)-407* AlkPhos-94 \nTotBili-0.3\n___ 10:23AM BLOOD Calcium-9.0 Phos-3.4 Mg-1.8\n___ 10:39AM BLOOD Lactate-1.3\n\nMicrobiology:\n================\n___: Stool: c. diff negative\n___: MRSA nasal swab negative\n___ 9:58 pm SPUTUM      Source: Endotracheal RT. VW. \n\n                            **FINAL REPORT ___\n\n   GRAM STAIN (Final ___: \n      <10 PMNs and <10 epithelial cells/100X field. \n      2+   ___ per 1000X FIELD):   GRAM NEGATIVE ROD(S). \n      QUALITY OF SPECIMEN CANNOT BE ASSESSED. \n\n   RESPIRATORY CULTURE (Final ___: \n      Commensal Respiratory Flora QUANTITATION NOT AVAILABLE. \n      PSEUDOMONAS AERUGINOSA.    SPARSE GROWTH. \n      ESCHERICHIA COLI.    SPARSE GROWTH. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             PSEUDOMONAS AERUGINOSA\n                             |          ESCHERICHIA COLI\n                             |          |   \nAMPICILLIN------------             =>32 R\nAMPICILLIN/SULBACTAM--             =>32 R\nCEFAZOLIN-------------             =>64 R\nCEFEPIME--------------     8 S          R\nCEFTAZIDIME-----------     4 S      <=1 S\nCEFTRIAXONE-----------                8 R\nCIPROFLOXACIN---------   =>4 R      =>4 R\nGENTAMICIN------------   <=1 S      <=1 S\nMEROPENEM-------------     1 S   <=0.25 S\nPIPERACILLIN/TAZO-----     8 S      <=4 S\nTOBRAMYCIN------------   <=1 S      <=1 S\nTRIMETHOPRIM/SULFA----             =>16 R\n\n___: urine culture < 10,000 CFU, no organism identified\n___: blood culture ___ set no growth to date\n___: blood culture ___ set no growth to date\n\nImaging:\n=========\n___ CT torso:\nIMPRESSION: \n1. There are multiple low and mixed density fluid collections: \nPartially rim enhancing centrally low attenuation left \nretroperitoneal fluid collection measuring 5.7 x 8.4 cm, an \nmixed density fluid collection abutting the left iliacus \nmeasuring 2.2 x 4.4 cm, bilateral intramuscular rim enhancing \nmixed density fluid collections in the left and right psoas \nmuscle measuring 2.5 x 3.0 and 3.3 x 2.3 cm, respectively.  \nThese correspond to hematomas further characterized on CTA \nabdomen pelvis ___.  Of note, each of these 4 \ncollections are smaller in size and lower in density as compared \nto ___ and compatible with expected evolution of \nhematomas.  There is no evidence of new or worsening hematoma. \n2. ___ opacities and ground-glass opacities in the left \nupper lobe \nlikely represent infection. \n\n___ CT head:\nIMPRESSION: \n1. No intracranial hemorrhage or other acute intracranial \nabnormality on \nnoncontrast head CT. \n2. Additional findings described above. \n\n___ CT c-spine:\nIMPRESSION: \n1. No fracture or malalignment. \n2. Additional findings described above. \n\n___ XR L femur:\nIMPRESSION:  \nSlightly limited assessment of the left hip due to overlying \nexternal \nradiopaque contrast.  No acute fracture or dislocation. \n\n___ EEG\nIMPRESSION: This is an abnormal continuous ICU EEG monitoring \nstudy because of moderate continuous focal slowing in the left \ntemporal region, as well as mild nearly continuous focal slowing \nin the right temporal region. These findings indicate of focal \ncerebral dysfunction, possibly structural in origin, in both \ntemporal regions, worse on the left. Diffuse background slowing \nand slow posterior dominant rhythm indicate mild diffuse \ncerebral dysfunction, which is nonspecific as to etiology. No \nepileptiform discharges or electrographic seizures are present. \nTwo clinical episodes of apparent shivering had no ictal EEG \nchange, but did show abundant EMG and shivering artifact. \nCompared to the prior day's EEG recording, there is no \nsignificant change. \n\nDischarge Labs:\n================\n___ 06:00AM BLOOD WBC-11.5* RBC-2.53* Hgb-7.7* Hct-25.3* \nMCV-100* MCH-30.4 MCHC-30.4* RDW-19.5* RDWSD-70.6* Plt ___\n___ 06:00AM BLOOD Glucose-104* UreaN-11 Creat-0.2* Na-140 \nK-3.3 Cl-103 HCO3-26 AnGap-11\n___ 06:30AM BLOOD ALT-42* AST-28 AlkPhos-83 TotBili-0.2\n___ 06:00AM BLOOD Calcium-8.6 Phos-3.2 Mg-1.5*\n \nBrief Hospital Course:\n___ female with h/o morbid obesity s/p RYGB (Billroth II \nanatomy now), DVT/PE (on apixaban), CVA, chronic pain syndrome \n(on methadone), and recent prolonged hospitalization for acute \nhypoxic respiratory failure ___ VAP s/p trach and RP bleed s/p \n___ embolization re-admitted one day after discharge after \nunwitnessed fall\n\nACTIVE ISSUES:\n#) Sepsis\n#) Pseudomonal VAP\nSIRS ___, QSOFA ___ for possible encephalopathy. Discharged on\nceftazidime for planned 2-week course (end date = ___. Now \nwith\nLUL ___ opacities and ground-glass opacities on CT, in\nkeeping with known Pseudomonal pneumonia. Repeat sputum culture \ngrowing pseudomonas and e.coli, with negative MRSA screen. \nInitially treated with vancomycin/ceftazadime/metronidazole, but \ndc'd vancomycin on ___ and dc'd metronidazole on ___. She should \ncontinue 14 day course for pseudomonas VAP with ceftazadime \n(end: ___. \n\n#) Leukocytosis: Admission WBC 16.8 from 10.2 on ___. Uptrend \neither from VAP (antibiotics started ___ or in setting of \nfall. Downtrending to 11.5 on ___. Other work-up included \nc.diff (neg) and urine culture with < 10,000 CFU with no \norganism identified.\n\n#) Encephalopathy: Initially with purported deviation from \nbaseline, per\ndaughter. Given history of non-convulsive status \nepilepticus,obtained continuous video EEG for 3 days which did \nnot show any evidence of seizure. Continued home Keppra and \nlacosamide. Patient required mitts for first 2 days of \nadmission, but mental status did improve and these were \ndiscontinued. \n\n#) Fall, unwitnessed: trauma survey negative. \n\nCHRONIC/STABLE ISSUES:\n#) Chronic respiratory failure: ___ VAP s/p trach. Continued\nhumidified O2 via trach collar and wean as tolerated.\n\n#) h/o RP bleed: CT with interval improvement. Subtle decline in\nall cell lines. Apixaban was continued with no evidence of \nbleeding.\n\n#) DVT/PE: continue home apixaban 5 mg BID with mindfulness of \nRP\nbleed. \n\n#) Hypotension: normotensive at present. Indication for \nmidodrine\n10 mg TID uncertain; normotensive since admission. Midodrine was \ndc'd.\n\n#) Severe protein-calorie malnutrition: on background\npost-surgical anatomy with probable poor absorption. Continue\ntube feeds and vitamins per nutrition via NGT. \nTube feeds: Vital High protein 60cc/hr. Free water flush 200cc \nq4h.\n\n#) Chronic pain syndrome, abdominal: complicated by substance \nuse\ndisorder. Home methadone 20 TID dc'd last admission on ___. \nWe resumed methadone 5 mg BID. \n\nTRANSITIONAL ISSUES:\n[ ] continue ceftazadime 2g IV q8h thru ___ for pseudomonas \nventilator associated pneumonia\n[ ] Recommend sitter given her fall risk, until she demonstrates \nstable mental status\n[ ] consider checking zinc level and discontinue supplement if \nnot deficient\n\nGreater than 30 minutes spent in care coordination and \ncounseling on the day of discharge. \n\n#Code status: Full\n#Health care proxy/emergency contact: ___ (mother) \n___\nalternate would be daughter ___ ___. Sister\n___ ___. Daughter ___ (RN) \n___.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild \n2. Apixaban 5 mg PO BID \n3. Ascorbic Acid ___ mg PO DAILY \n4. Cyanocobalamin 100 mcg PO DAILY \n5. Docusate Sodium 100 mg PO BID:PRN constipation \n6. FoLIC Acid 1 mg PO DAILY \n7. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n8. Senna 8.6 mg PO BID:PRN constipation \n9. Thiamine 100 mg PO DAILY \n10. Vitamin D 1000 UNIT PO DAILY \n11. CefTAZidime 2 g IV Q12H \n12. LACOSamide 200 mg PO BID \n13. Multivitamins W/minerals Liquid 15 mL PO DAILY \n14. Lansoprazole Oral Disintegrating Tab 30 mg PO BID \n15. LevETIRAcetam 1500 mg PO Q12H \n16. Midodrine 10 mg PO TID \n17. Niacin 100 mg PO QID \n18. Zinc Sulfate 220 mg PO DAILY \n19. Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry \neyes \n20. Sucralfate 1 gm PO QID:PRN GI upset \n21. Ranitidine 150 mg PO DAILY \n22. Promethazine 6.25 mg PO BID:PRN nausea \n23. Ferrous Sulfate 325 mg PO DAILY \n24. Lactulose 15 mL PO BID:PRN constipation \n25. Methadone 20 mg PO TID \n26. QUEtiapine Fumarate 25 mg PO QHS \n27. OxycoDONE Liquid 5 mg PO Q8H:PRN Pain - Moderate \n\n \nDischarge Medications:\n1.  GuaiFENesin ___ mL PO Q6H:PRN thick mucus  \n2.  CefTAZidime 2 g IV Q8H  \n3.  Methadone 5 mg PO BID  \n4.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild  \n5.  Apixaban 5 mg PO BID  \n6.  Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry \neyes  \n7.  Ascorbic Acid ___ mg PO DAILY  \n8.  Cyanocobalamin 100 mcg PO DAILY  \n9.  Docusate Sodium 100 mg PO BID:PRN constipation  \n10.  Ferrous Sulfate 325 mg PO DAILY  \n11.  FoLIC Acid 1 mg PO DAILY  \n12.  LACOSamide 200 mg PO BID  \n13.  Lactulose 15 mL PO BID:PRN constipation  \n14.  Lansoprazole Oral Disintegrating Tab 30 mg PO BID  \n15.  LevETIRAcetam 1500 mg PO Q12H  \n16.  Multivitamins W/minerals Liquid 15 mL PO DAILY  \n17.  Niacin 100 mg PO QID  \n18.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n19.  QUEtiapine Fumarate 25 mg PO QHS  \n20.  Ranitidine 150 mg PO DAILY  \n21.  Senna 8.6 mg PO BID:PRN constipation  \n22.  Sucralfate 1 gm PO QID:PRN GI upset  \n23.  Thiamine 100 mg PO DAILY  \n24.  Vitamin D 1000 UNIT PO DAILY  \n25.  Zinc Sulfate 220 mg PO DAILY  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary Diagnosis:\n- Fall\n- Ventilator Associated Pneumonia\n\nSecondary Diagnosis:\n- Hypernatremia\n- Toxic metabolic encephalopathy\n- Pulmonary Embolism, chronic\n- Chronic pain syndrome, abdominal\n\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Bedbound.\n\n \nDischarge Instructions:\nDear Ms. ___:\n\nIt was a pleasure caring for you at ___.\n\nWHY DID I COME TO THE HOSPITAL?\n- you came because you fell at your nursing facility\n\nWHAT DID YOU WE FOR YOU?\n- We scanned your head and body and did not find any bleeding or \nfractures\n- We monitored you on EEG for any evidence of seizures. You did \nnot show evidence of seizures.\n- We continued treating your pneumonia with antibiotics. \n\nWHAT SHOULD I DO WHEN I RETURN TO REHAB:\n- Please continue participating in rehab services\n- Follow instructions of your doctors and ___\n- ___ all follow-up appointment and all prescribed \nmedications\n\nWe wish you the best!\n\nYour ___ care team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb6a2"
  },
  "note_id": "12648465-DS-44",
  "subject_id": 12648465,
  "hadm_id": 24617497,
  "note_type": "DS",
  "note_seq": 44,
  "charttime": "2209-11-12 00:00:00",
  "storetime": "2209-11-12 15:17:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut\n \nAttending: ___.\n \nChief Complaint:\nChest pain, myalgia\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nPatient is a ___ y/o woman with CVA, seizure d/o, PE on\nanticoagulation admitted with right sided chest pain and\nmyalgias.   She has had a recent admission in ___\ninvolving respiratory failure, tracheostomy placement and\ntreatment for VAP. She then developed RP bleed while\nanticoagulation.   She presented to ED with myalgias and right\nsided pleuritic chest pain, and she was found to have RLL/RML\npneumonia.\n\nShe finds it difficult to take deep breath due to pain on\nanterior chest.  Would like more pain medicaitions, no\nn/v/ha/cp/sob\n \nPast Medical History:\n- h/o HTN and DMII, resolved after gastric bypass per patient   \n- s/p cholecystectomy and gastric bypass (___), with f/u \ncomplicated by multiple ex lap, gastrectomy, reversal surgery, \nfailed J-tube c/b colonic perforation  \n- multiple SBO during f/u from above  \n- hernia repair  \n- chronic abdominal pain, peptic ulcer disease   \n- asthma, stroke (left sided), osteoarthritis, GERD, DVT/PE    \n- narcotic abuse, tobacco abuse   \n- depression, anxiety   \n- muscle weakness / myelopathy, chronic low back pain    \n- vulvar folliculitis  \n- arthorplasty - right total knee    \n- hepatitis C - positive ab test, negative HCV viral load in 2x \ntests  \n- nephrolithiasis  \n- thyromegaly - TSH wnl, low free T4  \n\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. Brother with CHF\n \nPhysical Exam:\nADMISSION EXAM:\n\n98.7  100 / 64 80 18 96 RA \nGen:  Lying in bed, c/o right sided chest pain\nLung:  Limited by effort, but distinct rales in right side of\nlung, ___ up from base.  No rhonchi\nCV:  RRR\nAbd:  Nabs, soft\nExt:  No edema\n\nPatient examined on day of discharge. She was amble to ambulate \nwith a walker with no desaturations. Her lungs were CTAB. AVSS\n \nPertinent Results:\nLABORATORY RESULTS:\n\n___ 12:45PM BLOOD WBC-3.3* RBC-4.04 Hgb-11.7 Hct-37.2 \nMCV-92 MCH-29.0 MCHC-31.5* RDW-16.2* RDWSD-55.6* Plt ___\n___ 04:07AM BLOOD WBC-2.8* RBC-3.30* Hgb-9.3* Hct-30.2* \nMCV-92 MCH-28.2 MCHC-30.8* RDW-16.2* RDWSD-55.2* Plt ___\n___ 12:45PM BLOOD Glucose-126* UreaN-15 Creat-0.8 Na-136 \nK-4.2 Cl-100 HCO3-19* AnGap-17\n___ 04:07AM BLOOD Glucose-62* UreaN-9 Creat-0.5 Na-140 \nK-4.4 Cl-100 HCO3-32 AnGap-8*\n___ 12:45PM BLOOD ALT-28 AST-50* AlkPhos-88 TotBili-0.4\n___ 07:38AM BLOOD Calcium-8.2* Phos-3.0 Mg-1.4*\n___ 05:13AM BLOOD Calcium-8.7 Phos-4.3 Mg-1.7\n___ 12:52PM BLOOD Lactate-5.0*\n___ 03:36PM BLOOD Lactate-2.9*\n\nCHEST X-RAY\n\nRight lower lobe consolidation compatible with pneumonia. \n\nCT Abdomen/pelvis\n\n1. Dense ground-glass opacification in the right middle and \nlower lobes is \nonly partially evaluated on current exam but may be suggestive \nof pneumonia. \n2. Left retroperitoneal and left iliacus fluid collections are \nsmaller \ncompared to prior exam dated ___, and most likely \nrepresent \nevolving hematomas. \n3. Mild intrahepatic biliary dilatation of the left hepatic lobe \nappears \nmildly increased compared to ___ (02:22) potentially \nsecondary to \npost-cholecystectomy changes.  Recommend clinical correlation \nwith LFTs. \n4. Stable appearance of a urethral diverticulum with \nintraluminal \ncalcification. \n  \nSPUTUM CULTURE\n\n   GRAM STAIN (Final ___: \n      >25 PMNs and <10 epithelial cells/100X field. \n      3+  ___ per 1000X FIELD):   GRAM NEGATIVE ROD(S). \n      2+   ___ per 1000X FIELD):   GRAM POSITIVE ROD(S). \n      2+   ___ per 1000X FIELD):   GRAM POSITIVE COCCI IN \nPAIRS. \n      2+   ___ per 1000X FIELD):   BUDDING YEAST WITH \nPSEUDOHYPHAE. \n\n   RESPIRATORY CULTURE (Preliminary): \n      MODERATE GROWTH Commensal Respiratory Flora. \n      GRAM NEGATIVE ROD WORKUP REQUESTED BY ___ ___ \n___. \n      GRAM NEGATIVE ROD(S).    SPARSE GROWTH. \n      GRAM NEGATIVE ROD #2.    RARE GROWTH. \n      PSEUDOMONAS AERUGINOSA.    RARE GROWTH. \n \nBrief Hospital Course:\nMs. ___ was admitted with shortness of breath, hypoxia, and \npleuritic chest pain and found to have a large RML and RLL \npneumonia on chest imaging. Because of her recent admission for \na resistant pseudomonal ventilar-associated pneumonia (treated \nwith 10 days of IV ceftazadime), she was empirically started on \nvancomycin and ceftazidime, first day ___. Her hypoxia \nrapidly improved, and by HD#3 she was saturating normally. A \nsputum culture was obtained, which is growing a small amount of \npseudomonas. I discussed with the infectious disease team -- \ngiven her improvement with a nine day course of ceftazadime, she \nshould be sufficiently treated for a pseudomonal pneumonia. She \nwill discharge home on now antibiotics, and will follow up with \nthe ID team in ___ weeks to further discuss. If her cultures \nshow any resistance, I will follow up with her and discuss \nfurther IV antibiotics.\n\nOtherwise, on HD#2 she had a tonic clonic seizure in the setting \nof her mother visiting and developing an acute gastroenteritis, \nrequiring admission to the hospital. She had no other seizure \nactivities. A Keppra level was sent, which is still pending. She \nis being discharged on her home AEDs.\n\nHOSPITAL COURSE BY PROBLEM.\n\n1. Pseudomonal pneumonia\n2. Pleuritic chest pain.\nNo further antibiotics and follow up in ___ clinic as above. She \nwas started on Dilaudid for pleuritic chest pain; this was \ntapered over the course of the hospitalization, and she will \ndischarge with #10 hydromorphone 2 mg. PMP checked showing only \nprescribed meds by PCP.\n\n3. Epilepsy with an acute GTC seizure.\n- home lacosamide\n- home Keppra\n- f/u Keppra levels\n\n4. Deconditioning. Evaluated by ___ who recommends home ___ on \ndischarge. They will see her.\n\n5. History of PE. Home apixaban.\n\n6. Chronic pain. Home methadone.\n\nTRANSITIONAL ISSUES:\n- I will follow up sputum cultures and contact patient if \nresistance\n- follow up in ___ clinic\n- follow up Keppra levels\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild \n2. Apixaban 5 mg PO BID \n3. Cyanocobalamin 100 mcg PO DAILY \n4. Docusate Sodium 100 mg PO BID:PRN constipation \n5. Ferrous Sulfate 325 mg PO DAILY \n6. LACOSamide 200 mg PO BID \n7. LevETIRAcetam 1500 mg PO Q12H \n8. Methadone 10 mg PO TID \n9. Multivitamins W/minerals Liquid 15 mL PO DAILY \n10. QUEtiapine Fumarate 75 mg PO QHS \n11. Senna 8.6 mg PO BID:PRN constipation \n12. Sucralfate 1 gm PO QID:PRN GI upset \n13. Vitamin D 1000 UNIT PO DAILY \n14. Omeprazole 20 mg PO DAILY \n15. Doxepin HCl 10 mg PO HS \n16. Gabapentin 100 mg PO BID \n17. Gabapentin 200 mg PO DAILY \n18. Promethazine 12.5 mg PO BID:PRN nausea \n19. DULoxetine 40 mg PO DAILY \n\n \nDischarge Medications:\n1.  HYDROmorphone (Dilaudid) 2 mg PO Q4H:PRN Pain - Severe \nRX *hydromorphone 2 mg 1 tablet(s) by mouth Every six hours as \nneeded Disp #*15 Tablet Refills:*0 \n2.  Methadone 10 mg PO TID  \n3.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild  \n4.  Apixaban 5 mg PO BID  \n5.  Cyanocobalamin 100 mcg PO DAILY  \n6.  Docusate Sodium 100 mg PO BID:PRN constipation  \n7.  Doxepin HCl 10 mg PO HS  \n8.  DULoxetine 40 mg PO DAILY  \n9.  Ferrous Sulfate 325 mg PO DAILY  \n10.  Gabapentin 100 mg PO BID  \n11.  Gabapentin 200 mg PO DAILY  \n12.  LACOSamide 200 mg PO BID  \n13.  LevETIRAcetam 1500 mg PO Q12H  \n14.  Multivitamins W/minerals Liquid 15 mL PO DAILY  \n15.  Omeprazole 20 mg PO DAILY  \n16.  Promethazine 12.5 mg PO BID:PRN nausea  \n17.  QUEtiapine Fumarate 75 mg PO QHS  \n18.  Senna 8.6 mg PO BID:PRN constipation  \n19.  Sucralfate 1 gm PO QID:PRN GI upset  \n20.  Vitamin D 1000 UNIT PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nCommunity acquired pneumonia -- suspect pseudomonas\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nYou were admitted with a right middle and lower lobe pneumonia, \ncausing hypoxia. Because of your history of a resistant \npseudomonas pneumonia, you were started on ceftazadime, a broad \nspectrum antibiotic. I checked your sputum cultures, which were \nsuspicious for pseudomonas again. As you have now been treated \nwith IV antibiotics for 9 days, you are safe for discharge. \nHowever, I will follow up your culture results with you. If \nthere is any resistance (which I do not suspect), we will have \nto come up with a contingency plan, which may mean returning to \nthe hospital. Otherwise, you will follow up with the infectious \ndisease department to come up with a plan.\n\nOtherwise, you were developed a seizure in the setting of your \nmother becoming acutely ill. I checked your Keppra levels, which \nare not back yet, but otherwise you have been fine. You should \nfollow this up with your primary care doctor.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb6a3"
  },
  "note_id": "12648465-DS-45",
  "subject_id": 12648465,
  "hadm_id": 28161673,
  "note_type": "DS",
  "note_seq": 45,
  "charttime": "2210-02-04 00:00:00",
  "storetime": "2210-02-04 22:47:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut / \nWellbutrin / ciprofloxacin\n \nAttending: ___.\n \nChief Complaint:\nAbd Pain\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ y/o woman w/ complex medical history- seizure disorder, prior \nDVT/PE currently on apixaban, multiple prior CVAs (MRI brain \n___ showing 3 punctate areas in the right cerebellum \nsuggestive of acute to subacute infarction), nephrolithiasis \ncomplicated by persistent hematuria and E. coli sepsis \n(requiring ureteral stenting and lithotripsy), prior gastric \nbypass surgery complicated by SBOs/multiple surgeries/adhesions, \nsevere GERD/esophagitis, chronic lower back pain, osteoarthritis \nstatus post right TKA, depression/anxiety, and chronic opiate \nuse with history of abuse who is referred in from ___ clinic for \nevaluation of abdominal pain.  \n Per Dr. ___ note dated ___- \"She was most recently  \n discharged from the ED after AMS attributed to overdose of  \n methadone, s/p narcan administration ___. She was also seen \n \n in the ED on ___ after a tonic-clonic seizure in the setting \nof  \n medication non-adherence to Keppra. At this visit, she was  \n diagnosed with UTI and DC'd on CIPRO for 5 days. Urine was  \n contaminated. Subsequently, reduced methadone dosing to 10mg \nTID.  \n For the history of her multiple recent hospitalizations, please \n \n refer to last clinic F/U note from Dr. ___. Of note, she \nhas a history of cholecystectomy and gastric bypass in ___ and \nmultiple SBOs subsequently. Her last abdominal surgery was in \n___.  \n The patient presents today for pain with eating. This started  \n ___ and has been progressive. She will eat crackers or toast \n \n and she experiences pain once it gets to her stomach. Within 5  \n\n minutes of eating she experiences severe nausea and has to lay \nin  \n the fetal position and wait for it to go away. This also \npresents  \n with lower midline ABD pain which is non-radiating and severe.  \n\n She is able to take fluids with small sips only. She feels that \n \n she is severely dehydrated and is orthostatic. She has not  \n vomited at all, but an occasional gag. In terms of bowel  \n movements, she is having them every other day, formed and no  \n blood. Last bowel movement this morning was normal without \npain.  \n She is passing gas. Urinating frequently although not  \n particularly large volumes. She has a ___ who came yesterday \nand  \n called HCA to set up this appointment.  \n She has not had any seizures since her emergency department \nvisit  \n and has not been passing out, but appears generally sedated to  \n\n her family who is here with her today. She feels strongly that  \n\n her episode of AMS in the ED was NOT due to opioids and is  \n concerned that this might have been an additional seizure.  \n Patient does also have a known history of \nesophagitis/gastritis,  \n had undergone workup for possible LINX procedure given severe  \n reflux. Last EGD ___. Patient missed her appointment with  \n Dr. ___ ___, on omeprazole and promethazine. This does \nnot  \n feel like that sensation to her and the promethazine is not  \n helping. \"  \n In the ED, initial VS were:97.9 70 106/62 16 99% RA  \n Exam notable for:Upper quadrant epigastric and right lower \nquadrant abdominal tenderness, no acute distress, dry mucous \nmembranes, lungs clear to auscultation bilaterally.  \n ECG:  \n Labs showed: Trop-T: <0.01, WBC 3.6 Alb: 2.9 UA 45 ___  \n Imaging showed:  \n CT Abd and pelvis-  \n 1. No acute intra-abdominal process to explain the patient's \nsymptoms.  \n 2. Similar appearance of mild intrahepatic biliary ductal \ndilatation and dilation of the CBD, status post cholecystectomy. \n \n 3. There is little to no residual fluid component of a left \nretroperitoneal collection, now measuring 1.7 x 1.0 cm, likely \nrepresenting evolving hematoma. The left iliacus collection is \nno longer visualized.  \n 4. Unchanged 3 throughout diverticulum with intraluminal \ncalcification.  \n Patient received:  \n ___ 19:29 IV Ondansetron 4 mg ___  \n ___ 19:29 IVF NS ___ Started  \n ___ 19:54 IV Acetaminophen IV 1000 mg ___  \n\n ___ 20:40 IV Morphine Sulfate 4 mg ___  \n ___ 20:40 IVF NS ___ Started  \n ___ 20:41 IVF NS 1000 mL ___ Stopped (1h \n___  \n ___ 21:59 IV Morphine Sulfate 4 mg ___  \n ___ 21:59 IVF NS 1000 mL ___ Stopped (1h \n___  \n ___ 22:24 PO BuPROPion (Sustained Release) 200 mg \n___  \n ___ 22:24 PO/NG Doxepin HCl 10 mg ___  \n ___ 22:24 PO LevETIRAcetam 1500 mg ___  \n ___ 22:31 PO/NG Methadone 5 mg ___  \n ___ 00:11 IV HYDROmorphone (Dilaudid) 1 mg ___ \n \n ___ 01:16 PO Ciprofloxacin HCl 500 mg ___  \n ___ 01:16 IV Ondansetron 4 mg  \n Transfer VS were:98.3 66 115/65 18 100% RA  \n \n On arrival to the floor, patient reports that her abd pain is \nbetter after the pain meds they gave her in ED. Notes that it's \n___ and points to RUQ. Baseline abd pain is ___ and midline \nnear scars. Is not feeling nauseous anymore but hesitant to try \neating anything. No vomiting. Feels weak and hungry. Hasn't \neaten much since ___, especially hasn't really eaten since \n___.  \n Denies dysuria but endorses increased urinary freq and urgency. \nFelt feverish yesterday and this AM, subjectively. Denies any \ndiarrhea, blood in urine or stools, melena, CP/SOB.  \n\n \nPast Medical History:\n- h/o HTN and DMII, resolved after gastric bypass per patient  \n - s/p cholecystectomy and gastric bypass (___), with f/u  \n complicated by multiple ex lap, gastrectomy, reversal surgery,  \n\n failed J-tube c/b colonic perforation  \n - multiple SBO during f/u from above  \n - hernia repair  \n - chronic abdominal pain, peptic ulcer disease  \n - asthma, stroke (left sided), osteoarthritis, GERD, DVT/PE  \n - narcotic abuse, tobacco abuse  \n - depression, anxiety  \n - muscle weakness / myelopathy, chronic low back pain  \n - vulvar folliculitis  \n - arthorplasty - right total knee  \n - hepatitis C - positive ab test, negative HCV viral load in 2x \n \n tests  \n - nephrolithiasis  \n - thyromegaly - TSH wnl, low free T4  \n\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. Brother with CHF \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \n VS: 98.4 PO 128 / 89 74 18 100 Ra  \n GENERAL: NAD  \n HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, \nMMM  \n NECK: supple, no LAD, no JVD  \n HEART: RRR, S1/S2, no murmurs, gallops, or rubs  \n LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \n ABDOMEN: nondistended, mild TTP in RUQ, no rebound/guarding, no \nhepatosplenomegaly  \n BACK: no CVA tenderness  \n EXTREMITIES: no cyanosis, clubbing, or edema  \n PULSES: 2+ DP pulses bilaterally  \n NEURO: A&Ox3, moving all 4 extremities with purpose LUE and LLE \n___ in strength, her baseline post CVA, RLE and RUE ___  \n SKIN: warm and well perfused, no excoriations or lesions, no \nrashes  \n\nDISCHARGE PHYSICAL EXAM:\n24 HR Data (last updated ___ @ 1518)\n    Temp: 98.4 (Tm 98.8), BP: 132/82 (107-132/72-82), HR: 88 \n(69-94), RR: 17 (___), O2 sat: 97% (97-98), O2 delivery: Ra, \nWt: 154.2 lb/69.95 kg  \nGENERAL: NAD, laying back in bed with EEG leads on\nHEENT: AT/NC, EOMI, no JVD\nHEART: RRR, S1/S2 normal, no m/g/r appreciated\nLUNGS: CTAB\nABDOMEN: +BS, soft, non-distended, TTP in RUQ. Improved TTP in\nthe epigastric region, no rebound/guarding, no \nhepatosplenomegaly\nBACK: no CVA tenderness\nEXTREMITIES: no cyanosis, clubbing, or edema, +pulses\nNEURO: A&Ox3, ___ upper and lower motor strength, sensation in\ntact, in tact finger to nose testing\nSKIN: no rashes\n \nPertinent Results:\nADMISSION LABS:\n___ 10:00AM   GLUCOSE-69* UREA N-8 CREAT-0.8 SODIUM-141 \nPOTASSIUM-4.1 CHLORIDE-106 TOTAL CO2-26 ANION GAP-9*\n___ 10:00AM   ALT(SGPT)-18 AST(SGOT)-31 LD(LDH)-166 \nCK(CPK)-30 ALK PHOS-82 TOT BILI-0.3\n___ 10:00AM   CK-MB-1 cTropnT-<0.01\n___ 10:00AM   CALCIUM-8.2* PHOSPHATE-4.3 MAGNESIUM-1.6\n___ 10:00AM   WBC-2.7* RBC-2.98* HGB-9.3* HCT-29.9* \nMCV-100* MCH-31.2 MCHC-31.1* RDW-17.7* RDWSD-66.4*\n___ 10:00AM   NEUTS-43.5 ___ MONOS-8.2 EOS-2.6 \nBASOS-0.7 IM ___ AbsNeut-1.16* AbsLymp-1.19* AbsMono-0.22 \nAbsEos-0.07 AbsBaso-0.02\n___ 10:00AM   PLT COUNT-179\n___ 10:00AM   ___ PTT-36.8* ___\n___ 10:16PM URINE  HOURS-RANDOM\n___ 10:16PM URINE  UHOLD-HOLD\n___ 10:16PM URINE  COLOR-Yellow APPEAR-Hazy* SP ___\n___ 10:16PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 \nLEUK-LG*\n___ 10:16PM URINE  RBC-1 WBC-45* BACTERIA-FEW* YEAST-NONE \nEPI-1\n___ 10:16PM URINE  AMORPH-RARE*\n___ 10:16PM URINE  MUCOUS-RARE*\n___ 07:22PM   ___ COMMENTS-GREEN TOP \n___ 07:22PM   LACTATE-1.3\n___ 07:00PM   GLUCOSE-89 UREA N-13 CREAT-0.9 SODIUM-141 \nPOTASSIUM-3.9 CHLORIDE-103 TOTAL CO2-26 ANION GAP-12\n___ 07:00PM   estGFR-Using this\n___ 07:00PM   ALT(SGPT)-20 AST(SGOT)-33 ALK PHOS-97 TOT \nBILI-0.4\n___ 07:00PM   LIPASE-6\n___ 07:00PM   cTropnT-<0.01\n___ 07:00PM   ALBUMIN-2.9*\n___ 07:00PM   WBC-3.6* RBC-3.42* HGB-10.8* HCT-34.1 \nMCV-100* MCH-31.6 MCHC-31.7* RDW-17.8* RDWSD-65.4*\n___ 07:00PM   NEUTS-43.2 ___ MONOS-6.5 EOS-1.4 \nBASOS-0.6 IM ___ AbsNeut-1.54* AbsLymp-1.71 AbsMono-0.23 \nAbsEos-0.05 AbsBaso-0.02\n___ 07:00PM   ___ PTT-34.3 ___\n___ 07:00PM   PLT COUNT-212\n\nIMAGING:\n___ CXR:\nNo acute intrathoracic process.\n\n___ CT ABD & PELVIS WITH CO:\n1. No acute intra-abdominal process to explain the patient's \nsymptoms. \n2. Similar appearance of mild intrahepatic biliary ductal \ndilatation and \ndilation of the CBD, status post cholecystectomy. \n3. There is little to no residual fluid component of a left \nretroperitoneal collection, now measuring 1.7 x 1.0 cm, likely \nrepresenting evolving hematoma. The left iliacus collection is \nno longer visualized. \n4. Unchanged urethral diverticulum with intraluminal \ncalcification.\n\nEEG ___:\nThis is an abnormal continuous EEG monitoring study because of\nmild generalized background slowing consistent with a mild \nencephalopathy.\nThere are bursts of higher voltage sharply contoured theta/delta \nslowing\nconsistent with subcortical or deep midline dysfunction. There \nare no\ndefinite epileptiform discharges and no electrographic seizures.\n\nMICRO:\nTime Taken Not Noted     Log-In Date/Time: ___ 10:16 pm\n      URINE\n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \nWITH SKIN\n      AND/OR GENITAL CONTAMINATION. \n\nINTERVAL LABS:\n___: Vimpat level 10.9\n___: Keppra level pending\n\nDISCHARGE LABS:\n\n___ 06:15AM BLOOD WBC-3.5* RBC-3.46* Hgb-10.9* Hct-34.5 \nMCV-100* MCH-31.5 MCHC-31.6* RDW-17.1* RDWSD-62.8* Plt ___\n___ 04:15AM BLOOD Glucose-73 UreaN-16 Creat-0.8 Na-140 \nK-4.6 Cl-105 HCO3-27 AnGap-8*\n___ 06:15AM BLOOD ALT-16 AST-31 AlkPhos-87\n___ 04:15AM BLOOD Calcium-8.4 Phos-4.0 Mg-1.6\n___ 06:15AM BLOOD Vit___-___\n___ 06:15AM BLOOD 25VitD-51\n \nBrief Hospital Course:\nSUMMARY:\n========\n___ y/o woman w/ complex medical history- seizure disorder, prior \nDVT/PE currently on apixaban, multiple prior CVAs (MRI brain \n___ showing 3 punctate areas in the right cerebellum \nsuggestive of acute to subacute infarction), nephrolithiasis \ncomplicated by persistent hematuria and E. coli sepsis \n(requiring ureteral stenting and lithotripsy), prior gastric \nbypass surgery complicated by SBOs/multiple surgeries/adhesions, \nsevere GERD/esophagitis, chronic lower back pain, osteoarthritis \nstatus post right TKA, depression/anxiety, and chronic opiate \nuse with history of abuse who is referred in from ___ clinic for \nevaluation of abdominal pain. \n\nTRANSITIONAL ISSUES:\n====================\n[ ] Please provide outpatient taper of BID PPI if resolution of \ngastritis symptoms\n[ ] Follow up keppra levels, which were pending at the time of \ndischarge. Lacosamide level was 10.9 at time of discharge.\n[ ] Bupropion was discontinued during admission given concern \nfor seizures.\n\nACUTE ISSUES:\n=============\n# Acute on Chronic abdominal pain:\n# nausea:\nPt has chronic ___ mid abd pain at baseline, with ___ \nRUQ/epigastric abd pain on admission. Reassuringly, chemistries, \nLFTs and CBC are wnl, Lactate:1.3 and trop X 1 undetectable. CT \nA&P also showed no acute intra-abdominal process to explain the \npatient's symptoms. In fact, there is little to no residual \nfluid component of a left RP collection, measuring 1.7 x 1.0 cm, \n(likely representing evolving hematoma) and the left iliacus \ncollection is no longer visualized. There was mild intrahepatic \nbiliary ductal dilatation and dilation of the CBD (unchanged \nfrom prior), however she is s/p cholecystectomy and LFTs without \nany abnormalities. Multi-factoral pain possible from prior \ngastritis, secondary gastroparesis from prior abdominal \nsurgeries, narcotic bowel syndrome, and distorted GI anatomy. \nViral gastroenteritis less likely etiology of abd pain and \nnausea. Functional abdominal pain is also possible, but dx of \nexclusion and timing is atypical. Most likely dx is exacerbation \nof prior gastritis given location, prior hx of gastritis given \nEGD findings, and relationship to eating/taking pills with \nalmost instantaneous precipitation. She was thus escalated to PO \nBID PPI in addition to initiation of sucralfate. Maintained on \npromethazine for nausea given Compazine allergy. She was \nmaintained on standing bowel regimen. Over few days this \ncombination provided relief from instant pain/nausea following \nconsumption and ultimately allowed successful advancement of \ndiet. Remained on Methadone 10 TID per PCP, ___, and \ndaily EKGs for QTc monitoring.\n\n# Seizure disorder\nShe experienced generalized body shaking on ___ concerning for \ngeneralized tonic clonic seizure. She received IV Ativan 1mg x3 \nfor what appeared to be at least 2 separate episodes \napproximately 10 minutes apart. Etiology may be medication \nrelated, infectious from UTI though\nless likely, subtherapeutic on AEDs given questionable adherence\nat home per family, poor diet. Toxic metabolic and ischemic \ncauses were less likely to be the culprit. Also noted to use \neCigarettes per family, which can also be seizurogenic. Her \nciprofloxacin was discontinued as this can lower seizure \nthreshold. Neurology was consulted and EEG was placed to monitor \nfor seizure activity. She did not have any further seizures and \nwas only noted to have bursts of theta slowing, which are \nnonspecific, and will always be present on her EEG per \nneurology. Her wellbutrin was held on admission and was \ndiscontinued on discharge as this can also lower the seizure \nthreshold. Her lacosamide and keppra levels were drawn and \npending at the time of discharge.\n\n# UA abnormalities:\nUnknown if possible explanation of her abdominal pain (it would \nbe atypical), and certainly much less likely than gastritis as \nunderlying etiology. UA w/ WBCs w/out nitrites but w/ bacteria. \nNo documented fevers but urinary symptoms suggestive of UTI. Has \nhad recent h/o fluorquinolone sensitive Pseudomonas UTI. Had \nvery resistant E coli UTI in ___ ___ to ___, zosyn, tobra). \nReceived cipro in ED. UCx returned mixed flora. She was \ninitiated on ciprofloxacin, which was discontinued on ___ in the \nsetting of generalized body shaking concerning for generalized \ntonic clonic seizure as this medicine can lower the seizure \nthreshold.\n\nCHRONIC ISSUES:\n===============\n# mood d/o\nContinued duloxetine and discontinued buproprion per above\n\n# prior DVT/PE currently on apixaban\nContinued apixaban\n\n# leg pain\nContinued gabapentin \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Gabapentin 100 mg PO TID \n2. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild \n3. LACOSamide 200 mg PO BID \n4. LevETIRAcetam 1500 mg PO BID \n5. BuPROPion 200 mg PO BID \n6. QUEtiapine Fumarate 75 mg PO QHS \n7. Docusate Sodium 100 mg PO BID \n8. Apixaban 5 mg PO BID \n9. Multivitamins 1 TAB PO DAILY \n10. Methadone 10 mg PO 8 AM \n11. Methadone 15 mg PO 2PM \n12. Methadone 10 mg PO 8 ___ \n13. Promethazine 6.25 mg PO BID:PRN nausea \n14. Omeprazole 20 mg PO DAILY \n15. DULoxetine 40 mg PO DAILY \n16. Doxepin HCl 10 mg PO HS \n17. Cyanocobalamin 100 mcg PO DAILY \n18. Thiamine 100 mg PO DAILY \n19. Vitamin D 1000 UNIT PO DAILY \n\n \nDischarge Medications:\n1.  Polyethylene Glycol 17 g PO DAILY \nRX *polyethylene glycol 3350 17 gram 1 powder(s) by mouth daily \nDisp #*30 Packet Refills:*0 \n2.  Senna 8.6 mg PO BID \nRX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp \n#*60 Tablet Refills:*0 \n3.  Sucralfate 1 gm PO QID \nRX *sucralfate [Carafate] 1 gram/10 mL 10 ml by mouth four times \na day Refills:*0 \n4.  Omeprazole 40 mg PO BID \nRX *omeprazole 40 mg 1 capsule(s) by mouth twice a day Disp #*60 \nCapsule Refills:*0 \n5.  Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild  \n6.  Apixaban 5 mg PO BID  \n7.  Cyanocobalamin 100 mcg PO DAILY  \n8.  Docusate Sodium 100 mg PO BID  \n9.  Doxepin HCl 10 mg PO HS  \n10.  DULoxetine 40 mg PO DAILY  \n11.  Gabapentin 100 mg PO TID \nRX *gabapentin 100 mg 1 capsule(s) by mouth three times a day \nDisp #*30 Capsule Refills:*0 \n12.  LACOSamide 200 mg PO BID \nRX *lacosamide [Vimpat] 200 mg 1 tablet(s) by mouth twice a day \nDisp #*60 Tablet Refills:*0 \n13.  LevETIRAcetam 1500 mg PO BID \nRX *levetiracetam 750 mg 2 tablet(s) by mouth twice a day Disp \n#*60 Tablet Refills:*0 \n14.  Methadone 10 mg PO 8 AM \nRX *methadone [Dolophine] 5 mg 2 tabs by mouth three times a day \nDisp #*21 Tablet Refills:*0 \n15.  Methadone 15 mg PO 2PM \nConsider prescribing naloxone at discharge  \n16.  Methadone 10 mg PO 8 ___ \nConsider prescribing naloxone at discharge  \n17.  Multivitamins 1 TAB PO DAILY  \n18.  Promethazine 6.25 mg PO BID:PRN nausea  \n19.  QUEtiapine Fumarate 75 mg PO QHS  \n20.  Thiamine 100 mg PO DAILY  \n21.  Vitamin D 1000 UNIT PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY:\nGastritis\nUrinary tract infection\n\nSECONDARY:\nSeizure disorder\nMood disorder\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure taking care of you at ___ \n___.\n\nWhy was I in the hospital?\n  - You were admitted because you had a new episode of abdominal \npain which was separate from the one you had before.\n\nWhat was done while I was in the hospital?\n  - Pictures were taken that showed you did not have an sudden \ninjury in one of the major organs in your abdomen such as your \nappendix or intestines.\n  - You were suspected to have worsening of the gastritis \n(inflammation of your stomach) which you were diagnosed with in \nthe past, and thus started on medications to help suppress the \nexcess acid which may be generated in your stomach and to coat \nit and allow protection of its lining when you eat foods and \ntake pills.\n  - With treatment, your nausea and pain, which seemed to drive \none-another improved in that region and you were able to \ntolerate more foods.\n\nWhat should I do when I go home?\n  - It is very important that you take your medications as \nprescribed.\n  - Please go to your scheduled appointment with your primary \ndoctor, ___, and gastroenterologist\n  - Eat frequent, small meals. Continue to take the bowel \nregimen to ensure you are having regular bowel movements.\n  - If you have worsening pains, excessive vomiting, chest pain \nor shortness of breath, please tell your primary doctor or go to \nthe emergency room.\n\nBest wishes, \n  Your ___ team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb6a4"
  },
  "note_id": "12648465-DS-46",
  "subject_id": 12648465,
  "hadm_id": 29393328,
  "note_type": "DS",
  "note_seq": 46,
  "charttime": "2210-03-04 00:00:00",
  "storetime": "2210-03-04 17:34:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: NEUROLOGY\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut / \nWellbutrin / ciprofloxacin\n \nAttending: ___.\n \nChief Complaint:\nheadache, dysuria, L sided weakness\n \nMajor Surgical or Invasive Procedure:\nNone \n\n \nHistory of Present Illness:\nNeurology Resident Stroke Admission Note \n\nNeurology at bedside for evaluation after code stroke activation \nwithin: <1 minutes\nTime/Date the patient was last known well: ___ 1430\nPre-stroke mRS ___ social history for description): 3\nt-PA Administration\n  [] Yes - Time given:\n  [x] No - Reason t-PA was not given/considered: pt on apixaban, \nconfirms she took today's AM dose\nEndovascular intervention: []Yes [x]No\nI was present during the CT scanning and reviewed the images \ninstantly (within 20 minutes of their completion).\n\nThe NIHSS was performed: \n    Date: ___\n    Time: 1615\n(within 6 hours of patient presentation or neurology consult)  \n\n___ Stroke Scale score: Total [6]\n 1a. Level of Consciousness: 0 \n 1b. LOC Question: 0 \n 1c. LOC Commands: 0 \n 2. Best gaze: 0 \n 3. Visual fields: 0 \n 4. Facial palsy: 1  \n 5a. Motor arm, left: 1 \n 5b. Motor arm, right: 0 \n 6a. Motor leg, left: 1 \n 6b. Motor leg, right: 0 \n 7. Limb Ataxia: 0 \n 8. Sensory: 1 \n 9. Language: 1 \n 10. Dysarthria: 1 \n 11. Extinction and Neglect: 0 \n\nHPI: \nEucritical, Fifi (aka ___ ___ is a ___ yo woman \nwith history of stroke, baseline L arm/leg weakness, NCSE who \npresents with acute onset speech change and left weakness and  \nheadache. \n\nShe spent the day with her daughters, and they report she was at \nher baseline until approx ___, when she began to have \ndifficulty with language and at times said incorrect words. She \nalso had L facial droop at that time, which family states is not \nbaseline for her. Family thinks her left-sided weakness may also \nhave been worse. Ms. ___ states she began to feel some \nchange in her speech around 1000-1030, as well as feeling of \n'swelling' around her L eye. When this 1000 time discussed with \ndaughters, they state that they were with Ms. ___ at the \ntime and feel strongly there was no speech change at that time. \n\nMs. ___ had gradual onset headache approx 1300-1400. R \ntemporal/retroorbital, throbbing. This is the same as headaches \nshe has had in the past year, but more severe. Associated with \nnausea and photophobia. This is her main complaint at the time \nof my evaluation, though she notes the L-sided deficits. \n\nRegarding her history of stroke, some records indicate stroke \nwith subsequent L hemiparesis in ___. Some records also \nmention stroke in ___, though details are unknown and care for \nthese reported infarcts did not occur at ___. There were also \n3 punctate subacute cerebellar infarcts in ___. She has had \nhypercoagulable workup, all negative. (see ___ note by Dr. \n___ further details). \n\nShe has had numerous admissions for identical worsening \nneurologic symptoms during which she presents with speech \nchange, L facial droop, worsening of baseline L arm/leg \nweakness, and L hemibody sensory change. Examples include:\n___- attributed to recrudescence, associated with R-sided \nthrobbing headache. \n___- attributed to unwitnessed partial seizure, associated \nwith typical headache. \n___\n \nPast Medical History:\n- h/o HTN and DMII, resolved after gastric bypass per patient  \n - s/p cholecystectomy and gastric bypass (___), with f/u  \n complicated by multiple ex lap, gastrectomy, reversal surgery,  \n\n failed J-tube c/b colonic perforation  \n - multiple SBO during f/u from above  \n - hernia repair  \n - chronic abdominal pain, peptic ulcer disease  \n - asthma, stroke (left sided), osteoarthritis, GERD, DVT/PE  \n - narcotic abuse, tobacco abuse  \n - depression, anxiety  \n - muscle weakness / myelopathy, chronic low back pain  \n - vulvar folliculitis  \n - arthorplasty - right total knee  \n - hepatitis C - positive ab test, negative HCV viral load in 2x \n \n tests  \n - nephrolithiasis  \n - thyromegaly - TSH wnl, low free T4  \n\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. Brother with CHF \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM: \nPHYSICAL EXAMINATION\nVitals:  T: 98.5 HR: 72 BP: 110/76 RR: 12 SaO2: 99% RA\nGeneral: Awake, cooperative, NAD.\nHEENT: no scleral icterus, MMM, no oropharyngeal lesions. \nPulmonary: Breathing comfortably, no tachypnea nor increased WOB\nCardiac: Skin warm, well-perfused. \nAbdomen: soft, ND\nExtremities: Symmetric, no edema. \n\nNeurologic Examination:\n- Mental status: Awake, alert, oriented x 3. Able to relate \nhistory with some elaboration from and conflict with history per \nfamily members.  ___ inattentive to exam.  Speech fluency is \nmildly reduced. Occasional paraphasic errors. Naming intact to \nhigh but not low frequency words (with stroke card, calls chair \n'toilet seat', cactus 'tree'). Repetition intact. Comprehension \nintact to complex, cross-body commands. Normal prosody. Overall, \nspeech is somewhat effortful and labored. \n\n-Cranial Nerves: PERRL 3->2. VFF to confrontation. EOMI without \nnystagmus. Facial sensation intact to light touch. L facial \ndroop. Hearing intact to conversation. Palate elevates \nsymmetrically. ___ strength in trapezii bilaterally. Tongue \nprotrudes in midline and moves briskly to each side. Mild labial \ndysarthria. \n\n- Motor:  Normal bulk and tone. No tremor nor asterixis.\n  Delt Bic Tri WrE FFl FE IO IP Quad Ham TA Gastroc         \nL  4-   4+  ___  3     4   4+   4  4                  \nR  5    ___   5  5     5   5    5  5                 \n\n-DTRs:\n   Bi Tri ___ Pat Ach Pec jerk   Crossed Abductors\n L  3  2    3    2   0                        \n R  3  2    3    0*  0                           \nPlantar response was flexor bilaterally.\n*s/p knee replacement\n\n-Sensory: Decreased sensation to PP left hemibody. \n\n- Coordination: No dysmetria with finger to nose testing \nbilaterally. \n\n- Gait: deferred\nDISCHARGE PHYSICAL EXAM: \n- Mental status: Awake, alert, oriented x 3. Able to relate \nhistory with some elaboration from and conflict with history per \nfamily members.  Speech fluent without paraphasic errors.  \nRepetition intact. Comprehension intact to complex, cross-body \ncommands. Normal prosody. Overall, speech is somewhat effortful \nand labored. \n\n-Cranial Nerves: PERRL 3->2. VFF to confrontation. EOMI without \nnystagmus. Facial sensation intact to light touch. Slight L \nfacial droop. Hearing intact to conversation. Palate elevates \nsymmetrically. ___ strength in trapezii bilaterally. Tongue \nprotrudes in midline and moves briskly to each side. Mild labial \ndysarthria. \n\n- Motor:  Normal bulk and tone. No tremor nor asterixis.\n  Delt Bic Tri WrE FFl FE IO IP Quad Ham TA Gastroc         \nL  5    ___   ___  5   5    5  5    5                  \n\nR  5    ___   ___  5   5    5  5    5                \n*significant give-way weakness but with encouragement she is \nable to give full effort\n-DTRs:\n   Bi Tri ___ Pat Ach Pec jerk   Crossed Abductors\n L  3  2    3    2   0                        \n R  3  2    3    0*  0                           \nPlantar response was flexor bilaterally.\n*s/p knee replacement\n\n-Sensory: Intact to light touch throughout\n- Coordination: No dysmetria with finger to nose testing \nbilaterally. \n- Gait: deferred\n \nPertinent Results:\nLaboratory Testing: \n\n___ 04:35AM BLOOD WBC-3.5* RBC-2.57* Hgb-8.3* Hct-26.1* \nMCV-102* MCH-32.3* MCHC-31.8* RDW-14.7 RDWSD-54.9* Plt ___\n___ 04:35AM BLOOD ___ PTT-30.7 ___\n___ 04:35AM BLOOD Glucose-77 UreaN-16 Creat-0.8 Na-142 \nK-4.1 Cl-106 HCO3-26 AnGap-10\n___ 04:35AM BLOOD ALT-13 AST-21 AlkPhos-69 TotBili-<0.2\n___ 04:35AM BLOOD Albumin-2.3* Calcium-8.1* Phos-4.1 Mg-1.7 \nCholest-117\n___ 04:35AM BLOOD %HbA1c-4.7 eAG-88\n___ 04:35AM BLOOD Triglyc-42 HDL-83 CHOL/HD-1.4 LDLcalc-26\n___ 04:35AM BLOOD TSH-1.5\nIMAGING: \nCT PERFUSION: CBF <30%: 0 mL. Tmax >6.0s: 0 mL. Mismatch volume: \n0 mL.  \nMismatch ratio: None. \nCTA HEAD AND NECK: Bilateral carotid and vertebral arteries are \npatent without evidence of significant stenosis or occlusion. \nThe left vertebral artery is diminutive. The intracranial \nvessels are patent without stenosis occlusion or aneurysm \ngreater than 3 mm. \n  \nMultiple subcentimeter hypodense nodules are seen in bilateral \nthyroid lobes. \n  \nMRI brain\nIMPRESSION:  \n1.  Punctate focus mildly hyperintense diffusion weighted signal \nin the right cerebellar hemisphere (302:11) is less conspicuous \nthan on prior exams and may relate to a tiny punctate chronic \nright cerebellar infarct. \n  \n2.  No acute intracranial abnormality. \n\n \nBrief Hospital Course:\nBrief Hospital Course: \nMs. ___ is a ___ yo woman with history of stroke, baseline L \narm/leg weakness, and NCSE who presented with acute onset speech \nchange, left facial as well as left upper/lower extremity \nweakness and headache. Exam on admission with mildly decreased \nfluency aphasia with paraphasic errors, L facial droop with \n+labial dysarthria, and left hemiparesis in UMN pattern. This is \none of at least three identical presentations in the past year. \nMRI without co-localizing stroke in the other two admissions \n(during ___ admission, there were three punctate cerebellar \ninfarcts, felt to be incidental and unrelated). These \npresentations are all accompanied by throbbing R-sided headache. \nMRI brain did not reveal new lesions. Initial workup positive \nfor hypoglycemia and a UTI. Pt started on antibiotic for UTI, \nhypoglycemia corrected and headache was treated with migraine \ncocktail. With these interventions strength and fluency of \nspeech returned to baseline and dysarthria resolved.\n\n#Hx of CVAs/ Copper Myelopathy/ Left sided weakness\nPt reports that she had \"old strokes \" in ___ treated here \nat ___ we don't have notes dating back to that time. Earliest \nnote is in ___ which shows that she came to the ___ \nclinic with left sided weakness due to vitamin deficiency and \nthe weakness  improved back to normal with copper replacement. \nStrength is full again today,so her transient left sided \nweakness improved with migraine treatment, correction of \nhypoglycemia, and UTI antibiotics. \n-A1c: 4.7, LDL: 26, TSH: 1.5. MRI brain showed already known \npunctate cerebellar infarcts\n-Will start atorvastatin 40mg daily\n-Will continue apixiban for now \n\n# Headache\nMigrainous in nature and resolved with migraine cocktail (IV \nbenadryl, IV Compazine, IV mg and PO prednisone were required, \navoided NSAIDs secondary to allergy). Patient has ___ HAs/month \nsimilar in nature which normally resolve with Tylenol. Further \nmonitoring of headaches by PCP as an outpatient. \n-Finish steroid taper as outpatient \n-Consider substituting one of current AEDs with topamax\n\n#UTI\nUA indicative of UTI, patient reported symptoms of dysuria and \nfrequency which resolved with antibiotics.\n-Patient to complete course of macrobid upon discharge, follow \nup with PCP for further concerns\n\n#Heme: \nPt w/baseline anemia H/H 8.3/25.6; will continue home B12 \nfolate. Hx of pulmonary embolism/ DVTs in ___ for which pt was \nplaced on Xarelto. Hypercoag workup negative except for a \npositive anti-phospholipid antibody which was thought to be a \nfalse positive secondary to Xarelto use. At some point pt was \nswitched to Apixiban and is now taking this medication daily. Pt \nunsure how long she has been on this medication. Requesting \nfollowup by PCP or ___ for further hypercoaguability workup and \nto evaluate whether this medication is still indicated. From \nstroke standpoint she is okay to be on just antiplatelet as \nthere is no evidence of afib or hypercoaguability.\n\n#Epilepsy: \n-continue home levetiracetam 1500mg q12h\n-continue home lacosamide 200mg q12h\n\n# Cardiopulmonary:\nTroponin <.01, no abnormalities on telemetry. TTE was not \ncompleted as MRI brain without new stroke. Patient can continue \nhome cardioprudent meds upon discharge.\n\n_\n_\n_\n_\n_\n________________________________________________________________\nTransitional Issues:\n1. Follow up with already established epileptologist, Dr. \n___ the need for continued dual AEDs and potentially \nsubstituting one with Topamax given migraines. \n2. Follow up with PCP for UTI, migraine management, and general \nhealth maintenance\n3. Follow up with hematology for appropriateness/indication for\ncontinued OAC. ___\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Apixaban 5 mg PO BID \n2. BuPROPion (Sustained Release) 200 mg PO BID \n3. Doxepin HCl 10 mg PO HS \n4. DULoxetine 40 mg PO DAILY \n5. FoLIC Acid 1 mg PO DAILY \n6. Gabapentin 100 mg PO TID \n7. LACOSamide 200 mg PO BID \n8. LevETIRAcetam 1500 mg PO BID \n9. Methadone 10 mg PO TID \n10. Omeprazole 20 mg PO DAILY \n11. Promethazine 6.25 mg PO BID:PRN nausea \n12. QUEtiapine Fumarate 75 mg PO QHS \n13. Thiamine 100 mg PO DAILY \n14. Zinc Sulfate 75 mg PO DAILY \n15. Cyanocobalamin 100 mcg PO DAILY \n\n \nDischarge Medications:\n1.  Atorvastatin 40 mg PO QPM \nRX *atorvastatin 40 mg 40 tablet(s) by mouth once daily Disp \n#*90 Tablet Refills:*3 \n2.  Nitrofurantoin Monohyd (MacroBID) 100 mg PO Q12H Duration: 6 \nDoses \nRX *nitrofurantoin monohyd/m-cryst [Macrobid] 100 mg 1 \ncapsule(s) by mouth two times a day Disp #*6 Capsule Refills:*0 \n3.  PredniSONE 50 mg PO ONCE Duration: 1 Dose \nThis is dose # 1 of 6 tapered doses\nRX *prednisone 10 mg 1 tablet(s) by mouth dily Disp #*15 Tablet \nRefills:*0 \n4.  PredniSONE 40 mg PO ONCE migraine Duration: 1 Dose \nThis is dose # 2 of 6 tapered doses \n5.  PredniSONE 30 mg PO ONCE migraine Duration: 1 Dose \nThis is dose # 3 of 6 tapered doses \n6.  PredniSONE 20 mg PO ONCE migraine Duration: 1 Dose \nThis is dose # 4 of 6 tapered doses \n7.  PredniSONE 10 mg PO ONCE migraine Duration: 1 Dose \nThis is dose # 5 of 6 tapered doses \n8.  PredniSONE 5 mg PO ONCE migraine Duration: 1 Dose \nThis is dose # 6 of 6 tapered doses \n9.  Apixaban 5 mg PO BID  \n10.  BuPROPion (Sustained Release) 200 mg PO BID  \n11.  Cyanocobalamin 100 mcg PO DAILY  \n12.  Doxepin HCl 10 mg PO HS  \n13.  DULoxetine 40 mg PO DAILY  \n14.  FoLIC Acid 1 mg PO DAILY  \n15.  Gabapentin 100 mg PO TID  \n16.  LACOSamide 200 mg PO BID  \n17.  LevETIRAcetam 1500 mg PO BID  \n18.  Methadone 10 mg PO TID  \n19.  Omeprazole 20 mg PO DAILY  \n20.  Promethazine 6.25 mg PO BID:PRN nausea  \n21.  QUEtiapine Fumarate 75 mg PO QHS  \n22.  Thiamine 100 mg PO DAILY  \n23.  Zinc Sulfate 75 mg PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nMigraine \nUrinary tract infection\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear ___, \n\nYou were hospitalized due to symptoms of headache and UTI that \nworsened your left sided weakness. You were admitted and started \non antibiotics for your UTI. You also were given treatment for \nyour migraine including iv fluids, anti nausea medications, and \nmagnesium which is good for migraines. You also had an MRI brain \nto make sure you did not have any new strokes and it was \nnegative.  \n\nWe encourage you to continue taking your medications as \nprescribed including your apixaban, and your seizure \nmedications. You are scheduled to follow-up with Dr. ___ on \n___ at 4:00pm. \n\nIt was a pleasure taking care of you! \n\nSincerely,\nYour ___ Neurology Team\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb6a5"
  },
  "note_id": "12648465-DS-47",
  "subject_id": 12648465,
  "hadm_id": 28708815,
  "note_type": "DS",
  "note_seq": 47,
  "charttime": "2210-05-05 00:00:00",
  "storetime": "2210-05-05 15:42:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut / \nWellbutrin / ciprofloxacin\n \nAttending: ___.\n \nChief Complaint:\nLethargy, Abdominal Pain\n \nMajor Surgical or Invasive Procedure:\nNone.\n\n \nHistory of Present Illness:\n___ with hx of SBO, s/p gastric bypass, cholecystectomy, PUD/HCV\nand prior CVA presenting after 1 week of decreased appetite and\nPO intake in the setting of weakness, nausea, and nonbilious\nvomiting.\n\nPatient notes that since ___ she has had N/V and weakness.  The\nsymptoms progressed to epigastric and left sided abdominal pain\non ___ that she describes as constant in nature with ongoing\nthrobbing and sharpness.  Concerned that this pain is consistent\nwith prior bowel obstructions.  She take promethazine at home \nfor\nher nausea with improvement, however this week she has been\nunable to eat or drink consistently.  No\ndysuria/hematuria/diarrhea.   BM yesterday normal without\nblood/melena.  Passing gas.  No CP, cough, HA, neck pain,\nstiffness.  Of note patient has lost 20 lbs since ___.  \n\nOf note patient was seen at ED ___ for R. Flank pain of 4\ndays.  CTU without evidence of stone and exam was not consistent\nwith infection.  Was sent home without intervention. \n\nIn the ED, initial VS were:\n___ 1416\nPain ___, 98.1F, 92, 123/79, 18, 100% RA\n\nExam notable for:\nL. abdomen TTP with normal bowel sounds.\n\nECG: NSR, normal axis, flat T waves on V3-V6, TWI V1-V2,\nunchanged from prior.\n \nLabs showed:\nWBC 4.3, Hgb 8.9, PLT 185\nNa 141, K 3.5, Cl 103, HCO3 28, BUN 16, Cr 1.0\nALT 23, AST 24, AP 96, Tbili 0.8, Alb 2.3, Lip 4\nLactate 0.7\nUA: few bacteria, 6 WBC, trace blood, negative nitrites\n\nImaging showed:\n___ CT A/P w/o Contrast\nNo acute abnormality identified within the abdomen and pelvis,\nspecifically no findings of small-bowel obstruction.\n\nPatient received:\n___ 17:41 PO Ondansetron ODT 4 mg   \n___ 20:01 IVF  NS 1000 mL    \n___ 20:02 IV HYDROmorphone (Dilaudid) .5 mg   \n___ 20:02 IV Ondansetron 4 mg   \n___ 02:33 PO LevETIRAcetam 1500 mg   \n___ 02:33 PO/NG Ondansetron ODT 4 mg \n\nTransfer VS were:\n___ ___\n98.2F, 78, 108/78, 14, 100% on RA\n\nOn arrival to the floor, patient reports the above history. She\nstates that she has ongoing nausea and L. sided throbbing\nabdominal pain unlike her chronic pain.\n\nREVIEW OF SYSTEMS: 10 point ROS reviewed and negative except as\nper HPI\n\n \nPast Medical History:\n- h/o HTN and DMII, resolved after gastric bypass per patient  \n - s/p cholecystectomy and gastric bypass (___), with f/u  \n complicated by multiple ex lap, gastrectomy, reversal surgery,  \n\n failed J-tube c/b colonic perforation  \n - multiple SBO during f/u from above  \n - hernia repair  \n - chronic abdominal pain, peptic ulcer disease  \n - asthma, stroke (left sided), osteoarthritis, GERD, DVT/PE  \n - narcotic abuse, tobacco abuse  \n - depression, anxiety  \n - muscle weakness / myelopathy, chronic low back pain  \n - vulvar folliculitis  \n - arthorplasty - right total knee  \n - hepatitis C - positive ab test, negative HCV viral load in 2x \n \n tests  \n - nephrolithiasis  \n - thyromegaly - TSH wnl, low free T4  \n\n \nSocial History:\n___\nFamily History:\nMother with diabetes and HTN. Brother with CHF \n \nPhysical Exam:\n___ PHYSICAL EXAM:\n=======================\n24 HR Data (last updated ___ @ 524)\nTemp: 98.1 (Tm 98.1), BP: 128/84, HR: 92, RR: 20, O2 sat:\n97%, O2 delivery: Ra  \nGENERAL: NAD, appears older than stated age.\nHEENT: AT/NC, anicteric sclera, MMM\nNECK: supple, no LAD\nCV: RRR, S1/S2, no murmurs, gallops, or rubs\nPULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably\nwithout use of accessory muscles\nGI: abdomen soft, nondistended, TTP in LLQ without\nrebound/guarding, no hepatosplenomegaly\nEXTREMITIES: no cyanosis, clubbing, or edema\nPULSES: 2+ radial pulses bilaterally\nNEURO: Alert, moving all 4 extremities with purpose, face\nsymmetric\nDERM: warm and well perfused, no excoriations or lesions, no\nrashes\n\nDISCHARGE PHYSICAL EXAM:\n========================\nPHYSICAL EXAM:  \nVITALS: 24 HR Data (last updated ___ @ 611)\nTemp: 98.1 (Tm 98.4), BP: 126/86 (112-129/74-86), HR: 75\n(75-92), RR: 18 (___), O2 sat: 99% (98-100), O2 delivery: RA,\nWt: 156.53 lb/71 kg   \nHEENT: Sclera anicteric, MMM, oropharynx clear. No cervical\nlymphadenopathy. Non-tender, non-nodular thyroid.  \nLUNGS: Clear to auscultation bilaterally, no wheezes, rales,\nrhonchi.  \nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs,\ngallops.  \nABD: Soft, non-distended, bowel sounds present. Mild ttp.\nNo rebound tenderness or guarding. \nEXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or\nedema.  \nNEURO: CN II - XII intact. Face grossly symmetric. Moving all\nlimbs with purpose against gravity. Not dysarthric. ___ strength\nin right extremities. ___ strength in left extremities. \n \nPertinent Results:\nADMISSION LABS:\n===============\n___ 07:15PM BLOOD WBC-4.3 RBC-2.78* Hgb-8.9* Hct-26.9* \nMCV-97 MCH-32.0 MCHC-33.1 RDW-17.2* RDWSD-60.5* Plt ___\n___ 07:15PM BLOOD Neuts-50.7 ___ Monos-12.0 \nEos-0.5* Baso-0.5 Im ___ AbsNeut-2.19 AbsLymp-1.56 \nAbsMono-0.52 AbsEos-0.02* AbsBaso-0.02\n___ 07:15PM BLOOD Glucose-61* UreaN-16 Creat-1.0 Na-141 \nK-3.5 Cl-103 HCO3-28 AnGap-10\n___ 07:15PM BLOOD Lipase-4\n___ 07:15PM BLOOD ALT-23 AST-24 AlkPhos-96 TotBili-0.8\n___ 07:15PM BLOOD Albumin-2.3*\n___ 07:47PM BLOOD Lactate-0.7\n\nPERTINENT INTERMITTENT LABS:\n============================\n___ 10:22AM BLOOD ___ PTT-31.3 ___\n___ 10:22AM BLOOD Calcium-7.4* Phos-2.9 Mg-1.5*\n___ 07:45AM BLOOD Albumin-1.8* Calcium-7.5* Phos-2.3* \nMg-1.4*\n___ 05:28AM BLOOD Albumin-2.0* Calcium-7.4* Phos-3.9 Mg-1.9\n___ 09:00AM BLOOD Cortsol-14.8\n\nIMAGING:\n========\n___ CT ABD & PELVIS W/O CON:\nPost gastric bypass.  No bowel obstruction demonstrated.\n\nMICROBIOLOGY:\n=============\n___ BLOOD CULTURE: NO GROWTH. \n___ URINE CULTURE:\n   URINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \nWITH SKIN\n      AND/OR GENITAL CONTAMINATION. \n\nDISCHARGE LABS:\n===============\n___ 05:15AM BLOOD WBC-8.2 RBC-3.15* Hgb-10.1* Hct-30.7* \nMCV-98 MCH-32.1* MCHC-32.9 RDW-18.5* RDWSD-64.1* Plt ___\n___ 05:15AM BLOOD ___ PTT-35.1 ___\n___ 05:28AM BLOOD Glucose-87 UreaN-16 Creat-0.9 Na-139 \nK-5.0 Cl-106 HCO3-22 AnGap-11\n___ 05:28AM BLOOD Albumin-2.0* Calcium-7.4* Phos-3.9 Mg-1.9\n \nBrief Hospital Course:\nSUMMARY:\n====================  \n___ is a ___ y.o. F with a PMHx notable for gastric \nbypass (c/b SBO), esophagitis/gastritis, PUD/HCV, \ncholecystectomy, nephrolithiasis, and CVA (___) who presented \nto ___ on ___ with a week of nausea, abdominal discomfort, \nand vomiting x2 days. Of note, she had been previously evaluated \nby GI in ___ for the same presenting symptoms.\n\nACTIVE ISSUES:  \n====================  \n# Abdominal Pain\n# Gastritis\n# Esophagitis\nThe patient presented with weakness and lethargy in the setting \nof nausea and vomiting with poor PO intake. Of note, EGD ___: \nc/w esophagitis, gastritis. She was recently seen by GI in \n___ as a consult while admitted for identical symptoms. \nRecommendations at that time were to treat supportively with PPI \nBID and anti-emetics. Given her history of SBO, a CT A/P was \nperformed on ___ which demonstrated no bowel obstruction. Of \nnote despite recommendations to be discharged on BID PPI, her \ndaughter endorses that she has only been taking omeprazole 20mg \nonce daily at home (unclear how discrepancy arose). We treated \nher supportively with increased dose of PPI 40mg BID, \nsucralfate, and anti-emetics. She remained afebrile, without \ndiarrhea for the entire hospital stay and decreased frequency of \nnausea.\n\n#Prolonged QTc Interval:\n#Chronic Pain requiring methadone:\nPatient on home regimen of Methadone 10mg TID. Her QTc on \narrival to the ED ___ was 412. She received Zofran to treat her \nnausea. Repeat EKG on ___ was 527. A trial of Ativan was used to \ntreat her nausea which was effective, but there was concern of \ncontinued use given her concurrent use of other sedating \nmedications and a significant episode of transient confusion. \nAfter trialing Zofran again for her nausea her QTc returned to \n525. No further anti-emetics with QTc prolong effects were \ngiven. QTc on day of discharge was 420. We attempted to wean \nmethadone while inpatient however patient was unwilling to do so \ntherefore she was discharged on prior regimen.\n\n#Hypomagnesemia:\nPatient admitted with Mg2+ of 1.4. Her magnesium remained low \ndespite multiple attempts at IV repletion. She ranged from \n1.4-1.9 during her admission. This was of significant concern \ngiven the above issue of her prolonged QTc interval. She was \ndischarged on Magnesium Oxide 400 mg PO BID. Mg2+ on discharge \nwas 1.9.\n\n#Hypoglycemia \nDuring the early part of the admission, patient had glucose \nlevels from 49 - 74. This is likely due to minimal PO intake in \nthe setting of abdominal discomfort and nausea. As her nausea \nimproved and she was able tolerate po intake, nutrition was \nconsulted and recommended additional supplementation with \ncarnation instant breakfast at each meal. TSH and AM cortisol \nunremarkable. Her morning glucose on day of discharge was 87. If \nshe is persistently having issues with hypoglycemia in the \nfuture would consider endocrine referral.\n\n#Altered mental status\nThe patient had an episode of confusion and short term memory \nloss on morning of ___. She was awake, alert, and interactive. \nHowever, she was AOx1. Additionally, throughout her admission, \nthe patient had intermittent episodes of drowsiness and \nlethargy. We spoke to her daughter who says these episodes have \noccurred almost every day since she suffered her CVA. Given that \nthis is a long-standing issue we planned for continued follow-up \nwith neurology as an outpatient. This may be the presentation of \nsubclinical seizure activity, but there is also concern for \npolypharmacy. She was awake, alert, interactive, and AOx3 on \ndischarge. \n\n#Severe Hypoalbuminemia:\n#Malnutrition:\nSignificant weight loss, nearly 20lbs. Poor PO intake secondary \nto abdominal pain. Albumin as low as 1.8. Seen by nutrition. \nStarted on carnation supplementation and increased her zinc \ndose. Maintained on thiamine and folic acid. \n\n#Gait instability:\n___ evaluation reveals: Impairments of Body Functions and \nStructures, Activity Limitations and Participation Restrictions \n- Knowledge deficit RE: fall risk\n- Impaired cognition\n- Impaired functional mobility \n- Impaired balance\n- Impaired strength \nPatient is being discharged to SNF for further rehabilitation. \n\nCHRONIC ISSUES:\n===============\n#Hx of CVA despite xarelto\nThought initially to be embolic phenomenon.  Was seen ___ by \nhematology for ongoing anticoagulation with apixaban. \nRecommended follow up with neurology already scheduled.  No \nevidence of acute CVA symptoms at this time.\nRx:\n-Continued Atorvastatin\n-Continued Apixaban\n\n#CHRONIC PAIN\n-Continued Methadone 10 TID\n-Continued Gabapentin\n\n#CHRONIC ANEMIA\nAdmission Hgb of 8.3; discharge Hgb 10.1 near her baseline. \n-Continued home B12 and folate\n-Ferritin (drawn in ___ borderline low at 147.\n\n#Epilepsy\n-Continued Levetiracetam\n-Continued Lacosamide\n\n#Depression/Anxiety\n-Continued Doxepin\n-Continued Auetiapine\n-Continued Duloxetine\n\nTRANSITIONAL ISSUES:\n===================\n- Code status: Full (presumed)\n- Contacts:\n1. ___ - Mother, ___ \n2. ___ - daughter, ___ (* used this contact \nduring hospitalization)\n3. ___ - daughter, ___\n4. ___ - sister, ___ \n- Discharge weight: 71 kg\n\n[] Patient with prolonged QTc (525) during admission and prone \nto hypomagnesemia (1.4-1.9), especially while on omeprazole \ntwice daily. Continue to monitor EKG and make medication \nadjustments as needed. \n[] Avoid QTc prolonging medications for nausea (eg. Zofran, \nCompazine, Reglan)\n[] Started Magnesium Oxide 400 mg PO BID \n[] Increased PPI from 20mg Daily to 40mg twice daily for \ngastritis/esophagitis. Consider decreasing back to 20mg QD as \nher abdominal sx improve to avoid further hypomagnesemia. \n[] Consider slow Methadone taper\n[] Consider outpatient EGD, has f/u with GI on ___\n[] Patient is malnourished and should continue with \nsupplementation (eg. carnation instant breakfast) TID with \nmeals. \n[] Has continued to have transient episodes of confusion. Follow \nup with neurology is advised. \n[] Consider polypharmacy as a cause for her confusion, falls. \n[] Consider outpatient iron infusions (did not start PO iron \ngiven concern for abdominal discomfort and constipation)\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Cyanocobalamin 100 mcg PO DAILY \n2. Thiamine 100 mg PO DAILY \n3. Zinc Sulfate 75 mg PO DAILY \n4. Apixaban 5 mg PO BID \n5. Doxepin HCl 100 mg PO HS \n6. DULoxetine 40 mg PO DAILY \n7. FoLIC Acid 1 mg PO DAILY \n8. Gabapentin 100 mg PO TID \n9. LACOSamide 200 mg PO BID \n10. LevETIRAcetam 1500 mg PO BID \n11. Methadone 10 mg PO TID \n12. Omeprazole 20 mg PO DAILY \n13. QUEtiapine Fumarate 75 mg PO QHS \n14. Promethazine 6.25 mg PO BID:PRN nausea \n15. Atorvastatin 40 mg PO QPM \n\n \nDischarge Medications:\n1.  Docusate Sodium 100 mg PO BID  \n2.  Magnesium Oxide 400 mg PO BID  \n3.  Multivitamins W/minerals 1 TAB PO DAILY  \n4.  Senna 17.2 mg PO BID  \n5.  Sucralfate 1 gm PO QID  \n6.  Doxepin HCl 50 mg PO HS  \n7.  Omeprazole 40 mg PO BID  \n8.  Zinc Sulfate 220 mg PO DAILY  \n9.  Apixaban 5 mg PO BID  \n10.  Atorvastatin 40 mg PO QPM  \n11.  Cyanocobalamin 100 mcg PO DAILY  \n12.  DULoxetine 40 mg PO DAILY  \n13.  FoLIC Acid 1 mg PO DAILY  \n14.  Gabapentin 100 mg PO TID  \n15.  LACOSamide 200 mg PO BID  \n16.  LevETIRAcetam 1500 mg PO BID  \n17.  Methadone 10 mg PO TID  \n18.  Thiamine 100 mg PO DAILY  \n19. HELD- Promethazine 6.25 mg PO BID:PRN nausea  This \nmedication was held. Do not restart Promethazine until your \ndoctor says it is safe to do so based on your QTc interval\n20. HELD- QUEtiapine Fumarate 75 mg PO QHS  This medication was \nheld. Do not restart QUEtiapine Fumarate until your doctor says \nit is safe to do so based on your QTc interval\n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS:\n- Acute on chronic abdominal pain\n- Gastritis/esophagitis\n- Nausea\n\nSECONDARY DIAGNOSIS:\n- Prolonged QTc Interval\n- Hypomagnesemia\n- Hypoglycemia\n- Malnutrition \n- Altered mental status\n- Gait instability\n- History of cerebral vascular accident\n- Epilepsy\n- Depression\n- Anxiety\n\n \nDischarge Condition:\nMental Status: Clear and coherent; Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,  \n\nIt was a pleasure to care for you at the ___ \n___.  \n\nWHY DID YOU COME TO THE HOSPITAL?\n- Abdominal pain and vomiting.\n   \nWHAT DID YOU RECEIVE WHILE YOU WERE IN THE HOSPITAL?\n- We did imaging to make sure there was not a blockage in your \nabdomen causing your symptoms. The imaging came back as normal.\n- We increased the dose of your antacid medication to help with \nyour stomach pain and burning in your throat. \n- We looked at the electrical activity in your heart using an \nEKG. This showed that you were at high risk to develop an \nabnormal heart rhythm. This is caused by medications such as \nMethadone, Zofran, Compazine and Seroquel. We have stopped the \nZofran, Compazine and Seroquel; you are continued on your \nmethadone. We also prescribed you daily magnesium to help \ndecrease your risk of having an arrhythmia. \n- Our nutritionists saw you and recommended starting a \nnutritional supplement called Carnation instant breakfast.\n  \nWHAT SHOULD YOU DO ONCE YOU LEAVE THE HOSPITAL?\n- Please go to your outpatient doctors ___ below). \nIt is important to discuss your medications as you may be at \nhigh risk of developing an abnormal heart rhythm. \n- Please only take your medications as prescribed. Do not skip \ndoses or take more than one dose at a time.   \n- Please try to eat regularly and stay hydrated with water\n\n \nWe wish you the best!  \n- Your ___ Care Team  \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb6a6"
  },
  "note_id": "12648465-DS-48",
  "subject_id": 12648465,
  "hadm_id": 21884519,
  "note_type": "DS",
  "note_seq": 48,
  "charttime": "2210-05-19 00:00:00",
  "storetime": "2210-05-19 20:30:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut / \nWellbutrin / ciprofloxacin\n \nAttending: ___.\n \nChief Complaint:\nAltered mental status\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\n___ is a ___ y.o. F with a PMHx notable for gastric \nbypass (c/b SBO), esophagitis/gastritis, PUD, HCV, hx DVT/PE on \napixaban, CVA (___) with residual L \nhemiparesis/hemisensory loss, prior admission for non-convulsive\nstatus epilepticus in setting of infection/malnutrition, hx \nsubstance use disorder and chronic pain on methadone, recent \nadmission (___) for n/v/abdominal pain with unrevealing \nwork-up, who presents from SNF with acute on chronic confusion.\n\nPatient recently admitted ___ for lethargy and \nabdominal pain. At that time patient noted to have intermittent \nepisodes of drowsiness and lethargy, which per daughter, occurs \nalmost every day since she suffered her CVA. There was concern \nfor potential polypharmacy with use of methadone and multiple \nsedating medications. Attempt was made to wean methadone while \ninpatient but was not successful. Abdominal pain attributed to \nknown esophagitis/gastritis, and patient was treated with PPI 40 \nmg BID, sucralfate, and anti-emetics. Patient was also noted to \nhave significant weight loss of nearly 20 lbs thought secondary \nto abdominal pain, treated with carnation supplementation and \nmultivitamins. \n\nToday, per ___ house notes, patient \"appearing more \nconfused, repeated words and statement multiple times, \nagitated.\" Note was made of initiation of 20 mg furosemide over \nweekend due to ___ edema. Vitals @ ___ 98.5 116/74, HR \n112, 88% RA. She was evaluated by in house MD, and due to \nconcern for AMS patient was sent to us for further evaluation.  \n\nI called ___ overnight, and spoke with RN for further \nclarification. ___ the RN I spoke to last saw patient \n___ and all of following is per report- at baseline \npatient AOx3 but frequently very sleepy- has to be woken up to \neat and take medications, and is often too tired to engage in \n___. Needs 1 person assist with continuous supervision, and needs \nhelp getting\nto the bathroom due to sleepiness. Patient had been reporting \ndiarrhea, nut this was not witnessed by staff. Occasionally \npatient would have verbal outbursts, usually when she is \nfrustrated, but then would become very apologetic afterwards. \nSince last week, staff had noted increasing word finding\ndifficulty, with extra pauses in sentences. In this setting \npatient underwent ambulatory EEG (Rx by Dr. ___ last week \n___ with no clinical events. She has been receiving all \nher AED's on schedule, and there were no witnessed seizures. \n\nIn the ED:\nInitial vital signs notable for: T98 HR97 BP112/79 RR18 O2-100% \nRA\n\nExam notable for:\n+right lip droop baseline, AOx1 to person, generally confused\nduring conversation, diminished strength diffusely, weaker in\nlower extremitites\ndiffuse anasarca\nabd mildly tender diffusely, soft\nUpon reevaluation she has a stage II sacral decubitus pressure\nulcer will attempt to place mepilex no c/f infection\n\nLabs were notable for:\nWBC 5.1 Hgb 12.1 Plt 394\nGrossly hemolyzed sample- 134 | 100 | 18\n                          ---------------\n                          7.9 | 25 | 0.9\nK 5.6 \nLactate 2.7 -> 2.0 on repeat\nvBG 7.39/46/36 \nUTox +TCA\nUA: 23 WBC, no bacteria, large leuks, small blood, neg nitrites\n\nStudies performed include:\n\nNCHCT - No acute intracranial hemorrhage. No large territorial\ninfarct. No acute fracture.\nCXR - No acute cardiopulmonary abnormality.\n\nPatient was given: 1g ceftriaxone, calcium gluconate, home\ngabapentin, keppra\n\nConsults: Neurology - \nLess concerned for active epileptic process at this time, \nalthough brief EEG monitor may be useful to completely rule out \nsubclinical activity. Weakness in LLE is more notable than those \nrecently documented, but may be related to recrudescence I/s/o \napparent UTI and potential vascular congestion. Neurology will \nfollow as she is treated for her medical issues.\n-Recommend admit to Medicine; if admitted, will follow on \nConsult service\n-C/w home AED regimen\n-Recommend routine EEG on admission\n-Sz Precautions\n-If pt develops clinical activity, call Neurology stat\n-Ativan 2mg IV prn for seizure>5 minutes\n\nVitals on transfer: T98 HR88 BP122/78 RR17 O2-100\n\nWhen I spoke to patient, she was AO x 3, and able to recall \nrecent events. She shares that she has been having difficulty \nwith short term > long term memory, and that in the past week, \nhas had some trouble with word finding, often having to pause \nmid-sentence to stop and think. She wonders why this is the \ncase.\nShe endorses increased ___ edema over the past several days, \nLLE>RLE, which she says is new (usually symmetric). She notes \nthat at baseline she sleeps on ___ pillows and that she was \ninstructed to do so by her physicians. She has had no chest pain \nor palpitations. \n\nShe notes that she has not been eating well, and attributes this \nto post-prandial abdominal pain; also endorses dysphagia to \nsolids and liquids. She tells me that this AM, she experienced \nshortness of breath while walking to the bathroom (at baseline \nuses walker), and thinks that she is admitted for her dyspnea. \nOverall, she knows that she is not doing well and needs help \nwith\n___, but is reluctant to admit this to herself. She is worried \nabout her daughter, whom recently had brain surgery.\n\nWhen asked about urinary symptoms, she denies any urinary \nfrequency, hesitancy, dysuria. No fevers or chills.\n\nFinally she wonders about why she has yet to receive her home \nmethadone, noting that this is for chronic abdominal pain and \nthat it has been recently weaned to 10 mg TID, which she is \ndoing very well on.\n \nPast Medical History:\n- h/o HTN and DMII, resolved after gastric bypass per patient  \n - s/p cholecystectomy and gastric bypass (___), with f/u  \n complicated by multiple ex lap, gastrectomy, reversal surgery,  \n\n failed J-tube c/b colonic perforation  \n - multiple SBO during f/u from above  \n - hernia repair  \n - chronic abdominal pain, peptic ulcer disease  \n - asthma, stroke (left sided), osteoarthritis, GERD, DVT/PE  \n - narcotic abuse, tobacco abuse  \n - depression, anxiety  \n - muscle weakness / myelopathy, chronic low back pain  \n - vulvar folliculitis  \n - arthorplasty - right total knee  \n - hepatitis C - positive ab test, negative HCV viral load in 2x \n \n tests  \n - nephrolithiasis  \n - thyromegaly - TSH wnl, low free T4  \n\n \nSocial History:\n___\nFamily History:\nMany family members with strokes, HTN, DM. Brother with CHF. She \nreports her father may have had colon cancer around age ___, then \nhad brain metastases (unclear if related or separate).\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n========================\nVITALS: ___ 0020 Temp: 98.0 PO BP: 130/65 HR: 75 RR: 18 O2\nsat: 100% O2 delivery: ra \nGENERAL: Alert and interactive. In no acute distress.\nHEENT: NCAT. PERRL, EOMI. Sclera anicteric and without \ninjection.\nNECK: Thyroid is normal in size and texture, no nodules. No\ncervical lymphadenopathy. No JVD.\nCARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No\nmurmurs/rubs/gallops.\nLUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or\nrales. No increased work of breathing.\nBACK: No spinous process tenderness. No CVA tenderness.\nABDOMEN: +BS, diffusely tender to palpation throughout, most\nprominent in RLQ, but no rebound/guarding\nEXTREMITIES: 1+ ___ edema to level mid-shin on RLE, 2+ edema to\nlevel of knee on LLE.\nSKIN: Warm. Cap refill <2s. No rash.\nNEUROLOGIC: AO x3 [actually corrected me to say it was ___,\nwhich was indeed correct], occasional hesitancy when speaking,\nlanguage with intact repetition. Able to name high frequency\nobjects. CN II-XII notable for decreased sensation to light \ntouch\nover L V1-V3 and some facial droop. RUE and RLE strength grossly\n___, LUE ~4+/5 biceps flextion/extension, LLE ___ hip\nflexion/extension.  \n\nDISCHARGE PHYSICAL EXAM:\n========================\nVITALS: 98.4 PO 108 / 74 R Lying 88 17 98 Ra \nGENERAL: Alert and interactive. In no acute distress.\nHEENT: NCAT. EOMI. Sclera anicteric and without injection.\nNECK: No cervical lymphadenopathy. No JVD.\nCARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No \nmurmurs/rubs/gallops.\nLUNGS: Clear to auscultation bilaterally. No wheezes, rhonchi or \nrales. No increased work of breathing.\nABDOMEN: +BS, nontender to palpation throughout, no \nrebound/guarding\nEXTREMITIES: 1+ edema to level mid-shin on RLE, 2+ edema to\nlevel of knee on LLE.\nSKIN: Warm. Cap refill <2s. No rash.\nNEUROLOGIC: AO x3, occasional hesitancy when speaking, language \nwith intact repetition. CN II-XII notable for decreased \nsensation to light touch over L V1-V3 and some facial droop. R \nside ___, LUE ~4+/5 triceps, LLE ___ hip flexion/extension, ___ \nfoot flexion/extension  \n \nPertinent Results:\nADMISSION LABS:\n================\n___ 12:40PM BLOOD WBC-5.1 RBC-3.72* Hgb-12.1 Hct-37.2 \nMCV-100* MCH-32.5* MCHC-32.5 RDW-20.1* RDWSD-69.3* Plt ___\n___ 12:40PM BLOOD Neuts-84.4* Lymphs-13.0* Monos-2.0* \nEos-0.0* Baso-0.2 Im ___ AbsNeut-4.28 AbsLymp-0.66* \nAbsMono-0.10* AbsEos-0.00* AbsBaso-0.01\n___ 12:40PM BLOOD Glucose-95 UreaN-18 Creat-0.9 Na-134* \nK-7.9* Cl-100 HCO3-25 AnGap-9*\n___ 12:40PM BLOOD ALT-59* AST-155* AlkPhos-142* TotBili-0.7\n___ 10:24PM BLOOD ALT-30 AST-30 LD(LDH)-289* AlkPhos-112* \nTotBili-0.5\n___ 12:40PM BLOOD cTropnT-<0.01\n___ 10:24PM BLOOD CK-MB-3 cTropnT-<0.01\n___ 12:40PM BLOOD Albumin-2.3* Calcium-7.7* Phos-4.6* \nMg-1.9\n___ 10:24PM BLOOD Calcium-7.5* Phos-4.3 Mg-1.8\n___ 12:40PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-10 \nTricycl-POS*\n___ 10:33PM BLOOD ___ pO2-36* pCO2-46* pH-7.39 \ncalTCO2-29 Base XS-1\n___ 12:46PM BLOOD Lactate-2.7* K-5.6*\n___ 10:33PM BLOOD Lactate-2.0\n\n___ 01:36PM URINE Color-Yellow Appear-Clear Sp ___\n___ 01:36PM URINE Blood-SM* Nitrite-NEG Protein-TR* \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-LG*\n___ 01:36PM URINE RBC-5* WBC-23* Bacteri-NONE Yeast-NONE \nEpi-2\n___ 01:36PM URINE CastHy-90*\n___ 01:36PM URINE Mucous-RARE*\n\nDISCHARGE LABS:\n================\n___ 09:30AM BLOOD WBC-3.2* RBC-2.58* Hgb-8.8* Hct-26.8* \nMCV-104* MCH-34.1* MCHC-32.8 RDW-20.6* RDWSD-71.5* Plt ___\n___ 10:15AM BLOOD ___ PTT-29.0 ___\n___ 09:30AM BLOOD Glucose-80 UreaN-19 Creat-0.8 Na-141 \nK-4.4 Cl-106 HCO3-25 AnGap-10\n___ 09:30AM BLOOD Calcium-7.3* Phos-3.1 Mg-1.8\n___ 10:15AM BLOOD VitB12-996*\n___ 10:15AM BLOOD Ammonia-<10\n___ 10:15AM BLOOD TSH-2.9\n\nMICROBIOLOGY:\n=============\n___ SEROLOGY/BLOOD RAPID PLASMA REAGIN TEST- NONREACTIVE. \n\n___ Blood Culture, Routine-PENDING  \n___ URINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \nWITH SKIN\n      AND/OR GENITAL CONTAMINATION. \n___ Blood Culture, Routine-PENDING \n\nIMAGING:\n=========\n___ CXR\nNo acute cardiopulmonary abnormality.\n\n___ CT HEAD W/O CONTRAST\nNo acute intracranial process.\n\n___ LENIS\nNo evidence of deep venous thrombosis in the left lower \nextremity veins.  Note is made of limited visualization of the \nleft peroneal veins. \n \nBrief Hospital Course:\n___ y.o. F with PMHx of CVA (___) with residual L \nhemiparesis/hemisensory loss, hx DVT/PE on xarelto, Roux-en-Y \ngastric bypass, prior admission for non-convulsive status \nepilepticus in setting of infection/malnutrition, hx substance\nuse disorder and chronic pain on methadone who presents from ___ \nwith new confusion and report of dyspnea.\n\n# Altered mental status \n# Word finding difficulty\nPatient sent from rehab with report of \"appearing more confused, \nrepeated words and statement multiple times, agitated,\" \nincreasing word finding difficulty, with extra pauses in \nsentences. Initial concern was for CVA vs seizure. CT head \nwithout contrast was not concerning for stroke. Patient had \noutpatient EEG earlier that week which was reassuring. She was \nevaluated by Neurology who felt she was at baseline and \nrecommended against further imaging (MRI, EEG). Patient seemed \nto be mentating appropriately throughout her hospitalization. \nShe was ultimately treated for a UTI but this was felt unlikely \nto cause her AMS. Infectious and metabolic workup was otherwise \nunrevealing (TSH, B12 WNL, RPR nonreactive, blood cultures NGTD, \nno leukocytosis). Doxepin and Seroquel were held due to concern \nfor medication effect / prolonged QTc, patient was reported to \nbe very sleepy at rehab. Doxepin was restarted at discharge, \nSeroquel was held (though patient reported she had not been \nreceiving Seroquel at rehab to begin with). Methadone was also \nheld but restarted. Patient received 2 doses of high-dose IV \nThiamine, though ultimately Wernicke's was felt to be unlikely. \n\n# Dizziness\nPatient reported feeling dizzy upon standing for the past 3 days \nprior to admission, coinciding with starting Lasix for lower \nextremity edema, which was stopped on admission. Patient \ncontinued to report some dizziness with standing. Orthostatic \nvital signs were not positive but patient did not tolerate \nstanding due to dizziness. She was evaluated by ___ who suspected \nsome mild orthostasis (rather than vertigo) and recommended \ncontinuing to work on this at rehab. Neurology was not concerned \nfor BPPV. Compression stockings were placed and encouraged PO \nintake.\n\n# UTI\nPositive UA in ED, which appeared consistent with her priors. \nReceived 1 dose of IV ceftriaxone for UTI, then denied dysuria \nso antibiotics were stopped as she was thought to be colonized. \nThen she reported adamantly that she did have dysuria. Urine \nculture was contaminated, but patient was started on 5d course \nof macrobid for empiric treatment of uncomplicated UTI, to be \ncompleted ___.\n\n# Moderate Protein Calorie Malnutrition \n# Report of Weight Loss\n# Poor Appetite\n# History of gastric bypass\n# Gastritis / Esophagitis\n# Thrush\nPatient reported worsened abdominal pain after eating and \ndysphagia to both solids and liquids. She has had multiple prior \nGI workups, had EGD with esophagitis ___ which could \ncertainly contribute, and thrush on exam for which she was \nstarted on Nystatin. She had a10 lb weight loss 177 -> 165 since \n___, but it appears that her weight has been stable since at \nleast ___, though she reported a 13lb unintentional weight \nloss over the past two months. Nutrition consult was obtained, \nconcerned for moderate malnutrition, recommended appetite \nstimulant versus supplemental nutrition support if after a few \ndays her appetite did not improve. This was briefly discussed \nwith patient who agreed to defer decision to outpatient setting. \nRecommended carnation instant breakfast 4xday. Would recommend \noutpatient GI followup as well as routine screening colonoscopy \n(past due, was due ___. Continued home omeprazole 40 mg BID. \n\n# Dyspnea\nNo evidence of PNA on CXR and SpO2 100% on RA upon arrival to ED \nwithout any intervention, 100% on RA while on floor. Looked \neuvolemic to slightly dry. Last TTE ___ with moderate to \nsevere TR with moderate PA systolic hypertension, presumably \nrelated to history of significant PE. TTE was repeated which \nshowed improvement in the degree of TR (mild) and PA systolic \nhypertension (now mild), EF 57%.\n\n# Prolonged QTc Interval\n# Chronic Pain requiring methadone\nPatient on home regimen of Methadone 10mg TID. Her QTc on \narrival to the ED ___ was 584. Per most recent d/c summary, \nthere was an attempt to wean methadone while inpatient however \npatient was unwilling to do so therefore she was discharged on \nprior regimen. QTc improved on HD1, methadone was restarted. EKG \nwas obtained for QTc monitoring on discharge and was normal \n(though reported to be 485 via automated calculator). \n\n# History of DVT/PE\n# Asymmetric ___ edema\nNoted to have asymmetric ___ edema. + History of DVT/PE ___- \nbilateral popliteal DVTs, posterior tibial veins, bilateral \npulmonary emboli involving nearly all segmental branches and a \npossible pulmonary infarct, currently on apixaban (switched from \nrivaroxaban for better absorption)). LENIS were obtained showing \nno DVT. She remained on home apixaban. \n\n# Transaminitis: Likely lab error (hemolyzed), normalized on \nrepeat. \n# Elevated lactate: 2.7 -> 2.0, resolved without intervention. \n2.7 on admission. ___ also be secondary to hemolyzed labs. \n\n# Goals of care \nWhen asked about code status, patient notes she has thought \nabout this during her last stroke, and had wanted to be DNR/DNI, \nbut was told by her children that would be selfish. Currently \nwants more time to think about this question, but at the very \nleast she is certain that she wouldn't want to rely on machines \nlong term. She is thinking about what minimum quality of life \nwould be acceptable for her; notes that being able to \ncommunicate is important, and she also derives great pleasure in\nfeeding/taking care of her cat. Code status currently Full with \nlimited trial.\n\n===============\nCHRONIC ISSUES:\n===============\n# Hx of CVA despite Xarelto\n# L side weakness\nStable neurologic exam with L side weakness and decreased facial \nsensation, mild facial droop. Stroke thought likely embolic, \nalthough no documented afib. Was seen ___ by hematology for \nongoing anticoagulation with apixaban. Per neurology ___ opted \nto continue patient on anticoagulation pending stroke neurology \nfollow up. Continued home atorvastatin. \n\n# Chronic pain\nInitially held home Methadone 10 TID given prolonged QTc, \ncontinued home gabapentin, bowel regimen.\n\n# Chronic anemia\nAdmission Hgb 12.1, suspect hemoconcentration I/s/o dehydration. \n8.8 on discharge, consistent with prior hospitalization. \nContinued home B12 and folate.\n\n# Epilepsy\nContinued home Levetiracetam 1500 mg BID, Lacosamide 200 mg BID\n\n# Depression/Anxiety\nHeld home Doxepin and Seroquel (see above), restarted on \ndischarge. Continued home Duloxetine. \n\nTRANSITIONAL ISSUES:\n======================\n[] Started 5d course of macrobid ___ mg Q12H for UTI, end date \n___\n[] 7d course of Nystatin oral suspension ___ \n[] Added carnation instant breakfast 4xday, consider outpatient \nnutrition followup\n[] Would recommend outpatient GI followup as well as routine \nscreening colonoscopy (past due, was due ___. \n[] ___ have some mild orthostasis after starting Lasix, which \nwas discontinued. Started wearing compression stockings. Please \nmonitor for signs of orthostasis.\n[] QTc was prolonged on admission, would recommend repeat EKG \nprior to restarting Seroquel, which was held on discharge\n[] Continued discussion of goals of care recommended\n\n#CODE: Full, limited trial\n#CONTACT: ___ \n___: Mother \nPhone number: ___ \n \n___ on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Omeprazole 40 mg PO BID \n2. Zinc Sulfate 220 mg PO DAILY \n3. Apixaban 5 mg PO BID \n4. Atorvastatin 40 mg PO QPM \n5. Cyanocobalamin 100 mcg PO DAILY \n6. DULoxetine 40 mg PO DAILY \n7. FoLIC Acid 1 mg PO DAILY \n8. Gabapentin 100 mg PO TID \n9. LACOSamide 200 mg PO BID \n10. LevETIRAcetam 1500 mg PO BID \n11. Methadone 10 mg PO TID \n12. Thiamine 100 mg PO DAILY \n13. Docusate Sodium 100 mg PO BID \n14. Senna 17.2 mg PO BID \n15. Sucralfate 1 gm PO QID \n16. Magnesium Oxide 400 mg PO BID \n17. Multivitamins W/minerals 1 TAB PO DAILY \n18. Doxepin HCl 50 mg PO HS \n19. Promethazine 6.25 mg PO BID:PRN nausea \n20. QUEtiapine Fumarate 75 mg PO QHS \n21. Furosemide 20 mg PO DAILY \n\n \nDischarge Medications:\n1.  Nitrofurantoin Monohyd (MacroBID) 100 mg PO Q12H  \n2.  Nystatin Oral Suspension 5 mL PO QID Duration: 7 Days  \n3.  Apixaban 5 mg PO BID  \n4.  Atorvastatin 40 mg PO QPM  \n5.  Cyanocobalamin 100 mcg PO DAILY  \n6.  Docusate Sodium 100 mg PO BID  \n7.  Doxepin HCl 50 mg PO HS  \n8.  DULoxetine 40 mg PO DAILY  \n9.  FoLIC Acid 1 mg PO DAILY  \n10.  Gabapentin 100 mg PO TID  \n11.  LACOSamide 200 mg PO BID  \n12.  LevETIRAcetam 1500 mg PO BID  \n13.  Magnesium Oxide 400 mg PO BID  \n14.  Methadone 10 mg PO TID \nRX *methadone 10 mg 1 tablet by mouth three times a day Disp \n#*15 Tablet Refills:*0 \n15.  Multivitamins W/minerals 1 TAB PO DAILY  \n16.  Omeprazole 40 mg PO BID  \n17.  Promethazine 6.25 mg PO BID:PRN nausea  \n18.  Senna 17.2 mg PO BID  \n19.  Sucralfate 1 gm PO QID  \n20.  Thiamine 100 mg PO DAILY  \n21.  Zinc Sulfate 220 mg PO DAILY  \n22. HELD- QUEtiapine Fumarate 75 mg PO QHS  This medication was \nheld. Do not restart QUEtiapine Fumarate until you need it and \nyour heart can tolerate it\n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary:\nAltered mental status \nWord finding difficulty\nDizziness \nUTI\nModerate Protein Calorie Malnutrition \nThrush\nDyspnea\nProlonged QTc Interval\nAsymmetric ___ edema\n\nSecondary:\nCVA w left sided deficitis\nChronic pain\nEpilepsy\nChronic anemia\nDepression/Anxiety\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Out of Bed with assistance to chair or \nwheelchair.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou came to the hospital because your rehab was worried that you \nwere confused, and you felt dizzy and short of breath.\n\nWhile you were here, you were seen by our Neurologists and they \nfelt that you did not have a stroke or a seizure.\n\nYou had a urine sample that may show a urinary tract infection. \nYou will have 5 days of antibiotics for this.\n\nYou had dizziness with movement that may be due to starting \nLasix and becoming a little dehydrated. We stopped your Lasix \nand are hopeful this will improve as long as you stay well \nhydrated.\n\nYou had some sleepiness that improved with stopping Seroquel. \n\nWhen you leave the hospital:\n- please work on getting stronger at rehab\n- please make sure you are drinking enough water throughout the \nday especially if you feel dizzy\n- when you sit up and stand up, please take your time to do this \nvery slowly, pausing for a few minutes between movements \n- focus on increasing your food intake and drink the carnation \ninstant breakfast \n- talk to your primary care doctor about seeing a stomach doctor \nto talk about your belly pain and weight loss\n\nIt was a pleasure caring for you and we wish you the best,\nYour ___ Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb6a7"
  },
  "note_id": "12648465-DS-49",
  "subject_id": 12648465,
  "hadm_id": 20280405,
  "note_type": "DS",
  "note_seq": 49,
  "charttime": "2210-06-08 00:00:00",
  "storetime": "2210-06-08 13:09:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut / \nWellbutrin / ciprofloxacin\n \nAttending: ___.\n \nChief Complaint:\nShortness of breath\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\nMs. ___ is a ___ woman with h/o gastric bypass\n(c/b SBO, malnutrition), esphagtitis/PUD, h/o DVT/PE (apixaban),\nCVA ___, L-sided deficits), admission last year for\nnon-convulsive status epilpticus ___ infection/malnutrition,\nsubstance use disorder/chronic pain (methadone), recent\nadmissions for abdominal pain and AMS (last d/c on ___ who is\npresenting from her SNF with leg swelling and cough.\n\nShe was last admitted from ___ with AMS and dyspnea. For\nher AMS she was evaluated by neurology, who ultimately felt that\nher MS was close to baseline and no clear etiology was\ndetermined. She completed a 4d course of macrobid for UTI (UA\npositive, UCx mixed flora, inconsistent reports of dysuria. She\nalso noted \"dizziness\", which  began when she was started on\nLasix for ___ edema. Overall thought to be related to mild\northostaiss, and so lasix was held and she was given compression\nstockings. \n\nPer documentation from her SNF, the patient was sent in for\npossible pneumonia, new oxygen requirement. Weight 159.8\n\nToday she is reporting shortness of breath which has been \npresent\nfor ___ days prior to admission. She reports she is sedentary at\nbaseline and therefore is not sure if she is short of breath on\nexertion. She has a cough but it is non-productive. She has no\nfevers or chills. She has no chest pain. \nShe also complains of dysuria. She is incontinent at baseline \nand\nhas not noticed new hesitancy or urgency. She is not sure if her\nsymptoms improved after her treatment with macrobid. The patient\nalso complains of swelling in her hands and legs. She's not sure\nhow long this has been present.  She is very concerned with her\nnutritional status (had complicated ICU stay ___\nand was found to have malnutrition in setting of poor absorption\ngiven prior bowel surgery). She reports she has been eating OK \nat\nrehab. She reports one soft formed stool daily. Occasional\nnausea, none currently. She also complains of lower abdominal\npain and low back pain.\n \nPast Medical History:\n- h/o HTN and DMII, resolved after gastric bypass per patient  \n - s/p cholecystectomy and gastric bypass (___), with f/u  \n complicated by multiple ex lap, gastrectomy, reversal surgery,  \n\n failed J-tube c/b colonic perforation  \n - multiple SBO during f/u from above  \n - hernia repair  \n - chronic abdominal pain, peptic ulcer disease  \n - asthma, stroke (left sided), osteoarthritis, GERD, DVT/PE  \n - narcotic abuse, tobacco abuse  \n - depression, anxiety  \n - muscle weakness / myelopathy, chronic low back pain  \n - vulvar folliculitis  \n - arthorplasty - right total knee  \n - hepatitis C - positive ab test, negative HCV viral load in 2x \n \n tests  \n - nephrolithiasis  \n - thyromegaly - TSH wnl, low free T4  \n\n \nSocial History:\n___\nFamily History:\nMany family members with strokes, HTN, DM. Brother with CHF. She \nreports her father may have had colon cancer around age ___, then \nhad brain metastases (unclear if related or separate).\n \nPhysical Exam:\nADMISSION EXAM:\n====================\n\nVITALS: ___ 1846 Temp: 98.4 PO BP: 112/77 HR: 88 RR: 18 O2\nsat: 99% O2 delivery: 2L NC \nGENERAL: laying in bed in NAD, age appears older than stated\nEYES: Anicteric, PERRL\nENT: MMM. No OP lesion, erythema or exudate.  Ears and nose\nwithout visible erythema, masses, or trauma.  \nCV: Heart regular, no m/g.\nRESP: Lungs CTAB no w/r/r.  Breathing comfortably\nGI: Abdomen soft, NTND.  Bowel sounds present.\nGU: No suprapubic TTP some fullness. NO CVAT\nMSK: Extremities warm without edema. Moves all extremities\nSKIN: No rashes or ulcerations noted on examined skin\nNEURO: Alert, oriented, face symmetric, speech fluent sensation\nto light touch grossly intact throughout\nPSYCH: pleasant, appropriate affect\n\nDISCHARGE EXAM:\n====================\nVITALS: 99.3 PO  113/77  94  16  98%  RA \nGeneral: Comfortable appearing, sitting up in chair eating\nbreakfast\nHEENT: Anicteric, eyes conjugate, MMM, no JVD\nCardiovascular: RRR no MRG, nl. S1 and S2\nPulmonary: Lung fields clear to auscultation throughout\nGastroinestinal: Soft, nondistended, nontender to palpation\nthroughout \nMSK: anasarca throughout in upper and lower extremities as well\nas at hips improving\nSkin: No rashes or ulcerations evident\nNeurological: Alert, interactive, speech fluent, ___ strength in\nbilateral upper and lower extremities at baseline per patient\nPsychiatric: flat affect initially \n    \n\n \nPertinent Results:\n======================\nADMISSION LABS\n======================\n___ 12:41AM BLOOD WBC-3.9* RBC-2.88* Hgb-9.5* Hct-30.9* \nMCV-107* MCH-33.0* MCHC-30.7* RDW-19.4* RDWSD-76.1* Plt ___\n___ 12:41AM BLOOD Neuts-61.0 ___ Monos-7.4 Eos-0.0* \nBaso-0.8 Im ___ AbsNeut-2.38 AbsLymp-1.19* AbsMono-0.29 \nAbsEos-0.00* AbsBaso-0.03\n___ 12:41AM BLOOD Glucose-88 UreaN-15 Creat-0.7 Na-140 \nK-3.9 Cl-105 HCO3-28 AnGap-7*\n___ 12:41AM BLOOD ALT-39 AST-36 AlkPhos-110* TotBili-0.3\n___ 12:41AM BLOOD Lipase-5\n___ 12:41AM BLOOD proBNP-306*\n___ 12:41AM BLOOD Albumin-1.6*\n\n======================\nDISCHARGE LABS\n======================\n___ 05:16AM BLOOD WBC-8.9 RBC-2.31* Hgb-7.7* Hct-24.4* \nMCV-106* MCH-33.3* MCHC-31.6* RDW-17.8* RDWSD-67.9* Plt ___\n___ 05:16AM BLOOD ___ PTT-32.8 ___\n___ 05:16AM BLOOD Glucose-118* UreaN-9 Creat-0.4 Na-143 \nK-4.3 Cl-104 HCO3-31 AnGap-8*\n___ 05:16AM BLOOD Calcium-7.4* Phos-3.1 Mg-1.8\n\n======================\nMICRO\n======================\nUrine culture ___\nURINE CULTURE (Final ___: \n      ESCHERICHIA COLI.    >100,000 CFU/mL.  PRESUMPTIVE \nIDENTIFICATION. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             ESCHERICHIA COLI\n                             |   \nAMPICILLIN------------  =>32 R\nAMPICILLIN/SULBACTAM--  =>32 R\nCEFAZOLIN-------------  =>64 R\nCEFEPIME--------------  =>64 R\nCEFTAZIDIME-----------  =>64 R\nCEFTRIAXONE-----------  =>64 R\nCIPROFLOXACIN---------   =>4 R\nGENTAMICIN------------   <=1 S\nMEROPENEM-------------<=0.25 S\nNITROFURANTOIN--------  <=16 S\nPIPERACILLIN/TAZO-----     8 S\nTOBRAMYCIN------------   <=1 S\nTRIMETHOPRIM/SULFA----  =>16 R\n\n======================\nIMAGING\n======================\n\n___ CXR PA/LAT\n\nFINDINGS: \n \nSmall right pleural effusion is new.  Right lung base is \npartially obscured by the right hemidiaphragm.  Lungs elsewhere \nare clear.  Cardiomediastinal and hilar silhouettes are normal.\n \nThis examination neither specifically suggests nor excludes the \ndiagnosis of acute pulmonary embolism which should be evaluated \nfrom a clinical standpoint.\n \nIMPRESSION:\n\n1. Small right pleural effusion.\n2. No pneumonia or evidence of cardiac decompensation.\n\nEGD ___\nNormal mucosa in esophagus, evidence of Billroth I seen, suture\nsite with granulation tissue and mild erythema. NJ tube placed\nand passed the third portion of the duodenum. Tube was moved \nfrom\nthe mouth into the nose and bridled at 100cm. Flushed without\ndifficulty\n \nBrief Hospital Course:\n___ with history of CVA (___) with residual L \nhemiparesis/hemisensory loss, hx DVT/PE on Apixiban, Roux-en-Y \ngastric bypass, prior admission for non-convulsive\nstatus epilepticus in setting of infection/malnutrition, hx \nsubstance use disorder and chronic pain on methadone who \npresents from ___ with dyspnea, UTI and malnutrition/FTT. \n\n#Dyspnea\nPatient admitted from ___ with concern for new pneumonia \ninitially in the setting of dyspnea and possible new oxygen \nrequirement. She was afebrile with normal WBC count, no cough \nand CXR without clear pneumonia or edema. She was rapidly weaned \nfrom 2L NC to room air. She was maintained on oxygen for comfort \n(100%RA when trialed off) however this was weaned after diuresis \nas below and treatment of anemia. \n\n#Moderate Protein-Calorie Malnutrition\nPatient with history of malnutrition and complicated ICU course \nin ___. On this admission, she was noted to have \nmarkedly depressed albumin with anasarca consistent with \nmalnutrition. Etiology of her malnutrition was felt to be \nmultifactorial related to chronic multifactorial abdominal pain \n(extensively worked-up previously with multiple causes, stable \ncurrently), inability to take significant POs following RYGB in \n___, poor absorption post-bypass, pain and decreased appetite \nrelated to anasarca and underlying anxiety/depression. We \ndiscussed starting an appetite stimulant with the patient and \nher family who were interested in this option and she was \nstarted on mirtazapine which was uptitrated to 15mg qhs. She had \nsome improvement in PO intake with mirtazapine however given \ndegree of malnutrition, nutrition felt she was likely going to \nbe unable to meet her caloric needs and rebuild her nutritional \nstatus without nutritional assistance. ___ (___) was placed \nvia EGD by GI on ___. Tube feeds were started on ___ and \ncycled started on ___. Initially Ms. ___ had some vomiting \nafter starting to cycle the feeds, so the feeds were changed \nback to continuous for ___. The feeds were changed again to \ncycled on ___, this time increasing the rate to goal more \nslowly, and this time she tolerated it well without any nausea \nor vomiting. Plan is for tube feeds for ___ weeks pending \nnutritional status and improved PO intake (improving prior to \ndischarge). Cycled tube feeds for 12 hours daily to reach 71% of \ndaily caloric needs. \n\n#Anasarca\n#Total body pain\nMs. ___ was profoundly ___ on admission likely ___ \nhypoalbuminemia which improved with IV diuresis with albumin. \nShe will need ongoing lasix at discharge 20 mg PO daily and \nclose PCP follow up to determine her ongoing need for diuresis.\n\n# Acute on chronic macrocytic anemia: H/H at baseline initially, \ndowntrended possibly related to fluid shifts with albumin \nadministration and patient received 1u pRBC on ___. Hgb stable \nfollowing transfusion. Of note, she has had a progressive rise \nin MCV over the last few months. Will need ongoing anemia \nwork-up as outpatient. Continued home B12 and folate.  \n\n#Hypernatremia: Developed hypernatremia in setting of diuresis \nwhich resolved with free water flushes through dobhoff. \n\n#E. coli urinary tract infection\nPatient recently treated with macrobid however prior urine \nculture was contaminated. Reported complaints of dysuria. She \nwas started on meropenem due to history of resistant Ecoli and \nthen transitioned to macrobid for total of 5 day course for \nEcoli UTI.  \n\n# History of DVT/PE\n# Asymmetric ___ edema\nNoted to have asymmetric ___ edema. + History of DVT/PE ___- \nbilateral popliteal DVTs, posterior tibial veins, bilateral \npulmonary emboli involving nearly all segmental branches and a \npossible pulmonary infarct, currently on Apixaban. LENIS were \nobtained during last admission one week ago prior to admission \nshowing no DVT. \n\n# Hx of CVA despite Xarelto\n# L side weakness\nStable neurologic exam with L side weakness and decreased facial \nsensation, mild facial droop. Stroke thought likely embolic, \nalthough no documented afib. Was seen ___ by hematology for \nongoing anticoagulation with Apixaban. Per neurology ___ opted \nto continue patient on anticoagulation pending stroke neurology \nfollow up ___. Continued home atorvastatin. \n\n# Chronic pain: Continued home Methadone 10mg PO TID - of note \nplan as outpatient to wean this slowly. Continued home \ngabapentin.\n\n# Epilepsy\nContinued home Levetiracetam 1500 mg BID, Lacosamide 200 mg BID\n\n# Depression/Anxiety: Continued home duloxetine as above. \nDoxepin was decreased to 25mg daily (from 50mg daily) per plan \nto wean based on discussion with patient. Started on mirtazipine \nas above. \n\nTransitional Issues:\n=====================\n[ ]Repeat UA for hematuria seen on UA at time of UTI \n[ ]Doxepin decreased from 50mg qhs to 25mg qhs. Consider further \nweaning to 10mg qhs for sleep in ___ weeks\n[ ]Per discussion with patient's family, would benefit from \npsych follow-up or counseling as outpatient\n[ ]Plan for tube feeds for ___ weeks to increase nutrition, \nplease reassess nutritional status in 2 weeks to determine \ntiming of dobhoff removal. \n[ ]Monitoring of volume status and titration of lasix\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Apixaban 5 mg PO BID \n2. Atorvastatin 40 mg PO QPM \n3. Cyanocobalamin 100 mcg PO DAILY \n4. Docusate Sodium 100 mg PO BID \n5. DULoxetine 40 mg PO DAILY \n6. FoLIC Acid 1 mg PO DAILY \n7. Gabapentin 100 mg PO TID \n8. LACOSamide 200 mg PO BID \n9. LevETIRAcetam 1500 mg PO BID \n10. Methadone 10 mg PO TID \n11. Multivitamins W/minerals 1 TAB PO DAILY \n12. Omeprazole 40 mg PO BID \n13. Senna 17.2 mg PO BID \n14. Sucralfate 1 gm PO QID \n15. Zinc Sulfate 220 mg PO DAILY \n16. Nystatin Oral Suspension 5 mL PO QID \n17. Thiamine 100 mg PO DAILY \n18. Magnesium Oxide 400 mg PO BID \n19. Promethazine 6.25 mg PO BID:PRN nausea \n20. Doxepin HCl 50 mg PO HS \n\n \nDischarge Medications:\n1.  Acetaminophen (Liquid) 1000 mg PO Q8H:PRN Pain - Mild/Fever  \n\n2.  Furosemide 20 mg PO DAILY  \n3.  Mirtazapine 15 mg PO QHS  \n4.  Doxepin HCl 25 mg PO HS  \n5.  Apixaban 5 mg PO BID  \n6.  Atorvastatin 40 mg PO QPM  \n7.  Cyanocobalamin 100 mcg PO DAILY  \n8.  Docusate Sodium 100 mg PO BID  \n9.  DULoxetine 40 mg PO DAILY  \n10.  FoLIC Acid 1 mg PO DAILY  \n11.  Gabapentin 100 mg PO TID  \n12.  LACOSamide 200 mg PO BID  \n13.  LevETIRAcetam 1500 mg PO BID  \n14.  Magnesium Oxide 400 mg PO BID  \n15.  Methadone 10 mg PO TID  \n16.  Multivitamins W/minerals 1 TAB PO DAILY  \n17.  Omeprazole 40 mg PO BID  \n18.  Promethazine 6.25 mg PO BID:PRN nausea  \n19.  Senna 17.2 mg PO BID  \n20.  Sucralfate 1 gm PO QID  \n21.  Thiamine 100 mg PO DAILY  \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nModerate protein-calorie malnutrition\nAnasarca\nDyspnea\nE. Coli UTI\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the hospital with shortness of breath, \nmalnutrition and a UTI. \n\nYour urinary tract infection was treated with antibiotics with \nimprovement in your symptoms. \n\nYour shortness of breath was felt to be due to extra fluid on \nyour body causing swelling due to malnutrition and a low albumin \nlevel. You were started on a new medication called mirtazapine \nto help with your appetite. You also had a dobhoff (feeding \ntube) placed temporarily to help improve your nutrition while \nthe new medication takes effect. \n\nFor the extra fluid in your body, you were treated with lasix \nwith decreased swelling. You will continue to take this \nmedication by mouth after discharge to continue to get fluid out \nof your body. \n\nYou are being discharged to a different rehab, CareOne, where \nthey can help with your tube feeds. \n\nIt was a pleasure taking care of you,\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820ffb505ee7538fb6a8"
  },
  "note_id": "12648465-DS-50",
  "subject_id": 12648465,
  "hadm_id": 22241351,
  "note_type": "DS",
  "note_seq": 50,
  "charttime": "2210-09-16 00:00:00",
  "storetime": "2210-09-19 01:08:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nAspirin / Codeine / NSAIDS (Non-Steroidal Anti-Inflammatory \nDrug) / morphine / prochlorperazine / coconut oil / coconut / \nWellbutrin / ciprofloxacin\n \nAttending: ___.\n \nChief Complaint:\nConfusion\n \nMajor Surgical or Invasive Procedure:\nDobhoff tube placement\nNJ Tube placement x 3 \nJ tube placement and exchange\n\n \nHistory of Present Illness:\nPatient is a ___ F w/ hx of gastric bypass, lupus anticoagulant,\nDVT/PE (with systemic anticoagulation d/c'd ~ 1 week ago), CVA\n___, L-sided deficits), epilepsy (on keppra and vimpat),\nsubstance use disorder/chronic pain (on methadone), multiple\nrecent hospitalizations for UTI/AMS/malnutrition who presents\nwith lethargy, dysathria, aphasia. Her family was unable to\nlocate her today and when they did she was very lethargic. On\narrival she is unable to provide history. Per family, last known\nwell was at least 48 hours ago. Her baseline is walking with a\nwalker, follows instructions, A&Ox3. \n\nIn the ED, the patient continued to be confused and unable to\nprovide a history. She had an episode of eye fluttering, shaking\nand bowel incontinence lasting 2 minutes concerning for \nseizures,\nresolving with administration of Ativan. Following this episode,\nshe became hypotensive with SBPs in ___.\n\n- Initial Vitals: temp 97.8, HR 103, BP 97/80, RR 12, O2 100% RA\n- Exam: notable for pupils 2mm, equal and reactive, moderate \n___,\nswelling, erythema of upper extremities L>R, epigastric\ntenderness, moving all extremities, ___ stroke scale 9,\ndisoriented, combative, pushing away examiner.\n- Labs: elevated tbili, Ca 6, Mg 1.4, +UA\n- Imaging: NCHCT with chronic cerebellar infarcts\n- Consults: Neurology following seizure-like episode\n- Interventions: Due to initial concern for methadone overdose,\npt received naltrexone. Received Ativan 2mg IV following episode\nof seizure-like movement. s/p 2.5 L IVF with only mild\nimprovement in BP.\n\nOn the floor, patient appears confused. She says she is feeling\nuncomfortable but is unable to further specify. It is unclear\nwhether or not she understands questions as she will answer the\nsame question with opposite responses.\n\nROS: Positives as per HPI; otherwise negative; however, unclear\nif true negative.\n \nPast Medical History:\n- h/o HTN and DMII, resolved after gastric bypass per patient  \n - s/p cholecystectomy and gastric bypass (___), with f/u  \n complicated by multiple ex lap, gastrectomy, reversal surgery,  \n\n failed J-tube c/b colonic perforation  \n - multiple SBO during f/u from above  \n - hernia repair  \n - chronic abdominal pain, peptic ulcer disease  \n - asthma, stroke (left sided), osteoarthritis, GERD, DVT/PE  \n - narcotic abuse, tobacco abuse  \n - depression, anxiety  \n - muscle weakness / myelopathy, chronic low back pain  \n - vulvar folliculitis  \n - arthorplasty - right total knee  \n - hepatitis C - positive ab test, negative HCV viral load in 2x \n \n tests  \n - nephrolithiasis  \n - thyromegaly - TSH wnl, low free T4  \n\n \nSocial History:\n___\nFamily History:\nMany family members with strokes, HTN, DM. Brother with CHF. She \nreports her father may have had colon cancer around age ___, then \nhad brain metastases (unclear if related or separate).\n \nPhysical Exam:\nADMISSION EXAM:\nVS: T 98.1 HR 80 BP 103/65 RR 12 100% SPO2\nGEN: ___ yo woman who is sleepy but arousable. She appears older\nthan stated age. NAD.\nHENNT: Dry MM\nCV: RRR, no M/R/G\nRESP: No increased work of breathing. CTAB.\nGI: Firm, non-distended abdomen. no rebound/no guarding. \n(patient\nunsure of last BM timing)\nGU: Severe CVA tenderness, no suprapubic tenderness\nMSK: 2+ edema in bilateral upper extremities. 1+ edema in\nbilateral lower extremities. Bilateral upper and lower\nextremities cool to the touch. \nNEURO: AAOx2-3 (after multiple attempts)\nPSYCH: Flat affect\n\nDISCHARGE EXAM:\nDeceased\n \nPertinent Results:\nADMISSION LABS:\n================\n___ 09:00PM BLOOD WBC-5.4 RBC-3.17* Hgb-9.8* Hct-29.9* \nMCV-94 MCH-30.9 MCHC-32.8 RDW-17.0* RDWSD-55.1* Plt ___\n___ 09:00PM BLOOD Neuts-78.5* Lymphs-16.6* Monos-4.3* \nEos-0.0* Baso-0.2 Im ___ AbsNeut-4.20 AbsLymp-0.89* \nAbsMono-0.23 AbsEos-0.00* AbsBaso-0.01\n___ 09:00PM BLOOD ___ PTT-34.6 ___\n___ 09:00PM BLOOD Plt ___\n___ 09:00PM BLOOD Glucose-88 UreaN-24* Creat-1.0 Na-143 \nK-3.7 Cl-109* HCO3-22 AnGap-12\n___ 09:00PM BLOOD ALT-68* AST-29 AlkPhos-124* TotBili-1.8* \nDirBili-1.3* IndBili-0.5\n___ 09:00PM BLOOD cTropnT-0.02*\n___ 09:00PM BLOOD Albumin-1.8* Calcium-6.9* Phos-4.5 \nMg-1.4*\n___ 01:00PM BLOOD ___\n___ 01:00PM BLOOD HIV Ab-NEG\n___ 09:52PM BLOOD Lactate-0.9\n\nLipase 4\n25OH vit D: 22\nTSH 2.3\nZinc 25 (low)\nCopper 55 (low)\n\nUA (___): neg bld, neg nit, lg ___, 1 RBC, 44 WBCs, few bact, 0\nepi\n\nMICRO\n=====\nUCx (___): negative\nBCx (___): pending x 2\nC.diff (___): negative\nBCx (___): negative x 2\nUCx (___): negative\nBCx (___): negative\nUCx ___: >100K E.coli\n                     \n_________________________________________________________\n                             ESCHERICHIA COLI\n                             |   \nAMPICILLIN------------  =>32 R\nAMPICILLIN/SULBACTAM--  =>32 R\nCEFAZOLIN-------------  =>64 R\nCEFEPIME--------------    16 R\nCEFTAZIDIME-----------  =>64 R\nCEFTRIAXONE-----------  =>64 R\nCIPROFLOXACIN---------   =>4 R\nGENTAMICIN------------   <=1 S\nMEROPENEM-------------<=0.25 S\nNITROFURANTOIN--------  <=16 S\nPIPERACILLIN/TAZO-----   <=4 S\nTOBRAMYCIN------------   <=1 S\nTRIMETHOPRIM/SULFA----  =>16 R\n\nBCx (___): negative\n\nEKG (___):\nNSR at 93 bpm, nl axis, PR 180, QRS 80, QTC 435, biphasic T wave\nV3-V4 (unchanged from ___\n\nEKG (___): \nNSR at 85 bpm, poor baseline, PR 172, QRS 84, QTC 447, no clear\nischemic changes\n\nIMAGING:\n========\nJ tube repositioning (___):\nSuccessful exchange of a jejunostomy tube for a new 18 ___ \nMIC\njejunostomy tube. The tube is ready to use. \n\nCXR (___):\nComparison to ___.  The lung volumes are normal. \nNormal size of the cardiac silhouette.  Normal hilar and\nmediastinal contours. No pneumonia, no pulmonary edema, no\npleural effusions.  Stable position of the right-sided PICC \nline.\n\nKUB (___): \nNo evidence of small bowel obstruction.  Oral contrast from\nrecent CT examination extends the level of the rectum.  No free\nair. \n\nCT A/P w/cont (___):\n1. The J-tube is now malpositioned with the bulb external to the\nbowel, surrounded by soft tissue stranding in the region of the\nomentum/abdominal wall.  Postprocedure images at the time of\nJ-tube placement ___ showed the bulb in good\nposition within the bowel.  The tube tip remains well \nwithin the jejunum and there are no direct findings of active\nleak. ___ consultation suggested. \n2. No evidence of organized intra-abdominal abscess or bowel\nobstruction. \n3. Stable chronic central biliary dilation, which is likely\nrelated to postcholecystectomy changes. \n4. Bibasilar pulmonary ___ opacities are\nlikely inflammatory and could be related to aspiration given the\nrecent history of vomiting. \n\nCXR (___):\n1.  The right upper extremity PICC has been slightly retracted\nand now terminates in the mid superior vena cava. \n2.  No acute cardiopulmonary process. \n  \nRUQ U/S (___):\nPersistent moderate biliary dilatation, similar to prior MRI \nfrom\n___ and CT from ___. \n\nKUB (___):\nThe ascending and transverse colon is dilated with air measuring\nup to 8.8 cm. No dilated loops of small bowel or evidence of \nfree\nintraperitoneal air. \n\nKUB (___):\nNo radiographic evidence of bowel obstruction or free\nintraperitoneal air.\n\nJ tube placement (___):\nSuccessful placement of a 18 ___ modified MIC jejunostomy \ntube\nwith its tip in the jejunum.  The feeding tube should not be \nused\nfor 24 hours. \n\nMRCP (___):\n1. No evidence of choledocholithiasis. \n2. Biliary dilation is unchanged since at least ___, and is\nlikely due to post cholecystectomy ectasia. \n3. Extensive anasarca.  Trace ascites. \n4. Moderate bilateral pleural effusions. \n\nCT A/P w/cont (___):\n1. No evidence of bowel obstruction.  Status post gastric bypass\nsurgery \n2. Dilated common bile duct to 1.1 cm and mild intrahepatic\nbiliary ductal dilatation may be due to status post\ncholecystectomy.  There is no evidence of choledocholithiasis. \nIf this is of clinical concern MRCP could be considered. \n3. Extensive anasarca, small amount of ascites and moderate\nbilateral pleural effusions may represent fluid overload \n4. Bladder wall thickening and enhancement may be due to\ncystitis.  Please correlate with urinalysis \n  \nNCHCT (___):\nNo acute intracranial abnormality. \nPlease note MRI of the brain is more sensitive for the detection\nof acute infarct. \n  \nCXR (___):\nRight PICC line tip is at the level of lower SVC.  NG tube/type\nof tube terminates at the level of mid esophagus.  Bilateral\npleural effusions are large.  There is no pneumothorax.  There \nis\nmild vascular congestion but no overt pulmonary edema. \n\nL UENI (___):\nNo evidence of venous thrombosis.  Some flattening of the\nsubclavian venous waveforms compared to usual expectation.  This\nis not necessarily significant clinically but may potentially\nindicate more central obstruction.  Extensive superficial edema\nin the left upper extremity. \n\nEGD (___):\nEvidence of Billroth I. Normal jejunum. NJ placed. Old NJ stuck\nin patient's R nostril removed with assistance of ENT.\n\nCT sinus/orbit (___):\n1. Interval mild mucosal thickening of the right maxillary and\nethmoid sinuses, with obstruction of the right ostiomeatal\ncomplex. \n2. Right nare Dobhoff nasogastric tube, apparently causing\nnarrowing of the airway on the right, please correlate.          \n\n\nCT head ___:\nNo acute intracranial process.\n\nCXR ___:\nNo acute cardiopulmonary abnormality.\n\nMRI head with and without contrast ___:\n1. Unchanged 3 punctate areas of high signal on diffusion in the\nright cerebellar hemisphere.  Since these 3 punctate foci are\nunchanged dating back to ___, these are likely due to\nT2 shine through and chronic. \n2. No evidence of acute infarction or intracranial hemorrhage. \n3. No evidence of abnormal enhancement. \n\nTTE ___:\nThe left atrial volume index is normal. There is normal left\nventricular wall thickness with a normal cavity size. There is\nsuboptimal image quality to assess regional left ventricular\nfunction. Overall left ventricular systolic function is low\nnormal. Quantitative biplane left ventricular ejection fraction\nis 54 %. There is no resting left ventricular outflow tract\ngradient. Normal right ventricular cavity size with normal free\nwall motion. The aortic sinus diameter is normal for gender with\nnormal ascending aorta diameter for gender. The aortic arch\ndiameter is normal. The aortic valve leaflets (3) appear\nstructurally normal. There is no aortic valve stenosis. There is\nno aortic regurgitation. The mitral valve leaflets are mildly\nthickened with no mitral valve prolapse. There is trivial mitral\nregurgitation. The tricuspid valve leaflets appear structurally\nnormal. There is physiologic tricuspid regurgitation. The\nestimated pulmonary artery systolic pressure is normal. There is\nno pericardial effusion.\nCompared with the prior TTE (images not available for review) of\n___, there is no obvious change, but the suboptimal image\nquality of the studies precludes definitive comparison.\n\nCT A/P ___:\n1. Status post Roux-en-Y gastric bypass.  No evidence for\ninternal hernia. Please note that evaluation for ischemic bowel\nis limited due to the lack of IV contrast \n2. Hepatic steatosis \n3. Air within the bladder is likely related to recent\ninstrumentation \n4. Anasarca and small amount of ascites \nRECOMMENDATION(S):  Repeat CT with IV contrast should be\nconsidered if ischemic bowel is a clinical consideration \n\nMRI head w/w/o cont (___):\n1. Unchanged 3 punctate areas of high signal on diffusion in the\nright cerebellar hemisphere.  Since these 3 punctate foci are\nunchanged dating back to ___, these are likely due to\nT2 shine through and chronic. \n2. No evidence of acute infarction or intracranial hemorrhage. \n3. No evidence of abnormal enhancement. \n\n \nBrief Hospital Course:\n___ year old female with hx DVT/PE ___ (with systemic \nanticoagulation d/c'd ___, CVA ___, L-sided \ndeficits), HTN, DM, PUD/GERD, s/p cholecystectomy and gastric\nbypass ___, reversed to Billroth I) c/b multiple SBO's \nrequiring ex lap, FTT s/p failed J-tube with colonic \nperforation, and chronic abdominal pain (on methadone) admitted \nto the FICU ___ with encephalopathy and hypotension in setting \nof sepsis from UTI and seizure, improved and called out to the \nfloor ___, with course c/b acute on chronic abdominal pain, \nrecurrent emesis, severe protein-calorie malnutrition, and \nsepsis . The patient died on ___.\n\n# Comfort care\nPatient was made CMO on ___. Palliative care was consulted for \nhelp in making her as comfortable as possible. She was on \nfentanyl drip and switched to methadone and dilaudid. She died \non ___.\n\n# Sepsis:\n# UTI:\n# Elevated lactate:\nPresented initially with hypotension in setting of resistant \nE.coli UTI, which improved with fluids and Zosyn x 7d (through \n___. TTE with nl EF, and no evidence of ACS. Low suspicion \nfor recurrent PE given improvement with antibiotics. Patient \nsubsequently spiked fever ___ to 101.1F with associated \nleukocytosis, tachycardia, and increased lethargy with lactate \n4.7, concerning for recurrent sepsis. Source unclear, but was \nstarted on Vanc/Zosyn ___ and received 2L IVFs. Her \nleukocytosis and lactate elevation subsequently resolved; \nBCx/UCx negative and CXR without e/o PNA (despite micronodular \nopacities at bases on CT ___. Erythema around J tube \nresolved, and SSTI was thought an unlikely cause of sepsis. An \nintra-abdominal infection was considered given stranding on a CT \nand report of possible feculent J tube leakage, but no obvious \norganized collection, perforation, or extracolonic contrast \nleakage on imaging. She underwent J tube exchange on ___. \nAntibiotics were discontinued on ___ with no further fever or \nleukocytosis. The patient had recurrent fever and hypotension on \n___. She was started on vancomycin and zosyn given prior \ncuture data. Her urine culture grew resistant E. coli. She was \ncontinued on Zosyn alone to complete a 7 day course. The \nremainder of her infectious work up was negative.\n\n# Nausea/emesis:\n# Constipation alternating with diarrhea:\n# Acute on chronic abdominal pain:\n# Gastric bypass s/p reversal c/b multiple SBOs:\n# J tube malpositioning:\nPatient with chronic abdominal pain in setting of prior gastric \nbypass requiring reversal and report of multiple SBOs and prior \nfailed J tube c/b colonic perforation. Was recently discharged \n___ with NJ in place, removed for unclear reasons as \noutpatient. Presented with acute on chronic abdominal pain, with \nCT ___ showing dilated CBD to 1.1 cm and no e/o bowel \nobstruction or hernia. MRCP with no e/o choledocholithiasis and \nbiliary dilation unchanged since ___, likely from post \ncholecystectomy ectasia. She underwent placement of three NJ \ntubes this admission, all of which were dislodged or removed \n(one of which became lodged in a nare and had to be removed by \nENT). She ultimately underwent placement of J tube by ___ on \n___. Diffuse abdominal pain worsened after placement of J \ntube, and patient had multiple episodes of large-volume bilious \nemesis ___ (the latter two episodes while off TFs) in \nsetting of constipation (after treatment for TF-associated \ndiarrhea). CT A/P w/cont was performed ___, which showed no \nclear evidence of obstruction or perforation but was concerning \nfor possible J-tube\nmalpositioning (with bulb external to bowel with surrounding \nsoft tissue stranding in omentum/abdominal wall; tube remained \nwithin the jejunum per report with no e/o active leak). TFs were \nheld and she underwent J tube exchange ___ followed by slow \nresumption of TFs and diet. Nausea improved with no further \nepisodes of emesis. Abdominal pain slowly improved as well and \nwas treated with tylenol, home methadone, gabapentin, tramadol, \nand oxycodone PRN, which was being weaned at the time of \ndischarge. TF-associated diarrhea was controlled with ________. \nShe was tolerating a regular diet and TFs at goal at the time of \ndischarge to rehab and will f/u with GI on ______.  In addition, \nshe should f/u with her bariatric surgeon, Dr. ___, now at \n___. TF monitoring after discharge from rehab will \nbe coordinated by ________. \n\n# Severe Protein-Calorie Malnutrition:\n# Hypoalbuminemia:\n# Lower copper:\n# Low Zinc:\n# Vitamin D deficiency:\nPatient with history of malnutrition requiring supplemental TFs, \ns/p failed J-tube due to colonic perforation in past and recent \nNJ tube ___, d/c'd as outpatient for unclear reasons). \nEtiology of her malnutrition on prior admission was felt to be \nmultifactorial related to chronic multifactorial abdominal pain, \ninability to take significant POs following RYGB in ___, poor \nabsorption post-bypass, pain and decreased appetite related to \nanasarca and underlying anxiety/depression. S/p three NJ tubes \nthis admission, last removed ___. G tube not possible given \nanatomy; TPN thought too high risk. Surgery declined surgical J \ntube, so patient underwent ___ J-tube on ___ with \ninitiation of TFs ___, which were interrupted by recurrent \nemesis ___ and c/f J tube malpositioning (replaced\n___. As above, jejunal TFs were at goal and patient was \ntolerating a regular diet at discharge without e/o refeeding \nsyndrome. She remains profoundly malnourished, however, with \nalbumin <2, lower copper, low zinc. She completed a 5d course of \ncopper repletion and will complete a 14d course of zinc \nrepletion through ___. TF monitoring after discharge from \nrehab will be coordinated by ________.  Home mirtazapine, \nB12/folate/thiamine were continued at discharge.\n\n# Transaminitis with elevated alk phos:\nMild transaminitis in largely cholestatic pattern (with nl \nTbili) on ___. Unclear etiology. CT ___ showed dilated CBD \nto 1.1 cm and no e/o bowel obstruction or hernia. MRCP with no \ne/o choledocholithiasis and biliary dilation unchanged since \n___, likely from post cholecystectomy ectasia. Repeat RUQ U/S \non ___ showed stable mild biliary dilation, as did repeat CT \nA/P on ___. Stable at the time of discharge. She will f/u with \nGI as above.\n\n# Toxic metabolic encephalopathy:\n# Epilepsy:\nPatient presented with encephalopathy and c/f seizure in setting \nof UTI and low lacosamide level (<0.5). MRI with no clear new \nseizure focus. Neuro recommended deferring LP and continuing \nhome lacosamide and keppra and current dosing. Mental status \nreturned to baseline (AOx3), with stable, chronic L-sided \ndeficits secondary to prior CVAs. An appointment with patient's \nepileptologist, Dr. ___, is scheduled for ___.\n\n# History of CVA w/residual L-sided weakness:\nPer ICU team discussions with PCP, she had been on \ncoumadin-->apixiban-->xarelto. Anticoagulation d/c'd ___ by \nPCP after discussions with neuro, who felt that her CVAs were \ncryptogenic (no afib or PFO) and her DVT/PE provoked. Lupus \nanticoagulant per PCP notes was NEGATIVE. She was continued on \nher home statin. PCP notes reference ASA, but patient reports \nallergy to ASA (bruising) it was therefore not initiated. \n\n# History of DVT/PE (___): \nProvoked. Lupus anticoagulant NEGATIVE per recent PCP note, and \ntherapeutic anticoagulation had been d/c'd by PCP ___ prior \nto admission. Anticoagulation was not resumed this admission in \nabsence of new VTE.\n\n# Hypoglycemia:\nSymptomatic hypoglycemia to ___ AM while NPO, despite \ndextrose-containing fluids. Likely secondary to inadequate \nintake and improved with D5 amps. The patient was seen by \nendocrinology who felt the only way to definitively determine \nthe cause of hypoglycemia would be to perform a 72hr fast. Given \nthe patients overall illness, history of malabsorption it was \nfelt that her hypoglycemia is likely due to malabsorption and \nthat 72hr fast would not necessarily change management. The \npatient should continue on tube feeds and if NPO should have \nclose monitoring of her glucose to prevent hypoglycemia. \n\n# Coagulopathy:\nINR 1.5 ___. Likely nutritional and improved with advancement \nof diet and TFs.\n\n# Acute on chronic macrocytic anemia: \nHgb stable at ___ after 1u pRBC on ___, with no e/o active \nbleeding or hemolysis. B12/folate WNL. She received additional \n1unit PRBCs on ___.  She was continued on home B12/folate at \ndischarge. Hgb ____ at d/c.\n\n# Otitis media: \nS/p amoxicillin 5d course ___.\n\n# Depression/Anxiety: \nContinued home duloxetine, doxepin, and mirtazapine.\n\n# QT prolongation: \nMonitored closely in setting of QTC prolonging medications. QTC \n_____ at the time of discharge.\n\n# GOC:\nPatient has had multiple admissions for acute on chronic \nabdominal pain and FTT/malnutrition with serial complications. \nCourse this admission was complicated by pain, nausea/vomiting, \nand diarrhea, limiting patient's ability to receive adequate \nnutrition.\nUnfortunately there is no clear medical or surgical solution to \nher ongoing malnutrition and pain, and ___, patient's \nsister/HCP, is concerned about the patient's quality of life. \nMs. ___ was discouraged by her slow progress but expressed a \ndesire to continue aggressive therapy with the hope of using \nsupplemental nutrition as a bridge to a more definitive \nnutrition plan going forward. She was confirmed FULL code. \nShould she be readmitted for similar issues, would consider \npalliative care involvement and further discussion of GOC.\n\nName of health care proxy: Sister, ___ ___\nAlternate: ___ (mother) ___\nCode: FULL (confirmed)\n\n** TRANSITIONAL **\n[ ] wean TFs; to be monitored by _______\n[ ] f/u with GI (at ___ and colorectal (bariatric surgeon Dr. \n___ at ___)\n[ ] neuro f/u for epilepsy and prior CVAs; consider antiplatelet \ntherapy (ASA not initiated given report of allergy)\n[ ] continue to wean narcotics\n[ ] trend QTC given chronic anti-emetic use\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Atorvastatin 40 mg PO QPM \n2. Cyanocobalamin 100 mcg PO DAILY \n3. Docusate Sodium 100 mg PO BID \n4. Doxepin HCl 25 mg PO HS \n5. DULoxetine 40 mg PO DAILY \n6. FoLIC Acid 1 mg PO DAILY \n7. Gabapentin 100 mg PO TID \n8. LACOSamide 200 mg PO BID \n9. LevETIRAcetam 1500 mg PO BID \n10. Methadone 10 mg PO TID \n11. Acetaminophen (Liquid) 1000 mg PO Q8H:PRN Pain - Mild/Fever \n12. Thiamine 100 mg PO DAILY \n13. Sucralfate 1 gm PO QID \n14. Senna 17.2 mg PO BID \n15. Omeprazole 40 mg PO BID \n16. Promethazine 6.25 mg PO BID:PRN nausea \n17. Multivitamins W/minerals 1 TAB PO DAILY \n18. Mirtazapine 15 mg PO QHS \n19. Magnesium Oxide 400 mg PO BID \n20. Furosemide 20 mg PO DAILY \n\n \nDischarge Medications:\nDeceased\n \nDischarge Disposition:\nExpired\n \nDischarge Diagnosis:\nDeceased\n\n \nDischarge Condition:\nDeceased\n \nDischarge Instructions:\nDeceased\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048219fb505ee75390a3be"
  },
  "note_id": "14465589-DS-19",
  "subject_id": 14465589,
  "hadm_id": 29907102,
  "note_type": "DS",
  "note_seq": 19,
  "charttime": "2186-11-29 00:00:00",
  "storetime": "2186-12-01 12:05:00",
  "text": " \nName:  ___           Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nlisinopril / amlodipine\n \nAttending: ___.\n \nChief Complaint:\nChest discomfort/palpitations\n \nMajor Surgical or Invasive Procedure:\nAVNRT ablation\n\n \nHistory of Present Illness:\nMr. ___ is a ___ man with a past medical history of \nhypertension and tobacco use who presents to the emergency \ndepartment for evaluation of chest\ndiscomfort. \n\nPatient describes that he was driving to work on day of \npresenation when he had a brief left chest discomfort that \nassociated with lightheadedness and arm weakness. \n\nThese symptoms lasted from seconds to minutes. They continued to \noccur intermittently throughout the morning so the patient \npresented to an outpatient clinic. There patient was found to be \nhave a regular narrow complex SVT. EMS was called. \n\nOn EMS arrived, heart rate was in the 140s and twelve-lead \nshowed evidence of SVT. After a peripheral IV was inserted, SVT \nbroke and he went back in sinus rhythm in the ___. \n\nEn route to the hospital, patient again had another episode of \nSVT which broke with a vagal maneuver. On arrival, patient \nstated he felt well without any pain or discomfort. Stated \nsymptoms not pleuritic or exertional. \n\nOn initial interview, patient denied recent illness, fevers or \nchills. No cough. No recent medication changes. No recent travel \nor surgeries. Has never experienced anything like this in the \npast. He denies medication noncompliance\n \nPast Medical History:\nPUD, \nrenal calculi with bilateral stents, \nHTN\nupper endoscopy and appears to be being treated for H. pylori. \n___ ago\n \nSocial History:\n___\nFamily History:\nReviewed and found to be non-contributory to current \npresentation\n\n \nPhysical Exam:\nAdmission PE:\nVITALS: 97.8  164/95  55  18  96Ra \nGENERAL: Alert and interactive.\nHEENT: NCAT. \nCARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No\nmurmurs/rubs/gallops.\nLUNGS: Clear to auscultation bilaterally. \nABDOMEN: Normal bowels sounds, non distended, non-tender \nEXTREMITIES: No clubbing, cyanosis, or edema. \nSKIN: Warm. No rash.\nNEUROLOGIC: CN2-12 intact. AOx3.\n\nDischarge PE:\nVS: 97.4, 130-157/82-100, 60-81, 18, 95% RA\nWeight: 77.9 kg/171 LB\nTelemetry: Sinus ___ first-degree AV block, no ectopy\nGENERAL: Pleasant ___ speaking gentleman, sitting up in\nbed, NAD, alert and interactive.\nHEENT: NCAT. \nCARDIAC: Regular rhythm, normal rate. S1S2. No MRG \nLUNGS: LS CTA bilaterally\nABDOMEN: Normal bowels sounds, non distended, non-tender \nEXTREMITIES: No clubbing, cyanosis, or edema. \nSKIN: Warm. No rash.\nNEUROLOGIC:  AOx3.\n\n \nPertinent Results:\nEKG: ___: Sinus bradycardia, rate 50's, AV delay (PR 234)\n\nEKG (pre-hospital): Regular narrow complex tachycardia with rate\n160, no clear flutter waves or p waves; initiation and\ntermination or arrhythmia not captured\n\nETT echo ___:\nAverage functional exercise capacity for age and gender. No \nischemic ECG\nchanges with no symptoms. No 2D echocardiographic evidence of \ninducible ischemia to achieved treadmill stress. No Doppler \nevidence for a change in left ventricular filling pressure with \nexercise.\nResting systolic hypertension with a normal blood pressure and a \nnormal heart rate respose to achieved treadmill stress. \nModerately increased pulmonary artery systolic pressure at rest \nwith no change after exercise.\n\nTTE ___:\nThe left atrial volume index is mildly increased. The right \natrium is mildly enlarged. There is mild symmetric left \nventricular hypertrophy with a normal cavity size. There is \nnormal regional and global left ventricular\nsystolic function. Quantitative biplane left ventricular \nejection fraction is 68 %. There is no resting left ventricular \noutflow tract gradient. Normal right ventricular cavity size \nwith normal free wall motion. The aortic sinus diameter is \nnormal for gender with normal ascending aorta diameter for \ngender. The aortic arch is mildly dilated. The aortic valve \nleaflets (3) appear structurally normal. There is no aortic \nvalve stenosis. There is no aortic regurgitation. The mitral \nvalve leaflets appear structurally normal with no mitral valve \nprolapse. There is\ntrivial mitral regurgitation. The tricuspid valve leaflets \nappear structurally normal. There is mild [1+] tricuspid \nregurgitation. The estimated pulmonary artery systolic pressure \nis normal. There is no pericardial effusion.\n.\nAVNRT ablation report PND\n \nBrief Hospital Course:\nASSESSMENT AND PLAN:\nMr. ___ is a ___ man with a past medical history of\nhypertension and tobacco use who presented to the emergency\ndepartment ___ for evaluation of chest discomfort, found to \nhave\nintermittent SVT which broke with vagal maneuvers and IV\nmetoprolol. \n\n# Supraventricular tachycardia: Suspected AVNRT, ablation today \nthat req mult ablations and lesion near bundle of HISS. Possible \nbypass tract but more likely AVNRT. SVT was inducible after the \nprocedure and Pt may need another ablation in the future. \nMetoprolol restarted on DC. Aspirin 81 mg started for anti \ninflammation. \n\n# Troponin: In the setting of SVT 140s-150s, thought rate \nrelated. ETT echo negative for ischemic changes or arrhythmia. \nImaging revealed normal augmentation with exercise. TTE notable \nfor mild LVH and mild biatrial enlargement. \n\n# HTN: Poorly controlled on triple therapy, mild LVH on echo. \nFelodipine 10 mg added yesterday will not yet manifest full\nefficacy. Continued home HCTZ 50 mg QD, Losartan Potassium 100 \nmg QD. \n\n# HLD /CVD risk: Patient with > 15% ___ year risk of CVD. Lipids\ntoday under good control. Started atorvastatin 40 mg. \n\n# GERD: Continued Omeprazole 20 mg PO DAILY \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheeze \n2. Hydrochlorothiazide 50 mg PO DAILY \n3. Losartan Potassium 100 mg PO DAILY \n4. Metoprolol Succinate XL 200 mg PO DAILY \n5. Omeprazole 20 mg PO DAILY \n6. Doxazosin 4 mg PO HS \n\n \nDischarge Medications:\n1.  Aspirin 81 mg PO DAILY  \n2.  Atorvastatin 40 mg PO QPM  \n3.  Felodipine 10 mg PO DAILY  \n4.  Albuterol Inhaler 2 PUFF IH Q6H:PRN wheeze  \n5.  Doxazosin 4 mg PO HS  \n6.  Hydrochlorothiazide 50 mg PO DAILY  \n7.  Losartan Potassium 100 mg PO DAILY  \n8.  Metoprolol Succinate XL 200 mg PO DAILY  \n9.  Omeprazole 20 mg PO DAILY  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAtrioventricular non-reentry tachycardia\nHypertension\nHyperlipidemia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou had an supraventricular tachycardia ablation to treat your \nirregular heart rhythm, AVNRT.  \n Continue all your current medications with the following \nchanges:  \n1. Start aspirin 81 mg daily to prevent inflammation in your \nheart\n2. Start atorvastatin to lower your cholesterol. \n3. Start felodipine for your blood pressure  \n4. Continue metoprolol at home. \n\nIt is possible that you might need another ablation in the \nfuture. You have an appointment with Dr ___ in about a \nmonth to talk about this more.   \n \n Activity restrictions and information regarding care of the \naccess sites in the groin are included in your discharge \ninstructions.  \n If you have any urgent questions that are related to your \nrecovery from your procedure or are experiencing any symptoms \nthat are concerning to you and you think you may need to return \nto the hospital, please call the ___ HeartLine at ___ \nto speak to a cardiologist or cardiac nurse practitioner.  \n It has been a pleasure to have participated in your care and we \nwish you the best with your health!  \n Your ___ Cardiac Care Team  \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048225fb505ee753914dd7"
  },
  "note_id": "15777991-DS-14",
  "subject_id": 15777991,
  "hadm_id": 29125745,
  "note_type": "DS",
  "note_seq": 14,
  "charttime": "2169-04-19 00:00:00",
  "storetime": "2169-04-19 19:02:00",
  "text": " \nName:  ___           ___ No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\ntrauma s/p fall\n \nMajor Surgical or Invasive Procedure:\nIntubation and Extubation\n\n \nHistory of Present Illness:\nMr. ___ is a ___ old man, currently \nincarcerated ___ a medical unit undergoing detox for alcohol \nabuse, who received 2mg Ativan ___ the morning, then fell \nbackwards and hit his ___. There is report of possible seizure \nactivity, but this was unwitnessed. He does have a history of \nprior alcohol withdrawal seizures. He presents as a trauma \nactivation with altered mental status and a ___ laceration. \n \nPast Medical History:\nEtOH abuse, EtOH withdrawal seizures, possible hepatic \nencephalopathy on lactulose, cirrhosis, portal HTN\n \nSocial History:\n___\nFamily History:\nNo family history of sudden cardiac death\n \nPhysical Exam:\nADMISSION EXAM\n==============\nGENERAL: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNECK: supple, JVP not elevated, no LAD  \nLUNGS: Clear to auscultation bilaterally, no wheezes, rales,\nrhonchi  \nCV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs,\ngallops  \nABD: soft, non-tender, non-distended, bowel sounds present, no\nrebound tenderness or guarding, no organomegaly  \nEXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or\nedema  \n\nDISCHARGE EXAM\n==============\nVITALS: \n98.0, BP 122 / 63, HR 78, RR 18, O2 96 Ra  \nGENERAL: NAD, sitting upright ___ bed\nEYES: EOMI. R eye with notable hemorrhagic\nconjuncitivitis/chemosis that is significantly improved, mild\nproptosis compared to L eye.\nENT: OP clear, MMM.\nCV: RRR, no m/r/g\nRESP: Clear to auscultation \nGI: non-tender, non-distended. \nMSK: WWP, no lower extremity edema\nSKIN: No rashes noted\nNEURO: Oriented x3. Answers all questions appropriately \nEOMI, Moving all extremities. \n \nPertinent Results:\nADMISSION:\n============\n___ 09:20AM BLOOD WBC-2.1* RBC-3.51* Hgb-9.0* Hct-28.2* \nMCV-80* MCH-25.6* MCHC-31.9* RDW-16.7* RDWSD-48.0* Plt Ct-85*\n___ 05:00PM BLOOD Neuts-83* Bands-1 Lymphs-6* Monos-8 Eos-1 \nBaso-0 ___ Metas-1* Myelos-0 NRBC-1* AbsNeut-2.27 \nAbsLymp-0.16* AbsMono-0.22 AbsEos-0.03* AbsBaso-0.00*\n___ 05:00PM BLOOD Hypochr-1+* Anisocy-1+* Poiklo-1+* \nMacrocy-NORMAL Microcy-OCCASIONAL Polychr-OCCASIONAL \nOvalocy-OCCASIONAL Tear Dr-OCCASIONAL\n___ 02:31AM BLOOD Plt Ct-76*\n___ 09:20AM BLOOD ___ PTT-31.0 ___\n___ 05:00PM BLOOD Glucose-115* UreaN-9 Creat-0.8 Na-139 \nK-3.9 Cl-102 HCO3-23 AnGap-14\n___ 04:07AM BLOOD ALT-15 AST-45* AlkPhos-78 TotBili-1.1\n___ 09:20AM BLOOD Lipase-68*\n___ 05:00PM BLOOD Calcium-9.7 Phos-2.4* Mg-1.8\n___ 09:20AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nBnzodzp-POS* Barbitr-NEG Tricycl-NEG\n___ 04:20PM BLOOD TSH-2.6\n___ 06:05AM BLOOD Vanco-18.6\n___ 09:32AM BLOOD ___ pO2-29* pCO2-41 pH-7.44 \ncalTCO2-29 Base XS-2\n___ 09:32AM BLOOD Glucose-103 Lactate-1.9 Na-135 K-3.7 \nCl-103\n___ 09:32AM BLOOD Hgb-9.2* calcHCT-28 O2 Sat-44 COHgb-0.6 \nMetHgb-0\n___ 09:32AM BLOOD freeCa-1.25\n\nIMAGING:\n========\nCT ___ ___\n.\n\nN\no\n\ne\nv\ni\nd\ne\nn\nceoffractureoracutehemorrhage.Suggestionoflatesubacute \norchronictinylefthemisphericvertexhematoma.\n2.Rightparietalscalpsofttissueswelling,laceration.\n\nCT C-Spine ___. No acute fracture. \n2. Chronic subtle fracture left C1 transverse process. \n3. Moderate degenerative changes, as above.. \n\nCT C/A/P ___.Noevidenceofholloworsolidorganinjury.\n2.Agevaryingleft \nsidedribfractures.Ananteriorleftfourthribfracture \na\np\np\ne\na\nr\ns\n\np\nr\no\nb\na\n___subacute.Alateralleftfifthribfractureappearsacuteor \ns\nu\nb\na\nc\nu\nt\ne\n.\n\nA\nn\n\nanteriorlefttenthribfractureappearssubacute,withbridging \nc\na\nl\nl\nu\ns\n\nf\no\nr\nmation.Aposteriorlefteleventhribfractureappearssubacute, \nwithbridgingcallusformation.\n3\n.\n\nCirrhosiswithevidenceofportalhypertensionincludingalarge\nr\ne\nc\na\nn\na\nl\ni\nz\ne\nd\n\numbilicalvein,esophagealvarices,largeanteriorabdominaland \np\ne\nl\nv\ni\nc\n\nw\na\nllcollateralsdrainingintothebilateralinternalandexternal\ni\nl\ni\na\nc\nveins,splenomegaly,andprobablytracegallbladderwalledema.\n\nMRI ___ ___.Thestudyisdegradedbymotionartifact.\n2\n.\n\nT\nh\ne\nr\ne\n\ni\nsaquestionablesubacutetochronic5mminfarctversusartifac \n___ therightcentrumsemiovale.\n3\n.\n\nS\nu\ns\np\ne\nc\nt\ne\nd\n\nsubacutetochronicinfarct___theposterioraspectoftheright \nsuperiorfrontalgyrus.\n4\n.\n\nM\nu\nl\nt\ni\np\nl\ne\n\nbilateralchroniccerebellarinfarcts.Generalizedcerebraland \ncerebellaratrophyisslightlypronouncedforage.\n5\n.\n\nT\nh\ne\n\np\nr\neviouslynotedduralthickening/subduralhemorrhageonCT___the\nrightfrontalarea,isnotclearlynotedonthisMRIstudy.\n6\n.\n\nW\ni\nt\n___thelimitationsofthemarkedlymotiondegradedpostcontrast\nimaging,thereisnoabnormalenhancingintracraniallesions.\n7\n.\n\nM\ni\nl\nd\n\nm\no\nd\ne\nr\na\nt\ne\n\np\na\nr\nt\ni\na\nl\n\no\np\na\nc\ni\nf\ni\nc\na\nt\ni\no\nn\n\no\nf\n\nt\nh\ne\n\np\na\nr\na\nn\na\ns\na\nl\n\ns\ni\nn\nu\ns\ne\ns\n\nw\ni\nt\nh\n\nm\nu\nl\nt\ni\np\nl\ne\n\nf\nl\nu\nidlevelspresent___theethmoidaircellsandsphenoidsinuses.\n\nEEG ___:\nIMPRESSION: This is an abnormal continuous ICU EEG monitoring \nstudy because\nof diffuse and severe background attenuation and slowing, \nconsistent with a\nsevere encephalopathy. The most common causes include, but are \nnot limited\nto, medication effect, metabolic derangement and/or infection. \nThere are rare broad-based sharp waves seen ___ the frontal \ncentral regions bilaterally, sometimes more prominently on the \nright side, which may indicate underlying cortical \nhyperexcitability. There are no electrographic seizures.\n\nCTA ___ ___:\nNo definite CT findings to suggest a ___ fistula. \nThe intracranial arteries are patent with no evidence of \nstenosis, occlusion or aneurysm.  \nCT findings suggest preseptal/periorbital cellulitis.  No \nfindings to suggest orbital cellulitis. \nNOTE: Although there are no CT findings to suggest a \n___ fistula - given the filling of the venous \nsystem, an MRA may be more helpful for further evaluation. \n\nMICROBIOLOGY:\n=============\n\n___ 8:51 pm URINE      Source: Catheter. \n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      ENTEROCOCCUS FAECALIS.    >100,000 CFU/mL. \n\n                              SENSITIVITIES: MIC expressed ___ \nMCG/ML\n                      \n_________________________________________________________\n                             ENTEROCOCCUS FAECALIS\n                             |   \nAMPICILLIN------------   <=2 S\nNITROFURANTOIN--------  <=16 S\nTETRACYCLINE----------  =>16 R\nVANCOMYCIN------------     1 S\n\n___ 10:00 pm BRONCHIAL WASHINGS      LEFT. \n\n                            **FINAL REPORT ___\n\n   GRAM STAIN (Final ___: \n      4+   (>10 per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      4+   (>10 per 1000X FIELD):   GRAM NEGATIVE ROD(S). \n      1+    (<1 per 1000X FIELD):   GRAM POSITIVE COCCI. \n                                    ___ PAIRS. \n\n   RESPIRATORY CULTURE (Final ___: \n      ~6000 CFU/mL Commensal Respiratory Flora. \n      HAEMOPHILUS INFLUENZAE, BETA-LACTAMASE NEGATIVE.    \n>100,000 CFU/mL. \n         Beta-lactamse negative: presumptively sensitive to \nampicillin. \n         Confirmation should be requested ___ cases of treatment \nfailure ___\n         life-threatening infections.. \n\n___ 2:50 pm CSF;SPINAL FLUID      Source: LP. \n\n   Enterovirus Culture (Preliminary):    No Enterovirus \nisolated. \n\n___ 3:46 am SPUTUM      Source: Endotracheal. \n\n   GRAM STAIN (Final ___: \n      ___ PMNs and <10 epithelial cells/100X field. \n      1+    (<1 per 1000X FIELD):   GRAM POSITIVE COCCI. \n                                    ___ PAIRS. \n\n   RESPIRATORY CULTURE (Final ___: \n      RARE GROWTH Commensal Respiratory Flora. \n\nDISCHARGE LABS:\n================\n___ 06:30AM BLOOD WBC-3.0* RBC-3.22* Hgb-8.4* Hct-26.7* \nMCV-83 MCH-26.1 MCHC-31.5* RDW-19.9* RDWSD-56.9* Plt ___\n___ 02:25AM BLOOD Neuts-46.0 Lymphs-12.0* Monos-36.3* \nEos-3.4 Baso-0.3 Im ___ AbsNeut-1.61# AbsLymp-0.42* \nAbsMono-1.27* AbsEos-0.12 AbsBaso-0.01\n___ 06:00AM BLOOD ___ PTT-32.4 ___\n___ 06:30AM BLOOD Glucose-90 UreaN-14 Creat-0.6 Na-140 \nK-3.7 Cl-104 HCO3-24 AnGap-12\n___ 06:30AM BLOOD ALT-40 AST-87* AlkPhos-104 TotBili-1.2\n___ 03:26AM BLOOD Triglyc-64 HDL-31* CHOL/HD-3.5 LDLcalc-___ yo M with a past history of incarceration, HTN, alcohol \nabuse, presented from prison after fall from top bunk with ___ \nstrike, AMS, concern for alcohol detox, possible seizure-like \nactivity. Initially admitted to ___ for CIWA management and \nmonitoring, then to ___ for further AMS work up, now stabilized \nand transferred to medicine.\n\nACUTE ISSUES:\n=============\n#Metabolic Encephalopathy:\n___ the TSICU, on ___, his mental status remained stable but he \nwas not oriented and minimally communicative. A repeat NCHCT \n___ was stable. He had increasing secretions and there was \nconcern for respiratory infection so he was intubated & \nbronchoscopy was performed. Infectious work up was notable for H \nFlu on bronchoscopy and E. faecalis UTI so he received a course \nof ampicillin. Neurology was consulted ___ given concerns for \npersistently altered AM. EEG was performed w/o evidence of \nseizures. LP was performed and Enterovirus negative ___ CSF. An \nMRI ___ showed subacute & chronic infarcts ___ the posterior \naspect of the superior frontal gyrus, and bilateral chronic \ncerebellar infarcts. Ultimately Neurology felt AMS was ___ toxic \nmetabolic encephalopathy. On ___, he was started on \npolyethylene glycol given the fact that his girlfriend reported \nthat sometimes he would become altered if he stopped his home \nlactulose. He was able to have an adequate amount of stool \noutput over the next several days but AMS did not improve. He \nwas transferred to MICU for further work-up of his mental \nstatus. Upon MICU admission, he was started on an increased \nlactulose regimen and had a notable improvement ___ mental status \n___ his first day ___ the MICU. His mental status improved \nsignificantly to being able to be extubated without event. On \nthe floor, he was continued on lactulose and rifaximin. He was \nnoted to take gabapentin as a home medication 600 TID, although \nhe did not receive beginning when he was imprisoned, so there is \na question of whether an abrupt discontinuation could have \ncontributed to his AMS. The indication for the gabapentin is \nunclear, but he was resumed on 600 TID and tapered to 300 TID. \nThe overall etiology was deemed like to be hepatic \nencephalopathy given improvement with lactulose. Also possibly \n___ body dementia given visual hallucinations. \n\n#Lagophthalmos\n#Exposure keratopathy\n#Elevated Intraocular Pressure (R eye)\n#Hemorrhagic Chemosis:\nPatient with new chemosis and increased right sided intraocular \npressures compared to the left. Per optho, concern for carotid \ncavernous fistula. He had a CTA which was unable to rule out \nCCF, but the pretest probability was very low. He was evaluated \nby optho, and he was given ciprofloxacin, brimonidine, and \nartificial eye gtt. Prior to discharge, the cipro and \nbrimonidine was stopped and he was continued on artificial eye \nointment every 2 hours. On discharge, he can continue the \nointment every 6 hours until seeing ophthalmology. \n\n#Alcohol Withdrawal: \nETOH W/drawal: He was reported to have seizure-like activity \n___ at jail as well as alcohol withdrawal. His LFTs and \nammonia were wnl. He was loaded with phenobarbital and tapered \nfrom ___. He did not require rescue doses of \nphenobarbital and did not have withdrawal-like symptoms. He was \ncontinued on thiamine, folate, B12 supplementation. His HIV test \nwas pending at discharge. \n\n#Hypertension: \nPatient with history of HTN but his home medications are \nunknown. Regimen per pharmacy records: lisinopril 5mg Po daily, \nmetoprolol 75mg PO daily, although metoprolol not listed on meds \nlist when patient was initially incarcerated. BPs elevated to \n150s-160s. He was restarted on home lisinopril but metoprolol \nwas held.\n\n#Pancytopenia:\nPatient with decrease ___ all cell lines. Initially attributed to \nbone marrow suppression from acute illness and alcohol intake. \nPatient with iron deficiency anemia and s/p IV iron and 1 U PRBC \n___. Continued ferrous sulfate 325mg PO daily. \n\n#Rib fractures\n___ laceration:\nPatient with left 4,5,10,11 rib fractures. No chest pain at time \nof discharge. \n\nCHRONIC/RESOLVED ISSUES:\n========================\n#History of Strokes\nMR ___ notable for subacute to chronic infarcts ___ the R \ncentrum semiovale, posterior aspect of the R superior frontal \ngyrus, b/l chronic cerebellar infarcts. He was seen by Neurology \nwho recommended outpatient follow-up and initiation of aspirin. \nLipid panel showed LDL 65 and HDL 31.\n\n# PNA: Patient was initially intubated for airway protection and \ncopious secretions. Patient was bronched and was shown to be \ngrowing commensal respiratory flora and H. flu. He received \nampicillin for H. flu pneumonia finished on ___. \n\n# UTI: Urine culture from ___ grew Enterococcus Faecalis >100K \nCFU/mL sensitive to ampicillin and vancomycin. He received full \ncourse of ampicillin and finished on ___.\n\n# Anxiety: Continue FLUoxetine 40 mg PO/NG DAILY. Held home \nhydroxyzine\n\n# GERD: Continue omeprazole \n\nTRANSITIONAL ISSUES:\n#Alcohol withdrawal\n- STARTED thiamine, b12, folate\n\n#Encephalopathy: \n[] Please uptitrate lactulose to q4h if patient becomes more \nencephalopathic. If patient's mental status is clear, please \ncontinue lactulose TID\n- Patient has been arranged for follow-up with a new \nHepatologist at ___\n\n#Stroke:\n- STARTED aspirin 81 mg daily\n[] Consider statin initiation for secondary stroke prevention \nalthough baseline LDL 65\n\n#Right eye chemosis:\n[] CONTINUE artificial tears ointment q6h until follow-up with \nophthalmology \n[] Please ensure patient has close follow up with ophthalmology \nfor his right eye chemosis. ___ Ophthalmology will coordinate \nfollow-up, but if you do not hear back ___ 1 week, please call \n___ \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Gabapentin 600 mg PO TID \n2. Lactulose 30 mL PO TID \n3. Omeprazole 20 mg PO DAILY \n4. QUEtiapine Fumarate 50 mg PO QHS \n5. Rifaximin 550 mg PO BID \n6. Lisinopril 5 mg PO DAILY \n7. HydrOXYzine 25 mg PO Q4H:PRN anxiety \n\n \nDischarge Medications:\n1.  Artificial Tear Ointment 1 Appl RIGHT EYE Q2H eye \nlubrication  \n2.  Aspirin 81 mg PO DAILY  \n3.  Cyanocobalamin 1000 mcg PO DAILY  \n4.  Ferrous Sulfate 325 mg PO DAILY  \n5.  FoLIC Acid 1 mg PO DAILY  \n6.  Thiamine 100 mg PO DAILY  \n7.  FLUoxetine 40 mg PO DAILY  \n8.  Gabapentin 300 mg PO TID  \n9.  Lactulose 30 mL PO TID  \n10.  Lisinopril 5 mg PO DAILY  \n11.  Omeprazole 20 mg PO DAILY  \n12.  Rifaximin 550 mg PO BID  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary:\n- Acute toxic metabolic and hepatic encephalopathy \n- ETOH withdrawal seizures and delirium tremens\n- H. Influenza pneumonia and Enterococcal UTI\n- ETOH induced pancytopenia\n- Traumatic scalp laceration\n- Traumatic OD bullous/hemorrhagic chemosis and lagopthalmos\n- Traumatic rib fractures\n\nSecondary:\n- ETOH cirrhosis and portal hypertension\n- Subacute/chronic right superior frontal and bilateral \ncerebellar strokes\n- Hypertension\n- Anxiety\n- GERD\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\n\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___,\n\nIt was a pleasure to care for you during your hospital stay.\n\nYou were brought ___ because you had a fall from your bunk bed \nand there was concern you were having withdrawal symptoms from \nalcohol. When you came into the ED, you had multiple scans of \nyour ___ to look for reasons why you were confused. You were \nadmitted to the intensive care unit where you had multiple tests \ndone, including brain scans, spinal taps. The brain scans showed \nyou may have had small old strokes. You were treated for a \npneumonia and a urinary tract infection. You were also treated \nfor alcohol withdrawals. Your thinking became clearer after \ntaking lactulose.\n\nYour right eye also became red and swollen. You were seen by eye \ndoctors who thought ___ may have had damage from your fall. You \nmore scans and imaging done.\n\nWhen you leave, please make sure to take your medications and \nfollow up with your doctors as listed below. \n\nWe wish you all the best,\n\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048225fb505ee753914dd8"
  },
  "note_id": "15777991-DS-15",
  "subject_id": 15777991,
  "hadm_id": 24338955,
  "note_type": "DS",
  "note_seq": 15,
  "charttime": "2170-03-18 00:00:00",
  "storetime": "2170-03-18 20:27:00",
  "text": " \nName:  ___           ___ No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nAbdominal pain, variceal bleeding \n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ is a ___ year-old man with a history of alcoholic\ncirrhosis complicated by hepatic encephalopathy, withdrawal\nseizures, HTN, anxiety, PFO and CVA who presents as a transfer\nfrom an OSH for possible TIPS procedure following an aborted\nex-laparotomy for concern of ischemic large bowel which was\nunable to be completed in the setting of variceal hemorrhage. \n \nPer the patient and available records, the patient presented to\n___ 6 days ago on ___ with complaints of\ngeneralized abdominal pain, nausea, vomiting and diarrhea. He\ntypically has loose stools with his daily lactulose, however,\nsought medical attending with acute onset of diarrhea, nausea,\nand non-bloody, non-bilious emesis and generalized abdominal\npain. At ___ he was hemodynamically stable, his \nexam\nwas reportedly concerning for peritonitis. Labs were significant\nfor a lactate up to 3.0, Cr 4.6, EtOH level 0. A non-contrast CT\nscan was performed and demonstrated extensive mural thickening\nand pericolic fat stranding of the entire ascending colon with\nseveral small foci of extraluminal air but without mesenteric or\nportal venous air. \n\nHe was subsequently transferred to ___\nand taken to the OR emergently on ___ for an attempted\nexploratory laparotomy which was aborted prior to entering the\nperitoneum secondary to significant bleeding from abdominal\nvarices and recanalized umbilical vein. He was kept intubated \nand\nsedated until POD#2 at which time his lactate had normalized and\nhe was extubated. He had a fever to 101.0 on POD#2 and IV flagyl\nwas initiated. He was transferred to the floor, NGT removed and\nultimately transferred to ___ for possible TIPS procedure on\nthe evening of POD#5 (___).    \n\nOn arrival to the floor he reports feeling relatively well. He\nreports his foley was removed yesterday afterwhich he was able \nto\nvoid, however, it was subsequently replaced. He endorses\nincisional abdominal pain and mild right abdominal pain at rest\nwhich worsens with palpation. He also notes buttock pain and\nright elbow pain. He denies fevers, chills, chest pain,\npalpitation, nausea, vomiting, constipation, yellowing of the\neyes or skin, dizziness or new rashes. He reports 2 non-bloody\nbowel movements earlier today following the administration of\nlactulose.  \n\n \nPast Medical History:\nPMH:  \nCVA - embolic infarcts \nAlcohol abuse\nAlcoholic cirrhosis \nHepatic encephalopathy \nWithdrawal seizures \nToxic metabolic encephalopathy \nEsophageal varices\nPortal Hypertension \nPatent Foramen Ovale - undergoing work-up for closure \nPossible hypercoagulable state - pending work-up\nAnemia\nGERD\nHTN\nAnxiety \nRight eye chemosis \nUrinary tract infection (E. faecalis)\nPneumonia (H. influenza)\nColonoscopy - records not available, reportedly ___ years ago\n\nPSH:  \nKnee surgery \n\"Eye surgery\" not otherwise specified \n\n \nSocial History:\n___\nFamily History:\nMother - ___ cancer\nFather - EtOH abuse & CAD\nBrother - EtOH abuse & CAD\n \nPhysical Exam:\nADMISSION PHYSICAL EXAMINATION:\n24 HR Data (last updated ___ @ 2259)\nTemp: 99.0 (Tm 99.0), BP: 132/67, HR: 83, RR: 22, O2 sat: 96% %,\nO2 delivery: RA\n\nFluid Balance (last updated ___ @ 2255)\n  Last 8 hours  Total cumulative 0ml\n    IN: Total 0ml\n    OUT:  Total 0ml, Urine Amt 0ml\n  Last 24 hours  Total cumulative 0ml\n    IN: Total 0ml\n    OUT:  Total 0ml, Urine Amt 0ml\n\nGEN: A&Ox3, pleasant, conversant \nHEENT: Periorbital & perinasal dermatitis, no scleral icterus,\nmucous membranes moist, RIJ CVL in place without surrounding\nerythema  \nPULM: Breathing comfortably on room air  \nCV: RRR\nABD: Obese, distended, abdominal binder in place, recent ex-lap\nincision approximated with staples, no drainage or surrounding\nerythema, dressed with dry gauze, tender to palpation in RLQ, no\nrebound or guarding \nEXT: WWP bilaterally, +2 pitting edema bilaterally \nNEURO: moves all limbs spontaneously, no focal deficits, no\nasterixis \n\nDISCHARGE PHYSICAL EXAM: \nVITALS: 98.1PO, 128 / 69R Sitting, 91, 18, 95 Ra \nGeneral: NAD, resting comfortably\nHEENT: MMM, anicteric sclera\nNeck: supple, no JVD\nLung: scattered crackles bl, no rhonchi/wheeze, comfortable RA\nCard: RRR, ___ systolic murmur over upper sternal borders, no \nR/G\nAbd: Soft, abd obese/distended but soft and nontender. surgical \nwound covered with dry dressing c/d/I. wearing abdominal binder. \n\nExt: 1+ ___ edema \nNeuro: grossly intact, AAOX3, no asterixis \n\n \nPertinent Results:\nADMISSION LABS: \n===============\n___ 11:21PM BLOOD WBC-5.7 RBC-2.96* Hgb-9.3* Hct-27.5* \nMCV-93 MCH-31.4 MCHC-33.8 RDW-15.5 RDWSD-52.2* Plt Ct-93*\n___ 11:21PM BLOOD ___ PTT-28.4 ___\n___ 11:21PM BLOOD Glucose-112* UreaN-12 Creat-0.8# Na-149* \nK-3.7 Cl-115* HCO3-20* AnGap-14\n___ 11:21PM BLOOD ALT-10 AST-23 AlkPhos-50 TotBili-1.1\n___ 11:21PM BLOOD Calcium-8.7 Phos-2.0* Mg-1.6\n\nDISCHARGE LABS: \n===============\n___ 05:18AM BLOOD WBC-5.0 RBC-2.60* Hgb-8.2* Hct-24.4* \nMCV-94 MCH-31.5 MCHC-33.6 RDW-16.0* RDWSD-52.5* Plt Ct-88*\n___ 05:18AM BLOOD ___ PTT-33.4 ___\n___ 05:18AM BLOOD Glucose-102* UreaN-8 Creat-0.8 Na-140 \nK-4.2 Cl-109* HCO3-20* AnGap-11\n___ 05:18AM BLOOD ALT-8 AST-23 LD(LDH)-249 AlkPhos-51 \nTotBili-1.1\n___ 05:18AM BLOOD Albumin-3.1* Calcium-8.4 Phos-2.0* Mg-1.6\n\nMICRO: \n======\n__________________________________________________________\n___ 3:35 pm URINE      Source: ___. \n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___:    NO GROWTH. \n__________________________________________________________\n___ 5:32 am BLOOD CULTURE\n\n   Blood Culture, Routine (Pending):    No growth to date. \n__________________________________________________________\n___ 11:06 am STOOL     CONSISTENCY: NOT APPLICABLE\n      Source: Stool. \n\n                            **FINAL REPORT ___\n\n   OVA + PARASITES (Final ___: \n      CANCELLED.    PATIENT HAS BEEN HOSPITALIZED FOR >3 DAYS. \n__________________________________________________________\n___ 8:16 pm BLOOD CULTURE      Source: Line-PICC. \n\n   Blood Culture, Routine (Pending):    No growth to date. \n__________________________________________________________\n___ 10:28 am MRSA SCREEN      Source: Nasal swab. \n\n                            **FINAL REPORT ___\n\n   MRSA SCREEN (Final ___:    No MRSA isolated. \n__________________________________________________________\n___ 12:45 am STOOL     CONSISTENCY: NOT APPLICABLE\n      Source: Stool. \n\n   OVA + PARASITES (Pending): \n__________________________________________________________\n___ 4:03 pm STOOL     CONSISTENCY: WATERY      Source: \nStool. \n\n                            **FINAL REPORT ___\n\n   FECAL CULTURE (Final ___: \n      NO ENTERIC GRAM NEGATIVE RODS FOUND. \n      NO SALMONELLA OR SHIGELLA FOUND. \n\n   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER \nFOUND. \n\n   OVA + PARASITES (Final ___: \n      NO OVA AND PARASITES SEEN. \n      This test does not reliably detect Cryptosporidium, \nCyclospora or\n      Microsporidium. While most cases of Giardia are detected \nby routine\n      O+P, the Giardia antigen test may enhance detection when \norganisms\n      are rare. \n      MODERATE POLYMORPHONUCLEAR LEUKOCYTES. \n\n   FECAL CULTURE - R/O VIBRIO (Final ___:    NO VIBRIO \nFOUND. \n\n   FECAL CULTURE - R/O YERSINIA (Final ___:    NO YERSINIA \nFOUND. \n\n   FECAL CULTURE - R/O E.COLI 0157:H7 (Final ___: \n      No E. coli O157:H7 found. \n__________________________________________________________\n___ 4:03 pm STOOL     CONSISTENCY: WATERY      Source: \nStool. \n\n                            **FINAL REPORT ___\n\n   C. difficile PCR (Final ___: \n      NEGATIVE. \n           (Reference Range-Negative). \n      The C. difficile PCR is highly sensitive for toxigenic \nstrains of C.\n      difficile and detects both C. difficile infection (CDI) \nand\n      asymptomatic carriage. \n      A negative C. diff PCR test indicates a low likelihood of \nCDI or\n      carriage. \n__________________________________________________________\n___ 3:35 pm BLOOD CULTURE\n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n__________________________________________________________\n___ 2:37 pm URINE      Source: ___. \n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \nWITH SKIN\n      AND/OR GENITAL CONTAMINATION. \n__________________________________________________________\n___ 2:37 pm BLOOD CULTURE      Source: Line-IJ . \n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n__________________________________________________________\n___ 5:54 am BLOOD CULTURE\n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n__________________________________________________________\n___ 5:28 am URINE      Source: Catheter. \n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___:    NO GROWTH. \n__________________________________________________________\n___ 11:35 pm BLOOD CULTURE      Source: Line-cvl. \n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n\nSTUDIES: \n========\nCHEST (PORTABLE AP) Study Date of ___  \nCentral venous line terminates in the upper SVC.  No \npneumothorax.\n\nPORTABLE ABDOMEN Study Date of ___  \n1.  There is no gross pneumoperitoneum in this limited supine \nstudy. \n2.  Mild postoperative colonic ileus. \n\nCHEST (PORTABLE AP) Study Date of ___  \n1. Interval repositioning of a left PICC line, now projecting at \nthe superior \ncavoatrial junction. \n2. Interval removal of a right internal jugular central line. \n3. Otherwise no substantial interval change \n\nCTA ABD & PELVIS Study Date of ___ \n1. Interval improvement of signs of colitis, could be ischemic \ngiven the \nanatomical segment involved.  Diagnostic considerations include \ninflammatory \nand infectious causes. \n2. Interval splenic size increase. \n3. Cirrhosis with signs of portal hypertension. \n4. Pulmonary airspace disease, ground-glass opacities and a \nmiddle lobe \nnodule, likely infective, interstitial edema seems less likely, \ncorrelate \nclinically.  Follow-up after treatment is recommended. \n\nTTE ___ \nThe left atrial volume index is normal. There is a possible \natrial septal defect (clips 101, 102) that could\nnot be confirmed due to inability to obtain subcostal views. \nThere is normal left ventricular wall\nthickness with a normal cavity size. There is normal regional \nand global left ventricular systolic\nfunction. Quantitative biplane left ventricular ejection \nfraction is 64 %. Left ventricular cardiac\nindex is normal (>2.5 L/min/m2). There is no resting left \nventricular outflow tract gradient. No\nventricular septal defect is seen. Normal right ventricular \ncavity size with normal free wall motion. The\naortic sinus diameter is normal for gender with normal ascending \naorta diameter for gender. The aortic\narch is mildly dilated with a normal descending aorta diameter. \nThe aortic valve leaflets (3) are mildly\nthickened. There is no aortic valve stenosis. There is no aortic \nregurgitation. The mitral valve leaflets\nappear structurally normal with no mitral valve prolapse. There \nis trivial mitral regurgitation. The\ntricuspid valve leaflets appear structurally normal. There is \nmild [1+] tricuspid regurgitation. There is\nmild pulmonary artery systolic hypertension. There is no \npericardial effusion.\nIMPRESSION: Normal biventricular cavity sizes and \nregional/global systolic function. No\nvalvular pathology or pathologic flow identified. Mild pulmonary \nartery systolic hypertension.\nMildly dilated aortic arch. Possible secundum type atrial septal \ndefect.\nCompared with the prior TTE (images reviewed) of ___, the \nfindings are similar.\n\n \nBrief Hospital Course:\n___ with history of alcoholic cirrhosis complicated by hepatic \nencephalopathy, withdrawal seizures, HTN, anxiety, PFO and CVA \nwho presented with abdominal pain and diarrhea, transferred from \n___ to ___ after an attempted ex-lap for concern \nof ischemic bowel that was aborted ___ significant bleeding \nthought ___ abdominal wall varices. This admission at ___, he \nwas stable without evidence of bleeding, with imaging showing \nimprovement of colitis. \n\n#Colitis \n#Bleeding\n#S/P aborted Ex-Lap\nPt had urgent attempted ex-lap at ___ on ___ \nfor concern of ischemic colitis, with CT findings also of small \nfoci of extraluminal air. Ex lap was aborted prior to entering \nthe peritoneum due to significant bleeding reportedly from \nabdominal wall varices and recanalized umbilical vein. At ___. \n___ he was kept intubated and sedated until POD#2 at \nwhich time his lactate had normalized and he was extubated. He \nwas treated with CTX/flagyl. He was transferred to ___ due to \nquestion of need for TIPS. This admission, he was HDS and had no \nevidence of continued bleeding or signs of variceal bleeding, \nwithout indication for TIPS. Repeat CT showed interval \nimprovement in colitis without extraluminal air. Unclear \netiology of colitis - initial c/f ischemic colitis though \nsubsequent CTA unrevealing, though pt does have h/o PFO with \nprior CVAs and could consider embolic event in this setting. He \nwas treated with CTX/flagyl with transition to levofloxacin on \n___ as below. \n\n___ \nThis admission, Cr peak of 1.4 from 0.9 on admission. ___ \nresolved with albumin; most likely it was prerenal. Held home \ndiuretics/beta blocker and renally dosed gabapentin until renal \nfunction improved. Restarted home diuretics on discharge. \nStopped home atenolol as indication for this appeared to be HTN \n(no h/o afib) and pt was normotensive off of atenolol. \n\n#Shortness of breath\nPatient described subacute exertional dyspnea which had been \nworsening for\nthe last ___ weeks prior to admission. He had a history of \nenlarging PFO on TTE in ___. Repeat TTE this admission \ndemonstrated similar findings of possible secundum type ASD. \n\n#PNA\nFound incidentally on CT A/P to have pulmonary airspace disease, \nground-glass opacities and a middle lobe nodule, likely \ninfective. This imaging finding was noted after pt had been on \nCTX/flagyl for >7 days; patient was very well appearing and \nthese findings may have been partly treated. He was transitioned \nto levofloxacin ___ to complete a ___lcoholic cirrhosis complicated by hepatic encephalopathy, \nGrade\n1 varices. \nHe was stable from cirrhosis standpoint this admission. As \nabove, there was no indication for TIPS this admission. Home \nLasix and spironolactone were held for ___, but restarted upon \ndischarge. Continued home lactulose and rifaximin \n\n#History of Strokes/PFO\nWas worked up and considered by cardiology for PFO closure, with \nh/o CVA thought embolic related to PFO. Given the patient's \npresentation with a questionable ischemic event, he is being \narranged for continued cardiology followup with plan for closure \nof PFO. We continued the patient on his low dose aspirin.\n\nTRANSITIONAL ISSUES\n==================\nDischarge MELD: 13\nDischarge Cr: 0.8\nDischarge Hb: 8.2\n\n[] Will need outpatient screening EGD to assess for progression \nof varices\n[] Given hx of smoking, should receive PFTs to rule out COPD and \nfurther outpatient work up for recent exertional dyspnea\n[] He is being arranged for cardiology follow up for known PFO \nwith plan for closure. Cardiology was contacted about this \nduring admission and will be reaching out to the patient. \n[] Patient's abdominal surgical wound will need to have staples \nby ___. Pt has been instructed to called his original \nsurgeon at ___, Dr. ___, at ___, \nto make this follow up appointment for staple removal. \nOtherwise, in house transplant surgery says staples are OK to be \nremoved by PCP or in liver clinic. \n[] Patient's surgical wound is healing well. Dry dressings or \nopen to air. \n[] Patient's home diuretics were restarted on discharge. \n[] Please recheck BMP at PCP follow up appointment on ___ to \nevaluate for renal function on diuretics. \n[] discharged on short course of oxy 5 prn x10 tabs for pain \ncontrol. Please assess pain and need for pain meds at ___ follow \nup appointment. \n[] to complete course of levofloxacin (for ?PNA/colitis) on \n___\n\n# CODE: FULL, CONFIRMED\n# CONTACT: \nSon (___) ___\n\nThis patient was prescribed, or continued on, an opioid pain \nmedication at the time of discharge (please see the attached \nmedication list for details). As part of our safe opioid \nprescribing process, all patients are provided with an opioid \nrisks and treatment resource education sheet and encouraged to \ndiscuss this therapy with their outpatient providers to \ndetermine if opioid pain medication is still indicated.\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Atenolol 25 mg PO DAILY \n2. Lactulose 30 mL PO TID \n3. Magnesium Oxide 400 mg PO BID \n4. Gabapentin 800 mg PO TID \n5. QUEtiapine Fumarate 50 mg PO QHS \n6. Furosemide 40 mg PO DAILY \n7. Omeprazole 40 mg PO DAILY \n8. Rifaximin 550 mg PO BID \n9. FLUoxetine 40 mg PO DAILY \n10. FoLIC Acid 1 mg PO DAILY \n11. Thiamine 100 mg PO DAILY \n12. Aspirin 81 mg PO DAILY \n13. Ferrous GLUCONATE 324 mg PO BID \n14. Lisinopril 5 mg PO DAILY \n15. Spironolactone 25 mg PO BID \n16. Naltrexone Extended-release Suspension 380 mg IM EVERY 4  \nWEEKS (FR) \n17. Artificial Tear Ointment 1 Appl BOTH EYES PRN dry \n\n \nDischarge Medications:\n1.  Levofloxacin 750 mg PO DAILY Duration: 5 Days \nRX *levofloxacin 750 mg 1 tablet(s) by mouth daily Disp #*3 \nTablet Refills:*0 \n2.  OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Severe \nRX *oxycodone 5 mg 1 tablet(s) by mouth every 8 hours Disp #*10 \nTablet Refills:*0 \n3.  Artificial Tear Ointment 1 Appl BOTH EYES PRN dry  \n4.  Aspirin 81 mg PO DAILY  \n5.  Ferrous GLUCONATE 324 mg PO BID  \n6.  FLUoxetine 40 mg PO DAILY  \n7.  FoLIC Acid 1 mg PO DAILY  \n8.  Furosemide 40 mg PO DAILY  \n9.  Gabapentin 800 mg PO TID  \n10.  Lactulose 30 mL PO TID  \n11.  Magnesium Oxide 400 mg PO BID  \n12.  Naltrexone Extended-release Suspension 380 mg IM EVERY 4  \nWEEKS (FR)  \n13.  Omeprazole 40 mg PO DAILY  \n14.  QUEtiapine Fumarate 50 mg PO QHS  \n15.  Rifaximin 550 mg PO BID  \n16.  Spironolactone 25 mg PO BID  \n17.  Thiamine 100 mg PO DAILY  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS \ncolitis \ns/p ex lap \nbleeding \npneumonia \ncirrhosis \n\nSECONDARY DIAGNOSIS \nPFO \nhistory of CVA\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___,  \n \n WHY WERE YOU ADMITTED TO THE HOSPITAL?\n - You were admitted to the hospital because you had surgery and \nwere found to have enlarged blood vessels in your belly which \nwere likely due to liver disease. \n\n WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL?  \n - You received a CT scan which confirmed that you had \nimprovement in the inflammation of your gut. \n - You were given antibiotics to treat infection in your lungs \nand abdomen. \n - You improved and were ready to leave the hospital.  \n\n WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL?  \n - Please take all of your medications as prescribed and go to \nyour follow up appointments with your doctors ___ below)   \n - Weigh yourself every morning, before you eat or take your \nmedications. Call your doctor if your weight increases by more \nthan 3 pounds  \n - Please maintain a low salt diet and monitor your fluid intake \n \n - Be aware that the staples on your abdomen need to be removed \nby ___. Call your surgeon from ___, Dr. ___ \n___, at  ___ to make a follow up appointment to \nhave these staples removed. \n\n It was a pleasure participating in your care. We wish you the \nbest!\n \n - Your ___ Care Team  \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048225fb505ee753914dd9"
  },
  "note_id": "15777991-DS-16",
  "subject_id": 15777991,
  "hadm_id": 20298032,
  "note_type": "DS",
  "note_seq": 16,
  "charttime": "2170-03-28 00:00:00",
  "storetime": "2170-03-29 13:56:00",
  "text": " \nName:  ___           ___ No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nlower GI bleed\n \nMajor Surgical or Invasive Procedure:\nNONE\n\n \nHistory of Present Illness:\nMr. ___ is a ___ with a sig PMHx of EtOH cirrhosis c/b\nhepatic encephalopathy, h/o etoh withdrawal seizures, HTN,\nanxiety, PFO, CVA with a recent admission at ___ for TIPS\nconsideration after aborted ex-lap at ___ for \nconcern\nof ischemic bowel, now presenting with BRBPR.\n\nBriefly, the patient had an urgent attempted ex-lap at ___ on ___  for concern of ischemic colitis, with \nCT\nfindings also of small foci of extraluminal air. Ex lap was\naborted prior to entering the peritoneum due to significant\nbleeding reportedly from abdominal wall varices and recanalized\numbilical vein. At ___ he was kept intubated and\nsedated until POD#2 at which time his lactate had normalized and\nhe was extubated. He was treated with CTX/flagyl. \n\nHe was subsequently transferred to ___ on ___ due to \nquestion\nof need for TIPS. During that admission, he was hemodynamically\nstable and had no evidence of continued bleeding or signs of\nvariceal bleeding, without indication for TIPS. Repeat CT showed\ninterval improvement in colitis without extraluminal air.\nAlthough there was an initial concern for ischemic colitis, the \nsubsequent CTA was unrevealing. He was discharged on ___ with\nempiric CTX/Flagyl and transitioned to levofloxacin.\n\nOver the last 2 days, the patient reports 3 episodes passing\nbright red blood per rectum with blood in the toilet bowl. He\ndenies any pain with defecation. He admits to feeling \nlightheaded\nbut he denies any changes in vision. He denies any chest pain,\nnew shortness of breath, nausea, or vomiting. He does admit to\nsome abdominal pain over the area of his laparotomy incision it\nis not any worse than it has been over the past week. He denies\nany swelling in his legs.\n\nIn the ED, initial vitals:  \n98.9 101 136/62 20 97% RA \n\n- Exam notable for:  \nGeneral: Appearing stated age\nHEENT: NCAT, PEERL, MMM \nNeck: Supple, trachea midline\nHeart: RRR, no MRG. No peripheral edema. \nLungs: CTAB. No wheezes, rales, or rhonchi.\nAbd: Soft, NTND. Well-healing vertical laparotomy incision\nwithout drainage or erythema. Mildly tender to palpation over \nthe\nscar site. Brown, mucousy, strongly guaiac positive stool. No\nanal fissures or hemorrhoids.\nGU: No CVA tenderness\nMSK: No obvious limb deformities.\nDerm: Skin warm and dry\nNeuro: Awake, alert, moves all extremities. Mild asterixis.\nPsych: Appropriate affect and behavior\n\n- Labs notable for:  \nHgb 9.8, chem panel wnl, neg UA, nl lactate\n\n- Imaging notable for:  \nN/A\n\n- Pt given:  \n1L NS\ngabapentin 800 mg\nSeroquel 50 mg\nlactulose 30 ml\n\nUpon arrival to the floor, the patient endorses the above \nhistory\nand denies any new complaints. He had one BM which was dark red,\nwhich he says is different compared to his last few BMs. He\ndenies any lightheadedness, syncope, fevers, chills, cp, or\ndyspnea. He denies any abdominal pain or distension, and is\ncontinuing to use his abdominal binder without any issues.\n \nPast Medical History:\nPMH:  \nCVA - embolic infarcts \nAlcohol abuse\nAlcoholic cirrhosis \nHepatic encephalopathy \nWithdrawal seizures \nToxic metabolic encephalopathy \nEsophageal varices\nPortal Hypertension \nPatent Foramen Ovale - undergoing work-up for closure \nPossible hypercoagulable state - pending work-up\nAnemia\nGERD\nHTN\nAnxiety \nRight eye chemosis \nUrinary tract infection (E. faecalis)\nPneumonia (H. influenza)\nColonoscopy - records not available, reportedly ___ years ago\n\nPSH:  \nKnee surgery \n\"Eye surgery\" not otherwise specified \n\n \nSocial History:\n___\nFamily History:\nMother - ___ cancer\nFather - EtOH abuse & CAD\nBrother - EtOH abuse & CAD\n \nPhysical Exam:\nADMISSION EXAM\n====================\nVITALS: 99.0 PO 125 / 70 R Lying 85 18 96 Ra  \nGeneral: pleasant and conversant. lying in bed. nad. \nHEENT: No scleral icterus, dry mucous membranes,JVP not \nelevated,\nno LAD  \nCV: Regular rate and rhythm, ___ systolic ejection murmur over\nRUSB. normal S1 + S2\nLungs: Clear to auscultation bilaterally, no wheezes, rales,\nrhonchi  \nAbdomen: Soft, obese. non-tender, non-distended. wearing\nabdominal binder with abdominal wound c/d/I and covered with\ndressing\nExt: Warm, well perfused, 2+ DP and radial pulses b/l, no\nperipheral edema  \nSkin: Warm, dry, no rashes or notable lesions.  \n\nDISCHARGE EXAM\n====================\n24 HR Data (last updated ___ @ 338)\n    Temp: 98.9 (Tm 99.0), BP: 106/58 (106-143/58-77), HR: 96\n(85-96), RR: 18 (___), O2 sat: 94% (94-98), O2 delivery: RA,\nWt: 225.53 lb/102.3 kg  \nGeneral: pleasant and conversant. lying in bed. nad. \nHEENT: No scleral icterus, JVP not elevated,\nCV: Regular rate and rhythm, ___ systolic ejection murmur over\nRUSB. normal S1 + S2\nLungs: Bibasilar mid-inspiratory crackles.\nAbdomen: Soft, obese. mininmal tenderness in LLQ and RLQ,\nnon-distended. wearing abdominal binder with abdominal wound\nc/d/I and incision dry, staples in place, well-approximated\nExt: Warm, well perfused, 2+ DP and radial pulses b/l, no\nperipheral edema  \nSkin: Warm, dry, no rashes or notable lesions.  \n \nPertinent Results:\nADMISSION LABS\n=====================\n___ 05:27PM   WBC-5.9 RBC-3.10* HGB-9.8* HCT-29.2* MCV-94 \nMCH-31.6 MCHC-33.6 RDW-17.2* RDWSD-57.1*\n___ 05:27PM   NEUTS-65.2 LYMPHS-14.7* MONOS-14.7* EOS-4.6 \nBASOS-0.3 IM ___ AbsNeut-3.87 AbsLymp-0.87* AbsMono-0.87* \nAbsEos-0.27 AbsBaso-0.02\n___ 05:27PM   PLT COUNT-200\n___ 05:27PM   ___ PTT-35.1 ___\n___ 05:27PM   ALBUMIN-3.7 IRON-57\n___ 05:27PM   LIPASE-66*\n___ 05:27PM   ALT(SGPT)-9 AST(SGOT)-28 ALK PHOS-69 TOT \nBILI-1.3\n___ 05:27PM   GLUCOSE-121* UREA N-9 CREAT-1.2 SODIUM-137 \nPOTASSIUM-3.6 CHLORIDE-99 TOTAL CO2-24 ANION GAP-14\n___ 05:34PM   LACTATE-2.4*\n\nMICROBIOLOGY\n==================\n___ 9:42 pm STOOL     CONSISTENCY: WATERY     PRESENCE OF \nBLOOD.\n\n                            **FINAL REPORT ___\n\n   FECAL CULTURE (Final ___: \n      NO SALMONELLA OR SHIGELLA FOUND. \n      NO ENTERIC GRAM NEGATIVE RODS FOUND. \n\n   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER \nFOUND. \n\n   OVA + PARASITES (Final ___: \n      NO OVA AND PARASITES SEEN. \n      . \n      This test does not reliably detect Cryptosporidium, \nCyclospora or\n      Microsporidium. While most cases of Giardia are detected \nby routine\n      O+P, the Giardia antigen test may enhance detection when \norganisms\n      are rare. \n      . \n      MANY RBC'S. \n      FEW POLYMORPHONUCLEAR LEUKOCYTES. \n\n   FECAL CULTURE - R/O E.COLI 0157:H7 (Final ___: \n      No E. coli O157:H7 found. \n\nIMAGING/STUDIES\n=====================\nCTA ABD/PELVIS ___ IMPRESSION:\n1. Interval improvement of signs of colitis, could be ischemic \ngiven the anatomical segment involved.  Diagnostic \nconsiderations include inflammatory and infectious causes.\n2. Interval splenic size increase.\n3. Cirrhosis with signs of portal hypertension.\n4. Pulmonary airspace disease, ground-glass opacities and a \nmiddle lobe\nnodule, likely infective, interstitial edema seems less likely, \ncorrelate clinically.  Follow-up after treatment is recommended.\n\nECHO ___ IMPRESSION: Normal biventricular cavity sizes and \nregional/global systolic function. No valvular pathology or \npathologic flow identified. Mild pulmonary artery systolic \nhypertension. Mildly dilated aortic arch. Possible secundum type \natrial septal defect. \n\nBILATERAL LENIS LOWER EXTREMITIES ___ IMPRESSION: \n1. No evidence of deep venous thrombosis in the right or left \nlower extremity veins.\n2. 2.9 cm left ___ cyst.\n\nDISCHARGE LABS\n===================\n___ 04:09AM BLOOD WBC-2.9* RBC-2.44* Hgb-8.0* Hct-23.3* \nMCV-96 MCH-32.8* MCHC-34.3 RDW-17.0* RDWSD-57.9* Plt ___\n___ 04:09AM BLOOD ___ PTT-31.1 ___\n___ 04:09AM BLOOD Plt ___\n___ 04:09AM BLOOD Glucose-105* UreaN-9 Creat-0.9 Na-142 \nK-3.4* Cl-102 HCO3-25 AnGap-15\n \nBrief Hospital Course:\nMr. ___ is a ___ with a PMH of ETOH cirrhosis c/b hepatic \nencephalopathy, h/o etoh withdrawal seizures, HTN, anxiety, PFO, \nembolic CVA with a recent admission at ___ for TIPS \nconsideration after aborted ex-lap at ___ for \nconcern of ischemic bowel, who was readmitted with lower GI \nbleed. \n\n#BRBPR\n#Ischemic Colitis: Patient was recently admitted and discharged \non ___ for possible colitis, with prior CT evidence \nextraluminal air and concern for ischemic colitis. (Patient had \nundergone an attempted ex-lap on ___ ___ \nthat was aborted due to abdominal wall venous hemorrhage prior \nto transfer to ___ Patient was discharged from ___ ___ \nwith a prescription for levofloxacin to complete a course for \npossible infectious colitis. Shortly following discharge, \npatient began having maroon colored bowel movements multiple \ntimes per day at home. He presented to the liver clinic on \n___ with complaints of lower GI bleed and was admitted to \n___. Cause of lower GI bleed was felt to be most concerning \nfor ischemic colitis. CTA abd/pelvis from ___ had previously \nshown evidence of ischemic colitis but no large vessel embolus \nor thrombus found. Therefore embolism from PFO felt unlikely. \nAdditionally LENIs negative for DVT in lower extremities. \nIschemia most likely due to low flow state, although the timing \nrelative to his initial abdominal pain in early ___ and \nthen his lower GI bleeding in later ___ remained \nenigmatic. Hepatology was consulted during this admission and \nfelt ischemic colitis to be the most likely cause, and did not \nfeel the benefit of colonoscopy would outweigh the risk in this \nsetting. GI bleeding resolved with supportive care. H&H \nremained stable. No need for blood transfusion. \n\n#ETOH cirrhosis complicated by hepatic encephalopathy: MELD 14, \nChild's A. No current evidence of decompensation. Last EGD \n___ with Grade 1 varices. Patient was continued on his home \nlactulose and rifaximin. Lasix/spironolactone were held due to \nGI bleed then restarted prior discharge, which he tolerated \nwell. \n\n___: Patient's baseline Cr is 0.8 and was admitted with Cr \n1.2. This most likely represented pre-renal ___ in the setting \nof his active GI bleed. Received albumin 25g X1 with resolution \nof ___, and renal function subsequently remained stable without \nadditional intervention.\n\n#ETOH use disorder: Doing well with naltrexone. Currently \nsober. Due for next naltrexone injection as an outpatient. \n\n#Patent Foramen Ovale\n#History of Embolic CVA: Patient has a known PFO after an \nembolic CVA in the past. Given unremarkable CTA and lower \nextremity duplex findings, PFO was felt unlikely to be the \ncause of his ischemic colitis. Close outpatient cardiology \nfollow up recommended (not yet scheduled) for consideration of \nclosure. \n\nTRANSITIONAL ISSUES\n=======================\nDISCHARGE HGB: 8.0 \n[ ] Will need outpatient screening EGD to assess for \nprogression of varices\n[ ] Recommend cardiology follow up for known PFO with plan for \nclosure. \n[ ] Due for his next naltrexone injection. Recommend patient \nschedule appointment with PCP. \n[ ] If further episodes of ischemic colitis may consider \nreduction in diuretics in case this is causing hypovolemia and \nlow flow state\n[ ] Recurrent abdominal pain or GI bleeding should likely \nprompt CTA to rule out thrombotic cause\n\n# CODE: FULL, confirmed\n# CONTACT: Son (___) ___\n \n___ on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 81 mg PO DAILY \n2. Ferrous GLUCONATE 324 mg PO BID \n3. FLUoxetine 40 mg PO DAILY \n4. FoLIC Acid 1 mg PO DAILY \n5. Furosemide 40 mg PO DAILY \n6. Gabapentin 800 mg PO TID \n7. Lactulose 30 mL PO TID \n8. Omeprazole 40 mg PO DAILY \n9. QUEtiapine Fumarate 50 mg PO QHS \n10. Rifaximin 550 mg PO BID \n11. Spironolactone 25 mg PO BID \n12. Thiamine 100 mg PO DAILY \n13. Artificial Tear Ointment 1 Appl BOTH EYES PRN dry \n14. Magnesium Oxide 400 mg PO BID \n15. Naltrexone Extended-release Suspension 380 mg IM EVERY 4  \nWEEKS (FR) \n16. OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Severe \n\n \nDischarge Medications:\n1.  Artificial Tear Ointment 1 Appl BOTH EYES PRN dry  \n2.  Aspirin 81 mg PO DAILY  \n3.  Ferrous GLUCONATE 324 mg PO BID  \n4.  FLUoxetine 40 mg PO DAILY  \n5.  FoLIC Acid 1 mg PO DAILY  \n6.  Furosemide 40 mg PO DAILY  \n7.  Gabapentin 800 mg PO TID  \n8.  Lactulose 30 mL PO TID  \n9.  Magnesium Oxide 400 mg PO BID  \n10.  Naltrexone Extended-release Suspension 380 mg IM EVERY 4  \nWEEKS (MO) \nPlease call your primary care doctor to schedule your next \ninjection.   \n11.  Omeprazole 40 mg PO DAILY  \n12.  OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Severe \n \n13.  QUEtiapine Fumarate 50 mg PO QHS  \n14.  Rifaximin 550 mg PO BID  \n15.  Spironolactone 25 mg PO BID  \n16.  Thiamine 100 mg PO DAILY  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary Diagnosis:\n=====================\nLower GI Bleed\nIschemic Colitis\n\nSecondary Diagnosis:\n======================\nETOH Cirrhosis\nPatent Foramen Ovale\nAcute Kidney Injury\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Mr. ___, \n\nYou were admitted to ___. \n\nWHY YOU WERE ADMITTED TO THE HOSPITAL:\n=======================================\n- You were having blood in your bowel movements. \n\nWHAT WAS DONE WHILE YOU WERE IN THE HOSPITAL:\n==============================================\n- We think your bleeding was caused by ischemic colitis which is \ndue to poor blood flow to your intesties. \n- You were seen by the hepatology (liver) doctors. They did not \nthink you needed another colonoscopy. \n- Your blood counts remained stable, and you were not having any \nmore blood in your stool. \n\nWHAT YOU NEED TO DO WHEN YOU GO HOME: \n=====================================\n- Please continue to take all of your medicines as prescribed. \n- Please call your doctor if you have any blood in your stools. \n- Please follow up with your liver and cardiology doctors. \n\nIt was a pleasure taking care of you!\n\nSincerely,\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904820bfb505ee7538f45b8"
  },
  "note_id": "11788694-DS-11",
  "subject_id": 11788694,
  "hadm_id": 24273475,
  "note_type": "DS",
  "note_seq": 11,
  "charttime": "2172-12-21 00:00:00",
  "storetime": "2172-12-24 21:47:00",
  "text": " \nName:  ___                 Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: ORTHOPAEDICS\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nRight distal humerus fracture\n \nMajor Surgical or Invasive Procedure:\nOpen reduction internal fixation of right distal humerus \nfracture\n\n \nHistory of Present Illness:\n___ year old LHD male with hx of CVA with resulting RUE \nspasticity and right hand paralysis presenting with a right \ncomminuted distal humerus fracture s/p fall on ice. Denies \nHS/LOC. Patient does use the elbow for flexion/extension and \nholding items in the elbow, despite lack of hand function. \nClosed injury, he is at neurologic baseline and has palpable 2+ \nRA pulse. This will require surgical fixation.\n\n \nPast Medical History:\nGERD\nCVA (Right sided hemiparesis with spasticity)  \n \nSocial History:\n___\nFamily History:\nnone\n \nPhysical Exam:\nVitals: \n___ 0324 Temp: 98.3 PO BP: 107/71 L Lying HR: 92 RR: 18 O2\nsat: 99% \nGeneral: Well-appearing, breathing comfortably\nMSK:\nRUE:\nIn long arm splint\nNo motor function to hand\nSensation intact to light touch in m/r/u distributions of hand\nFingers warm\n \nPertinent Results:\n___ 03:42AM BLOOD WBC-9.6# RBC-3.88* Hgb-11.7* Hct-34.8* \nMCV-90 MCH-30.2 MCHC-33.6 RDW-13.1 RDWSD-42.7 Plt ___\n \nBrief Hospital Course:\nThe patient presented to the emergency department and was \nevaluated by the orthopedic surgery team. The patient was found \nto have right distal humerus fracture and was admitted to the \northopedic surgery service. The patient was taken to the \noperating room on ___ for open reduction and internal \nfixation of right distal humerus fracture, which the patient \ntolerated well. For full details of the procedure please see the \nseparately dictated operative report. The patient was taken from \nthe OR to the PACU in stable condition and after satisfactory \nrecovery from anesthesia was transferred to the floor. The \npatient was initially given IV fluids and IV pain medications, \nand progressed to a regular diet and oral medications by POD#1. \nThe patient was given ___ antibiotics and \nanticoagulation per routine. The patient's home medications were \ncontinued throughout this hospitalization. The patient worked \nwith ___ who determined that discharge to home was appropriate. \nThe ___ hospital course was otherwise remarkable for \npostoperative constipation associated with nausea and emesis.  \nThe medicine service was consulted to assist in management.  \nAfter aggressive bowel regimen, the patient passed a bowel \nmovement on POD5 and felt significant relief.  He was eager to \ndischarge to home.\n\nAt the time of discharge the patient's pain was well controlled \nwith oral medications, incisions were clean/dry/intact, and the \npatient was voiding/moving bowels spontaneously. The patient is \nnonweightbearing in the right upper extremity, and will be \ndischarged on aspirin for DVT prophylaxis. The patient will \nfollow up with Dr. ___ routine. A thorough discussion \nwas had with the patient regarding the diagnosis and expected \npost-discharge course including reasons to call the office or \nreturn to the hospital, and all questions were answered. The \npatient was also given written instructions concerning \nprecautionary instructions and the appropriate follow-up care. \nThe patient expressed readiness for discharge.\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Imipramine 200 mg PO QHS \n2. Baclofen 10 mg PO TID \n3. Omeprazole 40 mg PO BID \n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO Q8H \nRX *acetaminophen 500 mg 2 tablet(s) by mouth q8hr Disp #*80 \nTablet Refills:*0 \n2.  Aspirin 325 mg PO DAILY \nRX *aspirin 325 mg 1 tablet(s) by mouth daily Disp #*28 Tablet \nRefills:*0 \n3.  Bisacodyl ___AILY \nRX *bisacodyl 10 mg 1 suppository(s) rectally daily Disp #*12 \nSuppository Refills:*0 \n4.  Calcium Carbonate 500 mg PO QID:PRN acid reflux \nRX *calcium carbonate 500 mg calcium (1,250 mg) 1 tablet(s) by \nmouth four times a day Disp #*50 Tablet Refills:*0 \n5.  Docusate Sodium 100 mg PO BID \nRX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice \na day Disp #*60 Capsule Refills:*0 \n6.  Ondansetron ODT 4 mg PO Q8H:PRN nausea \nRX *ondansetron 4 mg 1 tablet(s) by mouth q8hr Disp #*12 Tablet \nRefills:*0 \n7.  OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - \nModerate \nRX *oxycodone 5 mg ___ tablet(s) by mouth q4hr Disp #*45 Tablet \nRefills:*0 \n8.  Polyethylene Glycol 17 g PO BID Constipation - Third Line \nRX *polyethylene glycol 3350 [Miralax] 17 gram 1 powder(s) by \nmouth twice a day Disp #*24 Packet Refills:*0 \n9.  Senna 8.6 mg PO BID \nRX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp \n#*60 Tablet Refills:*0 \n10.  Baclofen 15 mg PO TID  \n11.  Imipramine 200 mg PO QHS  \n12.  Omeprazole 40 mg PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nRight distal humerus fracture\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nINSTRUCTIONS AFTER ORTHOPAEDIC SURGERY:\n\n- You were in the hospital for orthopedic surgery. It is normal \nto feel tired or \"washed out\" after surgery, and this feeling \nshould improve over the first few days to week. \n- Resume your regular activities as tolerated, but please follow \nyour weight bearing precautions strictly at all times.\n\nACTIVITY AND WEIGHT BEARING:\n-Nonweightbearing to the right upper extremity in a splint\n\nMEDICATIONS:\n- Please take all medications as prescribed by your physicians \nat discharge.\n- Continue all home medications unless specifically instructed \nto stop by your surgeon.\n- Do not drink alcohol, drive a motor vehicle, or operate \nmachinery while taking narcotic pain relievers.\n- Narcotic pain relievers can cause constipation, so you should \ndrink eight 8oz glasses of water daily and take a stool softener \n(colace) to prevent this side effect.\n\nANTICOAGULATION:\n- Please take aspirin 325 mg daily for 4 weeks\n\nWOUND CARE:\n- You may shower. No baths or swimming for at least 4 weeks.\n- Any stitches or staples that need to be removed will be taken \nout at your 2-week follow up appointment.\n- Please remain in your dressing and do not change unless it is \nvisibly soaked or falling off.\n- Splint must be left on until follow up appointment unless \notherwise instructed\n- Do NOT get splint wet\n\nDANGER SIGNS:\nPlease call your PCP or surgeon's office and/or return to the \nemergency department if you experience any of the following:\n- Increasing pain that is not controlled with pain medications\n- Increasing redness, swelling, drainage, or other concerning \nchanges in your incision\n- Persistent or increasing numbness, tingling, or loss of \nsensation\n- Fever > 101.4\n- Shaking chills\n- Chest pain\n- Shortness of breath\n- Nausea or vomiting with an inability to keep food, liquid, \nmedications down\n- Any other medical concerns\n\nTHIS PATIENT IS EXPECTED TO REQUIRE <30 DAYS OF REHAB\n\nFOLLOW UP:\nPlease follow up with your Orthopaedic Surgeon, Dr. ___. \nYou will have follow up with ___, NP in the \nOrthopaedic Trauma Clinic ___ days post-operation for \nevaluation. Call ___ to schedule appointment upon \ndischarge.\n\nPlease follow up with your primary care doctor regarding this \nadmission within ___ weeks and for and any new \nmedications/refills.\n\nPhysical Therapy:\nNonweightbearing to the right upper extremity in a splint\nTreatments Frequency:\nRemain in the splint until your follow-up appointment.  The \nstaples/sutures will remain for at least 2 weeks \npostoperatively.  Please keep the splint dry.  If you have \nconcerns regarding the splint, please call the clinic at the \nnumber provided.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee7539342f3"
  },
  "note_id": "19644467-DS-18",
  "subject_id": 19644467,
  "hadm_id": 26930265,
  "note_type": "DS",
  "note_seq": 18,
  "charttime": "2193-08-24 00:00:00",
  "storetime": "2193-08-27 14:33:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium\n \nAttending: ___.\n \nChief Complaint:\nmassive epistaxis \n \nMajor Surgical or Invasive Procedure:\nPosterior nasal packing\n\n \nHistory of Present Illness:\n___ with hepatitis C (stage ___ fibrosis per liver bx in ___, \nHTN, GERD, depression presents with massive epistaxis. Pt notes \nacute onset of massive bilateral epistaxis last night at 7:30pm \nwhile sitting on the couch watching the baseball game. Would \nintermittently stop and then start again. No clear inciting \nevent. No nasal trauma. No history of epistaxis. She does note \nincreased rhinorrhea from her baseline over the past week or so \nbut had not been excessively blowing her nose. She used her \nregular flunisolide nasal spray, no new medications or other \nnasal irritants. She was home alone with her daughter (has \nDown's syndrome) who was sleeping and so waited for her husband \nto come home. When he arrived ~20 minutes later, EMS was called. \nShe admits to lightheadedness, heart burn, epigastric pain, \n\"liver pain\", but these are all chronic and unchanged. She has \nalso been having loose, watery stools, most recently this \nmorning, but also reports that this is unchanged.  \n.  \nIn the ED, initial vitals were T 97.1, BP 172/100, HR 84, RR 16, \nSaO2 99% on RA. She was actively bleeding on arrival. Initially \npacked anteriorly but she continued to bleed. She was packed \nposteriorly with epistat, which successfully stopped her \nbleeding. Hct was stable at 34.9. Re bled, able to stop with \npacking. INR 1.2. She was also given dilt 20mg IV x 2 in the ED \nfor elevated BP up to 216/18. Also received 2L IVF, ancef, and \nmorphine for pain. Admitted to the MICU for close monitoring.  \n.  \nOn arrival to the MICU, her main complaint is ___ pain in her \nface. She also complains of her chronic diffuse abdominal pain \nas well as feeling anxious and short of breath. Pt also c/o \nurinary retention, unable to void on multiple attempts, foley \nplaced with 1.6L urine output  \n.  \nOn ROS, she denies fever, chills, chest pain, cough, nausea, \nvomiting, constipation, urinary symptoms. \n\n \nPast Medical History:\nPMH:\n1.As above (Hep C  not a candidate for IFN due to depression)\n2.HTN (poorly controlled)\n3.dyslipidemia\n4.PVD (L subclavian stenosis seen on CTA ___ and MRA ___\nand RE arterial insufficiency)\n5.Depression, requiring hospitalization in past\n6.h/o polysubstance abuse and on-going alcohol and tobacco use. \nDrank 5 beers yesterday.\n7.Hiatal hernia, s/p nissen fundoplication\n8.GERD\n9.s/p fundoplication \n___ def anemia\n11.COPD\n___\n13.cervical spondylosis\n14.h/o Schatzkis ring\n___ early CAD  mother had MI at age ___, grandmother died of \nMI\nand sister reportedly died of MI at age ___.colitis\n17.h/o ARF\n18.s/p CCY\n19.urinary incontinence\n20.insomnia\n\nALLERGIES:\n1. Penicillin gives anaphylaxis.\n2. Valium gives nausea, vomiting, and rash.\n3. Codeine - unknown reaction.\n\n \nSocial History:\n___\nFamily History:\nMom had myocardial infarction at age ___.\nMom also had diabetes mellitus.\n\n \nPhysical Exam:\nVitals: 98,0, 98.0, 143/68 [136-180/54-85], 89 [79-105], 18, \n94%RA  \nGeneral: fatigued, uncomfortable but in no acute distress  \nHEENT: slightly dry MM, L nare packed with epistat in place, \ndried blood in bilateral nares, no evidence of active bleeding, \nOP clear  \nNeck: supple, no cervical or supraclavicular LAD  \nHeart: RRR, no m/r/g  \nLungs: CTAB, no w/r/r  \nAbdomen: +BS, soft, nondistended, diffusely tender to palpation  \n\nExtrem: no ___ edema, 2+ peripheral pulses  \nNeuro: A+O x 3, grossly intact  \n\n \nPertinent Results:\n4:10p Hct 29.1  \n11:20a Hct. 28.9  \n.  \n___: 14.1 PTT: 25.3 INR: 1.2  \n.  \n137 102 14  \n------------------< 102  \n3.9 23 0.8  \n.  \nALT: 98 AP: 130 Tbili: 0.4 Alb: 4.4  \nAST: 123  \n.  \nMCV 93  \n.     11.9  \n6.5 >--------< 241  \n.     34.9  \nN:68.1 L:22.2 M:8.9 E:0.5 Bas:0.___ with HTN, GERD, Hep C, presents with acute onset massive \nepistaxis.  \n.\nHospital Course by problems:\n.  \n# Epistaxis: Likely due to acute cocaine use (U tox positive \nalthough pt denies recent use). INR only mildly elevated at 1.2 \nhowever pt likely has some degree of plt dysfunction and \ncoagulopathy due to hepatitis and alcohol abuse. ENT placed \nposterior packing after pt bled through anterior packing. Pt was \nadmitted for monitoring until packing could be removed in 5 \ndays. Pt was kept on continuous O2 sat and telemetry monitoring. \n\n- Initial hct in ED 34.9--> 28.9 on arrival to the MICU \n(baseline low ___. Transferred out of MICU on HD #2, and Hct \nremained stable ___. \n- Initally NPO x 24 hours, then advanced to regular diet, \ntolerated well.  \n- Afrin PRN\n- No evidence of pressure necrosis in the nasal ala\n- prophylactic clindamycin while epistat in place for staph \ncoverage  \n.  \n# HTN: HTN on initial presentation likely due to cocaine use and \nmedication non-compliance at home. \n- Was initially controlled with IV dilt 20mg IV x 2 and her home \ndose of nifedipine in ED. Remained in good control (systolic \n120s) on home regimen subsequently.\n.  \n# GERD, hiatal hernia s/p ___: continued protonix per home \nregimen \n.  \n# COPD: Stable. Lungs remained clear on exam without wheezing.  \n- continued spiriva, advair, albuterol prn  \n.  \n# Polysubstance abuse: + U tox for Cocaine. Encouraged \nabstaining from substance use. Social work consult sought \nhowever pt resistant to intervention/sober program\n \nMedications on Admission:\nHCTZ 25mg PO daily  \nNifedipine SR 30mg PO dialy  \nValsartan 320mg PO daily  \nProtonix 80mg PO BID  \nPregabalin 225mg PO BID  \nAlbuterol inhaler ___ puffs inhaled q ___ hours prn  \nFlunisolide inhaler 29 mcg 2 spray each nostril BID  \nSpiriva 18mcg inhaled daily  \nAdvair 500/50 1 puff BID  \nFolate 1mg PO daily  \nIron 325mg PO TID  \nMultivitamin PO daily  \nThiamine 100mg PO daily  \nSLN prn  \nColace 100mg PO daily prn  \n\n \nDischarge Medications:\n1. Nifedipine 30 mg Tablet Sustained Release Sig: One (1) Tablet \nSustained Release PO DAILY (Daily).  \n2. Valsartan 160 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). \n \n3. Protonix 40 mg Tablet, Delayed Release (E.C.) Sig: Two (2) \nTablet, Delayed Release (E.C.) PO twice a day.  \n4. Pregabalin 75 mg Capsule Sig: Three (3) Capsule PO BID (2 \ntimes a day).  \n5. Albuterol Sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nTwo (2) Puff Inhalation Q6H (every 6 hours) as needed.  \n6. Flunisolide 250 mcg/Actuation Aerosol Sig: One (1)  \nInhalation once a day.  \n7. Tiotropium Bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) Cap Inhalation DAILY (Daily).  \n8. Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n9. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO three times a \nday.  \n10. Ferrous Sulfate 325 mg (65 mg Iron) Tablet Sig: One (1) \nTablet PO TID (3 times a day).  \n11. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n12. Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n13. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day as \nneeded for constipation.  \n14. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1)  \nSublingual see below: q5 mins prn chest pain, upto 3 doses.  \n15. Morphine 15 mg Tablet Sig: One (1) Tablet PO every ___ hours \nas needed for pain for 1 weeks.\nDisp:*10 Tablet(s)* Refills:*0*\n16. Terbinafine 1 % Cream Sig: One (1) Appl Topical BID (2 times \na day) as needed for tinea pedis: apply to affected area on \nfeet.\nDisp:*1 largest tube* Refills:*2*\n17. Ciprofloxacin 250 mg Tablet Sig: Two (2) Tablet PO Q12H \n(every 12 hours) for 2 doses.\nDisp:*4 Tablet(s)* Refills:*0*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary diagnosis:\n- Epistaxis\n- Polysubstance abuse\n- Hepatitis C\n- GERD\n- Depression\n\n \nDischarge Condition:\ngood\n\n \nDischarge Instructions:\nYou had a massive nose bleed. For this you had deep posterior \npacking, and given antibiotics. Your blood counts remained \nstable while this was going on. Please stop using cocaine as \nthis probably caused the nose bleed, and can also lead to a \nnasal septum rupture.  Cocaine can also cause a heart attack and \nsudden death. \n.\nNo nose blowing or heavy lifting for 2 weeks. \n.\nYour blood pressure was borderline low during your hospital stay \non your regular blood pressure medications. This ___ be because \nwe are giving you a strict low-salt diet. We stopped one \nmedicine (hydrochlorothiazide) but we are keeping Valsartan and \nNifedipine the same since extremely high blood pressure can \nprecipitate nose bleeds.\nIf you feel lightheaded, please take your blood pressure and if \nit's low, call your doctor. \n.\nIf you begin having severe nose bleeds again that lasts > 30 \nminutes despite afrin use, or you begin feeling light-headed and \nweak, return to the ED immediately.\n.\nMedication changes:\n- Continue cipro for 2 more doses\n- STOP hydrochlorothiazide\nAll other medications remain the same\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee7539342f4"
  },
  "note_id": "19644467-DS-19",
  "subject_id": 19644467,
  "hadm_id": 26008099,
  "note_type": "DS",
  "note_seq": 19,
  "charttime": "2195-01-04 00:00:00",
  "storetime": "2195-01-08 06:32:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril\n \nAttending: ___.\n \nChief Complaint:\nchest pressure\n \nMajor Surgical or Invasive Procedure:\nNone\n \nHistory of Present Illness:\n Ms. ___ is a ___ yo woman with emphysema, hepatitis C, PVD, \nHTN, HLD and GERD, who presents with chest pressure, shortness \nof breath and stabbing epigastric pain that started 2 days ago.  \nShe first noticed a sensation of something \"sitting on her \nchest\" with her heart \"fluttering\" on ___, at rest.  She \nalso was short of breath and nauseous, but as she has had these \nsymptoms before, last nearly 3 months ago, she was not alarmed \ninitially.  The following evening of ___ at 2 am, she awoke from \nher sleep with the same chest pressure, a heavy feeling over her \narms, sharp epigastric pain, dyspnea and nausea.  No vomiting or \ndiaphoresis.  She got out of bed and collapsed on the L hip 3x \non her way to get nitroglycerin, which provided no relief.  Did \nnot sustain any blows to the head or loss of consciousness.  She \nthen called ___ and was brought to the ___ ED.  The patient \ncould not recall if she has had prior hospitalizations for COPD \nexacerbation or MI w/u.\n.   \nOf note, the patient reports that she has been non-compliant \nwith all of her home medications for 1 month due to \npreoccupation with her visiting grandchildren.  Her grandaughter \nhad recently been sick and the patient did feel some symptoms of \nproductive cough, runny nose and upset stomach last week which \nhave now improved.  She denies other sick contacts or recent \ntravel.  \n.\nOn review of symptoms, the patient denies fevers or chills, \nheart palpitations, or diaphoresis.  She reports intermittent \nheadache and blurry vision, which she attributes to episodes of \nhypertension. She reports baseline numbness, tingling and \nweakness in her ___ b/l causing problems with balance without \nvertigo, sx which she attributes to her PVD.  She has stress \nincontinence at baseline but no dysuria.  She reports easy \nbruising of several weeks duration, and increasing stabbing RUQ \npain, which she suspects is due to her hepatitis.  Baseline \nlower back pain.  Recent 10 lb weight loss over last month.  No \nrashes or myalgias. \n.\nIn the ED, vital signs were 98.6 196/91 78 18 100% 2L. the \npatient had a hip film which showed no fractures, an EKG \nrevealing q waves in leads II and III, and a neg set of cardiac \nenzymes.  She was given 40 mg prednisone and duonebs for \npresumptive COPD flare and transferred to the Medicine floor.  \n.\n \nPast Medical History:\nPMH:\nCOPD (never formally dx by spirometry, bullous emphysema on CT \nimaging ___\nHepatitis C (stage ___ fibrosis per liver bx ___\nHTN (poorly controlled at b/l, non compliant with meds; P-MIBI \nnegative in ___, stress-Echo ___ EF 60%, trivial MR, no \ninducible ischemia)\nHLD\nPeripheral neuropathy\nPVD (L subclavian stenosis seen on CTA ___ and MRA ___\nand RE arterial insufficiency; ABI showing minimal disease below \nthe knee at the tibial level on ___\nDepression, requiring hospitalization in past\nh/o polysubstance abuse, including cocaine and iv drug use, and \non-going alcohol and tobacco use\nHiatal hernia, s/p nissen fundoplication\nGERD\nesophageal stricture (Schatzkis ring)\nFe def anemia\nFibromyalgia\nCervical spondylosis\nStress incontinence\nOsteoarthritis\n \nSocial History:\n___\nFamily History:\nHx of early CAD  mother had MI at age ___, grandmother died of \nMI and sister reportedly died of MI at age ___.\n \nPhysical Exam:\nVS: T=98.2, BP=180/82, HR=83, RR=18, O2 sat=100% on RA  \n.  \nGENERAL: NAD. Oriented x3. Mood stable, affect appropriate.  \nHEENT/Lymph: NCAT. Sclera anicteric. MMM, conjunctiva pink. No \nrash or lesions on OP. No ___ anterior cervical chain or \nsupraclavicualrly.  \nNECK: Supple, no JVD.  \nCARDIAC: RRR, no murmurs.  \nLUNGS: CTAB, no crackles, wheezes or rhonchi.  \nABDOMEN: Soft, tender to palpation in RUQ. No rebound \ntenderness. No HSM or masses.  Diffuse tenderness at base of \nspine and flank but no focal CVA tenderness.\nEXTREMITIES: Warm, dry, no edema.  \nSKIN: No rash or lesions.  \n.  \nMSK: Tenderness to palpation of lumbar spine.  \n.  \nNEURO: A/O x3, CNs II - XII intact. Resting tremor in R arm. \nMotor: normal tone. Strength: \n    Del Tri Bi WE FE FF IP Quad ___\n\nL   4+   5   5    ___  3  4    5    4    5      5       \n\nR   4+  5   5    ___   ___    4   5      5    \n.  \nDTRs: 2+ throughout. Sensory: intact to LT bilaterally.  \n.  \n \nPertinent Results:\n___ 04:30AM   GLUCOSE-87 UREA N-6 CREAT-0.8 SODIUM-137 \nPOTASSIUM-4.0 CHLORIDE-103 TOTAL CO2-21* ANION GAP-17\n\n___ 04:30AM   WBC-6.7 HCT-36.1 PLT 372\n\n3 sets of neg cardiac enzymes\n\nUrine tox screen neg\n\nEKG: Normal sinus rhythm. Tracing is within normal limits. \nCompared to the previous tracing of ___ no diagnostic \ninterim change.\n\nL hip film: no fracture or dislocation\n\nCXR no acute process\n\nMR ___ Spine w/o contrast: Degenerative changes of the lumbar \nspine without significant spinal canal or neural foraminal \nnarrowing. Partially visualized distended bladder.\n\n \nBrief Hospital Course:\nChest pain, dyspnea: \n\nThe patient was admitted to the floor hypertensive (180/82) but \notherwise in stable condition without chest pressure or dyspnea \n(T=98.2, BP=180/82, HR=83, RR=18, O2 sat=100% on RA). EKG in the \nED showed no ischemic changes, and 3 sets of cardiac enzymes \nwere normal, making acute coronary syndrome unlikely.  Urine tox \nwas negative for cocaine use, also ruling out a syndrome X, or \nacute narrowing of the coronary arteries.  Given the patient's \nlack of compliance with her HTN and GERD medications, her \nepisode likely reflected a hypertensive crisis with possible \noverlying reflux.  Her emphysema may have also contributed to \nher SOB.  \n\nThe patient received a prednisone taper 60 mg, ___, as well \nas albuterol prn, ipratropium nebs, and fluticasone-salmeterol \nfor her emphysema and experienced improvements in her breathing. \n She was restarted on her home nifedipine and was half her home \nvalsartan dose, which subsequently normalized her blood \npressures.  She was also started on her home aspirin 81 mg daily \nand ompeprazole.  A lipid panel was drawn, which was within \nnormal limits, including a LDL of 111.  Giver a ___ risk \nscore of 4%, a statin was not initiated.  At the time of \ndischarge, the patient had been free of chest pressure and SOB \nfor 48 hours. \n\nUrinary retention with baseline ___ weakness/numbness/tingling: \n\nDespite recent initiation of opiods for pain control in the ED \nand on the floor, the patient's new onset of urinary retention \nupon reaching the floor raised concern for cord compression.  L \nspine MR was performed showing no evidence for cord compression, \nspinal stenosis or foramenal narrowing.  The patient's urinary \nretention resolved that evening and recurred the next day with \nconstipation following her morning morphine dose.  Opiods were \ndiscontinued.  With a bowel regimen, the constipation and \nurinary retention resolved, and the patient was discharged on \ntylenol for pain control. \n\nGiven the patient's complaints of of baseline L leg weakness and \nb/l ___ numbness and tingling, B12, TSH, folate levels were drawn \nrule out possible metabolic sources of of peripheral neuropathy. \n An outpatient Neurology appointment was arranged to follow up \nlikely peripheral neuropathy underlying these symptoms.  \n\nA ___ consult was called and cleared the patient for ambulation \nat home, though visiting home services were arranged for the \npatient's chronic pain and anxiety.\n\nHTN: \n\nThe pt was acutely hypertensive on admission (SBP 180-190), and \nresolved on home nifedipine and ___ dose of valsartan with which \nshe was discharged.\n\nRUQ pain / bruising: \n\nLikely related to patient's hepatitis, the patient's LFTs were \nmildly elevated and coag studies wnl.  There were no acute \nissues during her hospital stay.\n\nPVD: \n\nNo issues. A recent Cardiology appointment judged the patient's \nlower extremity symptoms to be unlikely due to her PVD given ABI \nshowing minimal disease below the knees.  As discussed above, \nher ___ weakness, numbness and tingling is ossibly due to \nperipheral neuropathy secondary to alcohol abuse. Outpatient \nneurology appointment was scheduled. \n\nAlcohol abuse:\n\nGiven the patient's history of alcohol abuse, she was placed on \nCIWA protocol but showed no signs of withdrawal throughout her \nstay.\n\nFibromyalgia:\n\nThe patient was given Morphine 15 mg po q12h for pain control \nand then transitioned to tylenol given the patient's new onset \nof urinary retention and constipation. Home visiting services \nwere arranged to help the patient cope with the patient's \nchronic pain and anxiety. \n \nMedications on Admission:\nNon-compliant for 1 month.\n\nALBUTEROL SULFATE [PROAIR HFA] - 90 mcg HFA Aerosol Inhaler - \n___\npuffs inhaled q ___ hours as needed for sob\nCITALOPRAM - 20 mg Tablet - 0.5 (One half) Tablet(s) by mouth\nevery morning for 1 week, then start taking 1 tablet every\nmorning\nFEXOFENADINE - 180 mg Tablet - 1 Tablet(s) by mouth qday as\nneeded for allergies\nFLUTICASONE-SALMETEROL [ADVAIR DISKUS] - 500 mcg-50 mcg/Dose \nDisk\nwith Device - 1 puff inhaled twice daily rinse mouth after use\nFOLIC ACID - 1 mg Tablet - 1 Tablet(s) by mouth daily\nNIFEDIPINE [NIFEDIAC CC] -  (On Hold from ___ to unknown\nfor has not been taking. will hold until she takes the HCTZ\nfirst) - 30 mg Tablet Sustained Release - one Tablet(s) by mouth\nonce a day\nNITROGLYCERIN - 0.3 mg Tablet, Sublingual - 1 Tablet(s)\nsublingually as needed for chest pain. ___ repeat up to three\ntimes, if pain persists, call ___ and go to emergency \ndepartment.\nPANTOPRAZOLE [PROTONIX] - 40 mg Tablet, Delayed Release (E.C.) -\n2 Tablet(s) by mouth twice a day\nQUETIAPINE [SEROQUEL] - 25 mg Tablet - 1 Tablet(s) by mouth at\nbedtime\nTIOTROPIUM BROMIDE [SPIRIVA WITH HANDIHALER] - 18 mcg Capsule,\nw/Inhalation Device - one capsule inhaled daily\nVALSARTAN [DIOVAN] -  (Not Taking as Prescribed) - 320 mg \nTablet-\n1 (One) Tablet(s) by mouth once a day please keep appt with dr.\n___ ___\nDOCUSATE SODIUM [COLACE] - 100 mg Capsule - 1 by mouth QDAY as\nneeded for CONSTIPATION DUE TO IRON\nIRON - 325 mg (65 mg Iron) Tablet - 1 Tablet(s) by mouth three\ntimes a day take with colace to prevent constipation\nMULTI-VITAMIN -   Tablet - 1 Tablet(s) by mouth daily\nTHIAMINE HCL - 100 mg Tablet - 1 Tablet(s) by mouth daily\n \nDischarge Medications:\n1. Fluticasone-Salmeterol 500-50 mcg/Dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).\nDisp:*1 Disk with Device(s)* Refills:*0*\n2. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \n(1) Tablet, Delayed Release (E.C.) PO twice a day.\nDisp:*60 Tablet, Delayed Release (E.C.)(s)* Refills:*2*\n3. Thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).\nDisp:*30 Tablet(s)* Refills:*2*\n4. Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily).\nDisp:*30 Tablet(s)* Refills:*2*\n5. Nifedipine 30 mg Tablet Sustained Release Sig: One (1) Tablet \nSustained Release PO DAILY (Daily).\nDisp:*30 Tablet Sustained Release(s)* Refills:*2*\n6. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \nPO DAILY (Daily).\nDisp:*30 Tablet, Chewable(s)* Refills:*2*\n7. Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).\nDisp:*30 Tablet(s)* Refills:*0*\n8. Prednisone 10 mg Tablet Sig: One (1) Tablet PO qd () for 1 \ndays.\nDisp:*1 Tablet(s)* Refills:*0*\n9. Tiotropium Bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1)  Inhalation once a day.\nDisp:*30 capsules* Refills:*2*\n10. Iron 325 mg (65 mg Iron) Tablet Sig: One (1) Tablet PO three \ntimes a day.\nDisp:*90 Tablet(s)* Refills:*2*\n11. Docusate Sodium 100 mg Tablet Sig: One (1) Tablet PO once a \nday as needed for constipation.\nDisp:*30 Tablet(s)* Refills:*2*\n12. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1)  \nSublingual twice a day as needed for chest pain: sublingually as \nneeded for chest pain. ___ repeat up to three\ntimes, if pain persists, call ___ and go to emergency \ndepartment.  \n13. Albuterol Sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \n___  Inhalation every ___ hours as needed for shortness of \nbreath or wheezing.\nDisp:*1 inhaler* Refills:*0*\n14. Valsartan 160 mg Tablet Sig: One (1) Tablet PO once a day.\nDisp:*30 Tablet(s)* Refills:*2*\n15. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday) as needed for constipation.\nDisp:*60 Tablet(s)* Refills:*0*\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary Diagnoses:\n1) GERD\n2) Hypertensive strain\n3) emphysema\n4) 3 falls, no head trauma\nSecondary Diagnoses: \n1) Peripheral Neuropathy\n2) Peripheral Vascular Disease\n3) HTN\n4) Hepatitis C\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nYou were admitted to the ___ on ___ with an episode of \nchest pressure, shortness of breath and belly pain which woke \nyou from your sleep in the setting of not taking your acid \nreflux or blood pressure medications for over 1 month.  This \nepisode was possibly due to your gastric reflux as well as \nstrain on the heart due to hypertension.  Your emphysema was \nlikely contributing to your shortness of breath.  In the \nhospital, an electrocardiogram and lab tests showed that you did \nnot have a heart attack.  You were restarted on your home \nnifedipine and half dose of valsartan for your blood pressure \nand omeprazole for your GERD.  Your home aspirin was also \nstarted to help prevent future heart attack.  For your shortness \nof breath, you were given your a short course of oral steroids \nas well as ipratropium and Advair, which helped to relieve your \nsymptoms.  \n.\nDuring your episode of chest pressure, you also sustained 3 \nfalls on your L hip, which increased your L leg pain and \nweakness.  An MR scan of your lumbar spine showed no evidence of \nspinal cord or nerve root compression that might exacerbate your \nsymptoms.  In the hospital, your pain was well-controlled on \noral morphine.  This medication caused you to have urinary \nretention and constipation.  You should not take this medication \nin the future.  \n.\nYou were instructed to follow-up with an outpatient Neurologist \nfor further management of your lower extremity symptoms, which \nmay be due to peripheral neuropathy.      \n.\nOn ___, you were discharged without further episodes of chest \npressure and with your shortness of breath and hypertension \nunder control.  You were scheduled to follow-up with your \nprimary care doctor.  \n.\nIt is important to take your medications on a regular basis to \nprevent symptoms from your hypertension, acid reflux and most \nimportantly, strain on your heart.  Please discuss with your \nprimary care strategies that might make it easier for you to \ncontinue to take these medications.\n\nPlease note the following changes to your medications:\n1) TAKE one 10 mg dose of prednisone on the day after discharge\n2) DECREASE Valsartan to 160mg daily \n3) STOP Citalopram and Seroquel until you see Dr. ___ as an \noutpatient\n4) TAKE tylenol for pain, maximum 2 grams a day or 8 extra \nstrength tabs\nContinue the rest of your medications as prescribed at home    \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee7539342f5"
  },
  "note_id": "19644467-DS-20",
  "subject_id": 19644467,
  "hadm_id": 25240128,
  "note_type": "DS",
  "note_seq": 20,
  "charttime": "2195-04-25 00:00:00",
  "storetime": "2195-04-26 13:37:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril\n \nAttending: ___.\n \nChief Complaint:\nEmesis\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ yo woman with GERD, hiatial hernia s/p fundoplication, \nSchatzki's ring, Hep C (stage II-III fibrosis per Bx ___, \npolysubstance abuse, COPD/emphysema, PVD, HTN, HLD who presents \nto the ED with dark emesis x 3 over the past three days, dark \ntarry stools, and malaise. The patient's symptoms began three \ndays prior to admission, when she experienced nausea and had one \nepisode of dark emesis. She is unclear if the emesis contained \nblood or merely dark food products. Over the subsequent two \ndays, she had two similar episodes of emesis. She also describes \nthe onset of \"pasty,\" black stools during this time period. She \nstates that she has had stools with similar appearance in the \npast, but not for several months. There is associated right \nupper quadrant abdominal pain, though she is unable to provide a \ntime course for this pain. The patient has been taking her iron \npills regularly. She denies any NSAID use, but has been taking a \ndaily baby aspirin.\n.\nThe patient also reports intermittent L sided CP which is \nrelieved with NTG. The pain is in the ___ her chest, \nnon-radiating, and non-exertional. There is no associated SOB, \ndiaphoresis.\n.  \nIn the ED, initial vs were: T96.6 HR 85 BP 155/93 RR17 100% RA.  \nNG lavage w/ 350cc was clear (small blood flecks, no bile), \nguiac negative.  She remained fatigued and complained of \"vague \npain.\" She underwent Type and Cross, was given Pantoprazole 40 \nmg IV x1 and no IVF.  She is being admitted for episodes of \nhematemesis/hemoptysis.  VS on transfer 96.8F 73 160/86 18 \n100%RA.\n.  \nOn the floor, the patient continued to report symptoms of vague \npain in her abdomen and chest. This pain is unchanged from \nearlier in the day. She has not had an episode of emesis since \nearlier this AM. She is asking to eat dinner. She denies any \ncurrent nausea, diarrhea, constipation, fevers, chills.\n.  \n\n \nPast Medical History:\nPMH:\nCOPD (never formally dx by spirometry, bullous emphysema on CT \nimaging ___\nHepatitis C (stage ___ fibrosis per liver bx ___\nHTN (poorly controlled at b/l, non compliant with meds; P-MIBI \nnegative in ___, stress-Echo ___ EF 60%, trivial MR, no \ninducible ischemia)\nHLD\nPeripheral neuropathy\nPVD (L subclavian stenosis seen on CTA ___ and MRA ___\nand RE arterial insufficiency; ABI showing minimal disease below \nthe knee at the tibial level on ___\nDepression, requiring hospitalization in past\nh/o polysubstance abuse, including cocaine and iv drug use, and \non-going alcohol and tobacco use\nHiatal hernia, s/p nissen fundoplication\nGERD\nesophageal stricture (Schatzkis ring)\nFe def anemia\nFibromyalgia\nCervical spondylosis\nStress incontinence\nOsteoarthritis\n \nSocial History:\n___\nFamily History:\nHx of early CAD  mother had MI at age ___, grandmother died of \nMI at ___.\n\n \nPhysical Exam:\nVitals: T: 96.6 BP: 161/95 P: 66  R: 18  O2: 100%RA  \nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear  \nNeck: supple, JVP not elevated, no LAD  \nLungs: Clear to auscultation bilaterally, no wheezes appreciated\nCV: RRR, normal S1 + S2, no murmurs, rubs, gallops  \nAbdomen: soft, non-distended, bowel sounds present, tenderness \nin RUQ, voluntary guarding in all 4 quadrants\nExt: warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema\nNeuro: CNs2-12 intact, motor function grossly normal  \n\n \nPertinent Results:\nAdmission Labs:\n___ 10:53AM BLOOD WBC-10.4 RBC-4.37 Hgb-13.6# Hct-39.1 \nMCV-90# MCH-31.1# MCHC-34.7 RDW-17.1* Plt ___\n___ 10:53AM BLOOD Neuts-78.8* Lymphs-17.4* Monos-2.6 \nEos-1.0 Baso-0.3\n___ 10:53AM BLOOD ___ PTT-23.9 ___\n___ 10:53AM BLOOD Glucose-93 UreaN-13 Creat-0.8 Na-140 \nK-5.3* Cl-108 HCO3-20* AnGap-17\n___ 10:53AM BLOOD ALT-70* AST-79* AlkPhos-116* TotBili-0.3\n___ 10:53AM BLOOD cTropnT-<0.01\n___ 10:53AM BLOOD Calcium-9.6 Phos-3.4 Mg-2.1\n___ 11:07AM BLOOD Lactate-1.5 K-4.3\n.\nDischarge Labs:\n___ 12:50PM BLOOD Hct-38.7\n___ 06:25AM BLOOD Glucose-74 UreaN-19 Creat-0.8 Na-141 \nK-4.3 Cl-106 HCO3-25 AnGap-14\n___ 06:25AM BLOOD ALT-13 AST-22 AlkPhos-53 TotBili-0.2\n___ 06:25AM BLOOD Calcium-8.9 Phos-3.5 Mg-2.2\n.\nImaging: IMPRESSION: No acute cardiopulmonary process.\n.\n\n \nBrief Hospital Course:\n___ with GERD, hiatial hernia s/p fundoplication, Schatzki's \nring, Hep C (stage II-III fibrosis per Bx ___, polysubstance \nabuse, COPD/emphysema who presents to the ED with dark \nemesisover the past three days, tarry stools, and malaise.\n. \n#. Emesis/?Hematemesis: NG lavage in ED negative for active \nbleeding. Guiac negative in ED and on floor. Associated sx of \nmalaise, myalgias, cough, sore throat suggestive of viral \nillness, likely gastroenteritis. Pt does have hx of GERD, \nhiatial hernia s/p fundoplication, Schatzki's ring, but EGD \nearlier this year was unrevealing. No evidence of PUD, \nstricture, or varices. Patient was initially kept NPO and \nmaintained on IV PPI. Her HCT remained stable, and her diet was \nadvanced. She tolerated POs well. Remained hemodynamically \nstable throughout her hospital course. She was discharged home \nwith GI follow-up in the following weeks.\n. \n#. Tarry stools: Patient reports several episodes of tarry \nstools at home. Guiac negative in hospital. HCT stable. Patient \ndoes take iron supplementation at home, and has detected black \ncoloration to her stool in past. Low suspicion for active \nbleeding.\n.\n#. Chest Pain: Atypical for cardiac etiology. Trop negative X 2. \nNormal stress test in ___. EKG shows NSR without ischemic \nchanges. Aspirin was held in setting of tarry stools, but \nre-started at the time of discharge.\n.\n#. COPD: Stable. Reports no worsening of SOB. Continued spiriva, \nadvair, albuterol.\n.\n#. HTN: Continued valsartan once taking POs.\n.\n#. Transaminitis: Chronic, likely ___ hep C. Stable. \n.  \n\n \nMedications on Admission:\n1. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \n___ Puffs Inhalation Q4H (every 4 hours) as needed for wheeze.  \n2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO DAILY \n(Daily).  \n3. fexofenadine 60 mg Tablet Sig: Three (3) Tablet PO DAILY \n(Daily).  \n4. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) INH Inhalation BID (2 times a day).  \n5. multivitamin Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n6. nifedipine 30 mg Tablet Sustained Release Sig: One (1) Tablet \nSustained Release PO DAILY (Daily).  \n7. nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Tablet, \nSublingual Sublingual PRN (as needed) as needed for chest pain.  \n\n8. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday).  \n9. thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n10. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) Cap Inhalation DAILY (Daily).  \n11. valsartan 160 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n12. folic acid 1 mg Tablet Sig: One (1) Tablet PO once a day.  \n13. pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: Two \n(2) Tablet, Delayed Release (E.C.) PO twice a day.  \n14. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  \n15. Iron (ferrous sulfate) 325 mg (65 mg Iron) Tablet Sig: One \n(1) Tablet PO once a day.  \n\n \nDischarge Medications:\n1. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \n___ Puffs Inhalation Q4H (every 4 hours) as needed for wheeze.  \n2. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO DAILY \n(Daily).  \n3. fexofenadine 60 mg Tablet Sig: Three (3) Tablet PO DAILY \n(Daily).  \n4. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) INH Inhalation BID (2 times a day).  \n5. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily). \n \n6. nifedipine 30 mg Tablet Sustained Release Sig: One (1) Tablet \nSustained Release PO DAILY (Daily).  \n7. nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Tablet, \nSublingual Sublingual PRN (as needed) as needed for chest pain.  \n\n8. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday).  \n9. thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n10. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) Cap Inhalation DAILY (Daily).  \n11. valsartan 160 mg Tablet Sig: Two (2) Tablet PO DAILY \n(Daily).  \n12. folic acid 1 mg Tablet Sig: One (1) Tablet PO once a day.  \n13. pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: Two \n(2) Tablet, Delayed Release (E.C.) PO twice a day.  \n14. aspirin 81 mg Tablet Sig: One (1) Tablet PO once a day.  \n15. Iron (ferrous sulfate) 325 mg (65 mg Iron) Tablet Sig: One \n(1) Tablet PO once a day.  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary Diagnosis: Gastroenteritis\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nYou were admitted to the hospital after episodes of \nnausea/vomiting at your home. Your symptoms improved during the \ncourse of your hospital stay. There was no evidence of active \nbleeding during your stay. The decision was made not to perform \nany invasive studies, though you will need to follow-up with \nyour PCP and the GI doctors.\n.\nPlease continue all medications that you were taking prior to \nadmission. Please do not drink alcohol, as this may be \ncontributing to the symptoms you presented with.\n.\nShould you have any signs or symptoms concerning to you, please \ncall your doctor or go to the nearest emergency room.\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee7539342f6"
  },
  "note_id": "19644467-DS-21",
  "subject_id": 19644467,
  "hadm_id": 22408143,
  "note_type": "DS",
  "note_seq": 21,
  "charttime": "2196-04-21 00:00:00",
  "storetime": "2196-04-21 13:23:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril\n \nAttending: ___\n \nChief Complaint:\nabdominal pain\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMs ___ is a ___ y/o F with hx of COPD, hepatitis C, Htn, HL, \nPVD, GERD, fibromyalgia, hiatal hernia, and gastritis, who came \nto the ED this morning for three weeks of progressively \nworsening epigastric and RUQ pain, with single episode of emesis \nthis morning. The pain is consistently worse when she eats. She \nhas had abdominal pain most of her life but this is worse, and \nshe is also starting to feel \"kidney pain.\" She has had \ndiarrhea, which is a chronic issue for her. She also had a fever \nto 102 degrees yesterday. She reports that she had an unusually \naggressive day of drinking yesterday, drinking 18 beers and 8 \nliquor drinks over the prior 24 hours; she typically drinks one \nsix pack per day on the weekends.  \n.  \nIn the ED, initial VS: 96.5, 112/72, 92, 20, 100%. Exam was \nnotable for general discomfort and epigastric tenderness. Labs \nincluded elevated BUN/creat (___), alk phos 110, and lactate \n3.2. CT Abd/pelvis showed no acute processes, but had stable CBD \nand intrahepatic bile duct dilation. NG lavage was deferred \ngiven stable hct and possibility of varices (not reported on ___ EGD). The patient was given 2L of NS, ondansetron, \npantoprazole, and hydromorphone 2 mg IV x2. When her pain did \nnot improve with hydromorphone, she was admitted for pain \ncontrol. VS prior to transfer were 97.2, 78, 144/68, 18, 98% on \nRA.  \n.  \nCurrently, pt has ongoing pain and nausea, though improved from \nyesterday. Denies current fevers, chills, chest pain, \npalpitations.  \n.  \nREVIEW OF SYSTEMS: As per HPI. Also endorses chronic \"foot \ninfection\" (toenail thickening), \"warmness\" with urination, \nchronic upper and lower extremity pain due to fibromyalgia. Also \nhas baseline chest heaviness, from COPD. Denies headache, vision \nchanges, sore throat, constipation, BRBPR, melena, hematochezia, \nhematuria.  \n\n \nPast Medical History:\nPMH:\nCOPD (never formally dx by spirometry, bullous emphysema on CT \nimaging ___\nHepatitis C (stage ___ fibrosis per liver bx ___\nHTN (poorly controlled at b/l, non compliant with meds; P-MIBI \nnegative in ___, stress-Echo ___ EF 60%, trivial MR, no \ninducible ischemia)\nHLD\nPeripheral neuropathy\nPVD (L subclavian stenosis seen on CTA ___ and MRA ___\nand RE arterial insufficiency; ABI showing minimal disease below \nthe knee at the tibial level on ___\nDepression, requiring hospitalization in past\nh/o polysubstance abuse, including cocaine and iv drug use, and \non-going alcohol and tobacco use\nHiatal hernia, s/p nissen fundoplication\nGERD\nesophageal stricture (Schatzkis ring)\nFe def anemia\nFibromyalgia\nCervical spondylosis\nStress incontinence\nOsteoarthritis\n \nSocial History:\n___\nFamily History:\nMother: CAD, deceased. 9 siblings, one deceased (cause unknown). \nFour children, all healthy. \n \nPhysical Exam:\nVS - Temp 97.9F, BP 151/77, HR 80, R 20, O2-sat 94% RA  \nGENERAL - chronically ill appearing adult female in NAD, moving \naround in bed but not clearly uncomfortable  \nHEENT - NC/AT, PERRLA, EOMI, no conjunctival icterus, injection, \npallor, MMM, OP clear  \nNECK - supple, no JVD  \nLUNGS - CTAB except for occasional mild expiratory wheeze. good \nair movement, resp unlabored, no accessory muscle use  \nHEART - PMI non-displaced, RRR, no MRG, nl S1-S2  \nABDOMEN - NABS, +TTP ___ area, soft/ND, no masses or \nHSM, no rebound/guarding, ___ negative. No flank \ntenderness.  \nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, \nDPs); +onychomycosis  \nSKIN - no rashes or lesions  \nNEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength \n___ throughout, sensation grossly intact throughout, gait \nassessment deferred  \n\n \nPertinent Results:\n___ 07:00AM   GLUCOSE-117* UREA N-12 CREAT-0.9 SODIUM-136 \nPOTASSIUM-3.8 CHLORIDE-105 TOTAL CO2-23 ANION GAP-12\n___ 07:00AM   CALCIUM-8.1* PHOSPHATE-2.3* MAGNESIUM-1.9\n___ 07:00AM   WBC-8.4 RBC-3.53* HGB-11.4* HCT-33.5* MCV-95 \nMCH-32.3* MCHC-34.1 RDW-13.4\n___ 07:00AM   PLT COUNT-224\n___ 07:00AM   ___ PTT-28.6 ___\n___ 01:45AM URINE  BLOOD-LG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-0.2 PH-5.5 \nLEUK-NEG\n___ 11:00PM   LACTATE-3.2*\n___ 10:55PM   AMMONIA-23\n___ 10:03PM   ALT(SGPT)-29 AST(SGOT)-34 ALK PHOS-110* TOT \nBILI-0.3\n___ 10:03PM   LIPASE-30\n___ 10:03PM   ALBUMIN-4.9\n.\n___ CT abd/pelvis:\nIMPRESSION: \n1. 3.3-cm right hemorrhagic adnexal cyst. This would be within \nnormal \nphysiological limits if this patient is pre- or ___. \nIf the \npatient is post-menopausal, a pelvic US examination is \nrecommended.  \n2. Mild-to-moderate intrahepatic bile duct dilation and CBD \ndilation, \nunchanged since ___, compatible with cholecystectomy. \n3. No acute intra-abdominal or intrapelvic process detected. \n4. Soft and calcific atherosclerotic plaque causing mild \nproximal SMA \nstenosis.  \n\n \nBrief Hospital Course:\nThis is a ___ year old female with multiple medical problems \nincluding hepatitis C infection with hepatic fibrosis, \ngastritis, and heavy EtOH use admitted for intractable abdominal \npain with recent nausea, diarrhea, and fever after drinking \nheavily.  \n.  \n#.  Alcoholic gastritis: It is likely that her abdominal pain is \nsecondary to alcoholic gastritis after reportedly drinking 18 \nbeers and 8 liquor drinks the day of admission.  Her LFTs and \nlipase were normal.  Final CT read showed no acute process, but \ndid show 3.3-cm right hemorrhagic adnexal cyst which can be \nfurther evaluated as an outpatient, soft and calcific \natherosclerotic plaque causing mild proximal SMA stenosis, as \nwell as mild-to-moderate intrahepatic bile duct dilation and CBD \ndilation which is unchanged since ___.  She has known gastritis \non a recent EGD, which was likely exacerbated by her EtOH intake \nand also has significant GERD requiring fundoplication in the \npast.  She also has known chronic liver disease and fibromyalgia \nwith likely irritable bowel given her chronic diarrhea.  After \ninitially getting IV Dialudid for her pain control in the \nemergency department, she was continued on her home PPI BID and \nTylenol ___ q6 standing for pain control.  No narcotics were \ngiven while on the medical floor.  She was started on sucralfate \nand ondansetron ODT for her nausea.  Social work consult was \nobtained for EtOH abuse and the patient was not interested in \nabstaining from EtOH at this time.  She was given mutlivitamin, \nthiamine, and folate.  CIWA was also initiated, but the patient \ndid not score and left the hospital in less than 48 hours.\n.  \n#. COPD:  She did not have any respiratory symptoms and was not \nhypoxic.  Her home regimen of Advair, tiotropium, and albuterol \nwere continued.  \n.  \n#. Hepatitis C:  Genotype 1, followed by the liver clinic.  She \nremains untreated given her history of depression and \nunwillingness to undergo regular psychiatric care.  Her LFTs \nremained stable as well as her biliary findings found on CT \nscan.  \n.  \n# HTN:  Continued her home regimen of valsartan and nifedipine.\n.  \n#. CODE STATUS:  Confirmed Full Code\n.  \n#. CONTACT: fiance (___) or ___ (relative)  \n\n \nMedications on Admission:\n-albuterol  \n-fexofenadine  \n-advair  \n-folic acid  \n-nifedipine  \n-nitroglycerin  \n-pantoprazole  \n-tiotropium  \n-valsartan  \n-aspirin  \n-docusate  \n-ferrous sulfate  \n-MVI  \n-senna  \n-thiamine  \n\n \nDischarge Medications:\n1. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig: \nTwo (2) Puff Inhalation Q6H (every 6 hours) as needed for \ndyspnea, wheeze.  \n2. fexofenadine 180 mg Tablet Sig: One (1) Tablet PO once a day. \n \n3. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) inhalation Inhalation BID (2 times a day).  \n4. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n5. nifedipine 30 mg Tablet Extended Release Sig: One (1) Tablet \nExtended Release PO DAILY (Daily).  \n6. nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Tablet, \nSublingual Sublingual PRN (as needed) as needed for chest pain.  \n\n7. pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \n(1) Tablet, Delayed Release (E.C.) PO Q12H (every 12 hours).  \n8. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) inhlalation Inhalation DAILY (Daily).  \n9. valsartan 320 mg Tablet Sig: One (1) Tablet PO once a day.  \n10. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable \nPO DAILY (Daily).  \n11. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID \n(2 times a day).  \n12. ferrous sulfate 300  mg (60 mg iron) Tablet Sig: One (1) \nTablet PO TID (3 times a day).  \n13. multivitamin     Tablet Sig: One (1) Tablet PO once a day.  \n14. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday) as needed for constipation.  \n15. thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n16. acetaminophen 500 mg Tablet Sig: One (1) Tablet PO Q6H \n(every 6 hours): do not take more than 2 grams per day.  \n17. sucralfate 1 gram Tablet Sig: One (1) Tablet PO QID (4 times \na day).\nDisp:*120 Tablet(s)* Refills:*0*\n18. ondansetron 4 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, \nRapid Dissolve PO Q8H (every 8 hours) as needed for nausea for 4 \ndays.\nDisp:*12 Tablet, Rapid Dissolve(s)* Refills:*0*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAlcoholic gastritis\n.\nSecondary Diagnoses:\n-COPD \n-Hepatitis C  \n-HTN  \n-GERD  \n-Fibromyalgia  \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted to ___ for \nfurther evaluation of abdominal pain and vomiting.  Your \nworsened abdominal pain and vomiting was likely due to the large \namount of alcohol you took in prior to admission.  Alcohol is \nknown to be a stomach irritant and cause gastritis.  Given your \nlong history of stomach problems and your hepatitis C, it would \nbe best if you stopped drinking alcohol altogether.\n.\nThe following changes were made to your home medication regimen:\n- Please START sucralfate 1 gram four times daily to help with \nyour stomach inflammation \n- Please START ondansetron three times daily as needed for \nnausea\n \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee7539342f7"
  },
  "note_id": "19644467-DS-22",
  "subject_id": 19644467,
  "hadm_id": 20510907,
  "note_type": "DS",
  "note_seq": 22,
  "charttime": "2196-06-14 00:00:00",
  "storetime": "2196-06-16 12:37:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril\n \nAttending: ___.\n \nChief Complaint:\nDysuria  \n\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ y/o F with hx of COPD, hepatitis C, HTN, DLP, GERD, \nfibromyalgia, and gastritis presenting for pyelonephritis.  \n.  \nThe patient is a poor historian and tells and inconsistent \nhistory, but reports that for the past ___ days, she has \nexperienced rigth sided low back, flank, and right abdominal \npain radiating to her right groin. She also reports foul \nsmelling urine and dysuria. Denies hematuria. She also had \nnausea/vomiting for the past several days and stopped eating for \nthe past few days. She denies sick contacts, and reports her \nchronic, intermittent diarrhea is unchanged from baseline.  \n.  \nIn the ED, initial VS: 97.4 124 130/83 16 98%  \nThe patient reportedly complained of lightheadedness in the ED \non intial presentation which resolved after 1L NS and 1L LR with \nbanana bag. She underwent a CT abd/pelvis that showed bilateral \npyelonephritis. She was given Ceftriaxone 2 gm IV, Ciprofloxacin \n400 mg IV, Dilaudid 1 mg IV and 0.5 mg IV. Most Recent Vitals: \n98.9po, 96, 20, 140/92, 100%RA  \n.  \nOn the floor, the patient reported continued right sided flank, \nlow back, abdominal, and groin discomfort.  \n.  \nREVIEW OF SYSTEMS:  \nDenies chills, night sweats, headache, vision changes, \nrhinorrhea, congestion, sore throat, cough, shortness of breath, \nchest pain, abdominal pain, nausea, vomiting, diarrhea, \nconstipation, BRBPR, melena, hematochezia, hematuria.  \n\n \nPast Medical History:\nCOPD (never formally dx by spirometry, bullous emphysema on CT  \nimaging ___  \nHepatitis C (stage ___ fibrosis per liver bx ___  \nHTN (poorly controlled at b/l, non compliant with meds; P-MIBI  \nnegative in ___, stress-Echo ___ EF 60%, trivial MR, no  \ninducible ischemia)  \nHLD  \nPeripheral neuropathy  \nPVD (L subclavian stenosis seen on CTA ___ and MRA ___  \nand RE arterial insufficiency; ABI showing minimal disease below \n \nthe knee at the tibial level on ___  \nDepression, requiring hospitalization in past  \nh/o polysubstance abuse, including cocaine and iv drug use, and  \n\non-going alcohol and tobacco use  \nHiatal hernia, s/p nissen fundoplication  \nGERD  \nesophageal stricture (Schatzkis ring)  \nFe def anemia  \nFibromyalgia  \nCervical spondylosis  \nStress incontinence  \nOsteoarthritis \n \nSocial History:\n___\nFamily History:\nMother: CAD, deceased. 9 siblings, one deceased (cause unknown). \nFour children, all healthy. \n \nPhysical Exam:\nVS - 98.5 133/84 110 18 97%RA  \nGENERAL - Alert, interactive, well-appearing in NAD  \nHEENT - EOMI, sclerae anicteric, MMM  \nNECK - Supple  \nHEART - PMI non-displaced, RRR, nl S1-S2, no MRG  \nLUNGS - CTAB, no r/rh/wh, good air movement, resp unlabored, no \naccessory muscle use. Left low back pain. (+)CVA tenderness, \nR>L.  \nABDOMEN - NABS, soft, moderate distension, moderate tenderness \non the right quadrant diffusely  \nEXTREMITIES - WWP, no c/c/e, 2+ DP pulses.  \n\n \nPertinent Results:\nAdmission labs\n___ 05:35PM BLOOD WBC-13.0*# RBC-3.83* Hgb-13.0 Hct-36.8 \nMCV-96 MCH-33.8* MCHC-35.2* RDW-12.7 Plt ___\n___ 05:35PM BLOOD Neuts-84.4* Lymphs-9.0* Monos-5.4 Eos-0.2 \nBaso-1.1\n___ 05:35PM BLOOD Glucose-103* UreaN-15 Creat-1.0 Na-130* \nK-3.4 Cl-98 HCO3-20* AnGap-15\n___ 05:35PM BLOOD ALT-26 AST-23 AlkPhos-168* TotBili-0.4\n___ 05:35PM BLOOD Albumin-3.6\n___ 08:00PM BLOOD Lactate-1.0\n\nCXR ___: Stable cardiac and mediastinal contours. Lungs appear \nwell inflated. The interstitium is slightly prominent which may \nbe related to the patient's underlying emphysema, small airways \ndisease, or age-related changes. No focal airspace consolidation \nis seen to suggest pneumonia. There is no evidence of pulmonary \nedema. No pneumothorax or pleural effusions. Prominent amount of \ngas within the stomach. \n\nCT abd/pelvis ___: Right-sided pyelonephritis; perinephric \ninflammation of the left kidney as well. \n\nUCx:                              ESCHERICHIA COLI\n                             |   \nAMPICILLIN------------  =>32 R\nAMPICILLIN/SULBACTAM--     4 S\nCEFAZOLIN-------------   <=4 S\nCEFEPIME--------------   <=1 S\nCEFTAZIDIME-----------   <=1 S\nCEFTRIAXONE-----------   <=1 S\nCIPROFLOXACIN---------<=0.25 S\nGENTAMICIN------------   <=1 S\nMEROPENEM-------------<=0.25 S\nNITROFURANTOIN--------  <=16 S\nTOBRAMYCIN------------   <=1 S\nTRIMETHOPRIM/SULFA----  =>16 R\n\n \nBrief Hospital Course:\n___ y/o F with hx of COPD, hepatitis C, HTN, DLP, GERD, \nfibromyalgia, and gastritis presenting for pyelonephritis.  \n.  \n# Pyelonephritis: CT findings and micro data as above.  Was \ntreated with ceftriaxone and ciprofloxacin, which was later \nnarrowed to cipro monotherapy.  She was asymptomatic by day of \ndischarge, with stable vital signs, and was discharged with \nprescription to complete seven day course of antibiotics.  ECG \nwas checked to assess QTc interval on ciprofloxacin, which was \nnormal.\n.  \n#. Hyponatremia: Resolved with IV fluids on night of admission.  \nLikely due to volume depletion in setting of poor PO intake and \nnausea.\n.  \nINACTIVE ISSUES:\n#. h/o Alcoholism: Pt received banana bag in ED, was written for \n___, but did not require any benzodiazepines.\n.  \n#. COPD: Pt took her home regimen of Advair, Tiotropium, and \nAlbuterol.  \n.  \n#. Hepatitis C, Genotype 1:  LFTs were normal.  Had no RUQ \nsymptoms.\n.  \n#  Hypertension: She continued her home valsartan and \nnifedipine.  \n.  \nCODE: Confirmed Full Code\n.\nTRANSITIONAL:  Pt was instructed to call her PCP's office to \ncoordinate follow up appointment.  Also, blood cultures were \nstill pending at time of discharge.\n \nMedications on Admission:\n1. albuterol sulfate 90 mcg/Actuation HFA Aerosol Inhaler Sig:  \nTwo (2) Puff Inhalation Q6H (every 6 hours) as needed for  \ndyspnea, wheeze.  \n2. fexofenadine 180 mg Tablet Sig: One (1) Tablet PO once a day. \n \n3. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig:  \n\nOne (1) inhalation Inhalation BID (2 times a day).  \n4. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n5. nifedipine 30 mg Tablet Extended Release Sig: One (1) Tablet  \n\nExtended Release PO DAILY (Daily).  \n6. nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1) Tablet,  \n\nSublingual Sublingual PRN (as needed) as needed for chest pain.  \n\n7. pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One  \n(1) Tablet, Delayed Release (E.C.) PO Q12H (every 12 hours).  \n8. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig:  \nOne (1) inhlalation Inhalation DAILY (Daily).  \n9. valsartan 320 mg Tablet Sig: One (1) Tablet PO once a day.  \n10. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, PO DAILY \n \n11. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID  \n12. ferrous sulfate 300 mg (60 mg iron) Tablet Sig: One (1)  \nTablet PO TID (3 times a day).  \n13. multivitamin Tablet Sig: One (1) Tablet PO once a day.  \n14. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID prn  \n15. thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY  \n16. acetaminophen 500 mg Tablet Sig: One (1) Tablet PO Q6H  \n17. sucralfate 1 gram Tablet Sig: One (1) Tablet PO QID  \n18. ondansetron 4 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, \n \nRapid Dissolve PO Q8H (every 8 hours) as needed for nausea for 4 \n \ndays. \n \nDischarge Medications:\n1. albuterol sulfate 90 mcg/actuation HFA Aerosol Inhaler Sig: \n___ Puffs Inhalation Q4H (every 4 hours) as needed for dyspnea, \nwheeze.  \n2. fexofenadine 60 mg Tablet Sig: Three (3) Tablet PO DAILY \n(Daily).  \n3. fluticasone-salmeterol 500-50 mcg/dose Disk with Device Sig: \nOne (1) Disk with Device Inhalation BID (2 times a day).  \n4. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  \n\n5. nifedipine 30 mg Tablet Extended Release Sig: One (1) Tablet \nExtended Release PO DAILY (Daily).  \n6. tiotropium bromide 18 mcg Capsule, w/Inhalation Device Sig: \nOne (1) Cap Inhalation DAILY (Daily).  \n7. valsartan 160 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). \n \n8. aspirin 81 mg Tablet, Delayed Release (E.C.) Sig: One (1) \nTablet, Delayed Release (E.C.) PO DAILY (Daily).  \n9. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 \ntimes a day).  \n10. ferrous sulfate 300  mg (60 mg iron) Tablet Sig: One (1) \nTablet PO three times a day.  \n11. multivitamin     Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n12. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a \nday) as needed for constipation.  \n13. thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY \n(Daily).  \n14. Acetaminophen Extra Strength 500 mg Tablet Sig: One (1) \nTablet PO every six (6) hours as needed for pain.  \n15. sucralfate 1 gram Tablet Sig: One (1) Tablet PO QID (4 times \na day).  \n16. ondansetron 4 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, \nRapid Dissolve PO every eight (8) hours as needed for nausea.  \n17. pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One \n(1) Tablet, Delayed Release (E.C.) PO Q12H (every 12 hours).  \n18. ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO Q12H \n(every 12 hours).\nDisp:*11 Tablet(s)* Refills:*0*\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS: Pyelonephritis\n.\nSECONDARY DIAGNOSES:\nChronic obstructive pulmonary disease (COPD)\nHepatitis C\nHypertension\nHyperlipidemia\nPeripheral neuropathy  \nPeripheral vascular disease\nDepression\nPolysubstance abuse\nAnemia\nFibromyalgia  \nOsteoarthritis  \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMs. ___,\nYou were admitted to ___ for pain in your flank and groin, and \npain with urination, likely due to infection of your urinary \ntract and kidney.  A CT scan showed that your right kidney was \ninflamed.  You were given antibiotics, initially through an IV \nline, to treat the infection.  Before you left, your culture \nshowed that the infection was due to a bacteria called E. Coli, \nbut we did not yet have specific information about what \nantibiotics it will be susceptible to.  Since you are feeling \nbetter, we can presume that the antibiotics are working.  Please \ndiscuss this further with your PCP.\n.\nThe following changes were made to your medications:\n-Please CONTINUE taking CIPROFLOXACIN 500 mg tablets, one tablet \nby mouth every twelve hours (twice daily) for an additional five \ndays (last dose on the morning of ___.  We have checked an \nelectrocardiogram of your heart to make sure this medication is \nsafe for you.\n-Please discuss your dose of pantoprazole with your PCP.  Our \nrecords indicated you were taking a different dose than what you \ntold us.\n.\nIt is important that you follow up with your primary care \nphysician ___ at ___ \n(___) on ___.  Please make him aware that one of \nyour liver enzymes, alkaline phosphatase, was elevated and \nshould be followed up. Additionally, your antibiotics and some \nof your medications can cause changes to your EKG.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee7539342f8"
  },
  "note_id": "19644467-DS-23",
  "subject_id": 19644467,
  "hadm_id": 24658867,
  "note_type": "DS",
  "note_seq": 23,
  "charttime": "2197-01-13 00:00:00",
  "storetime": "2197-01-13 21:14:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril\n \nAttending: ___.\n \nChief Complaint:\nLeft ear redness and swelling\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nMs. ___ is a ___ year old woman with a history of COPD, \nHepatitis C infection, and IV drug use who presents with left \nexternal ear swelling and pain that began this morning when she \nawoke. The patient reports waking up this morning and noticing \nerythema and swelling of her left ear with progressively \nincreasing pain (___) and radiation down her left jaw/neck.  It \nis worse with movement of the ear/turning head to right side and \nassociated with \"muffled hearing,\" worsening of her chronic b/l \ntinnitis/HA, a \"bad sour/bitter taste\" in her mouth, and slight \nheadahce. She is notably negative for drainage from her left \near, neck stiffness, difficulty swallowing, numbness, sick \ncontacts, h/o trauma/animal bites, recent swimming, fever, \nchills, SOB, CP, urinary symptoms, GI symptoms.\n\nInitial VS in the ED were 97.5 101 187/91 18 99% RA.  Exam was \nnotable for edematous and erythematous left pinna/external ear \nwith erythema extending down neck with clear oropharynx and \nlungs.  Chem7 was within normal limits, CBC significant for WBC \n7.4 with neutrophlic predominance.  CT neck w/ contrast showed \n\"No abscess. Cellulitis over the left pinna. No prevertebral \nsoft tissue swelling\" with hyperenhancing of lymph nodes within \nparotid but no evidence of parotitis. \n\nShe was administered one dose of clindamycin/vancomycin and 1L \nNS and admitted to Medicine for concern of cellullitis vs. \nmastitis. On transfer, VS were 97.9 68 156/92 16 98%.  On the \nfloor, VS were 98.3 160/94 82 18 97%RA.  Patient remained stable \nwith complaints of left ear and neck pain/swelling.\n \nPast Medical History:\nCOPD (never formally dx by spirometry, bullous emphysema on CT  \nimaging ___  \nHepatitis C (stage ___ fibrosis per liver bx ___  \nHTN (poorly controlled at b/l, non compliant with meds; P-MIBI  \nnegative in ___, stress-Echo ___ EF 60%, trivial MR, no  \ninducible ischemia)  \nHLD  \nPeripheral neuropathy  \nPVD (L subclavian stenosis seen on CTA ___ and MRA ___  \nand RE arterial insufficiency; ABI showing minimal disease below \n \nthe knee at the tibial level on ___  \nDepression, requiring hospitalization in past  \nh/o polysubstance abuse, including cocaine and iv drug use, and  \n\non-going alcohol and tobacco use  \nHiatal hernia, s/p nissen fundoplication  \nGERD  \nesophageal stricture (Schatzkis ring)  \nFe def anemia  \nFibromyalgia  \nCervical spondylosis  \nStress incontinence  \nOsteoarthritis \n \nSocial History:\n___\nFamily History:\nMother: CAD, deceased. 9 siblings, one deceased (cause unknown). \nFour children, all healthy. \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\nVitals: T: 98.3  BP: 160/94  P: 82  R: 18  O2: 97% RA  \nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear. Erythema and \nedema of L pinna and ear canal extending down L cheek and neck \nto level of chin.  Ear canal is open with wax, gray and white \nexudate. \nNeck: supple, JVP not elevated, no LAD. \nLungs: Coarse lung sounds throughout, no wheezes, rales, ronchi  \n\nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nAbdomen: soft, non-distended, bowel sounds present, no rebound \ntenderness or guarding.  Tenderness in RUQ and epigastric region \nthat is baseline for patient.  No organomegaly\nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema \nNeuro: A&Ox2. Decreased sensation in bilateral lower \nextremities.\n\nDISCHARGE PHYSICAL EXAM\nVitals: T: 97.6  BP: 124/77  P: 78  R: 18  O2: 96% RA  \nGeneral: Alert, oriented, no acute distress  \nHEENT: Sclera anicteric, MMM, oropharynx clear. Erythema and \nedema of L pinna and ear canal improved and receded now only on \nlimited region of L cheek and neck.\nNeck: supple, JVP not elevated, no LAD. \nLungs: Coarse lung sounds throughout, no wheezes, rales, ronchi  \n\nCV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, \ngallops  \nAbdomen: soft, non-distended, bowel sounds present, no rebound \ntenderness or guarding.  Tenderness in RUQ and epigastric region \nthat is baseline for patient.  No organomegaly\nExt: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema \nNeuro: A&Ox2. Decreased sensation in bilateral lower \nextremities.\n \nPertinent Results:\nADMISSION LABS:\n___ 09:20AM BLOOD WBC-7.4 RBC-4.28 Hgb-13.9 Hct-41.1 MCV-96 \nMCH-32.5* MCHC-33.8 RDW-13.8 Plt ___\n___ 09:20AM BLOOD Neuts-70.7* ___ Monos-5.8 Eos-0.7 \nBaso-0.3\n___ 09:20AM BLOOD Glucose-101* UreaN-8 Creat-0.7 Na-139 \nK-4.0 Cl-105 HCO3-24 AnGap-14\n___ 10:05AM BLOOD Lactate-1.0\n\nPERTINENT LABS:\n___ 06:55AM BLOOD WBC-6.2 RBC-3.86* Hgb-12.8 Hct-37.5 \nMCV-97 MCH-33.2* MCHC-34.2 RDW-13.9 Plt ___\n___ 06:55AM BLOOD Glucose-105* UreaN-9 Creat-0.8 Na-135 \nK-3.7 Cl-104 HCO3-22 AnGap-13\n___ 06:55AM BLOOD Calcium-8.3* Phos-3.2 Mg-2.2\n\nDISCHARGE LABS:\n___ 06:40AM BLOOD WBC-6.2 RBC-3.78* Hgb-12.4 Hct-36.5 \nMCV-97 MCH-32.9* MCHC-34.1 RDW-13.9 Plt ___\n___ 06:40AM BLOOD Glucose-112* UreaN-12 Creat-1.1 Na-135 \nK-3.8 Cl-100 HCO3-24 AnGap-15\n___ 06:40AM BLOOD Calcium-8.7 Phos-4.4 Mg-2.1\n\nMICROBIOLOGY:\n___ Blood Cx x2 - pending\n\nSTUDIES:\n- ___ CT NECK W/CONTRAST: 1.  No evidence of abscess or \ndrainable fluid collection.  Soft tissue swelling around the \npinna of the left ear is consistent with cellulitis. No \ndefinitive signs of left parotitis.  2.  Carotid artery \naterosclerotic calcifications and severe bilateral apical \nemphysema are present. \n- ___ ABDOMEN (SUPINE & ERECT): \nMild gaseous distention of the stomach with a nonspecific \nabdominal bowel gas pattern, though there is no evidence of \nobstruction or free air.\n \nBrief Hospital Course:\n___ y/o F with COPD, Hep C presents w/ left external ear pain x 1 \nday. Physical exam significant for erythema/edema of external \near with open canal, concerning for otitis externa with \ncellullitis.  \n\n# Left ear erythema and swelling extending to cheek and neck: \nThe patient was admitted for acute-onset left ear swelling that \nshe noticed when she woke up.  On admission, she had erythema \nand edema of her left ear extending down her neck, an \nerythematous ear canal but no purulence.   Her clinical picture \nwas most consistent with external otitis with associated \nperiauricular cellulitis.  Neck CT done in the ED was consistent \nwith cellulitis of L pinna with parotid lymphadenopathy but no \nevidence of parotitis or mastoiditis making malignant external \notitis less likely.  Patient was administered a dose of \nvancomycin/clindamycin while in the ED, switched to IV Cipro \n400mg Q12H + Vanc 1g Q12H. The following day she was \ntransitioned to oral Bactrim and monitored overnight. She \nclinically improved and was discharged with plans to complete 7 \ndays of antibiotics and to follow up with her PCP. \n\n# Constipation: Patient reported feeling constipated. Abdomen \nwas slightly distended by soft. KUB revealed no evidence of \nobstruction. She was treated with colace, senna, miralax and a \nbisacodyl suppository. \n\n# Coronary artery disease: The patient was maintained on her \nhome dose of aspirin and simvastatin.  \n\n# COPD:  The patient was maintained on her home Advair and \nSpiriva inhalers, and placed on an albuteral nebulizers as \nneeded.  \n\n# Hypertension: The patient was maintained on her home regimen \nof hydrochlorothiazide and Valsartan during this admission.  Her \nblood pressures remained well-controlled with systolic blood \npressures in 120s.\n\n# Depression: The patient was maintained on her home regimen of \nAmitriptyline without any active symptoms throughout this \nhospitalization.\n\n# GERD: The patient was maintained on her home regimen of \nPantoprazole without any active symptoms throughout this \nhospitalization.\n\n# Iron deficiency anemia: The patient was maintained on her home \nregimen of Ferrous Sulfate. \n\n# Peripheral neuropathy: The patient was maintained on her home \nregimen of Gabapentin without any increased symptoms throughout \nthis hospitalization.\n\nTRANSITIONAL ISSUES\nPending studies\n- ___ Blood Cx x2\nMedications:\n- The patient was STARTED on Bactrim DS 2tabs BID x 7 days\nFollow-up\n- Dr. ___ at ___ on ___ at 11am\nCode status: Full\n \nMedications on Admission:\nPreadmission medications listed are correct and complete.  \nInformation was obtained from Patient.\n1. Aspirin 81 mg PO DAILY \n2. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath \n3. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n4. FoLIC Acid 1 mg PO DAILY \n5. Hydrochlorothiazide 25 mg PO DAILY \n6. Nitroglycerin SL 0.4 mg SL PRN chest pain \n7. Pantoprazole 80 mg PO BID \n8. Tiotropium Bromide 1 CAP IH DAILY \n9. Valsartan 320 mg PO DAILY \n10. Thiamine 50 mg PO DAILY \n11. Multivitamins 1 TAB PO DAILY \n12. Ferrous Sulfate 325 mg PO DAILY \n13. Docusate Sodium 100 mg PO DAILY \n14. HydrOXYzine 25 mg PO BID:PRN itching \n15. Caltrate 600+D Plus Minerals *NF* (calcium carbonate-vit \nD3-min) 600 mg calcium- 400 unit Oral Daily \n16. Amitriptyline 50 mg PO HS \n17. NIFEdipine CR 60 mg PO DAILY \n18. Loratadine *NF* 10 mg Oral DAILY:PRN allergies \n19. Biotene Oralbalance *NF* (lactoperoxi-gluc oxid-pot \nthio;<br>saliva stimulant agents comb.2)    Mucous Membrane TID: \nPRN dry mouth \n20. Simvastatin 20 mg PO DAILY \n21. Gabapentin 300 mg PO BID \n\n \nDischarge Medications:\n1. Sulfameth/Trimethoprim DS 2 TAB PO BID Duration: 28 Doses \n2. Nitroglycerin SL 0.4 mg SL PRN chest pain \n3. Loratadine *NF* 10 mg Oral DAILY:PRN allergies \n4. HydrOXYzine 25 mg PO BID:PRN itching \n5. Caltrate 600+D Plus Minerals *NF* (calcium carbonate-vit \nD3-min) 600 mg calcium- 400 unit Oral Daily \n6. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath \n7. Amitriptyline 50 mg PO HS \n8. Aspirin 81 mg PO DAILY \n9. Docusate Sodium 100 mg PO DAILY:PRN constipation \n10. Ferrous Sulfate 325 mg PO DAILY \n11. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n12. Valsartan 320 mg PO DAILY \n13. Simvastatin 20 mg PO DAILY \n14. Thiamine 50 mg PO DAILY \n15. Tiotropium Bromide 1 CAP IH DAILY \n16. Pantoprazole 80 mg PO BID \n17. NIFEdipine CR 60 mg PO DAILY \n18. Multivitamins 1 TAB PO DAILY \n19. Hydrochlorothiazide 25 mg PO DAILY \n20. FoLIC Acid 1 mg PO DAILY \n21. Biotene Oralbalance *NF* (lactoperoxi-gluc oxid-pot \nthio;<br>saliva stimulant agents comb.2) 0  pack MUCOUS MEMBRANE \nTID: PRN dry mouth \n22. Gabapentin 300 mg PO BID \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary diagnosis: External otitis with periauricular cellulitis\n\nSecondary diagnoses: Chronic obstructive pulmonary disease, \nHepatitis C infection, hypertension, hyperlipidemia, peripheral \nneuropathy, peripheral vascular disease, depression, hiatal \nhernia s/p ___ fundoplication, GERD, esophageal stricture \n(Schatzkis ring), Iron deficiency anemia, Fibromyalgia, \nCervical spondylosis, Stress incontinence, Osteoarthritis \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure to take care of you during this \nhospitalization.  You were admitted to ___ \n___ for redness and swelling of your left ear, cheek, \nand neck.  You were found to likely have an external ear \ninfection with infection of the surrounding skin.  You were \ntreated pain medication and intravenous antibiotics that were \nswitched to oral antibiotics prior to discharge. You are now \nsafe to go home.\n\nThe following changes were made to your medications:\n - Please START taking Bactrim DS 2tab twice daily for 7 days\n\nPlease take all your medications as directed and attend all your \nfollow-up appointments as scheduled\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee7539342f9"
  },
  "note_id": "19644467-DS-24",
  "subject_id": 19644467,
  "hadm_id": 29527425,
  "note_type": "DS",
  "note_seq": 24,
  "charttime": "2197-02-05 00:00:00",
  "storetime": "2197-02-07 10:45:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril\n \nAttending: ___\n \nChief Complaint:\ndyspnea \n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\n___ PMH PVD, Hep C, COPD, peripheral neuropathy who has had 1.5 \nweeks of dyspnea, also with increasing pain in RUE and R chest \n(with more chronic component as well). The patient states that \nthe dyspnea was also associated with a profound cough. The \ncoughing led to worsening pain. Pt states pain started around R \nneck and radiates to R arm, R shoulder blade, and R chest wall. \nPain is worse with breathing and is associated with SOB. Also \nhas had a cough for one week, productive of white and yellow \nlittle sputum and plugs.  \nR sided weakness/tremor progressive over years. Her mobility has \nbeen more limited, and she can't walk far w/out help. She fell \nyesterday she stated and fell on her buttocks, no head strike or \nLOC.  \n \nOf note, the patient continues to actively smoke. She also has \nseasonal allergies, and there has been a large deal of \nconstruction outside of her apartment building, with a good \namount of fine dust (changing bricks). She has kept her windows \nopen despite this for fresh, cool air.  \nIn the ED, initial VS were: 97.2 96 152/112 22 100% RA  \nOn exam, weak in RUE, RLE with decreased sensation. Wheezes. \nPain to palpation in R shoulder. She received solumedrol, \nazithromycin and duonebs in the ED. Received tylenol and \nmorphine x2 for pain. CXR was unrevealing. Troponin t was \nnegative x2. CBC and Chem 7 were unremarkable. UA was \nunremarkable.  \nOn arrival to the floor, the patient is cooperative and able to \ngive a coherent history.  \n \nREVIEW OF SYSTEMS:  \n(+) loose stools for weeks, R arm weakness and tremor, periodic \nmild nausea; periodic mild abdominal pain  \n(-) fever, chills, night sweats, headache, vision changes, \nrhinorrhea, congestion, sore throat, cough, shortness of breath, \nvomiting, diarrhea, constipation, BRBPR, melena, hematochezia, \ndysuria, hematuria. \n\n \nPast Medical History:\nCOPD (never formally dx by spirometry, bullous emphysema on CT  \nimaging ___  \nHepatitis C (stage ___ fibrosis per liver bx ___  \nHTN (poorly controlled at b/l, non compliant with meds; P-MIBI  \nnegative in ___, stress-Echo ___ EF 60%, trivial MR, no  \ninducible ischemia)  \nHLD  \nPeripheral neuropathy  \nPVD (L subclavian stenosis seen on CTA ___ and MRA ___  \nand RE arterial insufficiency; ABI showing minimal disease below \n \nthe knee at the tibial level on ___  \nDepression, requiring hospitalization in past  \nh/o polysubstance abuse, including cocaine and iv drug use, and  \n\non-going alcohol and tobacco use  \nHiatal hernia, s/p ___ fundoplication  \nGERD  \nesophageal stricture (Schatzkis ring)  \nFe def anemia  \nFibromyalgia  \nCervical spondylosis  \nStress incontinence  \nOsteoarthritis \n \nSocial History:\n___\nFamily History:\nMother: CAD, deceased. 9 siblings, one deceased (cause unknown). \nFour children, all healthy. \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVS - 97.6 149/84 22 98%RA  \nGENERAL - comfortable, appropriate  \nHEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear  \nNECK - supple, no thyromegaly, no JVD, some tenderness to \npalpation of R side of neck  \nLUNGS - scant wheeze bilaterally, good air movement, resp \nunlabored, no accessory muscle use  \nHEART - PMI non-displaced, RRR, no MRG, nl S1-S2  \nABDOMEN - NABS, soft, no masses or HSM, no rebound/guarding, \nmild tenderness to quadrant RUQ  \nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, \nDPs). Some tenderness to palpation of R shoulder area.  \nSKIN - no rashes or lesions  \nNEURO - awake, A&Ox3, CNs II-XII grossly intact aside from \nincreased sensation on R side of face; muscle strength ___ \nthroughout aside from ___ strength of R quad, and R biceps; ___ \nstrength interosseous muscles, sensation grossly intact \nthroughout  \n\nDISCHARGE PHYSICAL EXAM:\nVS - 97.7 125/87 81 18 99%RA  \nGENERAL - comfortable, appropriate, minimally distress, holds R \nshoulder when coughing  \nHEENT - NCAT, PERRL, EOMI, sclerae anicteric, MMM, OP clear  \nNECK - supple, no thyromegaly, no JVD, some tenderness to \npalpation of R side of neck  \nLUNGS - scant wheeze bilaterally, good air movement, resp \nunlabored, no accessory muscle use  \nHEART - PMI non-displaced, RRR, no MRG, nl S1-S2  \nABDOMEN - NABS, soft, ND, NT no masses or HSM, no \nrebound/guarding, mild tenderness to quadrant RUQ  \nEXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, \nDPs). Some tenderness to palpation of R shoulder area.  \nSKIN - no rashes or lesions  \nNEURO - AAOx3, CNs II-XII grossly intact; muscle strength ___ \nthroughout aside from ___ strength of R quad, and R biceps; ___ \nstrength interosseous muscles, sensation grossly intact \nthroughout  \n\n \nPertinent Results:\nADMISSION LABS:\n\n___ 07:06PM   LACTATE-3.4*\n___ 06:20AM   GLUCOSE-248* UREA N-14 CREAT-0.9 SODIUM-139 \nPOTASSIUM-4.0 CHLORIDE-102 TOTAL CO2-17* ANION GAP-24*\n___ 06:20AM   WBC-6.0 RBC-4.09* HGB-13.4 HCT-40.1 MCV-98 \nMCH-32.8* MCHC-33.5 RDW-13.2\n___ 06:20AM   PLT COUNT-252\n___ 12:30AM   cTropnT-<0.01\n___ 09:05PM URINE  HOURS-RANDOM\n___ 09:05PM URINE  GR HOLD-HOLD\n___ 09:05PM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 09:05PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 \nLEUK-NEG\n___ 07:33PM   GLUCOSE-119* UREA N-14 CREAT-0.7 SODIUM-140 \nPOTASSIUM-3.6 CHLORIDE-105 TOTAL CO2-21* ANION GAP-18\n___ 07:33PM   estGFR-Using this\n___ 07:33PM   cTropnT-<0.01\n___ 07:33PM   WBC-7.8 RBC-4.23 HGB-13.8 HCT-40.7 MCV-96 \nMCH-32.6* MCHC-33.9 RDW-13.2\n___ 07:33PM   NEUTS-58 ___ MONOS-7 EOS-4 BASOS-0\n___ 07:33PM   PLT COUNT-271\n\nImaging:\nCXR: No acute cardiopulmonary process. No significant change \nsince\nthe prior study.\nXray R shoulder: no acute fracture or dislocation\n\nCTA Chest: CONCLUSION:\n1.  There is no pulmonary embolism and no acute aortic syndrome.\n2.  There is no acute pulmonary process.\n3.  Pulmonary emphysema is severe.  \n\nDischarge Labs:\n___ 06:20AM BLOOD WBC-10.8# RBC-3.91* Hgb-12.9 Hct-38.6 \nMCV-99* MCH-32.9* MCHC-33.3 RDW-13.8 Plt ___\n___ 06:20AM BLOOD Glucose-111* UreaN-12 Creat-0.9 Na-139 \nK-3.9 Cl-99 HCO3-26 AnGap-18\n___ 06:20AM BLOOD Calcium-9.7 Phos-3.9 Mg-1.9\n___ 10:37AM BLOOD Lactate-3.6*\n \nBrief Hospital Course:\n___ PMH PVD, Hep C, COPD, peripheral neuropathy who presents \nwith dyspnea and has had 1.5 weeks increasing pain and weakness \nin RUE, RLE in relation to her cough who was found to have a \nCOPD exacerbation.  \n \nActive Issues:\n\n# Dyspnea: Patient has COPD and her 10 day history of dyspnea \nand increased cough is most likely a COPD exacerbation, likely \ntriggered by environmental agents (construction dust, cigarette \nsmoke, seasonal allergens). After receiving steroids, nebs and \nazithromycin in the ED, she states that her symptoms \nsubstantially improved. Pt has had no fevers, leukocytosis, or \nx-ray findings of consolidation, thus PNA is highly unlikely. Pt \nhas been ruled out for MI w/ two negative EKGs and troponin \nmarkers. Given patient's chest pain we also ruled her out for PE \nwith a negative CTA which did show severe emphysema. We gave \nprednisone burst x 5 days, albuterol and ipratropium nebulizers, \nand azithromycin. Smoking cessation counseling was provided but \npatient states she is not ready to quit and that she has already \nsignificantly cut down her smoking from 3 packs to about half a \npack per day. We advise pt to use air filter at home and keep \nwindows closed to limit environmental allergens. We continue \nhome spiriva inhaler and was able to arrange for patient to get \na home nebulizer unit for at home albuterol nebulizer treatments \nwhich the patient felt worked better than the MDI. On discharge \npatient was still short of breath given her severe COPD but her \nbreathing was back at baseline.\n  \n# RUE pain and weakness: Pt presented with pain and weakness in \nher right arm and hand which she states has been present for a \nlong time although it was now more painful. This increased pain \nwas likely related to cough and dyspnea, as patient pointed out \nsince when she coughs her right arm and shoulder shake when she \nviolently coughs. Pt does have chronic tremor and chronic R \nsided pain/weakness, which may be from cervical spinal \ndysfunction or peripheral nervous issues. An x-ray of her \nshoulder was negative for fracture or dislocation.\n \n# Fall: Pt had a recent mechanical fall at home, likely \nsecondary to neuropathy. ___ and OT were consulted which she \ndemonstrates decreased strength, decreased ROM, decreased \nsensation, decreased safety awareness, and decreased functional \nmobility affecting her ability to perform ADLs independently so \nit was recommended that patient have home OT and ___ \nrehabilitation. \n\nChronic Issues:\n\n# Hypertension: Pt was generally normotensive throughout \nadmission so we continue home HCTZ, Valsartan, and nifedipine.  \n\n# Depression: Stable without signs of worsening depression so we \ncontinued home Amitriptyline.\n  \n# GERD: Asymptomatic so we continued pantoprazole BID  \n\n# Iron deficiency anemia: At baseline, if not a bit better so we \ncontinued home Ferrous Sulfate.  \n\nTransitional Issues:\n1. Pt will need continued encouragement for smoking cessation. \nShe has severe COPD and should stop smoking immediately.\n2. Pt had elevated lactate level which is likely from her COPD \nwith no other evidence of end organ ischemia. This may need to \nbe followed up if there is concern for other etiologies other \nthan COPD.\n \nMedications on Admission:\nPreadmission medications listed are correct and complete.  \nInformation was obtained from PatientwebOMR.\n1. Nitroglycerin SL 0.4 mg SL PRN chest pain \n2. Loratadine *NF* 10 mg Oral DAILY:PRN allergies \n3. HydrOXYzine 25 mg PO BID:PRN itching \n4. Caltrate 600+D Plus Minerals *NF* (calcium carbonate-vit \nD3-min) 600 mg calcium- 400 unit Oral Daily \n5. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath \n6. Amitriptyline 50 mg PO HS \n7. Aspirin 81 mg PO DAILY \n8. Docusate Sodium 100 mg PO DAILY:PRN constipation \n9. Ferrous Sulfate 325 mg PO DAILY \n10. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n11. Valsartan 320 mg PO DAILY \n12. Simvastatin 20 mg PO DAILY \n13. Thiamine 50 mg PO DAILY \n14. Tiotropium Bromide 1 CAP IH DAILY \n15. Pantoprazole 80 mg PO BID \n16. NIFEdipine CR 60 mg PO DAILY \n17. Multivitamins 1 TAB PO DAILY \n18. Hydrochlorothiazide 25 mg PO DAILY \n19. FoLIC Acid 1 mg PO DAILY \n20. Biotene Oralbalance *NF* (lactoperoxi-gluc oxid-pot \nthio;<br>saliva stimulant agents comb.2) 0  pack MUCOUS MEMBRANE \nTID: PRN dry mouth \n21. Gabapentin 300 mg PO BID \n\n \nDischarge Medications:\n1. Amitriptyline 50 mg PO HS \n2. Aspirin 81 mg PO DAILY \n3. Ferrous Sulfate 325 mg PO DAILY \n4. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n5. FoLIC Acid 1 mg PO DAILY \n6. Gabapentin 300 mg PO BID \n7. Hydrochlorothiazide 25 mg PO DAILY \n8. Loratadine *NF* 10 mg Oral DAILY:PRN allergies \n9. Multivitamins 1 TAB PO DAILY \n10. NIFEdipine CR 60 mg PO DAILY \n11. Pantoprazole 40 mg PO Q12H \n12. Simvastatin 20 mg PO DAILY \n13. Thiamine 50 mg PO DAILY \n14. Valsartan 320 mg PO DAILY \n15. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath \n16. Caltrate 600+D Plus Minerals *NF* (calcium carbonate-vit \nD3-min) 600 mg calcium- 400 unit Oral Daily \n17. Biotene Oralbalance *NF* (lactoperoxi-gluc oxid-pot \nthio;<br>saliva stimulant agents comb.2) 0  pack MUCOUS MEMBRANE \nTID: PRN dry mouth \n18. Docusate Sodium 100 mg PO DAILY:PRN constipation \n19. HydrOXYzine 25 mg PO BID:PRN itching \n20. Nitroglycerin SL 0.4 mg SL PRN chest pain \n21. Tiotropium Bromide 1 CAP IH DAILY \n22. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN dyspnea, wheeze \nRX *albuterol sulfate 2.5 mg/3 mL (0.083 %) 1 Neb IH Q6H: PRN \nwheezing/SOB Disp #*30 Cartridge Refills:*0\n23. Nebulizer unit\nOne nebulizer unit.\n24. Azithromycin 250 mg PO Q24H Duration: 3 Days \nRX *azithromycin 250 mg 1 tablet(s) by mouth Daily Disp #*3 \nTablet Refills:*0\n25. PredniSONE 40 mg PO DAILY Duration: 3 Days \nRX *prednisone 20 mg 2 tablet(s) by mouth Daily Disp #*6 Tablet \nRefills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nCOPD exacerbation\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure caring for you on your recent hospitalization \nat ___. You came to the hospital because you were having \ndifficulty breathing, cough, and pain in your right shoulder and \narm. Reassuringly we found that you did not have a blood clot in \nyour lungs. We found that you have a COPD exacerbation for which \nwe treated you with antibiotics and steroids and you got better. \nReassuringly an x-ray of your shoulder did not reveal any \nfracture or dislocation.\n\nThe following changes were made to your medications:\nAdded:\n1. PredniSONE 40 mg DAILY for total of 5 days\n2. Azithromycin 250 mg Q24H for total of 5 days  \n3. Albuterol nebulizer 1 nebulizer tx every 4 hours as needed \nfor SOB/ wheezing. Do not use albuterol nebulizer and albuterol \ninhaler together, please use only one or the other per 4 hour \nperiod.\n\nChanges:\n1. Pantoprazole 40 mg twice per day    \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee7539342fa"
  },
  "note_id": "19644467-DS-25",
  "subject_id": 19644467,
  "hadm_id": 28136918,
  "note_type": "DS",
  "note_seq": 25,
  "charttime": "2197-05-23 00:00:00",
  "storetime": "2197-05-23 16:30:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril\n \nAttending: ___\n \nChief Complaint:\ndyspnea\n \nMajor Surgical or Invasive Procedure:\nnone \n\n \nHistory of Present Illness:\nMs. ___ is a ___ with history of COPD (no PFTs) who presents \nwith left chest and flank pain. She was in her usual state of \nhealth until ~ 3 days ago, when she noted increasing DOE, \ninitially controlled by albuterol inhaler, but increasingly non \nresponsive to albuterol, to point where pt felt unable to breath \nlast night.   EMS was called, and she received nebulizer \ntreatments en route, with some improvement in respiratory \nstatus. Of note, she was admitted most recently in ___ for \nCOPD exacerbation, which was treated with nebulizers, prednisone \nburst, and azithromycin; home nebulizer machine was arranged and \nsmoking cessation encouraged.  (Currently smoking ___ pack a \nday)\n \nIn the ED, initial vital signs were as follows: 98.7 ___ \n36 100%. Exam was notable for absence of adventitious breath \nsounds and left CVA tenderness. Admission labs were notable for \nbicarbonate of 19, initial VBG of 7.52/___,subsequent ABG \nof ___, lactate of 3.7 to 2.6 to 1.9, and negative \nurine hCG. UA included 82 Wbc and 182 Rbc. Serum toxicology \nscreen was negative. EKG revealed sinus tachycardia without \nacute ischemic changes. CTA was negative for pulmonary embolus \nwhile CT abdomen/pelvis without contrast was negative for \nnephrolithiasis, though study limited by presence of contrast \nfrom CTA. BCx were obtained, and she was swabbed for influenza. \nShe received ciprofloxacin 400mg IV for presumed UTI, as well as \nIV Ativan and PO Klonopin for anxiety, tachypnea with \nrespiratory alkalosis, and concern for benzodiazepine withdrawal \n(despite negative toxicology screen). She also received \nnebulizers and 125mg IV methylprednisolone. Vital signs prior to \ntransfer were as follows: 97.8 78 153/82 18 100%.  \n \nOn arrival to the floor, pt is 98% on RA with stable VS.  \n \nPast Medical History:\nCOPD (never formally dx by spirometry, bullous emphysema on CT  \nimaging ___  \nHepatitis C (stage ___ fibrosis per liver bx ___  \nHTN (poorly controlled at b/l, non compliant with meds; P-MIBI  \nnegative in ___, stress-Echo ___ EF 60%, trivial MR, no  \ninducible ischemia)  \nHLD  \nPeripheral neuropathy  \nPVD (L subclavian stenosis seen on CTA ___ and MRA ___  \nand RE arterial insufficiency; ABI showing minimal disease below \n \nthe knee at the tibial level on ___  \nDepression, requiring hospitalization in past  \nh/o polysubstance abuse, including cocaine and iv drug use, and  \n\non-going alcohol and tobacco use  \nHiatal hernia, s/p nissen fundoplication  \nGERD  \nesophageal stricture (Schatzkis ring)  \nFe def anemia  \nFibromyalgia  \nCervical spondylosis  \nStress incontinence  \nOsteoarthritis \n \nSocial History:\n___\nFamily History:\nMother: CAD, deceased. 9 siblings, one deceased (cause unknown). \nFour children, all healthy. \n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\nHYSICAL EXAM:  \nVS:  Tc: 98.3 HR: 84 BP: 146/82 RR:18 96% RA\nGENERAL: chronically ill-appearing in NAD  \nHEENT: NC/AT, PERRLA, EOMI, sclerae anicteric, MMM  \nNECK: supple, obese  \nLUNGS: CTA bilat, no r/rh/ quiet breath sounds, no wheeze, resp \nunlabored, no accessory muscle use  \nHEART: RRR, no MRG, nl S1-S2  \nABDOMEN: obese, NABS, soft/NT/ND, no masses or HSM, no \nrebound/guarding  \nEXTREMITIES: WWP, no edema bilaterally in lower extremities, no \nerythema, induration, or evidence of injury or infection  \nNEURO: awake, A&Ox3, CNs II-XII grossly intact, muscle strength \n___ throughout, sensation grossly intact throughout, DTRs 2+ and \nsymmetric  \n \nPertinent Results:\nADMISSION LABS:\n___ 11:23PM   PO2-75* PCO2-33* PH-7.44 TOTAL CO2-23 BASE \nXS-0\n___ 11:23PM   LACTATE-1.9\n___ 09:35PM URINE  UCG-NEGATIVE\n___ 08:51PM   ___ PO2-127* PCO2-17* PH-7.59* TOTAL \nCO2-17* BASE XS--1 COMMENTS-GREEN TOP \n___ 08:51PM   LACTATE-2.6*\n___ 08:50PM URINE  COLOR-Yellow APPEAR-Clear SP ___\n___ 08:50PM URINE  BLOOD-LG NITRITE-NEG PROTEIN-TR \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 \nLEUK-MOD\n___ 08:50PM URINE  RBC->182* WBC-82* BACTERIA-FEW \nYEAST-NONE EPI-1\n___ 07:39PM   ___ PO2-46* PCO2-25* PH-7.52* TOTAL \nCO2-21 BASE XS-0 COMMENTS-GREEN TOP \n___ 07:39PM   LACTATE-3.7*\n___ 07:35PM   GLUCOSE-99 UREA N-12 CREAT-0.7 SODIUM-140 \nPOTASSIUM-3.5 CHLORIDE-104 TOTAL CO2-19* ANION GAP-21*\n___ 07:35PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG \nbnzodzpn-NEG barbitrt-NEG tricyclic-NEG\n___ 07:35PM   WBC-6.7 RBC-4.70 HGB-15.4 HCT-46.7 MCV-99* \nMCH-32.6* MCHC-32.9 RDW-12.9\n___ 07:35PM   NEUTS-63 BANDS-0 ___ MONOS-3 EOS-1 \nBASOS-0 ATYPS-3* ___ MYELOS-0\n___ 07:35PM   PLT SMR-NORMAL PLT COUNT-249\n___ 07:35PM   ___ PTT-30.5 ___\n\nMICRO: \n___ URINE URINE CULTURE-FINAL <10, 000 \norganisms\n___ Influenza A/B by ___- NEGATIVE\n___ Influenza A/B by ___- INSUFFICIENT \nQUANTITY\n___ BLOOD CULTURE-PENDING\n___ BLOOD CULTURE-PENDING\n\nIMAGES: \nCT ABDOMEN, PELVIS\nFINDINGS:  The lung bases are clear.  The visualized portions of \nthe heart and\npericardium are unremarkable.  Evaluation of the liver is \nlimited in the\nabsence of intravenous contrast with no focal liver lesion \nidentified. \nCholecystectomy clips are noted in the gallbladder fossa.  The \nspleen,\npancreas, and adrenal are normal.  Excreted contrast from CTA \nchest opacifies\nthe proximal ureters.  There is no hydronephrosis.  However, \ntiny renal\ncalculi cannot be excluded.  Right-sided perinephric fat \nstranding is\ndecreased when compared to prior CT abdomen and pelvis.  The \nstomach and small\nbowel are unremarkable.  There is no portacaval, mesenteric, or\nretroperitoneal lymphadenopathy.  There is no free air or free \nfluid.\n \nCT PELVIS:  The appendix is normal.  There are no secondary \nsigns of\ninflammation.  Sigmoid diverticulosis is noted without evidence \nof\ndiverticulitis.  Visualization of the uterus and adnexa is \nsomewhat limited by\nstreak artifact from excreted contrast within the urinary \nbladder, but no\ngross abnormality is seen.  There is no pelvic lymphadenopathy \nor free fluid.\n \nOSSEOUS STRUCTURES:  There is no lytic or blastic lesion \nworrisome for\nmalignancy.\n \nIMPRESSION:  No hydronephrosis.  Evaluation for a \nnon-obstructing stone is\nlimited due to excreted contrast from CTA chest.\n\nCTA CHEST: ___\nFINDINGS: There is no pulmonary embolism.  The heart and great \nvessels are\nunremarkable.  The airways are centrally patent.  There is no \naxillary,\nmediastinal, or hilar lymphadenopathy noted. Heart size and \nshape is normal.\nThere is no pleural or pericardial effusion. \n \nThe lungs are clear, though note is made of upper lobe \npredominant\ncentrilobular emphysema and large paraseptal blebs.  There is no \nfocal\nconsolidation or worrisome nodule/mass. There is minimal lower \nlobe bronchial\nimpaction. \n \nThin articular for subdiaphragmatic evaluation included portion \nof the abdomen\nand pelvis are remarkable only for a  Nissen fundoplication.\n \nOsseous structures:  There is no lytic or blastic lesion \nworrisome for\nmalignancy.\n \nIMPRESSION: \n1.  No pulmonary embolism.\n2.  Emphysema. \n3.  Trace mucus plugging in small lower lobe bronchi.\n \n \nBrief Hospital Course:\nBRIEF HOSPITAL COURSE:\n\nMs. ___ is a ___ with history of COPD (no PFTs) who presented \nwith left chest and flank pain concerning for COPD exacerbation \nand UTI, respectively.  \n \n# COPD exacerbation: Her current presentation was most \nconsistent with recurrent COPD exacerbation, with most recent \nexacerbation in ___. CXR/CTA negative for focal infiltrate, \nand CTA negative for pulmonary embolus. Influenza test was \nnegative. She was treated with  nebulizers, advair, prednisone \n40mg daily for planned ___nd azithromycin for 5 day \ncourse with improvement. \n.\n# Positive UA: Concerning for UTI in the setting of flank pain. \nShe has a history of nearly pansensitive E. coli UTI \n(ampicillin/Bactrim-resistant, ciprofloxacin-sensitive) in ___. \nCT abdomen/pelvis negative for nephrolithiasis, though study \nlimited by IV contrast administration for CTA. Urine Cx showed \n<10,000 organisms. She was treated empirically with azithromycin \nfor UTI . \n \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Amitriptyline 50 mg PO HS \n2. Aspirin 81 mg PO DAILY \n3. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n4. FoLIC Acid 1 mg PO DAILY \n5. Gabapentin 300 mg PO BID \n6. Hydrochlorothiazide 25 mg PO DAILY \n7. Loratadine *NF* 10 mg Oral DAILY:PRN allergies \n8. Multivitamins 1 TAB PO DAILY \n9. Simvastatin 20 mg PO DAILY \n10. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath \n11. Caltrate 600+D Plus Minerals *NF* (calcium carbonate-vit \nD3-min) 600 mg calcium- 400 unit Oral Daily \n12. Biotene Oralbalance *NF* (lactoperoxi-gluc oxid-pot \nthio;<br>saliva stimulant agents comb.2) 0  pack MUCOUS MEMBRANE \nTID: PRN dry mouth \n13. Docusate Sodium 100 mg PO DAILY:PRN constipation \n14. HydrOXYzine 25 mg PO BID:PRN itching \n15. Tiotropium Bromide 1 CAP IH DAILY \n16. Ferrous Sulfate 325 mg PO TID \n17. Pantoprazole 80 mg PO Q12H \n18. Thiamine 100 mg PO DAILY \n19. NIFEdipine CR 30 mg PO DAILY \n20. Nitroglycerin SL 0.3 mg SL PRN chest pain \n\n \nDischarge Medications:\n1. Albuterol Inhaler 2 PUFF IH Q4H:PRN shortness of breath \n2. Amitriptyline 50 mg PO HS \n3. Aspirin 81 mg PO DAILY \n4. Docusate Sodium 100 mg PO DAILY:PRN constipation \n5. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n6. Gabapentin 300 mg PO BID \n7. Multivitamins 1 TAB PO DAILY \n8. NIFEdipine CR 30 mg PO DAILY \n9. Pantoprazole 80 mg PO Q12H \n10. Simvastatin 20 mg PO DAILY \n11. Thiamine 100 mg PO DAILY \n12. Tiotropium Bromide 1 CAP IH DAILY \n13. Azithromycin 500 mg PO Q24H \nRX *azithromycin 500 mg 1 tablet(s) by mouth every  day Disp #*2 \nTablet Refills:*0\n14. Cepacol (Menthol) 1 LOZ PO PRN sore throat \n15. Guaifenesin-Dextromethorphan 5 mL PO Q6H:PRN cough \n16. PredniSONE 40 mg PO DAILY \nRX *prednisone 20 mg 2 tablet(s) by mouth daily Disp #*4 Tablet \nRefills:*0\n17. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain  \nRX *tramadol 50 mg 1 tablet(s) by mouth every six hours Disp \n#*10 Tablet Refills:*0\n18. Biotene Oralbalance *NF* (lactoperoxi-gluc oxid-pot \nthio;<br>saliva stimulant agents comb.2) 0  pack MUCOUS MEMBRANE \nTID: PRN dry mouth \n19. Caltrate 600+D Plus Minerals *NF* (calcium carbonate-vit \nD3-min) 600 mg calcium- 400 unit Oral Daily \n20. Ferrous Sulfate 325 mg PO TID \n21. FoLIC Acid 1 mg PO DAILY \n22. Hydrochlorothiazide 25 mg PO DAILY \n23. HydrOXYzine 25 mg PO BID:PRN itching \n24. Loratadine *NF* 10 mg Oral DAILY:PRN allergies \n25. Nitroglycerin SL 0.3 mg SL PRN chest pain \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary\nCOPD exacerbation\nUrinary Tract Infection\n.\nSecondary\nPeripheral Neuropathy \nHypertension\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted to the hospital because you had shortness of \nbreath and coughing with pain. You had imaging of your chest and \nabdomen which was unremarkable. Your symptoms were due to a COPD \nexacerbation. You are encouraged to stop smoking as this \ncontributes to your COPD flares. \n\nInfluenza swab was negative. You were treated with steroids, \nnebulizers and azithromycin. The steroids and azithromycin will \ncontinue for 2 more days.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee7539342fb"
  },
  "note_id": "19644467-DS-26",
  "subject_id": 19644467,
  "hadm_id": 22611920,
  "note_type": "DS",
  "note_seq": 26,
  "charttime": "2198-06-20 00:00:00",
  "storetime": "2198-06-21 17:12:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril\n \nAttending: ___\n \nChief Complaint:\nShortness of Breath\n \nMajor Surgical or Invasive Procedure:\nDiagnostic paracentesis\nTherapeutic paracentesis\nEsophagogastroduodenoscopy (EGD)\n\n \nHistory of Present Illness:\n___ with PMH of HCV, COPD, EtOH use, HTN, HLD, PVD, and \nperipheral neuropathy who presented with 3 week h/o worsening \nSOB and abdominal distension in the setting of running out of \nher inhalers. Patient reports 4 days h/o intermittent CP \nradiating to LUQ present at rest and upon exertion, which she \nhas had for many years. Persantine stress test performed ___ was negative for ischemia. The SOB is worse with exertion, \nand she is unable to lie supine. She has had to increase the \nnumber of pillows she sleeps on, and often wakes up in the \nmiddle of the night feeling short of breath. The abdominal \ndistension has been worsening over the past 4 weeks, and is \nassociated with abdominal discomfort, anorexia, and nausea \nwithout vomiting. She reports having dark black stools for the \npast few weeks which over the past ___ days have become \nmucous-like and \"fluorescent green.\" Denies seeing red blood in \nher stool. Patient reports chronic intermittent dysuria, but \ndenies hematuria. Denies fevers or chills. Patient smokes \ntobacco and reports drinking two 24oz beers twice week, although \nshe told the ED she drinks daily. Patient has had tremor for \nmany years, but states that today it is better than usual. \nPatient states that she gets intermittently confused (forgets \nwhat she was doing or that she was cooking). She states the \nconfusion has been happening for years, but has gotten worse \nrecently. Patient has chronic insomnia which has not worsened \nrecently. She states she looks a little yellow sometimes. \n\nOf note, she used to follow with ___ but has not seen \nhim since ___. She is not currently seeing a hepatologist. \n\nIn the ED intial vitals were: \nT 96.2, HR 80, BP 156/53, RR 28, 98% 2L. \nLabs/imaging were significant for:\n# LFT: AST/ALT ratio >2:1 (AST 245, ALT 89), AP 233, Alb 3.4, \nTbili 1.1, lipase 38, lactate 2.9\n# CBC: WBC 7.2, Hct 42.5, plt 189, MCV 105. \n# INR 1.3 \n# Chem: Cr 0.6, Bicarb 19, lytes otherwise unremarkble. \n# UCG negative. UA negative.\n# Trop-T: <0.01 \n# EKG: ECG sinus 80, normal axis, normal intervals no evidence \nof ischemia. \n# CXR: Emphysema without superimposed pneumonia or CHF.\n# CT abd/pel: New ascites, not acute liver changes \n\nShe states she's never had a paracentesis before, but was noted \nto have ascites in the ED which was tapped. Paracentesis \nrevealed no evidence of SBP. Blood, urine and ascitic fluid \ncultures sent. Patient was given morphine, duonebs x2, \nazithromycin and methylpred. Vitals prior to transfer were: HR \n86, BP 150/90, RR 16, SpO2 96% RA.\n\nROS: per HPI\n \nPast Medical History:\nCOPD (never formally dx by spirometry, bullous emphysema on CT  \nimaging ___  \nHepatitis C (stage ___ fibrosis per liver bx ___  \nHTN (poorly controlled at b/l, non compliant with meds; P-MIBI  \nnegative in ___, stress-Echo ___ EF 60%, trivial MR, no  \ninducible ischemia)  \nHLD  \nPeripheral neuropathy  \nPVD (L subclavian stenosis seen on CTA ___ and MRA ___  \nand RE arterial insufficiency; ABI showing minimal disease below \n \nthe knee at the tibial level on ___  \nDepression, requiring hospitalization in past  \nh/o polysubstance abuse, including cocaine and iv drug use, and  \n\non-going alcohol and tobacco use  \nHiatal hernia, s/p nissen fundoplication  \nGERD  \nesophageal stricture (Schatzkis ring)  \nFe def anemia  \nFibromyalgia  \nCervical spondylosis  \nStress incontinence  \nOsteoarthritis \n \nSocial History:\n___\nFamily History:\nMother: CAD, deceased. 9 siblings, one deceased (cause unknown). \nFour children, all healthy. \n \nPhysical Exam:\nADMISSION\nVitals- 97.7 181/88 101, 20 100%2L\nGENERAL: sad, teary woman appearing older than states age \nHEENT: AT/NC, EOMI, PERRLA, anicteric sclera, pink conjunctiva, \npatent nares, dry MM, no sublingual icterus, nontender supple \nneck, no LAD, no JVD  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNG: CTAB with only wheezes at bases b/l, no rales, no rhonchi, \nbreathing comfortably without use of accessory muscles, speaking \nfull sentences  \nABDOMEN: soft, distended, +BS, diffusely tender in all \nquadrants, no rebound/guarding, unable to appreciate \nhepatosplenomegaly ___ large ascites. RLQ para site without \nbleeding, ecchymosis\nEXTREMITIES: moving all extremities well, no cyanosis, clubbing \nor edema, no obvious deformities  \nPULSES: 2+ DP pulses bilaterally  \nNEURO: A&Ox3, CN II-XII intact. + tremor, no asterixis. ___ \nstrength throughout, sensation intact to light touch and temp \nthoughout\nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes, no jaundice. Mild palmar erythema, no spiders noted\n\nDISCHARGE\nVitals- T 98.5  BP 126/72  HR 74  RR 16  SpO2 94% RA\nGeneral- Alert, oriented, no acute distress  \nHEENT- Sclera anicteric, MMM\nNeck- Supple, no JVD   \nLungs- CTAB. No wheezes, rales, ronchi. Not using accessory \nmuscles of respiration. Speaking in full sentences. \nCV- RRR, normal S1/S2, no murmurs, rubs, gallops  \nAbdomen- Mildly distended, diffusely tender to palpation \nthroughout with no guarding or rebound tenderness. Bowel sounds \npresent. Prominent superficial veins. Paracentesis site \ndressings C/D/I w/o surrounding erythema.   \nGU- No foley  \nExt- Warm, well perfused, 2+ pulses, no clubbing, cyanosis or \nedema  \nNeuro- CNs2-12 intact, motor function grossly normal. No \nasterexis. Intention tremor present. \n \nPertinent Results:\nADMISSION\n___ 07:00PM BLOOD WBC-7.2 RBC-4.07* Hgb-13.7 Hct-42.5 \nMCV-105* MCH-33.6* MCHC-32.2 RDW-14.4 Plt ___\n___ 07:00PM BLOOD Neuts-72.0* ___ Monos-6.8 Eos-0.7 \nBaso-0.5\n___ 07:00PM BLOOD ___ PTT-35.9 ___\n___ 07:00PM BLOOD Glucose-117* UreaN-6 Creat-0.6 Na-141 \nK-3.5 Cl-108 HCO3-19* AnGap-18\n___ 07:00PM BLOOD ALT-89* AST-245* AlkPhos-233* TotBili-1.1\n___ 07:00PM BLOOD Lipase-38\n___ 07:00PM BLOOD cTropnT-<0.01\n___ 07:00PM BLOOD Albumin-3.4*\n___ 07:00PM BLOOD AFP-11.5*\n___ 07:00PM BLOOD ASA-NEG Acetmnp-NEG Bnzodzp-NEG \nBarbitr-NEG Tricycl-NEG\n___ 07:14PM BLOOD Lactate-2.9*\n___ 10:50PM URINE bnzodzp-NEG barbitr-NEG opiates-POS \ncocaine-POS amphetm-NEG mthdone-NEG\n___ 10:50PM URINE UCG-NEGATIVE\n___ 10:50PM URINE Blood-NEG Nitrite-NEG Protein-NEG \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-NEG\n___ 10:50PM URINE Color-Straw Appear-Hazy Sp ___\n___ 09:30PM ASCITES WBC-540* RBC-206* Polys-2* Lymphs-50* \nMonos-29* Mesothe-6* Macroph-13*\n___ 09:30PM ASCITES TotPro-1.7 Glucose-137 Albumin-1.0\n\nMICRO\n___ SEROLOGY/BLOOD HELICOBACTER PYLORI \nANTIBODY TEST (Final ___: POSITIVE BY EIA. \n___ PERITONEAL FLUID  \n---FLUID CULTURE (Final ___: NO GROWTH. \n---ANAEROBIC CULTURE (Preliminary): NO GROWTH.\n---GRAM STAIN (Final ___: 1+ (<1 per 1000X FIELD): \nPOLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN.\n___  URINE CULTURE(Final ___ \norg/ml. \n___ Blood Culture, Routine-PENDING \n\nIMAGING\n___ (PA & LAT)\nIMPRESSION:  Emphysema without superimposed pneumonia or CHF.\n\n___ ABD & PELVIS W/O CONTRAST\nIMPRESSION: Large ascites, new compared to ___.  \n\n___ DOPP ABD/PEL\nIMPRESSION:\n1. Patent hepatic vasculature.  No portal vein thrombus \nidentified.\n2. Coarsened hepatic architecture consistent with cirrhosis.\n3. Small residual ascites seen in the abdomen.\n\n___       EGD report\nImpression: Erythema and mosaic appearance in the whole stomach \ncompatible with portal hypertensive gastropathy. No evidence of \nesophageal varices.\nNodularity and erythema in the duodenal bulb compatible with \nduodenitis. Evidence of fundoplication wrap on retroflex. \nOtherwise normal EGD to third part of the duodenum.\n\n___ (SUPINE & ERECT)\nIMPRESSION: No free air.\n\n___ (SUPINE & ERECT)\nIMPRESSION: Nonspecific bowel gas pattern.  No free air.\n\n___ ABD LIMIT, SINGLE ORGAN\nIMPRESSION: Small volume of ascites, insufficient for \ntherapeutic paracentesis.\n\nDISCHARGE\n___ 08:10AM BLOOD WBC-7.3 RBC-3.46* Hgb-11.6* Hct-37.1 \nMCV-107* MCH-33.5* MCHC-31.3 RDW-14.1 Plt ___\n___ 08:10AM BLOOD ___\n___ 08:10AM BLOOD Glucose-114* UreaN-4* Creat-0.8 Na-136 \nK-4.4 Cl-102 HCO3-25 AnGap-13\n___ 08:10AM BLOOD ALT-66* AST-129* AlkPhos-193* TotBili-1.3\n___ 08:10AM BLOOD Calcium-8.8 Phos-3.1 Mg-1.___ w/ COPD, hep C, ETOH use, HTN, HL, peripheral neuropathy, \nand PVD presented with worsening dyspnea and abdominal \ndistension in the setting of medication noncompliance and daily \nalcohol use.\n\n#Dyspnea: Patient presented with a 3 week history of worsening \nshortness of breath which was likely multifactorial due to \nmedication noncompliance with inhalers in the setting of COPD as \nwell as increased abdominal distension from new large volume \nascites. There was no evidence of heart failure, pneumonia, or \nhepatic hydrothorax on EKG and chest xray. Home Advair and \nSpiriva were restarted, and patient underwent therapeutic \nparacentesis yielding 1,200cc with improvement in respiratory \nfunction. No longer requiring supplemental O2 during the day, \nwas able to walk 100+ ft with SpO2>94% on RA.   \n\n#New large volume ascites: Likely due to the progression of \nliver disease to cirrhosis ___ to EtOH use in the setting of HCV \ninfection and liver fribrosis. Serum Albumin Ascites Gradient \n(SAAG) was 1.7, suggestive of portal HTN, Budd-Chiari syndrome, \nor CHF. The was no evidence of CHF on EKG or CXR. RUQ U/S showed \nliver cirrhosis but no portal venous thrombosis. Diagnostic \nparacentesis performed in ED was negative for SBP. Ascites fluid \ncultures did not grow anything. A therapeutic paracentesis was \nperformed as an inpatient yielding 1200cc with improvement in \nthe patient's abdominal discomfort as well respiratory function. \nPatient started on spiranolactone 25mg PO daily and lasix 20mg \nPO daily. Patient was educated by nutrition specialist on how to \nmaintain low sodium diet. Due to continued abdominal pain, KUB \nwas obtained which was negative for free air. Patient was then \nsent for ___ guided tap but only a small volume of ascites was \nfound which was insufficient for therapeutic paracentesis. \nPatient discharged with ultram for pain control. Appointment was \nmade for patient to follow-up with Dr. ___ on ___ \n___, at which time she will have her serum electolytes \nchecked again (K increased from 4.1 to 4.4 after 2 days on \nlasix/aldactone). An appointment was also made for patient to \nfollow-up with hepatology as an outpatient. \n\n#Transaminitis: Patient presented with an elevated AST(245) and \nALT(89). AST/ALT ratio >2:1, suggestive of alcoholic hepatitis, \nwhich is consistent with her drinking history. Alk phos was also \nelevated at 233. Tbili was normal at 1.1. ___ DF on \nadmission was 11. AST, ALT, and Alk Phos trended down slightly \nduring her stay. Tbili remained normal throughout her stay. \nPatient was counseled about the importance of stopping alcohol \nas well as cocaine use.\n\n#Alcoholic/HCV cirrhosis: ___ liver biospy showed stage ___ \nfibrosis, however ascites on exam suggests cirrhosis. CT abd/pel \nw/o contrast showed new ascites, no acute liver changes. RUQ \nultrasound showed cirrhosis of the liver but no PVT. Given \npatient's known HCV and heavy ETOH use, the progression to \ncirrhosis is not surprising. MELD score 11. Repeat EGD \n___ showed erythema and mosaic appearance in the whole \nstomach compatible with portal hypertensive gastropathy. No \nevidence of esophageal varices. Nodularity and erythema in the \nduodenal bulb compatible with duodenitis. Continued \npantoprazole. INR on admission was 1.3 and remained between \n1.3-1.5 during her stay.  Patient counseled on substance abuse \ncessation. Appointment made for patient to follow-up with \nhepatologist as an outpatient.\n \n#Elevated AFP: AFP slightlty elevated at 11.5 (nl ___. AFP \ncan be elevated in several types of malignancy, including HCC. \nAlthough no concerning liver lesion was identified on RUQ \nultrasound ___, patient should follow-up with a \nhepatologist as an outpatient to continue monitoring for the \ndevelopment of malignancy.  \n\n#ETOH use: Patient has history of EtOH use, told the ED she \ndrank daily but on the floor stated she drank two 24oz beer cans \ntwo times a week. Patient was monitored on CIWA due to concern \nof possible alcohol withdrawal. Social work consulted, offered \nsupport and information on substance abuse cessation. Patient \nwas started on thiamine, B12, folate, and multivitamins. \n\n#Macrocytosis: CBC showed marocytosis likely related to her \nliver disease. Nutrition consult obtained and patient started on \nthiamine, B12, folate, and multivitamins given her history of \nalcohol use. \n\n#Hypoalbunemia: Albumin on admission was low 3.4, likely due to \nher liver disease as well as poor nutrition. Nutrition consult \nobtained. \n\n#COPD: Current presentation of SOB partly due to having run out \nof the inhalers she takes on a daily basis for her COPD. \nRestarted inhalers with good improvement in respiratory \nfunction. \n\n#PVD: Continued ASA 81mg qD.\n\n#HTN: Continued valsartan.\n\n#GERD: Continued pantoprazole. \n\nTransitional Issues\n(1) Patient has appointment to follow-up with hepatologist as \noutpatient. \n(2) Elevated AFP will need to be ___ need periodic \nRUQ U/S to assess for malignancy. \n(3) Please check electrolytes at PCP appt after discharge in the \nsetting of being sent home on lasix/aldactone.\n(4) Consider continuing diuresis in the setting of her ascites \n(5) The patient was sent home with 7 tramadolol pills to help \nwith her abdominal pain. \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n2. FoLIC Acid 1 mg PO DAILY \n3. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN SOB, wheezing \n4. Aspirin EC 81 mg PO DAILY \n5. NIFEdipine CR 90 mg PO DAILY \n6. Simvastatin 20 mg PO QPM \n7. Triamterene-Hydrochlorothiazide (37.5/25) 1 CAP PO DAILY \n8. Fluticasone Propionate NASAL 1 SPRY NU BID \n9. Albuterol Inhaler 2 PUFF IH Q4-6H PRN SOB, wheezing \n10. Pantoprazole 80 mg PO BID \n11. Tiotropium Bromide 1 CAP IH DAILY \n12. Valsartan 320 mg PO DAILY \n13. Multivitamins 1 TAB PO DAILY \n14. Ferrous Sulfate 325 mg PO DAILY \n15. Caltrate 600+D Plus Minerals \n(\nC\na\n-___ \n600-400 mg-unit  oral Daily \n16. Amitriptyline 50 mg PO HS \n17. Gabapentin 300 mg PO BID \n18. Loratadine 10 mg PO DAILY:PRN allergies \n\n \nDischarge Medications:\n1. Loratadine 10 mg PO DAILY:PRN allergies \n2. Fluticasone Propionate NASAL 1 SPRY NU BID \n3. Ferrous Sulfate 325 mg PO DAILY \nRX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth \ndaily Disp #*30 Tablet Refills:*0\n4. Caltrate 600+D Plus Minerals \n(\nC\na\n-___ \n600-400 mg-unit  oral Daily \n5. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN SOB, wheezing \n6. Simvastatin 20 mg PO QPM \nRX *simvastatin 20 mg 1 tablet(s) by mouth daily Disp #*30 \nTablet Refills:*0\n7. Pantoprazole 40 mg PO Q24H \nRX *pantoprazole 40 mg 1 tablet,delayed release (___) by \nmouth daily Disp #*30 Tablet Refills:*0\n8. Tiotropium Bromide 1 CAP IH DAILY \nRX *tiotropium bromide [Spiriva with HandiHaler] 18 mcg 1 cap \ninh daily Disp #*30 Capsule Refills:*0\n9. Valsartan 320 mg PO DAILY \nRX *valsartan [Diovan] 320 mg 1 tablet(s) by mouth daily Disp \n#*30 Tablet Refills:*0\n10. Multivitamins 1 TAB PO DAILY \nRX *multivitamin   1 capsule(s) by mouth daily Disp #*30 Capsule \nRefills:*0\n11. FoLIC Acid 1 mg PO DAILY \nRX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet \nRefills:*0\n12. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \nRX *fluticasone-salmeterol [Advair Diskus] 500 mcg-50 mcg/Dose 1 \ninh po twice a day Disp #*1 Each Refills:*0\n13. Aspirin EC 81 mg PO DAILY \nRX *aspirin 81 mg 1 tablet,delayed release (___) by mouth \ndaily Disp #*30 Tablet Refills:*0\n14. Albuterol Inhaler 2 PUFF IH Q4-6H PRN SOB, wheezing \nRX *albuterol  2 puffs PO q4-6 hr Disp #*1 Inhaler Refills:*0\n15. Thiamine 100 mg PO DAILY \nRX *thiamine HCl 100 mg 1 tablet(s) by mouth daily Disp #*30 \nTablet Refills:*0\n16. Docusate Sodium 100 mg PO BID \nRX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day \nDisp #*60 Capsule Refills:*0\n17. Senna 8.6 mg PO BID \nRX *sennosides [senna] 8.6 mg 1 tab by mouth twice a day Disp \n#*60 Capsule Refills:*0\n18. Furosemide 20 mg PO DAILY \nRX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*10 Tablet \nRefills:*0\n19. Spironolactone 25 mg PO DAILY \nRX *spironolactone 25 mg 1 tablet(s) by mouth daily Disp #*10 \nTablet Refills:*0\n20. TraMADOL (Ultram) 50 mg PO Q8H:PRN pain  \nplease do not drive or operate heavy machinery while taking, \nplease avoid alcohol while taking \nRX *tramadol 50 mg 1 tablet(s) by mouth every eight (8) hours \nDisp #*7 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nLikely cirrhosis\nAscites \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was pleasure taking care of you during your hospital stay at \n___. As you know, you were \nadmitted to the hospital because you were having abdominal \ndiscomfort and shortness of breath. We performed blood tests \nwhich showed that your liver was injured, likely as a result of \nyou drinking alcohol on top of having Hepatitis C.\n\nAn ultrasound showed that your liver has become scarred, which \ncan represent a condition known as cirrhosis. \n\nBecause of your liver not working well, fluid accumulated in \nyour belly and made you feel uncomfortable. We removed some of \nthe fluid from your belly to alleviate your belly pain. We also \ntested the fluid to make sure it was not infected and it was \nnot. People who have cirrhosis sometimes develop varices \n(distended veins) in their esophagus which can bleed \nsignificantly. We performed an upper endoscopy and did not see \nany varices in you. In order to prevent even more damage to your \nliver, it is very important that you stop drinking alcohol and \nstop using cocaine.\n\nIn order to decrease the chance of fluid reaccumulating in your \nbelly, we started you on two new medications (lasix and \naldactone). You will need to go on a low salt diet as was \nexplained to you by the dietician. \n\nWe have made an appointment for you to follow-up with Dr. ___ \n___ ___. We have also made an \nappointment for you to see a liver doctor (___) on \n___ for further management of your likely liver \ncirrhosis and hepatitis C.\n \nThe shortness of breath you were experiencing when you came into \nthe hospital was probably due to a combination of the belly \nfluid as well as you not being able to take the inhalers for \nyour COPD. After we removed some of the belly fluid and gave you \nyour inhalers, your breathing improved. It is important that you \nfollow-up with your primary care doctor to ensure that you \nmaintain a constant supply of your medications.\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee7539342fc"
  },
  "note_id": "19644467-DS-27",
  "subject_id": 19644467,
  "hadm_id": 29911117,
  "note_type": "DS",
  "note_seq": 27,
  "charttime": "2200-01-23 00:00:00",
  "storetime": "2200-01-24 11:40:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril / mango / papaya\n \nAttending: ___\n \nChief Complaint:\nAcute arm, neck, and chest pain\n \nMajor Surgical or Invasive Procedure:\nEGD\nColonoscopy\n\n \nHistory of Present Illness:\n___ year old female with history of HCV genotype 1a, cirrhosis \nwith history of ascites, alcohol abuse, depression, CAD, \nhypertension, and hyperlipidemia presenting with weakness, chest \npain, and anemia with bright red blood per rectum.\n\nIn the ED, initial VS were 98.5 85 168/90 18 100% RA.  \nExam notable for   \nLabs notable for WBC 5.5, H/H 8.2/27.8 from baseline 11.3/35.0, \nplt 72, troponin negative x 2, negative D-dimer, ALT/AST 51/75, \nAP 151, tbili 0.7, lipase 52, and lactate 3.1, INR 1.3\nUA WNL  \nCXR demonstrated no acute intrathoracic processes  \nReceived Oxycodone and Tylenol   \nTransfer VS were 98.1 92 150/57 20 100% RA    \nDecision was made to admit to medicine for further management.  \nOn arrival to the floor, patient reports...  \n\nThe patient states that she was standing in her kitchen and her \narms hurt and then her legs gave out. She says she \"blanked for \na moment\" and partially remembers falling down. She then felt a \nstabbing chest pain that did not improve with sl nitro. She has \nhad the chest pain for several days and the pain in her arms for \nseveral weeks. She has chronic ___ neuropathy and her leg pain \nprevents her from walking more than 10 ft. \n\nShe also has had neck stiffness for the past several days and \nchronic photosensitivity for the past year that is not currently \nworsened. She also endorses a HA that is bilateral and very \npainful. She endorses palpitations and dizziness as well as \nlightheadedness. She also states that her hips lock up, such \nthat she was not able to sit on the toilet yesterday and \nurinated on herself. \n\nThe patient also notes that she has had red stools for the past \nweek (the actual color of the stools) with minimal other blood. \nHad a lot of blood x 2 2 days ago. Blood is always bright red. \nShe has noted pain with defecation and blood with wiping. She \nalso endorses AM and ___ nausea, and last vomited 5 days ago. \n\nShe also endorses ___ years of short-term memory loss where she \ncan't remember activities she's doing (ie cooking). \n\nShe also complains of SOB and an partially-productive cough for \nthe last ___ mo. \n\nREVIEW OF SYSTEMS:  \nNegative except as noted in HPI. \n\n \nPast Medical History:\nPAST MEDICAL AND SURGICAL HISTORY:  \nHepatitis C cirrhosis- genotype 1a decompensated with h/o\nascites; liver biopsy in ___ showed stage ___ fibrosis\nCOPD\nDepression\nHypertension\nHyperlipidemia\nAlcohol abuse\nCocaine abuse\nTobacco abuse\nAtypical chest pain\nBreast pain\nAbdominal pain\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\n\n \nSocial History:\n___\nFamily History:\n Mom had DM, CAD, and was in a wheelchair for neuropathy \n(deceased). Father had alcoholism and rectal CA. Sister has \nmental illness, also hx of falls. \n\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVS 98.3 152/62 75 18 99%RA \nGENERAL: Overweight, NAD \nHEENT: AT/NC, EOMI, anicteric sclera,  MMM, OP clear. Head \ntender to palp diffusely. \nNECK: supple neck, no LAD, tender to palp bilaterally.  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nCHEST: Tender to palpation diffusely. \nLUNG: Crackles in Lower Lobes b/l. Breathing comfortably without \nuse of accessory muscles.  \nBACK: Diffusely tender to spine, paraspine, sacrum, and CVA \npalpation. \nABDOMEN: mild distended, soft, diffusely tender especially in \nthe RUQ. + Rebound, no guarding.   \nEXTREMITIES: no cyanosis, clubbing or edema, moving all 4 \nextremities with purpose. Onychomycosis of toes. Warm.  \nNEURO: Face symmetric. EOMI. Tremor of R>>L hand, no asterixis. \nMotor: ___ shoulder shrug b/l, ___ elbow \nflexion, ___ hand strength, slowed rapid-alternating-movements. \nFinger-to-nose minimally impaired. ___ R leg flexion, ___ L leg \nflexion, back and leg pain ipsilaterally with leg raise b/l, ___ \nankle flexion. Decreased fine touch sensation of distal lower \nextremities b/l. \nRECTAL: No blood in vault. \nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes \n\nDISHCARGE EXAM: \nVS 98.4-99.1 98-105/36-60 ___ 18 94-96%RA\nWt: 62.1 <- 61.8 <- 60.1 <- 60.4 <- 59.3 <- 60.7 <- 59.9 <- 53.8\nGENERAL: Overweight, appears uncomfortable \nHEENT: AT/NC, anicteric sclera,  supple neck \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nCHEST: Notably tender to palpation diffusely. \nLUNG: Coarse breath sounds at bases\nABDOMEN: moderately distended, soft, notably tender in RUQ and \nLLQ. no guarding.   \nEXTREMITIES: moving all 4 extremities with purpose. No ___ edema. \nR hand tremor, no asterixis. \nNEURO: Face symmetric. A&Ox3.   \nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes \n\n \nPertinent Results:\nADMISSION LABS:\n___ 10:20AM BLOOD WBC-5.5 RBC-3.48* Hgb-8.2*# Hct-27.8*# \nMCV-80*# MCH-23.6*# MCHC-29.5* RDW-19.5* RDWSD-55.5* Plt Ct-72*\n___ 10:20AM BLOOD Neuts-71.4* Lymphs-17.3* Monos-10.0 \nEos-0.7* Baso-0.4 Im ___ AbsNeut-3.93 AbsLymp-0.95* \nAbsMono-0.55 AbsEos-0.04 AbsBaso-0.02\n___ 10:20AM BLOOD ___ PTT-35.6 ___\n___ 09:22PM BLOOD Ret Aut-2.5* Abs Ret-0.08\n___ 10:20AM BLOOD Glucose-167* UreaN-14 Creat-0.8 Na-139 \nK-3.6 Cl-102 HCO3-22 AnGap-19\n___ 10:20AM BLOOD ALT-51* AST-75* AlkPhos-151* TotBili-0.7\n___ 10:20AM BLOOD Lipase-52\n___ 10:20AM BLOOD cTropnT-<0.01\n___ 03:00PM BLOOD cTropnT-<0.01\n___ 10:20AM BLOOD Albumin-4.0 Calcium-9.2 Phos-3.4 Mg-1.8\n___ 10:20AM BLOOD D-Dimer-<150\n___ 09:22PM BLOOD calTIBC-451 ___ Ferritn-15 TRF-347\n___ 10:32AM BLOOD Lactate-3.1*\n\nDISCHARGE LABS:\n___ 05:54AM BLOOD WBC-5.3 RBC-3.27* Hgb-8.2* Hct-27.1* \nMCV-83 MCH-25.1* MCHC-30.3* RDW-19.4* RDWSD-57.6* Plt Ct-91*\n___ 06:05AM BLOOD ___ PTT-35.7 ___\n___ 05:54AM BLOOD Glucose-78 UreaN-9 Creat-0.9 Na-133 K-4.6 \nCl-98 HCO3-24 AnGap-16\n___ 06:25AM BLOOD ALT-62* AST-99* LD(___)-199 AlkPhos-158* \nTotBili-0.8\n___ 03:37PM BLOOD CK-MB-2 cTropnT-<0.01\n___ 05:54AM BLOOD CK-MB-2 cTropnT-<0.01\n___ 05:54AM BLOOD Calcium-8.8 Phos-3.7 Mg-2.0\n___ 06:40AM BLOOD AFP-8.2\n___ 09:12AM BLOOD Lactate-1.2\n\nIMAGING:\nColonoscopy ___:\nImpression: Diverticulosis of the sigmoid colon\nExam limited by poor prep proximally, but no bleeding or source \nof bleeding was identified. Otherwise normal colonoscopy to \ncecum\n\nEGD ___:\nVarices at the distal esophagus\nCongestion, mosaic appearance and erythema in the stomach \ncompatible with portal hypertensive gastropathy \nErythema in the duodenum compatible with duodenitis\nNissen wrap seen\nOtherwise normal EGD to third part of the duodenum\n\nLiver US: ___: \nIMPRESSION:\n1. Cirrhotic liver.  Questionable 0.7 cm lesion within the right \nhepatic lobe only seen in a single image.  This may be secondary \nto artifact.  If there is no elevation of AFP, then suggest that \nMRI be performed as the next screening study.  However, if there \nis elevated AFP then consider obtaining MRI earlier for further \ncharacterization.\n2. Splenomegaly measuring 14.2 cm.\nRECOMMENDATION(S):  If there is no elevation of AFP, then \nsuggest that MRI be performed as the next screening study in 6 \nmonths.  However, if there is elevated AFP then consider \nobtaining MRI earlier for further characterization.\n\nCXR ___\nIMPRESSION:    \nNo acute intrathoracic findings. \n  \n\n \nBrief Hospital Course:\nMs. ___ is a ___ year old female with history of HCV genotype \n1a, cirrhosis with history of ascites, alcohol abuse, \ndepression, CAD, hypertension, and hyperlipidemia who presented \nwith weakness and musculoskeletal chest pain.\n\n#Anemia: Pt notes BRBPR. Lower GI bleed vs hemorrhoids. Upper \nendoscopy showed no active bleeds but having blood in stool. \nColonoscopy showed no site of bleeding. Her hemoglobin was \nstable s/p 1U PRBC on ___. Her home ASA was held given her \nbleeding. \n\n#Acute urinary retention: The patient developed acute urinary \nretention of unclear etiology, possibly secondary to \nmedications. Her loratadine was discontinued and narcotics were \navoided. She was acutely managed with a foley and succeeded with \nher voiding trial ___.\n\n#Chest pain: Pt has been having persistent intermittent chest \npain with MSK component. Her chest has been stably tender to \npalpation. However, her EKG ___ showed nonspecific j-point \nelevation different from baseline 1 week ago. Chest pain \nresolved after taking her home inhaler and troponins were \nnegative.\n\n#Thrombocytopenia: Likely ___ liver disease. She was given \nvitamin K. \n\n#Cirrhosis: Patient has a history of cirrhosis from HCV and EtOH \nabuse. She had no ascites on ultrasound. Her AFP was within \nnormal limits. She should have an MRI as next screening \nmodality. Etoh abstinence was encourage. Hepatology was \nconsulted.\n\n#Generalized pain: Unclear etiology. No clear neurophysiologic \ncause. Troponins were negative & pain was reproducible with \npalpation. Opioids were avoided. \n\n#COPD: Pt has nonproductive cough. Minimal SOB. No fevers. Home \nmeds were continued. \n\n#HTN: home meds were held\n\n#Generalize weakness: Unclear etiology, not consistent with \nradiculopathy. \n\n#Peripheral neuropathy: Pt has minimal feeling in feet, \nneuropathic pain, and pain limiting her walking. She was started \non gabapentin 300 BID, which was titrated to 400 BID. In \naddition, she was started on tramadol PRN. \n\n#GERD: s/p lap fundoplication and hiatal hernia repair ___. She \nwas not complaining of symptoms. \n\nCODE: Full (confirmed) \nEMERGENCY CONTACT HCP: ___ (boyfriend) ___\n\n====================================================\nTRANISTIONAL ISSUES:\n[] Pt's home Lasix was held after she developed hyponatremia and \n___\n[] Pt's home nadolol was stopped per hepatology recommendations\n[] Pt's home ASA was held at discharge given thrombocytopenia \nand bleeding\n[] Loratadine was held given concern for urinary retention. \n[] Pt will follow up with hepatology and PCP after discharge\n[] Pt was screened by ___ who suggested rehab however pt refused \nand was discharged with skilled nursing, home health aid, and \n___\n[] Pt was discharged home with a walker per ___ recommendations\n[] Pt's RUQ ultrasound demonstrated a questionable 0.7 cm lesion \nwithin the right hepatic lobe only seen in a single image, which \nmay have been an artifact. AFP was not elevated. Radiology \nrecommends MRI for next ___ screening imaging. \n[] Pt started on gabapentin for neuropathic pain\n[] Per ___ recs, pt discharged home with walker, SN, ___, ___\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Loratadine 10 mg PO DAILY:PRN Allergies \n2. Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg (1,500 \nmg)-800 unit oral BID \n3. Ferrous Sulfate 325 mg PO DAILY \n4. Valsartan 320 mg PO DAILY \n5. Tiotropium Bromide 1 CAP IH DAILY \n6. Pantoprazole 40 mg PO Q12H \n7. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n8. Albuterol Inhaler 2 PUFF IH Q4H:PRN Wheezing \n9. Aspirin 81 mg PO DAILY \n10. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN Wheezing \n11. Fluticasone Propionate NASAL 1 SPRY NU BID \n12. Furosemide 20 mg PO DAILY \n13. Simvastatin 20 mg PO QPM \n14. HydrOXYzine 25 mg PO BID:PRN Itch \n15. Docusate Sodium 100 mg PO BID \n16. Nadolol 20 mg PO DAILY \n\n \nDischarge Medications:\n1. Equipment\nRolling walker\n\nICD 9 781.2\nGood prognosis\nNeeds for 13 months\n2. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN Wheezing \n3. Docusate Sodium 100 mg PO BID \n4. Fluticasone Propionate NASAL 1 SPRY NU BID \n5. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n6. Pantoprazole 40 mg PO Q12H \n7. Tiotropium Bromide 1 CAP IH DAILY \n8. Valsartan 320 mg PO DAILY \n9. Simvastatin 20 mg PO QPM \n10. Loratadine 10 mg PO DAILY:PRN Allergies \n11. HydrOXYzine 25 mg PO BID:PRN Itch \n12. Ferrous Sulfate 325 mg PO DAILY \n13. Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID \n14. Albuterol Inhaler 2 PUFF IH Q4H:PRN Wheezing \n15. Gabapentin 400 mg PO BID \nRX *gabapentin 400 mg 1 capsule(s) by mouth twice a day Disp \n#*60 Capsule Refills:*0\n16. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \nRX *tramadol 50 mg 1 tablet(s) by mouth every six (6) hours Disp \n#*56 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nLower GI Bleed\nHCV and alcoholic Cirrhosis\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were seen at ___ for your anemia. You anemia was primarily \ndue to bleeding in your GI tract. However, neither endoscopy nor \ncolonoscopy revealed a site of bleeding. You were treated with a \nblood transfusion and your blood levels remained stable \nafterward. \n\nYou also had an ultrasound of your liver that showed progression \nof cirrhosis. Please abstain from using alcohol and follow up \nwith your outpatient appointments. \n\nYou also developed an inability to urinate due to an inability \nto void your bladder. You were treated with a short-term foley \ncatheter and your symptoms then resolved.  \n\nYou also had some chest pain during your stay. Our tests \nindicated it was unlikely to be due to your heart. Please \ncontinue to take your inhalers as prescribed. \n\nPlease call your physician if you notice more blood in your \nstools and come to the emergency room if you experience acute \nworsening of shortness of breath or dizziness.\n\nBest wishes,\n\nYour ___ team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee7539342fd"
  },
  "note_id": "19644467-DS-28",
  "subject_id": 19644467,
  "hadm_id": 21611588,
  "note_type": "DS",
  "note_seq": 28,
  "charttime": "2200-06-07 00:00:00",
  "storetime": "2200-06-09 10:05:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril / mango / papaya\n \nAttending: ___\n \nChief Complaint:\nanemia\n \nMajor Surgical or Invasive Procedure:\nEGD on ___\n\n \nHistory of Present Illness:\n___ year old woman with history of HCV genotype 1a and alcoholic \ncirrhosis with history of ascites, alcohol abuse, depression, \nCAD, hypertension, and hyperlipidemia presenting with weakness, \nchest pain,and anemia presenting today from PCP due to anemia. \nPatient states she has generally feeling unwell with \nlightheadedness, nausea but no vomiting. She denies black or \nbloody stool. \n\nShe has baseline shortness of breath, which has worsened over \nthe past month.  She also endorses non-radiating chest tightness \nthat occurs with movement and sometime at rest. Also endorsing \nworsening headaches which she has had since she was hit by car ___ \nyears ago. \n\nIn the ED, initial vitals were:  T: 96.3 P: 100 BP: 197/84 RR: \n20 Sp02:100% RA. She was given Reglan x 1 for nausea, given 1L \nNS, IV morphine for pain. EKG showed no indication of ischemia. \n\nLabs were notable for:\nInitial H/H of 6.9/26.3 downtrended to 5.7/21.5 (possibly some \ndilution component, given 1L NS) - previous baseline 8.2 in \n___.\nLactate: 3.0-> 1.5 after NS \nSerum Tox: negative \nChem 7: Notable for sodium of 132, Bicarb of 16, Cr. 0.8 (at \nbaseline), anion gap 16. \n\nLFTs are significant for: ALT: 56 AST: 123 T Bili: 0.9 AP: 123 \nLip: 31. Alb: 3.9 \n  \nLiver/Gallbladder U/S showed patent portal vein, cirrhosis, and \nmild splenomegaly.\n \nPast Medical History:\nPAST MEDICAL AND SURGICAL HISTORY:  \nHepatitis C cirrhosis- genotype 1a decompensated with h/o\nascites; liver biopsy in ___ showed stage ___ fibrosis\nHypertension\nHyperlipidemia\nCOPD\nAlcohol abuse\nDepression\nCocaine abuse\nTobacco abuse\nAtypical chest pain\nBreast pain\nAbdominal pain\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair\n\n \nSocial History:\n___\nFamily History:\nMom had DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather had alcoholism and rectal CA (COD).\nSister has mental illness, also hx of falls. \nSiblings: 1 brother neonatal death, 1 brother death at 3 months, \n1 brother sudden death in ___.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \n========================\n\nVital Signs:  T: 98.2 BP: 164/60 P: 82 RR: 18 Sp02: 99% RA\nGENERAL: Overweight, NAD \nHEENT: AT/NC, EOMI, anicteric sclera,OP clear. Head \ntender to palp diffusely. \nNECK: supple neck, no LAD, tender to palp bilaterally.  \nCARDIAC: RRR, S1/S2, no murmurs, gallops, or rubs  \nCHEST: Tender to palpation diffusely. \nLUNG: On RA, good air exchange, no increased work of breathing, \nmild crackles in lower lobes bilaterally. \nBACK: Diffusely tender to spine, paraspine\nABDOMEN: mild distended, soft, diffusely tender especially in \nthe RUQ.    \nEXTREMITIES: no cyanosis, clubbing or edema, moving all 4 \nextremities with purpose. Warm.  \nNEURO: Face symmetric. EOMI. Tremor of R>>L hand, no asterixis. \nMotor: ___ shoulder shrug b/l, ___ elbow \nflexion, ___ hand strength, slowed rapid-alternating-movements. \nFinger-to-nose minimally impaired. ___ R leg flexion, ___ L leg \nflexion, back and leg pain ipsilaterally with leg raise b/l, ___ \n\nankle flexion. Decreased fine touch sensation of distal lower \nextremities b/l (from the knee down) \n\nDISCHARGE PHYSICAL EXAM:\n========================\n\nVitals: T: 97.8  P: 67  BP: 138/68 R: 24  O2: 98% RA  \n General: Alert, oriented, no acute distress  \n HEENT: MMM, sublingual petechiae, head and neck diffusely \ntender to palpation.\n Lungs: CTAB, no wheezes, rales, rhonchi  \n CV: RRR, normal S1 + S2, no MRG\n Abdomen: mildly distended, active bowel sounds. Soft with mild \ndiffuse tenderness, moderate tenderness to palpation in RUQ with \nno rebound or guarding.\n Ext: Warm and well perfused, 2+ pulses distally, no clubbing, \ncyanosis or edema. Varicose veins on bilateral lower \nextremities.\n Skin: ecchymoses at IV/venipuncture sites \n Neuro: Mental status: A&Ox3. Refused attention tests; \nsubjectively, evident inattentiveness. Cranial nerve exam \nnotable for facial sensation grossly decreased to light touch \nacross V1-V3 distributions bilaterally, no weakness of facial \nmusculature noted. Sensation: Decreased fine touch sensation of \ndistal lower extremities in stocking distribution to knees. \nMotor: R hand action tremor. No pronator drift or asterixis. \nBiceps ___, triceps ___ bilaterally. Foot plantarflexion ___, \ndorsiflexion ___ bilaterally. Coordination: Finger-to-nose \nimpaired, partially limited also by attentiveness. Gait: \nunsteady.\n \nPertinent Results:\nADMISSION LABS:\n===============\n\n___ 01:09AM BLOOD WBC-6.3 RBC-3.35* Hgb-6.9* Hct-26.3* \nMCV-79* MCH-20.6*# MCHC-26.2*# RDW-20.6* RDWSD-55.8* Plt Ct-40*#\n___ 01:09AM BLOOD Neuts-76.5* Lymphs-15.2* Monos-6.5 \nEos-0.6* Baso-0.6 Im ___ AbsNeut-4.84 AbsLymp-0.96* \nAbsMono-0.41 AbsEos-0.04 AbsBaso-0.04\n___ 01:09AM BLOOD ___ PTT-34.1 ___\n___ 01:09AM BLOOD Plt Smr-VERY LOW Plt Ct-40*#\n___ 01:09AM BLOOD Glucose-232* UreaN-8 Creat-0.8 Na-132* \nK-4.5 Cl-100 HCO3-16* AnGap-21*\n___ 01:09AM BLOOD ALT-56* AST-123* AlkPhos-164* TotBili-0.9\n___ 01:09AM BLOOD Albumin-3.9 Iron-132\n___ 01:09AM BLOOD ASA-NEG Acetmnp-NEG Bnzodzp-NEG \nBarbitr-NEG Tricycl-NEG\n___ 05:00AM BLOOD Lactate-3.0*\n\nDISCHARGE LABS:\n===============\n\n___ 04:11AM BLOOD WBC-4.7 RBC-3.06* Hgb-6.7* Hct-24.3* \nMCV-79* MCH-21.9* MCHC-27.6* RDW-19.8* RDWSD-54.7* Plt Ct-31*\n___ 03:33PM BLOOD Neuts-61.6 ___ Monos-8.0 Eos-0.6* \nBaso-0.2 Im ___ AbsNeut-3.10 AbsLymp-1.48 AbsMono-0.40 \nAbsEos-0.03* AbsBaso-0.01\n___ 04:11AM BLOOD Plt Ct-31*\n___ 04:11AM BLOOD ___\n___ 04:11AM BLOOD Glucose-139* UreaN-9 Creat-0.8 Na-139 \nK-3.7 Cl-106 HCO3-22 AnGap-15\n___ 04:11AM BLOOD ALT-42* AST-79* AlkPhos-128* TotBili-0.8\n___ 04:11AM BLOOD Calcium-8.7 Phos-3.5 Mg-2.0\n___ 04:11AM BLOOD %HbA1c-5.5 eAG-111\n \nBrief Hospital Course:\nMs. ___ is a ___ woman with HCV genotype 1a and \nalcoholic cirrhosis with previous complications of ascites and \npresumed GI bleed who presented for anemia in the setting of \nmonths of increasing dyspnea on exertion and chest tightness. \nShe was transfused 2 units packed RBCs (transfused second unit \nafter HgB of 6.7) and experienced improvement in symptoms after \nthe first unit. EGD on ___ showed no changed from prior with \nportal hypertensive gastropathy. We continued her home \nmedications for her chronic health conditions and additionally \nprescribed Nadolol 20mg daily. \n\nACUTE ISSUES:\n\n#Anemia: HgB 6.9 on admission (___) with nadir of 5.7 after \nreceiving IV fluids; worsened from prior baseline in ___ of \n8.0. Increasingly symptomatic over past months with dyspnea on \nexertion and increasing chest tightness. Treated with 2 units \npacked RBCs (second unit given after HgB of 6.7) with some \nsymptom improvement. EGD showed. Patient not open to discussion \nabout decreasing EtOH. \n\n#Cirrhosis: Patient has h/o cirrhosis from HCV (genotype 1a) and \nEtOH abuse complicated by ascites. MELD on ___: 14. No ascites \non clinical exam or bedside ultrasound. LFTs grossly unchanged \nfrom previous admission ___. Lasix was held while inpatient \nas there was no evidence of ascites, it was restarted on \ndischarge. \n\nCHRONIC ISSUES:\n#Abdominal Pain: Tenderness over liver. Stable per patient. \nLipase negative. LFTs similar to baseline. \n\n#Generalized pain: Unclear etiology, pt endorses fibromyalgia. \nStates that tramadol does not work. Patient unwilling to discuss \nlifestyle modifications. No alterations to home pain management \nregimen was continued while inpatient.\n- Outpt f/u with PCP and pain clinic for pain management\n\n#COPD: Pt has mild nonproductive cough, minimal SOB. Continued \non home nebulizers and prn Albuterol MDI.\n\n#HTN: Hypertensive on admission to 197/80; home meds not taken \non ___. Max SBP since arrival to floor 140s. Continued home \nAmlodipine 5mg QD and Valsartan 320 mg QD.\n\n#Generalized weakness: Unclear etiology, not consistent with \nradiculopathy. Most likely d/t EtOH abuse.\n\n#Peripheral neuropathy: Pt has minimal feeling in feet, \nneuropathic pain, and pain limiting her walking.  Has walker, \nwheelchair at home but does not use them. Continued home \ngabapentin 600 mg TID\n\n#GERD: s/p lap fundoplication and hiatal hernia repair ___. Has \nmild symptoms, states this is not currently a priority for her.\n\nTRANSITIONAL ISSUES:\n1. Anemia:\n[ ] follow up with PCP ___ ___ to monitor anemia \n[ ] continue oral iron supplements daily\n\n2. Cirrhosis:\n[ ] outpatient appointment with ___ on ___\n[ ] prescribed Nadolol 20mg daily\n\n3. Alcohol consumption: \n[ ] we encouraged her to stop drinking alcohol\n[ ] recommend outpatient social work follow up and support\n\n4. Pain, neuropathy, weakness:\n[ ] continued home doses of gabapentin and as needed tramadol\n[ ] outpatient follow up with PCP for monitoring\n[ ] follow up in pain clinic on ___. Possible Diabetes Mellitus: based on high glucose (200's) on \nchem\n[x] follow up A1c - 5.5% on ___. \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN wheezing \n2. Docusate Sodium 100 mg PO BID \n3. Fluticasone Propionate NASAL 1 SPRY NU BID \n4. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n5. Pantoprazole 40 mg PO Q12H \n6. Tiotropium Bromide 1 CAP IH DAILY \n7. Valsartan 320 mg PO DAILY \n8. Simvastatin 20 mg PO QPM \n9. Loratadine 10 mg PO DAILY:PRN allergies \n10. HydrOXYzine 25 mg PO BID:PRN itch \n11. Ferrous Sulfate 325 mg PO DAILY \n12. Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID \n13. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing \n14. Gabapentin 600 mg PO TID \n15. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \n16. Amlodipine 5 mg PO DAILY \n17. Aspirin 81 mg PO DAILY \n18. Furosemide 20 mg PO DAILY \n19. Thiamine 100 mg PO DAILY \n\n \nDischarge Medications:\n1. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN wheezing \n2. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing \n3. Amlodipine 5 mg PO DAILY \n4. Aspirin 81 mg PO DAILY \n5. Docusate Sodium 100 mg PO BID \n6. Ferrous Sulfate 325 mg PO DAILY \n7. Fluticasone Propionate NASAL 1 SPRY NU BID \n8. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n9. Gabapentin 600 mg PO TID \n10. HydrOXYzine 25 mg PO BID:PRN itch \n11. Loratadine 10 mg PO DAILY:PRN allergies \n12. Pantoprazole 40 mg PO Q12H \n13. Simvastatin 20 mg PO QPM \n14. Thiamine 100 mg PO DAILY \n15. Tiotropium Bromide 1 CAP IH DAILY \n16. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \n17. Valsartan 320 mg PO DAILY \n18. Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID \n19. Furosemide 20 mg PO DAILY \n20. Nadolol 20 mg PO DAILY \nRX *nadolol [Corgard] 20 mg 1 tablet(s) by mouth once a day Disp \n#*30 Tablet Refills:*0\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSES:\nMicrocytic anemia\nHepatitis C\nCirrhosis \n\nSECONDARY DIAGNOSES:\nChronic Pain\nCOPD\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane or holding onto surfaces as she walks).\n\n \nDischarge Instructions:\nDear Ms. ___, \n\nYou were admitted to the hospital for anemia (having less red \nblood cells in your blood). You had symptoms of shortness of \nbreath when you exerted yourself along with chest tightness. You \nwere treated with a blood transfusion and your symptoms \nimproved. You also had an upper endoscopy which showed no change \nfrom previous, but showed an ulcer you have had previously. \n\nIt is very important that you stop drinking. It is harmful to \nyour liver and your health in general.  Please follow-up with \nthe liver doctors, your primary care physician and the pain \nmanagement clinic. \n\nIt was a pleasure taking care of you, \n\n-Your ___ Team \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee7539342fe"
  },
  "note_id": "19644467-DS-29",
  "subject_id": 19644467,
  "hadm_id": 23611765,
  "note_type": "DS",
  "note_seq": 29,
  "charttime": "2201-12-03 00:00:00",
  "storetime": "2201-12-03 12:44:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril / mango / papaya\n \nAttending: ___\n \nChief Complaint:\nAbdominal pain\n \nMajor Surgical or Invasive Procedure:\nLarge volume paracentesis ___\n \nHistory of Present Illness:\n___ w/ HCV/ETOH cirrhosis (genotype 1a, child's class B with hx\nascites), polysubstance abuse, COPD, HTN, HLD, RA, p/w few month\nhx of worsening abd pain, distention, and difficulty taking a\ndeep breath. Patient follows at ___ clinic. Her \nlast\nvisit in ___ was notable for increased ascites for which her\nLasix dose was increased from 20mg PO QD to 40mg PO QD. She was\npreviously on HCTZ that has since been discontinued. Patient has\nhad paracentesis in the past for volume management of her\nascites. This has been a slowly progressive process leading to\nworsening diffuse waxing and waning abdominal pain. Patient\ndenies cough but reports SOB due to significant abdominal\ndistension. She denies fevers/chills. No chest pain. No\nnausea/vomiting/hematemesis. She reports feeling like she needs\nto have a bowel movement but not being able to move her bowels\nregularly. Still passing gas. Reports urine appearance has\nchanged color and decreased in output. Positive difficulty\nsleeping but no confusion or cloudiness. \n\nIn the ED, initial VS were: T 97.7 HR 104 BP 184/71 RR 18 100% \nra\nExam notable for: Diffuse abd distension, TTP, diminished BS b/l\nLabs showed: wbc 4.4, hgb 9 (higher than recent values in ___,\nplt 86, HCO3 20, Cr 0.6, INR 1.5, AST/ALT 41/13, AP 141, tbili\n1.3, alb 3.3, UA unremarkable, urine cocaine positive, negative\nserum tox.\nImaging showed: RUQUS pending.\nReceived: Fentanyl 50 mg IV x3, cipro 400 mg qd\nHepatology was consulted and recommended RUQUS w/ Doppler and\ndiagnostic paracentesis. Paracentesis w/ 1.4 protein, 131 glc,\n303 WBC (74% macrophages and 9% PMNs), gram stain w/ no\nmicroorganisms. \nTransfer VS were: T 98.6 HR 95 BP 128/80 RR 18 99% ra\n\nOn arrival to the floor, patient reports the above history. She\ncontinues to have ___ abdominal pain and ___ SOB due to\nabdominal distension. \n\n \nPast Medical History:\nPAST MEDICAL AND SURGICAL HISTORY:  \nHepatitis C cirrhosis- genotype 1a decompensated with h/o\nascites; liver biopsy in ___ showed stage ___ fibrosis\nHypertension\nHyperlipidemia\nCOPD\nAlcohol abuse\nDepression\nCocaine abuse\nTobacco abuse\nAtypical chest pain\nBreast pain\nAbdominal pain\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair\n\n \nSocial History:\n___\nFamily History:\nMom had DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather had alcoholism and rectal CA (COD).\nSister has mental illness, also hx of falls. \nSiblings: 1 brother neonatal death, 1 brother death at 3 months, \n1 brother sudden death in ___.\n \nPhysical Exam:\nADMISSION EXAM\n==============\nVS:  98.1  155/73  95  22  98%Ra \nGENERAL: Middle aged female, appears uncomfortable in bed.\nbreathing shallowly. \nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva,\nMMM\nNECK: supple, no LAD, no JVD  \nHEART: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNGS: CTAB, no wheezes, rales, rhonchi\nABDOMEN: +BS, significant abdominal distension with diffuse\ntenderness to palpation, greatest in RUQ. +fluid wave\nEXTREMITIES: no cyanosis, clubbing, or edema\nPULSES: 2+ DP pulses bilaterally  \nNEURO: A&Ox3, moving all 4 extremities with purpose. No\nasterixis.   \nSKIN: scattered spider angiomata\n\nDISCHARGE EXAM\n==============\nVS: 98.0, HR 85, 123/68, RR 18, 96% RA \nGENERAL: Middle aged female, appears well, NAD\nHEENT: AT/NC, EOMI, PERRL, anicteric sclera \nHEART: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNGS:  CTAB, no wheeze\nABDOMEN: +BS, mild abdominal distension, minimal tenderness,\nreducible umbilical hernia noted\nEXTREMITIES: No cyanosis, clubbing, or edema\nNEURO: Alert, oriented to person, place, time. Moving all 4\nextremities with purpose. No asterixis. Ambulating around the\nhalls without difficulty\n \nPertinent Results:\nADMISSION LABS\n==============\n___ 10:55AM BLOOD WBC-4.4 RBC-3.62* Hgb-9.0* Hct-30.2* \nMCV-83 MCH-24.9* MCHC-29.8* RDW-21.2* RDWSD-63.7* Plt Ct-86*\n___ 10:55AM BLOOD Neuts-70.6 Lymphs-17.0* Monos-10.8 \nEos-0.9* Baso-0.5 Im ___ AbsNeut-3.07 AbsLymp-0.74* \nAbsMono-0.47 AbsEos-0.04 AbsBaso-0.02\n___ 10:55AM BLOOD ___ PTT-34.2 ___\n___ 10:55AM BLOOD Glucose-117* UreaN-5* Creat-0.6 Na-136 \nK-3.6 Cl-101 HCO3-20* AnGap-15\n___ 10:55AM BLOOD ALT-13 AST-41* AlkPhos-141* TotBili-1.3 \nDirBili-0.4* IndBili-0.9\n___ 10:55AM BLOOD Albumin-3.3*\n\nNOTABLE LABS\n============\n___ 10:55AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nBnzodzp-NEG Barbitr-NEG Tricycl-NEG\n___ 04:27AM BLOOD HCV VL-6.0*\n\nMICRO\n=====\n___ URINE URINE CULTURE-FINAL INPATIENT \n___ BLOOD CULTURE Blood Culture, Routine-PENDING \nINPATIENT \n___ BLOOD CULTURE Blood Culture, Routine-FINAL \nINPATIENT \n___ PERITONEAL FLUID GRAM STAIN-FINAL; FLUID \nCULTURE-FINAL; ANAEROBIC CULTURE-FINAL EMERGENCY WARD \n___ URINE URINE CULTURE-FINAL EMERGENCY WARD \n\nIMAGING\n=======\n___ ABDOMINAL XR\nIMPRESSION:   \nCirrhosis with sequela of portal hypertension.  Moderate ascites \nis increased from most recent prior. \n\n___ ABD XR\nIMPRESSION:  \nNo definite radiographic evidence of bowel obstruction; mildly \nprominent loops \nof large bowel may represent colonic ileus. \n\n___ CXR\nIMPRESSION:  \nIn comparison with the study of ___, there is \nlittle change and no evidence of acute cardiopulmonary disease.  \nNo pneumonia, vascular \ncongestion, or pleural effusion. \nLarge left perihilar bleb is again seen, better demonstrated on \na prior CT \nscan. \n\n___ LIVER US\nIMPRESSION:  \nCirrhosis is of portal hypertension, including splenomegaly and \nsmall volume \nascites.  No focal hepatic lesion.  Patent portal veins with \nappropriate \ndirectional flow. \n\n___ CXR\nVery small pleural effusions unchanged.  No pneumothorax.  Mild \nleft basal \natelectasis.  Lungs otherwise clear.  Normal cardiomediastinal \nand hilar \nsilhouettes. \n\nDISCHARGE LABS\n==============\n___ 04:35AM BLOOD WBC-2.7* RBC-2.79* Hgb-7.2* Hct-23.8* \nMCV-85 MCH-25.8* MCHC-30.3* RDW-22.4* RDWSD-69.5* Plt Ct-76*\n___ 04:35AM BLOOD ___\n___ 04:35AM BLOOD Glucose-139* UreaN-7 Creat-0.8 Na-137 \nK-4.3 Cl-100 HCO3-23 AnGap-14\n___ 04:35AM BLOOD ALT-14 AST-40 AlkPhos-79 TotBili-1.0\n___ 04:35AM BLOOD Calcium-9.0 Phos-3.3 Mg-1.8\n \nBrief Hospital Course:\nHOSPITAL COURSE\n===============\n___ w/ HCV/ETOH cirrhosis (genotype 1a, child's class B with hx \nascites), polysubstance abuse, COPD, HTN, HLD, RA, who p/w few \nmonth hx of worsening abd pain, distention, and SOB due to large \nvolume ascites.  She received a large volume paracentesis with \nimprovement in symptoms.  She developed ___ in the setting of \ndiuresis, so her home Furosemide was decreased from 40mg to 20mg \ndaily.  She developed asterixis and encephalopathy early in her \nhospital course, and was thus started on lactulose and \nrifaximin.\n\nACTIVE ISSUES\n=============\n# Abdominal pain: Has had distended abdomen and TTP for 3+ \nmonths. RUQUS showed moderate ascites, patent portal veins, and \nevidence of cirrhosis. S/p 4L paracentesis on ___ with some \nimprovement.  Peritoneal studies not suggestive of SBP. Likely \nmultifactorial from constipation, abdominal hernia, ascites. On \ndischarge, pain was well controlled.  Received PO Dilaudid while \ninpatient, as needed.  She was given a 3 day prescription for \nher home Tramadol on discharge, with further narcotic refills \nneeding to be done by her outpatient providers.\n\n# ___: Cr up to 1.4 on ___, from baseline 0.6. Likely due to \ndiuresis and paracentesis. Trialed albumin challenge on ___, \n___, with improvement in Cr back to baseline.  She was \nsubsequently restarted on a lower dose diuretic, Lasix 20mg \ndaily (home dose was 40mg), and tolerated this with stable Cr on \nday of discharge.\n\n# Hepatic encephalopathy \n# HCV/ETOH cirrhosis:\n___ MELD-Na 15 on admission, w/ hx ascites on \ndiuretics. Last EGD (___) w/ 3 small varices.  Planned \nHarvoni therapy in future when medically able.  No prior history \nof SBP or Hepatic Encephalopathy.  Current presentation appeared \nto be slow decompensation of liver disease over time, as opposed \nto acute process. HCV-VL: 6.0. Diagnostic/therapeutic \nparacentesis showed no evidence of SBP.  Beta blocker and \ndiuretics were held while patient had ___, and on discharge the \nNadolol was held, and the Furosemide was decreased to 20mg \n(prior dose was 40mg).  Started lactulose and rifaximin given \nconcern for HE with asterixis and confusion early in the \nadmission.\n\n# Dyspnea: Likely secondary to ascites and abdominal distension. \nResolved after paracentesis. Afebrile, WBC stable, CXR without \npneumonia or significant fluid. Continued home COPD regimen\n\n# Polysubstance abuse: Hx heroin abuse in the past. Current ETOH \nuse daily and intermittent cocaine. Positive for cocaine by tox \nscreen in ED. SW consulted. Did not require CIWA inpatient.\n\n# HTN: Held home valsartan 320 mg qd and amlodipine 5 mg qd \ngiven normal BP and ___.  Not to be restarted until discussed \nwith PCP.\n\n# Pancytopenia:  Relatively stable, likely related to cirrhosis\n- Recheck as outpatient\n\nCHRONIC ISSUES\n==============\n# Anemia: Hgb 9 on admission. Recent baseline ___. Last \ncolonoscopy (___) and EGD (___) w/o source of bleeding. \nContinued folate and iron supplementation\n\n# Nutrition: Continue home folate, thiamine, MVI, ca/vitamin D, \niron. \n\n# Primary prevention: Continued home aspirin\n\n# Pain: Held home gabapentin 800 mg TID as ineffective.  Resume \nhome Tramadol on discharge.\n\n# Allergies: Continued home loratidine, hydroxyzine prn, and \nFlonase.\n\n# Insomnia: Continued home mirtazapine.\n\n# HLD: Continued home simvastatin 20 mg qd\n\n# GERD: Continued home pantoprazole 40 mg BID\n\nTRANSITIONAL ISSUES\n===================\n[] Recommend outpatient lab recheck, including CBC to trend \npancytopenia\n[] CHANGED MEDICATIONS:  Lasix decreased from 40mg to 20mg daily\n[] NEW MEDICATIONS:  Lactulose, Rifaximin\n[] MEDICATIONS STOPPED:  Gabapentin (ineffective for her), \nValsartan (developed ___, and BP was normal), Nadolol (developed \n___, varices were very small on last EGD, BP's were normal)\n[] MEDICATIONS HELD:  Amlodipine - told pt not to restart until \ndiscussing with PCP\n[] Re: hepatology, consider Harvoni as an outpatient\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing \n2. Amlodipine 5 mg PO DAILY \n3. Aspirin 81 mg PO DAILY \n4. Docusate Sodium 100 mg PO BID \n5. Ferrous Sulfate 325 mg PO DAILY \n6. Fluticasone Propionate NASAL 1 SPRY NU BID \n7. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n8. Gabapentin 800 mg PO TID \n9. HydrOXYzine 25 mg PO BID:PRN itch \n10. Loratadine 10 mg PO DAILY:PRN allergies \n11. Pantoprazole 40 mg PO Q12H \n12. Simvastatin 20 mg PO QPM \n13. Thiamine 100 mg PO DAILY \n14. Tiotropium Bromide 1 CAP IH DAILY \n15. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \n16. Valsartan 320 mg PO DAILY \n17. Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID \n18. Furosemide 40 mg PO DAILY \n19. Nadolol 20 mg PO DAILY \n20. FoLIC Acid 1 mg PO DAILY \n21. Mirtazapine 30 mg PO QHS \n22. Multivitamins W/minerals 1 TAB PO DAILY \n\n \nDischarge Medications:\n1.  Lactulose 30 mL PO Q8H:PRN constipation \ntake to ensure multiple bowel movements per day \nRX *lactulose 20 gram/30 mL 30 ml by mouth every 8 hours Disp \n#*1 Bottle Refills:*1 \n2.  Rifaximin 550 mg PO BID \nRX *rifaximin [Xifaxan] 550 mg 1 tablet(s) by mouth twice daily \nDisp #*60 Tablet Refills:*0 \n3.  Furosemide 20 mg PO DAILY \nRX *furosemide 20 mg 1 tablet(s) by mouth daily Disp #*30 Tablet \nRefills:*1 \n4.  Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing  \n5.  Aspirin 81 mg PO DAILY  \n6.  Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID  \n7.  Docusate Sodium 100 mg PO BID  \n8.  Ferrous Sulfate 325 mg PO DAILY  \n9.  Fluticasone Propionate NASAL 1 SPRY NU BID  \n10.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  \n11.  FoLIC Acid 1 mg PO DAILY  \n12.  HydrOXYzine 25 mg PO BID:PRN itch  \n13.  Loratadine 10 mg PO DAILY:PRN allergies  \n14.  Mirtazapine 30 mg PO QHS  \n15.  Multivitamins W/minerals 1 TAB PO DAILY  \n16.  Pantoprazole 40 mg PO Q12H  \n17.  Simvastatin 20 mg PO QPM  \n18.  Thiamine 100 mg PO DAILY  \n19.  Tiotropium Bromide 1 CAP IH DAILY  \n20.  TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \nRX *tramadol 50 mg 1 tablet(s) by mouth every 6 hours Disp #*12 \nTablet Refills:*0 \n21. HELD- Amlodipine 5 mg PO DAILY  This medication was held. Do \nnot restart Amlodipine until discussing with your primary care \ndoctor\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nCirrhosis with ascites, encephalopathy\nAcute Kidney Injury\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the hospital with abdominal pain.  There \nwere likely multiple causes for this, including ascites (fluid), \nand you improved somewhat after we drained out this fluid.\n\nYou were confused and had hand shaking (asterixis), which is a \nmarker of a condition called hepatic encephalopathy. We started \nyou medications called Lactulose and Rifaximin to treat this \ncondition.\n\nBecause a kidney injury developed, we decreased the dose of your \nwater pill (Lasix, aka Furosemide).  The dose is now 20mg, it \nused to be 40mg.  We also stopped your Nadolol, Amlodipine, and \nGabapentin.\n\nIt was a privilege to care for you in the hospital, and we wish \nyou all the best.\n\nSincerely,\n\nYour ___ Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee7539342ff"
  },
  "note_id": "19644467-DS-30",
  "subject_id": 19644467,
  "hadm_id": 29066661,
  "note_type": "DS",
  "note_seq": 30,
  "charttime": "2202-01-26 00:00:00",
  "storetime": "2202-02-06 12:55:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril / mango / papaya\n \nAttending: ___.\n \nChief Complaint:\nabdominal pain\n \nMajor Surgical or Invasive Procedure:\nNone \n\n \nHistory of Present Illness:\n___ is a ___ with a history of HCV/ETOH cirrhosis\n(genotype 1a, child's class B) decompensated by ascites,\npolysubstance abuse, COPD, HTN, and HLD who presents with\nabdominal pain. She reports ___ abdominal pain from her\numbilicus to her xyphoid process that began 2+ weeks ago and\nbecame more intense in the last few days. The pain is constant\nand sharp. She has had similar pain in the past and was admitted\nfor similar pain ___ with no evidence of SBP. It was\nthought to be multifactorial (constipation, hernia, ascites). \nShe\nimproved on this admission but has had recurrence of pain. She\nhas multiple soft BM per day and has not noticed blood but does\nnot pay attention. She has nausea but no vomiting. \n\nShe continues to drink alcohol and last drank the day prior to\nadmission (4 beers). She also used cocaine about a week prior to\nadmission. \n\nIn the ED, initial VS were: 10 88 140/90 16 \n\nLabs showed: \nWBC 7.6  Hgb 10.1  plts 119  \n\nNa 144, K 4.2, BUN 7, Cr 0.8\n\nALT: 12 AP: 128 Tbili: 1.2 Alb: 3.4 \nAST: 32 LDH:  Dbili:  TProt:  \n___:  Lip: 35 \n\n___: 14.6  PTT: 32.9  INR: 1.3  \n\nWBC 238 RBC 192 Poly 11 Lymph ___ Mono 0    \nMesothe: ___\nMacroph: 70 \n\nImaging showed:\nAbd US with Doppler: \n1. No evidence of portal vein thrombosis. \n2. Splenomegaly. \n\nPatient received:\n___ 20:53 IV Morphine Sulfate 4 mg   \n___ 22:15 IV Morphine Sulfate 4 mg   \n___ 03:10 IV Morphine Sulfate 4 mg \n\nHepatology was consulted and recommended admission to ET. \n\nTransfer VS were: 8 97.6 62 117/70 16 100% RA \n\nOn arrival to the floor, patient reports ongoing abdominal pain\nas described above. No CP, dyspnea, cough, fevers, dysuria.\n\n \nPast Medical History:\nPAST MEDICAL AND SURGICAL HISTORY:  \nHepatitis C cirrhosis- genotype 1a decompensated with h/o\nascites; liver biopsy in ___ showed stage ___ fibrosis\nHypertension\nHyperlipidemia\nCOPD\nAlcohol abuse\nDepression\nCocaine abuse\nTobacco abuse\nAtypical chest pain\nBreast pain\nAbdominal pain\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair\n\n \nSocial History:\n___\nFamily History:\nMom had DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather had alcoholism and rectal CA (COD).\nSister has mental illness, also hx of falls. \nSiblings: 1 brother neonatal death, 1 brother death at 3 months, \n1 brother sudden death in ___.\n \nPhysical Exam:\nVS: 97.6  124/68 56 18 99 Ra \nGENERAL:  NAD, comfortable in bed\nHEENT: AT/NC, EOMI, PERRL, anicteric sclera\nHEART: RRR, S1/S2, no murmurs, gallops, or rubs  \nLUNGS: Crackles in bilateral bases, no wheezes\nABDOMEN: +distended, + periumbilical hernia (soft), diffusely\ntender in all quadrants equally with light touch, percussion, \nand\ndeep palpation, no guarding or rigidity, normoactive BS\nEXTREMITIES: no cyanosis, clubbing, or edema  \nNEURO: AAOx3, positive for asterixis, can recite days of the \nweek\nbackwards \n \nPertinent Results:\nADMISSION LABS\n___ 08:09PM BLOOD WBC-7.6# RBC-4.00# Hgb-10.1*# Hct-34.4# \nMCV-86 MCH-25.3* MCHC-29.4* RDW-18.3* RDWSD-56.3* Plt ___\n___ 08:09PM BLOOD Neuts-75.2* Lymphs-10.6* Monos-12.2 \nEos-1.2 Baso-0.3 Im ___ AbsNeut-5.74# AbsLymp-0.81* \nAbsMono-0.93* AbsEos-0.09 AbsBaso-0.02\n___ 08:09PM BLOOD ___ PTT-32.9 ___\n___ 08:09PM BLOOD Glucose-161* UreaN-7 Creat-0.8 Na-144 \nK-4.2 Cl-107 HCO3-21* AnGap-16\n___ 08:09PM BLOOD ALT-12 AST-32 AlkPhos-128* TotBili-1.2\n___ 05:17AM BLOOD Albumin-3.3* Calcium-8.5 Phos-4.1 Mg-2.0\n___ 08:09PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nBnzodzp-NEG Barbitr-NEG Tricycl-NEG\n___ 09:34AM BLOOD Lactate-2.1*\n\nDISCHARGE LABS\n___ 05:08AM BLOOD WBC-4.1 RBC-3.17* Hgb-8.0* Hct-27.0* \nMCV-85 MCH-25.2* MCHC-29.6* RDW-18.5* RDWSD-57.1* Plt Ct-81*\n___ 05:08AM BLOOD Glucose-185* UreaN-11 Na-138 K-4.9 Cl-105 \nHCO3-22 AnGap-11\n___ 08:55AM BLOOD ___ PTT-35.1 ___\n___ 05:08AM BLOOD ALT-14 AST-46* AlkPhos-96 TotBili-0.5\n___ 05:08AM BLOOD Albumin-3.1* Calcium-8.0* Phos-2.7 Mg-2.4\n\nPERITONEAL FLUID\n___ 09:40PM ASCITES TNC-238* RBC-192* Polys-11* Lymphs-17* \n___ Mesothe-2* Macroph-70*\n___ 09:40PM ASCITES TotPro-1.7 Glucose-170\n\nMICRO\n___ 9:40 pm PERITONEAL FLUID      PERITONEAL FLUID. \n\n                            **FINAL REPORT ___\n\n   GRAM STAIN (Final ___: \n      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      NO MICROORGANISMS SEEN. \n      This is a concentrated smear made by cytospin method, \nplease refer to\n      hematology for a quantitative white blood cell count.. \n\n   FLUID CULTURE (Final ___:    NO GROWTH. \n\n   ANAEROBIC CULTURE (Final ___:    NO GROWTH. \n\nIMAGING\nKUB: Moderate to severe gaseous distension of the stomach.  No \ndefinite evidence of \nfree air. \n\nABDOMINAL ULTRASOUND W DOPPLER:\n1. No evidence of main portal vein thrombosis. \n2. Cirrhotic liver with sequela of portal hypertension and \nmoderate ascites. \n\n \nBrief Hospital Course:\nPATIENT SUMMARY:\n================\n___ with a history of HCV/ETOH cirrhosis (Genotype 1a, Child's \nClass B) decompensated by ascites, polysubstance abuse, COPD, \nHTN, and HLD who presented with abdominal pain and ascites. She \nreceived a large volume diagnostic and therapeutic paracentesis \nwith partial relief of her pain. \n\nACTIVE ISSUES:\n==============\n# Abdominal pain: \n# Ascites: \nPain likely secondary to ascites and gas pain. Diagnostic \nparacentesis not concerning for SBP. Her US was unremarkable for \nany gallbladder pathology or PVT. Her lipase and LFTs were \nunremarkable. Biopsies from her most recent EGD in OMR from ___ \nwere negative for H. pylori. Mesenteric ischemia secondary to \ncocaine use and history of HLD is possible, but less likely \ngiven low lactate and no history of hypotension. She also had \nsignificant bowel gas on KUB, possibly contributing to her \ndiscomfort. She received a therapeutic paracentesis on ___, \nwith improvement in discomfort. For her gaseous distension, \npatient was given Simethicone. She was also given Maalox. Her \nPPI was continued twice daily. She received a lidocaine patch \nand Tylenol ___ BID for pain. CT A/P was deferred given her \nsubjective improvement after paracentesis and her benign \nabdominal exam. \n\n# Hepatic encephalopathy: \nOn admission, patient had mild asterixis, with mild \nconfusion/inattention, possibly worsened by morphine given in \nthe ED. She reports having multiple loose BM per day without \nlactulose. Lactulose and Rifaximin were continued. Blood \ncultures were negative to date. Opiates were stopped.\n\nSTABLE ISSUES:\n==============\n# EtOH/HCV Cirrhosis: \nMELD on admission is 10. She is not a transplant candidate due \nto active alcohol/substance use. Her cirrhosis is decomensated \nby ascites, varices, HE. Her last EGD (___) showed 3 small \nvarices. She had previously been on nadolol but this was \ndiscontinued last admission ___ due to ___ and not \nre-started. Her blood pressures continued to be soft this \nadmission, so Nadolol was not started. She should receive \nHarvoni therapy in the future when medically stable. No changes \nwere made to her diuretic regimen given uncertainty of follow up \nand evidence of recent hyperkalemia on OMR review. \n\n# EtOH abuse:\n# Polysubstance abuse:\nTox screen was negative on admission. Her last reported drink \nwas the day prior to admission (4 beers). Patient scored once on \n___ protocol on ___, received x1 Lorazepam. No history \nwithdrawal reported. \n\nTRANSITIONAL ISSUES:\n====================\n[ ] Consider outpatient paracentesis on regular intervals\n[ ] Consider chronic pain outpatient referral\n[ ] Harvoni therapy when medically stable\n[ ] Nadolol if blood pressures can tolerate as outpatient\n\n-Discharge Weight: 61.55kg, 135.7 lbs\n-Discharge Creatinine: 0.9\n\nRESTARTED MEDS:\n- Lactulose, Rifaximin\n\nNEW MEDS:\n- Acetaminophen 1000 mg PO/NG BID do not exceed 2gm/day \n- Maalox/Diphenhydramine/Lidocaine 15 mL PO QID \n- Polyethylene Glycol 17 g PO/NG DAILY \n- Simethicone 40-80 mg PO/NG QID \n\nFOLLOW UP:\n-PCP (Follow up after hospitalization for ascites, hepatic \nencephalopathy. Management of chronic pain, substance use \ndisorder)\n-___ (for Hep C management, cirrhosis management). \n\n#CODE: Full (presumed) \n#CONTACT: ___ \nRelationship: fiance \nPhone number: ___ \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 81 mg PO DAILY \n2. Ferrous Sulfate 325 mg PO DAILY \n3. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n4. FoLIC Acid 1 mg PO DAILY \n5. Furosemide 20 mg PO DAILY \n6. Mirtazapine 30 mg PO QHS \n7. Multivitamins W/minerals 1 TAB PO DAILY \n8. Pantoprazole 40 mg PO Q12H \n9. Simvastatin 20 mg PO QPM \n10. Thiamine 100 mg PO DAILY \n11. Tiotropium Bromide 1 CAP IH DAILY \n12. Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID \n13. Docusate Sodium 100 mg PO BID \n14. Fluticasone Propionate NASAL 1 SPRY NU BID \n15. HydrOXYzine 25 mg PO BID:PRN itch \n16. Loratadine 10 mg PO DAILY:PRN allergies \n17. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing \n18. Rifaximin 550 mg PO BID \n19. Lactulose 30 mL PO Q8H:PRN constipation \n20. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \n\n \nDischarge Medications:\n1.  Acetaminophen 1000 mg PO BID \nRX *acetaminophen 500 mg 2 tablet(s) by mouth twice a day Disp \n#*30 Tablet Refills:*0 \n2.  Maalox/Diphenhydramine/Lidocaine 15 mL PO QID \nRX *alum-mag hydroxide-simeth [Maalox Maximum Strength] 400 \nmg-400 mg-40 mg/5 mL 15 mL by mouth four times a day Refills:*0 \n3.  Polyethylene Glycol 17 g PO DAILY \nRX *polyethylene glycol 3350 17 gram/dose 17g powder(s) by mouth \ndaily Refills:*0 \n4.  Simethicone 40-80 mg PO QID \nRX *simethicone 80 mg 1 tab by mouth four times a day Disp #*120 \nTablet Refills:*0 \n5.  Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing  \n6.  Aspirin 81 mg PO DAILY  \n7.  Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID  \n8.  Docusate Sodium 100 mg PO BID  \n9.  Ferrous Sulfate 325 mg PO DAILY  \n10.  Fluticasone Propionate NASAL 1 SPRY NU BID  \n11.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  \n12.  FoLIC Acid 1 mg PO DAILY  \n13.  Furosemide 20 mg PO DAILY  \n14.  HydrOXYzine 25 mg PO BID:PRN itch  \n15.  Lactulose 30 mL PO Q8H:PRN constipation  \n16.  Loratadine 10 mg PO DAILY:PRN allergies  \n17.  Mirtazapine 30 mg PO QHS  \n18.  Multivitamins W/minerals 1 TAB PO DAILY  \n19.  Pantoprazole 40 mg PO Q12H  \n20.  Rifaximin 550 mg PO BID  \n21.  Simvastatin 20 mg PO QPM  \n22.  Thiamine 100 mg PO DAILY  \n23.  Tiotropium Bromide 1 CAP IH DAILY  \n24.  TraMADOL (Ultram) 50 mg PO Q6H:PRN pain  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS\nAscites \nHepatic Encephalopathy\n\nSECONDARY DIAGNOSES\nEtOH and HCV Cirrhosis\nSubstance Use Disorder\nAlcohol Use Disorder\n\n \nDischarge Condition:\nActivity Status: Ambulatory - Independent.\nLevel of Consciousness: Alert and interactive.\nMental Status: Clear and coherent.\n\n \nDischarge Instructions:\nDear Ms ___,\n\nIt was a pleasure taking part in your care here at ___!\n\nWhy was I admitted to the hospital?\n-You were admitted for belly pain, and for confusion. \n \nWhat was done for me in the hospital?\n-You were given medicine for your abdominal pain. \n-You received imaging of your belly to make sure there wasn't an \ninfection.\n-Fluid in your belly was removed (a \"paracentesis\")\n-You were monitored for 24 hours. \n-You were given medicines to help you have a bowel movement. \n-Your liver medicines to help with confusion (lactulose and \nrifaximin) were restarted.\n\nWhat should I do when I leave the hospital?\n-Please see your primary care doctor, as listed in the \nappointment below.\n-Please follow up with liver clinic. \n-Please try to stop drinking alcohol. Alcohol will continue to \nmake your liver disease worse, and can ultimately lead to death. \n\n \nWhen should I return to the hospital?\n-You should return if you have severe abdominal pain, vomiting, \nblood in your vomit or in your stool, if you pass out, or any \nother symptoms that concern you. \n\nWe wish you the best of luck in your health!\n\nSincerely,\nYour ___ Treatment Team\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753934300"
  },
  "note_id": "19644467-DS-31",
  "subject_id": 19644467,
  "hadm_id": 28301833,
  "note_type": "DS",
  "note_seq": 31,
  "charttime": "2202-03-16 00:00:00",
  "storetime": "2202-03-17 11:47:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril / mango / papaya\n \nAttending: ___.\n \nChief Complaint:\nAbdominal Distension, Shortness of breath\n \nMajor Surgical or Invasive Procedure:\nDiagnostic and therapeutic paracentesis (___)\n\n \nHistory of Present Illness:\n___ year old female with HCV/EtOH\ncirrhosis (c/b ascites, varices, and hepatic encephalopathy),\ncurrent polysubstance abuse, COPD, HTN, and HLD who presents \nwith\nSOB and abdominal distention for ___ weeks.\n\nPatient reports that for the past ___ weeks she has noted\nincreasing abdominal distention, abdominal pain, and shortness \nof\nbreath accompanied by mild chest pain that she attributes to\npressure from the abdomen. She states that dyspnea is worse when\nlying flat and has a sensation of her abdomen pressing on her\nlungs. Denies any chest pain or palpitations.\n\nOf note, patient was recently admitted to ___ from ___\nfor abdominal pain thought to be secondary to ascites with a\ndiagnostic paracentesis not concerning for SBP. A large volume\ntherapeutic paracentesis performed during that admission \nresulted\nin partial relief of her pain.\n\nA paracentesis performed in the ED was negative for SBP.\nHepatology was consulted who recommended getting a UA and lipase\nand admitting the patient to the ___ service for \nfurther\nevaluation.\n\nIn the ED, initial vitals:  97.5  65  166/78  20  99% RA \n\n- Exam notable for:  Abdomen distended with tenderness to\npalpation diffusely. No asterixis or concern for hepatic\nencephalopathy.\n\n- Labs notable for:  Paracentesis negative for SBP, Hgb 9.9\n\n- Imaging notable for:  Normal CXR\n\n- Hepatology was consulted who recommended admission to ET for\nfurther evaluation.\n\n- Pt given: 4mg IV morphine x2\n\n- Vitals prior to transfer: 98.1 76 172/80 16 98% RA\n \nOn the floor patient reports history as above. Endorses \nabdominal\npain, and feeling of skin stretching from distention. Also\nreports chest pain, which may be from her abdominal pain as well\nas dyspnea due to distention. Reports compliance with \nmedications\nincluding home diuretics. Denies recent fevers, chills, rash,\nsick contacts. Cough stable. Reports passing gas and having\nmultiple very small BM a day. \n \nREVIEW OF SYSTEMS:  \nComplete ROS obtained and is otherwise negative. \n\n \nPast Medical History:\nPAST MEDICAL AND SURGICAL HISTORY:  \nHepatitis C cirrhosis- genotype 1a decompensated with h/o\nascites; liver biopsy in ___ showed stage ___ fibrosis\nHypertension\nHyperlipidemia\nCOPD\nAlcohol abuse\nDepression\nCocaine abuse\nTobacco abuse\nAtypical chest pain\nBreast pain\nAbdominal pain\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair\n\n \nSocial History:\n___\nFamily History:\nMom had DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather had alcoholism and rectal CA (COD).\nSister has mental illness, also hx of falls. \nSiblings: 1 brother neonatal death, 1 brother death at 3 months, \n1 brother sudden death in ___.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVITALS: 97.5 163/79 74 22 95% RA \nWt: 146lbs\nGENERAL: Laying comfortably in no acute distress \nHEENT: EOMI. PERRL. anicteric sclera\nHEART: RRR, S1. S2. No mrg\nLUNGS: shallow breathing. Crackles at b/l bases\nABDOMEN: tense ascites. +periumbilical hernia (soft,). Diffusely\ntender in all quadrants with mild palpation. No rebound\ntenderness, rigidity. +BS\nEXTREMITIES: NO ___ edema\nNEURO: AOx3. No asterixes. ___ backwards\n\nDISCHARGE PHYSICAL EXAM:\nVITALS: 98.3 121 / 61 80 18 94% on RA \nWeight: 127lbs\nGENERAL: Thin, unwell Caucasian woman, sitting up in bed, \ntearful\nwhen talking about how she doesn't like to be alone. \nHEENT: Sclerae anicteric\nHEART: RRR, normal S1-S2, no M/R/G.\nLUNGS: Clear to auscultation bilaterally. breathing comfortably\nwithout the use of accessory muscles. \nABDOMEN: Distended, but compressible. Diffuse tenderness to\npalpation.  Positive fluid wave.  Again noted is the soft\nperiumbilical hernia.  No rebound tenderness, or rigidity. +BS\nEXTREMITIES: No lower extremity edema\nNEURO: AOx3. No asterixis. \n\n \nPertinent Results:\nADMISSION LABS: ___ 12:30PM\n---------------\nWBC-4.9 RBC-3.70* Hgb-9.9* Hct-32.0* MCV-87 MCH-26.8 MCHC-30.9* \nRDW-18.6* RDWSD-59.1* Plt ___ Neuts-74.7* Lymphs-14.8* \nMonos-9.1 Eos-0.8* Baso-0.2 Im ___ AbsNeut-3.68 \nAbsLymp-0.73* AbsMono-0.45 AbsEos-0.04 AbsBaso-0.01\n___ PTT-35.1 ___\nGlucose-117* UreaN-8 Creat-0.7 Na-141 K-3.8 Cl-105 HCO3-24 \nAnGap-12\nALT-10 AST-28 AlkPhos-145* TotBili-1.0\nLipase-29\ncTropnT-<0.01\nAlbumin-3.0* Calcium-8.5 Phos-2.8 Mg-1.9\nLactate-1.8\n\nNotable Labs:\n--------------\n___ 06:30AM BLOOD CK-MB-1 cTropnT-<0.01\n\nPeritoneal Fluid:\n-----------------\n___ 01:53PM ASCITES TNC-235* RBC-629* Polys-3* Lymphs-35* \n___ Macroph-62*\n___ 12:44PM ASCITES TNC-175* RBC-214* Polys-5* Lymphs-18* \nMonos-0 NRBC-1* Mesothe-10* Macroph-66* Other-0 TotPro-1.5 \nGlucose-137 LD(LDH)-41\n\nDISCHARGE LABS: ___ 05:56AM\n---------------\nWBC-5.4 RBC-2.97* Hgb-7.9* Hct-26.3* MCV-89 MCH-26.6 MCHC-30.0* \nRDW-18.2* RDWSD-59.3* Plt Ct-72*\n___ PTT-38.1* ___\nGlucose-142* UreaN-6 Creat-0.7 Na-138 K-4.0 Cl-103 HCO3-21* \nAnGap-14\nALT-9 AST-27 AlkPhos-105 TotBili-1.3\nAlbumin-3.3* Calcium-8.2* Phos-2.7 Mg-1.9\n\nMICRO:\n-------\n___ 12:44 pm PERITONEAL FLUID      PERITONEAL FLUID. \n\nGRAM STAIN (Final ___: 1+    (<1 per 1000X FIELD):   \nPOLYMORPHONUCLEAR LEUKOCYTES. NO MICROORGANISMS SEEN. \nThis is a concentrated smear made by cytospin method, please \nrefer to\nhematology for a quantitative white blood cell count.. \nFLUID CULTURE (Preliminary): NO GROWTH. \nANAEROBIC CULTURE (Preliminary): NO GROWTH. \n\nIMAGING:\n--------\nChest XRay: ___\nIMPRESSION: No acute cardiopulmonary process. \n\nAbdominal Ultrasound ___\nIMPRESSION: Cirrhotic liver with large volume ascites and \nsplenomegaly measuring 16.1 cm. \n\nAbdominal XRay ___\nIMPRESSION:  \n1.No free intraperitoneal air. \n2.No bowel obstruction.  Mild gaseous distention of the \nascending and \ntransverse colon. \n\n \nBrief Hospital Course:\nSummary:\n--------\n___ with PMHx EtOH/HCV cirrhosis (previously complicated by \nascites, varices, and hepatic encephalopathy), polysubstance \nabuse, and HTN who presented with abdominal distention and SOB \nfor ___ weeks. Her shortness of breath was felt to be due to \ntense ascites, as she had not been drained in over a month and \nhad \"pushed back\" some of her prior paracentesis appointments. \nPt underwent a large volume paracentesis on ___ for 8.2 \nliters, which she tolerated well. Tap negative for SBP. Pt with \nimproved abdominal pain and breathing after her paracentesis; as \nsuch, she was discharged with a plan for more regular outpatient \nparacenteses.\n\nACTIVE ISSUES:\n---------------\n# TENSE ASCITES causing\n# SHORTNESS OF BREATH and\n# ABDOMINAL PAIN: \nThe patient presented with clear chest xray on ___. Likely \netiology of symptoms was due to not having undergone \nparacentesis since ___. The patient was supposed to have \nregularly scheduled paracenteses after her previous hospital \nstay, but did not make her appointments. She underwent large \nvolume paracentesis with 8.2L removed on ___, with \nsignificant improvement in her abdominal pain and shortness of \nbreath. She does have some element of chronic abdominal pain, \nwhich on her last hospital stay was thought multifactorial in \nthe setting of ascites + constipation; she was given oxycodone \nin house, and one dose of IV morphine as well as an uptitrated \nbowel regimen, for pain control. She was sent home with her home \ntramadol. When she was discharged, she was walking without \nassistance. \n\n# POLYSUBSTANCE/ETOH ABUSE:\nPt still drinking alcohol, and reported using cocaine 1 week \nprior to arrival. Would likely benefit from continued social \nwork guidance as an outpatient for substance abstinence.\n\nCHRONIC/STABLE ISSUES:\n# ETOH/HCV CIRRHOSIS:\nGenotype 1a HCV, with Child's B cirrhosis. Her last EGD on \n___ showed 3 small varices, and she had previously been on \nnadolol (held since ___ given ___ during hospitalization). \nHer HCV viral load was 6 in ___.\n- Will need Harvoni in the future, when more medically stable, \nfor HCV radiation\n- VOLUME: Restarted Pt's home furosemide 20mg PO daily.\n- INFECTION: No evidence or history of SBP.\n- BLEEDING: Hx of small varices. Nadolol 10mg daily was \nrestarted. She noted that she was not cutting her 20mg tablets, \nand she was given a pill cutter to use at home. ___ uptitrate as \noutpatient.\n- ENCEPHALOPATHY: Home lactulose/rifaximin.\n- SCREENING: Last EGD in ___. Most recent RUQUS on ___ \nwithout obvious liver lesions.\n\n# COPD: \nHome albuterol, tiotropium, advair.\n\n# PRIMARY PREVENTION: \nHome aspirin\n\n# CHRONIC ABDOMINAL PAIN:\nGiven morphine and oxycodone in house. Discharged on home \ntramadol.\n\n# HTN: \nRestarting home nadolol at discharge at half dose (10mg daily). \nProvided the patient with a pill cutter\n\n# SEASONAL ALLERGIES: \nHome loratadine and Flonase.\n\n# HLD: \nHome simvastatin.\n\n# GERD: \nHome pantoprazole, Maalox.\n\nTRANSITIONAL ISSUES:\n #Code status: Full\n #Health care proxy/emergency contact: \n ___ \n Relationship: fiance \n Phone number: ___ \n\n[] MEDICATION CHANGES:\n- Added: Nadolol 10mg daily. ___ increase if blood pressure/HR \nallows, or discontinue if not well tolerated.\n\n[] FOLLOW-UP LABS:\n- Please obtain CBC, chem10, LFT's, ___, PTT, INR on ___. \nPlease fax results to Pt's PCP ___, fax ___ \nand the ___ (___).\n\n[] SERIAL PARACENTESES:\n- Please schedule patient for q1week to q2week paracenteses, so \nthat she does not get behind and have reaccumulation of ascites. \nShould have albumin given per liter removed.\n\n[] ABDOMINAL PAIN:\n- Consider chronic pain outpatient referral, given that she has \nh/o substance abuse and significant pain medication requirements \nwhile in-house.\n\n[] HCV TREATMENT:\n- Pt should receive Harvoni therapy for her genotype 1a HCV when \nmedically stable.\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 81 mg PO DAILY \n2. Docusate Sodium 100 mg PO BID \n3. Ferrous Sulfate 325 mg PO DAILY \n4. Fluticasone Propionate NASAL 1 SPRY NU BID \n5. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n6. FoLIC Acid 1 mg PO DAILY \n7. Lactulose 30 mL PO Q8H:PRN constipation \n8. Multivitamins W/minerals 1 TAB PO DAILY \n9. Pantoprazole 40 mg PO Q12H \n10. Tiotropium Bromide 1 CAP IH DAILY \n11. Rifaximin 550 mg PO BID \n12. Simvastatin 20 mg PO QPM \n13. Thiamine 100 mg PO DAILY \n14. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing \n15. Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID \n16. Furosemide 20 mg PO DAILY \n17. HydrOXYzine 25 mg PO BID:PRN itch \n18. Loratadine 10 mg PO DAILY:PRN allergies \n19. TraMADOL (Ultram) 50 mg PO Q6H:PRN pain \n20. Acetaminophen 1000 mg PO BID \n21. Maalox/Diphenhydramine/Lidocaine 15 mL PO QID \n22. Simethicone 40-80 mg PO QID \n23. Polyethylene Glycol 17 g PO DAILY \n\n \nDischarge Medications:\n1.  Nadolol 10 mg PO DAILY  \n2.  Loratadine 10 mg PO DAILY allergies  \n3.  Acetaminophen 1000 mg PO BID  \n4.  Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing  \n5.  Aspirin 81 mg PO DAILY  \n6.  Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID  \n7.  Docusate Sodium 100 mg PO BID  \n8.  Ferrous Sulfate 325 mg PO DAILY  \n9.  Fluticasone Propionate NASAL 1 SPRY NU BID  \n10.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  \n11.  FoLIC Acid 1 mg PO DAILY  \n12.  Furosemide 20 mg PO DAILY  \n13.  HydrOXYzine 25 mg PO BID:PRN itch  \n14.  Lactulose 30 mL PO Q8H:PRN constipation  \n15.  Maalox/Diphenhydramine/Lidocaine 15 mL PO QID  \n16.  Multivitamins W/minerals 1 TAB PO DAILY  \n17.  Pantoprazole 40 mg PO Q12H  \n18.  Polyethylene Glycol 17 g PO DAILY  \n19.  Rifaximin 550 mg PO BID  \n20.  Simethicone 40-80 mg PO QID  \n21.  Simvastatin 20 mg PO QPM  \n22.  Thiamine 100 mg PO DAILY  \n23.  Tiotropium Bromide 1 CAP IH DAILY  \n24.  TraMADOL (Ultram) 50 mg PO Q6H:PRN pain  \n25.Outpatient Lab Work\n___: CBC, chem10, LFT's, ___, PTT, INR Fax results to \n___, fax ___ and ___ \n(___). ICD 10: ___ Alcohol Cirrhosis with Ascites\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSES:\nTense ascites\nAbdominal pain\n\nSECONDARY DIAGNOSES:\nSubstance use disorder\nCOPD\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure caring for you at the ___ \n___.\n\nWHY WAS I SEEN IN THE HOSPITAL?\n- You were having worsening belly pain and swelling.\n\nWHAT HAPPENED WHILE I WAS IN THE HOSPITAL?\n- You had a large amount of fluid removed from your belly.  It \ndid not have any signs of infection.\n- You got medicines for your belly pain.\n\nWHAT SHOULD I DO WHEN I AM AT HOME?\n- Please adhere to a low salt diet.\n- Follow up with the ___ at the number listed \nbelow, to make an appointment with a regular liver doctor.\n- Please discuss having regular scheduled drainage appointments \nto be done as an outpatient.\n- Please do NOT drink alcohol or use other substances.\n\nWe wish you the best,\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753934301"
  },
  "note_id": "19644467-DS-32",
  "subject_id": 19644467,
  "hadm_id": 29269849,
  "note_type": "DS",
  "note_seq": 32,
  "charttime": "2202-05-22 00:00:00",
  "storetime": "2202-05-23 07:54:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril / mango / papaya\n \nAttending: ___\n \nChief Complaint:\nABD Distention, Dyspnea \n \nMajor Surgical or Invasive Procedure:\n___ diagnostic and therapeutic paracentesis 6.1L \n___ diagnostic and therapeutic paracentesis 2.5L\n___ therapeutic paracentesis 1.6L\n___ diagnostic and therapeutic paracentesis 2.5L\n\n \nHistory of Present Illness:\n___ year old female with HCV (genotype 1a) and EtOH cirrhosis\n(child's class B) c/b ascites, varices, and hepatic\nencephalopathy, current polysubstance abuse, COPD, HTN, and HLD\nwho presented with abdominal distention and SOB, referred by Dr.\n___ to ED for tense ascites and c/f SBP. \n\nPatient reports abdominal distension and pain for the past week,\nassociated with SOB and poor PO. This feels similar to past\nepisodes of reaccumulating ascites. No f/c. Had emesis x4 total\nin recent days, no hematemesis. She reports baseline mild dry\ncough and SOB with exertion due to her underlying COPD. She\nreports being compliant with her home medications and with a low\nsodium diet. Reports she is supposed to go for outpatient para\nevery week, but has not been able to keep up with the schedule\ndue to some miscommunication. \n\nOf note, she was recently admitted ___ with\nabdominal distension and SOB, found to have tense ascites, after\nmissing some routine para appointments outpatient. She received\nlarge volume paracentesis and was discharged with plan for \nq1week\nto q2week paracenteses. Since then, she has had paracentesis\n___ for 8.2L, ___ for 7L, ___ for 9L, ___ for 6.2L (in\nED visit). \n\n In the ED initial vitals:  97.2 , 58 , 123/61 , 17 , 100% RA \n\n - Exam notable for:  \nLungs are clear to auscultation bilaterally with no wheezes or\nrales. There are diminished breath sounds at the bases.\nThere is a regular heart rate no murmur\nAbdomen is tense and distended\n\n - Imaging notable for:  \nRUQ U/S: 1. Patent main portal vein. 2. Cirrhotic liver and\nlikely sequela of portal hypertension, including large amount of\nascites and splenomegaly.  No focal hepatic lesion. \nCXR: no acute process \n\n - Labs notable for: diagnostic paracentesis without e/o SBP.\nCBC, BMP, LFTs stable. \n\n - Patient was given:  \n___ 01:12 PO Pantoprazole 80 mg ___  \n___ 01:12 PO/NG Furosemide 40 mg ___  \n___ 01:12 PO/NG Lactulose 15 mL ___  \n___ 08:11 PO/NG Valsartan 320 mg ___  \n___ 08:11 PO/NG Rifaximin 550 mg ___  \n___ 08:11 PO/NG amLODIPine 5 mg ___  \n___ 08:11 PO/NG Lactulose 15 mL ___  \n___ 08:11 PO Loratadine 10 mg ___  \n___ 08:11 PO TraMADol 50 mg ___  \n___ 16:28 IH Fluticasone-Salmeterol Diskus (500/50) 1 INH\n___  \n___ 16:28 IH Tiotropium Bromide 1 CAP ___  \n___ 16:35 PO/NG Lactulose 15 mL ___ \n\n - Vitals prior to transfer: 97.8 , 64 , 90/52 , 18 , 99% RA \n\nOn the floor, she reports history as above. Sensation of\nabdominal fullness is improved now after receiving therapeutic\nparacentesis in the ED. Still has abdominal pain, though notes\nshe has chronic abdominal pain at baseline. Chronic pain is\ndiffuse, but current pain is sharp and centered around \nepigastric\nand periumbilical area. Reports PCP was planning to start lyrica\nto help with pain control. Denies h/o prior withdrawal. \n\n REVIEW OF SYSTEMS: \n10-point ROS is negative except as in HPI above. \n\n \nPast Medical History:\nHepatitis C cirrhosis- genotype 1a decompensated with h/o\nascites; liver biopsy in ___ showed stage ___ fibrosis\nHypertension\nHyperlipidemia\nCOPD\nAlcohol abuse\nDepression\nCocaine abuse\nTobacco abuse\nAtypical chest pain\nBreast pain\nAbdominal pain\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair\n \nSocial History:\n___\nFamily History:\nMom had DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather had alcoholism and rectal CA (COD).\nSister has mental illness, also hx of falls. \nSiblings: 1 brother neonatal death, 1 brother death at 3 months, \n\n1 brother sudden death in ___.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAMINATION:  \n VS:  97.6PO 104 / 65R Lying 64 18 97 RA  \n GENERAL:  chronically ill malnourished appearing woman in bed \nin\nNAD\n HEENT:  NC/AT, PERRL, tacky MM, OP clear\n NECK:  supple, no LAD\n CARDIAC:  RRR, no m/r/g\n PULMONARY:  CTAB, comfortable on RA\n ABDOMEN:  soft, distended, +BS, moderately tender to palpation\nthroughout, worst periumbilically \n GENITOURINARY: no foley \n EXTREMITIES:  thin, no ___\n SKIN:  no rashes noted \n NEUROLOGIC:  alert, oriented, mentating well, no asterixis, has\na fine tremor ?baseline. \n PSYCHIATRIC:  pleasant, calm, sad affect \n\nDISCHARGE PHYSICAL EXAMINATION:  \nVS: 98.0PO, 118 / 69L Sitting, 80, 18, 100 Ra  \nGENERAL: NAD \nHEENT:  NC/AT, dry MM, posterior OP with small white plaques \nNECK:  supple, no LAD\nCARDIAC:  RRR, no m/r/g\nPULMONARY:  CTAB, comfortable on RA \nABDOMEN:  soft, distended, +BS, mildly tender to palpation\nthroughout and worse at site of hernia. hernia superior to\numbilicus \nGENITOURINARY: no foley \nEXTREMITIES:  thin, no ___\nSKIN:  no rashes noted \nNEUROLOGIC:  alert, oriented, mentating well, no asterixis, has\na fine tremor \nPSYCHIATRIC:  pleasant, calm, sad affect \n \nPertinent Results:\nADMISSION LABS: \n===============\n___ 06:20PM BLOOD WBC-4.6 RBC-3.31* Hgb-8.4* Hct-28.0* \nMCV-85 MCH-25.4* MCHC-30.0* RDW-18.6* RDWSD-56.9* Plt ___\n___ 06:20PM BLOOD Neuts-74.2* Lymphs-12.7* Monos-10.8 \nEos-1.5 Baso-0.4 Im ___ AbsNeut-3.44 AbsLymp-0.59* \nAbsMono-0.50 AbsEos-0.07 AbsBaso-0.02\n___ 06:20PM BLOOD ___ PTT-35.3 ___\n___ 06:20PM BLOOD Glucose-91 UreaN-11 Creat-0.8 Na-140 \nK-4.4 Cl-105 HCO3-22 AnGap-13\n___ 06:20PM BLOOD ALT-12 AST-36 AlkPhos-130* TotBili-1.0\n___ 06:20PM BLOOD Albumin-3.3* Calcium-8.3* Phos-4.2 Mg-2.3 \nIron-38\n___ 06:20PM BLOOD calTIBC-335 Ferritn-19 TRF-258\n___ 06:20PM BLOOD TSH-4.1\n___ 06:20PM BLOOD Ethanol-NEG\n___ 05:27PM BLOOD HCV VL-6.1*\n___ 06:35PM BLOOD Lactate-1.7\n\nRELEVANT LABS: \n==============\n___ 06:40AM BLOOD calTIBC-244* Hapto-25* Ferritn-15 \nTRF-188*\n___ 06:20PM BLOOD calTIBC-335 Ferritn-19 TRF-258\n___ 05:58AM BLOOD %HbA1c-5.4 eAG-108\n___ 06:20PM BLOOD TSH-4.1\n___ 05:27PM BLOOD HCV VL-6.1*\n___ 05:27PM BLOOD HEPATITIS C VIRAL RNA, GENOTYPE-Test      \n\n___ 07:39AM ASCITES TNC-499* RBC-904* Polys-1* Lymphs-29* \n___ Macroph-69* Other-1*\n___ 07:39AM ASCITES TotPro-1.5 Glucose-200 Albumin-0.7\n\nMICROBIOLOGY: \n=============\n___ blood cx - prelim negative but cancelled \n___ urine cx negative \n___ peritoneal cx negative \n___ urine cx negative \n___ peritoneal cx - negative \n___ c diff negative \n___ peritoneal cx - pending \n\nSTUDIES: \n========\n\nCT ABD & PELVIS W/O CONTRAST Study Date of ___  \n1. Cirrhotic liver with splenomegaly and moderate to large \nvolume simple \nascites. \n2. No free intraperitoneal air or hemoperitoneum. \n3. Supraumbilical hernia containing mesenteric vessels, fat and \nascitic fluid. \n\nPORTABLE ABDOMEN Study Date of ___  \n1. Nonobstructive bowel gas pattern, with mild to moderate fecal \nloading noted \nwithin the ascending and descending colon. \n2. No evidence of gross pneumoperitoneum on supine abdominal \nradiograph.  \nHowever, assessment for free intraperitoneal air is limited on \nsupine \nradiographs. If there is clinical concern for pneumoperitoneum, \nconsider \nupright or left lateral decubitus radiograph, or cross-sectional \nimaging. \n\nLIVER OR GALLBLADDER US (SINGLE ORGAN) Study Date of ___  \n\n1. Patent main portal vein. \n2. Cirrhotic liver and likely sequela of portal hypertension, \nincluding large \namount of ascites and splenomegaly.  No focal hepatic lesion. \n\n CHEST (PA & LAT) Study Date of ___  \nNo acute cardiopulmonary abnormality.  Bullous emphysema.\n\nDISCHARGE LABS: \n===============\n___ 05:37AM BLOOD WBC-5.1 RBC-3.21* Hgb-8.5* Hct-28.0* \nMCV-87 MCH-26.5 MCHC-30.4* RDW-20.0* RDWSD-60.9* Plt Ct-81*\n___ 05:37AM BLOOD ___ PTT-39.2* ___\n___ 05:37AM BLOOD Glucose-221* UreaN-21* Creat-0.9 Na-132* \nK-5.2* Cl-98 HCO3-20* AnGap-14\n___ 05:37AM BLOOD ALT-31 AST-63* AlkPhos-154* TotBili-0.8\n___ 05:37AM BLOOD Albumin-3.3* Calcium-8.6 Phos-3.7 Mg-2.___ year old female with HCV (genotype 1a) and EtOH cirrhosis \n(Child class B) c/b ascites, varices, and hepatic \nencephalopathy, polysubstance abuse, COPD, HTN, and HLD who \npresented with abdominal distension due to decompensated \nascites, with paracentesis negative for SBP. Course complicated \nby hyperkalemia likely due to spironolactone effect. \n\nACTIVE ISSUES: \n\n# Abdominal distension \n# Abdominal pain \nPatient presented with abdominal distension and pain, due to \nlarge ascites, with paracentesis negative for SBP. Paracentesis \non admission removed 6.1L fluid. She continued to have baseline \nchronic abdominal pain this admission. Her home diuretic regimen \nwas uptitrated, from Lasix 20 to 40 daily. She was trialed on \nspironolactone, but became hyperkalemic as below, so \nspironolactone was discontinued. She received multiple \nparacenteses over the course of admission, with the most recent \non ___ with removal of 2.5 L of fluid (no albumin was given \nafter). An order was placed in OMR to have weekly outpatient \ntherapeutic paracenteses. \n\n# Hyperkalemia, improved\nPatient became hyperkalemic this admission to peak K 5.7. This \nwas likely due to spironolactone effect; K was WNL prior to \ninitiation of spironolactone. She did not have EKG changes. She \nreceived her PO Lasix and no other temporizing measures, and K \non day of discharge ___ was 5.2. Would be hesitant to give \nher spironolactone in the future, as she was very sensitive to \nhyperkalemic medication effect. \n\n# Acute on chronic anemia \nPatient with acute on chronic anemia, hgb dropping from 8.4 to \n5.5, with transient hypotension after her paracentesis. There \nwas concern for bleed, but CT A/P was negative. She was \ntransfused 2U pRBC with hgb bumping to 9.4. Hemolysis labs were \nnot convincing for hemolysis being the primary cause of her \nanemia. Given her stability, and lack of active bleeding with \nnegative stool guaiac x1, inpatient EGD was deferred. She will \nneed outpatient EGD scheduled. \n\nCHRONIC ISSUES: \n\n# Cirrhosis \nGenotype 1a HCV. Child's B cirrhosis. Complicated in the past by \nesophageal varices, ascites, HE.\n- HCV: Not treated. HCV VL 6.1 this admission. Will need \ntreatment in the future. \n- ASCITES: As above, this admission she received multiple \ntherapeutic paracenteses, with most recent paracentesis on \n___ with removal of 2.5 L of fluid. Lasix was uptitrated \nfrom 20 to 40 daily. She could not tolerate spironolactone due \nto hyperkalemia. An order was placed in ___ to have weekly \noutpatient therapeutic paracenteses. \n- SBP: No h/o SBP. No SBP on diagnostic para this admission.\n- BLEEDING: 3 small varices on last EGD ___. She had been on \nnadolol 10mg daily in the past but it was discontinued prior to \nadmission. \n- ENCEPHALOPATHY: h/o HE in past. Continued home \nlactulose/rifaximin.\n- ___ SCREENING: Last EGD in ___. Most recent RUQUS on \npresentation WNL. \n- NUTRITION: Encouraged adherence to low sodium diet. Nutrition \ndiscussed feeding tube with patient but she refused. \n\n# Polysubstance abuse \nPatient currently with ETOH and infrequent cocaine use. Remote \nIVDU. No history of withdrawal. ETOH neg, urine tox with \ncocaine. She was seen by social work this admission with social \nwork follow up outpatient. \n\n# Chronic pain \nPatient with significant chronic pain at baseline, managed by \nher PCP on home ___ and tramadol. She was started on lyrica \nthis admission, given that her PCP had been planning to do so as \nan outpatient. \n\n# HTN \nPatient on home valsartan and amlodipine. However BPs generally \nranged ___ this admission while antihypertensives \nwere held. Amlodipine and valsartan were held on discharge. \n\n# COPD: Continued home albuterol, tiotropium, advair.\n\n# PRIMARY PREVENTION: Continued home aspirin, statin. \n\n# ALLERGIES: Continued home loratadine and Flonase.\n\n# GERD: Continued home pantoprazole\n\nTRANSITIONAL ISSUES: \n- An order was placed in ___ for future date therapeutic \nparacentesis on ___. The radiology department is to call patient \nwith date and time. she will need this procedure weekly. INR <2, \nPLT >50. \n- Please obtain repeat BMP at next PCP office visit on ___ to \nensure K stability. Monitor renal function and titrate diuretics \naccordingly.\n- Caution with spironolactone in the future given sensitivity to \nhyperkalemia. \n- Started on lyrica for pain control this admission per \noutpatient plan from PCP. Please uptitrate as appropriate. \n- Needs outpatient EGD given question of bleed. \n- Will need eventual treatment of HCV. \n- Held antihypertensives amlodipine and valsartan on discharge, \ngiven SBPs generally ___ while off of antihypertensives this \nadmission. \n- Recommend to continue zinc supplement for total 14 days, given \nmalnutrition and hair loss (ending on ___. \n- Please continue to encourage sobriety from EtOH and drugs. \n- Of note, patient fingersticks were noted to range from 148 \nfasting to 352 post prandially. Hba1c 5.4% on admission. Please \nrecheck as outpatient glycemic control. \n\n# CODE: Presumed FULL \n# CONTACT: ___ \nRelationship: boyfriend \nPhone number: ___ \n \n___ on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 81 mg PO DAILY \n2. Fluticasone Propionate NASAL 1 SPRY NU BID \n3. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n4. Lactulose 30 mL PO Q8H:PRN constipation \n5. Multivitamins W/minerals 1 TAB PO DAILY \n6. Pantoprazole 40 mg PO Q12H \n7. Polyethylene Glycol 17 g PO DAILY \n8. Rifaximin 550 mg PO BID \n9. Simethicone 40-80 mg PO QID \n10. Simvastatin 20 mg PO QPM \n11. Thiamine 100 mg PO DAILY \n12. Tiotropium Bromide 1 CAP IH DAILY \n13. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing \n14. Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID \n15. HydrOXYzine 25 mg PO BID:PRN itch \n16. Loratadine 10 mg PO DAILY allergies \n17. TraMADOL (Ultram) 50 mg PO TID:PRN pain \n18. Furosemide 20 mg PO DAILY \n19. Ondansetron ODT 4 mg PO Q8H:PRN nausea \n20. TraZODone 50 mg PO QHS:PRN insomnia \n21. amLODIPine 5 mg PO DAILY \n22. Ferrous GLUCONATE 324 mg PO DAILY \n23. Valsartan 320 mg PO DAILY \n\n \nDischarge Medications:\n1.  FoLIC Acid 1 mg PO DAILY \nRX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet \nRefills:*0 \n2.  Nystatin Oral Suspension 5 mL PO QID \nRX *nystatin 100,000 unit/mL 5 mL by mouth four times per day as \nneed for thrush in mouth Disp #*1 Bottle Refills:*0 \n3.  Pregabalin 75 mg PO BID \nRX *pregabalin [Lyrica] 75 mg 1 capsule(s) by mouth twice a day \nDisp #*60 Capsule Refills:*0 \n4.  Zinc Sulfate 220 mg PO DAILY \nRX *zinc sulfate 220 mg (50 mg zinc) 1 capsule(s) by mouth daily \nDisp #*6 Capsule Refills:*0 \n5.  Furosemide 40 mg PO DAILY \nRX *furosemide 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet \nRefills:*0 \n6.  Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing  \n7.  Aspirin 81 mg PO DAILY  \n8.  Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID  \n9.  Ferrous GLUCONATE 324 mg PO DAILY  \n10.  Fluticasone Propionate NASAL 1 SPRY NU BID  \n11.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  \n12.  HydrOXYzine 25 mg PO BID:PRN itch  \n13.  Lactulose 30 mL PO TID  \n14.  Loratadine 10 mg PO DAILY allergies  \n15.  Multivitamins W/minerals 1 TAB PO DAILY  \n16.  Ondansetron ODT 4 mg PO Q8H:PRN nausea  \n17.  Pantoprazole 40 mg PO Q12H  \n18.  Polyethylene Glycol 17 g PO DAILY  \n19.  Rifaximin 550 mg PO BID  \n20.  Simethicone 40-80 mg PO QID  \n21.  Simvastatin 20 mg PO QPM  \n22.  Thiamine 100 mg PO DAILY  \n23.  Tiotropium Bromide 1 CAP IH DAILY  \n24.  TraMADOL (Ultram) 50 mg PO TID:PRN pain  \n25.  TraZODone 50 mg PO QHS:PRN insomnia  \n26. HELD- amLODIPine 5 mg PO DAILY  This medication was held. Do \nnot restart amLODIPine until your doctor tells you to. \n27. HELD- Valsartan 320 mg PO DAILY  This medication was held. \nDo not restart Valsartan until your doctor tells you to. \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS: \nAscites \nAlcoholic Cirrhosis\nHyperkalemia  \nAnemia \nSubstance abuse \n\nSECONDARY DIAGNOSIS: \nChronic pain \n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___, \n\nIt was a pleasure caring for you at ___ \n___. \n\nWHY WERE YOU ADMITTED? \n- Your abdomen was very distended with fluid.\n\nWHAT HAPPENED IN THE HOSPITAL? \n- You received paracentesis procedures to drain the large amount \nof fluid that had built up in your abdomen. \n- You had a brief episode of low blood pressure, and your blood \ncounts dropped, so we were worried about bleeding. You were \ngiven 2 blood transfusions. In the end, it did not look like you \nhad any active bleeding, and you were stable. \n- Your home diuretic medications (\"water pills\") were adjusted \nand increased, to help prevent you from reaccumulating fluid so \nfast. \n- Your potassium became elevated, which was likely because of a \nmedication effect. Your potassium returned to more normal levels \nby discharge. \n\nWHAT SHOULD YOU DO ON DISCHARGE? \n- Please follow up with your primary care doctor and liver \ndoctor as scheduled.\n- An order was placed for you to have weekly paracenteses to \ndrain the fluid from your abdomen.  The radiology department \nwill call you to schedule a date and time but tentatively for \nnext week ___.  \n- Please take your medications as instructed. \n- Please be sure to eat well, and to eat a low salt diet.\n- Please stay sober from drugs and alcohol and cigarettes.  If \nyou are sober, you may be a candidate for a liver transplant. \n\nWe wish you the best, \nYour ___ team \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753934302"
  },
  "note_id": "19644467-DS-33",
  "subject_id": 19644467,
  "hadm_id": 25183928,
  "note_type": "DS",
  "note_seq": 33,
  "charttime": "2202-06-13 00:00:00",
  "storetime": "2202-06-13 18:06:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril / mango / papaya\n \nAttending: ___\n \nChief Complaint:\nAbdominal Pain\n \nMajor Surgical or Invasive Procedure:\nBedside Paracentesis ___\n___ Paracentesis ___\n \nHistory of Present Illness:\n___ with HCV/EtOH cirrhosis and polysubstance misuse with\nmultiple admissions for volume overload and abdominal pain\npresents with abdominal pain since a outpatient therapeutic\nparacentisis on ___ which was uncomplicated and removed 2.5L. \n\nOn ___, the patient was seen in ___ clinic where she was\ncomplaining of increasing abdominal girth, tenderness and pain \non\npalpation by prior paracentesis site. She was referred to the\nemergency department to rule out SBP. \n\nThe patient endorses a 1 week history of general malaise, \nmyalgia\nand total body aches in addition to her abdominal pain. She has\noccasional faint, chest pain and stable dyspnea. She is without\npalpitations. She endorses mild dysuria which is her baseline \nand\nhas ___ loose bowel movements daily.\n\nIn the emergency department a bedside paracentesis was attempted\nwhich withdrew free air. Ascites fluid was negative for SBP.\nGiven free air on paracentesis and abdominal pain a CT \nabd/pelvis\nwas obtained to rule out perforation which demonstrated no\nperforation or acute process. \n\nThe patient continued to have abdominal pain requiring morphine\nfor symptomatic relief. \n\nHer emergency department course was subsequently complicated by\nhypotension requiring the administration of saline. \n\nIn the ED, initial VS were:\nT 98 HR 88 BP 148/71 R 16 SpO2 100% RA \n\nExam notable for:\nABD: impressively distended, caput medusa, tympanic to \npercussion\nuntil lower flanks bilaterally, periubmilical hernia\n\nECG: Not performed\n\nLabs showed:\n\n137  97  23    \n----------< \n3.5  21  0.9 \n\n    9.4  \n6.8>---<125  \n   30.2  \n\n___: 15.4  PTT: 37.7  INR: 1.4 \n\nALT: 83 AP: 226 Tbili: 1.6 Alb: 3.4 \nAST: 112 \n\nTSH:4.1\n\nAscites  WBC 268 RBC 1365  13% Poly\n\nLactate:1.8\n\nImaging showed:\n___ CT Abd & Pelvis W/O Contrast   \n1. Enteric contrast is seen diffusely throughout the loops of\nsmall bowel without evidence of extraluminal contrast\nextravasation. There is no free air.\n2. Cirrhosis with moderate to large volume ascites.\n3. Ill-defined hypodensity within the spleen is incompletely\ncharacterized on the current study, similar in appearance to the\nprior study.\n\n___ US Abd Limit, Single Organ   \n1. Moderate volume ascites, decreased compared to ___.\n2. The largest pocket is current located in the midline pelvis,\njust below the umbilicus. A slightly smaller pocket of fluid \nalso\nseen in the right lower quadrant.\n\nConsults: Hepatology agreed with admission to the hepatology\nservice\n\nPatient received:\n___ 19:03 IV Morphine Sulfate 4 mg   \n___ 19:03 IV Ondansetron 4 mg   \n___ 20:31 IV Morphine Sulfate 4 mg \n___ 23:57 IVF  NS   \n___ 00:00 PO Pantoprazole 40 mg   \n___ 02:45 IV Morphine Sulfate 2 mg   \n___ 02:54 PO/NG Lactulose 30 mL  \n___ 05:39 PO/NG Lactulose 30 mL   \n___ 06:06 IV Ondansetron 4 mg  \n___ 07:43 PO/NG Lactulose 30 mL   \n___ 07:58 PO Pantoprazole 40 mg  \n___ 07:58 PO/NG amLODIPine 5 mg \n___ 07:58 PO/NG Aspirin 81 mg   \n___ 07:58 PO/NG FoLIC Acid 1 mg \n___ 07:58 PO/NG Furosemide 20 mg   \n___ 08:34 PO/NG Pregabalin 75 mg \n___ 11:14 IH Fluticasone-Salmeterol Diskus (500/50) 1 INH \n\n___ 11:14 PO/NG Valsartan 320 mg   \n___ 11:14 PO/NG Rifaximin 550 mg   \n___ 12:59 IVF  NS  \n___ 13:13 IV Ondansetron 4 mg \n___ 14:43 IV Morphine Sulfate 2 mg \n___ 16:54 IV Morphine Sulfate 2 mg  \n___ 21:41 PO/NG Mirtazapine 30 mg \n___ 21:41 PO/NG Pregabalin 75 mg \n___ 21:42 PO/NG Lactulose 30 mL \n\nOn arrival to the floor, patient reports continued abdominal \npain\n\n \nPast Medical History:\nHepatitis C cirrhosis- genotype 1a decompensated with h/o\nascites; liver biopsy in ___ showed stage ___ fibrosis\nHypertension\nHyperlipidemia\nCOPD\nAlcohol abuse\nDepression\nCocaine abuse\nTobacco abuse\nAtypical chest pain\nBreast pain\nAbdominal pain\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair \n \nSocial History:\n___\nFamily History:\nMom had DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather had alcoholism and rectal CA (COD).\nSister has mental illness, also hx of falls. \nSiblings: 1 brother neonatal death, 1 brother death at 3 months, \n\n1 brother sudden death in ___.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\nVS:  T 98.5 PO BP 105/65 HR 95 R 18 SpO2 95 RA \nGEN: Chronically ill and fatigued. Noted sarcopenia and temporal\nwasting\nHEENT: Sclerae anicteric, no tongue asterixis. Dry mucous\nmembranes\n___: RRR II/IV SEM. JVP to angle of jaw at 45 degrees\nRESP: No increased WOB, bibasilar crackles without wheezing or\nrhonchi\nABD: Tense, distended with caput medusa. L sided ecchymosis with\nclean, dry bandage on right abdominal wall. +rebound\nEXT: warm, no edema\nNEURO: CN II-XII intact. +asterixis\n\nDISCHARGE PHYSICAL EXAM:\n24 HR Data (last updated ___ @ 855)\n    Temp: 98.6 (Tm 98.6), BP: 115/65 (113-144/49-78), HR: 90\n(82-98), RR: 18, O2 sat: 98% (93-100), O2 delivery: Ra, Wt:\n128.31 lb/58.2 kg  \n\nFluid Balance (last updated ___ @ 854) \n  Last 8 hours  Total cumulative -600ml\n    IN: Total 0ml\n    OUT:  Total 600ml, Urine Amt 600ml\n  Last 24 hours  Total cumulative -855ml\n    IN: Total 420ml, PO Amt 420ml\n    OUT:  Total 1275ml, Urine Amt 1275ml  \n\nGEN: Chronically ill and fatigued. Noted sarcopenia and temporal\nwasting.\nHEENT: Sclerae anicteric, no tongue asterixis. Dry mucous\nmembranes\nCV: NR,RR. II/VI SEM.\nRESP: No increased WOB, bibasilar crackles without wheezing or\nrhonchi\nABD: Tense, distended. Tender to mild palpation. L sided\necchymosis with clean, dry bandage on right abdominal wall.\n+rebound\nEXT: warm, no edema.\nNEURO: CN II-XII intact. +asterixis. Gross tremor of BUE.\nFinger-to-nose intact bilaterally. 2+ Patellar reflexes. ___\nStrength BLE.\n \nPertinent Results:\nADMISSION LABS\n==============\n___ 11:42AM BLOOD WBC-6.8 RBC-3.46* Hgb-9.4* Hct-30.2* \nMCV-87 MCH-27.2 MCHC-31.1* RDW-19.8* RDWSD-62.1* Plt ___\n___ 11:42AM BLOOD ___ PTT-37.7* ___\n___ 11:42AM BLOOD UreaN-23* Creat-0.9 Na-137 K-3.5 Cl-97 \nHCO3-21* AnGap-19*\n___ 11:42AM BLOOD ALT-83* AST-112* AlkPhos-226* \nTotBili-1.6*\n___ 01:45AM BLOOD Albumin-3.1* Calcium-8.5 Phos-4.6* Mg-2.2\n___ 11:42AM BLOOD %HbA1c-6.3* eAG-134*\n___ 11:42AM BLOOD TSH-4.1\n___ 11:42AM BLOOD AFP-7.4\n___ 11:42AM BLOOD HCV VL-5.9*\n\nDISCHARGE LABS\n==============\n___ 06:45AM BLOOD WBC-4.5 RBC-2.91* Hgb-8.1* Hct-25.9* \nMCV-89 MCH-27.8 MCHC-31.3* RDW-21.4* RDWSD-65.5* Plt Ct-61*\n___ 06:45AM BLOOD ___\n___ 06:45AM BLOOD Glucose-170* UreaN-16 Creat-0.9 Na-138 \nK-4.6 Cl-103 HCO3-20* AnGap-15\n___ 06:45AM BLOOD ALT-34 AST-48* LD(LDH)-212 AlkPhos-156* \nTotBili-0.7\n___ 06:45AM BLOOD Calcium-9.0 Phos-3.0 Mg-2.4\n\nURINE\n=====\n___ 10:45PM URINE Color-Yellow Appear-Hazy* Sp ___\n___ 10:45PM URINE Blood-NEG Nitrite-NEG Protein-TR* \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-MOD*\n___ 10:45PM URINE RBC-3* WBC-9* Bacteri-MOD* Yeast-NONE \nEpi-26 TransE-<1\n___ 10:26AM URINE Color-Yellow Appear-Hazy* Sp ___\n___ 10:26AM URINE Blood-MOD* Nitrite-NEG Protein-30* \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-LG*\n___ 10:26AM URINE RBC-118* WBC-153* Bacteri-MOD* Yeast-NONE \nEpi-0\n___ 10:26AM URINE CastHy-42*\n\nSTUDIES\n=======\n___ US ABD\n1.  Moderate volume ascites, decreased compared to ___. \n2.  The largest pocket is currently located in the midline \npelvis, just below the umbilicus.  A slightly smaller pocket of \nfluid also seen in the right lower quadrant. \n\n___ CT A/P\n1. Enteric contrast is seen diffusely throughout the loops of \nsmall bowel \nwithout evidence of extraluminal contrast extravasation.  There \nis no free \nair. \n2. Cirrhosis with moderate to large volume ascites. \n3. Ill-defined hypodensity within the spleen is incompletely \ncharacterized on the current study, similar in appearance to the \nprior study and likely an infarct. \n\n___ KUB\nNo free intraperitoneal air.  No radiographic evidence of bowel \nobstruction or ileus. \n\n___ US Paracentesis\n1. Technically successful ultrasound guided therapeutic \nparacentesis. \n2. 3.4 L of fluid were removed. \n\n___ ABI\n1.  Mild right lower extremity (SFA) and tibia arterial \ninsufficiency at rest. \n2.  Moderate aorto-left iliac and left tibial arterial \ninsufficiency at rest. \n\n___ Hip XR\nMild degenerative changes in the bilateral hip joints. \n\n___ MRI Thoracic/Lumbar\n1. There is no high-grade spinal canal or neural foraminal \nnarrowing of the thoracic or lumbar spine.  No compression of \nthe cord or cauda equina. \n2. Degenerative changes are most prominent at L5-S1 where a \nright eccentric disc bulge crowds the right greater than left \nsubarticular zone contacting but not posteriorly displacing the \ntraversing right S1 nerve root. \n3. There is 9 mm long segment of T2 hyperintense central cord \nsignal at the T1 level on sagittal sequences, not seen on prior \nexaminations and not confirmed on motion degraded axial \nsequences.  This could represent syringohydromyelia or prominent \ncentral canal of uncertain clinical significance.  This could be \nfurther evaluated with contrast enhanced study. \n4. Additional findings described above including sequela of \nknown cirrhosis. \n\n \nBrief Hospital Course:\nMs. ___ is a ___ year-old lady with HCV/EtOH cirrhosis \nwho presented with abdominal pain after elective paracentesis, \ndeveloped transient urinary retention, and continued to have \nchronic pain.\n\n# Decompensated HCV/EtOH Cirrhosis\n# Hepatic encephalopathy\nKnown history of grade 1 varices, ascites and hepatic \nencephalopathy. No h/o SBP or GIB. Sent from Liver clinic to ED \nafter c/o abdominal pain 1 week after therapeutic paracentesis. \nMild asterixis and volume overload noted. Flu negative. Reported \nlast alcohol 1 month ago. Liver U/S with patent vasculature. \nDiagnostic bedside paracentesis performed, negative for SBP. \nContinued on rifaximin, lactulose. Therapeutic paracentesis \nperformed with 3L removed. Given albumin 25g x1, then 50g x2. \nAttempted repeat paracentesis, but insufficient fluid to \nsuccessfully drain. Held home furosemide/spironolactone.\n\n# Abdominal Pain\n# Chronic Pain\n# Polysubstance misuse disorder\nHistory of chronic pain. On tramadol, pregabalin, and APAP at \nhome. Last underwent paracentesis ___ and complained of \nabdominal pain afterwards. Multiple similar admission. Over the \ncourse of the admission, with further discussion it seems the \npain is severe, but longstanding. Notes \"bone pain\" throughout, \nR hip locking, mandible pain, and abdominal pain. Also notes \npain/odd sensation with urination and defection which she \nreports has been present since before the admission. Consulted \ndental and obtained panorex which showed no infection. Consulted \nchronic pain and trialed cyclobenzaprine and baclofen, however \nboth were discontinued due to urinary retention. Continued on \ntramadol, tylenol, pregabalin, and lidocaine patch. At time of \ndischarge, pain at baseline from prior to admission.\n\n# Urinary Retention\nNoted new inability to urinate with high bladder scans. Foley \ncatheter placed after several straight cath attempts. Also \ncomplained of new fecal incontinence to RN and thigh numbness. \nSensation intact on exam and rectal tone present, but obtained \nMRI spine which showed no signs of cord compression. Stopped \ncyclobenzaprine, Dilaudid, loratidine, baclofen. Urology \nconsulted and recommended home w/ foley for ___ days, but then \nshe briefly was able to void on her own. Retention presumed ___ \nmed effect from cyclobenzaprine and/or baclofen but also may be \na component of neurogenic bladder given neuropathy elsewhere. \nRepeat retention on day of discharge. ___ placed to remain in \nwith urology follow-up.\n\n# Acute Kidney Injury\nBaseline Cr 0.7-0.8. Admission Cr 1.1 likely representing \nsignificant decrease in GFR due to patient's size and lack of \nmuscle mass. No hyponatremia or hydronephrosis. Cr peaked at \n1.4, then improved s/p 2 day of 1mg/kg albumin. Held home \nfurosemide.\n\n# T2 Hyperintense Signal\n9mm segment of T2 hyperintensity noted in the central cord at \nthe T1 level on Thoracic MRI, not seen on previous exams and not \nconfirmed on axial sequences. Could be syringohydromyelia or \nprominent central canal; unclear clinical significance. No \nnotable dermatomal sensory or strength deficits. Deferred \nfurther evaluation, which could be done with a contrast-enhanced \nMRI.\n\nCHRONIC ISSUES\n==============\n# Severe Protein Malnutrition\nPatient with temporal wasting and sarcopenia on exam with \nreported decreased PO intake. Nutrition consulted. Provided \nsupplements with meals.\n\n# Anemia\nStable, without signs of active bleeding.\n\n# Thrombocytopenia\n# Coagulopathy\nDue to underlying cirrhosis. At baseline.\n\n# h/o HTN\nLosartan and amlodipine held on last admission for soft blood\npressures. BPs not elevated. Held antihypertensives\n\n# COPD\nStable. Continued home inhalers.\n\n# GERD\nContinued home PPI.\n\nTRANSITIONAL ISSUES\n===================\n[ ] Consider MRI T Spine with contrast to evaluate signal \nabnormality of unclear clinical significance noted on MRI.\n[ ] Should follow up with urology given persistent urinary \nretention.\n[ ] Developed acute urinary retention in setting of \ncyclobenzaprine and baclofen use. Should avoid using these \nmedications in the future.\n[ ] If persistent mandibular pain, consider dental appointment \nand adjustment of dentures.\n[ ] Volume overloaded, but unable to perform paracentesis \ninpatient. Likely will need short-interval paracentesis.\n[ ] Held diuretics on discharge due to rising creatinine every \ntime attempted to restart diuretics. Assess at f/u appointment \nand restart if indicated.\n[ ] Discharged with foley in place and urology follow-up for \nretention. Foley placed ___.\n\n#CODE: Full \n#CONTACT: Fiance, ___ (___)\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing \n2. Aspirin 81 mg PO DAILY \n3. Fluticasone Propionate NASAL 1 SPRY NU BID \n4. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n5. HydrOXYzine 25 mg PO BID:PRN itch \n6. Loratadine 10 mg PO DAILY allergies \n7. Multivitamins W/minerals 1 TAB PO DAILY \n8. Ondansetron ODT 4 mg PO Q8H:PRN nausea \n9. Pantoprazole 40 mg PO Q12H \n10. Polyethylene Glycol 17 g PO DAILY \n11. Rifaximin 550 mg PO BID \n12. Simethicone 40-80 mg PO QID \n13. Simvastatin 20 mg PO QPM \n14. Thiamine 100 mg PO DAILY \n15. Tiotropium Bromide 1 CAP IH DAILY \n16. TraMADOL (Ultram) 50 mg PO TID:PRN pain \n17. Ferrous GLUCONATE 324 mg PO DAILY \n18. TraZODone 50 mg PO QHS:PRN insomnia \n19. Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID \n20. Pregabalin 75 mg PO BID \n21. FoLIC Acid 1 mg PO DAILY \n22. Zinc Sulfate 220 mg PO DAILY \n23. Lactulose 30 mL PO TID \n24. Nystatin Oral Suspension 5 mL PO QID \n25. Furosemide 40 mg PO DAILY \n\n \nDischarge Medications:\n1.  Acetaminophen 650 mg PO Q8H  \n2.  Zinc Sulfate 220 mg PO DAILY  \n3.  Pregabalin 150 mg PO BID  \n4.  Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing  \n5.  Aspirin 81 mg PO DAILY  \n6.  Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID  \n7.  Ferrous GLUCONATE 324 mg PO DAILY  \n8.  Fluticasone Propionate NASAL 1 SPRY NU BID  \n9.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  \n10.  FoLIC Acid 1 mg PO DAILY  \n11.  HydrOXYzine 25 mg PO BID:PRN itch  \n12.  Lactulose 30 mL PO TID  \n13.  Multivitamins W/minerals 1 TAB PO DAILY  \n14.  Nystatin Oral Suspension 5 mL PO QID  \n15.  Pantoprazole 40 mg PO Q12H  \n16.  Polyethylene Glycol 17 g PO DAILY  \n17.  Rifaximin 550 mg PO BID  \n18.  Simethicone 40-80 mg PO QID  \n19.  Simvastatin 20 mg PO QPM  \n20.  Thiamine 100 mg PO DAILY  \n21.  Tiotropium Bromide 1 CAP IH DAILY  \n22.  TraMADOL (Ultram) 50 mg PO TID:PRN pain  \n23.  TraZODone 50 mg PO QHS:PRN insomnia  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSES\n=================\nDecompensated Hepatitis C/Alcohol Cirrhosis\nVolume Overload\nHepatic Encephalopathy\n\nSECONDARY DIAGNOSES\n===================\nClaudication\nUrinary Retention\nChronic Pain\nAcute Kidney Injury\nSevere Protein Malnutrition\nAnemia\nThrombocytopenia\nChronic Obstructive Pulmonary Disease\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure caring for you at ___.\n\nWHY WAS I IN THE HOSPITAL?\n- You were having increased abdominal pain.\n\nWHAT HAPPENED TO ME IN THE HOSPITAL?\n- We looked at the fluid in your abdomen and saw that you did \nnot have an infection.\n- We drained some fluid, but were unable to drain it a second \ntime.\n- We got x-rays of your hips which showed arthritis.\n- We got x-rays of your jaw and had the dentist see you and they \nsaid there was no infection.\n- We got an MRI of your back because you were having difficulty \npeeing and it showed no compression of your spinal cord.\n- We had to place a urinary drainage catheter as you were unable \nto reliably empty your bladder, if you should start having any \nnew symptoms or if the catheter is not functioning please \ncontact urology or come to the emergency room. \n\nWHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?\n- Continue to take all your medicines and keep your \nappointments.\n\nWe wish you the best!\n\nSincerely,\nYour ___ Team\n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753934303"
  },
  "note_id": "19644467-DS-34",
  "subject_id": 19644467,
  "hadm_id": 29908746,
  "note_type": "DS",
  "note_seq": 34,
  "charttime": "2202-06-21 00:00:00",
  "storetime": "2202-06-23 09:10:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril / mango / papaya\n \nAttending: ___\n \nChief Complaint:\nAbdominal distension\n \nMajor Surgical or Invasive Procedure:\nTherapeutic Paracentesis (___)\nDiagnostic Paracentesis (___)\n\n \nHistory of Present Illness:\nMs. ___ is a ___ with PMHx notable for HCV (genotype 1a) and\nEtOH cirrhosis (child's class B) c/b ascites, varices, and\nhepatic\nencephalopathy, hx polysubstance abuse, COPD, HTN, and HLD\nwho presented with abdominal distention. Referred in from PCP\n___ ___ when she reported abdominal pain and bloating above\nbaseline with associated low appetite, dyspnea especially when\nlaying supine.  She reported worsening in symptoms over past 2\ndays.  \n\nOf note, Ms. ___ has a recent admission at ___ from ___\nwith abdominal pain, urinary retention, ___. Discharged off of\ndiuretics given recurrent ___ with diuretic challenge. Last\nparacentesis ___ with 3L removed. Last admission had urinary\nretention and was discharged with foley & underwent successful\noutpatient voiding trial ___ with Urology.  Since last\nparacentesis ___, pt has felt increasing abdominal distension.\nHad been planned for outpatient para on ___. Also reports\nabdominal distension leading to SOB. She feels uncertain about\nwhat medications she is supposed to be on, due to recent \nchanges,\nand is currently only taking her \"breathing medications\", not\ntaking lactulose or rifaximin. \n  \nIn the ED, initial VS were:  98.5 88 146/66 18 99% RA \nExam notable for:  abd tense and distended, mildly tender to\npalpation throughout, no ___, alert and oriented, +tremor but no\nasterixis \nLabs notable for: Hgb of 10 (up from baseline of ___, plts 86.\nINR 1.5. Bicarb 18 (down from 20), Cr .8 (at baseline). Ascites\nwith TNC of 161 with 2.5kof RBCs. 10% polys. \nImaging showed:  \nRUQUS w/ Doppler:\n1. Cirrhotic liver, without evidence of focal lesion.  Main\nportal vein is patent with hepatopetal flow. \n2. Moderate volume ascites. \n3. Stable moderate splenomegaly. \n\nConsults:  Hepatology was onsulted and recommended infectious\nworkup and admission to ET service. \n\nPatient received:  Pregabalin, morphine IV, Lactulsoe, \nrifaximin,\nsimvastatin, fluticasone/salmeterol, and pantoprazole. \nTransfer VS were: 98.5 82 150/81 16 98% RA \n \nOn arrival to the floor, patient reports reacummulating ascites\nsince last discharge.  Her belly is so large that it is causing\nher dyspnea and a lot of pain.  Nothing helps her abdominal pain\nor chronic pain in general so she stopped taking her lyrica,\nTylenol, and tramadol.  Denies fevers, chills, dysuria, nausea,\nvomiting, diarrhea, chest pain, cough.  She has been sober from\nEtOH and drugs since ___.  Her goal is to \"live to get \na\nliver.\"  Also stopped tobacco ___. \n \nREVIEW OF SYSTEMS: 10 point ROS reviewed and negative except as\nper HPI  \n \nPast Medical History:\nHepatitis C cirrhosis- genotype 1a decompensated with h/o\nascites; liver biopsy in ___ showed stage ___ fibrosis\nHypertension\nHyperlipidemia\nCOPD\nAlcohol abuse\nDepression\nCocaine abuse\nTobacco abuse\nAtypical chest pain\nBreast pain\nAbdominal pain\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair \n \nSocial History:\n___\nFamily History:\nMom had DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather had alcoholism and rectal CA (COD).\nSister has mental illness, also hx of falls. \nSiblings: 1 brother neonatal death, 1 brother death at 3 months, \n\n1 brother sudden death in ___.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM\n======================\nVS:  98.1 153 / 80 85 20 99 RA \nGEN: Chronically ill and fatigued female, temoral muscle \nwasting,\nalert and oriented  \nHEENT: Sclerae anicteric, DMM\n___: RRR II/IV SEM, no JVD\nRESP: mild increasing WOB, has bibasilar crackles without\nwheezing or\nrhonchi\nABD: Tense, distended with caput medusa, tender diffusely \nEXT: WWP no ___\nNEURO: CN II-XII intact, MAE spontaneously, no asterixis\n\nDISCHARGE PHYSICAL EXAM\n======================\nVS: ___ 1139 BP: 136/60 RR: 22 O2 sat: 96% Pain Score: ___ \n\nGEN: Chronically ill and fatigued female, temporal muscle\nwasting, alert and oriented  \nHEENT: Sclerae anicteric, DMM\n___: RRR II/IV SEM, no JVD\nRESP: mild increasing WOB, has bibasilar crackles without\nwheezing or rhonchi\nABD: Tense, distended with caput medusa, tender diffusely \nEXT: WWP no ___\nNEURO: no asterixis \n \nPertinent Results:\nADMISSION LABS\n=============\n___ 12:33PM BLOOD WBC-6.2 RBC-3.51* Hgb-10.0* Hct-32.9* \nMCV-94 MCH-28.5 MCHC-30.4* RDW-22.5* RDWSD-76.3* Plt Ct-86*\n___ 12:33PM BLOOD Neuts-83.7* Lymphs-8.2* Monos-6.8 \nEos-0.5* Baso-0.3 Im ___ AbsNeut-5.18 AbsLymp-0.51* \nAbsMono-0.42 AbsEos-0.03* AbsBaso-0.02\n___ 12:33PM BLOOD ___ PTT-37.5* ___\n___ 12:33PM BLOOD Glucose-138* UreaN-13 Creat-0.8 Na-136 \nK-4.7 Cl-104 HCO3-18* AnGap-14\n___ 12:33PM BLOOD ALT-26 AST-71* AlkPhos-196* TotBili-1.7*\n___ 12:33PM BLOOD Albumin-3.6\n___ 12:33PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nTricycl-NEG\n___ 12:53PM BLOOD Lactate-2.2*\n___ 03:53PM URINE Color-Amber* Appear-Hazy* Sp ___\n___ 03:53PM URINE Blood-NEG Nitrite-NEG Protein-30* \nGlucose-NEG Ketone-NEG Bilirub-SM* Urobiln-NEG pH-6.0 Leuks-SM*\n___ 03:53PM URINE RBC-3* WBC-9* Bacteri-FEW* Yeast-NONE \nEpi-7\n___ 03:53PM URINE bnzodzp-NEG barbitr-NEG opiates-POS* \ncocaine-NEG amphetm-NEG oxycodn-NEG mthdone-NEG\n___ 05:30PM ASCITES TNC-161* RBC-2578* Polys-10* Lymphs-20* \n___ Mesothe-2* Macroph-68*\n___ 05:30PM ASCITES TotPro-1.2 Glucose-141\n\nMICROBIOLOGY\n============\n___ 5:30 pm PERITONEAL FLUID      PERITONEAL FLUID. \n\n   GRAM STAIN (Final ___: \n      2+   ___ per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      NO MICROORGANISMS SEEN. \n      This is a concentrated smear made by cytospin method, \nplease refer to\n      hematology for a quantitative white blood cell count.. \n\n   FLUID CULTURE (Preliminary):    NO GROWTH. \n\n   ANAEROBIC CULTURE (Preliminary): \n\n___ 3:53 pm URINE\n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \nWITH SKIN\n      AND/OR GENITAL CONTAMINATION. \n\n___ 12:33 pm BLOOD CULTURE\n\n   Blood Culture, Routine (Pending): \n\nIMAGING\n=======\nDUPLEX ULTRASOUND ___: \n1. Cirrhotic liver, without evidence of focal lesion.  Main \nportal vein is\npatent with hepatopetal flow.\n2. Moderate volume ascites.\n3. Stable moderate splenomegaly.\n\nDISCHARGE/INTERVAL LABS\n======================\n___ 07:09AM BLOOD WBC-5.8 RBC-3.32* Hgb-9.4* Hct-31.4* \nMCV-95 MCH-28.3 MCHC-29.9* RDW-22.3* RDWSD-76.0* Plt Ct-70*\n___ 07:09AM BLOOD ___ PTT-37.5* ___\n___ 07:09AM BLOOD Glucose-135* UreaN-12 Creat-0.7 Na-138 \nK-4.4 Cl-105 HCO3-20* AnGap-13\n___ 07:09AM BLOOD ALT-22 AST-42* LD(LDH)-249 AlkPhos-190* \nTotBili-1.4\n___ 07:09AM BLOOD Calcium-8.7 Phos-3.1 Mg-2.1\n \nBrief Hospital Course:\nMs. ___ is a ___ with PMHx notable for HCV (genotype 1a) and \nEtOH cirrhosis (child's class B) c/b ascites, varices, and \nhepatic encephalopathy, hx polysubstance abuse, COPD, HTN, and \nHLD who presented with abdominal distention secondary to \nre-accumulating ascites. \n\n# Abdominal Distension\n# HCV/ETOH Cirrhosis. Childs Class B. Admission MELD 14. \nDecompensated by ascites, varices, HE. No history of SBP or GI \nbleeding. Patient presents with increasing abdominal \ndistension/bloating likely secondary to reaccumulating ascites. \nDiuretics were stopped on recent admission given recurrent acute \nkidney injury. Last therapeutic paracentesis prior to this \nadmission was on ___ with 3L fluid removed. Diagnostic \nparacentesis in the ED without evidence to suggest SBP. RUQ \nultrasound without PVT. No obvious GI blood losses with stable \nH/H during hospitalization. Therapeutic paracentesis was \nperformed prior to discharge with 6L fluid removed. Diuretics \nwere not started given history of recurrent ___ on diuretics. \nShe will likely need bi-weekly paracentesis and she has been \nadvised to keep her paracentesis appointment on ___. \n\nTRANSITIONAL ISSUES\n====================\n[] Labs pending at time of discharge: blood, urine, peritoneal \ncultures\n[] Likely needs bi-weekly therapeutic paracentesis. Patient has \nbeen advised to keep her paracentesis appointment on ___\n[] Did not trial diuretics on patient given recurrent ___ in \npast\n[] HCV: Not treated, HCV VL 6.1 ___. Will need treatment in \nthe future.\n[] SBP: No history of SBP, no SBP on diagnostic paracentesis in \nED.\n[] Last EGD ___, 3 cords of small varices were seen in the \nlower esophagus. No history of GI bleeding. Not on home \nnaldolol.\n[] HE: History of HE in past. Continue home lactulose and \nrifaxmin, titrate 3BMs per day\n[] Consider MRI T Spine with contrast to evaluate signal \nabnormality of unclear clinical significance noted on MRI from \n___\n[] On prior hospitalizations, has developed acute urinary \nretention in setting of cyclobenzaprine and baclofen use. Should \navoid using these medications in the future.\n[] If persistent mandibular pain, consider dental appointment \nand adjustment of dentures.\n#CODE: Full \n#CONTACT: Fiance, ___ (___)\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 81 mg PO DAILY \n2. Fluticasone Propionate NASAL 1 SPRY NU BID \n3. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n4. FoLIC Acid 1 mg PO DAILY \n5. Lactulose 30 mL PO TID \n6. Multivitamins W/minerals 1 TAB PO DAILY \n7. Nystatin Oral Suspension 5 mL PO QID \n8. Pantoprazole 40 mg PO Q12H \n9. Rifaximin 550 mg PO BID \n10. Simethicone 40-80 mg PO QID \n11. Simvastatin 20 mg PO QPM \n12. Thiamine 100 mg PO DAILY \n13. Tiotropium Bromide 1 CAP IH DAILY \n14. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing \n15. Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID \n16. HydrOXYzine 25 mg PO BID:PRN itch \n\n \nDischarge Medications:\n1.  Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing  \n2.  Aspirin 81 mg PO DAILY  \n3.  Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID  \n4.  Fluticasone Propionate NASAL 1 SPRY NU BID  \n5.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  \n6.  FoLIC Acid 1 mg PO DAILY  \n7.  HydrOXYzine 25 mg PO BID:PRN itch  \n8.  Lactulose 30 mL PO TID  \n9.  Multivitamins W/minerals 1 TAB PO DAILY  \n10.  Nystatin Oral Suspension 5 mL PO QID  \n11.  Pantoprazole 40 mg PO Q12H  \n12.  Rifaximin 550 mg PO BID  \n13.  Simethicone 40-80 mg PO QID  \n14.  Simvastatin 20 mg PO QPM  \n15.  Thiamine 100 mg PO DAILY  \n16.  Tiotropium Bromide 1 CAP IH DAILY  \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS\n==================\nAscites\n\nSECONDARY DIAGNOSES\n====================\nDecompensated Hepatitis C/Alcohol Cirrhosis\nVolume Overload\nChronic Pain\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to ___ after experiencing increasing girth \nin your abdomen. This is likely a result of reaccumulation of \nfluid in your abdomen. Your kidneys have not been able to \ntolerate the medications that prevent this fluid from \nre-accumulating. Your blood, urine, and abdominal fluid were \ntested for infection and thus far we do not have concern for an \ninfection.\n\nYou will likely require a paracentesis twice per week as you \nmove forward. We have drained your abdomen of 6L of fluid and \nyour discomfort has improved. It is important that you keep your \nparacentesis appointment on ___. You should also see \nyour PCP ___ 5 days.\n\nPlease take your medications as prescribed.\n\nIt was a pleasure taking care of you!\n\nWe wish you the best!\n\nYour ___ Team \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753934304"
  },
  "note_id": "19644467-DS-35",
  "subject_id": 19644467,
  "hadm_id": 23290728,
  "note_type": "DS",
  "note_seq": 35,
  "charttime": "2202-07-02 00:00:00",
  "storetime": "2202-07-03 08:10:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril / mango / papaya\n \nAttending: ___\n \nChief Complaint:\n___\n \nMajor Surgical or Invasive Procedure:\nNone\n\n \nHistory of Present Illness:\nHISTORY OF PRESENT ILLNESS:  \n Ms ___ is a ___ female with HCV (genotype 1a) and \nEtOH cirrhosis (child's class B) c/b ascites, esophageal \nvarices, and hepatic encephalopathy, hx polysubstance abuse, \nCOPD, HTN, and HLD presenting with complaint of abdominal \ndistention, abnormal labs.  \n Over the past several days to weeks she has had ongoing \nworsening diffuse abdominal pain, distention. Yesterday she had \nan outpatient paracentesis in which 2.45 L fluid was removed, \nalso had surveillance labs that were notable for an elevated \ncreatinine of 1.4 (baseline 0.7). She was contacted by phone and \nadvised to present to the emergency department for admission.  \n Of note, recent admissions to ___ ___ with abdominal \npain, urinary retention, ___. Discharged off of diuretics given \nrecurrent ___ with diuretic challenge. Additional admission \n___ with abdominal distention secondary to re-accumulating \nascites, underwent therapeutic paracentesis with 6L fluid \nremoved. Diuretics not \n \nPast Medical History:\nHepatitis C cirrhosis- genotype 1a decompensated with h/o\nascites; liver biopsy in ___ showed stage ___ fibrosis\nHypertension\nHyperlipidemia\nCOPD\nAlcohol abuse\nDepression\nCocaine abuse\nTobacco abuse\nAtypical chest pain\nBreast pain\nAbdominal pain\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair \n \nSocial History:\n___\nFamily History:\nMom had DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather had alcoholism and rectal CA (COD).\nSister has mental illness, also hx of falls. \nSiblings: 1 brother neonatal death, 1 brother death at 3 months, \n\n1 brother sudden death in ___.\n \nPhysical Exam:\nAdmission Physical Exams:\nGENERAL: AOx3, NAD  \nHEENT: Normocephalic, atraumatic. Pupils equal, round, and \nreactive bilaterally, extraocular muscles intact. Sclera \nanicteric.  \nCARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No \nmurmurs/rubs/gallops. No JVD.  \nLUNGS: Decreased breath sounds in both bases b/l  \nABDOMEN: NABS, distended, periumbilical hernia present, pain \nwith palpation of the hernia and pain with palpation of the R \nflank, no rebound or guarding. Hernia reducible.  \nEXTREMITIES: Warm, well perfused. No ___ edema.  \nNEUROLOGIC: Mild asterixis \n\nDischarge Exam:\nGENERAL: AOx3, NAD  \nHEENT: Normocephalic, atraumatic. Pupils equal, round, and \nreactive bilaterally, extraocular muscles intact. Sclera \nanicteric.  \nCARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No \nmurmurs/rubs/gallops. No JVD.  \nLUNGS: Decreased breath sounds in both bases b/l  \nABDOMEN: NABS, distended, periumbilical hernia present, pain \nwith palpation of the hernia and pain with palpation of the R \nflank, no rebound or guarding. Hernia reducible. \nEXTREMITIES: Warm, well perfused. No ___ edema.  \nNEUROLOGIC: Mild asterixis  \n \n\n \nPertinent Results:\nAdmission Labs:\n===============\n___ 07:15AM BLOOD WBC-4.6 RBC-3.35* Hgb-9.4* Hct-30.9* \nMCV-92 MCH-28.1 MCHC-30.4* RDW-20.6* RDWSD-69.1* Plt ___\n___ 01:16PM BLOOD Neuts-73.9* Lymphs-14.5* Monos-9.6 \nEos-1.1 Baso-0.4 Im ___ AbsNeut-4.18 AbsLymp-0.82* \nAbsMono-0.54 AbsEos-0.06 AbsBaso-0.02\n___ 07:15AM BLOOD ___ PTT-39.2* ___\n___ 07:15AM BLOOD Glucose-231* UreaN-45* Creat-1.4* Na-140 \nK-5.2 Cl-108 HCO3-15* AnGap-17\n___ 07:15AM BLOOD ALT-20 AST-45* AlkPhos-221* TotBili-1.0 \nDirBili-0.5* IndBili-0.5\n___ 07:15AM BLOOD Albumin-3.2*\n___ 11:33PM BLOOD Lactate-2.4*\n\nMicrobiology:\n=============\n___ 1:10 pm BLOOD CULTURE\nBlood Culture, Routine (Pending): \n___ 3:08 pm URINE\nURINE CULTURE (Pending\n\nImaging:\n========\nCXR: ___\nIMPRESSION:  \nNo acute cardiopulmonary process. \n\nLiver Gb US ___:\nIMPRESSION:   \n1. Main portal vein is patent with hepatopetal flow. \n2. Small volume ascites. \n3. Splenomegaly measuring up to 17.3 cm. \n4. Coarsened and nodular hepatic parenchyma consistent with \nhistory of \ncirrhosis.  No evidence of focal liver mass. \n\n  \nDischarge Labs:\n===============\n___ 05:10AM BLOOD WBC-4.2 RBC-2.99* Hgb-8.7* Hct-27.6* \nMCV-92 MCH-29.1 MCHC-31.5* RDW-20.2* RDWSD-67.7* Plt Ct-95*\n___ 05:10AM BLOOD ___ PTT-39.3* ___\n___ 05:10AM BLOOD Glucose-124* UreaN-28* Creat-0.8 Na-141 \nK-5.1 Cl-110* HCO3-20* AnGap-11\n___ 05:10AM BLOOD ALT-22 AST-51* AlkPhos-216* TotBili-1.1\n___ 05:10AM BLOOD Albumin-3.6 Calcium-8.7 Phos-3.0 Mg-2.5 \nIron-44\n \nBrief Hospital Course:\nMs. ___ is a ___ with HCV (genotype 1a) and EtOH cirrhosis \n(child's class B) c/b ascites, varices, and hepatic \nencephalopathy, hx polysubstance abuse, COPD, HTN, and HLD \nreferred to the ___ ED for ___ resolved without \nintervention. Of note, the patient had not yet received her \nsofosbuvir-velpatasvir (___), which will be started at her \nnext ___ visit. \n\nACUTE ISSUES: \n============= \n___ \nThe patient ___ contacted to present to the ED after she was \nfound to have a creatinine of 1.7 after having a scheduled \ntherapeutic paracentesis. She received 25G albumin X 4 in ED. On \nrecheck creatinine down trended to 0.8 which is the patients \nbaseline. ___ may have been related to fluid removal given \nparacentesis prior to abnormal labs. Of note the patient is not \nmaintained on diuretics due to recurrent ___ when trialed on \ndiuretics. \n\n#ABDOMINAL DISTENTION \n#ABDOMINAL PAIN \nPatient notes chronic pain with history of hiatal hernia and R \ninguinal hernia and now with periumbilical hernia. She notes \nthat periumbilical hernia is chronic. Her hernia was reducible. \nLactate was elevated but was likely due to fluid shifts from \nparacentesis. She was seen by surgery in ___ and at \nthat time, it was asymptomatic and surgery was not offered. \nSuspect that some of pain is also related to ascites. Lipase was \nnormal. Pain was treated with lidocaine patch, tramadol. Surgery \nconsultation was deferred given no concerns for worsening or \nincarceration, but could consider referral as outpatient. \n\n#HCV/ETOH CIRRHOSIS \nPatient with Child Class B cirrhosis followed by hepatology at \n___. MELD NA 13. She last saw liver service at the end of \n___. Recurrent ascites with last paracentesis on ___. \nPer last hepatology note she will continue to get weekly \nparacentesis and have biweekly labs. There was no tapable pocket \nof fluid on ED ultrasound to evaluate for SBP. She continued on \nhome lactulose, rifamixin folic acid, thiamine.\nOf note, the patient was due to start antiviral \nsofosbuvir-velpatasvir [___]. It has been confirmed that \nthis will be started at her next liver clinic appointment later \nthis month. \n\n#Polypharmacy:\nThe patient is on 25 medications. Her home medications were \nconfirmed on filling history when speaking to pharmacy as well \nas to the patient. \n\n#Diuretics:\nPatient last filed furosemide on ___. She has a history of \nrecurrent ___ on diuretics and on recent admission was \ndiscontinue on diuretics with plan for weekly paracentesis. The \npatient was last seen a the ___ on ___ with no \ndocumented plan to resume diuretics. We will continue to hold \nfurosemide at discharge with plan for ___ check at ___ visit \nnext week.\n\nCHRONIC ISSUES: \n=============== \n#COPD: Continued home inhalers: albuterol, tiotropium, \nfluticasone-salmeterol \n\nTransitional Issues:\n===================\n[] Patient will start sofosbuvir-velpatasvir [___] following \nnext ___ appointment on ___. \n[] Recommend repeat BMP at ___ appointment on ___\n[] Did not trial diuretics on patient given recurrent ___ in \npast\n[] Evaluate periumbilical hernia as outpatient for consideration \nof outpatient surgical referral for elective hernia repair\n[] Continue paracentesis as needed, biweekly labs\n[] Last EGD ___, 3 cords of small varices were seen in the \nlower esophagus. No history of GI bleeding. Not on home \nnaldolol.\n[] HE: History of HE in past. Continue home lactulose and \nrifaxmin, titrate 3BMs per day\n#CODE: Full \n#CONTACT: Fiance, ___ (___)\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing \n2. Aspirin 81 mg PO DAILY \n3. Fluticasone Propionate NASAL 1 SPRY NU BID \n4. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n5. FoLIC Acid 1 mg PO DAILY \n6. HydrOXYzine 25 mg PO BID:PRN itch \n7. Lactulose 30 mL PO TID \n8. Multivitamins W/minerals 1 TAB PO DAILY \n9. Pantoprazole 40 mg PO Q12H \n10. Rifaximin 550 mg PO BID \n11. Simvastatin 20 mg PO QPM \n12. Thiamine 100 mg PO DAILY \n13. Tiotropium Bromide 1 CAP IH DAILY \n14. Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID \n15. Nystatin Oral Suspension 5 mL PO QID \n16. Simethicone 40-80 mg PO QID \n17. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n18. Ondansetron ODT 4 mg PO Q8H:PRN nausea \n19. Pregabalin 150 mg PO BID \n20. Valsartan 320 mg PO DAILY \n21. amLODIPine 5 mg PO DAILY \n22. Escitalopram Oxalate 10 mg PO DAILY \n23. Zinc Sulfate 220 mg PO DAILY \n24. ___ (sofosbuvir-velpatasvir) 400-100 mg oral Daily \n25. Furosemide 40 mg PO DAILY \n\n \nDischarge Medications:\n1.  Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing  \n2.  amLODIPine 5 mg PO DAILY  \n3.  Aspirin 81 mg PO DAILY  \n4.  Caltrate 600 + D (calcium carbonate-vitamin D3) 600 mg \n(1,500 mg)-800 unit oral BID  \n5.  Escitalopram Oxalate 10 mg PO DAILY  \n6.  Fluticasone Propionate NASAL 1 SPRY NU BID  \n7.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  \n8.  FoLIC Acid 1 mg PO DAILY  \n9.  HydrOXYzine 25 mg PO BID:PRN itch  \n10.  Lactulose 30 mL PO TID  \n11.  Multivitamins W/minerals 1 TAB PO DAILY  \n12.  Nystatin Oral Suspension 5 mL PO QID  \n13.  Ondansetron ODT 4 mg PO Q8H:PRN nausea  \n14.  Pantoprazole 40 mg PO Q12H  \n15.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n16.  Pregabalin 150 mg PO BID  \n17.  Rifaximin 550 mg PO BID  \n18.  Simethicone 40-80 mg PO QID  \n19.  Simvastatin 20 mg PO QPM  \n20.  Thiamine 100 mg PO DAILY  \n21.  Tiotropium Bromide 1 CAP IH DAILY  \n22.  Valsartan 320 mg PO DAILY  \n23.  Zinc Sulfate 220 mg PO DAILY  \n24. HELD- ___ (sofosbuvir-velpatasvir) 400-100 mg oral Daily \n This medication was held. Do not restart ___ until you have \nyour liver clinic appointment. \n25. HELD- Furosemide 40 mg PO DAILY  This medication was held. \nDo not restart Furosemide until you speak to your liver doctor\n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nPrimary Diagnosis:\n==================\nHCV/Alcoholic Cirrhosis\nAbdominal Pain\nAscites\n\nChronic Issues:\nPeriumbilical Hernia\nCOPD\nHypertention\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,  \n\nIt was a pleasure to care for you at the ___ \n___.  \n\nWhy did you come to the hospital?  \n -  Because your Creatinine, which looks at how well your \nkidneys are working, was not normal\n\nWhat did you receive in the hospital?  \n - We gave you albumin and your Creatinine improved\n- We called your pharmacy to make sure that you get your \nhepatitis C medication named ___. You can pick this up at \nthe ___ once you are discharged \n\nWhat should you do once you leave the hospital?  \n-  Please pick up your Hepatitis C medication named ___ at \nthe ___ \n\nWe wish you the best!  \nYour ___ Care Team  \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753934305"
  },
  "note_id": "19644467-DS-36",
  "subject_id": 19644467,
  "hadm_id": 26243711,
  "note_type": "DS",
  "note_seq": 36,
  "charttime": "2202-08-12 00:00:00",
  "storetime": "2202-08-14 13:12:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Morphine / \nLisinopril / mango / papaya\n \nAttending: ___.\n \nChief Complaint:\nabdominal pain \n \nMajor Surgical or Invasive Procedure:\n- EGD performed ___ uncomplicated\n- EGD guided NJ tube was placed ___ \n- Large volume paracentesis ___ \n\n \nHistory of Present Illness:\n___ with hx alcoholic and hepatitis C related cirrhosis, alcohol\nand substance use disorder, L subclavian stenosis, cervical\nspondylosis, COPD, c.diff colitis, depression, GERD, hiatal\nhernia, HTN, HLD, myofascial pain syndrome, and PVD who is\npresenting with failure to thrive and recent falls. \n\nShe has been having worsening of her chronic back and leg pain\nfor the past ___ days with increase in chronic muscle spasms. \nShe\nhas been taking Tizanidine for muscle spasms without significant\nimprovement. Patient reports multiple falls over the last few\ndays that have been in the setting of standing up from a seated\nposition and preceded by dizziness. Notes feeling of \"legs \ngiving\naway\" under her as well with walking. Has previously had \nproblems\nwith walking and needed a walker at home but not using assistive\ndevice because of upper extremity weakness. Last fall today, \nwhen\ngetting out of shower, lost her balance and struck the top of \nher\nhead on a shelf. Denies chest pain, heart palpitation or \nflushing\nwith falls. One episode of LOC day PTA with immediate return to\nbaseline mental status. \n\nShe also notes mid-abdominal pain at the site of umbilical \nhernia\nafter moving boxes at home 2 days ago. She's had significant \npain\nin the area but continues to pass gas and has regular daily BM.\nShe had a paracentesis, removing 2L fluids on ___ and due for\nrepeat para today but given fall reported to the ED instead. No\nnausea, vomiting, hematochezia or melena. No fever/chills, \nweight\nloss. Has had intermittent feeling food getting stuck in her\nthroat without odynophagia.  She denies changes in vision, \ncough,\nshortness of breath, chest pain, dysuria. Has had chronic\nneuropathy in bilateral feet as well as significant pain in the\nanterior shins that's been treated with lidocaine patches but\nremains ___. \n\nAlso states that over the past ___ weeks she's been having vague\nauditory/visual hallucinations, seeing grandmother sitting on \nher\nbed or thinking that there are people sitting next to her. Does\nnot recall history of hallucinations previously.  \n\nOf note, patient was started on Sofosbuvir-velpatasvir (Epclusa)\non ___ for treatment of HCV. Notes intermittent headaches and\nmild fatigue since onset of medication but no other notable side\neffects. \n \n\n \nPast Medical History:\nHepatitis C cirrhosis- genotype 1a decompensated with h/o\nascites; liver biopsy in ___ showed stage ___ fibrosis\nHypertension\nHyperlipidemia\nCOPD\nAlcohol abuse\nDepression\nCocaine abuse\nTobacco abuse\nAtypical chest pain\nBreast pain\nAbdominal pain\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair \n \nSocial History:\n___\nFamily History:\nMom had DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather had alcoholism and rectal CA (COD).\nSister has mental illness, also hx of falls. \nSiblings: 1 brother neonatal death, 1 brother death at 3 months, \n\n1 brother sudden death in ___.\n \nPhysical Exam:\nADMISSION EXAM:\n=================\n\nT 97.7 PO BP 125/65 HR 76 RR 18 ___ 99 Ra \nGENERAL: appears older than stated age, conversant and able to\nrecount medical history but oriented to self, month, and place\nand not to year or president. \nHEENT: Normocephalic, atraumatic. Pupils equal, round, and\nreactive bilaterally, extraocular muscles intact. Sclera\nanicteric and without injection. Moist mucous membranes.\nOropharynx is clear.\nCARDIAC: RRR, II/VII murmur at RUSB \nLUNGS: Clear to auscultation bilaterally,  No wheezes, rhonchi \nor\nrales.\nBACK: Tender to palpation of the lower back area\nABDOMEN: Normal bowels sounds, distended, significant \ngeneralized\ntenderness to mild palpation of the abdomen, umbilical hernia\nwith significant tenderness though reducible \nEXTREMITIES: ___ without edema, lidocaine patches on bilateral\ntibia with significant tenderness to mild palpation of the \ntibia,\nunable to assess pulses given tenderness \nSKIN: Right arm with large ecchymosis ___ fall), and ecchymosis\nof the left lower abdomen, \nNEUROLOGIC: mental status as above, CN2-12 intact. intact\nsensation bilaterally, able to lift bilateral legs anti-gravity,\nupper extremities ___ strength bilaterally, unable to assess\ngait. bilateral hand tremors without asterixis \n\nDischarge Exam:\n=====================\nTemp: \n___ 0805 Temp: 98.8 PO BP: 106/61 L HR: 65 RR: 18 O2 sat:\n97% O2 delivery: Ra \nGENERAL: Comfortable, in NAD\nHEENT: Normocephalic, atraumatic. Pupils equal, round, and\nreactive bilaterally, extraocular muscles intact. Sclera\nanicteric and without injection. No nystagmus, Moist mucous\nmembranes. \nCARDIAC: RRR, II/VII murmur at ___ \nLUNGS: CTAB\nABDOMEN: Soft, nt, mild distention, soft umbilical hernia\nEXTREMITIES: ___ without edema\nSKIN: Right arm with large ecchymosis ___ fall), and ecchymosis\nof the left lower abdomen\nNEUROLOGIC: CN2-12 intact. intact sensation bilaterally, able to\nlift bilateral legs anti-gravity, upper extremities ___ strength\nbilaterally, unable to assess gait. bilateral hand tremors that\nis high frequency and absent asterixis on exam.\n\n \nPertinent Results:\nAdmission labs:\n===================\n\n___ 10:59AM   PLT COUNT-63*\n___ 10:59AM   NEUTS-77.1* LYMPHS-9.0* MONOS-12.8 EOS-0.5* \nBASOS-0.3 IM ___ AbsNeut-5.75 AbsLymp-0.67* AbsMono-0.95* \nAbsEos-0.04 AbsBaso-0.02\n___ 10:59AM   WBC-7.5 RBC-2.77* HGB-8.2* HCT-25.5* MCV-92 \nMCH-29.6 MCHC-32.2 RDW-17.4* RDWSD-58.4*\n___ 10:59AM   ASA-NEG ETHANOL-NEG tricyclic-NEG\n___ 10:59AM   ACETONE-NEGATIVE\n___ 10:59AM   ALBUMIN-3.7 CALCIUM-9.1 PHOSPHATE-3.1 \nMAGNESIUM-2.4\n___ 10:59AM   cTropnT-<0.01\n___ 10:59AM   LIPASE-37\n___ 10:59AM   ALT(SGPT)-23 AST(SGOT)-36 CK(CPK)-198 ALK \nPHOS-144* TOT BILI-0.7\n___ 10:59AM   estGFR-Using this\n___ 10:59AM   GLUCOSE-179* UREA N-36* CREAT-1.4* SODIUM-137 \nPOTASSIUM-4.6 CHLORIDE-99 TOTAL CO2-22 ANION GAP-16\n___ 12:05PM   LACTATE-3.8*\n___ 12:05PM   COMMENTS-GREEN TOP\n___ 01:01PM   ___ PTT-38.9* ___\n___ 03:00PM ASCITES  TNC-569* ___ POLYS-5* \nLYMPHS-16* MONOS-37* MACROPHAG-42*\n___ 03:00PM ASCITES  TOT PROT-1.7 GLUCOSE-162\n___ 04:04PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 \nLEUK-NEG\n___ 04:04PM URINE  COLOR-Straw APPEAR-Clear SP ___\n___ 04:04PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG \ncocaine-NEG amphetmn-NEG mthdone-NEG\n___ 04:04PM URINE  OSMOLAL-248\n___ 04:04PM URINE  HOURS-RANDOM\n___ 04:04PM URINE  HOURS-RANDOM\n___ 06:25PM   LACTATE-1.1\n\nMicrobiology:\n===============\n\n                            **FINAL REPORT ___\n\n   RAPID PLASMA REAGIN TEST (Final ___: \n      NONREACTIVE. \n      Reference Range: Non-Reactive. \n\n___ 5:14 pm BLOOD CULTURE\n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH.\n\n___ 4:04 pm URINE      SOURCE: CATHETER. \n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___:    NO GROWTH. \n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n\n   Aerobic Bottle Gram Stain (Final ___: \n      THIS IS A CORRECTED REPORT ___. \n      Reported to and read back by ___ (___) AT \n11:07 AM\n      ___. \n      NO ORGANISMS SEEN. \n      PREVIOUSLY REPORTED AS GRAM POSITIVE COCCI IN CLUSTERS \n(___). \n      Reported to and read back by ___ (___) @15:25 \n___. \n\n___ 3:00 pm FLUID RECEIVED IN BLOOD CULTURE BOTTLES\n      PERITONEAL FLUID. \n\n                            **FINAL REPORT ___\n\n   Fluid Culture in Bottles (Final ___:    NO GROWTH. \n\n                            **FINAL REPORT ___\n\n   GRAM STAIN (Final ___: \n      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. \n      NO MICROORGANISMS SEEN. \n\n   FLUID CULTURE (Final ___:    NO GROWTH. \n\n   ANAEROBIC CULTURE (Final ___:    NO GROWTH. \n\nImaging:\n==========\n\nCXR ___\nIMPRESSION:  \n  \nNo definite radiographic evidence for pneumonia. \n\nCT C- Spine: w/o contrast  ___\n\nIMPRESSION: \n  \n1. No acute cervical spine fracture.  Minimal anterolisthesis of \nC2 on C3, \nsimilar to the prior study from ___. \n2. Mild, multilevel degenerative changes of the cervical spine, \nmost \npronounced at C4-C6. \n\nCT HEAD non contrast ___ \n\nIMPRESSION:  \n  \nNo acute intracranial abnormality.  No acute hemorrhage or \ncalvarial fracture. \n  \nABD US ___\n\nIMPRESSION: \n  \n1. Patent main, left and right portal veins with normal \ndirectional flow. \n2. Cirrhotic liver with sequela of portal hypertension, \nincluding moderate \nascites and splenomegaly of 17.0 cm. \n3. No focal liver mass lesions identified. \n  \n\nCT ABD Pelvis ___ \n\nIMPRESSION: \n  \n  \n1. Hepatic cirrhosis with splenomegaly.  Interval increase in \nthe amount of \nascites. \n2. Gradual interval increase in the size of umbilical hernia now \ncontaining \nincreased length of nonobstructed small bowel loops.  No \nevidence of bowel \nobstruction. \n3. 11 mm exophytic soft tissue density in the left adnexa, \nalthough stable \nfrom prior CT likely represents an adnexal/ovarian lesion.  If \nthis is not \npreviously evaluated, further assessment with a nonurgent pelvic \nultrasound \ncan be performed. \n  \n___ EGD: grade II esophageal varices and portal hypertensive \ngastropathy \n\n___ \n\nIMPRESSION: \n  \n1. The soft tissue lesion seen in the left adnexa on CT abdomen \nand pelvis \nfrom ___ssessed on the current study.  \nFurther \nevaluation with MR pelvis may be considered to further \ncharacterize. \n2. Large volume ascites. \n3. Trace endometrial fluid. \n\n___\n\nIMPRESSION:\n  \n1. Technically successful ultrasound guided therapeutic \nparacentesis. \n2. 3 L of fluid were removed. \n\nDischarge Labs:\n================\n\n___ 07:30AM BLOOD WBC-3.8* RBC-2.77* Hgb-8.3* Hct-26.0* \nMCV-94 MCH-30.0 MCHC-31.9* RDW-18.3* RDWSD-61.8* Plt Ct-40*\n___ 07:30AM BLOOD Plt Ct-40*\n___ 07:30AM BLOOD Glucose-167* UreaN-18 Creat-0.8 Na-142 \nK-4.4 Cl-108 HCO3-21* AnGap-13\n___ 07:30AM BLOOD ALT-13 AST-24 AlkPhos-123* TotBili-1.2\n___ 07:30AM BLOOD Calcium-8.1* Phos-2.0* Mg-2.6\n___ 06:40AM BLOOD CEA-6.8* CA12___-193*\n___ 06:25AM BLOOD HCV Ab-POS*\n \nBrief Hospital Course:\nSummary \n=========\nMs. ___ is a ___ female with HCV (genotype 1a) and \nEtOH cirrhosis (child's class B) c/b ascites, esophageal \nvarices, and hepatic encephalopathy, hx polysubstance abuse, \nCOPD, HTN, and HLD who presented with abdominal pain and FTT, \ns/p large volume paracentesis with no evidence of SBP, s/p EGD \nshowing grade II esophageal varices and portal hypertensive \ngastropathy, s/p NJ tube placement, who was started on tube \nfeeds prior to discharge. \n\n#Abdominal pain - Presented with acute on chronic abdominal \npain. S/p large volume paracentesis no e/o SBP. Likely ___ \nascites, also with midline hernias, reducible no evidence of \nstrangulation or incarceration. CT A/P showing increase in size \nof umbilical hernia no e/o obstruction, also with 11mm left \nadnexal mass. S/p EGD showing grade II esophageal varices and \nchanges c/w portal hypertensive gastropathy. She improved \nsymptomatically with therapeutic paracentesis. \n\n#HCV/alcohol cirrhosis (Child's C) - \n#Acute hepatic encephalopathy\nPt presented with acute alteration in MS and falls, thought to \nbe a combination of recent initiation of tizanidine and \nworsening hepatic encephalopathy. She cleared with cessation of \noffending medications and multiple bowel movements. She was \ncontinued on rifaximin and lactulose for control. During her \nstay she underwent EGD which showed Grade II esophageal varices \nwith some portal hypertensive gastropathy. She had x2 LVP's, \nmost recently on ___. She continued on her epclusa for HCV \ntreatment, and she was started on NJ feeds for protein-calorie \nmalnutrition. \n\n#L adenexal mass - Found to have 11mm left adenexal mass. \nAppears stable compared to prior to imaging, however with \nelevated CA-125. GYN saw the patient in house who recommended \nf/u in 4 weeks with repeated serum evaluation. Her peritoneal \nfluid cytology was pending at the time of discharge. \n\n___ \nBaseline Cr 0.8-1.1, elevated to 1.4 on admission. Diuretics had \nbeen previously held on discharge on ___ given recurrence ___ \niso diuresis and poor PO intake. Improved with holding diuretics \nand albumin infusion. Diuretics resumed prior to d/c with cycled \nTF's. \n\n#Ankle/back pain \n#Myofacial pain\nPt tolerated APAP only during admission for pain, additional \nmedications were held given initial AMS. \n\n#COPD \n- continue home fluticasone-salmeterol diskus\n- Continue tiotropium\n- Continue albuterol PRN \n\n#GERD\n- Continue pantoprazole 40mg daily \n\n#HLD\n- Continue simvastatin 20mg \n\n#HTN\n- hold valsartan, amlodipine\n\nTransitional issues:\n[] Pt will be getting cycled tube feeds overnight for her \nprotein-calorie malnutrition\n[] Cont with weekly large volume paracenteses for volume \nmanagement\n[] Pt will restart her lasix in an effort to prevent need for \nmore frequent paracenteses\n[] Pt should be considered for palliative care referral in the \noutpatient setting\n[] Pt needs f/u with GYN as scheduled for adnexal mass and \nelevated tumor markers\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing \n2. Aspirin 81 mg PO DAILY \n3. Fluticasone Propionate NASAL 1 SPRY NU BID \n4. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n5. FoLIC Acid 1 mg PO DAILY \n6. Lactulose 30 mL PO TID \n7. Multivitamins W/minerals 1 TAB PO DAILY \n8. Nystatin Oral Suspension 5 mL PO QID \n9. Pregabalin 150 mg PO BID \n10. Tiotropium Bromide 1 CAP IH DAILY \n11. Thiamine 100 mg PO DAILY \n12. Simvastatin 20 mg PO QPM \n13. Simethicone 40-80 mg PO QID:PRN gas \n14. Rifaximin 550 mg PO BID \n15. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n16. Pantoprazole 40 mg PO Q24H \n17. Ondansetron ODT 4 mg PO Q8H:PRN nausea \n18. Escitalopram Oxalate 10 mg PO DAILY \n19. HydrOXYzine 25 mg PO BID:PRN itch \n20. Zinc Sulfate 220 mg PO DAILY \n21. amLODIPine 5 mg PO DAILY \n22. Valsartan 320 mg PO DAILY \n23. Furosemide 40 mg PO DAILY \n24. Epclusa (sofosbuvir-velpatasvir) 400-100 mg oral Daily \n25. TraZODone 50 mg PO QHS:PRN insomnia  \n26. Tizanidine 2 mg PO DAILY:PRN muscle spasm  \n\n \nDischarge Medications:\n1.  Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing  \n2.  Aspirin 81 mg PO DAILY  \n3.  Epclusa (sofosbuvir-velpatasvir) 400-100 mg oral Daily  \n4.  Escitalopram Oxalate 10 mg PO DAILY  \n5.  Fluticasone Propionate NASAL 1 SPRY NU BID  \n6.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  \n7.  FoLIC Acid 1 mg PO DAILY  \n8.  Furosemide 40 mg PO DAILY  \n9.  HydrOXYzine 25 mg PO BID:PRN itch  \n10.  Lactulose 30 mL PO TID  \n11.  Multivitamins W/minerals 1 TAB PO DAILY  \n12.  Ondansetron ODT 4 mg PO Q8H:PRN nausea  \n13.  Pantoprazole 40 mg PO Q24H  \n14.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n15.  Rifaximin 550 mg PO BID  \n16.  Simethicone 40-80 mg PO QID:PRN gas  \n17.  Simvastatin 20 mg PO QPM  \n18.  Thiamine 100 mg PO DAILY  \n19.  Tiotropium Bromide 1 CAP IH DAILY  \n20.  Zinc Sulfate 220 mg PO DAILY  \n21.Tube Feeds\nOsmolite 1.5 Cal;  Nasojejunal (NJ); Goal rate: 50 ml/hr over 24 \nhours  Free water amount: 50 mL; Free water frequency: Q6H \nDispense 1 Month Supply Refills 2\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\n# Sarcopenia \n# Decompensated Cirrhosis \n# Acute anemia\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure taking care of you on this hospital stay at \n___.\n\nWhy was I admitted?\n\n- You were admitted to the hospital for abdominal pain, and \nweakness. \n- We think you stomach pain was from the large amount of fluid \nin your abdomen from your cirrhosis\n- We also found that you were very weak from malnutrition and \nstarted you on tube feeds\n\nWhat happened while I was in the hospital?\n\n- We started you on tube feeds to improve your nutrition\n- We took fluid off of your abdomen with two large volume \nparacentesis \n\nWhat you need to do once you leave the hospital. \n\n- It is important that you see your regular doctor and continue \nto see your liver doctor\n- It is also very important that you continue to take your home \nmedications\n\nWe wish you the best in the future- \n\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753934306"
  },
  "note_id": "19644467-DS-37",
  "subject_id": 19644467,
  "hadm_id": 23661711,
  "note_type": "DS",
  "note_seq": 37,
  "charttime": "2202-08-29 00:00:00",
  "storetime": "2202-08-29 22:29:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Lisinopril \n/ mango / papaya\n \nAttending: ___\n \nChief Complaint:\nAbdominal and flank pain\n\n \nMajor Surgical or Invasive Procedure:\n___ Diagnostic Paracentesis ___\n___ Therapeutic Paracentesis ___\n\n \nHistory of Present Illness:\n___ y/o female w/ a PMHx of HCV (genotype 1a) and EtOH cirrhosis\n(child's class B) c/b ascites, esophageal varices, and hepatic\nencephalopathy, hx polysubstance abuse, COPD, HTN, and HLD who\npresents with abdominal and flank pain for the last 1 week.\nPatient was getting her weekly therapeutic paracentesis earlier\ntoday when she had sudden onset of bilateral flank pain. 5L of\nfluid were removed. Also describes diffuse abdominal pain and\nendorses nausea, but denies vomiting, fevers, cough, chest pain. \n\n\nPatient had recent admission and was discharged on ___ for\nabdominal pain and FTT and had large volume paracentesis with no\nevidence of SBP, s/p EGD showing grade II esophageal varices and\nportal hypertensive gastropathy, s/p NJ tube placement, who was\nstarted on tube feeds prior to discharge. \n\nIn the ED:\n\nInitial vital signs were notable for:\nT 98.5 HR 78 BP 121/55 RR 16 O2 sat 100% on RA\n\nExam notable for:\nL CVAT\nsoft, distended, diffuse abd tenderness\n\nLabs were notable for:\n- UA with mod leuk, tr protein, urobili 2   \n- Lactate:1.3\n- CBC with Hgb 8.0, platelets 67 \n- Chem 7: ___\n- ALT 14, AST 27, Alk phod 143, Tbili 1.2, albumin 3.7\n- AFP 8.6\n- Lipase 44\n\nStudies performed include:\n- CT A/P:\n1. Stable mild prominence of the left biliary intrahepatic ducts\nand dilatation of the common bile duct status post\ncholecystectomy. No evidence to suggest acute biliary\nobstruction.\n2. Cirrhotic appearing liver with sequelae of portal \nhypertension\nincluding small to moderate volume ascites, persistent\nsplenomegaly, esophageal, gastrohepatic, and perirectal varices.\nPatent portal and splenic veins.\n3. 4-mm hyper enhanced right hepatic lobe lesion is incompletely\nevaluated. This could be further evaluated with MRI with \ncontrast\nin 3 to 6 months.\n4. Splenic infarcts appear chronic.\n5. Small fat containing ventral hernia.\n\n- CXR without acute process.\n\nPatient was given:\n- IV HYDROmorphone (Dilaudid) 0.5 mg \n\nConsults: Hepatology\n\nVitals on transfer:\nT 98.3 HR 80 BP 112/52 RR 19 O2 sat 98% RA \n \nUpon arrival to the floor, she is still endorsing ongoing \ndiffuse\nabdominal and \"kidney\" pain. Does not think she is more \nconfused.\nOngoing nausea but denies vomiting as above. Is unsure if she \nhas\nhad any bleeding episodes. Noticed that her urine may have been\nred over the past couples days, however more normal color now.\n\nReview of Systems:\n==================\nComplete ROS obtained and is otherwise negative.\n \nPast Medical History:\nHCV - genotype 1a decompensated with h/o ascites; liver biopsy \nin ___ showed stage ___ fibrosis \nEtOH cirrhosis (Child's Class B) c/b ascites, esophageal \nvarices,\nHE\nHypertension\nHyperlipidemia\nCOPD\nAlcohol abuse\nDepression\nCocaine abuse\nTobacco abuse\nBreast pain\nAbdominal pain\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair \n \nSocial History:\n___\nFamily History:\nMom had DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather had alcoholism and rectal CA (COD).\nSister has mental illness, also hx of falls. \nSiblings: 1 brother neonatal death, 1 brother death at 3 months, \n\n1 brother sudden death in ___.\n \nPhysical Exam:\nADMIT EXAM\n==========\nVITALS: 24 HR Data (last updated ___ @ 019)\nTemp: 97.4 (Tm 98.2), BP: 134/70 (131-134/68-70), HR: 89\n(72-89), RR: 18, O2 sat: 94% (94-96), O2 delivery: Ra, Wt: 113.3\nlb/51.39 kg  \nGENERAL: Alert and oriented to person, place, and time. Appears \nmildly uncomfortable ___ pain. Cachectic.\nHEENT: N-J tube in place. Sclera anicteric, pupils round and \nreactive to light, no sub lingual jaundice. Oropharynx clear \nwithout exudate. Poor dentition.\nCARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No \nmurmurs/rubs/gallops.\nLUNGS: Clear to auscultation bilaterally w/appropriate breath \nsounds appreciated in all fields. No wheezes, rhonchi or rales. \nNo increased work of breathing.\nABDOMEN: +CVA tenderness bilaterally. Diffusely tender to \npalpation. RUQ tenderness greater compared to other quadrants. \nvoluntary guarding.\nEXTREMITIES: No clubbing, cyanosis, or edema. Pulses DP/Radial \n2+ bilaterally.\nSKIN: Palmar erythema bilaterally. No jaundice or other stigmata \nof liver disease.\nNEUROLOGIC: No asterixis. ___ strength throughout. Normal \nsensation.\n\nDISCHARGE EXAM\n==============\nVS:98.3 ___\nGENERAL: Alert, oriented, NAD, Cachectic.\nHEENT: N-J tube in place w/TFs running. Sclera anicteric\nNECK: Mild JVD\nCARDIAC: RRR, s1/s2, no mgr\nLUNGS: ctabl no w/c/r\nABDOMEN: +flank ttp, +tympany, +ttp throughout, +ventral \nprotuberance, +guarding, no rebound. +caput medusa \nEXTREMITIES: No ___ edema b/l\nSKIN: Palmar erythema bilaterally\nNEUROLOGIC: Grossly non-focal, no asterixis, +baseline tremor \nb/l\n \nPertinent Results:\nADMIT LABS\n==========\n___ 01:15PM BLOOD WBC-4.0 RBC-2.58* Hgb-8.0* Hct-24.3* \nMCV-94 MCH-31.0 MCHC-32.9 RDW-18.1* RDWSD-61.6* Plt Ct-67*\n___ 01:15PM BLOOD Neuts-75.6* Lymphs-11.5* Monos-11.5 \nEos-0.7* Baso-0.2 Im ___ AbsNeut-3.03 AbsLymp-0.46* \nAbsMono-0.46 AbsEos-0.03* AbsBaso-0.01\n___ 01:15PM BLOOD ___\n___ 01:15PM BLOOD Glucose-165* UreaN-22* Creat-0.6 Na-135 \nK-4.2 Cl-101 HCO3-21* AnGap-13\n___ 01:15PM BLOOD ALT-14 AST-27 AlkPhos-143* TotBili-1.2\n___ 01:15PM BLOOD Lipase-44\n___ 08:00AM BLOOD Albumin-3.0*\n___ 08:00AM BLOOD AFP-8.6\n___ 01:25PM BLOOD Lactate-1.3\n___ 03:00PM URINE Blood-NEG Nitrite-NEG Protein-TR* \nGlucose-NEG Ketone-NEG Bilirub-NEG Urobiln-2* pH-7.5 Leuks-MOD*\n___ 03:00PM URINE RBC-1 WBC-2 Bacteri-NONE Yeast-NONE Epi-3\n\nMICRO\n=====\n\nIMAGING\n=======\nCXR ___\nNo acute cardiopulmonary abnormality.\n\nCT A/P ___. Stable mild prominence of the left biliary intrahepatic ducts \nand\ndilatation of the common bile duct status post cholecystectomy.  \nNo evidence\nto suggest acute biliary obstruction.\n2. Cirrhotic appearing liver with sequelae of portal \nhypertension including\nsmall to moderate volume ascites, persistent splenomegaly, \nesophageal,\ngastrohepatic, and perirectal varices.  Patent portal and \nsplenic veins.\n3. 4-mm hyper enhanced right hepatic lobe lesion is incompletely \nevaluated. \nThis could be further evaluated with MRI with contrast in 3 to 6 \nmonths.\n4. Splenic infarcts appear chronic.\n5. Small fat containing ventral hernia.\n\nKUB ___\nDobhoff tube positioning appears similar when compared to the \nscout image from\nthe previous CT scan from ___\n\nEGD ___\nVarices in distal esophagus\nCongestion, petechiae, and mosaic mucosal pattern in the stomach \nfundus and stomach body compatible with portal HTN gastropathy\nNormal mucosa in the whole examined duodenum\nAn NJT was placed passed the third portion of the duodenum. The \ntube was moved the mouth into the nose and bridled at 120cm. The \nflushed w/o difficulty.\n\nDISCHARGE LABS\n==============\n___ 05:16AM BLOOD WBC-4.4 RBC-2.33* Hgb-7.2* Hct-22.5* \nMCV-97 MCH-30.9 MCHC-32.0 RDW-17.8* RDWSD-63.1* Plt Ct-83*\n___ 05:16AM BLOOD ___\n___ 05:16AM BLOOD Glucose-177* UreaN-22* Creat-0.8 Na-140 \nK-3.7 Cl-102 HCO3-23 AnGap-15\n___ 05:16AM BLOOD ALT-20 AST-43* LD(LDH)-247 AlkPhos-123* \nTotBili-0.8\n___ 05:16AM BLOOD Albumin-3.7 Calcium-8.5 Phos-3.4 Mg-2.2\n\nMICRO\n=====\n___ 1:55 pm PERITONEAL FLUID      PERITONEAL FLUID. \n\n                            **FINAL REPORT ___\n\n   GRAM STAIN (Final ___: \n      3+  ___ per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      NO MICROORGANISMS SEEN. \n      This is a concentrated smear made by cytospin method, \nplease refer to\n      hematology for a quantitative white blood cell count.. \n\n   FLUID CULTURE (Final ___:    NO GROWTH. \n\n   ANAEROBIC CULTURE (Final ___:    NO GROWTH. \n__________________________________________________________\n___ 3:00 pm URINE\n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \nWITH SKIN\n      AND/OR GENITAL CONTAMINATION. \n__________________________________________________________\n___ 1:00 pm BLOOD CULTURE\n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n \nBrief Hospital Course:\nMs. ___ is a ___ female with HCV (genotype 1a) and \nEtOH cirrhosis (child's class B) c/b ascites, esophage varices, \nand hepatic encephalopathy, hx polysubstance abuse, COPD, HTN, \nand HLD who presented with abdominal pain and flank pain in \nsetting of large volume paracentesis. Pt empirically treated \nwith CTX for SBP, though repeat diagnostic para w/o c/f SBP. CT \nA/P without signs of new abdominal process. Palliative care \nconsulted, started on ___ for new abdominal pain in \nconjunction with Hepatologist. NJT clogged over admission, \nreplaced via EGD on ___.\n\n#Abdominal pain\n#Flank pain\nPresented with acute on chronic abdominal and flank pain s/p \nlarge volume paracentesis. Likely ___ ascites, also with midline \nhernias, reducible no evidence of strangulation or \nincarceration. CT scan negative for obstruction (bowel or \nbiliary), pyelonephritis, or other acute pathology to explain \nher abdominal pain. Pain most likely explained by her \nascites/abdominal distention, recent admission for similar issue \nthough per pt is now more severe though of same quality. s/p \nalbumin + CTX for empiric SBP, peritoneal fluid w/o signs of \nSBP. Palliative care consulted for assistance with pain \nmanagement, trialed MS-Contin but thought given leg cramps, \ntransitioned to ___ 15mg q4h:prn, max 4x tabs per day. Also \ngiven Lido TD.\n\n#Hyperglycemia: Pt noted to have elevated FSGs while on TFs \nrequiring insulin HISS. Would be hesitant to Rx PO \nanti-glyecmics ___ frail state/severe dz. Will likely require \nlow dose long acting insulin on DC. A1c<6.5, though Hb ~7. \n___ consulted, recommended home FSG monitoring with close \n___ f/u next week (apt scheduled) for consideration of \ninitiation of NPH, no DM meds on DC. Underwent ___ Diabetes \neducation on glucometer use.\n\n#___\nPatient met with outpatient Hepatologist Dr ___ \n___ care on ___ to discuss next steps. Please refer to \n___ care note for details, though currently plan is to c/w TFs \nand Epclusa to treat pt's HCV with hope that Dz process will \nimprove, though pt aware that she's living with chronic Dz that \nmay be life-limiting. Per Hepatologist, NJT replaced on ___ \nafter being clogged. Will also f/u with palliative care as \noutpatient \n\n#HCV/alcohol cirrhosis (Child's B)\nC/b ascites requiring weekly paracentesis, HE, esophageal \nvarices (+perirectal varices on imaging), portal hypertensive \ngastropathy. Was also on Epclusa for HCV which she is to take \nfor a total of 24 weeks. c/w home Epclusa, lactulose 30ml TID, \nrifaximin 550 BID. Palliative care consulted per above. Acute HE \nepisode per below quickly resolved.\n\n#Protein-calorie malnutrition: she is significantly cachectic. \nCurrently on cycled tube feeds overnight, briefly held while \ndobhoff clogged, replaced on ___ and TFs restarted. Continued \nfolic acid and zinc, thiamine, MV with minerals. Pt to continue \nzinc until ___, copper levels low, can consider ___ repletion.\n\n#COPD: continued home fluticasone-salmeterol diskus, tiotropium, \nalbuterol PRN \n\n#GERD: Continued home pantoprazole 40mg daily \n\n#HLD: Continued home simvastatin 20mg \n\n#L adenexal mass: Prior transitional issue: Had elevated ___ \nfrom prior admission. Per prior OMR note, initially planned for \ngyn-onc f/u, however pt called as thought to be pcp vs gyn \nissue, pt prefer to f/u for PCP for repeat ___, consider \npelvic u/s.\n\n#Depression: continued home sertraline\n\nRESOLVED ISSUE\n==============\n# Acute Hepatic Encephalopathy:\nThere were c/f HE on ___ though w/o asterixis and briefly given \nhigh dose lactulose, episode quickly resolved\n\nTRANSITIONAL ISSUES\n===================\n-Pt started on Morphine ___ 15mg q4h:prn with max 4x tabs per day \nafter discussions with palliative care and outpatient \nhepatology, also started on Lido TD for pain\n-Pt noted to have new hyperglycemia while on TFs, ___ \nconsulted, will check FSGs as outpatient with close outpatient \nf/u next wk with ___, underwent DM education prior to ___ with \n___, no DM meds for now upon DC per ___\n-Please check CBC on ___ outpatient PCP appointment \n-___ continue ___ discussions as outpatient, seen by pall \ncare and to follow with pall care as outpatient \n-Please check ___ at PCP apt per prior DC summary, Lt adnexal \nmass/elevated ___ f/u to be managed by PCP per pt preference, \nno need for gyn-onc apt \n-Pt continued on TFs, NJT replaced on ___ after clogging\n-Pt to continue Zinc repletion until ___ per nutrition recs\n-Pt with low copper levels, can consider repletion as outpatient\n-To c/w cycled TFs overnight\n-Pt to c/w weekly LVPs, though of note last LVP with only 750cc \nascites fluid, home PO Lasix 40 briefly held over admission, to \nbe continued on DC\n\n# DC WEIGHT: 52.21kg 115.1 lbs\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing \n2. Aspirin 81 mg PO DAILY \n3. Epclusa (sofosbuvir-velpatasvir) 400-100 mg oral Daily \n4. Escitalopram Oxalate 10 mg PO DAILY \n5. Fluticasone Propionate NASAL 1 SPRY NU BID \n6. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n7. FoLIC Acid 1 mg PO DAILY \n8. Furosemide 40 mg PO DAILY \n9. HydrOXYzine 25 mg PO BID:PRN itch \n10. Lactulose 30 mL PO TID \n11. Multivitamins W/minerals 1 TAB PO DAILY \n12. Ondansetron ODT 4 mg PO Q8H:PRN nausea \n13. Pantoprazole 40 mg PO Q24H \n14. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n15. Rifaximin 550 mg PO BID \n16. Simethicone 40-80 mg PO QID:PRN gas \n17. Simvastatin 20 mg PO QPM \n18. Thiamine 100 mg PO DAILY \n19. Tiotropium Bromide 1 CAP IH DAILY \n20. Zinc Sulfate 220 mg PO DAILY \n\n \nDischarge Medications:\n1.  Acetaminophen 650 mg PO Q8H:PRN Pain - Mild  \n2.  FreeStyle Lancets (lancets) 28 gauge miscellaneous ___ \nRX *lancets [FreeStyle Lancets] 28 gauge use as directed ___ \ntimes per day Disp #*100 Each Refills:*0 \n3.  FreeStyle Lite Strips (blood sugar diagnostic)    \nmiscellaneous ___ \nRX *blood sugar diagnostic [FreeStyle Lite Strips]  use as \ndirected ___ times per day Disp #*100 Strip Refills:*0 \n4.  GuaiFENesin ER 600 mg PO Q12H \nRX *guaifenesin 600 mg 1 tablet(s) by mouth twice a day Disp \n#*60 Tablet Refills:*0 \n5.  Lidocaine 5% Patch 1 PTCH TD QAM \nRX *lidocaine 5 % apply as directed qAM Disp #*30 Patch \nRefills:*0 \n6.  Morphine Sulfate ___ 15 mg PO Q4H:PRN Pain - Moderate \nRX *morphine 15 mg 1 tablet(s) by mouth q4h:prn Disp #*16 Tablet \nRefills:*0 \n7.  Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing  \n8.  Aspirin 81 mg PO DAILY  \n9.  Epclusa (sofosbuvir-velpatasvir) 400-100 mg oral Daily  \n10.  Escitalopram Oxalate 10 mg PO DAILY  \n11.  Fluticasone Propionate NASAL 1 SPRY NU BID  \n12.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  \n13.  FoLIC Acid 1 mg PO DAILY  \n14.  Furosemide 40 mg PO DAILY  \n15.  HydrOXYzine 25 mg PO BID:PRN itch  \n16.  Lactulose 30 mL PO TID  \n17.  Multivitamins W/minerals 1 TAB PO DAILY  \n18.  Ondansetron ODT 4 mg PO Q8H:PRN nausea  \n19.  Pantoprazole 40 mg PO Q24H  \n20.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n21.  Rifaximin 550 mg PO BID  \n22.  Simethicone 40-80 mg PO QID:PRN gas  \n23.  Simvastatin 20 mg PO QPM  \n24.  Thiamine 100 mg PO DAILY  \n25.  Tiotropium Bromide 1 CAP IH DAILY  \n26.  Zinc Sulfate 220 mg PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY\n=======\nAbdominal Pain\nHCV Cirrhosis\n\nSECONDARY\n==========\nCOPD\nGERD\nHLD\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms ___,\n\nYou were admitted to ___ after you had worsening \nabdominal pain associated with your paracentesis. There were no \nsigns of infection or explanation for your pain on CT-imaging \nand from your belly fluid. We had our palliative care \nspecialists evaluate you to help us with pain management and \nwith discussions about your overall care plan going forward.\n\nIt was a pleasure taking care of you!\n\nYour ___ Liver Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753934307"
  },
  "note_id": "19644467-DS-38",
  "subject_id": 19644467,
  "hadm_id": 22160533,
  "note_type": "DS",
  "note_seq": 38,
  "charttime": "2202-09-05 00:00:00",
  "storetime": "2202-09-05 14:11:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Lisinopril \n/ mango / papaya\n \nAttending: ___\n \nChief Complaint:\nClogged J-tube\n \nMajor Surgical or Invasive Procedure:\n___ Fluro for J-tube replacement \n___ Paracentesis \n\n \nHistory of Present Illness:\nMs. ___ is a ___ with a past medical history notable for HCV \n(genotype 1a) and EtOH cirrhosis (Child's class B) c/b ascites, \nesophageal varices, and hepatic encephalopathy, and hx \npolysubstance abuse, who was recently admitted from ___ for \nabdominal pain post-paracentesis and had a NJ tube placed during \nthat admission, presenting with a clogged J-tube.\n\nPatient was asymptomatic and had no acute complaints in the ED. \n\n \nPast Medical History:\nHCV - genotype 1a decompensated with h/o ascites; liver biopsy \nin ___ showed stage ___ fibrosis \nEtOH cirrhosis (Child's Class B) c/b ascites, esophageal \nvarices, HE\nHypertension\nHyperlipidemia\nCOPD\nAlcohol abuse\nDepression\nCocaine abuse\nTobacco abuse\nBreast pain\nAbdominal pain\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair \n\n \nSocial History:\n___\nFamily History:\nMother: DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather: ___, rectal CA (COD)\nSister: mental illness \n___: 1 brother neonatal death, 1 brother death at 3 months, \n1 brother sudden death in ___.\n\n \nPhysical Exam:\nADMISSION EXAM:\n===============\nVS: T 98.1 BP 124/65 HR 72 RR 18 O2 97% RA \nGENERAL: Chronically ill appearing, in NAD  \nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, MMM\nNECK: Supple, no LAD, no JVD  \nHEART: RRR, S1/S2, no murmurs, gallops, or rubs   \nLUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably \nwithout use of accessory muscles  \nABDOMEN: Soft, distended, diffuse TTP in all quadrants, no \nrebound/guarding, 5cm reducible hernia above umbilicus \nEXTREMITIES: No cyanosis, clubbing, or edema  \nSKIN: Warm and well perfused, no excoriations or lesions, no \nrashes\nNEURO: A&Ox3, moving all 4 extremities with purpose, no \nasterixis \n\nDISCHARGE EXAM:\n===============\nVS: ___ 0704 Temp: 98.0 PO BP: 129/65 L Lying HR: 88 RR: 16\nO2 sat: 95% O2 delivery: Ra \nGENERAL: Chronically ill appearing, sitting in bed, in NAD  \nHEENT: AT/NC, EOMI, anicteric sclera, MMM, NJT bridled in place \nLUNGS: Breathing comfortably on RA without use of accessory mm\nABDOMEN: Soft, distended, diffuse TTP in all quadrants, no\nrebound/guarding, 5cm reducible hernia above umbilicus \nEXTREMITIES: No cyanosis, clubbing, or edema  \nSKIN: Warm and well perfused\nNEURO: A&Ox3, moving all 4 extremities with purpose, no \nasterixis\n \nPertinent Results:\nADMISSION LABS\n==============\n___ 05:30PM   ___ PTT-40.2* ___\n___ 05:30PM   PLT COUNT-75*\n___ 05:30PM   NEUTS-76.2* LYMPHS-11.7* MONOS-10.6 EOS-1.1 \nBASOS-0.2 IM ___ AbsNeut-3.52 AbsLymp-0.54* AbsMono-0.49 \nAbsEos-0.05 AbsBaso-0.01\n___ 05:30PM   WBC-4.6 RBC-2.90* HGB-8.6* HCT-27.7* MCV-96 \nMCH-29.7 MCHC-31.0* RDW-17.5* RDWSD-61.1*\n___ 05:30PM   ALBUMIN-3.5\n___ 05:30PM   ALT(SGPT)-17 AST(SGOT)-31 ALK PHOS-108* TOT \nBILI-1.2\n___ 05:30PM   GLUCOSE-105* UREA N-21* CREAT-0.7 SODIUM-139 \nPOTASSIUM-4.7 CHLORIDE-103 TOTAL CO2-25 ANION GAP-11\n\nDISCHARGE LABS\n===============\n___ 05:16AM BLOOD WBC-5.3 RBC-2.62* Hgb-7.8* Hct-25.0* \nMCV-95 MCH-29.8 MCHC-31.2* RDW-17.0* RDWSD-59.4* Plt Ct-67*\n___ 05:16AM BLOOD Plt Ct-67*\n___ 05:16AM BLOOD ___ PTT-36.5 ___\n___ 05:16AM BLOOD Glucose-139* UreaN-20 Creat-0.7 Na-137 \nK-4.7 Cl-100 HCO3-23 AnGap-14\n___ 05:16AM BLOOD ALT-15 AST-30 LD(LDH)-205 AlkPhos-115* \nTotBili-0.9\n___ 05:16AM BLOOD Calcium-7.4* Phos-4.3 Mg-2.1\n\nMICRO\n=====\n- None\n\nIMAGING\n=======\n___ ___ TUBE\nRetrograde migration of the enteric tube towards the stomach \nwith the tip now pre-pyloric and bended tubing inside of the \nstomach.  Patient refuses \nmanipulation of the tubing without sedation. \n\n___ ___ TUBE\nSuccessful post-pyloric advancement of a Dobhoff feeding tube. \nThe tube is \nready to use. \n\n \nBrief Hospital Course:\nSUMMARY STATEMENT:\n===================\n___ with PMH of HCV (genotype 1a) and EtOH cirrhosis (Child's \nclass B, MELD 13 on admission) c/b ascites, esophageal varices, \nand hepatic encephalopathy, and hx polysubstance abuse, with \nrecent admission from ___ for abdominal pain \npost-paracentesis with NJ tube placement, presenting with a \nclogged NJ-tube, s/p NJT and therapeutic paracentesis. \n\nACTIVE ISSUES:\n==============\n# Clogged NJ-tube\nInitially seen in the ED by ___, but refused NJ-tube \nrepositioning without full sedation. Taken morning of ___ for \nNJ-tube replacement without complication. \n\nCHRONIC ISSUES:\n===============\n# EtOH cirrhosis (Child's Class B, MELD 13) c/b ascites, \nesophageal varices, and HE\nNo evidence of decompensation on admission. Continued home \nfurosemide, lactulose, and rifaxamin. Underwent therapeutic \nparacentesis on ___ with 2.25L fluid removal.\n\n# HCV (genotype 1a)\nContinued home Epclusa (NF so patient brought in from home). \n\n# Chronic pain\nContinued home APAP and morphine \n\n# Severe protein-calorie malnutrition \nNJT placed on last admission and replaced on ___. Continued home \nzinc and multivitamin. \n\n# COPD\nContinued home fluticasone-salmeterol diskus, tiotropium, \nalbuterol PRN \n\n# GERD\nContinued home pantoprazole 40mg daily \n\n# HLD\nContinued home simvastatin 20mg \n\n# Polysubstance abuse\nContinued home folic acid, thiamine, and multivitamin \n\n# Depression\nContinued home escitalopram\n\nTRANSITIONAL ISSUES:\n====================\n[] Known L adnexal mass with elevated Ca-125, ensure continued \nfollow-up with PCP\n[] Ensure follow-up with palliative care for ongoing ___ \ndiscussions; appointment set for ___ \n\n# CODE: Presumed FULL\n# CONTACT: ___ \n Relationship: HCP/fianc \n Phone number: ___ \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing \n2. Aspirin 81 mg PO DAILY \n3. Epclusa (sofosbuvir-velpatasvir) 400-100 mg oral Daily \n4. Escitalopram Oxalate 10 mg PO DAILY \n5. Fluticasone Propionate NASAL 1 SPRY NU BID \n6. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n7. FoLIC Acid 1 mg PO DAILY \n8. Furosemide 40 mg PO DAILY \n9. Lactulose 30 mL PO TID \n10. Multivitamins W/minerals 1 TAB PO DAILY \n11. Ondansetron ODT 4 mg PO Q8H:PRN nausea \n12. Pantoprazole 40 mg PO Q24H \n13. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n14. Rifaximin 550 mg PO BID \n15. Simethicone 40-80 mg PO QID:PRN gas \n16. Simvastatin 20 mg PO QPM \n17. Thiamine 100 mg PO DAILY \n18. Tiotropium Bromide 1 CAP IH DAILY \n19. Acetaminophen 650 mg PO Q8H:PRN Pain - Mild \n20. Lidocaine 5% Patch 1 PTCH TD QAM \n21. Morphine Sulfate ___ 15 mg PO Q4H:PRN Pain - Moderate \n22. HydrOXYzine 25 mg PO BID:PRN itch \n23. GuaiFENesin ER 600 mg PO Q12H \n24. Zinc Sulfate 220 mg PO DAILY \n\n \nDischarge Medications:\n1.  Acetaminophen 650 mg PO Q8H:PRN Pain - Mild  \n2.  Albuterol Inhaler 2 PUFF IH Q4H:PRN wheezing  \n3.  Aspirin 81 mg PO DAILY  \n4.  Epclusa (sofosbuvir-velpatasvir) 400-100 mg oral Daily  \n5.  Escitalopram Oxalate 10 mg PO DAILY  \n6.  Fluticasone Propionate NASAL 1 SPRY NU BID  \n7.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  \n8.  FoLIC Acid 1 mg PO DAILY  \n9.  Furosemide 40 mg PO DAILY  \n10.  GuaiFENesin ER 600 mg PO Q12H  \n11.  HydrOXYzine 25 mg PO BID:PRN itch  \n12.  Lactulose 30 mL PO TID  \n13.  Lidocaine 5% Patch 1 PTCH TD QAM  \n14.  Morphine Sulfate ___ 15 mg PO Q4H:PRN Pain - Moderate  \n15.  Multivitamins W/minerals 1 TAB PO DAILY  \n16.  Ondansetron ODT 4 mg PO Q8H:PRN nausea  \n17.  Pantoprazole 40 mg PO Q24H  \n18.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n19.  Rifaximin 550 mg PO BID  \n20.  Simethicone 40-80 mg PO QID:PRN gas  \n21.  Simvastatin 20 mg PO QPM  \n22.  Thiamine 100 mg PO DAILY  \n23.  Tiotropium Bromide 1 CAP IH DAILY  \n24.  Zinc Sulfate 220 mg PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPrimary diagnosis:\n- Clogged J-tube\n\nSecondary diagnosis: \n- EtOH cirrhosis\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nMs. ___,\n\n___ were admitted to the hospital because your NJ-tube was not \nworking properly.\n\nWhile ___ were here, the interventional radiologists replaced \nyour NJ-tube. ___ also had a paracentesis to remove extra fluid \nfrom your stomach.\n\nWhen ___ go home, ___ should continue taking all your \nmedications, as prescribed. ___ should follow-up with your \nprimary care doctor, ___, and the palliative care \ndoctors. ___ should call your doctors ___ develop any \nworrisome symptoms, like abdominal pain or distension, fevers, \nchills, or trouble breathing! \n\nIt was a privilege taking care of ___, and we wish ___ well.\n\nSincerely,\nYour ___ Care Team \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753934308"
  },
  "note_id": "19644467-DS-39",
  "subject_id": 19644467,
  "hadm_id": 20867757,
  "note_type": "DS",
  "note_seq": 39,
  "charttime": "2202-09-15 00:00:00",
  "storetime": "2202-09-15 18:47:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Lisinopril \n/ mango / papaya\n \nAttending: ___\n \nChief Complaint:\nKnee Pain, L Shoulder Pain, s/p Fall\n \nMajor Surgical or Invasive Procedure:\n___ Ultrasound guided therapeutic paracentesis\n___ Ultrasound guided therapeutic paracentesis\n\n \nHistory of Present Illness:\n___ PMH HCV (genotype 1a)/EtOH cirrhosis (c/b ascites, \nesophageal\nvarices, and hepatic encephalopathy), polysubstance use \ndisorder,\nHLD, COPD, PVD, GERD s/p lap fundoplication and hiatal hernia\nrepair, presenting with fever and s/p fall.  \n\nPatient too lethargic to give history, and unable to reach HCP\nfor collateral overnight. Per ED notes, patient was discharged\n___ after admission for NG tube dysfunction. Patient presenting\nwith fever and fall yesterday. Patient reports her boyfriend\nnoticed she was warm so called the ambulance. She was febrile to\n38.5 in the ED. She reports nausea without vomiting. Denies new\ncough. Denies dysuria, chest pain, SOB. She also had a fall\nyesterday, says she \"slipped going ot the bathroom,\" says it was\nbecause of one of the medications she is taking. Reports head\nstrike, left shoulder/knee strike. Denies LOC. Went to sleep and\nwoke up in a lot of pain, espeicially left arm and knee.  \n\nIn the ED, initial VS were: 38.5 100/60 72 12 95/RA \nExam notable for: AAOx3, poor attention, + Asterixis. CTAB. \nS1/S2\nRRR. Abdomen TTP, distended, but soft. No ___ edema. Ecchymosis \nof\nleft knee with small apbrasion. TTP of posterior skull. Reported\nTTP of upper C-spine. \n\nECG: Sinus, no ischemic changes \n\nLabs showed: \n- WBC 12.4 Hb 7.9 Plt 78\n- Cr 1.1 Na 138 Bicarb 23 AG 15 lytes WNL\n- AST 215 ALT 40 AP 88 Tbili 1.2 Alb 3.2\n- INR 1.7\n- VBG: pH 7.47 pCO2 37 \n- Serum tox negative, EtOH negative\n- Utox positive for opiates, otherwise negative \n\nImaging showed: \n- CT c-spine: No acute fracture or malalignment of the cervical\nspine.\n- CT head: No evidence of acute intracranial process.\n- L glenohumeral XR: No acute fracture or dislocation.\n- L knee XR: No acute fracture or dislocation.\n- CXR: New mild interstitial pulmonary edema. Patchy opacities\nwithin the lung bases likely reflect atelectasis in the setting\nof low lung volumes. \n \nConsults: GI: Will need diagnostic paracentesis, would attempt\nbefore starting abx. Agree with broad spectrum abx and will need\npan-culture.\nFollow-up CXR to evaluate for etiologies of hypoxia and for\nevidence of PNA. Can treated HE with lactulose + rifaximin.\nPlease check urine tox screen and EtOH level. Admit to\n___ under Dr. ___. \n\nPatient received:  \n___ 20:34 IV Albumin 25% (12.5g / 50mL) 25 g \n___\nPartial Administration  \n___ 21:30 IV Albumin 25% (12.5g / 50mL) 25 g \n___\nPartial Administration  \n___ 21:30 IV CefePIME  ___ Started  \n___ 21:57 IV Albumin 25% (12.5g / 50mL) 25 g \n___\nPartial Administration  \n___ 21:57 IV Vancomycin (1000 mg ordered) ___\nStarted Stop \n___ 21:57 IV CefePIME 2 g ___ Stopped (___)  \n___ 22:16 PO/NG Lactulose 30 mL ___  \n\nPer discussion w/ ED, by time of transfer patient was so\nlethargic and encephalpathic she required intermittent sternal\nrubbing to have her answer any question. \n\nOn arrival to the floor, patient is virtually unresponsive,\narousable to painful stimulus but a very limited historian.\nGenerally denies current symptoms, knows she is at ___, says year\nis ___.   \n \nREVIEW OF SYSTEMS: unable to perform due to mental status. \n \nPast Medical History:\nHCV - genotype 1a decompensated with h/o ascites; liver biopsy \nin ___ showed stage ___ fibrosis \nEtOH cirrhosis (Child's Class B) c/b ascites, esophageal \nvarices, HE\nHypertension\nHyperlipidemia\nCOPD\nAlcohol use disorder\nDepression\nCocaine use disorder\nTobacco use disorder\nBreast pain\nAbdominal pain\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair \n \nSocial History:\n___\nFamily History:\nMother: DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather: ___, rectal CA (COD)\nSister: mental illness \n___: 1 brother neonatal death, 1 brother death at 3 months, \n\n1 brother sudden death in ___.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:  \nVS: 98.2  112/63  94  18  95/2L  \nGENERAL: lethargic, arousable but only for a few seconds at a\ntime, oriented to person and place, says year is ___  \nHEENT: AT/NC, EOMI, PERRL, anicteric sclera\nNECK: supple, JVP 12cm \nHEART: RRR, S1/S2, no murmurs  \nLUNGS: CTAB on limited lung exam  \nABDOMEN: distended, no overt tenderness, + fluid wave\nEXTREMITIES: no cyanosis, clubbing, or edema  \nPULSES: 2+ DP pulses bilaterally  \nNEURO: grossly moving extremities, PEERLA, EOMI, no clear\nnystagmus. Asterixis present. \nSKIN: warm and well perfused, multiple telangectasias \n\nDISCHARGE PHYSICAL EXAM\n___ 1200 Temp: 98.1 PO BP: 119/55 HR: 98 RR: 18 O2 sat: 97%\nO2 delivery: Ra FSBG: 169  \nGENERAL: Awake and alert, conversant, following commands\nHEENT: AT/NC, PERRL, anicteric slcera, MMM. OP clear; several\naphous ulcers on inner lower lip\nNECK: supple\nHEART: RRR, S1/S2, diffuse holosystolic murmur\nLUNGS: CTAB, no wheezing, rales, or ronchi\nABDOMEN: distended, soft, mildly tender diffusely, slightly more\ntender on R surrounding para site, eccymosis on R side abdomen, \n+\nfluid wave, ventral hernia reducible, just superior to \numbilicus.\n+caput medusa. No rebound or guarding. R side prior paracentesis \nsite healing well with no overlying erythema.\nEXTREMITIES: WWP, no ___ edema. Scattered bruises. Bruising over \nL\nknee and medial aspect of R knee. No overlying erythema or\nwarmth, no evidence of knee joint effusions. 2+ DP pulses\nbilaterally \nSKIN: warm and well perfused, multiple telangectasias \n\n \nPertinent Results:\nADMISSION LABS\n=====================\n___ 07:53PM BLOOD WBC-12.4* RBC-2.67* Hgb-7.9* Hct-25.4* \nMCV-95 MCH-29.6 MCHC-31.1* RDW-17.8* RDWSD-61.2* Plt Ct-78*\n___ 07:53PM BLOOD Neuts-85.0* Lymphs-5.9* Monos-8.1 \nEos-0.2* Baso-0.2 Im ___ AbsNeut-10.50* AbsLymp-0.73* \nAbsMono-1.00* AbsEos-0.03* AbsBaso-0.03\n___ 07:53PM BLOOD ___ PTT-38.6* ___\n___ 07:53PM BLOOD Glucose-92 UreaN-20 Creat-1.1 Na-138 \nK-4.2 Cl-100 HCO3-23 AnGap-15\n___ 07:53PM BLOOD ALT-40 AST-215* AlkPhos-88 TotBili-1.2\n___ 07:53PM BLOOD Albumin-3.2* Calcium-8.6 Phos-3.7 Mg-2.3\n___ 07:53PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nTricycl-NEG\n___ 07:00AM BLOOD HCV VL-NOT DETECT\n___ 07:53PM BLOOD Lactate-1.8\n\nDISCHARGE LABS\n======================\n___ 07:00AM BLOOD WBC-5.3 RBC-2.81* Hgb-8.3* Hct-26.7* \nMCV-95 MCH-29.5 MCHC-31.1* RDW-18.6* RDWSD-62.2* Plt Ct-60*\n___ 01:28PM BLOOD ___ PTT-36.5 ___\n___ 07:00AM BLOOD Glucose-152* UreaN-33* Creat-0.7 Na-132* \nK-4.9 Cl-97 HCO3-24 AnGap-11\n___ 07:00AM BLOOD ALT-37 AST-54* AlkPhos-119* TotBili-0.8\n\n___ 07:00AM BLOOD Calcium-8.8 Phos-3.6 Mg-2.6\n\nPERTINENT LABS\n======================\n___ 07:00AM BLOOD CK-MB-5 cTropnT-<0.01\n___ 07:20AM BLOOD CK-MB-4 cTropnT-<0.01\n___ 07:00AM BLOOD CK-MB-7 cTropnT-0.03*\n___ 07:53PM BLOOD CK-MB-13* cTropnT-0.05* proBNP-310*\n___ 07:00AM BLOOD ALT-39 AST-202* LD(LDH)-268* \nCK(CPK)-3650* AlkPhos-78 TotBili-1.3\n___ 07:00AM BLOOD ALT-57* AST-237* CK(CPK)-3961* AlkPhos-92 \nTotBili-1.0\n___ 07:53PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG \nTricycl-NEG\n___ 07:00AM BLOOD HCV VL-NOT DETECT\n\nIMAGING\n======================\n___ C-SPINE W/O CONTRAST IMPRESSION: \n No acute fracture or malalignment of the cervical spine.\n\n___ HEAD W/O CONTRAS IMPRESSION: \nNo evidence of acute intracranial process.\n\n___ SHOULDER IMPRESSION: (lEFT)\nNo acute fracture or dislocation.\n\n___ (AP, LAT & OBLIQUE FINDINGS: \n \nNo acute fracture or dislocation.  No joint effusion.  Joint \nspaces are\npreserved without significant degenerative changes.  No \nsuspicious lytic or sclerotic osseous abnormalities.  Diffuse \nvascular calcifications.  No radiopaque foreign body.\n\n___ (PA & LAT) IMPRESSION: \n \nNew mild interstitial pulmonary edema.  Patchy opacities within \nthe lung bases likely reflect atelectasis in the setting of low \nlung volumes.\n\n___ DIAG/THERA IMPRESSION:  \n-Technically successful ultrasound guided therapeutic \nparacentesis.\n-1.4 L of fluid were removed.\n\n___ Report CONCLUSION:\nThe left atrial volume index is normal. The estimated right \natrial pressure is ___ mmHg. There is mild symmetric left \nventricular hypertrophy with a normal cavity size. There is \nsuboptimal image quality to assess regional left ventricular \nfunction. Global left ventricular systolic function is normal. \nQuantitative biplane left\nventricular ejection fraction is 67 %. The visually estimated \nleft ventricular ejection fraction is 70%. Tissue Doppler \nsuggests an increased left ventricular filling pressure (PCWP \ngreater than 18mmHg). Normal right ventricular cavity size with \nnormal free wall motion. The aortic sinus diameter is normal for \ngender with normal ascending aorta diameter for gender. The \naortic arch diameter is normal. The aortic valve leaflets (3) \nappear structurally normal. There is no aortic valve stenosis. \nThere is no aortic regurgitation. The mitral leaflets are mildly \nthickened. There is severe mitral annular calcification. There \nis mild mitral stenosis from the prominent mitral annular \ncalcification. There is trivial mitral regurgitation. The \ntricuspid valve leaflets appear structurally normal. There is \ntrivial tricuspid regurgitation. There is no pericardial \neffusion.\n\n___ Imaging LIVER OR GALLBLADDER US  IMPRESSION: \n1. Cirrhotic liver, with sequelae of portal hypertension \nincluding \nsplenomegaly and small to moderate ascites.  Patent main, left, \nand right \nportal veins. \n2. Stable prominence of the left intrahepatic biliary ducts with \nstable \ndilatation of the CBD status post cholecystectomy. \n\n___ Imaging ART EXT (REST ONLY)  IMPRESSION:  \nSevere multilevel occlusive disease bilaterally.  There is \nevidence of \ncritical limb throughout on the right.  There is been \nsignificant \ndeterioration compared to the prior study.\n\n___ Imaging PARACENTESIS DIAG/THERA  IMPRESSION: \n \n-Technically successful ultrasound guided therapeutic \nparacentesis. \n-1.8 L of fluid were removed \n\n___ Imaging ABDOMEN (SUPINE & ERECT  IMPRESSION:  \n  \nNonspecific, nonobstructive bowel gas pattern.  Distended \nstomach.   \nThe Dobhoff projects over the second portion of the duodenum \n\n___ ABD LIMIT, SINGLE OR IMPRESSION:\n1. Insufficient volume of ascites and a paracentesis was not \nperformed.\n\n \nMICROBIOLOGY\n===========================\nMicrobiology Results(last 7 days) ___  \n__________________________________________________________\n___ 4:21 pm STOOL     CONSISTENCY: NOT APPLICABLE\n      Source: Stool. \n\n                            **FINAL REPORT ___\n\n   FECAL CULTURE (Final ___:    NO SALMONELLA OR SHIGELLA \nFOUND. \n\n   CAMPYLOBACTER CULTURE (Final ___:    NO CAMPYLOBACTER \nFOUND. \n__________________________________________________________\n___ 4:21 pm STOOL     CONSISTENCY: NOT APPLICABLE\n      Source: Stool. \n\n                            **FINAL REPORT ___\n\n   C. difficile DNA amplification assay (Final ___: \n      Negative for toxigenic C. difficile by the Cepheid nucleic \nacid\n      amplification assay.. \n           (Reference Range-Negative). \n__________________________________________________________\n___ 12:08 pm MRSA SCREEN      Source: Nasal swab. \n\n                            **FINAL REPORT ___\n\n   MRSA SCREEN (Final ___:    No MRSA isolated. \n__________________________________________________________\n___ 6:50 am Blood (CMV AB)\n\n                            **FINAL REPORT ___\n\n   CMV IgG ANTIBODY (Final ___: \n      POSITIVE FOR CMV IgG ANTIBODY BY EIA. \n      6 AU/ML. \n      Reference Range:  Negative < 4 AU/ml, Positive >= 6 AU/ml. \n\n\n   CMV IgM ANTIBODY (Final ___: \n      NEGATIVE FOR CMV IgM ANTIBODY BY EIA. \n      INTERPRETATION:  INFECTION AT UNDETERMINED TIME. \n      A positive IgG result generally indicates past exposure. \n      Infection with CMV once contracted remains latent and may \nreactivate\n      when immunity is compromised. \n      Greatly elevated serum protein with IgG levels ___ mg/dl \nmay cause \n      interference with CMV IgM results. \n      If current infection is suspected, submit follow-up serum \nin ___\n      weeks. \n__________________________________________________________\nTime Taken Not Noted     Log-In Date/Time: ___ 2:08 am\n      URINE      ADDED TO ___. \n\n                            **FINAL REPORT ___\n\n   Legionella Urinary Antigen  (Final ___: \n      NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN. \n           (Reference Range-Negative). \n      Performed by Immunochromogenic assay. \n      A negative result does not rule out infection due to other \nL.\n      pneumophila serogroups or other Legionella species. \nFurthermore, in\n      infected patients the excretion of antigen in urine may \nvary. \n__________________________________________________________\nTime Taken Not Noted     Log-In Date/Time: ___ 12:10 am\n      URINE     Site: NOT SPECIFIED      ADDED TO ___. \n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___:    NO GROWTH. \n__________________________________________________________\nTime Taken Not Noted     Log-In Date/Time: ___ 10:58 pm\n      PERITONEAL FLUID      PERITONEAL FLUID. \n\n                            **FINAL REPORT ___\n\n   GRAM STAIN (Final ___: \n      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR \nLEUKOCYTES. \n      NO MICROORGANISMS SEEN. \n      This is a concentrated smear made by cytospin method, \nplease refer to\n      hematology for a quantitative white blood cell count.. \n\n   FLUID CULTURE (Final ___:    NO GROWTH. \n\n   ANAEROBIC CULTURE (Final ___:    NO GROWTH. \n__________________________________________________________\n___ 8:11 pm BLOOD CULTURE      2 OF 2. \n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n__________________________________________________________\n___ 7:53 pm BLOOD CULTURE\n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n\n \nBrief Hospital Course:\n___ PMH HCV (genotype 1a)/EtOH cirrhosis (c/b ascites, \nesophageal varices, and hepatic encephalopathy), polysubstance \nuse disorder, HLD, COPD, PVD, GERD s/p lap fundoplication and \nhiatal hernia repair, presenting with fall likely due to \novermedication or hepatic encephalopathy iso not taking \nsufficient lactulose, course c/b hyponatremia and anemia. \n\n# Hyponatremia: Likely due to free water intake and poor solute \nintake in the setting of cirrhosis, less likely HRS. Improved \nwith albumin, IV Lasix, and starting 2L fluid restriction. Na on \ndischarge 132.\n\n# Normocytic Anemia: Baseline Hb ___, Hb of 6.8 on ___ likely \ndue to fluid shifts rather than acute GIB. No melena per \nRN/patient report. EGD ___ showed grade II varices in the distal \nesophagus. Patient received 1U pRBC on ___ with appropriate \nresponse.\n\n# Abdominal Pain: Likely chronic due to cirrhosis and volume \noverload. No evidence of infection on initial diagnostic \nparacentesis. No e/o clot on RUQUS ___. S/p therapeutic \nparacentesis ___ and ___ (1.4L). Patient received pregabalin \n150 mg BID and morphine 10 mg Q4H:PRN max total daily dose of 40 \nmg for pain, and methadone 2.5 mg daily was started on this \nadmission per palliative care recommendations.\n\n# Hepatic Encephalopathy: Patient confused with positive \nasterixis on admission exam concerning for HE. Mental status \nimproved w/ lactulose. Pt reports she was not taking lactulose \nregularly at home. Infectious studies negative to date. Patient \nreceived lactulose to target ___ BM/day and rifaxamin 550 mg BID \nand mental status improved to baseline.\n\n# Transaminitis: Patient with new transaminitis on admission. \nLikely due to mild rhabdomyolysis given elevated CK on admission \nvs. patient taking statin at home which was supposed to be held. \nTransaminitis downtrended prior to discharge. Statin was removed \nfrom medication list. \n\n# T2DM: Pt with new hyperglycemia in setting of starting TF. \n___ was consulted. Patient was discarged on 8U lantus QAM, \nHumalog sliding scale, and 22U NPH prior to starting TF in the \nevening. Patient received education on how to use insulin and \ncheck her sugars. Requires close follow up with ___.\n\n# PAD: ___ pain worse with walking concerning for claudication. \n___ pulses intact on exam. ABI ___ shows severe b/l disease with \ne/o critical limb ischemia on the right, worse compared to \nprior. Vascular surgery recommended outpatient follow up.\n\n# Oral candidiasis: Patient received nystatin swish and swallow \n(___) with improvement in symptoms and resolution of oral \nthrush. Nystatin discontinued at discharge.\n\n# Troponemia. Patient w/ elevated troponin and CK-MB on \nadmission, however in the absence of EKG changes or chest pain \nheparin was deferred. TTE without evidence of wall motion \nabnormalities. Patient without chest pain throughout admission \nbut did note chest pressure during hospitalization. Troponin \ndown trended to normal and repeat EKG shows no changes compared \nto prior.\n\n# Fall: Patient presented with fall without LOC and presyncope. \nLikely due to medication effect (taking tizanidine which was \nsupposed to be on hold and not spacing morphine/pregabalin) and \nhepatic encephalopathy iso not taking home lactulose. Palliative \ncare had home medications brought in and inappropriate \nmedications were disposed.\n\nChronic/Resolved Issues:\n========================\n\n# Chronic pain: Received pregabalin 150 mg BID and morphine ___ m \nQ4H:PRN. Methadone 2.5 mg QD was started on this admission per \npalliative care recommendations.\n\n# ___: Patient w/ ___ to 1.1 from recent baseline 0.7-0.8. \nPossibly secondary to poor PO intake in setting of altered \nmental status vs hepatorenal syndrome. ___ resolved with \ninitiation of PO intake and IV albumin.\n\n# EtOH cirrhosis (Child's Class B, MELD 15 on admission): \nComplicated by ascites, esophageal varices, and HE. Last \nparacentesis ___ with 1.8 L removed. Last EGD ___ with grade II \nvarices in distal esophagus. No history of SBP. Patient received \nlactulose/rifaxamin as above and PRN IV lasix for volume \noverload. \n\nCHRONIC ISSUES:\n===============\n\n# HCV (genotype 1a): HCV VL undecetable on this admission. She \nwas continued on sofosbuvir-velpatasvir.\n\n# Severe protein-calorie malnutrition. NJT placed replaced on \n___ during last admission. Continued home zinc/multivitamin. TF \nwere cycled at night.\n\n# COPD: Continued on fluticasone-salmeterol, home tiotropium and \nPRN albuterol.\n\n# GERD: Patient reports home pantoprazole not compatible with \nher hep C medications.\n\n# Polysubstance use disorder: Continued home folic acid, \nthiamine, and multivitamin \n\n# Depression: Home escitalopram increased from 10 mg QD to 20 mg \nQD per palliative care recommendations.\n\nTRANSITIONAL ISSUES:\n=====================\n[ ] Close follow up with ___ required for new-insulin usage\n[ ] Statin discontinued iso potential cause of transaminitis \n[ ] Bladder scan at ___ to confirm she is not retaining \n[ ] Discharge weight 57.3kg/ 126.32 lbs (___)\n[ ] Discharge Na 132\n[ ] Discharge Cr 0.7\n[ ] Discharge Hb 8.3\n[ ] Repeat CBC and Na on ___ at to confirm Na stable and Hb \nstable\n[ ] F/u with vascular for PAD\n[ ] F/u B1 and Zinc\n[ ] Patient may need once weekly therapeutic paracentesis.\n[ ] F/u EKG for QTC on ___ as patient was started on methadone \non this admission. Discharge QTc (___) 427\n\n#CODE: Full \n#CONTACT: ___ (fianc) p: ___ \n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Aspirin 81 mg PO DAILY \n2. Epclusa (sofosbuvir-velpatasvir) 400-100 mg oral Daily \n3. Escitalopram Oxalate 10 mg PO DAILY \n4. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n5. FoLIC Acid 1 mg PO DAILY \n6. Furosemide 40 mg PO DAILY \n7. HydrOXYzine 25 mg PO BID:PRN itch \n8. Lactulose 30 mL PO TID \n9. Lidocaine 5% Patch 2 PTCH TD QAM \n10. Morphine Sulfate ___ 15 mg PO Q4H:PRN Pain - Moderate \n11. Multivitamins W/minerals 1 TAB PO DAILY \n12. Ondansetron ODT 4 mg PO Q8H:PRN nausea \n13. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n14. Rifaximin 550 mg PO BID \n15. Thiamine 100 mg PO DAILY \n16. Zinc Sulfate 220 mg PO DAILY \n17. Fluticasone Propionate NASAL 1 SPRY NU BID \n18. Valsartan 320 mg PO DAILY \n19. Tiotropium Bromide 1 CAP IH DAILY \n20. Albuterol Inhaler 2 PUFF IH Q4H-Q6H PRN shortness of breath, \nwheezing \n21. Pregabalin 150 mg PO BID \n22. Albuterol 0.083% Neb Soln ___ NEB IH Q4H:PRN shortness of \nbreath, wheezing \n23. GuaiFENesin 15 mL PO BID cough \n24. Loratadine 10 mg PO DAILY:PRN ASDIR \n25. TraZODone 50-100 mg PO QHS \n26. Simvastatin 20 mg PO QPM \n27. Tizanidine 2 mg PO DAILY:PRN muscle spasm \n28. amLODIPine 5 mg PO DAILY \n\n \nDischarge Medications:\n1.  Glargine 8 Units Breakfast\nNPH 22 Units Dinner\nInsulin SC Sliding Scale using HUM Insulin\nRX *insulin glargine [Lantus U-100 Insulin] 100 unit/mL AS DIR 8 \nUnits before BKFT; Disp #*5 Vial Refills:*0\nRX *insulin lispro [Humalog U-100 Insulin] 100 unit/mL AS DIR Up \nto 8 Units QID per sliding scale Disp #*5 Vial Refills:*0\nRX *insulin NPH isoph U-100 human [Novolin N NPH U-100 Insulin] \n100 unit/mL AS DIR 22 Units before DINR; Disp #*5 Vial \nRefills:*0\nRX *insulin syringe-needle U-100 [BD Insulin Syringe Ultra-Fine] \n31 gauge X ___  nine times per day Disp #*5 Syringe \nRefills:*0 \n2.  Methadone 2.5 mg PO DAILY \nRX *methadone 5 mg 0.5 (One half) tab by mouth daily Disp #*4 \nTablet Refills:*0 \n3.  Escitalopram Oxalate 20 mg PO DAILY \nRX *escitalopram oxalate 20 mg 1 tablet(s) by mouth daily Disp \n#*30 Tablet Refills:*0 \n4.  Morphine Sulfate ___ 10 mg PO Q4H:PRN Pain - Moderate \nMax 40mg per day. \nRX *morphine 10 mg/5 mL 5 ml by mouth every four (4) hours \nRefills:*0 \n5.  Albuterol 0.083% Neb Soln ___ NEB IH Q4H:PRN shortness of \nbreath, wheezing  \n6.  Albuterol Inhaler 2 PUFF IH Q4H-Q6H PRN shortness of breath, \nwheezing  \n7.  Aspirin 81 mg PO DAILY  \n8.  Epclusa (sofosbuvir-velpatasvir) 400-100 mg oral Daily  \n9.  Fluticasone Propionate NASAL 1 SPRY NU BID  \n10.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  \n11.  FoLIC Acid 1 mg PO DAILY  \n12.  Lactulose 30 mL PO TID  \n13.  Lidocaine 5% Patch 2 PTCH TD QAM  \n14.  Multivitamins W/minerals 1 TAB PO DAILY  \n15.  Ondansetron ODT 4 mg PO Q8H:PRN nausea  \n16.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n17.  Pregabalin 150 mg PO BID  \n18.  Rifaximin 550 mg PO BID  \n19.  Thiamine 100 mg PO DAILY  \n20.  Tiotropium Bromide 1 CAP IH DAILY  \n21.  Zinc Sulfate 220 mg PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS\n================\nHepatic encephalopathy\nCirrhosis\n\nSECONDARY DIAGNOSIS\n==================\nChronic pain\nAnemia\nThrombocytopenia\nPeripheral arterial disease\nDiabetes\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure caring for you at ___.\n\nWHY WAS I IN THE HOSPITAL?\n- You were here because you fell and you were confused.\n\nWHAT HAPPENED TO ME IN THE HOSPITAL?\n- You received procedures to remove fluid from your abdomen.\n- You received lactulose and your mental status improved.\n- We started you on insulin because your blood sugars were high.\n- You received a blood transfusion because your blood cell count \nwas low.\n\nWHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL?\n- Continue to take all your medicines and keep your \nappointments.\n- Please make sure you're taking lactulose and having ___ bowel \nmovements per day.\n- Your insulin regimen is provided for you at discharge.\n\nWe wish you the best!\n\nSincerely,\nYour ___ Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee753934309"
  },
  "note_id": "19644467-DS-40",
  "subject_id": 19644467,
  "hadm_id": 27828382,
  "note_type": "DS",
  "note_seq": 40,
  "charttime": "2202-10-03 00:00:00",
  "storetime": "2202-10-04 10:28:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Lisinopril \n/ mango / papaya\n \nAttending: ___.\n \nChief Complaint:\nAbdominal pain\n \nMajor Surgical or Invasive Procedure:\nTherapeutic paracentesis ___\n\n \nHistory of Present Illness:\nMs ___ is a ___ with HCV/EtOH cirrhosis (c/b ascites,\nesophageal varices, and hepatic encephalopathy), polysubstance\nuse disorder, HLD, COPD, PVD, GERD s/p lap fundoplication and\nhiatal hernia repair who p/w abd distention and discomfort in\nsetting of recurrent ascites and NGT clog. \n\nPt had recent admission to ET ___ after presenting with\nfall likely due to overmedication or HE iso not taking \nsufficient\nlactulose, course c/b hyponatremia and anemia. During\nhospitalization she required q1-2wk tx paras with the last on\n___ with 1.8L removed. She was set up with q1-2wk paras, the\nnext being ___. \n\nPt states that in the last few days she has had progressively\nworsening abd distention and discomfort, that is typical of when\nshe needs a tx para. She also states that in the last day her NG\ntube has clogged. This prompted her presentation to the ED.\n\nIn the ED initial vitals: 98.1, 77 137/67 20 98% RA  \n\n- Exam notable for: abd distention \n\n- Labs notable for:\nCBC: WBC 4.8, Hgb 9.6 (8.3 on ___, plt 84\nChem7: BUN 17, Cr 0.7, bicarb 21\nLFTs: ALT 23, AST 41, AP 162 (119 on ___, TB 1.4 (0.8 on ___\nCoags: INR 1.6 (1.4 on ___\nUA: Tr Prot otherwise WNL\n\n- Imaging notable for: None\n\n- Consults:\nLIVER: Outpt wants admit for multiple purposes including tx \npara,\ncoordinating pall care.\n\n- Patient was given: PO/NG Morphine Sulfate (Oral Solution) 10 \nmg\n\nOn arrival pt endorses history above. She denies f/c, confusion,\nCP, dyspnea, n/v, diarrhea, melena, hematochezia.\n\n \nPast Medical History:\nHCV - genotype 1a decompensated with h/o ascites; liver biopsy \nin ___ showed stage ___ fibrosis \nEtOH cirrhosis (Child's Class B) c/b ascites, esophageal \nvarices, HE\nHypertension\nHyperlipidemia\nCOPD\nAlcohol use disorder\nDepression\nCocaine use disorder\nTobacco use disorder\nBreast pain\nAbdominal pain\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair \n \nSocial History:\n___\nFamily History:\nMother: DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather: ___, rectal CA (COD)\nSister: mental illness \n___: 1 brother neonatal death, 1 brother death at 3 months, \n\n1 brother sudden death in ___.\n \nPhysical Exam:\nADMISSION EXAM:\n==============\nVS:98.6 PO 142 / 64 L Sitting 81 18 96 Ra \nGENERAL: NAD  \nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva,\nMMM  \nNECK: supple, no LAD, no JVD  \nHEART: RRR, S1/S2, no murmurs, gallops, or rubs   \nLUNGS: Bibasilar crackles\nABDOMEN: +caput medusa, significantly distended abdomen, tender\nto palpation diffusely, no rebound/guarding  \nEXTREMITIES: no cyanosis, clubbing, or edema    \nNEURO: A&Ox3, moving all 4 extremities with purpose, CN ___\nintact\nSKIN: warm and well perfused, no excoriations or lesions, no\nrashes\n\nDISCHARGE EXAM:\n==============\nVS: \n24 HR Data (last updated ___ @ 406)\n    Temp: 97.9 (Tm 98.5), BP: 129/69 (118-134/58-69), HR: 59\n(59-96), RR: 18 (___), O2 sat: 91% (91-98), O2 delivery: Ra,\nWt: 118.4 lb/53.71 kg     \nGENERAL: cachectic female lying in bed, appears uncomfortable\nHEENT: icteric sclera, MMM, EOMI  \nHEART: RRR, S1/S2, no murmurs, gallops, or rubs   \nLUNGS: CTAB. no w/r/r \nABDOMEN: +caput medusa, significantly distended abdomen, tender\nto palpation diffusely, no rebound/guarding, reducible ventral\nhernia present \nEXTREMITIES: Palmar erythema, no cyanosis, clubbing, or edema    \n\nNEURO: A&Ox3 (although slow to answer), moving all 4 extremities\nwith purpose, CN ___ grossly intact, tremor in all four\nextremities, so difficult to assess for asterixis \nSKIN: warm and well perfused, no excoriations or lesions, no\nrashes, palmar erythema as above\n \nPertinent Results:\nADMISSION LABS:\n==============\n___ 07:04PM URINE  HOURS-RANDOM\n___ 07:04PM URINE  UHOLD-HOLD\n___ 07:04PM URINE  COLOR-Yellow APPEAR-Clear SP ___\n___ 07:04PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-TR* \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 \nLEUK-NEG\n___ 07:04PM URINE  RBC-1 WBC-2 BACTERIA-NONE YEAST-NONE \nEPI-1 TRANS EPI-1\n___:04PM URINE  MUCOUS-RARE*\n___ 04:50PM   GLUCOSE-99 UREA N-17 CREAT-0.7 SODIUM-136 \nPOTASSIUM-3.9 CHLORIDE-104 TOTAL CO2-21* ANION GAP-11\n___ 04:50PM   estGFR-Using this\n___ 04:50PM   ALT(SGPT)-23 AST(SGOT)-41* ALK PHOS-162* TOT \nBILI-1.4\n___ 04:50PM   LIPASE-47\n___ 04:50PM   ALBUMIN-3.5 CALCIUM-8.3* PHOSPHATE-3.2 \nMAGNESIUM-2.2\n___ 04:50PM   WBC-4.8 RBC-3.34* HGB-9.6* HCT-31.1* MCV-93 \nMCH-28.7 MCHC-30.9* RDW-17.4* RDWSD-59.6*\n___ 04:50PM   NEUTS-80.9* LYMPHS-9.2* MONOS-8.0 EOS-1.5 \nBASOS-0.2 IM ___ AbsNeut-3.86 AbsLymp-0.44* AbsMono-0.38 \nAbsEos-0.07 AbsBaso-0.01\n___ 04:50PM   PLT COUNT-84*\n___ 04:50PM   ___ PTT-34.8 ___\n\nIMAGING:\n=======\nPARACENTESIS U/S ___:\n\n1. Technically successful ultrasound guided therapeutic \nparacentesis.\n2. 5.3 L of fluid were removed.\n\nDISCHARGE LABS:\n===============\n___ 05:34AM BLOOD WBC-3.7* RBC-2.66* Hgb-7.5* Hct-24.7* \nMCV-93 MCH-28.2 MCHC-30.4* RDW-17.5* RDWSD-59.1* Plt Ct-59*\n___ 05:34AM BLOOD ___ PTT-41.2* ___\n___ 05:34AM BLOOD Glucose-115* UreaN-9 Creat-0.8 Na-138 \nK-3.7 Cl-109* HCO3-19* AnGap-10\n___ 05:34AM BLOOD ALT-21 AST-35 AlkPhos-153* TotBili-1.0\n___ 05:34AM BLOOD Calcium-8.3* Phos-3.1 Mg-2.___ woman with HCV/EtOH cirrhosis (c/b ascites, \nesophageal varices, and hepatic encephalopathy), polysubstance \nuse disorder, HLD, COPD, PVD, GERD s/p lap fundoplication and \nhiatal hernia repair who presented with abdominal distention and \ndiscomfort consistent with her known recurrent ascites as well \nas dislodgement of NG tube. Her course was complicated by \nhematochezia and urinary retention. \n\nACUTE ISSUES:\n=============\n# Decompensated HCV/EtOH Cirrhosis\n# Malnutrition \nChild's Class B, MELD 14 on admission. Previously decompensated \nby recurrent ascites, esophageal varices, and HE. No history of \nSBP. Not transplant candidate. Last EGD ___ with grade II \nvarices in distal esophagus. Hgb 9.6 on admission, 7.5 at time \nof discharge. Patient underwent therapeutic paracentesis this \nadmission with > 5 L removed. No fluid studies were sent. She \nhad an additional paracentesis on ___ for ~2 L. Patient was \ncontinued on home medications including lactulose and rifaximin \nin house. NGT was not replaced this admission due to patient \npreference. Nutrition was consulted and recommended a somewhat \nmore liberalized diet to encourage eating. \n\n# Hematochezia \nShe developed maroon colored stools on ___ concerning for a \nlower GI bleed. Her hemoglobin was overall stable throughout \nthis from 7.3-7.8 and she received no blood transfusions. She \nwas prepped for a colonoscopy on ___ that unfortunately had to \nbe cancelled due to her not being able to wake up and \ncommunicate with the operating provider. She was then maintained \non clears and had the colonoscopy performed on ___. The \ncolonoscopy revealed only rectal varices that were likely \nresponsible for the bleeding. There was no need for \nintervention. Hgb was 7.5 on discharge. \n\n# PAD\nShe has worsening leg pain with walking concerning for \nclaudication. Her pulses are intact on exam. ABI ___ shows \nsevere b/l disease with e/o critical limb ischemia on the right, \nworse compared to prior. Vascular surgery was consulted and \narranged for outpatient follow up. No need for surgical \nintervention this admission. \n\n# Chronic pain\nPatient seen by palliative care in the past for help managing \nchronic pain. Palliative care was re-consulted this admission \nand recommended starting methadone. She developed urinary \nretention and this was discontinued. She was discharged on \nmorphine 10 mg PO Q4H:prn with a max of 40/day and pregabalin. \n\n# Urinary retention\nShe developed urinary retention requiring intermittent straight \ncatheterizations this admission. This may have been in the \nsetting of a new pain medication regimen, but per the patient \nthis has happened before and no cause was identified. Methadone \nwas discontinued to determine if this helped, but she continued \nto require intermittent catheterization. She will follow-up with \nurology as an outpatient. \n\nCHRONIC ISSUES:\n==============\n# HCV genotype 1a\nHCV VL undectable last admission. Continued \nsofosbuvir-velpatasvir\n\n# Continued home COPD, GERD meds. \n\n# Depression, continued SSRI. \n\n# Polysubstance use disorder, continued folate, multivitamin, \nand folate.\n\nTRANSITIONAL ISSUES:\n==================\n[ ] The patient had a clogged NG tube removed this admission. \nThis was placed for malnutrition but she did not want it \nreplaced. Continue to discuss the benefits/risks of NG tube \nfeeding for nutritional support. \n[ ] The patient had urinary retention this admission requiring \nintermittent straight catheterizations. She will require \nintermittent catheterization until this resolved by ___. She \nwill have an appointment with urology as an outpatient. \n[ ] The patient was seen by palliative care in the hospital and \nwill continue to see them as an outpatient for pain control and \nto discuss goals of care. \n[ ] She had questionable diplopia this admission (not \nconsistently reported and normal eye/neuro exam). This may have \nbeen related to not using her glasses and dry eyes. She was also \ngiven eye drops. \n[ ] Please check her Meld labs (electrolytes, CBC, INR, LFTs) at \nher next appointment. \n\n# CODE: Full \n# CONTACT: ___ (fiance) p: ___ \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Rifaximin 550 mg PO BID \n2. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n3. Albuterol 0.083% Neb Soln ___ NEB IH Q4H:PRN shortness of \nbreath, wheezing \n4. Epclusa (sofosbuvir-velpatasvir) 400-100 mg oral Daily \n5. Lactulose 30 mL PO TID \n6. Tiotropium Bromide 1 CAP IH DAILY \n7. Aspirin 81 mg PO DAILY \n8. Albuterol Inhaler 2 PUFF IH Q4H-Q6H PRN shortness of breath, \nwheezing \n9. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n10. Ondansetron ODT 4 mg PO Q8H:PRN nausea \n11. Zinc Sulfate 220 mg PO DAILY \n12. Thiamine 100 mg PO DAILY \n13. Pregabalin 150 mg PO BID \n14. FoLIC Acid 1 mg PO DAILY \n15. Lidocaine 5% Patch 2 PTCH TD QAM \n16. Multivitamins W/minerals 1 TAB PO DAILY \n17. Fluticasone Propionate NASAL 1 SPRY NU BID \n18. Morphine Sulfate ___ 10 mg PO Q4H:PRN Pain - Moderate \n19. Methadone 2.5 mg PO DAILY \n20. Escitalopram Oxalate 20 mg PO DAILY \n21. Glargine 8 Units Breakfast\nNPH 22 Units Dinner\nInsulin SC Sliding Scale using HUM Insulin\n\n \nDischarge Medications:\n1.  Morphine Sulfate ___ 15 mg PO Q6H:PRN Pain - Moderate \nRX *morphine 15 mg 1 tablet(s) by mouth every six (6) hours Disp \n#*12 Tablet Refills:*0 \n2.  Albuterol 0.083% Neb Soln ___ NEB IH Q4H:PRN shortness of \nbreath, wheezing  \n3.  Albuterol Inhaler 2 PUFF IH Q4H-Q6H PRN shortness of breath, \nwheezing  \n4.  Aspirin 81 mg PO DAILY  \n5.  Epclusa (sofosbuvir-velpatasvir) 400-100 mg oral Daily  \n6.  Escitalopram Oxalate 20 mg PO DAILY  \n7.  Fluticasone Propionate NASAL 1 SPRY NU BID  \n8.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  \n9.  FoLIC Acid 1 mg PO DAILY  \n10.  Glargine 8 Units Breakfast\nNPH 22 Units Dinner\nInsulin SC Sliding Scale using HUM Insulin \n11.  Lactulose 30 mL PO TID  \n12.  Lidocaine 5% Patch 2 PTCH TD QAM  \n13.  Multivitamins W/minerals 1 TAB PO DAILY  \n14.  Ondansetron ODT 4 mg PO Q8H:PRN nausea  \n15.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n16.  Pregabalin 150 mg PO BID  \n17.  Rifaximin 550 mg PO BID  \n18.  Thiamine 100 mg PO DAILY  \n19.  Tiotropium Bromide 1 CAP IH DAILY  \n20.  Zinc Sulfate 220 mg PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY:\n=======\nHCV/EtOH Cirrhosis\nPeripheral artery disease\n\nSECONDARY:\n==========\nChronic pain\nHepatitis C\nCOPD\nGERD\nPolysubstance use disorder\nDepression\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nIt was a pleasure taking care of your at ___.\n\nYou were admitted to the hospital because of worsening abdominal \npain and because your NG tube fell out.\n\nWhile in the hospital, you had a paracentesis to remove extra \nfluid from your abdomen. You also met with our palliative care \nteam to help address ongoing pain issues. You had bloody stools \nand had a colonoscopy that showed some varices or enlarged veins \nin your rectum that probably caused this. There was no need for \nan intervention. \n\nYou should continue to take all of your medications as \nprescribed after leaving the hospital. Please also follow up \nwith your doctors as ___. \n\nWe wish you the best,\nYour ___ Care Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee75393430a"
  },
  "note_id": "19644467-DS-41",
  "subject_id": 19644467,
  "hadm_id": 24899124,
  "note_type": "DS",
  "note_seq": 41,
  "charttime": "2203-01-03 00:00:00",
  "storetime": "2203-01-04 20:40:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Lisinopril \n/ mango / papaya / morphine\n \nAttending: ___.\n \nChief Complaint:\nAbdominal pain\n \nMajor Surgical or Invasive Procedure:\nParacentesis (___)\n \nHistory of Present Illness:\n___ woman with past medical history of hep C and \nalcoholic cirrhosis complicated by ascites, esophageal varices, \nrectal varices, hepatic encephalopathy, polysubstance use \ndisorder, hyperlipidemia, COPD, peripheral vascular disease, \nGERD status post lap fundoplication and hiatal hernia repair who \npresents with worsening abdominal pain, back pain, and bilateral \ninguinal pain. Patient fell off her uncles couch about 2 weeks \nago and broke her ribs. She was evaluated by her PCP after the \nfall. Reports that it may have been because she forgot that she \nwas on the edge of the couch and rolled over after taking her \nmorphine. Since that time, she has had worsening abdominal pain \nand believes is from her inguinal/abdominal hernias. She states \nthat all of her hernias are easily reducible and she has no \noverlying skin issues but notes that therapeutic paracentesis \n(8L on ___ did not make her abdominal pain better. Patient \notherwise denies chest pain, palpitations, cough, URI symptoms, \nurinary symptoms, vaginal bleeding, vaginal discharge. Does note \nsubjective chills and/or fevers.\n\nIn the ED initial vitals: \n98.1, 88, 128/70, 16, 100% RA  \n\n- Labs notable for:\n3.8 > 8.0/26.3 < 65 \n\n137 | 111 | 16     AGap=12 \n-------------< 244\n4.5 | 14 | 0.8  \n\nALT: 35 AP: 173 Tbili: 1.2 Alb: 3.2 \nAST: 51 LDH:  Dbili: 0.5 \n\nAFP 4.4\n\n___: 15.8  PTT: 31.8  INR: 1.5 \n\nAscitic Studies:\nWBC  285, RBC  884  \nPoly  4    \nLymph  23    \nMono  47    \n  \nBands: ___\nMesothe: ___\nMacroph: 18 \n\nProtein  1.3    \nGlucose  193  \n\npH 7.33 \npCO2 40  \n\n- Trauma Consult:\nRib fractures are not acute, no other surgical or traumatic \ninjuries\n\n- Patient was given:  \nSC Insulin 8 UNIT   \nDocusate Sodium 100 mg \nPregabalin 75 mg\nPolyethylene Glycol 17 g \nPantoprazole 40 mg \nAspirin 81 mg \nEscitalopram Oxalate 10 mg \nFoLIC Acid 1 mg \nHydrOXYzine 25 mg \nLactulose 30 mL \nThiamine 100 mg \nTizanidine 2 mg \nFluticasone-Salmeterol Diskus (500/50) 1 INH\nRifaximin 550 mg \nPregabalin 75 mg \nSC Insulin 4 Units\nTizanidine 2 mg \nDocusate Sodium 100 mg \nRifaximin 550 mg \nHydrOXYzine 25 mg \nTizanidine 2 mg\nPregabalin 150 mg \nMorphine Sulfate 4 mg \nSC Insulin 22 UNIT \nSC Insulin 8 Units\n\n- Transfer vitals;\n98.5, 69, 130/63, 16, 98% RA \n\nREVIEW OF SYSTEMS: Positive per HPI, remaining 10 point ROS \nreviewed and negative.\n \nPast Medical History:\nHCV - genotype 1a decompensated with h/o ascites; liver biopsy \nin ___ showed stage ___ fibrosis \nEtOH cirrhosis (Child's Class B) c/b ascites, esophageal \nvarices, HE\nHypertension\nHyperlipidemia\nCOPD\nAlcohol use disorder\nDepression\nCocaine use disorder\nTobacco use disorder\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair  \n \nSocial History:\n___\nFamily History:\nMother: DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather: ___, rectal CA (COD)\nSister: mental illness \n___: 1 brother neonatal death, 1 brother death at 3 months, \n\n1 brother sudden death in ___.\n \nPhysical Exam:\nADMISSION EXAM\n==============\nVS:97.6PO, 113/60, 65, 16, 98% RA\nGENERAL: NAD  \nHEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, \nMMM  \nNECK: supple, no LAD, no JVD  \nHEART: RRR, S1/S2, no murmurs, gallops, or rubs   \nLUNGS: Bibasilar crackles\nABDOMEN: significantly distended abdomen, tender to palpation \ndiffusely,  +caput medusa,  no rebound/guarding, para site c/d/i \n \nEXTREMITIES: no cyanosis, clubbing, or edema , TTP in right \ninguinal area with reducible hernia   \nNEURO: A&Ox3, moving all 4 extremities with purpose, CN ___ \nintact\nSKIN: warm and well perfused, no excoriations or lesions, no \nrashes\n\nDISCHARGE EXAM:\n================\nVITALS: Temp: 98.1 PO BP: 109/57 HR: 75 RR: 18 O2 sat: 97% O2 RA \n\nGENERAL: NAD, lying comfortably in bed. Jaundiced. \nHEENT: AT/NC. MMM. Sclera icterus. \nCV: RRR with normal S1 and S2. No murmur, rubs or gallops. \nLUNGS: Normal respiratory effort. CTAB without wheezes, rales or \nrhonchi. \nABDOMEN: Significantly distended abdomen, multiple reducible \nhernias, baseline tenderness throughout. Mild guarding, no \nrebound. Normoactive BS. \nEXTREMITIES: Warm, 1+ ___ edema, no erythema. Tenderness over \nBLE.\nNEURO: A&Ox3, moving all 4 extremities with purpose, no \nasterixis. \nSKIN: Warm and well perfused\n \nPertinent Results:\nADMISSION LABS\n==============\n___ 08:30AM BLOOD WBC-5.8 RBC-3.21* Hgb-8.9* Hct-28.3* \nMCV-88 MCH-27.7 MCHC-31.4* RDW-19.1* RDWSD-62.0* Plt Ct-85*\n___ 08:30AM BLOOD ___ PTT-31.8 ___\n___ 08:30AM BLOOD Plt Ct-85*\n___ 08:30AM BLOOD Glucose-174* UreaN-20 Creat-0.7 Na-137 \nK-3.9 Cl-107 HCO3-18* AnGap-12\n___ 08:30AM BLOOD ALT-35 AST-51* AlkPhos-173* TotBili-1.2 \nDirBili-0.5* IndBili-0.7\n___ 11:02PM BLOOD Calcium-7.8* Phos-3.2 Mg-1.9\n___ 08:30AM BLOOD Albumin-3.2*\n\nPERTINENT LABS/MICRO:\n====================\n___ 06:35AM BLOOD Folate->20\n___ 06:35AM BLOOD 25VitD-11*\n___ 08:30AM BLOOD AFP-4.4\n\n___ 06:20AM BLOOD Cortsol-0.4*\n___ 06:43AM BLOOD Cortsol-0.5*\n\n___ Stim Testing: \n___ 05:42AM BLOOD Cortsol-0.3* - before\n___ 06:30AM BLOOD Cortsol-3.2 - 30 min\n___ 07:00AM BLOOD Cortsol-4.5 - 60 min\n\n___ 09:30AM BLOOD Cortsol-1.4* - repeat AM cortisol \n\nDISCHARGE LABS\n=============\n___ 07:35AM BLOOD WBC-4.7 RBC-2.47* Hgb-7.1* Hct-23.1* \nMCV-94 MCH-28.7 MCHC-30.7* RDW-18.9* RDWSD-65.0* Plt Ct-55*\n___ 07:35AM BLOOD Glucose-109* UreaN-33* Creat-0.9 Na-140 \nK-5.3 Cl-101 HCO3-22 AnGap-17\n___ 07:35AM BLOOD ALT-20 AST-31 AlkPhos-130* TotBili-0.7\n___ 07:35AM BLOOD Calcium-8.4 Phos-3.6 Mg-2.6\n\nPERTINENT IMAGING:\n================\n___ RUQUS\n1. Cirrhotic liver, with sequela of portal hypertension, \nincluding\nsplenomegaly and moderate volume ascites.\n2. Patent main, right, and left portal veins, without evidence \nof thrombosis.\n\n___ CT ABD/PELVIS\n1. Multiple nondisplaced rib fractures within the left \nhemithorax, including\nthe anterolateral eighth through tenth ribs.\n2. Bowel containing ventral hernia without evidence of \nobstruction or\nstrangulation.\n3. Stable mild prominence of the left intrahepatic biliary ducts \nand\ndilatation of the common bile duct status post cholecystectomy.  \nAs with prior\nstudies, no evidence to suggest new biliary obstruction.\n4. Cirrhosis with portal hypertensive sequelae, with the \nexception of ascites,\nappear grossly similar to prior.\n5. Large volume ascites, increased from prior.\n6. Right femoral hernia containing ascitic fluid.\n7. Grossly unchanged 4 mm hyperenhancing focus in the right \nhepatic lobe is\nincompletely evaluated but may represent a perfusional anomaly.  \nAgree with\nprior recommendations for nonurgent evaluation with MRI with \ncontrast, if\nindicated.\n \nBrief Hospital Course:\n___ y/o woman with a history of HCV and alcoholic cirrhosis c/b \nascites requiring weekly paracentesis, esophageal/rectal \nvarices, and hepatic encephalopathy who presented with subacute \nrib fractures and diffuse abdominal pain, hospital course c/b \nodynophagia, anemia, and concern for adrenal insufficiency \n\nACUTE ISSUES:\n=============\n#Acute on Chronic Abdominal Pain\nThe patient has an extensive history of intermittent, diffuse \nabdominal pain though particularly worse over her multiple \numbilical hernias. Her pain has previously had minimal \nimprovement following large volume paracentesis.  She presented \nwith acute on chronic abdominal pain in the setting of a recent \ntraumatic fall resulting in possible rib fracture. CT abd/pelvis \nshowed no PVT and infectious work up was negative, including a \ndiagnostic paracentesis that showed no SBP.  The etiology \nremained unclear, possible due to baseline distention and \numbilical hernias. Her morphine regimen was increased in \nfrequency and her pain slowly improved. She tolerate tube feeds \nthroughout this time. She was discharged on her home morphine \nregimen. \n\n# Decompensated HCV/EtOH Cirrhosis\nShe has a history of HCV/EtOH cirrhosis c/b ascites requiring \nweekly LVP (did not tolerate diuretics), esophageal/rectal \nvaries and HE. Previously deemed to not be a transplant \ncandidate. On admission, found to have MELD-Na 14, Child's Class \nB. Diagnostic paracentesis negative for SBP. Given last EGD on \n___ showed grade II varices in distal esophagus, she was trialed \non nadolol 20mg QD beginning ___, but d/ced in setting of \nworsening Cr and Na. She continued to receive weekly LVP, last \non ___ ___s lactulose and rifaxamin. She will need q6 \nmonth HCC screening. \n\n#Adrenal insufficiency \nGiven persistent hyperkalemia, morning cortisol was checked and \nfound to be ~0.5 x2. Cosyntropin stimulation test then showed an \ninappropriate response concerning for adrenal insufficiency. \nEndocrine was consulted, recommended sending 21-hydroxylase Ab,  \npending at time of discharge, and holding off on imaging. She \nwas discharged on hydrocortisone 10 mg am and 5 mg at 3 pm with \nplan to follow up in the ___ for further \nmanagement, including possible repetition of the cosyntropin \nstimulation test and with aldosterone. \n\n# Odynophagia\nPatient presented with white plaques on tongue and pain with \nswallowing, concern for ___ esophagitis. The symptoms also \ncorresponded to two Dobhoff placements, so mechanical trauma to \nesophagus was also considered. She had only mild improvement \nwith Nystatin/Fluconazole x 14 days. GI was consulted and \nrecommended starting carafate and PPI for possible variceal \nirritation by ___. Overall her symptoms improved/remained \nstable. She should follow up with her PCP and GI as an \noutpatient to consider repeat EGD. \n\n# HCV, Genotype 1a\nHCV VL undetectable earlier in ___. She was previously started \non a 24 week course of sofosbuvir-velpatasvir (Epclusa) that was \nto end in late ___, but the patient had missed \nsignificant portion of the doses during serial admissions. She \nwas asked to bring in the Epclusa but she had recently ran out. \nShe will need to continue Epclusa as an outpatient, like for an \nextended period. She planned to refill her outpatient script \nupon discharge. \n\n# Normocytic anemia\n# BRBPR\nPatient has a history of chronic anemia in setting of cirrhosis, \ncompounded by occasional blood loss from rectal varices. She had \nreceived 4 units of pRBCs in ___ prior to admission.  On ___, \nthe patient developed blood-streaked stool and Hb dropped to \n6.8. She had no UGI symptoms or vital sign changes. She was \ntransfused 1 unit on ___ and her Hgb remained stable around \n___. She will need a repeat CBC as an outpatient.  \n\n#Malnutrition \nNoted to have very poor oral intake associated with significant \nweight loss in last month. ___ was placed this admission and \ntube feeds were started per nutrition recs. She should continue \non tube feeds and tolerated her goal rate. Discharged with plan \nto continue them at home. \n\n#Disposition\nPhysical therapy evaluated the patient and recommended rehab. \nThe patient refused and wished to be discharged home. Risks were \nreviewed, including concern for falls and serious harm. She \nunderstood the risks and still wished to go home. She was \nultimately discharged home with home services with plan for \nclose follow up. \n\nCHRONIC ISSUES\n==============\n# Diabetes Mellitus\nPresented with elevated blood glucose values after missing \nseveral doses of insulin. She was placed back on her home \nregimen of glargine, NPH and SSI with good blood glucose \ncontrol. She will need outpatient monitoring of her blood sugars \nand up titration of her insulin following initiation of \nsteroids. \n\n# COPD\n- Continued Albuterol nebs PRN\n\n# GERD\n- Continued home PPI\n\n# Depression\n- Continued home SSRI\n\n# Polysubstance use disorder\n- Continued MVI, folate, thiamine \n\n# Vitamin D deficiency\n- Vitamin D level low at 11. She was started on repletion on \n___. Consider further repletion as an outpatient. \n\nTRANSITIONAL ISSUES\n==================\n[ ] Please check her MELD labs (electrolytes, CBC, INR, LFTs) at \nher next appointment\n[ ] CT showing 4 mm hyperenhancing focus in the right hepatic \nlobe is, incompletely evaluated but may represent a perfusional \nanomaly. Agree with prior recommendations for nonurgent \nevaluation with MRI with contrast, if indicated\n[ ] Needs refill of Epclusa as outpatient and discussion with \nHepatology regarding extending her time course\n[ ] Seen by palliative care in the hospital with plan to \ncontinue to see them as an outpatient for pain control and GOC \ndiscussions \n[ ] Needs follow up with Endocrine for further management of \nadrenal insufficiency, will be arranged by Endocrinology \n[ ] Follow up 21-hydroxylase Ab, pending at time of discharge\n[ ] Consider outpatient repetition of cosyntropin stimulation \ntest and add aldosterone per Endocrine Recs\n[ ] Started on hydrocortisone 10 mg am, 5 mg pm, will need \nmonitoring of blood glucose levels and titration of insulin \nregimen \n[ ] Next paracentesis due on ___ \n[ ] Consider outpatient EGD if odynophagia does not improve\n\n# CONTACT: ___ (fiance) p: ___\n \nMedications on Admission:\nThe Preadmission Medication list may be inaccurate and requires \nfuther investigation.\n1. Aspirin 81 mg PO DAILY \n2. Escitalopram Oxalate 20 mg PO DAILY \n3. Fluticasone Propionate NASAL 1 SPRY NU BID \n4. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n5. FoLIC Acid 1 mg PO DAILY \n6. Lactulose 30 mL PO TID \n7. Multivitamins W/minerals 1 TAB PO DAILY \n8. Ondansetron ODT 4 mg PO Q8H:PRN nausea \n9. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n10. Pregabalin 150 mg PO BID \n11. Rifaximin 550 mg PO BID \n12. Thiamine 100 mg PO DAILY \n13. Tiotropium Bromide 1 CAP IH DAILY \n14. Zinc Sulfate 220 mg PO DAILY \n15. Albuterol 0.083% Neb Soln ___ NEB IH Q4H:PRN shortness of \nbreath, wheezing \n16. Albuterol Inhaler 2 PUFF IH Q4H-Q6H PRN shortness of breath, \nwheezing \n17. Epclusa (sofosbuvir-velpatasvir) 400-100 mg oral Daily \n18. Lidocaine 5% Patch 2 PTCH TD QAM \n19. Morphine Sulfate (Oral Solution) 2 mg/mL 10 mg PO Q2-4H:PRN \nPain - Moderate \n20. Tizanidine 2 mg PO DAILY:PRN muscle spasm \n21. Glargine 8 Units Breakfast\nNPH 22 Units Bedtime\nInsulin SC Sliding Scale using HUM Insulin\n\n \nDischarge Medications:\n1.  Hydrocortisone 10 mg PO DAILY \nRX *hydrocortisone 5 mg 1 tablet(s) by mouth twice a day Disp \n#*90 Tablet Refills:*0 \n2.  Hydrocortisone 5 mg PO AFTERNOON  \n3.  Pantoprazole 40 mg PO Q12H pill esophagitis \nRX *pantoprazole 40 mg 1 tablet(s) by mouth twice a day Disp \n#*60 Tablet Refills:*0 \n4.  Sucralfate 1 gm PO QID \nRX *sucralfate [Carafate] 1 gram/10 mL 1 suspension(s) by mouth \nfour times a day Refills:*0 \n5.  Glargine 8 Units Breakfast\nNPH 22 Units Bedtime\nInsulin SC Sliding Scale using HUM Insulin \n6.  Lactulose 30 mL PO QID  \n7.  Albuterol 0.083% Neb Soln ___ NEB IH Q4H:PRN shortness of \nbreath, wheezing  \n8.  Albuterol Inhaler 2 PUFF IH Q4H-Q6H PRN shortness of breath, \nwheezing  \n9.  Aspirin 81 mg PO DAILY  \n10.  Epclusa (sofosbuvir-velpatasvir) 400-100 mg oral Daily  \n11.  Escitalopram Oxalate 20 mg PO DAILY  \n12.  Fluticasone Propionate NASAL 1 SPRY NU BID  \n13.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  \n14.  FoLIC Acid 1 mg PO DAILY  \n15.  Lidocaine 5% Patch 2 PTCH TD QAM  \n16.  Morphine Sulfate (Oral Solution) 2 mg/mL 10 mg PO Q2-4H:PRN \nPain - Moderate  \n17.  Multivitamins W/minerals 1 TAB PO DAILY  \n18.  Ondansetron ODT 4 mg PO Q8H:PRN nausea  \n19.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n20.  Pregabalin 150 mg PO BID  \n21.  Rifaximin 550 mg PO BID  \n22.  Thiamine 100 mg PO DAILY  \n23.  Tiotropium Bromide 1 CAP IH DAILY  \n24.  Tizanidine 2 mg PO DAILY:PRN muscle spasm  \n25.  Zinc Sulfate 220 mg PO DAILY  \n26.Tube feeds\n- Osmolite 1.5 Cal; Full strength\n- 100ml/hr, cycled over 12 hours daily\n- 1 months supply, 2 refills\n- ICD10: ___\n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\n#Primary diagnosis\n- Abdominal pain, acute on chronic\n\n#Secondary diagnoses\n- Decompensated cirrhosis ___ alcoholic and hepatitis C\n- Odynophagia\n- Normocytic anemia \n- Malnutrition \n- Hepatitis C infection \n- Diabetes mellitus \n\n \nDischarge Condition:\nMental Status: Confused - sometimes.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,\n\nYou were admitted to the hospital with abdominal pain and chest \npain. The cause of this was from rib fractures and from the \nchronic abdominal pain related to your cirrhosis.\n\nYour labs were stable in the hospital, and we continued to treat \nthe symptoms and conditions related to your cirrhosis.\n\nYou developed pain in your throat while hospitalized. We felt \nthis may be related to the feeding tube which was placed to \nprovide extra nutrition. It could also be caused by a fungus \ncalled ___, and we started an anti-fungal medication to \ntreat this. If this pain does not resolve, you may need an \nendoscopy to take a look at the esophagus.\n\nWe discussed your prognosis; unfortunately, with your liver \ndisease, we can treat the symptoms but not the primary cause. As \nsome point you will get an infection or bleed which we cannot \ntreat. We don't think this will be tomorrow or next week, but it \ncould be in a year or less. The palliative care team helped and \nwill continue to help you make the best choices and support you \nin this difficult time.\n\nYou will need a repeat paracentesis on ___. Additionally, \nplease start taking the new medications as described below. \n\nIt was a privilege to care for you in the hospital, and we wish \nyou all the best.\n\nSincerely,\n\nYour ___ Health Team\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee75393430b"
  },
  "note_id": "19644467-DS-42",
  "subject_id": 19644467,
  "hadm_id": 24165964,
  "note_type": "DS",
  "note_seq": 42,
  "charttime": "2203-01-20 00:00:00",
  "storetime": "2203-01-20 19:36:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Lisinopril \n/ mango / papaya / morphine\n \nAttending: ___\n \nChief Complaint:\nAbdominal distension\n \nMajor Surgical or Invasive Procedure:\nUltrasound-guided therapeutic paracentesis (___) - 2L removed\nPARACENTESIS DIAG/THERAP W IMAGING GUID (___) - 0.425L removed\n \nHistory of Present Illness:\n___ woman with past medical history of hep\nC/alcoholic cirrhosis (complicated by ascites, esophageal &\nrectal varices, hepatic encephalopathy), polysubstance use\ndisorder, hyperlipidemia, COPD, peripheral vascular disease, \nGERD\nstatus post lap fundoplication and hiatal hernia repair,\ninsulin-dependent diabetes, recent admission for subacute rib\nfractures, diffuse abdominal pain, now sent in with worsening\nabdominal distension and need for therapeutic paracentesis. \n\nShe reports that she typically gets paracentesis weekly, last\ndocumented in chart on ___. She was not sure when to return for\none. She has had progressive swelling of her abdomen and\nworsening of her chronic abdominal pain, which can be sharp or\ncramping and all over her abdomen. She is quite uncomfortable. \nIn\naddition to her abdominal pain, she has has chest pain under her\nleft breast x weeks that is non-exertional and non-radiating. \nShe\nhas no dyspnea.\n\nIn terms of her recent admission, it was for Acute on Chronic\nAbdominal Pain and decompensated alcoholic cirrhosis. Her course\nwas complicated by new diagnosis of adrenal insufficiency,\nodynophagia, by he was recommended to go to rehabilitation but\ndeclined. \n\nInitial ED Vitals: 10 | 96.6 | 72 | 129/67 | 28 | 100% RA \n\nExam:\nVS: T 97.4 BP 123 / 65  HR 59 RR 20 SpO2 97% RA \nGEN: Chronically ill appearing, grossly cachectic. Appears\nuncomfortable but nontoxic. \nHEENT: NGT in right nare. Moist mucous membranes. \nSkin: +purple-red ecchymoses on bilateral feet and at base of \nher\ndistended abdomen.\nChest: Faint bibasilar crackles, otherwise good air movement\nthroughout\nCV: RRR without murmurs\nAbdomen: Distended, tense, diffusely tender to evne light\npalpation.  +5cm, and 2cm reducible hernias (umbilical,\nsupraumbilical). +many dilated veins across abdomen.\nExtremities: No peripheral edema\nNeuro: AOx3, +correct DOWB, +tremor with outstretched hands, no\ngross asterixis though her grip is gives way on hand-squeeze,\nsuggestive of some asterixis. \n\nLabs reviewed, stable from last discharge:\nWBC 4.5 | Hgb 8.7 (from 7.1) | plt 56\nINR 1.4\nK 4.5 | Na 139 | Cl 106 | Bicarb 22 | BUN 28 | Cr 0.9\nAST 43 | ALT 27 | AP 146 | Tbili 1.0 (from 0.7)\nLipase 58\nAlbumin 3.6\n\nDiagnostic paracentesis with 51 WBC (5 poly, 14 lymph); 1068 \nRBC.\n4 mesothelial, 61 macrophages, 3 other. 0.7 Protein, 173 \nglucose.\n\nImaging showed: \n___ RUQUS:\n1. Cirrhotic liver with splenomegaly and moderate volume ascites\nlikely secondary to portal venous hypertension.\n2. No evidence of portal vein thrombosis.\n3. Patient is status post cholecystectomy with stable, dilated\nCHD likely due to postoperative changes.\n\nShe was given:\n -Morphine 4mg\n -Levofloxacin \n -Albuterol & Ipratropium nebs\n -Morphine 4mg\n -Pregabalin 150mg \n -Pantoprazole 40mg \n -Rifaximin 550mg \n -Tizanidine 4mg\n\nROS: No headache, lightheadedness, fevers, chills, dyspnea,\ndysuria, rash. \n \nPast Medical History:\nHCV - genotype 1a decompensated with h/o ascites; liver biopsy \nin ___ showed stage ___ fibrosis \nEtOH cirrhosis (Child's Class B) c/b ascites, esophageal \nvarices, HE\nHypertension\nHyperlipidemia\nCOPD\nAlcohol use disorder\nDepression\nCocaine use disorder\nTobacco use disorder\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair  \n \nSocial History:\n___\nFamily History:\nMother: DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather: ___, rectal CA (COD)\nSister: mental illness \n___: 1 brother neonatal death, 1 brother death at 3 months, \n\n1 brother sudden death in ___.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n========================\nVS: T 97.4 BP 123 / 65  HR 59 RR 20 SpO2 97% RA \nGEN: Chronically ill appearing, grossly cachectic. Appears\nuncomfortable but nontoxic. \nHEENT: NGT in right nare. Moist mucous membranes. \nSkin: +purple-red ecchymoses on bilateral feet and at base of \nher\ndistended abdomen.\nChest: Faint bibasilar crackles, otherwise good air movement\nthroughout\nCV: RRR without murmurs\nAbdomen: Distended, tense, diffusely tender to evne light\npalpation.  +5cm, and 2cm reducible hernias (umbilical,\nsupraumbilical). +many dilated veins across abdomen.\nExtremities: No peripheral edema\nNeuro: AOx3, +correct DOWB, +tremor with outstretched hands, no\ngross asterixis though her grip is gives way on hand-squeeze,\nsuggestive of some asterixis. \n\nDISCHARGE PHYSICAL EXAM:\n========================\nGEN: Chronically ill appearing, grossly cachectic. Appears \nuncomfortable but nontoxic. \nHEENT: NGT bridled in right nare. Moist mucous membranes. \nSkin: +purple-red ecchymoses on bilateral feet and at base of \nher\ndistended abdomen.\nResp: Faint bibasilar crackles, diffuse rhonchi. \nChest: Tenderness to palpation anteriorly\nCV: RRR without murmurs, rub or gallop\nAbdomen: Distended, tense, diffusely tender to even light \npalpation. +5cm, and 2cm reducible hernias (umbilical, \nsupraumbilical). +many dilated veins across abdomen. \nExtremities: No peripheral edema\nNeuro: AOx3, +correct DOWB, +tremor with outstretched hands, no \ngross asterixis though her grip is gives way on hand-squeeze\n \nPertinent Results:\nADMISSION LABS:\n================\n___ 04:32PM BLOOD WBC-4.5 RBC-3.13* Hgb-8.7* Hct-28.9* \nMCV-92 MCH-27.8 MCHC-30.1* RDW-18.4* RDWSD-62.4* Plt Ct-56*\n___ 04:32PM BLOOD ___ PTT-31.4 ___\n___ 04:32PM BLOOD Glucose-172* UreaN-28* Creat-0.9 Na-139 \nK-4.5 Cl-106 HCO3-22 AnGap-11\n___ 04:32PM BLOOD ALT-27 AST-43* AlkPhos-146* TotBili-1.0\n___ 04:32PM BLOOD Albumin-3.6 Calcium-8.5 Phos-2.9 Mg-2.3\n___ 04:45PM ASCITES TNC-51* RBC-1068* Polys-15* Lymphs-14* \nMonos-0 Plasma-1* Mesothe-5* Macroph-65* Other-0\n\nMICROBIOLOGY:\n=============\n___ 4:00 am URINE      Source: Catheter. \n\n                            **FINAL REPORT ___\n\n   URINE CULTURE (Final ___: \n      MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT \nWITH SKIN\n      AND/OR GENITAL CONTAMINATION. \n__________________________________________________________\n___ 8:24 am BLOOD CULTURE      2 OF 2. \n\n                            **FINAL REPORT ___\n\n   Blood Culture, Routine (Final ___:    NO GROWTH. \n\nIMAGING:\n========\nCXR (___)\nLow lung volumes. Exclusion of the left costophrenic angle. \nStreaky bibasilar atelectasis. \n\nLIVER OR GALLBLADDER US (SINGLE ORGAN) (___)\n1. Cirrhotic liver with splenomegaly and moderate volume ascites \nlikely \nsecondary to portal venous hypertension. \n2. No evidence of portal vein thrombosis. \n3. Patient is status post cholecystectomy with stable, dilated \nCHD. \n\nCHEST (PA & LAT) (___):\nLungs are low volume with mild prominence of the interstitium.  \nAn emphysematous bleb in the left perihilar region is again \nseen.  Cardiomediastinal silhouette is stable.  There is no \npleural effusion.  No pneumothorax is seen\n\nDISCHARGE LABS:\n===============\n___ 05:41AM BLOOD WBC-7.2 RBC-2.56* Hgb-6.7* Hct-23.0* \nMCV-90 MCH-26.2 MCHC-29.1* RDW-18.3* RDWSD-60.1* Plt Ct-50*\n___ 05:41AM BLOOD ___ PTT-33.1 ___\n___ 05:41AM BLOOD Glucose-135* UreaN-28* Creat-0.8 Na-142 \nK-4.8 Cl-107 HCO3-24 AnGap-11\n___ 05:41AM BLOOD ALT-22 AST-33 LD(LDH)-233 AlkPhos-133* \nTotBili-0.___ woman with past medical history of hep C/alcoholic \ncirrhosis (c/b ascites, esophageal & rectal varices, hepatic \nencephalopathy) polysubstance use disorder, hyperlipidemia, \nCOPD, peripheral vascular disease, GERD status post lap \nfundoplication and hiatal hernia repair, recent admission for \nsubacute rib fractures, diffuse abdominal pain, hospital course \nc/b odynophagia and malnutrition s/p NGT placement, anemia, and \nconcern for adrenal insufficiency, now sent in with worsening \nabdominal distension for therapeutic paracentesis.\n\nActive Management:\n==================\n#Severe Ascites\n#HCV/EtOH Cirrhosis: \nChild's Class B, MELD 11 on admission. Previously decompensated \nby ascites (did not tolerate diuretics), esophageal varices, and \nHE. No history of SBP. Not a transplant candidate. Last EGD \n___ with grade II varices in distal esophagus. Diagnostic \npara in ED negative for SBP. Therapeutic/diagnostic paras \ncompleted on ___ (2.5L removed), ___ (0.425L removed), ___ \n(2.2L removed) and ___ (4L removed) which were negative for \nSBP. Following paras, she was still complaining of distension \nand some nausea due to incomplete drainage because of \nloculations. Per patient, she recently stopped taking home \nlactulose, this was restarted during admission as she appeared \nmildly confused, though was AOX3 during admission. Repeat HCV VL \nwas non-detectable on ___.\n\n#Adrenal insufficiency\nDiagnosed during previous admission. She was orthostatic in the \nmorning of her first hospital day. She was given fluids, \nfollowing which her vitals remained stable. She was continued on \nhome hydrocortisone.\n\n#Acute on chronic abdominal pain\nLong history of abdominal pain. Intermittent in waves with only \nmild improvement status post LVP. Diagnostic paras negative for \nSBP, CT without PVT, infectious workup negative. Her home \nmorphine regimen was continued, q4h with maximum 5 doses in 24 \nhours.\n\n#Normocytic anemia\nChronic anemia in setting of cirrhosis, compounded by occasional \nblood loss from rectal varices. She received 3U of pRBC during \nadmission with appropriate responses, otherwise Hgb stable ___. \n\n#Severe Protein Calorie Malnutrition\n#Deconditioning\nTolerating tube feeds via Dobhoff initially. However, on day of \ndischarge, dobhoff was noted to be partly out despite being \nbridled. Patient decided she did not want the dobhoff placed \nback prior to discharge. Patient struggles to walk because of \nweakness, however on last admission she was not accepted by \nnumerous inpatient rehabs.\n\n#Orthostatic Hypotension (resolved)\nSBP drop of 30 upon standing overnight on the first night of \nadmission. Most likely  combination of cardiovascular \ndysfunction ___ cirrhosis vs adrenal insufficiency. She was \ngiven fluid and throughout remainder of admission was not \northostatic.\n\nCHRONIC ISSUES\n==============\n# Diabetes Mellitus \nBG 100-200s on glargine, NPH, and SSI. Patient stated that she \njust recently found out about her diagnosis. However she has had \nseveral years of numbness and tingling in feet.\n\n# COPD\nContinued Albuterol nebs PRN.\n\n# GERD\nContinued home PPI.\n\n# Depression: \nContinued home escitalopram.\n \n# Polysubstance use disorder \nContinued MVI, folate, thiamine \n\n ===========================  \n TRANSITIONAL ISSUES:\n[]Hepatic Mass:\nCT A/P on previous admission showed a 4 mm hyperenhancing focus \nin the right hepatic lobe is, incompletely evaluated but may \nrepresent a perfusional anomaly. She will require MRI outpatient \nto further characterize.\n  \n[]Adrenal Insufficiency:\n-Will need outpatient endocrinology follow-up\n\n - New Meds:  None\n - Stopped/Held Meds: None  \n - Changed Meds:  None\n - Post-Discharge Follow-up Labs Needed:  None\n - Incidental Findings:  None\n - Discharge weight:  60kg\n # CODE:  DNR/DNI\n # CONTACT:  ___ (fianc) ___\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol 0.083% Neb Soln ___ NEB IH Q4H:PRN shortness of \nbreath, wheezing \n2. Aspirin 81 mg PO DAILY \n3. Escitalopram Oxalate 20 mg PO DAILY \n4. Fluticasone Propionate NASAL 1 SPRY NU BID \n5. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n6. FoLIC Acid 1 mg PO DAILY \n7. Lactulose 30 mL PO QID \n8. Morphine Sulfate (Oral Solution) 2 mg/mL 10 mg PO Q2-4H:PRN \nPain - Moderate \n9. Multivitamins W/minerals 1 TAB PO DAILY \n10. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n11. Pregabalin 150 mg PO BID \n12. Rifaximin 550 mg PO BID \n13. Thiamine 100 mg PO DAILY \n14. Tiotropium Bromide 1 CAP IH DAILY \n15. Albuterol Inhaler 2 PUFF IH Q4H-Q6H PRN shortness of breath, \nwheezing \n16. Lidocaine 5% Patch 2 PTCH TD QAM \n17. Ondansetron ODT 4 mg PO Q8H:PRN nausea \n18. Tizanidine 2 mg PO DAILY:PRN muscle spasm \n19. Zinc Sulfate 220 mg PO DAILY \n20. Pantoprazole 40 mg PO Q12H pill esophagitis \n21. Sucralfate 1 gm PO QID \n22. Hydrocortisone 10 mg PO DAILY \n23. Hydrocortisone 5 mg PO AFTERNOON \n24. insulin glargine 100 unit/mL (3 mL) subcutaneous BREAKFAST \n25. HumuLIN N NPH Insulin KwikPen (insulin NPH isoph U-100 \nhuman) 100 unit/mL (3 mL) SC QHS \n26. HumaLOG KwikPen Insulin (insulin lispro) 200 unit/mL (3 mL) \nsubcutaneous ASDIR \n\n \nDischarge Medications:\n1.  Albuterol 0.083% Neb Soln ___ NEB IH Q4H:PRN shortness of \nbreath, wheezing  \n2.  Albuterol Inhaler 2 PUFF IH Q4H-Q6H PRN shortness of breath, \nwheezing  \n3.  Aspirin 81 mg PO DAILY  \n4.  Escitalopram Oxalate 20 mg PO DAILY  \n5.  Fluticasone Propionate NASAL 1 SPRY NU BID  \n6.  Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID  \n7.  FoLIC Acid 1 mg PO DAILY  \n8.  HumaLOG KwikPen Insulin (insulin lispro) 200 unit/mL (3 mL) \nsubcutaneous ASDIR  \n9.  HumuLIN N NPH Insulin KwikPen (insulin NPH isoph U-100 \nhuman) 100 unit/mL (3 mL) SC QHS  \n10.  Hydrocortisone 10 mg PO DAILY  \n11.  Hydrocortisone 5 mg PO AFTERNOON  \n12.  insulin glargine 100 unit/mL (3 mL) subcutaneous BREAKFAST  \n\n13.  Lactulose 30 mL PO QID  \n14.  Lidocaine 5% Patch 2 PTCH TD QAM  \n15.  Morphine Sulfate (Oral Solution) 2 mg/mL 10 mg PO Q2-4H:PRN \nPain - Moderate  \n16.  Multivitamins W/minerals 1 TAB PO DAILY  \n17.  Ondansetron ODT 4 mg PO Q8H:PRN nausea  \n18.  Pantoprazole 40 mg PO Q12H pill esophagitis  \n19.  Polyethylene Glycol 17 g PO DAILY:PRN constipation  \n20.  Pregabalin 150 mg PO BID  \n21.  Rifaximin 550 mg PO BID  \n22.  Sucralfate 1 gm PO QID  \n23.  Thiamine 100 mg PO DAILY  \n24.  Tiotropium Bromide 1 CAP IH DAILY  \n25.  Tizanidine 2 mg PO DAILY:PRN muscle spasm  \n26.  Zinc Sulfate 220 mg PO DAILY  \n\n \nDischarge Disposition:\nHome With Service\n \nFacility:\n___\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSIS:\n==================\nEtOH cirrhosis (Child's Class B) c/b ascites, esophageal \nvarices,\nhepatic encephalopathy\nSECONDARY DIAGNOSES:\n====================\nHepatitis C\nHypertension\nHyperlipidemia\nCOPD\nDepression\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nSevere protein-calorie malnutrition\nGERD s/p lap fundoplication and hiatal hernia repair ___\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - requires assistance or aid (walker \nor cane).\n\n \nDischarge Instructions:\nDear Ms. ___,  \n You were admitted to the hospital because you had worsening \nascites causing abdominal distension.\n \n WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL?  \n - We completed 4 paracenteses during the admission.\n - You required blood transfusion three times.\n - We monitored your labs and vitals which remained stable\n - You improved and were ready to leave the hospital.  \n\n WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL?  \n - Take all of your medications as prescribed (listed below)  \n - Keep your follow up appointments with your doctors; \nspecifically your paracentesis on ___ \n - The hospice team will come visit you at your house.\n - Please maintain a high protein diet with low salt\n - If you experience any of the danger signs listed below please \ncall your primary care doctor or come to the emergency \ndepartment immediately.\n\n It was a pleasure participating in your care. We wish you the \nbest!  \n - Your ___ Care Team  \n\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048246fb505ee75393430c"
  },
  "note_id": "19644467-DS-43",
  "subject_id": 19644467,
  "hadm_id": 20097052,
  "note_type": "DS",
  "note_seq": 43,
  "charttime": "2203-02-10 00:00:00",
  "storetime": "2203-02-13 17:48:00",
  "text": " \nName:  ___                   Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   F\n \nService: MEDICINE\n \nAllergies: \nCodeine / Valium / Penicillins / Omeprazole Sodium / Lisinopril \n/ mango / papaya / morphine\n \nAttending: ___\n \nChief Complaint:\nabdominal pain \n \nMajor Surgical or Invasive Procedure:\nTherapeutic paracentesis x2 ___ removed; ___ \nremoved)\n\n \nHistory of Present Illness:\n___ woman with decompensated HCV/alcoholic cirrhosis \n(complicated by ascites, esophageal & rectal varices, hepatic \nencephalopathy), recent admission for subacute rib fractures and \nadrenal insufficiency, who presented with worsening abdominal \ndistension and pain.\n  \nShe reports that she typically gets paracentesis weekly, last \n___. She has had progressive swelling of her abdomen and \nworsening of her chronic abdominal pain, which can be sharp or \ncramping and all over her abdomen. She endorses subjective \nfevers, chills, nausea, and diarrhea as well.  \n\nIn addition to her abdominal pain, she has has chest pain under \nher left breast x weeks that is non-exertional and \nnon-radiating.  \n\nShe has no dyspnea.  \n\nOf note, she was recently admitted for acute on chronic \nabdominal pain and decompensated cirrhosis. Her course was \ncomplicated by new diagnosis of adrenal insufficiency and \nodynophagia. She was recommended to go to rehab but declined.  \n\nIn the ED, she was febrile to 101.8 but initially \nhemodynamically stable. She later developed worsening mental \nstatus and hypotension despite IV albumin 100g concerning for \nsepsis. Workup was notable for:  \n WBC 11.3, 9% bands  \n Hgb 9.9 -> 8.6  \n Plt 75 -> 50  \n K 5.8  \n 1 of 2 blood cultures with GPCs in pairs and chains  \n Ascitic fluid with 4038 PMNs, 2130 RBCs  \n She was initially given vanc/ceftriaxone, then broadened to \nvanc/cefepime/metronidazole. She received numerous additional \nmeds, notable for:  \n IV albumin 100g  \n lactulose  \n rifaximin  \n IV dilaudid (5mg total)  \n IV morphine (4mg total)  \n hydroxyzine  \n\n \nPast Medical History:\nHCV - genotype 1a decompensated with h/o ascites; liver biopsy \nin ___ showed stage ___ fibrosis \nEtOH cirrhosis (Child's Class B) c/b ascites, esophageal \nvarices, HE\nHypertension\nHyperlipidemia\nCOPD\nAlcohol use disorder\nDepression\nCocaine use disorder\nTobacco use disorder\nCervical spondylosis\nL subclavian stenosis\nPeripheral vascular disease\nGERD s/p lap fundoplication and hiatal hernia repair ___\ns/p cholecystectomy\ns/p R inguinal hernia repair  \n \nSocial History:\n___\nFamily History:\nMother: DM, CAD (COD), and was in a wheelchair for neuropathy.\nFather: ___, rectal CA (COD)\nSister: mental illness \n___: 1 brother neonatal death, 1 brother death at 3 months, \n\n1 brother sudden death in ___.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\n========================\nVS: BP: 115/61 HR: 70 RR: 12 O2 sat: 97% on RA; RASS: -1   \nGENERAL: NAD  \nHEENT: Patient appears uncomfortable, shaking\nNECK: supple, no LAD, no JVD  \nHEART: RRR, no appreciable murmurs\nLUNGS: bibasilar crackles, no accessory muscle use. clear in\nanterior fields. \nABDOMEN: distended abdomen with protuberant umbilical hernia, no\nskins changes surrounding umbilical hernia however painful to\ntouch. Diffusely tender abdomen. Notably a femoral hernia that\nwas painful with reduction.\nEXTREMITIES: no cyanosis, clubbing, or edema, warm extremities \non\nexam. \nPULSES: 2+ DP pulses bilaterally  \nNEURO: A&Ox3, moving all 4 extremities with purpose.  \nSKIN: warm and well perfused, no excoriations or lesions, no\nrashes  \n\nDISCHARGE PHYSICAL EXAM: \n========================\nN/A\n\n \nPertinent Results:\nADMISSION LABS:\n===============\n___ 10:01PM BLOOD WBC-10.1* RBC-3.65* Hgb-9.9* Hct-31.4* \nMCV-86 MCH-27.1 MCHC-31.5* RDW-17.9* RDWSD-56.5* Plt Ct-75*\n___ 10:01PM BLOOD Neuts-92.9* Lymphs-1.8* Monos-4.5* \nEos-0.1* Baso-0.1 Im ___ AbsNeut-9.40* AbsLymp-0.18* \nAbsMono-0.46 AbsEos-0.01* AbsBaso-0.01\n___ 11:13PM BLOOD ___ PTT-29.8 ___\n___ 10:01PM BLOOD Glucose-115* UreaN-20 Creat-0.8 Na-139 \nK-4.1 Cl-106 HCO3-21* AnGap-12\n___ 10:01PM BLOOD ALT-22 AST-33 AlkPhos-161* TotBili-1.5\n___ 10:01PM BLOOD Albumin-3.2* Calcium-8.4 Phos-2.2* Mg-1.9\n___ 10:07PM BLOOD Lactate-2.3*\n\nMICROBIOLOGY:\n=============\n___ 2:00 pm STOOL     CONSISTENCY: FORMED      Source: \nStool. \n                            **FINAL REPORT ___\n   C. difficile PCR (Final ___: \n      NEGATIVE. \n           (Reference Range-Negative). \n      The C. difficile PCR is highly sensitive for toxigenic \nstrains of C.\n      difficile and detects both C. difficile infection (CDI) \nand\n      asymptomatic carriage. \n      A negative C. diff PCR test indicates a low likelihood of \nCDI or\n      carriage. \n__________________________________________________________\n___ 2:00 pm URINE\n   URINE CULTURE (Pending): \n__________________________________________________________\n___ 10:43 am BLOOD CULTURE\n   Blood Culture, Routine (Pending):    No growth to date. \n__________________________________________________________\n___ 2:20 am BLOOD CULTURE\n   Blood Culture, Routine (Preliminary): \n      BETA STREPTOCOCCUS GROUP B. \n         Identification and susceptibility testing performed on \nculture # \n         ___ ___. \n   Aerobic Bottle Gram Stain (Final ___: \n      GRAM POSITIVE COCCI IN PAIRS AND CHAINS. \n   Anaerobic Bottle Gram Stain (Final ___: \n      GRAM POSITIVE COCCI IN PAIRS AND CHAINS. \n__________________________________________________________\n___ 2:20 am URINE\n   URINE CULTURE (Preliminary): \n      ENTEROCOCCUS SP..    >100,000 CFU/mL. \n__________________________________________________________\n___ 11:35 pm PERITONEAL FLUID      PERITONEAL FLUID. \n   GRAM STAIN (Final ___: \n      NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. \n      NO MICROORGANISMS SEEN. \n\n   FLUID CULTURE (Preliminary): \n\n   ANAEROBIC CULTURE (Preliminary): \n__________________________________________________________\n___ 10:01 pm BLOOD CULTURE\n\n   Blood Culture, Routine (Preliminary): \n      BETA STREPTOCOCCUS GROUP B.    PRELIMINARY SENSITIVITY. \n         These preliminary susceptibility results are offered to \nhelp guide\n         treatment; interpret with caution as final \nsusceptibilities may\n         change. Check for final susceptibility results in 24 \nhours. \n\n                              SENSITIVITIES: MIC expressed in \nMCG/ML\n                      \n_________________________________________________________\n                             BETA STREPTOCOCCUS GROUP B\n                             |   \nCLINDAMYCIN-----------       S\nERYTHROMYCIN----------       S\nVANCOMYCIN------------       S\n\n   Anaerobic Bottle Gram Stain (Final ___: \n      GRAM POSITIVE COCCI IN PAIRS AND CHAINS. \n      Reported to and read back by ___ (___) @11:35 \n(___). \n\n   Aerobic Bottle Gram Stain (Final ___: \n      GRAM POSITIVE COCCI IN PAIRS AND CHAINS. \n\nIMAGING:\n========\nCHEST (PA & LAT) (___):\nIll-defined density partially obscuring the right heart border \nmay represent atelectasis, however, a focal consolidation at the \nlocation cannot be excluded. \n\nDUPLEX DOPP ABD/PEL (___)\n1. Cirrhotic liver with splenomegaly and moderate ascites. \n2. No evidence of portal vein thrombosis. \n\nLIVER OR GALLBLADDER US (___)\n1. Cirrhotic liver with splenomegaly and moderate ascites. \n2. No evidence of portal vein thrombosis. \n\nCT ABD & PELVIS W/O CON (___)\n1. Cirrhotic liver with signs of portal hypertension. \n2. Severe ascites, which is increased compared to prior study. \n3. Prominent loops of small bowel measuring up to 3.1 cm most \nlikely represent ileus.  No signs of bowel obstruction.  No \npneumoperitoneum. \n4. Small right lower lobe consolidation, either representing \natelectasis or infection. \n\nCHEST (PORTABLE AP) (___):\nLungs are low volume with slight worsening of interstitial \nedema. \nCardiomediastinal silhouette is stable.  There is bibasilar \natelectasis.  \nTrace left pleural effusions unchanged.  No pneumothorax is seen \n\n\nTTE (___):\nIMPRESSION: Mild symmetric left ventricular hypertrophy with \nnormal cavity size and regional/ global biventricular systolic \nfunction. Heavily calcified mitral annulus with mild functional \nstenosis. At\nleast mild mitral regurgitation. Elevated LVEDP and mild \npulmonary hypertension. Compared with the prior TTE ___, \nthe findings are similar.\n\nPARACENTESIS LABS: \n==================\n___ 10:37AM ASCITES TNC-___* RBC-___* Polys-19* Lymphs-21* \nMonos-7* Eos-1* Mesothe-4* Macroph-48* Other-0\n___ 11:39AM ASCITES TNC-___* RBC-___* Polys-85* Lymphs-5* \nMonos-5* ___ Mesothe-1* Macroph-4*\n___ 11:35PM ASCITES TNC-___* ___-___* Polys-88* Lymphs-4* \nMonos-8*\n___ 10:37AM ASCITES TotPro-1.4 Albumin-0.6\n___ 11:39AM ASCITES TotPro-1.6 Albumin-0.8\n___ 11:35PM ASCITES TotPro-0.7 Glucose-117\n\nDISCHARGE LABS: \n===============\nN/A\n \nBrief Hospital Course:\nASSESSMENT AND PLAN:  \n====================\nMs. ___ is a ___ y/o woman with decompensated HCV/EtOH \ncirrhosis, admitted for spontaneous vs. secondary peritonitis, \nGPC bacteremia, and management for possible adrenal crisis. On \n___ patient noted to have a large bloody stool, management of \nwhich was not within her GOC. The patient was transitioned to \nCMO and passed away surrounded by her friends and family. \n\nACUTE ISSUES:\n=============\n#GI bleed\nPatient noted to have had a large bloody bowel movement on \n___. In discussion with the patient and her HCP, \ninvestigation/treatment of this would require intubation which \nwas not w/in the patient's GOC. With this in mind, in addition \nto her multiple medical issues discussed below and her numerous \nadmissions in the past year, the patient and HCP decided that \ncontinuing aggressive treatment was only prolonging of the \ninevitable and the patient was transitioned to CMO. \n\n#Acute Hypoxemic Respiratory Failure\nOn ___, patient was found struggling to breath. O2 sat was 82% \non 2L and tachypneic in ___. SBP started to rise peaking up to \n220s and HR was in the 140s. She was given lasix 80mg, and \nplaced on non-rebreather mask following which O2 sat increased \nto mid-90s. However, she continued to be tachypneic in ___ with \nSBP>200. Stat CXR and clinical assessment suggested flash \npulmonary edema vs. ARDS ___ to infection which was c/b \ndecompensated cirrhosis. She is DNI/DNR though respiratory code \nwas called and she was placed on BiPAP. She was transferred to \nICU for BiPAP management, nitro drip for HTN management, and \nvolume control. She was transitioned to CMO when transferred \nback to the floor when her family, the patient, and HCP decided \nthat her GOC did not include continued respiratory support. It \nwas felt that she would not recover from her sepsis, GI \nbleeding, and pulmonary edema.\n\n# HYPOTENSION, likely due:  \n# SEPSIS:  \n# ADRENAL INSUFFICIENCY:  \nHypotension likely multifactorial including sepsis given fever, \nbandemia, GPC bacteremia, and peritonitis. CXR on admission with \ninfiltrate concerning for possible HAP. Diagnostic para was \nconsistent with SBP. She was started with \nvanc/cefepime/metronidazole ___ transition). Additionally, \npatient has known adrenal insufficiency and she was started on \nstress dose steroids hydrocortisone 50mg Q8hrs which was \ndiscontinued on transition to CMO.\n\n# GPC BLOODSTREAM INFECTION:  \nPatient with GPCs in cluster and pairs. Regarding sources, there \nwas concern for enterococcal source from GI. Additionally \npatient with risks for MRSA including many recent \nhospitalizations. She was continued on Vancomycin, and ID was \nconsulted. However, she was transferred to ICU before speciation \nwas determined. When transferred back to the floor, ID was \nconsulted and felt that this organism was a contaminant. \n\n#Severe Ascites\n#HCV/EtOH Cirrhosis: \nChild's Class B on admission. Previously decompensated by \nascites (did not tolerate diuretics), esophageal varices, and \nHE. Diagnostic para in ED positive for SBP, though she had had \nmultiple recent paras that were negative for SBP. \n\n# PERITONITIS - SPONTANEOUS vs. SECONDARY:  \nConcomitant GPC bacteremia and significant abdominal pain raised \nsome concern for secondary peritonitis. However, ___ \ncriteria suggested otherwise (ascitic protein<1.0, glucose>50; \nLDH not checked). Studies concerning for SBP however. Given \nabove discussion of other potential sources, she was started on \nCefepime. \n\n# ACUTE ON CHRONIC ANEMIA:  \n# ACUTE ON CHRONIC THROMBOCYTOPENIA:  \n# COAGULOPATHY:  \nNo visible bleeding and patient's hemoglobin baseline is likely \nclose to 7.7. Presented with 9.9 iso poor PO intake which likely \nrepresented some degree of DDx includes marrow suppression and \nworsening liver function in setting of sepsis.\nAnemia was concerning for possible bleeding; though no clear \nevidence on exam but has known esophageal and rectal varices. \n\nCHRONIC ISSUES:\n===============\n# Adrenal Insufficiency: \nDiagnosed during recent hospitalization. She was previously on \nHydrocortisone 10 and 5mg BID. On admission however, given acute \nhypotension and underlying sepsis she was started on stress dose \nsteroids.\n\n# Chronic Abdominal Pain: \nShe was started with home PO Morphine Liquid ___ mg Q2-4H PRN \nspaced to Q6 given respiratory depression and hypotension as \nwell as home tizanidine was held\n\n# Diabetes Mellitus: \nBG 100-200s. She was continued on glargine, NPH, and SSI. \n\n# COPD: Albuterol nebs PRN, Duonebs\n\n# GERD: IV PPI BID\n\n# Depression: Home SSRI\n\n# Polysubstance use disorder: \n-Continue MVI, folate, thiamine \n\n# Vitamin D deficiency: \nContinue repletion during last admission on ___.\n\nTransitional Issues\n=====================\nPatient is deceased, none to report\n\n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Albuterol 0.083% Neb Soln ___ NEB IH Q4H:PRN shortness of \nbreath, wheezing \n2. Aspirin 81 mg PO DAILY \n3. Escitalopram Oxalate 20 mg PO DAILY \n4. Fluticasone Propionate NASAL 1 SPRY NU BID \n5. Fluticasone-Salmeterol Diskus (500/50)  1 INH IH BID \n6. FoLIC Acid 1 mg PO DAILY \n7. Hydrocortisone 10 mg PO DAILY \n8. Hydrocortisone 5 mg PO AFTERNOON \n9. Lactulose 30 mL PO QID \n10. Lidocaine 5% Patch 2 PTCH TD QAM \n11. Morphine Sulfate (Oral Solution) 2 mg/mL 10 mg PO Q2-4H:PRN \nPain - Moderate \n12. Multivitamins W/minerals 1 TAB PO DAILY \n13. Ondansetron ODT 4 mg PO Q8H:PRN nausea \n14. Pantoprazole 40 mg PO Q12H pill esophagitis \n15. Polyethylene Glycol 17 g PO DAILY:PRN constipation \n16. Pregabalin 150 mg PO BID \n17. Rifaximin 550 mg PO BID \n18. Sucralfate 1 gm PO QID \n19. Thiamine 100 mg PO DAILY \n20. Tiotropium Bromide 1 CAP IH DAILY \n21. Tizanidine 2 mg PO DAILY:PRN muscle spasm \n22. Zinc Sulfate 220 mg PO DAILY \n23. Albuterol Inhaler 2 PUFF IH Q4H-Q6H PRN shortness of breath, \nwheezing \n24. HumaLOG KwikPen Insulin (insulin lispro) 200 unit/mL (3 mL) \nsubcutaneous ASDIR \n25. HumuLIN N NPH Insulin KwikPen (insulin NPH isoph U-100 \nhuman) 100 unit/mL (3 mL) SC QHS \n26. insulin glargine 100 unit/mL (3 mL) subcutaneous BREAKFAST \n\n \nDischarge Medications:\nNone, patient deceased \n \nDischarge Disposition:\nExpired\n \nDischarge Diagnosis:\nPRIMARY DIAGNOSES\n==================\nGBS bacteremia\nGBS peritonitis\nEnterococcal UTI \ndecompensated HCV/ETOH cirrhosis\nSECONDARY DIAGNOSIS: \n====================\nacute respiratory failure ___ pulmonary flash edema \nadrenal insufficiency \n\n \nDischarge Condition:\nPatient expired\n\n \nDischarge Instructions:\nN/A, patient expired\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048204fb505ee7538e9f00"
  },
  "note_id": "10504668-DS-7",
  "subject_id": 10504668,
  "hadm_id": 22997950,
  "note_type": "DS",
  "note_seq": 7,
  "charttime": "2131-12-11 00:00:00",
  "storetime": "2132-03-01 18:11:00",
  "text": " \nName:  ___          Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: SURGERY\n \nAllergies: \nsimvastatin\n \nAttending: ___\n \nChief Complaint:\nabdominal pain\n \nMajor Surgical or Invasive Procedure:\nnone\n\n \nHistory of Present Illness:\n \nThis patient is a ___ year old male with a past medical\nhistory of CAD, NIDDM, hypertension, and\nhypercholesterolemia who presents with one week of diffuse\nabdominal pain.\n \nThe patient reports that his abdominal pain is occasionally\nexacerbated by eating. He reports that he is passing flatus\nand has been having normal bowel movements. The patient\nreports that his pain is severe (greater than 10 out of 10)\nand constantly located in the right lower quadrant.\nThe patient ___ any accompanying nausea, vomiting,\ndiarrhea, fevers, chills, shortness of breath, or dysuria.\nPatient's reports chronic lower back pain is unchanged from\nprior and is currently being treated at the ___ this.\n                       Timing: Gradual\n                      Quality: Crampy\n                     Severity: Moderate\n                     Duration: Days\n\n \nPast Medical History:\nCAD, NIDDM, HTN, High Cholesterol\n\n \nSocial History:\n___\nFamily History:\nnc\n \nPhysical Exam:\nPHYSICAL EXAMINATION: upon admission:  ___\n \nTemp: 98.2 HR: 91 BP: 153/79 Resp: 18 O(2)Sat: 99 Normal\n \nConstitutional: Uncomfortable\nHEENT: Normocephalic, atraumatic, Pupils equal, round and\nreactive to light, Extraocular muscles intact\nChest: Clear to auscultation\nCardiovascular: Regular Rate and Rhythm, Normal first and\nsecond heart sounds\nAbdominal: Soft, Nondistended. Focal tenderness to\npalpation in the right lower quadrant with guarding.\nExtr/Back: No cyanosis, clubbing or edema\nSkin: Warm and dry\nNeuro: Speech fluent, neuro intact\nPsych: Normal mood, Normal mentation\n\nPhysical examination upon discharge: ___\n\nVital signs:  t=98.5, hr=78, bp=153/84, oxygen sat=97%, rr=18\n\nGeneral:  NAD\nHEENT:  anicteric\nCV:  ns1, s2, -s3, -s4, no murmurs\nLUNGS:  clear\nABDOMEN: soft, non-tender, hypoactive BS\nEXT:  no calf tenderenss, no pedal edema bil.\nNEURO:  Follows commands, oriented x 3\n\n \n\n \nPertinent Results:\nHematology \n  COMPLETE BLOOD COUNT WBC RBC Hgb Hct MCV MCH MCHC RDW Plt Ct \n___ 05:40    5.2 4.85 13.0* 40.3 83 26.9* 32.3 12.7 173 \n___ 05:40AM BLOOD WBC-5.2 RBC-4.85 Hgb-13.0* Hct-40.3 \nMCV-83 MCH-26.9* MCHC-32.3 RDW-12.7 Plt ___\n___ 09:25AM BLOOD WBC-4.6 RBC-4.77 Hgb-12.9* Hct-40.1 \nMCV-84 MCH-27.0 MCHC-32.1 RDW-12.7 Plt ___\n___ 09:25AM BLOOD Neuts-54.1 ___ Monos-6.4 Eos-1.5 \nBaso-0.7\n___ 05:40AM BLOOD Plt ___\n___ 09:25AM BLOOD Plt ___\n___ 05:40AM BLOOD Glucose-110* UreaN-16 Creat-0.7 Na-137 \nK-4.1 Cl-103 HCO3-28 AnGap-10\n___ 09:25AM BLOOD Glucose-320* UreaN-16 Creat-0.8 Na-139 \nK-4.0 Cl-102 HCO3-27 AnGap-14\n___ 05:40AM BLOOD Calcium-8.9 Phos-3.1 Mg-2.0\n\n___:  cat scan of abdomen and pelvis:\n\nReportIMPRESSION: \nPreliminary Report1. Proximal portion of the appendix is dilated \nto 10-mm and has mild wall \nPreliminary Reportthickening, which can be seen with early \nappendicitis, though this is not \nPreliminary Reportsuggested by the clinical history. No \nperiappendiceal stranding or fluid. No \nPreliminary Reportother evidence for appendicitis. \nPreliminary Report2. 2.2-cm indeterminate left adrenal gland \nnodule. MR may be obtained for \nPreliminary Reportfurther evaluation. \nPreliminary Report3. Small fat-containing right inguinal hernia. \n\nPreliminary Report4. Diffuse hepatic steatosis. \n  \n\n \nBrief Hospital Course:\nThe patient was admitted to the acute care service with \nabdominal pain.  Upon admission, he was made NPO, given \nintravenous fluids, and underwent imaging.  He was found on cat \nscan to have an appendix dilated to 10-mm and mild wall \nthickening.  No ___ stranding or fluid was noted.  \nHe was ordered for serial abdominal examinations.  His white \nblood cell count was closely monitored and he was afebrile.  He \nwas not placed on antibiotcs. \n\nOn HD #2, he was started on a regular diet. His abdominal pain \nwas present only with palpation and that has diminished in \nintensity.  He was ambulating and voiding without difficulty. He \npassed flatus.\nHe was discharged on HD # 3 with instructions to follow-up in \nthe acute care clinic and with his primary care provider.\n \nMedications on Admission:\nAtenolol, Lisinopril, Metformin, ASA, Unknown narcotic for pain \n \nDischarge Medications:\n1. Lisinopril 2.5 mg PO DAILY \n2. Atenolol 50 mg PO DAILY \n3. MetFORMIN (Glucophage) 500 mg PO DAILY \nplease begin after you are tolerating a regular diet \n4. Docusate Sodium 100 mg PO BID \n5. Aspirin 81 mg PO DAILY \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nabdominal pain\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nYou were admitted to the hosptial with abdominal pain.  You \nunderwent a cat scan of the abdomen which showed showed a \ndilated appendix and there was concern for appendicitis.  You \nwere placed on bowel rest and your abdomen was closely assessed. \nYou had a normal white blood blood cell count.  You were placed \non bowel rest and your abdominal pain slowly resolved.  You were \nstarted on a regular diet.  You are preparing for discharge home \nwith the following instructions:\n\nPlease call your doctor or return to the emergency room if you \nhave any of the following:\n\n*  A recurrence of your abdominal pain\n \n\n * You experience new chest pain, pressure, squeezing or \n tightness.\n \n* New or worsening cough or wheezing.\n \n* If you are vomiting and cannot keep in fluids or your \n medications.\n \n* You are getting dehydrated due to continued vomiting, \n diarrhea or other reasons. Signs of dehydration include dry \n mouth, rapid heartbeat or feeling dizzy or faint when standing.\n \n* You see blood or dark/black material when you vomit or have a \n bowel movement.\n \n\n* You have shaking chills, or a fever greater than 101.5 (F) \n degrees or 38(C) degrees.\n \n* Any serious change in your symptoms, or any new symptoms that \n concern you. \n \n* Please resume all regular home medications and take any new \nmeds \n as ordered\n  \n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "69048204fb505ee7538e9f01"
  },
  "note_id": "10504668-DS-8",
  "subject_id": 10504668,
  "hadm_id": 24833533,
  "note_type": "DS",
  "note_seq": 8,
  "charttime": "2132-03-02 00:00:00",
  "storetime": "2132-03-02 19:23:00",
  "text": " \nName:  ___          Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: PSYCHIATRY\n \nAllergies: \nsimvastatin\n \nAttending: ___.\n \nChief Complaint:\n\"I won't last long\"\n\n \nMajor Surgical or Invasive Procedure:\nnone\n \nHistory of Present Illness:\n___ year old ___ speaking man, with no\nprevious psychiatric history but endorsing \"depression off and\non\" is brought in by family for SI with question of plan in the\ncontext of chronic back pain, trouble at work, and potential\nrevocation of his drivers license. The interview was difficult\nbecause the patient was cooperative but did not elaborate on any\nanswers and because the interview was done through the daughter\ninterpreting. The patient explains that he suffers from well\ndocumented chronic back pain and today actually received a\nscheduled triamcinolone injection that did not help his\nsuffering. He says he feels his pain is now worsened by \"stress\"\nand explains that because of 3 car crashes in the last month, \nthe\nRMV is now demanding he take a re-certifying driving test he is\nsure he will fail. He says these accidents are secondary to the\nstress of working 2 jobs and never being able to sleep more than\na few hours each day. He says he works as a ___ at a ___\nand somewhere else and that these jobs are psychically demanding\nespecially in light of his chronic back pain. He says that\nbecause of his pain, and the need to go to many appointments for\nsuch, there is now having trouble at work and his supervisors \nare\nupset at him. His wife says that the patient now comes home \"sad\nand stressed.\" His family says that his sleep has been poor\nrecently, he is eating less than he usually does, is always\nfatigued, seems to have less interests, and is now vaguely\ntalking about suicide. He makes remarks such as he wants to move\nback to ___ because a funeral would be cheaper there or\nthat he knows he won't last more than one month. When I asked \nhim\nif he was suicidal he said yes. When asked if he had a plan he \nat\nfirst nodded but then recanted such and said no. Of note, a\nfamily friend ___ suicide last week via OD. The patient and\nfamily deny any evidence of mania. He and his family also deny\nany access to weapons that the patient might have. \n \nPast Medical History:\nPSYCHIATRIC HISTORY: None reported per family and patient.\n\nPAST MEDICAL HISTORY: HTN and Diabetes and Chronic Back Pain and\nFatty Liver with elevated cholesterol. Spinal surgery for disc\nherniation ___\n\n \nSocial History:\n___\nFamily History:\nFAMILY PSYCHIATRIC HISTORY: Patient reports none\n\n \nPhysical Exam:\nExcerpted from inpatient psychiatry admission note written by \n___, MD dated ___\n\nPhysical Examination:\nVS:  BP: 111/75  HR: 60   temp: 98   resp: 18  O2 sat: 100    \nweight: 177.1 lbs\nGeneral- WDWN, middle age man in NAD, sitting in a chair\nSkin- Tatoo on left arm, else no rashes or lesions noted\nHEENT- NTAC, MMM, oropharynx clear, PEARLL\nLungs- CTAB, regular work of breathing\nCV- RRR, no m/r/g\nAbdomen: +BS, soft to palpate, no masses felt.\nExtremities- WWP, strong peripheral pulses\nNeuro- Cranial Nerves ___ grossly intact. ___ strength\nthroughout. Intact to light touch throughout. Coordination \nintact\non finger to nose testing.\n\nMENTAL STATUS EXAM:\n     APPEARANCE & FACIAL EXPRESSION: Middle age man, sitting   \n     in a chair, appearing sleepy.\n     BEHAVIOR : No abormal behavior noted.\n     ATTITUDE: Cooperative but guarded in that provides \n     minimal responses to questions.\n     SPEECH: Appears regular although at times rather monotone.\n     MOOD: \"Stressed\"\n     AFFECT: Depressed and blunted, congruent\n     THOUGHT FORM: Seems linear\n     THOUGHT CONTENT: Endorses SI with question of plan,no      \n     HI, no AVH.\n     INSIGHT AND JUDGMENT: poor/poor\n     COGNITIVE ASSESSMENT:\n          SENSORIUM: Alert.\n          ORIENTATION: Intact\n          ATTENTION: Days of week backwards ok\n          MEMORY: Unable to assess. Pt got confused.\n          CALCULATIONS: Says 7 quarters in $1.75\n          FUND OF KNOWLEDGE: Fair\n          PROVERB INTERPRETATION: Did not assess due to        \n          cultural background\n          SIMILARITIES/ANALOGIES: Round to apples/oranges\n\n \nPertinent Results:\n___ 10:10PM URINE  HOURS-RANDOM\n___ 10:10PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG \ncocaine-NEG amphetmn-NEG mthdone-NEG\n___ 10:10PM URINE  COLOR-Yellow APPEAR-Clear SP ___\n___ 10:10PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG \nGLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 \nLEUK-NEG\n___ 07:33PM   GLUCOSE-120* UREA N-15 CREAT-0.8 SODIUM-140 \nPOTASSIUM-4.4 CHLORIDE-100 TOTAL CO2-30 ANION GAP-14\n___ 07:33PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG \nbnzodzpn-NEG barbitrt-NEG tricyclic-NEG\n___ 07:33PM   WBC-7.6 RBC-5.17 HGB-14.3 HCT-43.0 MCV-83 \nMCH-27.6 MCHC-33.2 RDW-13.1\n___ 07:33PM   NEUTS-55.5 ___ MONOS-5.2 EOS-0.6 \nBASOS-0.8\n___ 07:33PM   PLT COUNT-214\n___ 06:08PM   GLUCOSE-101* UREA N-15 CREAT-0.8 SODIUM-138 \nPOTASSIUM-4.9 CHLORIDE-101 TOTAL CO2-30 ANION GAP-12\n___ 06:08PM   estGFR-Using this\n___ 06:08PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG \nbnzodzpn-NEG barbitrt-NEG tricyclic-NEG\n___ 06:08PM   WBC-7.5 RBC-5.06 HGB-14.2 HCT-42.3 MCV-84 \nMCH-28.0 MCHC-33.5 RDW-13.1\n___ 06:08PM   NEUTS-57.2 ___ MONOS-5.6 EOS-0.7 \nBASOS-0.3\n___ 06:08PM   PLT COUNT-227\n \nBrief Hospital Course:\nLEGAL: ___\n#HTN: continued home atenolol 50mg po daily, lisinopril 2.5mg po \ndaily, ASA 81mg po daily\n#DM: continued home metformin 500mg po bid, implemented ISS\n#Chronic back pain: continued home gabapentin 300mg po daily, \noxycodone ___ po q6-8h prn pain\n#Fatty Liver: LFTs stable\n\nPSYCH\nPt with no past psychiatric hx admitted to inpatient psychiatry \nfrom ED d/t concern for depression and SI after pt made comment \nto son about 'wanting to move back to ___ because \nfunerals are cheaper there.' Per collateral obtained in ED and \nconfirmed by primary team following admission, patient's \ndaughter, ___, was concerned that pt was suicidal when she \nlearned pt had made this statement as pt has been dealing with \nmultiple life stressors recently.  Of note, pt works two jobs \nand is still having difficulty affording his rent and other \nbills. Jobs are physcially taxing, and pt suffers from chronic \npain. Additionally, pt has been in three automobile accidents \nrecently, and as a result he received a notice in the mail that \nhe must pass a remediation driving test or his licenese will be \nsuspended. Per daughter and pt, the prospect of passing this \ntest was anxiety-provoking given that pt does not speak ___ \nand the test is in ___ and that pt needs to drive to get to \nwork. \n\nFollowing admission to inpatient psychiatric unit, pt adamantly \ndenied ever being suicidal, stating that the comment he made to \nhis son was a joke and that his words were misinterpreted. Pt \nstated that he would never kill himself because of his religion \nand that because he wants to continue living to work, to enjoy \nhis weekends off, and to spend time with his family. Pt denied \nfeeling depressed in face of increased stress, stating that he \nhas to \"just deal with it.\" Did c/o decreased sleep but denied \nanhedonia, denied changes in energy, concentration, appetite. Pt \ndid c/o feeling anxiety intermittently related to increased \nstress, denied being unable to function or feeling impaired \nbecause of this anxiety. Pt received single dose of seroquel \n25mg po on day of admission as a trial for anxiety. Pt stated \nthis medicine helped him calm down and sleep well. \n\nOne day following admission, had a family meeting with pt, wife, \nand daughter, ___. Wife stated that she was never concerned \nabout her husband being suicidal. Daughter stated that her \nconcerns that led to pt's admission were misinterpreted, stating \nthat she wanted pt to talk to someone to \"help him calm down\" \nbut did not intend for him to be admitted to psych unit. Family \nand team in agreement that pt safe for discharge. At time of \ndischarge, pt denied suicidal ideation, expressed future \norientation with plans to enjoy ___ with his family and \nreturn to work next week. Discussed with pt that he is to \nfollowup with PCP. Wrote pt a prescription for seroquel 25mg po \ndaily prn anxiety (#5), discussed side effects including \ndrowsiness/sedation. At time of discharge agreed that anxiety \nwas appropriate for level of stress, not impairing functioning. \nInstructed pt to monitor his feelings of anxiety and depression, \nseek help from PCP or ER if he noticed his anxiety or mood \nworsening and preventing him from engaging in daily activities.\n\nCOLLATERAL:\n-Spoke with PCP, ___ at ___ (___). PCP\nstates that pt has never had any psychiatric issues to his\nknowledge, has never c/o depression or anxiety.\n-family meeting with wife and daughter, ___, as outlined in \npsychiatry section of hospital course.\n\nSOCIAL/MILEU:\n-Pt did not attend groups d/t language barrier\n-Patient and family were involved in family meeting focused on \npsychoeducation and discharge planning.\n\nRISK ASSESSMENT: \n-Chronic risk factors for suicide include male sex and age, \nmaking him at low risk of suicide chronically. Supportive \nfactors include wife and children, future orientation, sobriety, \nbalanced mood. Patient is currently in good behavioral control, \nsober, and future oriented with plans to enjoy Thanksgivin, \nreturn to work next week, and f/u with outpt treatment. Do not \nbelieve pt is at any significant elevated acute risk of suicide \nat this time to warrant inpatient hospitalization.\n\nDISPO:\n-home, f/u with PCP, SW to arrange f/u with outpatient therapist\n\nCONTACTS:\nWife ___ at ___ \nDaughter #1 ___ at ___ \nPCP: Dr. ___ on ___ (___)\n \nMedications on Admission:\nATENOLOL - atenolol 50 mg tablet. 1 Tablet(s) by mouth daily\nGABAPENTIN - gabapentin 300 mg capsule. 1 capsule(s) by mouth\nthree times a day Week 1: 1 tablet qhs Week 2: 1 tablet bid Week\n3: 1 tablet tid\nLISINOPRIL - lisinopril 2.5 mg tablet. 1 Tablet(s) by mouth \ndaily\nMETFORMIN - metformin 500 mg tablet. 1 tablet(s) by mouth twice \na\nday with meals\nOXYCODONE - oxycodone 5 mg tablet. 1- 2 Tablet(s) by mouth every\n6 to 8 hours as needed as needed for for pain\nASPIRIN - aspirin 81 mg tablet,delayed release. 1 Tablet(s) by\nmouth daily\nBLOOD SUGAR DIAGNOSTIC [FREESTYLE LITE STRIPS] - FreeStyle Lite\nStrips. Use to test blood sugar once a day\nDOCUSATE SODIUM [COLACE] - Colace 100 mg capsule. 1 Capsule(s) \nby\nmouth twice a day\nLANCETS [FREESTYLE LANCETS] - FreeStyle Lancets. Use when \ntesting\nblood sugar once a day \n \nDischarge Medications:\n1. Aspirin 81 mg PO DAILY \n2. Atenolol 50 mg PO DAILY \n3. Gabapentin 300 mg PO TID \nweek 1: 300mg po qhs\nWeek 2: 300mg po bid\nWeek 3: 300mg po tid \n4. Lisinopril 2.5 mg PO DAILY \n5. MetFORMIN (Glucophage) 500 mg PO BIDWM \n6. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain \nTake ___ tabs q6-8hours prn pain \n7. Quetiapine Fumarate 25 mg PO ONCE Duration: 1 Doses \nRX *quetiapine 25 mg 1 tablet(s) by mouth once a day Disp #*5 \nTablet Refills:*0\n8. Docusate Sodium 100 mg PO BID \n\n \nDischarge Disposition:\nHome\n \nDischarge Diagnosis:\nAXIS I: R/o Anxiety disorder \nAXIS I: Deferred\nAXIS III: HTN, DM, Chronic back pain, Fatty liver\nAXIS IV: financial, three recent car accidents, chronic back\npain, working two jobs\nAXIS V: GAF 50\n\n \nDischarge Condition:\nStable\nAmbulatory\nMSE:\nVITALS: T98.0, 116/71, 58, 18, 98%RA\nAppearance: ___ ___, appears stated age, moustache, wearing\nhospital gown\nBehavior: aggravated attitude, eye contact directed to \ninterpreter,\nno abnormal movements\nSpeech: normal rate, normal-loud volume, irritated tone\nMood: 'depressed being in hospital, otherwise good'\nAffect: full range, appropriate. irritated by hospitalization \nbut mostly calm and cooperative\nTP: linear, goal oriented\nTC: denies AH,VH, denies SI, denies plan for suicide. \nJ/I: Good\n\n \nDischarge Instructions:\nDuring your admission at ___, you were not diagnosed with a \nmental illness. Please follow up with all outpatient \nappointments as listed.\nPlease continue all medications as directed.\nPlease avoid abusing alcohol and any drugs--whether prescription \ndrugs or illegal drugs--as this can further worsen your medical \nand psychiatric illnesses.\nPlease contact your outpatient psychiatrist or other providers \nif you have any concerns.\nPlease call ___ or go to your nearest emergency room if you feel \nunsafe in any way and are unable to immediately reach your \nhealth care providers.\nIt was a pleasure to have worked with you and we wish you the \nbest of health.\nIf you need to talk to a ___ Staff Member regarding issues of \nyour hospitalization, please call ___\n \nFollowup Instructions:\n___\n"
},
{
  "_id": {
    "$oid": "6904822dfb505ee75391b246"
  },
  "note_id": "16565675-DS-21",
  "subject_id": 16565675,
  "hadm_id": 20600319,
  "note_type": "DS",
  "note_seq": 21,
  "charttime": "2139-04-05 00:00:00",
  "storetime": "2139-04-05 17:13:00",
  "text": " \nName:  ___                    Unit No:   ___\n \nAdmission Date:  ___              Discharge Date:   ___\n \nDate of Birth:  ___             Sex:   M\n \nService: MEDICINE\n \nAllergies: \nNo Known Allergies / Adverse Drug Reactions\n \nAttending: ___.\n \nChief Complaint:\nHemoptysis\n \nMajor Surgical or Invasive Procedure:\n___ placement\n\n \nHistory of Present Illness:\n___ year old man with a history of IVDA, prior endocarditis \ncomplicated by septic emboli to lungs who presented for \nevaluation of recurrent PE and empyema. Patient was diagnosed \nwith endocarditis this past ___, report recent hospital \nadmission for pulmonary embolism in ___ now on warfarin for \nanticoagulation. Patient states the past 2 weeks he has felt \nincreasingly fatigued and tired, and began having hemoptysis \nyesterday. Presented to ___, where a repeat CT chest shows new \nversus persistent right lower lobe thromboembolism complicated \nby likely lobe necrosis and empyema. His INR was also noted to \nbe 13.7 so he was given 2U FFP and 10mg vit K prior to transfer. \n\n\nIn the ED, he reported chest pain several cups worth of \nhemoptysis today. Over the last 2 weeks he reported feeling \nincreasingly fatigued, tired, and progressively worsening right \nsided chest pain. ECG showed sinus tachycardia. 3 sets of blood \ncultures were drawn. \nHis labs were notable for a WBC 12.8 and INR 5.1. \n\nOn arrival to the MICU, the patient appears comfortable without \nactive hemoptysis. He states that his symptoms began about ___ \nweeks soon after stopping his methadone. He reports \nprogressively worsening right sided chest pain worse with deep \nbreath, night sweats, fevers, chills, cough, foul smelling and \ntasting sputum, weakness, fatigue, decreased appetite, and \nweight loss.\n \nPast Medical History:\n___: septic emboli from tricuspid endocarditis  \n___: admitted to ___ with PE vs septic emboli \nPneumonia  \nHepatitis C \nAsthma\nMSSA UTI ___\n\n \nSocial History:\n___\nFamily History:\nGrandmother died of COPD. Father died of brain aneurysm with hx \nalcoholism, CAD, and COPD.\n \nPhysical Exam:\nADMISSION PHYSICAL EXAM:\nPhysical Exam:  \nVitals: T: 100.0 BP: 123/79 P: 117 R: 26 O2: 96% ra  \nGeneral: comfortable\nHEENT: no scleral icterus, EMOI, PERRLA\nCV: tachy, S1S2, no m/r/g\nLungs: significantly decreased lung sounds on the right \nAbdomen: soft, nontender, nondistended\nExt: no ___ edema, no splinter hemorrhages \nNeuro: CN II-XII grossly in tact, moving all extremities \n\nDISCHARGE PHYSICAL EXAM:\nGeneral: awake, alert, NAD\nCV: RRR, no m/r/g  \nLungs: significantly decreased lung sounds on the right, \notherwise reasonably CTA  \nAbdomen: +BS, soft, NT/ND\nExt: WWP, no edema \n\n \nPertinent Results:\nADMISSION LABS:\n___ 12:06AM BLOOD WBC-12.8* RBC-3.85* Hgb-9.9* Hct-31.3* \nMCV-81* MCH-25.6* MCHC-31.6 RDW-15.0 Plt ___\n___ 12:06AM BLOOD Neuts-65.8 ___ Monos-5.0 Eos-1.8 \nBaso-0.5\n___ 12:06AM BLOOD ___ PTT-51.5* ___\n___ 12:06AM BLOOD Glucose-106* UreaN-7 Creat-0.6 Na-140 \nK-3.6 Cl-101 HCO3-26 AnGap-17\n___ 05:43AM BLOOD ALT-25 AST-11 AlkPhos-52 TotBili-0.3\n___ 05:43AM BLOOD Albumin-3.4* Calcium-8.8 Phos-4.7* Mg-1.8\n___ 12:06AM BLOOD Iron-18*\n___ 12:06AM BLOOD calTIBC-200* Ferritn-490* TRF-154*\n___ 12:06AM BLOOD Lactate-1.0\n\nSEROLOGIES:\n___ 08:50AM BLOOD HBsAg-NEGATIVE HBsAb-BORDERLINE \nHBcAb-NEGATIVE\n___ 07:00AM BLOOD HIV Ab-NEGATIVE\n\nDISCHARGE LABS: \n___ 05:31AM BLOOD WBC-12.0* RBC-3.35* Hgb-8.6* Hct-27.4* \nMCV-82 MCH-25.5* MCHC-31.3 RDW-17.0* Plt ___\n___ 05:31AM BLOOD ___ PTT-31.4 ___\n___ 04:38AM BLOOD Glucose-96 UreaN-16 Creat-2.4* Na-144 \nK-4.2 Cl-106 HCO3-28 AnGap-14\n___ 05:31AM BLOOD Calcium-9.0 Phos-4.3 Mg-2.1\n___ 05:50AM BLOOD ALT-11 AST-11 AlkPhos-54 TotBili-0.3\n___ 04:38AM BLOOD Vanco-22.1*\n\nMICROBIOLOGY:\nBlood cultures x4 - No growth, FINAL\nBlood cultures x4 - PENDING, no growth to date\n\nIMAGING: \n___ Cardiac Echo(TTE): The left atrium and right atrium are \nnormal in cavity size. Left ventricular wall thickness, cavity \nsize, and global systolic function are normal (LVEF>55%). \nTransmitral and tissue Doppler imaging suggests normal diastolic \nfunction, and a normal left ventricular filling pressure \n(PCWP<12mmHg). There is no left ventricular outflow obstruction \nat rest or with Valsalva. Right ventricular chamber size and \nfree wall motion are normal. The diameters of aorta at the \nsinus, ascending and arch levels are normal. The aortic valve \nleaflets (3) appear structurally normal with good leaflet \nexcursion and no aortic stenosis or aortic regurgitation. No \nmasses or vegetations are seen on the aortic valve. The mitral \nvalve leaflets are mildly thickened. No masses or vegetations \nare seen on the mitral valve, but cannot be fully excluded due \nto suboptimal image quality. Physiologic mitral regurgitation is \nseen (within normal limits). The tricuspid valve leaflets are \nmildly thickened. There is a probable vegetation on the \ntricuspid valve. There is no pericardial effusion. \nIMPRESSION: Normal regional and global biventricular systolic \nfunction. There is a small echodensity seen on the tricuspid \nvalve - see images 52-56. This could represent a vegetation or \nthickened valve/chord. A TEE could be done to help clarify. No \nabscess seen. No significant valvular regurgitation seen. \n\n___ CTA Chest: IMPRESSION: 1.  Calcification within the right \nposterior basal segmental pulmonary artery with occlusion of the \nartery distally - these features are suggestive of chronic \npulmonary embolism.  No acute PE is identified.  2.  Necrotizing \npneumonia involving the right lower lobe with surrounding \nabscess formation.  The appearances are similar to the previous \nCT.   3.  Multiple nodular opacities within the right middle, \ninferior segment of the left upper and the basal segments of \nleft lower lobes.  In conjunction with the clinical history, \nthese features are suggestive of septic emboli.  4.  Mediastinal \nand right hilar adenopathy which is likely reactive.   \n\n___ Cardiac Echo (TEE): No spontaneous echo contrast or \nthrombus is seen in the body of the left atrium/left atrial \nappendage or the body of the right atrium/right atrial \nappendage. No atrial septal defect or patent foramen ovale is \nseen by 2D, color Doppler or saline contrast with maneuvers. \nLeft ventricular systolic function is hyperdynamic (EF>75%). \nRight ventricular chamber size and free wall motion are normal. \nThe ascending, transverse and descending thoracic aorta are \nnormal in diameter and free of atherosclerotic plaque to 34 cm \nfrom the incisors. The aortic valve leaflets (3) appear \nstructurally normal with good leaflet excursion. There are three \naortic valve leaflets. No masses or vegetations are seen on the \naortic valve. There are filamentous strands on the aortic \nleaflets consistent with Lambl's excresences (normal variant). \nNo aortic valve abscess is seen. No aortic regurgitation is \nseen. The mitral valve leaflets are structurally normal. No mass \nor vegetation is seen on the mitral valve. No mitral \nregurgitation is seen. The tricuspid valve leaflets are mildly \nthickened. There is no pericardial effusion. \nIMPRESSION: No 2D echocardiographic evidence of endocarditis. No \nsignificant valvular regurgitation.\n\n___ Renal U/S: IMPRESSION:  Echogenic kidneys consistent with \nmedical renal disease.  No vascular abnormality seen. \n\n \nBrief Hospital Course:\n___ year old male with PMH presumed MSSA tricuspid valve \nendocarditis and PE presenting with right lung abscess and \npossible necrosis.\n\nActive issues: \n___: Patient noted to have elevation of his Cr to 2.6 on ___ \nwhich peaked at 2.8 on ___. Baseline Cr is 0.6-0.7. This is of \nunclear etiology. Patient had no episodes of hypotension, urine \nmicroscopy was unremarkable (few granular casts, no other \nfindings) and renal U/S was unrevealing (no evidence for \nthrombus/emboli).  Pt was clinically euvolemic and no \nimprovement with IVF. Possibly related to contrast though timing \nnot perfect. At time of discharge, Cr was downtrending to 2.4.\n\n# Lung abscess: History of recent PE on coumadin with symptoms \nand imaging consistent with likely lung abscess. He had a CT \nscan that showed a right lung abscess with air fluid level. He \nwas placed on vanco and zosyn and ID was consulted. They \nrecommended ___ weeks of IV antibiotics. CT surgery was also \nconsulted who ultimately felt that surgery was not appropriate \nin the acute setting. It appears that the abscess is draining \nthrough his airway at this time. Thoracics will see the patient \nas an outpt to evaluate for possible surgical options after \n___ of antibiotics. Patient should obtain repeat CT Chest \nscan prior to stopping antibiotics. In the setting of his ___ \n(see above), pt's Zosyn dose was reduced to 2.25g q8 hrs from \n4.5g q8hrs and his Vancomycin was reduced to 1000mg q48 hours \nfrom 1250mg IVq8hrs. As his kidney function improves, his \nantibiotic dosing will need adjustments. \n\n# Hemoptysis: Likely ___ PE and lung abscess complicated by \nsupratherapeutic INR which was improving by time of admission to \nthe MICU with FFP and vitamin K. He never had any evidence of \nactive bleeding and was felt to be stable for the floor.\n\n# Septic pulmonary emboli: Right-sided PEs noted on imaging and \npatient being treated with coumadin on admission. Patient taking \nKeflex since the diagnosis of PE was made. The OSH felt the PE \ncould be septic emboli so he was being treated with Keflex \nprophylactically. Given the above hemoptysis his anticoagulation \nwas held during his MICU course. In further review of OSH \nrecords (including LENIs which showed no DVTs) and conversation \nwith ID and ICU team, it was felt that these all represent \nseptic emboli and not thrombotic disease. As a result, pt was \nkept off anticoagulation and discharged without warfarin or \nalternative blood thinner.  \n\n# Endocarditis: Recent history of TV endocarditis that was \ntreated with 6 weeks of IV nafcillin. Patient did not have any \nsigns on admission, but blood cultures were drawn and came back \nnegative. He had a cardiac echo that showed possibly a small \nvegetation on his TV; however, TEE revealed no vegetations and \nhe was felt to have cleared any evidence of active endocarditis. \n\n\nChronic issues: \n# Anemia: Unclear if chronic or acute. Given the illness over \nthe last several months, likely chronic related to inflammation. \nHowever, given the hemoptysis could also be related to blood \nloss.  Iron studies were checked and were not abnormal. Over the \ncourse of his hospitalization his blood counts remained stable. \nHe was started back on his home iron supplement on discharge.\n\n# IVDA: Complicated social situation with long hx of drug abuse \nand recent withdrawal from stopping methadone. Patient's mother \ninvolved and concerned about addiction problems.  He was seen by \nsocial work, but the patient declined to speak with them. \nAttempts were made to limit narcotics and benzos after his \nmother reported that she felt that he was abusing them more than \nhe should on prior admissions. He was continued on his home \noxycodone and xanax with good effect. He did not ask for \nadditional medications during the course of his hospitalization. \n\n\n# Depression: He was continued on his home citalopram, \nalprazolam and mirtazapine.\n\nTransitional Issues:\n# Emergency contact: Patient, Mother ___ ___ \n \n# Code: Full  \n# Patient would benefit from Hepatitis B booster vaccination as \nHep B surface antibody was low (only borderline positive). \n# Patient will need to complete ___ weeks of IV antibiotics. \nExact course to be determined by infectious disease.\n# Needs at least weekly lab draw while on antibiotics: Vanco \ntrough, CBC, BUN/Cr, LFTs\n# Continued social support regarding sobriety \n# Should NOT be discharged to home with a PICC line in place\n# Patient should have repeat CT Chest in ___ weeks prior to \ndiscontinuing antibiotics\n# Will follow-up with thoracic surgery as may need surgical \nintervention to fully eradicate infection\n# Will need close monitoring of kidney function and Vanco \ntroughs in the next week to appropriately adjust his antibiotics \nand ensure appropriate coverage given the serious nature of the \ninfection and his rapidly changed kidney function. \n \nMedications on Admission:\nThe Preadmission Medication list is accurate and complete.\n1. Cephalexin 500 mg PO Q8H \n2. Citalopram 30 mg PO DAILY \n3. Warfarin 2.5 mg PO DAILY16 \n4. Ferrous Sulfate 325 mg PO DAILY \n5. Mirtazapine 15 mg PO DAILY \n6. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain \n7. ALPRAZolam 0.5 mg PO TID:PRN anxiety \n\n \nDischarge Medications:\n1. ALPRAZolam 0.5 mg PO TID:PRN anxiety \n2. Citalopram 30 mg PO DAILY \n3. Mirtazapine 15 mg PO DAILY \n4. OxycoDONE (Immediate Release)  5 mg PO Q6H:PRN pain \n5. Ferrous Sulfate 325 mg PO DAILY \n6. Acetaminophen 1000 mg PO Q6H:PRN Pain, fevers \n7. Benzonatate 100 mg PO TID \n8. Guaifenesin-Dextromethorphan ___ mL PO Q6H:PRN cough \n9. Heparin Flush (10 units/ml) 2 mL IV PRN line flush \n10. Nicotine Patch 21 mg TD DAILY \n11. Outpatient Lab Work\nPlease draw Vanco trough, CBC, BUN/Cr, LFTs daily for the next \nweek. If kidney function improves and Vanco troughs are stable, \ncan go to weekly. \n\n12. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN sob/congestion \n13. Docusate Sodium 100 mg PO BID \n14. Piperacillin-Tazobactam 2.25 g IV Q8H \n15. QUEtiapine Fumarate 50-100 mg PO QHS:PRN insomnia \n16. Vancomycin 1000 mg IV Q48H \n17. Zolpidem Tartrate ___ mg PO HS:PRN insomnia \n\n \nDischarge Disposition:\nExtended Care\n \nFacility:\n___\n \nDischarge Diagnosis:\nLung abscess\n\n \nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\n \nDischarge Instructions:\nIt was a pleasure taking care of you at ___. You were admitted \nbecause you were coughing up blood. A CT scan of your chest \nrevealed a large abscess (fluid collection) that is due to \nbacteria traveling from your heart valve infection to your \nlungs. We started you on strong, broad antibiotics and you were \nseen by the pulmonology team (the lung doctors), the infectious \ndisease doctors and the thoracic surgeons. Your symptoms \nimproved with the IV antibiotics but you continue to have cough \nand pain with deep breaths. We also performed ultrasounds of \nyour heart (TTE and TEE) which revealed that the infection on \nyour heart valve has resolved. You will need ___ weeks of \nantibiotics for this serious infection. A repeat CT scan of your \nchest will be arranged prior to the end of your antibiotic \ncourse.\n\nWe also tested you for Hepatitis B during this admission. It \nshowed that you have been immunized (vaccinated) against \nHepatitis B. However, the strength of your immunity is low. You \nwould benefit from booster vaccination as an outpatient. Please \ndiscuss this with your primary care provider. \n\nFinally, there a decrease in your kidney function. We monitored \nyour kidney function and it was improving at time of discharge. \nYour doctors at your ___ facility will continue to monitor your \nkidney function and the level of antibiotics (the vancomycin) in \nthe blood to ensure you are properly treated. \n \nFollowup Instructions:\n___\n"
}]